PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Castoria, G; Giovannelli, P; Lombardi, M; De Rosa, C; Giraldi, T; de Falco, A; Barone, MV; Abbondanza, C; Migliaccio, A; Auricchio, F				Castoria, G.; Giovannelli, P.; Lombardi, M.; De Rosa, C.; Giraldi, T.; de Falco, A.; Barone, M. V.; Abbondanza, C.; Migliaccio, A.; Auricchio, F.			Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells	ONCOGENE			English	Article						estradiol receptor; tyrosine phosphorylation; Src; nuclear export; cell cycle; breast cancer	HUMAN ESTROGEN-RECEPTOR; FORKHEAD TRANSCRIPTION FACTORS; DNA-SYNTHESIS; PROGESTERONE-RECEPTOR; PROTEIN-KINASE; MCF-7 CELLS; IN-VITRO; ACTIVATION; ALPHA; BINDING	We report that in breast cancer cells, tyrosine phosphorylation of the estradiol receptor alpha (ERalpha) by Src regulates cytoplasmic localization of the receptor and DNA synthesis. Inhibition of Src or use of a peptide mimicking the ERalpha p-Tyr537 sequence abolishes ERalpha tyrosine phosphorylation and traps the receptor in nuclei of estradiol-treated MCF-7 cells. An ERalpha mutant carrying a mutation of Tyr537 to phenylalanine (ER537F) persistently localizes in nuclei of various cell types. In contrast with ERalpha wt, ER537F does not associate with Ran and its interaction with Crm1 is insensitive to estradiol. Thus, independently of estradiol, ER537F is retained in nuclei, where it entangles FKHR-driving cell cycle arrest. Chromatin immunoprecipitation analysis reveals that overexpression of ER537F in breast cancer cells enhances FKHR interaction with cyclin D1 promoter. This mutant also counteracts cell transformation by the activated forms of Src or PI3-K. In conclusion, in addition to regulating receptor localization, ERalpha phosphorylation by Src is required for hormone responsiveness of DNA synthesis in breast cancer cells.	[Castoria, G.; Giovannelli, P.; Lombardi, M.; De Rosa, C.; Giraldi, T.; de Falco, A.; Abbondanza, C.; Migliaccio, A.; Auricchio, F.] Univ Naples 2, Dept Gen Pathol, I-80138 Naples, Italy; [Barone, M. V.] ELFID, Naples, Italy	Universita della Campania Vanvitelli	Migliaccio, A (corresponding author), Univ Naples 2, Dept Gen Pathol, Via L De Crecchio 7, I-80138 Naples, Italy.	antimo.migliaccio@unina2.it	Castoria, Gabriella/I-3349-2019; Migliaccio, Antimo/AAB-3376-2019; Giovannelli, Pia/J-7931-2019	Castoria, Gabriella/0000-0002-0576-4494; BARONE, Maria Vittoria/0000-0001-6190-4917; Giovannelli, Pia/0000-0002-2488-917X; Migliaccio, Antimo/0000-0002-4197-2055; ABBONDANZA, Ciro/0000-0001-5346-4835	Italian Association for Cancer Research (A.I.R.C.) [IG 5389]; A.I.R.C.	Italian Association for Cancer Research (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); A.I.R.C.(Fondazione AIRC per la ricerca sul cancro)	This work was funded by the Italian Association for Cancer Research (A.I.R.C.; Grant No. IG 5389). PG is supported by a fellowship from A.I.R.C.	Abbondanza C, 2012, J CELL PHYSIOL, V227, P964, DOI 10.1002/jcp.22803; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arnold SF, 1997, BIOCHEM BIOPH RES CO, V235, P336, DOI 10.1006/bbrc.1997.6779; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; ARNOLD SF, 1995, J BIOL CHEM, V270, P30205; AURICCHIO F, 1981, BIOCHEM J, V198, P699, DOI 10.1042/bj1980699; AURICCHIO F, 1995, CELL GROWTH DIFFER, V6, P105; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Blake Richard A., 2000, AMERICA, V181, P20; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; CASTORIA G, 1993, BIOCHEMISTRY-US, V32, P1740, DOI 10.1021/bi00058a007; Castoria G, 1996, INT J CANCER, V65, P574, DOI 10.1002/(SICI)1097-0215(19960301)65:5<574::AID-IJC4>3.0.CO;2-#; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Erenburg I, 1997, MOL ENDOCRINOL, V11, P2004, DOI 10.1210/me.11.13.2004; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; He X, 2010, ONCOGENE, V29, P2238, DOI 10.1038/onc.2009.513; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lazennec G, 1997, MOL ENDOCRINOL, V11, P1375, DOI 10.1210/me.11.9.1375; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MIGLIACCIO A, 1989, MOL ENDOCRINOL, V3, P1061, DOI 10.1210/mend-3-7-1061; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MIGLIACCIO A, 1992, INT J CANCER, V51, P733, DOI 10.1002/ijc.2910510512; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Morelli C, 2010, MOL CELL BIOL, V30, P857, DOI 10.1128/MCB.00824-09; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427	55	51	54	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	46					4868	4877		10.1038/onc.2011.642	http://dx.doi.org/10.1038/onc.2011.642			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22266855				2022-12-25	WOS:000311210700007
J	Guerini, FR; Cagliani, R; Forni, D; Agliardi, C; Caputo, D; Cassinotti, A; Galimberti, D; Fenoglio, C; Biasin, M; Asselta, R; Scarpini, E; Comi, GP; Bresolin, N; Clerici, M; Sironi, M				Guerini, Franca Rosa; Cagliani, Rachele; Forni, Diego; Agliardi, Cristina; Caputo, Domenico; Cassinotti, Andrea; Galimberti, Daniela; Fenoglio, Chiara; Biasin, Mara; Asselta, Rosanna; Scarpini, Elio; Comi, Giacomo P.; Bresolin, Nereo; Clerici, Mario; Sironi, Manuela			A Functional Variant in ERAP1 Predisposes to Multiple Sclerosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; AUTOIMMUNE-DISEASES; HLA-B; METAANALYSIS; POPULATION; RISK	The ERAP1 gene encodes an aminopeptidase involved in antigen processing. A functional polymorphism in the gene (rs30187, Arg528Lys) associates with susceptibility to ankylosying spondylitis (AS), whereas a SNP in the interacting ERAP2 gene increases susceptibility to another inflammatory autoimmune disorder, Crohn's disease (CD). We analysed rs30187 in 572 Italian patients with CD and in 517 subjects suffering from multiple sclerosis (MS); for each cohort, an independent sex- and age-matched control group was genotyped. The frequency of the 528Arg allele was significantly higher in both disease cohorts compared to the respective control population (for CD, OR = 1.20 95% CI: 1.01-1.43, p = 0.036; for RRMS, OR = 1.26; 95% CI: 1.04-1.51, p = 0.01). Meta-analysis with the Wellcome Trust Cases Control Consortium GWAS data confirmed the association with MS (p(meta) = 0.005), but not with CD. In AS, the rs30187 variant has a predisposing effect only in an HLA-B27 allelic background. It remains to be evaluated whether interaction between ERAP1 and distinct HLA class I alleles also affects the predisposition to MS, and explains the failure to provide definitive evidence for a role of rs30187 in CD. Results herein support the emerging concept that a subset of master-regulatory genes underlay the pathogenesis of autoimmunity.	[Guerini, Franca Rosa; Agliardi, Cristina; Caputo, Domenico; Clerici, Mario] Don C Gnocchi Fdn ONLUS, Milan, Italy; [Cagliani, Rachele; Forni, Diego; Bresolin, Nereo; Sironi, Manuela] Sci Inst IRCCS E Medea, Bioinformat Lab, Bosisio Parini, Italy; [Cassinotti, Andrea] Luigi Sacco Univ Hosp, Chair Gastroenterol, Dept Clin Sci, Milan, Italy; [Galimberti, Daniela; Fenoglio, Chiara; Scarpini, Elio; Comi, Giacomo P.; Bresolin, Nereo] Univ Milan, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Dept Neurol Sci, Dino Ferrari Ctr, Milan, Italy; [Biasin, Mara] Univ Milan, DISP LITA Vialba, Milan, Italy; [Asselta, Rosanna] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol LITA Segrate, Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Eugenio Medea; University of Milan; Luigi Sacco Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of Milan; University of Milan	Guerini, FR (corresponding author), Don C Gnocchi Fdn ONLUS, Milan, Italy.		Comi, Giacomo P/K-5702-2016; Cagliani, Rachele/K-4545-2016; Cassinotti, Andrea/AGZ-2661-2022; biasin, mara/G-7426-2012; Agliardi, Cristina/K-1401-2016; Asselta, Rosanna/AAC-2367-2019; Sironi, manuela/K-5633-2016; Galimberti, Daniela/N-7209-2019; Forni, Diego/K-5643-2016; Guerini, Franca R./G-8055-2012; Scarpini, Elio/K-6547-2016	Comi, Giacomo P/0000-0002-1383-5248; Cagliani, Rachele/0000-0003-2670-3532; biasin, mara/0000-0003-3671-4235; Agliardi, Cristina/0000-0003-2022-3386; Asselta, Rosanna/0000-0001-5351-0619; Sironi, manuela/0000-0002-2267-5266; Galimberti, Daniela/0000-0002-9284-5953; Forni, Diego/0000-0001-9291-5352; Guerini, Franca R./0000-0001-9461-5927; Bresolin, Nereo/0000-0001-6694-3595; Scarpini, Elio/0000-0002-6395-2119; Clerici, Mario/0000-0001-5920-6191	Broad Foundation [IBD-0294]; Ricerca Corrente [Italian Ministry of Health]; Fondazione CARIPLO	Broad Foundation; Ricerca Corrente [Italian Ministry of Health](Ministry of Health, Italy); Fondazione CARIPLO(Fondazione Cariplo)	This work was supported by the Broad Medical Research Program of The Broad Foundation (grant IBD-0294), by 2010 Ricerca Corrente [Italian Ministry of Health], and Fondazione CARIPLO. The funding sources had no involvement in study design, collection, analysis and interpretation of data, in the writing of the report as well as in the decision to submit the paper for publication. No additional external funding received for this study.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; Bolognesi E, 2003, TISSUE ANTIGENS, V61, P308, DOI 10.1034/j.1399-0039.2003.00028.x; Cagliani R, 2010, HUM MOL GENET, V19, P4705, DOI 10.1093/hmg/ddq401; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; de Vlam K, 2000, J RHEUMATOL, V27, P2860; Eike MC, 2009, GENES IMMUN, V10, P56, DOI 10.1038/gene.2008.74; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Langer-Gould A, 2010, MULT SCLER J, V16, P855, DOI 10.1177/1352458510369146; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MIELANTS H, 1995, J RHEUMATOL, V22, P2266; Nielsen NM, 2008, MULT SCLER J, V14, P823, DOI 10.1177/1352458508088936; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Weng X, 2007, AM J GASTROENTEROL, V102, P1429, DOI 10.1111/j.1572-0241.2007.01215.x; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003	31	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29931	10.1371/journal.pone.0029931	http://dx.doi.org/10.1371/journal.pone.0029931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253828	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100030
J	Arvand, M; Moser, V; Schwehn, C; Bettge-Weller, G; Hensgens, MP; Kuijper, EJ				Arvand, Mardjan; Moser, Vera; Schwehn, Christine; Bettge-Weller, Gudrun; Hensgens, Marjolein P.; Kuijper, Ed J.			High Prevalence of Clostridium difficile Colonization among Nursing Home Residents in Hesse, Germany	PLOS ONE			English	Article							TERM-CARE FACILITY; RISK-FACTORS; INFECTION; EPIDEMIOLOGY; RESISTANCE; DISEASE	Clostridium difficile is the most common cause of antibiotic-associated diarrhoea in hospitals and other healthcare facilities. The elderly are particularly susceptible and at increased risk for adverse outcome as a result of C. difficile infection. The aim of this study was to determine the prevalence of C. difficile colonization among residents of nursing homes in Hesse and to compare it with the prevalence in the general population living outside long-term care facilities (LTCF). We assessed possible risk factors for C. difficile colonization and determined the genotype of circulating strains. C. difficile was isolated from 11/240 (4.6%) nursing home residents and 2/249 (0.8%) individuals living outside LTCF (p = 0.02). Ten of 11 (90.9%) isolates from nursing homes and one of two isolates from the population outside LTCF were toxigenic. The prevalence of C. difficile colonization varied from 0% to 10% between different nursing homes. Facilities with known actual or recent CDI cases were more likely to have colonized residents than facilities without known CDI cases. C. difficile PCR-ribotypes 014 and 001 were the most prevalent genotypes and accounted for 30% and 20% of toxigenic isolates in nursing homes, respectively. Interestingly, no individuals carried the epidemic strain PCR-ribotype 027. Our results suggest that residents of nursing homes in Germany are at high risk for colonization by virulent C. difficile strains. The high prevalence of C. difficile colonization in nursing homes underscores the importance of good adherence to standard infection control precautions even in the absence of a diagnosed infection. They also emphasize the need for specific programs to increase the awareness of healthcare professionals in LTCF for CDI.	[Arvand, Mardjan; Moser, Vera; Schwehn, Christine; Bettge-Weller, Gudrun] Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany; [Hensgens, Marjolein P.; Kuijper, Ed J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Arvand, M (corresponding author), Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany.	mardjan.arvand@hlpug.hessen.de	Kuijper, ed/AAB-7853-2022	Kuijper, ed/0000-0001-5726-2405	German Ministry of Health (regional networks for prevention and control of antimicrobial resistance)	German Ministry of Health (regional networks for prevention and control of antimicrobial resistance)	This project was funded by the German Ministry of Health (regional networks for prevention and control of antimicrobial resistance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Arvand M, 2010, DEUT MED WOCHENSCHR, V135, P1963, DOI 10.1055/s-0030-1263342; Arvand M, 2009, EUROSURVEILLANCE, V14, P27; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Birgand G, 2010, EUROSURVEILLANCE, V15, P8; Borgmann S, 2008, Euro Surveill, V13; Burns K, 2010, J HOSP INFECT, V75, P287, DOI 10.1016/j.jhin.2010.03.025; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; CAMPBELL RR, 1988, AGE AGEING, V17, P333, DOI 10.1093/ageing/17.5.333; Crogan NL, 2007, GERIATR NURS, V28, P161, DOI 10.1016/j.gerinurse.2007.04.005; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Gaynes R, 2004, CLIN INFECT DIS, V38, P640, DOI 10.1086/381551; Gerding DN, 2004, CLIN INFECT DIS, V38, P646, DOI 10.1086/382084; Henrich TJ, 2009, EMERG INFECT DIS, V15, P415, DOI 10.3201/eid1503.080312; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Hensgens MP, 2010, NED TIJDSCHR GENEESK, V2010; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; SIMOR AE, 1993, CLIN INFECT DIS, V17, P672, DOI 10.1093/clinids/17.4.672; Zaiss NH, 2010, EMERG INFECT DIS, V16, P675, DOI 10.3201/eid1604.090859	24	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30183	10.1371/journal.pone.0030183	http://dx.doi.org/10.1371/journal.pone.0030183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253917	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700097
J	Ataga, KI; Brittain, JE; Desai, P; May, R; Jones, S; Delaney, J; Strayhorn, D; Hinderliter, A; Key, NS				Ataga, Kenneth I.; Brittain, Julia E.; Desai, Payal; May, Ryan; Jones, Susan; Delaney, John; Strayhorn, Dell; Hinderliter, Alan; Key, Nigel S.			Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; POTENTIAL ROLE; VENOUS THROMBOEMBOLISM; PULMONARY-HYPERTENSION; ENDOTHELIAL-CELLS; INFLAMMATION; HEMOLYSIS; ANEMIA; RATES	Background: The contribution of hypercoagulability to the pathophysiology of sickle cell disease (SCD) remains poorly defined. We sought to evaluate the association of markers of coagulation and platelet activation with specific clinical complications and laboratory variables in patients with SCD. Design and Methods: Plasma markers of coagulation activation (D-dimer and TAT), platelet activation (soluble CD40 ligand), microparticle-associated tissue factor (MPTF) procoagulant activity and other laboratory variables were obtained in a cohort of patients with SCD. Tricuspid regurgitant jet velocity was determined by Doppler echocardiography and the presence/history of clinical complications was ascertained at the time of evaluation, combined with a detailed review of the medical records. Results: No significant differences in the levels of D-dimer, TAT, soluble CD40 ligand, and MPTF procoagulant activity were observed between patients in the SS/SD/S beta(0) thalassemia and SC/S beta(+) thalassemia groups. Both TAT and D-dimer were significantly correlated with measures of hemolysis (lactate dehydrogenase, indirect bilirubin and hemoglobin) and soluble vascular cell adhesion molecule-1. In patients in the SS/SD/S beta(0) thalassemia group, D-dimer was associated with a history of stroke (p = 0.049), TAT was associated with a history of retinopathy (p = 0.0176), and CD40 ligand was associated with the frequency of pain episodes (p = 0.039). In multivariate analyses, D-dimer was associated with reticulocyte count, lactate dehydrogenase, NT-proBNP and history of stroke; soluble CD40 ligand was associated with WBC count and platelet count; and MPTF procoagulant activity was associated with hemoglobin and history of acute chest syndrome. Conclusions: This study supports the association of coagulation activation with hemolysis in SCD. The association of D-dimer with a history of stroke suggests that coagulation activation may contribute to the pathophysiology of stroke in clinically severe forms of SCD. More research is needed to evaluate the contribution of coagulation and platelet activation to clinical complications in SCD.	[Ataga, Kenneth I.; Desai, Payal; Jones, Susan; Delaney, John; Strayhorn, Dell; Key, Nigel S.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27515 USA; [Brittain, Julia E.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [May, Ryan] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Hinderliter, Alan] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ataga, KI (corresponding author), Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27515 USA.	kataga@med.unc.edu	Desai, Payal/D-4296-2017	/0000-0003-1038-2500	NIH [HL79915, HL091265, HL094592]; North Carolina State Sickle Cell Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079915, R21HL091265, R01HL094592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina State Sickle Cell Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants HL79915, HL091265, and HL094592. Support for this work was also provided by an award from the North Carolina State Sickle Cell Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedeji MO, 2001, ARCH PATHOL LAB MED, V125, P1436; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Brittain JE, 2010, BLOOD, V115, P2014, DOI 10.1182/blood-2009-04-217950; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; FRANCIS RB, 1991, BLOOD COAGUL FIBRIN, V2, P341, DOI 10.1097/00001721-199104000-00018; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; Levi M, 2002, CRIT CARE MED, V30, pS220, DOI 10.1097/00003246-200205001-00008; Manly DA, 2010, THROMB RES, V125, P511, DOI 10.1016/j.thromres.2009.09.019; Mohan JS, 2005, BLOOD COAGUL FIBRIN, V16, P209, DOI 10.1097/01.mbc.0000164431.98169.8f; Ohene-Frempong K, 1998, BLOOD, V91, P288; Orringer EP, 1996, BLOOD, V88, P1971; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Prengler M, 2002, ANN NEUROL, V51, P543, DOI 10.1002/ana.10192; Setty BNY, 2008, J THROMB HAEMOST, V6, P2202, DOI 10.1111/j.1538-7836.2008.03177.x; Setty Y, 2010, BLOOD, V116, P1711; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Solovey A, 2004, BLOOD, V104, P840, DOI 10.1182/blood-2003-10-3719; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Stein PD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.08.015; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Tripodi A, 2009, HAEMATOL-HEMATOL J, V94, P1520, DOI 10.3324/haematol.2009.010546; van Beers EJ, 2008, HAEMATOLOGICA, V93, pE42, DOI 10.3324/haematol.12632; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X	33	74	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29786	10.1371/journal.pone.0029786	http://dx.doi.org/10.1371/journal.pone.0029786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253781	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700051
J	Diem, O; Schaffner, M; Seifarth, W; Leib-Mosch, C				Diem, Olivia; Schaeffner, Marisa; Seifarth, Wolfgang; Leib-Moesch, Christine			Influence of Antipsychotic Drugs on Human Endogenous Retrovirus (HERV) Transcription in Brain Cells	PLOS ONE			English	Article							EXPRESSION PROFILES; BIPOLAR DISORDER; HUMAN TISSUES; SCHIZOPHRENIA; INDIVIDUALS; PROTEIN; RNA; BLOOD; GAG	Human endogenous retroviruses (HERVs) have been associated with various neurological and neuropsychiatric disorders. Transcripts and proteins of at least three HERV groups, HERV-W, ERV9 and HERV-K(HML-2) have been detected repeatedly in brain samples or cerebrospinal fluid of patients with schizophrenia suggesting that alterations in HERV activity may play a role in etiopathogenesis. Current therapies otherwise include neuroleptics and/or antidepressants that may induce epigenetic alterations and thus influence HERV expression. To investigate the effects of these drugs on HERV transcriptional activity, HERV expression profiles of a broad range of human brain cell lines treated with valproic acid (VPA), haloperidol, risperidone, and clozapine were analyzed using a retrovirus-specific microarray and qRT-PCR. Investigation of 52 HERV subgroups revealed upregulation of several class I and class II HERV elements by VPA in a dose-dependent manner. The strongest effect was observed on HERV-W and ERV9 groups in the human glioblastoma cell lines SK-N-SH and SK-N-MC, respectively. The transcript level of HERV-K(HML-2) elements was not influenced. Transcription of HERV-W, ERV9 and HERVK(HML-2) taxa was further quantified in postmortem brain samples of patients with schizophrenia, bipolar disorders and a healthy control group with regard to their medication. Patients with schizophrenia showed a significantly higher HERV-W transcription associated with VPA treatment. However in case of ERV9, enhanced transcript levels could not be explained solely by VPA treatment, since a slight increase was also found in untreated patients compared to healthy controls. HERVK( HML-2) elements appeared to be upregulated in some patients with bipolar disorders independent from medication. In conclusion, these results suggest that antipsychotic medication may contribute to increased expression of distinct HERV taxa in patients with neuropsychiatric diseases.	[Diem, Olivia; Schaeffner, Marisa; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Diem, Olivia; Seifarth, Wolfgang; Leib-Moesch, Christine] Heidelberg Univ, Med Klin 3, UMM, D-6800 Mannheim, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg	Diem, O (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany.	leib@helmholtz-muenchen.de	Ricceri, Laura/N-9168-2017		Stanley Medical Research Institute [07R/1729]	Stanley Medical Research Institute	This work was supported by grant 07R/1729 to CL-M and WS from the Stanley Medical Research Institute (http://www.stanleyresearch.org/dnn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Chen YX, 2004, WORLD J GASTROENTERO, V10, P2643, DOI 10.3748/wjg.v10.i18.2643; Choi KH, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-57; Christensen T, 2010, J NEUROIMMUNE PHARM, P1; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Ferguson-Smith AC, 2011, CELL METAB, V13, P115, DOI 10.1016/j.cmet.2011.01.011; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Guidotti A, 2009, TRENDS PHARMACOL SCI, V30, P55, DOI 10.1016/j.tips.2008.10.010; HELSON L, 1975, CANCER RES, V35, P2594; Huang WJ, 2006, SCHIZOPHR RES, V83, P193, DOI 10.1016/j.schres.2006.01.007; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karlsson H, 2004, MOL PSYCHIATR, V9, P12, DOI 10.1038/sj.mp.4001439; Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayer J, 2005, CYTOGENET GENOME RES, V110, P448, DOI 10.1159/000084977; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Perron H, 2008, BIOL PSYCHIAT, V64, P1019, DOI 10.1016/j.biopsych.2008.06.028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Schuhmann GG, 2011, INT REV CELL MOL BIO; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Seifarth W, 2003, J VIROL METHODS, V112, P79, DOI 10.1016/S0166-0934(03)00194-0; Seifarth W, 2011, ENCY DNA RESERACH, V3; Sharma RP, 2006, SCHIZOPHR RES, V88, P227, DOI 10.1016/j.schres.2006.07.015; Sharma RR, 2005, SCHIZOPHR RES, V72, P79, DOI 10.1016/j.schres.2004.03.001; Singer EJ, 2010, NEUROL CLIN, V28, P253, DOI 10.1016/j.ncl.2009.09.018; Sverdlov ED, 2005, RETROVIRUSES PRIMATE; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Weis S, 2007, J NEURAL TRANSM, V114, P261, DOI 10.1007/s00702-006-0544-0; Yao Y, 2008, GENES BRAIN BEHAV, V7, P103, DOI 10.1111/j.1601-183X.2007.00334.x; Yolken RH, 2001, CLIN NEUROSCI RES, V1, P164, DOI 10.1016/S1566-2772(00)00018-9; YOLKEN RH, 1995, CLIN MICROBIOL REV, V8, P131, DOI 10.1128/CMR.8.1.131; Yolken Robert, 2004, Herpes, V11 Suppl 2, p83A	41	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30054	10.1371/journal.pone.0030054	http://dx.doi.org/10.1371/journal.pone.0030054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253875	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700081
J	Krechowec, SO; Burton, KL; Newlaczyl, AU; Nunn, N; Vlatkovic, N; Plagge, A				Krechowec, Stefan O.; Burton, Katie L.; Newlaczyl, Anna U.; Nunn, Nicolas; Vlatkovic, Nikolina; Plagge, Antonius			Postnatal Changes in the Expression Pattern of the Imprinted Signalling Protein XL alpha s Underlie the Changing Phenotype of Deficient Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; CRE-MEDIATED RECOMBINATION; NERVOUS-SYSTEM; DORSOMEDIAL HYPOTHALAMUS; CONTROL REGION; FOOD-INTAKE; GNAS LOCUS; MELANOCORTIN-4 RECEPTORS; GLUCOSE-HOMEOSTASIS	The alternatively spliced trimeric G-protein subunit XL alpha s, which is involved in cAMP signalling, is encoded by the Gnasxl transcript of the imprinted Gnas locus. XL alpha s deficient mice show neonatal feeding problems, leanness, inertia and a high mortality rate. Mutants that survive to weaning age develop into healthy and fertile adults, which remain lean despite elevated food intake. The adult metabolic phenotype can be attributed to increased energy expenditure, which appears to be caused by elevated sympathetic nervous system activity. To better understand the changing phenotype of Gnasxl deficient mice, we compared XL alpha s expression in neonatal versus adult tissues, analysed its co-localisation with neural markers and characterised changes in the nutrient-sensing mTOR1-S6K pathway in the hypothalamus. Using a newly generated conditional Gnasxl lacZ gene trap line and immunohistochemistry we identified various types of muscle, including smooth muscle cells of blood vessels, as the major peripheral sites of expression in neonates. Expression in all muscle tissues was silenced in adults. While Gnasxl expression in the central nervous system was also developmentally silenced in some midbrain nuclei, it was upregulated in the preoptic area, the medial amygdala, several hypothalamic nuclei (e. g. arcuate, dorsomedial, lateral and paraventricular nuclei) and the nucleus of the solitary tract. Furthermore, expression was detected in the ventral medulla as well as in motoneurons and a subset of sympathetic preganglionic neurons of the spinal cord. In the arcuate nucleus of Gnasxl-deficient mice we found reduced activity of the nutrient sensing mTOR1-S6K signalling pathway, which concurs with their metabolic status. The expression in these brain regions and the hypermetabolic phenotype of adult Gnasxl-deficient mice imply an inhibitory function of XL alpha s in energy expenditure and sympathetic outflow. By contrast, the neonatal phenotype of mutant mice appears to be due to a transient role of XL alpha s in muscle tissues.	[Krechowec, Stefan O.; Burton, Katie L.; Newlaczyl, Anna U.; Nunn, Nicolas; Plagge, Antonius] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Krechowec, SO (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	a.plagge@liv.ac.uk	Vlatkovic, Nikolina/AAH-6654-2020; Vlatkovic, Nikolina/I-3481-2013; Plagge, Antonius/AAH-3877-2019	Vlatkovic, Nikolina/0000-0003-3003-794X; Vlatkovic, Nikolina/0000-0003-3003-794X; Plagge, Antonius/0000-0001-6592-1343; Nunn, Nicolas/0000-0002-0929-6907; Burton, Katie/0000-0002-7812-2310	Medical Research Council United Kingdom [G0601256]; Royal Society; Biomedical Services Unit of the University of Liverpool; Medical Research Council [G0601256] Funding Source: researchfish; MRC [G0601256] Funding Source: UKRI	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Biomedical Services Unit of the University of Liverpool; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council United Kingdom (grant G0601256) (http://www.mrc.ac.uk) and by a Royal Society research grant (http://royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank staff of the Biomedical Services Unit of the University of Liverpool for expert animal care and support. Furthermore, we are grateful to Dr. Bettina Wilm and Dr. John Quayle (University of Liverpool) for antibodies, Dr. Wendy Dean and Dr. Martin Turner (The Babraham Institute, Cambridge, UK) for CMV-Cre and Flpe transgenic mice, and Dr. Axel Behrens, (Cancer Research UK, London) for the Nestin-Cre transgenic line. We would also like to thank Dr. Gavin Kelsey (The Babraham Institute, Cambridge, UK) for comments on the manuscript.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Cerri M, 2006, NEUROSCIENCE, V140, P711, DOI 10.1016/j.neuroscience.2006.02.027; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chitravanshi VC, 2009, AM J PHYSIOL-REG I, V296, pR1402, DOI 10.1152/ajpregu.90978.2008; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fan W, 2007, BRAIN RES, V1179, P61, DOI 10.1016/j.brainres.2007.04.006; Fay RA, 1997, BRAIN RES REV, V25, P276, DOI 10.1016/S0165-0173(97)00027-1; Feldman JL, 2005, RESP PHYSIOL NEUROBI, V147, P131, DOI 10.1016/j.resp.2005.03.014; Frontera M, 2008, ADV EXP MED BIOL, V626, P41; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Grill HJ, 2009, INT J OBESITY, V33, pS11, DOI 10.1038/ijo.2009.10; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kelsey G, 2010, AM J MED GENET C, V154C, P377, DOI 10.1002/ajmg.c.30271; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kohlmeier KA, 2010, NEUROSCIENCE, V171, P812, DOI 10.1016/j.neuroscience.2010.09.034; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Lund JP, 1998, CURR OPIN NEUROBIOL, V8, P718, DOI 10.1016/S0959-4388(98)80113-X; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Martin EM, 2011, J COMP NEUROL, V519, P2574, DOI 10.1002/cne.22639; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Pacilli A, 2009, EXP CELL RES, V315, P901, DOI 10.1016/j.yexcr.2008.12.018; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Pasolli HA, 2001, NEUROSCI LETT, V301, P119, DOI 10.1016/S0304-3940(01)01620-2; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Phelps CJ, 2004, ENDOCRINOLOGY, V145, P5656, DOI 10.1210/en.2004-0931; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ren J, 2003, J NEUROSCI, V23, P1569; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ugur O, 2000, MOL BIOL CELL, V11, P1421, DOI 10.1091/mbc.11.4.1421; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Weinstein LS, 2010, INT J OBESITY, V34, P6, DOI 10.1038/ijo.2009.222; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang Y, 2011, J NEUROSCI, V31, P1873, DOI 10.1523/JNEUROSCI.3223-10.2011; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	97	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29753	10.1371/journal.pone.0029753	http://dx.doi.org/10.1371/journal.pone.0029753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253771	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700045
J	Liu, XK; Wang, DS; Wang, HG; Feng, EL; Zhu, L; Wang, HL				Liu, Xiankai; Wang, Dongshu; Wang, Huagui; Feng, Erling; Zhu, Li; Wang, Hengliang			Curing of Plasmid pXO1 from Bacillus anthracis Using Plasmid Incompatibility	PLOS ONE			English	Article							VIRULENCE; GENE; IDENTIFICATION; ENCAPSULATION; PROTEIN; REPLICATION; SALMONELLA; SEQUENCE	The large plasmid pXO1 encoding the anthrax toxin is important for the virulence of Bacillus anthracis. It is essential to cure pXO1 from B. anthracis to evaluate its role in the pathogenesis of anthrax infection. Because conventional methods for curing plasmids (e.g., curing agents or growth at elevated temperatures) can induce mutations in the host chromosomal DNA, we developed a specific and reliable method to eliminate pXO1 from B. anthracis using plasmid incompatibility. Three putative replication origins of pXO1 were inserted into a temperature-sensitive plasmid to generate three incompatible plasmids. One of the three plasmids successfully eliminated the large plasmid pXO1 from B. anthracis vaccine strain A16R and wild type strain A16. These findings provided additional information about the replication/partitioning of pXO1 and demonstrated that introducing a small incompatible plasmid can generate plasmid-cured strains of B. anthracis without inducing spontaneous mutations in the host chromosome.	[Liu, Xiankai; Wang, Dongshu; Wang, Huagui; Feng, Erling; Zhu, Li; Wang, Hengliang] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China		Liu, XK (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	wanghl@nic.bmi.ac.cn	Wang, Hengliang/AAL-5340-2021; Zhu, Li/Q-7499-2017; wang, hengliang/AAA-8300-2020; zhang, xiaoyan/F-4789-2013; Wang, Hengliang/AAT-4586-2021	Wang, Hengliang/0000-0001-8476-4320; Zhu, Li/0000-0001-9975-8978; 	State Major Science and Technology Special Projects of China [2009ZX10601]; National Natural Science Foundation of China [81071322]	State Major Science and Technology Special Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the State Major Science and Technology Special Projects of China (No. 2009ZX10601, http://www.nmp.gov.cn/) and the National Natural Science Foundation of China (No. 81071322, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; BRANA H, 1983, FOLIA MICROBIOL, V28, P441, DOI 10.1007/BF02879679; El-Mansi M, 2000, RES MICROBIOL, V151, P201, DOI 10.1016/S0923-2508(00)00140-6; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guidi-Rontani C, 1999, MOL MICROBIOL, V33, P407, DOI 10.1046/j.1365-2958.1999.01485.x; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; HOVI M, 1988, MICROB PATHOGENESIS, V4, P385, DOI 10.1016/0882-4010(88)90066-6; Keyhani J, 2006, J IND MICROBIOL BIOT, V33, P238, DOI 10.1007/s10295-005-0261-y; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Mesas JM, 2004, PLASMID, V51, P37, DOI 10.1016/S0147-619X(03)00074-X; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ni B, 2008, LETT APPL MICROBIOL, V47, P235, DOI 10.1111/j.1472-765X.2008.02426.x; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Pomerantsev AP, 2009, J BACTERIOL, V191, P5134, DOI 10.1128/JB.00422-09; POPPE C, 1988, VET MICROBIOL, V18, P73, DOI 10.1016/0378-1135(88)90117-4; Shatalin KY, 2005, FEMS MICROBIOL LETT, V245, P315, DOI 10.1016/j.femsle.2005.03.029; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Spengler G, 2006, CURR DRUG TARGETS, V7, P823, DOI 10.2174/138945006777709601; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Tinsley E, 2004, J BACTERIOL, V186, P2717, DOI 10.1128/JB.186.9.2717-2723.2004; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; UCHIDA I, 1985, J GEN MICROBIOL, V131, P363; Uraji M, 2002, GENES GENET SYST, V77, P1, DOI 10.1266/ggs.77.1; VIETRI NJ, 1995, GENE, V152, P1, DOI 10.1016/0378-1119(94)00662-C; Wang HG, 2011, CURR MICROBIOL, V62, P703, DOI 10.1007/s00284-010-9767-2	28	23	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29875	10.1371/journal.pone.0029875	http://dx.doi.org/10.1371/journal.pone.0029875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253811	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700061
J	Ren, YG; Yang, S; Tan, GQ; Ye, W; Liu, DH; Qian, X; Ding, ZY; Zhong, YH; Zhang, JR; Jiang, DD; Zhao, YH; Lu, JX				Ren, Yaguang; Yang, Su; Tan, Guoqiang; Ye, Wei; Liu, Danhui; Qian, Xu; Ding, Zhongying; Zhong, Yuhong; Zhang, Jingrui; Jiang, Dandan; Zhao, Yuhong; Lu, Jianxin			Reduction of Mitoferrin Results in Abnormal Development and Extended Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							SYSTEMATIC RNAI SCREEN; IRON ACCUMULATION; OXIDATIVE STRESS; MITOCHONDRIAL MUTANTS; DROSOPHILA-MITOFERRIN; FRIEDREICHS-ATAXIA; LONGEVITY; GENES; MODEL; OVEREXPRESSION	Iron is essential for organisms. It is mainly utilized in mitochondria for biosynthesis of iron-sulfur clusters, hemes and other cofactors. Mitoferrin 1 and mitoferrin 2, two homologues proteins belonging to the mitochondrial solute carrier family, are required for iron delivery into mitochondria. Mitoferrin 1 is highly expressed in developing erythrocytes which consume a large amount of iron during hemoglobinization. Mitoferrin 2 is ubiquitously expressed, whose functions are less known. Zebrafish with mitoferrin 1 mutation show profound hypochromic anaemia and erythroid maturation arrests, and yeast with defects in MRS3/4, the counterparts of mitoferrin 1/2, has low mitochondrial iron levels and grows poorly by iron depletion. Mitoferrin 1 expression is up-regulated in yeast and mouse models of Fiedreich's ataxia disease and in human cell culture models of Parkinson disease, suggesting its involvement in the pathogenesis of diseases with mitochondrial iron accumulation. In this study we found that reduced mitoferrin levels in C. elegans by RNAi treatment causes pleiotropic phenotypes such as small body size, reduced fecundity, slow movement and increased sensitivity to paraquat. Despite these abnormities, lifespan was increased by 50% to 80% in N2 wild type strain, and in further studies using the RNAi sensitive strain eri-1, more than doubled lifespan was observed. The pathways or mechanisms responsible for the lifespan extension and other phenotypes of mitoferrin RNAi worms are worth further study, which may contribute to our understanding of aging mechanisms and the pathogenesis of iron disorder related diseases.	[Ren, Yaguang; Yang, Su; Tan, Guoqiang; Ye, Wei; Liu, Danhui; Qian, Xu; Ding, Zhongying; Zhong, Yuhong; Zhang, Jingrui; Jiang, Dandan; Zhao, Yuhong; Lu, Jianxin] Wenzhou Med Coll, Key Lab Lab Med, Minist Educ China, Zhejiang Prov Key Lab Med Genet,Sch Lab Med & Lif, Wenzhou, Zhejiang, Peoples R China	Ministry of Education, China; Wenzhou Medical University	Ren, YG (corresponding author), Wenzhou Med Coll, Key Lab Lab Med, Minist Educ China, Zhejiang Prov Key Lab Med Genet,Sch Lab Med & Lif, Wenzhou, Zhejiang, Peoples R China.	jianxlu@163.com	Ren, Yaguang/H-7026-2017	Ren, Yaguang/0000-0002-3551-9609	National Basic Research Program of China [2007CB507402]; National Natural Science Foundation of China [30770448]; Science Foundation of Zhejiang Province [Y2081075, Y507233]; Zhejiang provincial top key discipline of laboratory medicine; Zhejiang provincial program for the cultivation of high level innovative health talents; Key Science and Technology Innovation Team of Zhejiang Province [2010R50048]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang provincial top key discipline of laboratory medicine; Zhejiang provincial program for the cultivation of high level innovative health talents; Key Science and Technology Innovation Team of Zhejiang Province	This work was supported by the National Basic Research Program of China (Grant No. 2007CB507402); the National Natural Science Foundation of China (Grant No. 30770448); the Science Foundation of Zhejiang Province (Grants No. Y2081075 and Y507233); Zhejiang provincial top key discipline of laboratory medicine, Zhejiang provincial program for the cultivation of high level innovative health talents, and Key Science and Technology Innovation Team of Zhejiang Province (2010R50048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 2008, J NEUROSCI METH, V173, P20, DOI 10.1016/j.jneumeth.2008.05.007; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2004, HUM MOL GENET, V13, pR275, DOI 10.1093/hmg/ddh224; Carroll CB, 2011, NEUROCHEM INT, V59, P73, DOI 10.1016/j.neuint.2011.05.006; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Dudley NR, 2005, METH MOL B, V309, P29; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Flurkey K, 2010, NATURE, V468, P386, DOI 10.1038/468386a; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Fujii M, 2005, BIOSCI BIOTECH BIOCH, V69, P2015, DOI 10.1271/bbb.69.2015; Gomez FJ, 2011, J NEURAL TRANSM, V118, P421, DOI 10.1007/s00702-010-0489-1; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hohn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu G, 2010, METHODS MOL BIOL, V610, P123, DOI 10.1007/978-1-60327-029-8_8; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Metzendorf C, 2009, BIOCHEM J, V421, P463, DOI 10.1042/BJ20082231; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Ou CY, 2011, DEV NEUROBIOL, V71, P554, DOI 10.1002/dneu.20858; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Potts MB, 2011, NAT REV CANCER, V11, P50, DOI 10.1038/nrc2984; Rawat S, 2011, CHEM-EUR J, V17, P746, DOI 10.1002/chem.201002143; Reddy MB, 2004, NUTR REV, V62, P120, DOI 10.1301/nr.2004.mar.120-124; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Samuelson AV, 2007, COLD SPRING HARB SYM, V72, P489, DOI 10.1101/sqb.2007.72.068; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Wan L, 2011, FREE RADICAL BIO MED, V50, P122, DOI 10.1016/j.freeradbiomed.2010.10.707; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556	65	24	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29666	10.1371/journal.pone.0029666	http://dx.doi.org/10.1371/journal.pone.0029666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253756	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700036
J	Belyaeva, ES; Goncharov, FP; Demakova, OV; Kolesnikova, TD; Boldyreva, LV; Semeshin, VF; Zhimulev, IF				Belyaeva, Elena S.; Goncharov, Fedor P.; Demakova, Olga V.; Kolesnikova, Tatyana D.; Boldyreva, Lidiya V.; Semeshin, Valeriy F.; Zhimulev, Igor F.			Late Replication Domains in Polytene and Non-Polytene Cells of Drosophila melanogaster	PLOS ONE			English	Article							DNA-REPLICATION; INTERCALARY HETEROCHROMATIN; PERICENTRIC HETEROCHROMATIN; GENERAL-CHARACTERISTICS; X-CHROMOSOME; SUUR GENE; UNDERREPLICATION; CHROMATIN; GENOME; REVEALS	In D. melanogaster polytene chromosomes, intercalary heterochromatin (IH) appears as large dense bands scattered in euchromatin and comprises clusters of repressed genes. IH displays distinctly low gene density, indicative of their particular regulation. Genes embedded in IH replicate late in the S phase and become underreplicated. We asked whether localization and organization of these late replicating domains is conserved in a distinct cell type. Using published comprehensive genome-wide chromatin annotation datasets (modENCODE and others), we compared IH organization in salivary land cells and in a Kc cell line. We first established the borders of 60 IH regions on a molecular map these regions gland underreplicated material and encompassing similar to 12% of Drosophila genome. We showed that in Kc cells repressed chromatin constituted 97% of the sequences that corresponded to IH bands. This chromatin is depleted for ORC-2 binding and largely replicates late. Differences in replication timing between the cell types analyzed are local and affect only sub-regions but never whole IH bands. As a rule such differentially replicating sub-regions display open chromatin organization, which apparently results from cell-type specific gene expression of underlying genes. We conclude that repressed chromatin organization of IH is generally conserved in polytene and non-polytene cells. Yet, IH domains do not function as transcription- and replication-regulatory units, because differences in transcription and replication between cell types are not domain-wide, rather they are restricted to small "islands" embedded in these domains. IH regions can thus be defined as a special class of domains with low gene density, which have narrow temporal expression patterns, and so displaying relatively conserved organization.	[Belyaeva, Elena S.; Goncharov, Fedor P.; Demakova, Olga V.; Kolesnikova, Tatyana D.; Boldyreva, Lidiya V.; Semeshin, Valeriy F.; Zhimulev, Igor F.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia	Russian Academy of Sciences	Belyaeva, ES (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Boldyreva, Lidiya/N-6978-2015; Demakova, Olga/N-7478-2015; Kolesnikova, Tatyana/N-5461-2015; Goncharov, Fedor/C-8891-2018; Belyaeva, Elena S/N-8066-2015; Zhimulev, Igor F/N-7978-2015	Boldyreva, Lidiya/0000-0003-0716-4545; Kolesnikova, Tatyana/0000-0002-5107-1445; Goncharov, Fedor/0000-0001-9728-2670; Zhimulev, Igor/0000-0002-6220-3028; Demakova, Olga/0000-0002-8538-7384	Ministry of Education and Science of the Russian Federation (ROSNAUKA) [02.740.11.0099]; RAS [6.4]; SB RAS [37]; Russian Foundation for Basic Research [09-04-00409]	Ministry of Education and Science of the Russian Federation (ROSNAUKA)(Ministry of Education and Science, Russian Federation); RAS(Russian Academy of SciencesRegione Sardegna); SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was funded by a grant of the Ministry of Education and Science of the Russian Federation (ROSNAUKA), governmental contract 02.740.11.0099; Program of RAS "Molecular and Cellular Biology" 6.4; Integration project of SB RAS #37, and the Russian Foundation for Basic Research (#09-04-00409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; AKAM ME, 1983, EMBO J, V2, P2075, DOI 10.1002/j.1460-2075.1983.tb01703.x; Andreyenkova NG, 2009, CHROMOSOMA, V118, P747, DOI 10.1007/s00412-009-0232-6; ARCOSTERAN L, 1972, CHROMOSOMA, V37, P233, DOI 10.1007/BF00319871; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2006, CHROMOSOMA, V115, P355, DOI 10.1007/s00412-006-0063-7; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Calvi BR, 2007, GENETICS, V177, P1291, DOI 10.1534/genetics.107.070862; Diffley JFX, 2002, J CELL SCI, V115, P869; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; HAGELE K, 1974, CHROMOSOMA, V47, P403, DOI 10.1007/BF00326362; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2009, EPIGENETICS-US, V4, P93, DOI 10.4161/epi.4.2.7772; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Koryakov DE, 2006, CHROMOSOMA, V115, P296, DOI 10.1007/s00412-005-0044-2; LAMB MM, 1987, CHROMOSOMA, V95, P227, DOI 10.1007/BF00294779; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Makunin IV, 2002, GENETICS, V160, P1023; MALCEVA NI, 1995, CHROMOSOME RES, V3, P191, DOI 10.1007/BF00710713; Moshkin YM, 2002, CHROMOSOMA, V111, P114, DOI 10.1007/s00412-002-0190-8; Moshkin YM, 2001, P NATL ACAD SCI USA, V98, P570, DOI 10.1073/pnas.021353598; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Pope BD, 2010, CHROMOSOME RES, V18, P127, DOI 10.1007/s10577-009-9100-8; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Semeshin VF, 2001, CHROMOSOMA, V110, P487; Sher N, GENOME RES IN PRESS; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; Slizynski B. N., 1945, PROC ROY SOC EDINBURG, V62B, P114; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Whittaker AJ, 2000, GENE DEV, V14, P1765; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9	55	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					352	363	e30035	10.1371/journal.pone.0030035	http://dx.doi.org/10.1371/journal.pone.0030035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253867	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900036
J	Chouvarine, P; Cooksey, AM; McCarthy, FM; Ray, DA; Baldwin, BS; Burgess, SC; Peterson, DG				Chouvarine, Philippe; Cooksey, Amanda M.; McCarthy, Fiona M.; Ray, David A.; Baldwin, Brian S.; Burgess, Shane C.; Peterson, Daniel G.			Transcriptome-Based Differentiation of Closely-Related Miscanthus Lines	PLOS ONE			English	Article							DNA-SEQUENCES; X GIGANTEUS; SORGHUM; GENOME; ANDROPOGONEAE; MARKERS	Background: Distinguishing between individuals is critical to those conducting animal/plant breeding, food safety/quality research, diagnostic and clinical testing, and evolutionary biology studies. Classical genetic identification studies are based on marker polymorphisms, but polymorphism-based techniques are time and labor intensive and often cannot distinguish between closely related individuals. Illumina sequencing technologies provide the detailed sequence data required for rapid and efficient differentiation of related species, lines/cultivars, and individuals in a cost-effective manner. Here we describe the use of Illumina high-throughput exome sequencing, coupled with SNP mapping, as a rapid means of distinguishing between related cultivars of the lignocellulosic bioenergy crop giant miscanthus (Miscanthus x giganteus). We provide the first exome sequence database for Miscanthus species complete with Gene Ontology (GO) functional annotations. Results: A SNP comparative analysis of rhizome-derived cDNA sequences was successfully utilized to distinguish three Miscanthus x giganteus cultivars from each other and from other Miscanthus species. Moreover, the resulting phylogenetic tree generated from SNP frequency data parallels the known breeding history of the plants examined. Some of the giant miscanthus plants exhibit considerable sequence divergence. Conclusions: Here we describe an analysis of Miscanthus in which high-throughput exome sequencing was utilized to differentiate between closely related genotypes despite the current lack of a reference genome sequence. We functionally annotated the exome sequences and provide resources to support Miscanthus systems biology. In addition, we demonstrate the use of the commercial high-performance cloud computing to do computational GO annotation.	[Chouvarine, Philippe; Cooksey, Amanda M.; McCarthy, Fiona M.; Ray, David A.; Burgess, Shane C.; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [McCarthy, Fiona M.; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [Ray, David A.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Baldwin, Brian S.; Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Chouvarine, P (corresponding author), Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA.	pc79@mafes.msstate.edu		Ray, David/0000-0002-3340-3987; Peterson, Daniel/0000-0002-0274-5968	U.S. Department of Agriculture [2009-34609-20222, ARS-58-6402-7-241]; National Science Foundation [DBI-0421717, MCB-0841821]; Direct For Biological Sciences [0841821] Funding Source: National Science Foundation	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in part, by the U.S. Department of Agriculture (2009-34609-20222 and ARS-58-6402-7-241) and the National Science Foundation (DBI-0421717 and MCB-0841821). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Castro P, 2011, J AGR SCI, V149, P451, DOI 10.1017/S0021859610001061; Cox CM, 2004, PHYTOPATHOLOGY, V94, P961, DOI 10.1094/PHYTO.2004.94.9.961; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gene Ontology Consortium, 2010, NUCLEIC ACIDS RES, V38, pD331; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Jaiswal P, 2002, COMPAR FUNCT GENOM, V3, P132, DOI 10.1002/cfg.156; Jung JK, 2010, EUPHYTICA, V175, P91, DOI 10.1007/s10681-010-0191-2; Kudtarkar P, 2010, EVOL BIOINFORM, V6, P197, DOI 10.4137/EBO.S6259; Kunihisa M, 2005, THEOR APPL GENET, V110, P1410, DOI 10.1007/s00122-005-1956-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McCarthy FM, 2011, NUCLEIC ACIDS RES, V39, pD497, DOI 10.1093/nar/gkq1115; Oppong-Konadu E, 1998, GHANA J AGR SCI, V31, P231; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rounsley SD, 2010, PLANT J, V61, P922, DOI 10.1111/j.1365-313X.2009.04030.x; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	27	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					168	175	e29850	10.1371/journal.pone.0029850	http://dx.doi.org/10.1371/journal.pone.0029850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253803	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900019
J	Peng, Z; Zhao, ZY; Nath, N; Froula, JL; Clum, A; Zhang, T; Cheng, JF; Copeland, AC; Pennacchio, LA; Chen, F				Peng, Ze; Zhao, Zhiying; Nath, Nandita; Froula, Jeff L.; Clum, Alicia; Zhang, Tao; Cheng, Jan-fang; Copeland, Alex C.; Pennacchio, Len A.; Chen, Feng			Generation of Long Insert Pairs Using a Cre-LoxP Inverse PCR Approach	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; GENOMES; TRANSCRIPTOME	Large insert mate pair reads have a major impact on the overall success of de novo assembly and the discovery of inherited and acquired structural variants. The positional information of mate pair reads generally improves genome assembly by resolving repeat elements and/or ordering contigs. Currently available methods for building such libraries have one or more of limitations, such as relatively small insert size; unable to distinguish the junction of two ends; and/or low throughput. We developed a new approach, Cre-LoxP Inverse PCR Paired-End (CLIP-PE), which exploits the advantages of (1) Cre-LoxP recombination system to efficiently circularize large DNA fragments, (2) inverse PCR to enrich for the desired products that contain both ends of the large DNA fragments, and (3) the use of restriction enzymes to introduce a recognizable junction site between ligated fragment ends and to improve the self-ligation efficiency. We have successfully created CLIP-PE libraries up to 22 kb that are rich in informative read pairs and low in small fragment background. These libraries have demonstrated the ability to improve genome assemblies. The CLIP-PE methodology can be implemented with existing and future next-generation sequencing platforms.	[Peng, Ze; Zhao, Zhiying; Nath, Nandita; Froula, Jeff L.; Clum, Alicia; Zhang, Tao; Cheng, Jan-fang; Copeland, Alex C.; Pennacchio, Len A.; Chen, Feng] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Chen, F (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	fchen@lbl.gov		Pennacchio, Len/0000-0002-8748-3732; Cheng, Jan-Fang/0000-0001-7315-7613; Zhao, zhiying/0000-0001-7524-397X	Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; Kelley JM, 1999, NUCLEIC ACIDS RES, V27, P1539, DOI 10.1093/nar/27.6.1539; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; STERNBERG N, 1981, J MOL BIOL, V150, P487, DOI 10.1016/0022-2836(81)90376-4; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	14	23	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29437	10.1371/journal.pone.0029437	http://dx.doi.org/10.1371/journal.pone.0029437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253722	gold, Green Published, Green Submitted			2022-12-25	WOS:000315865800008
J	Nishijima, T; Gatanaga, H; Komatsu, H; Tsukada, K; Shimbo, T; Aoki, T; Watanabe, K; Kinai, E; Honda, H; Tanuma, J; Yazaki, H; Honda, M; Teruya, K; Kikuchi, Y; Oka, S				Nishijima, Takeshi; Gatanaga, Hiroyuki; Komatsu, Hirokazu; Tsukada, Kunihisa; Shimbo, Takuro; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Tanuma, Junko; Yazaki, Hirohisa; Honda, Miwako; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi			Renal Function Declines More in Tenofovir-than Abacavir-Based Antiretroviral Therapy in Low-Body Weight Treatment-Naive Patients with HIV Infection	PLOS ONE			English	Article							CALCULATED CREATININE CLEARANCE; CHRONIC KIDNEY-DISEASE; DISOPROXIL FUMARATE; SERUM CREATININE; RISK-FACTORS; ADULTS; DYSFUNCTION; SAFETY; PHARMACOKINETICS; TENOFOVIR/EMTRICITABINE	Objective: To compare the rate of decline of renal function in tenofovir-and abacavir-based antiretroviral therapy (ART) in low-body weight treatment-naive patients with HIV infection. Design: We conducted a single-center retrospective cohort study of 503 Japanese patients who commenced on either tenofovir-or abacavir-based initial ART. Methods: The incidence of renal dysfunction, defined as more than 25% fall in estimated glomerular filtration rate (eGFR) from the baseline, was determined in each group. The effect of tenofovir on renal dysfunction was estimated by univariate and multivariate Cox hazards models as the primary exposure. Changes in eGFR until 96 weeks were estimated in both groups with a repeated measures mixed model. Results: The median body weight of the cohort was 64 kg. The estimated incidence of renal dysfunction in the tenofovir and the abacavir arm was 9.84 per 100 and 4.55 per 100 person-years, respectively. Tenofovir was significantly associated with renal dysfunction by univariate and multivariate analysis (HR = 1.747; 95% CI, 1.152-2.648; p = 0.009) (adjusted HR = 2.080; 95% CI, 1.339-3.232; p < 0.001). In subgroup analysis of the patients stratified by intertertile baseline body weight, the effect of tenofovir on renal dysfunction was more evident in patients with lower baseline body weight by multivariate analysis (<= 60 kg: adjusted HR = 2.771; 95% CI, 1.494-5.139; p = 0.001) (61-68 kg: adjusted HR = 1.908; 95% CI, 0.764-4.768; p = 0.167) (>68 kg: adjusted HR = 0.997; 95% CI, 0.318-3.121; p = 0.995). The fall in eGFR was significantly greater in the tenofovir arm than the abacavir arm after starting ART (p = 0.003). Conclusion: The incidence of renal dysfunction in low body weight patients treated with tenofovir was twice as high as those treated with abacavir. Close monitoring of renal function is recommended for patients with small body weight especially those with baseline body weight <60 kg treated with tenofovir.	[Nishijima, Takeshi; Gatanaga, Hiroyuki; Tsukada, Kunihisa; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Tanuma, Junko; Yazaki, Hirohisa; Honda, Miwako; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Int Clin Res Ctr, Tokyo, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Watanabe, Koji; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Tanuma, Junko/AAE-5395-2020	Oka, Shinichi/0000-0002-9283-2167; Yazaki, Hirohisa/0000-0002-6661-7869	Japanese Ministry of Health, Labour, and Welfare [H20-AIDS-002]; Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H20-AIDS-002), and the Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Chue CD, 2011, NEPHROL DIAL TRANSPL; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; De Beaudrap P, 2010, AIDS RES HUM RETROV, V26, P1221, DOI 10.1089/aid.2009.0261; Fux CA, 2007, ANTIVIR THER, V12, P1165; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; GARROW JS, 1985, INT J OBESITY, V9, P147; Gatanaga H, 2008, PHARMACOGENOMICS, V9, P207, DOI 10.2217/14622416.9.2.207; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Gayet-Ageron A, 2007, J ANTIMICROB CHEMOTH, V59, P1034, DOI 10.1093/jac/dkm064; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Jullien V, 2005, ANTIMICROB AGENTS CH, V49, P3361, DOI 10.1128/AAC.49.8.3361-3366.2005; Kinai E, 2009, AIDS RES HUM RETROV, V25, P387, DOI 10.1089/aid.2008.0202; Kiser JJ, 2008, ANTIMICROB AGENTS CH, V52, P631, DOI 10.1128/AAC.00761-07; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Nolan David, 2003, J HIV Ther, V8, P36; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Post FA, 2009, CURR OPIN INFECT DIS, V22, P43, DOI 10.1097/QCO.0b013e328320ffec; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Sun HY, 2007, J ANTIMICROB CHEMOTH, V60, P599, DOI 10.1093/jac/dkm243; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Verhelst D, 2002, AM J KIDNEY DIS, V40, P1331, DOI 10.1053/ajkd.2002.36924; Winston A, 2006, HIV MED, V7, P105, DOI 10.1111/j.1468-1293.2006.00349.x	37	47	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29977	10.1371/journal.pone.0029977	http://dx.doi.org/10.1371/journal.pone.0029977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242194	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100051
J	Waisberg, M; Vickers, BK; Yager, SB; Lin, CK; Pierce, SK				Waisberg, Michael; Vickers, Brandi K.; Yager, Stephanie B.; Lin, Christina K.; Pierce, Susan K.			Testing in Mice the Hypothesis That Melanin Is Protective in Malaria Infections	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MELANOCYTES IN-VITRO; VITAMIN-D; CEREBRAL MALARIA; PLASMODIUM-CHABAUDI; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; HUMAN-SKIN; CELLS; GROWTH	Malaria has had the largest impact of any infectious disease on shaping the human genome, exerting enormous selective pressure on genes that improve survival in severe malaria infections. Modern humans originated in Africa and lost skin melanization as they migrated to temperate regions of the globe. Although it is well documented that loss of melanization improved cutaneous Vitamin D synthesis, melanin plays an evolutionary ancient role in insect immunity to malaria and in some instances melanin has been implicated to play an immunoregulatory role in vertebrates. Thus, we tested the hypothesis that melanization may be protective in malaria infections using mouse models. Congenic C57BL/6 mice that differed only in the gene encoding tyrosinase, a key enzyme in the synthesis of melanin, showed no difference in the clinical course of infection by Plasmodium yoelii 17XL, that causes severe anemia, Plasmodium berghei ANKA, that causes severe cerebral malaria or Plasmodium chabaudi AS that causes uncomplicated chronic disease. Moreover, neither genetic deficiencies in vitamin D synthesis nor vitamin D supplementation had an effect on survival in cerebral malaria. Taken together, these results indicate that neither melanin nor vitamin D production improve survival in severe malaria.	[Waisberg, Michael; Vickers, Brandi K.; Yager, Stephanie B.; Lin, Christina K.; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Waisberg, M (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	waisbergm@niaid.nih.gov; spierce@niaid.nih.gov		Lin, Christina/0000-0001-9728-6591	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001064] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; BROWN AWA, 1966, J AMER MED ASSOC, V196, P249, DOI 10.1001/jama.196.3.249; Burkhart CG, 2005, INT J DERMATOL, V44, P340, DOI 10.1111/j.1365-4632.2004.02556.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Chilcott R, 2008, PRINCIPLES PRACTICE, P392; DAS BS, 1991, T ROY SOC TROP MED H, V85, P733, DOI 10.1016/0035-9203(91)90436-3; DELUCA M, 1988, J CELL BIOL, V107, P1919, DOI 10.1083/jcb.107.5.1919; El-Obeid A, 2006, PHYTOMEDICINE, V13, P324, DOI 10.1016/j.phymed.2005.03.007; Gasparini J, 2009, J EVOLUTION BIOL, V22, P2348, DOI 10.1111/j.1420-9101.2009.01831.x; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; GORDEUK VR, 1995, BLOOD, V85, P3297, DOI 10.1182/blood.V85.11.3297.bloodjournal85113297; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Herrling T, 2008, SPECTROCHIM ACTA A, V69, P1429, DOI 10.1016/j.saa.2007.09.030; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Hu DN, 2011, INVEST OPHTH VIS SCI, V52, P3767, DOI 10.1167/iovs.10-6908; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jin SH, 2010, ANN DERMATOL, V22, P486, DOI 10.5021/ad.2010.22.4.486; Johnson JK, 2003, INSECT BIOCHEM MOLEC, V33, P345, DOI 10.1016/S0965-1748(02)00257-6; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; LANGHORNE J, 1989, PARASITOL TODAY, V5, P362, DOI 10.1016/0169-4758(89)90113-0; LEPOOLE IC, 1993, EXP CELL RES, V205, P388, DOI 10.1006/excr.1993.1102; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Smolders J, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/629538; Mackintosh JA, 2001, J THEOR BIOL, V211, P101, DOI 10.1006/jtbi.2001.2331; Martins YC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-85; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Mohagheghpour N, 2000, CELL IMMUNOL, V199, P25, DOI 10.1006/cimm.1999.1599; Mohagheghpour N, 2001, MEDIATION CYTOKYNES; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; Narsaria N, 2011, J TROP PEDIAT; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; Newens K, 2006, T ROY SOC TROP MED H, V100, P41, DOI 10.1016/j.trstmh.2005.06.022; Pelajo CF, 2010, AUTOIMMUN REV, V9, P507, DOI 10.1016/j.autrev.2010.02.011; Pleass RJ, 2009, TRENDS PARASITOL, V25, P296, DOI 10.1016/j.pt.2009.04.002; Rajapakse R, 2005, J STEROID BIOCHEM, V96, P179, DOI 10.1016/j.jsbmb.2005.03.002; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Sergacheva Iu Iu, 1986, Med Parazitol (Mosk), P15; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2011, J NEUROIMMUNOL, V235, P91, DOI 10.1016/j.jneuroim.2011.03.012; Smolders J, 2011, VITAM HORM, V86, P401, DOI 10.1016/B978-0-12-386960-9.00018-6; Spector Stephen A, 2011, Top Antivir Med, V19, P6; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; TAYLORROBINSON AW, 1994, INFECT IMMUN, V62, P2490, DOI 10.1128/IAI.62.6.2490-2498.1994; Turhanoglu AD, 2010, RHEUMATOL INT, DOI 1007/s00296-010-1393-6; VIAL HJ, 1982, MOL BIOCHEM PARASIT, V5, P189, DOI 10.1016/0166-6851(82)90020-2; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Whitcomb James P, 2012, J Parasitol Res, V2012, P134645, DOI 10.1155/2012/134645; Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003; Zabierowski SE, 2011, PIGM CELL MELANOMA R, V24, P422, DOI 10.1111/j.1755-148X.2011.00847.x; Zhang SM, 2010, CHEM-BIOL INTERACT, V186, P30, DOI 10.1016/j.cbi.2010.03.021	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29493	10.1371/journal.pone.0029493	http://dx.doi.org/10.1371/journal.pone.0029493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242171	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100025
J	Nguyen, KDT; Morley, SA; Lai, CH; Clark, MS; Tan, KS; Bates, AE; Peck, LS				Nguyen, Khanh Dung T.; Morley, Simon A.; Lai, Chien-Houng; Clark, Melody S.; Tan, Koh Siang; Bates, Amanda E.; Peck, Lloyd S.			Upper Temperature Limits of Tropical Marine Ectotherms: Global Warming Implications	PLOS ONE			English	Article							CLIMATE-CHANGE; THERMAL TOLERANCE; AERIAL EXPOSURE; HEAT TOLERANCE; OCYPODID CRAB; CAPACITY; OXYGEN; OCEAN; SIZE; ACCLIMATION	Animal physiology, ecology and evolution are affected by temperature and it is expected that community structure will be strongly influenced by global warming. This is particularly relevant in the tropics, where organisms are already living close to their upper temperature limits and hence are highly vulnerable to rising temperature. Here we present data on upper temperature limits of 34 tropical marine ectotherm species from seven phyla living in intertidal and subtidal habitats. Short term thermal tolerances and vertical distributions were correlated, i.e., upper shore animals have higher thermal tolerance than lower shore and subtidal animals; however, animals, despite their respective tidal height, were susceptible to the same temperature in the long term. When temperatures were raised by 1 degrees C hour(-1), the upper lethal temperature range of intertidal ectotherms was 41-52 degrees C, but this range was narrower and reduced to 37-41 degrees C in subtidal animals. The rate of temperature change, however, affected intertidal and subtidal animals differently. In chronic heating experiments when temperature was raised weekly or monthly instead of every hour, upper temperature limits of subtidal species decreased from 40 degrees C to 35.4 degrees C, while the decrease was more than 10 degrees C in high shore organisms. Hence in the long term, activity and survival of tropical marine organisms could be compromised just 2-3 degrees C above present seawater temperatures. Differences between animals from environments that experience different levels of temperature variability suggest that the physiological mechanisms underlying thermal sensitivity may vary at different rates of warming.	[Nguyen, Khanh Dung T.; Lai, Chien-Houng; Tan, Koh Siang] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore; [Morley, Simon A.; Clark, Melody S.; Peck, Lloyd S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Bates, Amanda E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	National University of Singapore; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Tasmania	Nguyen, KDT (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore.	tmsntkd@nus.edu.sg	Clark, Melody S/D-7371-2014; Tan, Koh Siang/GOH-0321-2022; Bates, Amanda E./ABD-6874-2021	Clark, Melody S/0000-0002-3442-3824; Tan, Koh Siang/0000-0002-4599-9482; Bates, Amanda E./0000-0002-0198-4537	Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore [0821010024]; British Antarctic Survey; Natural Environment Research Council; Australian National Network in Marine Science (ANNiMS) Springboard initiative; National University of Singapore; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian National Network in Marine Science (ANNiMS) Springboard initiative; National University of Singapore(National University of Singapore); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by research grant 0821010024 from the Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore (http://www.a-star.edu.sg/) to K. S. Tan. The British Antarctic Survey collaboration with the National University of Singapore, was supported as part of the Polar Science for Planet Earth programme (Ecosystems/Adaptations and Physiology Work Package), funded by the Natural Environment Research Council. A. E. Bates was funded by the Australian National Network in Marine Science (ANNiMS) Springboard initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Finke GR, 2007, MAR ECOL PROG SER, V343, P57, DOI 10.3354/meps06918; Gastineau G, 2009, J CLIMATE, V22, P3993, DOI 10.1175/2009JCLI2794.1; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Gherardi F, 1999, J MAR BIOL ASSOC UK, V79, P281, DOI 10.1017/S0025315498000319; Gin KYH, 2000, J PLANKTON RES, V22, P1465, DOI 10.1093/plankt/22.8.1465; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; HONG WK, 1983, VELIGER, V26, P119; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; IPCC, 2001, ADV CLIM CHANG RES; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee SL, 2009, RAFFLES B ZOOL, V57, P551; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Marshall DJ, 2010, P ROYAL SOC B; Marshall DJ, 2011, BIOL LETT; MAYER AG, 1914, PAP TORTUGAS LAB, V6, P3; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Morley SA, 2009, COMP BIOCHEM PHYS A, V153, P154, DOI 10.1016/j.cbpa.2009.02.001; Munoz JLP, 2008, J THERM BIOL, V33, P149, DOI 10.1016/j.jtherbio.2007.10.002; Munoz JLP, 2005, COMP BIOCHEM PHYS A, V142, P92, DOI 10.1016/j.cbpa.2005.08.002; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Peck LS, 2011, MAR GEN IN PRESS; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Reid DG, 2007, ZOOTAXA, P3; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Richard J, 2011, PLOS ONE; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Spicer J. I., 1999, PHYSL DIVERSITY ITS; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 1996, J EXP BIOL, V199, P1845; STIRLING HP, 1982, J EXP MAR BIOL ECOL, V63, P133, DOI 10.1016/0022-0981(82)90027-2; Takeda S, 1996, J EXP MAR BIOL ECOL, V198, P237, DOI 10.1016/0022-0981(96)00007-X; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Turton S., 2004, ENV CRISIS CLIMATE C; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Zuur Alain F., 2009, P1	56	144	151	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29340	10.1371/journal.pone.0029340	http://dx.doi.org/10.1371/journal.pone.0029340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242115	Green Published, gold, Green Accepted			2022-12-25	WOS:000300677000026
J	Sanborn, AF; Heath, JE; Phillips, PK; Heath, MS; Noriega, FG				Sanborn, Allen F.; Heath, James E.; Phillips, Polly K.; Heath, Maxine S.; Noriega, Fernando G.			Thermal Adaptation and Diversity in Tropical Ecosystems: Evidence from Cicadas (Hemiptera, Cicadidae)	PLOS ONE			English	Article							AFRICAN PLATYPLEURINE CICADAS; TEMPERATURE RESPONSES; SPECIES-DIVERSITY; VERTICAL STRATIFICATION; LATITUDINAL GRADIENTS; BODY-TEMPERATURE; CACAMA-VALVATA; ANOLIS LIZARDS; RAIN-FOREST; HOMOPTERA	The latitudinal gradient in species diversity is a central problem in ecology. Expeditions covering approximately 16 degrees 54' of longitude and 21 degrees 4' of latitude and eight Argentine phytogeographic regions provided thermal adaptation data for 64 species of cicadas. We test whether species diversity relates to the diversity of thermal environments within a habitat. There are general patterns of the thermal response values decreasing in cooler floristic provinces and decreasing maximum potential temperature within a habitat except in tropical forest ecosystems. Vertical stratification of the plant communities leads to stratification in species using specific layers of the habitat. There is a decrease in thermal tolerances in species from the understory communities in comparison to middle level or canopy fauna. The understory Herrera umbraphila Sanborn & Heath is the first diurnally active cicada identified as a thermoconforming species. The body temperature for activity in H. umbraphila is less than and significantly different from active body temperatures of all other studied species regardless of habitat affiliation. These data suggest that variability in thermal niches within the heterogeneous plant community of the tropical forest environments permits species diversification as species adapt their physiology to function more efficiently at temperatures different from their potential competitors.	[Sanborn, Allen F.] Barry Univ, Dept Biol, Miami Shores, FL USA; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Sanborn, AF (corresponding author), Barry Univ, Dept Biol, Miami Shores, FL USA.	asanborn@mail.barry.edu			Fulbright Foundation; Tinker Foundation; United States Public Health Service [GMS07143]; Sigma Xi; Special Program for the Improvement and Development of the Ecological Research; University of Illinois Graduate College; Barry University	Fulbright Foundation; Tinker Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sigma Xi; Special Program for the Improvement and Development of the Ecological Research; University of Illinois Graduate College; Barry University	Financial support for this work was provided by the Fulbright Foundation (JEH), Tinker Foundation (MSH, AFS), United States Public Health Service traineeship GMS07143 (AFS), Sigma Xi (AFS), Special Program for the Improvement and Development of the Ecological Research (FGN), University of Illinois Graduate College (AFS), and Barry University (AFS). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 1967, NAT APPL SCI B, V20, P334; Basset Y, 2001, BIOL J LINN SOC, V72, P585, DOI 10.1111/j.1095-8312.2001.tb01340.x; Cabrera A. L., 1971, SOC ARGENTINA BOT, V14, P1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Dobzhansky T., 1950, American Scientist, V38, P209; Eyans GC, 1939, J ECOL, V27, P436, DOI 10.2307/2256374; Forster J. R., 1778, OBSERVATIONS MADE VO; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Haddow A. J., 1961, Transactions of the Royal Entomological Society of London, V113, P257; HADDOW AJ, 1947, B ENTOMOL RES, V37, P301, DOI 10.1017/S000748530003042X; HALES WAYNE B., 1949, BULL AMER METEOROL SOC, V30, P124; HASTINGS JM, 1991, OECOLOGIA, V85, P513, DOI 10.1007/BF00323763; Hastings JM, 1989, T KY ACAD SCI, V50, P145; HEATH J E, 1970, Physiologist, V13, P399; HEATH JE, 1967, AM MIDL NAT, V77, P64, DOI 10.2307/2423426; HEATH JE, 1972, PHYSIOL ZOOL, V45, P238, DOI 10.1086/physzool.45.3.30152503; HEATH JE, 1970, PHYSIOL ZOOL, V43, P145, DOI 10.1086/physzool.43.3.30155525; Heath MS, 2007, ANN ENTOMOL SOC AM, V100, P483, DOI 10.1603/0013-8746(2007)100[483:ANSOCO]2.0.CO;2; Heath M.S., 1972, Plateau, V45, P31; HERTZ PE, 1992, ECOLOGY, V73, P1405, DOI 10.2307/1940686; HUEY RB, 1976, ECOLOGY, V57, P985, DOI 10.2307/1941063; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; INGER RF, 1959, ECOLOGY, V40, P127, DOI 10.2307/1929930; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; LONGINO J T, 1990, Psyche (Cambridge), V97, P81, DOI 10.1155/1990/36505; MAC ARTHUR ROBERT H., 1967; May M.L., 1985, P507; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Phillips Polly K., 2007, Acta Zoologica Sinica, V53, P454; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; RAND A S, 1968, Proceedings of the United States National Museum, V125, P1; Rodgers DJ, 1998, ECOGRAPHY, V21, P392, DOI 10.1111/j.1600-0587.1998.tb00404.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Sanborn AF, 2000, J COMP PHYSIOL A, V186, P551, DOI 10.1007/s003590000110; Sanborn AF, 2004, PHYSIOL BIOCHEM ZOOL, V77, P816, DOI 10.1086/422226; Sanborn AF, 2004, BIOL J LINN SOC, V83, P281, DOI 10.1111/j.1095-8312.2004.00394.x; Sanborn AF, 2004, TROP ZOOL, V17, P65, DOI 10.1080/03946975.2004.10531199; SANBORN AF, 1995, FLA ENTOMOL, V78, P319, DOI 10.2307/3495905; SANBORN AF, 1995, J THERM BIOL, V20, P451, DOI 10.1016/0306-4565(95)00004-G; SANBORN AF, 1992, COMP BIOCHEM PHYS A, V102, P751, DOI 10.1016/0300-9629(92)90736-A; Sanborn AF, 2000, COMP BIOCHEM PHYS A, V125, P141, DOI 10.1016/S1095-6433(99)00169-5; Sanborn AF, 2004, J THERM BIOL, V29, P97, DOI 10.1016/j.jtherbio.2003.11.007; Sanborn AF, 2003, NATURWISSENSCHAFTEN, V90, P305, DOI 10.1007/s00114-003-0428-1; Sanborn AF, 2002, WEST N AM NATURALIST, V62, P437; Sanborn AF, 2003, J THERM BIOL, V28, P347, DOI 10.1016/S0306-4565(03)00013-5; Sanborn AF, 2002, J THERM BIOL, V27, P365, DOI 10.1016/S0306-4565(02)00004-9; Sanborn AF, 2001, FASEB J, V15, pA1106; Sanborn AF, 2011, SOUTHWEST NAT, V56, P363; Sanborn AF, 2011, J THERM BIOL, V36, P386, DOI 10.1016/j.jtherbio.2011.07.001; Sanborn AF, 2011, EUR J ENTOMOL, V108, P365, DOI 10.14411/eje.2011.045; Sanborn Allen F., 2009, Open Access Insect Physiology, V1, P13; Sanborn AF, 2011, J THERM BIOL, V36, P150, DOI 10.1016/j.jtherbio.2011.01.002; Sanborn Allen F., 2002, Denisia, V4, P455; Sanborn AF, 2010, ANN ENTOMOL SOC AM, V103, P860, DOI 10.1603/AN10040; Schulze CH, 2001, PLANT ECOL, V153, P133, DOI 10.1023/A:1017589711553; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Szarzynski J, 2001, PLANT ECOL, V153, P231, DOI 10.1023/A:1017536512887; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Tanabe S, 2002, ECOL ENTOMOL, V27, P720, DOI 10.1046/j.1365-2311.2002.00469.x; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Toolson EC, 1998, AM ZOOL, V38, P568; Turner J.R.G., 1986, Antenna, V10, P18; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Villet MH, 2003, CAN J ZOOL, V81, P1437, DOI 10.1139/Z03-119; von Humboldt A, 1807, ANSICHTEN NATUR WISS, P334; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	71	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29368	10.1371/journal.pone.0029368	http://dx.doi.org/10.1371/journal.pone.0029368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242117	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000029
J	Byles, V; Zhu, L; Lovaas, JD; Chmilewski, LK; Wang, J; Faller, DV; Dai, Y				Byles, V.; Zhu, L.; Lovaas, J. D.; Chmilewski, L. K.; Wang, J.; Faller, D. V.; Dai, Y.			SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis	ONCOGENE			English	Article						SIRT1; EMT; prostate cancer; migration; metastasis; E-cadherin	E-CADHERIN EXPRESSION; REPRESSES E-CADHERIN; MESENCHYMAL TRANSITION; BREAST-CANCER; CALORIE RESTRICTION; POOR-PROGNOSIS; CARCINOMA; PROGRESSION; SIRTUINS; FAMILY	The epithelial-to-mesenchymal transition (EMT) is a crucial program for the invasion and metastasis of epithelial tumors that involves loss of cell-cell adhesion and increased cell mobility; however, mechanisms underlying this transition are not fully elucidated. Here, we propose a novel mechanism through which the nicotinamide adenine dinucleotide-dependent histone deacetylase SIRT1 regulates EMT in prostate cancer cells through cooperation with the EMT inducing transcription factor ZEB1. We found that forced expression of SIRT1 in non-transformed PZ-HPV-7 prostate epithelial cells disrupts the epithelial morphology concomitant with decreased expression of the epithelial marker, E-cadherin, and increased expression of mesenchymal markers. In contrast, silencing SIRT1 in metastatic prostate tumor cells restores cell-cell adhesion and induces a shift toward an epithelial morphology concomitant with increased expression of E-cadherin and decreased expression of mesenchymal markers. We also found that SIRT1 has a physiologically relevant role in endogenous EMT induced by EGF signaling in prostate cancer cells. We propose that the regulation of EMT by SIRT1 involves modulation of, and cooperation with, the EMT inducing transcription factor ZEB1. Specifically, we show that SIRT1 silencing reduces expression of ZEB1 and that SIRT1 is recruited to the E-cadherin proximal promoter by ZEB1 to deacetylate histone H3 and to reduce binding of RNA polymerase II, ultimately suppressing E-cadherin transcription. We thus identify a necessary role for ZEB1 in SIRT1-mediated EMT. Finally, we show that reduction of SIRT1 decreases prostate cancer cell migration in vitro and metastasis in vivo in immunodeficient mice, which is largely independent of any general effects of SIRT1 on prostate cancer growth and survival. We therefore identify SIRT1 as a positive regulator of EMT and metastatic growth of prostate cancer cells and our findings implicate overexpressed SIRT1 as a potential therapeutic target to reverse EMT and to prevent prostate cancer progression.	[Dai, Y.] Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Dai, Y (corresponding author), Boston Univ, Sch Med, Ctr Canc, 72 E Concord St,L913, Boston, MA 02118 USA.	yandai@bu.edu		Dai, Yan/0000-0002-6894-6930	National Cancer Institute [1R21CA141036, CA101992]; Clinical and Translational Science Institute award of NIH [UL1RR025771]; Karin Grunebaum Cancer Research Foundation; American Cancer Society [IRG-72-001-27-IRG]; Department of Medicine Pilot Project Grant Award; NATIONAL CANCER INSTITUTE [R01CA101992, R21CA129046, R21CA141036] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Science Institute award of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karin Grunebaum Cancer Research Foundation; American Cancer Society(American Cancer Society); Department of Medicine Pilot Project Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr F Picard (Laval University, Canada), Dr Michael Korn (USCF, CA), Dr M Ott (UCSF, CA) for providing plasmid constructs. We greatly thank the technical support in tumor cell s.c. injection from Dr Zhijun Luo (Boston University School of Medicine). We thank Lora Forman for the technical assistant (Boston University) and Christine Chiao (Boston University) for the proofreading of this manuscript. This work was supported by grants from the National Cancer Institute (1R21CA141036) (YD), the Clinical and Translational Science Institute award of NIH (UL1RR025771) (YD), the National Cancer Institute (CA101992) (DVF), the Karin Grunebaum Cancer Research Foundation (YD and DVF), the American Cancer Society (IRG-72-001-27-IRG) (YD), and the Department of Medicine Pilot Project Grant Award (YD).	Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Dai Y, 2008, TRANSLATIONAL ONCOGE, V3, P137; Dai Y, 2008, CARCINOGENESIS, V29, P1725, DOI 10.1093/carcin/bgn117; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Ellis AL, 2010, J VIROL, V84, P6139, DOI 10.1128/JVI.02706-09; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lacher MD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-91; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Michael E, 2001, CURR PROTOC CELL BIO, P1921; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Richmond PJM, 1997, CANCER RES, V57, P3189; ROSS JS, 1994, MODERN PATHOL, V7, P835; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; UMBAS R, 1992, CANCER RES, V52, P5104; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	47	231	247	4	42	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	43					4619	4629		10.1038/onc.2011.612	http://dx.doi.org/10.1038/onc.2011.612			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22249256	Green Accepted			2022-12-25	WOS:000310528200005
J	Cozzi, R; Nuccitelli, A; D'Onofrio, M; Necchi, F; Rosini, R; Zerbini, F; Biagini, M; Norais, N; Beier, C; Telford, JL; Grandi, G; Assfalg, M; Zacharias, M; Maione, D; Rinaudo, CD				Cozzi, Roberta; Nuccitelli, Annalisa; D'Onofrio, Mariapina; Necchi, Francesca; Rosini, Roberto; Zerbini, Francesca; Biagini, Massimiliano; Norais, Nathalie; Beier, Christian; Telford, John L.; Grandi, Guido; Assfalg, Michael; Zacharias, Martin; Maione, Domenico; Rinaudo, C. Daniela			New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly	FASEB JOURNAL			English	Article						isopeptide bonds; molecular dynamic simulations; NMR spectroscopy; backbone protein	GRAM-POSITIVE BACTERIA; INTRAMOLECULAR ISOPEPTIDE BONDS; MOLECULAR-DYNAMICS METHOD; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; PROTEIN; SURFACE; WATER; AGALACTIAE; VACCINE	Group B Streptococcus pili are covalently linked structures assembled via a sortase-catalyzed transpeptidation mechanism involving specific residues and motifs. A sequence element containing a conserved glutamic acid, called the E-box, has been described to be involved in pilus formation. Although it is known that the glutamic acid is involved in stabilizing the internal isopeptide bonds, its role in pilus assembly still needs to be investigated. Using site-specific mutagenesis and complementation studies of knockout strains, we found that the E-box glutamic residue of the backbone and the major ancillary proteins is essential for pilus protein polymerization. NMR analysis revealed that the mutation of this residue seriously affected the folding of the protein. By contrast, the mutation of the lysine involved in the same isopeptide bond did not engender a structural destabilization, and the native fold was preserved. Moreover, molecular dynamics simulations on the E-box-containing domain of the backbone protein showed that the E-box glutamic acid is necessary to maintain the appropriate dryness of the domain core and that its mutation favors an unfolded state. The data provide the first direct evidence that the E-box has an additional and key role in maintaining the correct protein fold independently of isopeptide bond formation.-Cozzi, R., Nuccitelli, A., D'Onofrio, M., Necchi, F., Rosini, R., Zerbini, F., Biagini, M., Norais, N., Beier, C., Telford, J. L., Grandi, G., Assfalg, M., Zacharias, M., Maione, D., Rinaudo, C. D. New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. FASEB J. 26, 2008-2018 (2012). www.fasebj.org	[Cozzi, Roberta; Nuccitelli, Annalisa; Necchi, Francesca; Rosini, Roberto; Zerbini, Francesca; Biagini, Massimiliano; Norais, Nathalie; Telford, John L.; Grandi, Guido; Maione, Domenico; Rinaudo, C. Daniela] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [D'Onofrio, Mariapina; Assfalg, Michael] Univ Verona, Dept Biotechnol, Nucl Magnet Resonance Lab, I-37100 Verona, Italy; [Beier, Christian; Zacharias, Martin] Tech Univ Munich, Dept Phys, D-8000 Munich, Germany	Novartis; University of Verona; Technical University of Munich; University of Munich	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	daniela.rinaudo@novartis.com	Telford, John Laird/ABG-8144-2020	D'ONOFRIO, Mariapina/0000-0002-8699-0847; Assfalg, Michael/0000-0001-9331-3169; Grandi, Guido/0000-0001-9724-2185				Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Ball P, 2003, NATURE, V423, P25, DOI 10.1038/423025a; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398; Young T, 2010, PROTEINS, V78, P1856, DOI 10.1002/prot.22699	43	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2008	2018		10.1096/fj.11-196378	http://dx.doi.org/10.1096/fj.11-196378			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253480	Green Submitted			2022-12-25	WOS:000303680800027
J	Gupta, V; Discenza, M; Guyon, JR; Kunkel, LM; Beggs, AH				Gupta, Vandana; Discenza, Marie; Guyon, Jeffrey R.; Kunkel, Louis M.; Beggs, Alan H.			alpha-Actinin-2 deficiency results in sarcomeric defects in zebrafish that cannot be rescued by alpha-actinin-3 revealing functional differences between sarcomeric isoforms	FASEB JOURNAL			English	Article						skeletal muscle; cytoskeletal; myofibrillogenesis; gene duplication; evolution	ALPHA-ACTININ GENE; EXPRESSION; PROTEINS; MUTATIONS; CLONING; MUTANT; CELLS; MYOFIBRILLOGENESIS; CARDIOMYOPATHY; LOCALIZATION	alpha-Actinins are actin-binding proteins that can be broadly divided into Ca2+-sensitive cytoskeletal and Ca2+-insensitive sarcomeric isoforms. To date, little is known about functional differences between the isoforms due to their indistinguishable activities in most in vitro assays. To identify functional differences in vivo between sarcomeric isoforms, we employed computational and molecular approaches to characterize the zebrafish (Danio rerio) genome, which contains orthologoues of each human alpha-actinin gene, including duplicated copies of actn3. Each isoform exhibits a distinct and unique pattern of gene expression as assessed by mRNA in situ hybridization, largely sharing similar expression profiles as seen in humans. The spatial conservation of expression of these genes from lower invertebrates to humans suggests that regulation and subsequent functions of these genes are conserved during evolution. Morpholino-based knockdown of the sarcomeric isoform, actn2, leads to skeletal muscle, cardiac, and ocular defects evident over the first week of development. Remarkably, despite the high degree of sequence conservation between actn2 and actn3, the phenotypes of alpha-actinin-2 deficient zebrafish can be rescued by overexpression of alpha-actinin-2 but not by alpha-actinin-3 mRNAs from zebrafish or human. These data provide functional evidence that the primary sequences of alpha-actinin-2 and alpha-actinin-3 evolved differences to optimize their functions.-Gupta, V., Discenza, M., Guyon, J. R., Kunkel, L. M., Beggs, A. H. alpha-Actinin-2 deficiency results in sarcomeric defects in zebrafish that cannot be rescued by alpha-actinin-3 revealing functional differences between sarcomeric isoforms. FASEB J. 26, 1892-1908 (2012). www.fasebj.org	[Gupta, Vandana; Discenza, Marie; Guyon, Jeffrey R.; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Childrens Hosp Boston, Manton Ctr Orphan Dis Res,Div Genet, Boston, MA 02115 USA; [Gupta, Vandana; Discenza, Marie; Guyon, Jeffrey R.; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Childrens Hosp Boston, Manton Ctr Orphan Dis Res,Genom Program, Boston, MA 02115 USA; [Guyon, Jeffrey R.] Ted Stevens Marine Res Inst, Auke Bay Labs, Natl Marine Fisheries Serv, Juneau, AK USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Beggs, AH (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Manton Ctr Orphan Dis Res,Div Genet, CLSB 15026,300 Longwood Ave, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu		Beggs, Alan/0000-0001-8818-0568; Gupta, Vandana/0000-0002-4057-8451	U.S. National Institute for Child Health and Human Development; U.S. National Institutes of Health (NIH) [NIH-P30-HD-18655]; NIH, National Institute of Arthritis and Musculoskeletal and Skin Disease [R01 AR044345]; Muscular Dystrophy Association [MDA201302]; Lee and Penny Anderson Family Foundation; William Hearst Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345] Funding Source: NIH RePORTER	U.S. National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Lee and Penny Anderson Family Foundation; William Hearst Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully thank Dr. Genri Kawahara and Dr. Yukio Nakamura (Children's Hospital Boston, Boston, MA, USA) for sharing reagents. The authors thank Ryan Darnall for technical help in these studies and Dr. Yi Zhao for help with zebrafish genomic analysis. The authors thank members of the A. H. B. and L. M. K. laboratories for critically reading the manuscript. The authors also thank Chris Lawrence and Jason Best (Zebrafish Facility, Children's Hospital Boston) for sharing their wonderful expertise with zebrafish. Antibodies F59 and F310 (developed by F. E. Stockdale) and MF20 (developed by D. A. Fischman) were obtained from the Developmental Studies Hybridoma Bank supported under the auspices of the U.S. National Institute for Child Health and Human Development and maintained by The University of Iowa Department of Biology (Iowa City, IA, USA). Confocal microscopy was performed at Children's Hospital Boston Intellectual and Developmental Disability Research Center imaging core, supported by U.S. National Institutes of Health (NIH) grant NIH-P30-HD-18655. This work was supported by funding from the NIH, National Institute of Arthritis and Musculoskeletal and Skin Disease (R01 AR044345), the Muscular Dystrophy Association (MDA201302), and the Lee and Penny Anderson Family Foundation to A. H. B. and a William Hearst Foundation fellowship to V.G.	ARIKAWA K, 1989, J COMP NEUROL, V288, P640, DOI 10.1002/cne.902880410; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Berman Y, 2010, PHYSIOLOGY, V25, P250, DOI 10.1152/physiol.00008.2010; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Cabello N, 2007, J BIOL CHEM, V282, P12143, DOI 10.1074/jbc.M608880200; Chan YM, 1998, BIOCHEM BIOPH RES CO, V248, P134, DOI 10.1006/bbrc.1998.8920; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; FYRBERG E, 1990, J CELL BIOL, V110, P1999, DOI 10.1083/jcb.110.6.1999; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Henry CA, 2005, ZEBRAFISH, V2, P7, DOI 10.1089/zeb.2005.2.7; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Holterhoff CK, 2009, DEV DYNAM, V238, P2936, DOI 10.1002/dvdy.22123; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kremerskothen J, 2002, BIOCHEM BIOPH RES CO, V295, P678, DOI 10.1016/S0006-291X(02)00734-9; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; O'Sullivan ML, 2011, AM J VET RES, V72, P932, DOI 10.2460/ajvr.72.7.932; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; SANGER JM, 1986, J CELL BIOL, V102, P2053, DOI 10.1083/jcb.102.6.2053; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; SCHLEICHER M, 1988, J CELL SCI, V90, P59; SCHULTHEISS T, 1992, P NATL ACAD SCI USA, V89, P9282, DOI 10.1073/pnas.89.19.9282; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Steffen LS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-79; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Usmanova A, 1998, COMP BIOCHEM PHYS B, V120, P693, DOI 10.1016/S0305-0491(98)10065-2; Westerfield M, 2007, ZEBRAFISH BOOK; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	38	26	26	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1892	1908		10.1096/fj.11-194548	http://dx.doi.org/10.1096/fj.11-194548			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253474	Green Published			2022-12-25	WOS:000303680800018
J	Hashimoto, K; Eckert, C; Anschutz, U; Scholz, M; Held, K; Waadt, R; Reyer, A; Hippler, M; Becker, D; Kudla, J				Hashimoto, Kenji; Eckert, Christian; Anschuetz, Uta; Scholz, Martin; Held, Katrin; Waadt, Rainer; Reyer, Antonella; Hippler, Michael; Becker, Dirk; Kudla, Joerg			Phosphorylation of Calcineurin B-like (CBL) Calcium Sensor Proteins by Their CBL-interacting Protein Kinases (CIPKs) Is Required for Full Activity of CBL-CIPK Complexes toward Their Target Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; SIGNALING PATHWAY; REGULATES SALT; CA2+ SIGNALS; K+ CHANNEL; SOS2; ACTIVATION; DOMAIN; MECHANISMS; RESPONSES	Calcineurin B-like proteins (CBLs) represent a family of calcium sensor proteins that interact with a group of serine/threonine kinases designated as CBL-interacting protein kinases (CIPKs). CBL-CIPK complexes are crucially involved in relaying plant responses to many environmental signals and in regulating ion fluxes. However, the biochemical characterization of CBL-CIPK complexes has so far been hampered by low activities of recombinant CIPKs. Here, we report on an efficient wheat germ extract-based in vitro transcription/translation protocol that yields active full-length wild-type CIPK proteins. We identified a conserved serine residue within the C terminus of CBLs as being phosphorylated by their interacting CIPKs. Remarkably, our studies revealed that CIPK-dependent CBL phosphorylation is strictly dependent on CBL-CIPK interaction via the CIPK NAF domain. The phosphorylation status of CBLs does not appear to influence the stability, localization, or CIPK interaction of these calcium sensor proteins in general. However, proper phosphorylation of CBL1 is absolutely required for the in vivo activation of the AKT1 K+ channel by CBL1-CIPK23 and CBL9-CIPK23 complexes in oocytes. Moreover, we show that by combining CBL1, CIPK23, and AKT1, we can faithfully reconstitute CBL-dependent enhancement of phosphorylation of target proteins by CIPKs in vitro. In addition, we report that phosphorylation of CBL1 by CIPK23 is also required for the CBL1-dependent enhancement of CIPK23 activity toward its substrate. Together, these data identify a novel general regulatory mechanism of CBL-CIPK complexes in that CBL phosphorylation at their flexible C terminus likely provokes conformational changes that enhance specificity and activity of CBL-CIPK complexes toward their target proteins.	[Hashimoto, Kenji; Eckert, Christian; Scholz, Martin; Held, Katrin; Waadt, Rainer; Hippler, Michael; Kudla, Joerg] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Anschuetz, Uta; Reyer, Antonella; Becker, Dirk] Univ Wurzburg, Julius von Sachs Inst Mol Pflanzenphysiol & Bioph, D-97082 Wurzburg, Germany	University of Munster; University of Wurzburg	Kudla, J (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 4, D-48149 Munster, Germany.	jkudla@uni-muenster.de	Kudla, Jörg/C-2174-2012	Kudla, Jörg/0000-0002-8238-767X; Michael, Hippler/0000-0001-9670-6101; Reyer, Antonella/0000-0002-4993-8695; Waadt, Rainer/0000-0002-6772-3006; Becker, Dirk/0000-0003-0723-4160	Deutsche Forschungsgemeinschaft [964]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants within the frame of the Research Unit 964 (to D. B., M. H., and J. K.).	Akaboshi M, 2008, J MOL BIOL, V377, P246, DOI 10.1016/j.jmb.2008.01.006; Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geiger D, 2009, J BIOL CHEM, V284, P21288, DOI 10.1074/jbc.M109.017574; Gong DM, 2002, J BIOL CHEM, V277, P42088, DOI 10.1074/jbc.M205504200; Gong DM, 2002, PLANT PHYSIOL, V130, P256, DOI 10.1104/pp.004507; Gong DM, 2002, J BIOL CHEM, V277, P28340, DOI 10.1074/jbc.M107719200; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hedrich R, 2006, CELL, V125, P1221, DOI 10.1016/j.cell.2006.06.017; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Lin HX, 2009, PLANT CELL, V21, P1607, DOI 10.1105/tpc.109.066217; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mahajan S, 2006, FEBS J, V273, P907, DOI 10.1111/j.1742-4658.2006.05111.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Nagae M, 2003, ACTA CRYSTALLOGR D, V59, P1079, DOI 10.1107/S0907444903007029; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Sanchez-Barrena MJ, 2005, J MOL BIOL, V345, P1253, DOI 10.1016/j.jmb.2004.11.025; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Waadt Rainer, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4995; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Webb AAR, 1996, ADV BOT RES, V22, P45; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	69	118	142	6	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7956	7968		10.1074/jbc.M111.279331	http://dx.doi.org/10.1074/jbc.M111.279331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253446	Green Published, hybrid			2022-12-25	WOS:000301349400012
J	Krupka, M; Rivas, G; Rico, AI; Vicente, M				Krupka, Marcin; Rivas, German; Isabel Rico, Ana; Vicente, Miguel			Key Role of Two Terminal Domains in the Bidirectional Polymerization of FtsA Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSA; MEMBRANE TARGETING SEQUENCE; ACTIN-LIKE FTSA; Z-RING; SELF-INTERACTION; ZIPA; ULTRACENTRIFUGATION; LOCALIZATION; REGION	The effect of two different truncations involving either the 1C domain or the simultaneous absence of the S12-13 beta-strands of the FtsA protein from Streptococcus pneumoniae, located at opposite terminal sides in the molecular structure, suggests that they are essential for ATP-dependent polymerization. These two truncated proteins are not able to polymerize themselves but can be incorporated to some extent into the FtsA(+) polymers during the assembling process. Consequently, they block the growth of the FtsA(+) polymers and slow down the polymerization rate. The combined action of the two truncated proteins produces an additive effect on the inhibition of FtsA(+) polymerization, indicating that each truncation affects a different interaction site within the FtsA molecule.	[Krupka, Marcin; Isabel Rico, Ana; Vicente, Miguel] CSIC, CNB, Madrid 28049, Spain; [Rivas, German] CSIC, CIB, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Vicente, M (corresponding author), CSIC, CNB, C Darwin 3,Campus Cantoblanco, Madrid 28049, Spain.	mvicente@cnb.csic.es	Rivas, German/AAG-7458-2022; Rico, Ana Isabel/A-5242-2010; Rivas, German/AFL-7528-2022	Rivas, German/0000-0003-3450-7478; Rico, Ana Isabel/0000-0001-6021-3970; Rivas, German/0000-0003-3450-7478	Spanish Ministerio de Educacion y Ciencia [BIO2008-04478-C03]; European Commission [HEALTH-F3-2009-223431]; La Caixa Foundation	Spanish Ministerio de Educacion y Ciencia(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); La Caixa Foundation(La Caixa Foundation)	This work was supported by the Spanish Ministerio de Educacion y Ciencia through Grant BIO2008-04478-C03 and by the European Commission through Contract HEALTH-F3-2009-223431 (DIVINOCELL) (both to M. V. and G. R.).; A Ph.D. fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB).	Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carettoni D, 2003, PROTEINS, V50, P192, DOI 10.1002/prot.10244; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2007, J BACTERIOL, V189, P646, DOI 10.1128/JB.00992-06; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7756	7765		10.1074/jbc.M111.311563	http://dx.doi.org/10.1074/jbc.M111.311563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247552	hybrid, Green Published			2022-12-25	WOS:000301060200074
J	Dalmasso, M; Aubert, J; Briard-Bion, V; Chuat, V; Deutsch, SM; Even, S; Falentin, H; Jan, G; Jardin, J; Maillard, MB; Parayre, S; Piot, M; Tanskanen, J; Thierry, A				Dalmasso, Marion; Aubert, Julie; Briard-Bion, Valerie; Chuat, Victoria; Deutsch, Stephanie-Marie; Even, Sergine; Falentin, Helene; Jan, Gwenael; Jardin, Julien; Maillard, Marie-Bernadette; Parayre, Sandrine; Piot, Michel; Tanskanen, Jarna; Thierry, Anne			A Temporal -omic Study of Propionibacterium freudenreichii CIRM-BIA1(T) Adaptation Strategies in Conditions Mimicking Cheese Ripening in the Cold	PLOS ONE			English	Article							SUBSP SHERMANII; SWISS-CHEESE; LACTOCOCCUS-LACTIS; PROTEIN-SYNTHESIS; EXPRESSION; LACTATE; GENES; ACID; TRANSCRIPTOME; METABOLISM	Propionibacterium freudenreichii is used as a ripening culture in Swiss cheese manufacture. It grows when cheeses are ripened in a warm room (about 24 degrees C). Cheeses with an acceptable eye formation level are transferred to a cold room (about 4 degrees C), inducing a marked slowdown of propionic fermentation, but P. freudenreichii remains active in the cold. To investigate the P. freudenreichii strategies of adaptation and survival in the cold, we performed the first global gene expression profile for this species. The time-course transcriptomic response of P. freudenreichii CIRM-BIA1(T) strain was analyzed at five times of incubation, during growth at 30 degrees C then for 9 days at 4 degrees C, under conditions preventing nutrient starvation. Gene expression was also confirmed by RT-qPCR for 28 genes. In addition, proteomic experiments were carried out and the main metabolites were quantified. Microarray analysis revealed that 565 genes (25% of the protein-coding sequences of P. freudenreichii genome) were differentially expressed during transition from 30 degrees C to 4 degrees C (P < 0.05 and vertical bar fold change vertical bar > 1). At 4 degrees C, a general slowing down was observed for genes implicated in the cell machinery. On the contrary, P. freudenreichii CIRM-BIA1 T strain over-expressed genes involved in lactate, alanine and serine conversion to pyruvate, in gluconeogenesis, and in glycogen synthesis. Interestingly, the expression of different genes involved in the formation of important cheese flavor compounds, remained unchanged at 4 degrees C. This could explain the contribution of P. freudenreichii to cheese ripening even in the cold. In conclusion, P. freudenreichii remains metabolically active at 4 degrees C and induces pathways to maintain its long-term survival.	[Dalmasso, Marion; Chuat, Victoria] French Natl Inst Agr Res, Sci & Technol Lait & CEuf UMR1253, CIRM BIA, Rennes, France; [Dalmasso, Marion; Briard-Bion, Valerie; Chuat, Victoria; Deutsch, Stephanie-Marie; Even, Sergine; Falentin, Helene; Jan, Gwenael; Jardin, Julien; Maillard, Marie-Bernadette; Parayre, Sandrine; Piot, Michel; Thierry, Anne] AGROCAMPUS OUEST, Sci & Technol Lait & CEuf UMR1253, Rennes, France; [Aubert, Julie] French Natl Inst Agr Res, Math & Informat Appl UMR518, Paris, France; [Aubert, Julie] AgroParisTech, Math & Informat Appl UMR518, Paris, France; [Tanskanen, Jarna] Valio Ltd, Helsinki, Finland	INRAE; Institut Agro; Agrocampus Ouest; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Valio	Dalmasso, M (corresponding author), French Natl Inst Agr Res, Sci & Technol Lait & CEuf UMR1253, CIRM BIA, Rennes, France.	anne.thierry@rennes.inra.fr	Jan, Gwenael/K-6767-2014; AUBERT, Julie/AAJ-8960-2021; JARDIN, Julien/A-3241-2012; AUBERT, Julie/D-9120-2011; Thierry, Anne/AGH-4955-2022; Falentin, Hélène/ABD-2801-2020; Thierry, Anne/C-4760-2014; Thierry, Anne/AAX-1150-2020; Falentin, Helene/N-9088-2017	AUBERT, Julie/0000-0001-5203-5748; JARDIN, Julien/0000-0003-0520-9391; Thierry, Anne/0000-0002-9170-2889; Thierry, Anne/0000-0002-9170-2889; Falentin, Helene/0000-0001-6254-5303; Deutsch, Stephanie-Marie/0000-0002-5570-5193; Dalmasso, Marion/0000-0003-1875-2748	Tekes; INRA (French National Institute for Agricultural Research); Valio Ltd	Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); INRA (French National Institute for Agricultural Research); Valio Ltd	Along with Tekes, INRA (French National Institute for Agricultural Research) and Valio Ltd supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anastasiou R, 2006, INT J FOOD MICROBIOL, V108, P301, DOI 10.1016/j.ijfoodmicro.2005.11.015; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan YC, 2009, CRIT REV FOOD SCI NU, V49; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; CROW VL, 1986, APPL ENVIRON MICROB, V52, P352, DOI 10.1128/AEM.52.2.352-358.1986; CROW VL, 1986, APPL ENVIRON MICROB, V52, P359, DOI 10.1128/AEM.52.2.359-365.1986; Deborde C, 1999, METAB ENG, V1, P309, DOI 10.1006/mben.1999.0124; Deutsch SM, 2010, APPL ENVIRON MICROB, V76, P2740, DOI 10.1128/AEM.02591-09; Dherbecourt J, 2008, J APPL MICROBIOL, V105, P977, DOI 10.1111/j.1365-2672.2008.03830.x; Dherbecourt J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-16; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Eydallin G, 2010, DNA RES, V17, P61, DOI 10.1093/dnares/dsp028; Falentin H, 2010, INT J FOOD MICROBIOL, V144, P10, DOI 10.1016/j.ijfoodmicro.2010.06.003; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; FROHLICHWYDER MT, 2004, CHEESE CHEM PHYS MIC, V2, P141, DOI DOI 10.1016/S1874-558X(04)80042-3; Ganesan B, 2007, APPL ENVIRON MICROB, V73, P2498, DOI 10.1128/AEM.01832-06; Gilad O, 2010, APPL ENVIRON MICROB, V76, P7285, DOI 10.1128/AEM.00738-10; Gomez-Garcia MR, 2003, BIOCHEM BIOPH RES CO, V302, P601, DOI 10.1016/S0006-291X(03)00162-1; HOFHERR LA, 1983, J DAIRY SCI, V66, P1622, DOI 10.3168/jds.S0022-0302(83)81984-5; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jan G, 2001, APPL ENVIRON MICROB, V67, P2029, DOI 10.1128/AEM.67.5.2029-2036.2001; LANGSRUD T, 1973, J MILK FOOD TECHNOL, V36, P593, DOI 10.4315/0022-2747-36.12.593; Le Marechal C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-35; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Li SK, 2008, ARCH MICROBIOL, V189, P549, DOI 10.1007/s00203-007-0347-1; Liu H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-106; MALIK AC, 1968, CAN J MICROBIOL, V14, P1185, DOI 10.1139/m68-199; Pessione A, 2010, MOL BIOSYST, V6, P1419, DOI 10.1039/c001948h; Piette F, 2011, APPL ENVIRON MICROB, V77, P3881, DOI 10.1128/AEM.02757-10; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taibi A, 2011, INT J FOOD MICROBIOL, V146, P263, DOI 10.1016/j.ijfoodmicro.2011.02.034; Thieringer HA, 1998, BIOESSAYS, V20, P49; Thierry A, 2005, LAIT, V85, P57, DOI 10.1051/lait:2004036; Thierry A, 1998, LAIT, V78, P521, DOI 10.1051/lait:1998549; Thierry A, 2002, APPL ENVIRON MICROB, V68, P608, DOI 10.1128/AEM.68.2.608-615.2002; Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yvon M, 2011, INT DAIRY J, V21, P335, DOI 10.1016/j.idairyj.2010.11.010	46	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29083	10.1371/journal.pone.0029083	http://dx.doi.org/10.1371/journal.pone.0029083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253706	Green Submitted, Green Published, gold			2022-12-25	WOS:000301361500006
J	Hoogenboom, MO; Campbell, DA; Beraud, E; DeZeeuw, K; Ferrier-Pages, C				Hoogenboom, Mia O.; Campbell, Douglas A.; Beraud, Eric; DeZeeuw, Katrina; Ferrier-Pages, Christine			Effects of Light, Food Availability and Temperature Stress on the Function of Photosystem II and Photosystem I of Coral Symbionts	PLOS ONE			English	Article							2 SCLERACTINIAN CORALS; STYLOPHORA-PISTILLATA; CLIMATE-CHANGE; CHLOROPHYLL FLUORESCENCE; RADIATION INCREASES; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; CARBON; PHOTOSYNTHESIS; ZOOXANTHELLAE	Background: Reef corals are heterotrophic coelenterates that achieve high productivity through their photosynthetic dinoflagellate symbionts. Excessive seawater temperature destabilises this symbiosis and causes corals to "bleach," lowering their photosynthetic capacity. Bleaching poses a serious threat to the persistence of coral reefs on a global scale. Despite expanding research on the causes of bleaching, the mechanisms remain a subject of debate. Methodology/Principal Findings: This study determined how light and food availability modulate the effects of temperature stress on photosynthesis in two reef coral species. We quantified the activities of Photosystem II, Photosystem I and whole chain electron transport under combinations of normal and stressful growth temperatures, moderate and high light levels and the presence or absence of feeding of the coral hosts. Our results show that PS1 function is comparatively robust against temperature stress in both species, whereas PS2 and whole chain electron transport are susceptible to temperature stress. In the symbiotic dinoflagellates of Stylophora pistillata the contents of chlorophyll and major photosynthetic complexes were primarily affected by food availability. In Turbinaria reniformis growth temperature was the dominant influence on the contents of the photosynthetic complexes. In both species feeding the host significantly protected photosynthetic function from high temperature stress. Conclusions/Significance: Our findings support the photoinhibition model of coral bleaching and demonstrate that PS1 is not a major site for thermal damage during bleaching events. Feeding mitigates bleaching in two scleractinian corals, so that reef responses to temperature stresses will likely be influenced by the coinciding availabilities of prey for the host.	[Hoogenboom, Mia O.; Beraud, Eric; Ferrier-Pages, Christine] Ctr Sci Monaco, Ecophysiol & Ecol Res Team, Monaco, Monaco; [Campbell, Douglas A.; DeZeeuw, Katrina] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada	Mount Allison University	Hoogenboom, MO (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mia.hoogenboom1@jcu.edu.au	Hoogenboom, Mia O/D-3664-2012; Campbell, Douglas A./B-3768-2010	Hoogenboom, Mia O/0000-0003-3709-6344; Campbell, Douglas A./0000-0001-8996-5463; BERAUD, Eric/0000-0002-5223-9393; Ferrier-Pages, Christine/0000-0002-0357-4486	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Natural Sciences and Engineering Research Council of Canada; Mount Allison University	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mount Allison University	This study was funded by the Government of the Principality of Monaco through the Centre Scientifique de Monaco, the Natural Sciences and Engineering Research Council of Canada and Mount Allison University. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Bouchard JN, 2008, J EXP MAR BIOL ECOL, V359, P67, DOI 10.1016/j.jembe.2008.02.022; Brown BE, 2000, MAR ECOL PROG SER, V195, P117, DOI 10.3354/meps195117; Brown CM, 2008, MARINE BIOL, V151; Bruce D, 2004, ADV PHOTO RESPIRAT, V19, P497; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Campbell DA, 2003, PHYSIOL PLANTARUM, V119, P322, DOI 10.1034/j.1399-3054.2003.00175.x; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Ferrier-Pages C, 2007, BIOL BULL-US, V213, P76, DOI 10.2307/25066620; Ferrier-Pages C, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P215, DOI 10.1007/978-94-007-0114-4_15; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hill R, 2008, J PHYCOL, V44, P299, DOI 10.1111/j.1529-8817.2008.00468.x; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Leggat W, 2004, SYMBIOSIS, V37, P137; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 2001, MAR ECOL PROG SER, V212, P69, DOI 10.3354/meps212069; Lilley RM, 2010, PLANT CELL ENVIRON, V33, P995, DOI 10.1111/j.1365-3040.2010.02121.x; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; MacKenzie TDB, 2005, ARCH MICROBIOL, V183, P190, DOI 10.1007/s00203-005-0761-1; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Munekage Y, 2004, NATURE, V429, P581; Ogawa T, 2003, PHOTOSYNTH RES, V77, P105, DOI 10.1023/A:1025865500026; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Pompelli MF, 2010, J PLANT PHYSIOL, V167, P1052, DOI 10.1016/j.jplph.2010.03.001; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Whitney SM, 1998, AUST J PLANT PHYSIOL, V25, P131, DOI 10.1071/PP97131; Wilkinson C, 1999, AMBIO, V28, P188; Winters G, 2003, LIMNOL OCEANOGR, V48, P1388, DOI 10.4319/lo.2003.48.4.1388	63	56	56	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30167	10.1371/journal.pone.0030167	http://dx.doi.org/10.1371/journal.pone.0030167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253915	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000301361500036
J	Boyer, A; Yeh, JR; Zhang, XF; Paquet, M; Gaudin, A; Nagano, MC; Boerboom, D				Boyer, Alexandre; Yeh, Jonathan R.; Zhang, Xiangfan; Paquet, Marilene; Gaudin, Aurore; Nagano, Makoto C.; Boerboom, Derek			CTNNB1 Signaling in Sertoli Cells Downregulates Spermatogonial Stem Cell Activity via WNT4	PLOS ONE			English	Article							BETA-CATENIN; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; WNT/BETA-CATENIN; UP-REGULATION; GERM-CELLS; MOUSE; EXPRESSION; DIFFERENTIATION; MUTATION	Constitutive activation of the WNT signaling effector CTNNB1 (beta-catenin) in the Sertoli cells of the Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) mouse model results in progressive germ cell loss and sterility. In this study, we sought to determine if this phenotype could be due to a loss of spermatogonial stem cell (SSC) activity. Reciprocal SSC transplants between Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) and wild-type mice showed that SSC activity is lost in Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) testes over time, whereas the mutant testes could not support colonization by wild-type SSCs. Microarray analyses performed on cultured Sertoli cells showed that CTNNB1 induces the expression of genes associated with the female sex determination pathway, which was also found to occur in Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) testes. One CTNNB1 target gene encoded the secreted signaling molecule WNT4. We therefore tested the effects of WNT4 on SSC-enriched germ cell cultures, and found that WNT4 induced cell death and reduced SSC activity without affecting cell cycle. Conversely, conditional inactivation of Wnt4 in the Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) model rescued spermatogenesis and male fertility, indicating that WNT4 is the major effector downstream of CTNNB1 responsible for germ cell loss. Furthermore, WNT4 was found to signal via the CTNNB1 pathway in Sertoli cells, suggesting a self-reinforcing positive feedback loop. Collectively, these data indicate for the first time that ectopic activation of a signaling cascade in the stem cell niche depletes SSC activity through a paracrine factor. These findings may provide insight into the pathogenesis of male infertility, as well as embryonic gonadal development.	[Boyer, Alexandre; Gaudin, Aurore; Boerboom, Derek] Univ Montreal, Fac Med Vet, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ J2S 7C6, Canada; [Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Paquet, Marilene] McGill Univ, Comparat Med & Anim Resources Ctr, Montreal, PQ, Canada	Universite de Montreal; McGill University; McGill University	Boyer, A (corresponding author), Univ Montreal, Fac Med Vet, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ J2S 7C6, Canada.	derek.boerboom@umontreal.ca	Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636	Canadian Institutes of Health Research (CIHR) [MOP-102508, MOP-86532]; Natural Sciences and Engineering Research Council of Canada (NSERC) [340902-07]; Canada Research Chair in Ovarian Molecular Biology and Functional	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Ovarian Molecular Biology and Functional	This work was supported by the Canadian Institutes of Health Research (CIHR) operating grants MOP-102508 and MOP-86532, and by a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (340902-07) and the Canada Research Chair in Ovarian Molecular Biology and Functional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051; Brandon C, 2000, BLOOD, V96, P4132, DOI 10.1182/blood.V96.13.4132.h8004132_4132_4141; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chang H, 2009, BIOL REPROD, V81, P842, DOI 10.1095/biolreprod.109.077446; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; FLEISCHMAN RA, 1993, TRENDS GENET, V9, P285, DOI 10.1016/0168-9525(93)90015-A; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; KRAUSZ C, 1999, FRONT BIOSCI, V4, P1; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Millar JBA, 2002, GENOME BIOL, V3; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2004, SPERMATOGONIAL TRANS, P334; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; Shahid M, 2011, EUR J HUM GENET, V19, P23, DOI 10.1038/ejhg.2010.151; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273	55	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29764	10.1371/journal.pone.0029764	http://dx.doi.org/10.1371/journal.pone.0029764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253774	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100020
J	Guo, BS; Cheung, KK; Yeung, SS; Zhang, BT; Yeung, EW				Guo, Bao-Sheng; Cheung, Kwok-Kuen; Yeung, Simon S.; Zhang, Bao-Ting; Yeung, Ella W.			Electrical Stimulation Influences Satellite Cell Proliferation and Apoptosis in Unloading-Induced Muscle Atrophy in Mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; HINDLIMB SUSPENSION; SOLEUS MUSCLE; BCL-2 FAMILY; DENERVATION; GASTROCNEMIUS; MAINTENANCE; ACTIVATION; STRESS; YOUNG	Muscle atrophy caused by disuse is accompanied by adverse physiological and functional consequences. Satellite cells are the primary source of skeletal muscle regeneration. Satellite cell dysfunction, as a result of impaired proliferative potential and/or increased apoptosis, is thought to be one of the causes contributing to the decreased muscle regeneration capacity in atrophy. We have previously shown that electrical stimulation improved satellite cell dysfunction. Here we test whether electrical stimulation can also enhance satellite cell proliferative potential as well as suppress apoptotic cell death in disuse-induced muscle atrophy. Eight-week-old male BALB/c mice were subjected to a 14-day hindlimb unloading procedure. During that period, one limb (HU-ES) received electrical stimulation (frequency: 20 Hz; duration: 3 h, twice daily) while the contralateral limb served as control (HU). Immunohistochemistry and western blotting techniques were used to characterize specific proteins in cell proliferation and apoptosis. The HU-ES soleus muscles showed significant improvement in muscle mass, cross-sectional area, and peak tetanic force relative to the HU limb (p<0.05). The satellite cell proliferative activity as detected within the BrdU(+)/Pax7(+) population was significantly higher (p<0.05). The apoptotic myonuclei (detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) and the apoptotic satellite cells (detected by cleaved Poly [ADP-ribose] polymerase co-labeled with Pax7) were reduced (p<0.05) in the HU-ES limb. Furthermore the apoptosis-inducing factor and cleaved caspase-3 were down-regulated while the anti-apoptotic Bcl-2 protein was up-regulated (p<0.05), in the HU-ES limb. These findings suggest that the electrical stimulation paradigm provides an effective stimulus to rescue the loss of myonuclei and satellite cells in disuse muscle atrophy, thus maintaining a viable satellite cell pool for subsequent muscle regeneration. Optimization of stimulation parameters may enhance the outcome of the intervention.	[Guo, Bao-Sheng; Cheung, Kwok-Kuen; Yeung, Simon S.; Zhang, Bao-Ting; Yeung, Ella W.] Hong Kong Polytech Univ, Muscle Physiol Lab, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Guo, BS (corresponding author), Hong Kong Polytech Univ, Muscle Physiol Lab, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	ella.yeung@polyu.edu.hk	Zhang, Baoting/B-6273-2015; Guo, Baosheng/ABD-4800-2021; GUO, Baosheng/M-6023-2013; Yeung, Ella/D-6672-2011	Guo, Baosheng/0000-0002-4510-5418; YEUNG, Simon/0000-0002-9961-7347; Yeung, Ella/0000-0002-6396-1146; Cheung, Kwok Kuen/0000-0001-7367-9171; Zhang, Bao-Ting/0000-0003-1421-0212	The Hong Kong Polytechnic University; Development Fund for Niche Area [G-YJ42, 1-BB8D]; Innovation and Technology Commission, Government of Hong Kong Special Administrative Region, China [ITS/029/07]	The Hong Kong Polytechnic University(Hong Kong Polytechnic University); Development Fund for Niche Area; Innovation and Technology Commission, Government of Hong Kong Special Administrative Region, China	This work was supported by The Hong Kong Polytechnic University Central Research Grant, Development Fund for Niche Area (G-YJ42 and 1-BB8D to EWY), and the Innovation and Technology Commission, Government of Hong Kong Special Administrative Region, China (ITS/029/07 to SSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Baewer DV, 2004, J APPL PHYSIOL, V97, P930, DOI 10.1152/japplphysiol.00103.2004; BISCHOFF R, 1994, SATELLITE CELL MUSCL; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dargelos E, 2010, EXP CELL RES, V316, P115, DOI 10.1016/j.yexcr.2009.07.025; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Dupont AC, 2003, IEEE T NEUR SYS REH, V11, P218, DOI 10.1109/TNSRE.2003.817674; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Ellis S, 1984, Physiologist, V27, pS73; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Ferreira R, 2006, EUR J APPL PHYSIOL, V97, P340, DOI 10.1007/s00421-006-0197-6; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; GIBSON JNA, 1988, LANCET, V2, P767; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; HAYAT A, 1978, J PHYSIOL-PARIS, V74, P563; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Karalaki M, 2009, IN VIVO, V23, P779; Kim SJ, 2008, J APPL PHYSIOL, V105, P1246, DOI 10.1152/japplphysiol.90668.2008; Koryak Y, 2004, FUNCTIONAL ELECTROMY; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Mozdziak PE, 1998, EUR J APPL PHYSIOL O, V78, P136, DOI 10.1007/s004210050398; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Putman CT, 2001, J GERONTOL A-BIOL, V56, pB510, DOI 10.1093/gerona/56.12.B510; Reimann J, 2004, CELL TISSUE RES, V315, P233, DOI 10.1007/s00441-003-0833-y; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; SCHULTZ E, 1994, J APPL PHYSIOL, V76, P266, DOI 10.1152/jappl.1994.76.1.266; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Siu PM, 2009, FRONT BIOSCI-LANDMRK, V14, P432, DOI 10.2741/3253; Siu PM, 2005, AM J PHYSIOL-REG I, V289, pR1015, DOI 10.1152/ajpregu.00198.2005; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Turtikova O V, 2007, J Gravit Physiol, V14, pP95; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; WILLIAMS PE, 1978, J ANAT, V127, P459; Yeung EW, 2003, J PHYSIOL-LONDON, V552, P449, DOI 10.1113/jphysiol.2003.047373; Yeung EW, 2002, J APPL PHYSIOL, V92, P93, DOI 10.1152/jappl.2002.92.1.93; Zhang BT, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-87	49	71	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30348	10.1371/journal.pone.0030348	http://dx.doi.org/10.1371/journal.pone.0030348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253929	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100051
J	Li, J; Pandey, V; Kessler, T; Lehrach, H; Wierling, C				Li, Jian; Pandey, Vikash; Kessler, Thomas; Lehrach, Hans; Wierling, Christoph			Modeling of miRNA and Drug Action in the EGFR Signaling Pathway	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; DOWN-REGULATION; IN-VIVO; KINASE; CANCER; CARCINOMA; MIR-34A; GENES; TRANSCRIPTS; MODULATION	MicroRNAs have gained significant interest due to their widespread occurrence and diverse functions as regulatory molecules, which are essential for cell division, growth, development and apoptosis in eukaryotes. The epidermal growth factor receptor (EGFR) signaling pathway is one of the best investigated cellular signaling pathways regulating important cellular processes and its deregulation is associated with severe diseases, such as cancer. In this study, we introduce a systems biological model of the EGFR signaling pathway integrating validated miRNA-target information according to diverse studies, in order to demonstrate essential roles of miRNA within this pathway. The model consists of 1241 reactions and contains 241 miRNAs. We analyze the impact of 100 specific miRNA inhibitors (anit-miRNAs) on this pathway and propose that the embedded miRNA-network can help to identify new drug targets of the EGFR signaling pathway and thereby support the development of new therapeutic strategies against cancer.	[Li, Jian; Pandey, Vikash; Kessler, Thomas; Lehrach, Hans; Wierling, Christoph] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	Max Planck Society	Li, J (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.		Kessler, Thomas/AAY-5497-2020	kessler, Thomas/0000-0002-1693-4444; Wierling, Christoph/0000-0002-8856-8412	Germany Ministry of Research (BMBF) [0315428A]; NGFN [01GS08105]; Max Planck Society	Germany Ministry of Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NGFN; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Germany Ministry of Research (BMBF) within its MedSys program with the project PREDICT (No. 0315428A) and within its NGFN-Plus program with the project Mutanom (No. 01GS08105) (http://www.ngfn.de/index.php/ngfn_plus.html), and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Asslaber D, 2010, BLOOD, V115, P4191, DOI 10.1182/blood-2009-07-234823; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Bernardinello L, 1992, SURVEY BASIC NET MOD; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Chiocca EA, 2010, WORLD NEUROSURG, V73, P598, DOI 10.1016/j.wneu.2010.06.047; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Griffiths-Jones S, 2008, NAR, pD140; Gross ME, 2004, SEMIN ONCOL, V31, P9, DOI 10.1053/j.seminoncol.2004.01.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hemmati PG, 2010, J MOL MED, V88, P609, DOI 10.1007/s00109-010-0606-5; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iguchi Haruhisa, 2010, Curr Drug Discov Technol, V7, P95; Iravani M, 1997, ONCOGENE, V15, P2609, DOI 10.1038/sj.onc.1201428; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Klipp E, 2009, SYSTEM BIOL TXB, P68; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; MARKOWSKI CA, 1990, AM STAT, V44, P322, DOI 10.2307/2684360; Mei M, 2010, TECHNOL CANCER RES T, V9, P77, DOI 10.1177/153303461000900109; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Petri C. A., 1962, THESIS I INSTRUMENTE; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wierling Christoph, 2007, Briefings in Functional Genomics & Proteomics, V6, P240, DOI 10.1093/bfgp/elm027; WILLIAM M, 2008, NEW ENGL J MED, V359, P2641; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Yano S, 2003, ANTICANCER RES, V23, P3639; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	78	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30140	10.1371/journal.pone.0030140	http://dx.doi.org/10.1371/journal.pone.0030140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253908	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700094
J	Segev, A; Ramot, A; Akirav, I				Segev, Amir; Ramot, Assaf; Akirav, Irit			Stress Hormones Receptors in the Amygdala Mediate the Effects of Stress on the Consolidation, but Not the Retrieval, of a Non Aversive Spatial Task	PLOS ONE			English	Article							LONG-TERM POTENTIATION; OBJECT RECOGNITION; PREFRONTAL CORTEX; MEMORY RETRIEVAL; PSYCHOLOGICAL STRESS; INDUCED IMPAIRMENT; CB1 RECEPTOR; HIPPOCAMPUS; ACTIVATION; GLUCOCORTICOIDS	This study examined the effects of the arousal level of the rat and exposure to a behavioral stressor on acquisition, consolidation and retrieval of a non-aversive hippocampal-dependent learning paradigm, the object location task. Learning was tested under two arousal conditions: no previous habituation to the experimental context (high novelty stress/arousal level) or extensive prior habituation (reduced novelty stress/arousal level). Results indicated that in the habituated rats, exposure to an out-of-context stressor (i.e, elevated platform stress) impaired consolidation and retrieval, but not acquisition, of the task. Non-habituated animals under both stressed and control conditions did not show retention of the task. In habituated rats, RU-486 (10 ng/side), a glucocorticoid receptor (GR) antagonist, or propranolol (0.75 mu g/side), a beta-adrenergic antagonist, injected into the basolateral amygdala (BLA), prevented the impairing effects of the stressor on consolidation, but not on retrieval. The CB1/CB2 receptor agonist WIN55,212-2 (WIN, 5 mg/side) microinjected into the BLA did not prevent the effects of stress on either consolidation or retrieval. Taken together the results suggest that: (i) GR and beta-adrenergic receptors in the BLA mediate the impairing effects of stress on the consolidation, but not the retrieval, of a neutral, non-aversive hippocampal-dependent task, (ii) the impairing effects of stress on hippocampal consolidation and retrieval are mediated by different neural mechanisms (i. e., different neurotransmitters or different brain areas), and (iii) the effects of stress on memory depend on the interaction between several main factors such as the stage of memory processing under investigation, the animal's level of arousal and the nature of the task (neutral or aversive).	[Segev, Amir; Ramot, Assaf; Akirav, Irit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel	University of Haifa	Segev, A (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	irit.akirav@gmail.com		ramot, assaf/0000-0003-2851-9413	ISRAEL SCIENCE FOUNDATION [222/08]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	This research was supported by THE ISRAEL SCIENCE FOUNDATION (grant No. 222/08 to I. A.) (URL: http://www.isf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2002, J NEUROSCI, V22, P9912; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Akirav I, 2011, FRONT BEHAV NEUROSCI, V5, P2; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Alvares LD, 2006, BRAIN RES, V1075, P60, DOI 10.1016/j.brainres.2005.11.101; Bohus B, 1970, PROG BRAIN RES, V132, P171; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Cai WH, 2006, J NEUROSCI, V26, P9560, DOI 10.1523/JNEUROSCI.2397-06.2006; Conrad Cheryl D., 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P57, DOI 10.2201/nonlin.003.01.004; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Diamond DM, 1996, BEHAV NEUROSCI, V110, P661, DOI 10.1037/0735-7044.110.4.661; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; ENNACEUR A, 1994, EXP BRAIN RES, V100, P85; Ganon-Elazar E, 2011, NEUROPSYCHO IN PRESS; Ganon-Elazar E, 2009, J NEUROSCI, V29, P11078, DOI 10.1523/JNEUROSCI.1223-09.2009; Garcia R, 1997, NEUROSCI LETT, V233, P41, DOI 10.1016/S0304-3940(97)00621-6; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Holter SM, 2005, EUR J PHARMACOL, V510, P69, DOI 10.1016/j.ejphar.2005.01.008; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; KOVACS GL, 1977, HORM BEHAV, V8, P155, DOI 10.1016/0018-506X(77)90032-0; Liu L, 1999, BRAIN RES, V821, P134, DOI 10.1016/S0006-8993(99)01085-9; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McIntyre CK, 2003, BEHAV NEUROSCI, V117, P320, DOI 10.1037/0735-7044.117.2.320; Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2; Niyuhire F, 2007, PSYCHOPHARMACOLOGY, V191, P223, DOI 10.1007/s00213-006-0650-6; OITZL MS, 1992, BEHAV NEUROSCI, V106, P62, DOI 10.1037/0735-7044.106.1.62; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Pamplona FA, 2006, NEUROSCI LETT, V397, P88, DOI 10.1016/j.neulet.2005.12.026; Phan KL, 2008, J NEUROSCI, V28, P2313, DOI 10.1523/JNEUROSCI.5603-07.2008; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765; Roozendaal B, 1996, BRAIN RES, V709, P243, DOI 10.1016/0006-8993(95)01305-9; Roozendaal B, 2004, NEUROBIOL LEARN MEM, V81, P150, DOI 10.1016/j.nlm.2003.10.001; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Roozendaal B, 2007, LEARN MEMORY, V14, P29, DOI 10.1101/lm.403607; Sandi C, 1997, PSYCHOPHARMACOLOGY, V133, P152, DOI 10.1007/s002130050385; Tollenaar MS, 2009, NEUROBIOL LEARN MEM, V91, P23, DOI 10.1016/j.nlm.2008.08.002; Trneckova L, 2005, GEN PHYSIOL BIOPHYS, V24, P129; van Stegeren AH, 1998, PSYCHOPHARMACOLOGY, V138, P305, DOI 10.1007/s002130050675; Warburton EC, 2010, NEUROPSYCHOLOGIA, V48, P2262, DOI 10.1016/j.neuropsychologia.2009.12.022	54	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29988	10.1371/journal.pone.0029988	http://dx.doi.org/10.1371/journal.pone.0029988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253850	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700073
J	Zhong, YX; Liao, Y; Fang, SG; Tam, JP; Liu, DX				Zhong, Yanxin; Liao, Ying; Fang, Shouguo; Tam, James P.; Liu, Ding Xiang			Up-Regulation of Mcl-1 and Bak by Coronavirus Infection of Human, Avian and Animal Cells Modulates Apoptosis and Viral Replication	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BRONCHITIS VIRUS; DEPENDENT APOPTOSIS; OLIGOMERIZES BAK; PROTEIN-KINASE; CYTOCHROME-C; DEATH; BCL-2; P53; ADENOVIRUS	Virus-induced apoptosis and viral mechanisms that regulate this cell death program are key issues in understanding virushost interactions and viral pathogenesis. Like many other human and animal viruses, coronavirus infection of mammalian cells induces apoptosis. In this study, the global gene expression profiles are first determined in IBV-infected Vero cells at 24 hours post-infection by Affymetrix array, using avian coronavirus infectious bronchitis virus (IBV) as a model system. It reveals an up-regulation at the transcriptional level of both pro-apoptotic Bak and pro-survival myeloid cell leukemia-1 (Mcl-1). These results were further confirmed both in vivo and in vitro, in IBV-infected embryonated chicken eggs, chicken fibroblast cells and mammalian cells at transcriptional and translational levels, respectively. Interestingly, the onset of apoptosis occurred earlier in IBV-infected mammalian cells silenced with short interfering RNA targeting Mcl-1 (siMcl-1), and was delayed in cells silenced with siBak. IBV progeny production and release were increased in infected Mcl-1 knockdown cells compared to similarly infected control cells, while the contrary was observed in infected Bak knockdown cells. Furthermore, IBV infection-induced up-regulation of GADD153 regulated the expression of Mcl-1. Inhibition of the mitogen-activated protein/extracellular signal-regulated kinase (MEK/ERK) and phosphoinositide 3-kinase (PI3K/Akt) signaling pathways by chemical inhibitors and knockdown of GADD153 by siRNA demonstrated the involvement of ER-stress response in regulation of IBV-induced Mcl-1 expression. These results illustrate the sophisticated regulatory strategies evolved by a coronavirus to modulate both virus-induced apoptosis and viral replication during its replication cycle.	[Zhong, Yanxin; Liao, Ying; Fang, Shouguo; Tam, James P.; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhong, YX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	dxliu@ntu.edu.sg	Tam, James P/A-2176-2011; Liu, Ding Xiang/A-2226-2011	Tam, James P/0000-0003-4433-198X; 	Biomedical Research Council [BMRC 08/1/22/19.589]; Nanyang Technological University, Singapore [SUG M58080000]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported by a Biomedical Research Council grant (BMRC 08/1/22/19.589) and a grant from Nanyang Technological University (SUG M58080000), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Cao X, 2011, GENE THER; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dong L, 2011, ONCOGENE; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; King D. J., 1991, Diseases of poultry., P471; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kurokawa M, 1999, INT J MOL MED, V3, P527; Landman WJM, 2004, AVIAN PATHOL, V33, P591, DOI 10.1080/03079450400013170; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liao Y, 2011, VIROLOGY, V420, P106, DOI 10.1016/j.virol.2011.09.003; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; LIU DX, 1991, VIROLOGY, V185, P911, DOI 10.1016/0042-6822(91)90572-S; LIU DX, 1992, VIROLOGY, V186, P342, DOI 10.1016/0042-6822(92)90094-6; Liu TC, 2005, GENE THER, V12, P1333, DOI 10.1038/sj.gt.3302555; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Matthijs MGR, 2003, AVIAN PATHOL, V32, P473, DOI 10.1080/0307945031000154062; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mi J, 2001, HUM GENE THER, V12, P1343, DOI 10.1089/104303401750270995; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pearce AF, 2009, J VIROL, V83, P9102, DOI 10.1128/JVI.00436-09; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; PICAULT JP, 1986, AVIAN PATHOL, V15, P367, DOI 10.1080/03079458608436300; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Shen HY, 2009, J VIROL METHODS, V160, P48, DOI 10.1016/j.jviromet.2009.04.023; Shen S, 2004, VIROLOGY, V326, P288, DOI 10.1016/j.virol.2004.06.016; Shen S, 2003, VIROLOGY, V311, P16, DOI 10.1016/S0042-6822(03)00117-X; SHEN YQ, 1995, CURR OPIN GENET DEV, V5, P105, DOI 10.1016/S0959-437X(95)90061-6; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Wang YC, 2008, CANCER RES, V68, P2820, DOI 10.1158/0008-5472.CAN-07-1336; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Xu LH, 2011, J BIOL CHEM, V286, P39546, DOI 10.1074/jbc.M111.242206; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094	52	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30191	10.1371/journal.pone.0030191	http://dx.doi.org/10.1371/journal.pone.0030191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253918	Green Published, gold			2022-12-25	WOS:000301355700098
J	Peters, W; Drueppel, V; Kusche-Vihrog, K; Schubert, C; Oberleithner, H				Peters, Wladimir; Drueppel, Verena; Kusche-Vihrog, Kristina; Schubert, Carola; Oberleithner, Hans			Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CRATAEGUS EXTRACT; IN-VIVO; GLYCOCALYX; WS(R)-1442; SULFATE; FLOW; PROTEOGLYCAN; EFFICACY; BARRIER	The endothelial glycocalyx (eGC) plays a pivotal role in the physiology of the vasculature. By binding plasma proteins, the eGC forms the endothelial surface layer (ESL) which acts as an interface between bloodstream and endothelial cell surface. The functions of the eGC include mechanosensing of blood flow induced shear stress and thus flow dependent vasodilation. There are indications that levels of plasma sodium concentrations in the upper range of normal and beyond impair flow dependent regulation of blood pressure and may therefore increase the risk for hypertension. Substances therefore, that prevent sodium induced endothelial dysfunction may be attractive for the treatment of cardiovascular disease. By means of combined atomic force - epifluorescence microscopy we studied the impact of the hawthorn (Crcitaegus spp.) extract WS 1442, a herbal therapeutic with unknown mechanism of action, on the mechanics of the ESL of ex vivo murine aortae. Furthermore, we measured the impact of WS 1442 on the sodium permeability of endothelial EA.hy 926 cell rnonolayer. The data show that (i) the ESL contributes by about 11% to the total endothelial barrier resistance for sodium and (ii) WS 1442 strengthens the ESL resistance for sodium up to about 45%. This mechanism may explain some of the vasoprotective actions of this herbal therapeutic.	[Peters, Wladimir; Drueppel, Verena; Kusche-Vihrog, Kristina; Oberleithner, Hans] Univ Munster, Inst Physiol 2, Munster, Germany; [Schubert, Carola] Charite, Inst Gender Med, D-13353 Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Peters, W (corresponding author), Univ Munster, Inst Physiol 2, Munster, Germany.	petersw@uni-muenster.de		Schubert, Carola/0000-0002-9116-9105	Deutsche Forschungsgemeinschaft [OB63/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was supported by a Kosseleck grant to Hans Oberleithner (OB63/18) of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlMakdessi S, 1996, ARZNEIMITTELFORSCH, V46, P25; Anselm E, 2009, J CARDIOVASC PHARM, V53, P253, DOI 10.1097/FJC.0b013e31819ccfc9; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Brixius K, 2006, CARDIOVASC DRUG THER, V20, P177, DOI 10.1007/s10557-006-8723-7; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chatterjee SS, 1997, ARZNEIMITTEL-FORSCH, V47, P821; Curry FL, 2011, ANN BIOMED IN PRESS; Dvorak HF, 2010, CURR OPIN HEMATOL, V17, P225, DOI 10.1097/MOH.0b013e3283386638; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; Gao LJ, 2009, ANN BIOMED ENG, V37, P1781, DOI 10.1007/s10439-009-9743-9; Holubarsch CJF, 2008, EUR J HEART FAIL, V10, P1255, DOI 10.1016/j.ejheart.2008.10.004; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Iijima K, 2002, CIRCULATION, V105, P2404, DOI 10.1161/01.CIR.0000016349.36385.FB; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/NNANO.2009.77, 10.1038/nnano.2009.77]; Jacob M, 2006, ANESTHESIOLOGY, V104, P1223, DOI 10.1097/00000542-200606000-00018; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Koch E, 2011, PLANTA MED, V77, P1123, DOI 10.1055/s-0030-1270849; Koller M, 2006, MMW Fortschr Med, V148, P42; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Leuchtgens H, 1993, Fortschr Med, V111, P352; Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Oberleithner H, 2011, BLOOD PURIFICAT, V31, P82, DOI 10.1159/000321842; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Pries AR, 2005, AM J PHYSIOL-HEART C, V289, pH2657, DOI 10.1152/ajpheart.00297.2005; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Siegel G, 1996, BIOSENS BIOELECTRON, V11, P281, DOI 10.1016/0956-5663(96)88415-6; Siegel G, 1996, J AUTONOM NERV SYST, V57, P207, DOI 10.1016/0165-1838(95)00071-2; Sui XF, 2011, SMALL, V7, P1440, DOI 10.1002/smll.201002229; Tauchert M, 2002, AM HEART J, V143, P910, DOI 10.1067/mhj.2002.121463; Tauchert R, 1999, HERZ, V24, P465; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Tovar AMF, 2005, BBA-MOL BASIS DIS, V1740, P45, DOI 10.1016/j.bbadis.2005.02.008; Veveris M, 2004, LIFE SCI, V74, P1945, DOI 10.1016/j.lfs.2003.09.050; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Weikl A, 1996, Fortschr Med, V114, P291; Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100; Wilsie LC, 2003, J BIOL CHEM, V278, P15758, DOI 10.1074/jbc.M208786200; Yamashita K, 2004, GLYCOCONJUGATE J, V21, P31, DOI 10.1023/B:GLYC.0000043744.03329.f4; Yuan W, 2010, ANN BIOMED ENG, V38, P1463, DOI 10.1007/s10439-010-9920-x; Zapfe G, 2001, PHYTOMEDICINE, V8, P262, DOI 10.1078/0944-7113-00041; Zick SM, 2008, EUR J HEART FAIL, V10, P587, DOI 10.1016/j.ejheart.2008.04.008	46	34	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					264	270	e29972	10.1371/journal.pone.0029972	http://dx.doi.org/10.1371/journal.pone.0029972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253842	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900028
J	Schroder, E; Gebel, L; Eremeev, AA; Morgner, J; Grum, D; Knauer, SK; Bayer, P; Mueller, JW				Schroeder, Elisabeth; Gebel, Lena; Eremeev, Andrey A.; Morgner, Jessica; Grum, Daniel; Knauer, Shirley K.; Bayer, Peter; Mueller, Jonathan W.			Human PAPS Synthase Isoforms Are Dynamically Regulated Enzymes with Access to Nucleus and Cytoplasm	PLOS ONE			English	Article							IMPORTIN-ALPHA; EXPORT SIGNAL; LOCALIZATION SIGNALS; PROTEIN; BINDING; SULFATION; SULFOTRANSFERASES; SYNTHETASE-1; ASSOCIATION; ACTIVATION	In higher eukaryotes, PAPS synthases are the only enzymes producing the essential sulphate-donor 3'-phospho-adenosine-5'-phosphosulphate (PAPS). Recently, PAPS synthases have been associated with several genetic diseases and retroviral infection. To improve our understanding of their pathobiological functions, we analysed the intracellular localisation of the two human PAPS synthases, PAPSS1 and PAPSS2. For both enzymes, we observed pronounced heterogeneity in their subcellular localisation. PAPSS1 was predominantly nuclear, whereas PAPSS2 localised mainly within the cytoplasm. Treatment with the nuclear export inhibitor leptomycin B had little effect on their localisation. However, a mutagenesis screen revealed an Arg-Arg motif at the kinase interface exhibiting export activity. Notably, both isoforms contain a conserved N-terminal basic Lys-Lys-Xaa-Lys motif indispensable for their nuclear localisation. This nuclear localisation signal was more efficient in PAPSS1 than in PAPSS2. The activities of the identified localisation signals were confirmed by microinjection studies. Collectively, we describe unusual localisation signals of both PAPS synthase isoforms, mobile enzymes capable of executing their function in the cytoplasm as well as in the nucleus.	[Schroeder, Elisabeth; Knauer, Shirley K.] Univ Duisburg Essen, Dept Mol Biol 2, Ctr Med Biotechnol, Fac Biol, Essen, Germany; [Gebel, Lena; Eremeev, Andrey A.; Morgner, Jessica; Grum, Daniel; Bayer, Peter; Mueller, Jonathan W.] Univ Duisburg Essen, Dept Struct & Med Biochem, Ctr Med Biotechnol, Fac Biol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Knauer, SK (corresponding author), Univ Duisburg Essen, Dept Mol Biol 2, Ctr Med Biotechnol, Fac Biol, Essen, Germany.	shirley.knauer@uni-due.de; peter.bayer@uni-due.de; jonathan.mueller@uni-due.de	Bayer, Peter/B-8803-2009; Knauer, Shirley K/E-7931-2012; Mueller, Jonathan Wolf/D-1632-2010	Bayer, Peter/0000-0003-0435-7202; Knauer, Shirley K/0000-0003-4321-0924; Mueller, Jonathan Wolf/0000-0003-1212-189X	Deutsche Forschungsgemeinschaft (DFG) [GRK1431]; European Molecular Biology Organisation (EMBO) [ASTF 151/2011]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO))	Dr. Eremeev is a fellow of the graduate school GRK1431 funded by Deutsche Forschungsgemeinschaft (DFG). This study was funded in part by a fellowship from the European Molecular Biology Organisation (EMBO) to Dr. Mueller (ASTF 151/2011). Publication costs for this article were covered by the open access publishing program from Deutsche Forschungsgemeinschaft (DFG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Efthymiadis A, 1998, ARCH BIOCHEM BIOPHYS, V355, P254, DOI 10.1006/abbi.1998.0719; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Girard JP, 1998, FASEB J, V12, P603, DOI 10.1096/fasebj.12.7.603; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Gotoh I, 2007, GENES CELLS, V12, P105, DOI 10.1111/j.1365-2443.2006.01035.x; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Habtemichael N, 2010, GENE, V469, P9, DOI 10.1016/j.gene.2010.08.007; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; He DN, 2006, DRUG METAB DISPOS, V34, P1749, DOI 10.1124/dmd.106.011114; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Nowell S, 2006, ONCOGENE, V25, P1673, DOI 10.1038/sj.onc.1209376; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Shih WL, 2009, EUR J HUM GENET, V17, P1250, DOI 10.1038/ejhg.2009.48; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Thakurta AG, 2004, J BIOL CHEM, V279, P17434, DOI 10.1074/jbc.M309731200; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Verhagen J, 2006, J VIROL, V80, P10021, DOI 10.1128/JVI.01322-06	41	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29559	10.1371/journal.pone.0029559	http://dx.doi.org/10.1371/journal.pone.0029559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242175	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100029
J	Tagne, JB; Gupta, S; Gower, AC; Shen, SS; Varma, S; Lakshminarayanan, M; Cao, YX; Spira, A; Volkert, TL; Ramirez, MI				Tagne, Jean-Bosco; Gupta, Sumeet; Gower, Adam C.; Shen, Steven S.; Varma, Saaket; Lakshminarayanan, Meenakshi; Cao, Yuxia; Spira, Avrum; Volkert, Thomas L.; Ramirez, Maria I.			Genome-Wide Analyses of Nkx2-1 Binding to Transcriptional Target Genes Uncover Novel Regulatory Patterns Conserved in Lung Development and Tumors	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; FACTOR-I TTF-1; DEVELOPING MOUSE LUNG; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL-CELLS; C-MET; HUMAN CANCERS; CYCLIN B1; EXPRESSION; ADENOCARCINOMA	The homeodomain transcription factor Nkx2-1 is essential for normal lung development and homeostasis. In lung tumors, it is considered a lineage survival oncogene and prognostic factor depending on its expression levels. The target genes directly bound by Nkx2-1, that could be the primary effectors of its functions in the different cellular contexts where it is expressed, are mostly unknown. In embryonic day 11.5 (E11.5) mouse lung, epithelial cells expressing Nkx2-1 are predominantly expanding, and in E19.5 prenatal lungs, Nkx2-1-expressing cells are predominantly differentiating in preparation for birth. To evaluate Nkx2-1 regulated networks in these two cell contexts, we analyzed genome-wide binding of Nkx2-1 to DNA regulatory regions by chromatin immunoprecipitation followed by tiling array analysis, and intersected these data to expression data sets. We further determined expression patterns of Nkx2-1 developmental target genes in human lung tumors and correlated their expression levels to that of endogenous NKX2-1. In these studies we uncovered differential Nkx2-1 regulated networks in early and late lung development, and a direct function of Nkx2-1 in regulation of the cell cycle by controlling the expression of proliferation-related genes. New targets, validated in Nkx2-1 shRNA transduced cell lines, include E2f3, Cyclin B1, Cyclin B2, and c-Met. Expression levels of Nkx2-1 direct target genes identified in mouse development significantly correlate or anti-correlate to the levels of endogenous NKX2-1 in a dosage-dependent manner in multiple human lung tumor expression data sets, supporting alternative roles for Nkx2-1 as a transcriptional activator or repressor, and direct regulator of cell cycle progression in development and tumors.	[Tagne, Jean-Bosco; Varma, Saaket; Lakshminarayanan, Meenakshi; Cao, Yuxia; Ramirez, Maria I.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Gupta, Sumeet; Volkert, Thomas L.] Whitehead Inst Biomed Res, Ctr Microarray Technol, Cambridge, MA 02142 USA; [Gower, Adam C.; Spira, Avrum] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Shen, Steven S.; Spira, Avrum] Boston Univ, Sch Med, CTSI, Boston, MA 02118 USA	Boston University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Boston University; Boston University	Ramirez, MI (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	mramirez@bu.edu		Spira, Avrum/0000-0003-1467-0489; Cao, Yu-Xia/0000-0001-7396-9988; Ramirez, Maria Isabel/0000-0001-6294-4419; Tagne, Jean-Bosco/0000-0003-1830-9156; Shen, Steven/0000-0001-7725-1260; Gower, Adam/0000-0002-6122-7511	NHLBI [P01 HL047049]; NIH [UL1 RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047049] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI P01 HL047049 and NIH UL1 RR025771 (NIH URL http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinaga M, 2003, ONCOL REP, V10, P1381; ARNONE MI, 1995, J BIOL CHEM, V270, P12048, DOI 10.1074/jbc.270.20.12048; Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DEFELICE M, 1995, J BIOL CHEM, V270, P26649, DOI 10.1074/jbc.270.44.26649; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Elias LAB, 2008, NEURON, V59, P679, DOI 10.1016/j.neuron.2008.08.017; Feng Y, 2010, ONCOL REP, V23, P941, DOI 10.3892/or_00000718; Galambos C, 2010, AM J RESP CRIT CARE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hofmann HS, 2004, AM J RESP CRIT CARE, V170, P516, DOI 10.1164/rccm.200407-127OC; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Humbert PO, 2000, GENE DEV, V14, P690; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kimura S, 1999, BIOCHIMIE, V81, P321, DOI 10.1016/S0300-9084(99)80077-7; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Kumar AS, 1997, J BIOL CHEM, V272, P20764, DOI 10.1074/jbc.272.33.20764; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li CG, 2000, BIOCHEM BIOPH RES CO, V270, P462, DOI 10.1006/bbrc.2000.2443; Liu D, 2008, AM J PHYSIOL-LUNG C, V295, pL264, DOI 10.1152/ajplung.00069.2008; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Lu JN, 2005, J BIOL CHEM, V280, P4834, DOI 10.1074/jbc.M410714200; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Myong NH, 2003, J KOREAN MED SCI, V18, P494, DOI 10.3346/jkms.2003.18.4.494; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Peca D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-115; Perner S, 2009, J PATHOL, V217, P65, DOI 10.1002/path.2443; Powers S, 2008, CELL CYCLE, V7, P200, DOI 10.4161/cc.7.2.5284; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Reimer JJ, 2010, METHODS MOL BIOL, V631, P139, DOI 10.1007/978-1-60761-646-7_12; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007; Rigas JR, 2005, ONCOLOGIST, V10, P22, DOI 10.1634/theoncologist.10-1-22; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Silberschmidt D, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-9; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Stenhouse G, 2004, J CLIN PATHOL, V57, P383, DOI 10.1136/jcp.2003.007138; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Vias M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-17; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wert SE, 2002, DEV BIOL, V242, P75, DOI 10.1006/dbio.2001.0540; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zannini M, 1996, J BIOL CHEM, V271, P2249, DOI 10.1074/jbc.271.4.2249; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	71	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29907	10.1371/journal.pone.0029907	http://dx.doi.org/10.1371/journal.pone.0029907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242187	Green Submitted, Green Published, gold			2022-12-25	WOS:000312662100044
J	Tal, TL; Franzosa, JA; Tilton, SC; Philbrick, KA; Iwaniec, UT; Turner, RT; Waters, KM; Tanguay, RL				Tal, Tamara L.; Franzosa, Jill A.; Tilton, Susan C.; Philbrick, Kenneth A.; Iwaniec, Urszula T.; Turner, Russell T.; Waters, Katrina M.; Tanguay, Robert L.			MicroRNAs control neurobehavioral development and function in zebrafish	FASEB JOURNAL			English	Article						miR-9; miR-153; skeletal development	ETHANOL EXPOSURE; CONDITIONAL LOSS; GENE-EXPRESSION; BRAIN; ALCOHOL; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; MORPHOGENESIS; VARIANCE	microRNAs (miRNAs) have emerged as regulators of a broad spectrum of neurodevelopmental processes, including brain morphogenesis, neuronal differentiation, and survival. While the role of miRNAs in establishing and maintaining the developing nervous system is widely appreciated, the developmental neurobehavioral role of miRNAs has yet to be defined. Here we show that transient disruption of brain morphogenesis by ethanol exposure results in behavioral hyperactivity in larval zebrafish challenged with changes in lighting conditions. Aberrations in swimming activity persist in juveniles that were developmentally exposed to ethanol. During early neurogenesis, multiple gene expression profiling studies revealed widespread changes in mRNA and miRNA abundance in ethanol-exposed embryos. Consistent with a role for miRNAs in neurobehavioral development, target prediction analyses identified multiple miRNAs misexpressed in the ethanol-exposed cohorts that were also predicted to target inversely expressed transcripts known to influence brain morphogenesis. In vivo knockdown of miR9/9* or miR-153c persistently phenocopied the effect of ethanol on larval and juvenile swimming behavior. Structural analyses performed on adults showed that repression of miR-153c during development impacts craniofacial skeletal development. Together, these data support an integral role for miRNAs in the establishment of vertebrate neurobehavioral and skeletal systems.-Tal, T. L., Franzosa, J. A., Tilton, S. C., Philbrick, K. A., Iwaniec, U. T., Turner, R. T., Waters, K. M., Tanguay, R. L. MicroRNAs control neurobehavioral development and function in zebrafish. FASEB J. 26, 1452-1461 (2012). www.fasebj.org	[Tal, Tamara L.; Franzosa, Jill A.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, Corvallis, OR 97333 USA; [Philbrick, Kenneth A.; Iwaniec, Urszula T.; Turner, Russell T.] Oregon State Univ, Skeletal Biol Lab, Corvallis, OR 97333 USA; [Tilton, Susan C.; Waters, Katrina M.] Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA	Oregon State University; Oregon State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, 28645 E HWY 34, Corvallis, OR 97333 USA.	robert.tanguay@oregonstate.edu	Tal, Tamara/O-5414-2019	Tal, Tamara/0000-0001-8365-9385; Waters, Katrina/0000-0003-4696-5396; Philbrick, Kenneth/0000-0003-1424-6987	U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center [ES00210]; NIEHS [T32ES7060]; Oregon State University (OSU) Linus Pauling Institute; Superfund Basic Research Program [NIEHS P42 ES016465]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210, P42ES016465, T32ES007060] Funding Source: NIH RePORTER	U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Oregon State University (OSU) Linus Pauling Institute; Superfund Basic Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center grant ES00210, NIEHS training grant T32ES7060, an Oregon State University (OSU) Linus Pauling Institute grant to R. L. T., and Superfund Basic Research Program grant NIEHS P42 ES016465 to R. L. T. and K. M. W. The authors declare no conflicts of interest. The authors are grateful to Katrine Saili and Britton Goodale for their critical review of the manuscript. The authors are grateful to Carrie Barton, Cari Buchner, Brittany McCauslin, and the staff at the OSU Sinnhuber Aquatic Research Laboratory for exemplary fish husbandry and technical expertise. The authors thank Dawn Olsen for her assistance with skeletal analysis, Hao Truong for developing custom PERL software used to process locomotion data, and Gregory Gonnerman for providing body length measurements for the juvenile locomotion studies.	Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilotta J, 2004, NEUROTOXICOL TERATOL, V26, P737, DOI 10.1016/j.ntt.2004.06.011; Blaser R. E., PHARM BIOCH BEHAV, V95, P278; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P529; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; HAGINS WA, 1970, BIOPHYS J, V10, P380, DOI 10.1016/S0006-3495(70)86308-1; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Staddon JER, 2010, J EXP ANAL BEHAV, V94, P261, DOI 10.1901/jeab.2010.94-261; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039	57	58	60	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1452	1461		10.1096/fj.11-194464	http://dx.doi.org/10.1096/fj.11-194464			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22253472	Green Published			2022-12-25	WOS:000302359700008
J	Arima, Y; Hayashi, H; Sasaki, M; Hosonaga, M; Goto, TM; Chiyoda, T; Kuninaka, S; Shibata, T; Ohata, H; Nakagama, H; Taya, Y; Saya, H				Arima, Yoshimi; Hayashi, Hidemi; Sasaki, Mikako; Hosonaga, Mari; Goto, Takaaki M.; Chiyoda, Tatsuyuki; Kuninaka, Shinji; Shibata, Tatsuhiro; Ohata, Hirokazu; Nakagama, Hitoshi; Taya, Yoichi; Saya, Hideyuki			Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; MIR-200 FAMILY; FEEDBACK LOOP; TRANSITION; CELLS; INVASION; METASTASIS; EXPRESSION; PLASTICITY	We previously showed that depletion of the retinoblastoma protein (RB) induces down-regulation of the adhesion molecule E-cadherin and thereby triggers the epithelial-mesenchymal transition. To further characterize the effect of RB inactivation on the phenotype of cancer cells, we have now examined RB expression in human breast cancer cell lines and clinical specimens. We found that RB-inactive cells exhibit a mesenchymal-like morphology and are highly invasive. We also found that ZEB proteins, transcriptional repressors of the E-cadherin gene, are markedly up-regulated in these cells in a manner sensitive to the miR-200 family of microRNAs. Moreover, depletion of ZEB in RB-inactive cells suppressed cell invasiveness and proliferation and induced epithelial marker expression. These results implicate ZEB in induction of the epithelial-mesenchymal transition, as well as in maintenance of the mesenchymal phenotype in RB-inactive cells. We also developed a screening program for inhibitors of ZEB1 expression and thereby identified several cyclin-dependent kinase inhibitors that blocked both ZEB1 expression and RB phosphorylation. Together, our findings suggest that RB inactivation contributes to tumor progression not only through loss of cell cycle control but also through up-regulation of ZEB expression and induction of an invasive phenotype.	[Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan; [Arima, Yoshimi; Sasaki, Mikako; Goto, Takaaki M.; Chiyoda, Tatsuyuki; Kuninaka, Shinji; Saya, Hideyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Hayashi, Hidemi] Link Genom Inc, Dept Biomed Res & Dev, Tokyo 1030024, Japan; [Hosonaga, Mari] Tokyo Med Univ, Dept Breast Oncol, Tokyo 1600023, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo 1040045, Japan; [Ohata, Hirokazu] Natl Canc Ctr, Div Canc Differentiat, Tokyo 1040045, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Tokyo 1040045, Japan; [Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore	Keio University; Japan Science & Technology Agency (JST); Tokyo Medical University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National University of Singapore	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hsaya@a5.keio.jp	Chiyoda, Tatsuyuki/K-9325-2013; Arima, Yoshimi/J-8057-2013; Shibata, Tatsuhiro/AAO-1278-2021; Chiyoda, Tatsuyuki/Q-1971-2019; Kuninaka, Shinji/J-7158-2013; Saya, Hideyuki/J-4325-2013; Chiyoda, Tatsuyuki/GLR-5573-2022; Shibata, Tatsuhiro/ABA-8234-2020	Chiyoda, Tatsuyuki/0000-0002-8214-2242; Saya, Hideyuki/0000-0001-6610-1902; Arima, Yoshimi/0000-0002-2384-1406	Ministry of Health and Welfare of Japan; Keio University; MEXT; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Keio University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health and Welfare of Japan (to H. S.), a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (to Y. A.), and a Grant-in-Aid for Young Scientists (B) from MEXT (to Y. A.).; We thank E. Knudsen for providing Ad-RB Am; T. Yamori for providing the Screening Committee of Anticancer Drugs (SCADS) inhibitor kits I, II, and III, which is supported by a Grant-in-Aid for Scientific Research on Priority Area "Cancer" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Y. Hata (Link Genomics Inc.), K. Hizume (Shimadzu Corporation); K. Matsumoto for technical assistance; and laboratory members for discussion.	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dasgupta P, 2006, CURR MOL MED, V6, P719; Dawson S J, 2009, Eur J Cancer, V45 Suppl 1, P27, DOI 10.1016/S0959-8049(09)70013-9; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hajra KM, 2002, CANCER RES, V62, P1613; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kong DX, 2010, BIOL PHARM BULL, V33, P1600, DOI 10.1248/bpb.33.1600; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	26	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7896	7906		10.1074/jbc.M111.313759	http://dx.doi.org/10.1074/jbc.M111.313759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262832	Green Published, hybrid			2022-12-25	WOS:000301349400006
J	Zhou, BY; Liu, YX; Kahn, M; Ann, DK; Han, A; Wang, HJ; Nguyen, C; Flodby, P; Zhong, Q; Krishnaveni, MS; Liebler, JM; Minoo, P; Crandall, ED; Borok, Z				Zhou, Beiyun; Liu, Yixin; Kahn, Michael; Ann, David K.; Han, Arum; Wang, Hongjun; Cu Nguyen; Flodby, Per; Zhong, Qian; Krishnaveni, Manda S.; Liebler, Janice M.; Minoo, Parviz; Crandall, Edward D.; Borok, Zea			Interactions Between beta-Catenin and Transforming Growth Factor-beta Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; GENE-EXPRESSION; MYOFIBROBLAST TRANSITION; EXTRACELLULAR-MATRIX; DIFFERENTIAL ROLES; CELL TRANSITION; WNT PATHWAYS; SMAD3; P300	Interactions between transforming growth factor-beta (TGF-beta) and Wnt are crucial to many biological processes, although specific targets, rationale for divergent outcomes (differentiation versus block of epithelial proliferation versus epithelial-mesenchymal transition (EMT)) and precise mechanisms in many cases remain unknown. We investigated beta-catenin-dependent and transforming growth factor-beta 1 (TGF-beta 1) interactions in pulmonary alveolar epithelial cells (AEC) in the context of EMT and pulmonary fibrosis. We previously demonstrated that ICG-001, a small molecule specific inhibitor of the beta-catenin/CBP (but not beta-catenin/p300) interaction, ameliorates and reverses pulmonary fibrosis and inhibits TGF-beta 1-mediated alpha-smooth muscle actin (alpha-SMA) and collagen induction in AEC. We now demonstrate that TGF-beta 1 induces LEF/TCF TOPFLASH reporter activation and nuclear beta-catenin accumulation, while LiCl augments TGF-beta-induced alpha-SMA expression, further confirming co-operation between beta-catenin- and TGF-beta-dependent signaling pathways. Inhibition and knockdown of Smad3, knockdown of beta-catenin and overexpression of ICAT abrogated effects of TGF-beta 1 on alpha-SMA transcription/expression, indicating a requirement for beta-catenin in these Smad3-dependent effects. Following TGF-beta treatment, co-immunoprecipitation demonstrated direct interaction between endogenous Smad3 and beta-catenin, while chromatin immunoprecipitation (ChIP)re-ChIP identified spatial and temporal regulation of alpha-SMA via complex formation among Smad3, beta-catenin, and CBP. ICG-001 inhibited alpha-SMA expression/transcription in response to TGF-beta as well as alpha-SMA promoter occupancy by beta-catenin and CBP, demonstrating a previously unknown requisite TGF-beta 1/beta-catenin/CBP-mediated pro-EMT signaling pathway. Clinical relevance was shown by beta-catenin/Smad3 co-localization and CBP expression in AEC of IPF patients. These findings suggest a new therapeutic approach to pulmonary fibrosis by specifically uncoupling CBP/catenin-dependent signaling downstream of TGF-beta.	[Zhou, Beiyun; Liu, Yixin; Wang, Hongjun; Flodby, Per; Zhong, Qian; Krishnaveni, Manda S.; Liebler, Janice M.; Crandall, Edward D.; Borok, Zea] Univ So Calif, Will Rogers Inst Pulm, Res Ctr, Div Pulm & Crit Care Med,Dept Med, Los Angeles, CA 90033 USA; [Kahn, Michael; Cu Nguyen; Borok, Zea] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Minoo, Parviz] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90033 USA; [Han, Arum] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90033 USA; [Ann, David K.] City Hope Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope	Borok, Z (corresponding author), IRD 620,2020 Zonal Ave, Los Angeles, CA 90033 USA.	zborok@usc.edu	Borok, Zea/J-9015-2013; CRANDALL, EDWARD/AAD-8382-2020	Borok, Zea/0000-0001-8673-8177; Wu, Arum/0000-0003-1038-7176	National Institutes of Health. [DE014183, DE010742, ES017034, ES018782, HL038578, HL038621, HL056590, HL062569, HL089445, HL073722, HL095349]; Hastings Foundation; Whittier Foundation; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073722, R01HL095349, R01HL038578, R37HL038578, R01HL038621, R01HL056590, R01HL062569, R37HL062569, R01HL089445, R01HL112638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018782, R01ES017034] Funding Source: NIH RePORTER	National Institutes of Health.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; Whittier Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Grants DE014183 (to D. K. A.), DE010742 (to D. K. A.), ES017034 (to E. D. C.), ES018782 (to E. D. C.), HL038578 (to Z. B.), HL038621 (to E. D. C.), HL056590 (to P. M.), HL062569 (to Z. B.), HL089445 (to Z. B.), HL073722 (to M. K.), and HL095349 (to P. M.) from the National Institutes of Health. This work was also supported by the Hastings Foundation and the Whittier Foundation.	Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Dong YF, 2005, J CELL BIOCHEM, V95, P1057, DOI 10.1002/jcb.20466; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Han MLK, 2010, RESP MED, V104, P724, DOI 10.1016/j.rmed.2009.11.019; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; LaGamba D, 2005, DEV DYNAM, V234, P132, DOI 10.1002/dvdy.20489; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Minoo P, 2010, INT J BIOCHEM CELL B, V42, P809, DOI 10.1016/j.biocel.2010.02.011; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian XX, 2009, BIOCHEM BIOPH RES CO, V380, P478, DOI 10.1016/j.bbrc.2009.01.124; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	59	193	201	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7026	7038		10.1074/jbc.M111.276311	http://dx.doi.org/10.1074/jbc.M111.276311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241478	Green Published, hybrid			2022-12-25	WOS:000301060200008
J	Ciganda, M; Williams, N				Ciganda, Martin; Williams, Noreen			Characterization of a Novel Association between Two Trypanosome-Specific Proteins and 5S rRNA	PLOS ONE			English	Article							BINDING-PROTEINS; 5S-RIBOSOMAL RNA; HELIX-III; BRUCEI; L5; BIOGENESIS; BULGE; PARTICLE; DOMAIN	P34 and P37 are two previously identified RNA binding proteins in the flagellate protozoan Trypanosoma brucei. RNA interference studies have determined that the proteins are essential and are involved in ribosome biogenesis. Here, we show that these proteins interact in vitro with the 5S rRNA with nearly identical binding characteristics in the absence of other cellular factors. The T. brucei 5S rRNA has a complex secondary structure and presents four accessible loops (A to D) for interactions with RNA-binding proteins. In other eukaryotes, loop C is bound by the L5 ribosomal protein and loop A mainly by TFIIIA. The binding of P34 and P37 to T. brucei 5S rRNA involves the LoopA region of the RNA, but these proteins also protect the L5 binding site located on LoopC.	[Ciganda, Martin] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ciganda, M (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	nw1@buffalo.edu			NIH [GM09271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NIH GM09271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; CHOW CS, 1992, BIOCHEMISTRY-US, V31, P3534, DOI 10.1021/bi00128a030; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; DELIHAS N, 1982, NUCLEIC ACIDS RES, V10, P7323, DOI 10.1093/nar/10.22.7323; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Gate JH, 1996, SCIENCE, V273, P1696, DOI 10.1126/science.273.5282.1696; Hellman KM, 2007, EUKARYOT CELL, V6, P1766, DOI 10.1128/EC.00119-07; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Huber PW, 2001, J MOL BIOL, V312, P823, DOI 10.1006/jmbi.2001.4966; LARSON DE, 1991, BIOCHEM CELL BIOL, V69, P5, DOI 10.1139/o91-002; LUEHRSEN KR, 1981, P NATL ACAD SCI-BIOL, V78, P2150, DOI 10.1073/pnas.78.4.2150; MICHAELI S, 1990, MOL BIOCHEM PARASIT, V41, P7, DOI 10.1016/0166-6851(90)90091-Y; Neely LS, 1999, J MOL BIOL, V291, P549, DOI 10.1006/jmbi.1999.2985; Pitula J, 2002, BIOCHEM BIOPH RES CO, V290, P569, DOI 10.1006/bbrc.2001.6226; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Sarzynska J, 2000, BIOPHYS J, V79, P1213, DOI 10.1016/S0006-3495(00)76376-4; Schneider H, 2010, BIOL CELL, V102, P469, DOI 10.1042/BC20100034; Scripture JB, 2011, BIOCHEMISTRY-US, V50, P3827, DOI 10.1021/bi200286e; SCRIPTURE JB, 1995, J BIOL CHEM, V270, P27358, DOI 10.1074/jbc.270.45.27358; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; STEITZ JA, 1988, J CELL BIOL, V106, P545, DOI 10.1083/jcb.106.3.545; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Szymanski M, 2000, MOL BIOL EVOL, V17, P1194, DOI 10.1093/oxfordjournals.molbev.a026402; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Xiong Y, 2000, RNA, V6, P1316, DOI 10.1017/S135583820000090X; ZANG WQ, 1995, J MOL BIOL, V245, P549, DOI 10.1006/jmbi.1994.0045; Zhang J, 1998, MOL BIOCHEM PARASIT, V92, P79, DOI 10.1016/S0166-6851(97)00228-4; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1; ZIMMERN D, 1977, CELL, V11, P455, DOI 10.1016/0092-8674(77)90064-2	34	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30029	10.1371/journal.pone.0030029	http://dx.doi.org/10.1371/journal.pone.0030029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253864	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100036
J	Mintzer, R; Ramaswamy, S; Shah, K; Hannoush, RN; Pozniak, CD; Cohen, F; Zhao, XR; Plise, E; Lewcock, JW; Heise, CE				Mintzer, Robert; Ramaswamy, Sreemathy; Shah, Kinjalkumar; Hannoush, Rami N.; Pozniak, Christine D.; Cohen, Frederick; Zhao, Xianrui; Plise, Emile; Lewcock, Joseph W.; Heise, Christopher E.			A Whole Cell Assay to Measure Caspase-6 Activity by Detecting Cleavage of Lamin A/C	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; HUNTINGTONS-DISEASE; ALZHEIMER-DISEASE; ACTIVATION; APOPTOSIS; INHIBITORS; PEPTIDE; DEATH; DEGENERATION; SELECTIVITY	Caspase-6 is a cysteinyl protease implicated in neurodegenerative conditions including Alzheimer's and Huntington's disease making it an attractive target for therapeutic intervention. A greater understanding of the role of caspase-6 in disease has been hampered by a lack of suitable cellular assays capable of specifically detecting caspase-6 activity in an intact cell environment. This is mainly due to the use of commercially available peptide substrates and inhibitors which lack the required specificity to facilitate development of this type of assay. We report here a 384-well whole-cell chemiluminescent ELISA assay that monitors the proteolytic degradation of endogenously expressed lamin A/C during the early stages of caspase-dependent apoptosis. The specificity of lamin A/C proteolysis by caspase-6 was demonstrated against recombinant caspase family members and further confirmed in genetic deletion studies. In the assay, plasma membrane integrity remained intact as assessed by release of lactate dehydrogenase from the intracellular environment and the exclusion of cell impermeable peptide inhibitors, despite the induction of an apoptotic state. The method described here is a robust tool to support drug discovery efforts targeting caspase-6 and is the first reported to specifically monitor endogenous caspase-6 activity in a cellular context.	[Mintzer, Robert; Ramaswamy, Sreemathy; Shah, Kinjalkumar; Heise, Christopher E.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Pozniak, Christine D.; Lewcock, Joseph W.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Cohen, Frederick; Zhao, Xianrui] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Plise, Emile] Genentech Inc, Dept Drug Metab & PK, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Mintzer, R (corresponding author), Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA.	heise.christopher@gene.com						Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chang HK, 2008, [Caspase Inhibitors Based on Pyridazinone Scaffold, WO], Patent No. [2008/056897, 2008056897]; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fennell M, 2006, J BIOMOL SCREEN, V11, P296, DOI 10.1177/1087057105284618; Figueroa RA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-35; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Knegtel R, 2004, [Caspase Inhibitors and Uses Thereof., WO], Patent No. [2004/002961, 2004002961]; Komoriya A, 2000, J EXP MED, V191, P1819, DOI 10.1084/jem.191.11.1819; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Leyva MJ, 2010, CHEM BIOL, V17, P1189, DOI 10.1016/j.chembiol.2010.08.014; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maxwell D, 2009, BIOCONJUGATE CHEM, V20, P702, DOI 10.1021/bc800516n; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Mounkes LC, 2001, TRENDS CARDIOVAS MED, V11, P280, DOI 10.1016/S1050-1738(01)00126-8; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Packard BZ, 2008, METHOD ENZYMOL, V450, P1, DOI 10.1016/S0076-6879(08)03401-0; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang HZ, 2003, BIOCONJUGATE CHEM, V14, P458, DOI 10.1021/bc0256188	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30376	10.1371/journal.pone.0030376	http://dx.doi.org/10.1371/journal.pone.0030376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253931	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100053
J	Peel, AJ; Baker, KS; Crameri, G; Barr, JA; Hayman, DTS; Wright, E; Broder, CC; Fernandez-Loras, A; Fooks, AR; Wang, LF; Cunningham, AA; Wood, JLN				Peel, Alison J.; Baker, Kate S.; Crameri, Gary; Barr, Jennifer A.; Hayman, David T. S.; Wright, Edward; Broder, Christopher C.; Fernandez-Loras, Andres; Fooks, Anthony R.; Wang, Lin-Fa; Cunningham, Andrew A.; Wood, James L. N.			Henipavirus Neutralising Antibodies in an Isolated Island Population of African Fruit Bats	PLOS ONE			English	Article							EIDOLON-HELVUM; VIRUS-INFECTION; PTEROPUS-VAMPYRUS; RESERVOIR HOSTS; HENDRA VIRUS; NIPAH VIRUS; RABIES; LYSSAVIRUSES; MEGACHIROPTERA; REPRODUCTION	Isolated islands provide valuable opportunities to study the persistence of viruses in wildlife populations, including population size thresholds such as the critical community size. The straw-coloured fruit bat, Eidolon helvum, has been identified as a reservoir for henipaviruses (serological evidence) and Lagos bat virus (LBV; virus isolation and serological evidence) in continental Africa. Here, we sampled from a remote population of E. helvum annobonensis fruit bats on Annobon island in the Gulf of Guinea to investigate whether antibodies to these viruses also exist in this isolated subspecies. Henipavirus serological analyses (Luminex multiplexed binding and inhibition assays, virus neutralisation tests and western blots) and lyssavirus serological analyses (LBV: modified Fluorescent Antibody Virus Neutralisation test, LBV and Mokola virus: lentivirus pseudovirus neutralisation assay) were undertaken on 73 and 70 samples respectively. Given the isolation of fruit bats on Annobon and their lack of connectivity with other populations, it was expected that the population size on the island would be too small to allow persistence of viruses that are thought to cause acute and immunising infections. However, the presence of antibodies against henipaviruses was detected using the Luminex binding assay and confirmed using alternative assays. Neutralising antibodies to LBV were detected in one bat using both assays. We demonstrate clear evidence for exposure of multiple individuals to henipaviruses in this remote population of E. helvum annobonensis fruit bats on Annobon island. The situation is less clear for LBV. Seroprevalences to henipaviruses and LBV in Annobon are notably different to those in E. helvum in continental locations studied using the same sampling techniques and assays. Whilst cross-sectional serological studies in wildlife populations cannot provide details on viral dynamics within populations, valuable information on the presence or absence of viruses may be obtained and utilised for informing future studies.	[Peel, Alison J.; Baker, Kate S.; Hayman, David T. S.; Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Peel, Alison J.; Baker, Kate S.; Hayman, David T. S.; Fernandez-Loras, Andres; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Crameri, Gary; Barr, Jennifer A.; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Hayman, David T. S.; Fooks, Anthony R.] Vet Labs Agcy, Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Hayman, David T. S.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Wright, Edward] Univ Westminster, Sch Life Sci, London W1R 8AL, England; [Wright, Edward] UCL, Div Infect & Immun, London, England; [Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD USA	University of Cambridge; Zoological Society of London; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Veterinary Laboratories Agency; Colorado State University; University of Westminster; University of London; University College London; Uniformed Services University of the Health Sciences - USA	Peel, AJ (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	alisonpeel@gmail.com	Barr, Jennifer A/H-9254-2013; Cunningham, Andrew A/E-7536-2010; Broder, Christopher/E-1169-2013; Baker, Kate/P-2087-2016; Peel, Alison J/I-3202-2012; Wood, James/A-1626-2008; Crameri, Gary/H-8441-2013; wang, lin/GSE-3040-2022; Fooks, Anthony R/F-5418-2010	Baker, Kate/0000-0001-5850-1949; Peel, Alison J/0000-0003-3538-3550; Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Barr, Jennifer/0000-0001-5266-9142; Wright, Edward/0000-0001-7041-5138; Hayman, David/0000-0003-0087-3015	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge; Charles Slater Trust; Zebra Foundation for Veterinary Zoological Education; Wellcome Trust; Science and Technology Directorate, Department of Homeland Security, USA; Department for Environment, Food and Rural Affairs (Defra) [SEV3500]; Royal Society; UK Medical Research Council [G0801176]; Medical Research Council [G0801176] Funding Source: researchfish; MRC [G0801176] Funding Source: UKRI	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge(University of Cambridge); Charles Slater Trust; Zebra Foundation for Veterinary Zoological Education; Wellcome Trust(Wellcome Trust); Science and Technology Directorate, Department of Homeland Security, USA; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Society(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the Cambridge Infectious Diseases Consortium, University of Cambridge and the Institute of Zoology, Zoological Society of London. The Charles Slater Trust and the Zebra Foundation for Veterinary Zoological Education provided travel grants to AJP. DTSH and KSB are funded by the Wellcome Trust. DTSH, ARF and JLNW are funded by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, USA. ARF was partially funded by the Department for Environment, Food and Rural Affairs (Defra) projects SEV3500. AAC is partially funded by a Royal Society Wolfson Research Merit award. EW is supported by the UK Medical Research Council (grant number G0801176). Authors from these institutions conceived of, and conducted, the work and wrote the manuscript, however the funders had no direct role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON R M, 1991; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; BOULGER L. R., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P421, DOI 10.1016/0035-9203(58)90127-5; Breed AC, 2011, ECOHEALTH, V7, P39; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Brookes SM, 2005, EMERG INFECT DIS, V11, P572, DOI 10.3201/eid1104.040920; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chen JM, 2006, J VIROL METHODS, V136, P273, DOI 10.1016/j.jviromet.2006.05.003; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; CONSTANTINE DG, 1967, PUBLIC HEALTH REP, V82, P867, DOI 10.2307/4593153; DEFREES S L, 1988, Mammalian Species, P1, DOI 10.2307/3504095; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; FUNMILAYO O, 1979, Revue de Zoologie Africaine, V93, P589; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; GIRARD KF, 1965, NEW ENGL J MED, V272, P75, DOI 10.1056/NEJM196501142720204; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Harris SL, 2009, J WILDLIFE DIS, V45, P1030, DOI 10.7589/0090-3558-45.4.1030; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025256; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Holmes E., 2009, EVOLUTION EMERGENCE; Juste J, 2000, BIOL J LINN SOC, V71, P359, DOI 10.1006/bijl.2000.0449; JUSTE J, 1994, BIODIVERS CONSERV, V3, P837, DOI 10.1007/BF00129662; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; KEMP GE, 1988, B SOC PATHOL EXOT, V81, P40; Kingdon J., 1974, E AFRICAN MAMMALS AT, V2, P341; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; LEE DC, 1994, EARTH PLANET SC LETT, V123, P119, DOI 10.1016/0012-821X(94)90262-3; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Mutere F.A., 1980, Proceedings International Bat Research Conference, V5, P145; MUTERE FA, 1967, J ZOOL, V153, P153; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Pasteur I, 1985, IS LAG BAT VIR W AFR; Payne J, 2011, ECOHEALTH, V7, pS148; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; R Core Team, 2016, R FDN STAT COMP; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; Sohayati A R, 2011, Epidemiol Infect, V139, P1570, DOI 10.1017/S0950268811000550; STEECE R, 1989, J WILDLIFE DIS, V25, P490, DOI 10.7589/0090-3558-25.4.490; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Vos A, 2007, ACTA CHIROPTEROL, V9, P283, DOI 10.3161/1733-5329(2007)9[283:EBLAEE]2.0.CO;2; Wright E, 2008, J GEN VIROL, V89, P2204, DOI 10.1099/vir.0.2008/000349-0; Wright E, 2010, VIROLOGY, V408, P183, DOI 10.1016/j.virol.2010.09.014	59	54	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30346	10.1371/journal.pone.0030346	http://dx.doi.org/10.1371/journal.pone.0030346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253928	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100050
J	Sakuma, C; Sato, M; Takenouchi, T; Chiba, J; Kitani, H				Sakuma, Chisato; Sato, Mitsuru; Takenouchi, Takato; Chiba, Joe; Kitani, Hiroshi			Critical Roles of the WASP N-Terminal Domain and Btk in LPS-Induced Inflammatory Response in Macrophages	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; BRUTONS TYROSINE KINASE; KAPPA-B ACTIVATION; BINDING-PROTEIN; NITRIC-OXIDE; IKK-BETA; RECEPTOR; TOLL; PHOSPHORYLATION; IDENTIFICATION	While Wiskott-Aldrich syndrome protein (WASP) plays critical roles in TCR signaling as an adaptor molecule, how it transduces innate immune signals remains to be elucidated. To investigate the roles of WASP in innate immune cells, we established bone marrow-derived macrophage (BMDM) cell lines from WASP15 transgenic (Tg) mice overexpressing the WASP N-terminal region (exons 1-5). Upon LPS stimulation, WASP15 Tg BMDM cell lines produce lower levels of inflammatory cytokines, such as TNF-alpha, IL-6, and IL-12p40 than the wild-type BMDM cell line. In addition, the production of nitric oxide by WASP15 Tg BMDM cells in response to LPS and IFN-gamma was significantly impaired. Furthermore, we uncovered that the WASP N-terminal domain associates with the Src homology (SH) 3 domain of Bruton's tyrosine kinase (Btk). Overexpression of the WASP N-terminal domain diminishes the extent of tyrosine phosphorylation of endogenous WASP in WASP15 Tg BMDM cells, possibly by interfering with the specific binding between endogenous WASP and Btk during LPS signaling. These observations strongly suggest that the interaction between WASP N-terminal domain and Btk plays important roles in the LPS signaling cascade in innate immunity.	[Sakuma, Chisato; Sato, Mitsuru; Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Sakuma, Chisato; Chiba, Joe] Tokyo Univ Sci, Dept Biol Sci & Technol, Grad Sch, Fac Ind Sci & Technol, Noda, Chiba 278, Japan	National Institute of Agrobiological Sciences - Japan; Tokyo University of Science	Sakuma, C (corresponding author), Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan.	mitsuru.sato@affrc.go.jp			program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was funded in part by a program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anton IM, 2007, TRENDS CELL BIOL, V17, P555, DOI 10.1016/j.tcb.2007.08.005; Badolato R, 1998, J IMMUNOL, V161, P1026; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Cory GOC, 1996, J IMMUNOL, V157, P3791; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1; Sato M, 2005, FEBS J, V272, P6131, DOI 10.1111/j.1742-4658.2005.05011.x; Sato M, 2001, J IMMUNOL, V167, P4701, DOI 10.4049/jimmunol.167.8.4701; Sato M, 2007, INT IMMUNOL, V19, P901, DOI 10.1093/intimm/dxm074; Sato M, 2011, INT IMMUNOL, V23, P493, DOI 10.1093/intimm/dxr042; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	38	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30351	10.1371/journal.pone.0030351	http://dx.doi.org/10.1371/journal.pone.0030351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253930	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100052
J	Wallinger, C; Juen, A; Staudacher, K; Schallhart, N; Mitterrutzner, E; Steiner, EM; Thalinger, B; Traugott, M				Wallinger, Corinna; Juen, Anita; Staudacher, Karin; Schallhart, Nikolaus; Mitterrutzner, Evi; Steiner, Eva-Maria; Thalinger, Bettina; Traugott, Michael			Rapid Plant Identification Using Species- and Group-Specific Primers Targeting Chloroplast DNA	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; PREY DNA; ROOTS; UNIVERSAL; LAND; PCR; DIET; PERSPECTIVES; SEQUENCES; PATTERNS	Plant identification is challenging when no morphologically assignable parts are available. There is a lack of broadly applicable methods for identifying plants in this situation, for example when roots grow in mixture and for decayed or semi-digested plant material. These difficulties have also impeded the progress made in ecological disciplines such as soil- and trophic ecology. Here, a PCR- based approach is presented which allows identifying a variety of plant taxa commonly occurring in Central European agricultural land. Based on the trnT-F cpDNA region, PCR assays were developed to identify two plant families (Poaceae and Apiaceae), the genera Trifolium and Plantago, and nine plant species: Achillea millefolium, Fagopyrum esculentum, Lolium perenne, Lupinus angustifolius, Phaseolus coccineus, Sinapis alba, Taraxacum officinale, Triticum aestivum, and Zea mays. These assays allowed identification of plants based on size-specific amplicons ranging from 116 bp to 381 bp. Their specificity and sensitivity was consistently high, enabling the detection of small amounts of plant DNA, for example, in decaying plant material and in the intestine or faeces of herbivores. To increase the efficacy of identifying plant species from large number of samples, specific primers were combined in multiplex PCRs, allowing screening for multiple species within a single reaction. The molecular assays outlined here will be applicable manifold, such as for root- and leaf litter identification, botanical trace evidence, and the analysis of herbivory.	[Wallinger, Corinna; Juen, Anita; Staudacher, Karin; Schallhart, Nikolaus; Mitterrutzner, Evi; Steiner, Eva-Maria; Thalinger, Bettina; Traugott, Michael] Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, A-6020 Innsbruck, Austria	University of Innsbruck	Wallinger, C (corresponding author), Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, A-6020 Innsbruck, Austria.	corinna.wallinger@uibk.ac.at	Thalinger, Bettina/AAF-3956-2019	Thalinger, Bettina/0000-0001-9315-8648; Traugott, Michael/0000-0001-9719-5059; Wallinger, Corinna/0000-0002-7153-9690	project "Exploitation of plant diversity by below-ground herbivores''; Austrian Science Fund (FWF) [P20377]	project "Exploitation of plant diversity by below-ground herbivores''; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support was provided by the project "Exploitation of plant diversity by below-ground herbivores'' funded by the Austrian Science Fund (FWF, P20377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu B, 2006, SOIL BIOL BIOCHEM, V38, P1308, DOI 10.1016/j.soilbio.2005.08.019; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bakker FT, 2000, MOL BIOL EVOL, V17, P1146, DOI 10.1093/oxfordjournals.molbev.a026397; Bobowski BR, 1999, MOL ECOL, V8, P485, DOI 10.1046/j.1365-294X.1999.00603.x; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Brunner I, 2001, MOL ECOL, V10, P2079, DOI 10.1046/j.1365-294X.2001.01325.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Donini P, 1997, GENOME, V40, P521, DOI 10.1139/g97-068; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferri G, 2009, INT J LEGAL MED, V123, P395, DOI 10.1007/s00414-009-0356-5; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill D. S., 1987, Agricultural insect pests of temperate regions and their control.; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Jackson RB, 1999, P NATL ACAD SCI USA, V96, P11387, DOI 10.1073/pnas.96.20.11387; Johnson SN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P1, DOI 10.1079/9781845934613.0000; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; Lee EJ, 2010, J FORENSIC SCI, V55, P1202, DOI 10.1111/j.1556-4029.2010.01423.x; Linder CR, 2000, MOL ECOL, V9, P1549, DOI 10.1046/j.1365-294x.2000.01034.x; McNickle GG, 2008, BOTANY, V86, P485, DOI 10.1139/B08-014; Mommer L, 2008, MOL ECOL RESOUR, V8, P947, DOI 10.1111/j.1755-0998.2008.02130.x; Moore LA, 2005, J VEG SCI, V16, P131, DOI 10.1111/j.1654-1103.2005.tb02346.x; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pompanon F, MOL ECOLOGY IN PRESS; Pumarino L, 2011, B ENTOMOL RES, V101, P271, DOI 10.1017/S0007485310000465; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Ridgway K, 2003, BMC ECOLOGY, V3; Schnell IB, 2010, ARTHROPOD-PLANT INTE, V4, P107, DOI 10.1007/s11829-010-9089-0; Seeber J, 2010, SOIL BIOL BIOCHEM, V42, P1263, DOI 10.1016/j.soilbio.2010.04.008; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Spaniolas S, 2010, FOOD CHEM, V122, P850, DOI 10.1016/j.foodchem.2010.02.039; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taggart JM, 2011, MOL ECOL RESOUR, V11, P185, DOI 10.1111/j.1755-0998.2010.02893.x; Traugott M, 2008, MOL ECOL, V17, P3928, DOI 10.1111/j.1365-294X.2008.03878.x; Traugott M, 2008, SOIL BIOL BIOCHEM, V40, P342, DOI 10.1016/j.soilbio.2007.08.013; Tsai LC, 2006, FORENSIC SCI INT, V164, P193, DOI 10.1016/j.forsciint.2006.01.007; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vijayan K, 2010, CURR SCI INDIA, V99, P1530	52	32	34	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29473	10.1371/journal.pone.0029473	http://dx.doi.org/10.1371/journal.pone.0029473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253728	Green Submitted, gold, Green Published			2022-12-25	WOS:000301357100011
J	Geli, P; Laxminarayan, R; Dunne, M; Smith, DL				Geli, Patricia; Laxminarayan, Ramanan; Dunne, Michael; Smith, David L.			"One-Size-Fits-All"? Optimizing Treatment Duration for Bacterial Infections	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; ACUTE MAXILLARY SINUSITIS; CONCENTRATION-DEPENDENT SELECTION; URINARY-TRACT INFECTIONS; PRIMARY-CARE-NETWORK; ANTIBIOTIC-RESISTANCE; GENERAL-PRACTICE; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; CONTROLLED TRIAL	Historically, antibiotic treatment guidelines have aimed to maximize treatment efficacy and minimize toxicity, but have not considered the evolution of antibiotic resistance. Optimizing the duration and dosing of treatment to minimize the duration of symptomatic infection and selection pressure for resistance simultaneously has the potential to extend the useful therapeutic life of these valuable life-saving drugs without compromising the interests of individual patients. Here, using mathematical models, we explore the theoretical basis for shorter durations of treatment courses, including a range of ecological dynamics of bacteria that cause infections or colonize hosts as commensals. We find that immunity is an important mediating factor in determining the need for long duration of treatment. When immunity to infection is expected, shorter durations that reduce the selection for resistance without interfering with successful clinical outcome are likely to be supported. Adjusting drug treatment strategies to account for the impact of the differences in the ecological niche occupied by commensal flora relative to invasive bacteria could be effective in delaying the spread of bacterial resistance.	[Geli, Patricia; Laxminarayan, Ramanan; Smith, David L.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Dunne, Michael] Durata Therapeut Inc, Morristown, NJ USA; [Smith, David L.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Smith, David L.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Princeton University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Geli, P (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC USA.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021; Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Dunne, Michael/0000-0001-9041-4802	Bill and Melinda Gates Foundation; Pioneer Portfolio of the Robert Wood Johnson Foundation; Princeton University; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Pioneer Portfolio of the Robert Wood Johnson Foundation; Princeton University(Princeton University); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded primarily by Grant 50914 from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx) and a grant from the Pioneer Portfolio of the Robert Wood Johnson Foundation. Support for the project also comes from the Grand Challenges program in Health at Princeton University (http://www.princeton.edu/grandchallenges/). DLS also acknowledges funding support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security (http://www.dhs.gov/index.shtm), and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.V., 2009, ANSELS PHARM DOSAGE; Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bezakova N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2525; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; CHARLTON CAC, 1976, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.6002.124; Cincinnati Children's Hospital Medical Center, 2006, CINCINNATI OH CI JUL, P1; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Craig JE, 2002, INFECT IMMUN, V70, P708, DOI 10.1128/IAI.70.2.708-715.2002; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; Department of Health: Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance, 1997, PATH LEAST RES; DESAINTONGE DMC, 1982, BRIT MED J, V284, P1078; Drusano GL, 2005, PHARMACOTHERAPY, V25, p150S, DOI 10.1592/phco.2005.25.12part2.150S; FORSGREN J, 1994, INFECT IMMUN, V62, P673, DOI 10.1128/IAI.62.2.673-679.1994; FROOM J, 1990, BRIT MED J, V300, P582, DOI 10.1136/bmj.300.6724.582; Froom J, 1997, BRIT MED J, V315, P98, DOI 10.1136/bmj.315.7100.98; Guillemot D, 1999, CURR OPIN MICROBIOL, V2, P494, DOI 10.1016/S1369-5274(99)00006-5; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Handel A, 2009, J THEOR BIOL, V256, P655, DOI 10.1016/j.jtbi.2008.10.025; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; HYATT JM, 1995, CLIN PHARMACOKINET, V28, P143, DOI 10.2165/00003088-199528020-00005; HYATT JM, 1995, ANTIMICROB AGENTS CH, V39, P1711, DOI 10.1128/AAC.39.8.1711; IRAVANI A, 1995, ARCH INTERN MED, V155, P485, DOI 10.1001/archinte.155.5.485; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; LEYDEN JJ, 1983, J AM ACAD DERMATOL, V8, P41, DOI 10.1016/S0190-9622(83)70005-8; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Louie A, 2001, ANTIMICROB AGENTS CH, V45, P845, DOI 10.1128/AAC.45.3.845-851.2001; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Mouton JW, 1997, ANTIMICROB AGENTS CH, V41, P733, DOI 10.1128/AAC.41.4.733; Negri MC, 2000, ANTIMICROB AGENTS CH, V44, P2485, DOI 10.1128/AAC.44.9.2485-2491.2000; Nolting A, 1996, PHARM RES-DORDR, V13, P91, DOI 10.1023/A:1016085402278; Nordberg P., 2005, ANTIBACTERIAL DRUG R; NORRBY SR, 1990, REV INFECT DIS, V12, P458; Olofsson SK, 2007, CLIN INFECT DIS, V45, pS129, DOI 10.1086/519256; Olofsson SK, 2005, ANTIMICROB AGENTS CH, V49, P5081, DOI 10.1128/AAC.49.12.5081-5091.2005; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Pour F.Z. Pezesk, 2007, INTERNET J DERMATOLO, V5; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Rice LB, 2001, EMERG INFECT DIS, V7, P183, DOI 10.3201/eid0702.010205; SAGINUR R, 1992, ARCH INTERN MED, V152, P1233, DOI 10.1001/archinte.152.6.1233; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015	48	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29838	10.1371/journal.pone.0029838	http://dx.doi.org/10.1371/journal.pone.0029838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253798	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700059
J	Lucas, C; Thangaradjou, T; Papenbrock, J				Lucas, Christina; Thangaradjou, Thirunavakkarasu; Papenbrock, Jutta			Development of a DNA Barcoding System for Seagrasses: Successful but Not Simple	PLOS ONE			English	Article							RETICULATE EVOLUTION; PHYLOGENY; SEQUENCES; TAXONOMY; PLANTS; GENUS; MATK; DIVERSIFICATION; IDENTIFICATION; BIODIVERSITY	Seagrasses, a unique group of submerged flowering plants, profoundly influence the physical, chemical and biological environments of coastal waters through their high primary productivity and nutrient recycling ability. They provide habitat for aquatic life, alter water flow, stabilize the ground and mitigate the impact of nutrient pollution. at the coast region. Although on a global scale seagrasses represent less than 0.1% of the angiosperm taxa, the taxonomical ambiguity in delineating seagrass species is high. Thus, the taxonomy of several genera is unsolved. While seagrasses are capable of performing both, sexual and asexual reproduction, vegetative reproduction is common and sexual progenies are always short lived and epimeral in nature. This makes species differentiation often difficult, especially for non-taxonomists since the flower as a distinct morphological trait is missing. Our goal is to develop a DNA barcoding system assisting also non-taxonomists to identify regional seagrass species. The results will be corroborated by publicly available sequence data. The main focus is on the 14 described seagrass species of India, supplemented with seagrasses from temperate regions. According to the recommendations of the Consortium for the Barcoding of Life (CBOL) rbcL and matK were used in this study. After optimization of the DNA extraction method from preserved seagrass material, the respective sequences were amplified from all species analyzed. Tree-and character-based approaches demonstrate that the rbcL sequence fragment is capable of resolving up to family and genus level. Only matK sequences were reliable in resolving species and partially the ecotype level. Additionally, a plastidic gene spacer was included in the analysis to confirm the identification level. Although the analysis of these three loci solved several nodes, a few complexes remained unsolved, even when constructing a combined tree for all three loci. Our approaches contribute to the understanding of the morphological plasticity of seagrasses versus genetic differentiation.	[Lucas, Christina; Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, Hannover, Lower Saxony, Germany; [Thangaradjou, Thirunavakkarasu] Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai, Tamil Nadu, India	Leibniz University Hannover; Annamalai University	Lucas, C (corresponding author), Leibniz Univ Hannover, Inst Bot, Hannover, Lower Saxony, Germany.	Jutta.Papenbrock@botanik.uni-hannover.de		Lucas, Christina/0000-0002-6575-3877				Achamlale S, 2009, J APPL PHYCOL, V21, P347, DOI 10.1007/s10811-008-9375-8; Angel R, 2002, AQUAT BOT, V74, P165, DOI 10.1016/S0304-3770(02)00079-7; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bremer K, 2000, WENN GR INT, V77, P125; Bricker E, 2011, MAR ECOL PROG SER, V423, P57, DOI 10.3354/meps08962; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; den Hartog C, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P1; den Hartog C, 1970, SEAGRASSES WORLD; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Duarte CM, 2000, J EXP MAR BIOL ECOL, V250, P117, DOI 10.1016/S0022-0981(00)00194-5; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Ghosh Asish K., 2006, Lakes & Reservoirs Research and Management, V11, P239, DOI 10.1111/j.1440-1770.2006.00306.x; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ito Y, 2011, TELOPEA, V13, P219; Ivanova NV, 2009, MOL ECOL RESOUR, V9, P35, DOI 10.1111/j.1755-0998.2009.02630.x; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jiang K, 2011, AM J BOT, V98, pE155, DOI 10.3732/ajb.1100032; Jones TC, 2008, AQUAT BOT, V88, P39, DOI 10.1016/j.aquabot.2007.08.017; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Les DH, 2002, SYST BOT, V27, P468; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Munzner T, 2003, ACM T GRAPHIC, V22, P453, DOI 10.1145/882262.882291; Newby BMZ, 2006, JCT RES, V3, P69, DOI 10.1007/s11998-006-0007-4; Pillon Y, 2009, MOL ECOL, V18, P2263, DOI 10.1111/j.1365-294X.2009.04178.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Reusch TBH, 1999, HEREDITY, V83, P120, DOI 10.1038/sj.hdy.6885460; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Short FT, 2010, AQUAT BOT, V93, P141, DOI 10.1016/j.aquabot.2010.05.001; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka N, 1997, J PLANT RES, V110, P329, DOI 10.1007/BF02524931; Tate JA, 2003, SYST BOT, V28, P723; Uchimura M, 2008, BOT MAR, V51, P258, DOI 10.1515/BOT.2008.036; Vijayan K, 2010, CURR SCI INDIA, V99, P1530; von Crautlein M, 2011, BIODIVERS CONSERV, V20, P373, DOI 10.1007/s10531-010-9964-0; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Waycott M, 2002, B MAR SCI, V71, P1299; Waycott M, 2006, GENETIC PERSPECTIVE, V2, P25; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; White T., 1990, PCR PROTOCOLS GUIDE, P315; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533	65	45	49	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29987	10.1371/journal.pone.0029987	http://dx.doi.org/10.1371/journal.pone.0029987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253849	Green Submitted, gold, Green Published			2022-12-25	WOS:000301355700072
J	de Lauzon-Guillain, B; Wijndaele, K; Clark, M; Acerini, CL; Hughes, IA; Dunger, DB; Wells, JC; Ong, KK				de Lauzon-Guillain, Blandine; Wijndaele, Katrien; Clark, Matthew; Acerini, Carlo L.; Hughes, Ieuan A.; Dunger, David B.; Wells, Jonathan C.; Ong, Ken K.			Breastfeeding and Infant Temperament at Age Three Months	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; BEHAVIOR QUESTIONNAIRE; 12-WEEK-OLD INFANTS; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; GROWTH; LIFE; CHILDHOOD; DURATION; OBESITY	Background & Methods: To examine the relationship between breastfeeding and maternally-rated infant temperament at age 3 months, 316 infants in the prospective Cambridge Baby Growth Study, UK had infant temperament assessed at age 3 months by mothers using the Revised Infant Behavior Questionnaire, which produces scores for three main dimensions of temperament derived from 14 subscales. Infant temperament scores were related to mode of infant milk feeding at age 3 months (breast only; formula milk only; or mixed) with adjustment for infant's age at assessment and an index of deprivation. Results: Infant temperament dimension scores differed across the three infant feeding groups, but appeared to be comparable between exclusive breast-fed and mixed-fed infants. Compared to formula milk-fed infants, exclusive breast-fed and mixed-fed infants were rated as having lower impulsivity and positive responses to stimulation (adjusted mean [95% CI] "Surgency/Extraversion" in formula-fed vs. mixed-fed vs. breast-fed groups: 4.3 [4.2-4.5] vs. 4.0 [3.8-4.1] vs. 4.0 [3.9-4.1]; p-heterogeneity = 0.0006), lower ability to regulate their own emotions ("Orienting/Regulation": 5.1 [5.0-5.2], vs. 4.9 [4.8-5.1] vs. 4.9 [4.8-5.0]; p=0.01), and higher emotional instability ("Negative affectivity": 2.8 [2.6-2.9] vs. 3.0 [2.8-3.1] vs. 3.0 [2.9-3.1]; p=0.03). Conclusions: Breast and mixed-fed infants were rated by their mothers as having more challenging temperaments in all three dimensions; particular subscales included greater distress, less smiling, laughing, and vocalisation, and lower soothability. Increased awareness of the behavioural dynamics of breastfeeding, a better expectation of normal infant temperament and support to cope with difficult infant temperament could potentially help to promote successful breastfeeding.	[de Lauzon-Guillain, Blandine; Wijndaele, Katrien; Ong, Ken K.] MRC, Epidemiol Unit, Cambridge, England; [de Lauzon-Guillain, Blandine] Univ Paris Sud, INSERM, Villejuif, France; [Clark, Matthew] Univ Cambridge, Sch Clin Med, Cambridge, England; [Acerini, Carlo L.; Hughes, Ieuan A.; Dunger, David B.; Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge, England; [Wells, Jonathan C.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; University of Cambridge; University of London; University College London	de Lauzon-Guillain, B (corresponding author), MRC, Epidemiol Unit, Cambridge, England.	ken.ong@mrc-epid.cam.ac.uk	Wells, Jonathan/A-4604-2009; de Lauzon-Guillain, Blandine/P-4659-2016; Wijndaele, Katrien/H-5465-2013	Wells, Jonathan/0000-0003-0411-8025; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; Wijndaele, Katrien/0000-0003-2199-7981; Acerini, Carlo/0000-0003-2121-5871; Dunger, Professor David/0000-0002-2566-9304	European Union; World Cancer Research Foundation International; Medical Research Council; Mothercare Charitable Foundation; NIHR Cambridge Biomedical Research Centre; Societe Francaise de Nutrition; MRC [MC_U106179473, MC_U106179472, G0600717] Funding Source: UKRI; Medical Research Council [MC_U106179473, MC_U106179472, G0600717] Funding Source: researchfish	European Union(European Commission); World Cancer Research Foundation International; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mothercare Charitable Foundation; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Societe Francaise de Nutrition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Cambridge Baby Growth Study was supported by the European Union, the World Cancer Research Foundation International, the Medical Research Council, the Mothercare Charitable Foundation and the NIHR Cambridge Biomedical Research Centre. BL was a recipient for a grant from the "Societe Francaise de Nutrition". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Auestad N, 2001, PEDIATRICS, V108, P372, DOI 10.1542/peds.108.2.372; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; BARR RG, 1989, PEDIATRICS, V84, P514; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Birch LL, 2006, OBESITY, V14, P343, DOI 10.1038/oby.2006.45; Bolling K, 2007, INFANT FEEDING SURVE; Britton JR, 2011, WOMEN HEALTH, V51, P55, DOI 10.1080/03630242.2011.540741; Burton P, 2011, APPETITE, V57, P504, DOI 10.1016/j.appet.2011.07.002; Communities and Local Government, 2007, ENGL IND DEPR; CROCKENBERG SB, 1982, INFANT BEHAV DEV, V5, P105, DOI 10.1016/S0163-6383(82)80021-0; DELGADO HL, 1982, AM J CLIN NUTR, V35, P1468, DOI 10.1093/ajcn/35.6.1468; DIPIETRO JA, 1987, DEV PSYCHOL, V23, P467, DOI 10.1037/0012-1649.23.4.467; Faith MS, 2010, INT J OBESITY, V34, P1515, DOI 10.1038/ijo.2010.156; FERGUSSON DM, 1982, SOC SCI MED, V16, P1705, DOI 10.1016/0277-9536(82)90096-X; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Gray PH, 2011, EARLY HUM DEV; Hanington L, 2010, INFANT BEHAV DEV, V33, P88, DOI 10.1016/j.infbeh.2009.11.004; Horwood LJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e9; Jansen PW, 2009, SOC PSYCH PSYCH EPID, V44, P87, DOI 10.1007/s00127-008-0416-z; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Komsi N, 2006, INFANT BEHAV DEV, V29, P494, DOI 10.1016/j.infbeh.2006.05.002; Li RW, 2008, PEDIATRICS, V122, pS69, DOI 10.1542/peds.2008-1315i; Niegel S, 2008, J DEV BEHAV PEDIATR, V29, P458, DOI 10.1097/DBP.0b013e3181877a88; Parade SH, 2008, INFANT BEHAV DEV, V31, P637, DOI 10.1016/j.infbeh.2008.07.009; Redsell SA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-711; Slining MM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-51; Sullivan ML, 2004, J HUM LACT, V20, P196, DOI 10.1177/0890334404263732; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Thureen PJ, 1998, J APPL PHYSIOL, V85, P223, DOI 10.1152/jappl.1998.85.1.223; Vandiver TA, 1997, PSYCHOL REP, V80, P1375, DOI 10.2466/pr0.1997.80.3c.1375; Wells JCK, 1997, INT J OBESITY, V21, P400, DOI 10.1038/sj.ijo.0800420; Wells JCK, 1998, ARCH DIS CHILD, V78, P131, DOI 10.1136/adc.78.2.131; WELLS JCK, 1995, ANN HUM BIOL, V22, P207, DOI 10.1080/03014469500003872; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; Wells JCK, 1996, AM J HUM BIOL, V8, P465, DOI 10.1002/(SICI)1520-6300(1996)8:4<465::AID-AJHB6>3.0.CO;2-X; Whalen B, 2010, CURR OPIN PEDIATR, V22, P655, DOI 10.1097/MOP.0b013e32833c8996; WOROBEY J, 1993, ADV CHILD DEV BEHAV, V24, P37, DOI 10.1016/S0065-2407(08)60299-2; Worobey J, 1998, PERCEPT MOTOR SKILL, V86, P883, DOI 10.2466/pms.1998.86.3.883; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1353, DOI 10.1079/PHN2001217	41	46	46	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					39	45	e29326	10.1371/journal.pone.0029326	http://dx.doi.org/10.1371/journal.pone.0029326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906OA	22253712	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900004
J	Salvatore, MF; Pruett, BS				Salvatore, Michael F.; Pruett, Brandon S.			Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; MULTIPLE-SITE PHOSPHORYLATION; RAT SUBSTANTIA-NIGRA; AGED RHESUS-MONKEYS; IN-VIVO; NEUROTROPHIC FACTOR; CATECHOLAMINE SYNTHESIS; PROTEIN-KINASE; NOREPINEPHRINE BIOSYNTHESIS; PARKINSONIAN MONKEYS	Measures of dopamine-regulating proteins in somatodendritic regions are often used only as static indicators of neuron viability, overlooking the possible impact of somatodendritic dopamine (DA) signaling on behavior and the potential autonomy of DA regulation between somatodendritic and terminal field compartments. DA reuptake capacity is less in somatodendritic regions, possibly placing a greater burden on de novo DA biosynthesis within this compartment to maintain DA signaling. Therefore, regulation of tyrosine hydroxylase (TH) activity may be particularly critical for somatodendritic DA signaling. Phosphorylation of TH at ser31 or ser40 can increase activity, but their impact on L-DOPA biosynthesis in vivo is unknown. Thus, determining their relationship with L-DOPA tissue content could reveal a mechanism by which DA signaling is normally maintained. In Brown-Norway Fischer 344 F-1 hybrid rats, we quantified TH phosphorylation versus L-DOPA accumulation. After inhibition of aromatic acid decarboxylase, L-DOPA tissue content per recovered TH protein was greatest in NAc, matched by differences in ser31, but not ser40, phosphorylation. The L-DOPA per catecholamine and DA turnover ratios were significantly greater in SN and VTA, suggesting greater reliance on de novo DA biosynthesis therein. These compartmental differences reflected an overall autonomy of DA regulation, as seen by decreased DA content in SN and VTA, but not in striatum or NAc, following short-term DA biosynthesis inhibition from local infusion of the TH inhibitor alpha-methyl-rho-tyrosine, as well as in the long-term process of aging. Such data suggest ser31 phosphorylation plays a significant role in regulating TH activity in vivo, particularly in somatodendritic regions, which may have a greater reliance on de novo DA biosynthesis. Thus, to the extent that somatodendritic DA release affects behavior, TH regulation in the midbrain may be critical for DA bioavailability to influence behavior.	[Salvatore, Michael F.; Pruett, Brandon S.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Salvatore, MF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	msalva@lsuhsc.edu	Pruett, Brandon/ABE-4419-2020; Salvatore, Michael/ABC-8926-2021	Pruett, Brandon/0000-0001-9760-1635; 	American Federation for Aging Research; Edward P. Stiles Trust Fund; Biomedical Research Foundation of NW Louisiana	American Federation for Aging Research; Edward P. Stiles Trust Fund; Biomedical Research Foundation of NW Louisiana	This work was supported by grant awards to MFS by the American Federation for Aging Research, Edward P. Stiles Trust Fund and by the Biomedical Research Foundation of NW Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Bergquist F, 2003, BRAIN RES, V973, P81, DOI 10.1016/S0006-8993(03)02555-1; Bevilaqua LRM, 2001, J BIOL CHEM, V276, P40411, DOI 10.1074/jbc.M105280200; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bustos G, 2009, J NEUROSCI RES, V87, P2308, DOI 10.1002/jnr.22063; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Gash DM, 2005, ANN NEUROL, V58, P224, DOI 10.1002/ana.20549; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Grondin R, 2003, J NEUROSCI, V23, P1974; Hakansson K, 2004, EUR J NEUROSCI, V20, P1108, DOI 10.1111/j.1460-9568.2004.03547.x; Harada K, 1996, J NEUROCHEM, V67, P629; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; HAYCOCK JW, 1992, J NEUROCHEM, V58, P57, DOI 10.1111/j.1471-4159.1992.tb09276.x; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1998, J NEUROCHEM, V70, P179; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; JACKSON EA, 1983, BRAIN RES, V278, P366, DOI 10.1016/0006-8993(83)90274-3; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; LAVICKY J, 1993, J NEUROCHEM, V60, P602, DOI 10.1111/j.1471-4159.1993.tb03191.x; Leak RK, 2010, J NEUROSCI METH, V191, P234, DOI 10.1016/j.jneumeth.2010.06.023; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; Lindgren N, 2000, J NEUROCHEM, V74, P2470, DOI 10.1046/j.1471-4159.2000.0742470.x; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; MITCHELL JP, 1990, J BIOL CHEM, V265, P22358; MORGENROTH VH, 1975, J BIOL CHEM, V250, P1946; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nimitvilai S, 2010, J PHARMACOL EXP THER, V333, P555, DOI 10.1124/jpet.109.163931; NISSBRANDT H, 1989, J NEUROCHEM, V52, P1170, DOI 10.1111/j.1471-4159.1989.tb01863.x; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Pruett BS, 2010, J NEUROCHEM, V115, P707, DOI 10.1111/j.1471-4159.2010.06963.x; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBERTSON GS, 1989, J NEUROSCI, V9, P3326; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Salvatore MF, 2009, EXP NEUROL, V219, P197, DOI 10.1016/j.expneurol.2009.05.013; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Sarre S, 2004, J NEUROCHEM, V90, P29, DOI 10.1111/j.1471-4159.2004.02471.x; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; Trevitt JT, 2001, PSYCHOPHARMACOLOGY, V156, P32; VULLIET PR, 1980, P NATL ACAD SCI-BIOL, V77, P92, DOI 10.1073/pnas.77.1.92; Wang J, 2010, J NEUROSCI, V30, P14502, DOI 10.1523/JNEUROSCI.3909-10.2010; WAYMIRE JC, 1988, J BIOL CHEM, V263, P12439; WAYMIRE JC, 1991, J NEUROCHEM, V57, P1313, DOI 10.1111/j.1471-4159.1991.tb08296.x; Yurek DM, 1998, BRAIN RES, V791, P246, DOI 10.1016/S0006-8993(98)00110-3; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007	60	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29867	10.1371/journal.pone.0029867	http://dx.doi.org/10.1371/journal.pone.0029867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242182	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100038
J	Spadaro, A; Negri, M; Marchais-Oberwinkler, S; Bey, E; Frotscher, M				Spadaro, Alessandro; Negri, Matthias; Marchais-Oberwinkler, Sandrine; Bey, Emmanuel; Frotscher, Martin			Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17 beta-Hydroxysteroid Dehydrogenase Type 1 (17 beta-HSD1)	PLOS ONE			English	Article							HUMAN ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; BIOLOGICAL EVALUATION; STEROID-5-ALPHA-REDUCTASE TYPE-1; RECEPTOR-ALPHA; BONE MASS; BREAST; CANCER; ESTRADIOL; DESIGN; EXPRESSION	17 beta-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and progession of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17 beta-HSD1, which catalyses the reduction of the weak estrogen estrone (E1) to E2, is often overexpressed in breast cancer and endometriotic tissues. An inhibition of 17 beta-HSD1 could selectively reduce the local E2-level thus allowing for a novel, targeted approach in the treatment of EDD. Continuing our search for new nonsteroidal 17 beta-HSD1 inhibitors, a novel pharmacophore model was derived from crystallographic data and used for the virtual screening of a small library of compounds. Subsequent experimental verification of the virtual hits led to the identification of the moderately active compound 5. Rigidification and further structure modifications resulted in the discovery of a novel class of 17 beta-HSD1 inhibitors bearing a benzothiazole-scaffold linked to a phenyl ring via keto-or amide-bridge. Their putative binding modes were investigated by correlating their biological data with features of the pharmacophore model. The most active keto-derivative 6 shows IC50-values in the nanomolar range for the transformation of E1 to E2 by 17 beta-HSD1, reasonable selectivity against 17 beta-HSD2 but pronounced affinity to the estrogen receptors (ERs). On the other hand, the best amide-derivative 21 shows only medium 17 beta-HSD1 inhibitory activity at the target enzyme as well as fair selectivity against 17 beta-HSD2 and ERs. The compounds 6 and 21 can be regarded as first benzothiazole-type 17 beta-HSD1 inhibitors for the development of potential therapeutics.	[Spadaro, Alessandro; Marchais-Oberwinkler, Sandrine; Frotscher, Martin] Univ Saarland, D-6600 Saarbrucken, Germany; [Spadaro, Alessandro; Bey, Emmanuel] ElexoPharm GmbH, Saarbrucken, Germany; [Negri, Matthias] Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany	Saarland University; Helmholtz Association	Frotscher, M (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	m.frotscher@mx.uni-saarland.de			ElexoPharm GmbH, Inc.	ElexoPharm GmbH, Inc.	External funding for this study was provided by ElexoPharm GmbH, Inc. Authors from ElexoPharm participated in the design of the studies, analysis of the data, and preparation of the manuscript.	Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Al-Soud YA, 2009, MOL CELL ENDOCRINOL, V301, P212, DOI 10.1016/j.mce.2008.09.012; Alho-Richmond S, 2006, MOL CELL ENDOCRINOL, V248, P208, DOI 10.1016/j.mce.2005.12.004; Allan GM, 2008, BIOORGAN MED CHEM, V16, P4438, DOI 10.1016/j.bmc.2008.02.059; Baston E, 2000, EUR J MED CHEM, V35, P931, DOI 10.1016/S0223-5234(00)01167-3; Baston E, 1999, BIOORG MED CHEM LETT, V9, P1601, DOI 10.1016/S0960-894X(99)00234-6; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; Bey E, 2008, BIOORGAN MED CHEM, V16, P6423, DOI 10.1016/j.bmc.2008.04.073; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Brozic P, 2008, CURR MED CHEM, V15, P137; Brozic P, 2009, MOL CELL ENDOCRINOL, V301, P229, DOI 10.1016/j.mce.2008.09.004; Cabedo N, 2001, J MED CHEM, V44, P1794, DOI 10.1021/jm001128u; Cavalli A, 2005, J MED CHEM, V48, P7282, DOI 10.1021/jm058042r; CHEDEKEL MR, 1980, SYNTHETIC COMMUN, V10, P167, DOI 10.1080/00397918008064218; CHIKASHITA H, 1988, B CHEM SOC JPN, V61, P3637, DOI 10.1246/bcsj.61.3637; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Day JM, 2010, MINERVA ENDOCRINOL, V35, P87; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Day JM, 2008, INT J CANCER, V122, P1931, DOI 10.1002/ijc.23350; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; FERIN M, 1968, ENDOCRINOLOGY, V83, P565, DOI 10.1210/endo-83-3-565; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Gunnarsson C, 2003, ONCOGENE, V22, P34, DOI 10.1038/sj.onc.1206078; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Han Q, 2000, J BIOL CHEM, V275, P1105, DOI 10.1074/jbc.275.2.1105; Husen B, 2006, MOL CELL ENDOCRINOL, V248, P109, DOI 10.1016/j.mce.2005.11.042; Husen B, 2006, ENDOCRINOLOGY, V147, P5333, DOI 10.1210/en.2006-0778; Imai Y, 2009, ANN NY ACAD SCI, V1173, pE31, DOI 10.1111/j.1749-6632.2009.04954.x; Jacobs C, 2000, J MED CHEM, V43, P1841, DOI 10.1021/jm991180u; Janni W, 2010, CANCER TREAT REV, V36, P249, DOI 10.1016/j.ctrv.2009.12.010; Jansson A, 2006, ENDOCR-RELAT CANCER, V13, P875, DOI 10.1677/erc.1.01181; Jeon GH, 2010, MENOPAUSE, V17, P902, DOI 10.1097/gme.0b013e3181d76768; KAGECHIKA H, 1989, J MED CHEM, V32, P2292, DOI 10.1021/jm00130a011; Karkola S, 2008, CHEMMEDCHEM, V3, P461, DOI 10.1002/cmdc.200700271; Kim KS, 2002, J MED CHEM, V45, P3905, DOI 10.1021/jm0201520; Kruchten P, 2009, J STEROID BIOCHEM, V114, P200, DOI 10.1016/j.jsbmb.2009.02.006; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; Laplante Y, 2008, BIOORGAN MED CHEM, V16, P1849, DOI 10.1016/j.bmc.2007.11.007; LeBorgne M, 1997, ARCH PHARM, V330, P141; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Lilienkampf A, 2009, J MED CHEM, V52, P6660, DOI 10.1021/jm900928k; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Marchais-Oberwinkler S, 2011, J STEROID BIOCHEM, V125, P66, DOI 10.1016/j.jsbmb.2010.12.013; Marchais-Oberwinkler S, 2011, J MED CHEM, V54, P534, DOI 10.1021/jm1009082; Marchais-Oberwinkler S, 2009, MOL CELL ENDOCRINOL, V301, P205, DOI 10.1016/j.mce.2008.09.024; Mazumdar M, 2009, BIOCHEM J, V424, P357, DOI 10.1042/BJ20091020; Mazza C, 1997, HUMAN TYPE 1 17 BETA, DOI [10.2210/pdb1a27/pdb, DOI 10.2210/PDB1A27/PDB]; Messinger J, 2006, MOL CELL ENDOCRINOL, V248, P192, DOI 10.1016/j.mce.2005.11.044; National Cancer Institute (NCI), 2006, UND CANC SER ESTR RE; Negri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012026; Nelson TD, 1996, SYNTHESIS-STUTTGART, P1031; Oster A, 2011, CHEMMEDCHEM, V6, P476, DOI 10.1002/cmdc.201000457; Oster A, 2010, J MED CHEM, V53, P8176, DOI 10.1021/jm101073q; Oster A, 2010, BIOORGAN MED CHEM, V18, P3494, DOI 10.1016/j.bmc.2010.03.065; Picard F, 2000, BIOORGAN MED CHEM, V8, P1479, DOI 10.1016/S0968-0896(00)00070-5; Picard F, 2002, BIOORGAN MED CHEM, V10, P437, DOI 10.1016/S0968-0896(01)00293-0; Pillon A, 2005, ENVIRON HEALTH PERSP, V113, P278, DOI 10.1289/ehp.7522; Poirier D, 2003, CURR MED CHEM, V10, P453, DOI 10.2174/0929867033368222; Poirier D, 2010, EXPERT OPIN THER PAT, V20, P1123, DOI 10.1517/13543776.2010.505604; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Puranen TJ, 1999, ENDOCRINOLOGY, V140, P3334, DOI 10.1210/en.140.7.3334; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; Russo J, 2006, FASEB J, V20, P1622, DOI 10.1096/fj.05-5399com; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; Schuster D, 2008, J MED CHEM, V51, P4188, DOI 10.1021/jm800054h; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020; Speirs V, 1998, J STEROID BIOCHEM, V67, P267, DOI 10.1016/S0960-0760(98)00119-8; Starcevic S, 2011, J STEROID BIOCHEM, V127, P255, DOI 10.1016/j.jsbmb.2011.08.013; Starcevic S, 2011, J MED CHEM, V54, P248, DOI 10.1021/jm101104z; STONER EJ, 1995, TETRAHEDRON, V51, P11043, DOI 10.1016/0040-4020(95)00659-V; Suzuki T, 2000, BRIT J CANCER, V82, P518; Tang GZ, 2008, J MED CHEM, V51, P717, DOI 10.1021/jm701358v; THOMAS DB, 1984, CANCER-AM CANCER SOC, V53, P595, DOI 10.1002/1097-0142(19840201)53:3+<595::AID-CNCR2820531304>3.0.CO;2-Y; Tonezzer T, 2010, EUR J GYNAECOL ONCOL, V31, P262; Wetzel M, 2011, BIOORGAN MED CHEM, V19, P807, DOI 10.1016/j.bmc.2010.12.013; Xu KY, 2011, LETT DRUG DES DISCOV, V8, P406, DOI 10.2174/157018011795514230; Zeitoun K, 1998, J CLIN ENDOCR METAB, V83, P4474, DOI 10.1210/jc.83.12.4474; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113	79	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29252	10.1371/journal.pone.0029252	http://dx.doi.org/10.1371/journal.pone.0029252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242164	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100018
J	Johnson, MDL; Garrett, CK; Bond, JE; Coggan, KA; Wolfgang, MC; Redinbo, MR				Johnson, Michael D. L.; Garrett, Christopher K.; Bond, Jennifer E.; Coggan, Kimberly A.; Wolfgang, Matthew C.; Redinbo, Matthew R.			Pseudomonas aeruginosa PilY1 Binds Integrin in an RGD- and Calcium-Dependent Manner	PLOS ONE			English	Article							ARG-GLY-ASP; MULTIPLE SEQUENCE ALIGNMENT; EPITHELIAL-CELLS; BORDETELLA-PERTUSSIS; HUMAN AIRWAY; IN-VITRO; IV PILI; EXPRESSION; INFECTION; PROTEIN	PilY1 is a type IV pilus (tfp)-associated protein from the opportunistic pathogen Pseudomonas aeruginosa that shares functional similarity with related proteins in infectious Neisseria and Kingella species. Previous data have shown that PilY1 acts as a calcium-dependent pilus biogenesis factor necessary for twitching motility with a specific calcium binding site located at amino acids 850-859 in the 1,163 residue protein. In addition to motility, PilY1 is also thought to play an important role in the adhesion of P. aeruginosa tfp to host epithelial cells. Here, we show that PilY1 contains an integrin binding arginine-glycine-aspartic acid (RGD) motif located at residues 619-621 in the PilY1 from the PAK strain of P. aeruginosa; this motif is conserved in the PilY1s from the other P. aeruginosa strains of known sequence. We demonstrate that purified PilY1 binds integrin in vitro in an RGD-dependent manner. Furthermore, we identify a second calcium binding site (amino acids 600-608) located ten residues upstream of the RGD. Eliminating calcium binding from this site using a D608A mutation abolished integrin binding; in contrast, a calcium binding mimic (D608K) preserved integrin binding. Finally, we show that the previously established PilY1 calcium binding site at 851-859 also impacts the protein's association with integrin. Taken together, these data indicate that PilY1 binds to integrin in an RGD- and calcium-dependent manner in vitro. As such, P. aeruginosa may employ these interactions to mediate host epithelial cell binding in vivo.	[Johnson, Michael D. L.; Garrett, Christopher K.; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Bond, Jennifer E.] Duke Univ, Med Ctr, Dept Surg, Div Plast & Reconstruct Surg, Durham, NC USA; [Coggan, Kimberly A.; Wolfgang, Matthew C.; Redinbo, Matthew R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Wolfgang, Matthew C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	redinbo@unc.edu	Johnson, Michael D. L./B-4352-2012	Johnson, Michael/0000-0002-6347-0208	Ruth Kirschstein Supplement on the National Institutes of Health [AI078924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078924] Funding Source: NIH RePORTER	Ruth Kirschstein Supplement on the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Ruth Kirschstein Supplement (MDLJ) on the National Institutes of Health Grant AI078924 (MRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMPHLETT GW, 1983, BIOCHEM BIOPH RES CO, V111, P1045, DOI 10.1016/0006-291X(83)91405-5; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Cass DL, 1998, J PEDIATR SURG, V33, P312, DOI 10.1016/S0022-3468(98)90453-5; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Emam A, 2006, MICROBIOL-SGM, V152, P2789, DOI 10.1099/mic.0.28863-0; Fusi FM, 1996, MOL HUM REPROD, V2, P859, DOI 10.1093/molehr/2.11.859; GOLDMAN MJ, 1995, J VIROL, V69, P5951, DOI 10.1128/JVI.69.10.5951-5958.1995; Gravelle S, 2010, INNATE IMMUN-LONDON, V16, P14, DOI 10.1177/1753425909106170; HARFENIST EJ, 1987, BLOOD, V70, P827; Harvala H, 2003, J GEN VIROL, V84, P2375, DOI 10.1099/vir.0.19246-0; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang YJ, 2006, BIOCHEM BIOPH RES CO, V350, P537, DOI 10.1016/j.bbrc.2006.09.070; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Julio SM, 2009, MOL MICROBIOL, V71, P1574, DOI 10.1111/j.1365-2958.2009.06623.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Leroy-Dudal J, 2004, MICROBES INFECT, V6, P875, DOI 10.1016/j.micinf.2004.05.004; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Manning VA, 2008, MOL PLANT MICROBE IN, V21, P315, DOI 10.1094/MPMI-21-3-0315; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mihalyi E, 2004, BIOPHYS CHEM, V112, P131, DOI 10.1016/j.bpc.2004.07.012; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Pilewski JM, 1997, AM J PHYSIOL-LUNG C, V273, pL256, DOI 10.1152/ajplung.1997.273.1.L256; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Saalbach A, 1997, Wound Repair Regen, V5, P69; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Schroeder TH, 2001, INFECT IMMUN, V69, P719, DOI 10.1128/IAI.69.2.719-729.2001; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; Slater M, 2002, HISTOCHEM J, V34, P13, DOI 10.1023/A:1021335606896; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Swatzell LJ, 1999, PLANT CELL PHYSIOL, V40, P173, DOI 10.1093/oxfordjournals.pcp.a029525; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; WEBER C, 1994, J BIOL CHEM, V269, P15795; Xiao JQ, 2008, VIROLOGY, V370, P430, DOI 10.1016/j.virol.2007.09.012; Zimmermann L, 2010, J BACTERIOL, V192, P3773, DOI 10.1128/JB.00253-10	55	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29629	10.1371/journal.pone.0029629	http://dx.doi.org/10.1371/journal.pone.0029629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242136	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000052
J	Stoeckius, M; Erat, A; Fujikawa, T; Hiromura, M; Koulova, A; Otterbein, L; Bianchi, C; Tobiasch, E; Dagon, Y; Sellke, FW; Usheva, A				Stoeckius, Marlon; Erat, Anna; Fujikawa, Tatsuya; Hiromura, Makoto; Koulova, Anna; Otterbein, Leo; Bianchi, Cesario; Tobiasch, Edda; Dagon, Yossi; Sellke, Frank W.; Usheva, Anny			Essential Roles of Raf/Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway, YY1, and Ca2+ Influx in Growth Arrest of Human Vascular Smooth Muscle Cells by Bilirubin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; HEART-DISEASE; TRANSCRIPTION; PHOSPHORYLATION; PROGRESSION; INHIBITOR; LIFE	The biological effects of bilirubin, still poorly understood, are concentration-dependent ranging from cell protection to toxicity. Here we present data that at high nontoxic physiological concentrations, bilirubin inhibits growth of proliferating human coronary artery smooth muscle cells by three events. It impairs the activation of Raf/ERK/MAPK pathway and the cellular Raf and cyclin D1 content that results in retinoblastoma protein hypophosphorylation on amino acids S608 and S780. These events impede the release of YY1 to the nuclei and its availability to regulate the expression of genes and to support cellular proliferation. Moreover, altered calcium influx and calpain II protease activation leads to proteolytical degradation of transcription factor YY1. We conclude that in the serum-stimulated human vascular smooth muscle primary cell cultures, bilirubin favors growth arrest, and we propose that this activity is regulated by its interaction with the Raf/ERK/MAPK pathway, effect on cyclin D1 and Raf content, altered retinoblastoma protein profile of hypophosphorylation, calcium influx, and YY1 proteolysis. We propose that these activities together culminate in diminished 5 S and 45 S ribosomal RNA synthesis and cell growth arrest. The observations provide important mechanistic insight into the molecular mechanisms underlying the transition of human vascular smooth muscle cells from proliferative to contractile phenotype and the role of bilirubin in this transition.	[Usheva, Anny] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Bianchi, Cesario; Sellke, Frank W.] Brown Univ, Alpert Med Sch, Div Cardiothorac Surg, Providence, RI 02912 USA; [Hiromura, Makoto] RIKEN Kobe Inst, Multiple Mol Imaging Res Lab, Kobe, Hyogo 6500047, Japan; [Tobiasch, Edda] Bonn Rhein Sieg Univ Appl Sci, D-53359 Rheinbach, Germany; [Erat, Anna] Univ Zurich Hosp, Clin Internal Med, CH-8091 Zurich, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Brown University; RIKEN; Hochschule Bonn Rhein Sieg; University of Zurich; University Zurich Hospital	Usheva, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 3 Blackfan Circle,CLS 701, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	bianchi, cesario/H-6238-2012; Dagon, Yossi/AAI-5882-2020	Stoeckius, Marlon/0000-0002-5658-029X	National Institutes of Health [R01HL062458, RO1HL46716, RO1HL69024]; Swiss Public Health Institute; Finnish Medical Society; Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458, R01HL069024, R01HL046716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Public Health Institute; Finnish Medical Society; Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL062458 (to A. U.) and RO1HL46716 and RO1HL69024 (to F. W. S.). This work was also supported by a fellowship from the Swiss Public Health Institute, the Finnish Medical Society, and the Academy of Finland (to A. E.).	Beohar N, 2004, CIRCULATION, V109, P108, DOI 10.1161/01.CIR.0000105724.30980.CD; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Dumaz N, 2005, MOL CELL, V17, P164, DOI 10.1016/j.molcel.2005.01.001; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hahm Joon Soo, 1992, Korean Journal of Internal Medicine (English Edition), V7, P18; KUROSE K, 1995, NUCLEIC ACIDS RES, V23, P3704, DOI 10.1093/nar/23.18.3704; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; MUSTAFA MG, 1969, J BIOL CHEM, V244, P6403; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Sen CK, 1996, FEBS LETT, V385, P58, DOI 10.1016/0014-5793(96)00346-8; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Taille C, 2003, J BIOL CHEM, V278, P27160, DOI 10.1074/jbc.M300364200; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009	24	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15418	15426		10.1074/jbc.M111.266510	http://dx.doi.org/10.1074/jbc.M111.266510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22262839	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000304006300023
J	Lasagna-Reeves, CA; Castillo-Carranza, DL; Sengupta, U; Sarmiento, J; Troncoso, J; Jackson, GR; Kayed, R				Lasagna-Reeves, Cristian A.; Castillo-Carranza, Diana L.; Sengupta, Urmi; Sarmiento, Jose; Troncoso, Juan; Jackson, George R.; Kayed, Rakez			Identification of oligomers at early stages of tau aggregation in Alzheimer's disease	FASEB JOURNAL			English	Article						neurodegeneration; conformational antibodies; tauopathies; protein misfolding	RESONANCE ENERGY-TRANSFER; PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; CEREBROSPINAL-FLUID; TRANSGENIC MICE; MOUSE MODEL; CELL-DEATH; A-BETA; EXTRACELLULAR TAU; NEURITIC PLAQUES	Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease (AD); however, the relationship between NFTs and disease progression remains controversial. Analyses of tau animal models suggest that phenotypes coincide with accumulation of soluble aggregated tau species but not the accumulation of NFTs. The pathological role of prefilamentous tau aggregates, e. g., tau oligomeric intermediates, is poorly understood, in part because of methodological challenges. Here, we engineered a novel tau oligomer-specific antibody, T22, and used it to elucidate the temporal course and biochemical features of oligomers during NFT development in AD brain. We found that tau oligomers in human AD brain samples were 4-fold higher than those in the controls. We also revealed the role of oligomeric tau conformers in pretangles, neuritic plaques, and neuropil threads in the frontal cortex tissue from AD brains; this analysis uncovers a consistent code that governs tau oligomerization with regard to degree of neuronal cytopathology. These data are the first to characterize the role of tau oligomers in the natural history of NFTs, and they highlight the suitability of tau oligomers as therapeutic targets in AD and related tauopathies.-Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Troncoso, J., Jackson, G. R., Kayed, R. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J. 26, 1946-1959 (2012). www.fasebj.org	[Lasagna-Reeves, Cristian A.; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, George P & Cynthia Woods Mitchell Ctr Neurodegene, Galveston, TX 77555 USA; [Lasagna-Reeves, Cristian A.; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX USA; [Sarmiento, Jose; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA; [Troncoso, Juan] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University	Kayed, R (corresponding author), Univ Texas Med Branch, George P & Cynthia Woods Mitchell Ctr Neurodegene, 301 Univ Blvd,Med Res Bldg,Room 10-138C, Galveston, TX 77555 USA.	rakayed@utmb.edu	Lasagna-Reeves, Cristian/ABE-2001-2021	Castillo-Carranza, Diana/0000-0003-2511-949X	Cullen Family Trust for Health Care; Alzheimer's Drug Discovery Foundation; Mitchell Center for Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	Cullen Family Trust for Health Care; Alzheimer's Drug Discovery Foundation; Mitchell Center for Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Bridget E. Hawkins for her suggestions and critical reading of the manuscript. The authors are grateful to Prof. Carl Cotman [University of California-Irvine (UCI), Irvine, CA, USA] and the UCI-Alzheimer's Disease Research Center brain bank for providing brain samples, Dr. Marcos Guerrero-Munoz for his help in the purification and characterization of tau oligomers, and Dr. Adriana Paulucci for her help in using the confocal and image analyses. This work was supported by the Cullen Family Trust for Health Care, the Alzheimer's Drug Discovery Foundation, and the Mitchell Center for Neurodegenerative Diseases. R. K. is the founder of ConImm, Inc. and has patent applications on the compositions and methods related to tau oligomers.	Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Avila J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00049; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAAK H, 1988, NEUROPATH APPL NEURO, V14, P39, DOI 10.1111/j.1365-2990.1988.tb00864.x; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chatterjee S, 2009, HUM MOL GENET, V18, P164, DOI 10.1093/hmg/ddn326; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Delacourte A, 2002, EXP GERONTOL, V37, P1291, DOI 10.1016/S0531-5565(02)00141-9; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Duyckaerts C, 2011, ACTA NEUROPATHOL, V121, P145, DOI 10.1007/s00401-010-0794-7; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Galasko D, 1997, NEUROLOGY, V48, P632, DOI 10.1212/WNL.48.3.632; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hernandez F, 2010, CURR ALZHEIMER RES, V7, P670, DOI 10.2174/156720510793611583; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kayed R, 2009, CURR OPIN IMMUNOL, V21, P359, DOI 10.1016/j.coi.2009.05.001; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Knowles RB, 1999, J NEUROPATH EXP NEUR, V58, P1090, DOI 10.1097/00005072-199910000-00007; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee VMY, 1999, METHOD ENZYMOL, V309, P81; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Marx J, 2007, SCIENCE, V316, P1416, DOI 10.1126/science.316.5830.1416; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Rostagno A., 2009, CURR PROTOC CELL BIO, P31; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schultz C, 2004, NEUROBIOL AGING, V25, P397, DOI 10.1016/S0197-4580(03)00113-1; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sharma N, 2001, ACTA NEUROPATHOL, V102, P329; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spires-Jones TL, 2011, J MOL NEUROSCI, V45, P438, DOI 10.1007/s12031-011-9566-7; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Talmat-Amar Y, 2011, HUM MOL GENET, V20, P3738, DOI 10.1093/hmg/ddr290; Uchihara T, 2001, ACTA NEUROPATHOL, V101, P535; Umahara T, 2002, NEUROPATHOLOGY, V22, P9, DOI 10.1046/j.0919-6544.2002.00422.x; Vidal R, 2000, ACTA NEUROPATHOL, V100, P1, DOI 10.1007/s004010051186; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	99	322	327	2	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1946	1959		10.1096/fj.11-199851	http://dx.doi.org/10.1096/fj.11-199851			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253473	Green Published			2022-12-25	WOS:000303680800022
J	Zhang, X; Pino, GM; Shephard, F; Kiss-Toth, E; Qwarnstrom, EE				Zhang, Xiao; Pino, Gemma Montagut; Shephard, Freya; Kiss-Toth, Endre; Qwarnstrom, Eva E.			Distinct Control of MyD88 Adapter-dependent and Akt Kinase-regulated Responses by the Interleukin (IL)-1RI Co-receptor, TILRR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SECONDARY STRUCTURE; INDUCED APOPTOSIS; RECEPTOR; ACTIVATION; TOLL; PROTEIN; AMPLIFICATION; EXPRESSION; LOOP	Inflammatory responses are controlled through members of the interleukin-1 receptor (IL-1R)/Toll-like receptor superfamily. Our earlier work demonstrates that the IL-1 receptor type 1 (IL-1RI) co-receptor, Toll-like and IL-1 receptor regulator (TILRR), amplifies IL-1 activation of NF-kappa B and inflammatory genes. Here we show that TILRR similarly promotes IL-1-induced anti-apoptotic signals and reduces caspase-3 activity. Further, the TILRR-induced effects on cell survival and inflammatory responses are controlled through distinct parts of the IL-1RI regulatory Toll IL-1 receptor (TIR) domain. Alanine-scanning mutagenesis identified a functional TILRR mutant (R425A), which blocked increases in cell survival and upstream activation of Akt but had no effect on amplification of MyD88-dependent inflammatory responses. A second mutant (D448A) blocked TILRR potentiation of MyD88-dependent signals and inflammatory activation but had no impact on cell survival. Secondary structure predictions suggested that the mutations induce distinct alterations in the alpha-helical structure of the TILRR core protein. The results indicate a role for TILRR in selective amplification of NF-kappa B responses through IL-1RI and suggest that the specificity is determined by changes in receptor conformation and adapter protein recruitment.	[Zhang, Xiao; Pino, Gemma Montagut; Shephard, Freya; Qwarnstrom, Eva E.] Univ Sheffield, Cell Biol Grp, Dept Cardiovasc Sci, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Kiss-Toth, Endre] Univ Sheffield, Cell Signalling Grp, Dept Cardiovasc Sci, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Qwarnstrom, Eva E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Sheffield; University of Sheffield; University of Washington; University of Washington Seattle	Qwarnstrom, EE (corresponding author), Univ Sheffield, Cell Biol Grp, Dept Cardiovasc Sci, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	e.qwarnstrom@sheffield.ac.uk	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Zhang, Xiao/0000-0002-3894-8513; Qwarnstrom, Eva/0000-0003-4417-8663	Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056]; British Heart Foundation [PG/2000094, PG/07/094/23742]; Biotechnology and Biological Sciences Research Council [BB/J009687/1] Funding Source: researchfish; BBSRC [BB/J009687/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/C515798/1; BBS/B/04056) and the British Heart Foundation (PG/2000094; PG/07/094/23742) (to E. E. Q.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Burow ME, 2000, BIOCHEM BIOPH RES CO, V271, P342, DOI 10.1006/bbrc.2000.2626; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200; Zhang X, 2010, J BIOL CHEM, V285, P7222, DOI 10.1074/jbc.M109.073429	23	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12348	12352		10.1074/jbc.C111.321711	http://dx.doi.org/10.1074/jbc.C111.321711			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22262840	hybrid, Green Published			2022-12-25	WOS:000302782200074
J	Chartron, JW; VanderVelde, DG; Rao, M; Clemons, WM				Chartron, Justin W.; VanderVelde, David G.; Rao, Meera; Clemons, William M., Jr.			Get5 Carboxyl-terminal Domain Is a Novel Dimerization Motif That Tethers an Extended Get4/Get5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-ANCHORED PROTEINS; STRUCTURAL-CHARACTERIZATION; MOLECULAR-BASIS; INSERTION; SYSTEM; MODEL; HOMODIMERIZATION; SPECIFICITY; INTEGRATION; CHAPERONES	Tail-anchored trans-membrane proteins are targeted to membranes post-translationally. The proteins Get4 and Get5 form an obligate complex that catalyzes the transfer of tail-anchored proteins destined to the endoplasmic reticulum from Sgt2 to the cytosolic targeting factor Get3. Get5 forms a homodimer mediated by its carboxyl domain. We show here that a conserved motif exists within the carboxyl domain. A high resolution crystal structure and solution NMR structures of this motif reveal a novel and stable helical dimerization domain. We additionally determined a solution NMR structure of a divergent fungal homolog, and comparison of these structures allows annotation of specific stabilizing interactions. Using solution x-ray scattering and the structures of all folded domains, we present a model of the full-length Get4/Get5 complex.	[Chartron, Justin W.; VanderVelde, David G.; Rao, Meera; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,M-C 114-96, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009; Chartron, Justin/L-9096-2019	Clemons, William M/0000-0002-0021-889X; Chartron, Justin/0000-0003-1734-3424; VanderVelde, David/0000-0002-2907-0366	Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis; United States Department of Energy; National Institutes of Health [R01GM097572]; Searle Scholar program; Burroughs-Wellcome Fund career award for the biological sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097572] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis(Sanofi-Aventis); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; Burroughs-Wellcome Fund career award for the biological sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Molecular Observatory at Caltech is supported by the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program. Operations at SSRL are supported by the United States Department of Energy and the National Institutes of Health.; Supported by National Institutes of Health Grant R01GM097572, the Searle Scholar program, and a Burroughs-Wellcome Fund career award for the biological sciences. To whom correspondence should be addressed: California Institute of Technology, 1200 E. California Blvd., M/C 114-96, Pasadena, CA 91125. Tel.: 626-395-1796; E-mail: clemons@caltech.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhlman B, 2001, P NATL ACAD SCI USA, V98, P10687, DOI 10.1073/pnas.181354398; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simpson PJ, 2010, STRUCTURE, V18, P897, DOI 10.1016/j.str.2010.07.003; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020	52	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8310	8317		10.1074/jbc.M111.333252	http://dx.doi.org/10.1074/jbc.M111.333252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262836	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000301349400045
J	van Abel, D; Abdul-Hamid, O; van Dijk, M; Oudejans, CBM				van Abel, Daan; Abdul-Hamid, Omar; van Dijk, Marie; Oudejans, Cees B. M.			Transcription Factor STOX1A Promotes Mitotic Entry by Binding to the CCNB1 Promotor	PLOS ONE			English	Article							CYCLE-DEPENDENT REGULATION; CELL-CYCLE; ALZHEIMERS-DISEASE; B1; NEURONS; PROTEIN; DNA; SEGREGATION; CENTROSOMES; ACTIVATION	Background: In this study we investigated the involvement of the transcription factor STOX1A in the regulation of the cell cycle. Methodology/Principal Findings: We found that several major cell cycle regulatory genes were differentially expressed upon STOX1A stimulation and knockdown in the neuroblastoma cell line SH-SY5Y. This includes STOX1A dependent differential regulation of cyclin B1 expression, a cyclin which is known to regulate mitotic entry during the cell cycle. The differential regulation of cyclin B1 expression by STOX1A is direct as shown with chromatin immunoprecipitation. Results furthermore suggest that mitotic entry is enhanced through the direct upregulation of cyclin B1 expression effectuated by STOX1A. Conclusions: In conclusion we hereby show that STOX1A is directly involved in the regulation of the cell cycle.	[van Abel, Daan; Abdul-Hamid, Omar; van Dijk, Marie; Oudejans, Cees B. M.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Abel, D (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	van Dijk, Marie/L-1901-2014	Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441				Bassermann F, 2005, CELL CYCLE, V4, P1515, DOI 10.4161/cc.4.11.2192; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; HWANG A, 1995, J BIOL CHEM, V270, P28419; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; LIU WK, 1995, AM J PATHOL, V146, P228; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Sage J, 2004, DEV CELL, V6, P607, DOI 10.1016/S1534-5807(04)00137-6; SONG WH, 1995, NUCLEIC ACIDS RES, V23, P3609, DOI 10.1093/nar/23.17.3609; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; van Dijk M, 2010, HUM MOL GENET, V19, P2658, DOI 10.1093/hmg/ddq152; van Dijk M, 2010, J ALZHEIMERS DIS, V19, P673, DOI 10.3233/JAD-2010-1265; Vincent I, 1997, J NEUROSCI, V17, P3588; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	28	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29769	10.1371/journal.pone.0029769	http://dx.doi.org/10.1371/journal.pone.0029769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253775	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500020
J	Dittgen, T; Pitzer, C; Plaas, C; Kirsch, F; Vogt, G; Laage, R; Schneider, A				Dittgen, Tanjew; Pitzer, Claudia; Plaas, Christian; Kirsch, Friederike; Vogt, Gerhard; Laage, Rico; Schneider, Armin			Granulocyte-Colony Stimulating Factor (G-CSF) Improves Motor Recovery in the Rat Impactor Model for Spinal Cord Injury	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; STEM-CELLS; REGENERATION; DISEASE; LIGAND; DEATH; MICE	Granulocyte-colony stimulating factor (G-CSF) improves outcome after experimental SCI by counteracting apoptosis, and enhancing connectivity in the injured spinal cord. Previously we have employed the mouse hemisection SCI model and studied motor function after subcutaneous or transgenic delivery of the protein. To further broaden confidence in animal efficacy data we sought to determine efficacy in a different model and a different species. Here we investigated the effects of G-CSF in Wistar rats using the New York University Impactor. In this model, corroborating our previous data, rats treated subcutaneously with G-CSF over 2 weeks show significant improvement of motor function.	[Dittgen, Tanjew; Pitzer, Claudia; Plaas, Christian; Kirsch, Friederike; Vogt, Gerhard; Laage, Rico; Schneider, Armin] SYGNIS Biosci, Heidelberg, Germany		Dittgen, T (corresponding author), SYGNIS Biosci, Heidelberg, Germany.	Schneider@Sygnis.de		Schneider, Armin/0000-0003-0296-0059				BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Chen WF, 2010, NEUROSCIENCE, V165, P1217, DOI 10.1016/j.neuroscience.2009.11.033; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Schabitz W-R, 2010, STROKE IN PRESS; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Young W, 2002, PROG BRAIN RES, V137, P231; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	19	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29880	10.1371/journal.pone.0029880	http://dx.doi.org/10.1371/journal.pone.0029880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253813	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100028
J	Klann, M; Koeppl, H; Reuss, M				Klann, Michael; Koeppl, Heinz; Reuss, Matthias			Spatial Modeling of Vesicle Transport and the Cytoskeleton: The Challenge of Hitting the Right Road	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; STOCHASTIC SIMULATION; MEDIATED ENDOCYTOSIS; VESICULAR TRANSPORT; PROTEIN-TRANSPORT; MOLECULAR MOTORS; GOLGI; DYNAMICS; ER; COMPLEX	The membrane trafficking machinery provides a transport and sorting system for many cellular proteins. We propose a mechanistic agent-based computer simulation to integrate and test the hypothesis of vesicle transport embedded into a detailed model cell. The method tracks both the number and location of the vesicles. Thus both the stochastic properties due to the low numbers and the spatial aspects are preserved. The underlying molecular interactions that control the vesicle actions are included in a multi-scale manner based on the model of Heinrich and Rapoport (2005). By adding motor proteins we can improve the recycling process of SNAREs and model cell polarization. Our model also predicts that coat molecules should have a high turnover at the compartment membranes, while the turnover of motor proteins has to be slow. The modular structure of the underlying model keeps it tractable despite the overall complexity of the vesicle system. We apply our model to receptor-mediated endocytosis and show how a polarized cytoskeleton structure leads to polarized distributions in the plasma membrane both of SNAREs and the Ste2p receptor in yeast. In addition, we can couple signal transduction and membrane trafficking steps in one simulation, which enables analyzing the effect of receptor-mediated endocytosis on signaling.	[Klann, Michael; Koeppl, Heinz] Swiss Fed Inst Technol, Automat Control Lab, Zurich, Switzerland; [Reuss, Matthias] Univ Stuttgart, Ctr Syst Biol, Stuttgart, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Stuttgart	Klann, M (corresponding author), Swiss Fed Inst Technol, Automat Control Lab, Zurich, Switzerland.	mklann@control.ee.ethz.ch			Landesstiftung Baden-Wuerttemberg; Center Systems Biology (CSB) Stuttgart; Swiss SystemsX.ch initiative	Landesstiftung Baden-Wuerttemberg; Center Systems Biology (CSB) Stuttgart; Swiss SystemsX.ch initiative	MK and MR acknowledge the funding by Landesstiftung Baden-Wuerttemberg, Research Programm Center Systems Biology (CSB) Stuttgart. MK and HK acknowledge the funding of the Swiss SystemsX.ch initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan V, 1996, SEMIN CELL DEV BIOL, V7, P335, DOI 10.1006/scdb.1996.0043; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Barr FA, 2005, J CELL BIOL, V168, P993, DOI 10.1083/jcb.200501088; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Birbaumer M, 2011, EUR PHYS J B, V82, P245, DOI 10.1140/epjb/e2011-20283-x; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brusch L, 2008, J THEOR BIOL, V252, P370, DOI 10.1016/j.jtbi.2008.01.004; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Falk M, 2010, I S BIOMED IMAGING, P1301, DOI 10.1109/ISBI.2010.5490235; Falk M, 2009, IEEE PAC VIS SYMP, P169, DOI 10.1109/PACIFICVIS.2009.4906853; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Foret L, 2008, P NATL ACAD SCI USA, V105, P14763, DOI 10.1073/pnas.0801173105; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Fuchslin RM, 2009, EUR PHYS J E, V29, P431, DOI 10.1140/epje/i2009-10482-x; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gong HJ, 2008, BIOPHYS J, V95, P1674, DOI 10.1529/biophysj.107.127498; Graf C, 2006, THESIS FREIE U BERLI; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Hopfner S, 2005, THESIS TU DRESDEN; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kim K, 2006, MOL BIOL CELL, V17, P1354, DOI 10.1091/mbc.e05-10-0925; Kirk SJ, 2007, SEMIN CELL DEV BIOL, V18, P435, DOI 10.1016/j.semcdb.2007.07.007; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Klann MT, 2009, BIOPHYS J, V96, P5122, DOI 10.1016/j.bpj.2009.03.049; Klumpp S, 2005, BIOPHYS J, V88, P3118, DOI 10.1529/biophysj.104.056127; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Meyer HH, 2005, BBA-MOL CELL RES, V1744, P108, DOI 10.1016/j.bbamcr.2005.03.011; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Mulholland J, 1999, MOL BIOL CELL, V10, P799, DOI 10.1091/mbc.10.3.799; Olkkonen VM, 2006, J CELL SCI, V119, P5031, DOI 10.1242/jcs.03303; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Pollack G.H., 2001, CELLS GELS ENGINES L; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Shillcock JC, 2006, J PHYS-CONDENS MAT, V18, pS1191, DOI 10.1088/0953-8984/18/28/S06; Smith EA, 2011, BIOPHYS J, V100, P2141, DOI 10.1016/j.bpj.2011.03.015; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001	67	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29645	10.1371/journal.pone.0029645	http://dx.doi.org/10.1371/journal.pone.0029645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253752	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100017
J	Takahashi, K; Mizukami, H; Kamata, K; Inaba, W; Kato, N; Hibi, C; Yagihashi, S				Takahashi, Kazunori; Mizukami, Hiroki; Kamata, Kosuke; Inaba, Wataru; Kato, Noriaki; Hibi, Chihiro; Yagihashi, Soroku			Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE-RENAL-FAILURE; MYOCARDIAL ISCHEMIC-INJURY; REPERFUSION INJURY; MICE; SEPSIS; COMPLICATIONS; ACTIVATION; PATHWAY; ISCHEMIA/REPERFUSION	Background: Systemic inflammatory response syndrome is a fatal disease because of multiple organ failure. Acute kidney injury is a serious complication of systemic inflammatory response syndrome and its genesis is still unclear posing a difficulty for an effective treatment. Aldose reductase (AR) inhibitor is recently found to suppress lipopolysaccharide (LPS)-induced cardiac failure and its lethality. We studied the effects of AR inhibitor on LPS-induced acute kidney injury and its mechanism. Methods: Mice were injected with LPS and the effects of AR inhibitor (Fidarestat 32 mg/kg) before or after LPS injection were examined for the mortality, severity of renal failure and kidney pathology. Serum concentrations of cytokines (interleukin-1 beta, interleukin-6, monocyte chemotactic protein-1 and tumor necrosis factor-a) and their mRNA expressions in the lung, liver, spleen and kidney were measured. We also evaluated polyol metabolites in the kidney. Results: Mortality rate within 72 hours was significantly less in LPS-injected mice treated with AR inhibitor both before (29%) and after LPS injection (40%) than untreated mice (90%). LPS-injected mice showed marked increases in blood urea nitrogen, creatinine and cytokines, and AR inhibitor treatment suppressed the changes. LPS-induced acute kidney injury was associated with vacuolar degeneration and apoptosis of renal tubular cells as well as infiltration of neutrophils and macrophages. With improvement of such pathological findings, AR inhibitor treatment suppressed the elevation of cytokine mRNA levels in multiple organs and renal sorbitol accumulation. Conclusion: AR inhibitor treatment ameliorated LPS-induced acute kidney injury, resulting in the lowered mortality.	[Mizukami, Hiroki; Kamata, Kosuke; Inaba, Wataru; Yagihashi, Soroku] Hirosaki Univ, Dept Pathol & Mol Med, Grad Sch Med, Hirosaki, Aomori, Japan; [Kato, Noriaki; Hibi, Chihiro] Sanwa Kagaku Kenkyusho, Nagoya, Aichi, Japan	Hirosaki University; Sanwa Kagaku Kenkyusho Co., Ltd.	Takahashi, K (corresponding author), Hirosaki Univ, Dept Pathol & Mol Med, Grad Sch Med, Hirosaki, Aomori, Japan.	yagihasi@cc.hirosaki-u.ac.jp	Mizukami, Hiroki/ABE-7877-2021	Mizukami, Hiroki/0000-0003-2920-582X	Japanese Ministry of Science, Culture, Education and Sports [1011445]	Japanese Ministry of Science, Culture, Education and Sports	This study was supported by a grant from the Japanese Ministry of Science, Culture, Education and Sports, Explorative Research Project, to SY (#1011445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEDICT CR, 1992, CIRC SHOCK, V38, P165; Cheung AKH, 2007, EXP EYE RES, V85, P608, DOI 10.1016/j.exer.2007.07.013; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; Clermont G, 2001, CRIT CARE MED, V29, P291, DOI 10.1097/00003246-200102000-00012; CUMMING AD, 1988, AM J KIDNEY DIS, V11, P23, DOI 10.1016/S0272-6386(88)80170-7; Hollenberg SM, 2000, CIRC RES, V86, P774, DOI 10.1161/01.RES.86.7.774; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; Iwata T, 1999, J BIOL CHEM, V274, P7993, DOI 10.1074/jbc.274.12.7993; Kaneko K, 2006, AM J PHYSIOL-HEART C, V290, pH1484, DOI 10.1152/ajpheart.01006.2005; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Lo ACY, 2007, J CEREBR BLOOD F MET, V27, P1496, DOI 10.1038/sj.jcbfm.9600452; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nadkarni V, 1999, J BIOL CHEM, V274, P20185, DOI 10.1074/jbc.274.29.20185; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Oh DJ, 2008, AM J PHYSIOL-RENAL, V294, pF264, DOI 10.1152/ajprenal.00204.2007; Ramana KV, 2007, FREE RADICAL BIO MED, V42, P1290, DOI 10.1016/j.freeradbiomed.2007.01.033; Ramana KV, 2006, CIRCULATION, V114, P1838, DOI 10.1161/CIRCULATIONAHA.106.630830; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 1998, AM J PHYSIOL-HEART C, V275, pH195, DOI 10.1152/ajpheart.1998.275.1.H195; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Reddy ABM, 2009, CYTOKINE, V48, P170, DOI 10.1016/j.cyto.2009.07.004; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Schor N, 2002, KIDNEY INT, V61, P764, DOI 10.1046/j.1523-1755.2002.00178.x; Schrier RW, 2010, NAT REV NEPHROL, V6, P125, DOI 10.1038/nrneph.2010.1; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schwartz D, 1997, J CLIN INVEST, V100, P439, DOI 10.1172/JCI119551; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Yabe-Nishimura C, 1998, PHARMACOL REV, V50, P21; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Yagihashi S, 2010, J PATHOL, V220, P530, DOI 10.1002/path.2671	41	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30134	10.1371/journal.pone.0030134	http://dx.doi.org/10.1371/journal.pone.0030134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253906	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100041
J	Matia-Gonzalez, AM; Sotelo, J; Rodriguez-Gabriel, MA				Matia-Gonzalez, Ana M.; Sotelo, Jael; Rodriguez-Gabriel, Miguel A.			The RNA Binding Protein Csx1 Promotes Sexual Differentiation in Schizosaccharomyces pombe	PLOS ONE			English	Article							FISSION YEAST; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ENCODES; MEIOSIS; KINASE; STE11(+); PHOSPHORYLATION; REGULATOR; PHEROMONE	Sexual differentiation is a highly regulated process in the fission yeast Schizosaccharomyces pombe and is triggered by nutrient depletion, mainly nitrogen source. One of the key regulatory proteins in fission yeast sexual differentiation is the transcription factor Ste11. Ste11 regulates the transcription of many genes required for the initial steps of conjugation and meiosis, and its deficiency leads to sterility. Ste11 activity is mainly regulated at two levels: phosphorylation and abundance of its mRNA. Csx1 is an RNA binding protein that we have previously described to bind and regulate the turnover rate of the mRNA encoding the transcription factor Atf1 in the presence of oxidative stress. We have observed that Csx1-deficient cells have defects in sexual differentiation and are partially sterile. We investigated how Csx1 is regulating this process in S. pombe. Csx1 associates with ste11(+) mRNA and cells lacking Csx1 are sterile with a reduced amount of ste11(+) mRNA. Overexpression of ste11(+) mRNA completely rescues the mating deficiencies of csx1 Delta cells. Here, we present a novel mechanism of ste11(+) mRNA positive regulation through the activity of Csx1, an RNA binding protein that also have key functions in the response to oxidative stress in fission yeast. This finding opens interesting question about the possible coordination of sexual differentiation and oxidative stress response in eukaryotes and the role of RNA binding proteins in the adaptation to environmental signals.	[Matia-Gonzalez, Ana M.; Sotelo, Jael; Rodriguez-Gabriel, Miguel A.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Matia-Gonzalez, AM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	marodriguez@cbm.uam.es	Gonzalez, Ana M. Matia/N-3371-2019; Rodriguez-Gabriel, Miguel/L-2425-2013	Gonzalez, Ana M. Matia/0000-0002-8127-4219; Rodriguez-Gabriel, Miguel/0000-0002-6855-5286	Spanish Ministry of Science and Innovation (MICINN) [BFU2006-01767, BFU2009-09116]; MICINN; Madrid Government	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Madrid Government	Research in MARG laboratory was supported by BFU2006-01767 and BFU2009-09116 by the Spanish Ministry of Science and Innovation (MICINN). AMMG was supported by FPI (Formacion Personal Investigador) fellowship from MICINN. JS was supported by a grant from Madrid Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Amorim MJ, 2009, EMBO REP, V10, P186, DOI 10.1038/embor.2008.228; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Jeong HT, 2004, GENETICS, V167, P77, DOI 10.1534/genetics.167.1.77; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; Kjaerulff S, 2007, GENE DEV, V21, P347, DOI 10.1101/gad.407107; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ohmiya R, 2000, MOL GEN GENET, V264, P441, DOI 10.1007/s004380000305; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Oowatari Y, 2011, CURR GENET, V57, P191, DOI 10.1007/s00294-011-0335-5; Rodriguez-Gabriel MA, 2003, EMBO J, V22, P6256, DOI 10.1093/emboj/cdg597; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Valbuena N, PLOS ONE; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X	26	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30067	10.1371/journal.pone.0030067	http://dx.doi.org/10.1371/journal.pone.0030067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253882	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700086
J	Payne, MC; Brown, CA; Reusser, DA; Lee, H				Payne, Meredith C.; Brown, Cheryl A.; Reusser, Deborah A.; Lee, Henry, II			Ecoregional Analysis of Nearshore Sea-Surface Temperature in the North Pacific	PLOS ONE			English	Article							SEASONAL VARIABILITY; CLIMATE-CHANGE; COASTAL; EVOLUTION; PATTERNS; SHIFTS; CYCLE; RISK	The quantification and description of sea surface temperature (SST) is critically important because it can influence the distribution, migration, and invasion of marine species; furthermore, SSTs are expected to be affected by climate change. To better understand present temperature regimes, we assembled a 29-year nearshore time series of mean monthly SSTs along the North Pacific coastline using remotely-sensed satellite data collected with the Advanced Very High Resolution Radiometer (AVHRR) instrument. We then used the dataset to describe nearshore (<20 km offshore) SST patterns of 16 North Pacific ecoregions delineated by the Marine Ecoregions of the World (MEOW) hierarchical schema. Annual mean temperature varied from 3.8 degrees C along the Kamchatka ecoregion to 24.8 degrees C in the Cortezian ecoregion. There are smaller annual ranges and less variability in SST in the Northeast Pacific relative to the Northwest Pacific. Within the 16 ecoregions, 31-94% of the variance in SST is explained by the annual cycle, with the annual cycle explaining the least variation in the Northern California ecoregion and the most variation in the Yellow Sea ecoregion. Clustering on mean monthly SSTs of each ecoregion showed a clear break between the ecoregions within the Warm and Cold Temperate provinces of the MEOW schema, though several of the ecoregions contained within the provinces did not show a significant difference in mean seasonal temperature patterns. Comparison of these temperature patterns shared some similarities and differences with previous biogeographic classifications and the Large Marine Ecosystems (LMEs). Finally, we provide a web link to the processed data for use by other researchers.	[Payne, Meredith C.; Reusser, Deborah A.] US Geol Survey, Western Fisheries Res Ctr, Newport, OR USA; [Payne, Meredith C.; Reusser, Deborah A.] Oregon State Univ, Corvallis, OR 97331 USA; [Brown, Cheryl A.; Lee, Henry, II] US EPA, Pacific Coastal Ecol Branch, Western Ecol Div, Newport, OR USA	United States Department of the Interior; United States Geological Survey; Oregon State University; United States Environmental Protection Agency	Payne, MC (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Newport, OR USA.	mpayne@usgs.gov	Lee, Henry/GVS-2114-2022	Brown, Cheryl/0000-0003-1035-4251	United States Geological Survey National Wildlife Climate Change Center [3206-DU9-14]; Environmental Protection Agency (EPA)	United States Geological Survey National Wildlife Climate Change Center; Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was supported by the United States Geological Survey National Wildlife Climate Change Center # 3206-DU9-14 and an Environmental Protection Agency (EPA) summer student internship. The funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 2001, J PHYCOL, V37, P677, DOI 10.1046/j.1529-8817.2001.00176.x; Barth JA, 2005, DEEP-SEA RES PT II, V52, P5, DOI 10.1016/j.dsr2.2004.09.026; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; Broitman BR, 2009, OIKOS, V118, P219, DOI 10.1111/j.1600-0706.2008.17075.x; Broitman BR, 2008, ECOLOGY, V89, pS81, DOI 10.1890/08-0635.1; Casey KS, 2002, B MAR SCI, V70, P169; Casey KS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001060; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; CHELTON DB, 1984, J GEOPHYS RES-OCEANS, V89, P3473, DOI 10.1029/JC089iC03p03473; Chu P, 2005, ADV ATMOS SCI, V22, P1, DOI 10.1007/BF02930865; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Diaz JP, 2001, GEOPHYS RES LETT, V28, P1989, DOI 10.1029/2000GL012446; Dorman CE., 2006, OCEANOGRAPHY, V19, P96, DOI [DOI 10.5670/OCEANOG.2006.47, 10.5670/oceanog.2006.47]; GOLIKOV AN, 1990, MAR ECOL PROG SER, V63, P289, DOI 10.3354/meps063289; Gollasch S, 2006, ASSESSMENT CONTROL B, P88; HALL CA, 1964, ECOLOGY, V45, P226, DOI 10.2307/1933835; Herborg LM, 2007, ECOL APPL, V17, P663, DOI 10.1890/06-0239; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Keister JE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004256; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mislan KAS, 2009, GLOBAL CHANGE BIOL, V15, P3056, DOI 10.1111/j.1365-2486.2009.01936.x; Pauly D., 2008, UNEP LARGE MARINE EC, P23; Payne MC, 20101251 US GEOL SUR; Pearce A, 2006, INT J REMOTE SENS, V27, P2503, DOI 10.1080/01431160500472138; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Pirhalla DE, 2009, 90 NOAA NOS NCCOS; Qiu B., 2001, ENCY OCEAN SCI, P1413, DOI DOI 10.1006/RWOS.2001.0350; R Development Core Team, 2009, R FDN STAT COMP; Reusser DA, 2011, J BIOGEOGR, V38, P1225, DOI 10.1111/j.1365-2699.2011.02515.x; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Sherman K, 2007, WOODS HOLEMA NATL MA; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tokinaga H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011477; Vazquez-Cuervo J, 2004, J CLIMATE, V17, P3921, DOI 10.1175/1520-0442(2004)017<3921:TEOAAC>2.0.CO;2; Vazquez-Cuervo J, 2010, J CLIMATE, V23, P1047, DOI 10.1175/2009JCLI2839.1; Venegas RM, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004481; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Wyrtki K, 1965, LIMNOL OCEANOGR, V10, P307, DOI DOI 10.4319/L0.1965.10.3.0307; Yashayaev IM, 2001, INT J CLIMATOL, V21, P401, DOI 10.1002/joc.585; Zhang SP, 2009, J CLIMATE, V22, P6758, DOI 10.1175/2009JCLI2806.1	53	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30105	10.1371/journal.pone.0030105	http://dx.doi.org/10.1371/journal.pone.0030105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253893	Green Submitted, gold, Green Published			2022-12-25	WOS:000301355700090
J	Pendergast, JS; Niswender, KD; Yamazaki, S				Pendergast, Julie S.; Niswender, Kevin D.; Yamazaki, Shin			Tissue-Specific Function of Period3 in Circadian Rhythmicity	PLOS ONE			English	Article							TARGETED DISRUPTION; MUTANT MICE; OSCILLATORS; GENE	The mammalian circadian system is composed of multiple central and peripheral clocks that are temporally coordinated to synchronize physiology and behavior with environmental cycles. Mammals have three homologs of the circadian Period gene (Per1, 2, 3). While numerous studies have demonstrated that Per1 and Per2 are necessary for molecular timekeeping and light responsiveness in the master circadian clock in the suprachiasmatic nuclei (SCN), the function of Per3 has been elusive. In the current study, we investigated the role of Per3 in circadian timekeeping in central and peripheral oscillators by analyzing PER2::LUCIFERASE expression in tissues explanted from C57BL/6J wild-type and Per3(-/-) mice. We observed shortening of the periods in some tissues from Per3(-/-) mice compared to wild-types. Importantly, the periods were not altered in other tissues, including the SCN, in Per3(-/-) mice. We also found that Per3-dependent shortening of endogenous periods resulted in advanced phases of those tissues, demonstrating that the in vitro phenotype is also present in vivo. Our data demonstrate that Per3 is important for endogenous timekeeping in specific tissues and those tissue-specific changes in endogenous periods result in internal misalignment of circadian clocks in Per3(-/-) mice. Taken together, our studies demonstrate that Per3 is a key player in the mammalian circadian system.	[Pendergast, Julie S.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Pendergast, JS (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	shin.yamazaki@vanderbilt.edu		Yamazaki, Shin/0000-0002-6691-1531	MMPC MICROMouse [U24DK076169]; National Institutes of Health [F32NS061437, DK085712]; Tennessee Valley Healthcare System; Diabetes Research and Training Center [DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK076169, P30DK020593, R01DK085712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061437] Funding Source: NIH RePORTER	MMPC MICROMouse; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tennessee Valley Healthcare System; Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the MMPC MICROMouse program U24DK076169 (www.mmpc.org) to SY. JSP was supported by National Institutes of Health grant F32NS061437. KDN was supported by resources of the Tennessee Valley Healthcare System and National Institutes of Health grants DK085712 and the Diabetes Research and Training Center DK20593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Hasan S, 2011, AM J PHYSL REGUL INT; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Spoelstra K, 2004, J BIOL RHYTHM, V19, P518, DOI 10.1177/0748730404268122; van der Veen DR, 2010, J BIOL RHYTHM, V25, P3, DOI 10.1177/0748730409356680; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	45	45	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30254	10.1371/journal.pone.0030254	http://dx.doi.org/10.1371/journal.pone.0030254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253927	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700102
J	Luo, GPS; Lin, L; Ibrahim, AS; Baquir, B; Pantapalangkoor, P; Bonomo, RA; Doi, YH; Adams, MD; Russo, TA; Spellberg, B				Luo, Guanpingshen; Lin, Lin; Ibrahim, Ashraf S.; Baquir, Beverlie; Pantapalangkoor, Paul; Bonomo, Robert A.; Doi, Yohei; Adams, Mark D.; Russo, Thomas A.; Spellberg, Brad			Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection	PLOS ONE			English	Article							RECOMBINANT N-TERMINUS; CARE SAFETY NETWORK; RISK-FACTORS; PNEUMONIA; HOSPITALS; EMERGENCE; MORTALITY; PATHOGENS; COLISTIN; EFFICACY	Extreme-drug-resistant (XDF1) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine discovery program, OmpA was identified as the primary target of humoral immune response after intravenous infection by A. baumannii in mice. OmpA was >99% conserved at the amino acid level across clinical isolates harvested between 1951 and 2009 from cerebrospinal fluid, blood, lung, and wound infections, including carbapenem-resistant isolates, and was >= 89% conserved among other sequenced strains, but had minimal homology to the human proteome. Vaccination of diabetic mice with recombinant OmpA (rOmpA) with aluminum hydroxide adjuvant markedly improved survival and reduced tissue bacterial burden in mice infected intravenously. Vaccination induced high titers of anti-OmpA antibodies, the levels of which correlated with survival in mice. Passive transfer with immune sera recapitulated protection. Immune sera did not enhance complement-mediated killing but did enhance opsonophagocytic killing of A. baumannii. These results define active and passive immunization strategies to prevent and treat highly lethal, XDR A baumannii infections.	[Luo, Guanpingshen; Ibrahim, Ashraf S.] Harbor Univ Calif Los Angeles UCLA, Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90502 USA; [Lin, Lin; Baquir, Beverlie; Pantapalangkoor, Paul; Spellberg, Brad] Harbor Univ Calif Los Angeles UCLA, Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA USA; [Lin, Lin; Ibrahim, Ashraf S.; Spellberg, Brad] Univ Calif Los Angeles UCLA, David Geffen Sch Med, Los Angeles, CA USA; [Bonomo, Robert A.] Case Western Reserve Univ, Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Med Ctr, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Med Ctr, Dept Mol Biol & Microbiol, Louis Stokes Cleveland Dept Vet Affairs, Cleveland, OH 44106 USA; [Doi, Yohei] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA USA; [Adams, Mark D.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Adams, Mark D.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Russo, Thomas A.] SUNY Buffalo, Div Infect Dis, Vet Adm Western New York Healthcare Syst, Buffalo, NY 14260 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Case Western Reserve University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Luo, GPS (corresponding author), Harbor Univ Calif Los Angeles UCLA, Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90502 USA.	bspellberg@labiomed.org	a, a/M-9467-2013; Russo, Thomas/ABE-9633-2020	Doi, Yohei/0000-0002-9620-2525	Public Health Services/National Institute of Allergy and Infectious Diseases [R01 AI081719, AI077681, AI072052]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077681, R01AI072052, R01AI081719] Funding Source: NIH RePORTER	Public Health Services/National Institute of Allergy and Infectious Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by Public Health Services/National Institute of Allergy and Infectious Diseases R01 AI081719, AI077681, and AI072052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Alsultan AA, 2009, J CHEMOTHERAPY, V21, P290, DOI 10.1179/joc.2009.21.3.290; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Beavers SF, 2009, PUBLIC HEALTH REP, V124, P868, DOI 10.1177/003335490912400615; Caricato A, 2009, INTENS CARE MED, V35, P1964, DOI 10.1007/s00134-009-1582-5; Chiang DH, 2008, J MICROBIOL IMMUNOL, V41, P397; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Chollims ER, 2010, FORUM MICROBIAL THRE; D'Agata EMC, 2000, INFECT CONT HOSP EP, V21, P588, DOI 10.1086/501808; Dizbay M, 2010, SCAND J INFECT DIS; Doi Y, 2009, EMERG INFECT DIS, V15, P980, DOI 10.3201/eid1506.081006; Falagas ME, 2008, INT J ANTIMICROB AG, V32, P450, DOI 10.1016/j.ijantimicag.2008.05.016; Furniss D, 2005, J BURN CARE REHABIL, V26, P405, DOI 10.1097/01.bcr.0000176882.69354.7e; Gomez J, 1999, EUR J CLIN MICROBIOL, V18, P358, DOI 10.1007/PL00015019; Gordon NC, 2009, J ANTIMICROB CHEMOTH, V63, P775, DOI 10.1093/jac/dkn555; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hoffmann MS, 2010, INFECT CONT HOSP EP, V31, P196, DOI 10.1086/650379; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Jang TN, 2009, J HOSP INFECT, V73, P143, DOI 10.1016/j.jhin.2009.06.007; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, P528, DOI 10.1086/652152; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P1186, DOI 10.1086/648450; Livermore DM, 2010, INT J ANTIMICROB AG, V35, P19, DOI 10.1016/j.ijantimicag.2009.09.014; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Metan G, 2009, EUR J INTERN MED, V20, P540, DOI 10.1016/j.ejim.2009.05.005; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Munoz-Price LS, 2010, INFECT CONT HOSP EP, V31, P1057, DOI 10.1086/656247; Park YK, 2009, DIAGN MICR INFEC DIS, V64, P43, DOI 10.1016/j.diagmicrobio.2009.01.012; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; PIECHAUD D, 1951, ANN I PASTEUR PARIS, V80, P97; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Pitarch A, 1999, ELECTROPHORESIS, V20, P1001, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5&lt;1001::AID-ELPS1001&gt;3.0.CO;2-L; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smolinski MS, MICROBIAL THREATS HL; Soares NC, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-37; Song JY, 2009, INT J ANTIMICROB AG, V33, P33, DOI 10.1016/j.ijantimicag.2008.07.008; Spellberg B, 2005, ANTIMICROB AGENTS CH, V49, P830, DOI 10.1128/AAC.49.2.830-832.2005; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Spellberg BJ, 2005, INFECT IMMUN, V73, P6191, DOI 10.1128/IAI.73.9.6191-6193.2005; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P429, DOI 10.1128/AAC.01155-10; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325	54	119	132	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					46	56	e29446	10.1371/journal.pone.0029446	http://dx.doi.org/10.1371/journal.pone.0029446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253723	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900005
J	Kuo, CJ; Tsai, SY; Liao, YT; Conwell, Y; Lee, WC; Huang, MC; Lin, SK; Chen, CC; Chen, WJ				Kuo, Chian-Jue; Tsai, Shang-Ying; Liao, Ya-Tang; Conwell, Yeates; Lee, Wen-Chung; Huang, Ming-Chyi; Lin, Shih-Ku; Chen, Chiao-Chicy; Chen, Wei J.			Elevated Aspartate and Alanine Aminotransferase Levels and Natural Death among Patients with Methamphetamine Dependence	PLOS ONE			English	Article							SUICIDE; MORTALITY; TAIWAN; RISK	Background: Methamphetamine is one of the fastest growing illicit drugs worldwide, causing multiple organ damage and excessive natural deaths. The authors aimed to identify potential laboratory indices and clinical characteristics associated with natural death through a two-phase study. Methods: Methamphetamine-dependent patients (n = 1,254) admitted to a psychiatric center in Taiwan between 1990 and 2007 were linked with a national mortality database for causes of death. Forty-eight subjects died of natural causes, and were defined as the case subjects. A time-efficient sex-and age-matched nested case-control study derived from the cohort was conducted first to explore the potential factors associated with natural death through a time-consuming standardized review of medical records. Then the identified potential factors were evaluated in the whole cohort to validate the findings. Results: In phase I, several potential factors associated with natural death were identified, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), comorbid alcohol use disorder, and the prescription of antipsychotic drugs. In phase II, these factors were confirmed in the whole cohort using survival analysis. For the characteristics at the latest hospital admission, Cox proportional hazards models showed that the adjusted hazard ratios for natural death were 6.75 (p<0.001) in the group with markedly elevated AST (>80 U/L) and 2.66 (p<0.05) in the group with mildly elevated AST (40-80 U/L), with reference to the control group (>40 U/L). As for ALT, the adjusted hazard ratios were 5.41 (p<0.001), and 1.44 (p>0.05). Comorbid alcohol use disorder was associated with an increased risk of natural death, whereas administration of antipsychotic drugs was not associated with lowered risk. Conclusions: This study highlights the necessity of intensive follow-up for those with elevated AST and ALT levels and comorbid alcohol use disorder for preventing excessive natural deaths.	[Kuo, Chian-Jue; Liao, Ya-Tang; Lee, Wen-Chung; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Kuo, Chian-Jue; Huang, Ming-Chyi; Lin, Shih-Ku; Chen, Chiao-Chicy] Taipei City Psychiat Ctr, Dept Gen Psychiat, Taipei, Taiwan; [Kuo, Chian-Jue; Tsai, Shang-Ying; Huang, Ming-Chyi; Lin, Shih-Ku; Chen, Chiao-Chicy] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Conwell, Yeates] Univ Rochester, Med Ctr, Ctr Study & Prevent Suicide, Rochester, NY 14642 USA	National Taiwan University; Taipei Medical University; University of Rochester	Chen, WJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wjchen@ntu.edu.tw	Conwell, Yeates/C-9347-2011; Huang, Ming-Chyi/W-9515-2019	Conwell, Yeates/0000-0001-8517-2132; Chen, Wei Jen/0000-0001-5899-5870; Lee, Wen-Chung/0000-0003-3171-7672	National Science Council of Taiwan [NSC 97-2314-B-532-002-MY2]; Food and Drug Administration of Taiwan [DOH99-FDA-71023]; Taipei City Hospital, Taipei, Taiwan [97002-62-044, 98001-62-012]; National Institutes of Health, Bethesda, Maryland, USA [P20 MH071897]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071897] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Food and Drug Administration of Taiwan; Taipei City Hospital, Taipei, Taiwan; National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Science Council (NSC 97-2314-B-532-002-MY2) of Taiwan, the Food and Drug Administration of Taiwan (DOH99-FDA-71023), Taipei City Hospital (97002-62-044; 98001-62-012), Taipei, Taiwan, and the National Institutes of Health (P20 MH071897), Bethesda, Maryland, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMPH ECST 2008 GLOB; CATRAVAS JD, 1977, J PHARMACOL EXP THER, V202, P230; Chen CY, 2010, ADDICTION, V105, P920, DOI 10.1111/j.1360-0443.2009.02894.x; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Department of Statistics, 2007, YB STAT; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kuo CJ, 2011, J CLIN PSYCHIAT, V72, P487, DOI 10.4088/JCP.09m05360gry; Kuo CJ, 2010, AM J PSYCHIAT, V167, P1092, DOI 10.1176/appi.ajp.2010.09101455; Kuo CJ, 2005, J CLIN PSYCHIAT, V66, P579, DOI 10.4088/JCP.v66n0506; Lai SW, 2007, INTERN MED J, V37, P472, DOI 10.1111/j.1445-5994.2007.01361.x; Lin SK, 2004, PSYCHIAT CLIN NEUROS, V58, P206, DOI 10.1111/j.1440-1819.2003.01218.x; MENDELSON J, 1995, CLIN PHARMACOL THER, V57, P559, DOI 10.1016/0009-9236(95)90041-1; Raheem KA, 1997, GEN PHARMACOL-VASC S, V29, P687, DOI 10.1016/S0306-3623(96)00156-5; Singleton J, 2009, DRUG ALCOHOL DEPEN, V105, P1, DOI 10.1016/j.drugalcdep.2009.05.028; United Nations Office on Drugs and Crime, 2008, 2008 WORLD DRUG REP; ZALIS EG, 1967, J PHARMACOL EXP THER, V158, P115	18	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29325	10.1371/journal.pone.0029325	http://dx.doi.org/10.1371/journal.pone.0029325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242166	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100020
J	Spanopoulos, D; Ratschen, E; McNeill, A; Britton, J				Spanopoulos, Dionysis; Ratschen, Elena; McNeill, Ann; Britton, John			Retail Price and Point of Sale Display of Tobacco in the UK: A Descriptive Study of Small Retailers	PLOS ONE			English	Article							CIGARETTE PACK DISPLAYS; SMOKING; PROMOTIONS	Background: Since the implementation of the 2002 Tobacco Advertising and Promotion Act, point-of-sale (PoS) tobacco displays are one of few remaining means of communication between the tobacco industry and customers in the UK. This study aimed to explore the characteristics of tobacco displays in a UK city, and particularly to assess the tobacco prices and promotional offers, types and pack sizes on display. Methods: Digital pictures of PoS displays were taken in 117 small retail shops in Nottingham in mid 2010. Data were analysed using Windows Photo Gallery software and SPSS version 16. Results: Just over half (52%) of cigarette packs on display were packs of 20, and 43% packs of 10. Cigarette prices differed substantially between brands, ranging from 4.19 pound to 6.85 pound for 20-packs, and from 2.12 pound to 3.59 pound for 10-packs. Forty four percent of cigarette packs and 40% of RYO (Roll-Your-Own) tobacco pouches, almost exclusively lower priced brands, were displayed with a pricemark, implying a promotional price offer. Eighty percent of 20-pack cigarette brand or brand variants on sale were priced below the EU-defined Most Popular Price Category (MPPC) for the UK in 2010; 45% were priced below the Weighted Average Price (WAP), which replaced the MPPC in 2011. Conclusion: PoS displays communicate value by displaying a high proportion of lower cost brands, and smaller and hence lower-cost packs, and by displaying price discounts on packs. The MPPC substantially overestimated the prices at which most 20-cigarette packs were available. Removal of PoS displays will prevent this means of price marketing but our study also suggests that minimum pricing of 20-pack cigarettes, prohibition of sale of cigarettes in packs less than 20, and plain packaging to prevent pricemarking are necessary if price is to be used effectively as a tobacco control measure.	[Spanopoulos, Dionysis; Ratschen, Elena; McNeill, Ann; Britton, John] Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England; [Spanopoulos, Dionysis; Ratschen, Elena; McNeill, Ann; Britton, John] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Spanopoulos, D (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England.	mcxds5@nottingham.ac.uk	Britton, John R/G-9705-2011	McNeill, Ann/0000-0002-6223-4000	Nottingham City Primary Care Trust; University of Nottingham; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Department of Health; UK Clinical Research Collaboration	Nottingham City Primary Care Trust; University of Nottingham; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; UK Clinical Research Collaboration	This study was funded by the Nottingham City Primary Care Trust, supported by a University of Nottingham PhD studentship, with input from the UK Centre for Tobacco Control Studies, which is a UKCRC Centre of Public Health Research Excellence for which funding from the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Medical Research Council and the Department of Health, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter OBJ, 2009, TOB CONTROL, V18, P218, DOI 10.1136/tc.2008.027870; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Euromonitor International, 2010, CIG AUSTR BELG BULG; Euromonitor International, 2010, CIG UK; Federal Trade Commission, 2011, CIG REP 2007 2008; Garman K, 2010, TOB CONTROL, V19, P264; Germain D, 2010, ADDICTION, V105, P159, DOI 10.1111/j.1360-0443.2009.02714.x; Moodie C, 2010, TOB CONTROL, V19, P168, DOI 10.1136/tc.2009.033449; Paynter J, 2009, TOB CONTROL, V18, P268, DOI 10.1136/tc.2008.027482; Robinson LA, 1997, J CONSULT CLIN PSYCH, V65, P653; Rooke C, 2010, TOB CONTROL, V19, P279, DOI 10.1136/tc.2009.034447; Slater SJ, 2007, ARCH PEDIAT ADOL MED, V161, P440, DOI 10.1001/archpedi.161.5.440; Tauras JA, 2006, REV IND ORGAN, V28, P253, DOI 10.1007/s11151-006-0016-6; The Health and Social Care Information Centre, 2010, SMOK DRINK DRUG US Y; Tobacco Manufacturers' Association, UK CIG PRIC; Wakefield M, 2008, ADDICTION, V103, P322, DOI 10.1111/j.1360-0443.2007.02062.x	16	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29871	10.1371/journal.pone.0029871	http://dx.doi.org/10.1371/journal.pone.0029871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	058VE	22242183	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100039
J	Alter, J; Bengal, E				Alter, Joel; Bengal, Eyal			Stress-Induced C/EBP Homology Protein (CHOP) Represses MyoD Transcription to Delay Myoblast Differentiation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ADULT SKELETAL-MUSCLE; GENE-EXPRESSION; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; STEM-CELLS; ER STRESS; ELEMENT	When mouse myoblasts or satellite cells differentiate in culture, the expression of myogenic regulatory factor, MyoD, is downregulated in a subset of cells that do not differentiate. The mechanism involved in the repression of MyoD expression remains largely unknown. Here we report that a stress-response pathway repressing MyoD transcription is transiently activated in mouse-derived C2C12 myoblasts growing under differentiation-promoting conditions. We show that phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2 alpha) is followed by expression of C/EBP homology protein (CHOP) in some myoblasts. ShRNA-driven knockdown of CHOP expression caused earlier and more robust differentiation, whereas its constitutive expression delayed differentiation relative to wild type myoblasts. Cells expressing CHOP did not express the myogenic regulatory factors MyoD and myogenin. These results indicated that CHOP directly repressed the transcription of the MyoD gene. In support of this view, CHOP associated with upstream regulatory region of the MyoD gene and its activity reduced histone acetylation at the enhancer region of MyoD. CHOP interacted with histone deacetylase 1 (HDAC1) in cells. This protein complex may reduce histone acetylation when bound to MyoD regulatory regions. Overall, our results suggest that the activation of a stress pathway in myoblasts transiently downregulate the myogenic program.	[Alter, Joel; Bengal, Eyal] Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Alter, J (corresponding author), Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, Haifa, Israel.	bengal@tx.technion.ac.il			Israel Ministry of Health; Chief Scientist's office; Rappaport Foundation for Medical Research; Women's Division	Israel Ministry of Health; Chief Scientist's office; Rappaport Foundation for Medical Research; Women's Division	This study was supported by: Israel Ministry of Health, Chief Scientist's office to E. B., Rappaport Foundation for Medical Research and Women's Division/Weisz Gerontology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Freer-Prokop M, 2009, DIFFERENTIATION, V78, P205, DOI 10.1016/j.diff.2009.05.002; FUCHTBAUER EM, 1992, DEV DYNAM, V193, P34; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Hunter RB, 2001, AM J PHYSIOL-CELL PH, V281, pC1285, DOI 10.1152/ajpcell.2001.281.4.C1285; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Weidenfeld-Baranboim K, 2009, NUCLEIC ACIDS RES, V37, P2194, DOI 10.1093/nar/gkp083; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yoshida N, 1998, J CELL SCI, V111, P769	47	36	40	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29498	10.1371/journal.pone.0029498	http://dx.doi.org/10.1371/journal.pone.0029498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242125	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000040
J	Glas, J; Seiderer, J; Bayrle, C; Wetzke, M; Fries, C; Tillack, C; Olszak, T; Beigel, F; Steib, C; Friedrich, M; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Bayrle, Corinna; Wetzke, Martin; Fries, Christoph; Tillack, Cornelia; Olszak, Torsten; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			The Role of Osteopontin (OPN/SPP1) Haplotypes in the Susceptibility to Crohn's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; IL-17 PRODUCTION; GENE-EXPRESSION; PROTECTS MICE; HOST-DEFENSE; T-CELLS; DIFFERENTIATION	Background: Osteopontin represents a multifunctional molecule playing a pivotal role in chronic inflammatory and autoimmune diseases. Its expression is increased in inflammatory bowel disease (IBD). The aim of our study was to analyze the association of osteopontin (OPN/SPP1) gene variants in a large cohort of IBD patients. Methodology/Principal Findings: Genomic DNA from 2819 Caucasian individuals (n = 841 patients with Crohn's disease (CD), n = 473 patients with ulcerative colitis (UC), and n = 1505 healthy unrelated controls) was analyzed for nine OPN SNPs (rs2728127, rs2853744, rs11730582, rs11739060, rs28357094, rs4754 = p.Asp80Asp, rs1126616 = p.Ala236Ala, rs1126772 and rs9138). Considering the important role of osteopontin in Th17-mediated diseases, we performed analysis for epistasis with IBD-associated IL23R variants and analyzed serum levels of the Th17 cytokine IL-22. For four OPN SNPs (rs4754, rs1126616, rs1126772 and rs9138), we observed significantly different distributions between male and female CD patients. rs4754 was protective in male CD patients (p = 0.0004, OR = 0.69). None of the other investigated OPN SNPs was associated with CD or UC susceptibility. However, several OPN haplotypes showed significant associations with CD susceptibility. The strongest association was found for a haplotype consisting of the 8 OPN SNPs rs2728127-rs2853744-rs11730582-rs11439060-rs28357094-rs112661-rs1126772-rs9138 (omnibus p-value = 2.07x10(-8)). Overall, the mean IL-22 secretion in the combined group of OPN minor allele carriers with CD was significantly lower than that of CD patients with OPN wildtype alleles (p = 3.66x10(-5)). There was evidence for weak epistasis between the OPN SNP rs28357094 with the IL23R SNP rs10489629 (p = 4.18x10(-2)) and between OPN SNP rs1126616 and IL23R SNP rs2201841 (p = 4.18x10(-2)) but none of these associations remained significant after Bonferroni correction. Conclusions/Significance: Our study identified OPN haplotypes as modifiers of CD susceptibility, while the combined effects of certain OPN variants may modulate IL-22 secretion.	[Glas, Juergen; Bayrle, Corinna; Fries, Christoph; Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, D-3000 Hannover, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med, Boston, MA 02115 USA; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; RWTH Aachen University; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	Stephan.Brand@med.uni-muenchen.de	Wetzke, Martin/HDM-2614-2022		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01, 2010_EKES.32]; DFG [BR 1912/6-1]; Ludwig- Maximilians-University Munich	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); Ludwig- Maximilians-University Munich	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMU Excellent to J. S. and Promotionsstipendium to J. D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), and by grants of Ludwig- Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Bazzichi L, 2009, MOL MED, V15, P402, DOI 10.2119/molmed.2009.00052; Begum MD, 2007, MICROBIOL IMMUNOL, V51, P135, DOI 10.1111/j.1348-0421.2007.tb03884.x; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Buommino E, 2009, ARCH DERMATOL RES, V301, P397, DOI 10.1007/s00403-009-0939-5; Chen GJ, 2010, ARTHRITIS RHEUM-US, V62, P2900, DOI 10.1002/art.27603; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chiocchetti A, 2010, INT J IMMUNOPATH PH, V23, P263, DOI 10.1177/039463201002300124; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Diegelmann J, 2011, J BIOL CHEM     1108; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, INFLAMM BOWEL DIS, V17, P1917, DOI 10.1002/ibd.21562; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Gordon JN, 2005, GUT, V54, P1213, DOI 10.1136/gut.2004.063412; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Hensiek AE, 2003, J NEUROL, V250, P943, DOI 10.1007/s00415-003-1120-2; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Koguchi Y, 2002, INFECT IMMUN, V70, P1042, DOI 10.1128/IAI.70.3.1042-1048.2002; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Liaw L, 1998, J CLIN INVEST, V101, P1468; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Marciano R, 2006, ANN RHEUM DIS, V65, P662, DOI 10.1136/ard.2005.040626; Marciano R, 2009, CLIN IMMUNOL, V131, P84, DOI 10.1016/j.clim.2008.11.004; Mas A, 2007, MULT SCLER J, V13, P250, DOI 10.1177/1352458506070944; Masuda H, 2005, J GASTROENTEROL, V40, P409, DOI 10.1007/s00535-005-1567-2; Masuda H, 2003, J SURG RES, V111, P85, DOI 10.1016/S0022-4804(03)00046-5; Maver A, 2009, DIS MARKERS, V27, P295, DOI [10.1155/2009/864313, 10.3233/DMA-2009-0675]; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Niino M, 2003, J NEUROIMMUNOL, V136, P125, DOI 10.1016/S0165-5728(03)00004-3; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt-Petersen K, 2009, ATHEROSCLEROSIS, V206, P209, DOI 10.1016/j.atherosclerosis.2009.02.015; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Sennels HP, 2008, SCAND J RHEUMATOL, V37, P241, DOI 10.1080/03009740801910320; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Standal T, 2004, EXP ONCOL, V26, P179; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Urcelay E, 2005, J RHEUMATOL, V32, P405; Vogt MHJ, 2010, MULT SCLER J, V16, P443, DOI 10.1177/1352458509359723; Xu AP, 2007, CHINESE MED J-PEKING, V120, P2124, DOI 10.1097/00029330-200712010-00011; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015; Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x	76	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29309	10.1371/journal.pone.0029309	http://dx.doi.org/10.1371/journal.pone.0029309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242114	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000025
J	Zhang, K; Wong, P; Zhang, L; Jacobs, B; Borden, EC; Aster, JC; Bedogni, B				Zhang, K.; Wong, P.; Zhang, L.; Jacobs, B.; Borden, E. C.; Aster, J. C.; Bedogni, B.			A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth	ONCOGENE			English	Article						NIC: Notch1 intracellular domain; Notch1-TM: transmembrane Notch1; NRG1: neuregulin1; ERBB: erythroblastic leukemia viral oncogene homolog or EGF (epidermal growth factor) family of transmembrane receptor tyrosine kinases; p27KIP1: CDKN1B: cyclin-dependent kinase inhibitor 1B	GENE-EXPRESSION PROFILES; STEM-CELLS; NOTCH; INHIBITION; PHOSPHORYLATION; DIFFERENTIATION; PROGRESSION; ACTIVATION; APOPTOSIS; PROLIFERATION	The Notch pathway is an evolutionary conserved signaling cascade that has an essential role in melanoblast and melanocyte stem cell homeostasis. Notch signaling is emerging as a key player in melanoma, the most deadly form of skin cancer. In melanoma, Notch1 is inappropriately reactivated and contributes to melanoma tumorigenicity. Here, we propose a novel mechanism by which Notch1 promotes the disease. We found that Notch1 directly regulates the transcription of neuregulin1 (NRG1) by binding to its promoter region. NRG1 is the ligand for ERBB3 and 4, members of the epidermal growth factor family of receptors that are involved in the genesis and progression of a number of cancers. Notch1 and NRG1 expression are associated in melanoma and inhibition of NRG1 signaling leads to melanoma cell growth inhibition and tumor growth delay. Mechanistically, these effects are associated with the inhibition of the PI3Kinase/Akt signaling pathway and with the accumulation of p27Kip1. On the other end, addition of recombinant NRG1 can partially restore melanoma cell growth that is inhibited by Notch1 ablation. Taken together, our findings underline a new, previously undescribed autocrine signaling loop between Notch1 and NRG1 that controls melanoma growth and provide experimental evidence that the targeting of Notch and ERBB signaling may represent a novel potential therapeutic approach in melanoma.	[Zhang, K.; Wong, P.; Zhang, L.; Bedogni, B.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jacobs, B.; Borden, E. C.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Aster, J. C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Aster, J. C.] Harvard Univ, Sch Med, Boston, MA USA	Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bedogni, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Wood Bldg,Room W420,10900 Euclid Ave, Cleveland, OH 44106 USA.	barbara.bedogni@case.edu			American Cancer Society [ACS-IRG-91-022, ACS-RSG-11-139-01-DDC]; National Institute of Health [P30CA147877]; NATIONAL CANCER INSTITUTE [P30CA147877] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant # ACS-IRG-91-022 and Grant # ACS-RSG-11-139-01-DDC from the American Cancer Society and by start up funds awarded by the National Institute of Health (award number: P30CA147877: New Faculty Recruitment to Enhance Melanoma Research). We thank Drs Scott Welford and David Samols for critical discussion; Dr Marianne Broome Powell for making available many of the melanoma cell lines used in this work.	Altekruse SFKC, 1975, SEER CANC STAT REV; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; Calvo M, 2011, GLIA, V59, P554, DOI 10.1002/glia.21124; Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620; Dong YY, 2010, CANCER RES, V70, P5465, DOI 10.1158/0008-5472.CAN-10-0173; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Herzog C, 2007, SEER AYA MONOGRAPH, P53; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Osawa M, 2008, J INVEST DERMATOL, V128, P2571, DOI 10.1038/jid.2008.289; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Pahlman S, 2004, SEMIN CANCER BIOL, V14, P365, DOI 10.1016/j.semcancer.2004.04.016; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rangarajan A, 2001, VIROLOGY, V286, P23, DOI 10.1006/viro.2001.0867; Rasul S, 2009, BRIT J CANCER, V100, P1879, DOI 10.1038/sj.bjc.6605034; Razorenova O V, 2005, Mol Biol (Mosk), V39, P286; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tworkoski K, 2011, MOL CANC RES; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Zhou K, 2010, ANN HEMATOL, V89, P749, DOI 10.1007/s00277-010-0923-3	53	39	39	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	43					4609	4618		10.1038/onc.2011.606	http://dx.doi.org/10.1038/onc.2011.606			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22249266	Green Accepted			2022-12-25	WOS:000310528200004
J	Fatima, S; Lee, NP; Tsang, FH; Kolligs, FT; Ng, IOL; Poon, RTP; Fan, ST; Luk, JM				Fatima, S.; Lee, N. P.; Tsang, F. H.; Kolligs, F. T.; Ng, I. O. L.; Poon, R. T. P.; Fan, S. T.; Luk, J. M.			Dickkopf 4 (DKK4) acts on Wnt/beta-catenin pathway by influencing beta-catenin in hepatocellular carcinoma	ONCOGENE			English	Article						hepatocellular carcinoma; Wnt/beta-catenin signalling; DKK4; tumourigenesis	FREQUENT EPIGENETIC INACTIVATION; LIVER-CANCER; PROGNOSTIC-SIGNIFICANCE; NEGATIVE REGULATOR; FAMILY GENES; TUMOR-GROWTH; COLON-CANCER; EXPRESSION; ANTAGONIST; PHOSPHORYLATION	Deregulation of Wnt/beta-catenin pathway is a hallmark of major gastrointestinal cancers including hepatocellular carcinoma (HCC). The oncogenic role of beta-catenin is well defined but reasons for its accumulation in HCC remain unclear. Dickkopf 4 (DKK4) acts as a negative regulator of Wnt/beta-catenin pathway but its functional role in liver carcinogenesis has not been studied. We investigated the role of DKK4 in beta-catenin regulation in HCC. Reduced expression of DKK4 was found in 47% (38/81) of HCC, as measured by quantitative real time PCR. Ectopic expression of DKK4 in two HCC cell lines, PLC/PRF/5 (PLC) and MHCC97L (97L), attenuated beta-catenin responsive luciferase activity, and decreased both beta-catenin and cyclin D1 protein levels. To study the effect of DKK4 on cell growth and tumourigenicity, two stable HCC cell lines were established from PLC and 97L cells. Functional assays demonstrated that overexpression of DKK4 hampered cell proliferation, reduced colony formation and retarded cell migration. When DKK4-expressing 97L stable cells were used to induce tumour xenografts in nude mice (n = 8), reduction in tumour sizes was observed (P = 0.027). Furthermore, immunohistochemical studies showed that decreased expression of DKK4 was associated with beta-catenin accumulation in HCC tissues. Additionally, inhibition of the proteasome using specific inhibitor in DKK4-expressing 97L stable cells masked the effect of beta-catenin. Our findings suggest a potential tumour suppressive role of DKK4 as well as that of an important regulator of HCC. Oncogene (2012) 31, 4233-4244; doi:10.1038/onc.2011.580; published online 16 January 2012	[Luk, J. M.] pRED China, Roche R& Ctr, Dept Oncol, Shanghai 201203, Peoples R China; [Fatima, S.; Lee, N. P.; Tsang, F. H.; Poon, R. T. P.; Fan, S. T.; Luk, J. M.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Kolligs, F. T.] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; [Ng, I. O. L.] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Luk, J. M.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Luk, J. M.] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Luk, J. M.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Luk, J. M.] Canc Sci Inst, Singapore, Singapore	University of Hong Kong; University of Munich; University of Hong Kong; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Luk, JM (corresponding author), pRED China, Roche R& Ctr, Dept Oncol, 720 Cai Lun Rd, Shanghai 201203, Peoples R China.	dr.johnluk@gmail.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940; Ng, Irene Oi-lin/0000-0001-7532-2029				Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Baehs S, 2009, CANCER LETT, V276, P152, DOI 10.1016/j.canlet.2008.11.003; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen TC, 1998, CANCER LETT, V134, P23, DOI 10.1016/S0304-3835(98)00238-9; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding Z, 2009, WORLD J GASTROENTERO, V15, P2595, DOI 10.3748/wjg.15.2595; Fatima S, 2011, WORLD J CLIN ONCOL, V2, P311, DOI 10.5306/wjco.v2.i8.311; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gonzalez FJ, 2006, HEPATOLOGY, V43, P650, DOI 10.1002/hep.21154; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hirata H, 2011, CANCER-AM CANCER SOC, V117, P1649, DOI 10.1002/cncr.25666; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kemp W, 2005, J GASTROEN HEPATOL, V20, P873, DOI 10.1111/j.1440-1746.2005.03844.x; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z; Lee NPY, 2008, PROTEOMICS, V8, P2136, DOI 10.1002/pmic.200700590; Lee NPY, 2006, FEBS LETT, V580, P923, DOI 10.1016/j.febslet.2006.01.019; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Liao CH, 2011, HEPATOLOGY; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Matsui A, 2009, CANCER SCI, V100, P1923, DOI 10.1111/j.1349-7006.2009.01272.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pineau P, 1999, ONCOGENE, V18, P3127, DOI 10.1038/sj.onc.1202648; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shih YL, 2007, INT J CANCER, V121, P1028, DOI 10.1002/ijc.22750; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tung EKK, 2011, LIVER INT, V31, P1494, DOI 10.1111/j.1478-3231.2011.02597.x; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Wiesman KC, 2010, J CELL COMMUN SIGNAL, V4, P91, DOI 10.1007/s12079-010-0087-x; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yang B, 2010, WORLD J GASTROENTERO, V16, P755, DOI 10.3748/wjg.v16.i6.755; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Yuan BZ, 1998, CANCER RES, V58, P2196; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang K, 2010, INT J ONCOL, V37, P1495, DOI 10.3892/ijo_00000802; Zhang LH, 2003, J CANCER RES CLIN, V129, P279, DOI 10.1007/s00432-002-0407-5	70	38	41	1	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	38					4233	4244		10.1038/onc.2011.580	http://dx.doi.org/10.1038/onc.2011.580			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22249261				2022-12-25	WOS:000308975800006
J	Thompson, AJ; McGonigle, I; Duke, R; Johnston, GAR; Lummis, SCR				Thompson, Andrew J.; McGonigle, Ian; Duke, Rujee; Johnston, Graham A. R.; Lummis, Sarah C. R.			A single amino acid determines the toxicity of Ginkgo biloba extracts	FASEB JOURNAL			English	Article						Cys-loop receptor; picrotoxin; antagonist	DROSOPHILA GABA RECEPTOR; BINDING; RDL; PICROTOXININ; ANTAGONIST; MUTATIONS; FIPRONIL	Ginkgo biloba extracts are currently used for a wide range of health-related conditions. Some of the medical benefits of these extracts are controversial, but their lack of toxicity in humans is not in doubt. These extracts are, however, highly toxic to insects. Their active components (ginkgolides and bilobalide) have structures similar to the convulsant picrotoxin, a GABA(A) receptor antagonist, so their lack of toxicity in mammals is puzzling. Here, we show that the different compositions of insect and vertebrate GABA receptor pores are responsible for the differing toxicities. Insect GABA receptors contain Ala at their 2' position in the pore. Substitution with Val, which is the equivalent residue in vertebrate GABA(A) receptor alpha-subunits, decreases ginkgolide potency by up to 10,000-fold. The reverse mutation in vertebrate GABA(A) alpha 1 subunits increased the sensitivity of alpha 1 beta 2 and alpha 1 beta 2 gamma 2 receptors to ginkgolides. Mutant cycle analysis demonstrates a strong interaction between the ginkgolides and the 2' residue, a result supported by in silico docking of compounds into a model of the pore. We conclude that the insecticidal activity of G. biloba extracts can be attributed to their effects at insect GABA receptors, and the presence of a Val at the 2' position in vertebrate GABA(A) receptors explains why these compounds are not similarly toxic to humans.-Thompson, A. J., McGonigle, I., Duke, R., Johnston, G. A. R., Lummis, S. C. R. A single amino acid determines the toxicity of Ginkgo biloba extracts. FASEB J. 26, 1884-1891 (2012). www.fasebj.org	[Thompson, Andrew J.; McGonigle, Ian; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Duke, Rujee; Johnston, Graham A. R.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia	University of Cambridge; University of Sydney	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	sl120@cam.ac.uk	Johnston, Graham/AAJ-9569-2021; Johnston, Graham AR/B-9827-2009	Johnston, Graham/0000-0001-8872-4078; McGonigle, Ian/0000-0003-0837-080X; Thompson, Andrew/0000-0002-7046-6792	University of Sydney	University of Sydney(University of Sydney)	The authors thank The Wellcome Trust (81925; S. C. R. L., A.J.T.; S. C. R. L. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science), the UK Medical Research Council (I. M. held a MRC studentship), the National Health and Medical Research Council of Australia (R. D.; G.A.R.J.) and the University of Sydney (a travel grant to S. C. R. L.). A.J.T. and I. M. conducted the experiments; R. D. and G.A.R.J. contributed new reagents or analytic tools; A.J.T. and S. C. R. L. performed data analysis; A.J.T., S. C. R. L., I. M., R. D., and G.A.R.J. wrote or contributed to the writing of the manuscript; A.J.T. and S. C. R. L. participated in research design; S. C. R. L. and G.A.R.J. acquired funding for the research. The authors declare no conflicts of interest.	Ahlemeyer B, 2003, CELL MOL LIFE SCI, V60, P1779, DOI 10.1007/s00018-003-3080-1; Ahn YJ, 1997, ACS SYM SER, V658, P90; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Chen LG, 2006, P NATL ACAD SCI USA, V103, P5185, DOI 10.1073/pnas.0600370103; Drieu K, 2000, PROSTAG LEUKOTR ESS, V63, P293, DOI 10.1054/plef.2000.0217; Erkkila BE, 2008, BIOPHYS J, V94, P4299, DOI 10.1529/biophysj.107.118455; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Harrison JB, 1996, CELL TISSUE RES, V284, P269, DOI 10.1007/s004410050587; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Hori T., 1997, GINKGO BILOBA GLOBAL; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jensen AA, 2010, J BIOL CHEM, V285, P10141, DOI 10.1074/jbc.M109.079319; Le Goff G, 2005, J NEUROCHEM, V92, P1295, DOI 10.1111/j.1471-4159.2004.02922.x; Ludmerer SW, 2002, BIOCHEMISTRY-US, V41, P6548, DOI 10.1021/bi015920o; MILLAR NS, 1994, P ROY SOC B-BIOL SCI, V258, P307, DOI 10.1098/rspb.1994.0178; MILLER TA, 1979, PESTIC BIOCHEM PHYS, V10, P128, DOI 10.1016/0048-3575(79)90014-2; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sedelnikova A, 2006, J PHYSIOL-LONDON, V577, P569, DOI 10.1113/jphysiol.2006.120287; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Thompson AJ, 2011, J PHYSIOL-LONDON, V589, P4243, DOI 10.1113/jphysiol.2011.208439; Thompson AJ, 2011, MOL PHARMACOL, V80, P183, DOI 10.1124/mol.111.071415; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tomlin C D S, 2006, PESTICIDE MANUAL WOR, P462; Woelkart K, 2010, PHYTOTHER RES, V24, P445, DOI 10.1002/ptr.3074; Xie JS, 2008, J CHROMATOGR B, V864, P87, DOI 10.1016/j.jchromb.2008.01.045; Zhao XL, 2003, J PHARMACOL EXP THER, V306, P914, DOI 10.1124/jpet.103.051839	28	16	17	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1884	1891		10.1096/fj.11-192765	http://dx.doi.org/10.1096/fj.11-192765			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253475	Green Published, hybrid			2022-12-25	WOS:000303680800017
J	Monne, M; Miniero, DV; Daddabbo, L; Robinson, AJ; Kunji, ERS; Palmieri, F				Monne, Magnus; Miniero, Daniela Valeria; Daddabbo, Lucia; Robinson, Alan J.; Kunji, Edmund R. S.; Palmieri, Ferdinando			Substrate Specificity of the Two Mitochondrial Ornithine Carriers Can Be Swapped by Single Mutation in Substrate Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; RECONSTITUTED CARNITINE CARRIER; SACCHAROMYCES-CEREVISIAE; OXOGLUTARATE CARRIER; BACTERIAL EXPRESSION; TRANSPORT PROTEIN; AMINO-ACIDS; FUNCTIONAL-CHARACTERIZATION; BOVINE MITOCHONDRIA	Mitochondrial carriers are a large family of proteins that transport specific metabolites across the inner mitochondrial membrane. Sequence and structure analysis has indicated that these transporters have substrate binding sites in a similar location of the central cavity consisting of three major contact points. Here we have characterized mutations of the proposed substrate binding site in the human ornithine carriers ORC1 and ORC2 by carrying out transport assays with a set of different substrates. The different substrate specificities of the two isoforms, which share 87% identical amino acids, were essentially swapped by exchanging a single residue located at position 179 that is arginine in ORC1 and glutamine in ORC2. Altogether the substrate specificity changes demonstrate that Arg-179 and Glu-180 of contact point II bind the C-alpha carboxylate and amino group of the substrates, respectively. Residue Glu-77 of contact point I most likely interacts with the terminal amino group of the substrate side chain. Furthermore, it is likely that all three contact points are involved in the substrate-induced conformational changes required for substrate translocation because Arg-179 is probably connected with Arg-275 of contact point III through Trp-224 by cation-pi interactions. Mutations at position 179 also affected the turnover number of the ornithine carrier severely, implying that substrate binding to residue 179 is a rate-limiting step of the catalytic transport cycle. Given that Arg-179 is located in the vicinity of the matrix gate, it is concluded that it is a key residue in the opening of the carrier to the matrix side.	[Monne, Magnus; Miniero, Daniela Valeria; Daddabbo, Lucia; Palmieri, Ferdinando] Univ Bari, Lab Biochem & Mol Biol, Dept Pharmacobiol, I-70125 Bari, Italy; [Monne, Magnus] Univ Basilicata, Dept Chem, I-85100 Potenza, Italy; [Robinson, Alan J.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 2XY, England; [Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Basilicata; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	Kunji, Edmund/AAH-2362-2020; Miniero, Daniela Valeria/P-9786-2019; Monné, Magnus/D-5642-2012	Kunji, Edmund/0000-0002-0610-4500; Miniero, Daniela Valeria/0000-0002-3324-9692; Monné, Magnus/0000-0003-2344-3878	Ministero dell'Universita e della Ricerca (MIUR); Center of Excellence in Genomics; Italian Human ProteomeNet [RBRN07BMCT_009 (MIUR)]; Medical Research Council; European Community under European Drug Initiative on Channels and Transporters (EDICT) Consortium [HEALTH-F4-2007-201924]; Medical Research Council [MC_U105674181, MC_U105663139] Funding Source: researchfish; MRC [MC_U105674181, MC_U105663139] Funding Source: UKRI	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics; Italian Human ProteomeNet; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community under European Drug Initiative on Channels and Transporters (EDICT) Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MIUR), the Center of Excellence in Genomics, the Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR), and the Medical Research Council (to A. J. R. and E. R. S. K.). The collaboration was funded by the European Community Seventh Framework Programme FP7/2007-2013 under Grant HEALTH-F4-2007-201924, European Drug Initiative on Channels and Transporters (EDICT) Consortium.	Al-Hassnan ZN, 2008, J NEUROL SCI, V264, P187, DOI 10.1016/j.jns.2007.08.003; Aluvila S, 2010, J BIOL CHEM, V285, P27314, DOI 10.1074/jbc.M110.137364; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; Briggs C, 1999, BIOCHEMISTRY-US, V38, P5096, DOI 10.1021/bi982945n; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Echtay KS, 2001, BIOCHEMISTRY-US, V40, P5243, DOI 10.1021/bi002130q; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2008, NEW ENGL J MED, V358, P1408, DOI 10.1056/NEJMc0707353; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Giangregorio N, 2010, BBA-BIOENERGETICS, V1797, P839, DOI 10.1016/j.bbabio.2010.03.017; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1065, P231, DOI 10.1016/0005-2736(91)90235-Z; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; INDIVERI C, 1994, BBA-BIOMEMBRANES, V1189, P65, DOI 10.1016/0005-2736(94)90281-X; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Klingenberg M, 1976, ENZYMES BIOLOGICAL M, V3, P383; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Lawrence SA, 2011, J BIOL CHEM, V286, P31480, DOI 10.1074/jbc.M111.272187; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583; Miniero DV, 2011, BBA-BIOENERGETICS, V1807, P302, DOI 10.1016/j.bbabio.2010.12.005; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2012, ENCY BIOL C IN PRESS; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 2006, BBA-BIOENERGETICS, V1757, P1277, DOI 10.1016/j.bbabio.2006.03.025; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; Salvi S, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1221; Stipani V, 2001, BIOCHEMISTRY-US, V40, P15805, DOI 10.1021/bi011616j; Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trotter PJ, 2005, ARCH BIOCHEM BIOPHYS, V442, P21, DOI 10.1016/j.abb.2005.07.016; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200	54	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7925	7934		10.1074/jbc.M111.324855	http://dx.doi.org/10.1074/jbc.M111.324855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262851	Green Published, hybrid			2022-12-25	WOS:000301349400009
J	Post, DMB; Yu, LP; Krasity, BC; Choudhury, B; Mandel, MJ; Brennan, CA; Ruby, EG; McFall-Ngai, MJ; Gibson, BW; Apicella, MA				Post, Deborah M. B.; Yu, Liping; Krasity, Benjamin C.; Choudhury, Biswa; Mandel, Mark J.; Brennan, Caitlin A.; Ruby, Edward G.; McFall-Ngai, Margaret J.; Gibson, Bradford W.; Apicella, Michael A.			O-antigen and Core Carbohydrate of Vibrio fischeri Lipopolysaccharide COMPOSITION AND ANALYSIS OF THEIR ROLE IN EUPRYMNA SCOLOPES LIGHT ORGAN COLONIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; MASS-SPECTROMETRY; FLAGELLIN; ACID; LIPOOLIGOSACCHARIDES; POLYSACCHARIDE; GLYCOSYLATION; RESOLUTION	Vibrio fischeri exists in a symbiotic relationship with the Hawaiian bobtail squid, Euprymna scolopes, where the squid provides a home for the bacteria, and the bacteria in turn provide camouflage that helps protect the squid from night-time predators. Like other Gram-negative organisms, V. fischeri expresses lipopolysaccharide (LPS) on its cell surface. The structure of the O-antigen and the core components of the LPS and their possible role in colonization of the squid have not previously been determined. In these studies, an O-antigen ligase mutant, waaL, was utilized to determine the structures of these LPS components and their roles in colonization of the squid. WaaL ligates the O-antigen to the core of the LPS; thus, LPS from waaL mutants lacks O-antigen. Our results show that the V. fischeri waaL mutant has a motility defect, is significantly delayed in colonization, and is unable to compete with the wildtype strain in co-colonization assays. Comparative analyses of the LPS from the wild-type and waaL strains showed that the V. fischeri LPS has a single O-antigen repeat composed of yersiniose, 8-epi-legionaminic acid, and N-acetylfucosamine. In addition, the LPS from the waaL strain showed that the core structure consists of L-glycero-D-manno-heptose, D-glycero-D-manno-heptose, glucose, 3-deoxy-D-manno-octulosonic acid, N-acetylgalactosamine, 8-epi-legionaminic acid, phosphate, and phosphoethanolamine. These studies indicate that the unusual V. fischeri O-antigen sugars play a role in the early phases of bacterial colonization of the squid.	[Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Yu, Liping] Univ Iowa, Carver Coll Med NMR Facil, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Krasity, Benjamin C.; Brennan, Caitlin A.; Ruby, Edward G.; McFall-Ngai, Margaret J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Choudhury, Biswa] Univ Calif San Diego, La Jolla, CA 92093 USA; [Mandel, Mark J.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Iowa; Buck Institute for Research on Aging; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; Northwestern University; University of California System; University of California San Francisco	Apicella, MA (corresponding author), Univ Iowa, Dept Microbiol, 51 Newton Rd, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu		Brennan, Caitlin/0000-0002-6074-9502; Mandel, Mark/0000-0001-6506-6711; Yu, Liping/0000-0003-3536-6427	National Institutes of Health [PO1 AI44642, RO1 AI24616, R01 AI50661, R01 RR 12294, IOS 0817232]; University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, P01AI044642, R01AI050661, T32AI007414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 AI44642 and RO1 AI24616 (to B. W. G. and M. A. A.), R01 AI50661 (to M. M.-N.), and R01 RR 12294 and IOS 0817232 (to E. G. R. and M. M.-N.). This work was also supported by University of Wisconsin Medical Scientist Training Program (to the M. M.-N. laboratory).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Apicella Michael A., 2008, V431, P3; Banoub JH, 2010, MASS SPECTROM REV, V29, P606, DOI 10.1002/mas.20258; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; BOETTCHER KJ, 1994, CURR MICROBIOL, V29, P279, DOI 10.1007/BF01577441; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; BRADE H, 1985, J BACTERIOL, V161, P795, DOI 10.1128/JB.161.2.795-798.1985; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; CHARY KVR, 1993, J MAGN RESON SER B, V102, P81, DOI 10.1006/jmrb.1993.1065; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Cox AD, 1997, CARBOHYD RES, V304, P191, DOI 10.1016/S0008-6215(97)00207-3; Cox AD, 1996, CARBOHYD RES, V290, P43, DOI 10.1016/0008-6215(96)00135-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUNLAP PV, 1989, J BACTERIOL, V171, P1199, DOI 10.1128/jb.171.2.1199-1202.1989; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; HAN TJ, 1992, J BACTERIOL, V174, P3140, DOI 10.1128/jb.174.10.3140-3146.1992; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hashii N, 2003, CARBOHYD RES, V338, P2711, DOI 10.1016/j.carres.2003.06.003; Hashii N, 2003, CARBOHYD RES, V338, P1063, DOI 10.1016/S0008-6215(03)00078-8; Holst O, 2003, ADV EXP MED BIOL, V529, P219; IGUCHI T, 1995, FEMS MICROBIOL LETT, V130, P287, DOI 10.1016/0378-1097(95)00220-Y; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Le Quere AJL, 2006, J BIOL CHEM, V281, P28981, DOI 10.1074/jbc.M513639200; Lee P. N., 2009, COLD SPRING HARBOR P; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lyell NL, 2008, APPL ENVIRON MICROB, V74, P7059, DOI 10.1128/AEM.01330-08; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mattos KA, 2005, GLYCOBIOLOGY, V15, P313, DOI 10.1093/glycob/cwi009; MCFALLNGAI MJ, 1991, SCIENCE, V254, P1491, DOI 10.1126/science.1962208; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; MELAUGH W, 1994, BIOCHEMISTRY-US, V33, P13070, DOI 10.1021/bi00248a016; Millikan DS, 2004, J BACTERIOL, V186, P4315, DOI 10.1128/JB.186.13.4315-4325.2004; MONTGOMERY MK, 1993, BIOL BULL, V184, P296, DOI 10.2307/1542448; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Olsson U, 2005, CARBOHYD RES, V340, P167, DOI 10.1016/j.carres.2004.11.008; Petersen BO, 2006, CARBOHYD RES, V341, P550, DOI 10.1016/j.carres.2005.11.020; Phillips NJ, 2011, J BIOL CHEM, V286, P21203, DOI 10.1074/jbc.M111.239475; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; PHILLIPS NJ, 1993, BIOCHEMISTRY-US, V32, P2003, DOI 10.1021/bi00059a017; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Pupo E, 2004, ELECTROPHORESIS, V25, P2156, DOI 10.1002/elps.200405980; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Sato H, 2005, CARBOHYD RES, V340, P469, DOI 10.1016/j.carres.2004.12.011; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; SONESSON A, 1994, MICROBIOL-SGM, V140, P1261, DOI 10.1099/00221287-140-6-1261; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Tambalo DD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-219; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Tsvetkov YE, 2001, CARBOHYD RES, V335, P221, DOI 10.1016/S0008-6215(01)00235-X; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; Wollenberg MS, 2012, ISME J, V6, P352, DOI 10.1038/ismej.2011.92; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZUBKOV VA, 1992, CARBOHYD RES, V225, P189, DOI 10.1016/S0008-6215(00)90496-8	73	47	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8515	8530		10.1074/jbc.M111.324012	http://dx.doi.org/10.1074/jbc.M111.324012			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247546	Green Published, hybrid			2022-12-25	WOS:000301349400065
J	Shi, S; Deng, YZ; Zhao, JS; Ji, XD; Shi, J; Feng, YX; Li, G; Li, JJ; Zhu, D; Koeffler, HP; Zhao, Y; Xie, D				Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Shi, Jun; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Zhu, Di; Koeffler, H. Phillip; Zhao, Yun; Xie, Dong			RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DEVELOPMENTAL PATHWAYS; PATCHED-GLI; CARCINOMA; WNT; PHOSPHORYLATION; EXPRESSION; DROSOPHILA; TRANSDUCTION; REQUIREMENT	Non-small-cell lung cancer (NSCLC) is a deadly disease due to lack of effective diagnosis biomarker and therapeutic target. Much effort has been made in defining gene defects in NSCLC, but its full molecular pathogenesis remains unexplored. Here, we found RACK1 (receptor of activated kinase 1) was elevated in most NSCLC, and its expression level correlated with key pathological characteristics including tumor differentiation, stage, and metastasis. In addition, RACK1 activated sonic hedgehog signaling pathway by interacting with and activating Smoothened to mediate Gli1-dependent transcription in NSCLC cells. And silencing RACK1 dramatically inhibited in vivo tumor growth and metastasis by blocking the sonic hedgehog signaling pathway. These results suggest that RACK1 represents a new promising diagnosis biomarker and therapeutic target for NSCLC.	[Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Xie, Dong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Shi, Jun] Second Peoples Hosp Zhuhai, Zhuhai 519000, Guangdong, Peoples R China; [Zhu, Di] Dana Farber Canc Inst, Boston, MA 02115 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 119077, Singapore; [Zhao, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Harvard University; Dana-Farber Cancer Institute; National University of Singapore; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xie, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Mol Oncol Lab, 294 Tai Yuan Rd, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn		Xie, Dong/0000-0002-1150-8657; Xie, Dong/0000-0003-2804-8578	National Basic Research Program of China [2010CB912102]; Ministry of Science and Technology [2012ZX10002009-017]; National Natural Science Foundation of China [30930023, 90813023, Y239X31111, 81021002, 31100551, 81070325]; National Natural Science Funds for Distinguished Young Scholar [30725010]; Nature Science Foundation of China-Guangdong [U0932001]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Nature Science Foundation of China-Guangdong	This work was supported by National Basic Research Program of China Grant 2010CB912102, Ministry of Science and Technology Key Program 2012ZX10002009-017, National Natural Science Foundation of China 30930023, 90813023, Y239X31111, 81021002, 31100551, 81021002, and 81070325, National Natural Science Funds for Distinguished Young Scholar Grant 30725010, and Nature Science Foundation of China-Guangdong Joint Fund U0932001.	Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Battaini F, 1997, TRENDS NEUROSCI, V20, P410, DOI 10.1016/S0166-2236(97)01084-9; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Daniel VC, 2006, RESPIROLOGY, V11, P234, DOI 10.1111/j.1440-1843.2006.00838.x; Fujita E, 1997, BIOCHEM BIOPH RES CO, V238, P658, DOI 10.1006/bbrc.1997.7262; Gialmanidis IP, 2009, LUNG CANCER, V66, P64, DOI 10.1016/j.lungcan.2009.01.007; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; He B, 2005, CLIN LUNG CANCER, V7, P54, DOI 10.3816/CLC.2005.n.022; Hu LJ, 2006, J MOL NEUROSCI, V29, P55, DOI 10.1385/JMN:29:1:55; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li CL, 2002, INT IMMUNOPHARMACOL, V2, P823, DOI 10.1016/S1567-5769(02)00023-1; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015; Paul S, 2008, NEOPLASMA, V55, P165; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Subauste MC, 2009, CANCER BIOL THER, V8, P2297; Toftgard R, 2000, CELL MOL LIFE SCI, V57, P1720, DOI 10.1007/PL00000654; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Walterhouse DO, 1999, ENVIRON HEALTH PERSP, V107, P167, DOI 10.2307/3434504; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Warburton D, 1999, AM J PHYSIOL-LUNG C, V276, pL697, DOI 10.1152/ajplung.1999.276.5.L697; Warburton David, 1999, Current Opinion in Pediatrics, V11, P188, DOI 10.1097/00008480-199906000-00002; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yagui-Beltran Adam, 2006, Thorac Surg Clin, V16, P379, DOI 10.1016/j.thorsurg.2006.07.001; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhao Y, 2007, FLY, V1, P333, DOI 10.4161/fly.5570; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	54	73	78	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7845	7858		10.1074/jbc.M111.315416	http://dx.doi.org/10.1074/jbc.M111.315416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262830	Green Published, hybrid			2022-12-25	WOS:000301349400002
J	Song, Q; Sherrer, SM; Suo, ZC; Taylor, JS				Song, Qian; Sherrer, Shanen M.; Suo, Zucai; Taylor, John-Stephen			Preparation of Site-specific T = (m)CG cis-syn Cyclobutane Dimer-containing Template and Its Error-free Bypass by Yeast and Human Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-THYMINE DIMER; DNA-POLYMERASE; PYRIMIDINE DIMERS; REPLICATIVE BYPASS; LESION BYPASS; POL-ETA; DEAMINATION; 5-METHYLCYTOSINE; PHOTOPRODUCTS; MUTATIONS	C-to-T mutations are a hallmark of UV light and, in humans, occur preferentially at methylated Py(m)CG sites, which are also sites of preferential cyclobutane pyrimidine dimer (CPD) formation. In response, cells have evolved DNA damage bypass polymerases, of which polymerase eta (pol eta) appears to be specifically adapted to synthesize past cis-syn CPDs. Although T = T CPDs are stable, CPDs containing C or 5-methylcytosine (C-m) are not and spontaneously deaminate to U or T at pH 7 and 37 C over a period of hours or days, making their preparation and study difficult. Furthermore, there is evidence to suggest that, depending on solvent polarity, a C or an C-m in a CPD can adopt three tautomeric forms, one of which could code as T. Although many in vitro studies have established that synthesis past T or U in a CPD by pol eta occurs in a highly error-free manner, the only in vitro evidence that synthesis past C or C-m in a CPD also occurs in an error-free manner is for an C-m in the 5'-position of an C-m = T CPD. Herein, we describe the preparation and characterization of an oligodeoxynucleotide containing a CPD of a T(m)CG site, one of the major sites of C methylation and C-to-T mutations found in the p53 gene of basal and squamous cell cancers. We also demonstrate that both yeast and human pol eta synthesize past the 3'-C-m CPD in a >99% error-free manner, consistent with the highly water-exposed nature of the active site.	[Song, Qian; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Sherrer, Shanen M.; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	Washington University (WUSTL); Ohio State University	Taylor, JS (corresponding author), Washington Univ, Dept Chem, 1 Brookings Dr, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Institutes of Health [CA40463]; American Heart Association [GRT00014861]; NATIONAL CANCER INSTITUTE [R01CA040463, R37CA040463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA40463 (to J.-S. T. and Z. S.).; Supported by American Heart Association Great Rivers Affiliate Predoctoral Fellowship GRT00014861.	BARAK Y, 1995, J BIOL CHEM, V270, P24174, DOI 10.1074/jbc.270.41.24174; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BROWN DM, 1968, J CHEM SOC C, P2050, DOI 10.1039/j39680002050; Brown JA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/871939; Cannistraro VJ, 2010, NUCLEIC ACIDS RES, V38, P6943, DOI 10.1093/nar/gkq582; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Cannistraro VJ, 2004, J BIOL CHEM, V279, P18288, DOI 10.1074/jbc.M400282200; Danilov VI, 2000, CHEM PHYS LETT, V328, P75, DOI 10.1016/S0009-2614(00)00909-X; Danilov VI, 2001, J BIOMOL STRUCT DYN, V19, P179, DOI 10.1080/07391102.2001.10506730; DUPUYMAN.N, 1967, J CHIM PHYS PCB, V64, P708, DOI 10.1051/jcp/1967640708; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Horsfall MJ, 1997, J BACTERIOL, V179, P2835, DOI 10.1128/jb.179.9.2835-2839.1997; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Hwang HS, 2005, BIOCHEMISTRY-US, V44, P4850, DOI 10.1021/bi048244+; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LIU FT, 1978, BIOCHEMISTRY-US, V17, P4865, DOI 10.1021/bi00616a003; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SETLOW RB, 1965, P NATL ACAD SCI USA, V53, P1111, DOI 10.1073/pnas.53.5.1111; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Smith CA, 1998, J BIOL CHEM, V273, P21933, DOI 10.1074/jbc.273.34.21933; Song QA, 2011, J BIOL CHEM, V286, P6329, DOI 10.1074/jbc.M110.183178; Sun LP, 2003, BIOCHEMISTRY-US, V42, P9431, DOI 10.1021/bi0345687; Sun LP, 2000, BIOCHEMISTRY-US, V39, P14603, DOI 10.1021/bi001446v; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Taylor JS, 2002, MUTAT RES-FUND MOL M, V510, P55, DOI 10.1016/S0027-5107(02)00252-X; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; WANG CI, 1991, P NATL ACAD SCI USA, V88, P9072, DOI 10.1073/pnas.88.20.9072; Wang YS, 1999, CHEM RES TOXICOL, V12, P1077, DOI 10.1021/tx9900831; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; You HY, 2000, CARCINOGENESIS, V21, P2113, DOI 10.1093/carcin/21.11.2113; You YH, 1999, J MOL BIOL, V293, P493, DOI 10.1006/jmbi.1999.3174; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	50	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8021	8028		10.1074/jbc.M111.333591	http://dx.doi.org/10.1074/jbc.M111.333591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262850	Green Published, hybrid			2022-12-25	WOS:000301349400018
J	Kaya, AI; Onaran, HO; Ozcan, G; Ambrosio, C; Costa, T; Balli, S; Ugur, O				Kaya, Ali I.; Onaran, H. Ongun; Ozcan, Gulnihal; Ambrosio, Caterina; Costa, Tommaso; Balli, Sezen; Ugur, Ozlem			Cell Contact-dependent Functional Selectivity of beta(2)-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BETA-ADRENERGIC-RECEPTORS; MAP KINASE; B-RAF; ADHESION; TRANSDUCTION; INHIBITION; BINDING; EQUILIBRIUM; INTEGRINS	Activation of beta(2)-adrenegic receptor (beta(2)-AR) leads to an increase in intracellular cAMP and activation of ERK. These two signals are activated by the interaction of the receptor with different transducer partners. We showed that the intrinsic activities of beta(2)-AR ligands for stimulating cAMP production and ERK phosphorylation responses in HEK-293 cells were not correlated. The lack of correlation resulted mainly from the discrepancy between the intrinsic activities of two groups of ligands for these two responses: The first group consisted of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP production but displayed very weak effect on ERK phosphorylation. The second group comprised adrenaline and noradrenaline which displayed higher intrinsic activity for the ERK phosphorylation than for the cAMP response. Thus, both groups behaved as functionally selective ligands. The functional selectivity of the first group was observable only in adherent cells when confluence was approximately 100%. When cell-cell contact was minimized either by decreasing the density of the adherent cells or by bringing the cells into suspension, the first group of ligands gained the ability to stimulate ERK phosphorylation without a change in their effect on cAMP production. In contrast, selectivity of the second group was independent of the adherence state of the cells. Our results show that the inherent "bias" of ligands in coupling a G protein-coupled receptor to different transducers may not always be revealed as functional selectivity when there is a "cross-talk" between the signaling pathways activated by the same receptor.	[Kaya, Ali I.; Onaran, H. Ongun; Ozcan, Gulnihal; Balli, Sezen; Ugur, Ozlem] Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey; [Kaya, Ali I.; Onaran, H. Ongun] Ankara Univ, Fac Med, Mol Biol & Technol Res & Dev Unit, TR-06100 Ankara, Turkey; [Ambrosio, Caterina; Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy	Ankara University; Ankara University; Istituto Superiore di Sanita (ISS)	Ugur, O (corresponding author), Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey.	ougur@medicine.ankara.edu.tr	costa, tommaso/AAD-3714-2019; Ozcan, Gulnihal/A-1086-2013; Ugur, Özlem/J-3169-2019; Onaran, Ongun/AAI-5348-2020; ambrosio, caterina/M-7952-2017	costa, tommaso/0000-0002-8729-3357; Ugur, Özlem/0000-0002-5404-5242; Onaran, Ongun/0000-0001-6766-4774; Ozcan, Gulnihal/0000-0001-5354-0148; ambrosio, caterina/0000-0002-0807-9003	Turkish Scientific and Technical Research Council [107S086, 110S159]	Turkish Scientific and Technical Research Council(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Grants 107S086 and 110S159 from the Turkish Scientific and Technical Research Council.	Amber-Cicek F, 2008, EUR J PHARMACOL, V590, P12, DOI 10.1016/j.ejphar.2008.05.012; Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Aplin AE, 1998, PHARMACOL REV, V50, P197; Casella I, 2011, BIOCHEM J, V438, P191, DOI 10.1042/BJ20110374; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kukkonen JP, 2001, TRENDS PHARMACOL SCI, V22, P616, DOI 10.1016/S0165-6147(00)01864-2; Laakko T, 2003, J BIOL CHEM, V278, P31621, DOI 10.1074/jbc.M304700200; LAZOU A, 1994, CIRC RES, V75, P932, DOI 10.1161/01.RES.75.5.932; Lin TH, 1997, J BIOL CHEM, V272, P8849; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; MILLIGAN G, 1988, BIOCHEM J, V255, P1; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shikata Y, 1999, BIOCHEM BIOPH RES CO, V257, P234, DOI 10.1006/bbrc.1999.0441; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Short SM, 2000, J BIOL CHEM, V275, P12970, DOI 10.1074/jbc.275.17.12970; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Ugur O, 1997, BIOCHEM J, V323, P765, DOI 10.1042/bj3230765; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098	40	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6362	6374		10.1074/jbc.M111.301820	http://dx.doi.org/10.1074/jbc.M111.301820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22241475	hybrid, Green Published			2022-12-25	WOS:000300791800028
J	Ito, M; Sugihara, K; Asaka, T; Toyama, T; Yoshihara, T; Furuichi, K; Wada, T; Asano, M				Ito, Mitutoshi; Sugihara, Kazushi; Asaka, Tomoya; Toyama, Tadashi; Yoshihara, Toru; Furuichi, Kengo; Wada, Takashi; Asano, Masahide			Glycoprotein Hyposialylation Gives Rise to a Nephrotic-Like Syndrome That Is Prevented by Sialic Acid Administration in GNE V572L Point-Mutant Mice	PLOS ONE			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; MAJOR SIALOPROTEIN; PODOCALYXIN; GENE; PROTEINURIA; MUTATION; KIDNEY; DISEASE; SIALYLATION; DISRUPTION	Mutations in the key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosamine kinase, result in distal myopathy with rimmed vacuoles (DMRV)/hereditary inclusion body myopathy (HIBM) in humans. Sialic acid is an acidic monosaccharide that modifies non-reducing terminal carbohydrate chains on glycoproteins and glycolipids, and it plays an important role in cellular adhesions and interactions. In this study, we generated mice with a V572L point mutation in the GNE kinase domain. Unexpectedly, these mutant mice had no apparent myopathies or motor dysfunctions. However, they had a short lifespan and exhibited renal impairment with massive albuminuria. Histological analysis showed enlarged glomeruli with mesangial matrix deposition, leading to glomerulosclerosis and abnormal podocyte foot process morphologies in the kidneys. Glycan analysis using several lectins revealed glomerular epithelial cell hyposialylation, particularly the hyposialylation of podocalyxin, which is one of important molecules for the glomerular filtration barrier. Administering Neu5Ac to the mutant mice from embryonic stages significantly suppressed the albuminuria and renal pathology, and partially recovered the glomerular glycoprotein sialylation. These findings suggest that the nephrotic-like syndrome observed in these mutant mice resulted from impaired glomerular filtration due to the hyposialylation of podocyte glycoproteins, including podocalyxin. Furthermore, it was possible to prevent the nephrotic-like disease in these mice by beginning Neu5Ac treatment during gestation.	[Ito, Mitutoshi; Sugihara, Kazushi; Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Asaka, Tomoya] Nanao Natl Hosp, Nanao, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Toyama, Tadashi; Furuichi, Kengo; Wada, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Lab Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Ito, M (corresponding author), Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan.	asano@kiea.m.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19300144, 22300142]; Grants-in-Aid for Scientific Research [23500493] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (grant No. 19300144 and 22300142) (to M.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arai A, 2002, ANN NEUROL, V52, P516, DOI 10.1002/ana.10341; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Avasthi P S, 1988, Contrib Nephrol, V68, P104; Benoit G, 2010, ANN NY ACAD SCI, V1214, P83, DOI 10.1111/j.1749-6632.2010.05817.x; BERNARD A, 1992, ARCH TOXICOL, V66, P272, DOI 10.1007/BF02307173; CHAREST PM, 1985, P NATL ACAD SCI USA, V82, P8508, DOI 10.1073/pnas.82.24.8508; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; D'souza YB, 2009, KIDNEY INT, V75, P824, DOI 10.1038/ki.2008.658; Daskalakis N, 2006, CELL MOL LIFE SCI, V63, P2506, DOI 10.1007/s00018-006-6171-y; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; HOLTHOFER H, 1987, HISTOCHEM J, V19, P351, DOI 10.1007/BF01680452; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAPOLA J, 1987, PEDIATR NEPHROL, V1, P441, DOI 10.1007/BF00849252; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tong YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007165; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vogtlander NPJ, 2010, NEPHROL DIAL TRANSPL, V25, P478, DOI 10.1093/ndt/gfp465; WADA T, 1994, J EXP MED, V180, P1135, DOI 10.1084/jem.180.3.1135; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	47	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29873	10.1371/journal.pone.0029873	http://dx.doi.org/10.1371/journal.pone.0029873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253810	gold, Green Submitted, Green Published			2022-12-25	WOS:000301361500025
J	Damera, G; Druey, KM; Cooper, PR; Krymskaya, VP; Soberman, RJ; Amrani, Y; Hoshi, T; Brightling, CE; Panettieri, RA				Damera, Gautam; Druey, Kirk M.; Cooper, Philip R.; Krymskaya, Vera P.; Soberman, Roy J.; Amrani, Yassine; Hoshi, Toshinori; Brightling, Christopher E.; Panettieri, Reynold A., Jr.			An RGS4-Mediated Phenotypic Switch of Bronchial Smooth Muscle Cells Promotes Fixed Airway Obstruction in Asthma	PLOS ONE			English	Article							RGS PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; EXPRESSION; GROWTH; REGULATORS; PROLIFERATION; THERMOPLASTY; MECHANISMS; KINASE; ADULTS	In severe asthma, bronchodilator-and steroid-insensitive airflow obstruction develops through unknown mechanisms characterized by increased lung airway smooth muscle (ASM) mass and stiffness. We explored the role of a Regulator of G-protein Signaling protein (RGS4) in the ASM hyperplasia and reduced contractile capacity characteristic of advanced asthma. Using immunocytochemical staining, ASM expression of RGS4 was determined in endobronchial biopsies from healthy subjects and those from subjects with mild, moderate and severe asthma. Cell proliferation assays, agonist-induced calcium mobilization and bronchoconstriction were determined in cultured human ASM cells and in human precision cut lung slices. Using gain-and loss-of-function approaches, the precise role of RGS proteins was determined in stimulating human ASM proliferation and inhibiting bronchoconstriction. RGS4 expression was restricted to a subpopulation of ASM and was specifically upregulated by mitogens, which induced a hyperproliferative and hypocontractile ASM phenotype similar to that observed in recalcitrant asthma. RGS4 expression was markedly increased in bronchial smooth muscle of patients with severe asthma, and expression correlated significantly with reduced pulmonary function. Whereas RGS4 inhibited G protein-coupled receptor (GPCR)-mediated bronchoconstriction, unexpectedly RGS4 was required for PDGF-induced proliferation and sustained activation of PI3K, a mitogenic signaling molecule that regulates ASM proliferation. These studies indicate that increased RGS4 expression promotes a phenotypic switch of ASM, evoking irreversible airway obstruction in subjects with severe asthma.	[Damera, Gautam; Cooper, Philip R.; Krymskaya, Vera P.; Panettieri, Reynold A., Jr.] Univ Penn, Airways Biol Initiat, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Druey, Kirk M.] NIAID, NIH, Bethesda, MD 20892 USA; [Soberman, Roy J.] Harvard Univ, Sch Med, Boston, MA USA; [Amrani, Yassine; Brightling, Christopher E.] Univ Leicester, Leicester, Leics, England; [Hoshi, Toshinori] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard Medical School; University of Leicester; University of Pennsylvania	Damera, G (corresponding author), Univ Penn, Airways Biol Initiat, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	rap@mail.med.upenn.edu	Amrani, Yassine/A-1826-2013; Amrani, Yassine/Q-6323-2019; panettieri, reynold/AAG-9485-2019	Amrani, Yassine/0000-0002-7042-6926; brightling, chris/0000-0002-9345-4903	National Institutes of Health [RO1-HL097796, R01-AI068871, RO1-GM057654, RO1-GM078579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068871, ZIAAI000939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057654, R01GM078579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health RO1-HL097796 to RAP, R01-AI068871 to RJS and RO1-GM057654 and RO1-GM078579 to TH. CEB is a Welcome Trust Senior Fellow. All funding sources supported the design, execution and interpretation of the results. None of the sources played a role in the performance, decision to publish or preparation of the manuscript. National Disease Research Interchange (NDRI) provided the human tissue for the studies.	Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chiou YL, 2006, PEDIATR RES, V60, P657, DOI 10.1203/01.pdr.0000246105.56278.98; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Derrien A, 2003, J BIOL CHEM, V278, P16107, DOI 10.1074/jbc.M210371200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; GABELLA G, 1989, ANAT EMBRYOL, V180, P213, DOI 10.1007/BF00315880; GABELLA G, 1976, CELL TISSUE RES, V170, P161; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Krymskaya VP, 2000, AM J RESP CELL MOL, V23, P546, DOI 10.1165/ajrcmb.23.4.4115; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; Neubig RR, 2008, CIRC RES, V103, P444, DOI 10.1161/CIRCRESAHA.108.183384; O'Brien M, 2008, REPROD SCI, V15, P382, DOI 10.1177/1933719108316179; Owen VJ, 2001, EUR HEART J, V22, P1015, DOI 10.1053/euhj.2000.2578; OWENS GK, 1995, PHYSIOL REV, V75, P487; Panettieri RA, 2008, J ALLERGY CLIN IMMUN, V121, P607, DOI 10.1016/j.jaci.2008.01.006; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Salomonis N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r12; Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Thyberg J, 1997, LAB INVEST, V77, P93; Tliba O, 2009, ANNU REV PHYSIOL, V71, P509, DOI 10.1146/annurev.physiol.010908.163227; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005	41	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e28504	10.1371/journal.pone.0028504	http://dx.doi.org/10.1371/journal.pone.0028504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253691	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100002
J	Stockwell, SR; Platt, G; Barrie, SE; Zoumpoulidou, G; Poele, RHT; Aherne, GW; Wilson, SC; Sheldrake, P; McDonald, E; Venet, M; Soudy, C; Elustondo, F; Rigoreau, L; Blagg, J; Workman, P; Garrett, MD; Mittnacht, S				Stockwell, Simon R.; Platt, Georgina; Barrie, S. Elaine; Zoumpoulidou, Georgia; Poele, Robert H. Te; Aherne, G. Wynne; Wilson, Stuart C.; Sheldrake, Peter; McDonald, Edward; Venet, Mathilde; Soudy, Christelle; Elustondo, Frederic; Rigoreau, Laurent; Blagg, Julian; Workman, Paul; Garrett, Michelle D.; Mittnacht, Sibylle			Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; CYCLIN D1; ENDOPLASMIC-RETICULUM; CELL-CYCLE; RETINOBLASTOMA PROTEIN; TRANSLATIONAL REGULATION; MULTIPLE-MYELOMA; BREAST-CANCER; ER STRESS; PHOSPHORYLATION	Human cancers often contain genetic alterations that disable G1/S checkpoint control and loss of this checkpoint is thought to critically contribute to cancer generation by permitting inappropriate proliferation and distorting fate-driven cell cycle exit. The identification of cell permeable small molecules that activate the G1/S checkpoint may therefore represent a broadly applicable and clinically effective strategy for the treatment of cancer. Here we describe the identification of several novel small molecules that trigger G1/S checkpoint activation and characterise the mechanism of action for one, CCT020312, in detail. Transcriptional profiling by cDNA microarray combined with reverse genetics revealed phosphorylation of the eukaryotic initiation factor 2-alpha (EIF2A) through the eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3/PERK) as the mechanism of action of this compound. While EIF2AK3/PERK activation classically follows endoplasmic reticulum (ER) stress signalling that sets off a range of different cellular responses, CCT020312 does not trigger these other cellular responses but instead selectively elicits EIF2AK3/PERK signalling. Phosphorylation of EIF2A by EIF2A kinases is a known means to block protein translation and hence restriction point transit in G1, but further supports apoptosis in specific contexts. Significantly, EIF2AK3/PERK signalling has previously been linked to the resistance of cancer cells to multiple anticancer chemotherapeutic agents, including drugs that target the ubiquitin/proteasome pathway and taxanes. Consistent with such findings CCT020312 sensitizes cancer cells with defective taxane-induced EIF2A phosphorylation to paclitaxel treatment. Our work therefore identifies CCT020312 as a novel small molecule chemical tool for the selective activation of EIF2A-mediated translation control with utility for proof-of-concept applications in EIF2A-centered therapeutic approaches, and as a chemical starting point for pathway selective agent development. We demonstrate that consistent with its mode of action CCT020312 is capable of delivering potent, and EIF2AK3 selective, proliferation control and can act as a sensitizer to chemotherapy-associated stresses as elicited by taxanes.	[Stockwell, Simon R.; Zoumpoulidou, Georgia; Mittnacht, Sibylle] UCL Canc Inst, Res Dept Canc Biol, London, England; [Stockwell, Simon R.; Platt, Georgina; Barrie, S. Elaine; Zoumpoulidou, Georgia; Mittnacht, Sibylle] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Poele, Robert H. Te; Aherne, G. Wynne; Wilson, Stuart C.; Sheldrake, Peter; McDonald, Edward; Blagg, Julian; Workman, Paul; Garrett, Michelle D.] Inst Canc Res, Haddow Labs, Div Canc Therapeut, Sutton, Surrey, England; [Venet, Mathilde; Soudy, Christelle; Elustondo, Frederic; Rigoreau, Laurent] Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs London, London, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; University College London	Stockwell, SR (corresponding author), UCL Canc Inst, Res Dept Canc Biol, London, England.	s.mittnacht@cancer.ucl.ac.uk		Stockwell, Simon/0000-0002-3345-8945; elustondo, frederic/0000-0003-1136-6932	Cancer Research UK [C107/A3096, C107/A4567, C309/A2187, C107/10433, C309/A8274]; NHS; Cancer Research UK [11566] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); NHS; Cancer Research UK(Cancer Research UK)	Cancer Research UK; grant numbers C107/A3096, C107/A4567, C309/A2187, C107/10433 and C309/A8274. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre. PW is a Cancer Research UK Life Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Barrie SE, 2003, ANAL BIOCHEM, V320, P66, DOI 10.1016/S0003-2697(03)00349-X; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campo PA, 2002, CELL GROWTH DIFFER, V13, P409; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Clemens MJ, 2001, PROG MOLEC, V27, P57; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Drexler HCA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004161; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hansson J, 2010, ADV EXP MED BIOL, V685, P134; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; LACRAMPE JFA, 2004, Patent No. 2004007499; LACRAMPE JFA, 2004, Patent No. 200460512; LACRAMPE JFA, 2004, Patent No. 20040122; LACRAMPE JFA, 2004, Patent No. 140111195; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lesage D, 2005, INT J CANCER, V115, P171, DOI 10.1002/ijc.20907; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu N, 2009, CURR MED CHEM, V16, P4869, DOI 10.2174/092986709789909611; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malumbres Marcos, 2003, Prog Cell Cycle Res, V5, P5; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Mittnacht S, 2005, EUR J CELL BIOL, V84, P97, DOI 10.1016/j.ejcb.2004.12.012; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Rowlands TM, 2004, CELL CYCLE, V3, P145; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Zarkowska T, 1997, ONCOGENE, V14, P249, DOI 10.1038/sj.onc.1200824; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	57	60	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e28568	10.1371/journal.pone.0028568	http://dx.doi.org/10.1371/journal.pone.0028568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253692	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100003
J	Jayaswal, V; Lutherborrow, M; Yang, YH				Jayaswal, Vivek; Lutherborrow, Mark; Yang, Yee Hwa			Measures of Association for Identifying MicroRNA-mRNA Pairs of Biological Interest	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; MULTIPLE-MYELOMA; MOLECULAR SUBTYPES; IDENTIFICATION; PROFILES; NORMALIZATION; DEREGULATION; NETWORK; TARGETS	MicroRNAs are a class of small non-protein coding RNAs that play an important role in the regulation of gene expression. Most studies on the identification of microRNA-mRNA pairs utilize the correlation coefficient as a measure of association. The use of correlation coefficient is appropriate if the expression data are available for several conditions and, for a given condition, both microRNA and mRNA expression profiles are obtained from the same set of individuals. However, there are many instances where one of the requirements is not satisfied. Therefore, there is a need for new measures of association to identify the microRNA-mRNA pairs of interest and we present two such measures. The first measure requires expression data for multiple conditions but, for a given condition, the microRNA and mRNA expression may be obtained from different individuals. The new measure, unlike the correlation coefficient, is suitable for analyzing large data sets which are obtained by combining several independent studies on microRNAs and mRNAs. Our second measure is able to handle expression data that correspond to just two conditions but, for a given condition, the microRNA and mRNA expression must be obtained from the same set of individuals. This measure, unlike the correlation coefficient, is appropriate for analyzing data sets with a small number of conditions. We apply our new measures of association to multiple myeloma data sets, which cannot be analyzed using the correlation coefficient, and identify several microRNA-mRNA pairs involved in apoptosis and cell proliferation.	[Jayaswal, Vivek; Yang, Yee Hwa] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Jayaswal, Vivek; Yang, Yee Hwa] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia; [Lutherborrow, Mark] St Vincent Ctr Appl Med Res, Dept Haematol, Darlinghurst, NSW, Australia	University of Sydney; University of Sydney	Jayaswal, V (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	vivek.jayaswal@sydney.edu.au	Jayaswal, Vivek/B-4258-2013; Yang, Jean YH/D-2920-2015	Jayaswal, Vivek/0000-0002-5130-8588; Yang, Jean YH/0000-0002-5271-2603	Australian Research Council [DP1095320, FT0991918]	Australian Research Council(Australian Research Council)	This work was supported in part by Australian Research Council through grants DP1095320 (VJ) and FT0991918 (YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsagel PL, 2003, IMMUNOL REV, V194, P96, DOI 10.1034/j.1600-065X.2003.00052.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chi JX, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-23; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lionetti M, 2009, BLOOD, V114, P1104; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutherborrow M, 2011, AM J HEMATOL, V86, P2, DOI 10.1002/ajh.21864; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shringarpure R, 2006, BRIT J HAEMATOL, V134, P145, DOI 10.1111/j.1365-2141.2006.06132.x; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Team. RDC, 2007, R LANG ENV STAT COMP; Tiedemann RE, 2008, J CLIN INVEST, V118, P1750, DOI 10.1172/JCI34149; Usui E, 2004, HEMATOL J, V5, P505, DOI 10.1038/sj.thj.6200565; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wang L, 2009, PLOS ONE, V4; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Yu SC, 2011, HISTOPATHOLOGY, V58, P896, DOI 10.1111/j.1365-2559.2011.03793.x; Zhang SH, 2011, BIOINFORMATICS, V27, pI401, DOI 10.1093/bioinformatics/btr206; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	52	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29612	10.1371/journal.pone.0029612	http://dx.doi.org/10.1371/journal.pone.0029612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253745	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700031
J	Mura, E; Zappettini, S; Preda, S; Biundo, F; Lanni, C; Grilli, M; Cavallero, A; Olivero, G; Salamone, A; Govoni, S; Marchi, M				Mura, Elisa; Zappettini, Stefania; Preda, Stefania; Biundo, Fabrizio; Lanni, Cristina; Grilli, Massimo; Cavallero, Anna; Olivero, Guendalina; Salamone, Alessia; Govoni, Stefano; Marchi, Mario			Dual Effect of Beta-Amyloid on alpha 7 and alpha 4 beta 2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus	PLOS ONE			English	Article							EXTRACELLULAR AMINO-ACIDS; ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; DOPAMINE RELEASE; SYNAPTOSOMES; PEPTIDE; PROTEIN; A-BETA(1-42); TRANSMISSION	Background: We previously showed that beta-amyloid (A beta), a peptide considered as relevant to Alzheimer's Disease, is able to act as a neuromodulator affecting neurotransmitter release in absence of evident sign of neurotoxicity in two different rat brain areas. In this paper we focused on the hippocampus, a brain area which is sensitive to Alzheimer's Disease pathology, evaluating the effect of A beta (at different concentrations) on the neurotransmitter release stimulated by the activation of presynaptic cholinergic nicotinic receptors (nAChRs, alpha 4 beta 2 and alpha 7 subtypes). Particularly, we focused on some neurotransmitters that are usually involved in learning and memory: glutamate, aspartate and GABA. Methodology/Findings: We used a dual approach: in vivo experiments (microdialysis technique on freely moving rats) in parallel to in vitro experiments (isolated nerve endings derived from rat hippocampus). Both in vivo and in vitro the administration of nicotine stimulated an overflow of aspartate, glutamate and GABA. This effect was greatly inhibited by the highest concentrations of A beta considered (10 mu M in vivo and 100 nM in vitro). In vivo administration of 100 nM A beta (the lowest concentration considered) potentiated the GABA overflow evoked by nicotine. All these effects were specific for A beta and for nicotinic secretory stimuli. The in vitro administration of either choline or 5-Iodo-A-85380 dihydrochloride (alpha 7 and alpha 4 beta 2 nAChRs selective agonists, respectively) elicited the hippocampal release of aspartate, glutamate, and GABA. High A beta concentrations (100 nM) inhibited the overflow of all three neurotransmitters evoked by both choline and 5-Iodo-A-85380 dihydrochloride. On the contrary, low A beta concentrations (1 nM and 100 pM) selectively acted on alpha 7 subtypes potentiating the choline-induced release of both aspartate and glutamate, but not the one of GABA. Conclusions/Significance: The results reinforce the concept that A beta has relevant neuromodulatory effects, which may span from facilitation to inhibition of stimulated release depending upon the concentration used.	[Mura, Elisa; Preda, Stefania; Biundo, Fabrizio; Lanni, Cristina; Govoni, Stefano] Univ Pavia, Ctr Excellence Appl Biol, Dept Drug Sci, I-27100 Pavia, Italy; [Zappettini, Stefania; Grilli, Massimo; Cavallero, Anna; Olivero, Guendalina; Salamone, Alessia; Marchi, Mario] Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy; [Marchi, Mario] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy	University of Pavia; University of Genoa; University of Genoa	Mura, E (corresponding author), Univ Pavia, Ctr Excellence Appl Biol, Dept Drug Sci, Via Palestro 3, I-27100 Pavia, Italy.	govonis@unipv.it	Biundo, Fabrizio/ABH-7843-2020; Govoni, Stefano/K-2965-2015; Olivero, Guendalina/AAL-7489-2020; Lanni, Cristina/AAI-2182-2020; Biundo, Fabrizio/AAJ-1715-2021; Grilli, Massimo/C-4217-2008; Salamone, Alessia/AGV-0658-2022; biundo, fabrizio/A-4611-2019; mura, elisa/ABD-9249-2020	Govoni, Stefano/0000-0002-7243-6837; Grilli, Massimo/0000-0003-1046-7897; Salamone, Alessia/0000-0002-1090-7517; mario, marchi/0000-0003-0263-9070; Biundo, Fabrizio/0000-0003-2264-1872; Olivero, Guendalina/0000-0001-8571-3736; LANNI, CRISTINA/0000-0002-3061-4738; Zappettini, PharmD, PhD, PMP, Stefania/0000-0002-1238-9573	Italian Ministero Universita Ricerca [2007HJCCSF, 20072BTSR2_002]; Compagnia di San Paolo; AROMA; European project PYRGI	Italian Ministero Universita Ricerca(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo); AROMA; European project PYRGI	This work was supported by the Italian Ministero Universita Ricerca to Prof. S. Govoni (prot. N<SUP>o</SUP> 2007HJCCSF and MIUR 2009) and to Prof. M. Marchi (prot. N<SUP>o</SUP> 20072BTSR2_002), by Compagnia di San Paolo; AROMA ([ALCOTRA] Alpi Latine Cooperazione Transfrontaliera 2007-2013), European project PYRGI. Dr. E. Mura is an awardee of the Alzheimer's Association (NIRG-11-205183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BRAIN RES, V1029, P41, DOI 10.1016/j.brainres.2004.09.016; ALONSO JR, 1995, J COMP NEUROL, V355, P135, DOI 10.1002/cne.903550202; Battaglia G, 1997, NEUROSCI LETT, V229, P161, DOI 10.1016/S0304-3940(97)00442-4; Benowitz N. L, 1990, NICOTINE PSYCHOPHARM, P112; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Boyd-Kimball D, 2005, BRAIN RES, V1044, P206, DOI 10.1016/j.brainres.2005.02.086; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; DICHIARA G, 1990, TRENDS PHARMACOL SCI, V11, P116, DOI 10.1016/0165-6147(90)90197-G; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Fedele E, 1998, BRIT J PHARMACOL, V125, P1042, DOI 10.1038/sj.bjp.0702130; Fekete A, 2009, J NEUROCHEM, V111, P745, DOI 10.1111/j.1471-4159.2009.06368.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grilli M, 2010, NEUROSCIENCE, V167, P482, DOI 10.1016/j.neuroscience.2010.01.058; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kar S, 1996, J NEUROSCI, V16, P1034; Kirkitadze MD, 2005, ACTA BIOCHIM POL, V52, P417; Lee DHS, 2003, J NEUROBIOL, V55, P25, DOI 10.1002/neu.10203; Lu Y, 1998, J PHARMACOL EXP THER, V287, P648; Luccini E, 2010, J NEUROCHEM, V114, P1074, DOI 10.1111/j.1471-4159.2010.06829.x; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Mehta TK, 2009, J NEUROCHEM, V109, P1452, DOI 10.1111/j.1471-4159.2009.06070.x; Mura E, 2010, CURR PHARM DESIGN, V16, P672, DOI 10.2174/138161210790883723; Mura E, 2010, J ALZHEIMERS DIS, V19, P1041, DOI 10.3233/JAD-2010-1299; Parri HR, 2010, CURR ALZHEIMER RES, V7, P27, DOI 10.2174/156720510790274464; Preda S, 2008, NEUROPSYCHOPHARMACOL, V33, P1062, DOI 10.1038/sj.npp.1301485; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Sabella S, 2004, ELECTROPHORESIS, V25, P3186, DOI 10.1002/elps.200406062; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Stitzel JA, 1998, J PHARMACOL EXP THER, V284, P1104; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Terai K, 2001, NEUROSCIENCE, V104, P299, DOI 10.1016/S0306-4522(01)00095-1; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; Toth E, 1996, NEUROCHEM RES, V21, P903, DOI 10.1007/BF02532339; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; Verdile G, 2004, PHARMACOL RES, V50, P397, DOI 10.1016/j.phrs.2003.12.028; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wu M, 2003, EUR J NEUROSCI, V18, P1155, DOI 10.1046/j.1460-9568.2003.02847.x; YOSHIDA K, 1995, NEUROSCI RES, V21, P199, DOI 10.1016/0168-0102(94)00852-7; Zappettini S, 2010, BRIT J PHARMACOL, V161, P1161, DOI 10.1111/j.1476-5381.2010.00958.x; Zappettini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016911	57	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29661	10.1371/journal.pone.0029661	http://dx.doi.org/10.1371/journal.pone.0029661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253754	gold, Green Submitted, Green Published			2022-12-25	WOS:000301355700034
J	Reinhard, L; Rupp, C; Riedel, HD; Ruppert, T; Giese, T; Flechtenmacher, C; Weiss, KH; Kloeters-Plachky, P; Stremmel, W; Schirmacher, P; Sauer, P; Gotthardt, DN				Reinhard, Lisa; Rupp, Christian; Riedel, Hans-Dieter; Ruppert, Thomas; Giese, Thomas; Flechtenmacher, Christa; Weiss, Karl Heinz; Kloeters-Plachky, Petra; Stremmel, Wolfgang; Schirmacher, Peter; Sauer, Peter; Gotthardt, Daniel Nils			S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; HUMAN BILE; SECRETION; TRANSPORT; PATHOGENESIS; DIAGNOSIS; MEMBRANE; HISTORY	Background and Aims: Bile analysis has the potential to serve as a surrogate marker for inflammatory and neoplastic disorders of the biliary epithelium and may provide insight into biliary pathophysiology and possible diagnostic markers. We aimed to identify biliary protein markers of patients with primary sclerosing cholangitis (PSC) by a proteomic approach. Methods: Bile duct-derived bile samples were collected from PSC patients (n = 45) or patients with choledocholithiasis (n = 24, the control group). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed to analyse the proteins, 2-D-gel patterns were compared by densitometry, and brush cytology specimens were analysed by RT-PCR. Results: A reference bile-duct bile proteome was established in the control group without signs of inflammation or maligancy comprising a total of 379 non-redundant biliary proteins; 21% were of unknown function and 24% had been previously described in serum. In PSC patients, the biliary S100A9 expression was elevated 95-fold (p<0.005), serum protein expression was decreased, and pancreatic enzyme expression was unchanged compared to controls. The S100A9 expression was 2-fold higher in PSC patients with high disease activity than in those with low activity (p<0.05). The brush cytology specimens from the PSC patients with high disease activity showed marked inflammatory activity and leukocyte infiltration compared to the patients with low activity, which correlated with S100A9 mRNA expression (p<0.05). Conclusions: The bile-duct bile proteome is complex and its analysis might enhance the understanding of cholestatic liver disease. Biliary S100A9 levels may be a useful marker for PSC activity, and its implication in inflammation and carcinogenesis warrants further investigation.	[Reinhard, Lisa; Rupp, Christian; Riedel, Hans-Dieter; Weiss, Karl Heinz; Kloeters-Plachky, Petra; Stremmel, Wolfgang; Sauer, Peter; Gotthardt, Daniel Nils] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany; [Ruppert, Thomas] Heidelberg Univ, Ctr Mol Biol, Deptartment Prote, D-6900 Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Dept Immunol, Heidelberg, Germany; [Flechtenmacher, Christa; Schirmacher, Peter] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Reinhard, L (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany.	Daniel.Gotthardt@med.uni-heidelberg.de	Ruppert, Thomas/AAC-2467-2021; Rupp, Christian/E-7652-2019; Weiss, Karl Heinz/AAA-9117-2022	Ruppert, Thomas/0000-0001-9152-2266; Rupp, Christian/0000-0003-2808-9230; Stremmel, Wolfgang/0000-0002-8545-1753	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (Dr. Gotthardt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; DEMETRIS AJ, 1989, AM J PATHOL, V134, P741; Farid SG, 2011, PROTEOMICS, V11, P2134, DOI 10.1002/pmic.201000653; Farina A, 2011, J PROTEOME RES, V10, P2047, DOI 10.1021/pr200011b; Farina A, 2009, J PROTEOME RES, V8, P159, DOI 10.1021/pr8004925; FISHER MM, 1979, P NATL ACAD SCI USA, V76, P2008, DOI 10.1073/pnas.76.4.2008; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200; Gotthardt DN, 2010, GASTROINTEST ENDOSC, V71, P527, DOI 10.1016/j.gie.2009.10.041; Green-Church KB, 2008, MOL VIS, V14, P456; GROEN AK, 1995, GASTROENTEROLOGY, V109, P1997, DOI 10.1016/0016-5085(95)90768-8; Guerrier L, 2007, J CHROMATOGR A, V1176, P192, DOI 10.1016/j.chroma.2007.11.007; Hirschfield GM, 2009, CURR OPIN GASTROEN, V25, P175, DOI 10.1097/MOG.0b013e32832914b4; Hofmann AF, 2007, ANN HEPATOL, V6, P15, DOI 10.1016/S1665-2681(19)31949-0; HOLAN KR, 1979, GASTROENTEROLOGY, V77, P611; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Keulemans YCA, 1998, HEPATOLOGY, V28, P11, DOI 10.1002/hep.510280103; Kim WR, 2000, MAYO CLIN PROC, V75, P688; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Lankisch TO, 2010, HEPATOLOGY; LARUSSO NF, 1984, AM J PHYSIOL, V247, pG199, DOI 10.1152/ajpgi.1984.247.3.G199; Lo Sasso G, 2008, BBA-MOL CELL BIOL L, V1781, P79, DOI 10.1016/j.bbalip.2007.12.002; Mendes F, 2010, NAT REV GASTRO HEPAT, V7, P611, DOI 10.1038/nrgastro.2010.155; MULLOCK BM, 1981, TRENDS BIOCHEM SCI, V6, P188, DOI 10.1016/0968-0004(81)90069-4; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; REUBEN A, 1984, HEPATOLOGY, V4, pS46, DOI 10.1002/hep.1840040808; SAUCAN L, 1992, HEPATOLOGY, V15, P714, DOI 10.1002/hep.1840150427; Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012; Zhou H, 2005, RAPID COMMUN MASS SP, V19, P3569, DOI [10.1002/rcm.2207, 10.1007/rcm.2207]	36	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29821	10.1371/journal.pone.0029821	http://dx.doi.org/10.1371/journal.pone.0029821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253789	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700055
J	Sabatini, A; Vacca, A; Iotti, S				Sabatini, Antonio; Vacca, Alberto; Iotti, Stefano			Balanced Biochemical Reactions: A New Approach to Unify Chemical and Biochemical Thermodynamics	PLOS ONE			English	Article							ATP HYDROLYSIS; CYTOSOLIC ADP; BINDING; MUSCLE; BRAIN; PMG; PH	A novel procedure is presented which, by balancing elements and electric charge of biochemical reactions which occur at constant pH and pMg, allows assessing the thermodynamics properties of reaction Delta(r)G'(0), Delta H-r'(0), Delta S-r'(0) and the change in binding of hydrogen and magnesium ions of these reactions. This procedure of general applicability avoids the complex calculations required by the use of the Legendre transformed thermodynamic properties of formation Delta(f)G'(0), Delta H-f'(0) and Delta S-f'(0) hitherto considered an obligatory prerequisite to deal with the thermodynamics of biochemical reactions. As a consequence, the term "conditional" is proposed in substitution of "Legendre transformed" to indicate these thermodynamics properties. It is also shown that the thermodynamic potential G is fully adequate to give a criterion of spontaneous chemical change for all biochemical reactions and then that the use of the Legendre transformed G' is unnecessary. The procedure proposed can be applied to any biochemical reaction, making possible to re-unify the two worlds of chemical and biochemical thermodynamics, which so far have been treated separately.	[Sabatini, Antonio; Vacca, Alberto] Univ Florence, Dipartimento Chim, Sesto Fiorentino, Italy; [Iotti, Stefano] Univ Bologna, Dipartimento Med Interna Invecchiamento & Malatti, Bologna, Italy; [Iotti, Stefano] Natl Inst Biostruct & Biosyst, Rome, Italy	University of Florence; University of Bologna	Sabatini, A (corresponding author), Univ Florence, Dipartimento Chim, Sesto Fiorentino, Italy.	stefano.iotti@unibo.it	iotti, stefano/I-6812-2017	iotti, stefano/0000-0003-1426-6400	RFO (Ricerca Fondamentale Orientata - Oriented Fundamental Research) from the University of Bologna; MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca - Ministry of Instruction, University and Research) [2007ZT39FN]	RFO (Ricerca Fondamentale Orientata - Oriented Fundamental Research) from the University of Bologna; MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca - Ministry of Instruction, University and Research)	This work was supported by RFO (Ricerca Fondamentale Orientata - Oriented Fundamental Research) grants from the University of Bologna and PRIN (Progetti di Rilevante Interesse Nazionale - Projects of Relevant National Interest) 2007ZT39FN from MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca - Ministry of Instruction, University and Research) to SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty R. A., 2003, THERMODYNAMICS BIOCH; Alberty RA, 2003, J PHYS CHEM B, V107, P12324, DOI 10.1021/jp030576l; Alberty RA, 1998, BIOPHYS CHEM, V70, P109, DOI 10.1016/S0301-4622(97)00114-2; Alberty RA, 2002, J THEOR BIOL, V215, P491, DOI 10.1006/jtbi.2001.2516; ALBERTY RA, 1992, BIOPHYS CHEM, V43, P239, DOI 10.1016/0301-4622(92)85024-X; Alberty RA, 2001, PURE APPL CHEM, V73, P1349, DOI 10.1351/pac200173081349; Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; Iotti S, 2005, BBA-BIOENERGETICS, V1708, P164, DOI 10.1016/j.bbabio.2005.01.008; Iotti S, 2010, J PHYS CHEM B, V114, P1985, DOI 10.1021/jp903990j; Lawson RWJ, 1979, J BIOL CHEM, V254, P6528; Moss G. P., 1994, IUBMB IUPAC JOINT CO; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Schwarzenbach G., 1969, COMPLEXOMETRIC TITRA; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WYMAN J, 1974, P NATL ACAD SCI USA, V71, P3431, DOI 10.1073/pnas.71.9.3431	15	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29529	10.1371/journal.pone.0029529	http://dx.doi.org/10.1371/journal.pone.0029529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247780	Green Submitted, gold, Green Published			2022-12-25	WOS:000301355700028
J	Trinder, CJ; Brooker, RW; Davidson, H; Robinson, D				Trinder, Clare J.; Brooker, Rob W.; Davidson, Hazel; Robinson, David			A New Hammer to Crack an Old Nut: Interspecific Competitive Resource Capture by Plants Is Regulated by Nutrient Supply, Not Climate	PLOS ONE			English	Article							NICHE COMPLEMENTARITY; NITROGEN; SOIL; RESPONSES; AVAILABILITY; DEPENDENCE; PHOSPHATE; DEPLETION; DYNAMICS; BIOMASS	Although rarely acknowledged, our understanding of how competition is modulated by environmental drivers is severely hampered by our dependence on indirect measurements of outcomes, rather than the process of competition. To overcome this, we made direct measurements of plant competition for soil nitrogen (N). Using isotope pool-dilution, we examined the interactive effects of soil resource limitation and climatic severity between two common grassland species. Pool-dilution estimates the uptake of total N over a defined time period, rather than simply the uptake of N-15 label, as used in most other tracer experiments. Competitive uptake of N was determined by its available form (NO32- or NH4+). Soil N availability had a greater effect than the climatic conditions (location) under which plants grew. The results did not entirely support either of the main current theories relating the role of competition to environmental conditions. We found no evidence for Tilman's theory that competition for soil nutrients is stronger at low, compared with high nutrient levels and partial support for Grime's theory that competition for soil nutrients is greater under potentially more productive conditions. These results provide novel insights by demonstrating the dynamic nature of plant resource competition.	[Trinder, Clare J.; Davidson, Hazel; Robinson, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Brooker, Rob W.] James Hutton Inst, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute	Trinder, CJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	c.j.trinder@abdn.ac.uk	Brooker, Rob W/F-9569-2012; Robinson, David/C-2112-2009	Brooker, Rob W/0000-0002-7014-0071; Robinson, David/0000-0003-3504-5981	United Kingdom Natural Environment Research Council [NE/F004591/1]; Natural Environment Research Council [NE/F004591/1] Funding Source: researchfish; NERC [NE/F004591/1] Funding Source: UKRI	United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was funded by the United Kingdom Natural Environment Research Council [grant number NE/F004591/1](http://www.nerc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LANG ENV STAT COMP; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Ashton IW, 2008, OECOLOGIA, V156, P625, DOI 10.1007/s00442-008-1006-1; Ashton IW, 2010, ECOLOGY, V91, P3252, DOI 10.1890/09-1849.1; BARRACLOUGH D, 1991, PLANT SOIL, V131, P89, DOI 10.1007/BF00010423; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; BEDDOWS AR, 1959, J ECOL, V47, P223, DOI 10.2307/2257254; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; BROOKS PD, 1989, SOIL SCI SOC AM J, V53, P1707, DOI 10.2136/sssaj1989.03615995005300060016x; Cahill JF, 2005, J ECOL, V93, P958, DOI 10.1111/j.1365-2745.2005.01013.x; CALDWELL MM, 1985, SCIENCE, V229, P384, DOI 10.1126/science.229.4711.384; CALDWELL MM, 1987, NATURE, V327, P615, DOI 10.1038/327615a0; CALDWELL MM, 1991, FUNCT ECOL, V5, P757, DOI 10.2307/2389538; CAMPBELL BD, 1992, ECOLOGY, V73, P15, DOI 10.2307/1938717; Chave J., 2009, PRINCETON GUIDE ECOL, P264, DOI DOI 10.1515/9781400833023.264; CLARKE AL, 1968, AUST J SOIL RES, V6, P75, DOI 10.1071/SR9680075; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; Cookson WR, 2004, SOIL BIOL BIOCHEM, V36, P2097, DOI 10.1016/j.soilbio.2004.05.013; Cooper CB, 2007, ECOLOGY, V88, P864, DOI 10.1890/06-0855; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; Crawley M.J., 2007, R BOOK; DONALD C. M., 1958, Australian Journal of Agricultural Research, V9, P421, DOI 10.1071/AR9580421; Evans GC., 1972, QUANTITATIVE ANAL PL; Fotelli MN, 2002, PLANT BIOLOGY, V4, P311, DOI 10.1055/s-2002-32334; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; GRIME JP, 1973, NATURE, V244, P311, DOI 10.1038/244311a0; Grime JP., 2014, COMP PLANT ECOLOGY F; Grime JP, 2001, PLANT STRATEGIES VEG, p[67, 31]; Harper J. L., 1977, POPULATION BIOL PLAN; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hubbell Stephen P., 2001, V32, pi; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Keddy P.A., 1989, COMPETITION; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Lamb EG, 2006, ECOLOGY, V87, P1452, DOI 10.1890/0012-9658(2006)87[1452:ANRATT]2.0.CO;2; Leake J. R., 1993, P170; LINHART YB, 1988, EVOLUTION, V42, P1047, DOI 10.1111/j.1558-5646.1988.tb02523.x; MAHMOUD A, 1976, NEW PHYTOL, V77, P431, DOI 10.1111/j.1469-8137.1976.tb01532.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; Murphy DV, 2003, ADV AGRON, V79, P69, DOI 10.1016/S0065-2113(02)79002-0; Newman E. I., 1983, Encyclopedia of Plant Physiology. New Series. Volume 12C. Physiological plant ecology III. Responses to the chemical and biological environment, P679; OBRIEN TA, 1967, J APPL ECOL, V4, P513, DOI 10.2307/2401352; Quinn GP, 2003, EXPT DESIGN DATA ANA; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rees M, 1996, AM NAT, V147, P1, DOI 10.1086/285837; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; ROBINSON D, 1983, PLANT CELL ENVIRON, V6, P641; Robinson D, 2010, ANN BOT-LONDON, V106, P921, DOI 10.1093/aob/mcq186; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Scrimgeour CM., 2003, STABLE ISOTOPE ANAL; Tilman D, 1987, FUNCT ECOL, V1, P304, DOI 10.2307/2389785; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; TILMAN D, 1981, LIMNOL OCEANOGR, V26, P1020, DOI 10.4319/lo.1981.26.6.1020; TILMAN D, 1988; Violle C, 2007, FUNCT ECOL, V21, P185, DOI 10.1111/j.1365-2435.2006.01241.x; Violle C, 2009, OECOLOGIA, V160, P747, DOI 10.1007/s00442-009-1333-x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Watkins NK, 1996, SOIL BIOL BIOCHEM, V28, P471, DOI 10.1016/0038-0717(95)00189-1; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Williams G. C., 1966, P307; WONG SC, 1991, AUST J PLANT PHYSIOL, V18, P137, DOI 10.1071/PP9910137	67	18	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29413	10.1371/journal.pone.0029413	http://dx.doi.org/10.1371/journal.pone.0029413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247775	Green Published, gold			2022-12-25	WOS:000301355700023
J	Asghari, HR; Cavagnaro, TR				Asghari, Hamid R.; Cavagnaro, Timothy R.			Arbuscular Mycorrhizas Reduce Nitrogen Loss via Leaching	PLOS ONE			English	Article							TOMATO; SOIL; MUTANT; FUNGI; COLONIZATION; LYCOPERSICON; INOCULATION; TRANSPORT; NITRATE; HYPHAE	The capacity of mycorrhizal and non-mycorrhizal root systems to reduce nitrate (NO3-) and ammonium (NH4+) loss from soils via leaching was investigated in a microcosm-based study. A mycorrhiza defective tomato mutant and its mycorrhizal wildtype progenitor were used in this experiment in order to avoid the indirect effects of establishing non-mycorrhizal control treatments on soil nitrogen cycling and the wider soil biota. Mycorrhizal root systems dramatically reduced nitrate loss (almost 40 times less) via leaching, compared to their non-mycorrhizal counterparts, following a pulse application of ammonium nitrate to experimental microcosms. The capacity of AM to reduce nutrient loss via leaching has received relatively little attention, but as demonstrated here, can be significant. Taken together, these data highlight the need to consider the potential benefits of AM beyond improvements in plant nutrition alone.	[Asghari, Hamid R.] Shahrood Univ Technol, Fac Agr, Shahrood, Iran; [Cavagnaro, Timothy R.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Cavagnaro, Timothy R.] Monash Univ, Australian Ctr Biodivers, Clayton, Vic, Australia	Shahrood University of Technology; Monash University; Monash University	Asghari, HR (corresponding author), Shahrood Univ Technol, Fac Agr, Shahrood, Iran.	timothy.cavagnaro@monash.edu	Cavagnaro, Timothy/HGC-7768-2022; Asghari, Hamidreza/Z-4524-2019	Cavagnaro, Timothy/0000-0002-9922-5677	Murray Darling Basin Authority; Shahrood University of Technology of Iran; Australian Government; Monash Research Accelerator Program	Murray Darling Basin Authority; Shahrood University of Technology of Iran; Australian Government(Australian GovernmentCGIAR); Monash Research Accelerator Program	Murray Darling Basin Authority provided financial support for plant analysis. HRA was supported by Shahrood University of Technology of Iran and with an Endeavor award from the Australian Government. TRC also wishes to acknowledge the Monash Research Accelerator Program for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2008, PLANT PHYSIOL, V147, P13, DOI 10.1104/pp.108.117101; AMES RN, 1983, NEW PHYTOL, V95, P381, DOI 10.1111/j.1469-8137.1983.tb03506.x; Asghari HR, 2011, FUNCT PLANT BIOL, V38, P219, DOI 10.1071/FP10180; Asghari HR, 2005, PLANT SOIL, V275, P181, DOI 10.1007/s11104-005-1328-2; Barker SJ, 1998, PLANT J, V15, P791, DOI 10.1046/j.1365-313X.1998.00252.x; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Burger B, 2010, AUSTRAL ECOL, V35, P980, DOI 10.1111/j.1442-9993.2010.02112.x; Cavagnaro TR, 2007, MICROB ECOL, V54, P618, DOI 10.1007/s00248-007-9212-7; Cavagnaro TR, 2006, PLANT SOIL, V282, P209, DOI 10.1007/s11104-005-5847-7; Cavagnaro TR, 2008, PLANT SOIL, V304, P315, DOI 10.1007/s11104-008-9559-7; Cavagnaro TR, 2011, PLANT SOIL, V340, P327, DOI 10.1007/s11104-010-0603-z; Cavagnaro TR, 2004, NEW PHYTOL, V161, P485, DOI 10.1111/j.1469-8137.2004.00967.x; Cavagnaro TR, 2001, NEW PHYTOL, V149, P105, DOI 10.1046/j.1469-8137.2001.00001.x; Cavagnaro TR, PLANT SOIL IN PRESS; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; David-Schwartz R, 2003, MOL PLANT MICROBE IN, V16, P382, DOI 10.1094/MPMI.2003.16.5.382; Entry JA, 2007, WATER AIR SOIL POLL, V180, P283, DOI 10.1007/s11270-006-9270-3; Forster J.C., 1995, METHODS APPL SOIL MI, P79, DOI DOI 10.1016/B978-012513840-6/50023-9; Gao LL, 2006, FUNCT PLANT BIOL, V33, P289, DOI 10.1071/FP05153; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Jackson LE, 2008, ANNU REV PLANT BIOL, V59, P341, DOI 10.1146/annurev.arplant.59.032607.092932; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; JOHANSEN A, 1993, BIOL FERT SOILS, V16, P66, DOI 10.1007/BF00336518; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Lowrance R, 1997, ENVIRON MANAGE, V21, P687, DOI 10.1007/s002679900060; LOWRANCE R, 1984, BIOSCIENCE, V34, P374, DOI 10.2307/1309729; Marschner P, 2005, APPL SOIL ECOL, V28, P23, DOI 10.1016/j.apsoil.2004.06.007; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Poulsen KH, 2005, NEW PHYTOL, V168, P445, DOI 10.1111/j.1469-8137.2005.01523.x; Puckett LJ, 1999, J ENVIRON QUAL, V28, P2015, DOI 10.2134/jeq1999.00472425002800060043x; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Ruzicka DR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-75; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; van der Heijden MGA, 2010, ECOLOGY, V91, P1163, DOI 10.1890/09-0336.1	40	53	59	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					151	155	e29825	10.1371/journal.pone.0029825	http://dx.doi.org/10.1371/journal.pone.0029825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253790	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900017
J	Daly-Engel, TS; Seraphin, KD; Holland, KN; Coffey, JP; Nance, HA; Toonen, RJ; Bowen, BW				Daly-Engel, Toby S.; Seraphin, Kanesa D.; Holland, Kim N.; Coffey, John P.; Nance, Holly A.; Toonen, Robert J.; Bowen, Brian W.			Global Phylogeography with Mixed-Marker Analysis Reveals Male-Mediated Dispersal in the Endangered Scalloped Hammerhead Shark (Sphyrna lewini)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; POPULATION-STRUCTURE; REPRODUCTIVE-BIOLOGY; MICROSATELLITE LOCI; GENETIC-DIVERGENCE; BLACKTIP SHARK; SITE-FIDELITY; REEF FISH; CONSERVATION; MITOCHONDRIAL	Background: The scalloped hammerhead shark, Sphyrna lewini, is a large endangered predator with a circumglobal distribution, observed in the open ocean but linked ontogenetically to coastal embayments for parturition and juvenile development. A previous survey of maternal (mtDNA) markers demonstrated strong genetic partitioning overall (global Phi(ST) = 0.749) and significant population separations across oceans and between discontinuous continental coastlines. Methodology/Principal Findings: We surveyed the same global range with increased sample coverage (N = 403) and 13 microsatellite loci to assess the male contribution to dispersal and population structure. Biparentally inherited microsatellites reveal low or absent genetic structure across ocean basins and global genetic differentiation (F-ST = 0.035) over an order of magnitude lower than the corresponding measures for maternal mtDNA lineages (Phi(ST) = 0.749). Nuclear allelic richness and heterozygosity are high throughout the Indo-Pacific, while genetic structure is low. In contrast, allelic diversity is low while population structure is higher for populations at the ends of the range in the West Atlantic and East Pacific. Conclusions/Significance: These data are consistent with the proposed Indo-Pacific center of origin for S. lewini, and indicate that females are philopatric or adhere to coastal habitats while males facilitate gene flow across oceanic expanses. This study includes the largest sampling effort and the most molecular loci ever used to survey the complete range of a large oceanic predator, and findings emphasize the importance of incorporating mixed-marker analysis into stock assessments of threatened and endangered shark species.	[Seraphin, Kanesa D.] Univ Hawaii Manoa, Coll Educ, Honolulu, HI 96822 USA; [Holland, Kim N.; Coffey, John P.; Toonen, Robert J.; Bowen, Brian W.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Nance, Holly A.] Florida Atlantic Univ, Oceanog Inst, Harbor Branch, Ft Pierce, FL USA; [Daly-Engel, Toby S.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Hawaii System; University of Hawaii Manoa	Daly-Engel, TS (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	tengel@email.arizona.edu	Toonen, Rob/K-2891-2012; Toonen, Rob/V-6230-2019; Holland, Kim/ABH-1490-2021	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Daly-Engel, Toby/0000-0002-6471-2870	University of Hawaii; National Science Foundation (NSF) [0232016, OCE-0453167, OCE-0623678, OCE-0929031, EPS-0554657]; Zoology Department at the University of Hawaii; American Association of University Women; University of Arizona from National Institutes of Health [2 K12 GM000708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	University of Hawaii; National Science Foundation (NSF)(National Science Foundation (NSF)); Zoology Department at the University of Hawaii; American Association of University Women; University of Arizona from National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from the Ecology, Evolution and Conservation Biology (EECB) Program at the University of Hawaii, the National Science Foundation (NSF Graduate K-12 program grant to EECB No. 0232016, OCE-0453167, OCE-0623678, and OCE-0929031 to BB and RT, and EPS-0554657 to University of Hawaii), the Zoology Department at the University of Hawaii, the American Association of University Women, and by grant No. 2 K12 GM000708 to the PERT Program at the University of Arizona from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS U DUBLIN; [Anonymous], [No title captured]; Barber PH, 2006, EVOLUTION, V60, P1825; BIRKY CW, 1983, GENETICS, V103, P513; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC, 2006, J BIOGEOGR, V33, P1, DOI 10.1111/j.1365-2699.2005.01374.x; BRIGGS JC, 1992, GLOBAL ECOL BIOGEOGR, V2, P149, DOI 10.2307/2997803; Carrier JC, 2004, CRC MAR BIOL SER, P269; Chapman DD, 2004, MOL ECOL, V13, P1965, DOI 10.1111/j.1365-294X.2004.02178.x; Chapman Demian D., 2010, Endangered Species Research, V9, P221, DOI 10.3354/esr00241; Chapman DD, 2009, MOL ECOL, V18, P3500, DOI 10.1111/j.1365-294X.2009.04289.x; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Compagno L.J.V., 2005, SHARKS WORLD; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Dibattista JD, 2008, MOL ECOL, V17, P3337, DOI 10.1111/j.1365-294X.2008.03833.x; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Duncan KM, 2006, MAR ECOL PROG SER, V312, P211, DOI 10.3354/meps312211; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hazin F, 2001, ENVIRON BIOL FISH, V61, P151, DOI 10.1023/A:1011040716421; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kalinowski ST, 2009, HEREDITY, V102, P506, DOI 10.1038/hdy.2008.136; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; LACSON JM, 1995, MAR BIOL, V121, P585, DOI 10.1007/BF00349293; Larsson LC, 2009, CONSERV GENET, V10, P1255, DOI 10.1007/s10592-008-9693-z; Leuteritz T., 2008, IUCN RED LIST THREAT; Maddock MB, 1996, B MAR SCI, V58, P147; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Musick JA, 1999, AM FISH S S, V23, P1; Nance HA, 2009, MOL ECOL RESOUR, V9, P955, DOI 10.1111/j.1755-0998.2008.02510.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; *NMFS, 2003, FIN AM 1 FISH MAN PL; NMFS (National Marine Fisheries Service), 2008, FIN AM 2 CONS ATL HI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Piercy AN, 2007, MAR FRESHWATER RES, V58, P34, DOI 10.1071/MF05195; Planes S, 2002, EVOLUTION, V56, P378; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; Pratt H.L., 1990, NOAA TECHNICAL REPOR, P17; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, GENETIC DATA ANAL; White WT, 2008, J FISH BIOL, V72, P1675, DOI 10.1111/j.1095-8649.2008.01843.x; Zeh DW, 2000, BIO ESSAYS, P22	71	104	105	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					279	289	e29986	10.1371/journal.pone.0029986	http://dx.doi.org/10.1371/journal.pone.0029986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253848	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900030
J	DeLong, JP; Vasseur, DA				DeLong, John P.; Vasseur, David A.			Coexistence via Resource Partitioning Fails to Generate an Increase in Community Function	PLOS ONE			English	Article							INTERFERENCE COMPETITION; BIODIVERSITY; NICHE; PRODUCTIVITY; PRINCIPLE; RESPONSES	Classic ecological theory suggests that resource partitioning facilitates the coexistence of species by reducing inter-specific competition. A byproduct of this process is an increase in overall community function, because a greater spectrum of resources can be used. In contrast, coexistence facilitated by neutral mechanisms is not expected to increase function. We studied coexistence in laboratory microcosms of the bactivorous ciliates Paramecium aurelia and Colpidium striatum to understand the relationship between function and coexistence mechanism. We quantified population and community-level function (biomass and oxygen consumption), competitive interactions, and resource partitioning. The two ciliates partitioned their bacterial resource along a size axis, with the larger ciliate consuming larger bacteria than the smaller ciliate. Despite this, there was no gain in function at the community level for either biomass or oxygen consumption, and competitive effects were symmetrical within and between species. Because other potential coexistence mechanisms can be ruled out, it is likely that inter-specific interference competition diminished the expected gain in function generated by resource partitioning, leading to a system that appeared competitively neutral even when structured by niche partitioning. We also analyzed several previous studies where two species of protists coexisted and found that the two-species communities showed a broad range of biomass levels relative to the single-species states.	[DeLong, John P.; Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Yale University	DeLong, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA.	john.delong@yale.edu	Vasseur, David/A-2545-2013	DeLong, John/0000-0003-0558-8213; Vasseur, David/0000-0003-1706-9613	Yale University	Yale University	Funding came from Yale University start-up funds to DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; BALCIUNAS D, 1995, ECOLOGY, V76, P1327, DOI 10.2307/1940939; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COSGROVE WB, 1952, PHYSIOL ZOOL, V25, P287, DOI 10.1086/physzool.25.3.30152238; DeLong JP, 2008, OIKOS, V117, P1329, DOI 10.1111/j.0030-1299.2008.16832.x; DeLong John P., 2011, BMC Ecology, V11, P1, DOI 10.1186/1472-6785-11-1; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; FENCHEL T, 1980, MICROBIAL ECOL, V6, P1, DOI 10.1007/BF02020370; FENCHEL T, 1975, OECOLOGIA, V20, P19, DOI 10.1007/BF00364319; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Fox JW, 2001, J ANIM ECOL, V70, P80; Gause G. F., 1934, STRUGGLE EXISTENCE; Gotelli NJ, 2001, PRIMER ECOLOGY; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell Stephen P., 2001, V32, pi; Isbell FI, 2009, ECOLOGY, V90, P1821, DOI 10.1890/08-0514.1; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Jiang L, 2007, OIKOS, V116, P324, DOI 10.1111/j.2006.0030-1299.15371.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Power LD, 2009, OIKOS, V118, P1703, DOI 10.1111/j.1600-0706.2009.17585.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; TAYLOR WD, 1979, ECOLOGY, V60, P876, DOI 10.2307/1936855; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VAN OIJEN MJP, 1982, NETH J ZOOL, V32, P336, DOI 10.1163/002829681X00374; VANCE RR, 1984, ECOLOGY, V65, P1349, DOI 10.2307/1939115; VANDERMEER J, 1981, BIOSCIENCE, V31, P361, DOI 10.2307/1308400; VANDERMEER JH, 1969, ECOLOGY, V50, P362, DOI 10.2307/1933884	38	17	17	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					406	411	e30081	10.1371/journal.pone.0030081	http://dx.doi.org/10.1371/journal.pone.0030081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253888	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900041
J	Reynolds, JM; Paciga, SA; Sanders, FA; Hyde, CL; Loomis, AK; Johnston, GI				Reynolds, Jennifer M.; Paciga, Sara A.; Sanders, Frances A.; Hyde, Craig L.; Loomis, A. Katrina; Johnston, Geoffrey I.			Sequence Analysis of the IL28A/IL28B Inverted Gene Duplication That Contains Polymorphisms Associated with Treatment Response in Hepatitis C Patients	PLOS ONE			English	Article							HCV INFECTION; IL28B; CLEARANCE; THERAPY	Several SNPs located in or around the IL28B gene are associated with response of patients infected with Hepatitis C virus to treatment with pegylated interferon-alpha +/- ribavirin or with spontaneous clearance of the virus. The results of such studies are so compelling that future treatment approaches are likely to involve clinical decisions being made on the basis of a patient's genotype. Since IL28B is a paralogue of IL28A with greater than 95% sequence identity, it is possible that without genotyping assay specificity, sequences in IL28A may contribute to genotype identification, and potentially confound treatment decisions. This study aimed to 1) examine DNA sequences in IL28B surrounding each of the reported associated SNPs and the corresponding regions in IL28A; and 2) develop a robust assay for rs12979860, the most 'cosmopolitan' SNP most strongly associated with treatment response across all global populations studied to date. Bioinformatic analysis of genomic regions surrounding IL28A and IL28B demonstrated that 3 SNPs were unique to IL28B, whereas the remaining 6 SNP regions shared >93% identity between IL28A and IL28B. Using a panel of DNA samples, PCR amplification followed by Sanger sequencing was used to examine IL28B SNPs and the corresponding regions in IL28A. For the overlapping SNPs, all 6 in IL28B were confirmed to be polymorphic whereas the corresponding positions in IL28A were monomorphic. Based upon IL28A and IL28B sequence data, a specific Taq Man assay was developed for SNP rs12979860 that was 100% concordant to the sequence-derived genotypes. Analysis using a commercial assay identified one discordant result which led to a change in their genotype-calling algorithm. Where future treatment decisions are made upon the results of genotyping assays, it is very important that results are concordant with data from a sequence-based format. This is especially so in situations where designing specific PCR primers is a challenge.	[Reynolds, Jennifer M.] Pfizer Global Res & Dev, DNA & BioFluids Res Ctr Emphasis, Groton, CT 06340 USA; [Paciga, Sara A.; Loomis, A. Katrina] Pfizer Global Res & Dev, Precis Med, Groton, CT USA; [Sanders, Frances A.; Johnston, Geoffrey I.] Pfizer Global Res & Dev, Precis Med, Sandwich, Kent, England; [Hyde, Craig L.] Pfizer Global Res & Dev, Biostat, Groton, CT USA	Pfizer; Pfizer; Pfizer; Pfizer	Reynolds, JM (corresponding author), Pfizer Global Res & Dev, DNA & BioFluids Res Ctr Emphasis, Groton, CT 06340 USA.	Geoff.Johnston@astrazeneca.com	Johnston, Geoffrey/AAB-5278-2022		Pfizer Inc.	Pfizer Inc.(Pfizer)	All authors are employees of Pfizer Inc., who funded this work. Through the authors' employment at Pfizer, the funders (Pfizer Inc.) had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Enserink M, 2011, SCIENCE, V332, P159, DOI 10.1126/science.332.6026.159; Fonseca-Coronado S, 2011, J CLIN MICROBIOL, V49, P2706, DOI 10.1128/JCM.00877-11; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Knapp S, 2011, GASTROENTEROLOGY, V141, P320, DOI 10.1053/j.gastro.2011.04.005; Nguyen CM, 2011, PLOS CURR       0108; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008	16	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					271	278	e29983	10.1371/journal.pone.0029983	http://dx.doi.org/10.1371/journal.pone.0029983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253847	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900029
J	Cafiso, V; Bertuccio, T; Spina, D; Purrello, S; Campanile, F; Di Pietro, C; Purrello, M; Stefani, S				Cafiso, Viviana; Bertuccio, Taschia; Spina, Daniela; Purrello, Simona; Campanile, Floriana; Di Pietro, Cinzia; Purrello, Michele; Stefani, Stefania			Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; REDUCED SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; INTERMEDIATE RESISTANCE; D-ALANINE; AGR; METHICILLIN; MPRF; METABOLISM; DLTABCD	Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant Staphylococcus aureus) infections, but their widespread use has led to vancomycin-reduced susceptibility [heterogeneous Vancomycin-Intermediate-Staphylococcus aureus (hVISA) and Vancomycin-Intermediate-Staphylococcus aureus (VISA)], in which different genetic loci (regulatory, autolytic, cell-wall turnover and cell-envelope positive charge genes) are involved. In addition, reduced susceptibility to vancomycin can influence the development of resistance to daptomycin. Although the phenotypic and molecular changes of hVISA/VISA have been the focus of different papers, the molecular mechanisms responsible for these different phenotypes and for the vancomycin and daptomycin cross-resistance are not clearly understood. The aim of our study was to investigate, by real time RT-PCR, the relative quantitative expression of genes involved in autolysis (atl-lytM), cell-wall turnover (sceD), membrane charges (mprF-dltA) and regulatory mechanisms (agr-locus-graRS-walKR), in hVISA and VISA cultured with or without vancomycin and daptomycin, in order to better understand the molecular basis of vancomycin-reduced susceptibility and the modulating activity of vancomycin and daptomycin on the expression of genes implicated in their reduced susceptibility mechanisms. Our results show that hVISA and VISA present common features that distinguish them from Vancomycin-Susceptible Staphylococcus aureus (VSSA), responsible for the intermediate glycopeptide resistance i.e. an increased cell-wall turnover, an increased positive cell-wall charge responsible for a repulsion mechanism towards vancomycin and daptomycin, and reduced agr-functionality. Indeed, VISA emerges from hVISA when VISA acquires a reduced autolysis caused by a down-regulation of autolysin genes, atl/lytM, and a reduction of the net negative cell-envelope charge via dltA over-expression. Vancomycin and daptomycin, acting in a similar manner in hVISA and VISA, can influence their cross-resistance mechanisms promoting VISA behavior in hVISA and enhancing the cell-wall pathways responsible for the intermediate vancomycin resistance in VISA. Daptomycin can also induce a charge repulsion mechanism both in hVISA and VISA increasing the activity of the mprF.	[Cafiso, Viviana; Bertuccio, Taschia; Spina, Daniela; Purrello, Simona; Campanile, Floriana; Stefani, Stefania] Univ Catania, Microbiol Unit, Dept Biomed Sci, Catania, Italy; [Di Pietro, Cinzia; Purrello, Michele] Dept Gian Filippo Ingrassia, Unit Genome & Mol Complex Syst BioMed G Sichel, Catania, Italy	University of Catania	Cafiso, V (corresponding author), Univ Catania, Microbiol Unit, Dept Biomed Sci, Catania, Italy.	stefanis@unict.it	Stefani, Stefania/K-8075-2016	Stefani, Stefania/0000-0003-1594-7427; Cafiso, Viviana/0000-0002-0785-7934; DI PIETRO, Cinzia Santa/0000-0002-6036-4469; Purrello, Simona Maria/0000-0002-3575-7447; CAMPANILE, Floriana Rosa Maria/0000-0002-8405-5425	Italian Minister of Health (MIUR) [20087SM5HM]	Italian Minister of Health (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was funded by grants from the Italian Minister of Health (MIUR PRIN 20087SM5HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boyle-Vavra S, 2001, J ANTIMICROB CHEMOTH, V48, P617, DOI 10.1093/jac/48.5.617; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Campanile F, 2009, ANN CLIN MICROB ANTI, P8; Campanile F, 2010, INT J ANTIMICROB AG, V36, P415, DOI 10.1016/j.ijantimicag.2010.06.044; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Drummelsmith J, 2007, J PROTEOME RES, V6, P4690, DOI 10.1021/pr070521m; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; ELEK SD, 1950, J PATHOL BACTERIOL, V62, P541, DOI 10.1002/path.1700620405; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P315, DOI 10.1093/jac/42.3.315; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73.8.4793-4802.2005; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Rubio A, 2011, ANTIMICROB AGENTS CH, V55, P364, DOI 10.1128/AAC.00429-10; Ruzin A, 2003, BBA-GEN SUBJECTS, V1621, P117, DOI 10.1016/S0304-4165(03)00028-X; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Sakoulas G, 2006, CLIN INFECT DIS, V42, pS40, DOI 10.1086/491713; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Shoji M, 2011, ANTIMICROB AGENTS CH, V55, P3870, DOI 10.1128/AAC.01563-10; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Stefani S, 2009, DIAGN MICR INFEC DIS, V63, P100, DOI 10.1016/j.diagmicrobio.2008.09.012; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Utaida S, 2006, ANTIMICROB AGENTS CH, V50, P1541, DOI 10.1128/AAC.50.4.1541-1545.2006; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WADSTROEM T, 1970, Biochemical Journal, V120, P725; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08	52	56	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29573	10.1371/journal.pone.0029573	http://dx.doi.org/10.1371/journal.pone.0029573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253738	Green Submitted, Green Published, gold			2022-12-25	WOS:000301352400004
J	Dupont, S; Moya, A; Bailly, X				Dupont, Sam; Moya, Aurelie; Bailly, Xavier			Stable Photosymbiotic Relationship under CO2-Induced Acidification in the Acoel Worm Symsagittifera Roscoffensis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBON-DIOXIDE; CALCIFICATION; SEAWATER; DISSOCIATION; TEMPERATURE; TOLERANCE; SYMBIONTS; CONSTANTS; PATTERNS	As a consequence of anthropogenic CO2 emissions, oceans are becoming more acidic, a phenomenon known as ocean acidification. Many marine species predicted to be sensitive to this stressor are photosymbiotic, including corals and foraminifera. However, the direct impact of ocean acidification on the relationship between the photosynthetic and nonphotosynthetic organism remains unclear and is complicated by other physiological processes known to be sensitive to ocean acidification (e. g. calcification and feeding). We have studied the impact of extreme pH decrease/pCO(2) increase on the complete life cycle of the photosymbiotic, non-calcifying and pure autotrophic acoel worm, Symsagittifera roscoffensis. Our results show that this species is resistant to high pCO(2) with no negative or even positive effects on fitness (survival, growth, fertility) and/or photosymbiotic relationship till pCO(2) up to 54 K mu atm. Some sub-lethal bleaching is only observed at pCO(2) up to 270 K mu atm when seawater is saturated by CO2. This indicates that photosymbiosis can be resistant to high pCO(2). If such a finding would be confirmed in other photosymbiotic species, we could then hypothesize that negative impact of high pCO(2) observed on other photosymbiotic species such as corals and foraminifera could occur through indirect impacts at other levels (calcification, feeding).	[Dupont, Sam] Univ Gothenburg, Dept Marine Ecol, Fiskebackskil, Sweden; [Moya, Aurelie] INSU CNRS, Villefranche Sur Mer, France; [Moya, Aurelie] Univ Paris 06, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Moya, Aurelie] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bailly, Xavier] Univ Paris 06, CNRS, FR2424, Stn Biol Roscoff, Roscoff, France	University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; James Cook University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Dupont, S (corresponding author), Univ Gothenburg, Dept Marine Ecol, Fiskebackskil, Sweden.	sam.dupont@marecol.gu.se	Dupont, Sam T/F-5527-2013; Moya, Aurelie/E-9948-2011	Moya, Aurelie/0000-0002-8776-4710	Swedish Research Council VR; Swedish Research Council Formas; European Community [211384]; European Commission [265847]	Swedish Research Council VR(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was performed thanks to an ASSEMBLE grant to SD and within the Linnaeus Centre for Marine Evolutionary Biology at the University of Gothenburg (http://www.cemeb.science.gu.se/), and supported by a Linnaeus-grant from the Swedish Research Councils VR and Formas. This paper is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384 and the "Sub-seabed carbon storage and the marine environment" (ECO2) a Collaborative Project funded under the European Commission's Framework Seven Programme Topic OCEAN.2010.3, project number 265847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baguna J, CHIMERIC SYMSA UNPUB; Barnes R.S.K., 2001, INVERTEBRATES SYNTHE; BOYLE JE, 1975, PROC R SOC SER B-BIO, V189, P121, DOI 10.1098/rspb.1975.0046; Brownlee C, 2009, P NATL ACAD SCI USA, V106, P16541, DOI 10.1073/pnas.0909140106; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Dickson A., 2007, PICES SPEC PUBL; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DOONAN SA, 1982, MAR ECOL PROG SER, V8, P69, DOI 10.3354/meps008069; Drzewina A., 1924, CR Acad Sci Paris, V178, P876; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; DUPONT S, 2009, CIESM WORKSHOP MONOG, V36, P89; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Galgani I, 1996, MAR BIOL, V279, P1; Gattuso JP, 2000, LIMNOL OCEANOGR, V45, P246, DOI 10.4319/lo.2000.45.1.0246; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Leandro SM, 2006, MAR ECOL PROG SER, V322, P189, DOI 10.3354/meps322189; Lee DL, 1975, S SOC EXP BIOL, V29, P205; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Merle P-L, 2010, CNIDARIAN DINOFLAGEL, P145; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Portner HO, 2010, GUIDE BEST PRACTICES; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; Thomsen J, 2010, BIOGEOSCIENCES DISCU, V7, P5119, DOI DOI 10.5194/BGD-7-5119-2010; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	46	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29568	10.1371/journal.pone.0029568	http://dx.doi.org/10.1371/journal.pone.0029568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253736	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000315865800011
J	Ling, Y; Zhang, CY; Chen, T; Hao, HQ; Liu, P; Bressan, RA; Hasegawa, PM; Jin, JB; Lin, JX				Ling, Yu; Zhang, Chunyu; Chen, Tong; Hao, Huaiqing; Liu, Peng; Bressan, Ray A.; Hasegawa, Paul M.; Jin, Jing Bo; Lin, Jinxing			Mutation in SUMO E3 ligase, SIZ1, Disrupts the Mature Female Gametophyte in Arabidopsis	PLOS ONE			English	Article							POLLEN-TUBE GUIDANCE; SALICYLIC-ACID; TRANSCRIPTIONAL REPRESSION; HISTONE METHYLATION; SYNERGID CELL; PIAS PROTEINS; ABSCISIC-ACID; SUMOYLATION; GROWTH; THALIANA	Female gametophyte is the multicellular haploid structure that can produce embryo and endosperm after fertilization, which has become an attractive model system for investigating molecular mechanisms in nuclei migration, cell specification, cell-to-cell communication and many other processes. Previous reports found that the small ubiquitin-like modifier (SUMO) E3 ligase, SIZ1, participated in many processes depending on particular target substrates and suppression of salicylic acid (SA) accumulation. Here, we report that SIZ1 mediates the reproductive process. SIZ1 showed enhanced expression in female organs, but was not detected in the anther or pollen. A defect in the siz1-2 maternal source resulted in reduced seed-set regardless of high SA concentration within the plant. Moreover, aniline blue staining and scanning electron microscopy revealed that funicular and micropylar pollen tube guidance was arrested in siz1-2 plants. Some of the embryo sacs of ovules in siz1-2 were also disrupted quickly after stage FG7. There was no significant affects of the siz1-2 mutation on expression of genes involved in female gametophyte development-or pollen tube guidance in ovaries. Together, our results suggest that SIZ1 sustains the stability and normal function of the mature female gametophyte which is necessary for pollen tube guidance.	[Ling, Yu; Zhang, Chunyu; Chen, Tong; Hao, Huaiqing; Liu, Peng; Jin, Jing Bo; Lin, Jinxing] Chinese Acad Sci, Key Lab Plant Mol Physiol, Inst Bot, Beijing, Peoples R China; [Ling, Yu; Zhang, Chunyu; Liu, Peng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Bressan, Ray A.; Hasegawa, Paul M.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Bressan, Ray A.] King Abdullah Univ Sci & Technol, Plant Stress Genom Ctr, Thuwal, Saudi Arabia; [Bressan, Ray A.] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Bressan, Ray A.] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus; King Abdullah University of Science & Technology; King Abdulaziz University; Gyeongsang National University	Jin, JB (corresponding author), Chinese Acad Sci, Key Lab Plant Mol Physiol, Inst Bot, Beijing, Peoples R China.	jinjb@ibcas.ac.cn; linjx@ibcas.ac.cn	Zhang, Chun-yu/HDP-5776-2022; Chen, Tong/C-5684-2014	Chen, Tong/0000-0002-2456-7170; Lin, Jinxing/0000-0001-9338-1356; Bressan, Ray/0000-0002-8754-606X; Ling, Yu/0000-0002-8067-523X; Liu, Peng/0000-0002-1667-6617	Knowledge Innovation Program of the Chinese Academy of Sciences [KJCX2-YW-L08]; Major Research Plan of the National Natural Science Foundation of China [90817010, 90917012]; National Natural Science Foundation of China [30821007]; CAS/SAFEA International Partnership Program for Creative Research Teams [20090491019]; National Basic Research Program of China [2011CB944601]; Natural Science Foundation of China [31000092]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KJCX2-YW-L08), Major Research Plan of the National Natural Science Foundation of China (No. 90817010 and No. 90917012), the National Natural Science Foundation of China (30821007), the CAS/SAFEA International Partnership Program for Creative Research Teams (No. 20090491019), the National Basic Research Program of China (2011CB944601) and the Natural Science Foundation of China (31000092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenta-Medina A, 2011, SEX PLANT REPROD, V24, P137, DOI 10.1007/s00497-011-0166-z; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Chen YH, 2007, PLANT CELL, V19, P3563, DOI 10.1105/tpc.107.053967; Cheong MS, 2009, PLANT PHYSIOL, V151, P1930, DOI 10.1104/pp.109.143719; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 2003, CURR OPIN PLANT BIOL, V6, P36, DOI 10.1016/S1369-5266(02)00010-9; Huang LX, 2009, PLANT J, V60, P666, DOI 10.1111/j.1365-313X.2009.03992.x; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Ishida T, 2009, PLANT CELL, V21, P2284, DOI 10.1105/tpc.109.068072; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Li N, 2009, PLANT PHYSIOL, V151, P1486, DOI 10.1104/pp.109.142414; Lyst MJ, 2006, EMBO J, V25, P5317, DOI 10.1038/sj.emboj.7601404; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2010, PLANT CELL PHYSIOL, V51, P103, DOI 10.1093/pcp/pcp171; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Shimizu KK, 2008, PLANT CELL PHYSIOL, V49, P1478, DOI 10.1093/pcp/pcn130; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Srilunchang KO, 2010, DEVELOPMENT, V137, P333, DOI 10.1242/dev.035964; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Yoo CY, 2006, PLANT PHYSIOL, V142, P1548, DOI 10.1104/pp.106.088831	44	21	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29470	10.1371/journal.pone.0029470	http://dx.doi.org/10.1371/journal.pone.0029470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253727	Green Submitted, gold, Green Published			2022-12-25	WOS:000315865800009
J	van Zonneveld, M; Scheldeman, X; Escribano, P; Viruel, MA; Van Damme, P; Garcia, W; Tapia, C; Romero, J; Siguenas, M; Hormaza, JI				van Zonneveld, Maarten; Scheldeman, Xavier; Escribano, Pilar; Viruel, Maria A.; Van Damme, Patrick; Garcia, Willman; Tapia, Cesar; Romero, Jose; Siguenas, Manuel; Hormaza, Jose I.			Mapping Genetic Diversity of Cherimoya (Annona cherimola Mill.): Application of Spatial Analysis for Conservation and Use of Plant Genetic Resources	PLOS ONE			English	Article							GERMPLASM COLLECTION; POPULATION-STRUCTURE; LANDSCAPE GENETICS; CLIMATE-CHANGE; SAMPLE-SIZE; SEED BANKS; MARKERS; TREE; AGROBIODIVERSITY; PREDICTION	There is a growing call for inventories that evaluate geographic patterns in diversity of plant genetic resources maintained on farm and in species' natural populations in order to enhance their use and conservation. Such evaluations are relevant for useful tropical and subtropical tree species, as many of these species are still undomesticated, or in incipient stages of domestication and local populations can offer yet-unknown traits of high value to further domestication. For many outcrossing species, such as most trees, inbreeding depression can be an issue, and genetic diversity is important to sustain local production. Diversity is also crucial for species to adapt to environmental changes. This paper explores the possibilities of incorporating molecular marker data into Geographic Information Systems (GIS) to allow visualization and better understanding of spatial patterns of genetic diversity as a key input to optimize conservation and use of plant genetic resources, based on a case study of cherimoya (Annona cherimola Mill.), a Neotropical fruit tree species. We present spatial analyses to (1) improve the understanding of spatial distribution of genetic diversity of cherimoya natural stands and cultivated trees in Ecuador, Bolivia and Peru based on microsatellite molecular markers (SSRs); and (2) formulate optimal conservation strategies by revealing priority areas for in situ conservation, and identifying existing diversity gaps in ex situ collections. We found high levels of allelic richness, locally common alleles and expected heterozygosity in cherimoya's putative centre of origin, southern Ecuador and northern Peru, whereas levels of diversity in southern Peru and especially in Bolivia were significantly lower. The application of GIS on a large microsatellite dataset allows a more detailed prioritization of areas for in situ conservation and targeted collection across the Andean distribution range of cherimoya than previous studies could do, i.e. at province and department level in Ecuador and Peru, respectively.	[van Zonneveld, Maarten; Scheldeman, Xavier] Biovers Int, Reg Off Amer, Cali, Colombia; [van Zonneveld, Maarten; Van Damme, Patrick] Univ Ghent, Fac Biosci Engn, B-9000 Ghent, Belgium; [Escribano, Pilar; Viruel, Maria A.; Hormaza, Jose I.] CSIC, UMA, IHSM, Estn Expt La Mayora, Malaga, Spain; [Van Damme, Patrick] World Agroforestry Ctr ICRAF, Domesticat GRP1, Nairobi, Kenya; [Garcia, Willman] PROINPA, Oficina Reg Valle Norte, Cochabamba, Bolivia; [Tapia, Cesar] Inst Nacl Autonomo Invest Agr INIAP, Quito, Ecuador; [Romero, Jose] NCI, Loja, Ecuador; [Siguenas, Manuel] INIA, Lima, Peru	Alliance; Bioversity International; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); CGIAR; World Agroforestry (ICRAF)	van Zonneveld, M (corresponding author), Biovers Int, Reg Off Amer, Cali, Colombia.	mvanzonneveld@cgiar.org	Van Damme, Patrick/H-6693-2018; Scheldeman, Xavier/ABE-9909-2021; Hormaza, Jose/D-8066-2011; Scheldeman, Xavier/AAF-7960-2021; , Patrick/AAI-8779-2020; Escribano, Pilar/M-2387-2014; Viruel, Maria Angeles/M-8312-2014	Van Damme, Patrick/0000-0002-2548-633X; Scheldeman, Xavier/0000-0001-7967-7361; Hormaza, Jose/0000-0001-5449-7444; Escribano, Pilar/0000-0001-6254-4570; Viruel, Maria Angeles/0000-0002-5684-2536; tapia, cesar/0000-0002-9844-4595	European Commission [015100]; Spanish Ministry of Education [AGL2010-15140]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain [RF2009-00010]; Junta de Andalucia [FEDER AGR2742]; INIA-Spain	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education(Spanish Government); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain; Junta de Andalucia(Junta de Andalucia); INIA-Spain(Instituto de Investigacion Agropecuaria (INIA))	This study has been carried out within the context of the CHERLA project funded by the International Cooperation with Developing Countries (INCO-DEV) Sixth Framework Programme (Contract 015100) of the European Commission. Additional financial support was provided by the Spanish Ministry of Education (Project Grants AGL2010-15140), the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain (RF2009-00010), Junta de Andalucia (FEDER AGR2742) and by the INIA-Spain financed project 'Strengthening Regional Collaboration in Conservation and Sustainable Use of Forest Genetic Resources in Latin America and Sub-Saharan Africa.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bonavia D, 2004, ECON BOT, V58, P509, DOI 10.1663/0013-0001(2004)058[0509:AEOCAC]2.0.CO;2; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chapman AD., 2005, PRINCIPLES METHODS D; CHERLA, 2008, INV CURR SIT GERMPL; Cornelius J. P., 2006, Forests, Trees and Livelihoods, V16, P17; Damme P. van, 1999, Unasylva (English ed.), V50, P43; Dawson IK, 2011, AGROFOREST SYST, V81, P67, DOI 10.1007/s10457-010-9302-2; Dawson IK, 2009, BIODIVERS CONSERV, V18, P969, DOI 10.1007/s10531-008-9516-z; Degen B., 1998, Forest Genetics, V5, P191; Eaton D, 2006, 200605 CGNDLO FDN; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Escribano P, 2008, ANN APPL BIOL, V153, P25, DOI 10.1111/j.1744-7348.2008.00232.x; Escribano P, 2008, MOL ECOL RESOUR, V8, P317, DOI 10.1111/j.1471-8286.2007.01941.x; Escribano P, 2007, J AM SOC HORTIC SCI, V132, P357, DOI 10.21273/JASHS.132.3.357; Escribano P, 2004, MOL ECOL NOTES, V4, P746, DOI 10.1111/j.1471-8286.2004.00809.x; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, 2 GLOB PLAN ACT PLAN; FAO, 2010, 2 FAO; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRANKEL OH, 1995, CONSERVATION PLANT B, P79; Frankel OH, 1995, CONSERVATION PLANT B; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Guarino L., 2002, P387, DOI 10.1079/9780851995229.0387; Guzman VL, 1951, INFORME VIAJE EXPLOR; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2001, AM J BOT, V88, P2101, DOI 10.2307/3558435; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hoffmann MH, 2003, MOL ECOL, V12, P1007, DOI 10.1046/j.1365-294X.2003.01791.x; Holderegger R, 2010, TRENDS PLANT SCI, V15, P675, DOI 10.1016/j.tplants.2010.09.002; Jarvis A, 2003, CROP SCI, V43, P1100, DOI 10.2135/cropsci2003.1100; Jarvis A, 2010, J NAT CONSERV, V18, P180, DOI 10.1016/j.jnc.2009.08.003; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kiambi DK, 2008, AFR J BIOTECHNOL, V7, P1446; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leeuwen J. van, 2005, Agrociencia (Montevideo), V9, P61; Lora J, 2010, ANN BOT-LONDON, V105, P221, DOI 10.1093/aob/mcp276; Lora J, 2011, P NATL ACAD SCI USA, V108, P5461, DOI 10.1073/pnas.1014514108; Lowe A, 2004, ECOLOGICAL GENETICS, P50; Lowe AJ, 2000, MOL ECOL, V9, P831, DOI 10.1046/j.1365-294x.2000.00936.x; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Mercer KL, 2010, EVOL APPL, V3, P480, DOI 10.1111/j.1752-4571.2010.00137.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palmberg-Lerche C, 2008, J TROP FOR SCI, V20, P300; PASCUAL L, 1993, HORTSCIENCE, V28, P845, DOI 10.21273/HORTSCI.28.8.845; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perfectti F, 2005, GENET RESOUR CROP EV, V52, P959, DOI 10.1007/s10722-003-6093-6; Perfectti F, 1998, FRUIT VARIETIES J, V52, P53; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Popenoe H, 1989, LOST CROPS INCAS LIT, P228; Popenoe W, 1921, J HERED, V12, P331, DOI 10.1093/oxfordjournals.jhered.a102116; Pozorski Thomas, 1997, Journal of Ethnobiology, V17, P235; Pritchard JK, 2000, GENETICS, V155, P945; Raebild A, 2011, NEW FOREST, V41, P297, DOI 10.1007/s11056-010-9237-5; Rajora OP, 2001, EUPHYTICA, V118, P197, DOI 10.1023/A:1004150525384; Scheldeman X, 2007, BIODIVERS CONSERV, V16, P1867, DOI 10.1007/s10531-006-9086-x; Scheldeman X, 2003, ACTA HORTIC, P97, DOI 10.17660/ActaHortic.2003.598.14; Scheldeman X., 2010, TRAINING MANUAL SPAT; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tapia ME, 2000, MT RES DEV, V20, P220, DOI 10.1659/0276-4741(2000)020[0220:MAIP]2.0.CO;2; Van Damme V, 2011, MOL BREEDING, V28, P597, DOI 10.1007/s11032-010-9512-3; van Etten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012060; Vanhove W, 2009, ACTA HORTIC, V806, P497; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Viruel MA, 2004, THEOR APPL GENET, V108, P896, DOI 10.1007/s00122-003-1497-4; Willemen L, 2007, GENET RESOUR CROP EV, V54, P1599, DOI 10.1007/s10722-006-9172-7	76	64	66	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29845	10.1371/journal.pone.0029845	http://dx.doi.org/10.1371/journal.pone.0029845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048GV	22253801	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000311900100001
J	Xu, L; Wang, YX; Wang, S; Jonas, JB				Xu, Liang; Wang, Ya X.; Wang, Shuang; Jonas, Jost B.			Neuroretinal Rim Area and Body Mass Index	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; OCULAR BLOOD-FLOW; LAMINA-CRIBROSA; INTRAOCULAR-PRESSURE; RISK-FACTORS; CHINA; PROGRESSION; POPULATION; PREVALENCE	Purpose: To examine associations between neuroretinal rim area, pressure related factors and anthropometric parameters in a population-based setting. Methods: The population-based cross-sectional Beijing Eye Study 2006 included 3251 subjects with an age of 45+ years. The participants underwent a detailed ophthalmic examination. Exclusion criteria for our study were high myopia of more than -8 diopters and angle-closure glaucoma. Results: The study included 2917 subjects with a mean age of 59.8 +/- 9.8 years (range: 45-89 years). Mean neuroretinal rim area was 1.97 +/- 0.38 mm(2), mean intraocular pressure 15.6 +/- 3.0 mmHg, mean diastolic blood pressure 79.0 +/- 5.9 mm Hg, mean systolic blood pressure 133.5 +/- 11.1 mmHg, and mean body mass index was 25.5 +/- 3.7. In univariate analysis, neuroretinal rim area was significantly associated with optic disc size, open-angle glaucoma, refractive error, age and gender. After adjustment for these parameters in a multivariate analysis, a larger neuroretinal rim area was significantly correlated with a higher body mass index (P<0.001), in addition to be associated with a lower intraocular pressure (P=0.004), lower mean blood pressure (P=0.02), and higher ocular perfusion pressure. Conclusions: In a general population, neuroretinal rim as equivalent of the optic nerve fibers is related to a higher body mass index, after adjustment for disc area, refractive error, age, gender, open-angle glaucoma, intraocular pressure, blood pressure and ocular perfusion pressure. Since body mass index is associated with cerebrospinal fluid pressure, the latter may be associated with neuroretinal rim area. It may serve as an indirect hint for an association between cerebrospinal fluid pressure and glaucoma.	[Xu, Liang; Wang, Ya X.; Wang, Shuang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Fac Clin Med Mannheim, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio@yahoo.cn; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Key Laboratory Fund	National Key Laboratory Fund	Supported by the National Key Laboratory Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar LM, 2010, INVEST OPHTH VIS SCI, V51, P3531, DOI 10.1167/iovs.09-4350; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Chung HS, 1999, SURV OPHTHALMOL, V43, pS43, DOI 10.1016/S0039-6257(99)00050-8; Deokule S, 2009, AM J OPHTHALMOL, V147, P736, DOI 10.1016/j.ajo.2008.10.020; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Gasser P, 1999, J GLAUCOMA, V8, P8; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; O'Leary N, 2010, ARCH OPHTHALMOL-CHIC, V128, P560, DOI 10.1001/archophthalmol.2010.52; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; See JLS, 2009, OPHTHALMOLOGY, V116, P840, DOI 10.1016/j.ophtha.2008.12.005; Tian G, 2011, GRAEFES ARCH CLIN EX; Uchida H, 1996, INVEST OPHTH VIS SCI, V37, P2393; VARMA R, 1995, ARCH OPHTHALMOL-CHIC, V113, P1001, DOI 10.1001/archopht.1995.01100080053029; Wang S, 2009, OPHTHALMOLOGY, V116, P2373, DOI 10.1016/j.ophtha.2009.05.041; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	36	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30104	10.1371/journal.pone.0030104	http://dx.doi.org/10.1371/journal.pone.0030104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253892	Green Published, Green Submitted, gold			2022-12-25	WOS:000315865800026
J	Abdul-Rahman, MF; Qiu, AQ; Woon, PS; Kuswanto, C; Collinson, SL; Sim, K				Abdul-Rahman, Muhammad Farid; Qiu, Anqi; Woon, Puay San; Kuswanto, Carissa; Collinson, Simon L.; Sim, Kang			Arcuate Fasciculus Abnormalities and Their Relationship with Psychotic Symptoms in Schizophrenia	PLOS ONE			English	Article							PLANUM TEMPORALE; AUDITORY HALLUCINATIONS; HESCHLS GYRUS; IN-VIVO; DIFFUSION; ASYMMETRY; TRACTOGRAPHY; PATHWAYS; DEFORMATION; ASSOCIATION	Disruption of fronto-temporal connections involving the arcuate fasciculus (AF) may underlie language processing anomalies and psychotic features such as auditory hallucinations in schizophrenia. No study to date has specifically investigated abnormalities of white matter integrity at particular loci along the AF as well as its regional lateralization in schizophrenia. We examined white matter changes (fractional anisotropy (FA), axial diffusivity (AD), asymmetry indices) along the whole extent of the AF and their relationship with psychotic symptoms in 32 males with schizophrenia and 44 healthy males. Large deformation diffeomorphic metric mapping and Fiber Assignment Continuous Tracking were employed to characterize FA and AD along the geometric curve of the AF. Our results showed that patients with schizophrenia had lower FA in the frontal aspects of the left AF compared with healthy controls. Greater left FA and AD lateralization in the temporal segment of AF were associated with more severe positive psychotic symptoms such as delusions and hallucinations in patients with schizophrenia. Disruption of white matter integrity of the left frontal AF and accentuation of normal left greater than right asymmetry of FA/AD in the temporal AF further support the notion of aberrant fronto-temporal connectivity in schizophrenia. AF pathology can affect corollary discharge of neural signals from frontal speech/motor initiation areas to suppress activity of auditory cortex that may influence psychotic phenomena such as auditory hallucinations and facilitate elaboration of delusional content.	[Abdul-Rahman, Muhammad Farid; Qiu, Anqi] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Woon, Puay San; Kuswanto, Carissa; Collinson, Simon L.; Sim, Kang] Inst Mental Hlth, Div Res, Singapore, Singapore; [Collinson, Simon L.] Inst Mental Hlth, Dept Psychol, Singapore, Singapore; [Sim, Kang] Natl Univ Singapore, Dept Gen Psychiat, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Collinson, Simon Lowes/HHZ-6965-2022; Kuswanto, Carissa/AAR-6230-2021; Qiu, Anqi/H-2267-2011	Collinson, Simon Lowes/0000-0001-9232-9732; Qiu, Anqi/0000-0002-0215-6338; Sim, Kang/0000-0003-3209-9626	A*STAR SERC [082-101-0025]; National University of Singapore [NUSYIA FY10 P07]; National University of Singapore MOE AcRF; National Healthcare Group SIG [NHG-SIG/05004]; A*STAR/Singapore Biomedical Imaging Consortium [SBIC RP C-009/2006]	A*STAR SERC(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); National University of Singapore MOE AcRF(Ministry of Education, SingaporeNational University of Singapore); National Healthcare Group SIG; A*STAR/Singapore Biomedical Imaging Consortium(Agency for Science Technology & Research (A*STAR))	This work was supported by A*STAR SERC 082-101-0025 (to AQ), the Young Investigator Award at National University of Singapore (NUSYIA FY10 P07, to AQ), National University of Singapore MOE AcRF Tier 1 (to AQ), National Healthcare Group SIG Grant NHG-SIG/05004 (to KS) and A*STAR/Singapore Biomedical Imaging Consortium Grant SBIC RP C-009/2006 (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1997, BRAIN RES REV, V25, P381, DOI 10.1016/S0165-0173(97)00053-2; Anderson B, 1999, NEUROPSY NEUROPSY BE, V12, P247; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bernal B, 2010, MAGN RESON IMAGING, V28, P217, DOI 10.1016/j.mri.2009.07.008; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Bleich-Cohen M, 2009, PSYCHIAT RES-NEUROIM, V171, P82, DOI 10.1016/j.pscychresns.2008.03.002; Buchsbaum MS, 2006, BIOL PSYCHIAT, V60, P1181, DOI 10.1016/j.biopsych.2005.11.028; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Chance SA, 2005, SCHIZOPHR RES, V74, P163, DOI 10.1016/j.schres.2004.09.001; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Clark GM, 2010, SCHIZOPHR RES, V120, P84, DOI 10.1016/j.schres.2009.12.032; Collinson SL, 2009, SCHIZOPHR RES, V112, P24, DOI 10.1016/j.schres.2009.03.034; Desmond JE, 2005, ANN NEUROL, V58, P553, DOI 10.1002/ana.20604; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; FIRST MB, 1994, HOSP COMMUNITY PSYCH, V45, P18; First MB, 2002, STRUCTURED CLIN INTE; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heinks-Maldonado TH, 2007, ARCH GEN PSYCHIAT, V64, P286, DOI 10.1001/archpsyc.64.3.286; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; Hof PR, 2002, NEUROCHEM RES, V27, P1193, DOI 10.1023/A:1020981510759; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; Hyatt BA, 1998, CELL, V93, P37, DOI 10.1016/S0092-8674(00)81144-7; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Konrad A, 2008, SCHIZOPHRENIA BULL, V34, P72, DOI 10.1093/schbul/sbm034; Kubicki M, 2005, CURR OPIN PSYCHIATR, V18, P121, DOI 10.1097/00001504-200503000-00004; Kubicki M, 2005, NEUROIMAGE, V26, P1109, DOI 10.1016/j.neuroimage.2005.03.026; KULYNYCH JJ, 1995, BRIT J PSYCHIAT, V166, P742, DOI 10.1192/bjp.166.6.742; Levitan C, 1999, BIOL PSYCHIAT, V46, P955, DOI 10.1016/S0006-3223(98)00373-4; Liu XM, 2005, SCHIZOPHR RES, V73, P275, DOI 10.1016/j.schres.2004.07.018; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Neckelmann G, 2006, INT J NEUROSCI, V116, P9, DOI 10.1080/00207450690962244; Oertel V, 2010, J NEUROSCI, V30, P2289, DOI 10.1523/JNEUROSCI.4575-09.2010; ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; PETTY RG, 1995, AM J PSYCHIAT, V152, P715; Phillips OR, 2009, SCHIZOPHR RES, V107, P30, DOI 10.1016/j.schres.2008.10.019; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Qiu AQ, 2007, LECT NOTES COMPUT SC, V4791, P186; Qiu AQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009811; ROSSI A, 1994, SCHIZOPHR RES, V12, P1, DOI 10.1016/0920-9964(94)90078-7; Rotarska-Jagiela A, 2009, PSYCHIAT RES-NEUROIM, V174, P9, DOI 10.1016/j.pscychresns.2009.03.002; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Shergill SS, 2000, AM J PSYCHIAT, V157, P1691, DOI 10.1176/appi.ajp.157.10.1691; Shergill SS, 2007, AM J PSYCHIAT, V164, P467, DOI 10.1176/appi.ajp.164.3.467; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sommer IEC, 2001, SCHIZOPHR RES, V52, P57, DOI 10.1016/S0920-9964(00)00180-8; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Startup M, 2008, BEHAV RES THER, V46, P1176, DOI 10.1016/j.brat.2008.07.003; Takahashi T, 2003, BIOL PSYCHIAT, V53, P593, DOI 10.1016/S0006-3223(02)01483-X; Tanskanen P, 2010, SCHIZOPHRENIA BULL, V36, P766, DOI 10.1093/schbul/sbn141; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013	70	31	33	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29315	10.1371/journal.pone.0029315	http://dx.doi.org/10.1371/journal.pone.0029315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242165	Green Submitted, Green Published, gold			2022-12-25	WOS:000312662100019
J	Huang, SY; Ouyang, NY; Lin, L; Chen, LL; Wu, W; Su, FX; Yao, YD; Yao, HR				Huang, Songyin; Ouyang, Nengyong; Lin, Ling; Chen, Lili; Wu, Wei; Su, Fengxi; Yao, Yandan; Yao, Herui			HGF-Induced PKC zeta Activation Increases Functional CXCR4 Expression in Human Breast Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; CHEMOKINE RECEPTOR CXCR4; HEPATOCYTE GROWTH-FACTOR; ENDOTHELIAL-CELLS; CARCINOMA CELLS; TUMOR INVASION; MET; RAC; METALLOPROTEINASE; PHOSPHORYLATION	The chemokine receptor CXCR4 and its ligand CXCL12 have been shown to mediate the metastasis of many malignant tumors including breast carcinoma. Interaction between hepatocyte growth factor (HGF) and the Met receptor tyrosine kinase mediates development and progression of cancers. HGF is able to induce CXCR4 expression and contributes to tumor cell invasiveness in breast carcinoma. However, the mechanism of the CXCR4 expression modulated by c-Met-HGF axis to enhance the metastatic behavior of breast cancer cells is still unclear. In this study, we found that HGF induced functional CXCR4 receptor expression in breast cancer cells. The effect of HGF was specifically mediated by PKC zeta activity. After transfection with PKC zeta-siRNA, the phosphorylation of PKC zeta and CXCR4 was abrogated in breast cancer cells. Interference with the activation of Rac1, a downstream target of HGF, prevented the HGF-induced increase in PKC zeta activity and CXCR4 levels. The HGF-induced, LY294002-sensitive translocation of PKC zeta from cytosol to plasma membrane indicated that HGF was capable of activating PKC zeta, probably via phosphoinositide (PI) 3-kinases. HGF treatment also increased MT1-MMP secretion. Inhibition of PKC zeta, Rac-1 and phosphatidylinositol 3-kinase may attenuate MT1-MMP expression in cells exposed to HGF. Functional manifestation of the effects of HGF revealed an increased ability for migration, chemotaxis and metastasis in MDA-MB-436 cells in vitro and in vivo. Our findings thus provided evidence that the process of HGF-induced functional CXCR4 expression may involve PI 3-kinase and atypical PKC zeta. Moreover, HGF may promote the invasiveness and metastasis of breast tumor xenografts in BALB/c-nu mice via the PKC zeta-mediated pathway, while suppression of PKC zeta by RNA interference may abrogate cancer cell spreading.	[Lin, Ling; Chen, Lili; Wu, Wei; Su, Fengxi; Yao, Yandan; Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Songyin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Lab, Guangzhou 510275, Guangdong, Peoples R China; [Ouyang, Nengyong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynaecol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ling] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Rheumatol, Shantou City, Guangdong, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Sun Yat Sen University	Yao, YD (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yaoherui@163.com; yyandan@126.com			National Natural Science Foundation of China [81102020, 30973505, 81172526, 81072177]; Guangdong Natural Science Foundation [S2011040000385]; Foundation of the Health Department of the Guangdong Province [A2009182, B2009067]; Science and Technology Foundation of the Guangdong Province [2009B030801005, 2009B030801080, 2008B030301092, 2008B030301238]; China Postdoctoral Science Foundation [201104379]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]; Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation of the Health Department of the Guangdong Province; Science and Technology Foundation of the Guangdong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Guangzhou Science and Technology Bureau; Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University	This work was supported by grants from the National Natural Science Foundation of China (81102020, 30973505, 81172526, 81072177), Guangdong Natural Science Foundation (S2011040000385), the Foundation of the Health Department of the Guangdong Province (A2009182, B2009067), the Science and Technology Foundation of the Guangdong Province (2009B030801005, 2009B030801080, 2008B030301092, 2008B030301238), the special financial grant from the China Postdoctoral Science Foundation (201104379), and the Foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1). This work was also supported by the Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University (KLB09001). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; Bourbon NA, 2000, J BIOL CHEM, V275, P35617, DOI 10.1074/jbc.M007346200; Busillo JM, J BIOL CHEM, V285, P7805; Chen J, CANC CELL, V19, P541; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Chianale F, P NATL ACAD SCI US, V107, P4182; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Comoglio PM, 2001, SEMIN CANCER BIOL, V11, P153, DOI 10.1006/scbi.2000.0366; Duran A, 2004, EMBO J, V23, P4595, DOI 10.1038/sj.emboj.7600468; Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679; Esencay M, J NEUROONCOL, V99, P33; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Gong C, PLOS ONE, V5; Gschwendt M, 1998, FEBS LETT, V421, P165, DOI 10.1016/S0014-5793(97)01530-5; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Jiang WG, 2006, INT J MOL MED, V17, P583; Kanazawa S, PLOS ONE, V5; Kim JI, 2008, ENDOTHELIUM-J ENDOTH, V15, P33, DOI 10.1080/10623320802092260; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; McBain VA, 2003, INVEST OPHTH VIS SCI, V44, P540, DOI 10.1167/iovs.02-0570; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagy J, 1996, SURG ONCOL, V5, P15, DOI 10.1016/S0960-7404(96)80017-X; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Ramos-Nino ME, 2008, AM J RESP CELL MOL, V38, P209, DOI 10.1165/rcmb.2007-0206OC; Ridolfi E, 2008, BRIT J CANCER, V99, P1623, DOI 10.1038/sj.bjc.6604726; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shirvaikar N, STEM CELLS DEV, V20, P19; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tu HJ, 2009, ONKOLOGIE, V32, P331, DOI 10.1159/000216352; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Tyan SW, PLOS ONE, V6; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	59	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29124	10.1371/journal.pone.0029124	http://dx.doi.org/10.1371/journal.pone.0029124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242160	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100014
J	Minozzo, FC; Hilbert, L; Rassier, DE				Minozzo, Fabio C.; Hilbert, Lennart; Rassier, Dilson E.			Pre-Power-Stroke Cross-Bridges Contribute to Force Transients during Imposed Shortening in Isolated Muscle Fibers	PLOS ONE			English	Article							NON-CROSSBRIDGE CONTRIBUTIONS; SKELETAL-MUSCLE; BLEBBISTATIN INHIBITION; TENSION RESPONSES; MYOSIN-II; STRIATED-MUSCLE; RAMP STRETCHES; ACTIVE FORCE; CONTRACTION; MECHANISM	When skeletal muscles are activated and mechanically shortened, the force that is produced by the muscle fibers decreases in two phases, marked by two changes in slope (P-1 and P-2) that happen at specific lengths (L-1 and L-2). We tested the hypothesis that these force transients are determined by the amount of myosin cross-bridges attached to actin and by changes in cross-bridge strain due to a changing fraction of cross-bridges in the pre-power-stroke state. Three separate experiments were performed, using skinned muscle fibers that were isolated and subsequently (i) activated at different Ca2+ concentrations (pCa(2+) 4.5, 5.0, 5.5, 6.0) (n = 13), (ii) activated in the presence of blebbistatin (n = 16), and (iii) activated in the presence of blebbistatin at varying velocities (n = 5). In all experiments, a ramp shortening was imposed (amplitude 10% L-o, velocity 1 L-o.sarcomere length (SL).s(-1)), from an initial SL of 2.5 mm (except by the third group, in which velocities ranged from 0.125 to 2.0 L-o.s(-1)). The values of P-1, P-2, L-1, and L-2 did not change with Ca2+ concentrations. Blebbistatin decreased P-1, and it did not alter P-2, L-1, and L-2. We developed a mathematical cross-bridge model comprising a load-dependent power-stroke transition and a pre-power-stroke cross-bridge state. The P-1 and P-2 critical points as well as the critical lengths L-1 and L-2 were explained qualitatively by the model, and the effects of blebbistatin inhibition on P-1 were also predicted. Furthermore, the results of the model suggest that the mechanism by which blebbistatin inhibits force is by interfering with the closing of the myosin upper binding cleft, biasing cross-bridges into a pre-power-stroke state.	[Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Hilbert, Lennart; Rassier, Dilson E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Hilbert, Lennart] McGill Univ, Ctr Appl Math Biosci & Med, Montreal, PQ, Canada; [Hilbert, Lennart; Rassier, Dilson E.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Phys, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Rassier, DE (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	dilson.rassier@mcgill.ca	Hilbert, Lennart/W-8195-2019; Minozzo, Fabio/D-9988-2014	Hilbert, Lennart/0000-0003-4478-5607; Minozzo, Fabio/0000-0003-0733-8744	Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds Quebecois de la Recherche Nature et Technologies (FQRNT); Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre; Studienstiftung des deutschen Volkes	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche Nature et Technologies (FQRNT); Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre; Studienstiftung des deutschen Volkes	This study was supported by the Canadian Institutes for Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). FCM is supported by the Fonds Quebecois de la Recherche Nature et Technologies (FQRNT), LH is supported by Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre, and Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; BRESSLER BH, 1985, CAN J PHYSIOL PHARM, V63, P1617, DOI 10.1139/y85-268; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; Chinn M, 2003, J MUSCLE RES CELL M, V24, P571, DOI 10.1023/B:JURE.0000009846.05582.89; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; FABIATO A, 1988, METHODS ENZYMOL, V157, P378; Farman GP, 2008, PFLUG ARCH EUR J PHY, V455, P995, DOI 10.1007/s00424-007-0375-3; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hill TL, 2004, FREE ENERGY TRANSDUC; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Koubassova NA, 2008, BIOPHYS J, V95, P2880, DOI 10.1529/biophysj.107.120832; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Minozzo FC, 2010, AM J PHYSIOL-CELL PH, V299, pC1127, DOI 10.1152/ajpcell.00073.2010; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Ranatunga KW, 2010, ADV EXP MED BIOL, V682, P207, DOI 10.1007/978-1-4419-6366-6_12; Rassier DE, 2004, J APPL PHYSIOL, V97, P1395, DOI 10.1152/japplphysiol.00377.2004; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roots H, 2007, J MUSCLE RES CELL M, V28, P123, DOI 10.1007/s10974-007-9110-0; Stewart M, 2009, J MUSCLE RES CELL M, V30, P17, DOI 10.1007/s10974-008-9162-9; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; VIETH E, 1989, J APPL PHYSIOL, V67, P390, DOI 10.1152/jappl.1989.67.1.390; Vilfan A, 2003, BIOPHYS J, V85, P818, DOI 10.1016/S0006-3495(03)74522-6	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29356	10.1371/journal.pone.0029356	http://dx.doi.org/10.1371/journal.pone.0029356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242168	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100022
J	Quaglietta, L; Martins, BH; de Jongh, A; Mira, A; Boitani, L				Quaglietta, Lorenzo; Martins, Bruno Herlander; de Jongh, Addy; Mira, Antonio; Boitani, Luigi			A Low-Cost GPS GSM/GPRS Telemetry System: Performance in Stationary Field Tests and Preliminary Data on Wild Otters (Lutra lutra)	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; DIFFERENTIAL CORRECTION; COLLAR PERFORMANCE; HABITAT SELECTION; ACCURACY; BEHAVIOR	Background: Despite the increasing worldwide use of global positioning system (GPS) telemetry in wildlife research, it has never been tested on any freshwater diving animal or in the peculiar conditions of the riparian habitat, despite this latter being one of the most important habitat types for many animal taxa. Moreover, in most cases, the GPS devices used have been commercial and expensive, limiting their use in low-budget projects. Methodology/Principal Findings: We have developed a low-cost, easily constructed GPS GSM/GPRS (Global System for Mobile Communications/General Packet Radio Service) and examined its performance in stationary tests, by assessing the influence of different habitat types, including the riparian, as well as water submersion and certain climatic and environmental variables on GPS fix-success rate and accuracy. We then tested the GPS on wild diving animals, applying it, for the first time, to an otter species (Lutra lutra). The rate of locations acquired during the stationary tests reached 63.2%, with an average location error of 8.94 m (SD = 8.55). GPS performance in riparian habitats was principally affected by water submersion and secondarily by GPS inclination and position within the riverbed. Temporal and spatial correlations of location estimates accounted for some variation in the data sets. GPS-tagged otters also provided accurate locations and an even higher GPS fix-success rate (68.2%). Conclusions/Significance: Our results suggest that GPS telemetry is reliably applicable to riparian and even diving freshwater animals. They also highlight the need, in GPS wildlife studies, for performing site-specific pilot studies on GPS functioning as well as for taking into account eventual spatial and temporal correlation of location estimates. The limited price, small dimensions, and high performance of the device presented here make it a useful and cost-effective tool for studies on otters and other aquatic or terrestrial medium-to-large-sized animals.	[Quaglietta, Lorenzo; Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Martins, Bruno Herlander] CIBIO Ctr Invest Biodiversidade & Recursos Genet, Oporto, Portugal; [de Jongh, Addy] Dutch Otterstat Fdn, Leeuwarden, Netherlands; [Mira, Antonio] Univ Evora, ICAAM Mediterranean Agr & Environm Sci Inst, Evora, Portugal	Sapienza University Rome; University of Evora	Quaglietta, L (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	lorenzo.quaglietta@uniroma1.it	Mira, Antonio/E-5715-2010; Quaglietta, Lorenzo/L-7460-2013	Mira, Antonio/0000-0001-6152-0454; Quaglietta, Lorenzo/0000-0002-9703-0171; Martins, Bruno/0000-0002-7993-7319	AM through the Fundacao Luis de Molina of University of Evoraby; Dutch Otterstation Foundation; Fundacao Luis de Molina	AM through the Fundacao Luis de Molina of University of Evoraby; Dutch Otterstation Foundation; Fundacao Luis de Molina	This work was integrated in LQ's PhD project on otter ecology and behaviour that was carried out independently (although under formal supervision of LB) in southern Portugal. A small amount of funding was provided by AM through the Fundacao Luis de Molina of University of Evoraby to help with field expenses. The Dutch Otterstation Foundation also provided a small discount on the GPS used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some of the GPS devices were partially sponsored by the Dutch Otterstation Foundation and Fundacao Luis de Molina. The aid of B. Wroblewski was indispensable in the development of the python software. We thank L. Lerone, who helped in the field tests' data collection; D. Cardador and M. Fernandes, for their cooperation concerning the wild-born otter in captivity; Tj. de Jong who helped with otter trapping, and two anonymous referees whose suggestions considerably improved the article.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Beja PR, 1996, J ZOOL, V239, P741, DOI 10.1111/j.1469-7998.1996.tb05475.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; Carmel Y, 2004, LANDSCAPE ECOL, V19, P573, DOI 10.1023/B:LAND.0000042874.94085.28; D'Eon RG, 2005, J MAMMAL, V86, P736, DOI 10.1644/1545-1542(2005)086[0736:MDSMAM]2.0.CO;2; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Durbin LS, 1998, J ZOOL, V245, P85, DOI 10.1111/j.1469-7998.1998.tb00075.x; Dussault C, 2001, WILDLIFE SOC B, V29, P171; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Green J., 1984, Lutra, V27, P85; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Heard DC, 2008, J WILDLIFE MANAGE, V72, P596, DOI 10.2193/2007-175; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hulbert IAR, 2001, J APPL ECOL, V38, P869, DOI 10.1046/j.1365-2664.2001.00624.x; Jay CV, 2002, POLAR BIOL, V25, P235, DOI 10.1007/s00300-001-0338-7; Kruuk H., 2006, OTTERS ECOLOGY BEHAV; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Mason C.F., 1986, OTTERS; Matos HM, 2009, BIODIVERS CONSERV, V18, P373, DOI 10.1007/s10531-008-9493-2; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Melquist W.E., 1979, 8 U ID FOR WILDL RAN, P8; MELQUIST WE, 1983, WILDLIFE MONOGR, P1; Mitchell-Jones A.J., 1984, Lutra, V27, P71; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Neill LO, 2008, EUR J WILDLIFE RES, V54, P681, DOI 10.1007/s10344-008-0196-5; Neill LO, 2007, J WILDLIFE MANAGE, V71, P2776, DOI 10.2193/2006-482; Pellerin M, 2008, WILDLIFE BIOL, V14, P101, DOI 10.2981/0909-6396(2008)14[101:RDCCHS]2.0.CO;2; Pinto-Correia T, 2011, AGROFOREST SYST, V82, P99, DOI 10.1007/s10457-011-9388-1; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rempel RS, 1997, J WILDLIFE MANAGE, V61, P525, DOI 10.2307/3802611; Rodgers AR, 2000, RES TECHNIQUES ANIMA, P79; Rondinini C, 2006, J ZOOL, V269, P213, DOI 10.1111/j.1469-7998.2006.00073.x; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Schwartz CC, 2009, J WILDLIFE MANAGE, V73, P1174, DOI 10.2193/2008-514; Sisak MM, 1998, MAR TECHNOL SOC J, V32, P30; Thompson W.L., 1998, MONITORING VERTEBRAT; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Trindade A, 1998, ESTUDOS BIOL CONSERV, V28; Withey J. C., 2001, RADIO TRACKING ANIMA, P45; Zschille J, 2008, EUR J WILDLIFE RES, V54, P263, DOI 10.1007/s10344-007-0139-6; Zucco CA, 2009, J WILDLIFE MANAGE, V73, P452, DOI 10.2193/2007-492; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	52	25	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29235	10.1371/journal.pone.0029235	http://dx.doi.org/10.1371/journal.pone.0029235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242163	Green Published, gold			2022-12-25	WOS:000312662100017
J	Quave, CL; Estevez-Carmona, M; Compadre, CM; Hobby, G; Hendrickson, H; Beenken, KE; Smeltzer, MS				Quave, Cassandra L.; Estevez-Carmona, Miriam; Compadre, Cesar M.; Hobby, Gerren; Hendrickson, Howard; Beenken, Karen E.; Smeltzer, Mark S.			Ellagic Acid Derivatives from Rubus ulmifolius Inhibit Staphylococcus aureus Biofilm Formation and Improve Response to Antibiotics	PLOS ONE			English	Article							MEDICINAL-PLANTS; EXTRACTS; SARA; INFECTIONS; EXPRESSION; GLYCOSIDES; HYPERICUM; PHENOTYPE; ALPHA; BARK	Background: Biofilms contribute to the pathogenesis of many forms of Staphylococcus aureus infection. Treatment of these infections is complicated by intrinsic resistance to conventional antibiotics, thus creating an urgent need for strategies that can be used for the prevention and treatment of biofilm-associated infections. Methodology/Principal Findings: This study demonstrates that a botanical natural product composition (220D-F2) rich in ellagic acid and its derivatives can limit S. aureus biofilm formation to a degree that can be correlated with increased antibiotic susceptibility. The source of this composition is Rubus ulmifolius Schott. (Rosaceae), a plant used in complementary and alternative medicine in southern Italy for the treatment of skin and soft tissue infections. All S. aureus clonal lineages tested exhibited a reduced capacity to form a biofilm at 220D-F2 concentrations ranging from 50200 mu g/mL, which were well below the concentrations required to limit bacterial growth (530-1040 mu g/mL). This limitation was therapeutically relevant in that inclusion of 220D-F2 resulted in enhanced susceptibility to the functionally-distinct antibiotics daptomycin, clindamycin and oxacillin. Testing with kidney and liver cell lines also demonstrated a lack of host cell cytotoxicity at concentrations of 220D-F2 required to achieve these effects. Conclusions/Significance: These results demonstrate that extract 220D-F2 from the root of Rubus ulmifolius can be used to inhibit S. aureus biofilm formation to a degree that can be correlated with increased antibiotic susceptibility without toxic effects on normal mammalian cells. Hence, 220D-F2 is a strong candidate for development as a botanical drug for use in the prevention and treatment of S. aureus biofilm-associated infections.	[Quave, Cassandra L.; Hobby, Gerren; Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Estevez-Carmona, Miriam; Compadre, Cesar M.; Hendrickson, Howard] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [Smeltzer, Mark S.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Little Rock, AR 72205 USA; [Estevez-Carmona, Miriam] Natl Polytech Inst, Natl Sch Biol Sci, Dept Pharm, Mexico City, DF, Mexico	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Instituto Politecnico Nacional - Mexico	Smeltzer, MS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	SmeltzerMarkS@uams.edu	Estévez, Mirian/AAD-5011-2019; Compadre, Cesar M/D-1286-2009; Quave, Cassandra/AAD-2066-2020; Smeltzer, Mark/M-2009-2018	Compadre, Cesar M/0000-0002-5652-0203; Quave, Cassandra/0000-0001-9615-7886; Estevez-Carmona, Maria Mirian/0000-0001-9945-8545; Smeltzer, Mark/0000-0002-0878-0692	F32 Fellowship from the National Center for Complementary and Alternative Medicine (NCCAM) [AT005040]; Department of the Army USAMRAA [OR090571]; Clinical and Translational Sciences Award [RR0298884]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F32AT005040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069087, R01AI074935] Funding Source: NIH RePORTER	F32 Fellowship from the National Center for Complementary and Alternative Medicine (NCCAM); Department of the Army USAMRAA; Clinical and Translational Sciences Award; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an F32 Fellowship to CQ (AT005040) from the National Center for Complementary and Alternative Medicine (NCCAM) and by a grant from the Department of the Army USAMRAA to MSS (OR090571). Support was also obtained from resources provided through the Clinical and Translational Sciences Award (RR0298884) to the University of Arkansas for Medical Sciences. The content is solely the responsibility of the authors and does not necessarily reflect the official views of NCCAM, USAMRAA, or NIH. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alviano DS, 2009, CURR PHARM BIOTECHNO, V10, P106, DOI 10.2174/138920109787048607; Atta-Ur-Rahman, 2001, PLANTA MED, V67, P335, DOI 10.1055/s-2001-14306; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Beenken KE, 2010, PLOS ONE, V5; Bodini SF, 2009, LETT APPL MICROBIOL, V49, P551, DOI 10.1111/j.1472-765X.2009.02704.x; Brause B. D, 2005, PRINCIPLES PRACTICE, P1332; Cherigo L, 2008, J NAT PROD, V71, P1037, DOI 10.1021/np800148w; COX PA, 1994, SCI AM, V270, P82, DOI 10.1038/scientificamerican0694-82; Cozza G, 2006, J MED CHEM, V49, P2363, DOI 10.1021/jm060112m; Dall'Acqua S, 2008, FOOD CHEM, V106, P745, DOI 10.1016/j.foodchem.2007.06.055; Durig A, 2010, APPL MICROBIOL BIOT, V87, P309, DOI 10.1007/s00253-010-2471-0; Elkhateeb A, 2005, PHYTOCHEMISTRY, V66, P2577, DOI 10.1016/j.phytochem.2005.08.020; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Flamini G, 2002, PHYTOCHEMISTRY, V59, P873, DOI 10.1016/S0031-9422(02)00012-2; Fulghesu L, 2007, J CHEMOTHERAPY, V19, P388, DOI 10.1179/joc.2007.19.4.388; Gibbons S, 2002, FITOTERAPIA, V73, P300, DOI 10.1016/S0367-326X(02)00082-5; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Gibbons S, 2008, PLANTA MED, V74, P594, DOI 10.1055/s-2008-1074518; Giusti ME, 2004, Times, Places, Passages: Ethnological Approaches in the New Millennium, P237; Hancock V, 2010, J MED MICROBIOL, V59, P496, DOI 10.1099/jmm.0.013680-0; Harjai K, 2010, FEMS IMMUNOL MED MIC, V58, P161, DOI 10.1111/j.1574-695X.2009.00614.x; Harro JM, 2010, FEMS IMMUNOL MED MIC, V59, P306, DOI 10.1111/j.1574-695X.2010.00708.x; Hildron AI, 2009, LANCET INFECT DIS, V9, P384; Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Huber B, 2003, Z NATURFORSCH C, V58, P879; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027; Lee JH, 2004, J AGR FOOD CHEM, V52, P361, DOI 10.1021/jf034971k; Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10; Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004; Low CF, 2008, J APPL MICROBIOL, V105, P2169, DOI 10.1111/j.1365-2672.2008.03912.x; Matthew S, 2007, NAT PROD RES, V21, P83, DOI 10.1080/14786410500441516; National Committee for Clinical Laboratory Standards (NCCLS), 1999, METH DET BACT ACT AN; *NCCLS, 2001, METH DIL ANT SUSC TE; Panizzi L, 2002, J ETHNOPHARMACOL, V79, P165, DOI 10.1016/S0378-8741(01)00363-4; Papoutsi Z, 2005, J AGR FOOD CHEM, V53, P7715, DOI 10.1021/jf0510539; Perez-Lopez FR, 2009, J OBSTET GYNAECOL RE, V35, P630, DOI 10.1111/j.1447-0756.2009.01026.x; Quave CL, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-5; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Quave CL, 2010, PLANTA MED, V76, P1; Simoes-Pires CA, 2009, NAT PROD COMMUN, V4, P1371; Smith ECJ, 2007, ANTIMICROB AGENTS CH, V51, P4480, DOI 10.1128/AAC.00216-07; Thomas JG, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P21; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x; Wang W, 2010, J NAT PROD, V73, P1815, DOI 10.1021/np1004483; Weidner-Wells MA, 1998, BIOORG MED CHEM LETT, V8, P97, DOI 10.1016/S0960-894X(97)10197-4; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; WHO, 2003, GUID GOOD AGR COLL P; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966; Wolcott R, 2011, PLAST RECONSTR SURG, V127, p28S, DOI 10.1097/PRS.0b013e3181fca244; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zafrilla P, 2001, J AGR FOOD CHEM, V49, P3651, DOI 10.1021/jf010192x; ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487; [No title captured]	60	129	134	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28737	10.1371/journal.pone.0028737	http://dx.doi.org/10.1371/journal.pone.0028737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242149	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100003
J	Rajarajan, A; Stokes, A; Bloor, BK; Ceder, R; Desai, H; Grafstrom, RC; Odell, EW				Rajarajan, Abirami; Stokes, Angela; Bloor, Balvinder K.; Ceder, Rebecca; Desai, Hemini; Grafstrom, Roland C.; Odell, Edward W.			CD44 Expression in Oro-Pharyngeal Carcinoma Tissues and Cell Lines	PLOS ONE			English	Article							VARIANT EXONS; CLINICOPATHOLOGICAL SIGNIFICANCE; PROGNOSTIC-FACTOR; HOMING RECEPTOR; SPLICE VARIANTS; GENE-EXPRESSION; HUMAN BREAST; ISOFORMS; HEAD; CANCER	Expression of CD44, a transmembrane hyaluronan-binding glycoprotein, is variably considered to have prognostic significance for different cancers, including oral squamous cell carcinoma. Although unclear at present, tissue-specific expression of particular isoforms of CD44 might underlie the different outcomes in currently available studies. We mined public transcriptomics databases for gene expression data on CD44, and analyzed normal, immortalized and tumour-derived human cell lines for splice variants of CD44 at both the transcript and protein levels. Bioinformatics readouts, from a total of more than 15,000 analyses, implied an increased CD44 expression in head and neck cancer, including increased expression levels relative to many normal and tumor tissue types. Also, meta-analysis of over 260 cell lines and over 4,000 tissue specimens of diverse origins indicated lower CD44 expression levels in cell lines compared to tissue. With minor exceptions, reverse transcribed polymerase chain reaction identified expression of the four main isoforms of CD44 in normal oral keratinocytes, transformed lines termed DT and HaCaT, and a series of paired primary and metastasis-derived cell lines from oral or pharyngeal carcinomas termed HN4/HN12, HN22/HN8 and HN30/HN31. Immunocytochemistry, Western blotting and flow cytometric assessments all confirmed the isoform expression pattern at the protein level. Overall, bioinformatic processing of large numbers of global gene expression analyses demonstrated elevated CD44 expression in head and neck cancer relative to other cancer types, and that the application of standard cell culture protocols might decrease CD44 expression. Additionally, the results show that the many variant CD44 exons are not fundamentally deregulated in a diverse range of cultured normal and transformed keratinocyte lines.	[Rajarajan, Abirami; Stokes, Angela; Bloor, Balvinder K.; Desai, Hemini; Odell, Edward W.] Kings Coll London, Dept Oral Pathol, London WC2R 2LS, England; [Ceder, Rebecca; Grafstrom, Roland C.] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden; [Grafstrom, Roland C.] VTT Tech Res Ctr Finland, Turku, Finland	University of London; King's College London; Karolinska Institutet; VTT Technical Research Center Finland	Stokes, A (corresponding author), Kings Coll London, Dept Oral Pathol, London WC2R 2LS, England.	angela.stokes@kcl.ac.uk	Grafström, Roland C/N-7217-2016; odell, edward w/E-9920-2012	odell, edward w/0000-0001-8435-0048	Guy's and St Thomas' Charitable Trust; Swedish Cancer and Allergy Fund; Swedish Research Council; Swedish Fund for Research without Animal Experiments; Karolinska Institutet	Guy's and St Thomas' Charitable Trust; Swedish Cancer and Allergy Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Fund for Research without Animal Experiments; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Guy's and St Thomas' Charitable Trust, the Swedish Cancer and Allergy Fund, the Swedish Research Council, the Swedish Fund for Research without Animal Experiments as well as research funds from the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar R, 1997, INT J ORAL MAX SURG, V26, P443, DOI 10.1016/S0901-5027(97)80010-0; Bloor BK, 2002, INT J ONCOL, V21, P907; Bloor BK, 2001, INT J ONCOL, V18, P1053; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Carinci F, 2002, J CRANIOFAC SURG, V13, P85, DOI 10.1097/00001665-200201000-00020; COLOMBATTI A, 1982, P NATL ACAD SCI-BIOL, V79, P1926, DOI 10.1073/pnas.79.6.1926; DALL P, 1995, INT J CANCER, V60, P471, DOI 10.1002/ijc.2910600408; Fonseca I, 2001, J SURG ONCOL, V76, P115, DOI 10.1002/1096-9098(200102)76:2<115::AID-JSO1021>3.0.CO;2-9; FOX SB, 1994, CANCER RES, V54, P4539; Franzmann EJ, 2001, OTOLARYNG HEAD NECK, V124, P426, DOI 10.1067/mhn.2001.114674; Gaspar RH, 1999, ANAL CELL PATHOL, V18, P183, DOI 10.1155/1999/518350; GOODFELLOW PN, 1982, EUR J IMMUNOL, V12, P659, DOI 10.1002/eji.1830120807; Gorham H, 1996, J CLIN PATHOL, V49, P482, DOI 10.1136/jcp.49.6.482; GRAFSTROM RC, 2002, CULTURE EPITHELIAL C, P195; HAGGERTY JG, 1992, J INVEST DERMATOL, V99, P374, DOI 10.1111/1523-1747.ep12616087; HAYNES BF, 1991, CANCER CELL-MON REV, V3, P347; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; Hirvikoski P, 1999, VIRCHOWS ARCH, V434, P37, DOI 10.1007/s004280050302; Hudson DL, 1996, INT J CANCER, V66, P457, DOI 10.1002/(SICI)1097-0215(19960516)66:4<457::AID-IJC8>3.0.CO;2-V; Ioachim E, 1999, HISTOL HISTOPATHOL, V14, P1113, DOI 10.14670/HH-14.1113; JALKANEN S, 1988, J IMMUNOL, V141, P1615; Kan M, 1995, Int J Urol, V2, P295; Kanke M, 2000, JPN J CANCER RES, V91, P410, DOI 10.1111/j.1349-7006.2000.tb00960.x; KAWASHIRI S, 1995, ORAL ONCOL, V31B, P216, DOI 10.1016/0964-1955(95)00027-F; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kunishi M, 1997, INT J ORAL MAX SURG, V26, P280, DOI 10.1016/S0901-5027(97)80869-7; Kuo MYP, 1998, J ORAL PATHOL MED, V27, P428; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martegani MP, 1999, AM J PATHOL, V154, P291, DOI 10.1016/S0002-9440(10)65275-3; Masuda M, 2000, HEAD NECK-J SCI SPEC, V22, P662, DOI 10.1002/1097-0347(200010)22:7<662::AID-HED4>3.0.CO;2-O; Mori S, 1998, ORAL ONCOL, V34, P549, DOI 10.1016/S1368-8375(98)00048-7; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307; Oliveira DT, 1998, J ORAL PATHOL MED, V27, P303; Oliveira DT, 1997, ORAL ONCOL, V33, P260, DOI 10.1016/S0964-1955(97)00081-X; Ostwald J, 1997, LARYNGO RHINO OTOL, V76, P295, DOI 10.1055/s-2007-997430; Piffko J, 1996, J ORAL PATHOL MED, V25, P502; Piffko J, 1999, CANCER DETECT PREV, V23, P45, DOI 10.1046/j.1525-1500.1999.09903.x; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reategui EP, 2006, CANCER BIOL THER, V5, P1163, DOI 10.4161/cbt.5.9.3065; Repassy G, 1998, Pathol Oncol Res, V4, P14; Rodrigo JP, 2002, AM J CLIN PATHOL, V118, P67; Sato S, 2003, ORAL ONCOL, V39, P27, DOI 10.1016/S1368-8375(01)00132-4; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Soukka T, 1997, CANCER RES, V57, P2281; Spafford MF, 1996, ARCH OTOLARYNGOL, V122, P627; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; Stoll C, 1998, ADV EXP MED BIOL, V451, P51; Sugar J, 1997, ACTA OTO-LARYNGOL, P52; TARIN D, 1993, J CELL BIOCHEM, P173; Ue T, 1998, J ORAL PATHOL MED, V27, P197; Van Hal NLW, 1999, INT J CANCER, V82, P837, DOI 10.1002/(SICI)1097-0215(19990909)82:6<837::AID-IJC12>3.3.CO;2-8; VANDEKERCKHOVE J, 1978, P NATL ACAD SCI USA, V75, P1106, DOI 10.1073/pnas.75.3.1106; Wang SJ, 2007, HEAD NECK-J SCI SPEC, V29, P550, DOI 10.1002/hed.20544; Woodman AC, 1996, AM J PATHOL, V149, P1519; Zhou J, 1999, IN VITRO CELL DEV-AN, V35, P228; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; ZOON KC, 1979, J GEN VIROL, V44, P227, DOI 10.1099/0022-1317-44-1-227	65	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28776	10.1371/journal.pone.0028776	http://dx.doi.org/10.1371/journal.pone.0028776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242150	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100004
J	Ohnishi, T; Yamada, K; Watanabe, A; Ohba, H; Sakaguchi, T; Honma, Y; Iwayama, Y; Toyota, T; Maekawa, M; Watanabe, K; Detera-Wadleigh, SD; Wakana, S; Yoshikawa, T				Ohnishi, Tetsuo; Yamada, Kazuo; Watanabe, Akiko; Ohba, Hisako; Sakaguchi, Toru; Honma, Yota; Iwayama, Yoshimi; Toyota, Tomoko; Maekawa, Motoko; Watanabe, Kazutada; Detera-Wadleigh, Sevilla D.; Wakana, Shigeharu; Yoshikawa, Takeo			Ablation of Mrds1/Ofcc1 Induces Hyper-gamma-Glutamyl Transpeptidasemia without Abnormal Head Development and Schizophrenia-Relevant Behaviors in Mice	PLOS ONE			English	Article							PEDIGREE DISEQUILIBRIUM TEST; GENE DTNBP1; COMMON VARIANTS; 6P22.3 GENE; ASSOCIATION; IDENTIFICATION; DYSBINDIN; LINKAGE; RISK; MORPHOGENESIS	Mutations in the Opo gene result in eye malformation in medaka fish. The human ortholog of this gene, MRDS1/OFCC1, is a potentially causal gene for orofacial cleft, as well as a susceptibility gene for schizophrenia, a devastating mental illness. Based on this evidence, we hypothesized that this gene could perform crucial functions in the development of head and brain structures in vertebrates. To test this hypothesis, we created Mrds1/Ofcc1-null mice. Mice were examined thoroughly using an abnormality screening system referred to as "the Japan Mouse Clinic". No malformations of the head structure, eye or other parts of the body were apparent in these knockout mice. However, the mutant mice showed a marked increase in serum c-glutamyl transpeptidase (GGT), a marker for liver damage, but no abnormalities in other liver-related measurements. We also performed a family-based association study on the gene in schizophrenia samples of Japanese origin. We found five single nucleotide polymorphisms (SNPs) located across the gene that showed significant transmission distortion, supporting a prior report of association in a Caucasian cohort. However, the knockout mice showed no behavioral phenotypes relevant to schizophrenia. In conclusion, disruption of the Mrds1/Ofcc1 gene elicits asymptomatic hyper-c-glutamyl-transpeptidasemia in mice. However, there were no phenotypes to support a role for the gene in the development of eye and craniofacial structures in vertebrates. These results prompt further examination of the gene, including its putative contribution to hyper-c-glutamyl transpeptidasemia and schizophrenia.	[Ohnishi, Tetsuo; Yamada, Kazuo; Watanabe, Akiko; Ohba, Hisako; Sakaguchi, Toru; Honma, Yota; Iwayama, Yoshimi; Toyota, Tomoko; Maekawa, Motoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Sakaguchi, Toru; Honma, Yota; Watanabe, Kazutada] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan; [Detera-Wadleigh, Sevilla D.] NIMH, Mood & Anxiety Disorders Program, Bethesda, MD 20892 USA; [Wakana, Shigeharu] RIKEN BioResource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan	RIKEN; Nagaoka University of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); RIKEN	Ohnishi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan.	tohnishi@brain.riken.jp	Ohnishi, Tetsuo/AAC-2767-2022; Yoshikawa, Takeo/F-9599-2019; Ohnishi, Tetsuo/AAC-5694-2019; Ohnishi, Tetsuo/D-3791-2018	Ohnishi, Tetsuo/0000-0002-6696-9725; Ohnishi, Tetsuo/0000-0002-6696-9725	RIKEN BSI	RIKEN BSI	This study was supported mainly by the RIKEN BSI Funds. A part of this study is the result of "Development of Biomarker Candidates for Social Behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Davies SJ, 2004, CYTOGENET GENOME RES, V105, P47, DOI 10.1159/000078008; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Holliday EG, 2006, TWIN RES HUM GENET, V9, P531, DOI 10.1375/twin.9.4.531; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; LEWONTIN RC, 1988, GENETICS, V120, P849; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Mason Jennifer E, 2010, Prev Cardiol, V13, P36, DOI 10.1111/j.1751-7141.2009.00054.x; Matsumoto M, 2002, AM J MED GENET, V114, P857; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mertes F, 2009, GENE EXPR PATTERNS, V9, P562, DOI 10.1016/j.gep.2009.09.003; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Ohnishi T, 2010, NEUROSCI RES, V67, P86, DOI 10.1016/j.neures.2010.02.003; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Radhakrishnan R, 2011, PSYCHIAT RES; Martinez-Morales JR, 2009, DEVELOPMENT, V136, P2165, DOI 10.1242/dev.033563; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Straub R. E., 2003, American Journal of Medical Genetics, V122B, P18; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.06.002; Tochigi M, 2006, NEUROSCI RES, V56, P154, DOI 10.1016/j.neures.2006.06.009; Turunen JA, 2007, SCHIZOPHR RES, V91, P27, DOI 10.1016/j.schres.2006.11.028; Vilella E, 2008, J PSYCHIATR RES, V42, P278, DOI 10.1016/j.jpsychires.2007.02.005; Wakana S, 2009, EXP ANIM TOKYO, V58, P443, DOI 10.1538/expanim.58.443; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Zuo LJ, 2009, PSYCHIAT GENET, V19, P292, DOI 10.1097/YPG.0b013e32832a50bc	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29499	10.1371/journal.pone.0029499	http://dx.doi.org/10.1371/journal.pone.0029499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242126	Green Submitted, gold, Green Published			2022-12-25	WOS:000300677000041
J	Villa-Cuesta, E; Boylan, JM; Tatar, M; Gruppuso, PA				Villa-Cuesta, Eugenia; Boylan, Joan M.; Tatar, Marc; Gruppuso, Philip A.			Resveratrol Inhibits Protein Translation in Hepatic Cells	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CAP-DEPENDENT TRANSLATION; DIETARY RESTRICTION; IN-VIVO; CAENORHABDITIS-ELEGANS; LOW BIOAVAILABILITY; AMPK ACTIVATION; S6 KINASE; RAPAMYCIN; CANCER	Resveratrol is a plant-derived polyphenol that extends lifespan and healthspan in model organism. Despite extensive investigation, the biological processes mediating resveratrol's effects have yet to be elucidated. Because repression of translation shares many of resveratrol's beneficial effects, we hypothesized that resveratrol was a modulator of protein synthesis. We studied the effect of the drug on the H4-II-E rat hepatoma cell line. Initial studies showed that resveratrol inhibited global protein synthesis. Given the role of the mammalian Target of Rapamycin (mTOR) in regulating protein synthesis, we examined the effect of resveratrol on mTOR signaling. Resveratrol inhibited mTOR self-phosphorylation and the phosphorylation of mTOR targets S6K1 and eIF4E-BP1. It attenuated the formation of the translation initiation complex eIF4F and increased the phosphorylation of eIF2 alpha. The latter event, also a mechanism for translation inhibition, was not recapitulated by mTOR inhibitors. The effects on mTOR signaling were independent of effects on AMP-activated kinase or AKT. We conclude that resveratrol is an inhibitor of global protein synthesis, and that this effect is mediated through modulation of mTOR-dependent and independent signaling.	[Villa-Cuesta, Eugenia; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Boylan, Joan M.; Gruppuso, Philip A.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Boylan, Joan M.; Gruppuso, Philip A.] Rhode Isl Hosp, Providence, RI USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Villa-Cuesta, E (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Eugenia_Villa-Cuesta@brown.edu		Villa-Cuesta, Eugenia/0000-0002-8919-6788	National Institutes of Health [R01HD24455, R01AG024360]; American Parkinson Disease Association [529302]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health grant R01HD24455 (to P. A. G.), R01AG024360 (to M. T.) and American Parkinson Disease Association grant 529302 (to M. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; BALLARD FJ, 1986, BIOCHEM J, V233, P223, DOI 10.1042/bj2330223; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Bishayee A, 2009, CHEM-BIOL INTERACT, V179, P131, DOI 10.1016/j.cbi.2008.11.015; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Delmas D, 2000, ONCOL REP, V7, P847; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Efeyan A., 2009, CURR OPIN CELL BIOL; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2007, AGING CELL, V6, P415, DOI 10.1111/j.1474-9726.2007.00314.x; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2010, BIOESSAYS, V32, P96, DOI 10.1002/bies.200900171; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lancon A, 2004, BIOCHEM BIOPH RES CO, V316, P1132, DOI 10.1016/j.bbrc.2004.02.164; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Montgomery J. L., 2002, Methods in Cell Science, V24, P123, DOI 10.1023/A:1024498316958; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Sonenberg N., TRANSLATIONAL CONTRO; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	80	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29513	10.1371/journal.pone.0029513	http://dx.doi.org/10.1371/journal.pone.0029513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242130	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000045
J	Wade, JJ; McDaid, LJ; Harkin, J; Crunelli, V; Kelso, JAS				Wade, John J.; McDaid, Liam J.; Harkin, Jim; Crunelli, Vincenzo; Kelso, J. A. Scott			Bidirectional Coupling between Astrocytes and Neurons Mediates Learning and Dynamic Coordination in the Brain: A Multiple Modeling Approach	PLOS ONE			English	Article							LESS-THAN-0.1 HZ OSCILLATIONS; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; CALCIUM OSCILLATIONS; GLIAL-CELLS; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; IN-SITU; GLUTAMATE; CA2+	In recent years research suggests that astrocyte networks, in addition to nutrient and waste processing functions, regulate both structural and synaptic plasticity. To understand the biological mechanisms that underpin such plasticity requires the development of cell level models that capture the mutual interaction between astrocytes and neurons. This paper presents a detailed model of bidirectional signaling between astrocytes and neurons (the astrocyte-neuron model or AN model) which yields new insights into the computational role of astrocyte-neuronal coupling. From a set of modeling studies we demonstrate two significant findings. Firstly, that spatial signaling via astrocytes can relay a "learning signal" to remote synaptic sites. Results show that slow inward currents cause synchronized postsynaptic activity in remote neurons and subsequently allow Spike-Timing-Dependent Plasticity based learning to occur at the associated synapses. Secondly, that bidirectional communication between neurons and astrocytes underpins dynamic coordination between neuron clusters. Although our composite AN model is presently applied to simplified neural structures and limited to coordination between localized neurons, the principle (which embodies structural, functional and dynamic complexity), and the modeling strategy may be extended to coordination among remote neuron clusters.	[Wade, John J.; McDaid, Liam J.; Harkin, Jim; Kelso, J. A. Scott] Univ Ulster, Sch Comp & Intelligent Syst, Intelligent Syst Res Ctr, Derry, North Ireland; [Crunelli, Vincenzo] Univ Cardiff, Cardiff Sch Biosci, Neurosci Div, Cardiff, S Glam, Wales; [Kelso, J. A. Scott] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Ulster University; Cardiff University; State University System of Florida; Florida Atlantic University	Wade, JJ (corresponding author), Univ Ulster, Sch Comp & Intelligent Syst, Intelligent Syst Res Ctr, Derry, North Ireland.	jj.wade@ulster.ac.uk	; Harkin, Jim/F-8958-2013	Crunelli, Vincenzo/0000-0001-7154-9752; Harkin, Jim/0000-0001-7484-8205; Wade, John Joseph/0000-0003-1300-9429	Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems; Integrated Development Fund; InvestNI; Wellcome Trust [91882]; MRC [900671]; European Union [Health F2-2007-202167]; NIMH [080838]; NSF [BCS0826897]; US ONR [N000140510117]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER	Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems; Integrated Development Fund; InvestNI; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); US ONR(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems grant, funded by the Integrated Development Fund and InvestNI. VC is supported by The Wellcome Trust (grant 91882), the MRC (900671) and the European Union (Health F2-2007-202167). JASK is supported by NIMH grant 080838, NSF grant BCS0826897 and US ONR award N000140510117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aguado F, 2002, J NEUROSCI, V22, P9430; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bacci A, 1999, PHILOS T R SOC B, V354, P403, DOI 10.1098/rstb.1999.0393; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Basar E, 2004, CONC ADV BRAIN RES, P153; Benuskova L, 2007, NEUROCOMPUTING, V70, P2035, DOI 10.1016/j.neucom.2006.10.133; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bonansco C, 2011, EUR J NEUROSCI, V33, P1483, DOI 10.1111/j.1460-9568.2011.07631.x; Bugmann G, 1997, BIOSYSTEMS, V40, P11, DOI 10.1016/0303-2647(96)01625-5; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Buszsaki G, 2006, RHYTHMS BRAIN, P111; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; De Pitta M, 2009, J BIOL PHYS, V35, P383, DOI 10.1007/s10867-009-9155-y; De Pitta M, 2009, COGN PROCESS, V10, pS55, DOI 10.1007/s10339-008-0242-y; De Pitta M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030903; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Engel A.K., 2010, DYNAMIC COORDINATION, P267; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gerstner W., 2002, SPIKING NEURON MODEL; Gerstner W, 2009, SCIENCE, V326, P379, DOI 10.1126/science.1181936; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Goldberg M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000909; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hebb DO, 1949, ORG BEHAVIOR, P62; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hennequin G, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00143; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hughes SW, 2011, PROG BRAIN RES, V193, P145, DOI 10.1016/B978-0-444-53839-0.00010-7; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kazantsev VB, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.010901; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Kelso JAS, 1995, DYNAMIC PATTERNS SEL, P218; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopach O, 2011, PAIN, V152, P912, DOI 10.1016/j.pain.2011.01.016; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Lorincz ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004447; Maass W, 1999, NEURAL COMPUT, V11, P903, DOI 10.1162/089976699300016494; Macdonald Christopher L, 2008, Front Neuroeng, V1, P1, DOI 10.3389/neuro.16.001.2008; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matrosov VV, 2011, CHAOS, V21, DOI 10.1063/1.3574031; Matveev V, 2000, J NEUROSCI, V20, P1575; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; Nadkarni S, 2007, PHYS BIOL, V4, P1, DOI 10.1088/1478-3975/4/1/001; Nadkarni S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000983; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Phillips WA, 2010, DYNAMIC COORDINATION, P1; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Smith K, 2010, NATURE, V468, P160, DOI 10.1038/468160a; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stamatakis M, 2006, J THEOR BIOL, V241, P649, DOI 10.1016/j.jtbi.2006.01.002; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Thul R, 2009, CELLULAR OSCILLATORY, P1; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; Toivari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017914; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Volman V, 2007, NEURAL COMPUT, V19, P303, DOI 10.1162/neco.2007.19.2.303; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wade JJ, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3149, DOI 10.1109/IJCNN.2011.6033638; Wade JJ, 2010, IEEE T NEURAL NETWOR, V21, P1817, DOI 10.1109/TNN.2010.2074212; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Wenker I, 2010, J NEUROPHYSIOL, V104, P1216, DOI 10.1152/jn.00429.2010; Xi Q, 2011, AM J PHYSIOL-HEART C, V301, pH428, DOI 10.1152/ajpheart.01277.2010; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	119	82	84	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29445	10.1371/journal.pone.0029445	http://dx.doi.org/10.1371/journal.pone.0029445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242121	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000033
J	Xiao, Y; Zhang, L; Gao, SH; Saechao, SK; Di, P; Chen, JF; Chen, WS				Xiao, Ying; Zhang, Lei; Gao, Shouhong; Saechao, Saengking; Di, Peng; Chen, Junfeng; Chen, Wansheng			The c4h, tat, hppr and hppd Genes Prompted Engineering of Rosmarinic Acid Biosynthetic Pathway in Salvia miltiorrhiza Hairy Root Cultures	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; CELL-SUSPENSION; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; CINNAMATE 4-HYDROXYLASE; SECONDARY METABOLISM; JASMONIC ACID; VITAMIN-E; EXPRESSION; ACCUMULATION; ELICITOR	Rational engineering to produce biologically active plant compounds has been greatly impeded by our poor understanding of the regulatory and metabolic pathways underlying the biosynthesis of these compounds. Here we capitalized on our previously described gene-to-metabolite network in order to engineer rosmarinic acid (RA) biosynthesis pathway for the production of beneficial RA and lithospermic acid B (LAB) in Salvia miltiorrhiza hairy root cultures. Results showed their production was greatly elevated by (1) overexpression of single gene, including cinnamic acid 4-hydroxylase (c4h), tyrosine aminotransferase (tat), and 4-hydroxyphenylpyruvate reductase (hppr), (2) overexpression of both tat and hppr, and (3) suppression of 4-hydroxyphenylpyruvate dioxygenase (hppd). Co-expression of tat/hppr produced the most abundant RA (906 mg/liter) and LAB (992 mg/liter), which were 4.3 and 3.2-fold more than in their wild-type (wt) counterparts respectively. And the value of RA concentration was also higher than that reported before, that produced by means of nutrient medium optimization or elicitor treatment. It is the first report of boosting RA and LAB biosynthesis through genetic manipulation, providing an effective approach for their large-scale commercial production by using hairy root culture systems as bioreactors.	[Xiao, Ying; Gao, Shouhong; Di, Peng; Chen, Junfeng; Chen, Wansheng] Second Mil Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China; [Zhang, Lei] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai, Peoples R China; [Chen, Wansheng] Second Mil Med Univ, Modern Res Ctr Tradit Chinese Med, Shanghai, Peoples R China; [Zhang, Lei; Saechao, Saengking] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Xiao, Ying] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; University of California System; University of California Davis; Shanghai University of Traditional Chinese Medicine	Chen, WS (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China.	smmusubmit@gmail.com	Di, Peng/E-4751-2013; Di, Peng/T-2456-2019	Di, Peng/0000-0002-8537-9245; 	National Natural Science Foundation of China [31100221, 31160059, 30900786]; Shanghai Science and Technology Committee [09XD1405900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was funded by grants from National Natural Science Foundation of China (31100221, 31160059, 30900786) and Program of Shanghai Subject Chief Scientist (09XD1405900), Shanghai Science and Technology Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2004, PLANT CELL, V16, P3098, DOI 10.1105/tpc.104.024406; Allen DK, 2009, PLANT CELL ENVIRON, V32, P1241, DOI 10.1111/j.1365-3040.2009.01992.x; [Anonymous], 1997, JAPAN J FOOD CHEM; Aquil S, 2009, PLANTA MED, V75, P1453, DOI 10.1055/s-0029-1185775; Blee K, 2001, PHYTOCHEMISTRY, V57, P1159, DOI 10.1016/S0031-9422(01)00150-9; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Chen H, 2000, PLANT CELL REP, V19, P710, DOI 10.1007/s002999900166; CHILTON MD, 1982, NATURE, V295, P432, DOI 10.1038/295432a0; Crowell EF, 2008, TRANSGENIC RES, V17, P205, DOI 10.1007/s11248-007-9091-1; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Falk J, 2003, FEBS LETT, V540, P35, DOI 10.1016/S0014-5793(03)00166-2; Georgiev MI, 2007, WORLD J MICROB BIOT, V23, P301, DOI 10.1007/s11274-006-9214-5; Grzegorczyk I, 2006, Z NATURFORSCH C, V61, P351; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Huang B, 2008, RUSS J PLANT PHYSL+, V55, P390, DOI 10.1134/S1021443708030163; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jouhikainen K, 1999, PLANTA, V208, P545, DOI 10.1007/s004250050592; Kai GY, 2009, BIOTECHNOL APPL BIOC, V54, P177, DOI 10.1042/BA20090171; Kim KH, 2002, PLANT SCI, V163, P1001, DOI 10.1016/S0168-9452(02)00274-1; Li W, 2005, PLANT CELL TISS ORG, V80, P151, DOI 10.1007/s11240-004-9541-x; Lu WQ, 2011, J MED PLANTS RES, V5, P1664; MIZUKAMI H, 1991, PLANT CELL REP, V10, P321, DOI 10.1007/BF00193150; MIZUKAMI H, 1993, PLANT CELL REP, V12, P706, DOI 10.1007/BF00233424; MOZO T, 1991, PLANT MOL BIOL, V16, P917, DOI 10.1007/BF00015085; Munoz-Bertomeu J, 2008, METAB ENG, V10, P166, DOI 10.1016/j.ymben.2008.04.002; Murakami Y, 1998, PLANT CELL TISS ORG, V53, P75, DOI 10.1023/A:1006007707722; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Pavlov AI, 2005, BIOTECHNOL PROGR, V21, P394, DOI 10.1021/bp049678z; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peebles CAM, 2009, METAB ENG, V11, P76, DOI 10.1016/j.ymben.2008.09.002; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Petersen M, 2009, PHYTOCHEMISTRY, V70, P1663, DOI 10.1016/j.phytochem.2009.05.010; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Sewalt VJH, 1997, PLANT PHYSIOL, V115, P41, DOI 10.1104/pp.115.1.41; Song J, 2011, J PLANT RES, V124, P183, DOI 10.1007/s10265-010-0350-5; Szabo E, 1999, PLANT CELL REP, V18, P485, DOI 10.1007/s002990050608; Tsegaye Y, 2002, PLANT PHYSIOL BIOCH, V40, P913, DOI 10.1016/S0981-9428(02)01461-4; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; Xiao Y, 2010, BIOSCIENCE REP, V30, P33, DOI 10.1042/BSR20080124; Xiao Y, 2009, PHYSIOL PLANTARUM, V137, P1, DOI 10.1111/j.1399-3054.2009.01257.x; Xiao Y, 2009, MOL BIOL REP, V36, P2019, DOI 10.1007/s11033-008-9413-2; Yan Q, 2006, PLANT SCI, V170, P853, DOI 10.1016/j.plantsci.2005.12.004; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang HC, 2009, PLANT CELL REP, V28, P1205, DOI 10.1007/s00299-009-0721-3; Zhang L, 2004, P NATL ACAD SCI USA, V101, P6786, DOI 10.1073/pnas.0401391101	49	86	97	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29713	10.1371/journal.pone.0029713	http://dx.doi.org/10.1371/journal.pone.0029713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242141	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000058
J	Colas, E; Muinelo-Romay, L; Alonso-Alconada, L; Llaurado, M; Monge, M; Barbazan, J; Gonzalez, M; Schoumacher, M; Pedrola, N; Ertekin, T; Devis, L; Ruiz, A; Castellvi, J; Doll, A; Gil-Moreno, A; Vazquez-Levin, M; Lapyckyj, L; Lopez-Lopez, R; Robine, S; Friederich, E; Castro, M; Reventos, J; Vignjevic, D; Abal, M				Colas, E.; Muinelo-Romay, L.; Alonso-Alconada, L.; Llaurado, M.; Monge, M.; Barbazan, J.; Gonzalez, M.; Schoumacher, M.; Pedrola, N.; Ertekin, T.; Devis, L.; Ruiz, A.; Castellvi, J.; Doll, A.; Gil-Moreno, A.; Vazquez-Levin, M.; Lapyckyj, L.; Lopez-Lopez, R.; Robine, S.; Friederich, E.; Castro, M.; Reventos, J.; Vignjevic, D.; Abal, M.			ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas	ONCOGENE			English	Article						ETV5; EMT; LPP; carcinoma invasion; endometrial cancer	EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR; MYOMETRIAL INFILTRATION; CELL-ADHESION; UP-REGULATION; CANCER; FIBROBLASTS; PROGRESSION; EXPRESSION; INITIATION	Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital tract, with myometrial invasion representing an increase in the rate of recurrences and a decrease in survival. We have previously described ETV5 transcription factor associated with myometrial infiltration in human ECs. In this work, we further investigated ETV5 orchestrating downstream effects to confer the tumor the invasive capabilities needed to disseminate in the early stages of EC dissemination. Molecular profiling evidenced ETV5 having a direct role on epithelial-to-mesenchymal transition (EMT). In particular, ETV5 modulated Zeb1 expression and E-Cadherin repression leading to a complete reorganization of cell-cell and cell-substrate contacts. ETV5-promoted EMT resulted in the acquisition of migratory and invasive capabilities in endometrial cell lines. Furthermore, we identified the lipoma-preferred partner protein as a regulatory partner of ETV5, acting as a sensor for extracellular signals promoting tumor invasion. All together, we propose ETV5-transcriptional regulation of the EMT process through a crosstalk with the tumor surrounding microenvironment, as a principal event initiating EC invasion.	[Muinelo-Romay, L.; Alonso-Alconada, L.; Barbazan, J.; Lopez-Lopez, R.; Abal, M.] Complexo Hosp Univ Santiago SERGAS, Dept Med Oncol, Translat Lab, Santiago De Compostela 15706, Spain; [Colas, E.; Llaurado, M.; Monge, M.; Gonzalez, M.; Pedrola, N.; Ertekin, T.; Devis, L.; Ruiz, A.; Doll, A.; Reventos, J.; Abal, M.] Vall dHebron Univ Hosp, Res Inst, Biomed Res Unit, Barcelona, Spain; [Schoumacher, M.; Robine, S.; Vignjevic, D.] Inst Curie, CNRS, UMR 144, F-75231 Paris, France; [Castellvi, J.] Vall dHebron Univ Hosp, Dept Gynecol Oncol, Barcelona, Spain; [Gil-Moreno, A.] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Vazquez-Levin, M.; Lapyckyj, L.] Consejo Nacl Invest Cient & Tecn, Natl Res Council Argentina, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Friederich, E.] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Castro, M.] Univ Santiago de Compostela, Dept Pharmacol, BioFarma Res Grp, Santiago De Compostela, Spain; [Colas, E.; Gil-Moreno, A.; Reventos, J.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari Vall d'Hebron; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Luxembourg; Universidade de Santiago de Compostela; Autonomous University of Barcelona	Abal, M (corresponding author), Complexo Hosp Univ Santiago SERGAS, Dept Med Oncol, Translat Lab, Trav Choupana S-N, Santiago De Compostela 15706, Spain.	miguel.abal.posada@sergas.es	Gil-Moreno, Antonio/C-1122-2016; Monge, Marta/I-3667-2015; Castellvi, Josep/C-5092-2014; vignjevic, Danijela Matic/R-5160-2019; Vignjevic, Danijela/L-9721-2017; Doll, Andreas/I-1449-2012; Barbazán, Jorge/AAM-3263-2020; Castro, Marián/K-5747-2014; Jauregui, Laura Devis/ABH-5740-2020	Gil-Moreno, Antonio/0000-0003-1106-5590; Monge, Marta/0000-0002-9839-4903; Castellvi, Josep/0000-0001-5745-9996; vignjevic, Danijela Matic/0000-0003-4250-703X; Barbazán, Jorge/0000-0002-7165-8497; Castro, Marián/0000-0002-4732-1966; Lopez Lopez, Rafael/0000-0003-1315-655X; Doll, Andreas/0000-0001-8965-8682; Devis-Jauregui, Laura/0000-0003-3736-3983; Abal Posada, Miguel/0000-0003-3533-7781	Spanish Ministry of Science and Innovation [SAF 2005-06771, SAF 2008-03996]; Spanish Ministry of Health [RTICC RD06/0020/0058, CP08/00142, PI08/0797]; European Commission Program Fondo Europeo de Desarrollo Regional (FEDER); Catalan Institute of Health [DURSI 2005SGR00553]; Fundacio La Marato de TV3 [050431]; ACCIO [RDITSCON07-1-0001]; AECC; National Programme of Biotecnology [FIT-010000-2007-26]; Basque Government (Spain); Spanish Ministry of Education and Science	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Commission Program Fondo Europeo de Desarrollo Regional (FEDER); Catalan Institute of Health; Fundacio La Marato de TV3; ACCIO; AECC; National Programme of Biotecnology; Basque Government (Spain)(Basque Government); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (SAF 2005-06771; SAF 2008-03996), Spanish Ministry of Health (RTICC RD06/0020/0058; CP08/00142, PI08/0797), European Commission Program Fondo Europeo de Desarrollo Regional (FEDER), Catalan Institute of Health (DURSI 2005SGR00553), Fundacio La Marato de TV3 (grant 050431), ACCIO (RDITSCON07-1-0001), AECC (Grupos Estables de Investigacion 2011) and National Programme of Biotecnology (FIT-010000-2007-26). LAA and JB are recipients of fellowships from the Basque Government (Spain) and the Spanish Ministry of Education and Science, respectively.	Abal M, 2007, CLIN TRANSL ONCOL, V9, P272, DOI 10.1007/s12094-007-0054-z; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chacon MR, 2011, CELL ADHES MIGR, V5, P52, DOI 10.4161/cam.5.1.13681; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Llaurado M, 2012, INT J CANCER, V130, P1532, DOI 10.1002/ijc.26148; Monge M, 2007, CANCER RES, V67, P6753, DOI 10.1158/0008-5472.CAN-06-4487; Monge M, 2009, J PROTEOME RES, V8, P4676, DOI 10.1021/pr900390t; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Muinelo-Romay L, 2011, MOL CANCER THER, V10, P1357, DOI 10.1158/1535-7163.MCT-10-1019; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petit MMR, 2003, J BIOL CHEM, V278, P2157, DOI 10.1074/jbc.M206106200; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Planaguma J, 2004, CANCER RES, V64, P8846, DOI 10.1158/0008-5472.CAN-04-2066; Planaguma J, 2005, J PATHOL, V207, P422, DOI 10.1002/path.1853; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Sivridis E, 2001, ANTICANCER RES, V21, P4383; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Swart GWM, 2005, CANCER METAST REV, V24, P223, DOI 10.1007/s10555-005-1573-0; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tsukamoto H, 2007, CLIN EXP METASTAS, V24, P423, DOI 10.1007/s10585-007-9079-5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	43	33	34	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	45					4778	4788		10.1038/onc.2011.632	http://dx.doi.org/10.1038/onc.2011.632			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22266854	Green Published			2022-12-25	WOS:000311033000006
J	Petrelli, A; Perra, A; Schernhuber, K; Cargnelutti, M; Salvi, A; Migliore, C; Ghiso, E; Benetti, A; Barlati, S; Ledda-Columbano, GM; Portolani, N; De Petro, G; Columbano, A; Giordano, S				Petrelli, A.; Perra, A.; Schernhuber, K.; Cargnelutti, M.; Salvi, A.; Migliore, C.; Ghiso, E.; Benetti, A.; Barlati, S.; Ledda-Columbano, G. M.; Portolani, N.; De Petro, G.; Columbano, A.; Giordano, S.			Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression	ONCOGENE			English	Article						miRNA; HCC; animal model; PLK1; hepatocarcinogenesis	HUMAN HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION PROFILES; AGGRESSIVE LIVER-CANCER; POLO-LIKE KINASES; GENE-EXPRESSION; CELLS; IDENTIFICATION; MODEL; CARCINOGENESIS; MICROARRAY	MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR-100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. Oncogene (2012) 31, 4517-4526; doi:10.1038/onc.2011.631; published online 16 January 2012	[Petrelli, A.; Schernhuber, K.; Cargnelutti, M.; Migliore, C.; Ghiso, E.; Giordano, S.] Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC, Turin, Italy; [Perra, A.; Ledda-Columbano, G. M.; Columbano, A.] Univ Cagliari, Dept Toxicol, Unit Oncol & Mol Pathol, Cagliari, Italy; [Salvi, A.; Barlati, S.; De Petro, G.] Univ Brescia, Sch Med, Div Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Benetti, A.] Univ Brescia, Sch Med, Dept Pathol, Brescia, Italy; [Portolani, N.] Univ Brescia, Sch Med, Surg Clin, Dept Med & Surg Sci, Brescia, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Cagliari; University of Brescia; University of Brescia; University of Brescia	Petrelli, A (corresponding author), Inst Canc Res & Treatment, Div Mol Oncol, SP 142km 3-9, I-10060 Candiolo, TO, Italy.	annalisa.petrelli@ircc.it; columbano@unica.it; silvia.giordano@unito.it	Columbano, Amedeo/C-7463-2011; Salvi, Alessandro/AAB-7896-2019; De Petro, Giuseppina/C-2719-2011; Giordano, Silvia/J-9858-2018	Columbano, Amedeo/0000-0002-6956-9030; Salvi, Alessandro/0000-0001-6993-1565; De Petro, Giuseppina/0000-0001-9306-0851; Giordano, Silvia/0000-0003-1854-1086; Migliore, Cristina/0000-0003-3722-2814	Associazione Italiana per la Ricerca sul Cancro (AIRC); Regione Piemonte; MIUR	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte); MIUR(Ministry of Education, Universities and Research (MIUR))	We thank L Tamagnone, S Corso, MM Angioni and our colleagues for helpful discussions; C Manca for the preparation of rat samples and C Isella for statistical analysis; L Palmas for technical assistance. Work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC grants to SG, AC), Regione Piemonte (grant to SG) and MIUR (grants to SG, AC, GMLC, GDP).	Andersen JB, 2010, HEPATOLOGY, V51, P1401, DOI 10.1002/hep.23488; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; De Petro G, 1998, CANCER RES, V58, P2234; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; ENOMOTO K, 1982, CANCER RES, V42, P2330; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Leite KR, 2009, UROL ONCOL, V29, P265; Liu W, 2009, CHINESE MED J-PEKING, V122, P2405, DOI 10.3760/cma.j.issn.0366-6999.2009.20.002; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; SOLT DB, 1977, AM J PATHOL, V88, P595; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Thorgeirsson SS, 2011, J HEPATOL, V55, P486, DOI 10.1016/j.jhep.2011.01.042; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666	33	63	66	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2012	31	42					4517	4526		10.1038/onc.2011.631	http://dx.doi.org/10.1038/onc.2011.631			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22249248	Green Submitted			2022-12-25	WOS:000309982100003
J	Faries, KM; Kressel, LL; Wander, MJ; Holten, D; Laible, PD; Kirmaier, C; Hanson, DK				Faries, Kaitlyn M.; Kressel, Lucas L.; Wander, Marc J.; Holten, Dewey; Laible, Philip D.; Kirmaier, Christine; Hanson, Deborah K.			High Throughput Engineering to Revitalize a Vestigial Electron Transfer Pathway in Bacterial Photosynthetic Reaction Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULATUS REACTION CENTERS; SPHAEROIDES REACTION-CENTER; PRIMARY CHARGE SEPARATION; REACTION-CENTER MUTANT; RHODOBACTER-SPHAEROIDES; PHOTOSYSTEM-I; M-SIDE; RHODOPSEUDOMONAS-CAPSULATA; DIRECTED EVOLUTION; QUINONE REDUCTION	Photosynthetic reaction centers convert light energy into chemical energy in a series of transmembrane electron transfer reactions, each with near 100% yield. The structures of reaction centers reveal two symmetry-related branches of cofactors (denoted A and B) that are functionally asymmetric; purple bacterial reaction centers use the A pathway exclusively. Previously, site-specific mutagenesis has yielded reaction centers capable of transmembrane charge separation solely via the B branch cofactors, but the best overall electron transfer yields are still low. In an attempt to better realize the architectural and energetic factors that underlie the directionality and yields of electron transfer, sites within the protein-cofactor complex were targeted in a directed molecular evolution strategy that implements streamlined mutagenesis and high throughput spectroscopic screening. The polycistronic approach enables efficient construction and expression of a large number of variants of a heteroligomeric complex that has two intimately regulated subunits with high sequence similarity, common features of many prokaryotic and eukaryotic transmembrane protein assemblies. The strategy has succeeded in the discovery of several mutant reaction centers with increased efficiency of the B pathway; they carry multiple substitutions that have not been explored or linked using traditional approaches. This work expands our understanding of the structure-function relationships that dictate the efficiency of biological energy-conversion reactions, concepts that will aid the design of bio-inspired assemblies capable of both efficient charge separation and charge stabilization.	[Faries, Kaitlyn M.; Holten, Dewey; Kirmaier, Christine] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Kressel, Lucas L.; Wander, Marc J.; Laible, Philip D.; Hanson, Deborah K.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Washington University (WUSTL); United States Department of Energy (DOE); Argonne National Laboratory	Kirmaier, C (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	kirmaier@wustl.edu; dkhanson@anl.gov		Faries, Kaitlyn/0000-0003-1777-7716	United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG-02-09ER16116];  [DE-AC02-06CH11357]	United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); 	This work was supported by Grant DE-FG-02-09ER16116 from the United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences (to C. K., D. H., P. D. L., and D. K. H.). Argonne, a United States Department of Energy Office of Science laboratory, is operated under Contract DE-AC02-06CH11357.	ALLEN JP, 1995, J BIOENERG BIOMEMBR, V27, P275, DOI 10.1007/BF02110097; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; BYLINA EJ, 1988, NATURE, V336, P182, DOI 10.1038/336182a0; BYLINA EJ, 1989, BIO-TECHNOL, V7, P69, DOI 10.1038/nbt0189-69; BYLINA EJ, 1988, ISRAEL J CHEM, V28, P73; BYLINA EJ, 1986, PLASMID, V16, P175, DOI 10.1016/0147-619X(86)90055-7; CHANG CH, 1991, BIOCHEMISTRY-US, V30, P5352, DOI 10.1021/bi00236a005; Chuang JI, 2006, BIOCHEMISTRY-US, V45, P3845, DOI 10.1021/bi0601048; COLEMAN WJ, 1993, NATURE, V366, P517, DOI 10.1038/366517a0; Coleman WJ, 1990, STRUCTURE FUNCTION B, P273; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; de Boer AL, 2002, BIOCHEMISTRY-US, V41, P3081, DOI 10.1021/bi011450m; de Boer AL, 2002, PHOTOSYNTH RES, V71, P221, DOI 10.1023/A:1015533126685; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DiMagno TJ, 1998, SPECTROCHIM ACTA A, V54, P1247, DOI 10.1016/S1386-1425(98)00074-2; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Haffa ALM, 2005, J PHYS CHEM B, V109, P19923, DOI 10.1021/jp052007e; HANSON DK, 1992, BIOCHIM BIOPHYS ACTA, V1102, P260, DOI 10.1016/0005-2728(92)90108-E; HELLER BA, 1995, SCIENCE, V269, P940, DOI 10.1126/science.7638616; HELLER BA, 1995, BIOCHEMISTRY-US, V34, P5294, DOI 10.1021/bi00015a045; Heller BA, 1996, BIOCHEMISTRY-US, V35, P15418, DOI 10.1021/bi961362f; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; JIA YW, 1993, J PHYS CHEM-US, V97, P13180, DOI 10.1021/j100152a024; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Katilius E, 1999, J PHYS CHEM B, V103, P7386, DOI 10.1021/jp991670y; Katilius E, 2003, J PHYS CHEM B, V107, P12029, DOI 10.1021/jp035013o; Kee HL, 2006, BIOCHEMISTRY-US, V45, P7314, DOI 10.1021/bi060277x; KIRMAIER C, 1991, SCIENCE, V251, P922, DOI 10.1126/science.2000491; Kirmaier C, 1999, BIOCHEMISTRY-US, V38, P11516, DOI 10.1021/bi9908585; Kirmaier C, 2005, J PHYS CHEM B, V109, P24160, DOI 10.1021/jp054726z; Kirmaier C, 2003, CHEM PHYS, V294, P305, DOI [10.1016/S0301-0104(03)00283-0, 10.1016/S0301 -0104(03)00283-0]; Kirmaier C, 2003, BIOCHEMISTRY-US, V42, P2016, DOI 10.1021/bi026973o; Kirmaier C, 2002, J PHYS CHEM B, V106, P1799, DOI 10.1021/jp013264w; Kirmaier C, 2001, BIOCHEMISTRY-US, V40, P12132, DOI 10.1021/bi0113263; KIRMAIER C, 1988, P NATL ACAD SCI USA, V85, P7562, DOI 10.1073/pnas.85.20.7562; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Laible PD, 2003, BIOCHEMISTRY-US, V42, P1718, DOI 10.1021/bi026959b; Laible PD, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P849; Li J, 2000, PHOTOSYNTH RES, V64, P41, DOI 10.1023/A:1026531925602; MCDOWELL LM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P239, DOI 10.1016/0005-2728(90)90153-U; Paddock ML, 2005, BIOCHEMISTRY-US, V44, P6920, DOI 10.1021/bi047559m; Ramesh VM, 2004, BIOCHEMISTRY-US, V43, P1369, DOI 10.1021/bi0354177; ROBLES SJ, 1990, SCIENCE, V248, P1402, DOI 10.1126/science.2192455; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; TAGUCHI AKW, 1992, BIOCHEMISTRY-US, V31, P10345, DOI 10.1021/bi00157a024; Wakeham MC, 2005, BIOCHEM SOC T, V33, P851, DOI 10.1042/BST0330851; Wakeham MC, 2003, BBA-BIOENERGETICS, V1607, P53, DOI 10.1016/j.bbabio.2003.08.008; Wakeham MC, 2003, FEBS LETT, V540, P234, DOI 10.1016/S0014-5793(03)00270-9; Watson AJ, 2005, BBA-BIOENERGETICS, V1710, P34, DOI 10.1016/j.bbabio.2005.08.005; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; WILLIAMS JC, 1992, BIOCHEMISTRY-US, V31, P11029, DOI 10.1021/bi00160a012; Wise KJ, 2002, TRENDS BIOTECHNOL, V20, P387, DOI 10.1016/S0167-7799(02)02023-1; YOUVAN DC, 1985, GENE, V38, P19, DOI 10.1016/0378-1119(85)90199-4; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	58	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8507	8514		10.1074/jbc.M111.326447	http://dx.doi.org/10.1074/jbc.M111.326447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247556	hybrid, Green Published			2022-12-25	WOS:000301349400064
J	Helfer, S; Schott, J; Stoecklin, G; Forstemann, K				Helfer, Stephanie; Schott, Johanna; Stoecklin, Georg; Foerstemann, Klaus			AU-Rich Element-Mediated mRNA Decay Can Occur Independently of the miRNA Machinery in Mouse Embryonic Fibroblasts and Drosophila S2-Cells	PLOS ONE			English	Article							GFP-BASED ASSAY; TRISTETRAPROLIN; MICRORNA; PROTEIN; IDENTIFICATION; REPRESSION; COMPLEXES; TURNOVER; DATABASE; STRESS	AU-rich elements (AREs) are regulatory sequences located in the 39 untranslated region of many short-lived mRNAs. AREs are recognized by ARE-binding proteins and cause rapid mRNA degradation. Recent reports claimed that the function of AREs may be - at least in part - relayed through the miRNA pathway. We have revisited this hypothesis using dicer knockout mouse embryonic fibroblasts and cultured Drosophila cells. In contrast to the published results, we find no evidence for a general requirement of the miRNA pathway in the function of AREs. Endogenous ier3 mRNA, which is known to contain a functional ARE, was degraded rapidly at indistinguishable rates in wild type and dicer knock-out mouse embryonic fibroblasts. In cultured Drosophila cells, both ARE-containing GFP reporter mRNAs and the endogenous cecA1 mRNA were resistant to depletion of the mi/siRNA factors dcr-1, dcr-2, ago1 and ago2. Furthermore, the Drosophila miRNA originally proposed to recognize AU-rich elements, miR-289, is not detectably expressed in flies or cultured S2 cells. Even our attempts to overexpress this miRNA from its genomic hairpin sequence failed. Thus, this sequence cannot serve as link between the miRNA and the AU-rich element mediated silencing pathways. Taken together, our studies in mammalian and Drosophila cells strongly argue that AREs can function independently of miRNAs.	[Helfer, Stephanie; Foerstemann, Klaus] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany; [Schott, Johanna; Stoecklin, Georg] German Canc Res Ctr DKFZ ZMBH Alliance, Helmholtz Jr Res Grp Posttranscript Control Gene, Heidelberg, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Helfer, S (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany.	Foerstemann@lmb.uni-muenchen.de		Stoecklin, Georg/0000-0001-9284-9834	Deutsche Forschungsgemeinschaft (DFG) [FO-360/2, STO 859/2-1, Sonderforschungsbereich 646]; Helmholtz Gemeinschaft [HZ-NG-210]; Munich Center for Integrated Protein Science CIPSM; Human Frontier Science Program Career Development Award	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Gemeinschaft(Helmholtz Association); Munich Center for Integrated Protein Science CIPSM; Human Frontier Science Program Career Development Award	This work was funded by a Deutsche Forschungsgemeinschaft (DFG) research grant to KF (FO-360/2), a young investigator grant (HZ-NG-210) from the Helmholtz Gemeinschaft to GS, a DFG research grant (STO 859/2-1) to GS and JS, the DFG Sonderforschungsbereich 646 and the Munich Center for Integrated Protein Science CIPSM. KF is the recipient of a Human Frontier Science Program Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benjamin D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh086; Benjamin D, 2006, MOL BIOSYST, V2, P561, DOI 10.1039/b609448a; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Shah C, 2008, BBA-GENE REGUL MECH, V1779, P766, DOI 10.1016/j.bbagrm.2008.06.008; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Soller M, 2005, MOL CELL BIOL, V25, P7580, DOI 10.1128/MCB.25.17.7580-7591.2005; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; VASUDEVAN S, 2007, SCIENCE; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	26	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e28907	10.1371/journal.pone.0028907	http://dx.doi.org/10.1371/journal.pone.0028907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253700	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500003
J	Alexander, KA; Janssen, R; Arciniegas, G; O'Higgins, TG; Eikelboom, T; Wilding, TA				Alexander, Karen A.; Janssen, Ron; Arciniegas, Gustavo; O'Higgins, Timothy G.; Eikelboom, Tessa; Wilding, Thomas A.			Interactive Marine Spatial Planning: Siting Tidal Energy Arrays around the Mull of Kintyre	PLOS ONE			English	Article							DECISION-SUPPORT; SCIENCE; SYSTEM	The rapid development of the offshore renewable energy sector has led to an increased requirement for Marine Spatial Planning (MSP) and, increasingly, this is carried out in the context of the 'ecosystem approach' (EA) to management. We demonstrate a novel method to facilitate implementation of the EA. Using a real-time interactive mapping device (touch-table) and stakeholder workshops we gathered data and facilitated negotiation of spatial trade-offs at a potential site for tidal renewable energy off the Mull of Kintyre (Scotland). Conflicts between the interests of tidal energy developers and commercial and recreational users of the area were identified, and use preferences and concerns of stakeholders were highlighted. Social, cultural and spatial issues associated with conversion of common pool to private resource were also revealed. The method identified important gaps in existing spatial data and helped to fill these through interactive user inputs. The workshops developed a degree of consensus between conflicting users on the best areas for potential development suggesting that this approach should be adopted during MSP.	[Alexander, Karen A.; O'Higgins, Timothy G.; Wilding, Thomas A.] Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland; [Janssen, Ron; Arciniegas, Gustavo; Eikelboom, Tessa] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands	UHI Millennium Institute; Vrije Universiteit Amsterdam	Alexander, KA (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland.	Karen.Alexander@sams.ac.uk	Alexander, Karen/O-7042-2017; Wilding, Tom/AAN-8904-2020; O'Higgins, Tim/G-6717-2015; Janssen, R./L-1346-2013	Alexander, Karen/0000-0001-8801-413X; O'Higgins, Tim/0000-0003-1274-4480; Janssen, R./0000-0001-6257-3507; Wilding, Thomas/0000-0002-4946-4020; Arciniegas, Gustavo/0000-0002-9211-5467	European Research Development Fund; Highland and Islands Enterprise; European Community [226675]; Knowledge for Climate Research Programme; NERC [dml010007, dml010005] Funding Source: UKRI; Natural Environment Research Council [dml010007, dml010005] Funding Source: researchfish	European Research Development Fund; Highland and Islands Enterprise; European Community(European Commission); Knowledge for Climate Research Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for KAA and TAW was obtained from the European Research Development Fund and Highland and Islands Enterprise. TGO was funded from the European Community's Seventh Framework Programme [FP7/2007-2013](grant: 226675). RJ and GA were funded by the European Community's Seventh Framework Programme [FP7/2007-2013](grant: 226675), and the Knowledge for Climate Research Programme. TE was funded by the Knowledge for Climate Research Programme. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciniegas G, 2011, INT J GEOGR INF SYST, P1; Bacic ILZ, 2006, LANDSCAPE URBAN PLAN, V77, P54, DOI 10.1016/j.landurbplan.2005.01.005; BBC News Scotland, 2011, BBC NEWS SCOTLAND; Begg K, 2009, SPATIAL PLANNING MAR; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Cabral RB, 2011, OCEAN COAST MANAGE, V54, P66, DOI 10.1016/j.ocecoaman.2010.10.023; Commission of the European Communities, 2007, REN EN ROADM REN EN; Daw T, 2005, MAR POLICY, V29, P189, DOI 10.1016/j.marpol.2004.03.003; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; European Union, 2008, OFF J           0617; European Union, 2010, OFF J           0901; GESAMP (IMO/FAO/UNESCO-IOC/WMO/WHO/IAEA/UN/UNEP Joint Group of Experts on the Scientific Aspects of Marine Environmental Protection), 2001, SEA TROUBL AR NORW G; Goosen H, 2007, ECOL ENG, V30, P187, DOI 10.1016/j.ecoleng.2006.11.004; Gray T, 2005, OFFSHORE WIND FARMS, P127; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hofstra H., 2008, REMOTE SENSING GIS T, P243, DOI [DOI 10.1007/978-3-540-79259-8_14, 10.1007/978-3-540-79259-8_14]; Jay S, 2009, MARINE POLL IN PRESS; Jobert A, 2007, ENERG POLICY, V35, P2751, DOI 10.1016/j.enpol.2006.12.005; Johansson TB, 2004, ENERGY SUSTAIN DEV, V8, P5, DOI DOI 10.1016/S0973-0826(08)60387-7; Kaiser MJ, 2000, CONSERV BIOL, V14, P1512, DOI 10.1046/j.1523-1739.2000.99264.x; Ladenburg J, 2009, OCEAN COAST MANAGE, V52, P233, DOI 10.1016/j.ocecoaman.2009.02.002; Mackinson S, 1998, REV FISH BIOL FISHER, V8, P481, DOI 10.1023/A:1008847106984; Mackinson S., 2006, REPORT PERCEPTIONS F; Marine Energy Group, 2009, MAR EN ROAD MAP; Marine Management Organisation, 2011, MAR PLANN PORT; MarineMap Consortium, 2011, MAR MAP DEC SUPP MAR; [Maritime and Coastguard Agency Agency MaC], OFFSH REN EN INST OR; Matthies M, 2007, ENVIRON MODELL SOFTW, V22, P123, DOI 10.1016/j.envsoft.2005.09.005; Maurstad A, 2002, MAR POLICY, V26, P159, DOI 10.1016/S0308-597X(01)00045-8; MCZ Project, 2010, MCZ PROJ INT MAP; O'Higgins TG, 2010, ECOL SOC, V15; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pelizaro C, 2009, PLANNING SUPPORT SYS; Pendleton L, 2007, OCEAN COAST MANAGE, V50, P363, DOI 10.1016/j.ocecoaman.2006.11.004; Pettit CJ, 2005, ENVIRON PLANN B, V32, P523, DOI 10.1068/b31109; ROBERTS CM, 1993, AMBIO, V22, P363; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Schroth O, 2011, MULTIPLE CASE STUDY; Scottish Development International, 2011, SALT PRIZ; Sowman M, 2011, ENVIRON MANAGE, V47, P573, DOI 10.1007/s00267-010-9499-x; St Martin K, 2008, MAR POLICY, V32, P779, DOI 10.1016/j.marpol.2008.03.015; Stinson BL, 1999, CONCENSUS BUILDING H; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Toke D, 2011, ENERG POLICY, V39, P526, DOI 10.1016/j.enpol.2010.08.043; Vonk G, 2010, LANDSCAPE URBAN PLAN, V94, P166, DOI 10.1016/j.landurbplan.2009.10.001; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zerger A, 2011, ENVIRON MODELL SOFTW, V26, P103, DOI 10.1016/j.envsoft.2010.04.001	48	58	60	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30031	10.1371/journal.pone.0030031	http://dx.doi.org/10.1371/journal.pone.0030031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906ON	22253865	Green Published, gold			2022-12-25	WOS:000301355700077
J	Ilan, L; Katzav, S				Ilan, Lena; Katzav, Shulamit			Human Vav1 Expression in Hematopoietic and Cancer Cell Lines Is Regulated by c-Myb and by CpG Methylation	PLOS ONE			English	Article							DRIVE TRANSGENE EXPRESSION; SIGNAL TRANSDUCER VAV1; TRANSCRIPTIONAL REGULATION; FIBROBLAST TRANSFORMATION; GDP/GTP EXCHANGE; LUNG-CANCER; IN-VITRO; GENE; PROTOONCOGENE; ACTIVATION	Vav1 is a signal transducer protein that functions as a guanine nucleotide exchange factor for the Rho/Rac GTPases in the hematopoietic system where it is exclusively expressed. Recently, Vav1 was shown to be involved in several human malignancies including neuroblastoma, lung cancer, and pancreatic ductal adenocarcinoma (PDA). Although some factors that affect vav1 expression are known, neither the physiological nor pathological regulation of vav1 expression is completely understood. We demonstrate herein that mutations in putative transcription factor binding sites at the vav1 promoter affect its transcription in cells of different histological origin. Among these sites is a consensus site for c-Myb, a hematopoietic-specific transcription factor that is also found in Vav1-expressing lung cancer cell lines. Depletion of c-Myb using siRNA led to a dramatic reduction in vav1 expression in these cells. Consistent with this, co-transfection of c-Myb activated transcription of a vav1 promoter-luciferase reporter gene construct in lung cancer cells devoid of Vav1 expression. Together, these results indicate that c-Myb is involved in vav1 expression in lung cancer cells. We also explored the methylation status of the vav1 promoter. Bisulfite sequencing revealed that the vav1 promoter was completely unmethylated in human lymphocytes, but methylated to various degrees in tissues that do not normally express vav1. The vav1 promoter does not contain CpG islands in proximity to the transcription start site; however, we demonstrated that methylation of a CpG dinucleotide at a consensus Sp1 binding site in the vav1 promoter interferes with protein binding in vitro. Our data identify two regulatory mechanisms for vav1 expression: binding of c-Myb and CpG methylation of 59 regulatory sequences. Mutation of other putative transcription factor binding sites suggests that additional factors regulate vav1 expression as well.	[Ilan, Lena; Katzav, Shulamit] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Ilan, L (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	shulamitk@ekmd.huji.ac.il		Ilan, Lena/0000-0002-7300-4606	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	This work was partially supported by grants from the Israel Academy of Sciences, Israel Cancer Research Foundation, The Israeli Cancer Association and the Hubert H. Humphrey Center for Experimental Medicine and Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarza E, 2004, EXP HEMATOL, V32, P360, DOI 10.1016/j.exphem.2004.01.005; Almarza E, 2011, HUM GENE THER, V22, P263, DOI 10.1089/hum.2010.119; Anantharaman A, 2011, MOL CELL BIOL, V31, P1332, DOI 10.1128/MCB.01186-10; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; BROWER M, 1986, CANCER RES, V46, P798; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1994, ONCOGENE, V9, P2405; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Chen RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-172; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Denkinger DJ, 2002, J CELL BIOCHEM, V84, P772, DOI 10.1002/jcb.10089; Denkinger DJ, 1997, EXP CELL RES, V232, P388, DOI 10.1006/excr.1997.3535; Feng DX, 2005, P NATL ACAD SCI USA, V102, P9896, DOI 10.1073/pnas.0502041102; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Katryniok C, 2010, BBA-MOL CELL BIOL L, V1801, P49, DOI 10.1016/j.bbalip.2009.09.003; KATZAV S, 1995, ONCOGENE, V11, P1079; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lazer G, 2010, J BIOL CHEM, V285, P23073, DOI 10.1074/jbc.M109.094508; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; MOUTHON MA, 1993, BLOOD, V81, P647; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Ogilvy S, 1999, BLOOD, V94, P1855; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schapira V, 2006, CANCER RES, V66, P6183, DOI 10.1158/0008-5472.CAN-05-3735; Sincic N, 2011, CURR OPIN ONCOL, V23, P69, DOI 10.1097/CCO.0b013e3283412eb4; Sokalski KM, 2011, BLOOD; Turner SD, 2003, ONCOGENE, V22, P7750, DOI 10.1038/sj.onc.1207048; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; WEISS A, 1984, J IMMUNOL, V133, P123; Wilson NK, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt47	52	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29939	10.1371/journal.pone.0029939	http://dx.doi.org/10.1371/journal.pone.0029939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253833	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700067
J	Rittmeyer, EN; Allison, A; Grundler, MC; Thompson, DK; Austin, CC				Rittmeyer, Eric N.; Allison, Allen; Gruendler, Michael C.; Thompson, Derrick K.; Austin, Christopher C.			Ecological Guild Evolution and the Discovery of the World's Smallest Vertebrate	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; AMPHIBIA ANURA MICROHYLIDAE; SOUTHERN HIGHLANDS PROVINCE; LOWER SIZE LIMIT; CHOEROPHRYNE ANURA; COPHIXALUS ANURA; BODY-SIZE; ANCESTRAL STATES; CRANIAL ONTOGENY; DIMINUTIVE FROG	Living vertebrates vary drastically in body size, yet few taxa reach the extremely minute size of some frogs and teleost fish. Here we describe two new species of diminutive terrestrial frogs from the megadiverse hotspot island of New Guinea, one of which represents the smallest known vertebrate species, attaining an average body size of only 7.7 mm. Both new species are members of the recently described genus Paedophryne, the four species of which are all among the ten smallest known frog species, making Paedophryne the most diminutive genus of anurans. This discovery highlights intriguing ecological similarities among the numerous independent origins of diminutive anurans, suggesting that minute frogs are not mere oddities, but represent a previously unrecognized ecological guild.	[Rittmeyer, Eric N.; Austin, Christopher C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Rittmeyer, Eric N.; Austin, Christopher C.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Allison, Allen] Bernice P Bishop Museum, Honolulu, HI USA; [Gruendler, Michael C.; Thompson, Derrick K.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Cornell University	Rittmeyer, EN (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	ccaustin@lsu.edu			National Science Foundation [DEB 0103794, DEB 0743890, DEB 0445213, DBI 0400797]; Division Of Environmental Biology [0743890] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation grants DEB 0103794 and DEB 0743890 to AA and DEB 0445213 and DBI 0400797 to CCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Santos M, 2011, J HERPETOL, V45, P251, DOI 10.1670/10-015.1; Alves ACR, 2006, HERPETOLOGICA, V62, P221, DOI 10.1655/05-41.1; Austin CC, 2010, MOL PHYLOGENET EVOL, V57, P227, DOI 10.1016/j.ympev.2010.06.005; Austin CC, 2010, CONSERV GENET, V11, P889, DOI 10.1007/s10592-009-9931-z; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Chakrabarty P, 2010, ZOOTAXA, P67, DOI 10.11646/zootaxa.2632.1.4; Davies H. L, 1996, PETROLEUM EXPLORATIO, P53; Davies HL, 1997, GEM 97: PNG GEOLOGY EXPLORATION AND MINING CONFERENCE, PROCEEDINGS, P61; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman William E., 1995, University of Kansas Science Bulletin, V55, P329; Estrada AR, 1996, COPEIA, P852, DOI 10.2307/1447647; Estrada AR, 1996, HERPETOLOGICA, V52, P435; Giaretta AA, 1998, COPEIA, P985, DOI 10.2307/1447345; Glaw F., 1992, FIELD GUIDE AMPHIBIA; Guenther Rainer, 2010, Bonn Zoological Bulletin, V57, P231; Guenther Rainer, 2006, Herpetozoa, V19, P59; Guenther Rainer, 2009, Vertebrate Zoology, V59, P147; Guenther Rainer, 2009, Zoosystematics and Evolution, V85, P171, DOI 10.1002/zoos.200900002; Guenther Rainer, 2009, Vertebrate Zoology, V59, P81; Guenther Rainer, 2008, Acta Zoologica Sinica, V54, P653; Gunther R., 2001, SPIXIANA, V24, P257; Gunther R., 2000, MITTEILUNGEN MUSEUM, V76, P167; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; HANKEN J, 1992, J MORPHOL, V211, P95, DOI 10.1002/jmor.1052110111; HANKEN J, 1994, COPEIA, P573; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hedges SB, 2001, CARIBB J SCI, V37, P168; HEDGES SB, 1988, COPEIA, P636, DOI 10.2307/1445381; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS180, DOI 10.1098/rsbl.2003.0136; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inger R.F., 1979, Sarawak Museum Journal, V27, P311; Kerney R, 2007, J MORPHOL, V268, P715, DOI 10.1002/jmor.10545; Kohler F, 2008, MOL PHYLOGENET EVOL, V47, P353, DOI 10.1016/j.ympev.2007.11.032; Kottelat M, 2006, P ROY SOC B-BIOL SCI, V273, P895, DOI 10.1098/rspb.2005.3419; Kraus F, 2005, COPEIA, P312, DOI 10.1643/CH-04-093R1; Kraus F, 2006, HERPETOLOGICA, V62, P202, DOI 10.1655/05-09.1; Kraus F, 2010, ZOOKEYS, P39, DOI 10.3897/zookeys.48.446; Kraus Fred, 2009, Bishop Museum Occasional Papers, V104, P1; Kraus F, 2009, COPEIA, P690, DOI 10.1643/CH-09-015; Kraus F, 2009, ZOOKEYS, P53, DOI 10.3897/zookeys.26.258; Kraus F, 2009, ZOOTAXA, P1; Krugel P, 1995, COPEIA, P955; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehr E, 2009, COPEIA, P148, DOI 10.1643/CH-07-270; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; LYNCH J D, 1976, Herpetologica, V32, P48; MACLEAN WP, 1985, COMP BIOCHEM PHYS A, V82, P759, DOI 10.1016/0300-9629(85)90479-7; Maddison, 2019, MESQUITE MODULAR SYS; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Matsui Masafumi, 2011, Zootaxa, V2814, P33; Menzies J., 2006, FROGS NEW GUINEA SOL; Menzies JI, 1976, HDB COMMON NEW GUINE; NELSON C E, 1975, Journal of Herpetology, V9, P81, DOI 10.2307/1562693; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pombal JP, 2007, REV BRAS ZOOL, V24, P841, DOI 10.1590/S0101-81752007000300034; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, TRACER V1 4; Ribeiro Luiz F., 2005, Boletim do Museu Nacional Rio de Janeiro Zoologia, P1; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; Richards S, 2000, RAFFLES B ZOOL, V48, P257; Richards SJ, 2007, T ROY SOC SOUTH AUST, V131, P135, DOI 10.1080/03721426.2007.10887076; Richards SJ, 2003, T ROY SOC SOUTH AUST, V127, P47; Richards SJ, 2007, PAC SCI, V61, P279, DOI 10.2984/1534-6188(2007)61[279:ANSOCA]2.0.CO;2; Richards SJ, 2010, J HERPETOL, V44, P555, DOI 10.1670/09-044.1; Richards Stephen J., 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P83, DOI 10.1002/mmnz.200600030; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Toledo Luis Felipe, 2005, Herpetological Review, V36, P395; Tracy CR, 2008, COMP BIOCHEM PHYS A, V150, P102, DOI 10.1016/j.cbpa.2006.04.031; TRUEB L, 1985, FORTS ZOOL, V30, P113; Van der Meijden A, 2007, BIOL J LINN SOC, V91, P347, DOI 10.1111/j.1095-8312.2007.00800.x; Walker C.F., 1973, Occasional Papers Mus Nat Hist Univ Kans, VNo. 20, P1; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Yeh J, 2002, EVOLUTION, V56, P628; Young JE, 2006, COPEIA, P83, DOI 10.1643/0045-8511(2006)006[0083:ROCEWL]2.0.CO;2; Young JE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P847, DOI 10.1086/432152; Zweifel R.G., 1989, American Museum Novitates, P1; ZWEIFEL R G, 1972, Bulletin of the American Museum of Natural History, V148, P415; Zweifel R.G., 1979, AM MUS NOVIT, V2678, P1; ZWEIFEL RG, 1980, PAC SCI, V34, P269; Zweifel RG, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)415<0001:SOMFGO>2.0.CO;2; Zweifel RG, 2000, B AM MUS NAT HIST, P4; Zweifel RG, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)495[0001:SOMFGO]2.0.CO;2; Zweifel RG, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)419<0001:ANSOMF>2.0.CO;2; ZWEIFEL RG, 1982, AM MUS NOVIT, P1; ZWEIFEL RICHARP G., 1963, AMER MUS NOVITATES, V2141, P1; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	95	58	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29797	10.1371/journal.pone.0029797	http://dx.doi.org/10.1371/journal.pone.0029797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253785	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700052
J	Selsby, JT; Morine, KJ; Pendrak, K; Barton, ER; Sweeney, HL				Selsby, Joshua T.; Morine, Kevin J.; Pendrak, Klara; Barton, Elisabeth R.; Sweeney, H. Lee			Rescue of Dystrophic Skeletal Muscle by PGC-1 alpha Involves a Fast to Slow Fiber Type Shift in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; UTROPHIN GENE; NEUROMUSCULAR-JUNCTION; CELL-DEATH; MICE; CALCIUM; SIRT1; RESVERATROL	Increased utrophin expression is known to reduce pathology in dystrophin-deficient skeletal muscles. Transgenic overexpression of PGC-1 alpha has been shown to increase levels of utrophin mRNA and improve the histology of mdx muscles. Other reports have shown that PGC-1 alpha signaling can lead to increased oxidative capacity and a fast to slow fiber type shift. Given that it has been shown that slow fibers produce and maintain more utrophin than fast skeletal muscle fibers, we hypothesized that over-expression of PGC-1 alpha in post-natal mdx mice would increase utrophin levels via a fiber type shift, resulting in more slow, oxidative fibers that are also more resistant to contraction-induced damage. To test this hypothesis, neonatal mdx mice were injected with recombinant adeno-associated virus (AAV) driving expression of PGC-1 alpha. PGC-1 alpha over-expression resulted in increased utrophin and type I myosin heavy chain expression as well as elevated mitochondrial protein expression. Muscles were shown to be more resistant to contraction-induced damage and more fatigue resistant. Sirt-1 was increased while p38 activation and NRF-1 were reduced in PGC-1 alpha over-expressing muscle when compared to control. We also evaluated if the use a pharmacological PGC-1 alpha pathway activator, resveratrol, could drive the same physiological changes. Resveratrol administration (100 mg/kg/day) resulted in improved fatigue resistance, but did not achieve significant increases in utrophin expression. These data suggest that the PGC-1 alpha pathway is a potential target for therapeutic intervention in dystrophic skeletal muscle.	[Selsby, Joshua T.; Morine, Kevin J.; Pendrak, Klara; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Selsby, Joshua T.] Iowa State Univ, Coll Agr & Life Sci, Dept Anim Sci, Ames, IA USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Iowa State University; University of Pennsylvania	Selsby, JT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	lsweeney@mail.med.upenn.edu			Center for Integrated Animal Genomics; National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR052646-03];  [F32AR055005-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646, F32AR055005] Funding Source: NIH RePORTER	Center for Integrated Animal Genomics; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by F32AR055005-01 (Dr. Selsby), the Center for Integrated Animal Genomics (Dr. Selsby) and U54AR052646-03 (Dr. Sweeney) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Barton ER, 2010, J BIOL CHEM, V285, P17263, DOI 10.1074/jbc.M109.063990; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bertoni C, 2008, FRONT BIOSCI-LANDMRK, V13, P517, DOI 10.2741/2697; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; COHEN L, 1977, RES COMMUN CHEM PATH, V17, P529; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; FDA drug safety communications, 2010, FDA DRUG SAF COMM ON; Foster K, 2006, GENE THER, V13, P1677, DOI 10.1038/sj.gt.3302877; Galvagni F, 2002, J BIOL CHEM, V277, P19106, DOI 10.1074/jbc.M109642200; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gardan-Salmon D, 2011, EUR J APPL PHYSIOL, V111, P2763, DOI 10.1007/s00421-011-1906-3; Gardan-Salmon D, EUR J APPL IN PRESS; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gramolini AO, 1997, J BIOL CHEM, V272, P8117, DOI 10.1074/jbc.272.13.8117; Grounds MD, 2007, NEUROMUSCULAR DISORD, V17, P206, DOI 10.1016/j.nmd.2007.01.007; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Herrero A, 1997, J BIOENERG BIOMEMBR, V29, P241, DOI 10.1023/A:1022458010266; Hirst R C, 2005, Acta Myol, V24, P209; Hopf F. W., 2007, V45, P429; Kleopa KA, 2006, HUM MOL GENET, V15, P1623, DOI 10.1093/hmg/ddl083; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LUCASHERON B, 1990, J NEUROL SCI, V95, P327, DOI 10.1016/0022-510X(90)90078-2; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morine K, 2010, HUM GENE THER; Morine KJ, 2010, MUSCLE NERVE, V42, P722, DOI 10.1002/mus.21743; Morris CA, 2010, J APPL PHYSIOL, V109, P1492, DOI 10.1152/japplphysiol.01283.2009; MURATA M, 1994, HEPATOLOGY, V19, P1223, DOI 10.1016/0270-9139(94)90870-2; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Selsby J, 2010, AM J PHYSIOL-REG I, V299, pR1192, DOI 10.1152/ajpregu.00586.2009; Selsby JT, 2011, EXP PHYSIOL, V96, P194, DOI 10.1113/expphysiol.2010.054379; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; STARK K, 1989, BIOCHEM BIOPH RES CO, V165, P858, DOI 10.1016/S0006-291X(89)80045-2; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin HF, 2008, MOL THER, V16, P38, DOI 10.1038/sj.mt.6300329; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	68	139	141	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30063	10.1371/journal.pone.0030063	http://dx.doi.org/10.1371/journal.pone.0030063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253880	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700085
J	Zhang, TY; Li, SY; Nuermberger, EL				Zhang, Tianyu; Li, Si-Yang; Nuermberger, Eric L.			Autoluminescent Mycobacterium tuberculosis for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy	PLOS ONE			English	Article							BACTERIAL LUCIFERASE; REPORTER; PLASMIDS; LUXCDABE; GENES; CURE	Preclinical efforts to discover and develop new drugs and vaccines for tuberculosis are hampered by the reliance on colony-forming unit (CFU) counts as primary outcomes for in vivo efficacy studies and the slow growth of Mycobacterium tuberculosis. The utility of bioluminescent M. tuberculosis reporter strains for real-time in vitro and ex vivo assessment of drug and vaccine activity has been demonstrated but a simple, non-invasive, real-time surrogate marker to replace CFU counts for real-time evaluation of drug and vaccine efficacy in vivo has not been described. We describe the development of a fully virulent and stable autoluminescent strain of M. tuberculosis and proof-of-concept experiments demonstrating its utility for in vivo bioluminescence imaging to assess the efficacy of new drugs and vaccines for tuberculosis in a mouse model. Relative light unit (RLU) counts paralleled CFU counts during the active phase of bacterial growth, with a lower limit of detection of approximately 10(6) CFU in live, anesthetized mice. Experiments distinguishing active from inactive anti-tuberculosis drugs and bacteriostatic drug effects from bactericidal effects were completed in less than 5 days. The ability of a recombinant BCG vaccine to limit bacterial growth was demonstrated within 3 weeks. Use of this autoluminescent reporter strain has the potential to drastically reduce the time, effort, animals and costs consumed in the evaluation of drug activity in vitro and the in vivo assessment of drug and vaccine efficacy.	[Zhang, Tianyu; Li, Si-Yang; Nuermberger, Eric L.] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA; [Zhang, Tianyu] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Ctr Infect & Immun, Guangzhou, Guangdong, Peoples R China; [Nuermberger, Eric L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, TY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA.	enuermb@jhmi.edu	Zhang, Tianyu/K-4801-2015	Zhang, Tianyu/0000-0001-5647-6014	National Institute of Allergy and Infectious Diseases [R01 AI082612]; Bill & Melinda Gates Foundation [42851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082612] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (R01 AI082612) and by a TB Drug Accelerator grant (#42851) from The Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1536, DOI 10.1128/AAC.40.6.1536; Craney A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm086; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Demidova TN, 2005, J PHOTOCH PHOTOBIO B, V81, P15, DOI 10.1016/j.jphotobiol.2005.05.007; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Heuts F, 2009, MICROBES INFECT, V11, P1114, DOI 10.1016/j.micinf.2009.08.005; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Roberts EA, 2005, FEMS MICROBIOL LETT, V243, P243, DOI 10.1016/j.femsle.2004.12.010; Saviola B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh005; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Szittner R, 2003, BIOCHEM BIOPH RES CO, V309, P66, DOI 10.1016/S0006-291X(03)01530-4; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Williams KN, 2009, AM J RESP CRIT CARE, V180, P371, DOI 10.1164/rccm.200904-0611OC; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Zhang M, 2011, AM J RESP CRIT CARE, V183, P1254, DOI 10.1164/rccm.201012-1949OC; Zhang TY, 2011, ANTIMICROB AGENTS CH, V55, P56, DOI 10.1128/AAC.01260-10; Zhang TY, 2010, ANTIMICROB AGENTS CH, V54, P2806, DOI 10.1128/AAC.00400-10; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	27	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29774	10.1371/journal.pone.0029774	http://dx.doi.org/10.1371/journal.pone.0029774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253776	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700048
J	Bai, H; Sang, GJ; You, Y; Xue, XY; Zhou, Y; Hou, Z; Meng, JR; Luo, XX				Bai, Hui; Sang, Guojun; You, Yu; Xue, Xiaoyan; Zhou, Ying; Hou, Zheng; Meng, Jingru; Luo, Xiaoxing			Targeting RNA Polymerase Primary sigma(70) as a Therapeutic Strategy against Methicillin-Resistant Staphylococcus aureus by Antisense Peptide Nucleic Acid	PLOS ONE			English	Article							ESCHERICHIA-COLI; INHIBITION; BACTEREMIA; CHALLENGES; MRSA; OLIGONUCLEOTIDES; INFECTIONS; EXPRESSION; VIRULENCE; PNA	Background: Methicillin-resistant Staphylococcus aureus (MRSA) causes threatening infection-related mortality worldwide. Currently, spread of multi-drug resistance (MDR) MRSA limits therapeutic options and requires new approaches to "druggable" target discovery, as well as development of novel MRSA-active antibiotics. RNA polymerase primary sigma(70) (encoded by gene rpoD) is a highly conserved prokaryotic factor essential for transcription initiation in exponentially growing cells of diverse S. aureus, implying potential for antisense inhibition. Methodology/Principal Findings: By synthesizing a serial of cell penetrating peptide conjugated peptide nucleic acids (PPNAs) based on software predicted parameters and further design optimization, we identified a target sequence (234 to 243 nt) within rpoD mRNA conserved region 3.0 being more sensitive to antisense inhibition. A (KFF)(3)K peptide conjugated 10-mer complementary PNA (PPNA2332) was developed for potent micromolar-range growth inhibitory effects against four pathogenic S. aureus strains with different resistance phenotypes, including clinical vancomycin-intermediate resistance S. aureus and MDR-MRSA isolates. PPNA2332 showed bacteriocidal antisense effect at 3.2 fold of MIC value against MRSA/VISA Mu50, and its sequence specificity was demonstrated in that PPNA with scrambled PNA sequence (Scr PPNA2332) exhibited no growth inhibitory effect at higher concentrations. Also, PPNA2332 specifically interferes with rpoD mRNA, inhibiting translation of its protein product sigma(70) in a concentration-dependent manner. Full decay of mRNA and suppressed expression of sigma(70) were observed for 40 mu M or 12.5 mu M PPNA2332 treatment, respectively, but not for 40 mu M Scr PPNA2332 treatment in pure culture of MRSA/VISA Mu50 strain. PPNA2332 (>= 1 mu M) essentially cleared lethal MRSA/VISA Mu50 infection in epithelial cell cultures, and eliminated viable bacterial cells in a time- and concentration- dependent manner, without showing any apparent toxicity at 10 mu M. Conclusions:The present result suggested that RNAP primary sigma(70) is a very promising candidate target for developing novel antisense antibiotic to treat severe MRSA infections.	[Bai, Hui; Sang, Guojun; Xue, Xiaoyan; Zhou, Ying; Hou, Zheng; Meng, Jingru; Luo, Xiaoxing] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China; [Bai, Hui] 451 Hosp, Xian, Shaanxi, Peoples R China; [Bai, Hui] Acad Mil Med Sci, Beijing Inst Radiat Med, Beijing, Peoples R China; [You, Yu] Hosp 309, Dept Neurosurg, Beijing, Peoples R China	Air Force Military Medical University; Academy of Military Medical Sciences - China	Bai, H (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China.	xxluo3@fmmu.edu.cn	Hou, Zheng/AAE-5173-2020	/0000-0002-0358-7869	National Natural Science Foundation of China [30973666]; Graduate School of Fourth Military Medical University [2009D11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate School of Fourth Military Medical University	This work was supported by National Natural Science Foundation of China (National Fund for Natural Science 30973666 to X.X.L.) and Graduate School of Fourth Military Medical University (special fund for doctoral dissertation 2009D11 to H.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Hui, 2011, Infectious Disorders - Drug Targets, V11, P175; Bai Hui, 2010, Curr Drug Discov Technol, V7, P76; Bal AM, 2011, CURR OPIN INFECT DIS, V24, P357, DOI 10.1097/QCO.0b013e3283483262; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Borukhov S, 2008, TRENDS MICROBIOL, V16, P126, DOI 10.1016/j.tim.2007.12.006; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Cataldo MA, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.11.2218; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deere J, 2005, ANTIMICROB AGENTS CH, V49, P249, DOI 10.1128/AAC.49.1.249-255.2005; Eriksson M, 2002, J BIOL CHEM, V277, P7144, DOI 10.1074/jbc.M106624200; Forcade NA, 2011, J AM BOARD FAM MED, V24, P543, DOI 10.3122/jabfm.2011.05.110073; Gait MJ, 2003, CELL MOL LIFE SCI, V60, P844, DOI 10.1007/s00018-003-3044-5; Geller BL, 2005, CURR OPIN MOL THER, V7, P109; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Gould IM, 2011, INT J ANTIMICROB AG, V37, P202, DOI 10.1016/j.ijantimicag.2010.10.030; Hatamoto M, 2010, APPL MICROBIOL BIOT, V86, P397, DOI 10.1007/s00253-009-2387-8; Imaz A, 2010, AIDS REV, V12, P153; Ippolito G, 2010, INT J INFECT DIS, V14, pS7, DOI 10.1016/j.ijid.2010.05.003; Ji YD, 2004, FEMS MICROBIOL LETT, V231, P177, DOI 10.1016/S0378-1097(03)00931-5; Kaslow DC, 2011, ANNU REV MED, V62, P201, DOI 10.1146/annurev-med-051109-101544; Kern WV, 2010, CURR OPIN INFECT DIS, V23, P346, DOI 10.1097/QCO.0b013e32833bcc8a; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Mellbye BL, 2009, ANTIMICROB AGENTS CH, V53, P525, DOI 10.1128/AAC.00917-08; Meng JR, 2009, ANTIMICROB AGENTS CH, V53, P2871, DOI 10.1128/AAC.01542-08; Morell Emily A., 2010, Yale Journal of Biology and Medicine, V83, P223; Morosini Maria Isabel, 2010, Med Clin (Barc), V135 Suppl 3, P16, DOI 10.1016/S0025-7753(10)70036-1; Nannini E, 2010, CURR OPIN PHARMACOL, V10, P516, DOI 10.1016/j.coph.2010.06.006; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Oliveira DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023287; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Rasmussen LCV, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-24; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Singh P, 2010, DRUG NEWS PERSPECT, V23, P295, DOI 10.1358/dnp.2010.23.5.1429489; Tice AD, 2010, CLIN INFECT DIS, V51, pS171, DOI 10.1086/653517; Tilley LD, 2006, ANTIMICROB AGENTS CH, V50, P2789, DOI 10.1128/AAC.01286-05; Welsh KJ, 2011, J CLIN MICROBIOL, V49, P3669, DOI 10.1128/JCM.05287-11; Welte T, 2010, INT J ANTIMICROB AG, V36, P391, DOI 10.1016/j.ijantimicag.2010.06.045; Wiener-Kronish JP, 2011, SEMIN RESP CRIT CARE, V32, P228, DOI 10.1055/s-0031-1275535; Williams KJ, 1998, J ANTIMICROB CHEMOTH, V42, P597, DOI 10.1093/jac/42.5.597; Wright GD, 2009, CELL HOST MICROBE, V6, P197, DOI 10.1016/j.chom.2009.08.009	41	42	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					196	205	e29886	10.1371/journal.pone.0029886	http://dx.doi.org/10.1371/journal.pone.0029886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253815	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900022
J	Choi, W; Shah, JB; Tran, M; Svatek, R; Marquis, L; Lee, IL; Yu, D; Adam, L; Wen, S; Shen, Y; Dinney, C; McConkey, DJ; Siefker-Radtke, A				Choi, Woonyoung; Shah, Jay B.; Mai Tran; Svatek, Robert; Marquis, Lauren; Lee, I-Ling; Yu, Dasom; Adam, Liana; Wen, Sijin; Shen, Yu; Dinney, Colin; McConkey, David J.; Siefker-Radtke, Arlene			p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; E-CADHERIN; UROTHELIAL CARCINOMA; GENE-EXPRESSION; STEM-CELLS; REDUCED EXPRESSION; TISSUE MICROARRAY; TUMOR PROGRESSION; MIR-200 FAMILY; PROFILES	Background: p63 is a member of the p53 family that has been implicated in maintenance of epithelial stem cell compartments. Previous studies demonstrated that p63 is downregulated in muscle-invasive bladder cancers, but the relationship between p63 expression and survival is not clear. Methodology/Principal Findings. We used real-time PCR to characterize p63 expression and several genes implicated in epithelial-to-mesenchymal transition (EMT) in human bladder cancer cell lines (n = 15) and primary tumors (n = 101). We correlated tumor marker expression with stage, disease-specific (DSS), and overall survival (OS). Expression of E-cadherin and p63 correlated directly with one another and inversely with expression of the mesenchymal markers Zeb-1, Zeb-2, and vimentin. Non-muscle-invasive (Ta and T1) bladder cancers uniformly expressed high levels of E-cadherin and p63 and low levels of the mesenchymal markers. Interestingly, a subset of muscle invasive (T2-T4) tumors maintained high levels of E cadherin and p63 expression. As expected, there was a strongly significant correlation between EMT marker expression and muscle invasion (p<0.0001). However, OS was shorter in patients with muscle-invasive tumors that retained p63 (p = 0.007). Conclusions/Significance:Our data confirm that molecular markers of EMT are elevated in muscle-invasive bladder cancers, but interestingly, retention of the "epithelial" marker p63 in muscle-invasive tumors is associated with a worse outcome.	[Choi, Woonyoung; Shah, Jay B.; Marquis, Lauren; Lee, I-Ling; Yu, Dasom; Adam, Liana; Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Mai Tran] Univ Texas Houston, Hlth Sci Ctr, GSBS, Houston, TX USA; [Svatek, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Wen, Sijin; Shen, Yu] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Siefker-Radtke, Arlene] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Choi, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.	asiefker@mdanderson.org		Shen, Yu/0000-0002-3899-7868; Wen, Sijin/0000-0002-6955-2917; Dinney, Colin/0000-0002-8969-711X; Siefker-Radtke, Arlene/0000-0002-6328-9599	Cancer Center [CA016672]; MD Anderson SPORE in Genitourinary Cancer [CA091846]; NATIONAL CANCER INSTITUTE [P50CA091846, P30CA016672] Funding Source: NIH RePORTER	Cancer Center; MD Anderson SPORE in Genitourinary Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Center Support Grant (CA016672) and the MD Anderson SPORE in Genitourinary Cancer (CA091846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baumgart E, 2007, CLIN CANCER RES, V13, P1685, DOI 10.1158/1078-0432.CCR-06-2330; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; BRINGUIER PP, 1993, CANCER RES, V53, P3241; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; Comperat E, 2006, VIRCHOWS ARCH, V448, P319, DOI 10.1007/s00428-005-0092-2; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He XB, 2009, STEM CELLS, V27, P1487, DOI 10.1002/stem.92; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Koga F, 2003, CLIN CANCER RES, V9, P5501; Koga F, 2003, BRIT J CANCER, V88, P740, DOI 10.1038/sj.bjc.6600764; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; LIPPONEN PK, 1995, J CANCER RES CLIN, V121, P303, DOI 10.1007/BF01209598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Moll UM, 2003, CLIN CANCER RES, V9, P5437; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Park BJ, 2000, CANCER RES, V60, P3370; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Reis JS, 2003, VIRCHOWS ARCH, V443, P122, DOI 10.1007/s00428-003-0859-2; Ripley B, 2002, RPART VERSION, V3, P1; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	42	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					453	462	e30206	10.1371/journal.pone.0030206	http://dx.doi.org/10.1371/journal.pone.0030206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253920	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900046
J	Louzada, S; Adega, F; Chaves, R				Louzada, Sandra; Adega, Filomena; Chaves, Raquel			Defining the Sister Rat Mammary Tumor Cell Lines HH-16 cl.2/1 and HH-16.cl.4 as an In Vitro Cell Model for Erbb2	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; CHROMOSOMAL INSTABILITY; SITU HYBRIDIZATION; DNA METHYLATION; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; 5-METHYLCYTOSINE CONTENT; ALTERED DIFFERENTIATION; CLINICAL-APPLICATIONS; MONOCLONAL-ANTIBODY	Cancer cell lines have been shown to be reliable tools in genetic studies of breast cancer, and the characterization of these lines indicates that they are good models for studying the biological mechanisms underlying this disease. Here, we describe the molecular cytogenetic/genetic characterization of two sister rat mammary tumor cell lines, HH-16 cl.2/1 and HH-16.cl.4, for the first time. Molecular cytogenetic analysis using rat and mouse chromosome paint probes and BAC/PAC clones allowed the characterization of clonal chromosome rearrangements; moreover, this strategy assisted in revealing detected breakpoint regions and complex chromosome rearrangements. This comprehensive cytogenetic analysis revealed an increase in the number of copies of the Mycn and Erbb2 genes in the investigated cell lines. To analyze its possible correlation with expression changes, relative RNA expression was assessed by real-time reverse transcription quantitative PCR and RNA FISH. Erbb2 was found to be overexpressed in HH-16.cl.4, but not in the sister cell line HH-16 cl.2/1, even though these lines share the same initial genetic environment. Moreover, the relative expression of Erbb2 decreased after global genome demethylation in the HH-16.cl.4 cell line. As these cell lines are commercially available and have been used in previous studies, the present detailed characterization improves their value as an in vitro cell model. We believe that the development of appropriate in vitro cell models for breast cancer is of crucial importance for revealing the genetic and cellular pathways underlying this neoplasy and for employing them as experimental tools to assist in the generation of new biotherapies.	[Louzada, Sandra; Adega, Filomena; Chaves, Raquel] Univ Tras Os Montes, Inst Biotechnol & Bioengn, Ctr Genom & Biotechnol, Vila Real, Portugal; [Louzada, Sandra; Adega, Filomena; Chaves, Raquel] Alto Douro IBB CGB UTAD, Vila Real, Portugal; [Chaves, Raquel] Univ Tras Os Montes, Dept Genet & Biotechnol, Vila Real, Portugal	University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro	Louzada, S (corresponding author), Univ Tras Os Montes, Inst Biotechnol & Bioengn, Ctr Genom & Biotechnol, Vila Real, Portugal.	rchaves@utad.pt	Adega, Filomena/J-2875-2013; Chaves, Raquel/S-2882-2019; Chaves, Raquel/K-3044-2013	Adega, Filomena/0000-0001-5646-5534; Chaves, Raquel/0000-0002-5970-7428; Chaves, Raquel/0000-0002-5970-7428; Louzada Gomes Pereira, Sandra/0000-0003-2245-8453	Science and Technology Foundation (FCT) from Portugal [POCI/BIA-BCM/58541/2004, SFRH/BD/25813/2005]	Science and Technology Foundation (FCT) from Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the project POCI/BIA-BCM/58541/2004, the PhD grant SFRH/BD/25813/2005 and a research position on Animal Genomics of the "Sistema Cientifico e Tecnologico Nacional - Ciencia 2007", all from the Science and Technology Foundation (FCT) from Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic T, 2005, GENE CHROMOSOME CANC, V44, P139, DOI 10.1002/gcc.20220; Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bieche I, 1999, CLIN CHEM, V45, P1148; Brown CJ, 1996, J NATL CANCER I, V88, P480, DOI 10.1093/jnci/88.8.480; Chaves R, 2002, CYTOGENET GENOME RES, V96, P113, DOI 10.1159/000063020; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Cuadros M, 2010, PATHOBIOLOGY, V77, P38, DOI 10.1159/000272953; Dirks RW, 2003, METHODS, V29, P51, DOI 10.1016/S1046-2023(02)00290-6; FEINBERG AP, 1988, CANCER RES, V48, P1159; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Glazyrin A, 2007, J HISTOCHEM CYTOCHEM, V55, P25, DOI 10.1369/jhc.6A7017.2006; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; Haag JD, 1996, MOL CARCINOGEN, V17, P134, DOI 10.1002/(SICI)1098-2744(199611)17:3<134::AID-MC5>3.3.CO;2-N; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Hamta A, 2006, CYTOGENET GENOME RES, V115, P158, DOI 10.1159/000095237; Hamta A, 2010, YAKHTEH, V12, P59; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HIRATA J, 1993, CANCER GENET CYTOGEN, V65, P107, DOI 10.1016/0165-4608(93)90216-9; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Karlsson A, 2001, GENE CHROMOSOME CANC, V31, P345, DOI 10.1002/gcc.1153; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kerler R, 1996, CANCER GENET CYTOGEN, V87, P140, DOI 10.1016/0165-4608(95)00215-4; Koelsch BU, 1998, CYTOGENET CELL GENET, V81, P182, DOI 10.1159/000015024; Lahortiga I, 2004, GENE CHROMOSOME CANC, V40, P179, DOI 10.1002/gcc.20033; LAPEYRE JN, 1979, BIOCHEM BIOPH RES CO, V87, P698, DOI 10.1016/0006-291X(79)92015-1; Laurent D, 2001, CANCER GENET CYTOGEN, V125, P52, DOI 10.1016/S0165-4608(00)00359-9; Lee CLY, 1999, CANCER GENET CYTOGEN, V111, P99; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LEVAN G, 1974, HEREDITAS, V77, P37; Li-Ping Zheng, 2010, Reprod Biol Endocrinol, V8, P66, DOI 10.1186/1477-7827-8-66; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2005, CLIN CANCER RES, V11, P4393, DOI 10.1158/1078-0432.CCR-04-2256; Mrhalova M, 2003, PATHOL RES PRACT, V199, P453, DOI 10.1078/0344-0338-00445; Mund C, 2006, EPIGENETICS-US, V1, P7; O'Connell P, 2003, BREAST CANCER RES TR, V78, P347, DOI 10.1023/A:1023037925950; OHYASHIKI K, 1992, CANCER GENET CYTOGEN, V58, P174, DOI 10.1016/0165-4608(92)90107-J; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; PERRY M, 1972, BRIT J SURG, V59, P731, DOI 10.1002/bjs.1800590912; Popescu NC, 1999, CARCINOGENESIS, V20, P2033, DOI 10.1093/carcin/20.10.2033; Ross Jeffrey S, 2003, Am J Clin Pathol, V120 Suppl, pS53; SAVINO A, 1971, ACTA CYTOL, V15, P372; SCHERDIN U, 1990, ONCOGENE, V5, P1619; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; SEABRIGH.M, 1971, LANCET, V2, P971; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sirchia SM, 2005, CANCER RES, V65, P2139, DOI 10.1158/0008-5472.CAN-04-3465; Sjoling A, 2001, CYTOGENET CELL GENET, V95, P202, DOI 10.1159/000059347; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE; Souzaki R, 2011, PEDIATR SURG INT, V27, P231, DOI 10.1007/s00383-010-2781-4; STEFFEN M, 1988, CANCER RES, V48, P7212; STEFFEN M, 1992, GENE CHROMOSOME CANC, V4, P46, DOI 10.1002/gcc.2870040107; Strefford JC, 2006, CYTOGENET GENOME RES, V112, P45, DOI 10.1159/000087512; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Toydemir R, 2010, CANCER GENET CYTOGEN, V201, P81, DOI 10.1016/j.cancergencyto.2010.05.014; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van de Corput MPC, 1998, J HISTOCHEM CYTOCHEM, V46, P1249, DOI 10.1177/002215549804601105; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Walentinsson A, 2000, GENE CHROMOSOME CANC, V28, P184, DOI 10.1002/(SICI)1098-2264(200006)28:2<184::AID-GCC7>3.0.CO;2-V; WALTER TA, 1990, AM J HEMATOL, V33, P210, DOI 10.1002/ajh.2830330310; Wang SJ, 2002, MODERN PATHOL, V15, P137, DOI 10.1038/modpathol.3880505; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Wienberg J, 1997, CYTOGENET CELL GENET, V77, P211, DOI 10.1159/000134579; Zhang XC, 2008, INT J BIOL SCI, V4, P259	75	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					206	220	e29923	10.1371/journal.pone.0029923	http://dx.doi.org/10.1371/journal.pone.0029923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253826	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900023
J	O'Toole, E; Greenan, G; Lange, KI; Srayko, M; Muller-Reichert, T				O'Toole, Eileen; Greenan, Garrett; Lange, Karen I.; Srayko, Martin; Mueller-Reichert, Thomas			The Role of gamma-Tubulin in Centrosomal Microtubule Organization	PLOS ONE			English	Article							SPINDLE POLE BODY; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; RING COMPLEX; PROTEIN; CENTRIOLAR; IDENTIFICATION; RECRUITMENT; TOMOGRAPHY; MATURATION	As part of a multi subunit ring complex, gamma-tubulin has been shown to promote microtubule nucleation both in vitro and in vivo, and the structural properties of the complex suggest that it also seals the minus ends of the polymers with a conical cap. Cells depleted of gamma-tubulin, however, still display many microtubules that participate in mitotic spindle assembly, suggesting that gamma-tubulin is not absolutely required for microtubule nucleation in vivo, and raising questions about the function of the minus end cap. Here, we assessed the role of gamma-tubulin in centrosomal microtubule organisation using three-dimensional reconstructions of gamma-tubulin-depleted C. elegans embryos. We found that microtubule minus-end capping and the PCM component SPD-5 are both essential for the proper placement of microtubules in the centrosome. Our results further suggest that gamma-tubulin and SPD-5 limit microtubule polymerization within the centrosome core, and we propose a model for how abnormal microtubule organization at the centrosome could indirectly affect centriole structure and daughter centriole replication.	[O'Toole, Eileen] Univ Colorado, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA; [Greenan, Garrett] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Lange, Karen I.; Srayko, Martin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mueller-Reichert, Thomas] Tech Univ Dresden, Med Theoret Ctr, Dresden, Germany	University of Colorado System; University of Colorado Boulder; Max Planck Society; University of Alberta; Technische Universitat Dresden	O'Toole, E (corresponding author), Univ Colorado, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA.	mueller-reichert@tu-dresden.de	Srayko, Martin/A-3755-2014; Lange, Karen/AAI-3401-2021	Lange, Karen/0000-0002-2414-5277; Srayko, Martin/0000-0003-0196-0364	Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft (DFG) [MU 1423/2-1, MU 1423/3-1]; Human Frontier Science Program [RGP 0034/2010]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by an operating grant from the Natural Sciences and Engineering Research Council of Canada as well as scholar awards from Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research to MS and grants from the Deutsche Forschungsgemeinschaft (DFG: MU 1423/2-1 and MU 1423/3-1) and a Human Frontier Science Program grant (RGP 0034/2010) to TMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bobinnec Y, 2000, J CELL SCI, V113, P3747; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Cuschieri L, 2007, CELL CYCLE, V6, P2788, DOI 10.4161/cc.6.22.4941; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LI QQ, 1995, J CELL BIOL, V131, P207, DOI 10.1083/jcb.131.1.207; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Raynaud-Messina B, 2004, J CELL SCI, V117, P5497, DOI 10.1242/jcs.01401; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Toya M, 2011, NAT CELL BIOL, V13, P708, DOI 10.1038/ncb2242; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wilson Edmund B, 1897, CELL DEV INHERITANCE; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	47	39	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					140	150	e29795	10.1371/journal.pone.0029795	http://dx.doi.org/10.1371/journal.pone.0029795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253783	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900016
J	Scott, NA; Murphy, TH				Scott, Nadia A.; Murphy, Timothy H.			Hemodynamic Responses Evoked by Neuronal Stimulation via Channelrhodopsin-2 Can Be Independent of Intracortical Glutamatergic Synaptic Transmission	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; CEREBRAL-BLOOD-FLOW; TRANSGENIC MICE; OLFACTORY-BULB; IN-VIVO; FUNCTIONAL ARCHITECTURE; INTRINSIC SIGNALS; LASER-SPECKLE; MOTOR CORTEX; BRAIN	Maintenance of neuronal function depends on the delivery of oxygen and glucose through changes in blood flow that are linked to the level of ongoing neuronal and glial activity, yet the underlying mechanisms remain unclear. Using transgenic mice expressing the light-activated cation channel channelrhodopsin-2 in deep layer pyramidal neurons, we report that changes in intrinsic optical signals and blood flow can be evoked by activation of a subset of channelrhiodopsin-2-expressing neurons in the sensorimotor cortex. We have combined imaging and pharmacology to examine the importance of glutamatergic synaptic transmission in this form of neurovascular coupling. Blockade of ionotropic glutamate receptors with the antagonists CNQX and MK 301 significantly reduced forepaw-evoked hemodynamic responses, yet resulted in no significant reduction of channelrhodopsin-evoked hemodynamic responses, suggesting that stimulus-dependent coupling of neuronal activity to blood flow can be independent of local excitatory synaptic transmission. Together, these results indicate that channelrhodopsin-2 activation of sensorimotor excitatory neurons produces changes in intrinsic optical signals and blood flow that can occur under conditions where synaptic activation of neurons or other cells through ionotropic glutamate receptors would be blocked.	[Scott, Nadia A.; Murphy, Timothy H.] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada; [Scott, Nadia A.; Murphy, Timothy H.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1W5, Canada; [Murphy, Timothy H.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Scott, NA (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada.	thmurphy@interchange.ubc.ca	Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490	Canadian Institutes of Health Research [MOP49586]; Canadian Stroke Network; Heart and Stroke Foundation of BC and the Yukon; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network; Heart and Stroke Foundation of BC and the Yukon; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants to THM (MOP49586) from Canadian Institutes of Health Research, Canadian Stroke Network and the Heart and Stroke Foundation of BC and the Yukon. NAS was supported by studentships from Natural Sciences and Engineering Research Council and the Canadian Institutes of Health Research Strategic Training Program in Neurobiology and Behaviour. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Calcinaghi N, 2011, J CEREB BLOOD FLOW M, V31; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Devor A, 2008, J NEUROSCI, V28, P14347, DOI 10.1523/JNEUROSCI.4307-08.2008; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Dunn JF, 2009, MAGN RESON MED, V61, P222, DOI 10.1002/mrm.21803; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Harrison TC, 2009, J NEUROSCI METH, V182, P211, DOI 10.1016/j.jneumeth.2009.06.021; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Lecoq J, 2009, J NEUROSCI, V29, P1424, DOI 10.1523/JNEUROSCI.4817-08.2009; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Nemoto M, 2004, J NEUROSCI, V24, P3850, DOI 10.1523/JNEUROSCI.4870-03.2004; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Sigler A, 2008, J NEUROSCI METH, V170, P35, DOI 10.1016/j.jneumeth.2007.12.015; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Vanzetta I, 2008, HFSP J, V2, P79, DOI 10.2976/1.2889618; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	36	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					176	185	e29859	10.1371/journal.pone.0029859	http://dx.doi.org/10.1371/journal.pone.0029859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253807	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900020
J	Zhang, CS; Wang, JH; Lu, GD; Li, J; Lu, XM; Mantion, G; Vuitton, DA; Wen, H; Lin, RY				Zhang, Chuanshan; Wang, Junhua; Lu, Guodong; Li, Jing; Lu, Xiaomei; Mantion, Georges; Vuitton, Dominique A.; Wen, Hao; Lin, Renyong			Hepatocyte Proliferation/Growth Arrest Balance in the Liver of Mice during E-multilocularis Infection: A Coordinated 3-Stage Course	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELLULAR IMMUNE-RESPONSE; NF-KAPPA-B; CYCLIN-DEPENDENT KINASES; ECHINOCOCCUS-MULTILOCULARIS; ALVEOLAR ECHINOCOCCOSIS; HEPATOCELLULAR-CARCINOMA; NUCLEAR ANTIGEN; DOWN-REGULATION; DNA-SYNTHESIS	Background: Alveolar echinococcosis (AE) is characterized by the tumor-like growth of Echinococcus (E.) multilocularis. Very little is known on the influence of helminth parasites which develop in the liver on the proliferation/growth arrest metabolic pathways in the hepatocytes of the infected liver over the various stages of infection. Methodology/Principal Findings:Using Western blot analysis, qPCR and immunohistochemistry, we measured the levels of MAPKs activation, Cyclins, PCNA, Gadd4513, Gadd457, p53 and p21 expression in the murine AE model, from day 2 to 360 post-infection. Within the early (day 2-60) and middle (day60-180) stages, CyclinB1 and CyclinD1 gene expression increased up to day30 and then returned to control level after day60; Gadd4513, CyclinA and PCNA increased all over the period; ERK1/2 was permanently activated. Meanwhile, p53, p21 and Gadd457 gene expression, and caspase 3 activation, gradually increased in a time-dependent manner. In the late stage (day180-360), p53, p21 and Gadd457 gene expression were significantly higher in infected mice; JNK and caspase 3 were activated. TUNEL analysis showed apoptosis of hepatocytes. No significant change in CyclinE, p53 mRNA and p-p38 expression were observed at any time. Conclusions: Our data support the concept of a sequential activation of metabolic pathways which 1) would first favor parasitic, liver and immune cell proliferation and survival, and thus promote metacestode fertility and tolerance by the host, and 2) would then favor liver damage/apoptosis, impairment in protein synthesis and xenobiotic metabolism, as well as promote immune deficiency, and thus contribute to the dissemination of the protoscoleces after metacestode fertility has been acquired. These findings give a rational explanation to the clinical observations of hepatomegaly and of unexpected survival of AE patients after major hepatic resections, and of chronic liver injury, necrosis and of hepatic failure at an advanced stage and in experimental animals.	[Zhang, Chuanshan; Wang, Junhua; Lu, Guodong; Li, Jing; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Major Dis Xinjiang, Urumqi, Xinjiang, Peoples R China; [Zhang, Chuanshan; Wang, Junhua; Lu, Guodong; Li, Jing; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Xinjiang, Peoples R China; [Mantion, Georges; Vuitton, Dominique A.] Univ Franche Comte, Jean Minjoz Hosp, World Hlth Org Collaborating Ctr Prevent & Treatm, Dept Digest Surg, F-25030 Besancon, France; [Vuitton, Dominique A.] Univ Franche Comte, Res Unit EA Epithelial Carcinogenesis Predict Pre, F-25030 Besancon, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; CHU Besancon; World Health Organization; Universite de Franche-Comte	Zhang, CS (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Major Dis Xinjiang, Urumqi, Xinjiang, Peoples R China.	Dr.wenhao@163.com; renyongl@yahoo.com.cn	Wang, Junhua/ABB-6324-2021	Wang, Junhua/0000-0002-6110-3711	National Natural Science Foundation of China [30860253, 30960341]; Xinjiang Natural Science fund [201091154, 200810104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Natural Science fund	This work was supported by grants from the National Natural Science Foundation of China (30860253, 30960341) and Xinjiang Natural Science fund (201091154, 200810104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexia C, 2004, ANN NY ACAD SCI, V1030, P219, DOI 10.1196/annals.1329.028; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Berres ML, 2009, BIOL CHEM, V390, P1039, DOI 10.1515/BC.2009.119; Bouzahzah B, 2006, CELL CYCLE, V5, P2396, DOI 10.4161/cc.5.20.3380; Bresson-Hadni S, 1991, Eur Cytokine Netw, V2, P339; Bresson-Hadni S, 2000, EUR J GASTROEN HEPAT, V12, P327, DOI 10.1097/00042737-200012030-00011; Bresson-Hadni S., 2007, TXB HEPATOLOGY, P1047; BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; BRESSONHADNI S, 1989, CLIN EXP IMMUNOL, V78, P61; Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Clark SP, 2008, TOXICOL PATHOL, V36, P190, DOI 10.1177/0192623307311406; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Crenesse D, 2000, HEPATOLOGY, V32, P1029, DOI 10.1053/jhep.2000.19065; Dai WJ, 1999, IMMUNOLOGY, V97, P107, DOI 10.1046/j.1365-2567.1999.00723.x; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Emery I, 1997, PARASITE IMMUNOL, V19, P493, DOI 10.1046/j.1365-3024.1997.d01-162.x; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; GOTTSTEIN B, 1991, AM J TROP MED HYG, V45, P734, DOI 10.4269/ajtmh.1991.45.734; GOTTSTEIN B, 1994, CLIN EXP IMMUNOL, V96, P245, DOI 10.1111/j.1365-2249.1994.tb06549.x; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; HALL PA, 1995, ONCOGENE, V10, P2427; HARPER JW, 1993, CELL, V75, P805; Jiang CP, 2005, WORLD J GASTROENTERO, V11, P4611, DOI 10.3748/wjg.v11.i30.4611; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kawanaka H, 2001, LIFE SCI, V69, P3019, DOI 10.1016/S0024-3205(01)01409-6; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; LIANCE M, 1984, EXPERIENTIA, V40, P1436, DOI 10.1007/BF01951932; Lin RY, 2009, WORLD J GASTROENTERO, V15, P2116, DOI 10.3748/wjg.15.2116; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; Marino M, 2002, MOL BIOL CELL, V13, P3720, DOI 10.1091/mbc.E02-03-0153; Masaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Neuwirt H, 2009, AM J PATHOL, V174, P1921, DOI 10.2353/ajpath.2009.080751; NICOD L, 1994, PARASITE, V1, P261, DOI 10.1051/parasite/1994013261; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravenhall C, 2000, BRIT J PHARMACOL, V131, P17, DOI 10.1038/sj.bjp.0703454; RicardBlum S, 1996, GASTROENTEROLOGY, V111, P172, DOI 10.1053/gast.1996.v111.pm8698196; Rinaudo JS, 1997, CELL GROWTH DIFFER, V8, P301; Rodriguez EVA, 2003, J LEUKOCYTE BIOL, V73, P127, DOI 10.1189/jlb.0702353; RUDI J, 1995, J HEPATOL, V22, P43, DOI 10.1016/0168-8278(95)80258-4; Satomi Y, 2009, BBA-GEN SUBJECTS, V1790, P260, DOI 10.1016/j.bbagen.2009.01.003; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Stiles JK, 2001, ANN TROP MED PARASIT, V95, P797, DOI 10.1080/00034980120111145; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Viebahn CS, 2008, INT J BIOCHEM CELL B, V40, P855, DOI 10.1016/j.biocel.2007.11.025; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; VUITTON DA, 1989, CLIN EXP IMMUNOL, V78, P67; Vuitton DA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/923193; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; WOLF HK, 1992, HEPATOLOGY, V15, P707, DOI 10.1002/hep.1840150426; Wu DF, 2008, HEPATOLOGY, V47, P1005, DOI 10.1002/hep.22087; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zhang S, 2008, J INFECT DIS, V197, P1341, DOI 10.1086/586709; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zhu N, 2009, MOL BIOL REP, V36, P2075, DOI 10.1007/s11033-008-9419-9	77	23	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					436	452	e30127	10.1371/journal.pone.0030127	http://dx.doi.org/10.1371/journal.pone.0030127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253905	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900045
J	Tanaka, K; Arao, T; Tamura, D; Aomatsu, K; Furuta, K; Matsumoto, K; Kaneda, H; Kudo, K; Fujita, Y; Kimura, H; Yanagihara, K; Yamada, Y; Okamoto, I; Nakagawa, K; Nishio, K				Tanaka, Kaoru; Arao, Tokuzo; Tamura, Daisuke; Aomatsu, Keiichi; Furuta, Kazuyuki; Matsumoto, Kazuko; Kaneda, Hiroyasu; Kudo, Kanae; Fujita, Yoshihiko; Kimura, Hideharu; Yanagihara, Kazuyoshi; Yamada, Yasuhide; Okamoto, Isamu; Nakagawa, Kazuhiko; Nishio, Kazuto			SRPX2 Is a Novel Chondroitin Sulfate Proteoglycan That Is Overexpressed in Gastrointestinal Cancer	PLOS ONE			English	Article							DISORDERS; ADHESION; GROWTH; CORTEX	SRPX2 (Sushi repeat-containing protein, X-linked 2) has recently emerged as a multifunctional protein that is involved in seizure disorders, angiogenesis and cellular adhesion. Here, we analyzed this protein biochemically. SRPX2 protein was secreted with a highly posttranslational modification. Chondroitinase ABC treatment completely decreased the molecular mass of purified SRPX2 protein to its predicted size, whereas heparitinase, keratanase and hyaluroinidase did not. Secreted SRPX2 protein was also detected using an anti-chondroitin sulfate antibody. These results indicate that SRPX2 is a novel chondroitin sulfate proteoglycan (CSPG). Furthermore, a binding assay revealed that hepatocyte growth factor dose-dependently binds to SRPX2 protein, and a ligand-glycosaminoglycans interaction was speculated to be likely in proteoglycans. Regarding its molecular architecture, SRPX2 has sushi repeat modules similar to four other CSPGs/lecticans; however, the molecular architecture of SRPX2 seems to be quite different from that of the lecticans. Taken together, we found that SRPX2 is a novel CSPG that is overexpressed in gastrointestinal cancer cells. Our findings provide key glycobiological insight into SRPX2 in cancer cells and demonstrate that SRPX2 is a new member of the cancer-related proteoglycan family.	[Tanaka, Kaoru; Arao, Tokuzo; Tamura, Daisuke; Aomatsu, Keiichi; Furuta, Kazuyuki; Matsumoto, Kazuko; Kaneda, Hiroyasu; Kudo, Kanae; Fujita, Yoshihiko; Kimura, Hideharu; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Tanaka, Kaoru; Kaneda, Hiroyasu; Okamoto, Isamu; Nakagawa, Kazuhiko] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan; [Yanagihara, Kazuyoshi] Yasuda Womens Univ, Fac Pharm, Dept Life Sci, Asaminami Ku, Hiroshima, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Dept Med Oncol, Chuo Ku, Tokyo, Japan	Kindai University (Kinki University); Kindai University (Kinki University); National Cancer Center - Japan	Nishio, K (corresponding author), Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan.	knishio@med.kindai.ac.jp	Yamada, Yasuhide/AAH-9124-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [19209018]; Health and Labor Scientific Research Grants; Grants-in-Aid for Scientific Research [23701106] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Scientific Research Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funds for the Comprehensive 3rd Term of the 10-Year Strategy for Cancer Control, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19209018), and a fund from the Health and Labor Scientific Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Miljkovic-Licina M, 2009, FASEB J, V23, P4105, DOI 10.1096/fj.09-135202; O'Leary JM, 2004, PROTEIN SCI, V13, P1238, DOI 10.1110/ps.03582704; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Tanaka K, 2009, INT J CANCER, V124, P1072, DOI 10.1002/ijc.24065; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289	14	65	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e27922	10.1371/journal.pone.0027922	http://dx.doi.org/10.1371/journal.pone.0027922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242148	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100001
J	Cutrupi, S; Reineri, S; Panetto, A; Grosso, E; Caizzi, L; Ricci, L; Friard, O; Agati, S; Scatolini, M; Chiorino, G; Lykkesfeldt, AE; De Bortoli, M				Cutrupi, S.; Reineri, S.; Panetto, A.; Grosso, E.; Caizzi, L.; Ricci, L.; Friard, O.; Agati, S.; Scatolini, M.; Chiorino, G.; Lykkesfeldt, A. E.; De Bortoli, M.			Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells	ONCOGENE			English	Article						Tab2; tamoxifen resistance; estrogen receptor; breast cancer	ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; ANTIESTROGEN RESISTANCE; N-COR; KINASE; GROWTH; TAK1; PHOSPHORYLATION; METAANALYSIS; ACTIVATION	Pharmacological resistance is a serious threat to the clinical success of hormone therapy for breast cancer. The antiproliferative response to antagonistic drugs such as tamoxifen (Tam) critically depends on the recruitment of NCoR/SMRT corepressors to estrogen receptor alpha (ER alpha) bound to estrogen target genes. Under certain circumstances, as demonstrated in the case of interleukin-1 beta (IL-1 beta) treatment, the protein Tab2 interacts with ER alpha/NCoR and causes dismissal of NCoR from these genes, leading to loss of the antiproliferative response. In Tam-resistant (TamR) ER-positive breast cancer cells, we observed that Tab2 presents a shift in mobility on sodium dodecyl sulfate-PAGE (SDS-PAGE) similar to that seen in MCF7 wt upon stimulation with IL-1 beta, suggesting constitutive activation. Accordingly, TamR treatment with Tab2-specific short interfering RNA, restored the antiproliferative response to Tam in these cells. As Tab2 is known to directly interact with the N-terminal domain of ER alpha , we synthesized a peptide composed of a 14-aa motif of this domain, which effectively competes with ER alpha/Tab2 interaction in pull-down and co-immunoprecipitation experiments, fused to the carrier TAT peptide to allow internalization. Treatment of TamR cells with this peptide resulted in partial recovery of the antiproliferative response to Tam, suggesting a strategy to revert pharmacological resistance in breast cancer. Silencing of Tab2 in TamR cells by siRNA caused modulation of a gene set related to the control of cell cycle and extensively connected to BRCA1 in a functional network. These genes were able to discern two groups of patients, from a published data set of Tam-treated breast cancer profiles, with significantly different disease-free survival. Altogether, our data implicate Tab2 as a mediator of resistance to endocrine therapy and as a potential new target to reverse pharmacological resistance and potentiate antiestrogen action. Oncogene (2012) 31, 4353-4361; doi:10.1038/onc.2011.627; published online 16 January 2012	[Cutrupi, S.; Reineri, S.; Panetto, A.; Grosso, E.; Caizzi, L.; Ricci, L.; Friard, O.; De Bortoli, M.] Univ Turin, Ctr Mol Syst Biol, I-10060 Turin, Italy; [Cutrupi, S.] Univ Turin, Dept Human & Anim Biol, I-10060 Turin, Italy; [Reineri, S.; Caizzi, L.; Agati, S.; De Bortoli, M.] Univ Turin, Dept Oncol Sci, I-10060 Turin, Italy; [Panetto, A.; Ricci, L.] Bioind Pk Silvano Fumero, Turin, Italy; [Grosso, E.; Scatolini, M.; Chiorino, G.] Fdn Edo & Elvo Tempia Valenta, Lab Canc Genom, Biella, Italy; [Lykkesfeldt, A. E.] Danish Canc Soc, Inst Canc Biol, Dept Breast Canc Res, Copenhagen, Denmark	University of Turin; University of Turin; University of Turin; Danish Cancer Society	De Bortoli, M (corresponding author), Univ Turin, Ctr Mol Syst Biol, C-O IRCC SP142,Km 3-95, I-10060 Turin, Italy.	michele.debortoli@unito.it	De Bortoli, Michele/B-5418-2013; Scatolini, Maria/ABA-7311-2020; cutrupi, santina/AAC-4479-2022; Chiorino, Giovanna/K-5037-2016; Caizzi, Livia/AAO-2725-2021; Friard, Olivier/ABG-2435-2021	De Bortoli, Michele/0000-0002-6666-9052; Chiorino, Giovanna/0000-0002-9502-6400; Friard, Olivier/0000-0002-0374-9872; CUTRUPI, SANTINA/0000-0002-2358-5852; Caizzi, Livia/0000-0001-9723-6893	PRIN [2008PC9CFW_002]; Associazione Italiana per la Ricerca sul Cancro [IG9397]; public grant 'ERSF -DOCUP (Misura 3.4)' - hitechplat project; Associazione Sviluppo Piemonte (Turin); Compagnia di San Paolo (Turin) grant; UICC travel fellowship	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); public grant 'ERSF -DOCUP (Misura 3.4)' - hitechplat project; Associazione Sviluppo Piemonte (Turin); Compagnia di San Paolo (Turin) grant(Compagnia di San Paolo); UICC travel fellowship	This work was supported by grants from PRIN (2008PC9CFW_002) and from the Associazione Italiana per la Ricerca sul Cancro (Grant number IG9397), and in part by the public grant 'ERSF -DOCUP 2000-2006 (Misura 3.4)' - hitechplat project. LR is a CRT Fondazione Lagrange (Turin) fellow. AP was supported in part by the Associazione Sviluppo Piemonte (Turin). EG was a CRT Fondazione Lagrange (Turin) fellow and was supported in part by a Compagnia di San Paolo (Turin) grant and by a UICC travel fellowship.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Carroll JS, 2003, CANCER RES, V63, P4322; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Frankel LB, 2007, BREAST CANCER RES TR, V104, P165, DOI 10.1007/s10549-006-9399-1; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Hackshaw A, 2011, J CLIN ONCOL, V29, P1657, DOI 10.1200/JCO.2010.32.2933; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; Hughes-Davies L, 2009, BRIT J CANCER, V101, P875, DOI 10.1038/sj.bjc.6605231; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee YH, 2001, GENE DEV, V25, P176; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; LYKKESFELDT AE, 1986, BRIT J CANCER, V53, P29, DOI 10.1038/bjc.1986.5; Madsen MW, 1997, CANCER RES, V57, P585; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nabha SM, 2005, ONCOGENE, V24, P3166, DOI 10.1038/sj.onc.1208502; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schiff R, 2005, CANCER CHEMOTH PHARM, V56, pS10, DOI 10.1007/s00280-005-0108-2; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shin MS, 2009, BBA-MOL CELL RES, V1793, P1156, DOI 10.1016/j.bbamcr.2009.04.005; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	40	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	40					4353	4361		10.1038/onc.2011.627	http://dx.doi.org/10.1038/onc.2011.627			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	017LL	22249258	Green Published			2022-12-25	WOS:000309591300002
J	Serhan, CN; Dalli, J; Karamnov, S; Choi, A; Park, CK; Xu, ZZ; Ji, RR; Zhu, M; Petasis, NA				Serhan, Charles N.; Dalli, Jesmond; Karamnov, Sergey; Choi, Alexander; Park, Chul-Kyu; Xu, Zhen-Zhong; Ji, Ru-Rong; Zhu, Min; Petasis, Nicos A.			Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain	FASEB JOURNAL			English	Article						DHA metabolome; eicosanoids; inflammation resolution; neutrophils; resolvins	DOCOSAHEXAENOIC ACID; INFLAMMATORY PAIN; RESOLUTION-PHASE; LIPID MEDIATORS; RESOLVINS; MECHANISMS; ASPIRIN; BIOSYNTHESIS; PROTECTINS; SENSATION	Self-resolving inflammatory exudates and lipid mediator metabolomics recently uncovered a new family of potent anti-inflammatory and proresolving mediators biosynthesized by macrophages (M Phi s), denoted maresins. Here we determined that maresin 1 (MaR1) produced by human M Phi s from endogenous docosahexaenoic acid (DHA) matched synthetic 7R,14S-dihydroxydocosa-4Z, 8E, 10E, 12Z, 16Z, 19Z-hexaenoic acid. The MaR1 alcohol groups and Z/E geometry of conjugated double bonds were matched using isomers prepared by total organic synthesis. MaR1's potent defining actions were confirmed with synthetic MaR1, i.e., limiting poly-morphonuclear neutrophil (PMN) infiltration in murine peritonitis (ng/mouse range) as well as enhancing human macrophage uptake of apoptotic PMNs. At 1 nM, MaR1 was slightly more potent than resolvin D1 in stimulating human M Phi efferocytosis, an action not shared by leukotriene B-4. MaR1 also accelerated surgical regeneration in planaria, increasing the rate of head reappearance. On injury of planaria, MaR1 was biosynthesized from deuterium-labeled (d(5))-DHA that was blocked with lipoxygenase (LOX) inhibitor. MaR1 dose-dependently inhibited TRPV1 currents in neurons, blocked capsaicin (100 nM)-induced inward currents (IC50 0.49 +/- 0.02 nM), and reduced both inflammation- and chemotherapy-induced neuropathic pain in mice. These results demonstrate the potent actions of MaR1 in regulating inflammation resolution, tissue regeneration, and pain resolution. These findings suggest that chemical signals are shared in resolution cellular trafficking, a key process in tissue regeneration. Moreover, immunoresolvents of the innate immune response, such as MaR1, offer new opportunities for assessing M Phi s and their local DHA metabolome in the return to tissue homeostasis.-Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C.-K., Xu, Z.-Z., Ji, R.-R., Zhu, M., Petasis, N. A. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26, 1755-1765 (2012). www.fasebj.org	[Serhan, Charles N.; Dalli, Jesmond; Karamnov, Sergey; Choi, Alexander] Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Park, Chul-Kyu; Xu, Zhen-Zhong; Ji, Ru-Rong] Brigham & Womens Hosp, Pain Res Ctr, Sensory Plast Lab, Boston, MA 02115 USA; [Serhan, Charles N.; Dalli, Jesmond; Karamnov, Sergey; Choi, Alexander; Park, Chul-Kyu; Xu, Zhen-Zhong; Ji, Ru-Rong] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Zhu, Min; Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Petasis, Nicos A.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern California; University of Southern California	Serhan, CN (corresponding author), Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 77 Ave Louis Pasteur,HIM 829, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Karamnov, Sergey/ABD-6350-2020; Petasis, Nicos/B-3162-2009; Ji, Ru-Rong/L-7070-2017; Karamnov, Sergey/D-7554-2016	Petasis, Nicos/0000-0002-8864-4446; Ji, Ru-Rong/0000-0002-9355-3688; Karamnov, Sergey/0000-0002-4198-7548; Xu, Zhen-Zhong/0000-0001-6578-211X; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health [1P01GM095467, 1R01DE019938, 1R01NS067686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Mary Halm Small for expert assistance in manuscript preparation, Thad W. Vickery for technical assistance, and Dr. Rong Yang for initial LC-MS/MS methods to isolate isomers of MaR1 and related structures. The authors also thank Iris Kao for assistance in the initial planaria experiments. The work was supported in part by U.S. National Institutes of Health grants 1P01GM095467 (C.N.S., N.A.P.), 1R01DE019938 (C.N.S.), and 1R01NS067686 (R.R.J., C.N.S.). The authors report no conflicts of interest.	Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cotran R S, 1982, Monogr Pathol, P18; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Hong S, 2005, PROSTAG OTH LIPID M, V78, P107, DOI 10.1016/j.prostaglandins.2005.04.004; Huang LA, 2011, PAIN, V152, P557, DOI 10.1016/j.pain.2010.11.021; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Majno G., 1982, CURRENT TOPICS INFLA; Majno G., 2004, CELLS TISSUES DIS PR; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Oh SF, 2011, BBA-MOL CELL BIOL L, V1811, P737, DOI 10.1016/j.bbalip.2011.06.007; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Price Sarah, 2010, Nat Rev Rheumatol, V6, P379, DOI 10.1038/nrrheum.2010.88; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raatz SK, 2011, J AGR FOOD CHEM, V59, P11278, DOI 10.1021/jf202576k; Rossi A, 2008, RESOLUTION INFLAMMAT; Rowley A. F., 1998, EICOSANOIDS RELATED; Russell DG, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, pXIII; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sasaki K, 2011, CHEM-ASIAN J, V6, P534, DOI 10.1002/asia.201000494; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Tian HB, 2011, J BIOL CHEM, V286, P4443, DOI 10.1074/jbc.M110.100388; Xu ZZ, 2011, BRIT J PHARMACOL, V164, P274, DOI 10.1111/j.1476-5381.2011.01348.x; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang R., 2011, CURR PROTOC IMMUNOL, V95; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zayas RM, 2010, DEV DYNAM, V239, P2888, DOI 10.1002/dvdy.22427	48	308	316	7	108	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1755	1765		10.1096/fj.11-201442	http://dx.doi.org/10.1096/fj.11-201442			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22253477	Green Published			2022-12-25	WOS:000302359700036
J	Prasad, M; Thomas, JL; Whittal, RM; Bose, HS				Prasad, Manoj; Thomas, James L.; Whittal, Randy M.; Bose, Himangshu S.			Mitochondrial 3 beta-Hydroxysteroid Dehydrogenase Enzyme Activity Requires Reversible pH-dependent Conformational Change at the Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MOLTEN GLOBULE STATE; CYTOCHROME-C; HUMAN TYPE-1; IMPORT; INTERMEDIATE; STEROIDOGENESIS; MECHANISMS; MEMBRANES	The inner mitochondrial membrane protein 3 beta-hydroxysteroid dehydrogenase 2 (3 beta HSD2) synthesizes progesterone and androstenedione through its dehydrogenase and isomerase activities. This bifunctionality requires 3 beta HSD2 to undergo a conformational change. Given its proximity to the proton pump, we hypothesized that pH influences 3 beta HSD2 conformation and thus activity. Circular dichroism (CD) showed that between pH 7.4 and 4.5, 3 beta HSD2 retained its primarily alpha-helical character with a decrease in alpha-helical content at lower pH values, whereas the beta-sheet content remained unchanged throughout. Titrating the pH back to 7.4 restored the original conformation within 25 min. Metabolic conversion assays indicated peak 3 beta HSD2 activity at pH 4.5 with similar to 2-fold more progesterone synthesized at pH 4.5 than at pH 3.5 and 7.4. Increasing the 3 beta HSD2 concentration from 1 to 40 mu g resulted in a 7-fold increase in progesterone at pH 4.5, but no change at pH 7.4. Incubation with guanidinum hydrochloride (GdmHCl) showed a three-step cooperative unfolding of 3 beta HSD2 from pH 7.4 to 4.5, possibly due to the native state unfolding to the intermediate ion core state. With further decreases in pH, increasing concentrations of GdmHCl led to rapid two-step unfolding that may represent complete loss of structure. Between pH 4 and 5, the two intermediate states appeared stable. Stopped-flow kinetics showed slower unfolding at around pH 4, where the protein is in a pseudostable state. Based on our data, we conclude that at pH 4-5, 3 beta HSD2 takes on a molten globule conformation that promotes the dual functionality of the enzyme.	[Thomas, James L.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA; [Bose, Himangshu S.] Mem Univ Med Ctr, Savannah, GA 31404 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	Mercer University; University of Alberta	Bose, HS (corresponding author), Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Prasad, Manoj/I-9623-2014	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation; Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.), the Anderson Cancer Institute, and the Mercer University School of Medicine.; Funding for equipment in the Mass Spectrometry Facility at the University of Alberta is supported by the Canada Foundation for Innovation and Alberta Science and Research Investment Program	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Ali V, 1999, BIOCHEMISTRY-US, V38, P13635, DOI 10.1021/bi9907835; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Brooks CL, 1998, P NATL ACAD SCI USA, V95, P11037, DOI 10.1073/pnas.95.19.11037; CHAN HS, 1991, ANNU REV BIOPHYS BIO, V20, P447, DOI 10.1146/annurev.biophys.20.1.447; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; Cunningham EL, 2003, BIOCHEMISTRY-US, V42, P13212, DOI 10.1021/bi035409q; Fasman G.D., 1996, CIRCULAR DICHROISM C; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glick B.S., 1992, CELL, V69, P347; Huang C.Y., 1982, METHOD ENZYMOL, V87, P525; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; KUWAJIMA K, 1991, BIOCHEMISTRY-US, V30, P7693, DOI 10.1021/bi00245a005; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rajapaksha M, 2011, BIOCHEMISTRY-US, V50, P11015, DOI 10.1021/bi2016102; REDFIELD C, 1994, J MOL BIOL, V238, P23, DOI 10.1006/jmbi.1994.1265; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Thomas JL, 2003, J BIOL CHEM, V278, P35483, DOI 10.1074/jbc.M304752200; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Thomas JL, 2002, J BIOL CHEM, V277, P42795, DOI 10.1074/jbc.M208537200; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; WANG JL, 1971, J BIOL CHEM, V246, P1185; Woody RW, 1996, CIRCULAR DICHROISM C, P109	46	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9534	9546		10.1074/jbc.M111.333278	http://dx.doi.org/10.1074/jbc.M111.333278			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262841	Green Published, hybrid			2022-12-25	WOS:000301797800084
J	Ashpole, NM; Song, WH; Brustovetsky, T; Engleman, EA; Brustovetsky, N; Cummins, TR; Hudmon, A				Ashpole, Nicole M.; Song, Weihua; Brustovetsky, Tatiana; Engleman, Eric A.; Brustovetsky, Nickolay; Cummins, Theodore R.; Hudmon, Andy			Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibition Induces Neurotoxicity via Dysregulation of Glutamate/Calcium Signaling and Hyperexcitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; CULTURED HIPPOCAMPAL-NEURONS; FOCAL CEREBRAL-ISCHEMIA; INDUCED CELL-DEATH; SELF-ASSOCIATION; SENSORY NEURONS; BRAIN-INJURY; SLICE MODEL; RAT; RECEPTOR	Aberrant glutamate and calcium signalings are neurotoxic to specific neuronal populations. Calcium/calmodulin-dependent kinase II (CaMKII), a multifunctional serine/threonine protein kinase in neurons, is believed to regulate neurotransmission and synaptic plasticity in response to calcium signaling produced by neuronal activity. Importantly, several CaMKII substrates control neuronal structure, excitability, and plasticity. Here, we demonstrate that CaMKII inhibition for >4 h using small molecule and peptide inhibitors induces apoptosis in cultured cortical neurons. The neuronal death produced by prolonged CaMKII inhibition is associated with an increase in TUNEL staining and caspase-3 cleavage and is blocked with the translation inhibitor cycloheximide. Thus, this neurotoxicity is consistent with apoptotic mechanisms, a conclusion that is further supported by dysregulated calcium signaling with CaMKII inhibition. CaMKII inhibitory peptides also enhance the number of action potentials generated by a ramp depolarization, suggesting increased neuronal excitability with a loss of CaMKII activity. Extracellular glutamate concentrations are augmented with prolonged inhibition of CaMKII. Enzymatic buffering of extracellular glutamate and antagonism of the NMDA subtype of glutamate receptors prevent the calcium dysregulation and neurotoxicity associated with prolonged CaMKII inhibition. However, in the absence of CaMKII inhibition, elevated glutamate levels do not induce neurotoxicity, suggesting that a combination of CaMKII inhibition and elevated extracellular glutamate levels results in neuronal death. In sum, the loss of CaMKII observed with multiple pathological states in the central nervous system, including epilepsy, brain trauma, and ischemia, likely exacerbates programmed cell death by sensitizing vulnerable neuronal populations to excitotoxic glutamate signaling and inducing an excitotoxic insult itself.	[Ashpole, Nicole M.; Song, Weihua; Brustovetsky, Nickolay; Cummins, Theodore R.; Hudmon, Andy] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Engleman, Eric A.; Hudmon, Andy] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hudmon, A (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 950 W Walnut St,R2-480, Indianapolis, IN 46202 USA.	ahudmon@iupui.edu			National Institutes of Health [NS053422, NS050131]; Ralph W. and Grace M. Showalter; Indiana State Department of Health [ISDH/A70-0-0-079212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008, R56NS053422, R01NS050131, R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter; Indiana State Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS053422 (to T. R. C.) and NS050131 (to N. B.). This work was also supported by Ralph W. and Grace M. Showalter and the Indiana State Department of Health Spinal Cord Brain Injury Research Grant ISDH/A70-0-0-079212 (to A. H.).	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; BEATON GH, 1957, ARCH BIOCHEM BIOPHYS, V70, P288, DOI 10.1016/0003-9861(57)90104-2; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHURN SB, 1995, J NEUROSCI, V15, P3200; CHURN SB, 1992, J NEUROCHEM, V59, P1221, DOI 10.1111/j.1471-4159.1992.tb08431.x; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Laabich A, 2000, MOL BRAIN RES, V85, P32, DOI 10.1016/S0169-328X(00)00226-6; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PERLIN JB, 1992, EPILEPSY RES, V11, P111, DOI 10.1016/0920-1211(92)90045-U; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Tao-Cheng JH, 2002, NEUROSCIENCE, V115, P435, DOI 10.1016/S0306-4522(02)00451-7; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang Y, 2005, J NEUROPHYSIOL, V94, P3670, DOI 10.1152/jn.00489.2005; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; WESTGATE SA, 1994, J NEUROCHEM, V63, P2217; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yamagata Y, 2006, NEUROSCIENCE, V140, P981, DOI 10.1016/j.neuroscience.2006.02.054; Zalewska T, 1996, NEUROREPORT, V7, P637, DOI 10.1097/00001756-199601310-00062; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439	52	65	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8495	8506		10.1074/jbc.M111.323915	http://dx.doi.org/10.1074/jbc.M111.323915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253441	Green Published, hybrid			2022-12-25	WOS:000301349400063
J	Tchorz, JS; Suply, T; Ksiazek, I; Giachino, C; Cloetta, D; Danzer, CP; Doll, T; Isken, A; Lemaistre, M; Taylor, V; Bettler, B; Kinzel, B; Mueller, M				Tchorz, Jan S.; Suply, Thomas; Ksiazek, Iwona; Giachino, Claudio; Cloetta, Dimitri; Danzer, Claus-Peter; Doll, Thierry; Isken, Andrea; Lemaistre, Marianne; Taylor, Verdon; Bettler, Bernhard; Kinzel, Bernd; Mueller, Matthias			A Modified RMCE-Compatible Rosa26 Locus for the Expression of Transgenes from Exogenous Promoters	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; BETA-ACTIN LOCUS; CRE RECOMBINASE; REPORTER STRAIN; MOUSE EMBRYOS; MICE; GENE; MUTAGENESIS; INTEGRATION	Generation of gain-of-function transgenic mice by targeting the Rosa26 locus has been established as an alternative to classical transgenic mice produced by pronuclear microinjection. However, targeting transgenes to the endogenous Rosa26 promoter results in moderate ubiquitous expression and is not suitable for high expression levels. Therefore, we now generated a modified Rosa26 (modRosa26) locus that combines efficient targeted transgenesis using recombinase-mediated cassette exchange (RMCE) by Flipase (Flp-RMCE) or Cre recombinase (Cre-RMCE) with transgene expression from exogenous promoters. We silenced the endogenous Rosa26 promoter and characterized several ubiquitous (pCAG, EF1 alpha and CMV) and tissue-specific (VeCad, alpha SMA) promoters in the modRosa26 locus in vivo. We demonstrate that the ubiquitous pCAG promoter in the modRosa26 locus now offers high transgene expression. While tissue-specific promoters were all active in their cognate tissues they additionally led to rare ectopic expression. To achieve high expression levels in a tissue-specific manner, we therefore combined Flp-RMCE for rapid ES cell targeting, the pCAG promoter for high transgene levels and Cre/LoxP conditional transgene activation using well-characterized Cre lines. Using this approach we generated a Cre/LoxP-inducible reporter mouse line with high EGFP expression levels that enables cell tracing in live cells. A second reporter line expressing luciferase permits efficient monitoring of Cre activity in live animals. Thus, targeting the modRosa26 locus by RMCE minimizes the effort required to target ES cells and generates a tool for the use exogenous promoters in combination with single-copy transgenes for predictable expression in mice.	[Tchorz, Jan S.; Suply, Thomas; Ksiazek, Iwona; Danzer, Claus-Peter; Doll, Thierry; Isken, Andrea; Lemaistre, Marianne; Kinzel, Bernd; Mueller, Matthias] Novartis Pharma AG, Novartis Inst Biomed Res Dev & Mol Pathways, Basel, Switzerland; [Tchorz, Jan S.; Cloetta, Dimitri; Bettler, Bernhard] Univ Basel, Dept Biomed, Inst Physiol, Basel, Switzerland; [Giachino, Claudio; Taylor, Verdon] Max Planck Inst Immunobiol, Freiburg, Germany; [Taylor, Verdon] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England	Novartis; University of Basel; Max Planck Society; University of Sheffield	Tchorz, JS (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res Dev & Mol Pathways, Basel, Switzerland.	matthias.mueller@novartis.com	bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207; GIACHINO, Claudio/0000-0002-8332-0899; Taylor, Verdon/0000-0003-3497-5976	Oncosuisse grant [KFP OCS-01613-12-2004]	Oncosuisse grant	This work was supported by Oncosuisse grant number KFP OCS-01613-12-2004. http://www2.oncosuisse.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; CLARK AJ, 1994, REPROD FERT DEVELOP, V6, P589, DOI 10.1071/RD9940589; COSTANTINI F, 1989, PROG NUCLEIC ACID RE, V36, P159; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Giachino Claudio, 2009, V482, P143, DOI 10.1007/978-1-59745-060-7_9; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; GOULD SJ, 1988, ANAL BIOCHEM, V175, P5, DOI 10.1016/0003-2697(88)90353-3; GRIDLEY T, 1987, TRENDS GENET, V3, P162, DOI 10.1016/0168-9525(87)90218-6; Guillot PV, 2000, PHYSIOL GENOMICS, V2, P77, DOI 10.1152/physiolgenomics.2000.2.2.77; HENNIGHAUSEN L, 1986, EMBO J, V5, P1367, DOI 10.1002/j.1460-2075.1986.tb04368.x; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Husken D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng103; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; OWENS GK, 1995, PHYSIOL REV, V75, P487; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; ROSSERT JA, 1995, KIDNEY INT, V47, pS34; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strathdee D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000004; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; West S, 2006, RNA, V12, P655, DOI 10.1261/rna.2232406; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	46	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30011	10.1371/journal.pone.0030011	http://dx.doi.org/10.1371/journal.pone.0030011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253858	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500030
J	Grietens, KP; Xuan, XN; Ribera, JM; Duc, TN; van Bortel, W; Ba, NT; Van, KP; Xuan, HL; D'Alessandro, U; Erhart, A				Grietens, Koen Peeters; Xa Nguyen Xuan; Ribera, Joan Muela; Thang Ngo Duc; van Bortel, Wim; Nhat Truong Ba; Ky Pham Van; Xuan, Hung Le; D'Alessandro, Umberto; Erhart, Annette			Social Determinants of Long Lasting Insecticidal Hammock-Use Among the Ra-Glai Ethnic Minority in Vietnam: Implications for Forest Malaria Control	PLOS ONE			English	Article							TREATED HAMMOCK; TRANSMISSION; HEALTH; TRIAL; NETS; RISK	Background: Long-lasting insecticidal hammocks (LLIHs) are being evaluated as an additional malaria prevention tool in settings where standard control strategies have a limited impact. This is the case among the Ra-glai ethnic minority communities of Ninh Thuan, one of the forested and mountainous provinces of Central Vietnam where malaria morbidity persist due to the sylvatic nature of the main malaria vector An. dirus and the dependence of the population on the forest for subsistence - as is the case for many impoverished ethnic minorities in Southeast Asia. Methods: A social science study was carried out ancillary to a community-based cluster randomized trial on the effectiveness of LLIHs to control forest malaria. The social science research strategy consisted of a mixed methods study triangulating qualitative data from focused ethnography and quantitative data collected during a malariometric cross-sectional survey on a random sample of 2,045 study participants. Results: To meet work requirements during the labor intensive malaria transmission and rainy season, Ra-glai slash and burn farmers combine living in government supported villages along the road with a second home at their fields located in the forest. LLIH use was evaluated in both locations. During daytime, LLIH use at village level was reported by 69.3% of all respondents, and in forest fields this was 73.2%. In the evening, 54.1% used the LLIHs in the villages, while at the fields this was 20.7%. At night, LLIH use was minimal, regardless of the location (village 4.4%; forest 6.4%). Discussion: Despite the free distribution of insecticide-treated nets (ITNs) and LLIHs, around half the local population remains largely unprotected when sleeping in their forest plot huts. In order to tackle forest malaria more effectively, control policies should explicitly target forest fields where ethnic minority farmers are more vulnerable to malaria.	[Grietens, Koen Peeters; van Bortel, Wim; D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters; Ribera, Joan Muela] PASS Int, Tessenderlo, Belgium; [Xa Nguyen Xuan; Thang Ngo Duc; Xuan, Hung Le] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Nhat Truong Ba; Ky Pham Van] Prov Malaria Stn, Phan Rang, Vietnam; [D'Alessandro, Umberto] MRC Unit, Basse, Gambia; [Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM)	Grietens, KP (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	kpeeters@itg.be	Van Bortel, Wim/AAU-5948-2021; Ribera, JM/B-8181-2009; Van Bortel, Wim/AFV-4687-2022; Peeters Grietens, Koen/G-7028-2019; D'Alessandro, Umberto/D-3457-2015	Ribera, JM/0000-0003-1042-6024; Van Bortel, Wim/0000-0002-6644-518X; Peeters Grietens, Koen/0000-0001-6570-9887; D'Alessandro, Umberto/0000-0001-6341-5009; muela ribera, joan/0000-0003-2111-6275	UBS Optimus Foundation	UBS Optimus Foundation	The study was funded by the UBS Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Anthropological Association, AM ANTHR ASS STAT ET; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Erhart A, 2006, MALARIA CONTROL VIET; Girod R, 2008, MEM I OSWALDO CRUZ, V103, P702, DOI 10.1590/S0074-02762008000700013; Grietens KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-23; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; ITM, 2007, ITM ANN C MAL MEK DE; Kondrashin A. V., 1991, Forest malaria in southeast Asia: proceedings of an informal consultative meeting WHO/MRC, 18-22 February 1991., P1; Lansang MAD, 1997, ACTA TROP, V63, P257, DOI 10.1016/S0001-706X(96)00625-0; Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; NIMPE, 2003, ANN REP NAT MAL CONT; NIMPE, 2004, ANN REP NAT MAL CONT; *NIMPE, 2005, ANN REP NAT MAL CONT; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Rahman W. A., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P537; ROZENDAAL JA, 1989, MED VET ENTOMOL, V3, P353, DOI 10.1111/j.1365-2915.1989.tb00242.x; Seale C., 1999, QUALITY QUALITATIVE; Singhasivanon Pratap, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P399; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3; Tashakkori A., 1998, APPL SOCIAL RES METH; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Zimmerman R H, 1997, Rev Panam Salud Publica, V2, P18, DOI 10.1590/S1020-49891997000700004	31	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29991	10.1371/journal.pone.0029991	http://dx.doi.org/10.1371/journal.pone.0029991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253852	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100035
J	Singh, S; Verma, R; Pradeep, A; Leu, K; Mortensen, RB; Young, PR; Oyasu, M; Schatz, PJ; Green, JM; Wojchowski, DM				Singh, Seema; Verma, Rakesh; Pradeep, Anamika; Leu, Karen; Mortensen, R. Bruce; Young, Peter R.; Oyasu, Miho; Schatz, Peter J.; Green, Jennifer M.; Wojchowski, Don M.			Dynamic Ligand Modulation of EPO Receptor Pools, and Dysregulation by Polycythemia-Associated EPOR Alleles	PLOS ONE			English	Article							ERYTHROPOIETIN-RECEPTOR; CONGENITAL POLYCYTHEMIA; SIGNAL-TRANSDUCTION; ERYTHROID-CELLS; C-KIT; JAK2; EXPRESSION; INTERNALIZATION; DEGRADATION; MUTATIONS	Erythropoietin (EPO) and its cell surface receptor (EPOR) are essential for erythropoiesis; can modulate non-erythroid target tissues; and have been reported to affect the progression of certain cancers. Basic studies of EPOR expression and trafficking, however, have been hindered by low-level EPOR occurrence, and the limited specificity of anti-EPOR antibodies. Consequently, these aspects of EPOR biology are not well defined, nor are actions of polycythemia-associated mutated EPOR alleles. Using novel rabbit monoclonal antibodies to intracellular, PY-activated and extracellular EPOR domains, the following properties of the endogenous hEPOR in erythroid progenitors first are unambiguously defined. 1) High-Mr EPOR forms become obviously expressed only when EPO is limited. 2) EPOR-68K plus -70K species sequentially accumulate, and EPOR-70K comprises an apparent cell surface EPOR population. 3) Brefeldin A, N-glycanase and associated analyses point to EPOR-68K as a core-glycosylated intracellular EPOR pool (of modest size). 4) In contrast to recent reports, EPOR inward trafficking is shown (in UT7epo cells, and primary proerythroblasts) to be sharply ligand-dependent. Beyond this, when C-terminal truncated hEPOR-T mutant alleles as harbored by polycythemia patients are co-expressed with the wild-type EPOR in EPO-dependent erythroid progenitors, several specific events become altered. First, EPOR-T alleles are persistently activated upon EPO-challenge, yet are also subject to apparent turn-over (to low-Mr EPOR products). Furthermore, during exponential cell growth EPOR-T species become both over-represented, and hyper-activated. Interestingly, EPOR-T expression also results in an EPO dose-dependent loss of endogenous wild-type EPOR's (and, therefore, a squelching of EPOR C-terminal-mediated negative feedback effects). New knowledge concerning regulated EPOR expression and trafficking therefore is provided, together with new insight into mechanisms via which mutated EPOR-T polycythemia alleles dysregulate the erythron. Notably, specific new tools also are characterized for studies of EPOR expression, activation, action and metabolism.	[Singh, Seema; Verma, Rakesh; Pradeep, Anamika; Wojchowski, Don M.] Maine Med Ctr Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA; [Leu, Karen; Mortensen, R. Bruce; Young, Peter R.; Oyasu, Miho; Schatz, Peter J.; Green, Jennifer M.] Affymax Inc, Palo Alto, CA USA	Maine Medical Center	Singh, S (corresponding author), Maine Med Ctr Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA.	jennifer_green@affymax.com; wojchd@mmc.org			National Institutes of Health (NIH) [5R01HL44491]; COBRE NIH/NCRR [5P20RR018789]; Affymax, Inc. (Palo Alto, CA); Takeda Global Research & Development Center, Inc. (Deerfield, IL); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE NIH/NCRR; Affymax, Inc. (Palo Alto, CA); Takeda Global Research & Development Center, Inc. (Deerfield, IL); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Studies were supported by the National Institutes of Health (NIH) 5R01HL44491 (Dr. Wojchowski). Core facility support ( progenitor cell analysis, and bioinformatics cores) was provided via COBRE NIH/NCRR 5P20RR018789 (Dr. Wojchowski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supporting contributions by Affymax, Inc. (Palo Alto, CA) and Takeda Global Research & Development Center, Inc. (Deerfield, IL) are gratefully acknowledged. The authors also wish to acknowledge strong expert technical assistance provided by Ruth Asch and Edward Jachimowicz (MMCRI).	Arcasoy MO, 2005, BBA-MOL BASIS DIS, V1740, P17, DOI 10.1016/j.bbadis.2005.03.003; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Bulut GB, 2011, J BIOL CHEM, V286, P6449, DOI 10.1074/jbc.M110.186890; Carraway MS, 2010, CIRC RES, V106, P1722, DOI 10.1161/CIRCRESAHA.109.214353; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Dev A, 2010, BLOOD; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Germeshausen M, 2008, CURR OPIN HEMATOL, V15, P332, DOI 10.1097/MOH.0b013e328303b9f6; HE TC, 1993, BLOOD, V82, P3530; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Huang LJ, 2010, BRIT J HAEMATOL, V148, P844, DOI 10.1111/j.1365-2141.2009.08069.x; Jegalian AG, 2002, J INTERF CYTOK RES, V22, P853, DOI 10.1089/107999002760274863; Jiao B, 2009, LEUKEMIA, V23, P1598, DOI 10.1038/leu.2009.104; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; KOMATSU N, 1993, BLOOD, V82, P456; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Liu L, 1997, LEUKEMIA, V11, P181, DOI 10.1038/sj.leu.2400559; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Motohashi T, 2001, EUR J HAEMATOL, V67, P88, DOI 10.1034/j.1600-0609.2001.t01-1-00446.x; NEUMANN D, 1993, J BIOL CHEM, V268, P13639; Patnaik MM, 2009, LEUKEMIA, V23, P834, DOI 10.1038/leu.2009.54; Pedersen M, 2009, CELL SIGNAL, V21, P413, DOI 10.1016/j.cellsig.2008.11.008; Perrotta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012015; Perugini M, 2009, CYTOKINE GROWTH F R, V20, P87, DOI 10.1016/j.cytogfr.2009.01.002; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasson SC, 2010, CYTOKINE, V50, P58, DOI 10.1016/j.cyto.2009.12.001; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Teofili L, 2010, HAEMATOL-HEMATOL J, V95, P65, DOI 10.3324/haematol.2009.007542; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong ZZ, 2008, P NATL ACAD SCI USA, V105, P6998, DOI 10.1073/pnas.0800454105; Usenko T, 2007, LEUKEMIA LYMPHOMA, V48, P134, DOI 10.1080/10428190601043138; Wickrema A, 1999, EXP HEMATOL, V27, P1124, DOI 10.1016/S0301-472X(99)00043-0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139	49	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29064	10.1371/journal.pone.0029064	http://dx.doi.org/10.1371/journal.pone.0029064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253704	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100006
J	de Blasio, BF; Iversen, BG; Tomba, GS				de Blasio, Birgitte Freiesleben; Iversen, Bjorn G.; Tomba, Gianpaolo Scalia			Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing	PLOS ONE			English	Article							TRANSMISSION PARAMETERS; H1N1; DISEASE; VIRUS	To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI surveillance data from 5 October 2009 to 4 January 2010. We estimate a clinical attack rate of approximately 30% (281-29.8%), with highest disease rates among children 0-14 years (43-44%). Vaccination started in week 43 and came too late to have a strong influence on the pandemic in Norway. Our results indicate that the countermeasures prevented approximately 11-12% of potential cases relative to an unmitigated pandemic. Vaccination was found responsible for roughly 3 in 4 of the avoided infections. An estimated 50% reduction in the clinical attack rate would have resulted from vaccination alone, had the campaign started 6 weeks earlier. Had vaccination been prioritized for children first, the intervention should have commenced approximately 5 weeks earlier in order to achieve the same 50% reduction. In comparison, we estimate that a non-adjiavanted vaccination program should have started 8 weeks earlier to lower the clinical attack rate by 50%. In conclusion, vaccination timing was a critical factor in relation to the spread of the 2009 A(H1N1) influenza. Our results also corroborate the central role of children for the transmission of A(H1N1) pandemic influenza.	[de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [de Blasio, Birgitte Freiesleben; Iversen, Bjorn G.] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy; [Tomba, Gianpaolo Scalia] Norwegian Comp Ctr, Oslo, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Rome Tor Vergata	de Blasio, BF (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway.	birgitte.deblasio@medisin.uio.no			Norwegian Research Council [166056/V50]; (sfi)2, Norway; EU	Norwegian Research Council(Research Council of NorwayEuropean Commission); (sfi)2, Norway; EU(European Commission)	Birgitte Freiesleben de Blasio was supported by the Norwegian Research Council (Projects 166056/V50). Gianpaolo Scalia Tomba acknowledges support from (sfi)2, Norway, and from the EU FP 7 project FLUMODCONT. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Aavitsland P, 2010, RAPPORT SCENARIER PA; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; European Centre for Disease Prevention and Control, 2010, ANN EP REP COMM DIS, P1; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ghani AC, 2009, PLOS CURR, V1, pRRN1130; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Health Protection Agency, 2009, PAND H1N1 2009 ENGL; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Keeling M.J., 2008, MODELING INFECT DIS; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Madhun AS, 2010, VACCINE, V29, P266, DOI 10.1016/j.vaccine.2010.10.038; Norwegian Institute of Public Health, 2011, REG PAND VACC; Norwegian Institute of Public Health, 2009, RAD BESK HELS MOT NY; Norwegian Institute of Public Health, 2010, STAT NY INFL A H1N1, P1; Norwegian Institute of Public Health, 2007, RIKT BRUK ANT MIDL M; Poyry Management Consulting, 2011, R2011022 POYR MAN CO, P1; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; West Midlands Regional Epidemiology Unit HPAUK, 2009, PREL DESCR EP LARG S, P14; Wichmann O, 2010, EUROSURVEILLANCE, V15, P2; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P481; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	31	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					327	338	e30018	10.1371/journal.pone.0030018	http://dx.doi.org/10.1371/journal.pone.0030018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253862	gold, Green Submitted, Green Published			2022-12-25	WOS:000301353900034
J	Jobling, MG; Holmes, RK				Jobling, Michael G.; Holmes, Randall K.			Type II Heat-Labile Enterotoxins from 50 Diverse Escherichia coli Isolates Belong Almost Exclusively to the LT-IIc Family and May Be Prophage Encoded	PLOS ONE			English	Article							VIRULENCE FACTORS; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCES; TOXIN; STRAINS; GENES; IDENTIFICATION; DIARRHEA; CLONING; SUBUNIT	Some enterotoxigenic Escherichia coli (ETEC) produce a type II heat-labile enterotoxin (LT-II) that activates adenylate cyclase in susceptible cells but is not neutralized by antisera against cholera toxin or type I heat-labile enterotoxin (LT-I). LT-I variants encoded by plasmids in ETEC from humans and pigs have amino acid sequences that are >= 95% identical. In contrast, LT-II toxins are chromosomally encoded and are much more diverse. Early studies characterized LT-IIa and LT-IIb variants, but a novel LT-IIc was reported recently. Here we characterized the LT-II encoding loci from 48 additional ETEC isolates. Two encoded LT-IIa, none encoded LT-IIb, and 46 encoded highly related variants of LT-IIc. Phylogenetic analysis indicated that the predicted LT-IIc toxins encoded by these loci could be assigned to 6 subgroups. The loci corresponding to individual toxins within each subgroup had DNA sequences that were more than 99% identical. The LT-IIc subgroups appear to have arisen by multiple recombinational events between progenitor loci encoding LT-IIc1- and LT-IIc3-like variants. All loci from representative isolates encoding the LT-IIa, LT-IIb, and each subgroup of LT-IIc enterotoxins are preceded by highly-related genes that are between 80 and 93% identical to predicted phage lysozyme genes. DNA sequences immediately following the B genes differ considerably between toxin subgroups, but all are most closely related to genomic sequences found in predicted prophages. Together these data suggest that the LT-II loci are inserted into lambdoid type prophages that may or may not be infectious. These findings raise the possibility that production of LT-II enterotoxins by ETEC may be determined by phage conversion and may be activated by induction of prophage, in a manner similar to control of production of Shiga-like toxins by converting phages in isolates of enterohemmorhagic E. coli.	[Jobling, Michael G.; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Jobling, MG (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA.	michael.jobling@ucdenver.edu	Jobling, Michael G/AAJ-3814-2021	Jobling, Michael/0000-0001-7689-3093	National Institutes of Health [R01 AI031940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014107, R01AI031940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a research grant from National Institutes of Health R01 AI031940 to RKH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Blanco M, 1997, J CLIN MICROBIOL, V35, P2958, DOI 10.1128/JCM.35.11.2958-2963.1997; BRAZIL GM, 1988, EXPERIENTIA, V44, P848, DOI 10.1007/BF01941182; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; CELEMIN C, 1994, MICROB PATHOGENESIS, V16, P77, DOI 10.1006/mpat.1994.1008; CELEMIN C, 1995, VET MICROBIOL, V45, P121, DOI 10.1016/0378-1135(94)00129-K; CERQUEIRA AMF, 1994, J FOOD PROTECT, V57, P734, DOI 10.4315/0362-028X-57.8.734; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chern EC, 2004, APPL ENVIRON MICROB, V70, P356, DOI 10.1128/AEM.70.1.356-362.2004; Cieplak W, 1995, J BIOL CHEM, V270, P30545, DOI 10.1074/jbc.270.51.30545; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; CONNELL TD, 1992, INFECT IMMUN, V60, P63, DOI 10.1128/IAI.60.1.63-70.1992; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRANCO BDGM, 1991, INT J FOOD MICROBIOL, V12, P333, DOI 10.1016/0168-1605(91)90147-H; Gascon J, 2006, DIGESTION, V73, P102, DOI 10.1159/000089785; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; GREEN BA, 1983, INFECT IMMUN, V41, P383, DOI 10.1128/IAI.41.1.383-390.1983; GUTH BEC, 1986, INFECT IMMUN, V54, P587, DOI 10.1128/IAI.54.2.587-589.1986; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; HOLMES RK, 1986, INFECT IMMUN, V53, P464, DOI 10.1128/IAI.53.3.464-473.1986; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Jobling MG, 1997, PLASMID, V38, P158, DOI 10.1006/plas.1997.1309; Jobling MG, 2000, P NATL ACAD SCI USA, V97, P14662, DOI 10.1073/pnas.011442598; Johnson JR, 2006, MICROBES INFECT, V8, P1702, DOI 10.1016/j.micinf.2006.02.007; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kato M, 1997, FEMS MICROBIOL LETT, V152, P219, DOI 10.1016/S0378-1097(97)00200-0; Khatib LA, 2002, APPL MICROBIOL BIOT, V59, P97, DOI 10.1007/s00253-002-0959-y; Lecointre G, 1998, MOL BIOL EVOL, V15, P1685, DOI 10.1093/oxfordjournals.molbev.a025895; Liang SA, 2010, IMMUNOL INVEST, V39, P449, DOI 10.3109/08820130903563998; LOBET Y, 1991, INFECT IMMUN, V59, P2870, DOI 10.1128/IAI.59.9.2870-2879.1991; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; MORRIS JA, 1982, J GEN MICROBIOL, V128, P2097; Nardi ARM, 2005, VET MICROBIOL, V105, P245, DOI 10.1016/j.vetmic.2004.11.005; Nawar HF, 2011, VACCINE, V29, P721, DOI 10.1016/j.vaccine.2010.11.020; Nawar HF, 2010, INFECT IMMUN, V78, P4705, DOI 10.1128/IAI.00730-10; OSWALD E, 1991, J CLIN MICROBIOL, V29, P2522, DOI 10.1128/JCM.29.11.2522-2527.1991; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; PICKETT CL, 1989, J BACTERIOL, V171, P4945, DOI 10.1128/jb.171.9.4945-4952.1989; PICKETT CL, 1987, J BACTERIOL, V169, P5180, DOI 10.1128/jb.169.11.5180-5187.1987; PICKETT CL, 1986, J BACTERIOL, V165, P348, DOI 10.1128/jb.165.2.348-352.1986; Pilhofer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm836; POHL P, 1989, VET REC, V125, P382, DOI 10.1136/vr.125.14.382; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; RASRINAUL L, 1988, AM J TROP MED HYG, V39, P97, DOI 10.4269/ajtmh.1988.39.97; Rigobelo EC, 2006, ARQ BRAS MED VET ZOO, V58, P305, DOI 10.1590/S0102-09352006000300003; ROBERTSON DC, 1985, PHARMACOL THERAPEUT, V28, P303, DOI 10.1016/0163-7258(85)90057-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salvadori MR, 2003, BRAZ J MICROBIOL, V34, P230, DOI 10.1590/S1517-83822003000300009; SERIWATANA J, 1988, INFECT IMMUN, V56, P1158, DOI 10.1128/IAI.56.5.1158-1161.1988; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; SMITH HW, 1974, J GEN MICROBIOL, V83, P95, DOI 10.1099/00221287-83-1-95; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOKHI AM, 1993, EPIDEMIOL INFECT, V110, P197, DOI 10.1017/S0950268800068114; Tsai YL, 2003, CAN J MICROBIOL, V49, P391, DOI 10.1139/W03-048; Ugrinovich Leila Aidar, 2002, Cienc. Rural, V32, P289, DOI 10.1590/S0103-84782002000200017; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yoder JS, 2006, CLIN INFECT DIS, V42, P1513, DOI 10.1086/503842	63	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29898	10.1371/journal.pone.0029898	http://dx.doi.org/10.1371/journal.pone.0029898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242186	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100043
J	John, JMM; Cattaert, T; Van Lishout, F; Gusareva, ES; Van Steen, K				John, Jestinah M. Mahachie; Cattaert, Tom; Van Lishout, Francois; Gusareva, Elena S.; Van Steen, Kristel			Lower-Order Effects Adjustment in Quantitative Traits Model-Based Multifactor Dimensionality Reduction	PLOS ONE			English	Article							ASSOCIATION; EPISTASIS	Identifying gene-gene interactions or gene-environment interactions in studies of human complex diseases remains a big challenge in genetic epidemiology. An additional challenge, often forgotten, is to account for important lower-order genetic effects. These may hamper the identification of genuine epistasis. If lower-order genetic effects contribute to the genetic variance of a trait, identified statistical interactions may simply be due to a signal boost of these effects. In this study, we restrict attention to quantitative traits and bi-allelic SNPs as genetic markers. Moreover, our interaction study focuses on 2-way SNP-SNP interactions. Via simulations, we assess the performance of different corrective measures for lower-order genetic effects in Model-Based Multifactor Dimensionality Reduction epistasis detection, using additive and co-dominant coding schemes. Performance is evaluated in terms of power and familywise error rate. Our simulations indicate that empirical power estimates are reduced with correction of lower-order effects, likewise familywise error rates. Easy-to-use automatic SNP selection procedures, SNP selection based on "top'' findings, or SNP selection based on p-value criterion for interesting main effects result in reduced power but also almost zero false positive rates. Always accounting for main effects in the SNP-SNP pair under investigation during Model-Based Multifactor Dimensionality Reduction analysis adequately controls false positive epistasis findings. This is particularly true when adopting a co-dominant corrective coding scheme. In conclusion, automatic search procedures to identify lower-order effects to correct for during epistasis screening should be avoided. The same is true for procedures that adjust for lower-order effects prior to Model-Based Multifactor Dimensionality Reduction and involve using residuals as the new trait. We advocate using "on-the-fly'' lower-order effects adjusting when screening for SNP-SNP interactions using Model-Based Multifactor Dimensionality Reduction analysis.	[John, Jestinah M. Mahachie; Cattaert, Tom; Van Lishout, Francois; Gusareva, Elena S.; Van Steen, Kristel] Univ Liege, Inst Montefiore, Syst & Modeling Unit, B-4000 Liege, Belgium; [John, Jestinah M. Mahachie; Cattaert, Tom; Van Lishout, Francois; Gusareva, Elena S.; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium	University of Liege; University of Liege	John, JMM (corresponding author), Univ Liege, Inst Montefiore, Syst & Modeling Unit, B-4000 Liege, Belgium.	jmahachie@ulg.ac.be		Gusareva, Elena/0000-0001-9019-8097; Van Steen, Kristel/0000-0001-9868-5033	Interuniversity Attraction Poles Programme; Belgian State, Science Policy Office; IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning) [IST-2007-216886]; Alma in Silico; European Commission; Walloon Region through the Interreg IV Program	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office(Belgian Federal Science Policy Office); IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning); Alma in Silico; European Commission(European CommissionEuropean Commission Joint Research Centre); Walloon Region through the Interreg IV Program	All authors acknowledge research opportunities offered by the Belgian Network BioMAGNet (Bioinformatics and Modelling: From Genomes to Networks), funded by the Interuniversity Attraction Poles Programme (Phase VI/4), initiated by the Belgian State, Science Policy Office. Their work was also supported in part by the IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning), IST-2007-216886. In addition, F. Van Lishout acknowledges support by Alma in Silico, funded by the European Commission and Walloon Region through the Interreg IV Program. Tom Cattaert is a Postdoctoral Researcher of the Funds for Scientific Research - FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BRADLEY JV, 1978, BRIT J MATH STAT PSY, V31, P144, DOI 10.1111/j.2044-8317.1978.tb00581.x; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Calle ML, 2008, MODEL BASED MULTIFAC; Cattaert T, 2010, PUBLIC LIB SCI ONE; Cattaert T, 2011, ANN HUM GENET, V75, P78, DOI 10.1111/j.1469-1809.2010.00604.x; Chanda P, 2007, AM J HUM GENET, V81, P939, DOI 10.1086/521878; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Gauderman WJ, 2010, AM J EPIDEMIOL, V172, P116, DOI 10.1093/aje/kwq097; Hothorn LA, 2009, BIOMETRICAL J, V51, P659, DOI 10.1002/bimj.200800203; John JMM, 2010, ALLERGY, V65, P875, DOI 10.1111/j.1398-9995.2009.02297.x; John JMM, 2011, EUR J HUM GENET, V19, P696, DOI 10.1038/ejhg.2011.17; Ma SJ, 2011, BIOINFORMATICS, V27, P2119, DOI 10.1093/bioinformatics/btr318; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Van Steen K, BRIEFINGS B IN PRESS; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	16	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29594	10.1371/journal.pone.0029594	http://dx.doi.org/10.1371/journal.pone.0029594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242176	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100031
J	Goh, KS; Li, CW				Goh, King-Siang; Li, Chia-Wei			A Photocytes-Associated Fatty Acid-Binding Protein from the Light Organ of Adult Taiwanese Firefly, Luciola cerata	PLOS ONE			English	Article							FLIGHT-MUSCLE; NITRIC-OXIDE; L-FABP; LUCIFERASE; PEROXISOMES; EVOLUTION; INSIGHTS; ENZYME; LOCUST; SIGNAL	Background: Intracellular fatty acid-binding proteins (FABPs) are considered to be an important energy source supplier in lipid metabolism; however, they have never been reported in any bioluminescent tissue before. In this study, we determined the structural and functional characteristics of a novel FABP (lcFABP) from the light organ of adult Taiwanese firefly, Luciola cerata, and showed anatomical association of lcFABP with photocytes. Principal Findings: Our results demonstrated the primary structure of lcFABP deduced from the cDNA clone of light organ shares structural homologies with other insect and human FABPs. In vitro binding assay indicated the recombinant lcFABP binds saturated long chain fatty acids (C-14-C-18) more strongly than other fatty acids and firefly luciferin. In addition, tissue distribution screening assay using a rabbit antiserum specifically against the N-terminal sequence of lcFABP confirmed the light organ-specific expression of lcFABP. In the light organ, the lcFABP constituted about 15% of total soluble proteins, and was detected in both cytosol and nucleus of photocytes. Conclusions: The specific localization of abundant lcFABP in the light organ suggests that sustained bioluminescent flashes in the light organ might be a high energy demanding process. In photocytes, lcFABP might play a key role in providing long chain fatty acids to peroxisomes for the luciferase-catalyzed long chain acyl-CoA synthetic reaction.	[Goh, King-Siang; Li, Chia-Wei] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan	National Tsing Hua University	Goh, KS (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	cwli@life.nthu.edu.tw			National Science Council (Taiwan, R.O.C) [NSC97-2311-B-007-001-MY3]	National Science Council (Taiwan, R.O.C)(Ministry of Science and Technology, Taiwan)	This work was supported by NSC97-2311-B-007-001-MY3 from the National Science Council (Taiwan, R.O.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Antonenkov VD, 2006, BIOCHEM J, V394, P475, DOI 10.1042/BJ20051058; Aprille JR, 2004, INTEGR COMP BIOL, V44, P213, DOI 10.1093/icb/44.3.213; BARBER VC, 1965, Q J MICROSC SCI, V106, P247; Binas B, 2007, MOL CELL BIOCHEM, V299, P75, DOI 10.1007/s11010-005-9043-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck J, 2002, J INSECT BEHAV, V15, P51, DOI 10.1023/A:1014480028731; Choi YS, 2003, COMP BIOCHEM PHYS B, V134, P199, DOI 10.1016/S1096-4959(02)00249-X; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Falabella P, 2005, INSECT MOL BIOL, V14, P195, DOI 10.1111/j.1365-2583.2004.00548.x; Folli C, 2005, BBA-PROTEINS PROTEOM, V1747, P229, DOI 10.1016/j.bbapap.2004.11.013; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ghiradella H, 2004, INTEGR COMP BIOL, V44, P203, DOI 10.1093/icb/44.3.203; Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Guglielmo CG, 2002, AM J PHYSIOL-REG I, V282, pR1405, DOI 10.1152/ajpregu.00267.2001; HANNA CH, 1976, J ULTRA MOL STRUCT R, V57, P150, DOI 10.1016/S0022-5320(76)80105-0; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Haunerland NH, 2004, ADV MOL CEL, V33, P99; HAUNERLAND NH, 1994, COMP BIOCHEM PHYS B, V109, P199, DOI 10.1016/0305-0491(94)90003-5; HAUNERLAND NH, 1992, EUR J BIOCHEM, V210, P1045, DOI 10.1111/j.1432-1033.1992.tb17510.x; Haunerland NH, 1997, COMP BIOCHEM PHYS B, V117, P475, DOI 10.1016/S0305-0491(97)00185-5; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Inouye S, 2010, CELL MOL LIFE SCI, V67, P387, DOI 10.1007/s00018-009-0170-8; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; KELLER GA, 1987, P NATL ACAD SCI USA, V84, P3264, DOI 10.1073/pnas.84.10.3264; Kim KY, 1998, PROTEIN SCI, V7, P1821, DOI 10.1002/pro.5560070818; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Lucke C, 2006, BIOCHEMISTRY-US, V45, P6296, DOI 10.1021/bi060224f; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Ohtsuki H, 2008, ARCH INSECT BIOCHEM, V69, P176, DOI 10.1002/arch.20275; PETERSON MK, 1968, BIOL BULL, V135, P335, DOI 10.2307/1539786; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; SHA RS, 1993, J BIOL CHEM, V268, P7885; SMITH AF, 1992, J BIOL CHEM, V267, P380; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wu CH, 2010, COLEOPTS BULL, V64, P235, DOI 10.1649/0010-065X-64.3.235.9; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	42	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29576	10.1371/journal.pone.0029576	http://dx.doi.org/10.1371/journal.pone.0029576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242133	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000049
J	Mitra, A; Menezes, ME; Pannell, LK; Mulekar, MS; Honkanen, RE; Shevde, LA; Samant, RS				Mitra, A.; Menezes, M. E.; Pannell, L. K.; Mulekar, M. S.; Honkanen, R. E.; Shevde, L. A.; Samant, R. S.			DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3 beta to downregulate beta-catenin transcription target, osteopontin	ONCOGENE			English	Article						DNAJB6; cancer; SPP1; OPN; GSK3 beta; PP2A	PROTEIN PHOSPHATASE 2A; MRJ CO-CHAPERONE; METASTATIC MELANOMA; TUMOR-SUPPRESSOR; BREAST-CANCER; J-DOMAIN; T-CELLS; EXPRESSION; PROGRESSION; WNT	Elevated levels of the oncoprotein, osteopontin (OPN), are associated with poor outcome of several types of cancers including melanoma. We have previously reported an important involvement of DNAJB6, a member of heat-shock protein 40 (HSP40) family, in negatively impacting tumor growth. The current study was prompted by our observations reported here which revealed a reciprocal relationship between DNAJB6 and OPN in melanoma specimens. The 'J domain' is the most conserved domain of HSP40 family of proteins. Hence, we assessed the functional role of the J domain in activities of DNAJB6. We report that the J domain of DNAJB6 is involved in mediating OPN suppression. Deletion of the J domain renders DNAJB6 incapable of impeding malignancy and suppressing OPN. Our mechanistic investigations reveal that DNAJB6 binds HSPA8 (heat-shock cognate protein, HSC70) and causes dephosphorylation of glycogen synthase kinase 3 beta (GSK3 beta) at Ser 9 by recruiting protein phosphatase, PP2A. This dephosphorylation activates GSK3 beta, leading to degradation of beta-catenin and subsequent loss of TCF/LEF (T cell factor1/lymphoid enhancer factor1) activity. Deletion of the J domain abrogates assembly of this multiprotein complex and renders GSK3 beta inactive, thus, stabilizing beta-catenin, a transcription coactivator for OPN expression. Our in-vitro and in-vivo functional analyses show that silencing OPN expression in the background of deletion of the J domain renders the resultant tumor cells less malignant despite the presence of stabilized beta-catenin. Thus, we have uncovered a new mechanism for regulation of GSK3 beta activity leading to inhibition of Wnt/beta-catenin signaling. Oncogene (2012) 31, 4472-4483; doi: 10.1038/onc.2011.623; published online 23 January 2012	[Mitra, A.; Menezes, M. E.; Pannell, L. K.; Shevde, L. A.; Samant, R. S.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Mulekar, M. S.] Univ S Alabama, Dept Math & Stat, Mobile, AL 36604 USA; [Honkanen, R. E.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36604 USA	University of South Alabama; University of South Alabama; University of South Alabama	Samant, RS (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Spring Hill Ave, Mobile, AL 36604 USA.	rsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	USPHS [CA140472, CA138850]; Mayer Mitchell Award for Excellence in Cancer Research; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850, R01CA060750] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Mayer Mitchell Award for Excellence in Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by USPHS grants CA140472 (RSS) and CA138850 (LAS). RSS is the recipient of the Mayer Mitchell Award for Excellence in Cancer Research and acknowledges the support. We thank Dr Randall Moon (HHMI University of Washington) for providing the TOP-Flash reporter.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Denhardt D, 2005, J INVEST DERMATOL, V124, pXVI, DOI 10.1111/j.0022-202X.2005.23708.x; Dey S, 2009, MOL CELL BIOCHEM, V322, P137, DOI 10.1007/s11010-008-9950-y; Dhennin-Duthille I, 2011, J BIOL CHEM, V286, P5034, DOI 10.1074/jbc.M110.155903; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; El-Tanani M, 2001, CANCER RES, V61, P5619; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Fillmore RA, 2009, INT J CANCER, V125, P556, DOI 10.1002/ijc.24276; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; Greillier L, 2008, MOL DIAGN THER, V12, P375, DOI 10.2165/1250444-200812060-00004; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Howe LR, 2003, CANCER RES, V63, P1906; Hunter PJ, 1999, DEVELOPMENT, V126, P1247; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kurzik-Dumke U, 2008, INT J MOL MED, V21, P19; Kurzik-Dumke U, 2007, CELL SIGNAL, V19, P1973, DOI 10.1016/j.cellsig.2007.05.008; Kushiro K, 2011, CLIN EXP METASTAS, V28, P877, DOI 10.1007/s10585-011-9418-4; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lin Kimberly, 2010, Genes Cancer, V1, P409; Lopez-Bergami P, 2008, PHOTOCHEM PHOTOBIOL, V84, P289, DOI 10.1111/j.1751-1097.2007.00254.x; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Martin MJ, 2009, CANCER CELL, V15, P163, DOI 10.1016/j.ccr.2009.02.006; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Metge BJ, 2010, ONCOLOGY-BASEL, V78, P75, DOI 10.1159/000292363; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Mitra A, 2010, J BIOL CHEM, V285, P24686, DOI 10.1074/jbc.M109.094847; Mitra A, 2009, CLIN EXP METASTAS, V26, P559, DOI 10.1007/s10585-009-9255-x; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Moore SR, 2008, CLIN CANCER RES, V14, P2927, DOI 10.1158/1078-0432.CCR-07-4068; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pecina-Slaus N, 2007, J CUTAN PATHOL, V34, P239, DOI 10.1111/j.1600-0560.2006.00601.x; PolanowskaGrabowska R, 1997, BLOOD, V90, P1516, DOI 10.1182/blood.V90.4.1516.1516_1516_1526; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rodolfo M, 2004, CANCER LETT, V214, P133, DOI 10.1016/j.canlet.2004.06.049; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Saika S, 2007, LAB INVEST, V87, P130, DOI 10.1038/labinvest.3700508; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Watson ED, 2009, DEV DYNAM, V238, P2564, DOI 10.1002/dvdy.22088; Weeraratna AT, 2005, CANCER METAST REV, V24, P237, DOI 10.1007/s10555-005-1574-z; Whalen KA, 2005, J VIROL, V79, P9982, DOI 10.1128/JVI.79.15.9982-9990.2005; Yeatman TJ, 2003, CLIN EXP METASTAS, V20, P85, DOI 10.1023/A:1022502805474; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x; Zuidervaart W, 2007, MELANOMA RES, V17, P380, DOI 10.1097/CMR.0b013e3282f1d302	75	41	41	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4472	4483		10.1038/onc.2011.623	http://dx.doi.org/10.1038/onc.2011.623			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22266849	Green Accepted			2022-12-25	WOS:000309704500005
J	Agarwal, S; Agarwal, S; Jin, H; Pancholi, P; Pancholi, V				Agarwal, Shivani; Agarwal, Shivangi; Jin, Hong; Pancholi, Preeti; Pancholi, Vijay			Serine/Threonine Phosphatase (SP-STP), Secreted from Streptococcus pyogenes, Is a Pro-apoptotic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; CYTOLYSIN-MEDIATED TRANSLOCATION; ACTIN-BASED MOTILITY; EPITHELIAL-CELLS; NAD(+) GLYCOHYDROLASE; VIRULENCE FACTOR; STREPTOLYSIN-O; DEATH PATHWAY; HISTONE H3; PHOSPHORYLATION	This investigation illustrates an important property of eukaryote-type serine/threonine phosphatase (SP-STP) of group A Streptococcus (GAS) in causing programmed cell death of human pharyngeal cells. The secretory nature of SP-STP, its elevated expression in the intracellular GAS, and the ability of wild-type GAS but not the GAS mutant devoid of SP-STP to cause apoptosis of the host cell both in vitro and in vivo suggest that GAS deploys SP-STP as an important virulence determinant to exploit host cell machinery for its own advantage during infection. The exogenously added SP-STP is able to enter the cytoplasm and subsequently traverses into the nucleus in a temporal fashion to cause apoptosis of the pharyngeal cells. The programmed cell death induced by SP-STP, which requires active transcription and de novo protein synthesis, is also caspase-dependent. Furthermore, the entry of SP-STP into the cytoplasm is dependent on its secondary structure as the catalytically inactive SP-STP with an altered structure is unable to internalize and cause apoptosis. The ectopically expressed wildtype SP-STP was found to be in the nucleus and conferred apoptosis of Detroit 562 pharyngeal cells. However, the catalytically inactive SP-STP was unable to cause apoptosis even when intracellularly expressed. The ability of SP-STP to activate pro-apoptotic signaling cascades both in the cytoplasm and in the nucleus resulted in mitochondrial dysfunctioning and perturbation in the phosphorylation status of histones in the nucleus. SP-STP thus not only functions as a virulence regulator but also as an important factor responsible for host-related pathogenesis.	[Agarwal, Shivani; Agarwal, Shivangi; Jin, Hong; Pancholi, Preeti; Pancholi, Vijay] Ohio State Univ, Dept Pathol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), Ohio State Univ, Dept Pathol, Coll Med, 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	Vijay.Pancholi@osumc.edu	Pancholi, Vijay/E-3810-2011	Agarwal, Shivangi/0000-0002-2406-7678	National Institutes of Health [AI64912, AI76889]; Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076889, R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI64912 and AI76889 (to V. P.). This work was also supported by Ohio State University departmental funds (to P. P.).	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BODE AM, 2005, SCI STKE, pRE4; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Dong ZG, 2006, MOL CARCINOGEN, V45, P416, DOI 10.1002/mc.20220; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Hagimoto N, 1999, AM J RESP CELL MOL, V21, P436, DOI 10.1165/ajrcmb.21.3.3397; Jeon ES, 2007, J CELL BIOCHEM, V100, P1536, DOI 10.1002/jcb.21141; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kobayashi S, 2005, GENES CELLS, V10, P253, DOI 10.1111/j.1365-2443.2005.00835.x; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Medina E, 2003, INFECT IMMUN, V71, P5376, DOI 10.1128/IAI.71.9.5376-5380.2003; Meehl MA, 2004, MOL MICROBIOL, V52, P1665, DOI 10.1111/j.1365-2958.2004.04082.x; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; North JA, 2011, NUCLEIC ACIDS RES, V39, P6465, DOI 10.1093/nar/gkr304; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Pancholi V, 2010, J BIOL CHEM, V285, P30861, DOI 10.1074/jbc.M110.153825; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Riddle DJ, 2010, J BACTERIOL, V192, P3735, DOI 10.1128/JB.00234-10; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Tong Y, 2001, MOL CANCER THER, V1, P95; Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902	52	19	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9147	9167		10.1074/jbc.M111.316554	http://dx.doi.org/10.1074/jbc.M111.316554			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262847	Green Published, hybrid			2022-12-25	WOS:000301797800044
J	Boucard, AA; Ko, JW; Sudhof, TC				Boucard, Antony A.; Ko, Jaewon; Suedhof, Thomas C.			High Affinity Neurexin Binding to Cell Adhesion G-protein-coupled Receptor CIRL1/Latrophilin-1 Produces an Intercellular Adhesion Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN RECEPTOR; EXCITATORY SYNAPSE FORMATION; BETA-NEUREXINS; SURFACE PROTEINS; CA2+ CHANNELS; FAMILY; NEUROLIGINS; LATROPHILIN; EXOCYTOSIS; INTERACTS	The G-protein-coupled receptor CIRL1/latrophilin-1 (CL1) and the type-1 membrane proteins neurexins represent distinct neuronal cell adhesion molecules that exhibit no similarities except for onecommonfunction: both proteins are receptors for alpha-latrotoxin, a component of black widow spider venom that induces massive neurotransmitter release at synapses. Unexpectedly, we have now identified a direct binding interaction between the extracellular domains of CL1 and neurexins that is regulated by alternative splicing of neurexins at splice site 4 (SS4). Using saturation binding assays, we showed that neurexins lacking an insert at SS4 bind to CL1 with nanomolar affinity, whereas neurexins containing an insert at SS4 are unable to bind. CL1 competed for neurexin binding with neuroligin-1, a well characterized neurexin ligand. The extracellular sequences of CL1 contain five domains (lectin, olfactomedin-like, serine/threonine-rich, hormone-binding, and G-protein-coupled receptor autoproteolysis-inducing (GAIN) domains). Of these domains, the olfactomedin-like domain mediates neurexin binding as shown by deletion mapping. Cell adhesion assays using cells expressing neurexins and CL1 revealed that their interaction produces a stable intercellular adhesion complex, indicating that their interaction can be trans-cellular. Thus, our data suggest that CL1 constitutes a novel ligand for neurexins that may be localized postsynaptically based on its well characterized interaction with intracellular SH3 and multiple ankyrin repeats adaptor proteins (SHANK) and could form a trans-synaptic complex with presynaptic neurexins.	[Boucard, Antony A.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Boucard, Antony A.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Boucard, AA (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	aboucard@stanford.edu; tcs1@stanford.edu	Boucard, Antony/CAJ-3093-2022; Boucard, Antony/ABA-9769-2020	BOUCARD, Antony Jr/0000-0002-5538-0464	Canadian Institutes of Health Research; Human Frontier Science Program Organization [LT00021/2008-L]; NIH [R37 MH052804-18]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a fellowship grant from the Canadian Institutes of Health Research (to A. A. B.) and Human Frontier Science Program Organization Grant LT00021/2008-L (to J. K.). This study was also supported by NIH Grant R37 MH052804-18.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; DAVLETOV BA, 1995, J BIOL CHEM, V270, P23903, DOI 10.1074/jbc.270.41.23903; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kreienkamp HJ, 2000, J BIOL CHEM, V275, P32387, DOI 10.1074/jbc.C000490200; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schioth HB, 2010, ADV EXP MED BIOL, V706, P1; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	53	120	123	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9399	9413		10.1074/jbc.M111.318659	http://dx.doi.org/10.1074/jbc.M111.318659			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262843	Green Published, hybrid			2022-12-25	WOS:000301797800070
J	Doyle, JD; Danthi, P; Kendall, EA; Ooms, LS; Wetzel, JD; Dermody, TS				Doyle, Joshua D.; Danthi, Pranav; Kendall, Emily A.; Ooms, Laura S.; Wetzel, J. Denise; Dermody, Terence S.			Molecular Determinants of Proteolytic Disassembly of the Reovirus Outer Capsid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES MEMBRANE DISRUPTION; REVERSE GENETICS SYSTEM; PROTEASE INHIBITOR E64; L-CELLS; PERSISTENT INFECTIONS; CATHEPSIN-L; MAMMALIAN REOVIRUSES; PENETRATION PROTEIN; CARBOXY-TERMINUS; INFLUENZA-VIRUS	Following attachment and internalization, mammalian reoviruses undergo intracellular proteolytic disassembly followed by viral penetration into the cytoplasm. The initiating event in reovirus disassembly is the cathepsin-mediated proteolytic degradation of viral outer capsid protein sigma 3. A single tyrosine-to-histidine mutation at amino acid 354 (Y354H) of strain type 3 Dearing (T3D) sigma 3 enhances reovirus disassembly and confers resistance to protease inhibitors such as E64. The sigma 3 amino acid sequence of strain type 3 Abney (T3A) differs from that of T3D at eight positions including Y354H. However, T3A displays disassembly kinetics and protease sensitivity comparable with T3D. We hypothesize that one or more additional sigma 3 polymorphisms suppress the Y354H phenotype and restore T3D disassembly characteristics. To test this hypothesis, we engineered a panel of reovirus variants with T3A sigma 3 polymorphisms introduced individually into T3D-sigma 3Y354H. We evaluated E64 resistance and in vitro cathepsin L susceptibility of these viruses and found that one containing a glycine-to-glutamate substitution at position 198 (G198E) displayed disassembly kinetics and E64 sensitivity similar to those properties of T3A and T3D. Additionally, viruses containing changes at positions 233 and 347 (S233L and I347T) developed de novo compensatory mutations at position 198, strengthening the conclusion that residue 198 is a key determinant of sigma 3 proteolytic susceptibility. Variants with Y354H in sigma 3 lost infectivity more rapidly than T3A or T3D following heat treatment, an effect abrogated by G198E. These results identify a regulatory network of residues that control sigma 3 cleavage and capsid stability, thus providing insight into the regulation of nonenveloped virus disassembly.	[Doyle, Joshua D.; Ooms, Laura S.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Danthi, Pranav; Kendall, Emily A.; Wetzel, J. Denise; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Doyle, Joshua D.; Danthi, Pranav; Kendall, Emily A.; Ooms, Laura S.; Wetzel, J. Denise; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Dermody, TS (corresponding author), Vanderbilt Univ, Sch Med, Lamb Ctr Pediat Res, D7235 MCN, Nashville, TN 37232 USA.	terry.dermody@vanderbilt.edu	Danthi, Pranav/H-6330-2019	Danthi, Pranav/0000-0001-6199-6022; Kendall, Emily/0000-0002-0083-422X	National Institutes of Health from USPHS [T32 GM008554]; National Institutes of Health [R01 AI032539]; Elizabeth B. Lamb Center for Pediatric Research; United States Public Health Service [CA68485, DK20593]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth B. Lamb Center for Pediatric Research; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM008554 from USPHS (to J. D. D.) and R01 AI032539 (to T. S. D.). This work was also supported by the Elizabeth B. Lamb Center for Pediatric Research.; We express our appreciation to Karl Boehme and Greg Wilson for careful review of the manuscript and to Chris Aiken for helpful suggestions. We thank John Mort for the kind gift of purified cathepsin L. Additional support was provided by United States Public Health Service Awards CA68485 for the Vanderbilt Cancer Center and DK20593 for the Vanderbilt Diabetes Research and Training Center.	Baer GS, 1999, J VIROL, V73, P9532, DOI 10.1128/JVI.73.11.9532-9543.1999; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; Clark KM, 2006, J VIROL, V80, P671, DOI 10.1128/JVI.80.2.671-681.2006; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Ebert DH, 2004, J BIOL CHEM, V279, P3837, DOI 10.1074/jbc.M310048200; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ebert DH, 2001, J VIROL, V75, P3197, DOI 10.1128/JVI.75.7.3197-3206.2001; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; HAND R, 1973, J VIROL, V11, P223, DOI 10.1128/JVI.11.2.223-231.1973; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Johnson EM, 2009, J VIROL, V83, P9630, DOI 10.1128/JVI.01095-09; KEDL R, 1995, J VIROL, V69, P552, DOI 10.1128/JVI.69.1.552-559.1995; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; ROSEN L, 1960, AM J HYG, V71, P258, DOI 10.1093/oxfordjournals.aje.a120109; SCHIFF LA, 2007, FIELDS VIROLOGY, P1853; SILVERSTEIN SC, 1972, VIROLOGY, V47, P797, DOI 10.1016/0042-6822(72)90571-5; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wetzel JD, 1997, J VIROL, V71, P1362, DOI 10.1128/JVI.71.2.1362-1369.1997; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wilson GJ, 2002, J VIROL, V76, P9832, DOI 10.1128/JVI.76.19.9832-9843.2002; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	40	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8029	8038		10.1074/jbc.M111.334854	http://dx.doi.org/10.1074/jbc.M111.334854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253447	hybrid, Green Published			2022-12-25	WOS:000301349400019
J	Paulmann, M; Arnold, T; Linke, D; Ozdirekcan, S; Kopp, A; Gutsmann, T; Kalbacher, H; Wanke, I; Schuenemann, VJ; Habeck, M; Burck, J; Ulrich, AS; Schittek, B				Paulmann, Maren; Arnold, Thomas; Linke, Dirk; Oezdirekcan, Suat; Kopp, Annika; Gutsmann, Thomas; Kalbacher, Hubert; Wanke, Ines; Schuenemann, Verena J.; Habeck, Michael; Buerck, Jochen; Ulrich, Anne S.; Schittek, Birgit			Structure-Activity Analysis of the Dermcidin-derived Peptide DCD-1L, an Anionic Antimicrobial Peptide Present in Human Sweat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIENTED CIRCULAR-DICHROISM; LIPID-BILAYERS; PERMEABLE CHANNELS; MEMBRANES; BACTERIAL; SPECTROSCOPY; ORGANISMS; DEFENSE; PROTEIN; MODE	Dermcidin encodes the anionic amphiphilic peptide DCD-1L, which displays a broad spectrum of antimicrobial activity under conditions resembling those in human sweat. Here, we have investigated its mode of antimicrobial activity. We found that DCD-1L interacts preferentially with negatively charged bacterial phospholipids with a helix axis that is aligned flat on a lipid bilayer surface. Upon interaction with lipid bilayers DCD-1L forms oligomeric complexes that are stabilized by Zn2+. DCD-1L is able to form ion channels in the bacterial membrane, and we propose that Zn2+-induced self-assembly of DCD-1L upon interaction with bacterial lipid bilayers is a prerequisite for ion channel formation. These data allow us for the first time to propose a molecular model for the antimicrobial mechanism of a naturally processed human anionic peptide that is active under the harsh conditions present in human sweat.	[Paulmann, Maren; Wanke, Ines; Schittek, Birgit] Univ Tubingen, Dept Dermatol, D-72074 Tubingen, Germany; [Arnold, Thomas; Linke, Dirk; Oezdirekcan, Suat; Schuenemann, Verena J.; Habeck, Michael] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Kopp, Annika; Gutsmann, Thomas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany; [Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76344 Eggenstein Leopoldshafen, Germany; [Buerck, Jochen; Ulrich, Anne S.] Inst Organ Chem CFN, D-76344 Eggenstein Leopoldshafen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Forschungszentrum Borstel; Eberhard Karls University of Tubingen; Helmholtz Association; Karlsruhe Institute of Technology	Schittek, B (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeisterstr 25, D-72074 Tubingen, Germany.	birgit.schittek@med.uni-tuebingen.de	Gutsmann, Thomas/E-6100-2011; Ulrich, Anne S/H-5519-2013; Linke, Dirk/F-9147-2010	Ulrich, Anne S/0000-0001-5571-9483; Linke, Dirk/0000-0003-3150-6752; Habeck, Michael/0000-0002-2188-5667; Schittek, Birgit/0000-0003-0081-2001	Deutsche Forschungsgemeinschaft [SFB766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB766.	Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Bruhn H, 2006, DEV COMP IMMUNOL, V30, P597, DOI 10.1016/j.dci.2005.09.002; Burck J, 2008, BIOPHYS J, V95, P3872, DOI 10.1529/biophysj.108.136085; Chen FY, 2002, BIOPHYS J, V82, P908, DOI 10.1016/S0006-3495(02)75452-0; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cipakova I, 2006, PROTEIN EXPRES PURIF, V45, P269, DOI 10.1016/j.pep.2005.07.002; Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084; DUCLOHIER H, 1989, BIOPHYS J, V56, P1017, DOI 10.1016/S0006-3495(89)82746-8; Flad T, 2002, J IMMUNOL METHODS, V270, P53, DOI 10.1016/S0022-1759(02)00229-6; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goumon Y, 1998, J BIOL CHEM, V273, P29847, DOI 10.1074/jbc.273.45.29847; Grage SL, 2010, METHODS MOL BIOL, V618, P183, DOI 10.1007/978-1-60761-594-1_13; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Harris F., 2011, CURR CHEM BIOL, V5, P142; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Jung HH, 2010, BMB REP, V43, P362, DOI 10.5483/BMBRep.2010.43.5.362; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KORDEL M, 1988, J BACTERIOL, V170, P84, DOI 10.1128/jb.170.1.84-88.1988; Lai R, 2002, BIOCHEM BIOPH RES CO, V295, P796, DOI 10.1016/S0006-291X(02)00762-3; Lai YP, 2005, BIOCHEM BIOPH RES CO, V328, P243, DOI 10.1016/j.bbrc.2004.12.143; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; Malkoski M, 2001, ANTIMICROB AGENTS CH, V45, P2309, DOI 10.1128/AAC.45.8.2309-2315.2001; OLAH GA, 1988, J CHEM PHYS, V89, P2531, DOI 10.1063/1.455047; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; PUSKIN JS, 1977, J MEMBRANE BIOL, V35, P39, DOI 10.1007/BF01869939; Rieg S, 2005, J IMMUNOL, V174, P8003, DOI 10.4049/jimmunol.174.12.8003; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Senyurek I, 2009, ANTIMICROB AGENTS CH, V53, P2499, DOI 10.1128/AAC.01679-08; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	44	72	75	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8434	8443		10.1074/jbc.M111.332270	http://dx.doi.org/10.1074/jbc.M111.332270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262861	Green Published, hybrid			2022-12-25	WOS:000301349400058
J	Yin, LM; Edwards, MA; Li, J; Yip, CM; Deber, CM				Yin, Lois M.; Edwards, Michelle A.; Li, Jessica; Yip, Christopher M.; Deber, Charles M.			Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED-SPECTROSCOPY; LIPID-BILAYERS; PROTEINS; ORGANIZATION; SELECTIVITY; MICROSCOPY; PREDICTION; BACTERIAL; AMIDE; AFM	Cationic antimicrobial peptides (CAPs) occur as important innate immunity agents in many organisms, including humans, and offer a viable alternative to conventional antibiotics, as they physically disrupt the bacterial membranes, leading to membrane lysis and eventually cell death. In this work, we studied the biophysical and microbiological characteristics of designed CAPs varying in hydrophobicity levels and charge distributions by a variety of biophysical and biochemical approaches, including in-tandem atomic force microscopy, attenuated total reflection-FTIR, CD spectroscopy, and SDS-PAGE. Peptide structural properties were correlated with their membrane-disruptive abilities and antimicrobial activities. In bacterial lipid model membranes, a time-dependent increase in aggregated beta-strand-type structure in CAPs with relatively high hydrophobicity (such as KKKKKKALFALW-LAFLA-NH2) was essentially absent in CAPs with lower hydrophobicity (such as KKKKKKAAFAAWAAFAA-NH2). Redistribution of positive charges by placing three Lys residues at both termini while maintaining identical sequences minimized self-aggregation above the dimer level. Peptides containing four Leu residues were destructive to mammalian model membranes, whereas those with corresponding Ala residues were not. This finding was mirrored in hemolysis studies in human erythrocytes, where Ala-only peptides displayed virtually no hemolysis up to 320 mu M, but the four-Leu peptides induced 40-80% hemolysis at the same concentration range. All peptides studied displayed strong antimicrobial activity against Pseudomonas aeruginosa (minimum inhibitory concentrations of 4-32 mu M). The overall findings suggest optimum routes to balancing peptide hydrophobicity and charge distribution that allow efficient penetration and disruption of the bacterial membranes without damage to mammalian (host) membranes.	[Yin, Lois M.; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Yin, Lois M.; Yip, Christopher M.; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S IA8, Canada; [Edwards, Michelle A.; Li, Jessica; Yip, Christopher M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca		Yip, Christopher/0000-0003-4507-556X	Canadian Institutes of Health Research (CIHR) [FRN-79284]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 194435]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant FRN-79284 (to C. M. D.) and Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN 194435 (to C. M. Y.).	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; Burrows LL, 2006, J ANTIMICROB CHEMOTH, V57, P899, DOI 10.1093/jac/dkl056; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i; Florin-Christensen J, 2001, P NATL ACAD SCI USA, V98, P7736, DOI 10.1073/pnas.131580998; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; La Rocca P, 1999, BIOPHYS CHEM, V76, P145, DOI 10.1016/S0301-4622(98)00232-4; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; Leptihn S, 2010, BIOCHEMISTRY-US, V49, P9161, DOI 10.1021/bi1011578; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mukherjee S, 2007, J PHYS CHEM B, V111, P4596, DOI 10.1021/jp0689060; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oreopoulos J, 2009, J STRUCT BIOL, V168, P21, DOI 10.1016/j.jsb.2009.02.011; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Van Mau N, 1999, J MEMBRANE BIOL, V167, P241; Verity JE, 2009, BIOPHYS J, V97, P1225, DOI 10.1016/j.bpj.2009.06.013; Vie V, 2000, BIOPHYS J, V78, P846, DOI 10.1016/S0006-3495(00)76642-2; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yin L. M., 2011, P 22 AM PEPT S SAN D, P252; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	36	250	258	6	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7738	7745		10.1074/jbc.M111.303602	http://dx.doi.org/10.1074/jbc.M111.303602			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253439	hybrid, Green Published			2022-12-25	WOS:000301060200072
J	Teng, ZH; Yuan, CJ; Zhang, F; Huan, ML; Cao, WD; Li, KC; Yang, JY; Cao, DY; Zhou, SY; Mei, QB				Teng, Zenghui; Yuan, Chengjun; Zhang, Feng; Huan, Menglei; Cao, Weidong; Li, Kangchu; Yang, Jingyue; Cao, Dayong; Zhou, Siyuan; Mei, Qibing			Intestinal Absorption and First-Pass Metabolism of Polyphenol Compounds in Rat and Their Transport Dynamics in Caco-2 Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; DIETARY POLYPHENOLS; QUANTITATION ASSAY; GLUCOSE-UPTAKE; BIOAVAILABILITY; PHARMACOKINETICS; CHEMOPREVENTION; RESVERATROL; FLAVONOIDS; MONOLAYERS	Background: Polyphenols, a group of complex naturally occurring compounds, are widely distributed throughout the plant kingdom and are therefore readily consumed by humans. The relationship between their chemical structure and intestinal absorption, transport, and first-pass metabolism remains unresolved, however. Methods: Here, we investigated the intestinal absorption and first-pass metabolism of four polyphenol compounds, apigenin, resveratrol, emodin and chrysophanol, using the in vitro Caco-2 cell monolayer model system and in situ intestinal perfusion and in vivo pharmacokinetic studies in rats, so as to better understand the relationship between the chemical structure and biological fate of the dietary polyphenols. Conclusion: After oral administration, emodin and chrysophanol exhibited different absorptive and metabolic behaviours compared to apigenin and resveratrol. The differences in their chemical structures presumably resulted in differing affinities for drug-metabolizing enzymes, such as glucuronidase and sulphatase, and transporters, such as MRP2, SGLT1, and P-glycoprotein, which are found in intestinal epithelial cells.	[Teng, Zenghui; Huan, Menglei; Zhou, Siyuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Yuan, Chengjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Cardiovasc Dept, Xian, Peoples R China; [Zhang, Feng; Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, State Adm Tradit Chinese Med, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, Xian 710032, Peoples R China; [Cao, Weidong; Yang, Jingyue; Cao, Dayong] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China; [Li, Kangchu] Fourth Mil Med Univ, Dept Radiat Med, Xian 710032, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Teng, ZH (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China.	zhousiyuan1@hotmail.com; tengzenghui@hotmail.com			National Natural Science Foundation of China [31000767]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant (No. 31000767) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andlauer W, 2000, J NUTR, V130, P843, DOI 10.1093/jn/130.4.843; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Cai KH, 2006, BIOCHEM PHARMACOL, V71, P1570, DOI 10.1016/j.bcp.2006.02.013; Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128; Chen ZS, 1999, MOL PHARMACOL, V56, P1219, DOI 10.1124/mol.56.6.1219; Corder R, 2006, NATURE, V444, P566, DOI 10.1038/444566a; DuPont MS, 2002, J NUTR, V132, P172, DOI 10.1093/jn/132.2.172; Fresco P, 2006, MED RES REV, V26, P747, DOI 10.1002/med.20060; Higaki Kazutaka, 2004, Drug Metab Pharmacokinet, V19, P198, DOI 10.2133/dmpk.19.198; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Kroon PA, 2004, AM J CLIN NUTR, V80, P15; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Liu Y, 2002, DRUG METAB DISPOS, V30, P370, DOI 10.1124/dmd.30.4.370; Ma Y, 2006, INT J PHARMACEUT, V307, P292, DOI 10.1016/j.ijpharm.2005.10.018; Maier-Salamon A, 2006, PHARM RES-DORDR, V23, P2107, DOI 10.1007/s11095-006-9060-z; Moon YJ, 2007, MOL PHARM, V4, P865, DOI 10.1021/mp7000928; Nabokina SM, 2005, AM J PHYSIOL-CELL PH, V289, pC97, DOI 10.1152/ajpcell.00009.2005; Prasain JK, 2007, MOL PHARMACEUT, V4, P846, DOI 10.1021/mp700116u; Silberberg M, 2006, EUR J NUTR, V45, P88, DOI 10.1007/s00394-005-0568-5; Teng ZH, 2007, BIOL PHARM BULL, V30, P1628, DOI 10.1248/bpb.30.1628; Teng ZH, 2007, BIOSCI BIOTECH BIOCH, V71, P1636, DOI 10.1271/bbb.70025; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yi WG, 2006, J AGR FOOD CHEM, V54, P5651, DOI 10.1021/jf0531959	24	68	70	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29647	10.1371/journal.pone.0029647	http://dx.doi.org/10.1371/journal.pone.0029647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253753	Green Submitted, gold, Green Published			2022-12-25	WOS:000301361500017
J	Ord, RL; Rodriguez, M; Yamasaki, T; Takeo, S; Tsuboi, T; Lobo, CA				Ord, Rosalynn Louise; Rodriguez, Marilis; Yamasaki, Tsutomu; Takeo, Satoru; Tsuboi, Takafumi; Lobo, Cheryl A.			Targeting Sialic Acid Dependent and Independent Pathways of Invasion in Plasmodium falciparum	PLOS ONE			English	Article							ERYTHROCYTE-BINDING ANTIGEN; GLYCOPHORIN-B; MEROZOITE PROTEINS; MALARIA PARASITES; RECEPTOR; EBA-175; LIGAND; ANTIBODIES; REGION; HOMOLOG	The pathology of malaria is a consequence of the parasitaemia which develops through the cyclical asexual replication of parasites in a patient's red blood cells. Multiple parasite ligand-erythrocyte receptor interactions must occur for successful Plasmodium invasion of the human red cell. Two major malaria ligand families have been implicated in these variable ligand-receptor interactions used by Plasmodium falciparum to invade human red cells: the micronemal proteins from the Erythrocyte Binding Ligands (EBL) family and the rhoptry proteins from the Reticulocyte binding Homolog (PfRH) family. Ligands from the EBL family largely govern the sialic acid (SA) dependent pathways of invasion and the RH family ligands (except for RH1) mediate SA independent invasion. In an attempt to dissect out the invasion inhibitory effects of antibodies against ligands from both pathways, we have used EBA-175 and RH5 as model members of each pathway. Mice were immunized with either region II of EBA-175 produced in Pichia pastoris or full-length RH5 produced by the wheat germ cell-free system, or a combination of the two antigens to look for synergistic inhibitory effects of the induced antibodies. Sera obtained from these immunizations were tested for native antigen recognition and for efficacy in invasion inhibition assays. Results obtained show promise for the potential use of such hybrid vaccines to induce antibodies that can block multiple parasite ligand-red cell receptor interactions and thus inhibit parasite invasion.	[Ord, Rosalynn Louise; Rodriguez, Marilis; Lobo, Cheryl A.] New York Blood Ctr, Dept Blood Borne Parasites, New York, NY 10021 USA; [Yamasaki, Tsutomu; Takeo, Satoru; Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Venture Business Lab, Matsuyama, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Ehime Proteomed Res Ctr, Toon, Ehime, Japan	New York Blood Center; Ehime University; Ehime University; Ehime University	Lobo, CA (corresponding author), New York Blood Ctr, Dept Blood Borne Parasites, New York, NY 10021 USA.	clobo@nybloodcenter.org	Tsuboi, Takafumi/AAK-6145-2021	Tsuboi, Takafumi/0000-0002-7415-1325	National Institute of Allergy and Infectious Diseases/Division of Microbiology and Infectious Diseases (NIAID/DMID) [AI-N01-045210]; Ministry of Education, Culture, Sports, Science and Technology [21249028, 23117008]; Ministry of Health, Labour, and Welfare, Japan [H21-Chikyukibo-ippan-005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045210] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23406007] Funding Source: KAKEN	National Institute of Allergy and Infectious Diseases/Division of Microbiology and Infectious Diseases (NIAID/DMID); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by National Institute of Allergy and Infectious Diseases/Division of Microbiology and Infectious Diseases (NIAID/DMID) contract AI-N01-045210 to SAIC, which also provided the EBA-175 region II recombinant protein. This work was also supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (21249028, 23117008), and from the Ministry of Health, Labour, and Welfare, Japan (H21-Chikyukibo-ippan-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; HADLEY TJ, 1987, J CLIN INVEST, V80, P1190, DOI 10.1172/JCI113178; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020947; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Peek LJ, 2006, VACCINE, V24, P5839, DOI 10.1016/j.vaccine.2006.04.067; Peterson DS, 2000, MOL BIOCHEM PARASIT, V105, P105, DOI 10.1016/S0166-6851(99)00173-5; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; SIM BKL, 1990, MOL BIOCHEM PARASIT, V41, P293, DOI 10.1016/0166-6851(90)90193-P; Sim BKL, 1998, MOL BIOCHEM PARASIT, V95, P183, DOI 10.1016/S0166-6851(98)00078-4; SIM BKL, 1994, EXP PARASITOL, V78, P259, DOI 10.1006/expr.1994.1027; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, ACTA TROP, V114, P171, DOI 10.1016/j.actatropica.2009.10.024; Tsuboi T, 2010, METHODS MOL BIOL, V607, P73, DOI 10.1007/978-1-60327-331-2_8; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P127; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005	44	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30251	10.1371/journal.pone.0030251	http://dx.doi.org/10.1371/journal.pone.0030251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253925	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100049
J	Wu, XQ; Zhu, MJ; Fletcher, JA; Giobbie-Hurder, A; Hodi, FS				Wu, Xinqi; Zhu, Meijun; Fletcher, Jonathan A.; Giobbie-Hurder, Anita; Hodi, F. Stephen			The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma	PLOS ONE			English	Article							BETA INHIBITOR; CANCER CELLS; AKT PATHWAY; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; BRAF MUTATIONS; PKC ISOFORMS; MAPK PATHWAY; IN-VITRO; ACTIVATION	GNAQ mutations at codon 209 have been recently identified in approximately 50% of uveal melanomas (UM) and are reported to be oncogenic through activating the MAPK/Erk1/2 pathway. Protein kinase C ( PKC) is a component of signaling from GNAQ to Erk1/2. Inhibition of PKC might regulate GNAQ mutation-induced Erk1/2 activation, resulting in growth inhibition of UM cells carrying GNAQ mutations. UM cells carrying wild type or mutant GNAQ were treated with the PKC inhibitor enzastaurin. Effects on proliferation, apoptosis, and signaling events were evaluated. Enzastaurin downregulated the expression of several PKC isoforms including PKC beta II PKC theta, PKC epsilon and/or their phosphorylation in GNAQ mutated cells. Downregulation of these PKC isoforms in GNAQ mutated cells by shRNA resulted in reduced viability. Enzastaurin exhibited greater antiproliferative effect on GNAQ mutant cells than wild type cells through induction of G1 arrest and apoptosis. Enzastaurin-induced G1 arrest was associated with inhibition of Erk1/2 phosphorylation, downregulation of cyclin D1, and accumulation of cyclin dependent kinase inhibitor p27(Kip1). Furthermore, enzastaurin reduced the expression of antiapoptotic Bcl-2 and survivin in GNAQ mutant cells. Inhibition of Erk1/2 phosphorylation with a MEK specific inhibitor enhanced the sensitivity of GNAQ wild type cells to enzastaurin, accompanied by p27(Kip1) accumulation and/or inhibition of enzastaurin-induced survivin and Bcl-2 upregulation. PKC inhibitors such as enzastaurin have activity against UM cells carrying GNAQ mutations through inhibition of the PKC/Erk1/2 pathway and induction of G1 arrest and apoptosis. Inhibition of the PKC pathway provides a basis for clinical investigation in patients with UM.	[Wu, Xinqi; Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Xinqi; Zhu, Meijun; Fletcher, Jonathan A.; Hodi, F. Stephen] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Xinqi; Hodi, F. Stephen] Dana Farber Brigham & Womens Canc Ctr, Melanoma Program, Boston, MA USA; [Zhu, Meijun; Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Giobbie-Hurder, Anita] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Wu, XQ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	stephen_hodi@dfci.harvard.edu	Giobbie-Hurder, Anita/AAU-6193-2021		Sharon Crowley Martin Memorial Fund for Melanoma Research; Dana-Farber Cancer Institute	Sharon Crowley Martin Memorial Fund for Melanoma Research; Dana-Farber Cancer Institute	This work was supported in part by Sharon Crowley Martin Memorial Fund for Melanoma Research (FSH.) and Malcolm, Emily Mac Naught Fund for Melanoma Research (FSH.) at Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakalian S, 2008, CLIN CANCER RES, V14, P951, DOI 10.1158/1078-0432.CCR-06-2630; Brautigam K, 2009, TRANSL ONCOL, V2, P164, DOI 10.1593/tlo.09121; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Ciuffreda L, 2009, NEOPLASIA, V11, P720, DOI 10.1593/neo.09398; Clark AS, 2003, CANCER RES, V63, P780; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; Cohen C, 2002, CLIN CANCER RES, V8, P3728; da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Engers R, 2000, BRIT J CANCER, V82, P1063; Faul MM, 2003, BIOORG MED CHEM LETT, V13, P1857, DOI 10.1016/S0960-894X(03)00286-5; Feldman ED, 2004, ANN SURG ONCOL, V11, P290, DOI 10.1245/ASO.2004.07.004; Fields AP, 2009, CANCER RES, V69, P1643, DOI 10.1158/0008-5472.CAN-08-3187; Folberg R, 2008, INVEST OPHTH VIS SCI, V49, P4697, DOI 10.1167/iovs.08-2324; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Grover A, 2004, ONCOLOGIST, V9, P653, DOI 10.1634/theoncologist.9-6-653; Guo K, 2008, CANCER SCI, V99, P486, DOI 10.1111/j.1349-7006.2007.00702.x; Hanauske AR, 2007, INVEST NEW DRUG, V25, P205, DOI 10.1007/s10637-007-9038-7; Herbst RS, 2007, CLIN CANCER RES, V13, p4641S, DOI 10.1158/1078-0432.CCR-07-0538; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jane EP, 2008, CANCER LETT, V268, P46, DOI 10.1016/j.canlet.2008.03.039; Jane EP, 2010, EUR J CANCER, V46, P412, DOI 10.1016/j.ejca.2009.10.014; Keyes KA, 2004, CANCER CHEMOTH PHARM, V53, P133, DOI 10.1007/s00280-003-0713-x; Kilic E, 2004, MELANOMA RES, V14, P203, DOI 10.1097/cmr.0000130006.46885.a0; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Kortylewski M, 2001, BIOCHEM J, V357, P297, DOI 10.1042/0264-6021:3570297; Lee KW, 2008, CANCER RES, V68, P1916, DOI 10.1158/0008-5472.CAN-07-3195; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Matsuoka H, 2009, EXP CELL RES, V315, P2022, DOI 10.1016/j.yexcr.2009.04.009; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Morgillo F, 2008, MOL CANCER THER, V7, P1698, DOI 10.1158/1535-7163.MCT-07-0547; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; PHILIPP A, 1994, MOL CELL BIOL, V14, P4032, DOI 10.1128/MCB.14.6.4032; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Populo H, 2011, BRIT J OPHTHALMOL, V95, P715, DOI 10.1136/bjo.2009.174417; Retzer-Lidl M, 2007, INT J CANCER, V121, P66, DOI 10.1002/ijc.22619; Rieger J, 2008, J NEUROCHEM, V106, P2436, DOI 10.1111/j.1471-4159.2008.05586.x; Rimoldi D, 2003, CANCER RES, V63, P5712; Rizvi MA, 2006, MOL CANCER THER, V5, P1783, DOI 10.1158/1535-7163.MCT-05-0465; Robertson MJ, 2007, J CLIN ONCOL, V25, P1741, DOI 10.1200/JCO.2006.09.3146; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Satyamoorthy K, 2003, CANCER RES, V63, P756; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P143, DOI 10.1016/j.ohc.2004.07.003; Tekle C, 2008, BRIT J CANCER, V99, P750, DOI 10.1038/sj.bjc.6604566; Triozzi PL, 2008, CANCER TREAT REV, V34, P247, DOI 10.1016/j.ctrv.2007.12.002; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	53	66	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29622	10.1371/journal.pone.0029622	http://dx.doi.org/10.1371/journal.pone.0029622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253748	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100016
J	Blackman, RK; Cheung-Ong, K; Gebbia, M; Proia, DA; He, SQ; Kepros, J; Jonneaux, A; Marchetti, P; Kluza, J; Rao, PE; Wada, Y; Giaever, G; Nislow, C				Blackman, Ronald K.; Cheung-Ong, Kahlin; Gebbia, Marinella; Proia, David A.; He, Suqin; Kepros, Jane; Jonneaux, Aurelie; Marchetti, Philippe; Kluza, Jerome; Rao, Patricia E.; Wada, Yumiko; Giaever, Guri; Nislow, Corey			Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-DELETION; CANCER-CELLS; GENOME; YEAST; APOPTOSIS; COPPER; MECHANISMS	Elesclomol is a first-in-class investigational drug currently undergoing clinical evaluation as a novel cancer therapeutic. The potent antitumor activity of the compound results from the elevation of reactive oxygen species (ROS) and oxidative stress to levels incompatible with cellular survival. However, the molecular target(s) and mechanism by which elesclomol generates ROS and subsequent cell death were previously undefined. The cellular cytotoxicity of elesclomol in the yeast S. cerevisiae appears to occur by a mechanism similar, if not identical, to that in cancer cells. Accordingly, here we used a powerful and validated technology only available in yeast that provides critical insights into the mechanism of action, targets and processes that are disrupted by drug treatment. Using this approach we show that elesclomol does not work through a specific cellular protein target. Instead, it targets a biologically coherent set of processes occurring in the mitochondrion. Specifically, the results indicate that elesclomol, driven by its redox chemistry, interacts with the electron transport chain (ETC) to generate high levels of ROS within the organelle and consequently cell death. Additional experiments in melanoma cells involving drug treatments or cells lacking ETC function confirm that the drug works similarly in human cancer cells. This deeper understanding of elesclomol's mode of action has important implications for the therapeutic application of the drug, including providing a rationale for biomarker-based stratification of patients likely to respond in the clinical setting.	[Blackman, Ronald K.; Proia, David A.; He, Suqin; Kepros, Jane; Rao, Patricia E.; Wada, Yumiko] Synta Pharmaceut Corp, Lexington, MA USA; [Cheung-Ong, Kahlin; Gebbia, Marinella; Giaever, Guri; Nislow, Corey] Univ Toronto, Donnelly Ctr Cellular & Biomed Res, Toronto, ON, Canada; [Jonneaux, Aurelie; Marchetti, Philippe; Kluza, Jerome] Univ Lille 2, INSERM, UMR 837, Lille, France; [Jonneaux, Aurelie; Marchetti, Philippe; Kluza, Jerome] CHRU LILLE, Lille, France	University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Blackman, RK (corresponding author), Synta Pharmaceut Corp, Lexington, MA USA.	corey.nislow@utoronto.ca	Giaever, Guri/D-3930-2009; Kluza, Jérome/B-6312-2012	Kluza, Jérome/0000-0002-7346-1305; Nislow, Corey/0000-0002-4016-8874; MARCHETTI, Philippe/0000-0002-4663-6800	NHGRI [R01 HG003317 08]; CIHR [84305]; Canadian Cancer Society [020380]; Ligue contre le Cancer-Comite de l'Aisne; Societe de Recherche Dermatologique; ARC (Association pour la Recherche sur le Cancer); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003317] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Ligue contre le Cancer-Comite de l'Aisne(Ligue nationale contre le cancer); Societe de Recherche Dermatologique; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	CN and GG are funded by a Grant from the NHGRI R01 HG003317 08 and from the CIHR (84305 to CN) and Canadian Cancer Society (#020380 to GG). This work was supported in part by fellowships of the Ligue contre le Cancer-Comite de l'Aisne and the Societe de Recherche Dermatologique (to PM) and the ARC (Association pour la Recherche sur le Cancer) (to J. Kluza). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot C, 2010, APOPTOSIS, V15, P769, DOI 10.1007/s10495-010-0471-2; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Berkenblit A, 2007, CLIN CANCER RES, V13, P584, DOI 10.1158/1078-0432.CCR-06-0964; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hersey P, 2009, CLIN CANCER RES, V15, P6490, DOI 10.1158/1078-0432.CCR-09-0251; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Kirshner JR, 2008, MOL CANCER THER, V7, P2319, DOI 10.1158/1535-7163.MCT-08-0298; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nagai M, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-C11; O'Day S, 2009, J CLIN ONCOL, V27, P5452, DOI 10.1200/JCO.2008.17.1579; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Proctor M, 2011, METHODS MOL BIOL, V759, P239, DOI 10.1007/978-1-61779-173-4_15; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vukovic VM, 2010, J CLIN ONCOL, V28; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu LM, 2011, J PHARMACEUT BIOMED, V54, P331, DOI 10.1016/j.jpba.2010.09.007; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231	41	117	121	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29798	10.1371/journal.pone.0029798	http://dx.doi.org/10.1371/journal.pone.0029798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253786	Green Submitted, gold, Green Published			2022-12-25	WOS:000301355700053
J	Weber, DG; Johnen, G; Bryk, O; Jockel, KH; Bruning, T				Weber, Daniel G.; Johnen, Georg; Bryk, Oleksandr; Joeckel, Karl-Heinz; Bruening, Thomas			Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma - A Pilot Study	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; PLEURAL MESOTHELIOMA; CANCER-DETECTION; TUMOR-MARKERS; UNITED-STATES; RT-PCR; DISEASES; GENES; SERUM; ASSAY	Background: To date, no biomarkers with reasonable sensitivity and specificity for the early detection of malignant mesothelioma have been described. The use of microRNAs (miRNAs) as minimally-invasive biomarkers has opened new opportunities for the diagnosis of cancer, primarily because they exhibit tumor-specific expression profiles and have been commonly observed in blood of both cancer patients and healthy controls. The aim of this pilot study was to identify miRNAs in the cellular fraction of human peripheral blood as potential novel biomarkers for the detection of malignant mesothelioma. Methodology/Principal Findings: Using oligonucleotide microarrays for biomarker identification the miRNA levels in the cellular fraction of human peripheral blood of mesothelioma patients and asbestos-exposed controls were analyzed. Using a threefold expression change in combination with a significance level of p<0.05, miR-103 was identified as a potential biomarker for malignant mesothelioma. Quantitative real-time PCR (qRT-PCR) was used for validation of miR-103 in 23 malignant mesothelioma patients, 17 asbestos-exposed controls, and 25 controls from the general population. For discrimination of mesothelioma patients from asbestos-exposed controls a sensitivity of 83% and a specificity of 71% were calculated, and for discrimination of mesothelioma patients from the general population a sensitivity of 78% and a specificity of 76%. Conclusions/Significance: The results of this pilot study show that miR-103 is characterized by a promising sensitivity and specificity and might be a potential minimally-invasive biomarker for the diagnosis of mesothelioma. In addition, our results support the concept of using the cellular fraction of human blood for biomarker discovery. However, for early detection of malignant mesothelioma the feasibility of miR-103 alone or in combination with other biomarkers needs to be analyzed in a prospective study.	[Weber, Daniel G.; Johnen, Georg; Bryk, Oleksandr; Bruening, Thomas] Ruhr Univ Bochum IPA, German Social Accid Insurance Inst, Inst Prevent & Occupat Med, Ctr Mol Med, Bochum, Germany; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany	Ruhr University Bochum; University of Duisburg Essen	Weber, DG (corresponding author), Ruhr Univ Bochum IPA, German Social Accid Insurance Inst, Inst Prevent & Occupat Med, Ctr Mol Med, Bochum, Germany.	weber@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125; Bang K. M., 2009, Morbidity and Mortality Weekly Report, V58, P393; Benjamin H, 2010, J MOL DIAGN, V12, P771, DOI 10.2353/jmoldx.2010.090169; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gee GV, 2010, INT J CANCER, V127, P2859, DOI 10.1002/ijc.25285; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gube M, 2011, ARCH TOXICOL, V85, P185, DOI 10.1007/s00204-010-0580-2; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Guthrie JL, 2008, J CLIN MICROBIOL, V46, P3798, DOI 10.1128/JCM.01551-08; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Liang QL, 2008, THORAX, V63, P35, DOI 10.1136/thx.2007.077958; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ning BT, 2008, J BIOMOL SCREEN, V13, P194, DOI 10.1177/1087057108315513; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Paranjape T, 2009, GUT, V58, P1546, DOI 10.1136/gut.2009.179531; Park EK, 2008, AM J RESP CRIT CARE, V178, P832, DOI 10.1164/rccm.200802-258OC; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Raiko I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-242; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Scherpereel A, 2007, CURR OPIN PULM MED, V13, P339, DOI 10.1097/MCP.0b013e32812144bb; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Weber DG, 2008, J APPL MICROBIOL, V105, P951, DOI 10.1111/j.1365-2672.2008.03799.x; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Weber DG, 2010, BIOMARK INSIGHTS, V5, P1; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	49	62	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30221	10.1371/journal.pone.0030221	http://dx.doi.org/10.1371/journal.pone.0030221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253921	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700099
J	Ziegler, ME; Souda, P; Jin, YP; Whitelegge, JP; Reed, EF				Ziegler, Mary E.; Souda, Puneet; Jin, Yi-Ping; Whitelegge, Julian P.; Reed, Elaine F.			Characterization of the Endothelial Cell Cytoskeleton following HLA Class I Ligation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; TRANSLATION INITIATION; INHIBITS TRANSLATION; LYMPHOCYTE MIGRATION; SIGNAL-TRANSDUCTION; MESSENGER-RNA; ACTIN; PROLIFERATION; PROTEIN	Background: Vascular endothelial cells (ECs) are a target of antibody-mediated allograft rejection. In vitro, when the HLA class I molecules on the surface of ECs are ligated by anti-HLA class I antibodies, cell proliferation and survival pathways are activated and this is thought to contribute to the development of antibody-mediated rejection. Crosslinking of HLA class I molecules by anti-HLA antibodies also triggers reorganization of the cytoskeleton, which induces the formation of F-actin stress fibers. HLA class I induced stress fiber formation is not well understood. Methodology and Principal Findings: The present study examines the protein composition of the cytoskeleton fraction of ECs treated with HLA class I antibodies and compares it to other agonists known to induce alterations of the cytoskeleton in endothelial cells. Analysis by tandem mass spectrometry revealed unique cytoskeleton proteomes for each treatment group. Using annotation tools a candidate list was created that revealed 12 proteins, which were unique to the HLA class I stimulated group. Eleven of the candidate proteins were phosphoproteins and exploration of their predicted kinases provided clues as to how these proteins may contribute to the understanding of HLA class I induced antibody-mediated rejection. Three of the candidates, eukaryotic initiation factor 4A1 (eIF4A1), Tropomyosin alpha 4-chain (TPM4) and DDX3X, were further characterized by Western blot and found to be associated with the cytoskeleton. Confocal microscopy analysis showed that class I ligation stimulated increased eIF4A1 co-localization with F-actin and paxillin. Conclusions/Significance: Colocalization of eIF4A1 with F-actin and paxillin following HLA class I ligation suggests that this candidate protein could be a target for understanding the mechanism(s) of class I mediated antibody-mediated rejection. This proteomic approach for analyzing the cytoskeleton of ECs can be applied to other agonists and various cells types as a method for uncovering novel regulators of cytoskeleton changes.	[Ziegler, Mary E.; Jin, Yi-Ping; Reed, Elaine F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ziegler, ME (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	ereed@mednet.ucla.edu		Ziegler, Mary/0000-0002-2223-5025; JIN, YIPING/0000-0001-6620-4274	National Institute of Allergy and Infectious Diseases [RO1 AI 042819]; NIH [U01AI077821]; National Heart Lung and Blood Institute [RO1 HL 090995]; NSF; NIH-NCRR [S10 RR023045]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042819, U01AI077821] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF(National Science Foundation (NSF)); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases Grant RO1 AI 042819 (E. F. R.), NIH U01AI077821 (E. F. R.), the National Heart Lung and Blood Institute Grant RO1 HL 090995 (E. F. R.), and the NSF Graduate Research Fellowship to M.E.Z. The LTQ-FT was purchased with NIH-NCRR support (S10 RR023045)(J.P.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson P, 1999, J IMMUNOL, V162, P2964; Bandhakavi S, 2011, METHODS MOL BIOL, V790, P47, DOI 10.1007/978-1-61779-319-6_4; Barbee KA, 1995, BIOCHEM CELL BIOL, V73, P501, DOI 10.1139/o95-055; Bian H, 1999, J IMMUNOL, V163, P1010; Bottley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013030; Brunner PM, 2011, BLOOD, V117, P4154, DOI 10.1182/blood-2010-09-307694; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Couty JP, 2007, J NEUROCHEM, V103, P793, DOI 10.1111/j.1471-4159.2007.04782.x; Csortos C, 2007, AM J PHYSIOL-LUNG C, V293, pL843, DOI 10.1152/ajplung.00120.2007; DAMORE PA, 1992, AM J RESP CELL MOL, V6, P1; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; HANCOCK WW, 1992, TRANSPLANT P, V24, P2315; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; HOWE JG, 1984, CELL, V37, P85; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin YP, 2007, J IMMUNOL, V178, P7911, DOI 10.4049/jimmunol.178.12.7911; Jin YP, 2004, HUM IMMUNOL, V65, P291, DOI 10.1016/j.humimm.2004.01.002; Jin YP, 2002, J IMMUNOL, V168, P5415, DOI 10.4049/jimmunol.168.11.5415; Jindra PT, 2008, J IMMUNOL, V180, P2357, DOI 10.4049/jimmunol.180.4.2357; Jindra PT, 2006, TRANSPLANTATION, V82, pS33, DOI 10.1097/01.tp.0000231447.34240.3c; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kurner J, 2004, EXP CELL RES, V301, P38, DOI 10.1016/j.yexcr.2004.08.005; Lee JSY, 2005, HISTOL HISTOPATHOL, V20, P455, DOI 10.14670/HH-20.455; Lepin EJ, 2004, BIOCHEM BIOPH RES CO, V323, P213, DOI 10.1016/j.bbrc.2004.08.082; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Meng XB, 2005, J PROTEOME RES, V4, P2081, DOI 10.1021/pr0502121; Nath N, 1999, J IMMUNOL, V162, P5351; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; PATTON WF, 1990, J CELL PHYSIOL, V143, P140, DOI 10.1002/jcp.1041430119; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; Steven AC, 2003, TRENDS CELL BIOL, V13, P107, DOI 10.1016/S0962-8924(03)00023-0; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Vinals F, 1999, MOL CELL BIOL, V19, P2763; VLODAVSKY I, 1979, P NATL ACAD SCI USA, V76, P2306, DOI 10.1073/pnas.76.5.2306; VLODAVSKY I, 1979, J SUPRAMOL STR CELL, V12, P73, DOI 10.1002/jss.400120108; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Willett M, 2006, EXP CELL RES, V312, P2942, DOI 10.1016/j.yexcr.2006.05.020; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001158; Zhou L, 2010, FEBS LETT	63	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29472	10.1371/journal.pone.0029472	http://dx.doi.org/10.1371/journal.pone.0029472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247778	Green Published, gold			2022-12-25	WOS:000301355700026
J	Alfred, T; Ben-Shlomo, Y; Cooper, R; Hardy, R; Cooper, C; Deary, IJ; Gaunt, TR; Gunnell, D; Harris, SE; Kumari, M; Martin, RM; Sayer, AA; Starr, JM; Kuh, D; Day, INM				Alfred, Tamuno; Ben-Shlomo, Yoav; Cooper, Rachel; Hardy, Rebecca; Cooper, Cyrus; Deary, Ian J.; Gaunt, Tom R.; Gunnell, David; Harris, Sarah E.; Kumari, Meena; Martin, Richard M.; Sayer, Avan Aihie; Starr, John M.; Kuh, Diana; Day, Ian N. M.		HALCyon Study Team	A Multi-Cohort Study of Polymorphisms in the GH/IGF Axis and Physical Capability: The HALCyon Programme	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GROWTH-HORMONE; SKELETAL-MUSCLE MASS; ADULT HEIGHT; IGF-I; INSULIN-LIKE-GROWTH-FACTOR-2 GENE; INSULIN-RESISTANCE; COMMON VARIATION; BODY-COMPOSITION; GRIP STRENGTH	Background: Low muscle mass and function have been associated with poorer indicators of physical capability in older people, which are in-turn associated with increased mortality rates. The growth hormone/insulin-like growth factor (GH/IGF) axis is involved in muscle function and genetic variants in genes in the axis may influence measures of physical capability. Methods: As part of the Healthy Ageing across the Life Course (HALCyon) programme, men and women from seven UK cohorts aged between 52 and 90 years old were genotyped for six polymorphisms: rs35767 (IGF1), rs7127900 (IGF2), rs2854744 (IGFBP3), rs2943641 (IRS1), rs2665802 (GH1) and the exon-3 deletion of GHR. The polymorphisms have previously been robustly associated with age-related traits or are potentially functional. Meta-analysis was used to pool within-study genotypic effects of the associations between the polymorphisms and four measures of physical capability: grip strength, timed walk or get up and go, chair rises and standing balance. Results:Few important associations were observed among the several tests. We found evidence that rs2665802 in GH1 was associated with inability to balance for 5 s (pooled odds ratio per minor allele = 0.90, 95% Cl: 0.82-0.98, p-value = 0.01, n = 10,748), after adjusting for age and sex. We found no evidence for other associations between the polymorphisms and physical capability traits. Conclusion: Our findings do not provide evidence for a substantial influence of these common polymorphisms in the GH/IGF axis on objectively measured physical capability levels in older adults.	[Alfred, Tamuno; Ben-Shlomo, Yoav; Gaunt, Tom R.; Gunnell, David; Martin, Richard M.; Day, Ian N. M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Cooper, Rachel; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Cooper, Rachel; Hardy, Rebecca; Kuh, Diana] UCL, Div Populat Hlth, London, England; [Cooper, Cyrus; Sayer, Avan Aihie] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, Inst Musculoskeletal Sci, Oxford, England; [Deary, Ian J.; Harris, Sarah E.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gaunt, Tom R.; Martin, Richard M.; Day, Ian N. M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London, England; [Sayer, Avan Aihie] Univ Southampton, Southampton Gen Hosp, Acad Geriatr Med, Southampton, Hants, England; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland	University of Bristol; University of London; University College London; University of London; University College London; University of Southampton; University of Oxford; University of Edinburgh; University of Edinburgh; University of Bristol; University of Edinburgh; University of London; University College London; University of Southampton; University of Edinburgh	Alfred, T (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	tamuno.alfred@bristol.ac.uk	Deary, Ian J/C-6297-2009; Gunnell, David/ABE-6653-2020; Ben-Shlomo, Yoav/ABD-2004-2021; Cooper, Rachel/ABE-3768-2021; Hardy, Rebecca/AFR-1989-2022; Gaunt, Tom R/O-3918-2014; Sayer, Avan Aihie/A-4359-2012; Kuh, Diana/L-6019-2014	Deary, Ian J/0000-0002-1733-263X; Gunnell, David/0000-0002-0829-6470; Ben-Shlomo, Yoav/0000-0001-6648-3007; Cooper, Rachel/0000-0003-3370-5720; Gaunt, Tom R/0000-0003-0924-3247; Kuh, Diana/0000-0001-7386-2857; Kumari, Meena/0000-0001-9716-1035; Aihie Sayer, Avan/0000-0003-1283-6457; Martin, Richard/0000-0002-7992-7719; Martin-Ruiz, Carmen/0000-0002-3361-6974; Hardy, Rebecca/0000-0001-9949-0799; Demakakos, Panayotes/0000-0002-7663-2122; Shiels, Paul/0000-0002-7577-9843; Cooper, Cyrus/0000-0003-3510-0709; McNeill, Geraldine/0000-0003-0373-650X; von Zglinicki, Thomas/0000-0002-5939-0248	Medical Research Council (MRC); Arthritis Research (United Kingdom); Wellcome Trust [GR068468MA]; World Cancer Research Fund; Research into Ageing; British Heart Foundation; MRC of the United Kingdom; National Institute on Ageing (NIA) [AG1764406S1]; University of Southampton; Biotechnology and Biological Sciences Research Council (BBSRC) [15/SAG09977, BB/F019394/1]; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health ad Wellbeing Initiative [G0700704/84698]; Engineering and Physical Sciences Research Council; Economic and Social Research Council (ESRC); New Dynamics of Ageing cross council; HALCyon programme; New Dynamics of Ageing [RES-353-25-0001]; NIA, National Institutes of Health [AG176440651]; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Economic and Social Research Council [ES/G00773X/1] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1015, MC_U123092724, U1475000001, G0700704B, G0600705, MC_U123092720, U1475000002, G0900686, MC_U147585824, G0700704, MC_UP_A620_1014] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_UP_A620_1015, G0600705, G0700704, G0900686, MC_U123092720, MC_U123092724] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research (United Kingdom)(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Research into Ageing; British Heart Foundation(British Heart Foundation); MRC of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Southampton; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health ad Wellbeing Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); New Dynamics of Ageing cross council; HALCyon programme; New Dynamics of Ageing; NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the support of Medical Research Council (MRC) and Arthritis Research (United Kingdom). Boyd Orr Funding: The Boyd Orr DNA bank was funded by the Wellcome Trust (Grant number GR068468MA). Follow-up of the Boyd Orr cohort was supported by grants from the Wellcome Trust, World Cancer Research Fund, Research into Ageing and the British Heart Foundation. The Caerphilly Prospective study was funded by the MRC of the United Kingdom. Samples from the English Longitudinal Study of Ageing DNA Repository, received support under a grant (AG1764406S1) awarded by the National Institute on Ageing (NIA). The Hertfordshire Cohort Study and the Hertfordshire Ageing Study were funded by the MRC and the University of Southampton. Lothian Birth Cohort 1921: The Biotechnology and Biological Sciences Research Council (BBSRC) funded the phenotypic data collection and DNA preparation (project grant 15/SAG09977) and genome-wide association study (project grant BB/F019394/1). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health ad Wellbeing Initiative (Centre grant G0700704/84698). Funding from the BBSRC, Engineering and Physical Sciences Research Council, Economic and Social Research Council (ESRC) and MRC is gratefully acknowledged. The MRC National Survey of Health and development is funded by the United Kingdom MRC. HALCyon is funded by the New Dynamics of Ageing cross council research programme. DG is a National Institute of Health Research Senior Investigator. RC receives support from the HALCyon programme funded by the New Dynamics of Ageing (RES-353-25-0001). DK and RH are supported by the United Kingdom MRC. MK is supported by NIA, National Institutes of Health (AG176440651). TA is an ESRC PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2005, J GERONTOL A-BIOL, V60, P1278, DOI 10.1093/gerona/60.10.1278; Adetunji OR, 2009, EUR J ENDOCRINOL, V161, P541, DOI 10.1530/EJE-09-0405; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bachner-Melman R, 2005, AM J PSYCHIAT, V162, P2256, DOI 10.1176/appi.ajp.162.12.2256; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Baserga R, 2009, EXP CELL RES, V315, P727, DOI 10.1016/j.yexcr.2008.09.017; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bougneres P, 2010, J CLIN ENDOCR METAB, V95, P56, DOI 10.1210/jc.2009-2233; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Committee of Experts on Sports Research, 1993, EUR HDB EUROFTT TEST; Cook RD, 2000, TECHNOMETRICS, V42, P65, DOI 10.2307/1271434; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Devaney JM, 2007, J APPL PHYSIOL, V102, P1815, DOI 10.1152/japplphysiol.01165.2006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Gaunt TR, 2005, GENETIC VARIANCE DET, P131; Giovannini S, 2008, MECH AGEING DEV, V129, P593, DOI 10.1016/j.mad.2008.08.001; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hand BD, 2007, J APPL PHYSIOL, V103, P1678, DOI 10.1152/japplphysiol.00420.2007; Heude B, 2007, J CLIN ENDOCR METAB, V92, P2734, DOI 10.1210/jc.2006-1948; Hietaniemi M, 2005, ANN MED, V37, P373, DOI 10.1080/07853890510011967; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Janssen I, 2006, J AM GERIATR SOC, V54, P56, DOI 10.1111/j.1532-5415.2005.00540.x; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Kenth G, 2007, J CLIN ENDOCR METAB, V92, P725, DOI 10.1210/jc.2006-1695; Khoury-Shakour S, 2008, CANCER EPIDEM BIOMAR, V17, P3314, DOI 10.1158/1055-9965.EPI-08-0062; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kostek MC, 2010, EUR J APPL PHYSIOL, V110, P315, DOI 10.1007/s00421-010-1500-0; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Le Marchand L, 2002, JNCI-J NATL CANCER I, V94, P454, DOI 10.1093/jnci/94.6.454; Lettre G, 2007, HUM GENET, V122, P129, DOI 10.1007/s00439-007-0385-4; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Little J, 2009, J CLIN EPIDEMIOL, V62, P597, DOI 10.1016/j.jclinepi.2008.12.004; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Marmot M, 2003, HLTH WEALTH LIFESTYL; Martin RM, 2005, INT J EPIDEMIOL, V34, P742, DOI 10.1093/ije/dyi124; Matteini AM, 2010, J GERONTOL A-BIOL, V65, P1375, DOI 10.1093/gerona/glq154; McKay JD, 2007, CANCER EPIDEM BIOMAR, V16, P169, DOI 10.1158/1055-9965.EPI-06-0320; Millar David S., 2010, Human Genomics, V4, P289; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Palles C, 2008, HUM MOL GENET, V17, P1457, DOI 10.1093/hmg/ddn034; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ren MF, 2004, CANCER-AM CANCER SOC, V101, P251, DOI 10.1002/cncr.20375; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sayer AA, 2002, AGE AGEING, V31, P468, DOI 10.1093/ageing/31.6.468; Schrager MA, 2004, J APPL PHYSIOL, V97, P2176, DOI 10.1152/japplphysiol.00985.2003; Schumacher FR, 2010, HUM MOL GENET, V19, P3089, DOI 10.1093/hmg/ddq210; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Stessman J, 2005, MECH AGEING DEV, V126, P333, DOI 10.1016/j.mad.2004.08.025; Stevens KN, 2008, AGE AGEING, V37, P300, DOI 10.1093/ageing/afn019; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeney C, 2005, CANCER EPIDEM BIOMAR, V14, P1802, DOI 10.1158/1055-9965.EPI-05-0149; Syddall HE, 2010, INT J EPIDEMIOL, V39, P36, DOI 10.1093/ije/dyn275; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Szulc P, 2010, AM J CLIN NUTR, V91, P1227, DOI 10.3945/ajcn.2009.28256; Tiainen K, 2004, J APPL PHYSIOL, V96, P173, DOI 10.1152/japplphysiol.00200.2003; Van Dyke AL, 2009, J CANCER EPIDEMIOL, V2009, DOI 10.1155/2009/242151; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Van Kan GA, 2009, J NUTR HEALTH AGING, V13, P708, DOI 10.1007/s12603-009-0201-z; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Walpole B, 2006, BRIT J SPORT MED, V40, P145, DOI 10.1136/bjsm.2005.020669; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang TL, 2008, EUR J HUM GENET, V16, P1380, DOI 10.1038/ejhg.2008.113; Zhang W, 2006, ANN HUM GENET, V70, P848, DOI 10.1111/j.1469-1809.2006.00290.x	83	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					186	195	e29883	10.1371/journal.pone.0029883	http://dx.doi.org/10.1371/journal.pone.0029883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906OA	22253814	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000301353900021
J	Glauser, DL; Kratz, AS; Stevenson, PG				Glauser, Daniel L.; Kratz, Anne-Sophie; Stevenson, Philip G.			Herpesvirus Glycoproteins Undergo Multiple Antigenic Changes before Membrane Fusion	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; MURINE GAMMAHERPESVIRUS 68; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; VIRION NEUTRALIZATION; GAMMA-HERPESVIRUSES; PSEUDORABIES VIRUS; IN-VIVO; ENTRY; COMPLEX	Herpesvirus entry is a complicated process involving multiple virion glycoproteins and culminating in membrane fusion. Glycoprotein conformation changes are likely to play key roles. Studies of recombinant glycoproteins have revealed some structural features of the virion fusion machinery. However, how the virion glycoproteins change during infection remains unclear. Here using conformation-specific monoclonal antibodies we show in situ that each component of the Murid Herpesvirus-4 (MuHV-4) entry machinery-gB, gH/gL and gp150-changes in antigenicity before tegument protein release begins. Further changes then occurred upon actual membrane fusion. Thus virions revealed their final fusogenic form only in late endosomes. The substantial antigenic differences between this form and that of extracellular virions suggested that antibodies have only a limited opportunity to block virion membrane fusion.	[Glauser, Daniel L.; Kratz, Anne-Sophie; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060	Swiss National Science Foundation; Swiss Foundation for Grants in Biology and Medicine [PBZHP3-122925, PASMP3-132554]; ERASMUS mobility grant from the University of Wurzburg, Germany; Medical Research Council [G0701185]; Wellcome Trust [WT089111MA]; MRC [G9800943, G0701185, G0400427] Funding Source: UKRI; Medical Research Council [G0400427, G9800943] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; ERASMUS mobility grant from the University of Wurzburg, Germany; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). DLG is supported by fellowships from the Swiss National Science Foundation and the Swiss Foundation for Grants in Biology and Medicine (PBZHP3-122925 and PASMP3-132554). A-SK is supported by an ERASMUS mobility grant from the University of Wurzburg, Germany. This work was also supported by Medical Research Council grant G0701185 and by Wellcome Trust project grant WT089111MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Backovic M, 2010, P NATL ACAD SCI USA, V107, P22635, DOI 10.1073/pnas.1011507107; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; COHEN GH, 1972, J VIROL, V10, P1021, DOI 10.1128/JVI.10.5.1021-1030.1972; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dollery SJ, 2010, J VIROL, V84, P3759, DOI 10.1128/JVI.02573-09; Gaspar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002781; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2009, J GEN VIROL, V90, P1202, DOI 10.1099/vir.0.008755-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002811; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Glauser DL, 2011, J GEN VIROL, V92, P2020, DOI 10.1099/vir.0.032177-0; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Klupp BG, 1997, J VIROL, V71, P7687, DOI 10.1128/JVI.71.10.7687-7695.1997; KOYAMA AH, 1987, MICROBIOL IMMUNOL, V31, P123, DOI 10.1111/j.1348-0421.1987.tb03075.x; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Machiels B, 2011, J VIROL, V85, P1011, DOI 10.1128/JVI.01092-10; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; May JS, 2010, J GEN VIROL, V91, P2542, DOI 10.1099/vir.0.023085-0; Moorman NJ, 2004, J VIROL, V78, P10282, DOI 10.1128/JVI.78.19.10282-10290.2004; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Stampfer SD, 2010, J VIROL, V84, P12924, DOI 10.1128/JVI.01750-10; Stevenson PG, 2009, J GEN VIROL, V90, P2317, DOI 10.1099/vir.0.013300-0; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30152	10.1371/journal.pone.0030152	http://dx.doi.org/10.1371/journal.pone.0030152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253913	gold, Green Published, Green Submitted			2022-12-25	WOS:000315865800028
J	Sainz, N; Rodriguez, A; Catalan, V; Becerril, S; Ramirez, B; Lancha, A; Burgos-Ramos, E; Gomez-Ambrosi, J; Fruhbeck, G				Sainz, Neira; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Lancha, Andoni; Burgos-Ramos, Emma; Gomez-Ambrosi, Javier; Fruehbeck, Gema			Leptin Reduces the Expression and Increases the Phosphorylation of the Negative Regulators of GLUT4 Traffic TBC1D1 and TBC1D4 in Muscle of ob/ob Mice	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; STIMULATED GLUCOSE-UPTAKE; FATTY-ACID OXIDATION; INSULIN SENSITIVITY; AS160 PHOSPHORYLATION; GENE-EXPRESSION; AKT SUBSTRATE; OBESE MICE; PROTEIN; TRANSLOCATION	Leptin improves insulin sensitivity in skeletal muscle. Our goal was to determine whether proteins controlling GLUT4 traffic are altered by leptin deficiency and in vivo leptin administration in skeletal muscle of wild type and ob/ob mice. Leptin-deficient ob/ob mice were divided in three groups: control, leptin-treated (1 mg/kg/d) and leptin pair-fed ob/ob mice. Microarray analysis revealed that 1,546 and 1,127 genes were regulated by leptin deficiency and leptin treatment, respectively. Among these, we identified 24 genes involved in intracellular vesicle-mediated transport in ob/ob mice. TBC1 domain family, member 1 (Tbc1d1), a negative regulator of GLUT4 translocation, was up-regulated (P = 0.001) in ob/ob mice as compared to wild types. Importantly, leptin treatment reduced the transcript levels of Tbc1d1 (P < 0.001) and Tbc1d4 (P = 0.004) in the leptin-treated ob/ob as compared to pair-fed ob/ob animals. In addition, phosphorylation levels of TBC1D1 and TBC1D4 were enhanced in leptin-treated ob/ob as compared to control ob/ob (P = 0.015 and P = 0.023, respectively) and pair-fed ob/ob (P = 0.036 and P = 0.034, respectively) mice. Despite similar GLUT4 protein expression in wild type and ob/ob groups a different immunolocalization of this protein was evidenced in muscle sections. Leptin treatment increased GLUT4 immunoreactivity in gastrocnemius and extensor digitorum longus sections of leptin-treated ob/ob mice. Moreover, GLUT4 protein detected in immunoprecipitates from TBC1D4 was reduced by leptin replacement compared to control ob/ob (P = 0.013) and pair-fed ob/ob (P = 0.037) mice. Our findings suggest that leptin enhances the intracellular GLUT4 transport in skeletal muscle of ob/ob animals by reducing the expression and activity of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4.	[Sainz, Neira; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Lancha, Andoni; Gomez-Ambrosi, Javier; Fruehbeck, Gema] Univ Navarra, Metab Res Lab, E-31080 Pamplona, Spain; [Fruehbeck, Gema] Univ Navarra Clin, Dept Endocrinol & Nutr, Pamplona, Spain; [Burgos-Ramos, Emma] Hosp Infantil Univ Nino Jesus, Dept Endocrinol, Madrid, Spain; [Sainz, Neira; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Lancha, Andoni; Burgos-Ramos, Emma; Gomez-Ambrosi, Javier; Fruehbeck, Gema] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Fruhbeck, G (corresponding author), Univ Navarra, Metab Res Lab, E-31080 Pamplona, Spain.	gfruhbeck@unav.es	Sáinz, Neira/AAA-4624-2019; Ramírez, Beatriz/I-1922-2017; Lancha, Antonio Herbert/C-9130-2012; Burgos Ramos, Emma/A-7070-2015; Gómez-Ambrosi, Javier/D-2984-2017; Catalan, Victoria/H-3566-2017; Burgos-Ramos, Emma/AAI-7833-2020; Rodriguez, Amaia/D-3044-2019	Ramírez, Beatriz/0000-0003-3381-7220; Lancha, Antonio Herbert/0000-0003-2128-1182; Burgos Ramos, Emma/0000-0002-6942-3023; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Catalan, Victoria/0000-0002-7513-7509; Burgos-Ramos, Emma/0000-0002-6942-3023; Rodriguez, Amaia/0000-0002-2180-461X; Sainz, Neira/0000-0003-0298-3031; Becerril, Sara/0000-0002-3441-1970	Department of Industry of the Gobierno de Navarra of Spain; Fundacion Mutua Madrilena; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo; Department of Health of the Gobierno de Navarra of Spain	Department of Industry of the Gobierno de Navarra of Spain; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo; Department of Health of the Gobierno de Navarra of Spain	This work was supported by a fellowship from the Department of Industry of the Gobierno de Navarra of Spain to NS and grants from the Fundacion Mutua Madrilena to GF; from the Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo to GF and JG-A; and from the Department of Health of the Gobierno de Navarra of Spain to GF and JG-A. CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative of the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1056, DOI 10.1152/ajpendo.90908.2008; Alonso A, 2005, J NUTR BIOCHEM, V16, P602, DOI 10.1016/j.jnutbio.2005.03.002; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Borghouts LB, 2000, PFLUG ARCH EUR J PHY, V441, P351, DOI 10.1007/s004240000431; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Breen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020613; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Ceddia RB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0158rev; Ceddia RB, 1999, INT J OBESITY, V23, P75, DOI 10.1038/sj.ijo.0800762; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Cheng IS, 2005, J NUTR BIOCHEM, V16, P267, DOI 10.1016/j.jnutbio.2004.12.006; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Frosig C, 2010, J PHYSIOL-LONDON, V588, P4539, DOI 10.1113/jphysiol.2010.194811; Fruhbeck G, 2001, FASEB J, V15, P1996, DOI 10.1096/fj.00-0829hyp; Fruhbeck G, 2000, DIABETOLOGIA, V43, P3, DOI 10.1007/s001250050002; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Fruhbeck G, 2003, DIABETOLOGIA, V46, P143, DOI 10.1007/s00125-003-1053-4; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Funai K, 2009, DIABETES, V58, P1096, DOI 10.2337/db08-1477; Furnsinn C, 1998, DIABETOLOGIA, V41, P524, DOI 10.1007/s001250050941; Gaidhu MP, 2010, MOL ENDOCRINOL, V24, P1434, DOI 10.1210/me.2009-0502; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V278, pE910, DOI 10.1152/ajpendo.2000.278.5.E910; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Manco M, 2004, DIABETES OBES METAB, V6, P402, DOI 10.1111/j.1462-8902.2004.00356.x; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Ranganathan S, 1998, ENDOCRINOLOGY, V139, P2509, DOI 10.1210/en.139.5.2509; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Stefanyk LE, 2011, AM J PHYSIOL-REG I, V301, pR159, DOI 10.1152/ajpregu.00636.2010; Stuart CA, 2000, AM J PHYSIOL-ENDOC M, V279, pE855, DOI 10.1152/ajpendo.2000.279.4.E855; Stuart CA, 2001, METABOLISM, V50, P771, DOI 10.1053/meta.2001.24202; Stuart CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE1067, DOI 10.1152/ajpendo.00250.2006; Stuart CA, 2009, J CLIN ENDOCR METAB, V94, P3535, DOI 10.1210/jc.2009-0162; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Tajmir P, 2003, J CELL PHYSIOL, V197, P122, DOI 10.1002/jcp.10351; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; Wang JL, 1999, ENDOCRINOLOGY, V140, P2117, DOI 10.1210/en.140.5.2117; WIELAND O, 1957, BIOCHEM Z, V329, P313; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Yaspelkis BB, 2004, LIFE SCI, V74, P1801, DOI 10.1016/j.lfs.2003.08.037; Yaspelkis BB, 2002, METABOLISM, V51, P859, DOI 10.1053/meta.2002.33338; Zierath JR, 1998, DIABETES, V47, P1, DOI 10.2337/diabetes.47.1.1	71	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29389	10.1371/journal.pone.0029389	http://dx.doi.org/10.1371/journal.pone.0029389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253718	Green Published, gold			2022-12-25	WOS:000315865800007
J	Juhasz, A; Makai, S; Sebestyen, E; Laszlo, T; Balazs, E				Juhasz, Angela; Makai, Szabolcs; Sebestyen, Endre; Laszlo Tamas; Balazs, Ervin			Role of Conserved Non-Coding Regulatory Elements in LMW Glutenin Gene Expression	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ENDOSPERM-SPECIFIC EXPRESSION; MYB TRANSCRIPTION FACTOR; PROTEIN GLUTELIN GENE; ZINC-FINGER PROTEIN; PROLAMIN-BOX; ACTIVATES TRANSCRIPTION; BIFACTORIAL ENDOSPERM; NUCLEOTIDE-SEQUENCE; PROMOTER ELEMENTS	Transcriptional regulation of LMW glutenin genes were investigated in-silico, using publicly available gene sequences and expression data. Genes were grouped into different LMW glutenin types and their promoter profiles were determined using cis-acting regulatory elements databases and published results. The various cis-acting elements belong to some conserved non-coding regulatory regions (CREs) and might act in two different ways. There are elements, such as GCN4 motifs found in the long endosperm box that could serve as key factors in tissue-specific expression. Some other elements, such as the AACA/TA motifs or the individual prolamin box variants, might modulate the level of expression. Based on the promoter sequences and expression characteristic LMW glutenin genes might be transcribed following two different mechanisms. Most of the s- and i-type genes show a continuously increasing expression pattern. The m-type genes, however, demonstrate normal distribution in their expression profiles. Differences observed in their expression could be related to the differences found in their promoter sequences. Polymorphisms in the number and combination of cis-acting elements in their promoter regions can be of crucial importance in the diverse levels of production of single LMW glutenin gene types.	[Juhasz, Angela; Sebestyen, Endre; Balazs, Ervin] Hungarian Acad Sci, Agr Res Inst, Appl Genom Dept, H-2462 Martonvasar, Hungary; [Makai, Szabolcs; Laszlo Tamas] Eotvos Lorand Univ, Dept Plant Physiol & Mol Plant Biol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University	Juhasz, A (corresponding author), Hungarian Acad Sci, Agr Res Inst, Appl Genom Dept, H-2462 Martonvasar, Hungary.	juhasza@mail.mgki.hu	Juhasz, Angela/P-7169-2019; Juhasz, Angela/B-9727-2019; Sebestyén, Endre/H-3999-2011; Tamas, Laszlo/A-5330-2008	Juhasz, Angela/0000-0002-4317-2027; Juhasz, Angela/0000-0002-4317-2027; Sebestyén, Endre/0000-0001-5470-2161; Tamas, Laszlo/0000-0002-3084-5851				Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Albani D, 1997, PLANT CELL, V9, P171, DOI 10.1105/tpc.9.2.171; Albani D, 1995, GENE, V167, P209, DOI 10.1016/0378-1119(95)00680-X; [Anonymous], 2009, US Patent Application, Patent No. 20090064374; BARTELS D, 1986, PLANT SCI, V46, P117, DOI 10.1016/0168-9452(86)90118-4; Bernard V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-166; BEVAN M, 1993, PHILOS T R SOC B, V342, P209, DOI 10.1098/rstb.1993.0149; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; BUSTOS MM, 1989, PLANT CELL, V1, P839, DOI 10.1105/tpc.1.9.839; Chen RM, 2005, PLANT SCI, V169, P1146, DOI 10.1016/j.plantsci.2005.07.018; Clarke BC, 1999, PLANT SYST EVOL, V214, P1, DOI 10.1007/BF00985728; COLOT V, 1987, EMBO J, V6, P3559, DOI 10.1002/j.1460-2075.1987.tb02685.x; Conlan RS, 1999, PLANT J, V19, P173, DOI 10.1046/j.1365-313X.1999.00522.x; CZARNECKA E, 1992, PLANT MOL BIOL, V19, P985, DOI 10.1007/BF00040530; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; Diaz I, 2005, PLANT J, V42, P652, DOI 10.1111/j.1365-313X.2005.02402.x; Diaz I, 2002, PLANT J, V29, P453, DOI 10.1046/j.0960-7412.2001.01230.x; DORN A, 1987, P NATL ACAD SCI USA, V84, P6249, DOI 10.1073/pnas.84.17.6249; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Duffus C. M., 1992, Barley: genetics, biochemistry, molecular biology and biotechnology., P291; Edwards D, 1998, PLANT PHYSIOL, V117, P1015, DOI 10.1104/pp.117.3.1015; Fauteux F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-126; FORDE BG, 1985, NUCLEIC ACIDS RES, V13, P7327, DOI 10.1093/nar/13.20.7327; Gu YQ, 2010, FUNCT INTEGR GENOMIC, V10, P111, DOI 10.1007/s10142-009-0135-x; HAMMONDKOSACK MCU, 1993, EMBO J, V12, P545, DOI 10.1002/j.1460-2075.1993.tb05686.x; HARTINGS H, 1990, PLANT MOL BIOL, V14, P1031, DOI 10.1007/BF00019399; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ikeda TM, 2002, THEOR APPL GENET, V104, P680, DOI 10.1007/s001220100756; IZAWA T, 1993, J MOL BIOL, V230, P1131, DOI 10.1006/jmbi.1993.1230; Juhasz A., 2006, Gliadin and glutenin: the unique balance of wheat quality, P171; Juhasz A, 2004, ROY SOC CH, P62; KASARDA DD, 1988, J EXP BOT, V39, P899, DOI 10.1093/jxb/39.7.899; Kawakatsu T, 2010, PLANT BIOTECHNOL J, V8, P939, DOI 10.1111/j.1467-7652.2010.00559.x; Kisu Y, 1998, PLANT CELL PHYSIOL, V39, P1054, DOI 10.1093/oxfordjournals.pcp.a029302; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; KREIS M, 1985, J MOL BIOL, V183, P499, DOI 10.1016/0022-2836(85)90017-8; KRIDL JC, 1984, GENE, V28, P113, DOI 10.1016/0378-1119(84)90093-3; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; LEW EJL, 1992, CEREAL CHEM, V69, P508; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MASCI S, 1995, CEREAL CHEM, V72, P100; Mena M, 1998, PLANT J, V16, P53, DOI 10.1046/j.1365-313x.1998.00275.x; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; NIETOSOTELO J, 1994, PLANT CELL, V6, P287, DOI 10.1105/tpc.6.2.287; Norre F, 2002, PLANT MOL BIOL, V50, P699, DOI 10.1023/A:1019953914467; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Piston F, 2009, MOL BREEDING, V23, P655, DOI 10.1007/s11032-009-9263-1; Schaaf GJ, 2005, FASEB J, V19, P404, DOI 10.1096/fj.04-2104fje; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; SHEWRY PR, 1994, PROG BIOPHYS MOL BIO, V61, P37; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; SO JS, 1991, PLANT MOL BIOL, V17, P309, DOI 10.1007/BF00040627; SORENSEN MB, 1989, MOL GEN GENET, V217, P195, DOI 10.1007/BF02464881; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; Stoger E, 1999, TRANSGENIC RES, V8, P73, DOI 10.1023/A:1008801929494; SUGIYAMA T, 1985, NUCLEIC ACIDS RES, V13, P8729, DOI 10.1093/nar/13.24.8729; Suzuki A, 1998, PLANT CELL PHYSIOL, V39, P555, DOI 10.1093/oxfordjournals.pcp.a029404; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Takaiwa F, 1996, PLANT MOL BIOL, V30, P1207, DOI 10.1007/BF00019553; THOMPSON GA, 1989, BIOESSAYS, V10, P108, DOI 10.1002/bies.950100404; UEDA T, 1994, MOL CELL BIOL, V14, P4350, DOI 10.1128/MCB.14.7.4350; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Wu CY, 2000, PLANT J, V23, P415, DOI 10.1046/j.1365-313x.2000.00797.x; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yoshihara T, 1996, FEBS LETT, V383, P213, DOI 10.1016/0014-5793(96)00233-5; Yoshihara T, 1996, PLANT CELL PHYSIOL, V37, P107, DOI 10.1093/oxfordjournals.pcp.a028907; ZHAO WM, 1983, FEBS LETT, V162, P96, DOI 10.1016/0014-5793(83)81056-4	76	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29501	10.1371/journal.pone.0029501	http://dx.doi.org/10.1371/journal.pone.0029501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242127	Green Submitted, gold, Green Published			2022-12-25	WOS:000300677000042
J	Qiu, DJ; Huang, LM; Liu, S; Lin, SJ				Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Lin, Senjie			Nuclear, Mitochondrial and Plastid Gene Phylogenies of Dinophysis miles (Dinophyceae): Evidence of Variable Types of Chloroplasts	PLOS ONE			English	Article							REAL-TIME PCR; HIGH-LEVEL; MOLECULAR EVIDENCE; MYRIONECTA-RUBRA; DINOFLAGELLATE; DIVERSITY; CELL; KLEPTOPLASTIDY; MORPHOLOGY; ACUMINATA	The Dinophysis genus is an ecologically and evolutionarily important group of marine dinoflagellates, yet their molecular phylogenetic positions and ecological characteristics such as trophic modes remain poorly understood. Here, a population of Dinophysis miles var. indica was sampled from South China Sea in March 2010. Nuclear ribosomal RNA gene (rDNA) SSU, ITS1-5.8S-ITS2 and LSU, mitochondrial genes encoding cytochrome B (cob) and cytochrome C oxidase subunit I (cox1), and plastid rDNA SSU were PCR amplified and sequenced. Phylogenetic analyses based on cob, cox1, and the nuclear rRNA regions showed that D. miles was closely related to D. tripos and D. caudata while distinct from D. acuminata. Along with morphology the LSU and ITS1-5.8S-ITS2 molecular data confirmed that this population was D. miles var. indica. Furthermore, the result demonstrated that ITS1-5.8S-ITS2 fragment was the most effective region to distinguish D. miles from other Dinophysis species. Three distinct types of plastid rDNA sequences were detected, belonging to plastids of a cryptophyte, a haptophyte, and a cyanobacterium, respectively. This is the first documentation of three photosynthetic entities associated with a Dinophysis species. While the cyanobacterial sequence likely represented an ectosymbiont of the D. miles cells, the detection of the cryptophyte and haptophyte plastid sequences indicates that the natural assemblage of D. miles likely retain more than one type of plastids from its prey algae for temporary use in photosynthesis. The result, together with recent findings of plastid types in other Dinophysis species, suggests that more systematic research is required to understand the complex nutritional physiology of this genus of dinoflagellates.	[Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Lin, Senjie] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Qiu, Dajun; Liu, Sheng] Chinese Acad Sci, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Connecticut	Qiu, DJ (corresponding author), Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China.	senjie.lin@uconn.edu	Qiu, Dajun/D-3045-2017; Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016; Qiu, Dajun/I-5944-2019; zhang, yaqun/J-8478-2014	Qiu, Dajun/0000-0003-2315-3432; Qiu, Dajun/0000-0003-2315-3432; 	National Science Foundation of China [41129001, 40828006, 41006067, 41076096]; Chinese Academy of Sciences/SAFEA [KZCX2-YW-T001]; US National Science Foundation [EF - 0629624]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences/SAFEA(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF))	This research is supported by the National Science Foundation of China-Overseas Collaboration Fund (41129001, 40828006) (http://www.nsfc.gov.cn/), Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams grants KZCX2-YW-T001 (http://www.cas.cn/), the National Science Foundation of China (41006067, 41076096) (http://www.nsfc.gov.cn/) and the US National Science Foundation "Assembly of a Tree of Life" grant EF - 0629624 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	CARPENTER EJ, 1995, EUR J PHYCOL, V30, P1, DOI 10.1080/09670269500650751; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Escalera L, 2011, PROTIST, V162, P304, DOI 10.1016/j.protis.2010.07.003; Fensome RA, 1993, MICROPALEONTOLOGY SP, V7, P355; Foster RA, 2006, J PHYCOL, V42, P243, DOI 10.1111/j.1529-8817.2006.00185.x; Garcia-Cuetos L, 2009, HARMFUL ALGAE, V8, P196; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Gomez F, 2007, REV BIOL TROP, V55, P459; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; Hackett JD, 2009, HARMFUL ALGAE, V8, P873, DOI 10.1016/j.hal.2009.04.004; Handy SM, 2008, HARMFUL ALGAE, V7, P599, DOI 10.1016/j.hal.2007.12.018; Handy SM, 2009, J PHYCOL, V45, P1163, DOI 10.1111/j.1529-8817.2009.00738.x; Janson S, 2004, ENVIRON MICROBIOL, V6, P1102, DOI 10.1111/j.1462-2920.2004.00646.x; Jensen MH, 2009, J PHYCOL, V45, P1136, DOI 10.1111/j.1529-8817.2009.00741.x; Kataoka T, 2009, DEEP-SEA RES PT II, V56, P2779, DOI 10.1016/j.dsr2.2009.06.013; Koike K, 2005, PROTIST, V156, P225, DOI 10.1016/j.protis.2005.04.002; Larsen J., 1992, Fiches d'Identification du Plancton, P1; LESSARD EJ, 1986, J PLANKTON RES, V8, P1209, DOI 10.1093/plankt/8.6.1209; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Lin Y, 1993, DINOFLAGELLATES S CH, P30; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; LUCAS IAN, 1991, OPHELIA, V33, P213, DOI 10.1080/00785326.1991.10429712; Marasigan AN, 2001, FISHERIES SCI, V67, P994, DOI 10.1046/j.1444-2906.2001.00353.x; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Minnhagen S, 2006, FEMS MICROBIOL ECOL, V57, P47, DOI 10.1111/j.1574-6941.2006.00096.x; MOREYGAINES G, 1982, PHYCOLOGIA, V21, P154, DOI 10.2216/i0031-8884-21-2-154.1; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; Nishitani G, 2008, AQUAT MICROB ECOL, V52, P209, DOI 10.3354/ame01233; Nishitani G, 2010, APPL ENVIRON MICROB, V76, P2791, DOI 10.1128/AEM.02566-09; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Raho N, 2008, HARMFUL ALGAE, V7, P839, DOI 10.1016/j.hal.2008.04.006; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; Takahashi Y, 2005, MAR BIOTECHNOL, V7, P95, DOI 10.1007/s10126-004-0482-5; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tarangkoon W, 2007, J PHYCOL, V43, P38; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1973, J PHYCOL, V9, P1; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Wood EJF, 1963, DINOFLAGELLATES AUST, P193; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yamaguchi A, 2005, PHYCOL RES, V53, P30; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002; Zhang H, 2008, APPL ENVIRON MICROB, V74, P1546, DOI 10.1128/AEM.02103-07	48	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29398	10.1371/journal.pone.0029398	http://dx.doi.org/10.1371/journal.pone.0029398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242118	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000030
J	Russo, A; O'Bryan, JP				Russo, A.; O'Bryan, J. P.			Intersectin 1 is required for neuroblastoma tumorigenesis	ONCOGENE			English	Article						scaffold protein; SH3 domains; EH domains; endocytosis; transformation; oncogenesis	PHOSPHOINOSITIDE 3-KINASE; ACTIVATING MUTATIONS; ALK KINASE; EXPRESSION; ENDOCYTOSIS; CELLS; GENE; RECEPTOR; GROWTH; PROTEINS	Intersectin 1 (ITSN1) is a scaffold protein that regulates diverse cellular pathways, including endocytosis and several signal transduction pathways, including phosphatidylinositol 3-kinase, Class II beta (PI3K-C2 beta). ITSN1's transforming potential in vitro suggests that this scaffold protein may be involved in human tumorigenesis. Herein, we demonstrate that ITSN1 is expressed in primary human neuroblastoma tumors and tumor cell lines and is necessary for their in vitro and in vivo tumorigenic properties. Silencing ITSN1 significantly inhibits the anchorage independent growth of tumor cells in vitro and tumor formation in xenograft assays independent of MYCN status. Overexpression of the ITSN1 target, PI3K-C2 beta, rescues the soft agar growth of ITSN1-silenced cells demonstrating the importance of the ITSN1-PI3K-C2 beta pathway in neuroblastoma tumorigenesis. These findings represent the first demonstration that the ITSN1-PI3K-C2 beta pathway has a requisite role in human cancer, specifically neuroblastomas.	[O'Bryan, J. P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	O'Bryan, JP (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 4091 COMRB,835 S Wolcott,E403 M-C 868, Chicago, IL 60612 USA.	obryanj@uic.edu		O'Bryan, John/0000-0001-5386-1080	National Institutes of Health [HL090651]; Department of Defense [PR080428]; Foundation Jerome Lejeune; St Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation Jerome Lejeune; St Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Naohiko Ikegaki and Bernard Weissman for providing various neuroblastoma cell lines, and Drs Michael Hogarty and Wendy London and the Children's Oncology Group ANBL00B1 Neuroblastoma Biology Studies for providing the primary neuroblastoma tumor samples for analysis. We also thank Dr Ikegaki for providing advice on the xenograft assay, Dr Javed Khan for his helpful discussions regarding the Oncogenomics database, and members of the O'Bryan lab for comments on the manuscript. These studies were supported by grants to JPO from the National Institutes of Health (HL090651), Department of Defense (PR080428), the Foundation Jerome Lejeune, and the St Baldrick's Foundation.	Adams A, 2000, J BIOL CHEM, V275, P27414; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; Eggert A, 2000, KLIN PADIATR, V212, P200, DOI 10.1055/s-2000-9677; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Floyd S, 1998, TRENDS CELL BIOL, V8, P299, DOI 10.1016/S0962-8924(98)01316-6; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Izbicka Elzbieta, 2005, Curr Opin Investig Drugs, V6, P1200; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Koutros S, 2010, CANCER RES, V70, P2389, DOI 10.1158/0008-5472.CAN-09-3575; Ma YJ, 2011, J NEUROSCI RES, V89, P1079, DOI 10.1002/jnr.22616; Ma YJ, 2010, BRAIN RES, V1351, P222, DOI 10.1016/j.brainres.2010.05.028; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Marras E, 2001, INT J ONCOL, V19, P395; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Momboisse F, 2010, CELL MOL NEUROBIOL, V30, P1327, DOI 10.1007/s10571-010-9580-2; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224	43	28	33	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	46					4828	4834		10.1038/onc.2011.643	http://dx.doi.org/10.1038/onc.2011.643			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22266851	Green Accepted			2022-12-25	WOS:000311210700003
J	Bai, H; Inoue, J; Kawano, T; Inazawa, J				Bai, H.; Inoue, J.; Kawano, T.; Inazawa, J.			A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers	ONCOGENE			English	Article						autophagy; microtubule-associated protein; human cancers; DNA methylation; ESCC	PROGNOSTIC RELEVANCE; LIGHT; TUMORIGENESIS; BECLIN-1; DEFICIENT; PATTERNS; PROTEIN; MAP1A; P62	Microtubule-associated protein 1 light chain 3 has an important role in autophagy. The human LC3 gene family has five members, LC3A (variant-1: v1 and -2: v2), LC3B, LC3B2 and LC3C. Although a form of LC3B modified by phosphatidylethanolamine (form-II) is localized in autophagosomes, it is not clear whether other LC3 proteins also function in autophagy. Here, we examined the association between autophagy and human LC3 proteins during starvation- or p53-induced autophagy in Saos-2 cells. In an analysis of the intracellular distribution of each LC3 protein fused with GFP, GFP-LC3Av1 was frequently localized in autophagosomes with a punctate pattern, similar to GFP-LC3B. Further, endogenous LC3Av1 generated form-II and mostly localized in LC3B-positive autophagosomes during the induced autophagy. Interestingly, LC3Av1, not LC3B, was frequently inactivated at the transcriptional level in various human cancer cell lines (111/244 cell lines, 45.5%) and its inactivation was due to aberrant DNA methylation in esophageal squamous cell carcinoma (ESCC) cell lines and primary tumors. Restoration of LC3Av1 expression in KYSE170 cells, an LC3Av1-inactivated ESCC cell line, showed the inhibition of tumor growth in vivo. These results suggest that LC3Av1, not only LC3B, functions in autophagy and further, LC3Av1 may be crucial in carcinogenesis. Oncogene (2012) 31, 4397-4408; doi: 10.1038/onc.2011.613; published online 16 January 2012	[Inazawa, J.] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Bai, H.; Inoue, J.; Inazawa, J.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo 1138510, Japan; [Kawano, T.] Tokyo Med & Dent Univ, Dept Surg, Grad Sch, Tokyo 1138510, Japan; [Bai, H.; Inazawa, J.] Tokyo Med & Dent Univ, Global Ctr, Excellence Program Frontier Res Mol Destruct & Re, Tokyo 1138510, Japan; [Inazawa, J.] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp			Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology (JST) Corporation; New Energy and Industrial Technology Development Organization (NEDO); Grants-in-Aid for Scientific Research [22134002] Funding Source: KAKEN	Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology (JST) Corporation; New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ayako Takahashi and Rumi Mori for technical assistance. This work is supported by Grant-in-Aid for Scientific Research on Priority Areas and Innovative Areas, young scientists (B) and a Global Center of Excellence (GCOE) Program from the Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology (JST) Corporation, and New Energy and Industrial Technology Development Organization (NEDO).	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Faller EM, 2009, MOL CELL NEUROSCI, V41, P85, DOI 10.1016/j.mcn.2009.02.001; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Karpathiou G, 2011, CHEST, V140, P127, DOI 10.1378/chest.10-1831; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; MANN SS, 1994, J BIOL CHEM, V269, P11492; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Sivridis E, 2011, AUTOPHAGY, V7, P74, DOI 10.4161/auto.7.1.13947; Sivridis E, 2010, AUTOPHAGY, V6, P830, DOI 10.4161/auto.6.6.12588; Sivridis E, 2010, AM J PATHOL, V176, P2477, DOI 10.2353/ajpath.2010.090049; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	38	57	61	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	40					4397	4408		10.1038/onc.2011.613	http://dx.doi.org/10.1038/onc.2011.613			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	017LL	22249245				2022-12-25	WOS:000309591300006
J	Niemela, M; Kauko, O; Sihto, H; Mpindi, JP; Nicorici, D; Pernila, P; Kallioniemi, OP; Joensuu, H; Hautaniemi, S; Westermarck, J				Niemela, M.; Kauko, O.; Sihto, H.; Mpindi, J-P; Nicorici, D.; Pernila, P.; Kallioniemi, O-P; Joensuu, H.; Hautaniemi, S.; Westermarck, J.			CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes	ONCOGENE			English	Article						KIAA1524; breast cancer; gene expression profile; PLAUR; SERPINE2; PP2A B-subunit	C-MYC; EXPRESSION SIGNATURE; PP2A COMPLEXES; IDENTIFICATION; AMPLIFICATION; METAANALYSIS; CARCINOMA; APOPTOSIS; VARIANCE	Protein phosphatase 2A (PP2A) is a critical human tumor-suppressor complex. A recently characterized PP2A inhibitor protein, namely cancerous inhibitor of PP2A (CIP2A), has been found to be overexpressed at a high frequency in most of the human cancer types. However, our understanding of gene expression programs regulated by CIP2A is almost absent. Moreover, clinical relevance of the CIP2A-regulated transcriptome has not been addressed thus far. Here, we report a high-confidence transcriptional signature regulated by CIP2A. Bioinformatic pathway analysis of the CIP2A signature revealed that CIP2A regulates several MYC-dependent and MYC-independent gene programs. With regard to MYC-independent signaling, JNK2 expression and transwell migration were inhibited by CIP2A depletion, whereas MYC depletion did not affect either of these phenotypes. Instead, depletion of either CIP2A or MYC inhibited cancer cell colony growth with statistically indistinguishable efficiency. Moreover, CIP2A depletion was shown to regulate the expression of several established MYC target genes, out of which most were MYC-repressed genes. CIP2A small-interfering RNA-elicited inhibition of colony growth or activation of MYC-repressed genes was reversed at large by concomitant PP2A inhibition. Finally, the CIP2A signature was shown to cluster with basal-type and human epidermal growth factor receptor (HER) 2-positive (HER2+) breast cancer signatures. Accordingly, CIP2A protein expression was significantly associated with basal-like (P = 0.0014) and HER2+ (P<0.0001) breast cancers. CIP2A expression also associated with MYC gene amplification (P<0.001). Taken together, identification of CIP2A-driven transcriptional signature, and especially novel MYC-independent signaling programs regulated by CIP2A, provides important resource for understanding CIP2A's role as a clinically relevant human oncoprotein. With regard to MYC, these results both validate CIP2A's role in regulating MYC-mediated gene expression and provide a plausible novel explanation for the high MYC activity in basal-like and HER2+ breast cancers. Oncogene (2012) 31, 4266-4278; doi:10.1038/onc.2011.599; published online 16 January 2012	[Westermarck, J.] Univ Turku, Ctr Biotechnol, Dept Pathol, FIN-20520 Turku, Finland; [Niemela, M.; Kauko, O.; Westermarck, J.] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Niemela, M.; Kauko, O.; Westermarck, J.] Abo Akad Univ, Turku, Finland; [Niemela, M.; Kauko, O.] Turku Grad Sch Biomed Sci, Turku, Finland; [Niemela, M.] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Sihto, H.; Pernila, P.; Joensuu, H.] Univ Helsinki, Lab Mol Oncol, Biomedicum, Helsinki, Finland; [Mpindi, J-P; Nicorici, D.; Kallioniemi, O-P; Westermarck, J.] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Hautaniemi, S.] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Hautaniemi, S.] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland	University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Westermarck, J (corresponding author), Univ Turku, Ctr Biotechnol, Dept Pathol, Tykistokatu 6A, FIN-20520 Turku, Finland.	jukwes@utu.fi	Hautaniemi, Sampsa/CAG-0362-2022; Westermarck, Jukka/AAL-6464-2020; Sihto, Harri J/B-3432-2015; Kallioniemi, Olli P/H-5111-2011; Hautaniemi, Sampsa/A-3122-2009	Hautaniemi, Sampsa/0000-0002-7749-2694; Westermarck, Jukka/0000-0001-7478-3018; Sihto, Harri J/0000-0001-5265-5509; Kallioniemi, Olli P/0000-0002-3231-0332; Hautaniemi, Sampsa/0000-0002-7749-2694; Nicorici, Daniel/0000-0002-0278-8263; Joensuu, Heikki/0000-0003-0281-2507	Academy of Finland [125826, 1131449, 8217676]; Sigrid Juselius Foundation; Cancer Society of Finland; Helsinki University Central Hospital [TYH2009304]; Foundation of Finnish Cancer Institute; Cancer Foundation Finland sr [120139, 110071, 120084, 110134] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Helsinki University Central Hospital; Foundation of Finnish Cancer Institute; Cancer Foundation Finland sr	We thank Taina Kalevo-Mattila for expert technical assistance. Melissa R Junttila is acknowledged for PP2A assay data and Minna-Maija Lintunen for performing the FISH hybridizations. Panu Jaakkola is acknowledged for B-subunit siRNAs. The Finnish DNA Microarray centre is acknowledged for the microarray and qRT-PCR analysis. This study was supported by grants from the Academy of Finland (grant no. 125826, 1131449 and 8217676), Sigrid Juselius Foundation, the Cancer Society of Finland, Helsinki University Central Hospital Research Funds (TYH2009304) and the Foundation of Finnish Cancer Institute.	Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Ben-Israel H, 2008, J VIROL, V82, P9381, DOI 10.1128/JVI.00791-08; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Choi YA, 2011, FEBS LETT, V585, P755, DOI 10.1016/j.febslet.2011.01.018; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Joensuu H, 2003, CLIN CANCER RES, V9, P923; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Mannava S, 2011, ONCOGENE, DOI [10.1038/onc.2011.339, DOI 10.1038/0NC.2011.339]; Mathiasen DP, 2011, ONCOGENE, DOI [10.1038/onc.2011.230, DOI 10.1038/0NC.2011.230]; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Qu W, 2010, MED ONCOL; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	43	60	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	39					4266	4278		10.1038/onc.2011.599	http://dx.doi.org/10.1038/onc.2011.599			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22249265				2022-12-25	WOS:000309520200002
J	Lam, V; Su, JD; Koprowski, S; Hsu, AN; Tweddell, JS; Rafiee, P; Gross, GJ; Salzman, NH; Baker, JE				Lam, Vy; Su, Jidong; Koprowski, Stacy; Hsu, Anna; Tweddell, James S.; Rafiee, Parvaneh; Gross, Garrett J.; Salzman, Nita H.; Baker, John E.			Intestinal microbiota determine severity of myocardial infarction in rats	FASEB JOURNAL			English	Article						bacteria; leptin; probiotics; biomarkers; cytokines	CORONARY-HEART-DISEASE; CHLAMYDIA-PNEUMONIAE; GUT MICROBIOTA; RIBOSOMAL-RNA; HELICOBACTER-PYLORI; DNA EXTRACTION; PCR ASSAYS; LACTOBACILLUS; METABOLISM; ATHEROSCLEROSIS	Signals from the intestinal microbiota are important for normal host physiology; alteration of the microbiota (dysbiosis) is associated with multiple disease states. We determined the effect of antibiotic-induced intestinal dysbiosis on circulating cytokine levels and severity of ischemia/reperfusion injury in the heart. Treatment of Dahl S rats with a minimally absorbed antibiotic vancomycin, in the drinking water, decreased circulating leptin levels by 38%, resulted in smaller myocardial infarcts (27% reduction), and improved recovery of postischemic mechanical function (35%) as compared with untreated controls. Vancomycin altered the abundance of intestinal bacteria and fungi, measured by 16S and 18S ribosomal DNA quantity. Pretreatment with leptin (0.12 mu g/kg i.v.) 24 h before ischemia/reperfusion abolished cardioprotection produced by vancomycin treatment. Dahl S rats fed the commercially available probiotic product Goodbelly, which contains the leptin-suppressing bacteria Lactobacillus plantarum 299v, also resulted in decreased circulating leptin levels by 41%, smaller myocardial infarcts (29% reduction), and greater recovery of postischemic mechanical function (23%). Pretreatment with leptin (0.12 mu g/kg i.v.) abolished cardioprotection produced by Goodbelly. This proof-of-concept study is the first to identify a mechanistic link between changes in intestinal microbiota and myocardial infarction and demonstrates that a probiotic supplement can reduce myocardial infarct size.-Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J. S., Rafiee, P., Gross, G. J., Salzman, N. H., Baker, J. E. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26, 1727-1735 (2012). www.fasebj.org	[Lam, Vy; Su, Jidong; Koprowski, Stacy; Tweddell, James S.; Baker, John E.] Med Coll Wisconsin, Childrens Res Inst, Div Cardiothorac Surg, Milwaukee, WI 53226 USA; [Hsu, Anna; Gross, Garrett J.; Baker, John E.] Med Coll Wisconsin, Childrens Res Inst, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Rafiee, Parvaneh] Med Coll Wisconsin, Childrens Res Inst, Div Colorectal Surg, Milwaukee, WI 53226 USA; [Baker, John E.] Med Coll Wisconsin, Childrens Res Inst, Dept Biochem, Milwaukee, WI 53226 USA; [Salzman, Nita H.] Med Coll Wisconsin, Childrens Res Inst, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Baker, JE (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Div Cardiothorac Surg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jbaker@mcw.edu	Baker, John/V-8897-2019	Baker, John/0000-0001-7899-3266; Salzman, Nita/0000-0003-0939-6139	U.S. National Institutes of Health [HL-54075, AI-080363, AI-057757, HL-074317]; Foundation for Heart Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057757, R01AI080363, R01AI057757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Heart Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Ravinder Singh (Mayo Laboratories, Rochester, MN, USA) for determining vancomycin levels in blood; Michael Hayward (Medical College of Wisconsin) for guidance with the PCR determinations; and Dr. Jeffrey I. Gordon (Washington University School of Medicine, St. Louis, MO, USA) for providing genomic DNA from M. smithii. This work was supported by U.S. National Institutes of Health grants HL-54075 and AI-080363 (to J.E.B.), AI-057757 (to N.H.S.), and HL-074317 (to G.J.G.) and by the Foundation for Heart Science (to V.L.). J.E.B. has filed a provisional patent application based on the findings of this study. J.E.B. holds an equity interest in Microbiota Diagnostics, a limited-liability corporation formed to develop the findings of this study.	Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker JE, 2000, AM J PHYSIOL-HEART C, V278, pH1395, DOI 10.1152/ajpheart.2000.278.4.H1395; Baker JE, 2008, CARDIOVASC RES, V77, P44, DOI 10.1093/cvr/cvm026; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Chang HW, 2007, J MICROBIOL METH, V71, P191, DOI 10.1016/j.mimet.2007.08.013; Costa C, 2002, J CLIN MICROBIOL, V40, P2224, DOI 10.1128/JCM.40.6.2224-2227.2002; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; Fryer RM, 2001, J PHARMACOL EXP THER, V296, P642; Gross ER, 2003, J MOL CELL CARDIOL, V35, P985, DOI 10.1016/S0022-2828(03)00183-4; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Kubota H., APPL ENV MICROBIOL, V76, P5440; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loscalzo J, 2011, CIRC RES, V109, P127, DOI 10.1161/RES.0b013e3182290620; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; Muhlestein JB, 1998, CIRCULATION, V97, P633, DOI 10.1161/01.CIR.97.7.633; Muller A, 1999, CLIN DIAGN LAB IMMUN, V6, P243; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Ombrouck C, 1997, J CLIN MICROBIOL, V35, P652, DOI 10.1128/JCM.35.3.652-655.1997; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajesh KG, 2003, CARDIOVASC RES, V59, P297, DOI 10.1016/S0008-6363(03)00358-4; Ren J, 2008, OBESITY, V16, P2417, DOI 10.1038/oby.2008.381; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Shi Y, 2005, J MOL CELL CARDIOL, V38, P625, DOI 10.1016/j.yjmcc.2005.02.005; Smith CCT, 2011, PHARMACOL THERAPEUT, V129, P206, DOI 10.1016/j.pharmthera.2010.09.003; Smith CCT, 2010, AM J PHYSIOL-HEART C, V299, pH1265, DOI 10.1152/ajpheart.00092.2010; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x	49	176	192	0	45	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1727	1735		10.1096/fj.11-197921	http://dx.doi.org/10.1096/fj.11-197921			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22247331	Green Published			2022-12-25	WOS:000302359700033
J	Li, XX; Liu, KX; Li, FD; Wang, JC; Huang, HD; Wu, JH; Shi, YY				Li, Xinxin; Liu, Kaixian; Li, Fudong; Wang, Juncheng; Huang, Hongda; Wu, Jihui; Shi, Yunyu			Structure of C-terminal Tandem BRCT Repeats of Rtt107 Protein Reveals Critical Role in Interaction with Phosphorylated Histone H2A during DNA Damage Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; CRYSTAL-STRUCTURE; CHECKPOINT; DOMAIN; PHOSPHOPEPTIDE; RECRUITMENT; 53BP1; YEAST; COMPLEX	Rtt107 (regulator of Ty1 transposition 107; Esc4) is a DNA repair protein from Saccharomyces cerevisiae that can restore stalled replication forks following DNA damage. There are six BRCT (BRCA1 C-terminal) domains in Rtt107 that act as binding sites for other recruited proteins during DNA repair. Several Rtt107 binding partners have been identified, including Slx4, Rtt101, Rad55, and the Smc5/6 (structural maintenance of chromosome) protein complex. Rtt107 can reportedly be recruited to chromatin in the presence of Rtt101 and Rtt109 upon DNA damage, but the chromatin-binding site of Rtt107 has not been identified. Here, we report our investigation of the interaction between phosphorylated histone H2A (gamma H2A) and the C-terminal tandem BRCT repeats (BRCT5-BRCT6) of Rtt107. The crystal structures of BRCT5-BRCT6 alone and in a complex with gamma H2A reveal the molecular basis of the Rtt107-gamma H2A interaction. We used in vitro mutagenesis and a fluorescence polarization assay to confirm the location of the Rtt107 motif that is crucial for this interaction. In addition, these assays indicated that this interaction requires the phosphorylation of H2A. An in vivo phenotypic analysis in yeast demonstrated the critical role of BRCT5-BRCT6 and its interaction with gamma H2A during the DNA damage response. Our results shed new light on the molecular mechanism by which Rtt107 is recruited to chromatin in response to stalled DNA replication forks.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Liu, Kaixian/0000-0001-9711-6509	National Basic Research Program of China 973 Program [2011CB966302, 2011CB911104]; Chinese National Natural Science Foundation [30830031, 31170693]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302 and 2011CB911104 and by Chinese National Natural Science Foundation Grants 30830031 and 31170693.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Dore AS, 2006, DNA REPAIR, V5, P362, DOI 10.1016/j.dnarep.2005.11.004; Downey M, 2010, MOL CELL, V39, P162, DOI 10.1016/j.molcel.2010.07.007; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Germann SM, 2011, DNA REPAIR, V10, P210, DOI 10.1016/j.dnarep.2010.11.001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Leung GP, 2011, J BIOL CHEM, V286, P26250, DOI 10.1074/jbc.M111.235200; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moore JD, 2007, GENETICS, V176, P15, DOI 10.1534/genetics.106.063792; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Scholes DT, 2001, GENETICS, V159, P1449; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Ullal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020152; Watts FZ, 2010, DNA REPAIR, V9, P103, DOI 10.1016/j.dnarep.2009.10.010; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40	46	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9137	9146		10.1074/jbc.M111.311860	http://dx.doi.org/10.1074/jbc.M111.311860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262834	Green Published, hybrid			2022-12-25	WOS:000301797800043
J	Mayer, C; Slater, L; Erat, MC; Konrat, R; Vakonakis, I				Mayer, Christina; Slater, Leanne; Erat, Michele C.; Konrat, Robert; Vakonakis, Ioannis			Structural Analysis of the Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Intracellular Domain Reveals a Conserved Interaction Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; VAR GENES; CYTOADHERENCE; LIGAND; BINDING	Plasmodium falciparum-infected red blood cells adhere to endothelial cells, thereby obstructing the microvasculature. Erythrocyte adherence is directly associated with severe malaria and increased disease lethality, and it is mediated by the PfEMP1 family. PfEMP1 clustering in knob-like protrusions on the erythrocyte membrane is critical for cytoadherence, however the molecular mechanisms behind this system remain elusive. Here, we show that the intracellular domains of the PfEMP1 family (ATS) share a unique molecular architecture, which comprises a minimal folded core and extensive flexible elements. A conserved flexible segment at the ATS center is minimally restrained by the folded core. Yeast-two-hybrid data and a novel sequence analysis method suggest that this central segment contains a conserved protein interaction epitope. Interestingly, ATS in solution fails to bind the parasite knob-associated histidine-rich protein (KAHRP), an essential cytoadherence component. Instead, we demonstrate that ATS associates with PFI1780w, a member of the Plasmodium helical interspersed sub-telomeric (PHIST) family. PHIST domains are widespread in exported parasite proteins, however this is the first specific molecular function assigned to any variant of this family. We propose that PHIST domains facilitate protein interactions, and that the conserved ATS epitope may be targeted to disrupt the parasite cytoadherence system.	[Mayer, Christina; Slater, Leanne; Erat, Michele C.; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Konrat, Robert] Univ Vienna, Dept Biomol Struct Chem, A-1030 Vienna, Austria	University of Oxford; University of Vienna	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Wellcome Trust; Marie Curie Fellowships programme (FP7); Royal Society	Wellcome Trust(Wellcome Trust); Marie Curie Fellowships programme (FP7); Royal Society(Royal Society of London)	This work was supported by the Wellcome Trust (to C. M. and I. V.) and the Marie Curie Fellowships programme (FP7) and the Royal Society (to M. C. E.).	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bonnefoy S, 2008, CELL, V134, P20, DOI 10.1016/j.cell.2008.06.040; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hora R, 2009, J BIOL CHEM, V284, P6260, DOI 10.1074/jbc.M809756200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Narang P, 2005, PHYS CHEM CHEM PHYS, V7, P2364, DOI 10.1039/b502226f; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	28	46	46	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7182	7189		10.1074/jbc.M111.330779	http://dx.doi.org/10.1074/jbc.M111.330779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249178	hybrid, Green Published			2022-12-25	WOS:000301060200021
J	Venteo, S; Bourane, S; Mechaly, I; Sar, C; Samad, OA; Puech, S; Blostein, R; Valmier, J; Pattyn, A; Carroll, P				Venteo, Stephanie; Bourane, Steeve; Mechaly, Ilana; Sar, Chamroeun; Samad, Omar Abdel; Puech, Sylvie; Blostein, Rhoda; Valmier, Jean; Pattyn, Alexandre; Carroll, Patrick			Regulation of the Na,K-ATPase Gamma-Subunit FXYD2 by Runx1 and Ret Signaling in Normal and Injured Non-Peptidergic Nociceptive Sensory Neurons	PLOS ONE			English	Article							FOLLISTATIN-LIKE 1; RECEPTOR COMPONENTS; FUNCTIONAL-ROLE; EXPRESSION; GDNF; IDENTIFICATION; PROTEINS; FAMILY; CELLS	Dorsal root ganglia (DRGs) contain the cell bodies of sensory neurons which relay nociceptive, thermoceptive, mechanoceptive and proprioceptive information from peripheral tissues toward the central nervous system. These neurons establish constant communication with their targets which insures correct maturation and functioning of the somato-sensory nervous system. Interfering with this two-way communication leads to cellular, electrophysiological and molecular modifications that can eventually cause neuropathic conditions. In this study we reveal that FXYD2, which encodes the gamma-subunit of the Na, K-ATPase reported so far to be mainly expressed in the kidney, is induced in the mouse DRGs at postnatal stages where it is restricted specifically to the TrkB-expressing mechanoceptive and Ret-positive/IB4-binding non-peptidergic nociceptive neurons. In non-peptidergic nociceptors, we show that the transcription factor Runx1 controls FXYD2 expression during the maturation of the somato-sensory system, partly through regulation of the tyrosine kinase receptor Ret. Moreover, Ret signaling maintains FXYD2 expression in adults as demonstrated by the axotomy-induced down-regulation of the gene that can be reverted by in vivo delivery of GDNF family ligands. Altogether, these results establish FXYD2 as a specific marker of defined sensory neuron subtypes and a new target of the Ret signaling pathway during normal maturation of the non-peptidergic nociceptive neurons and after sciatic nerve injury.	[Venteo, Stephanie; Bourane, Steeve; Mechaly, Ilana; Sar, Chamroeun; Valmier, Jean; Pattyn, Alexandre; Carroll, Patrick] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France; [Mechaly, Ilana; Valmier, Jean] Univ Montpellier 2, Montpellier, France; [Puech, Sylvie] Univ Montpellier I, Montpellier, France; [Blostein, Rhoda] Montreal Gen Hosp, Res Inst, Dept Med, Montreal, PQ H3G 1A4, Canada; [Blostein, Rhoda] Montreal Gen Hosp, Res Inst, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Samad, Omar Abdel] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Neurobiol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Venteo, S (corresponding author), Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France.	carroll@univ-montp2.fr	Carroll, Patrick/AAL-7773-2021; Bourane, Steeve/AAI-6143-2020; Carroll, Patrick/C-2933-2012; samad, omar/K-1921-2012; Alexandre, Pattyn/ABF-1346-2020	Bourane, Steeve/0000-0002-9805-2196; Carroll, Patrick/0000-0003-3287-8195; Pattyn, Alexandre/0000-0003-1215-1482	INSERM; CNRS; University of Montpellier II; Association Francaise contre les Myopathies	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier II; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by INSERM, CNRS, University of Montpellier II and the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2004, NEUROSCIENCE, V129, P691, DOI 10.1016/j.neuroscience.2004.08.041; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Grimal S, 2010, GLIA, V58, P1977, DOI 10.1002/glia.21066; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Hubert T, 2008, J COMP NEUROL, V507, P1588, DOI 10.1002/cne.21631; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jones DH, 2001, PHYSIOL GENOMICS, V6, P129, DOI 10.1152/physiolgenomics.2001.6.3.129; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Leitner ML, 1999, J NEUROSCI, V19, P9322; Li KC, 2011, CELL RES, V21, P697, DOI 10.1038/cr.2011.43; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; Pezet S, 2006, MOL THER, V13, P1101, DOI 10.1016/j.ymthe.2005.11.026; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanelderen P, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.09.006; Zhang JM, 1997, J NEUROPHYSIOL, V78, P2790, DOI 10.1152/jn.1997.78.5.2790; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	31	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29852	10.1371/journal.pone.0029852	http://dx.doi.org/10.1371/journal.pone.0029852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253804	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500024
J	Strochlic, L; Falk, J; Goillot, E; Sigoillot, S; Bourgeois, F; Delers, P; Rouviere, J; Swain, A; Castellani, V; Schaeffer, L; Legay, C				Strochlic, Laure; Falk, Julien; Goillot, Evelyne; Sigoillot, Severine; Bourgeois, Francine; Delers, Perrine; Rouviere, Jerome; Swain, Amanda; Castellani, Valerie; Schaeffer, Laurent; Legay, Claire			Wnt4 Participates in the Formation of Vertebrate Neuromuscular Junction	PLOS ONE			English	Article							POSTSYNAPTIC DIFFERENTIATION; SYNAPSE FORMATION; GENE-EXPRESSION; MOTOR-NEURONS; KINASE MUSK; MUSCLE; RECEPTOR; AGRIN; NEUROTRANSMITTER; ACETYLCHOLINESTERASE	Neuromuscular junction (NMJ) formation requires the highly coordinated communication of several reciprocal signaling processes between motoneurons and their muscle targets. Identification of the early, spatially restricted cues in target recognition at the NMJ is still poorly documented, especially in mammals. Wnt signaling is one of the key pathways regulating synaptic connectivity. Here, we report that Wnt4 contributes to the formation of vertebrate NMJ in vivo. Results from a microarray screen and quantitative RT-PCR demonstrate that Wnt4 expression is regulated during muscle cell differentiation in vitro and muscle development in vivo, being highly expressed when the first synaptic contacts are formed and subsequently downregulated. Analysis of the mouse Wnt4(-/-) NMJ phenotype reveals profound innervation defects including motor axons overgrowing and bypassing AChR aggregates with 30% of AChR clusters being unapposed by nerve terminals. In addition, loss of Wnt4 function results in a 35% decrease of the number of prepatterned AChR clusters while Wnt4 overexpression in cultured myotubes increases the number of AChR clusters demonstrating that Wnt4 directly affects postsynaptic differentiation. In contrast, muscle structure and the localization of several synaptic proteins including acetylcholinesterase, MuSK and rapsyn are not perturbed in the Wnt4 mutant. Finally, we identify MuSK as a Wnt4 receptor. Wnt4 not only interacts with MuSK ectodomain but also mediates MuSK activation. Taken together our data reveal a new role for Wnt4 in mammalian NMJ formation that could be mediated by MuSK, a key receptor in synaptogenesis.	[Strochlic, Laure; Sigoillot, Severine; Bourgeois, Francine; Delers, Perrine; Rouviere, Jerome; Legay, Claire] Univ Paris 05, Sorbonne Paris Cite, France; [Falk, Julien; Castellani, Valerie] Univ Lyon, Villeurbanne, France; [Goillot, Evelyne; Schaeffer, Laurent] Univ Lyon, Lyon, France; [Swain, Amanda] Inst Canc Res, Sect Gene Funct & Regulat, London SW3 6JB, England	UDICE-French Research Universities; Universite Paris Cite; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Strochlic, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, France.	laure.strochlic@inserm.fr	castellani, valérie/H-3100-2017; Strochlic, Laure/J-3610-2017; Falk, Julien/G-9020-2017	castellani, valérie/0000-0001-9623-9312; Strochlic, Laure/0000-0001-5373-4284; Falk, Julien/0000-0001-8590-5615; Swain, Amanda/0000-0001-8666-1608; Goillot, Evelyne/0000-0003-0026-4690; Rouviere, Jerome/0000-0002-0269-1971; schaeffer, laurent/0000-0001-6600-503X	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Association Francaise contre les Myopathies (AFM); Universite Paris Descartes	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Universite Paris Descartes	This work was funded by the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Association Francaise contre les Myopathies (AFM) and Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; CONDON K, 1990, DEV BIOL, V138, P256, DOI 10.1016/0012-1606(90)90196-P; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Henriquez JP, 2011, ACTA PHYSL OXF; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kim CH, 2003, J BIOL CHEM, V278, P38522, DOI 10.1074/jbc.M305058200; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Loganathan PG, 2005, HISTOCHEM CELL BIOL, V123, P195, DOI 10.1007/s00418-005-0756-7; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MARSH D, 1984, J NEUROCHEM, V43, P204, DOI 10.1111/j.1471-4159.1984.tb06698.x; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sigoillot SM, 2010, J NEUROSCI, V30, P13, DOI 10.1523/JNEUROSCI.4374-09.2010; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305; Strochlic L, 2001, J CELL BIOL, V153, P1127, DOI 10.1083/jcb.153.5.1127; Takata H, 2007, DEV DYNAM, V236, P2800, DOI 10.1002/dvdy.21327; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yumoto N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003322; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	50	64	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29976	10.1371/journal.pone.0029976	http://dx.doi.org/10.1371/journal.pone.0029976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253844	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100033
J	Chen, DW; Zhang, YW; Yi, QY; Huang, Y; Hou, HL; Zhang, YY; Hao, QM; Cooke, HJ; Li, L; Sun, QY; Shi, QH				Chen, Dawei; Zhang, Yuanwei; Yi, Qiyi; Huang, Yun; Hou, Heli; Zhang, Yingyin; Hao, Qiaomei; Cooke, Howard J.; Li, Lei; Sun, Qingyuan; Shi, Qinghua			Regulation of Asymmetrical Cytokinesis by cAMP during Meiosis I in Mouse Oocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; POLAR BODY EXTRUSION; CELL-DIVISION; MYOSIN-II; MEIOTIC RESUMPTION; CYCLIC-AMP; MAMMALIAN OOCYTES; SMOOTH-MUSCLE; NEURITE OUTGROWTH; ADENYLATE-CYCLASE	Mammalian oocytes undergo an asymmetrical first meiotic division, extruding half of their chromosomes in a small polar body to preserve maternal resources for embryonic development. To divide asymmetrically, mammalian oocytes relocate chromosomes from the center of the cell to the cortex, but little is known about the underlying mechanisms. Here, we show that upon the elevation of intracellular cAMP level, mouse oocytes produced two daughter cells with similar sizes. This symmetrical cell division could be rescued by the inhibition of PKA, a cAMP-dependent protein kinase. Live cell imaging revealed that a symmetrically localized cleavage furrow resulted in symmetrical cell division. Detailed analyses demonstrated that symmetrically localized cleavage furrows were caused by the inappropriate central positioning of chromosome clusters at anaphase onset, indicating that chromosome cluster migration was impaired. Notably, high intracellular cAMP reduced myosin II activity, and the microinjection of phospho-myosin II antibody into the oocytes impeded chromosome migration and promoted symmetrical cell division. Our results support the hypothesis that cAMP plays a role in regulating asymmetrical cell division by modulating myosin II activity during mouse oocyte meiosis I, providing a novel insight into the regulation of female gamete formation in mammals.	[Chen, Dawei; Zhang, Yuanwei; Yi, Qiyi; Huang, Yun; Hou, Heli; Zhang, Yingyin; Hao, Qiaomei; Cooke, Howard J.; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Zhang, Yingyin; Cooke, Howard J.; Shi, Qinghua] Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Sun, Qingyuan] Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Edinburgh; Chinese Academy of Sciences	Chen, DW (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013; Zhang, Yuanwei/C-7695-2016; Huang, Yun/AGX-8953-2022; Chen, Dawei/V-4296-2019	Zhang, Yuanwei/0000-0002-2814-8061; Huang, Yun/0000-0001-5987-1319; Chen, Dawei/0000-0002-8201-0549; Li, Lei/0000-0001-5478-5681; Yi, Qiyi/0000-0001-5143-8828	National Basic Research Program of China (973) [2011CB944501, 2007CB947401]; Chinese Academy of Sciences [KSCX2-EW-R-07]	National Basic Research Program of China (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2011CB944501, 2007CB947401) of China (973), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2005, J NEUROSCI, V25, P8432, DOI 10.1523/JNEUROSCI.1289-05.2005; Asano S, 2009, GENES CELLS, V14, P555, DOI 10.1111/j.1365-2443.2009.01288.x; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Bezanilla M, 2009, CURR BIOL, V19, pR168, DOI 10.1016/j.cub.2008.12.026; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; Carmena A, 2008, DEV BIOL, V321, P1, DOI 10.1016/j.ydbio.2008.06.010; Chen J, 2009, REPRODUCTION, V138, P759, DOI 10.1530/REP-08-0535; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHO WK, 1974, J EXP ZOOL, V187, P383, DOI 10.1002/jez.1401870307; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; D'Avino PP, 2009, J CELL SCI, V122, P1071, DOI 10.1242/jcs.034785; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; Dekel N, 2005, MOL CELL ENDOCRINOL, V234, P19, DOI 10.1016/j.mce.2004.09.010; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Fabritius AS, 2010, CURR OPIN CELL BIOL; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Han D, 2010, REPRODUCTION, V139, P959, DOI 10.1530/REP-09-0485; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; JOHNSON MH, 1984, J EMBRYOL EXP MORPH, V82, P97; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kovo M, 2006, REPRODUCTION, V132, P33, DOI 10.1530/rep.1.00824; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LaRosa C, 2006, BIOL REPROD, V74, P585, DOI 10.1095/biolreprod.105.046524; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Maruoka H, 2010, J BIOCHEM, V148, P93, DOI 10.1093/jb/mvq036; McCollum D, 2004, CURR BIOL, V14, pR953, DOI 10.1016/j.cub.2004.10.040; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; MEIJER L, 1989, DEV BIOL, V133, P58, DOI 10.1016/0012-1606(89)90296-0; Menke FLH, 2009, CELL, V137, P1189, DOI 10.1016/j.cell.2009.06.007; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TORNELL J, 1990, MOL REPROD DEV, V27, P254, DOI 10.1002/mrd.1080270312; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Tsafriri A., 1994, MOL BIOL FEMALE REPR, P207; URNER F, 1983, ENDOCRINOLOGY, V113, P1170, DOI 10.1210/endo-113-3-1170; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; VIVARELLI E, 1983, CELL DIFFER DEV, V12, P271, DOI 10.1016/0045-6039(83)90023-4; Wang J, 2006, CELL CYCLE, V5, P213, DOI 10.4161/cc.5.2.2365; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Wang Q, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-17; Wu Q, 2010, ONCOGENE; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yang JX, 2005, LIFE SCI, V77, P2669, DOI 10.1016/j.lfs.2005.04.026; Yuan Wei, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS10, DOI 10.1186/1471-2393-7-S1-S10	73	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29735	10.1371/journal.pone.0029735	http://dx.doi.org/10.1371/journal.pone.0029735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253767	gold, Green Submitted, Green Published			2022-12-25	WOS:000301355700043
J	Gorlich, A; Zimmermann, AM; Schober, D; Bottcher, RT; Sassoe-Pognetto, M; Friauf, E; Witke, W; Rust, MB				Goerlich, Andreas; Zimmermann, Anika-Maria; Schober, Doreen; Boettcher, Ralph T.; Sassoe-Pognetto, Marco; Friauf, Eckhard; Witke, Walter; Rust, Marco B.			Preserved Morphology and Physiology of Excitatory Synapses in Profilin1-Deficient Mice	PLOS ONE			English	Article							DENDRITIC SPINE; PROFILIN-I; ACTIN CYTOSKELETON; LTP; ARCHITECTURE	Profilins are important regulators of actin dynamics and have been implicated in activity-dependent morphological changes of dendritic spines and synaptic plasticity. Recently, defective presynaptic excitability and neurotransmitter release of glutamatergic synapses were described for profilin2-deficient mice. Both dendritic spine morphology and synaptic plasticity were fully preserved in these mutants, bringing forward the hypothesis that profilin1 is mainly involved in postsynaptic mechanisms, complementary to the presynaptic role of profilin2. To test the hypothesis and to elucidate the synaptic function of profilin1, we here specifically deleted profilin1 in neurons of the adult forebrain by using conditional knockout mice on a CaMKII-cre-expressing background. Analysis of Golgi-stained hippocampal pyramidal cells and electron micrographs from the CA1 stratum radiatum revealed normal synapse density, spine morphology, and synapse ultrastructure in the absence of profilin1. Moreover, electrophysiological recordings showed that basal synaptic transmission, presynaptic physiology, as well as postsynaptic plasticity were unchanged in profilin1 mutants. Hence, loss of profilin1 had no adverse effects on the morphology and function of excitatory synapses. Our data are in agreement with two different scenarios: i) profilins are not relevant for actin regulation in postsynaptic structures, activity-dependent morphological changes of dendritic spines, and synaptic plasticity or ii) profilin1 and profilin2 have overlapping functions particularly in the postsynaptic compartment. Future analysis of double mutant mice will ultimately unravel whether profilins are relevant for dendritic spine morphology and synaptic plasticity.	[Goerlich, Andreas; Zimmermann, Anika-Maria; Schober, Doreen; Rust, Marco B.] Univ Kaiserslautern, Neurobiol Neurophysiol Grp, Kaiserslautern, Germany; [Boettcher, Ralph T.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Sassoe-Pognetto, Marco] Univ Turin, Natl Inst Neurosci Italy, Turin, Italy; [Friauf, Eckhard] Univ Kaiserslautern, Anim Physiol Grp, Kaiserslautern, Germany; [Witke, Walter; Rust, Marco B.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Witke, Walter] Univ Bonn, Inst Genet, Bonn, Germany	University of Kaiserslautern; Max Planck Society; University of Turin; University of Turin; University of Kaiserslautern; European Molecular Biology Laboratory (EMBL); University of Bonn	Gorlich, A (corresponding author), Univ Kaiserslautern, Neurobiol Neurophysiol Grp, Kaiserslautern, Germany.	marco.rust@biologie.uni-kl.de	Sassoe-Pognetto, Marco/AAE-3536-2022; Friauf, Eckhard/D-7529-2012	Friauf, Eckhard/0000-0002-1833-1698; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Research Initiative Membrane Transport RIMB of the University of Kaiserslautern; Deutscher Akademischer Austausch-Dienst (DAAD) [50756644]; Deutsche Forschungsgemeinschaft (DFG) [RU-1232/1-1]; Stiftung Rheinland-Pfalz [961-386261/877]; Compagnia di San Paolo	Research Initiative Membrane Transport RIMB of the University of Kaiserslautern; Deutscher Akademischer Austausch-Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stiftung Rheinland-Pfalz; Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by the Research Initiative Membrane Transport RIMB of the University of Kaiserslautern and by the Vigoni-Program of the Deutscher Akademischer Austausch-Dienst (DAAD; 50756644). MBR was supported by a post-doctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG; RU-1232/1-1) and by the Stiftung Rheinland-Pfalz (961-386261/877). MS-P was supported by a grant from Compagnia di San Paolo (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gorlich A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026789; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kullmann JA, 2011, EMBO REP IN PRESS; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Michaelsen K, 2010, P NATL ACAD SCI USA, V107, P15780, DOI 10.1073/pnas.1004406107; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	24	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30068	10.1371/journal.pone.0030068	http://dx.doi.org/10.1371/journal.pone.0030068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253883	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700087
J	Ho, NK; Crandall, I; Sherman, PM				Ho, Nathan K.; Crandall, Ian; Sherman, Philip M.			Identifying Mechanisms by Which Escherichia coli O157:H7 Subverts Interferon-gamma Mediated Signal Transducer and Activator of Transcription-1 Activation	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT; O157H7; PLASMID; STAT1; GENE; DEFICIENCY; SECRETION; ADHERENCE; IMMUNITY; O157-H7	Enterohemorrhagic Escherichia coli serotype O157:H7 is a food borne enteric bacterial pathogen that causes significant morbidity and mortality in both developing and industrialized nations. E. coli O157:H7 infection of host epithelial cells inhibits the interferon gamma pro-inflammatory signaling pathway, which is important for host defense against microbial pathogens, through the inhibition of Stat-1 tyrosine phosphorylation. The aim of this study was to determine which bacterial factors are involved in the inhibition of Stat-1 tyrosine phosphorylation. Human epithelial cells were challenged with either live bacteria or bacterial-derived culture supernatants, stimulated with interferon-gamma, and epithelial cell protein extracts were then analyzed by immunoblotting. The results show that Stat-1 tyrosine phosphorylation was inhibited by E. coli O157:H7 secreted proteins. Using sequential anion exchange and size exclusion chromatography, YodA was identified, but not confirmed to mediate subversion of the Stat-1 signaling pathway using isogenic mutants. We conclude that E. coli O157:H7 subverts Stat-1 tyrosine phosphorylation in response to interferon-gamma through a still as yet unidentified secreted bacterial protein.	[Ho, Nathan K.; Sherman, Philip M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Crandall, Ian] Univ Toronto, Dept Pharm, Toronto, ON, Canada; [Ho, Nathan K.; Sherman, Philip M.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ho, NK (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	philip.sherman@sickkids.ca		Sherman, Philip/0000-0002-4733-6690	Canadian Institutes of Health Research [MOP-89894, JDD-95413]; CIHR POP [CIHR PPP-84167]; BioDiscovery Grant [BDT-2012-S3a]; Canada Research Chair in Gastrointestinal Disease	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR POP(Canadian Institutes of Health Research (CIHR)); BioDiscovery Grant; Canada Research Chair in Gastrointestinal Disease	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-89894). NKH was supported by a doctoral research award from the Canadian Institutes of Health Research (JDD-95413). IC was funded by a CIHR POP grant (CIHR PPP-84167) and a BioDiscovery Grant (BDT-2012-S3a). PMS was supported by a Canada Research Chair in Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Castillo A, 2005, P NATL ACAD SCI USA, V102, P1542, DOI 10.1073/pnas.0408633102; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; David G, 2002, ACTA CRYSTALLOGR D, V58, P1243, DOI 10.1107/S0907444902008326; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; Ho NH, 2011, INFECT IMMUN UNPUB; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Jones RM, 2011, CELL MICROBIOL, V13, P670, DOI 10.1111/j.1462-5822.2011.01579.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Muller D, 2009, INFECT IMMUN, V77, P3501, DOI 10.1128/IAI.00090-09; NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; SCHMIDT H, 1994, FEMS MICROBIOL LETT, V117, P189, DOI 10.1016/0378-1097(94)90193-7; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Shea-Donohue T, 2010, GUT MICROBES, V1, P316, DOI 10.4161/gmic.1.5.13329; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30145	10.1371/journal.pone.0030145	http://dx.doi.org/10.1371/journal.pone.0030145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253910	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700095
J	Little, MA; Al-Ani, B; Ren, SY; Al-Nuaimi, H; Leite, M; Alpers, CE; Savage, CO; Duffield, JS				Little, Mark A.; Al-Ani, Bahjat; Ren, Shuyu; Al-Nuaimi, Hamad; Leite, Maurilo, Jr.; Alpers, Charles E.; Savage, Caroline O.; Duffield, Jeremy S.			Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System	PLOS ONE			English	Article							WEGENERS-GRANULOMATOSIS; CRESCENTIC GLOMERULONEPHRITIS; NEUTROPHILS; MYELOPEROXIDASE; PROTEINASE-3; ANTIBODIES; KIDNEY; CELLS; SPECIFICITY; ACTIVATION	Evidence is lacking for direct pathogenicity of human anti-proteinase-3 (PR3) antibodies in development of systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener's granulomatosis). Progress in study of these antibodies in rodents has been hampered by lack of PR3 expression on murine neutrophils, and by different Fc-receptor affinities for IgG across species. Therefore, we tested whether human anti-PR3 antibodies can induce acute vasculitis in mice with a human immune system. Chimeric mice were generated by injecting human haematopoietic stem cells into irradiated NOD-scid-IL2R gamma(-/-) mice. Matched chimera mice were treated with human IgG from patients with: anti-PR3 positive renal and lung vasculitis; patients with non-vasculitic renal disease; or healthy controls. Six-days later, 39% of anti-PR3 treated mice had haematuria, compared with none of controls. There was punctate bleeding on the surface of lungs of anti-PR3 treated animals, with histological evidence of vasculitis and haemorrhage. Anti-PR3 treated mice had mild pauci-immune proliferative glomerulonephritis, with infiltration of human and mouse leukocytes. In 3 mice (17%) more severe glomerular injury was present. There were no glomerular changes in controls. Human IgG from patients with anti-PR3 autoantibodies is therefore pathogenic. This model of anti-PR3 antibody-mediated vasculitis may be useful in dissecting mechanisms of microvascular injury.	[Little, Mark A.] UCL, Royal Free Hosp, Ctr Nephrol, London, England; [Al-Ani, Bahjat; Al-Nuaimi, Hamad; Alpers, Charles E.] Univ Birmingham, Renal Inst Birmingham, Sch Infect Immunol & Inflammat, Birmingham, W Midlands, England; [Ren, Shuyu; Leite, Maurilo, Jr.; Duffield, Jeremy S.] Univ Washington, Dept Med, Div Nephrol, Ctr Lung Biol, Seattle, WA 98195 USA; [Ren, Shuyu; Leite, Maurilo, Jr.; Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Leite, Maurilo, Jr.] Univ Fed Rio de Janeiro, Div Nephrol, Rio De Janeiro, Brazil; [Alpers, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Savage, Caroline O.] GlaxoSmithKline UK Ltd, Uxbridge, Middx, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Birmingham; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidade Federal do Rio de Janeiro; University of Washington; University of Washington Seattle; GlaxoSmithKline	Little, MA (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, London, England.	mark.little@ucl.ac.uk; jeremysd@u.washington.edu	Little, Mark/O-2161-2019; Little, Mark/E-7072-2014	Little, Mark/0000-0001-6003-397X; Little, Mark/0000-0001-6003-397X	NIH [DK73299, DK84077, DK87389]; MRC (UK); Division of Nephrology and Center for Lung Biology, University of Washington; GRIP from Genzyme; Higher Education Funding Council of England; Medical Research Council [G0801025]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087389, K08DK073299, R01DK084077] Funding Source: NIH RePORTER; MRC [G0801025] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Nephrology and Center for Lung Biology, University of Washington; GRIP from Genzyme; Higher Education Funding Council of England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All studies were funded by NIH funds or MRC (UK). JSD's laboratory is supported by the Division of Nephrology and Center for Lung Biology, University of Washington, NIH grants DK73299, DK84077, DK87389 and a GRIP award from Genzyme. ML is supported by Higher Education Funding Council of England and BA is supported by Medical Research Council grant number G0801025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal PJ, 2004, ANN ALLERG ASTHMA IM, V93, P398, DOI 10.1016/S1081-1206(10)61400-7; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; GOLDSCHMEDING R, 1989, J CLIN INVEST, V84, P1577, DOI 10.1172/JCI114335; Heeringa P, 1996, AM J PATHOL, V149, P1695; Hussain A, 2009, IMMUNOLOGY, V128, P236, DOI 10.1111/j.1365-2567.2009.03108.x; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JENNETTE JC, 1990, BLOOD, V75, P2263; Kallenberg Cees G M, 2010, Curr Rheumatol Rep, V12, P399, DOI 10.1007/s11926-010-0138-6; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Little MA, 2009, AM J PATHOL, V174, P1212, DOI 10.2353/ajpath.2009.080458; NILES JL, 1989, BLOOD, V74, P1888; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Pfister H, 2004, BLOOD, V104, P1411, DOI 10.1182/blood-2004-01-0267; Primo VC, 2010, CLIN EXP IMMUNOL, V159, P327, DOI 10.1111/j.1365-2249.2009.04072.x; Radford DJ, 1999, CLIN EXP IMMUNOL, V118, P171; Rauova L, 2002, CLIN IMMUNOL, V103, P69, DOI 10.1006/clim.2002.5194; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Taneda S, 2003, KIDNEY INT, V63, P576, DOI 10.1046/j.1523-1755.2003.00778.x; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van der Geld YM, 2007, ANN RHEUM DIS, V66, P1679, DOI 10.1136/ard.2006.064626; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Weidner S, 2001, ARTHRITIS RHEUM, V44, P1698, DOI 10.1002/1529-0131(200107)44:7<1698::AID-ART294>3.0.CO;2-J; Williams JM, 2003, J AM SOC NEPHROL, V14, P661, DOI 10.1097/01.ASN.0000050223.34749.F4; Williams JM, 2007, J AM SOC NEPHROL, V18, P1112, DOI 10.1681/ASN.2006090973; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573	34	121	125	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28626	10.1371/journal.pone.0028626	http://dx.doi.org/10.1371/journal.pone.0028626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247758	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700006
J	Considine, MJ; Wan, YZ; D'Antuono, MF; Zhou, Q; Han, MY; Gao, H; Wang, M				Considine, Michael J.; Wan, Yizhen; D'Antuono, Mario F.; Zhou, Qian; Han, Mingyu; Gao, Hua; Wang, Man			Molecular Genetic Features of Polyploidization and Aneuploidization Reveal Unique Patterns for Genome Duplication in Diploid Malus	PLOS ONE			English	Article							APPLE; EVOLUTION; MEIOSIS; ORIGIN; AGE	Polyploidization results in genome duplication and is an important step in evolution and speciation. The Malus genome confirmed that this genus was derived through auto-polyploidization, yet the genetic and meiotic mechanisms for polyploidization, particularly for aneuploidization, are unclear in this genus or other woody perennials. In fact the contribution of aneuploidization remains poorly understood throughout Plantae. We add to this knowledge by characterization of eupolyploidization and aneuploidization in 27,542 F-1 seedlings from seven diploid Malus populations using cytology and microsatellite markers. We provide the first evidence that aneuploidy exceeds eupolyploidy in the diploid crosses, suggesting aneuploidization is a leading cause of genome duplication. Gametes from diploid Malus had a unique combinational pattern; ova preserved euploidy exclusively, while spermatozoa presented both euploidy and aneuploidy. All non-reduced gametes were genetically heterozygous, indicating first-division restitution was the exclusive mode for Malus eupolyploidization and aneuploidization. Chromosome segregation pattern among aneuploids was non-uniform, however, certain chromosomes were associated for aneuploidization. This study is the first to provide molecular evidence for the contribution of heterozygous non-reduced gametes to fitness in polyploids and aneuploids. Aneuploidization can increase, while eupolyploidization may decrease genetic diversity in their newly established populations. Auto-triploidization is important for speciation in the extant Malus. The features of Malus polyploidization confer genetic stability and diversity, and present heterozygosity, heterosis and adaptability for evolutionary selection. A protocol using co-dominant markers was proposed for accelerating apple triploid breeding program. A path was postulated for evolution of numerically odd basic chromosomes. The model for Malt's derivation was considerably revised. Impacts of aneuploidization on speciation and evolution, and potential applications of aneuploids and polyploids in breeding and genetics for other species were evaluated in depth. This study greatly improves our understanding of evolution, speciation, and adaptation of the Malus genus, and provides strategies to exploit polyploidization in other species.	[Wan, Yizhen; Zhou, Qian; Han, Mingyu; Gao, Hua; Wang, Man] NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Considine, Michael J.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Considine, Michael J.] Univ Western Australia, Inst Agr, Crawley, WA, Australia; [Considine, Michael J.; D'Antuono, Mario F.] Dept Agr & Food Western Australia, S Perth, WA, Australia	Northwest A&F University - China; University of Western Australia; University of Western Australia; Government of Western Australia; Department of Agriculture & Food - Western Australia	Wan, YZ (corresponding author), NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	wyz689@hotmail.com; hanmy62@gmail.com	Wan, Yizhen/H-8493-2013; Considine, Michael/A-9978-2011	Considine, Michael/0000-0002-4468-6820	National Yang ling Bio-Tech Breeding Centre [2001-01]; Young Scientist Foundation of NWAFU [QN2009-013]; Department of Agriculture and Food Western Australia	National Yang ling Bio-Tech Breeding Centre; Young Scientist Foundation of NWAFU; Department of Agriculture and Food Western Australia	This research was supported by the National Yang ling Bio-Tech Breeding Centre Project (2001-01); the Young Scientist Foundation of NWAFU (QN2009-013); and Department of Agriculture and Food Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, FRUIT BREEDING; Belfanti E, 2004, P NATL ACAD SCI USA, V101, P886, DOI 10.1073/pnas.0304808101; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; BOUGHEY AS, 1959, NATURE, V184, P1200; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; Cifuentes M, 2010, NEW PHYTOL, V186, P29, DOI 10.1111/j.1469-8137.2009.03084.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DERMEN H, 1965, AM J BOT, V52, P353, DOI 10.2307/2440329; Dzialuk A, 2007, ANN BOT-LONDON, V99, P959, DOI 10.1093/aob/mcm043; Eckardt NA, 2010, PLANT CELL, V22, P3, DOI 10.1105/tpc.110.220112; Einset John, 1944, SCIENCE, V99, P345, DOI 10.1126/science.99.2574.345; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gaudilliere JP, 2004, CLASSICAL GENETIC RE; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Han Y, 2007, GENOMICS, V89, P630, DOI 10.1016/j.ygeno.2006.12.010; Harding J, 1991, GENETICS BREEDING OR; Hughes CE, 2007, P NATL ACAD SCI USA, V104, P14389, DOI 10.1073/pnas.0702193104; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liu SL, 2010, MOL BIOL EVOL, V27, P2817, DOI 10.1093/molbev/msq169; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; PRATT C, 1978, J AM SOC HORTIC SCI, V103, P690; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Sankoff D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000483; Scheid OM, 1996, P NATL ACAD SCI USA, V93, P7114, DOI 10.1073/pnas.93.14.7114; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; VAN HARTEN A. M., 2002, BREEDING ORNAMENTALS, P155; Van Ooijen JW, 1996, JOINMAP 4 SOFTWARE C; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yoshizumi T, 2006, PLANT CELL, V18, P2452, DOI 10.1105/tpc.106.043869; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Yuan YW, 2006, MOL BIOL EVOL, V23, P2263, DOI 10.1093/molbev/msl099	54	27	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					57	65	e29449	10.1371/journal.pone.0029449	http://dx.doi.org/10.1371/journal.pone.0029449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253724	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900006
J	Kanan, C; Cottrell, GW				Kanan, Christopher; Cottrell, Garrison W.			Color-to-Grayscale: Does the Method Matter in Image Recognition?	PLOS ONE			English	Article								In image recognition it is often assumed the method used to convert color images to grayscale has little impact on recognition performance. We compare thirteen different grayscale algorithms with four types of image descriptors and demonstrate that this assumption is wrong: not all color-to-grayscale algorithms work equally well, even when using descriptors that are robust to changes in illumination. These methods are tested using a modern descriptor-based image recognition framework, on face, object, and texture datasets, with relatively few training instances. We identify a simple method that generally works best for face and object recognition, and two that work well for recognizing textures.	[Kanan, Christopher; Cottrell, Garrison W.] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kanan, C (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	ckanan@ucsd.edu		Cottrell, Garrison/0000-0001-7538-1715; Kanan, Christopher/0000-0002-6412-995X	James S. McDonnell Foundation (Perceptual Expertise Network); National Science Foundation (NSF) [SBE-0542013]	James S. McDonnell Foundation (Perceptual Expertise Network); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the James S. McDonnell Foundation (Perceptual Expertise Network, I. Gauthier, PI), and the National Science Foundation (NSF) (grant #SBE-0542013 to the Temporal Dynamics of Learning Center, G.W. Cottrell, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya T, 2005, IMAGE PROCESSING: PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471745790; Andreopoulos A, 2012, IEEE T PATTERN ANAL, V34, P110, DOI 10.1109/TPAMI.2011.91; Barnard K, 2000, COLOR RES APPL, V27, P148; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berg AC, 2005, PROC CVPR IEEE, P26; Boiman O, 2008, PROC CVPR IEEE, P1992, DOI 10.1109/CVPR.2008.4587598; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Cadik M, 2008, COMPUT GRAPH FORUM, V27, P1745; Coates A., 2011, P 28 INT C MACH LEAR, V28, P921; Dana KJ, 1999, ACM T GRAPHIC, V18, P1, DOI 10.1145/300776.300778; Evans C, 2009, CSTR09001 U BRIST; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; Grundland M, 2007, PATTERN RECOGN, V40, P2891, DOI 10.1016/j.patcog.2006.11.003; HOEFFDING W, 1963, J AM STAT ASSOC, V58, P13, DOI 10.2307/2282952; Jack K., 2007, VIDEO DEMYSTIFIED; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Martinez A. M., 1998, 24 COMP VIS CTR; Ohba K, 2000, MACH VISION APPL, V12, P189, DOI 10.1007/s001380050138; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Pratt WK, 2007, DIGITAL IMAGE PROCES, Vxix; Raina R, 2007, 24 ANN INT C MACH LE, V227, P759, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Simard PY, 2003, PROC INT CONF DOC, P958; Vedaldi A, 2008, VLTEAT OPEN PORTABLE; Yang Jun, 2009, Proceedings of the 2009 2nd International Congress on Image and Signal Processing (CISP), DOI 10.1109/CISP.2009.5304123; Yoo S, 2007, P IAPR C MACH VIS AP, DOI 10.1.1.140.7931	27	149	151	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					133	139	e29740	10.1371/journal.pone.0029740	http://dx.doi.org/10.1371/journal.pone.0029740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253768	gold, Green Published			2022-12-25	WOS:000301353900015
J	Keyaerts, M; Remory, I; Caveliers, V; Breckpot, K; Boss, TJ; Poelaert, J; Bossuyt, A; Lahoutte, T				Keyaerts, Marleen; Remory, Isabel; Caveliers, Vicky; Breckpot, Karine; Boss, Tomas J.; Poelaert, Jan; Bossuyt, Axel; Lahoutte, Tony			Inhibition of Firefly Luciferase by General Anesthetics: Effect on In Vitro and In Vivo Bioluminescence Imaging	PLOS ONE			English	Article							CARDIAC-FUNCTION; MICE; SEVOFLURANE; ISOFLURANE; HALOTHANE; PROTECTS; INJURY; TIME	Bioluminescence imaging is routinely performed in anesthetized mice. Often isoflurane anesthesia is used because of its ease of use and fast induction/recovery. However, general anesthetics have been described as important inhibitors of the luciferase enzyme reaction. Aim:To investigate frequently used mouse anesthetics for their direct effect on the luciferase reaction, both in vitro and in vivo. Materials and Methods: isoflurane, sevoflurane, desflurane, ketamine, xylazine, medetomidine, pentobarbital and avertin were tested in vitro on luciferase-expressing intact cells, and for non-volatile anesthetics on intact cells and cell lysates. In vivo, isoflurane was compared to unanesthetized animals and different anesthetics. Differences in maximal photon emission and time-to-peak photon emission were analyzed. Results: All volatile anesthetics showed a clear inhibitory effect on the luciferase activity of 50% at physiological concentrations. Avertin had a stronger inhibitory effect of 80%. For ketamine and xylazine, increased photon emission was observed in intact cells, but this was not present in cell lysate assays, and was most likely due to cell toxicity and increased cell membrane permeability. In vivo, the highest signal intensities were measured in unanesthetized mice and pentobarbital anesthetized mice, followed by avertin. Isoflurane and ketamine/medetomidine anesthetized mice showed the lowest photon emission (40% of unanesthetized), with significantly longer time-to-peak than unanesthetized, pentobarbital or avertin-anesthetized mice. We conclude that, although strong inhibitory effects of anesthetics are present in vitro, their effect on in vivo BLI quantification is mainly due to their hemodynamic effects on mice and only to a lesser extent due to the direct inhibitory effect.	[Keyaerts, Marleen; Remory, Isabel; Caveliers, Vicky; Poelaert, Jan; Bossuyt, Axel; Lahoutte, Tony] Vrije Univ Brussel, Vivo Cellular & Mol Imaging ICMI Lab, Brussels, Belgium; [Keyaerts, Marleen; Caveliers, Vicky; Bossuyt, Axel; Lahoutte, Tony] Vrije Univ Brussel, UZ Brussel, Dept Nucl Med BEFY, Brussels, Belgium; [Remory, Isabel; Poelaert, Jan] Vrije Univ Brussel, UZ Brussel, Dept Anesthesiol, Brussels, Belgium; [Breckpot, Karine] Vrije Univ Brussel, Dept Immunol & Physiol, Lab Mol & Cellular Therapy, Brussels, Belgium; [Boss, Tomas J.] Vrije Univ Brussel, Dept Hematol & Immunol, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Keyaerts, M (corresponding author), Vrije Univ Brussel, Vivo Cellular & Mol Imaging ICMI Lab, Brussels, Belgium.	mkeyaerts@gmail.com	Lahoutte, Tony/O-6381-2016; Poelaert, Jan IT/P-9070-2015; Breckpot, Karine RP/A-4298-2008; Keyaerts, Marleen/J-2851-2013	Breckpot, Karine RP/0000-0003-4331-3480; Keyaerts, Marleen/0000-0002-9997-4571; Poelaert, Jan/0000-0002-0065-2899; Lahoutte, Tony/0000-0002-1773-8664; Remory, Isabel/0000-0003-4785-0371; Caveliers, Vicky/0000-0002-4301-5902	Belgian State - Belgian Science Policy	Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office)	The research at ICMI is funded by the Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy. Marleen Keyaerts is an aspirant, Karine Breckpot is a postdoctoral fellow and Tony Lahoutte is a senior clinical investigator of the Research Foundation - Flanders (Belgium) (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton GO, 2004, J INTERV CARD ELECTR, V11, P5, DOI 10.1023/B:JICE.0000035922.14870.56; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Cali JJ, 2008, EXPERT OPIN DRUG MET, V4, P103, DOI [10.1517/17425255.4.1.103, 10.1517/17425255.4.1.103 ]; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; DICKINSON R, 1993, BIOPHYS J, V64, P1264, DOI 10.1016/S0006-3495(93)81491-7; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Hart CYT, 2001, AM J PHYSIOL-HEART C, V281, pH1938, DOI 10.1152/ajpheart.2001.281.5.H1938; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Jeon YH, 2010, MOL IMAGING, V9, P343, DOI 10.2310/7290.2010.00021; Kawahara Y, 2005, J PHARMACOL SCI, V99, P95, DOI 10.1254/jphs.FP0050343; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Keyaerts M, 2011, MOL IMAGING BIOL, V13, P59, DOI 10.1007/s11307-010-0325-x; Kober F, 2004, MAGN RESON MATER PHY, V17, P157, DOI 10.1007/s10334-004-0086-0; Lee HT, 2008, AM J PHYSIOL-RENAL, V295, pF128, DOI 10.1152/ajprenal.00577.2007; Lee HT, 2007, SHOCK, V27, P373, DOI 10.1097/01.shk.0000248595.17130.24; Leitao JMM, 2010, J PHOTOCH PHOTOBIO B, V101, P1, DOI 10.1016/j.jphotobiol.2010.06.015; Liao M, 2006, ANESTH ANALG, V102, P1452, DOI 10.1213/01.ane.0000204254.87933.f6; LOVELL DP, 1986, LAB ANIM, V20, P85, DOI 10.1258/002367786780865142; Matsuda Y, 2007, BIOL PHARM BULL, V30, P1716, DOI 10.1248/bpb.30.1716; MERKEL G, 1963, ANESTHESIOLOGY, V24, P346, DOI 10.1097/00000542-196305000-00016; Page S.W., 2008, SMALL ANIMAL CLIN PH, P198; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Schaefer A, 2005, ECHOCARDIOGR-J CARD, V22, P665, DOI 10.1111/j.1540-8175.2005.40096.x; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; Tehouate Gainkam LO, 1304, MOL IMAGING BIOL, DOI [10.1007/s11307-11010-10428-11304, DOI 10.1007/S11307-11010-10428-11304]; Udagawa T, 2007, CANCER RES, V67, P2040, DOI 10.1158/0008-5472.CAN-06-2877; UEDA I, 1965, ANESTHESIOLOGY, V26, P603, DOI 10.1097/00000542-196509000-00003; UEDA I, 1976, P NATL ACAD SCI USA, V73, P481, DOI 10.1073/pnas.73.2.481; Ueda I, 1998, BIOPHYS J, V75, P1052, DOI 10.1016/S0006-3495(98)77594-0; Vaneycken I, 2010, J NUCL MED, V51, P1099, DOI 10.2967/jnumed.109.069823; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	38	40	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					374	383	e30061	10.1371/journal.pone.0030061	http://dx.doi.org/10.1371/journal.pone.0030061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253879	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900038
J	Whitney, HM; Rands, SA; Elton, NJ; Ellis, AG				Whitney, Heather M.; Rands, Sean A.; Elton, Nick J.; Ellis, Allan G.			A Technique for Measuring Petal Gloss, with Examples from the Namaqualand Flora	PLOS ONE			English	Article							TEMPERATURE	The degree of floral gloss varies between species. However, little is known about this distinctive floral trait, even though it could be a key feature of floral biotic and abiotic interactions. One reason for the absence of knowledge is the lack of a repeatable le method of gloss measurement that can be used in the field to study floral gloss. A protocol is described or measuring gloss in petal samples collected in the field, using a glossmeter. Repeatability of the technique is assessed. We demonstrate a simple yet highly accurate and repeatable method that can easily be implemented in the field. We also highlight the huge variety of glossiness found within flowers and between species in a sample of spring-blooming flowers collected in Namaqualand, South Africa. We discuss the potential uses of this method and its applications for furthering studies in plant-pollinator interactions. We also discuss the potential functions of gloss in flowers.	[Whitney, Heather M.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Rands, Sean A.] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England; [Elton, Nick J.] Univ Bristol, Interface Anal Ctr, Bristol, Avon, England; [Ellis, Allan G.] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa	University of Bristol; University of Bristol; University of Bristol; Stellenbosch University	Whitney, HM (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	heather.whitney@bristol.ac.uk	Ellis, Allan G/H-1105-2011; Rands, Sean A/B-2243-2008	Ellis, Allan G/0000-0001-6310-2870; Rands, Sean A/0000-0002-7400-005X; Whitney, Heather/0000-0001-6450-8266	Royal Society (United Kingdom); National Research Foundation (South Africa); Royal Society; Lloyds of London	Royal Society (United Kingdom)(Royal Society of London); National Research Foundation (South Africa)(National Research Foundation - South AfricaSouth African Medical Research Council); Royal Society(Royal Society of London); Lloyds of London	HMW and AGE were funded by a networking grant from the Royal Society (United Kingdom) and the National Research Foundation (South Africa). Equipment was funded by a Royal Society Research grant. HMW was funded by a Lloyds of London Tercentenary fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; Eigenbrode SD, 2002, INTEGR COMP BIOL, V42, P1091, DOI 10.1093/icb/42.6.1091; Galsterer S, 1999, PLANT BIOLOGY, V1, P670, DOI 10.1055/s-2007-978571; Galvan I, 2009, J AVIAN BIOL, V40, P475, DOI 10.1111/j.1600-048X.2009.04820.x; Hell D, 1983, BLUTE; Hunter R.S., 1987, MEASUREMENT APPEARAN, V2nd; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Maia R, 2011, P ROY SOC B-BIOL SCI, V278, P1973, DOI 10.1098/rspb.2010.1637; Nada K, 1994, NATURE, V369, P661, DOI [10.1038/369661a0, DOI 10.1038/369661A0]; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Parkin J, 1928, ANN BOT-LONDON, V42, P739, DOI 10.1093/oxfordjournals.aob.a090138; Pfundel EE., 2008, BIOL PLANT CUTICLE, V3, P216, DOI [10.1002/9780470988718.ch6, DOI 10.1002/9780470988718.CH6]; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Rands SA, 2011, ARTHROPOD-PLANT INTE, V5, P279, DOI 10.1007/s11829-011-9146-3; Toomey MB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1047, DOI 10.1007/s00265-010-0926-z; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9; Whitney HM, 2011, ANN BOT-LONDON, V108, P609, DOI 10.1093/aob/mcr065; Whitney HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017576; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256	24	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					66	70	e29476	10.1371/journal.pone.0029476	http://dx.doi.org/10.1371/journal.pone.0029476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253729	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900007
J	Mendez-Gomez, HR; Vicario-Abejon, C				Mendez-Gomez, Hector R.; Vicario-Abejon, Carlos			The Homeobox Gene Gsx2 Regulates the Self-Renewal and Differentiation of Neural Stem Cells and the Cell Fate of Postnatal Progenitors	PLOS ONE			English	Article							LATERAL GANGLIONIC EMINENCE; ADULT OLFACTORY-BULB; PALLIAL-SUBPALLIAL BOUNDARY; SUBVENTRICULAR ZONE; TELENCEPHALIC PROGENITORS; MUTANT MICE; RADIAL GLIA; PAX6; GSH2; INTERNEURONS	The Genetic screened homeobox 2 (Gsx2) transcription factor is required for the development of olfactory bulb (OB) and striatal neurons, and for the regional specification of the embryonic telencephalon. Although Gsx2 is expressed abundantly by progenitor cells in the ventral telencephalon, its precise function in the generation of neurons from neural stem cells (NSCs) is not clear. Similarly, the role of Gsx2 in regulating the self-renewal and multipotentiality of NSCs has been little explored. Using retroviral vectors to express Gsx2, we have studied the effect of Gsx2 on the growth of NSCs isolated from the OB and ganglionic eminences (GE), as well as its influence on the proliferation and cell fate of progenitors in the postnatal mouse OB. Expression of Gsx2 reduces proliferation and the self-renewal capacity of NSCs, without significantly affecting cell death. Furthermore, Gsx2 overexpression decreases the differentiation of NSCs into neurons and glia, and it maintains the cells that do not differentiate as cycling progenitors. These effects were stronger in GESCs than in OBSCs, indicating that the actions of Gsx2 are cell-dependent. In vivo, Gsx2 produces a decrease in the number of Pax6(+) cells and doublecortin(+) neuroblasts, and an increase in Olig2(+) cells. In summary, our findings show that Gsx2 inhibits the ability of NSCs to proliferate and self-renew, as well as the capacity of NSC-derived progenitors to differentiate, suggesting that this transcription factor regulates the quiescent and undifferentiated state of NSCs and progenitors. Furthermore, our data indicate that Gsx2 negatively regulates neurogenesis from postnatal progenitor cells.	[Mendez-Gomez, Hector R.; Vicario-Abejon, Carlos] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Mendez-Gomez, Hector R.; Vicario-Abejon, Carlos] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Vicario-Abejon, C (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	cvicario@cajal.csic.es	Vicario-Abejón, Carlos/G-2814-2016	Vicario-Abejón, Carlos/0000-0002-7060-0250	Spanish Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion (MEC/MICINN) [SAF2004-05798, BFU2007-61230/BFI]; Comunidad de Madrid (CM) [GR/SAL/0835/2004]; Instituto de Salud Carlos III (ISCIII; CIBERNED) [CB06/05/0065]	Spanish Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion (MEC/MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (CM)(Comunidad de Madrid); Instituto de Salud Carlos III (ISCIII; CIBERNED)	This work was funded by grants from the Spanish Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion (MEC/MICINN, www.micinn.es; Grant numbers: SAF2004-05798 and BFU2007-61230/BFI), the Comunidad de Madrid (CM, www.madrimasd.org; Grant number: GR/SAL/0835/2004) and the Instituto de Salud Carlos III (ISCIII; CIBERNED, www.ciberned.es; Grant number: CB06/05/0065) to C. V.-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bovetti S, 2007, J MOL HISTOL, V38, P563, DOI 10.1007/s10735-007-9111-8; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123; Cave JW, 2009, ADV EXP MED BIOL, V651, P15; Cocas LA, 2011, J NEUROSCI, V31, P5313, DOI 10.1523/JNEUROSCI.3867-10.2011; Cools J, 2002, BLOOD, V99, P1776, DOI 10.1182/blood.V99.5.1776; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; Jensen JB, 2004, J NEUROSCI, V24, P6958, DOI 10.1523/JNEUROSCI.1331-04.2004; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Luskin MB, 1998, J NEUROBIOL, V36, P221; Mendez-Gomez HR, 2011, MOL CELL NEUROSCI, V46, P108, DOI 10.1016/j.mcn.2010.08.011; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Pei Z, 2011, P NATL ACAD SCI US; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Stenman J, 2003, J NEUROSCI, V23, P167; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Teissier A, 2011, CEREB CORTE IN PRESS; Toresson H, 2001, DEVELOPMENT, V128, P4769; Toresson H, 2000, DEVELOPMENT, V127, P4361; Urban N, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-21; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; Vergano-Vera E, 2006, DEVELOPMENT, V133, P4367, DOI 10.1242/dev.02601; Von Ohlen T, 2007, MECH DEVELOP, V124, P925, DOI 10.1016/j.mod.2007.08.001; Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015; Wang B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-5; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Yun K, 2001, DEVELOPMENT, V128, P193; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29799	10.1371/journal.pone.0029799	http://dx.doi.org/10.1371/journal.pone.0029799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242181	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100037
J	Stallaert, W; Dorn, JF; van der Westhuizen, E; Audet, M; Bouvier, M				Stallaert, Wayne; Dorn, Jonas F.; van der Westhuizen, Emma; Audet, Martin; Bouvier, Michel			Impedance Responses Reveal beta(2)-Adrenergic Receptor Signaling Pluridimensionality and Allow Classification of Ligands with Distinct Signaling Profiles	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; FUNCTIONAL SELECTIVITY; LABEL-FREE; DRUG DISCOVERY; BETA-ARRESTINS; LIVING CELLS; ACTIVATION; EFFICACY; PHARMACOLOGY; TECHNOLOGY	The discovery that drugs targeting a single G protein-coupled receptor (GPCR) can differentially modulate distinct subsets of the receptor signaling repertoire has created a challenge for drug discovery at these important therapeutic targets. Here, we demonstrate that a single label-free assay based on cellular impedance provides a real-time integration of multiple signaling events engaged upon GPCR activation. Stimulation of the beta(2)-adrenergic receptor (beta(2)AR) in living cells with the prototypical agonist isoproterenol generated a complex, multi-featured impedance response over time. Selective pharmacological inhibition of specific arms of the beta(2)AR signaling network revealed the differential contribution of G(s)-, G(i)- and G beta gamma-dependent signaling events, including activation of the canonical cAMP and ERK1/2 pathways, to specific components of the impedance response. Further dissection revealed the essential role of intracellular Ca2+ in the impedance response and led to the discovery of a novel beta(2)AR-promoted Ca2+ mobilization event. Recognizing that impedance responses provide an integrative assessment of ligand activity, we screened a collection of beta-adrenergic ligands to determine if differences in the signaling repertoire engaged by compounds would lead to distinct impedance signatures. An unsupervised clustering analysis of the impedance responses revealed the existence of 5 distinct compound classes, revealing a richer signaling texture than previously recognized for this receptor. Taken together, these data indicate that the pluridimensionality of GPCR signaling can be captured using integrative approaches to provide a comprehensive readout of drug activity.	[Stallaert, Wayne; van der Westhuizen, Emma; Audet, Martin; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Stallaert, Wayne; Dorn, Jonas F.; van der Westhuizen, Emma; Audet, Martin; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Bouvier, M (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014; van der Westhuizen, Emma T/G-4224-2011	Bouvier, Michel/0000-0003-1128-0100; van der Westhuizen, Emma T/0000-0001-9165-8526; Dorn, Jonas/0000-0001-6696-0117; Stallaert, Wayne/0000-0001-8064-6503	Roche Applied Science; Canadian Institutes of Health Research (CIHR) [FRN-10501]; Natural Science and Engineering Research Council of Canada [355641]; Fonds de Recherche Quebec - Sante; Heart and Stroke Foundation of Canada	Roche Applied Science; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Quebec - Sante; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by grants to MB from Roche Applied Science and the Canadian Institutes of Health Research (CIHR; #FRN-10501). WS holds a Vanier Canada Graduate Scholarship from the CIHR. JD is a postdoctoral fellow of the Swiss National Science Foundation and his work was funded by a grant from the Natural Science and Engineering Research Council of Canada (#355641) to Dr. Paul Maddox. EvdW holds a post-doctoral fellowship from the Fonds de Recherche Quebec - Sante. MA holds a scholarship from the Heart and Stroke Foundation of Canada. MB holds the Canada Research Chair in Cell Signalling and Molecular Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Exceptionally, the manuscript was shown to Roche Applied Science prior to submission, but this funder did not participate in the preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Atienza JM, 2006, J BIOMOL SCREEN, V11, P634, DOI 10.1177/1087057106289334; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Bezdek JC, 2002, IEEE IJCNN, P2225, DOI 10.1109/IJCNN.2002.1007487; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Fang Y, 2008, FEBS LETT, V582, P558, DOI 10.1016/j.febslet.2008.01.021; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; HERSHBERGER RE, 1990, J CARDIOVASC PHARM, V15, P959, DOI 10.1097/00005344-199006000-00014; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kenakin T, 2010, J PHARM EXPT THERAPE; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Markova SV, 2002, BIOCHEMISTRY-US, V41, P2227, DOI 10.1021/bi0117910; MARSTON S, 1995, INT J BIOCHEM CELL B, V27, P97, DOI 10.1016/1357-2725(94)00080-U; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; McGuinness RP, 2009, COMB CHEM HIGH T SCR, V12, P812, DOI 10.2174/138620709789104861; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Scandroglio P., 2010, J BIOMOL SCREEN; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	44	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29420	10.1371/journal.pone.0029420	http://dx.doi.org/10.1371/journal.pone.0029420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242170	Green Submitted, gold, Green Published			2022-12-25	WOS:000312662100024
J	Theis, A; Salzburger, W; Egger, B				Theis, Anya; Salzburger, Walter; Egger, Bernd			The Function of Anal Fin Egg-Spots in the Cichlid Fish Astatotilapia burtoni	PLOS ONE			English	Article							MALE-MALE COMPETITION; SEXUAL SELECTION; LAKE VICTORIA; MICROSATELLITE LOCI; SYMPATRIC SPECIATION; AGONISTIC BEHAVIOR; FEMALE CHOICE; MATE CHOICE; AFRICAN; EVOLUTION	Color and pigmentation patterns of animals are often targets of sexual selection because of their role in communication. Although conspicuous male traits are typically implicated with intersexual selection, there are examples where sex-specific displays play a role in an intrasexual context, e. g. when they serve as signals for aggression level and/or status. Here, we focus on the function of a conspicuous male ornament in the most species-rich tribe of cichlid fishes, the haplochromines. A characteristic feature of these ca. 1500 species are so-called egg-spots in form of ovoid markings on the anal fins of males, which are made up of carotenoid based pigment cells. It has long been assumed that these yellow, orange or reddish egg-spots play an important role in the courtship and spawning behavior of these maternal mouth-brooding fishes by mimicking the eggs of a conspecific female. The exact function of egg-spots remains unknown, however, and there are several hypotheses about their mode of action. To uncover the function of this cichlid-specific male ornament, we used female mate choice experiments and a male aggression test in the haplochromine species Astatotilapia burtoni. We manipulated the number and arrangement of egg-spots on the anal fins of males, or removed them entirely, and tested (1) female preference with visual contact only using egg-traps, (2) female preference with free contact using paternity testing with microsatellites and (3) male aggression. We found that females did not prefer males with many egg-spots over males with fewer egg-spots and that females tended to prefer males without egg-spots over males with egg-spots. Importantly, males without egg-spots sired clutches with the same fertilization rate as males with egg-spots. In male aggression trials, however, males with fewer egg-spots received significantly more attacks, suggesting that egg-spots are an important signal in intrasexual communication.	[Theis, Anya; Salzburger, Walter; Egger, Bernd] Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland	University of Basel	Salzburger, W (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	walter.salzburger@unibas.ch; bernd.egger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674	European Research Council (ERC); Austrian Science Foundation (FWF)	European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This work was supported by the the European Research Council (ERC; Starting Grant 'INTERGENADAPT') and the Austrian Science Foundation (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Axelrod H. R., 1979, AFRICAN CICHLIDS LAK; Baerends G.P., 1950, INTRO STUDY ETHOLOGY; Balon EK., 1977, ENVIRON BIOL FISH, V2, P147, DOI [DOI 10.1007/BF00005370, 10.1007/BF00005370]; Bates D., 2011, IME4 LINEAR MIXED EF; Baube CL, 1997, ANIM BEHAV, V53, P819, DOI 10.1006/anbe.1996.0347; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Carleton KL, 2002, ANIM GENET, V33, P140, DOI 10.1046/j.1365-2052.2002.00817.x; Clement TS, 2005, BEHAV ECOL, V16, P83, DOI 10.1093/beheco/arh134; Couldridge VCK, 2002, J FISH BIOL, V60, P726, DOI 10.1006/jfbi.2002.1896; Coyne JA, 2004, SPECIATION, V37; Darwin G., 1871, P423; Deutsch JC, 1997, BIOL J LINN SOC, V62, P1; Dijkstra PD, 2007, J EVOLUTION BIOL, V20, P496, DOI 10.1111/j.1420-9101.2006.01266.x; Dijkstra PD, 2005, BEHAV ECOL SOCIOBIOL, V58, P136, DOI 10.1007/s00265-005-0919-5; DOMINEY WJ, 1984, EVOLUTION FISH SPECI, P231; FERNALD RD, 1979, Z TIERPSYCHOL, V50, P180; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Fryer G., 1972, CICHLID FISHES GREAT, P641; Genner MJ, 2008, J EVOLUTION BIOL, V21, P1387, DOI 10.1111/j.1420-9101.2008.01558.x; GOLDSCHMIDT T, 1991, ETHOLOGY, V88, P177, DOI 10.1111/j.1439-0310.1991.tb00273.x; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; HERT E, 1986, ETHOLOGY, V72, P165; Hert EM, 1987, FUNKTION ANALFLOSSEN; Heule C, 2011, J FISH BIOL, V78, P1588, DOI 10.1111/j.1095-8649.2011.02944.x; Jackson PBN, 1975, MBUNA ROCK DWELLING; KELLOGG KA, 1995, P ROY SOC B-BIOL SCI, V260, P79, DOI 10.1098/rspb.1995.0062; Kidd MR, 2006, MOL ECOL, V15, P459, DOI 10.1111/j.1365-294X.2005.02787.x; Kirchshofer R., 1954, Zeitschrift fuer Tierpsychologie, V10, P297; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Korzan WJ, 2007, BEHAV ECOL, V18, P318, DOI 10.1093/beheco/arl093; Lee WJ, 1996, J FISH BIOL, V49, P169, DOI 10.1111/j.1095-8649.1996.tb00014.x; Lehtonen TK, 2011, P ROY SOC B-BIOL SCI, V278, P2318, DOI 10.1098/rspb.2010.2483; LEONG CY, 1969, Z VERGL PHYSIOL, V65, P29, DOI 10.1007/BF00297988; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Maeda K, 2008, MOL ECOL RESOUR, V8, P428, DOI 10.1111/j.1471-8286.2007.01981.x; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pryke SR, 2001, EVOLUTION, V55, P1452; R Core Team, 2016, R FDN STAT COMP; RADESATER T, 1979, BEHAV PROCESS, V4, P5, DOI 10.1016/0376-6357(79)90044-5; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-51; Salzburger W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-96; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Sanetra M, 2009, GENETICS, V182, P387, DOI 10.1534/genetics.108.089367; Seehausen O, 1999, ECOL LETT, V2, P262; Seehausen O, 2004, P ROY SOC B-BIOL SCI, V271, P1345, DOI 10.1098/rspb.2004.2737; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Taylor MI, 2002, MOL ECOL NOTES, V2, P443, DOI 10.1046/j.1471-8286.2002.00272.x; Theis A, 2010, THESIS; Tobler Michael, 2006, Zeitschrift fuer Fischkunde, V8, P39; Turner GF, 2007, CURR BIOL, V17, pR827, DOI 10.1016/j.cub.2007.07.026; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; VanOppen MJH, 1997, MOL ECOL, V6, P387, DOI 10.1046/j.1365-294X.1997.00188.x; Werner NY, 2003, ANIM BEHAV, V66, P293, DOI 10.1006/anbe.2003.2208; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Wickler W., 1962, Zeitschrift fuer Tierpsychologie, V19, P129; WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0; Wu L, 1999, MOL ECOL, V8, P895	68	44	44	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29878	10.1371/journal.pone.0029878	http://dx.doi.org/10.1371/journal.pone.0029878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242184	Green Submitted, Green Published, gold			2022-12-25	WOS:000312662100041
J	Gonzalez-Alvaro, I; Ortiz, AM; Alvaro-Gracia, JM; Castaneda, S; Diaz-Sanchez, B; Carvajal, I; Garcia-Vadillo, JA; Humbria, A; Lopez-Bote, JP; Patino, E; Tomero, EG; Vicente, EF; Sabando, P; Garcia-Vicuna, R				Gonzalez-Alvaro, Isidoro; Ortiz, Ana M.; Maria Alvaro-Gracia, Jose; Castaneda, Santos; Diaz-Sanchez, Belen; Carvajal, Inmaculada; Alberto Garcia-Vadillo, J.; Humbria, Alicia; Pedro Lopez-Bote, J.; Patino, Esther; Tomero, Eva G.; Vicente, Esther F.; Sabando, Pedro; Garcia-Vicuna, Rosario			Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; NATURAL-KILLER; CROSS-TALK; IL-15; CELLS; INFLAMMATION; ASSOCIATION; LYMPHOCYTES; EXPRESSION; INITIATION	Background: Interleukin-15 (IL-15) is thought to be involved in the physiopathological mechanisms of RA and it can be detected in the serum and the synovial fluid of inflamed joints in patients with RA but not in patients with osteoarthritis or other inflammatory joint diseases. Therefore, the objective of this work is to analyse whether serum IL-15 (sIL-15) levels serve as a biomarker of disease severity in patients with early arthritis (EA). Methodology and Results: Data from 190 patients in an EA register were analysed (77.2% female; median age 53 years; 6-monthmedian disease duration at entry). Clinical and treatment information was recorded systematically, especially the prescription of disease modifying anti-rheumatic drugs. Two multivariate longitudinal analyses were performed with different dependent variables: 1) DAS28 and 2) a variable reflecting intensive treatment. Both included sIL-15 as predictive variable and other variables associated with disease severity, including rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). Of the 171 patients (638 visits analysed) completing the follow-up, 71% suffered rheumatoid arthritis and 29% were considered as undifferentiated arthritis. Elevated sIL-15 was detected in 29% of this population and this biomarker did not overlap extensively with RF or ACPA. High sIL-15 levels (beta Coefficient [95% confidence interval]: 0.12 [0.06-0.18]; p<0.001) or ACPA (0.34 [0.01-0.67]; p=0.044) were significantly and independently associated with a higher DAS28 during follow-up, after adjusting for confounding variables such as gender, age and treatment. In addition, those patients with elevated sIL-15 had a significantly higher risk of receiving intensive treatment (RR 1.78, 95% confidence interval 1.18-2.7; p=0.007). Conclusions: Patients with EA displaying high baseline sIL-15 suffered a more severe disease and received more intensive treatment. Thus, sIL-15 may be a biomarker for patients that are candidates for early and more intensive treatment.	[Carvajal, Inmaculada] Sanat Nuestra Senora Rosario, Madrid, Spain; [Gonzalez-Alvaro, Isidoro; Ortiz, Ana M.; Maria Alvaro-Gracia, Jose; Castaneda, Santos; Diaz-Sanchez, Belen; Alberto Garcia-Vadillo, J.; Humbria, Alicia; Pedro Lopez-Bote, J.; Patino, Esther; Tomero, Eva G.; Vicente, Esther F.; Sabando, Pedro; Garcia-Vicuna, Rosario] Hosp Univ La Princesa, Rheumatol Serv, IIS Princesa, Madrid, Spain		Gonzalez-Alvaro, I (corresponding author), Hosp Univ La Princesa, Rheumatol Serv, IIS Princesa, Madrid, Spain.	isidoro.ga@ser.es	de VicuÃa, Rosario Garcia/ABD-7892-2020	de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Garcia Vadillo, Alberto/0000-0003-3262-8364	RETICS; RIER [Red de Inflamacion y Enfermedades Reumaticas; Inflammation and Rheumatic Diseases Network]) from the Instituto de Salud Carlos III, Spain [RD08/0075]; Instituto de Salud Carlos III, Spain; Instituto de Salud Carlos III [08/0754]	RETICS; RIER [Red de Inflamacion y Enfermedades Reumaticas; Inflammation and Rheumatic Diseases Network]) from the Instituto de Salud Carlos III, Spain; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The work of Belen Diaz-Sanchez was supported by the RETICS Programme (Programa de Redes Tematicas de Investigacion Colaborativa [Colaborative Research Thematic Network Programme]; RD08/0075 - RIER [Red de Inflamacion y Enfermedades Reumaticas; Inflammation and Rheumatic Diseases Network]) from the Instituto de Salud Carlos III, Spain (URL: www.isciii.es) within the VI National Plan for I+D+I 2008-2011 (FEDER). The work of Isidoro Gonzalez-Alvaro was in part supported by a grant for the Intensification of the Research Tasks in the National Health Care System from Instituto de Salud Carlos III, Spain. The consumables for measurements and data analysis were supported by a Fondo de Investigacion Sanitaria grant (08/0754) from the Instituto de Salud Carlos III. No additional external funding was received for this study. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Allaart CF, 2007, J RHEUMATOL, V34, P25; [Anonymous], 2008, CURR OPIN RHEUMATOL, V20, P314, DOI 10.1097/BOR.0b013e3282f5fcf6; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baslund B, 2005, ARTHRITIS RHEUM-US, V52, P2686, DOI 10.1002/art.21249; Carroll HP, 2008, RHEUMATOLOGY, V47, P1269, DOI 10.1093/rheumatology/ken257; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Cho ML, 2007, IMMUNOL LETT, V108, P88, DOI 10.1016/j.imlet.2006.11.001; Cordero OJ, 2001, RHEUMATOL INT, V21, P69, DOI 10.1007/s002960100134; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; Emery P, 2009, ANN RHEUM DIS, V68, P456, DOI 10.1136/ard.2008.100362; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Gonzalez-Alvaro I, 2003, CLIN EXP RHEUMATOL, V21, P639; Gonzalez-Alvaro I, 2009, ANN RHEUM DIS, V68, P1644, DOI 10.1136/ard.2008.096743; Gonzalez-Alvaro I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1955; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Haupl T, 2010, ANN RHEUM DIS, V69, P37, DOI 10.1136/ard.2009.119487; Hardin J. W., 2007, GEN LINEAR MODELS EX, DOI DOI 10.1016/j.marpol.2012.12.026; Ibanez M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2961; Lamana A, 2010, EUR CYTOKINE NETW, V21, P186, DOI 10.1684/ecn.2010.0203; Liu CC, 2000, IMMUNOL TODAY, V21, P113, DOI 10.1016/S0167-5699(99)01581-9; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Miranda-Carus ME, 2006, ARTHRITIS RHEUM-US, V54, P1151, DOI 10.1002/art.21731; Miranda-Carus ME, 2004, J IMMUNOL, V173, P1463, DOI 10.4049/jimmunol.173.2.1463; Neumann E, 2005, ARTHRITIS RHEUM-US, V52, P2960, DOI 10.1002/art.21361; Ogata Y, 1999, J IMMUNOL, V162, P2754; Ortiz AM, 2002, RHEUMATOL INT, V21, P182, DOI 10.1007/s00296-001-0161-z; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raza Karim, 2009, Best Pract Res Clin Rheumatol, V23, P25, DOI 10.1016/j.berh.2008.08.001; Rodriguez-Valverde V, 2006, REUMATOL CLIN, V2, P52; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Schett G, 2005, NAT CLIN PRACT RHEUM, V1, P47, DOI 10.1038/ncprheum0036; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Smolen JS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2418; Suzuki J, 2001, J RHEUMATOL, V28, P2389; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006; Thurkow EW, 1997, J PATHOL, V181, P444; Molina JT, 2010, REUMATOL CLIN, V6, P23, DOI 10.1016/j.reuma.2009.10.006; Yoshihara K, 2007, EUR J IMMUNOL, V37, P2744, DOI 10.1002/eji.200737229; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	41	47	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29492	10.1371/journal.pone.0029492	http://dx.doi.org/10.1371/journal.pone.0029492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242124	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000039
J	Wade, M; Li, YC; Matani, AS; Braun, SMG; Milanesi, F; Rodewald, LW; Wahl, GM				Wade, M.; Li, Y. C.; Matani, A. S.; Braun, S. M. G.; Milanesi, F.; Rodewald, L. W.; Wahl, G. M.			Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells	ONCOGENE			English	Article						Mdm2; ligase; p53; RING; ubiquitin; Nutlin	DNA-DAMAGE; P53 ACTIVATION; IN-VIVO; ALLOSTERIC ACTIVATION; RING; DEGRADATION; DOMAIN; CANCER; HDM2; ATM	Mdm2 is the major negative regulator of p53 tumor-suppressor activity. This oncoprotein is overexpressed in many human tumors that retain the wild-type p53 allele. As such, targeted inhibition of Mdm2 is being considered as a therapeutic anticancer strategy. The N-terminal hydrophobic pocket of Mdm2 binds to p53 and thereby inhibits the transcription of p53 target genes. Additionally, the C-terminus of Mdm2 contains a RING domain with intrinsic ubiquitin E3 ligase activity. By recruiting E2 ubiquitin-conjugating enzyme(s), Mdm2 acts as a molecular scaffold to facilitate p53 ubiquitination and proteasome-dependent degradation. Mdmx (Mdm4), an Mdm2 homolog, also has a RING domain and hetero-oligomerizes with Mdm2 to stimulate its E3 ligase activity. Recent studies have shown that C-terminal residues adjacent to the RING domain of both Mdm2 and Mdmx contribute to Mdm2 E3 ligase activity. However, the molecular mechanisms mediating this process remain unclear, and the biological consequences of inhibiting Mdm2/Mdmx co-operation or blocking Mdm2 ligase function are relatively unexplored. This study presents biochemical and cell biological data that further elucidate the mechanisms by which Mdm2 and Mdmx co-operate to regulate p53 level and activity. We use chemical and genetic approaches to demonstrate that functional inhibition of Mdm2 ubiquitin ligase activity is insufficient for p53 activation. This unexpected result suggests that concomitant treatment with Mdm2/Mdmx antagonists may be needed to achieve therapeutic benefit.	[Wade, M.; Li, Y. C.; Matani, A. S.; Braun, S. M. G.; Rodewald, L. W.; Wahl, G. M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Wade, M.; Milanesi, F.] IIT SEMM, Ctr Genom Sci, I-20139 Milan, Italy; [Matani, A. S.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA	Salk Institute; Istituto Italiano di Tecnologia - IIT; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mark.wade@iit.it; wahl@salk.edu	Wade, Mark/B-6719-2009	Wade, Mark/0000-0002-2688-5965; Braun, Simon/0000-0003-2622-9914; Wade, Mark/0000-0002-8355-9680	National Institutes of Health [CA61449]; sanofi-aventis; NATIONAL CANCER INSTITUTE [R01CA061449, P30CA014195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); sanofi-aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a National Institutes of Health R01 Grant CA61449 and a Discovery Research Grant from sanofi-aventis awarded to GMW. We thank all members of the Wahl lab for input on various aspects of this project, Dimitris Xirodimas (Dundee University) for advice on the ubiquitylation assays and Masha Poyurovsky (Columbia University) for productive discussions. We also thank Rachel Klevit and Chris Pierini (University of Washington) for their comments and insight into ubiquitylation during this project.	Aranda-Anzaldo A, 2007, MECH AGEING DEV, V128, P293, DOI 10.1016/j.mad.2007.01.001; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dastidar SG, 2011, CELL CYCLE, V10, P82, DOI 10.4161/cc.10.1.14345; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kitagaki J, 2008, MOL CANCER THER, V7, P2445, DOI 10.1158/1535-7163.MCT-08-0063; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Wade M, 2008, CELL CYCLE, V7, P1973, DOI 10.4161/cc.7.13.6072; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Weissman A M, 2008, Ernst Schering Found Symp Proc, P171; Wong ET, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni145; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	46	19	19	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	45					4789	4797		10.1038/onc.2011.625	http://dx.doi.org/10.1038/onc.2011.625			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22266850	Green Accepted			2022-12-25	WOS:000311033000007
J	Punn, A; Chen, J; Delidaki, M; Tang, JY; Liapakis, G; Lehnert, H; Levine, MA; Grammatopoulos, DK				Punn, Anu; Chen, Jing; Delidaki, Maria; Tang, Jiyou; Liapakis, George; Lehnert, Hendrik; Levine, Michael A.; Grammatopoulos, Dimitris K.			Mapping Structural Determinants within Third Intracellular Loop That Direct Signaling Specificity of Type 1 Corticotropin-releasing Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 7TH TRANSMEMBRANE DOMAIN; CYTOPLASMIC DOMAINS; TRANSDUCTION PATHWAY; ADENYLYL-CYCLASE; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; EXPRESSION; MOTIFS	The type 1 corticotropin-releasing hormone receptor (CRH-R1) influences biological responses important for adaptation to stressful stimuli, through activation of multiple downstream effectors. The structural motifs within CRH-R1 that mediate G protein activation and signaling selectivity are unknown. The aim of this study was to gain insights about important structural determinants within the third intracellular loop (IC3) of the human CRH-R1 alpha important for cAMP and ERK1/2 pathways activation and selectivity. We investigated the role of the juxtamembrane regions of IC3 by mutating amino acid cassettes or specific residues to alanine. Although simultaneous tandem alanine mutations of both juxtamembrane regions Arg(292)-Met(295) and Lys(311)-Lys(314) reduced ligand binding and impaired signaling, all other mutant receptors retained high affinity binding, indistinguishable from wild-type receptor. Agonist-activated receptors with tandem mutations at the proximal or distal terminal segments enhanced activation of adenylyl cyclase by 50-75% and diminished activation of inositol trisphosphate and ERK1/2 by 60-80%. Single Ala mutations identified Arg(292), Lys(297), Arg(310), Lys(311), and Lys(314) as important residues for the enhanced activation of adenylyl cyclase, partly due to reduced inhibition of adenylyl cyclase activity by pertussis toxin-sensitive G proteins. In contrast, mutation of Arg(299) reduced receptor signaling activity and cAMP response. Basic as well as aliphatic amino acids within both juxtamembrane regions were identified as important for ERK1/2 phosphorylation through activation of pertussis toxin-sensitive G proteins as well as G(q) proteins. These data uncovered unexpected roles for key amino acids within the highly conserved hydrophobic N- and C-terminal microdomains of IC3 in the coordination of CRH-R1 signaling activity.	[Punn, Anu; Chen, Jing; Delidaki, Maria; Tang, Jiyou; Lehnert, Hendrik; Grammatopoulos, Dimitris K.] Univ Warwick, Dept Endocrinol & Metab, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Liapakis, George] Univ Crete, Fac Med, Dept Pharmacol, Iraklion 71003, Crete, Greece; [Lehnert, Hendrik] Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Levine, Michael A.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Dept Pediat, Sch Med, Philadelphia, PA 19104 USA	University of Warwick; University of Crete; University of Lubeck; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Grammatopoulos, DK (corresponding author), Univ Warwick, Dept Endocrinol & Metab, Clin Sci Res Inst, Warwick Med Sch, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	d.grammatopoulos@warwick.ac.uk		Levine, Michael/0000-0003-0036-7809; grammatopoulos, dimitris/0000-0002-6296-8290	Wellcome Trust; United States Endocrine Society	Wellcome Trust(Wellcome TrustEuropean Commission); United States Endocrine Society	This work was supported by a Wellcome Trust University Award (to D. K. G.). Dedicated to Wylie Vale and his enormous legacy.; Supported by a United States Endocrine Society summer research fellowship award.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; Berger H, 2006, BRIT J PHARMACOL, V149, P942, DOI 10.1038/sj.bjp.0706926; Brar BK, 2004, ENDOCRINOLOGY, V145, P1718, DOI 10.1210/en.2003-1023; Buck F, 2000, ENDOCRINOLOGY, V141, P3717, DOI 10.1210/en.141.10.3717; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Conner AC, 2006, BIOCHEMISTRY-US, V45, P12976, DOI 10.1021/bi0615801; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; Cypess AM, 1999, J BIOL CHEM, V274, P19455, DOI 10.1074/jbc.274.27.19455; Estall JL, 2005, J BIOL CHEM, V280, P22124, DOI 10.1074/jbc.M500078200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grammatopoulos DK, 2000, MOL ENDOCRINOL, V14, P2076, DOI 10.1210/me.14.12.2076; Granier S, 2008, REGUL PEPTIDES, V148, P76, DOI 10.1016/j.regpep.2008.01.007; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Huang ZM, 1996, J BIOL CHEM, V271, P33382, DOI 10.1074/jbc.271.52.33382; Karteris E, 2004, J MOL ENDOCRINOL, V32, P21, DOI 10.1677/jme.0.0320021; Lee NH, 1996, MOL PHARMACOL, V50, P140; Markovic D, 2008, MOL ENDOCRINOL, V22, P2505, DOI 10.1210/me.2008-0177; Markovic D, 2010, METHODS MOL BIOL, V634, P285, DOI 10.1007/978-1-60761-652-8_21; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; McPherson G, 1983, PROGR BIOMED, V17, P107; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2007, AM J PHYSIOL-REG I, V293, pR209, DOI 10.1152/ajpregu.00099.2006; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Papadopoulou N, 2004, MOL ENDOCRINOL, V18, P624, DOI 10.1210/me.2003-0365; Peverelli E, 2008, MOL ENDOCRINOL, V22, P676, DOI 10.1210/me.2007-0068; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Teli T, 2005, MOL ENDOCRINOL, V19, P474, DOI 10.1210/me.2004-0275; Timossi C, 2004, MOL CELL ENDOCRINOL, V223, P17, DOI 10.1016/j.mce.2004.06.004; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Ulfers AL, 2002, BIOCHEMISTRY-US, V41, P11344, DOI 10.1021/bi0259610; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	43	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8974	8985		10.1074/jbc.M111.272161	http://dx.doi.org/10.1074/jbc.M111.272161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22247544	hybrid, Green Published			2022-12-25	WOS:000301797800028
J	Gong, WB; Zhou, T; Mo, JJ; Perrett, S; Wang, JF; Feng, YG				Gong, Weibin; Zhou, Tao; Mo, Jinjin; Perrett, Sarah; Wang, Jinfeng; Feng, Yingang			Structural Insight into Recognition of Methylated Histone Tails by Retinoblastoma-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE COMPLEX; MACROMOLECULAR STRUCTURE; FAMILY PROTEINS; MOLECULAR-BASIS; CHEMICAL-SHIFT; GROWTH ARREST; NMR; IDENTIFICATION; DOMAIN; PROGRAM	Retinoblastoma-binding protein 1 (RBBP1), also named AT-rich interaction domain containing 4A (ARID4A), is a tumor and leukemia suppressor involved in epigenetic regulation in leukemia and Prader-Willi/Angelman syndromes. Although the involvement in epigenetic regulation is proposed to involve its chromobarrel and/or Tudor domains because of their potential binding to methylated histone tails, the structures of these domains and their interactions with methylated histone tails are still uncharacterized. In this work, we first found that RBBP1 contains five domains by bioinformatics analysis. Three of the five domains, i.e. chromobarrel, Tudor, and PWWP domains, are Royal Family domains, which potentially bind to methylated histone tails. We further purified these domains and characterized their interaction with methylated histone tails by NMR titration experiments. Among the three Royal Family domains, only the chromobarrel domain could recognize trimethylated H4K20 (with an affinity of similar to 3 mM), as well as recognizing trimethylated H3K9, H3K27, and H3K36 (with lower affinities). The affinity could be further enhanced up to 15-fold by the presence of DNA. The structure of the chromobarrel domain of RBBP1 determined by NMR spectroscopy has an aromatic cage. Mutagenesis analysis identified four aromatic residues of the cage as the key residues for methylated lysine recognition. Our studies indicate that the chromobarrel domain of RBBP1 is responsible for recognizing methylated histone tails in chromatin remodeling and epigenetic regulation, which presents a significant advance in our understanding of the mechanism and relationship between RBBP1-related gene suppression and epigenetic regulation.	[Gong, Weibin; Zhou, Tao; Mo, Jinjin; Perrett, Sarah; Wang, Jinfeng; Feng, Yingang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Mo, Jinjin] Beijing Normal Univ, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Beijing Normal University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, JF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	jfw@sun5.ibp.ac.cn; fengyg@qibebt.ac.cn	Feng, Yingang/B-6304-2008; Perrett, Sarah/AAS-9483-2020	Feng, Yingang/0000-0002-0879-1316; Perrett, Sarah/0000-0003-0137-0997	National Natural Science Foundation of China [30970571, 30770434]; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 30970571 (to Y. F.) and 30770434 (to J. W.) and the China Postdoctoral Science Foundation (to W. G.).	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Cheng Y, 2004, BIOCHEM BIOPH RES CO, V317, P401, DOI 10.1016/j.bbrc.2004.03.068; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001	37	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8531	8540		10.1074/jbc.M111.299149	http://dx.doi.org/10.1074/jbc.M111.299149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247551	Green Published, hybrid			2022-12-25	WOS:000301349400066
J	Iglesias-Guimarais, V; Gil-Guinon, E; Gabernet, G; Garcia-Belinchon, M; Sanchez-Osuna, M; Casanelles, E; Comella, JX; Yuste, VJ				Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.			Apoptotic DNA Degradation into Oligonucleosomal Fragments, but Not Apoptotic Nuclear Morphology, Relies on a Cytosolic Pool of DFF40/CAD Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; CELL-DEATH; CHROMATIN CONDENSATION; CLEAVAGE; INHIBITOR; PROTEIN; STAUROSPORINE; LOCALIZATION; ASSOCIATION; ABSENCE	Apoptotic cell death is characterized by nuclear fragmentation and oligonucleosomal DNA degradation, mediated by the caspase-dependent specific activation of DFF40/CAD endonuclease. Here, we describe how, upon apoptotic stimuli, SK-N-AS human neuroblastoma-derived cells show apoptotic nuclear morphology without displaying concomitant internucleosomal DNA fragmentation. Cytotoxicity afforded after staurosporine treatment is comparable with that obtained in SH-SY5Y cells, which exhibit a complete apoptotic phenotype. SK-N-AS cell death is a caspase-dependent process that can be impaired by the pan-caspase inhibitor q-VD-OPh. The endogenous inhibitor of DFF40/CAD, ICAD, is correctly processed, and dff40/cad cDNA sequence does not reveal mutations altering its amino acid composition. Biochemical approaches show that both SH-SY5Y and SK-N-AS resting cells express comparable levels of DFF40/CAD. However, the endonuclease is poorly expressed in the cytosolic fraction of healthy SK-N-AS cells. Despite this differential subcellular distribution of DFF40/CAD, we find no differences in the subcellular localization of both pro-caspase-3 and ICAD between the analyzed cell lines. After staurosporine treatment, the preferential processing of ICAD in the cytosolic fraction allows the translocation of DFF40/CAD from this fraction to a chromatin-enriched one. Therefore, the low levels of cytosolic DFF40/CAD detected in SK-N-AS cells determine the absence of DNA laddering after staurosporine treatment. In these cells DFF40/CAD cytosolic levels can be restored by the overexpression of their own endonuclease, which is sufficient to make them proficient at degrading their chromatin into oligonucleosome-size fragments after staurosporine treatment. Altogether, the cytosolic levels of DFF40/CAD are determinants in achieving a complete apoptotic phenotype, including oligonucleosomal DNA degradation.	[Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurosci, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.] Vall Hebron Inst Recerca, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08035, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.] Vall Hebron Inst Recerca, Cell Signaling & Apoptosis Grp, Barcelona 08035, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Yuste, Victor J./C-7071-2008; Comella, Joan/GQA-4279-2022; Gil, Estel/B-9786-2015; Comella, Joan X/D-7333-2012	Yuste, Victor J./0000-0001-5322-9261; Comella, Joan X/0000-0002-6218-0786; Gil, Estel/0000-0003-4502-4623; Gabernet, Gisela/0000-0001-7049-9474	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) [BFU2008-01328, TRA2009-0185, SAF2010-19953]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas [CB06/05/0042]; Generalitat de Catalunya [SGR2009-346]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Spanish Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas; Generalitat de Catalunya(Generalitat de Catalunya); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) Grants BFU2008-01328 and TRA2009-0185 (to V. J. Y.) and SAF2010-19953 (to J. X. C.), Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant CB06/05/0042, and Generalitat de Catalunya Grant SGR2009-346.; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya).; Funded by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia).	Baguley BC, 2011, FRONT BIOSCI-LANDMRK, V16, P1759, DOI 10.2741/3819; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Chen DX, 2000, J BIOL CHEM, V275, P38508, DOI 10.1074/jbc.M003906200; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; de la Taille A, 1999, CANCER RES, V59, P5461; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gozzelino R, 2008, CELL RES, V18, P1020, DOI 10.1038/cr.2008.76; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kuribayashi N, 1996, ANTICANCER RES, V16, P1225; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo M, 2010, CELL RES, V20, P211, DOI 10.1038/cr.2010.9; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nagase H, 2003, CELL DEATH DIFFER, V10, P142, DOI 10.1038/sj.cdd.4401139; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Sabol SL, 1998, BIOCHEM BIOPH RES CO, V253, P151, DOI 10.1006/bbrc.1998.9770; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2000, EXP CELL RES, V255, P314, DOI 10.1006/excr.2000.4801; Samejima K, 1998, EXP CELL RES, V243, P453, DOI 10.1006/excr.1998.4212; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Walker PR, 1999, ANN NY ACAD SCI, V887, P48, DOI 10.1111/j.1749-6632.1999.tb07921.x; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Widlak P, 2006, APOPTOSIS, V11, P1331, DOI 10.1007/s10495-006-6983-0; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Yan B, 2009, CARCINOGENESIS, V30, P1776, DOI 10.1093/carcin/bgp146; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122	52	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7766	7779		10.1074/jbc.M111.290718	http://dx.doi.org/10.1074/jbc.M111.290718			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253444	hybrid, Green Published			2022-12-25	WOS:000301060200075
J	Tan, EJ; Thuault, S; Caja, L; Carletti, T; Heldin, CH; Moustakas, A				Tan, E-Jean; Thuault, Sylvie; Caja, Laia; Carletti, Tea; Heldin, Carl-Henrik; Moustakas, Aristidis			Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mobility Group A2 during Epithelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CANCER; HMGA2; METASTASIS; PROGRESSION	Deciphering molecular mechanisms that control epithelial-to-mesenchymal transition (EMT) contributes to our understanding of how tumor cells become invasive and competent for intravasation. We have established that transforming growth factor beta activates Smad proteins, which induce expression of the embryonic factor high mobility group A2 (HMGA2), which causes mesenchymal transition. HMGA2 associates with Smad complexes and induces expression of an established regulator of EMT, the zinc finger transcription factor Snail. We now show that HMGA2 can also induce expression of a second regulator of EMT, the basic helix-loop-helix transcription factor Twist. Silencing of endogenous Twist demonstrated that this protein acts in a partially redundant manner together with Snail. Double silencing of Snail and Twist reverts mesenchymal HMG-A2-expressing cells to a more epithelial phenotype when compared with single silencing of Snail or Twist. Furthermore, HMGA2 can directly associate with A:T-rich sequences and promote transcription from the Twist promoter. The new evidence proposes a model whereby HMGA2 directly induces multiple transcriptional regulators of the EMT program and, thus, is a potential biomarker for carcinomas displaying EMT during progression to more advanced stages of malignancy.	[Tan, E-Jean; Thuault, Sylvie; Caja, Laia; Carletti, Tea; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595 Biomed Ctr, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Caja, Laia/J-4618-2019; Tan, E-Jean/J-3425-2019	Caja, Laia/0000-0002-8786-8763; Tan, E-Jean/0000-0002-4631-174X; THUAULT, Sylvie/0000-0003-0133-3803	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC, CAN 2006/1078]; Marie Curie Research Training Network "EpiPlastCarcinoma" under European Union [MRTN-2005-005428]	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Marie Curie Research Training Network "EpiPlastCarcinoma" under European Union	This work was supported in part by the Ludwig Institute for Cancer Research and the Swedish Cancer Society (project numbers: 4855-B03-01XAC and CAN 2006/1078 to A. M.).; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program (project MRTN-2005-005428).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Howe LR, 2003, CANCER RES, V63, P1906; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sgarra R, 2009, J PROTEOME RES, V8, P2978, DOI 10.1021/pr900087r; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658	23	84	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7134	7145		10.1074/jbc.M111.291385	http://dx.doi.org/10.1074/jbc.M111.291385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241470	Green Published, hybrid			2022-12-25	WOS:000301060200017
J	Thompson, JW; Salahudeen, AA; Chollangi, S; Ruiz, JC; Brautigam, CA; Makris, TM; Lipscomb, JD; Tomchick, DR; Bruick, RK				Thompson, Joel W.; Salahudeen, Ameen A.; Chollangi, Srinivas; Ruiz, Julio C.; Brautigam, Chad A.; Makris, Thomas M.; Lipscomb, John D.; Tomchick, Diana R.; Bruick, Richard K.			Structural and Molecular Characterization of Iron-sensing Hemerythrin-like Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS PROTEIN; REGULATORY PROTEIN-2; MAMMALIAN IRON; TARGETED DELETION; UBIQUITIN LIGASE; BINDING PROTEIN; HOMEOSTASIS; OXYGEN; MICE; MYOHEMERYTHRIN	Mammalian cells maintain iron homeostasis by sensing changes in bioavailable iron levels and promoting adaptive responses. FBXL5 is a subunit of an E3 ubiquitin ligase complex that mediates the stability of iron regulatory protein 2, an important posttranscriptional regulator of several genes involved in iron metabolism. The stability of FBXL5 is regulated in an iron- and oxygen-responsive manner, contingent upon the presence of its N-terminal domain. Here we present the atomic structure of the FBXL5 N terminus, a hemerythrin-like alpha-helical bundle fold not previously observed in mammalian proteins. The core of this domain employs an unusual assortment of amino acids necessary for the assembly and sensing properties of its diiron center. These regulatory features govern the accessibility of a mapped sequence required for proteasomal degradation of FBXL5. Detailed molecular and structural characterization of the ligand-responsive hemerythrin domain provides insights into the mechanisms by which FBXL5 serves as a unique mammalian metabolic sensor.	[Thompson, Joel W.; Salahudeen, Ameen A.; Chollangi, Srinivas; Ruiz, Julio C.; Brautigam, Chad A.; Tomchick, Diana R.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Makris, Thomas M.; Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu	Makris, Thomas/W-9965-2019; Tomchick, Diana/HGV-2018-2022	Makris, Thomas/0000-0001-7927-620X; Thompson, Joel/0000-0002-5131-3248; Lipscomb, John/0000-0002-8158-5594; A Salahudeen, Ameen/0000-0001-9037-3481; Brautigam, Chad/0000-0001-6563-1338; Tomchick, Diana/0000-0002-7529-4643	University of Texas Board of Regents; Sara and Frank McKnight Graduate Student Fellowship; Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; National Institutes of Health [HL102481]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Center for Research Resources, National Institutes of Health [C06 RR 15437-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024689, R01GM024689] Funding Source: NIH RePORTER	University of Texas Board of Regents; Sara and Frank McKnight Graduate Student Fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Graduate Programs Initiative from the University of Texas Board of Regents.; A Howard Hughes Medical Institute Scholar. Supported by a Sara and Frank McKnight Graduate Student Fellowship.; The Michael L. Rosenberg Scholar in Medical Research. Supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, the Robert A. Welch Foundation (Grant I-1568) and National Institutes of Health Grant HL102481. To whom correspondence should be addressed: University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-6477; Fax: 214-648-0320; E-mail: richard.bruick@utsouthwestern.edu.; The structure shown in this report is derived from work performed on beamlines 19-BM and 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. uChicago Argonne, LLC, operates Argonne for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR 15437-01) from the National Center for Research Resources, National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BEARDEN JA, 1967, REV MOD PHYS, V39, P125, DOI 10.1103/RevModPhys.39.125; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carugo O, 2005, TRENDS BIOCHEM SCI, V30, P213, DOI 10.1016/j.tibs.2005.02.009; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEMUYNCK S, 1993, EUR J BIOCHEM, V217, P151, DOI 10.1111/j.1432-1033.1993.tb18230.x; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOLMES MA, 1991, J MOL BIOL, V218, P583, DOI 10.1016/0022-2836(91)90703-9; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; JHA KK, 1980, SOMAT CELL GENET, V6, P603, DOI 10.1007/BF01538640; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kao WC, 2008, J INORG BIOCHEM, V102, P1607, DOI 10.1016/j.jinorgbio.2008.02.008; Kurtz DM, 1999, ESSAYS BIOCHEM, V34, P85, DOI 10.1042/bse0340085; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; MCCORMICK JM, 1991, J AM CHEM SOC, V113, P9066, DOI 10.1021/ja00024a007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; REEM RC, 1987, J AM CHEM SOC, V109, P1216, DOI 10.1021/ja00238a035; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, ANN NY ACAD SCI, V1177, P30, DOI 10.1111/j.1749-6632.2009.05038.x; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Traverso ME, 2010, BIOCHEMISTRY-US, V49, P7060, DOI 10.1021/bi100866b; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wirstam M, 2003, J AM CHEM SOC, V125, P3980, DOI 10.1021/ja017692r; Xiong JJ, 2000, BIOCHEMISTRY-US, V39, P5117, DOI 10.1021/bi992796o; ZHANG JH, 1992, P NATL ACAD SCI USA, V89, P7065, DOI 10.1073/pnas.89.15.7065	42	47	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7357	7365		10.1074/jbc.M111.308684	http://dx.doi.org/10.1074/jbc.M111.308684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253436	hybrid, Green Published			2022-12-25	WOS:000301060200037
J	Berkowitz, BA; Bissig, D; Ye, YQ; Valsadia, P; Kern, TS; Roberts, R				Berkowitz, Bruce A.; Bissig, David; Ye, Yongquan; Valsadia, Puja; Kern, Timothy S.; Roberts, Robin			Evidence for Diffuse Central Retinal Edema In Vivo in Diabetic Male Sprague Dawley Rats	PLOS ONE			English	Article							ION REGULATION; MACULAR EDEMA; ENHANCED MRI; PERMEABILITY; BARRIER; BRAIN; MODEL; PHOTORECEPTORS; DEGENERATION; RETINOPATHY	Background: Investigations into the mechanism of diffuse retinal edema in diabetic subjects have been limited by a lack of animal models and techniques that co-localized retinal thickness and hydration in vivo. In this study we test the hypothesis that a previously reported supernormal central retinal thickness on MRI measured in experimental diabetic retinopathy in vivo represents a persistent and diffuse edema. Methodology/Principal Findings: In diabetic and age-matched control rats, and in rats experiencing dilutional hyponatremia (as a positive edema control), whole central retinal thickness, intraretinal water content and apparent diffusion coefficients (ADC, 'water mobility') were measured in vivo using quantitative MRI methods. Glycated hemoglobin and retinal thickness ex vivo (histology) were also measured in control and diabetic groups. In the dilutional hyponatremia model, central retinal thickness and water content were supernormal by quantitative MRI, and intraretinal water mobility profiles changed in a manner consistent with intracellular edema. Groups of diabetic (2, 3, 4, 6, and 9 mo of diabetes), and age-matched controls were then investigated with MRI and all diabetic rats showed supernormal whole central retinal thickness. In a separate study in 4 mo diabetic rats (and controls), MRI retinal thickness and water content metrics were significantly greater than normal, and ADC was subnormal in the outer retina; the increase in retinal thickness was not detected histologically on sections of fixed and dehydrated retinas from these rats. Conclusions/Significance: Diabetic male Sprague Dawley rats demonstrate a persistent and diffuse retinal edema in vivo, providing, for the first time, an important model for investigating its pathogenesis and treatment. These studies also validate MRI as a powerful approach for investigating mechanisms of diabetic retinal edema in future experimental and clinical investigations.	[Berkowitz, Bruce A.; Bissig, David; Valsadia, Puja; Roberts, Robin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Ye, Yongquan] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Vet Adm Med Ctr Res Serv 151, Cleveland, OH USA	Wayne State University; Wayne State University; Wayne State University; Case Western Reserve University	Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	baberko@med.wayne.edu		Ye, Yongquan/0000-0002-6673-6753; Bissig, David/0000-0001-9664-5433	NIH [EY018109, AG034752, EY00300]; Juvenile Diabetes Research Foundation; Medical Research Service of the Department of Veteran Affairs; Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL EYE INSTITUTE [R21EY018109, R56EY000300, R01EY000300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Service of the Department of Veteran Affairs; Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by NIH EY018109 (BAB), Juvenile Diabetes Research Foundation (BAB), NIH AG034752 (DB), NIH EY00300 (TSK), the Medical Research Service of the Department of Veteran Affairs (TSK), Wayne State University School of Medicine MD/PhD program (DB), and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO J, 1985, INVEST OPHTH VIS SCI, V26, P692; Aizu Y, 2002, NEUROPATHOLOGY, V22, P161, DOI 10.1046/j.1440-1789.2002.00439.x; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BELLHORN RW, 1984, SURV OPHTHALMOL, V28, P520, DOI 10.1016/0039-6257(84)90235-2; Berkowitz BA, 2004, INVEST OPHTH VIS SCI, V45, P2391, DOI 10.1167/iovs.03-1381; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4753, DOI 10.1167/iovs.07-0433; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P3796, DOI 10.1167/iovs.06-1278; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2010, MOL VIS, V16, P1776; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; Clermont A, 2011, DIABETES; COHEN AI, 1971, J CELL BIOL, V48, P547, DOI 10.1083/jcb.48.3.547; Cunha-Vaz J, 1998, EUR J OPHTHALMOL, V8, P127, DOI 10.1177/112067219800800301; DALLAL MM, 1994, J APPL PHYSIOL, V77, P1030, DOI 10.1152/jappl.1994.77.2.1030; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; ENNIS SR, 1986, INVEST OPHTH VIS SCI, V27, P1095; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghazi NG, 2007, AM J OPHTHALMOL, V144, P747, DOI 10.1016/j.ajo.2007.07.012; GOVARDOVSKII VI, 1994, INVEST OPHTH VIS SCI, V35, P2712; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; LI JD, 1994, VISUAL NEUROSCI, V11, P743, DOI 10.1017/S0952523800003047; Luan H, 2006, INVEST OPHTH VIS SCI, V47, P320, DOI 10.1167/iovs.05-0272; MACGREGOR LC, 1986, J BIOL CHEM, V261, P4052; MACGREGOR LC, 1986, METABOLISM, V35, P28, DOI 10.1016/0026-0495(86)90184-8; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Nair G, 2010, INT J IMAG SYST TECH, V20, P126, DOI 10.1002/ima.20237; OLSON JE, 1990, ANN EMERG MED, V19, P1113, DOI 10.1016/S0196-0644(05)81514-8; OSTEEN WK, 1974, INVEST OPHTH VISUAL, V13, P334; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Park JW, 2006, NEUROBIOL DIS, V21, P43, DOI 10.1016/j.nbd.2005.06.007; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Quirk JD, 2003, MAGNET RESON MED, V50, P493, DOI 10.1002/mrm.10565; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sander B, 2007, INVEST OPHTH VIS SCI, V48, P3983, DOI 10.1167/iovs.06-1102; SCHUPP DG, 1993, MAGNET RESON MED, V30, P18, DOI 10.1002/mrm.1910300105; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; Sood R, 2009, J CEREBR BLOOD F MET, V29, P308, DOI 10.1038/jcbfm.2008.121; STEFANSSON E, 1987, INVEST OPHTH VIS SCI, V28, P1281; Stolba U, 2005, AM J OPHTHALMOL, V140, P295, DOI 10.1016/j.ajo.2005.03.045; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhang XY, 2008, DIABETES, V57, P1026, DOI 10.2337/db07-0982; Zhang Y, 2009, GRAEF ARCH CLIN EXP, V247, P699, DOI 10.1007/s00417-008-1004-3	48	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29619	10.1371/journal.pone.0029619	http://dx.doi.org/10.1371/journal.pone.0029619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253747	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700033
J	Embers, ME; Barthold, SW; Borda, JT; Bowers, L; Doyle, L; Hodzic, E; Jacobs, MB; Hasenkampf, NR; Martin, DS; Narasimhan, S; Phillippi-Falkenstein, KM; Purcell, JE; Ratterree, MS; Philipp, MT				Embers, Monica E.; Barthold, Stephen W.; Borda, Juan T.; Bowers, Lisa; Doyle, Lara; Hodzic, Emir; Jacobs, Mary B.; Hasenkampf, Nicole R.; Martin, Dale S.; Narasimhan, Sukanya; Phillippi-Falkenstein, Kathrine M.; Purcell, Jeanette E.; Ratterree, Marion S.; Philipp, Mario T.			Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; TERMINAL INVARIABLE DOMAIN; NONHUMAN PRIMATE MODEL; SURFACE PROTEIN-C; NERVOUS-SYSTEM; ANTIBODY-RESPONSE; CONTROLLED-TRIALS; IMMUNE-RESPONSE; C-6 TEST; NEUROBORRELIOSIS	The persistence of symptoms in Lyme disease patients following antibiotic therapy, and their causes, continue to be a matter of intense controversy. The studies presented here explore antibiotic efficacy using nonhuman primates. Rhesus macaques were infected with B. burgdorferi and a portion received aggressive antibiotic therapy 4-6 months later. Multiple methods were utilized for detection of residual organisms, including the feeding of lab-reared ticks on monkeys (xenodiagnosis), culture, immunofluorescence and PCR. Antibody responses to the B. burgdorferi-specific C6 diagnostic peptide were measured longitudinally and declined in all treated animals. B. burgdorferi antigen, DNA and RNA were detected in the tissues of treated animals. Finally, small numbers of intact spirochetes were recovered by xenodiagnosis from treated monkeys. These results demonstrate that B. burgdorferi can withstand antibiotic treatment, administered post-dissemination, in a primate host. Though B. burgdorferi is not known to possess resistance mechanisms and is susceptible to the standard antibiotics (doxycycline, ceftriaxone) in vitro, it appears to become tolerant post-dissemination in the primate host. This finding raises important questions about the pathogenicity of antibiotic-tolerant persisters and whether or not they can contribute to symptoms post-treatment.	[Embers, Monica E.; Bowers, Lisa; Jacobs, Mary B.; Hasenkampf, Nicole R.; Martin, Dale S.; Philipp, Mario T.] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA; [Embers, Monica E.; Bowers, Lisa; Jacobs, Mary B.; Hasenkampf, Nicole R.; Martin, Dale S.; Philipp, Mario T.] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [Barthold, Stephen W.; Hodzic, Emir] Univ Calif Davis, Ctr Comparat Med, Sch Med, Davis, CA 95616 USA; [Barthold, Stephen W.; Hodzic, Emir] Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA; [Narasimhan, Sukanya] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA	Tulane University; Tulane University; University of California System; University of California Davis; University of California System; University of California Davis; Yale University	Embers, ME (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA.	members@tulane.edu; Philipp@tulane.edu		Embers, Monica/0000-0003-4051-7592	NIAID [R01-AI042352, R01-AI26815]; TNPRC; NCRR [RR00164]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026815, R01AI042352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TNPRC; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIAID grant R01-AI042352 (MTP), R01-AI26815 (SWB and EH), a TNPRC Pilot Study Grant (MEE), and NCRR grant RR00164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH ES, 1994, J RHEUMATOL, V21, P454; Auwaerter PG, 2007, CLIN INFECT DIS, V45, P143, DOI 10.1086/518854; Bai YH, 2004, LAB INVEST, V84, P160, DOI 10.1038/labinvest.3700024; BaradaranDilmaghani R, 1996, INFECTION, V24, P60, DOI 10.1007/BF01780660; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; Bolz DD, 2004, AUTOIMMUNITY, V37, P387, DOI 10.1080/08916930410001713098; Cadavid D, 2004, LAB INVEST, V84, P1439, DOI 10.1038/labinvest.3700177; Cadavid D, 2003, INFECT IMMUN, V71, P7087, DOI 10.1128/IAI.71.12.7087-7098.2003; Cadavid D, 2000, LAB INVEST, V80, P1043, DOI 10.1038/labinvest.3780109; Crowley H, 2003, INFECT IMMUN, V71, P4003, DOI 10.1128/IAI.71.7.4003-4010.2003; DELRIO M, 1982, ANTIMICROB AGENTS CH, V22, P622, DOI 10.1128/AAC.22.4.622; Embers ME, 2008, INFECT IMMUN, V76, P3984, DOI 10.1128/IAI.00387-08; England JD, 1997, SEMIN NEUROL, V17, P53, DOI 10.1055/s-2008-1040913; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Fleming RV, 2004, EUR J CLIN MICROBIOL, V23, P615, DOI 10.1007/s10096-004-1163-z; Gilmore RD, 1996, INFECT IMMUN, V64, P2234, DOI 10.1128/IAI.64.6.2234-2239.1996; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; HOVINDHOUGEN K, 1984, YALE J BIOL MED, V57, P543; Jacobs MB, 2006, INFECT IMMUN, V74, P3678, DOI 10.1128/IAI.00043-06; KALISH RA, 1993, INFECT IMMUN, V61, P2774, DOI 10.1128/IAI.61.7.2774-2779.1993; KATONA LI, 1992, INFECT IMMUN, V60, P4995, DOI 10.1128/IAI.60.12.4995-5003.1992; KELLY DJ, 1992, J INFECT DIS, V166, P1184, DOI 10.1093/infdis/166.5.1184; Klempner MS, 2002, VECTOR-BORNE ZOONOT, V2, P255, DOI 10.1089/153036602321653842; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Liang FT, 2001, INFECT IMMUN, V69, P1337, DOI 10.1128/IAI.69.3.1337-1343.2001; Liang FT, 2001, INFECT IMMUN, V69, P3224, DOI 10.1128/IAI.69.5.3224-3231.2001; Liang FT, 1999, INFECT IMMUN, V67, P6702; MAESEN FPV, 1989, J ANTIMICROB CHEMOTH, V23, P123, DOI 10.1093/jac/23.1.123; MATSUI H, 1984, ANTIMICROB AGENTS CH, V26, P204, DOI 10.1128/AAC.26.2.204; Mayer L, 2008, NEW ENGL J MED, V358, P428, DOI 10.1056/NEJMc073063; Narasimhan S, 2003, P NATL ACAD SCI USA, V100, P15953, DOI 10.1073/pnas.2432412100; Pachner AR, 2001, ANN NEUROL, V50, P330, DOI 10.1002/ana.1287; PACHNER AR, 1995, AM J MED, V98, pS30, DOI 10.1016/S0002-9343(99)80042-4; PACHNER AR, 1995, NEUROLOGY, V45, P165, DOI 10.1212/WNL.45.1.165; Pachner AR, 1998, J CLIN MICROBIOL, V36, P3243, DOI 10.1128/JCM.36.11.3243-3247.1998; PATEL IH, 1984, AM J MED, V77, P17; Philipp Mario T., 1994, Trends in Microbiology, V2, P431, DOI 10.1016/0966-842X(94)90800-1; Philipp MT, 2005, CLIN DIAGN LAB IMMUN, V12, P1069, DOI 10.1128/CDLI.12.9.1069-1074.2005; Philipp MT, 2003, J CLIN MICROBIOL, V41, P4955, DOI 10.1128/JCM.41.11.4955-4960.2003; PHILIPP MT, 1993, INFECT IMMUN, V61, P3047, DOI 10.1128/IAI.61.7.3047-3059.1993; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P2012, DOI 10.1128/JCM.25.10.2012-2013.1987; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Roberts ED, 1998, J INFECT DIS, V178, P722, DOI 10.1086/515357; ROBERTS ED, 1995, LAB INVEST, V72, P146; SAMBROOK J, 1989, LAB MAN, V9, P31; Scheiblhofer S, 2003, MICROBES INFECT, V5, P939, DOI 10.1016/S1286-4579(03)00182-5; SHADICK NA, 1994, ANN INTERN MED, V121, P560, DOI 10.7326/0003-4819-121-8-199410150-00002; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Stricker RB, 2007, CLIN INFECT DIS, V45, P149, DOI 10.1086/518853; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Yrjanainen H, 2010, APMIS, V118, P665, DOI 10.1111/j.1600-0463.2010.02615.x	59	160	161	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29914	10.1371/journal.pone.0029914	http://dx.doi.org/10.1371/journal.pone.0029914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253822	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700066
J	Ji, CC; Wu, L; Zhao, WC; Wang, SS; Lv, JH				Ji, Chengcheng; Wu, Liang; Zhao, Wenchan; Wang, Sishuo; Lv, Jianhao			Echinoderms Have Bilateral Tendencies	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HOX GENE-CLUSTER; SEA-URCHIN; EVOLUTION; ORGANIZATION; STARFISH; LARVAE; HOMOLOGIES; EXPRESSION; PHYLOGENY	Echinoderms take many forms of symmetry. Pentameral symmetry is the major form and the other forms are derived from it. However, the ancestors of echinoderms, which originated from Cambrian period, were believed to be bilaterians. Echinoderm larvae are bilateral during their early development. During embryonic development of starfish and sea urchins, the position and the developmental sequence of each arm are fixed, implying an auxological anterior/posterior axis. Starfish also possess the Hox gene cluster, which controls symmetrical development. Overall, echinoderms are thought to have a bilateral developmental mechanism and process. In this article, we focused on adult starfish behaviors to corroborate its bilateral tendency. We weighed their central disk and each arm to measure the position of the center of gravity. We then studied their turning-over behavior, crawling behavior and fleeing behavior statistically to obtain the center of frequency of each behavior. By joining the center of gravity and each center of frequency, we obtained three behavioral symmetric planes. These behavioral bilateral tendencies might be related to the A/P axis during the embryonic development of the starfish. It is very likely that the adult starfish is, to some extent, bilaterian because it displays some bilateral propensity and has a definite behavioral symmetric plane. The remainder of bilateral symmetry may have benefited echinoderms during their evolution from the Cambrian period to the present.	[Ji, Chengcheng; Wu, Liang; Zhao, Wenchan; Wang, Sishuo] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Lv, Jianhao] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Ji, CC (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	jichengcheng@yahoo.com.cn	Wang, Sishuo/S-1993-2019	Wang, Sishuo/0000-0002-7220-7305; Wang, Sishuo/0000-0002-2695-7607	National Natural Science Foundation of China [J1103520]; National Basic Science Foundation of China [0830630]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Foundation of China	This work was supported by the grant from the National Natural Science Foundation of China (Project J1103520) and National Basic Science Foundation of China, (Education of Field Research, Project 0830630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agersborg HPK, 1922, BIOL BULL-US, V42, P202, DOI 10.2307/1536522; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Batschelet E, 1981, CIRCULAR STAT BIOL, P52; Byrne M, 2002, J COMP NEUROL, V451, P101, DOI 10.1002/cne.10315; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Cole LJ, 1913, J EXP ZOOL, V14, P1, DOI 10.1002/jez.1400140102; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Hotchkiss FHC, 1998, PALEOBIOLOGY, V24, P200; HOTCHKISS FHC, 1995, P BIOL SOC WASH, V108, P401; Hotchkiss FHC, 2000, AM ZOOL, V40, P340, DOI 10.1668/0003-1569(2000)040[0340:OTNORI]2.0.CO;2; Hotchkiss FHC, 2011, TABLE RAY IDENTIFICA; Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101, DOI 10.1111/j.1463-6395.1996.tb01256.x; Jennings H. S., 1907, U CALIFORNIA PUBLICA, V4, P53; Jones DA, 1968, SOME BIOL PROBLEMS A; Knight-Jones EW, 1964, CHALLENGER SOC LONDO, V3, P27; Long S, 2001, EVOL DEV, V3, P302, DOI 10.1046/j.1525-142X.2001.01036.x; Lowe CJ, 2002, EVOL DEV, V4, P111, DOI 10.1046/j.1525-142X.2002.01066.x; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; MCCAIN ER, 1994, DEVELOPMENT, V120, P395; MCEDWARD LR, 1993, BIOL BULL, V184, P255, DOI 10.2307/1542444; Migita M, 2005, BIOSYSTEMS, V82, P107, DOI 10.1016/j.biosystems.2005.05.012; Mooi R, 1998, AM ZOOL, V38, P965; Mooi R, 2008, ANNU REV ECOL EVOL S, V39, P43, DOI 10.1146/annurev.ecolsys.39.110707.173521; Morris VB, 1999, BIOL J LINN SOC, V66, P293, DOI 10.1006/bijl.1998.0284; O'Donoghue CH, 1926, B C FISHERIES RES BO, V1, P455; Pawson DL, 2007, ZOOTAXA, P749, DOI 10.11646/zootaxa.1668.1.31; Peterson KJ, 2000, EVOL DEV, V2, P93, DOI 10.1046/j.1525-142x.2000.00042.x; Popodi E, 1996, MOL BIOL EVOL, V13, P1078, DOI 10.1093/oxfordjournals.molbev.a025670; Popodi E, 2001, BIOESSAYS, V23, P211, DOI 10.1002/1521-1878(200103)23:3<211::AID-BIES1030>3.0.CO;2-6; Raff RA, 2006, HEREDITY, V97, P244, DOI 10.1038/sj.hdy.6800866; Reese E. S., 1966, P157; Rodenhouse Inria Zintheo, 1946, UNIV WASHINGTON PUBL BIOL, V12, P21; Smith AB, 1997, ANNU REV ECOL SYST, V28, P219, DOI 10.1146/annurev.ecolsys.28.1.219; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Smith AB, 2008, EVOL DEV, V10, P493, DOI 10.1111/j.1525-142X.2008.00260.x; Smith JE, 1950, S SOC EXPT BIOL; UBAGHS G, 1975, ANNU REV EARTH PL SC, V3, P79, DOI 10.1146/annurev.ea.03.050175.000455; Wray GA, 2000, SYST BIOL, V49, P28, DOI 10.1080/10635150050207375; Yoshimura K, 2010, MAR BIOL, V157, P2475, DOI 10.1007/s00227-010-1512-7	39	10	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28978	10.1371/journal.pone.0028978	http://dx.doi.org/10.1371/journal.pone.0028978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247765	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700013
J	Lemos, APC; Cervenak, J; Bender, B; Hoffmann, OI; Baranyi, M; Kerekes, A; Farkas, A; Bosze, Z; Hiripi, L; Kacskovics, I				Lemos, Ana Paula Catunda; Cervenak, Judit; Bender, Balazs; Hoffmann, Orsolya Ivett; Baranyi, Maria; Kerekes, Andrea; Farkas, Anita; Bosze, Zsuzsanna; Hiripi, Laszlo; Kacskovics, Imre			Characterization of the Rabbit Neonatal Fc Receptor (FcRn) and Analyzing the Immunophenotype of the Transgenic Rabbits That Overexpresses FcRn	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; I-RELATED RECEPTOR; YOLK-SAC MEMBRANE; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-G; DENDRITIC CELLS; IGG-BINDING; MEDIATED PRESENTATION; CRYSTAL-STRUCTURE; MAMMARY-GLAND	The neonatal Fc receptor (FcRn) regulates IgG and albumin homeostasis, mediates maternal IgG transport, takes an active role in phagocytosis, and delivers antigen for presentation. We have previously shown that overexpression of FcRn in transgenic mice significantly improves the humoral immune response. Because rabbits are an important source of polyclonal and monoclonal antibodies, adaptation of our FcRn overexpression technology in this species would bring significant advantages. We cloned the full length cDNA of the rabbit FcRn alpha-chain and found that it is similar to its orthologous analyzed so far. The rabbit FcRn - IgG contact residues are highly conserved, and based on this we predicted pH dependent interaction, which we confirmed by analyzing the pH dependent binding of FcRn to rabbit IgG using yolk sac lysates of rabbit fetuses by Western blot. Using immunohistochemistry, we detected strong FcRn staining in the endodermal cells of the rabbit yolk sac membrane, while the placental trophoblast cells and amnion showed no FcRn staining. Then, using BAC transgenesis we generated transgenic rabbits carrying and overexpressing a 110 kb rabbit genomic fragment encoding the FcRn. These transgenic rabbits - having one extra copy of the FcRn when hemizygous and two extra copies when homozygous - showed improved IgG protection and an augmented humoral immune response when immunized with a variety of different antigens. Our results in these transgenic rabbits demonstrate an increased immune response, similar to what we described in mice, indicating that FcRn overexpression brings significant advantages for the production of polyclonal and monoclonal antibodies.	[Lemos, Ana Paula Catunda; Hoffmann, Orsolya Ivett; Kerekes, Andrea; Bosze, Zsuzsanna; Hiripi, Laszlo] Agr Biotechnol Ctr, H-2101 Godollo, Hungary; [Cervenak, Judit; Bender, Balazs; Baranyi, Maria; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary; [Farkas, Anita; Kacskovics, Imre] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary	Eotvos Lorand University	Lemos, APC (corresponding author), Agr Biotechnol Ctr, H-2101 Godollo, Hungary.	hiripi@yahoo.com; ikacsko@elte.hu	Kacskovics, Imre/J-8449-2013; Bosze, Zsuzsanna/N-9689-2019; Hiripi, Laszlo/AAL-8243-2021	Kacskovics, Imre/0000-0002-0402-3862; Hiripi, Laszlo/0000-0002-1023-0112	Hungarian Scientific Research Fund [OTKA K68126]; National Office for Research and Technology [OM-00117-119/2008]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Office for Research and Technology(National Office for Research and TechnologyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research was supported by grants from the Hungarian Scientific Research Fund (OTKA K68126) and National Office for Research and Technology Fund (OM-00117-119/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; ANDERSEN SB, 1964, J EXP MED, V119, P537, DOI 10.1084/jem.119.4.537; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Bender B, 2007, TRANSGENIC RES, V16, P613, DOI 10.1007/s11248-007-9108-9; Bodrogi L, 2006, TRANSGENIC RES, V15, P627, DOI 10.1007/s11248-006-9015-5; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Bosze Z, 2011, RECOMBINANT GENE EXP; BRAMBELL FW, 1964, NATURE, V203, P1352, DOI 10.1038/2031352a0; BRAMBELL FWR, 1958, PROC R SOC SER B-BIO, V149, P1, DOI 10.1098/rspb.1958.0046; BRAMBELL FWR, 1958, BIOL REV, V33, P488, DOI 10.1111/j.1469-185X.1958.tb01412.x; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; Butler J. E., 1971, FERTIL STERIL, P92; Cervenak J, 2011, J IMMUNOL, V186, P959, DOI 10.4049/jimmunol.1000353; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; COLIGAN JE, 2009, CURRENT PROTOCOLS IM; DIMA S, 1983, EUR J IMMUNOL, V13, P605, DOI 10.1002/eji.1830130802; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; GATES FT, 1979, BIOCHEMISTRY-US, V18, P2267, DOI 10.1021/bi00578a021; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; Hiripi L, 2003, DNA CELL BIOL, V22, P41, DOI 10.1089/104454903321112488; JOHANSON RA, 1981, J IMMUNOL, V126, P194; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kacskovics I, 2006, INT IMMUNOL, V18, P525, DOI 10.1093/intimm/dxh393; Kacskovics I, 2000, J IMMUNOL, V164, P1889, DOI 10.4049/jimmunol.164.4.1889; Kacskovics I, 2011, MABS-AUSTIN, V3, P431, DOI 10.4161/mabs.3.5.17023; Kacskovics I, 2006, DEV COMP IMMUNOL, V30, P1203, DOI 10.1016/j.dci.2006.02.006; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; KRAEHENBUHL JP, 1969, J CELL BIOL, V42, P345, DOI 10.1083/jcb.42.2.345; Kuo TT, 2009, J BIOL CHEM, V284, P8292, DOI 10.1074/jbc.M805877200; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Martin PL, 2010, BIRTH DEFECTS RES B, V89, P87, DOI 10.1002/bdrb.20227; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; MEADS TJ, 1994, PLACENTA, V15, P525, DOI 10.1016/S0143-4004(05)80421-7; Mendicino M, 2011, TRANSGENIC RES, V20, P625, DOI 10.1007/s11248-010-9444-z; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Newton EE, 2005, J CELL SCI, V118, P2461, DOI 10.1242/jcs.02367; Nicholas KB., 1997, GENEDOC TOOL EDITING; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAGHAVAN M, 1994, IMMUNITY, V1, P303, DOI 10.1016/1074-7613(94)90082-5; Ramsoondar J, 2011, TRANSGENIC RES, V20, P643, DOI 10.1007/s11248-010-9445-y; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; Rogel-Gaillard C, 2001, MAMM GENOME, V12, P253, DOI 10.1007/s003350010260; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHADE R, 1991, ATLA-ALTERN LAB ANIM, V19, P403; SCHLAMOWITZ M, 1975, J IMMUNOL, V115, P296; Schneider Z, 2011, IMMUNOL LETT, V137, P62, DOI 10.1016/j.imlet.2011.02.018; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; SONODA S, 1973, J IMMUNOL, V110, P1682; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Vegh A, 2011, MABS-AUSTIN, V3, P173, DOI 10.4161/mabs.3.2.14462; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Warner CM, 2000, AM J REPROD IMMUNOL, V43, P234, DOI 10.1111/j.8755-8920.2000.430408.x; Wernick NLB, 2005, J BIOL CHEM, V280, P7309, DOI 10.1074/jbc.M410752200; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	70	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28869	10.1371/journal.pone.0028869	http://dx.doi.org/10.1371/journal.pone.0028869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247762	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700010
J	Mosco, A; Zlatev, V; Guarnaccia, C; Pongor, S; Campanella, A; Zahariev, S; Giulianini, PG				Mosco, Alessandro; Zlatev, Vientsislav; Guarnaccia, Corrado; Pongor, Sandor; Campanella, Antonella; Zahariev, Sotir; Giulianini, Piero G.			Novel Protocol for the Chemical Synthesis of Crustacean Hyperglycemic Hormone Analogues - An Efficient Experimental Tool for Studying Their Functions	PLOS ONE			English	Article							MOLT-INHIBITING HORMONE; D-AMINO-ACID; CRAYFISH PROCAMBARUS-CLARKII; LOBSTER HOMARUS-AMERICANUS; CARCINUS-MAENAS; BIOLOGICAL-ACTIVITY; SHORE CRAB; OPIOID-PEPTIDES; CDNA CLONING; KURUMA PRAWN	The crustacean Hyperglycemic Hormone (cHH) is present in many decapods in different isoforms, whose specific biological functions are still poorly understood. Here we report on the first chemical synthesis of three distinct isoforms of the cHH of Astacus leptodactylus carried out by solid phase peptide synthesis coupled to native chemical ligation. The synthetic 72 amino acid long peptide amides, containing L- or D-Phe(3) and (Glp(1), D-Phe(3)) were tested for their biological activity by means of homologous in vivo bioassays. The hyperglycemic activity of the D-isoforms was significantly higher than that of the L-isoform, while the presence of the N-terminal Glp residue had no influence on the peptide activity. The results show that the presence of D-Phe(3) modifies the cHH functionality, contributing to the diversification of the hormone pool.	[Mosco, Alessandro; Campanella, Antonella; Giulianini, Piero G.] Univ Trieste, Dept Life Sci, Trieste, Italy; [Zlatev, Vientsislav; Guarnaccia, Corrado; Pongor, Sandor; Zahariev, Sotir] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Mosco, A (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	alessandro.mosco@phd.units.it		Giulianini, Piero Giulio/0000-0001-5356-7754; Mosco, Alessandro/0000-0002-4885-3665	Ministry of Education, University and Research (MIUR) [PRIN 2008 - 2008BZFFFY]	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by a grant assigned to E.A. Ferrero from the Ministry of Education, University and Research (MIUR, http://prin.miur.it/) (project PRIN 2008 - 2008BZFFFY "Modulazione ormonale e riconoscimento individuale nel comportamento agonistico dei Crostacei Decapodi''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR MB, 1995, PEPTIDES, V16, P1375, DOI 10.1016/0196-9781(95)02024-1; [Anonymous], 2010, R LANG ENV STAT COMP; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; Bulau P, 2003, PEPTIDES, V24, P1871, DOI 10.1016/j.peptides.2003.10.002; Chen SH, 2005, MAR BIOTECHNOL, V7, P193, DOI 10.1007/s10126-004-0020-5; Chung JS, 2006, GEN COMP ENDOCR, V147, P206, DOI 10.1016/j.ygcen.2006.01.002; Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 1996, EUR J BIOCHEM, V240, P358, DOI 10.1111/j.1432-1033.1996.0358h.x; Chung JS, 1998, REGUL PEPTIDES, V77, P17, DOI 10.1016/S0167-0115(98)00024-X; Chung JS, 2003, EUR J BIOCHEM, V270, P3280, DOI 10.1046/j.1432-1033.2003.03720.x; de Kleijn DPV, 1998, J ENDOCRINOL, V156, P291, DOI 10.1677/joe.0.1560291; DEKLEIJN DPV, 1994, FEBS LETT, V353, P255, DOI 10.1016/0014-5793(94)01055-2; Edomi P, 2002, GENE, V284, P93, DOI 10.1016/S0378-1119(02)00389-X; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giulianini Piero Giulio, 2006, P225; Gu PL, 2000, FEBS LETT, V472, P122, DOI 10.1016/S0014-5793(00)01420-4; Han YX, 1997, J ORG CHEM, V62, P4307, DOI 10.1021/jo9622744; Huberman A, 2000, PEPTIDES, V21, P331, DOI 10.1016/S0196-9781(00)00155-8; KAMATANI Y, 1990, FEBS LETT, V276, P95, DOI 10.1016/0014-5793(90)80516-L; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; KEGEL G, 1989, FEBS LETT, V255, P10, DOI 10.1016/0014-5793(89)81051-8; KLEIN JM, 1993, FEBS LETT, V334, P139, DOI 10.1016/0014-5793(93)81699-Z; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; Marco HG, 2004, INT CONGR SER, V1275, P126, DOI 10.1016/j.ics.2004.08.053; Mettulio R, 2004, PEPTIDES, V25, P1899, DOI 10.1016/j.peptides.2004.06.013; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700; Ohira T, 1999, BIOSCI BIOTECH BIOCH, V63, P1576, DOI 10.1271/bbb.63.1576; Ohira T, 2006, ZOOL SCI, V23, P383, DOI 10.2108/zsj.23.383; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Santos EA, 1997, PHYSIOL ZOOL, V70, P415, DOI 10.1086/515846; SEDLMEIER D, 1988, REGUL PEPTIDES, V20, P91, DOI 10.1016/0167-0115(88)90042-0; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; SIEBER P, 1987, TETRAHEDRON LETT, V28, P2107, DOI 10.1016/S0040-4039(00)96055-6; Sonobe H, 2001, GEN COMP ENDOCR, V121, P196, DOI 10.1006/gcen.2000.7586; Soyez D, 1998, NEUROSCIENCE, V82, P935; SOYEZ D, 1987, J EXP ZOOL, V244, P479, DOI 10.1002/jez.1402440314; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Spanings-Pierrot C, 2000, GEN COMP ENDOCR, V119, P340, DOI 10.1006/gcen.2000.7527; TANCREDI T, 1991, BIOPOLYMERS, V31, P751, DOI 10.1002/bip.360310620; Treerattrakool S, 2003, MAR BIOTECHNOL, V5, P373, DOI 10.1007/s10126-002-0078-x; Tsutsui N, 2005, GEN COMP ENDOCR, V144, P232, DOI 10.1016/j.ygcen.2005.06.001; von Eggelkraut-Gottanka R, 2003, TETRAHEDRON LETT, V44, P3551, DOI 10.1016/S0040-4039(03)00582-3; WEBSTER SG, 1986, J COMP PHYSIOL B, V156, P617, DOI 10.1007/BF00692738; WEIDEMANN W, 1989, FEBS LETT, V257, P31, DOI 10.1016/0014-5793(89)81778-8; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30052	10.1371/journal.pone.0030052	http://dx.doi.org/10.1371/journal.pone.0030052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253873	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700080
J	Cho, HR; Choi, SH; Lee, N; Hyeon, T; Kim, H; Moon, WK				Cho, Hye Rim; Choi, Seung Hong; Lee, Nohyun; Hyeon, Taeghwan; Kim, Hyeonjin; Moon, Woo Kyung			Macrophages Homing to Metastatic Lymph Nodes Can Be Monitored with Ultrasensitive Ferromagnetic Iron-Oxide Nanocubes and a 1.5T Clinical MR Scanner	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; SINGLE CELLS; STEM-CELLS; RAT MODEL; VIVO; CANCER; TUMORS; RECRUITMENT; SURVIVAL; BRAIN	Background: Due to the ability of macrophages to specifically home to tumors, their potential use as a delivery vehicle for cancer therapeutics has been suggested. Tracking the delivery and engraftment of macrophages into human tumors with a 1.5T clinical MR scanner requires the development of sensitive contrast agents for cell labeling. Therefore, this study aimed to determine whether intravenously injected macrophages could target a primary tumor as well as metastatic LNs, and whether these cells could be detected in vivo by MRI. Methodology: Peritoneal macrophages were obtained from BALB/c nude mice. The viability, phagocytotic capacity and migratory activity of the macrophages were assessed. MR imaging was performed using a clinical 1.5 T MR scanner and we estimated the T2* of the labeled macrophages. Metastatic lymph nodes were produced in BALB/c nude mice. We administrated 2x10(6) macrophages labeled with 50 mu g Fe/mL FIONs intravenously into the mice. In the 3D T2* GRE MR images obtained one day after the injection of the labeled macrophages or FION solution, the percentages of pixels in the tumors or LNs below the minimum normalized SI (signal intensity) threshold were summated and reported as the black pixel count (%) for the FION hypointensity. Tumors in the main tumor model as well as the brachial, axillary and inguinal lymph nodes in the metastatic LN models were removed and stained. For all statistical analyses, single-group data were assessed using t test or the Mann-Whitney test. Repeated measurements analysis of variance (ANOVA) with Tukey-Kramer post hoc comparisons were performed for multiple comparisons. Conclusions: The FION-labeled macrophages, which could be non-invasively monitored using a 1.5 T clinical MR scanner, targeted both the main tumors and LN metastases. Overall, the results of this study suggest that the use of macrophages may have many future applications in the clinic for vectorizing therapeutic agents toward main tumors as well as LN metastases.	[Cho, Hye Rim; Choi, Seung Hong; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Cho, Hye Rim; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Radiat Appl Life Sci, Seoul, South Korea; [Lee, Nohyun; Hyeon, Taeghwan] Seoul Natl Univ, Natl Creat Res Initiat Ctr Oxide Nanocrystalline, Seoul, South Korea; [Lee, Nohyun; Hyeon, Taeghwan] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Cho, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	moonwk@snu.ac.kr	Lee, Nohyun/K-5712-2013; Hyeon, Taeghwan/J-5315-2012; Kim, Hyeonjin/M-3761-2019; Kim, Hyeonjin/J-2751-2012; Moon, Woo Kyung/J-2755-2012; Lee, Junyoung/D-5463-2012	Lee, Junyoung/0000-0001-6689-2759; Choi, Seung Hong/0000-0002-0412-2270	NRF; MEST [20090080219]; Ministry of Health & Welfare, Republic of Korea [A01185, 1120300]	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Mid-Career Researcher Program through a NRF grant funded by the MEST (No. 20090080219), a grant from the National R&D Program for Cancer Control, the Ministry of Health & Welfare, Republic of Korea (A01185), and a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Chae EY, 2010, RADIOLOGY, V256, P847, DOI 10.1148/radiol.10091732; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; CLAASEN HHV, 1992, LAB INVEST, V67, P166; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deepak P, 2010, INT REV IMMUNOL, V29, P421, DOI 10.3109/08830185.2010.483027; Ehtesham M, 2002, CANCER RES, V62, P5657; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fortier AH, 2005, CURRENT PROTOCOLS IM, P141111; Foster P, 2008, NEOPLASIA, V10, P207, DOI 10.1593/neo.07937; Hauger O, 2000, RADIOLOGY, V217, P819, DOI 10.1148/radiology.217.3.r00dc04819; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A; Kim D, 2009, J AM CHEM SOC, V131, P454, DOI 10.1021/ja8086906; Lee JS, 2008, EUR RADIOL, V18, P2033, DOI 10.1007/s00330-008-0975-0; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Lee N, 2011, P NATL ACAD SCI USA, V108, P2662, DOI 10.1073/pnas.1016409108; Loebinger MR, 2009, CANCER RES, V69, P8862, DOI 10.1158/0008-5472.CAN-09-1912; MCBRIDE WH, 1986, BIOCHIM BIOPHYS ACTA, V865, P27, DOI 10.1016/0304-419X(86)90011-9; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Modo M, 2005, MOL IMAGING, V4, P143; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nguyen DX, 2011, J PATHOL, V223, P195, DOI 10.1002/path.2801; Ohlfest JR, 2005, MOL THER, V12, P778, DOI 10.1016/j.ymthe.2005.07.689; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; STEPHENS TC, 1978, BRIT J CANCER, V38, P573, DOI 10.1038/bjc.1978.252; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; Valable S, 2007, NEUROIMAGE, V37, pS47, DOI 10.1016/j.neuroimage.2007.05.041; Virchow R., 1863, KRANKHAFTEN GESCHWUL, P57; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009	38	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					90	99	e29575	10.1371/journal.pone.0029575	http://dx.doi.org/10.1371/journal.pone.0029575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253739	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900010
J	Laurent, S; Burtea, C; Thirifays, C; Hafeli, UO; Mahmoudi, M				Laurent, Sophie; Burtea, Carmen; Thirifays, Coralie; Haefeli, Urs O.; Mahmoudi, Morteza			Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and "Cell Vision"	PLOS ONE			English	Article								Until now, the results of nanotoxicology research have shown that the interactions between nanoparticles (NPs) and cells are remarkably complex. In order to get a deep understanding of the NP-cell interactions, scientists physicochemical effects. However, there are still considerable debates about the regulation of nanomaterials and the reported results are usually in contradictions. Here, we are going to introduce the potential key reasons for these conflicts. In this case, modification of conventional in vitro toxicity assays, is one of the crucial ignored matter in nanotoxicological sciences. More specifically, the conventional methods neglect important factors such as the sedimentation of NPs and absorption of proteins and other essential biomolecules onto the surface of NPs. Another ignored matter in nanotoxicological sciences is the effect of cell "vision" (i.e., cell type). In order to show the effects of these ignored subjects, we probed the effect of superparamagnetic iron oxide NPs (SPIONs), with various surface chemistries, on various cell lines. We found that the modification of conventional toxicity assays and the consideration of the "cell vision" concept are crucial matters to obtain reliable, and reproducible nanotoxicology data. These new concepts offer a suitable way to obtain a deep understanding on the cell-NP interactions. In addition, by consideration of these ignored factors the conflict of future toxicological reports would be significantly decreased.	[Laurent, Sophie; Burtea, Carmen; Thirifays, Coralie] Univ Mons, Dept Gen Organ & Biomed Chem, Nucl Magnet Resonance & Mol Imaging Lab, B-7000 Mons, Belgium; [Haefeli, Urs O.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Mahmoudi, Morteza] Pasteur Inst Iran, Natl Cell Bank, Tehran, Iran; [Mahmoudi, Morteza] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran, Iran	University of Mons; University of British Columbia; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences	Laurent, S (corresponding author), Univ Mons, Dept Gen Organ & Biomed Chem, Nucl Magnet Resonance & Mol Imaging Lab, B-7000 Mons, Belgium.	Mahmoudi@biospion.com	Mahmoudi, Morteza/L-5332-2017; Hafeli, Urs O/B-4097-2012; Burtea, Carmen/L-6223-2016; Mahmoudi, Morteza/F-3432-2011	Mahmoudi, Morteza/0000-0002-2575-9684; Burtea, Carmen/0000-0002-1117-1935; Mahmoudi, Morteza/0000-0002-2575-9684; Hafeli, Urs/0000-0003-0671-4509	European Science Foundation	European Science Foundation(European Science Foundation (ESF)European Commission)	This work was partially supported by the European Science Foundation for the activity entitled 'Mapping the Detailed Composition of Surface-Absorbed Protein Layers on Biomaterials and Nanoparticles'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT NANOTECHNOL, V6, P329, DOI 10.1038/nnano.2011.87; Bolton S., 1990, PHARM STAT PRACTICAL; Chiaramonte R, 2001, J CELL BIOCHEM, V82, P437, DOI 10.1002/jcb.1158; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/nnano.2011.58, 10.1038/NNANO.2011.58]; Chung LWK, 2003, UROLOGY, V62, P44, DOI 10.1016/S0090-4295(03)00796-9; Gu F, 2009, FORMULATION PREPARAT, P589; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832; Mahmoudi M, 2010, COLLOID SURFACE B, V75, P300, DOI 10.1016/j.colsurfb.2009.08.044; Mahmoudi M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225104; Maynard AD, 2007, ANN OCCUP HYG, V51, P1, DOI 10.1093/annhyg/mel071; Nelson D.L., LEHNINGER PRINCIPLES, Vthird; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJH, 2010, CONTRAST ME IN PRESS, DOI [10.1002/cmmi.1415, DOI 10.1002/CMMI.1415]; Soenen SJH, 2009, CONTRAST MEDIA MOL I, V4, P207, DOI 10.1002/cmmi.282; Summers H, 2010, NANO TODAY, V5, P83, DOI 10.1016/j.nantod.2010.01.003	19	128	129	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					306	314	e29997	10.1371/journal.pone.0029997	http://dx.doi.org/10.1371/journal.pone.0029997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253854	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900032
J	Yu, WQ; Gotz, F				Yu, Wenqi; Goetz, Friedrich			Cell Wall Antibiotics Provoke Accumulation of Anchored mCherry in the Cross Wall of Staphylococcus aureus	PLOS ONE			English	Article							SURFACE-PROTEINS; SECRETION; SORTASE; PEPTIDE; CARNOSUS; DIVISION; RED	A fluorescence microscopy method to directly follow the localization of defined proteins in Staphylococcus was hampered by the unstable fluorescence of fluorescent proteins. Here, we constructed plasmid (pCX) encoded red fluorescence (RF) mCherry (mCh) hybrids, namely mCh-cyto (no signal peptide and no sorting sequence), mCh-sec (with signal peptide), and mCh-cw (with signal peptide and cell wall sorting sequence). The S. aureus clones targeted mCh-fusion proteins into the cytosol, the supernatant and the cell envelope respectively. in all cased mCherry exhibited bright fluorescence. In staphylococci tow types of signal peptides (SP) can be distinguished: the +YSIRK motif SPlip and the -YSIRK motif SPsasF. mCh-hybrids supplied with the -YSIRK motif SPlip were always expressed higher than those with -YSIRK motif SPsasF. To study the location of the anchoring process and also the influence of SP type, mCh-cw as supplied on the one hand with +YSIRK motif (mCh-cw1) and the other hand with -YSIRK motif (mCh-cw2). MCh-w1 preferentially localized at the cross wall, while mCh-cw2 preferentially localized at the peripheral wall. Interestingly, when treated with sub-lethal concentrations of penicillin or moenomycin, both mCh-cw1 and mCh-cw2 were concentrated at the cross wall. The shift from the peripheral wall to the cross wall required Sortase A (SrtA), as in the srtA mutant this effect was blunted. The effect is most likely due to antibiotic mediated increase of free anchoring sites (Lipid II) at the cross wall, the substrate of SrtA, leading to a preferential incorporation of anchored proteins at the cross wall.	[Yu, Wenqi; Goetz, Friedrich] Univ Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen	Yu, WQ (corresponding author), Univ Tubingen, Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de			DFG (Deutsche Forschungsgemeinschaft) [SFB (Sonderforschungsbereich) 766]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by DFG (Deutsche Forschungsgemeinschaft), SFB (Sonderforschungsbereich) 766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; DEMLEITNER G, 1994, FEMS MICROBIOL LETT, V121, P189, DOI 10.1016/0378-1097(94)90126-0; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; HAHN JJ, 1963, J EXP MED, V118, P659, DOI 10.1084/jem.118.5.659; IZAKI K, 1966, P NATL ACAD SCI USA, V55, P656, DOI 10.1073/pnas.55.3.656; KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Strauss A, 1996, MOL MICROBIOL, V21, P491, DOI 10.1111/j.1365-2958.1996.tb02558.x; Sturmfels A, 2001, ARCH MICROBIOL, V175, P295, DOI 10.1007/s002030100266; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; VANHEIJENOORT Y, 1987, J GEN MICROBIOL, V133, P667; Weidenmaier C, 2008, INT J MED MICROBIOL, V298, P505, DOI 10.1016/j.ijmm.2007.11.006; WIELAND KP, 1995, GENE, V158, P91, DOI 10.1016/0378-1119(95)00137-U	35	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					384	392	e30076	10.1371/journal.pone.0030076	http://dx.doi.org/10.1371/journal.pone.0030076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253886	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900039
J	Morandi, F; Scaruffi, P; Gallo, F; Stigliani, S; Moretti, S; Bonassi, S; Gambini, C; Mazzocco, K; Fardin, P; Haupt, R; Arcamone, G; Pistoia, V; Tonini, GP; Corrias, MV				Morandi, Fabio; Scaruffi, Paola; Gallo, Fabio; Stigliani, Sara; Moretti, Stefano; Bonassi, Stefano; Gambini, Claudio; Mazzocco, Katia; Fardin, Paolo; Haupt, Riccardo; Arcamone, Giampaolo; Pistoia, Vito; Tonini, Gian Paolo; Corrias, Maria Valeria		Italian Cooperative Grp	Bone Marrow-Infiltrating Human Neuroblastoma Cells Express High Levels of Calprotectin and HLA-G Proteins	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; STROMAL CELLS; TASK-FORCE; QRT-PCR; MOLECULE; SYSTEM; CANCER; CRITERIA; SURVIVAL; TUMORS	Metastases in the bone marrow (BM) are grim prognostic factors in patients with neuroblastoma (NB). In spite of extensive analysis of primary tumor cells from high- and low-risk NB patients, a characterization of freshly isolated BM-infiltrating metastatic NB cells is still lacking. Our aim was to identify proteins specifically expressed by metastatic NB cells, that may be relevant for prognostic and therapeutic purposes. Sixty-six Italian children over 18 months of age, diagnosed with stage 4 NB, were included in the study. Metastatic NB cells were freshly isolated from patients' BM by positive immunomagnetic bead manipulation using anti-GD2 monoclonal antibody. Gene expression profiles were compared with those obtained from archived NB primary tumors from patients with 5y-follow-up. After validation by RT-qPCR, expression/secretion of the proteins encoded by the up-regulated genes in the BM-infiltrating NB cells was evaluated by flow cytometry and ELISA. Compared to primary tumor cells, BM-infiltrating NB cells down-modulated the expression of CX3CL1, AGT, ATP1A2 mRNAs, whereas they up-regulated several genes commonly expressed by various lineages of BM resident cells. BM-infiltrating NB cells expressed indeed the proteins encoded by the top-ranked genes, S100A8 and A9 (calprotectin), CD177 and CD3, and secreted the CXCL7 chemokine. BM-infiltrating NB cells also expressed CD271 and HLA-G. We have identified proteins specifically expressed by BM-infiltrating NB cells. Among them, calprotectin, a potent inflammatory protein, and HLA-G, endowed with tolerogenic properties facilitating tumor escape from host immune response, may represent novel biomarkers and/or targets for therapeutic intervention in high-risk NB patients.	[Morandi, Fabio; Pistoia, Vito; Corrias, Maria Valeria] Gaslini Inst, Lab Oncol, Genoa, Italy; [Scaruffi, Paola; Gallo, Fabio; Stigliani, Sara; Mazzocco, Katia; Tonini, Gian Paolo] Natl Inst Canc Res, Genoa, Italy; [Moretti, Stefano] Univ Paris 09, LAMSADE, CNRS, Paris, France; [Bonassi, Stefano] IRCCS San Raffaele Pisana, Rome, Italy; [Gambini, Claudio] Gaslini Inst, Sci Directorate, Serv Pathol, Genoa, Italy; [Fardin, Paolo] Gaslini Inst, Sci Directorate, Mol Biol Lab, Genoa, Italy; [Haupt, Riccardo] Gaslini Inst, Sci Directorate, Lab Epidemiol, Genoa, Italy; [Haupt, Riccardo] Gaslini Inst, Sci Directorate, Biostat Sect, Genoa, Italy; [Arcamone, Giampaolo] Policlin Univ Bari, Bari, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; IRCCS San Raffaele Pisana; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita degli Studi di Bari Aldo Moro	Morandi, F (corresponding author), Gaslini Inst, Lab Oncol, Genoa, Italy.	gianpaolo.tonini@istge.it	Haupt, Riccardo/AAA-7437-2020; mazzocco, katia/AAA-7357-2020; Bonassi, Stefano/ABI-6281-2020; Scaruffi, Paola/AAB-3999-2020; stigliani, sara/AAB-2797-2020; Corrias, Maria Valeria/E-4571-2011; Morandi, Fabio/I-1185-2012	Haupt, Riccardo/0000-0003-0571-8460; mazzocco, katia/0000-0002-6599-5681; Bonassi, Stefano/0000-0003-3833-6717; stigliani, sara/0000-0001-5115-2520; Corrias, Maria Valeria/0000-0002-7316-0772; Morandi, Fabio/0000-0002-2849-7595; scaruffi, paola/0000-0001-9799-1661	Fondazione Italiana per la Lotta al Neuroblastoma; Ministero dell'Universita, Ricerca Scientifica e Tecnologica; Regione Liguria; Ministero della Salute	Fondazione Italiana per la Lotta al Neuroblastoma; Ministero dell'Universita, Ricerca Scientifica e Tecnologica; Regione Liguria(Regione Liguria); Ministero della Salute(Ministry of Health, Italy)	This study was supported by Fondazione Italiana per la Lotta al Neuroblastoma ("Bone marrow microenvironment'' to M.V.C., "Identification of a genetic signature associated with disease progression in high-risk neuroblastoma'' to P.S.), by Ministero dell'Universita, Ricerca Scientifica e Tecnologica ("Development of nanopore-array prototype to detect gene expression'' to P.S.), by Regione Liguria ("Identification of tumor biomarkers through a biology-driven integrated approach'' to S.S.), and by Ministero della Salute ("New immunotherapeutic approaches to neuroblastoma'' to M.V.C.). K.M. and P.F. were recipients of Fondazione Italiana per la Lotta al Neuroblastoma fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Bassili M, 2010, CANCER CHEMOTH PHARM, V65, P1047, DOI 10.1007/s00280-009-1110-x; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Beiske K, 2009, BRIT J CANCER, V100, P1627, DOI 10.1038/sj.bjc.6605029; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Bilke S, 2008, CLIN CANCER RES, V14, P5540, DOI 10.1158/1078-0432.CCR-07-4461; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Coco S, 2005, J PATHOL, V207, P346, DOI 10.1002/path.1843; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Conte M, 2006, CANCER, V106, P1409, DOI 10.1002/cncr.21751; Corrias MV, 2008, BRIT J CANCER, V98, P263, DOI 10.1038/sj.bjc.6604179; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Garaventa A, 2009, EUR J CANCER, V45, P2835, DOI 10.1016/j.ejca.2009.06.010; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Ito Y, 2005, PATHOL RES PRACT, V201, P551, DOI 10.1016/j.prp.2005.08.003; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Miettinen M, 1998, AM J SURG PATHOL, V22, P327, DOI 10.1097/00000478-199803000-00007; Morandi F, 2007, CANCER RES, V67, P6433, DOI 10.1158/0008-5472.CAN-06-4588; Morozova O, 2010, CLIN CANCER RES, V16, P4572, DOI 10.1158/1078-0432.CCR-10-0627; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Pagnan G, 1999, INT J CANCER, V81, P268, DOI 10.1002/(SICI)1097-0215(19990412)81:2<268::AID-IJC17>3.3.CO;2-T; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003; Scaruffi P, 2011, PEDIAT BLOOD CANC; Scaruffi P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-441; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; Stievano L, 2004, CRIT REV IMMUNOL, V24, P205, DOI 10.1615/CritRevImmunol.v24.i3.40; Swerts K, 2005, J HISTOCHEM CYTOCHEM, V53, P1433, DOI 10.1369/jhc.5C6661.2005; Tang Z, 2008, AM J SURG, V196, P690, DOI 10.1016/j.amjsurg.2008.08.001; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Viprey VF, 2007, EUR J CANCER, V43, P341, DOI 10.1016/j.ejca.2006.08.007; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wachowiak R, 2008, PEDIATR SURG INT, V24, P1361, DOI 10.1007/s00383-008-2264-z; Zeng Y, 2007, CANCER RES, V67, P2331, DOI 10.1158/0008-5472.CAN-06-3041	48	32	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29922	10.1371/journal.pone.0029922	http://dx.doi.org/10.1371/journal.pone.0029922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253825	Green Published, Green Submitted, gold			2022-12-25	WOS:000301352400007
J	Rehman, S; Husain, M; Yadav, A; Kasinath, BS; Malhotra, A; Singhal, PC				Rehman, Shabina; Husain, Mohammad; Yadav, Anju; Kasinath, Balakuntalam S.; Malhotra, Ashwani; Singhal, Pravin C.			HIV-1 Promotes Renal Tubular Epithelial Cell Protein Synthesis: Role of mTOR Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; POLYCYSTIC KIDNEY-DISEASE; MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; ELONGATION FACTOR-2; SIGNALING PATHWAY; MAMMALIAN-TARGET; OXIDATIVE STRESS; C-ELEGANS; RAPAMYCIN	Tubular cell HIV-infection has been reported to manifest in the form of cellular hypertrophy and apoptosis. In the present study, we evaluated the role of mammalian target of rapamycin (mTOR) pathway in the HIV induction of tubular cell protein synthesis. Mouse proximal tubular epithelial cells (MPTECs) were transduced with either gag/pol-deleted NL4-3 (HIV/MPTEC) or empty vector (Vector/MPTEC). HIV/MPTEC showed enhanced DNA synthesis when compared with Vector/MPTECs by BRDU labeling studies. HIV/MPTECs also showed enhanced production of beta-laminin and fibronection in addition to increased protein content per cell. In in vivo studies, renal cortical sections from HIV transgenic mice and HIVAN patients showed enhanced tubular cell phosphorylation of mTOR. Analysis of mTOR revealed increased expression of phospho (p)-mTOR in HIV/MPTECs when compared to vector/MPTECs. Further downstream analysis of mTOR pathway revealed enhanced phosphorylation of p70S6 kinase and associated diminished phosphorylation of eEF2 (eukaryotic translation elongation factor 2) in HIV/MPTECs; moreover, HIV/MPTECs displayed enhanced phosphorylation of eIF4B (eukaryotic translation initiation factor 4B) and 4EBP-1 (eukaryotic 4E binding protein). To confirm our hypothesis, we evaluated the effect of rapamycin on HIV-induced tubular cell downstream signaling. Rapamycin not only attenuated phosphorylation of p70S6 kinase and associated down stream signaling in HIV/MPTECs but also inhibited HIV-1 induced tubular cell protein synthesis. These findings suggest that mTOR pathway is activated in HIV-induced enhanced tubular cell protein synthesis and contributes to tubular cell hypertrophy.	[Rehman, Shabina; Husain, Mohammad; Yadav, Anju; Malhotra, Ashwani; Singhal, Pravin C.] North Shore LIJ Hlth Syst, Dept Med, New York, NY USA; [Kasinath, Balakuntalam S.] Texas Hlth Sci Ctr, Dept Med, San Antonio, TX USA	Northwell Health; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health San Antonio	Singhal, PC (corresponding author), North Shore LIJ Hlth Syst, Dept Med, New York, NY USA.	psinghal@nshs.edu	Rehman, Shabina/E-7470-2015	Rehman, Shabina/0000-0003-2613-8537; Singhal, Pravin/0000-0002-6898-358X; Husain, Mohammad/0000-0003-3876-8181	National Institutes of Health, Bethesda, Maryland [RO1DK084910, RO1 DK083931, RO1DK077295]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084910, R01DK083931, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants RO1DK084910 (PCS), RO1 DK083931 (PCS) and RO1DK077295 (BSK) from the National Institutes of Health, Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Bijian K, 2005, CONTRIB NEPHROL, V148, P8, DOI 10.1159/000086039; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Brenner BM, 1997, KIDNEY INT, pS124; Chen JK, 2009, AM J PHYSIOL-RENAL, V297, pF585, DOI 10.1152/ajprenal.00186.2009; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; Di Benedetto F, 2010, TRANSPLANTATION, V89, P733, DOI 10.1097/TP.0b013e3181c7dcc0; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Heredia A, 2008, P NATL ACAD SCI USA, V105, P20476, DOI 10.1073/pnas.0810843106; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Kasinath BS, 2006, J AM SOC NEPHROL, V17, P3281, DOI 10.1681/ASN.2006050488; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kramer S, 2008, AM J PHYSIOL-RENAL, V294, pF440, DOI 10.1152/ajprenal.00379.2007; Kumar D, 2010, AM J PATHOL, V177, P813, DOI 10.2353/ajpath.2010.100131; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136; Nairn AC, 2001, PROG MOLEC, V27, P91; Nicoletti F, 2009, CLIN EXP IMMUNOL, V155, P28, DOI 10.1111/j.1365-2249.2008.03780.x; Nicoletti F, 2011, DRUG DISCOV TODAY, V16, P715, DOI 10.1016/j.drudis.2011.05.008; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Redpath NT, 1996, J BIOL CHEM, V271, P17547, DOI 10.1074/jbc.271.29.17547; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Weir M R, 2009, Transplant Proc, V41, pS13, DOI 10.1016/j.transproceed.2009.06.096; Wittmann S, 2008, NEPHRON EXP NEPHROL, V108, P45, DOI 10.1159/000116112; WOLF G, 1994, J AM SOC NEPHROL, V4, P1995; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009; Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30071	10.1371/journal.pone.0030071	http://dx.doi.org/10.1371/journal.pone.0030071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253885	Green Submitted, Green Published, gold			2022-12-25	WOS:000315865800025
J	Zhuge, ZY; Zhu, YH; Liu, PQ; Yan, XD; Yue, Y; Weng, XG; Zhang, R; Wang, JF				Zhuge, Zeng-Yu; Zhu, Yao-Hong; Liu, Pan-Qi; Yan, Xiao-Dong; Yue, Yuan; Weng, Xiao-Gang; Zhang, Rong; Wang, Jiu-Feng			Effects of Astragalus Polysaccharide on Immune Responses of Porcine PBMC Stimulated with PRRSV or CSFV	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; MESSENGER-RNA EXPRESSION; IN-VITRO; PROINFLAMMATORY CYTOKINES; DIFFERENTIAL REGULATION; HOST RESPONSE; IFN-GAMMA; CD28; CD8(+); CTLA-4	Background: Astragalus polysaccharide (APS) has been used as an immunomodulator that can enhance immune responses, whereas the immunomodulatory effects of APS on porcine peripheral blood mononuclear cells (PBMCs) exposed to porcine reproductive and respiratory syndrome virus (PRRSV) and classical swine fever virus (CSFV) have not been investigated. Methodology/Principal Findings: Porcine PBMCs were cultured in complete RPMI media in the presence of the R98-strain of PRRSV (5 x 10(4) TCID50/ml) or C-strain of CSFV (10(3) TCID50/ml) with or without APS. The expression of mRNA for CD28, cytotoxic T-lymphocyte antigen 4 (CTLA-4), transforming growth factor-beta (TGF-beta), interleukin 2 (IL-2) and IL-10 was assayed by TaqMan real-time RT-PCR. The expression of mRNA for CD28 and CTLA-4 increased at 24 h after stimulation of PBMCs with CSFV and the increased production of CTLA-4 was confirmed by western blot analysis, whereas the increases were inhibited by the addition of APS. In addition, APS alone upregulated IL-2 and TGF-beta mRNA expression in PBMCs and the addition of APS had the capacity to prevent a further increase in IL-2 mRNA expression in PBMCs during CSFV or PRRSV infection, but had no effect on TGF-beta mRNA expression. The production of tumor necrosis factor-alpha (TNF-alpha) increased at 12 h after stimulation with PRRSV or CSFV, but not with PRRSV plus APS or CSFV plus APS, whereas the addition of APS to PBMCs infected with PRRSV or CSFV promoted IL-10 mRNA expression. Conclusions: We suggested that APS had immunomodulatory effects on cells exposed to PRRSV or CSFV. It might be that APS via different mechanisms affects the activities of immune cells during either PRRSV or CSFV infection. This possibility warrants further studies to evaluate whether APS would be an effective adjuvant in vaccines against PRRSV or CSFV.	[Zhuge, Zeng-Yu; Zhu, Yao-Hong; Liu, Pan-Qi; Yan, Xiao-Dong; Yue, Yuan; Weng, Xiao-Gang; Zhang, Rong; Wang, Jiu-Feng] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University	Wang, JF (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	Jiufeng_wang@hotmail.com			Program for New Century Excellent Talents in University (China) [NCET-08-0816]; Special Fund for Agro-Scientific Research in the Public Interest (China) [201003060-07]; National Key Program of China [2009ZX08009-152B]	Program for New Century Excellent Talents in University (China)(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-Scientific Research in the Public Interest (China); National Key Program of China	This project was supported by grants from the Program for New Century Excellent Talents in University (China) (Project No. NCET-08-0816) and the Special Fund for Agro-Scientific Research in the Public Interest (China) (Project No. 201003060-07), and the National Key Program of China (Project No. 2009ZX08009-152B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1998, VET IMMUNOL IMMUNOP, V61, P49, DOI 10.1016/S0165-2427(97)00134-7; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bautista EM, 1999, ARCH VIROL, V144, P1191, DOI 10.1007/s007050050578; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001; Cho WCS, 2007, J ETHNOPHARMACOL, V113, P132, DOI 10.1016/j.jep.2007.05.020; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Dotti S, 2011, RES VET SCI, V90, P218, DOI 10.1016/j.rvsc.2010.06.011; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Jiang JB, 2010, VACCINE, V28, P5614, DOI 10.1016/j.vaccine.2010.06.025; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Knoetig SM, 1999, IMMUNOLOGY, V97, P359, DOI 10.1046/j.1365-2567.1999.00775.x; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Liu QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019811; Mao XF, 2005, J ANIM SCI, V83, P2775; Martelli P, 2007, VACCINE, V25, P3400, DOI 10.1016/j.vaccine.2006.12.050; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Ndejembi MP, 2006, J IMMUNOL, V177, P7698, DOI 10.4049/jimmunol.177.11.7698; Paton DJ, 2003, RES VET SCI, V75, P169, DOI 10.1016/S0034-5288(03)00076-6; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Shao P, 2006, INT IMMUNOPHARMACOL, V6, P1161, DOI 10.1016/j.intimp.2006.02.009; Summerfield A, 1998, J VIROL, V72, P1853, DOI 10.1128/JVI.72.3.1853-1861.1998; Sun JL, 2006, VACCINE, V24, P2343, DOI 10.1016/j.vaccine.2005.11.053; Suradhat S, 2003, J GEN VIROL, V84, P2755, DOI 10.1099/vir.0.19230-0; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Thanawongnuwech R, 2001, VET IMMUNOL IMMUNOP, V79, P115, DOI 10.1016/S0165-2427(01)00243-4; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Wang DY, 2006, VACCINE, V24, P7109, DOI 10.1016/j.vaccine.2006.07.005; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei K, 2011, VACCINE, V29, P2530, DOI 10.1016/j.vaccine.2011.01.068; Yuan CT, 2008, INT IMMUNOPHARMACOL, V8, P51, DOI 10.1016/j.intimp.2007.10.009; Zhang NW, 2010, CARBOHYD POLYM, V82, P680, DOI 10.1016/j.carbpol.2010.05.030; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhu YH, 2008, VET IMMUNOL IMMUNOP, V125, P182, DOI 10.1016/j.vetimm.2008.05.002	48	26	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29320	10.1371/journal.pone.0029320	http://dx.doi.org/10.1371/journal.pone.0029320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253710	Green Submitted, Green Published, gold			2022-12-25	WOS:000315865800006
J	Fassl, A; Tagscherer, KE; Richter, J; Diaz, MB; Llaguno, SRA; Campos, B; Kopitz, J; Herold-Mende, C; Herzig, S; Schmidt, MHH; Parada, LF; Wiestler, OD; Roth, W				Fassl, A.; Tagscherer, K. E.; Richter, J.; Diaz, M. Berriel; Llaguno, S. R. Alcantara; Campos, B.; Kopitz, J.; Herold-Mende, C.; Herzig, S.; Schmidt, M. H. H.; Parada, L. F.; Wiestler, O. D.; Roth, W.			Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1	ONCOGENE			English	Article						glioblastoma; apoptosis; Notch1; Mcl-1; EGFR	GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELLS; MALIGNANT GLIOMA; BRAIN-TUMORS; EXPRESSION; PATHWAY; ACTIVATION; ORIGIN; BCL-2; P53	The Notch1-mediated signaling pathway has a central role in the maintenance of neural stem cells and contributes to growth and progression of glioblastomas, the most frequent malignant brain tumors in adults. Here, we demonstrate that the Notch1 receptor promotes survival of glioblastoma cells by regulation of the anti-apoptotic Mcl-1 protein. Notch1-dependent regulation of Mcl-1 occurs cell type dependent at a transcriptional or post-translational level and is mediated by the induction of epidermal growth factor receptor (EGFR). Inhibition of the Notch1 pathway overcomes apoptosis resistance and sensitizes glioblastoma cells to apoptosis induced by ionizing radiation, the death ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) or the Bcl-2/Bcl-XL inhibitor ABT-737. In conclusion, targeting Notch1 might represent a promising novel strategy in the treatment of glioblastomas.	[Diaz, M. Berriel; Herzig, S.] Univ Heidelberg, Ctr Mol Biol, DKFZ, Joint Div Mol Metab Control, D-6900 Heidelberg, Germany; [Diaz, M. Berriel; Herzig, S.] Univ Heidelberg Hosp, Heidelberg, Germany; [Llaguno, S. R. Alcantara; Parada, L. F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Campos, B.; Herold-Mende, C.] Univ Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Kopitz, J.; Roth, W.] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany; [Schmidt, M. H. H.] Goethe Univ Frankfurt, Inst Neurol, Frankfurt, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Roth, W (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	W.Roth@dkfz.de	Tagscherer, Katrin/AAS-3809-2021; Parada, luis F/B-9400-2014; Diaz, Mauricio Berriel/AAF-8285-2021; Fassl, Anne/AAA-5249-2022; Schmidt, Mirko H. H./ABI-6650-2020	Tagscherer, Katrin/0000-0002-0657-6399; Schmidt, Mirko H. H./0000-0001-7411-8835; Berriel Diaz, Mauricio/0000-0003-4670-919X; Alcantara, Sheila/0000-0002-1586-4384; Herzig, Stephan/0000-0003-3950-3652	Deutsche Krebshilfe (German Cancer Aid)	Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe)	We thank Tabea Sinkovic and Martina Keith for technical assistance. We further thank Anja Reimann (Molecular Metabolic Control, DKFZ, Heidelberg, Germany) for help with purification of recombinant adenoviruses, David Capper, David Reuss and Andreas v Deimling (Department of Neuropathology, University of Heidelberg, Germany) for providing histological sections of glioblastomas and Tamara Quandel, Lodovica Borghese, Philipp Koch and Oliver Brustle (Institute of Reconstructive Neurobiology, Life and Brain, Bonn, Germany) for providing cell pellets and RNA from neural stem cells. This work was supported by a grant from the Deutsche Krebshilfe to WR (German Cancer Aid, Max Eder Program).	Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Capper D, 2009, ACTA NEUROPATHOL, V117, P445, DOI 10.1007/s00401-009-0494-3; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Karcher S, 2006, INT J CANCER, V118, P2182, DOI 10.1002/ijc.21648; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krajewski S, 1997, AM J PATHOL, V150, P805; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Liu WH, 2007, EMBO J, V26, P1660, DOI 10.1038/sj.emboj.7601611; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yoon JH, 2002, CANCER RES, V62, P6500; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	50	53	55	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	44					4698	4708		10.1038/onc.2011.615	http://dx.doi.org/10.1038/onc.2011.615			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22249262				2022-12-25	WOS:000310724400005
J	Brimer, N; Lyons, C; Wallberg, AE; Vande Pol, SB				Brimer, N.; Lyons, C.; Wallberg, A. E.; Vande Pol, S. B.			Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling	ONCOGENE			English	Article						CBF1; RBP-J; RBP-Jk; squamous; epithelial; transformation	SQUAMOUS-CELL CARCINOMA; CERVICAL-CANCER CELLS; TUMOR-SUPPRESSOR FUNCTION; TERMINAL DIFFERENTIATION; GROWTH ARREST; TYPE-1 E6; TRANSCRIPTIONAL COACTIVATOR; HUMAN KERATINOCYTES; NEOPLASTIC LESIONS; HUMAN HOMOLOG	Papillomavirus E6 oncoproteins associate with LXXLL motifs on target cellular proteins to alter their function. Using a proteomic approach, we found the E6 oncoproteins of cutaneous papillomaviruses Bovine Papillomavirus Type 1 (BPV-1) E6 and human papillomavirus (HPV) types 1 and 8 (1E6 and 8E6) associated with the MAML1 transcriptional co-activator. All three E6 proteins bind to an acidic LXXLL motif at the carboxy-terminus of MAML1 and repress transactivation by MAML1. MAML1 is best known as the co-activator and effector of NOTCH-induced transcription, and BPV-1 E6 represses synthetic NOTCH-responsive promoters, endogenous NOTCH-responsive promoters, and is found in a complex with MAML1 in stably transformed cells. BPV-1-induced papillomas show characteristics of repressed NOTCH signal transduction, including suprabasal expression of integrins, talin and basal type keratins, and delayed expression of the NOTCH-dependent HES1 transcription factor. These observations give rise to a model whereby papillomavirus oncoproteins, including BPV-1 E6, and the cancer-associated HPV-8 E6 repress NOTCH-induced transcription, thereby delaying keratinocyte differentiation.	[Brimer, N.; Lyons, C.; Vande Pol, S. B.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Wallberg, A. E.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	University of Virginia; Karolinska Institutet	Vande Pol, SB (corresponding author), Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	vandepol@virginia.edu	Pol, Scott Vande/AAO-1068-2020	Pol, Scott Vande/0000-0002-0587-4802	NIH [CA120352, CA08093]; Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA134737, R01CA120352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SVP, NB and CL were supported by NIH grants (CA120352 and CA08093) to SVP, and institutional support from the University of Virginia and the Department of Pathology Mass Spectrometry Facility. AEW is supported by the Swedish Research Council. We would like to thank Janet Cross and Benjamin Purow at UVA for helpful discussions and critical reading of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; CHOW LT, 1994, INTERVIROLOGY, V37, P150, DOI 10.1159/000150373; Cooper B, 2006, VIROLOGY, V355, P102, DOI 10.1016/j.virol.2006.06.032; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; Das K, 2000, J VIROL, V74, P812, DOI 10.1128/JVI.74.2.812-816.2000; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Elston RC, 1998, J GEN VIROL, V79, P371, DOI 10.1099/0022-1317-79-2-371; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jin YH, 2009, MOL CELLS, V27, P15, DOI 10.1007/s10059-009-0001-7; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; KAISER HW, 1993, J INVEST DERMATOL, V101, P789, DOI 10.1111/1523-1747.ep12371696; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lathion S, 2003, CANCER RES, V63, P8687; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Peng S, 2011, CELL BIOL INT, V35, P587, DOI 10.1042/CBI20100452; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rangarajan A, 2001, VIROLOGY, V286, P23, DOI 10.1006/viro.2001.0867; Rasul S, 2009, BRIT J CANCER, V100, P1879, DOI 10.1038/sj.bjc.6605034; Ribeiro MSJ, 2009, CURR PROTEIN PEPT SC, V10, P570; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rous P, 1935, J EXP MED, V62, P523, DOI 10.1084/jem.62.4.523; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stubenrauch F, 1999, SEMIN CANCER BIOL, V9, P379, DOI 10.1006/scbi.1999.0141; Sun Xiao-mei, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P369; Talora C, 2005, EXP CELL RES, V305, P343, DOI 10.1016/j.yexcr.2005.01.015; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Tanigaki K, 2010, CURR TOP DEV BIOL, V92, P231, DOI 10.1016/S0070-2153(10)92007-3; Tong X, 1998, J VIROL, V72, P476, DOI 10.1128/JVI.72.1.476-482.1998; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Wade R, 2008, J VIROL, V82, P5962, DOI 10.1128/JVI.02747-07; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang L, 2007, INT J GYNECOL CANCER, V17, P1283, DOI 10.1111/j.1525-1438.2007.00927.x; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; WATT FM, 1993, J CELL SCI, V106, P175; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yao J, 2007, INT J GYNECOL CANCER, V17, P502, DOI 10.1111/j.1525-1438.2007.00872.x; YEDVOBNICK B, 1988, GENETICS, V118, P483; Yu Hai, 2007, Ai Zheng, V26, P148; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	77	93	93	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	43					4639	4646		10.1038/onc.2011.589	http://dx.doi.org/10.1038/onc.2011.589			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22249263	Green Accepted			2022-12-25	WOS:000310528200007
J	Dallosso, AR; Oster, B; Greenhough, A; Thorsen, K; Curry, TJ; Owen, C; Hancock, AL; Szemes, M; Paraskeva, C; Frank, M; Andersen, CL; Malik, K				Dallosso, A. R.; Oster, B.; Greenhough, A.; Thorsen, K.; Curry, T. J.; Owen, C.; Hancock, A. L.; Szemes, M.; Paraskeva, C.; Frank, M.; Andersen, C. L.; Malik, K.			Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways	ONCOGENE			English	Article						colorectal cancer; protocadherin; epigenetic silencing; Wnt; mTOR	DNA METHYLATION; MICROSATELLITE INSTABILITY; GAMMA-PROTOCADHERINS; HOMOPHILIC INTERACTION; CYTOPLASMIC DOMAIN; TUMOR-SUPPRESSOR; HUMAN BREAST; CANCER; GENE; CARCINOMA	Loss of tumour suppressor gene function can occur as a result of epigenetic silencing of large chromosomal regions, referred to as long-range epigenetic silencing (LRES), and genome-wide analyses have revealed that LRES is present in many cancer types. Here we utilize Illumina Beadchip methylation array analysis to identify LRES across 800 kb of chromosome 5q31 in colorectal adenomas and carcinomas (n = 34) relative to normal colonic epithelial DNA (n = 6). This region encompasses 53 individual protocadherin (PCDH) genes divided among three gene clusters. Hypermethylation within these gene clusters is asynchronous; while most PCDH hypermethylation occurs early, and is apparent in adenomas, PCDHGC3 promoter methylation occurs later in the adenoma-carcinoma transition. PCDHGC3 was hypermethylated in 17/28 carcinomas (60.7%) according to methylation array analysis. Quantitative real-time reverse transcription-polymerase chain reaction showed that PCDHGC3 is the highest expressed PCDH in normal colonic epithelium, and that there was a strong reciprocal relationship between PCDHGC3 methylation and expression in carcinomas (R = -0.84). PCDH LRES patterns are reflected in colorectal tumour cell lines; adenoma cell lines are not methylated at PCDHGC3 and show abundant expression at the mRNA and protein level, while the expression is suppressed in hypermethylated carcinoma cell lines (R = -0.73). Short-interfering RNA-mediated reduction of PCDHGC3 led to a decrease of apoptosis in RG/C2 adenoma cells, and overexpression of PCDHGC3 in HCT116 cells resulted in the reduction of colony formation, consistent with tumour suppressor capabilities for PCDHGC3. Further functional analysis showed that PCDHGC3 can suppress Wnt and mammalian target of rapamycin signalling in colorectal cancer cell lines. Taken together, our data suggest that the PCDH LRES is an important tumour suppressor locus in colorectal cancer, and that PCDHGC3 may be a strong marker and driver for the adenoma-carcinoma transition. Oncogene (2012) 31, 4409-4419; doi: 10.1038/onc.2011.609; published online 16 January 2012	[Oster, B.; Thorsen, K.; Andersen, C. L.] Aarhus Univ Hosp, Dept Mol Med, DK-8200 Skejby, Denmark; [Dallosso, A. R.; Curry, T. J.; Owen, C.; Hancock, A. L.; Szemes, M.; Malik, K.] Univ Bristol, Sch Cellular & Mol Med, Canc Epigenet Lab, Bristol BS8 1TD, Avon, England; [Greenhough, A.; Paraskeva, C.] Univ Bristol, Sch Cellular & Mol Med, Colorectal Canc Lab, Bristol, Avon, England; [Frank, M.] Univ Freiburg, Inst Biol 1, Freiburg, Germany	Aarhus University; University of Bristol; University of Bristol; University of Freiburg	Andersen, CL (corresponding author), Aarhus Univ Hosp, Dept Mol Med, DK-8200 Skejby, Denmark.	cla@ki.au.dk; k.t.a.malik@bristol.ac.uk	Andersen, Claus L/C-1477-2017; Greenhough, Alexander/Y-6728-2019; Greenhough, Alexander/J-9308-2012; Andersen, Claus Lindbjerg/A-9217-2012	Greenhough, Alexander/0000-0002-8306-811X; Greenhough, Alexander/0000-0002-8306-811X; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Dallosso, Anthony/0000-0002-1460-2550; Malik, Karim/0000-0002-8965-200X	Wellcome Trust VIP award; Cancer Research UK [C20791/A12743, C19/A11975]; Kidney Research UK; Cancer and Leukaemia in Childhood-Sargent Trust; John and Birthe Meyer Foundation; Lundbeck Foundation; European Union [SYSCOL HEALTHF5-2010-258236]; Cancer Research UK [12743, 11975] Funding Source: researchfish; Kidney Research UK [RP42/2009] Funding Source: researchfish	Wellcome Trust VIP award(Wellcome Trust); Cancer Research UK(Cancer Research UK); Kidney Research UK(Kidney Research UK (KRUK)); Cancer and Leukaemia in Childhood-Sargent Trust; John and Birthe Meyer Foundation; Lundbeck Foundation(Lundbeckfonden); European Union(European Commission); Cancer Research UK(Cancer Research UK); Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by a Wellcome Trust VIP award, Cancer Research UK Grants C20791/A12743 and C19/A11975, Kidney Research UK and the Cancer and Leukaemia in Childhood-Sargent Trust. Further funding was from the John and Birthe Meyer Foundation, the Lundbeck Foundation and The European Union's Seventh Framework Program (SYSCOL HEALTHF5-2010-258236). We thank Dr Greg Phillips for the antibody towards the gamma-PCDH constant domain, Professor Moon for reporter plasmids and Professor Vogelstein for mutant HCT116 cells. We also thank Dr Andrea Buda, Dr Katy Petherick, Dr Zsombor Melegh, Dr Newton Wong and Professor Andrew Silver for helpful discussions and comments.	Ahuja N, 1997, CANCER RES, V57, P3370; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Bass T, 2007, DEV GENES EVOL, V217, P337, DOI 10.1007/s00427-007-0145-4; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Elder DJE, 1996, CANCER RES, V56, P2273; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Greenhough A, 2010, ONCOGENE, V29, P3398, DOI 10.1038/onc.2010.94; Greenspan EJ, 2006, CARCINOGENESIS, V27, P1316, DOI 10.1093/carcin/bgi373; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Lin CY, 2010, J BIOL CHEM, V285, P41675, DOI 10.1074/jbc.M110.179895; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; O'Leary R, 2011, MOL BIOL CELL, V22, P4362, DOI 10.1091/mbc.E11-04-0283; OBATA S, 1995, J CELL SCI, V108, P3765; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; PARASKEVA C, 1989, CANCER RES, V49, P1282; Paz MF, 2003, CANCER RES, V63, P1114; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schmidt WM, 2007, MOL CARCINOGEN, V46, P766, DOI 10.1002/mc.20307; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Wang XZ, 2009, J BIOL CHEM, V284, P2880; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong JJL, 2011, MODERN PATHOL, V24, P396, DOI 10.1038/modpathol.2010.212; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154	57	50	55	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	40					4409	4419		10.1038/onc.2011.609	http://dx.doi.org/10.1038/onc.2011.609			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	017LL	22249255	Green Accepted			2022-12-25	WOS:000309591300007
J	Fernandes, RA; Shore, DA; Vuong, MT; Yu, C; Zhu, XY; Pereira-Lopes, S; Brouwer, H; Fennelly, JA; Jessup, CM; Evans, EJ; Wilson, IA; Davis, SJ				Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Zhu, Xueyong; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Wilson, Ian A.; Davis, Simon J.			T Cell Receptors are Structures Capable of Initiating Signaling in the Absence of Large Conformational Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-RICH SEQUENCE; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; TCR-ALPHA; CD3-EPSILON-GAMMA HETERODIMER; SURFACE MOLECULES; TYROSINE KINASE; TCR/CD3 COMPLEX; LOW-AFFINITY; CD3 COMPLEX	Native and non-native ligands of the T cell receptor (TCR), including antibodies, have been proposed to induce signaling in T cells via intra- or intersubunit conformational rearrangements within the extracellular regions of TCR complexes. We have investigated whether any signatures can be found for such postulated structural changes during TCR triggering induced by antibodies, using crystallographic and mutagenesis-based approaches. The crystal structure of murine CD3 epsilon complexed with the mitogenic anti-CD3 epsilon antibody 2C11 enabled the first direct structural comparisons of antibody-liganded and unliganded forms of CD3 epsilon from a single species, which revealed that antibody binding does not induce any substantial rearrangements within CD3 epsilon. Saturation mutagenesis of surface-exposed CD3 epsilon residues, coupled with assays of antibody-induced signaling by the mutated complexes, suggests a new configuration for the complex within which CD3 epsilon is highly exposed and reveals that no large new CD3 epsilon interfaces are required to form during antibody-induced signaling. The TCR complex therefore appears to be a structure that is capable of initiating intracellular signaling in T cells without substantial structural rearrangements within or between the component subunits. Our findings raise the possibility that signaling by native ligands might also be initiated in the absence of large structural rearrangements in the receptor.	[Zhu, Xueyong; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England	Scripps Research Institute; University of Oxford; University of Oxford	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; simon.davis@ndm.ox.ac.uk	Fernandes, Ricardo/AAB-8165-2019; Zhu, Xueyong/ABE-3068-2021	Fernandes, Ricardo/0000-0001-5343-3334; Jessup, Claire/0000-0003-1184-6653	National Institutes of Health [AI042266]; Wellcome Trust; United Kingdom Medical Research Council; Fundacao para a Ciencia e a Tecnologia of Portugal; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12010/4] Funding Source: researchfish; MRC [MC_UU_12010/4] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI042266. This work was also supported by the Wellcome Trust, the United Kingdom Medical Research Council, the Fundacao para a Ciencia e a Tecnologia of Portugal, and the Skaggs Institute for Chemical Biology.	Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; BURNS GF, 1982, J IMMUNOL, V129, P1451; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; FRANK SJ, 1990, SCIENCE, V249, P174, DOI 10.1126/science.2371564; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gouaillard C, 2001, EUR J IMMUNOL, V31, P3798, DOI 10.1002/1521-4141(200112)31:12<3798::AID-IMMU3798>3.0.CO;2-Z; HUBBARD SJ, 1992, FARADAY DISCUSS, V93, P13, DOI 10.1039/fd9929300013; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Karaivanova V, 1999, HYBRIDOMA, V18, P497; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; KONING F, 1988, J IMMUNOL, V140, P3126; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Mohan S, 2009, BIOCHEMISTRY-US, V48, P1390, DOI 10.1021/bi801901d; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394	71	26	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13324	13335		10.1074/jbc.M111.332783	http://dx.doi.org/10.1074/jbc.M111.332783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22262845	hybrid, Green Published			2022-12-25	WOS:000302903700068
J	Zhao, B; Lei, L; Kagawa, N; Sundaramoorthy, M; Banerjee, S; Nagy, LD; Guengerich, FP; Waterman, MR				Zhao, Bin; Lei, Li; Kagawa, Norio; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.			Three-dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-associated Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; DIOXYGEN COMPLEX; PROTON-TRANSFER; ACTIVE-SITE; WILD-TYPE; DEFICIENCY; GENE	Steroid 21-hydroxylase (cytochrome P450 21A2, CYP21A2) deficiency accounts for similar to 95% of individuals with congenital adrenal hyperplasia, a common autosomal recessive metabolic disorder of adrenal steroidogenesis. The effects of amino acid mutations on CYP21A2 activity lead to impairment of the synthesis of cortisol and aldosterone and the excessive production of androgens. In order to understand the structural and molecular basis of this group of diseases, the bovine CYP21A2 crystal structure complexed with the substrate 17-hydroxyprogesterone (17OHP) was determined to 3.0 angstrom resolution. An intriguing result from this structure is that there are two molecules of 17OHP bound to the enzyme, the distal one being located at the entrance of the substrate access channel and the proximal one bound in the active site. The substrate binding features locate the key substrate recognition residues not only around the heme but also along the substrate access channel. In addition, orientation of the skeleton of the proximal molecule is toward the interior of the enzyme away from the substrate access channel. The 17OHP complex of CYP21A2 provides a good relationship between the crystal structure, clinical data, and genetic mutants documented in the literature, thereby enhancing our understanding of congenital adrenal hyperplasia. In addition, the location of certain CYP21A2 mutations provides general understanding of structure/function relationships in P450s.	[Zhao, Bin; Lei, Li; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Kagawa, Norio] Nagoya Univ, Grad Sch Med, Global Ctr Excellence Program, Nagoya, Aichi 4668550, Japan	Vanderbilt University; Vanderbilt University; Nagoya University	Zhao, B (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 632 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	bin.zhao@vanderbilt.edu; Michael.Waterman@vanderbilt.edu		Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health [GM69970, R37 CA090426, P30 ES000267]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69970 (to M. R. W. and F. P. G.), R37 CA090426 (to F. P. G.), and P30 ES000267 (to F. P. G. and M. R. W.).	Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Concolino P, 2010, CLIN CHEM LAB MED, V48, P1057, DOI 10.1515/CCLM.2010.239; Dauber A, 2010, CLIN CHEM, V56, P1245, DOI 10.1373/clinchem.2010.146035; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghosh D, 2010, J STEROID BIOCHEM, V118, P197, DOI 10.1016/j.jsbmb.2009.09.012; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hatae T, 1996, FEBS LETT, V389, P268, DOI 10.1016/0014-5793(96)00600-X; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; KAGAWA N, 1991, J BIOL CHEM, V266, P11199; Krone N, 1998, CLIN CHEM, V44, P2075; Krone N, 2009, BEST PRACT RES CL EN, V23, P181, DOI 10.1016/j.beem.2008.10.014; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mornet E, 2000, HUM GENET, V106, P330, DOI 10.1007/s004390051046; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shaw AM, 2010, NEONATAL NETW, V29, P191, DOI 10.1891/0730-0832.29.3.191; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Wedell A, 2011, ENDOCR DEV, V20, P80, DOI 10.1159/000321223; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	40	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10613	10622		10.1074/jbc.M111.323501	http://dx.doi.org/10.1074/jbc.M111.323501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262854	Green Published, hybrid			2022-12-25	WOS:000302167200086
J	Timme, RE; Bachvaroff, TR; Delwiche, CF				Timme, Ruth E.; Bachvaroff, Tsvetan R.; Delwiche, Charles F.			Broad Phylogenomic Sampling and the Sister Lineage of Land Plants	PLOS ONE			English	Article							GREEN-ALGAE; CHARA-VULGARIS; EST ANALYSIS; SEQUENCE; CHLOROPLAST; ORIGIN; MITOCHONDRIAL; INTEGRATION; EVOLUTION; RELATIVES	The tremendous diversity of land plants all descended from a single charophyte green alga that colonized the land somewhere between 430 and 470 million years ago. Six orders of charophyte green algae, in addition to embryophytes, comprise the Streptophyta s.l. Previous studies have focused on reconstructing the phylogeny of organisms tied to this key colonization event, but wildly conflicting results have sparked a contentious debate over which lineage gave rise to land plants. The dominant view has been that 'stoneworts,' or Charales, are the sister lineage, but an alternative hypothesis supports the Zygnematales (often referred to as "pond scum") as the sister lineage. In this paper, we provide a well-supported, 160-nuclear-gene phylogenomic analysis supporting the Zygnematales as the closest living relative to land plants. Our study makes two key contributions to the field: 1) the use of an unbiased method to collect a large set of orthologs from deeply diverging species and 2) the use of these data in determining the sister lineage to land plants. We anticipate this updated phylogeny not only will hugely impact lesson plans in introductory biology courses, but also will provide a solid phylogenetic tree for future green-lineage research, whether it be related to plants or green algae.	[Timme, Ruth E.; Delwiche, Charles F.] Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA; [Bachvaroff, Tsvetan R.] Smithsonian Inst, Smithsonian Environm Res Ctr, Edgewater, MD USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian Environmental Research Center	Timme, RE (corresponding author), Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA.	retimme@gmail.com	Delwiche, Charles F/C-6549-2008	Delwiche, Charles F/0000-0001-7854-8584; Timme, Ruth/0000-0002-9705-5897	National Science Foundation (Division of Molecular and Cell Biosciences) [MCB-0523719]; Division Of Environmental Biology [1036506] Funding Source: National Science Foundation	National Science Foundation (Division of Molecular and Cell Biosciences)(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was supported in full by the National Science Foundation (Division of Molecular and Cell Biosciences, Microbial genome Sequencing Program), MCB-0523719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Bower F. O., 1908, ORIGIN LAND FLORA TH; Bower FO, 1908, ORIGIN LAND FLORA; Campbell NA, 2007, BIOL MASTERINGBIOLOG; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Forment J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-5; GENSEL P G, 1990, Palaios, V5, P520, DOI 10.2307/3514860; GRAY J, 1985, GEOLOGY, V13, P521, DOI 10.1130/0091-7613(1985)13<521:SFFTPP>2.0.CO;2; Hall JD, 2008, J PHYCOL, V44, P467, DOI 10.1111/j.1529-8817.2008.00485.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Marin B, 1999, PROTIST, V150, P399, DOI 10.1016/S1434-4610(99)70041-6; Mattox K.R., 1984, SYSTEMATICS GREEN AL, V27, P29, DOI DOI 10.1017/S0024282985000482; McCourt RM, 2004, TRENDS ECOL EVOL, V19, P661, DOI 10.1016/j.tree.2004.09.013; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Simon A, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-2; Stamatakis A, 2005, LECT NOTES COMPUT SC, V3606, P288, DOI 10.1007/11535294_25; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, J PHYCOL, V38, P364, DOI 10.1046/j.1529-8817.2002.01163.x; Turmel M, 2006, MOL BIOL EVOL, V23, P1324, DOI 10.1093/molbev/msk018; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339; [No title captured]	42	205	211	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29696	10.1371/journal.pone.0029696	http://dx.doi.org/10.1371/journal.pone.0029696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253761	Green Submitted, gold, Green Published			2022-12-25	WOS:000301361500019
J	Aldworth, ZN; Bender, JA; Miller, JP				Aldworth, Zane N.; Bender, John A.; Miller, John P.			Information Transmission in Cercal Giant Interneurons Is Unaffected by Axonal Conduction Noise	PLOS ONE			English	Article							SPIKE-TIMING PRECISION; PROPAGATION; CRICKET; MORPHOLOGY; NERVE; RELIABILITY; PLASTICITY; FREQUENCY; GANGLION; IMPULSE	What are the fundamental constraints on the precision and accuracy with which nervous systems can process information? One constraint must reflect the intrinsic "noisiness" of the mechanisms that transmit information between nerve cells. Most neurons transmit information through the probabilistic generation and propagation of spikes along axons, and recent modeling studies suggest that noise from spike propagation might pose a significant constraint on the rate at which information could be transmitted between neurons. However, the magnitude and functional significance of this noise source in actual cells remains poorly understood. We measured variability in conduction time along the axons of identified neurons in the cercal sensory system of the cricket Acheta domesticus, and used information theory to calculate the effects of this variability on sensory coding. We found that the variability in spike propagation speed is not large enough to constrain the accuracy of neural encoding in this system.	[Aldworth, Zane N.; Bender, John A.; Miller, John P.] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Aldworth, ZN (corresponding author), NICHHD, Lab Cellular & Synapt Physiol, NIH, Bethesda, MD 20892 USA.	zaldworth@gmail.com	Miller, John J/GZG-5663-2022		National Institute of Mental Health (NIMH) [2R01 MH-064416]; US National Science Foundation [EF-0425878, IGERT DGE-9972824]; Kopriva fellowship; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064416] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Science Foundation(National Science Foundation (NSF)); Kopriva fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health to J.P.M. (NIMH 2R01 MH-064416), the US National Science Foundation to J.P.M. (EF-0425878) and to Z.N.A. (IGERT DGE-9972824), and by a Kopriva fellowship to Z.N.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank M. Stopfer and Clara Bodelon for helpful comments on the manuscript. Information theoretic analyses in this study were conducted with the Spike Train Analysis Toolkit, a neuroinformatics resource funded by the NIH's Human Brain Project.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ABELES M, 1975, BIOL CYBERN, V19, P121, DOI 10.1007/BF00337250; Adrian ED, 1912, J PHYSIOL-LONDON, V44, P68; Aldworth ZN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002041; Aldworth ZN, 2005, J NEUROSCI, V25, P5323, DOI 10.1523/JNEUROSCI.0359-05.2005; BABA Y, 1991, ZOOL SCI, V8, P437; Ballo AW, 2009, J NEUROSCI, V29, P5062, DOI 10.1523/JNEUROSCI.0716-09.2009; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BORG J, 1983, J NEUROL NEUROSUR PS, V46, P317, DOI 10.1136/jnnp.46.4.317; BOWE CM, 1987, NEUROSCIENCE, V21, P585, DOI 10.1016/0306-4522(87)90144-8; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; BULLOCK TH, 1951, J PHYSIOL-LONDON, V114, P89, DOI 10.1113/jphysiol.1951.sp004605; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DiCaprio RA, 2007, J NEUROPHYSIOL, V98, P1706, DOI 10.1152/jn.00176.2007; Dimitrov AG, 2003, NETWORK-COMP NEURAL, V14, P151, DOI 10.1088/0954-898X/14/1/309; EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gasser HS, 1925, AM J PHYSIOL, V73, P613, DOI 10.1152/ajplegacy.1925.73.3.613; GEORGE SA, 1977, BIOL CYBERN, V26, P209, DOI 10.1007/BF00366592; Goldberg DH, 2009, NEUROINFORMATICS, V7, P165, DOI 10.1007/s12021-009-9049-y; Gotch F, 1910, J PHYSIOL-LONDON, V40, P250; HIROTA K, 1993, ZOOL SCI, V10, P705; HORIKAWA Y, 1991, BIOL CYBERN, V66, P19, DOI 10.1007/BF00196449; Horikawa Y, 1992, BIOL CYBERNETICS; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; JACOBS GA, 1987, J COMP NEUROL, V265, P145, DOI 10.1002/cne.902650110; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; Kennel MB, 2005, NEURAL COMPUT, V17, P1531, DOI 10.1162/0899766053723050; KOCSIS JD, 1983, J PHYSIOL-LONDON, V334, P225, DOI 10.1113/jphysiol.1983.sp014491; KOHSTALLSCHNELL D, 1994, J EXP BIOL, V193, P157; Kuriscak E, 2002, PHYSIOL RES, V51, P205; LASS Y, 1975, BIOL CYBERN, V19, P61, DOI 10.1007/BF00364102; MacKAY DONALD M., 1952, BULL MATH BIOPHYS, V14, P127, DOI 10.1007/BF02477711; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MENDENHALL B, 1974, J NEUROBIOL, V5, P565, DOI 10.1002/neu.480050607; MILLER RN, 1981, BIOPHYS J, V34, P227, DOI 10.1016/S0006-3495(81)84847-3; Monsivais P, 2005, J NEUROSCI, V25, P464, DOI 10.1523/JNEUROSCI.3871-04.2005; MUSHA T, 1981, IEEE T BIO-MED ENG, V28, P616, DOI 10.1109/TBME.1981.324751; OSHEA M, 1981, SCIENCE, V213, P567, DOI 10.1126/science.6113690; Oswald AMM, 2004, J NEUROSCI, V24, P4351, DOI 10.1523/JNEUROSCI.0459-04.2004; RITZMANN RE, 1978, J COMP PHYSIOL, V125, P305, DOI 10.1007/BF00656865; Roddey JC, 2000, J COMPUT NEUROSCI, V8, P95, DOI 10.1023/A:1008921114108; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shlens J, 2007, NEURAL COMPUT, V19, P1683, DOI 10.1162/neco.2007.19.7.1683; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vedenina VY, 1998, J COMP PHYSIOL A, V183, P553, DOI 10.1007/s003590050281; Weidner C, 2002, J NEUROSCI, V22, P6704	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30115	10.1371/journal.pone.0030115	http://dx.doi.org/10.1371/journal.pone.0030115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253900	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100040
J	Khan, JM; Qadeer, A; Chaturvedi, SK; Ahmad, E; Rehman, SAA; Gourinath, S; Khan, RH				Khan, Javed Masood; Qadeer, Atiyatul; Chaturvedi, Sumit Kumar; Ahmad, Ejaz; Rehman, Syed Arif Abdul; Gourinath, Samudrala; Khan, Rizwan Hasan			SDS Can Be Utilized as an Amyloid Inducer: A Case Study on Diverse Proteins	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; FIBRIL FORMATION; SURFACTANT INTERACTIONS; NEUTRAL PH; ACIDIC PH; AGGREGATION; LYSOZYME; BETA(2)-MICROGLOBULIN; PROPENSITY; RELEVANCE	Sodium dodecyl sulphate (SDS), an anionic surfactant that mimics some characteristics of biological membrane has also been found to induce aggregation in proteins. The present study was carried out on 25 diverse proteins using circular dichroism, fluorescence spectroscopy, dye binding assay and electron microscopy. It was found that an appropriate molar ratio of protein to SDS readily induced amyloid formation in all proteins at a pH below two units of their respective isoelectric points (pI) while no aggregation was observed at a pH above two units of pI. We also observed that electrostatic interactions play a leading role in the induction of amyloid. This study can be used to design or hypothesize a molecule or drug, which may counter act the factor responsible for amyloid formation.	[Khan, Javed Masood; Qadeer, Atiyatul; Chaturvedi, Sumit Kumar; Ahmad, Ejaz; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Rehman, Syed Arif Abdul; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Aligarh Muslim University; Jawaharlal Nehru University, New Delhi	Khan, JM (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	khan, Javed Masood/AAZ-8079-2021; Khan, Javed Masood/AAZ-8034-2021; chaturvedi, sumit k/O-6083-2019; Khan, Rizwan/GXZ-5789-2022; Chaturvedi, Sumit K/P-5052-2014; Khan, Rizwan Hasan/F-8276-2014; Ahmad, Ejaz/L-1506-2013	khan, Javed Masood/0000-0003-0567-5712; chaturvedi, sumit k/0000-0003-3600-8883; Chaturvedi, Sumit K/0000-0003-3600-8883; Khan, Rizwan Hasan/0000-0002-9965-8982; Ahmad, Ejaz/0000-0002-5713-6713	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The financial assistance to the authors was provided by Council of Scientific and Industrial Research (http://csirhrdg.res.in/), New Delhi, India in the form of Senior Research Fellowship and Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; Hansted JG, 2011, BBA-PROTEINS PROTEOM, V1814, P713, DOI 10.1016/j.bbapap.2011.03.011; Hung YT, 2010, COLLOID SURFACE B, V81, P141, DOI 10.1016/j.colsurfb.2010.07.001; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jason P, 2003, PROTEIN SCI, V12, P2374; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Moosavi-Movahedi AA, 2007, COLLOID SURFACE B, V60, P55, DOI 10.1016/j.colsurfb.2007.05.018; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; Stenstam A, 2001, LANGMUIR, V17, P7513, DOI 10.1021/la011096t; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Valstar A, 2000, LANGMUIR, V16, P922, DOI 10.1021/la990423i; Vasilescu M, 1999, LANGMUIR, V15, P2635, DOI 10.1021/la981424y; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yamamoto K, 2008, J MOL BIOL, V376, P258, DOI 10.1016/j.jmb.2007.12.002; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Zerovnik E, 2002, EUR J BIOCHEM, V269, P3362, DOI 10.1046/j.1432-1033.2002.03024.x	27	113	113	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29694	10.1371/journal.pone.0029694	http://dx.doi.org/10.1371/journal.pone.0029694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253760	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100018
J	Sundrani, DP; Chavan-Gautam, PM; Pisal, HR; Mehendale, SS; Joshi, SR				Sundrani, Deepali P.; Chavan-Gautam, Preeti M.; Pisal, Hemlata R.; Mehendale, Savita S.; Joshi, Sadhana R.			Matrix Metalloproteinase-1 and-9 in Human Placenta during Spontaneous Vaginal Delivery and Caesarean Sectioning in Preterm Pregnancy	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SMOOTH-MUSCLE-CELLS; FETAL MEMBRANES; MATRIX-METALLOPROTEINASE-9 MMP-9; PREMATURE RUPTURE; HUMAN MYOMETRIUM; AMNIOTIC-FLUID; TERM LABOR; EXPRESSION; (MMP)-2	Preterm birth is a major public health problem in terms of loss of life, long-term and short term disabilities worldwide. The process of parturition (both term and preterm) involves intensive remodelling of the extracellular matrix (ECM) in the placenta and fetal membranes by matrix metalloproteinases (MMPs). Our previous studies show reduced docosahexaenoic acid (DHA) in women delivering preterm. Further omega 3 fatty acids are reported to regulate MMP levels. This study was undertaken to examine the placental levels of MMPs and their association with placental DHA levels in women delivering preterm. The levels of MMP-1 and MMP-9 in 74 women delivering preterm (52 by spontaneous vaginal delivery and 22 by caesarean sectioning) and 75 women delivering at term (59 by spontaneous vaginal delivery and 16 by caesarean sectioning) were determined by enzyme-linked immunosorbent assay (ELISA) and their association with placental DHA was studied. Placental MMP-1 levels were higher (p<0.05) in women delivering preterm (both by spontaneous vaginal delivery and caesarean sectioning) as compared to those delivering at term. In contrast, placental MMP-9 levels in preterm pregnancies was higher (p<0.05) in women with spontaneous vaginal delivery while lower (p<0.05) in women delivering by caesarean sectioning. Low placental DHA was associated with higher placental MMP-9 levels. Our study suggests a differential effect of mode of delivery on the levels of MMPs from placenta. Further this study suggests a negative association of DHA and the levels of MMP-9 in human placenta although the mechanisms need further study.	[Sundrani, Deepali P.; Chavan-Gautam, Preeti M.; Pisal, Hemlata R.; Joshi, Sadhana R.] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India; [Mehendale, Savita S.] Bharati Vidyapeeth Univ, Bharati Med Coll & Hosp, Dept Obstet & Gynecol, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Sundrani, DP (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Chavan-Gautam, Preeti/0000-0001-8514-3171; Sundrani, Deepali/0000-0002-2403-5115	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was partially supported by the Department of Science and Technology, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Athayde N, 1999, J Matern Fetal Med, V8, P213; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Choi SJ, 2007, EUR J OBSTET GYN R B, V132, P182, DOI 10.1016/j.ejogrb.2006.07.024; Delbosc S, 2008, AM J PATHOL, V172, P1430, DOI 10.2353/ajpath.2008.070951; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Fortunato SJ, 1999, J PERINAT MED, V27, P362, DOI 10.1515/JPM.1999.049; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldman S, 2003, MOL HUM REPROD, V9, P367, DOI 10.1093/molehr/gag040; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilari AS, 2010, J PERINAT MED, V38, P659, DOI [10.1515/JPM.2010.112, 10.1515/jpm.2010.112]; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Locksmith GJ, 1999, OBSTET GYNECOL, V94, P1, DOI 10.1016/S0029-7844(99)00011-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McLaren J, 2000, AM J OBSTET GYNECOL, V182, P409, DOI 10.1016/S0002-9378(00)70232-8; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Perez MA, 2006, J NUTR BIOCHEM, V17, P446, DOI 10.1016/j.jnutbio.2005.10.003; Poon LCY, 2009, PRENATAL DIAG, V29, P553, DOI 10.1002/pd.2234; Riley SC, 2000, J REPROD FERTIL, V118, P19, DOI 10.1530/reprod/118.1.19; Roh CR, 2000, MOL HUM REPROD, V6, P96, DOI 10.1093/molehr/6.1.96; Shinto L, 2009, PROSTAG LEUKOTR ESS, V80, P131, DOI 10.1016/j.plefa.2008.12.001; Shokry M, 2009, EXP MOL PATHOL, V87, P219, DOI 10.1016/j.yexmp.2009.08.001; Solakivi T, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-11; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Sundrani DP, 2011, MED HYPOTHE IN PRESS; Tsatas D, 1999, J REPROD FERTIL, V116, P43; Ulug U, 2001, MOL HUM REPROD, V7, P1187, DOI 10.1093/molehr/7.12.1187; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TD, 2008, REPROD SCI, V15, P420, DOI 10.1177/1933719108314625; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yasemin A, 2007, ACTA HISTOCHEM, V109, P403, DOI 10.1016/j.acthis.2007.04.001; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014; Zainal Z, 2009, OSTEOARTHR CARTILAGE, V17, P896, DOI 10.1016/j.joca.2008.12.009; Zeydanli EN, 2009, CAN J PHYSIOL PHARM, V87, P1063, DOI 10.1139/Y09-112; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	38	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29855	10.1371/journal.pone.0029855	http://dx.doi.org/10.1371/journal.pone.0029855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253805	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100024
J	Benesova, J; Rusnakova, V; Honsa, P; Pivonkova, H; Dzamba, D; Kubista, M; Anderova, M				Benesova, Jana; Rusnakova, Vendula; Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Kubista, Mikael; Anderova, Miroslava			Distinct Expression/Function of Potassium and Chloride Channels Contributes to the Diverse Volume Regulation in Cortical Astrocytes of GFAP/EGFP Mice	PLOS ONE			English	Article							K+-CL-COTRANSPORTER; 3-DIMENSIONAL CONFOCAL MORPHOMETRY; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS; IN-SITU; MOLECULAR-MECHANISMS; CULTURED ASTROCYTES; RAT HIPPOCAMPUS; GLIOMA-CELLS	Recently, we have identified two astrocytic subpopulations in the cortex of GFAP-EGFP mice, in which the astrocytes are visualized by the enhanced green-fluorescent protein (EGFP) under the control of the human glial fibrillary acidic protein (GFAP) promotor. These astrocytic subpopulations, termed high response-(HR-) and low response-(LR-) astrocytes, differed in the extent of their swelling during oxygen-glucose deprivation (OGD). In the present study we focused on identifying the ion channels or transporters that might underlie the different capabilities of these two astrocytic subpopulations to regulate their volume during OGD. Using three-dimensional confocal morphometry, which enables quantification of the total astrocytic volume, the effects of selected inhibitors of K+ and Cl- channels/transporters or glutamate transporters on astrocyte volume changes were determined during 20 minute-OGD in situ. The inhibition of volume regulated anion channels (VRACs) and two-pore domain potassium channels (K-2P) highlighted their distinct contributions to volume regulation in HR-/LR-astrocytes. While the inhibition of VRACs or K-2P channels revealed their contribution to the swelling of HR-astrocytes, in LR-astrocytes they were both involved in anion/K+ effluxes. Additionally, the inhibition of Na+-K+-Cl- co-transporters in HR-astrocytes led to a reduction of cell swelling, but it had no effect on LR-astrocyte volume. Moreover, employing real-time single-cell quantitative polymerase chain reaction (PCR), we characterized the expression profiles of EGFP-positive astrocytes with a focus on those ion channels and transporters participating in astrocyte swelling and volume regulation. The PCR data revealed the existence of two astrocytic subpopulations markedly differing in their gene expression levels for inwardly rectifying K+ channels (Kir4.1), K-2P channels (TREK-1 and TWIK-1) and Cl- channels (ClC2). Thus, we propose that the diverse volume changes displayed by cortical astrocytes during OGD mainly result from their distinct expression patterns of ClC2 and K-2P channels.	[Benesova, Jana; Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Anderova, Miroslava] Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Rusnakova, Vendula; Kubista, Mikael] Acad Sci Czech Republic, Inst Biotechnol, Gene Express Lab, Prague, Czech Republic; [Benesova, Jana; Honsa, Pavel; Pivonkova, Helena; Dzamba, David] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Kubista, Mikael] TATAA Bioctr, Gothenburg, Sweden	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague	Benesova, J (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Anderova, Miroslava/H-2249-2014; Novosadova, Vendula/G-6388-2014; Pivonkova, Helena/ABE-4845-2021; Kubista, Mikael/A-5689-2008; Novosadova, Vendula/AAJ-1449-2021	Anderova, Miroslava/0000-0002-9030-4571; Kubista, Mikael/0000-0002-2940-352X; Pivonkova, Helena/0000-0003-2790-9778	Grant Agency of the Czech Republic [CZ:GA CR:GA P303/10/1338, CZ:GA CR:GA 309/08/H079]; Academy of Sciences of the Czech Republic [UEM AV CR - AV0Z50390703]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This study was supported by the grants: CZ:GA CR:GA P303/10/1338 and CZ:GA CR:GA 309/08/H079 from the Grant Agency of the Czech Republic and UEM AV CR - AV0Z50390703 from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Beck J, 2003, J NEUROSCI, V23, P5061; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Buckler KJ, 2005, J PHYSIOL-LONDON, V562, P213, DOI 10.1113/jphysiol.2004.077503; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Dibaj P, 2007, J NEUROCHEM; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Hibino H, 2004, EUR J NEUROSCI, V19, P76, DOI 10.1111/j.1460-9568.2004.03092.x; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KOYAMA Y, 1991, NEUROSCI LETT, V122, P210, DOI 10.1016/0304-3940(91)90860-V; Kucheryavykh Lilia Y, 2009, Open Neurosci J, V3, P40; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nolte C, 2001, GLIA, V33, P72; Obara-Michlewska M, 2011, J NEUROSCI RES, V89, P2018, DOI 10.1002/jnr.22656; Obara-Michlewska M, 2010, PHARMACOL REP, V62, P1237, DOI 10.1016/S1734-1140(10)70388-1; Ochoa-de la Paz LD, 2005, PFLUG ARCH EUR J PHY, V449, P526, DOI 10.1007/s00424-004-1357-3; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Pasler D, 2007, BRAIN RES, V1173, P14, DOI 10.1016/j.brainres.2007.07.013; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Phillis JW, 2000, BRAIN RES, V880, P224, DOI 10.1016/S0006-8993(00)02755-4; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; Ringel F, 2008, NEUROSCI LETT, V442, P219, DOI 10.1016/j.neulet.2008.07.017; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Skatchkov SN, 2006, GLIA, V53, P266, DOI 10.1002/glia.20280; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5; Yan YP, 2001, BRAIN RES, V911, P43, DOI 10.1016/S0006-8993(01)02649-X; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	53	42	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29725	10.1371/journal.pone.0029725	http://dx.doi.org/10.1371/journal.pone.0029725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253765	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700041
J	Beniac, DR; Melito, PL; Devarennes, SL; Hiebert, SL; Rabb, MJ; Lamboo, LL; Jones, SM; Booth, TF				Beniac, Daniel R.; Melito, Pasquale L.; Devarennes, Shauna L.; Hiebert, Shannon L.; Rabb, Melissa J.; Lamboo, Lindsey L.; Jones, Steven M.; Booth, Timothy F.			The Organisation of Ebola Virus Reveals a Capacity for Extensive, Modular Polyploidy	PLOS ONE			English	Article							NUCLEOPROTEIN-RNA COMPLEX; INFLUENZA-A VIRUS; MARBURG VIRUSES; ELECTRON-MICROSCOPY; VIRAL ENTRY; VERO CELLS; PARTICLES; GLYCOPROTEIN; BINDING; PROTEIN	Background: Filoviruses, including Ebola virus, are unusual in being filamentous animal viruses. Structural data on the arrangement, stoichiometry and organisation of the component molecules of filoviruses has until now been lacking, partially due to the need to work under level 4 biological containment. The present study provides unique insights into the structure of this deadly pathogen. Methodology and Principal Findings: We have investigated the structure of Ebola virus using a combination of cryoelectron microscopy, cryo-electron tomography, sub-tomogram averaging, and single particle image processing. Here we report the three-dimensional structure and architecture of Ebola virus and establish that multiple copies of the RNA genome can be packaged to produce polyploid virus particles, through an extreme degree of length polymorphism. We show that the helical Ebola virus inner nucleocapsid containing RNA and nucleoprotein is stabilized by an outer layer of VP24-VP35 bridges. Elucidation of the structure of the membrane-associated glycoprotein in its native state indicates that the putative receptor-binding site is occluded within the molecule, while a major neutralizing epitope is exposed on its surface proximal to the viral envelope. The matrix protein VP40 forms a regular lattice within the envelope, although its contacts with the nucleocapsid are irregular. Conclusions: The results of this study demonstrate a modular organization in Ebola virus that accommodates a well-ordered, symmetrical nucleocapsid within a flexible, tubular membrane envelope.	[Beniac, Daniel R.; Melito, Pasquale L.; Devarennes, Shauna L.; Hiebert, Shannon L.; Rabb, Melissa J.; Lamboo, Lindsey L.; Jones, Steven M.; Booth, Timothy F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada; [Rabb, Melissa J.; Booth, Timothy F.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Lamboo, Lindsey L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba	Beniac, DR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada.	tim.booth@phac-aspc.gc.ca			Office of the Chief Scientist, Health Canada	Office of the Chief Scientist, Health Canada	This work was funded partly from grants from the Office of the Chief Scientist, Health Canada. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; ELLIS DS, 1978, J CLIN PATHOL, V31, P201, DOI 10.1136/jcp.31.3.201; ELLIS DS, 1979, J MED VIROL, V4, P213, DOI 10.1002/jmv.1890040307; ELLIS DS, 1979, J MED VIROL, V4, P201, DOI 10.1002/jmv.1890040306; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feldmann H, 2007, FIELDS VIROLOGY, P1409; FISHBEIN WN, 1972, ANAL BIOCHEM, V46, P388, DOI 10.1016/0003-2697(72)90312-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Groseth A, 2009, VIRUS RES, V140, P8, DOI 10.1016/j.virusres.2008.10.017; Halfmann P, 2009, J VIROL, V83, P3810, DOI 10.1128/JVI.00074-09; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; HOSAKA Y, 1966, VIROLOGY, V29, P205, DOI 10.1016/0042-6822(66)90027-4; Huang Y, 2002, MOL CELL, V10, P307, DOI 10.1016/S1097-2765(02)00588-9; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kallstrom G, 2005, J VIROL METHODS, V127, P1, DOI 10.1016/j.jviromet.2005.02.015; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Mavrakis M, 2002, VIROLOGY, V296, P300, DOI 10.1006/viro.2002.1433; Melito PL, 2008, J VIROL METHODS, V148, P237, DOI 10.1016/j.jviromet.2007.12.004; Mpanju OM, 2006, VIRUS RES, V121, P205, DOI 10.1016/j.virusres.2006.06.002; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noda T, 2005, J VET MED SCI, V67, P325, DOI 10.1292/jvms.67.325; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Noda T, 2010, J GEN VIROL, V91, P1478, DOI 10.1099/vir.0.019794-0; OSSET M, 1989, ELECTROPHORESIS, V10, P271, DOI 10.1002/elps.1150100412; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; SIEGERT R, 1967, DEUT MED WOCHENSCHR, V92, P2341, DOI 10.1055/s-0028-1106144; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; TAL M, 1985, J BIOL CHEM, V260, P9976; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Welsch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000875; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	58	108	112	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29608	10.1371/journal.pone.0029608	http://dx.doi.org/10.1371/journal.pone.0029608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247782	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700030
J	Currie, DR; McClatchie, S; Middleton, JF; Nayar, S				Currie, David R.; McClatchie, Sam; Middleton, John F.; Nayar, Sasi			Biophysical Factors Affecting the Distribution of Demersal Fish around the Head of a Submarine Canyon Off the Bonney Coast, South Australia	PLOS ONE			English	Article							CONTINENTAL-SLOPE; COMMUNITY STRUCTURE; PHYSICAL PROCESSES; STANDING STOCK; BOUNDARY-LAYER; NEW-ZEALAND; SHELF; CIRCULATION; WATER; PRODUCTIVITY	We sampled the demersal fish community of the Bonney Canyon, South Australia at depths (100-1,500 m) and locations that are poorly known. Seventy-eight species of demersal fish were obtained from 12 depth-stratified trawls along, and to either side, of the central canyon axis. Distributional patterns in species richness and biomass were highly correlated. Three fish assemblage groupings, characterised by small suites of species with narrow depth distributions, were identified on the shelf, upper slope and mid slope. The assemblage groupings were largely explained by depth (rho w = 0.78). Compared to the depth gradient, canyon-related effects are weak or occur at spatial or temporal scales not sampled in this study. A conceptual physical model displayed features consistent with the depth zonational patterns in fish, and also indicated that canyon upwelling can occur. The depth zonation of the fish assemblage was associated with the depth distribution of water masses in the area. Notably, the mid-slope community (1,000 m) coincided with a layer of Antarctic Intermediate Water, the upper slope community (500 m) resided within the core of the Flinders Current, and the shelf community was located in a well-mixed layer of surface water (<450 m depth).	[Currie, David R.; Middleton, John F.; Nayar, Sasi] S Australian Res & Dev Inst Aquat Sci, Adelaide, SA, Australia; [McClatchie, Sam] Natl Ocean & Atmospher Adm NOAA Fisheries, SW Fisheries Sci Ctr, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Currie, DR (corresponding author), S Australian Res & Dev Inst Aquat Sci, Adelaide, SA, Australia.	david.currie@sa.gov.au	nayar, Sasi/Q-8101-2019	nayar, Sasi/0000-0002-3730-6682	South Australian Government (through the Marine Innovation South Australia initiative); Australian Federal Government; MNF Steering Committee	South Australian Government (through the Marine Innovation South Australia initiative); Australian Federal Government(Australian Government); MNF Steering Committee	This project was jointly funded by the South Australian Government (through the Marine Innovation South Australia initiative) and the Australian Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work could not have been undertaken safely and efficiently without the assistance of a highly skilled group of mariners. In particular, we would like to thank the Captain (Ian Taylor) and the crew of the RV Southern Surveyor for their professional and enthusiastic support throughout the voyage. Thanks are also due the following Marine National Facility staff for their outstanding contributions to a highly successful voyage: Fred Stein (Director), Don McKenzie (Voyage Manager), Steve Thomas (Electronics), Bob Beattie (Computing), Mark Rayner (Hydrochemistry) and Anne Kennedy (Swath Mapping). We are also very much indebted to the following voyage scientists for their help and collaboration on this research project: Graham Hooper and Mike Steer (SARDI), James Paterson (Flinders University), Wayne Rumball (SAM), Peter Boult, Toby Payenberg and Ruan Gannon (University of Adelaide). Thanks also to Mark Lewis (CSIRO), Hugh McKenna (Neptune Trawls), Hec Kavanagh and the many support staff at SARDI who helped develop and mobilize the sampling equipment. We are also most grateful to Craig Johnson (Chair, MNF Steering Committee) for supporting our research, and to Laura Richardson (ANU) for her help in developing the hydrodynamic model. The authors would also like to thank Kevin Stieroff and Andrew Thomson (NOAA) for providing helpful comments on an earlier version of the manuscript.	Allen SE, 2001, CAN J FISH AQUAT SCI, V58, P671, DOI 10.1139/cjfas-58-4-671; AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beattie RD, 2008, SS022008 CSIRO DIV M; Bosley KL, 2004, J MARINE SYST, V50, P21, DOI 10.1016/j.jmarsys.2003.06.006; Boult PJ, 2006, AAPG SEARCH DISCOVER; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bulman C, 2001, MAR FRESHWATER RES, V52, P537, DOI 10.1071/MF99152; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; ESRI, 2007, ARCGIS MAPP SOFTW; FINE RA, 1993, DEEP-SEA RES PT I, V40, P2021, DOI 10.1016/0967-0637(93)90043-3; Garcia R, 2008, J MARINE SYST, V74, P44, DOI 10.1016/j.jmarsys.2007.11.004; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gomes M. C., 1992, Journal of Northwest Atlantic Fishery Science, V14, P13; GREENE CH, 1988, SCIENCE, V241, P359, DOI 10.1126/science.241.4863.359; Griffin DA, 1997, MAR FRESHWATER RES, V48, P27, DOI 10.1071/MF96052; HALL SJ, 1994, OCEANOGR MAR BIOL, V32, P179; Hickey BM, 1997, J PHYS OCEANOGR, V27, P697, DOI 10.1175/1520-0485(1997)027<0697:TROASS>2.0.CO;2; Hill PJ, 2005, AUST J EARTH SCI, V52, P117, DOI 10.1080/08120090500100085; Hoese D.F., 1994, FISHES AUSTR S COAST, P781; Hoese DF, 2007, ZOOLOGICAL CATALOGUE; Huthnance JM, 1995, PROG OCEANOGR, V35, P353, DOI 10.1016/0079-6611(95)00012-6; Jacob W, 1998, DEEP-SEA RES PT I, V45, P2119, DOI 10.1016/S0967-0637(98)00051-X; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Kampf J, 2007, CONT SHELF RES, V27, P2211, DOI 10.1016/j.csr.2007.05.010; Klinck JM, 1996, J GEOPHYS RES-OCEANS, V101, P1211, DOI 10.1029/95JC02901; KOSLOW JA, 1994, DEEP-SEA RES PT I, V41, P113; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Lampitt RS, 1995, DEEP-SEA RES PT I, V42, P1865, DOI 10.1016/0967-0637(95)00084-4; LEWIS RK, 1981, AUST J MAR FRESH RES, V32, P843; Mackas DL, 1997, CAN J FISH AQUAT SCI, V54, P2080, DOI 10.1139/cjfas-54-9-2080; MacquartMoulin C, 1996, DEEP-SEA RES PT I, V43, P579, DOI 10.1016/0967-0637(96)00039-8; McClain CR, 2010, ECOLOGY, V91, P964, DOI 10.1890/09-0087.1; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; McClatchie S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002699; Middleton JF, 1996, J GEOPHYS RES-OCEANS, V101, P18061, DOI 10.1029/96JC01272; Middleton JF, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000701; Middleton JF, 2003, J PHYS OCEANOGR, V33, P2270, DOI 10.1175/1520-0485(2003)033<2270:TMSCAA>2.0.CO;2; Middleton JF, 2007, PROG OCEANOGR, V75, P1, DOI 10.1016/j.pocean.2007.07.001; Mizobata K, 2004, J MARINE SYST, V50, P101, DOI 10.1016/j.jmarsys.2003.09.014; Nieblas AE, 2009, LIMNOL OCEANOGR, V54, P1548, DOI 10.4319/lo.2009.54.5.1548; Pakhomov EA, 2006, J FISH BIOL, V68, P1834, DOI 10.1111/j.1095-8649.2006.01076.x; PEREYRA WT, 1969, J FISH RES BOARD CAN, V26, P2211, DOI 10.1139/f69-205; Powell Shawna M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P19; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; Rennie SJ, 2009, CONT SHELF RES, V29, P2020, DOI 10.1016/j.csr.2009.04.010; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ryan JP, 2005, MAR ECOL PROG SER, V287, P23, DOI 10.3354/meps287023; SCHAHINGER RB, 1987, AUST J MAR FRESH RES, V38, P439; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schodlok MP, 1997, GEOPHYS RES LETT, V24, P2785, DOI 10.1029/97GL01929; Smetacek V., 1984, NATO Conference Series IV Marine Sciences, V13, P517; SNELGROVE PVR, 1985, MAR ECOL PROG SER, V27, P99, DOI 10.3354/meps027099; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; SPSS Inc, 2007, SPSS BAS 16 0 WIND U; STEFANESCU C, 1994, J MAR BIOL ASSOC UK, V74, P499, DOI 10.1017/S0025315400047627; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; TROWBRIDGE JH, 1991, J PHYS OCEANOGR, V21, P1171, DOI 10.1175/1520-0485(1991)021<1171:ABOAOB>2.0.CO;2; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Williams A, 2001, MAR ECOL PROG SER, V212, P247, DOI 10.3354/meps212247; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189	71	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30138	10.1371/journal.pone.0030138	http://dx.doi.org/10.1371/journal.pone.0030138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253907	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700093
J	Kelly, D; Dillingham, M; Hudson, A; Wiesner, K				Kelly, David; Dillingham, Mark; Hudson, Andrew; Wiesner, Karoline			A New Method for Inferring Hidden Markov Models from Noisy Time Sequences	PLOS ONE			English	Article							SINGLE-MOLECULE FRET; STATISTICAL COMPLEXITY; HOLLIDAY JUNCTIONS; DNA; DYNAMICS; TRANSITION; MECHANICS; SERIES; CELLS	We present a new method for inferring hidden Markov models from noisy time sequences without the necessity of assuming a model architecture, thus allowing for the detection of degenerate states. This is based on the statistical prediction techniques developed by Crutchfield et al. and generates so called causal state models, equivalent in structure to hidden Markov models. The new method is applicable to any continuous data which clusters around discrete values and exhibits multiple transitions between these values such as tethered particle motion data or Fluorescence Resonance Energy Transfer (FRET) spectra. The algorithms developed have been shown to perform well on simulated data, demonstrating the ability to recover the model used to generate the data under high noise, sparse data conditions and the ability to infer the existence of degenerate states. They have also been applied to new experimental FRET data of Holliday Junction dynamics, extracting the expected two state model and providing values for the transition rates in good agreement with previous results and with results obtained using existing maximum likelihood based methods. The method differs markedly from previous Markov-model reconstructions in being able to uncover truly hidden states.	[Kelly, David; Wiesner, Karoline] Univ Bristol, Sch Math, Bristol, Avon, England; [Dillingham, Mark] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Hudson, Andrew] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Bristol; University of Bristol; University of Leicester	Kelly, D (corresponding author), Univ Bristol, Sch Math, Bristol, Avon, England.	dk3531@bristol.ac.uk	Wiesner, Karoline/O-3967-2015	Wiesner, Karoline/0000-0003-2944-1988; Hudson, Andrew/0000-0003-1849-9666; Dillingham, Mark/0000-0002-4612-7141	Engineering and Physical Sciences Research Council [RB1297]; EPSRC [EP/I013709/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I013709/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/Pages/default.aspx), grant number RB1297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MODEL SELECTION MODE; Beausang JF, 2007, BIOPHYS J, V92, pL64, DOI 10.1529/biophysj.107.104828; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Cover TM, 1991, ELEMENTS INFORM THEO; Crutchfield JP, 2006, J R SOC INTERFACE, V3, P345, DOI 10.1098/rsif.2006.0114; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Crutchfield JP, 1997, PHYS REV E, V55, pR1239, DOI 10.1103/PhysRevE.55.R1239; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Feingold M, 2001, PHYSICA E, V9, P616, DOI 10.1016/S1386-9477(00)00270-8; Gornerup O, 2008, ARTIF LIFE, V14, P245, DOI 10.1162/artl.2008.14.3.14301; Hilario J, 2010, CURR OPIN CHEM BIOL, V14, P15, DOI 10.1016/j.cbpa.2009.10.035; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Laurens N, 2009, NUCLEIC ACIDS RES, P1; Li CB, 2008, P NATL ACAD SCI USA, V105, P536, DOI 10.1073/pnas.0707378105; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; McKinney SA, 2005, P NATL ACAD SCI USA, V102, P5715, DOI 10.1073/pnas.0409328102; McKinney SA, 2004, BIOCHEM SOC T, V32, P41, DOI 10.1042/BST0320041; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Palmer A, 2002, IEEE T GEOSCI REMOTE, V38, P2056; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schwarz FW, 2009, BIOPHYS J, V96, p415A, DOI 10.1016/j.bpj.2008.12.2123; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Shalizi C. R., 2004, UNCERTAINTY ARTIFICI, P504; Shalizi CR, 2001, J STAT PHYS, V104, P817, DOI 10.1023/A:1010388907793; Shalizi CR, 2001, THESIS U WISCONSIN; Shalizi CR, 2002, CSLG0210025 COMP RES; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Spence P, 2008, EUR BIOPHYS J BIOPHY, V37, P1335, DOI 10.1007/s00249-008-0343-7; Tino P, 1999, IEEE T NEURAL NETWOR, V10, P284, DOI 10.1109/72.750555; Varn DP, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174110; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Yu J, 2004, NUCLEIC ACIDS RES, V32, P6683, DOI 10.1093/nar/gkh1006	37	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29703	10.1371/journal.pone.0029703	http://dx.doi.org/10.1371/journal.pone.0029703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247783	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700038
J	Sharp, ER; Willberg, CB; Kuebler, PJ; Abadi, J; Fennelly, GJ; Dobroszycki, J; Wiznia, AA; Rosenberg, MG; Nixon, DF				Sharp, Elizabeth R.; Willberg, Christian B.; Kuebler, Peter J.; Abadi, Jacob; Fennelly, Glenn J.; Dobroszycki, Joanna; Wiznia, Andrew A.; Rosenberg, Michael G.; Nixon, Douglas F.			Association of Differentiation State of CD4+T Cells and Disease Progression in HIV-1 Perinatally Infected Children	PLOS ONE			English	Article							CD8(+) T-CELLS; VIRAL LOAD; CD4(+); MEMORY; RESPONSES; REPLICATION; MAGNITUDE; PHENOTYPE; DECLINE; PREDICT	Background: In the USA, most HIV-1 infected children are on antiretroviral drug regimens, with many individuals surviving through adolescence and into adulthood. The course of HIV-1 infection in these children is variable, and understudied. Methodology/Principal Findings: We determined whether qualitative differences in immune cell subsets could explain a slower disease course in long term survivors with no evidence of immune suppression (LTS-NS; CD4%>= 25%) compared to those with severe immune suppression (LTS-SS; CD4%<= 15%). Subjects in the LTS-NS group had significantly higher frequencies of naive (CCR7+CD45RA+) and central memory (CCR7+CD45RA-) CD4+ T cells compared to LTS-SS subjects (p = 0.0005 and <0.0001, respectively). Subjects in the rapid progressing group had significantly higher levels of CD4+ T-EMRA (CCR7-CD45RA+) cells compared to slow progressing subjects (p<0.0001). Conclusions/Significance: Rapid disease progression in vertical infection is associated with significantly higher levels of CD4+ T-EMRA (CCR7-CD45RA+) cells.	[Sharp, Elizabeth R.; Willberg, Christian B.; Kuebler, Peter J.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Abadi, Jacob; Fennelly, Glenn J.; Dobroszycki, Joanna; Wiznia, Andrew A.; Rosenberg, Michael G.] Jacobi Med Ctr, Bronx, NY USA	University of California System; University of California San Francisco; Jacobi Medical Center	Sharp, ER (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Willberg, Christian/0000-0001-5299-9344	National Institutes of Health [AI060379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R21AI060379, R01AI060379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by a grant from the National Institutes of Health AI060379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bitmansour AD, 2002, J IMMUNOL, V169, P1207, DOI 10.4049/jimmunol.169.3.1207; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chomont N, 2011, CURR OPIN HIV AIDS, V6, P30, DOI 10.1097/COH.0b013e3283413775; Dion ML, 2007, BLOOD, V109, P2912, DOI 10.1182/blood-2006-09-047308; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Garber DA, 2004, J CLIN INVEST, V113, P836, DOI 10.1172/JCI200419442; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; Nahmias AJ, 1998, J INFECT DIS, V178, P680, DOI 10.1086/515368; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; Younes SA, 2007, J IMMUNOL, V178, P788, DOI 10.4049/jimmunol.178.2.788	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29154	10.1371/journal.pone.0029154	http://dx.doi.org/10.1371/journal.pone.0029154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247768	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700016
J	Mulder, MB; Msalu, L; Caro, T; Salerno, J				Mulder, Monique Borgerhoff; Msalu, Lameck; Caro, Tim; Salerno, Jonathan			Remarkable Rates of Lightning Strike Mortality in Malawi	PLOS ONE			English	Article								Livingstone's second mission site on the shore of Lake Malawi suffers very high rates of consequential lightning strikes. Comprehensive interviewing of victims and their relatives in seven Traditional Authorities in Nkhata Bay District, Malawi revealed that the annual rate of consequential strikes was 419/million, more than six times higher than that in other developing countries; the rate of deaths from lightning was 84/million/year, 5.4 times greater than the highest ever recorded. These remarkable figures reveal that lightning constitutes a significant stochastic source of mortality with potential life history consequences, but it should not deflect attention away from the more prominent causes of mortality in this rural area.	[Mulder, Monique Borgerhoff] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Msalu, Lameck] Mpamba Hlth Ctr PA Mpamba, Nkhata Bay, Malawi; [Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Caro, Tim] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Salerno, Jonathan] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Mulder, Monique Borgerhoff] Wissensch Kolleg Berlin, Berlin, Germany	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mulder, MB (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	mborgerhoffmulder@ucdavis.edu						[Anonymous], 2007, COL DECL; [Anonymous], MEAS HLTH INF; Charnov Eric L., 1993, P1; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Cooper M. A., 2010, 21 INT LIGHTN DET C; Dlamini WM, 2009, NAT HAZARDS, V50, P179, DOI 10.1007/s11069-008-9331-6; FAO, 2000, FOOD AGR ORG UN COUN; Gant L, 2009, SOC WORK PUBLIC HLTH, V24, P39, DOI 10.1080/19371910802569435; Hedegaard H, 1999, 11 C APPL CLIM AM ME; Holle R., 2008, P 20 INT LIGHTN DET; Livingstone WP, 2006, LIFE R LAWS LIVINGST; Mills B, 2008, NAT HAZARDS, V47, P157, DOI 10.1007/s11069-007-9204-4; National Statistics Office website, 2008, REP MAL 2008 POP CEN; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; PENNINGTON R, 1988, AM J PHYS ANTHROPOL, V77, P303, DOI 10.1002/ajpa.1330770304; Quinlan RJ, 2007, P ROY SOC B-BIOL SCI, V274, P121, DOI 10.1098/rspb.2006.3690; Roff Derek A., 1992; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271	18	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29281	10.1371/journal.pone.0029281	http://dx.doi.org/10.1371/journal.pone.0029281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253708	gold, Green Published			2022-12-25	WOS:000315865800005
J	Balzeau, A; Gilissen, E; Grimaud-Herve, D				Balzeau, Antoine; Gilissen, Emmanuel; Grimaud-Herve, Dominique			Shared Pattern of Endocranial Shape Asymmetries among Great Apes, Anatomically Modern Humans, and Fossil Hominins	PLOS ONE			English	Article							TEMPORAL BONE PNEUMATIZATION; HUMAN MOTOR CORTEX; CEREBRAL ASYMMETRIES; STRUCTURAL ASYMMETRIES; NONHUMAN-PRIMATES; BRAIN ASYMMETRY; HANDEDNESS; ORGANIZATION; MORPHOMETRY; EVOLUTION	Anatomical asymmetries of the human brain are a topic of major interest because of their link with handedness and cognitive functions. Their emergence and occurrence have been extensively explored in human fossil records to document the evolution of brain capacities and behaviour. We quantified for the first time antero-posterior endocranial shape asymmetries in large samples of great apes, modern humans and fossil hominins through analysis of "virtual'' 3D models of skull and endocranial cavity and we statistically test for departures from symmetry. Once based on continuous variables, we show that the analysis of these brain asymmetries gives original results that build upon previous analysis based on discrete traits. In particular, it emerges that the degree of petalial asymmetries differs between great apes and hominins without modification of their pattern. We indeed demonstrate the presence of shape asymmetries in great apes, with a pattern similar to modern humans but with a lower variation and a lower degree of fluctuating asymmetry. More importantly, variations in the position of the frontal and occipital poles on the right and left hemispheres would be expected to show some degree of antisymmetry when population distribution is considered, but the observed pattern of variation among the samples is related to fluctuating asymmetry for most of the components of the petalias. Moreover, the presence of a common pattern of significant directional asymmetry for two components of the petalias in hominids implicates that the observed traits were probably inherited from the last common ancestor of extant African great apes and Homo sapiens. These results also have important implications for the possible relationships between endocranial shape asymmetries and functional capacities in hominins. It emphasizes the uncoupling between lateralized activities, some of them well probably distinctive to Homo, and large-scale cerebral lateralization itself, which is not unique to Homo.	[Balzeau, Antoine; Grimaud-Herve, Dominique] Museum Natl Hist Nat, CNRS, Dept Prehist, UMR 7194, Paris, France; [Balzeau, Antoine; Gilissen, Emmanuel] Royal Museum Cent Africa, Dept African Zool, Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium; [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Royal Museum for Central Africa; Universite Libre de Bruxelles; University of Arkansas System; University of Arkansas Fayetteville	Balzeau, A (corresponding author), Museum Natl Hist Nat, CNRS, Dept Prehist, UMR 7194, Paris, France.	abalzeau@mnhn.fr	Balzeau, Antoine/B-3302-2011	Balzeau, Antoine/0000-0002-4226-611X	European Community [029023]	European Community(European Commission)	This research was supported by the "Paul Broca II - The evolution of cerebral asymmetry in Homo sapiens'' project, contract number 029023, 6th Framework of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Balzeau A, 2005, J HUM EVOL, V48, P535, DOI 10.1016/j.jhevol.2005.01.002; Balzeau A, 2005, THESIS MUSUUM NATL H; Balzeau A, 2008, J HUM EVOL, V54, P546, DOI 10.1016/j.jhevol.2007.07.009; Balzeau A, 2006, J HUM EVOL, V51, P350, DOI 10.1016/j.jhevol.2006.04.007; Balzeau A, 2010, J HUM EVOL, V59, P54, DOI 10.1016/j.jhevol.2010.03.013; Balzeau A, 2009, J HUM EVOL, V56, P205, DOI 10.1016/j.jhevol.2008.07.013; Broca P., 1861, B SOCI T ANTHROPOLOG, V2, P235; Bryden MP, 1988, HDB NEUROPSYCHOLOGY, V1, P143; CAIN DP, 1979, BRAIN BEHAV EVOLUT, V16, P222, DOI 10.1159/000121838; CHEVERUD JM, 1990, BRAIN BEHAV EVOLUT, V35, P368, DOI 10.1159/000115881; Dax G, 1865, GAZ HEBDOM MED CHI 2, V2, P259; Dax G, 1863, C R ACAD SCI 3, V56, P534; FALK D, 1990, BRAIN RES, V512, P40, DOI 10.1016/0006-8993(90)91167-F; Galaburda Albert M., 1995, P51; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; GAZZANIGA MS, 1995, NEURON, V14, P217, DOI 10.1016/0896-6273(95)90280-5; GAZZANIGA MS, 1995, NEURAL COMPUT, V7, P1, DOI 10.1162/neco.1995.7.1.1; Gilissen E, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P187; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Grimaud-Herve D, 1997, CAHIERS PALEOANTHROP, P406; Grubbs FE, 1974, PROCEDURES DETECTING, P53; HADZISELIMOVIC H, 1966, ACTA ANAT, V63, P289; Halpern ME, 2005, J NEUROSCI, V25, P10351, DOI 10.1523/JNEUROSCI.3439-05.2005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrington Anne, 1995, P3; HECAEN H, 1978, HUMAN NEUROPSYCHOLOG; HOLLOWAY RL, 1981, AM J PHYS ANTHROPOL, V55, P385, DOI 10.1002/ajpa.1330550312; HOLLOWAY RL, 1981, AM J PHYS ANTHROPOL, V55, P503, DOI 10.1002/ajpa.1330550412; HOLLOWAY RL, 1982, AM J PHYS ANTHROPOL, V58, P101, DOI 10.1002/ajpa.1330580111; Holloway RL, 2004, BRAIN ENDOCASTS PALE, V3; Hopkins WD, 2010, NEUROSCIENCE, V171, P544, DOI 10.1016/j.neuroscience.2010.07.018; Hopkins WD, 2000, NEUROPSYCHOLOGIA, V38, P493, DOI 10.1016/S0028-3932(99)00090-1; Hopkins WD, 2008, NEUROIMAGE, V42, P491, DOI 10.1016/j.neuroimage.2008.05.014; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; KERTESZ A, 1990, BRAIN RES, V530, P40, DOI 10.1016/0006-8993(90)90655-U; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; LEARY RF, 1985, EVOLUTION, V39, P1318, DOI 10.1111/j.1558-5646.1985.tb05697.x; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; LeMay M., 1985, P233; LEMAY M, 1977, J NEUROL SCI, V32, P243, DOI 10.1016/0022-510X(77)90239-8; LeMay M., 1982, P263; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Mackay CE, 2003, PSYCHIAT RES-NEUROIM, V124, P25, DOI 10.1016/S0925-4927(03)00088-X; Nass RD, 1987, HDB PHYSL NERVOUS SY, V5, P701; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2398, DOI 10.1016/j.neuropsychologia.2007.02.021; Pilcher DL, 2001, LATERALITY, V6, P165; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Sequeira SD, 2006, NEUROPSYCHOLOGIA, V44, P622, DOI 10.1016/j.neuropsychologia.2005.06.014; Smaers JB, 2011, BRAIN BEHAV EVOLUT, V77, P67, DOI 10.1159/000323671; Sokal RR, 1995, BIOMETRY; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; TOBIAS PV, 1987, J HUM EVOL, V16, P741, DOI 10.1016/0047-2484(87)90022-4; VANVALEN L, 1962, EVOLUTION, V16, P125; Vauclair J, 2007, EVOLUTION HEMISPHERI, P183; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; Zilles K, 1996, NEUROSCI BIOBEHAV R, V20, P593, DOI 10.1016/0149-7634(95)00072-0	64	51	52	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29581	10.1371/journal.pone.0029581	http://dx.doi.org/10.1371/journal.pone.0029581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242147	Green Submitted, gold, Green Published			2022-12-25	WOS:000312662100030
J	Silva, JS; Andrade, AC; Santana, CC; Santos, LQ; de Oliveira, CI; Veras, PST; Vassallo, J; Dos-Santos, WLC				Silva, Joselli S.; Andrade, Alan C.; Santana, Claudia C.; Santos, Leina Q.; de Oliveira, Camila I.; Veras, Patricia S. T.; Vassallo, Jose; dos-Santos, Washington L. C.			Low CXCL13 Expression, Splenic Lymphoid Tissue Atrophy and Germinal Center Disruption in Severe Canine Visceral Leishmaniasis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; MARGINAL ZONE; DONOVANI INFECTION; SPLEEN; DOGS; CHAGASI; BRAZIL; MICE; PCR	Visceral leishmaniasis is associated with atrophy and histological disorganization of splenic compartments. In this paper, we compared organized and disorganized splenic lymphoid tissue from dogs naturally infected with Leishmania infantum assessing the size of the white pulp compartments, the distribution of T, B and S100(+) dendritic cells, using immunohistochemistry and morphometry and the expression of CCR7 and the cytokines, CXCL13, lymphotoxin (LT)-alpha, LT-beta, CCL19, CCL21, TNF-alpha, IL-10, IFN-gamma and TGF-beta, using by real time RT-PCR. The lymphoid follicles and marginal zones were smaller (3.2 and 1.9 times, respectively; Mann-Whitney, P<0.02) in animals with disorganized splenic tissue in comparison to those with organized splenic lymphoid tissue. In spleens with disorganized lymphoid tissue, the numbers of T cells and S100(+) dendritic cells were decreased in the follicles, and the numbers of B cells were reduced in both the follicles and marginal zones. CXCL13 mRNA expression was lower in animals with disorganized lymphoid tissue (0.5+/-0.4) compared to those with organized lymphoid tissue (2.7+/-2.9, both relative to 18S expression, P = 0.01). These changes in the spleen were associated with higher frequency of severe disease (7/12) in the animals with disorganized than in animals with organized (2/13, Chi-square, P = 0.01) splenic lymphoid tissue. The data presented herein suggest that natural infection with Leishmania infantum is associated with the impairment of follicular dendritic cells, CXCL13 expression, B cell migration and germinal center formation and associates these changes with severe clinical forms of visceral leishmaniasis. Furthermore the fact that this work uses dogs naturally infected with Leishmania infantum emphasizes the relevance of the data presented herein for the knowledge on the canine and human visceral leishmaniasis.	[Silva, Joselli S.; Andrade, Alan C.; Santos, Leina Q.; de Oliveira, Camila I.; Veras, Patricia S. T.; dos-Santos, Washington L. C.] Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Santana, Claudia C.] Escola Bahiana Med & Saude Publ Biomed, Salvador, BA, Brazil; [Vassallo, Jose] Univ Estadual Campinas, Fac Ciencias Med, Campinas, SP, Brazil	Fundacao Oswaldo Cruz; Escola Bahiana de Medicina e Saude Publica; Universidade Estadual de Campinas	Dos-Santos, WLC (corresponding author), Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.	wluis@bahia.fiocruz.br	dos-Santos, Washington LC/AAO-4649-2021; Veras, Patricia S T Sampaio Tavares/I-9632-2014; de Oliveira, Camila I/B-4358-2009; VASSALLO, JOSE/AAP-4600-2021; DoenÃas Tropicais, Inct/K-2308-2013; DOS-SANTOS, WASHINGTON/B-4173-2009	dos-Santos, Washington LC/0000-0002-5075-1254; Veras, Patricia S T Sampaio Tavares/0000-0001-8308-9263; de Oliveira, Camila I/0000-0002-7868-5164; VASSALLO, JOSE/0000-0002-2192-4865; DOS-SANTOS, WASHINGTON/0000-0003-1445-2318; Cronemberger Andrade, Alan/0000-0003-1645-0500; Santana, Cesar/0000-0002-8962-173X	Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb) [APR0434/2005]; Fundacao Oswaldo Cruz (Fiocruz) PAPES V [403470/2008-0]	Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao Oswaldo Cruz (Fiocruz) PAPES V	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb) grant no. APR0434/2005 and Fundacao Oswaldo Cruz (Fiocruz) PAPES V grant 403470/2008-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354; ANDRADE ZILTON A., 1966, REV INST MED TROP SAO PAULO, V8, P259; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ato M, 2004, J IMMUNOL, V173, P4815, DOI 10.4049/jimmunol.173.8.4815; Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; Ato M, 2006, J IMMUNOL, V176, P5486, DOI 10.4049/jimmunol.176.9.5486; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BARRALNETTO M, 1991, J INFECT DIS, V163, P853, DOI 10.1093/infdis/163.4.853; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; CARBONE A, 1988, HUM PATHOL, V19, P51, DOI 10.1016/S0046-8177(88)80315-0; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; COCCHIA D, 1983, CELL TISSUE RES, V230, P95; Dos-Santos WLC, 2008, VET IMMUNOL IMMUNOP, V123, P251, DOI 10.1016/j.vetimm.2008.02.004; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; GLANTZ SA, 1997, PRIMER BIOSTATISTICS, P1; Glantz SA., 1997, PRIMER BIOSTATISTICS; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; JANOSSY G, 1985, CLIN EXP IMMUNOL, V59, P257; KEENAN CM, 1984, VET PATHOL, V21, P80, DOI 10.1177/030098588402100114; Kemming G, 2004, EUR SURG RES, V36, P198, DOI 10.1159/000078853; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Melby PC, 2001, EXP PARASITOL, V99, P17, DOI 10.1006/expr.2001.4640; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Ministerio da Saude do Brasil, 2006, MAN VIG CONTR LEISHM; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Ruiz Felipe Sueiro, 2005, J. Bras. Patol. Med. Lab., V41, P263, DOI 10.1590/S1676-24442005000400008; Machado CJS, 2009, SCIENCE, V324, P1643, DOI 10.1126/science.324_1643; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Smelt SC, 1997, J IMMUNOL, V158, P3813; Solano-Gallego L, 2008, VET PARASITOL, V157, P211, DOI 10.1016/j.vetpar.2008.07.024; Steiniger B, 1999, MICROANATOMY FUNCTIO; Rodrigues CAT, 2009, VET IMMUNOL IMMUNOP, V127, P382, DOI 10.1016/j.vetimm.2008.10.324; TRYPHONAS L, 1977, CAN J COMP MED, V41, P1; VERESS B, 1983, BRIT J EXP PATHOL, V64, P505; VERESS B, 1977, IMMUNOLOGY, V33, P605	49	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29103	10.1371/journal.pone.0029103	http://dx.doi.org/10.1371/journal.pone.0029103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242159	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100013
J	Tian, WH; Dong, XY; Liu, XR; Wang, G; Dong, ZY; Shen, W; Zheng, G; Lu, JX; Chen, JZ; Wang, Y; Wu, ZJ; Wu, XB				Tian, Wenhong; Dong, Xiaoyan; Liu, Xuerong; Wang, Gang; Dong, Zheyue; Shen, Wei; Zheng, Gang; Lu, Jianxin; Chen, Jinzhong; Wang, Yue; Wu, Zhijian; Wu, Xiaobing			High-Throughput Functional MicroRNAs Profiling by Recombinant AAV-Based MicroRNA Sensor Arrays	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CELLS; DIFFERENTIATION; EXPRESSION; TARGET; VIRUS; IDENTIFICATION; BIOGENESIS; LUCIFERASE; MIR-21	Background: microRNAs (miRNAs) are small and non-coding RNAs which play critical roles in physiological and pathological processes. A number of methods have been established to detect and quantify miRNA expression. However, method for high-throughput miRNA function detection is still lacking. Principal Findings: We describe an adeno-associated virus (AAV) vector-based microRNA (miRNA) sensor (Asensor) array for high-throughput functional miRNA profiling. Each Asensor contains a Gaussia luciferase (Gluc) and a firefly luciferase (Fluc) expression cassette to sense functional miRNA and to serve as an internal control respectively. Using this array, we acquired functional profiles of 115 miRNAs for 12 cell lines and found "functional miRNA signatures'' for several specific cell lines. The activities of specific miRNAs including the let-7 family, miR-17-92 cluster, miR-221, and miR-222 in HEK 293 cells were compared with their expression levels determined by quantitative reverse transcriptase polymerase chain reaction (QRT-PCR). We also demonstrate two other practical applications of the array, including a comparison of the miRNA activity between HEK293 and HEK293T cells and the ability to monitor miRNA activity changes in K562 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA). Conclusions/Significance: Our approach has potential applications in the identification of cell types, the characterization of biological and pathological processes, and the evaluation of responses to interventions.	[Wu, Zhijian] NEI, Unit Ocular Gene Therapy, NIH, Bethesda, MD 20892 USA; [Dong, Xiaoyan; Chen, Jinzhong] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Tian, Wenhong] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China; [Dong, Xiaoyan; Dong, Zheyue; Shen, Wei; Zheng, Gang] Beijing FivePlus Mol Med Inst, Beijing, Peoples R China; [Tian, Wenhong; Liu, Xuerong; Wang, Gang; Wang, Yue; Wu, Xiaobing] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Liu, Xuerong; Lu, Jianxin] Wenzhou Med Coll, Wenzhou, Zhejiang, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Fudan University; Jilin University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Wu, ZJ (corresponding author), NEI, Unit Ocular Gene Therapy, NIH, Bethesda, MD 20892 USA.	wuzh@mail.nih.gov; wuxb0168@vip.sina.com	wu, zhi/GXH-3041-2022	Wu, Xiaobing/0000-0002-2823-2634	China Special Key Program on Infectious Diseases [2008ZX10002-023, 2008ZX10001-012]; State Key Laboratory of Molecular Virology and Genetic Engineering [2008-S-0003]; NATIONAL EYE INSTITUTE [ZIAEY000443] Funding Source: NIH RePORTER	China Special Key Program on Infectious Diseases; State Key Laboratory of Molecular Virology and Genetic Engineering; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the China Special Key Program on Infectious Diseases (2008ZX10002-023 and 2008ZX10001-012) and Research Program from the State Key Laboratory of Molecular Virology and Genetic Engineering (2008-S-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013479; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tricoli James V, 2007, Cancer Res, V67, P4553, DOI 10.1158/0008-5472.CAN-07-0563; Wu XB, 2001, CHINESE SCI BULL, V46, P485, DOI 10.1007/BF03187263; Wu X, 2009, SCAND J GASTROENTERO, V44, P1332, DOI 10.3109/00365520903215305; Wu ZJ, 1999, CHINESE SCI BULL, V44, P715, DOI 10.1007/BF02909710; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021	45	33	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29551	10.1371/journal.pone.0029551	http://dx.doi.org/10.1371/journal.pone.0029551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242174	Green Submitted, Green Published, gold			2022-12-25	WOS:000312662100028
J	Lago, CU; Nowinski, SM; Rundhaug, JE; Pfeiffer, ME; Kiguchi, K; Hirasaka, K; Yang, X; Abramson, EM; Bratton, SB; Rho, O; Colavitti, R; Kenaston, MA; Nikawa, T; Trempus, C; DiGiovanni, J; Fischer, SM; Mills, EM				Lago, C. U.; Nowinski, S. M.; Rundhaug, J. E.; Pfeiffer, M. E.; Kiguchi, K.; Hirasaka, K.; Yang, X.; Abramson, E. M.; Bratton, S. B.; Rho, O.; Colavitti, R.; Kenaston, M. A.; Nikawa, T.; Trempus, C.; DiGiovanni, J.; Fischer, S. M.; Mills, E. M.			Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesis	ONCOGENE			English	Article						mitochondria; uncoupling proteins; skin; carcinogenesis; differentiation	STEM-CELLS; HAIR FOLLICLE; SKELETAL-MUSCLE; CANCER; EXPRESSION; MUTATIONS; METABOLISM; ACTIVATION; INDUCTION; CARCINOMA	Decreased mitochondrial oxidative metabolism is a hallmark bioenergetic characteristic of malignancy that may have an adaptive role in carcinogenesis. By stimulating proton leak, mitochondrial uncoupling proteins (UCP1-3) increase mitochondrial respiration and may thereby oppose cancer development. To test this idea, we generated a mouse model that expresses an epidermal-targeted keratin-5-UCP3 (K5-UCP3) transgene and exhibits significantly increased cutaneous mitochondrial respiration compared with wild type (FVB/N). Remarkably, we observed that mitochondrial uncoupling drove keratinocyte/epidermal differentiation both in vitro and in vivo. This increase in epidermal differentiation corresponded to the loss of markers of the quiescent bulge stem cell population, and an increase in epidermal turnover measured using a bromodeoxyuridine (BrdU)-based transit assay. Interestingly, these changes in K5-UCP3 skin were associated with a nearly complete resistance to chemically-mediated multistage skin carcinogenesis. These data suggest that targeting mitochondrial respiration is a promising novel avenue for cancer prevention and treatment.	[Lago, C. U.; Abramson, E. M.; Bratton, S. B.; Mills, E. M.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lago, C. U.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Rundhaug, J. E.; Fischer, S. M.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX USA; [Yang, X.] Fudan Univ, Shanghai 200433, Peoples R China; [Colavitti, R.] Stanford Univ, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Nikawa, T.] Univ Tokushima, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 770, Japan; [Trempus, C.] NIEHS, Matrix Biol Grp, Lab Resp Biol, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; UTMD Anderson Cancer Center; Fudan University; Stanford University; Tokushima University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mills, EM (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	ted_mills@mail.utexas.edu	Hirasaka, Katsuya/AAJ-7371-2021; Hirasaka, Katsuya/J-5283-2019; Rundhaug, Joyce E/E-9114-2011	Hirasaka, Katsuya/0000-0003-2645-8450; Rundhaug, Joyce E/0000-0002-2481-6317; Nowinski, Sara/0000-0002-4744-6101; Bratton, Shawn/0000-0003-2895-5020	National Institutes of Health [DK089224, T32ES07247]; Grants-in-Aid for Scientific Research [24700753] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089224, R56DK089224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	EMM was supported by the National Institutes of Health grant # DK089224. SMN was supported by the National Institutes of Health Toxicology Training grant T32ES07247.	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dang CV, 1997, J BIOENERG BIOMEMBR, V29, P345, DOI 10.1023/A:1022446730452; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Faurschou A, 2007, EXP DERMATOL, V16, P485, DOI 10.1111/j.1600-0625.2007.00551.x; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Guigal N, 2002, J BIOL CHEM, V277, P47407, DOI 10.1074/jbc.M208048200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; Mori S, 2008, J INVEST DERMATOL, V128, P1894, DOI 10.1038/jid.2008.20; Morris RJ, 2000, CANCER RES, V60, P226; NICHOLLS DG, 1984, BIOCHEM SOC T, V12, P388, DOI 10.1042/bst0120388; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Oakes SA, 2007, P NATL ACAD SCI USA, V104, P15171, DOI 10.1073/pnas.0707798104; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Rundhaug JE, 1997, MOL CARCINOGEN, V20, P125, DOI 10.1002/(SICI)1098-2744(199709)20:1<125::AID-MC14>3.0.CO;2-3; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; Tamiji S, 2005, J INVEST DERMATOL, V125, P647, DOI 10.1111/j.0022-202X.2005.23885.x; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu WY, 2004, METH MOL B, V289, P79; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	42	13	13	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	44					4725	4731		10.1038/onc.2011.630	http://dx.doi.org/10.1038/onc.2011.630			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22266853	Green Accepted			2022-12-25	WOS:000310724400008
J	Zeller, C; Dai, W; Steele, NL; Siddiq, A; Walley, AJ; Wilhelm-Benartzi, CSM; Rizzo, S; van der Zee, A; Plumb, JA; Brown, R				Zeller, C.; Dai, W.; Steele, N. L.; Siddiq, A.; Walley, A. J.; Wilhelm-Benartzi, C. S. M.; Rizzo, S.; van der Zee, A.; Plumb, J. A.; Brown, R.			Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling	ONCOGENE			English	Article						drug resistance; cisplatin; DNA methylation; ovarian cancer; DNMTi; HDACi	HISTONE DEACETYLASE INHIBITION; DRUG-RESISTANCE; CPG ISLANDS; MISMATCH REPAIR; CELL-LINES; GENES; CHEMOTHERAPY; DEMETHYLATION; PROMOTER; STEM	Multiple DNA methylation changes in the cancer methylome are associated with the acquisition of drug resistance; however it remains uncertain how many represent critical DNA methylation drivers of chemoresistance. Using isogenic, cisplatin-sensitive/resistant ovarian cancer cell lines and inducing resensitizaton with demethylating agents, we aimed to identify consistent methylation and expression changes associated with chemoresistance. Using genome-wide DNA methylation profiling across 27 578 CpG sites, we identified loci at 4092 genes becoming hypermethylated in chemoresistant A2780/cp70 compared with the parental-sensitive A2780 cell line. Hypermethylation at gene promoter regions is often associated with transcriptional silencing; however, expression of only 245 of these hypermethylated genes becomes downregulated in A2780/cp70 as measured by microarray expression profiling. Treatment of A2780/cp70 with the demethylating agent 2-deoxy-5'-azacytidine induces resensitization to cisplatin and re-expression of 41 of the downregulated genes. A total of 13/41 genes were consistently hypermethylated in further independent cisplatin-resistant A2780 cell derivatives. CpG sites at 9 of the 13 genes (ARHGDIB, ARMCX2, COL1A, FLNA, FLNC, MEST, MLH1, NTS and PSMB9) acquired methylation in ovarian tumours at relapse following chemotherapy or chemoresistant cell lines derived at the time of patient relapse. Furthermore, 5/13 genes (ARMCX2, COL1A1, MDK, MEST and MLH1) acquired methylation in drug-resistant ovarian cancer-sustaining (side population) cells. MLH1 has a direct role in conferring cisplatin sensitivity when reintroduced into cells in vitro. This combined genomics approach has identified further potential key drivers of chemoresistance whose expression is silenced by DNA methylation that should be further evaluated as clinical biomarkers of drug resistance. Oncogene (2012) 31, 4567-4576; doi:10.1038/onc.2011.611; published online 16 January 2012	[Zeller, C.; Dai, W.; Wilhelm-Benartzi, C. S. M.; Brown, R.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Epigenet Unit, London W12 0NN, England; [Steele, N. L.] Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Siddiq, A.; Walley, A. J.] Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Rizzo, S.; Brown, R.] Inst Canc Res, Med Sect, Sutton, Surrey, England; [van der Zee, A.] Univ Groningen, Dept Obstet & Gynecol, Univ Med Ctr Groningen, Groningen, Netherlands; [Plumb, J. A.] Univ Glasgow, Inst Canc Sci, Canc Res UK Beatson Labs, Glasgow, Lanark, Scotland	Imperial College London; Beatson Oncology Centre; Imperial College London; University of London; Institute of Cancer Research - UK; University of Groningen; Beatson Institute; University of Glasgow	Brown, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Epigenet Unit, Hammersmith Campus,IRDB 4th Floor, London W12 0NN, England.	b.brown@imperial.ac.uk	Walley, Andrew J/D-2573-2009; Dai, Wei/T-8889-2019	Walley, Andrew J/0000-0001-7707-7549; Dai, Wei/0000-0002-5558-0685; Brown, Robert/0000-0001-7960-5755; Siddiq, Afshan/0000-0002-9110-1434; Wilhelm-Benartzi, Charlotte/0000-0003-4927-6158	Cancer Research UK [C536/A6689]; Imperial Experimental Cancer Medicine Centre; Imperial Biomedical Research Centre; Ovarian Cancer Action; Cancer Research UK [13086] Funding Source: researchfish; Ovarian Cancer Action [OCA3] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Imperial Experimental Cancer Medicine Centre; Imperial Biomedical Research Centre; Ovarian Cancer Action(Ovarian Cancer Action); Cancer Research UK(Cancer Research UK); Ovarian Cancer Action(Ovarian Cancer Action)	We thank Lisa McMillan for her valuable contribution to the initial analysis of the Affymetrix expression data. We also thank Nahal Masrour for preparation of samples and Kerra Pearce for running the Infinium HumanMethylation450 BeadChips at the UCL Genomics Center, London. This work was supported by a Cancer Research UK (CZ, WD and RB) grant (C536/A6689), Imperial Experimental Cancer Medicine Centre, Imperial Biomedical Research Centre and Ovarian Cancer Action (SR and CSMWB).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Anthoney DA, 1996, CANCER RES, V56, P1374; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Dai W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-337; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gifford G, 2004, CLIN CANCER RES, V10, P4420, DOI 10.1158/1078-0432.CCR-03-0732; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung H, 2011, BIOCHEM J, V436, P263, DOI 10.1042/BJ20101512; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7; LANGDON SP, 1988, CANCER RES, V48, P6166; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Nakanishi H, 2004, ONCOL REP, V12, P1273; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Ozols Robert F, 2004, J Natl Compr Canc Netw, V2 Suppl 2, pS60; Papouli E, 2004, CANCER RES, V64, P3391, DOI 10.1158/0008-5472.CAN-04-0513; Pedersen IS, 2002, HUM MOL GENET, V11, P1449, DOI 10.1093/hmg/11.12.1449; Peng CJ, 2011, INT J GYNECOL CANCER, V21, P280, DOI 10.1097/IGC.0b013e31820aaadb; Plumb JA, 2000, CANCER RES, V60, P6039; Rajasekhar Vinagolu K, 2008, Stem Cells, V26, P292; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith CA, 2005, DEV DYNAM, V233, P188, DOI 10.1002/dvdy.20309; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	50	188	193	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2012	31	42					4567	4576		10.1038/onc.2011.611	http://dx.doi.org/10.1038/onc.2011.611			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22249249	Green Submitted			2022-12-25	WOS:000309982100008
J	Brison, Y; Pijning, T; Malbert, Y; Fabre, E; Mourey, L; Morel, S; Potocki-Veronese, G; Monsan, P; Tranier, S; Remaud-Simeon, M; Dijkstra, BW				Brison, Yoann; Pijning, Tjaard; Malbert, Yannick; Fabre, Emeline; Mourey, Lionel; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Tranier, Samuel; Remaud-Simeon, Magali; Dijkstra, Bauke W.			Functional and Structural Characterization of alpha-(1 -> 2) Branching Sucrase Derived from DSR-E Glucansucrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO FERMENTATION; ALPHA-AMYLASE FAMILY; 2 CATALYTIC DOMAINS; LEUCONOSTOC-MESENTEROIDES; GLYCOSYL HYDROLASES; CRYSTAL-STRUCTURE; GNOTOBIOTIC-RATS; OLIGOSACCHARIDES; DEXTRANSUCRASE; SPECIFICITY	Delta N-123-glucan-binding domain-catalytic domain 2 (Delta N-123-GBD-CD2) is a truncated form of the bifunctional glucansucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299. It was constructed by rational truncation of GBD-CD2, which harbors the second catalytic domain of DSR-E. Like GBD-CD2, this variant displays alpha-(1-->2) branching activity when incubated with sucrose as glucosyl donor and (oligo-)dextran as acceptor, transferring glucosyl residues to the acceptor via a ping-pong bi-bi mechanism. This allows the formation of prebiotic molecules containing controlled amounts of alpha-(1-->2) linkages. The crystal structure of the apo alpha-(1-->2) branching sucrase Delta N-123-GBD-CD2 was solved at 1.90 angstrom resolution. The protein adopts the unusual U-shape fold organized in five distinct domains, also found in GTF180-Delta N and GTF-SI glucansucrases of glycoside hydrolase family 70. Residues forming subsite -1, involved in binding the glucosyl residue of sucrose and catalysis, are strictly conserved in both GTF180-Delta N and Delta N-123-GBD-CD2. Subsite +1 analysis revealed three residues (Ala-2249, Gly-2250, and Phe-2214) that are specific to Delta N-123-GBD-CD2. Mutation of these residues to the corresponding residues found in GTF180-Delta N showed that Ala-2249 and Gly-2250 are not directly involved in substrate binding and regiospecificity. In contrast, mutant F2214N had lost its ability to branch dextran, although it was still active on sucrose alone. Furthermore, three loops belonging to domains A and B at the upper part of the catalytic gorge are also specific to Delta N-123-GBD-CD2. These distinguishing features are also proposed to be involved in the correct positioning of dextran acceptor molecules allowing the formation of alpha-(-->2) branches.	[Mourey, Lionel; Tranier, Samuel] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] CNRS, UMR 5504, F-31400 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] INRA, UMR Ingn Syst Biol & Proc 792, F-31400 Toulouse, France; [Pijning, Tjaard; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [Mourey, Lionel; Tranier, Samuel] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Monsan, Pierre] Inst Univ France, F-75005 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Groningen; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Tranier, S (corresponding author), CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.	Samuel.Tranier@ipbs.fr; remaud@insa-toulouse.fr; b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019; Pijning, Tjaard/HDO-3704-2022; Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011; Veronese, Gabrielle/GTF-3473-2022; Pijning, Tjaard/ABA-2929-2021	Dijkstra, Bauke W./0000-0001-9731-6586; Mourey, Lionel/0000-0002-8259-1259; Pijning, Tjaard/0000-0003-4107-3663; Tranier, Samuel/0000-0001-9751-163X	region Midi-Pyrenees (France); European Molecular Biology Organization	region Midi-Pyrenees (France)(Region Occitanie); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the region Midi-Pyrenees (France) and the European Molecular Biology Organization.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DJOUZI Z, 1995, J APPL BACTERIOL, V79, P117, DOI 10.1111/j.1365-2672.1995.tb00924.x; Djouzi Z, 1997, BRIT J NUTR, V78, P313, DOI 10.1079/BJN19970149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Flickinger EA, 2000, J NUTR, V130, P1267, DOI 10.1093/jn/130.5.1267; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Ito K, 2010, ACTA CRYSTALLOGR F, V66, P1086, DOI 10.1107/S1744309110029714; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monsan P, 2010, CURR OPIN MICROBIOL, V13, P293, DOI 10.1016/j.mib.2010.03.002; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pijning T, 2008, BIOCATAL BIOTRANSFOR, V26, P12, DOI 10.1080/10242420701789163; Remaud-Simeon M, 2000, J MOL CATAL B-ENZYM, V10, P117, DOI 10.1016/S1381-1177(00)00119-3; ROBYT JF, 1979, CARBOHYD RES, V68, P95, DOI 10.1016/S0008-6215(00)84059-8; Sarbini SR, 2011, APPL ENVIRON MICROB, V77, P5307, DOI 10.1128/AEM.02568-10; Shah DSH, 2004, J BACTERIOL, V186, P8301, DOI 10.1128/JB.186.24.8301-8308.2004; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; VALETTE P, 1993, J SCI FOOD AGR, V62, P121, DOI 10.1002/jsfa.2740620204; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	69	74	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7915	7924		10.1074/jbc.M111.305078	http://dx.doi.org/10.1074/jbc.M111.305078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262856	hybrid, Green Published			2022-12-25	WOS:000301349400008
J	Bullen, HE; Charnaud, SC; Kalanon, M; Riglar, DT; Dekiwadia, C; Kangwanrangsan, N; Torii, M; Tsuboi, T; Baum, J; Ralph, SA; Cowman, AF; de Koning-Ward, TF; Crabb, BS; Gilson, PR				Bullen, Hayley E.; Charnaud, Sarah C.; Kalanon, Ming; Riglar, David T.; Dekiwadia, Chaitali; Kangwanrangsan, Niwat; Torii, Motomi; Tsuboi, Takafumi; Baum, Jacob; Ralph, Stuart A.; Cowman, Alan F.; de Koning-Ward, Tania F.; Crabb, Brendan S.; Gilson, Paul R. d			Biosynthesis, Localization, and Macromolecular Arrangement of the Plasmodium falciparum Translocon of Exported Proteins (PTEX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; DENSE GRANULES; MEMBRANE; CLYA; VIRULENCE; REVEALS; VACCINE; TOXIN	To survive within its host erythrocyte, Plasmodium falciparum must export hundreds of proteins across both its parasite plasma membrane and surrounding parasitophorous vacuole membrane, most of which are likely to use a protein complex known as PTEX (Plasmodium translocon of exported proteins). PTEX is a putative protein trafficking machinery responsible for the export of hundreds of proteins across the parasitophorous vacuole membrane and into the human host cell. Five proteins are known to comprise the PTEX complex, and in this study, three of the major stoichiometric components are investigated including HSP101 (a AAA(+) ATPase), a protein of no known function termed PTEX150, and the apparent membrane component EXP2. We show that these proteins are synthesized in the preceding schizont stage (PTEX150 and HSP101) or even earlier in the life cycle (EXP2), and before invasion these components reside within the dense granules of invasive merozoites. From these apical organelles, the protein complex is released into the host cell where it resides with little turnover in the parasitophorous vacuole membrane for most of the remainder of the following cell cycle. At this membrane, PTEX is arranged in a stable macromolecular complex of >1230 kDa that includes an similar to 600-kDa apparently homo-oligomeric complex of EXP2 that can be separated from the remainder of the PTEX complex using non-ionic detergents. Two different biochemical methods undertaken here suggest that PTEX components associate as EXP2-PTEX150-HSP101, with EXP2 associating with the vacuolar membrane. Collectively, these data support the hypothesis that EXP2 oligomerizes and potentially forms the putative membrane-spanning pore to which the remainder of the PTEX complex is attached.	[Bullen, Hayley E.; Charnaud, Sarah C.; Crabb, Brendan S.; Gilson, Paul R. d] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Bullen, Hayley E.; Riglar, David T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Charnaud, Sarah C.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; [Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia; [Riglar, David T.; Baum, Jacob; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic 3052, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Kangwanrangsan, Niwat; Torii, Motomi] Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime 7910295, Japan; [Tsuboi, Takafumi] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Crabb, Brendan S.; Gilson, Paul R. d] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Burnet Institute; University of Melbourne; Monash University; Deakin University; Walter & Eliza Hall Institute; University of Melbourne; Ehime University; Ehime University; Ehime University; University of Melbourne; Monash University	Crabb, BS (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	crabb@burnet.edu.au; gilson@burnet.edu.au	de Koning-Ward, Tania F/N-3572-2017; Crabb, Brendan/F-5287-2013; Tsuboi, Takafumi/AAK-6145-2021; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	de Koning-Ward, Tania F/0000-0001-5810-8063; Cowman, Alan F/0000-0001-5145-9004; Baum, Jake/0000-0002-0275-352X; Tsuboi, Takafumi/0000-0002-7415-1325; Riglar, David/0000-0002-5004-4373; Bullen, Hayley/0000-0003-4923-3019; Charnaud, Sarah/0000-0002-9029-9696; Ralph, Stuart/0000-0003-0114-7808	Australian National Health and Medical Research Council [516740, 533811, 406601]; Pratt Foundation through University of Melbourne; National Health and Medical Research Council; Grants-in-Aid for Scientific Research [23406007] Funding Source: KAKEN	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation through University of Melbourne; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Australian National Health and Medical Research Council Grants 516740, 533811, and 406601).; Supported by a Pratt Foundation Scholarship through University of Melbourne.; Supported by a National Health and Medical Research Council Career Development Fellowship award.	Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989; TRAGER W, 1992, INFECT IMMUN, V60, P4656, DOI 10.1128/IAI.60.11.4656-4661.1992; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, METHODS MOL BIOL, V607, P73, DOI 10.1007/978-1-60327-331-2_8; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	28	91	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7871	7884		10.1074/jbc.M111.328591	http://dx.doi.org/10.1074/jbc.M111.328591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253438	Green Published, hybrid			2022-12-25	WOS:000301349400004
J	Kumarasiri, M; Llarrull, LI; Borbulevych, O; Fishovitz, J; Lastochkin, E; Baker, BM; Mobashery, S				Kumarasiri, Malika; Llarrull, Leticia I.; Borbulevych, Oleg; Fishovitz, Jennifer; Lastochkin, Elena; Baker, Brian M.; Mobashery, Shahriar			An Amino Acid Position at Crossroads of Evolution of Protein Function ANTIBIOTIC SENSOR DOMAIN OF BlaR1 PROTEIN FROM STAPHYLOCOCCUS AUREUS VERSUS CLASS D beta-LACTAMASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; N-ZETA-DECARBOXYLATION; BLAR1 PROTEIN; SENSOR DOMAIN; CRYSTAL-STRUCTURES; ANTIBIOTICS; MECHANISM; LYSINE; ACTIVATION; DESIGN	The integral membrane protein BlaR1 of Staphylococcus aureus senses the presence of beta-lactam antibiotics in the milieu and transduces the information to its cytoplasmic side, where its activity unleashes the expression of a set of genes, including that for BlaR1 itself, which manifest the antibiotic-resistant phenotype. The x-ray structure of the sensor domain of this protein exhibits an uncanny similarity to those of the class D beta-lactamases. The former is a membrane-bound receptor/sensor for the beta-lactam antibiotics, devoid of catalytic competence for substrate turnover, whereas the latter are soluble periplasmic enzymes in Gram-negative bacteria with avid ability for beta-lactam turnover. The two are clearly related to each other from an evolutionary point of view. However, the high resolution x-ray structures for both by themselves do not reveal why one is a receptor and the other an enzyme. It is documented herein that a single amino acid change at position 439 of the BlaR1 protein is sufficient to endow the receptor/sensor protein with modest turnover ability for cephalosporins as substrates. The x-ray structure for this mutant protein and the dynamics simulations revealed how a hydrolytic water molecule may sequester itself in the antibiotic-binding site to enable hydrolysis of the acylated species. These studies document how the nature of the residue at position 439 is critical for the fate of the protein in imparting unique functions on the same molecular template, to result in one as a receptor and in another as a catalyst.	[Kumarasiri, Malika; Llarrull, Leticia I.; Borbulevych, Oleg; Fishovitz, Jennifer; Lastochkin, Elena; Baker, Brian M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mobashery@nd.edu	Baker, Brian/B-4584-2009; Fishovitz, Jennifer/R-8507-2018	Baker, Brian/0000-0002-0864-0964; 	National Institutes of Health [AI33170]; NIAID, National Institutes of Health [HHSN272200700055C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104987, R01AI033170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI33170. This work was also supported by the Network on Antimicrobial Resistance in Staphylococcus aureus program under NIAID, National Institutes of Health Contract HHSN272200700055C.	[Anonymous], 2010, SYB X; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Case DA, 2008, AMBER 11; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher J. F., 2010, ENZYMOLOGY ANTIBACTE; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knox JR, 1996, CHEM BIOL, V3, P937, DOI 10.1016/S1074-5521(96)90182-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Maveyraud L, 2002, J AM CHEM SOC, V124, P2461, DOI 10.1021/ja016736t; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOBASHERY S, 1990, P NATL ACAD SCI USA, V87, P578, DOI 10.1073/pnas.87.2.578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vercheval L, 2010, BIOCHEM J, V432, P495, DOI 10.1042/BJ20101122; WALEY SG, 1991, BIOCHEM J, V279, P87, DOI 10.1042/bj2790087; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Wilkinson AS, 2003, BIOCHEMISTRY-US, V42, P1950, DOI 10.1021/bi0266941	31	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8232	8241		10.1074/jbc.M111.333179	http://dx.doi.org/10.1074/jbc.M111.333179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262858	Green Published, hybrid			2022-12-25	WOS:000301349400038
J	Zou, L; Cao, S; Kang, NL; Huebert, RC; Shah, VH				Zou, Li; Cao, Sheng; Kang, Ningling; Huebert, Robert C.; Shah, Vijay H.			Fibronectin Induces Endothelial Cell Migration through beta 1 Integrin and Src-dependent Phosphorylation of Fibroblast Growth Factor Receptor-1 at Tyrosines 653/654 and 766	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; I COLLAGEN MATRICES; FACTOR EGF RECEPTOR; C-SRC; SIGNAL-TRANSDUCTION; BINDING-SITE; SH2 DOMAIN; ACTIVATION; INTEGRIN; AUTOPHOSPHORYLATION	The extracellular matrix microenvironment regulates cell phenotype and function. One mechanism by which this is achieved is the transactivation of receptor tyrosine kinases by specific matrix molecules. Here, we demonstrate that the provisional matrix protein, fibronectin (FN), activates fibroblast growth factor (FGF) receptor-1 (FGFR1) independent of FGF ligand in liver endothelial cells. FN activation of FGFR1 requires beta 1 integrin, as evidenced by neutralizing antibody and siRNA-based studies. Complementary genetic and pharmacologic approaches identify that the non-receptor tyrosine kinase Src is required for FN transactivation of FGFR1. Whereas FGF ligand-induced phosphorylation of FGFR1 preferentially activates ERK, FN-induced phosphorylation of FGFR1 preferentially activates AKT, indicating differential downstream signaling of FGFR1 in response to alternate stimuli. Mutation analysis of known tyrosine residues of FGFR1 reveals that tyrosine 653/654 and 766 residues are required for FN-FGFR1 activation of AKT and chemotaxis. Thus, our study mechanistically dissects a new signaling pathway by which FN achieves endothelial cell chemotaxis, demonstrates how differential phosphorylation profiles of FGFR1 can achieve alternate downstream signals, and, more broadly, highlights the diversity of mechanisms by which the extracellular matrix microenvironment regulates cell behavior through transactivation of receptor tyrosine kinases.	[Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA; Mayo Clin, Canc Cell Biol Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Shah, VH (corresponding author), Mayo Clin, Gastroenterol Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	shah.vijay@mayo.edu		Huebert, Robert/0000-0002-9812-7573	National Institutes of Health [DK59615-06, HL086990, AA021171-01, P30DK084567]; NATIONAL CANCER INSTITUTE [R01CA160069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059615, P30DK084567, R56DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021171, R37AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59615-06 (to V. H. S.), HL086990 (to V. H. S.), AA021171-01 (to V. H. S.), and P30DK084567 (to the Mayo Clinic Center for Cell Signaling in Gastroenterology).	Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bhaskar V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-61; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cross MJ, 2000, J CELL SCI, V113, P643; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dell'Era P, 1999, MOL BIOL CELL, V10, P23, DOI 10.1091/mbc.10.1.23; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; di Bonzo LV, 2009, HISTOL HISTOPATHOL, V24, P1323, DOI 10.14670/HH-24.1323; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Erba EB, 2005, MOL CELL PROTEOMICS, V4, P1107, DOI 10.1074/mcp.M500070-MCP200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Hu YL, 2009, J BIOL CHEM, V284, P29905, DOI 10.1074/jbc.M109.049155; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Kang NL, 2010, AM J PATHOL, V177, P1888, DOI 10.2353/ajpath.2010.100187; Kilkenny DM, 2003, J BIOL CHEM, V278, P17448, DOI 10.1074/jbc.M209698200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Larsson H, 1999, J BIOL CHEM, V274, P25726, DOI 10.1074/jbc.274.36.25726; Lei L, 2008, MOL CELL BIOL, V28, P794, DOI 10.1128/MCB.00443-07; Lundin L, 2003, EXP CELL RES, V287, P190, DOI 10.1016/S0014-4827(03)00125-3; Marsden M, 2001, DEVELOPMENT, V128, P3635; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nagel M, 1999, DEVELOPMENT, V126, P1975; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Paternostro C, 2010, WORLD J GASTROENTERO, V16, P281, DOI 10.3748/wjg.v16.i3.281; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Sahni A, 2004, BLOOD, V104, P3635, DOI 10.1182/blood-2004-04-1358; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Serini G, 2008, CURR OPIN HEMATOL, V15, P235, DOI 10.1097/MOH.0b013e3282fa745b; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Tsakiridis T, 1998, J BIOL CHEM, V273, P28322, DOI 10.1074/jbc.273.43.28322; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang JF, 2001, J BIOL CHEM, V276, P41950, DOI 10.1074/jbc.M101370200; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; ZHAN X, 1994, J BIOL CHEM, V269, P20221	68	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7190	7202		10.1074/jbc.M111.304972	http://dx.doi.org/10.1074/jbc.M111.304972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247553	hybrid, Green Published			2022-12-25	WOS:000301060200022
J	Martin, J; Lopez, P				Martin, Jose; Lopez, Pilar			Supplementation of Male Pheromone on Rock Substrates Attracts Female Rock Lizards to the Territories of Males: A Field Experiment	PLOS ONE			English	Article							FEMORAL GLAND SECRETIONS; MATE CHOICE; CHEMICAL CUES; SENSORY BIAS; CONSPECIFIC ATTRACTION; CHEMOSENSORY RESPONSES; PUBLIC INFORMATION; IGUANID LIZARD; HEALTH STATE; SELECTION	Background: Many animals produce elaborated sexual signals to attract mates, among them are common chemical sexual signals (pheromones) with an attracting function. Lizards produce chemical secretions for scent marking that may have a role in sexual selection. In the laboratory, female rock lizards (Iberolacerta cyreni) prefer the scent of males with more ergosterol in their femoral secretions. However, it is not known whether the scent-marks of male rock lizards may actually attract females to male territories in the field. Methodology/Principal Findings: In the field, we added ergosterol to rocks inside the territories of male lizards, and found that this manipulation resulted in increased relative densities of females in these territories. Furthermore, a higher number of females were observed associated to males in manipulated plots, which probably increased mating opportunities for males in these areas. Conclusions/Significance: These and previous laboratory results suggest that female rock lizards may select to settle in home ranges based on the characteristics of scent-marks from conspecific males. Therefore, male rock lizards might attract more females and obtain more matings by increasing the proportion of ergosterol when scent-marking their territories. However, previous studies suggest that the allocation of ergosterol to secretions may be costly and only high quality males could afford it, thus, allowing the evolution of scent-marks as an honest sexual display.	[Martin, Jose; Lopez, Pilar] CSIC, Museo Nacl Ciencias Nat, Dept Ecol & Evolut, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Martin, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol & Evolut, E-28006 Madrid, Spain.	jose.martin@mncn.csic.es	Martin, Jose/B-1073-2014; Lopez, Pilar/K-6221-2014; Martinez Hernandez, J Alfredo/K-8709-2014; Marti, Jose Luis/F-3833-2016	Martin, Jose/0000-0001-6648-3998; Lopez, Pilar/0000-0001-6577-1509; Campion, Javier/0000-0002-6522-8271; Martinez Hernandez, J Alfredo/0000-0001-5218-6941; Marti, Jose Luis/0000-0001-5828-8746; Milagro, Fermin/0000-0002-3228-9916	Spanish Ministerio de Ciencia e Innovacion [MCI-CGL2008-02119/BOS]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion project MCI-CGL2008-02119/BOS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; ALBERTS AC, 1993, BRAIN BEHAV EVOLUT, V41, P255, DOI 10.1159/000113847; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; Aragon P, 2001, BEHAV ECOL SOCIOBIOL, V50, P128, DOI 10.1007/s002650100344; Aragon P, 2007, ETHOL ECOL EVOL, V19, P69; Aragon P, 2004, ETHOLOGY, V110, P1001, DOI 10.1111/j.1439-0310.2004.01046.x; Aragon P, 2001, J HERPETOL, V35, P681, DOI 10.2307/1565912; Aragon P, 2000, ETHOLOGY, V106, P1115, DOI 10.1046/j.1439-0310.2000.00638.x; Aragon P, 2006, ANIM BEHAV, V72, P965, DOI 10.1016/j.anbehav.2005.11.023; Barata EN, 2008, ANIM BEHAV, V75, P379, DOI 10.1016/j.anbehav.2007.05.018; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Bull CM, 1999, BEHAV ECOL, V10, P136, DOI 10.1093/beheco/10.2.136; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Carazo P, 2007, ANIM BEHAV, V74, P895, DOI 10.1016/j.anbehav.2007.02.011; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DESLIPPE RJ, 1991, ECOLOGY, V72, P1218, DOI 10.2307/1941095; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Garcia CM, 2005, NATURE, V434, P501, DOI 10.1038/nature03363; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; HEWS DK, 1993, ANIM BEHAV, V46, P279, DOI 10.1006/anbe.1993.1189; HURST JL, 1993, ANIM BEHAV, V45, P55, DOI 10.1006/anbe.1993.1007; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Kopena R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019410; Kwiatkowski MA, 2002, BEHAV ECOL, V13, P201, DOI 10.1093/beheco/13.2.201; Labra A, 2007, CHEMOECOLOGY, V17, P103, DOI 10.1007/s00049-007-0369-9; LOFSTEDT C, 1989, OIKOS, V55, P402, DOI 10.2307/3565601; Lopez P, 2005, Z NATURFORSCH C, V60, P632; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lopez P, 1998, ETHOLOGY, V104, P809, DOI 10.1111/j.1439-0310.1998.tb00033.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V51, P461, DOI 10.1007/s00265-001-0447-x; Lopez P, 2009, NATURWISSENSCHAFTEN, V96, P65, DOI 10.1007/s00114-008-0451-3; Macdonald D.W., 1980, Symposia of the Zoological Society of London, P107; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; MARTIN J, 1992, OIKOS, V65, P328, DOI 10.2307/3545026; Martin J, 1997, BIOL CONSERV, V79, P303, DOI 10.1016/0006-3207(95)00110-7; Martin J, 2008, BEHAV ECOL SOCIOBIOL, V62, P1927, DOI 10.1007/s00265-008-0624-2; Martin J, 2007, BEHAV ECOL SOCIOBIOL, V62, P173, DOI 10.1007/s00265-007-0451-x; Martin J, 2007, BIOL LETTERS, V3, P125, DOI 10.1098/rsbl.2006.0589; Martin J, 2006, P ROY SOC B-BIOL SCI, V273, P2619, DOI 10.1098/rspb.2006.3619; Martin J, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P141; Martin J, 2008, AMPHIBIA-REPTILIA, V29, P572, DOI 10.1163/156853808786230479; Martins EP, 2006, J CHEM ECOL, V32, P881, DOI 10.1007/s10886-006-9029-8; Mason Robert T., 1992, V18, P114; Mason RT, 2010, J COMP PHYSIOL A, V196, P729, DOI 10.1007/s00359-010-0551-3; McLennan DA, 2005, ANIM BEHAV, V69, P181, DOI 10.1016/j.anbehav.2003.11.025; MCLOSKEY RT, 1987, ECOLOGY, V68, P2059, DOI 10.2307/1939897; Moreira PL, 2008, ACTA ETHOL, V11, P26, DOI 10.1007/s10211-007-0038-6; Muller KL, 1997, AM NAT, V150, P650, DOI 10.1086/286087; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; Nichols J., 2001, DISPERSAL; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; OLSSON M, 1995, ETHOLOGY, V101, P222; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019360; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Perez-Mellado V., 1998, FAUNA IBERICA, V10, P207; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; Quinn VS, 1999, ETHOLOGY, V105, P993, DOI 10.1046/j.1439-0310.1999.00486.x; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Sakaluk SK, 2000, P ROY SOC B-BIOL SCI, V267, P339, DOI 10.1098/rspb.2000.1006; Salvador A, 2008, BEHAV ECOL, V19, P169, DOI 10.1093/beheco/arm118; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sokal RR, 1995, BIOMETRY; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; WEDEKIND C, 1994, AM NAT, V143, P936, DOI 10.1086/285641; Weldon PJ, 2008, NAT PROD REP, V25, P738, DOI 10.1039/b509854h; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Woody DR, 1997, J HERPETOL, V31, P316, DOI 10.2307/1565407; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	77	69	73	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30108	10.1371/journal.pone.0030108	http://dx.doi.org/10.1371/journal.pone.0030108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253895	Green Published, gold			2022-12-25	WOS:000301361500033
J	Piyaphongkul, J; Pritchard, J; Bale, J				Piyaphongkul, Jiranan; Pritchard, Jeremy; Bale, Jeffrey			Can Tropical Insects Stand the Heat? A Case Study with the Brown Planthopper Nilaparvata lugens (Stal)	PLOS ONE			English	Article							GLOSSINA-PALLIDIPES DIPTERA; CRITICAL THERMAL MAXIMUM; CLIMATE-CHANGE; DROSOPHILA-MELANOGASTER; PHYSIOLOGICAL VARIATION; COLD TOLERANCE; TSETSE-FLY; ACCLIMATION; TEMPERATURE; RESPONSES	The brown planthopper Nilaparvata lugens (Stal) is the most serious pest of rice across the world, especially in tropical climates. N. lugens nymphs and adults were exposed to high temperatures to determine their critical thermal maximum (CTmax), heat coma temperature (HCT) and upper lethal temperature (ULT). Thermal tolerance values differed between developmental stages: nymphs were consistently less heat tolerant than adults. The mean (+/- SE) CTmax of nymphs and adult females and males were 34.9 +/- 0.3, 37.0 +/- 0.2 and 37.4 +/- 0.2 degrees C respectively, and for the HCT were 37.7 +/- 0.3, 43.5 +/- 0.4 and 42.0 +/- 0.4 degrees C. The ULT50 values (+/- SE) for nymphs and adults were 41.8 +/- 0.1 and 42.5 +/- 0.1 degrees C respectively. The results indicate that nymphs of N. lugens are currently living at temperatures close to their upper thermal limits. Climate warming in tropical regions and occasional extreme high temperature events are likely to become important limiting factors affecting the survival and distribution of N. lugens.	[Piyaphongkul, Jiranan; Pritchard, Jeremy; Bale, Jeffrey] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Piyaphongkul, J (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	J.S.Bale@bham.ac.uk			Royal Thai Government	Royal Thai Government	This work was supported by the Royal Thai Government (http://www.oeauk.net/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Albritton DL, 2002, CLIMATE CHANGE 2001; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 2000, POLAR BIOL, V23, P77, DOI 10.1007/s003000050011; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bale JS, 2001, J INSECT PHYSIOL, V47, P1161, DOI 10.1016/S0022-1910(01)00097-X; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Bowler K, 2005, J THERM BIOL, V30, P125, DOI 10.1016/j.jtherbio.2004.09.001; BUFFINGTON JD, 1969, COMP BIOCHEM PHYSIOL, V30, P865, DOI 10.1016/0010-406X(69)90041-3; Bursell E., 1964, PHYSL INSECTA, P283; CASEY TM, 1992, AM ZOOL, V32, P225; Chapman R.F., 2012, INSECTS STRUCTURE FU; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2001, J INSECT PHYSIOL, V47, P649, DOI 10.1016/S0022-1910(00)00163-3; Cuong NL, 1997, CROP PROT, V16, P707, DOI 10.1016/S0261-2194(97)00068-9; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Feder ME, 1998, AM ZOOL, V38, P503; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Folk DG, 2007, J EXP BIOL, V210, P2649, DOI 10.1242/jeb.003350; FRY FEJ, 1958, ANNU REV PHYSIOL, V20, P207, DOI 10.1146/annurev.ph.20.030158.001231; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Giese A, 2011, GLOBAL TEMPERATURE P; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Gutierrez AP, 2008, CLIMATIC CHANGE, V87, pS167, DOI 10.1007/s10584-007-9379-4; Hanna CJ, 2007, J ARACHNOL, V35, P193, DOI 10.1636/SH06-01.1; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; HEATH JE, 1971, AM ZOOL, V11, P145; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hilyard NC, 1977, PHYS APPL BIOL; Hodkinson ID, 1999, J ANIM ECOL, V68, P1259, DOI 10.1046/j.1365-2656.1999.00372.x; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; HUEY RB, 1979, AM ZOOL, V19, P357; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kisimoto R., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P113; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Klose MK, 2008, J NEUROPHYSIOL, V99, P2420, DOI 10.1152/jn.01251.2007; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Krebs RA, 1996, GENETICS, V142, P471; Lapointe SL, 2007, ENVIRON ENTOMOL, V36, P73, DOI 10.1603/0046-225X(2007)36[73:EOLTOM]2.0.CO;2; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Mazur L, 2011, ASIA PACIFIC ENCY NA; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Purves WK, 2001, PHYSL HOMEOSTASIS TE, P693; Recktenwald GW, 2006, HEAT TRANSFER SINGLE, P1; Renault D, 2005, J THERM BIOL, V30, P611, DOI 10.1016/j.jtherbio.2005.09.003; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Romero SA, 2010, ENVIRON ENTOMOL, V39, P919, DOI 10.1603/EN09324; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Seo B. Y., 2009, PLANTHOPPERS NEW THR, P303; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; STEVENSON RD, 1985, AM NAT, V125, P102, DOI 10.1086/284330; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Turnock WJ, 1999, ENTOMOLOGIA EXPT APP, V91, P373; Walsberg GE, 1996, J THERM BIOL, V21, P275, DOI 10.1016/S0306-4565(96)00017-4; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wharton DA, 2002, INTRO EXTREME LIFE L, P1; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Win S. S., 2011, Journal of Entomology, V8, P183, DOI 10.3923/je.2011.183.190; Yang J, 2008, J COMP PHYSIOL B, V178, P343, DOI 10.1007/s00360-007-0227-7	73	50	54	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29409	10.1371/journal.pone.0029409	http://dx.doi.org/10.1371/journal.pone.0029409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253720	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100010
J	Varshney, B; Agnihotram, S; Tan, YJ; Baric, R; Lal, SK				Varshney, Bhavna; Agnihotram, Sudhakar; Tan, Yee-Joo; Baric, Ralph; Lal, Sunil K.			SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; CORE-BINDING-FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; FACTOR-RECEPTOR PROMOTER; ACUTE MYELOID-LEUKEMIA; GENE-TRANSCRIPTION; AML1 GENE; HISTONE DEACETYLASE; I INTERFERON; ORF3 PROTEIN	Background: The causative agent of severe acute respiratory syndrome, SARS coronavirus (SARS-CoV) genome encodes several unique group specific accessory proteins with unknown functions. Among them, accessory protein 3b (also known as ORF4) was lately identified as one of the viral interferon antagonist. Recently our lab uncovered a new role for 3b in upregulation of AP-1 transcriptional activity and its downstream genes. Thus, we believe that 3b might play an important role in SARS-CoV pathogenesis and therefore is of considerable interest. The current study aims at identifying novel host cellular interactors of the 3b protein. Methodology/Principal Findings: In this study, using yeast two-hybrid and co-immunoprecipitation techniques, we have identified a host transcription factor RUNX1b (Runt related transcription factor, isoform b) as a novel interacting partner for SARS-CoV 3b protein. Chromatin immunoprecipitaion (ChIP) and reporter gene assays in 3b expressing jurkat cells showed recruitment of 3b on the RUNX1 binding element that led to an increase in RUNX1b transactivation potential on the IL2 promoter. Kinase assay and pharmacological inhibitor treatment implied that 3b also affect RUNX1b transcriptional activity by regulating its ERK dependent phosphorylation levels. Additionally, mRNA levels of MIP-1 alpha, a RUNX1b target gene upregulated in SARS-CoV infected monocyte-derived dendritic cells, were found to be elevated in 3b expressing U937 monocyte cells. Conclusions/Significance: These results unveil a novel interaction of SARS-CoV 3b with the host factor, RUNX1b, and speculate its physiological relevance in upregulating cytokines and chemokine levels in state of SARS virus infection.	[Varshney, Bhavna; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Agnihotram, Sudhakar; Baric, Ralph] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Tan, Yee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore	Varshney, B (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	sunillal@icgeb.res.in		Tan, Yee-Joo/0000-0002-2278-4497	Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The research is supported by a grant from the Department of Biotechnology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Brady G, 2009, J VIROL, V83, P6909, DOI 10.1128/JVI.00216-09; Bristow CAP, 2003, NUCLEIC ACIDS RES, V31, P2735, DOI 10.1093/nar/gkg401; Chan WS, 2005, MODERN PATHOL, V18, P1432, DOI 10.1038/modpathol.3800439; Chen J, J VIROL, V84; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Freundt EC, 2009, J VIROL, V83, P6631, DOI 10.1128/JVI.00367-09; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 1998, BIOCHEM BIOPH RES CO, V252, P582, DOI 10.1006/bbrc.1998.9705; Javed A, 2000, J CELL SCI, V113, P2221; Khan S, 2006, VIRUS RES, V122, P20, DOI 10.1016/j.virusres.2006.06.005; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Marshall LJ, 2008, J VIROL, V82, P6395, DOI 10.1128/JVI.00043-08; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Mikhail FM, 2002, CANCER GENET CYTOGEN, V135, P96, DOI 10.1016/S0165-4608(01)00633-1; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schmidt HM, 1997, J VIROL, V71, P8029, DOI 10.1128/JVI.71.10.8029-8034.1997; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Slobedman B, 2004, J VIROL, V78, P4054, DOI 10.1128/JVI.78.8.4054-4062.2004; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; Starkova J, 2007, CLIN CANCER RES, V13, P1726, DOI 10.1158/1078-0432.CCR-06-2569; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Sutton KA, 1997, VIROLOGY, V229, P240, DOI 10.1006/viro.1996.8432; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taylor DS, 1996, J BIOL CHEM, V271, P14020, DOI 10.1074/jbc.271.24.14020; Tyagi S, 2004, J BIOL CHEM, V279, P29308, DOI 10.1074/jbc.M402017200; Uchida H, 1997, J IMMUNOL, V158, P2251; Varshney B, BIOCHEMISTRY, V50, P5419; Wang L, 2009, BLOOD CELL MOL DIS, V43, P30, DOI 10.1016/j.bcmd.2009.03.005; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yuan XL, 2006, MOL CELLS, V21, P186; Yuan XL, 2005, VIRUS RES, V114, P70, DOI 10.1016/j.virusres.2005.06.001; ZAIMAN AL, 1995, J VIROL, V69, P2898, DOI 10.1128/JVI.69.5.2898-2906.1995; Zaiman AL, 1996, J VIROL, V70, P5618, DOI 10.1128/JVI.70.8.5618-5629.1996; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	60	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29542	10.1371/journal.pone.0029542	http://dx.doi.org/10.1371/journal.pone.0029542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253733	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100013
J	Andrew, M; Barua, R; Short, SM; Kohn, LM				Andrew, Marion; Barua, Reeta; Short, Steven M.; Kohn, Linda M.			Evidence for a Common Toolbox Based on Necrotrophy in a Fungal Lineage Spanning Necrotrophs, Biotrophs, Endophytes, Host Generalists and Specialists	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; PROGRAMMED CELL-DEATH; SCLEROTINIA-SCLEROTIORUM; BOTRYTIS-CINEREA; OXALIC-ACID; ARABIDOPSIS-THALIANA; MOLECULAR PHYLOGENY; POSITIVE SELECTION; EVOLUTION; GENE	The Sclerotiniaceae (Ascomycotina, Leotiomycetes) is a relatively recently evolved lineage of necrotrophic host generalists, and necrotrophic or biotrophic host specialists, some latent or symptomless. We hypothesized that they inherited a basic toolbox of genes for plant symbiosis from their common ancestor. Maintenance and evolutionary diversification of symbiosis could require selection on toolbox genes or on timing and magnitude of gene expression. The genes studied were chosen because their products have been previously investigated as pathogenicity factors in the Sclerotiniaceae. They encode proteins associated with cell wall degradation: acid protease 1 (acp1), aspartyl protease (asps), and polygalacturonases (pg1, pg3, pg5, pg6), and the oxalic acid (OA) pathway: a zinc finger transcription factor (pac1), and oxaloacetate acetylhydrolase (oah), catalyst in OA production, essential for full symptom production in Sclerotinia sclerotiorum. Site-specific likelihood analyses provided evidence for purifying selection in all 8 pathogenicity-related genes. Consistent with an evolutionary arms race model, positive selection was detected in 5 of 8 genes. Only generalists produced large, proliferating disease lesions on excised Arabidopsis thaliana leaves and oxalic acid by 72 hours in vitro. In planta expression of oah was 10-300 times greater among the necrotrophic host generalists than necrotrophic and biotrophic host specialists; pac1 was not differentially expressed. Ability to amplify 6/8 pathogenicity related genes and produce oxalic acid in all genera are consistent with the common toolbox hypothesis for this gene sample. That our data did not distinguish biotrophs from necrotrophs is consistent with 1) a common toolbox based on necrotrophy and 2) the most conservative interpretation of the 3-locus housekeeping gene phylogeny - a baseline of necrotrophy from which forms of biotrophy emerged at least twice. Early oah overexpression likely expands the host range of necrotrophic generalists in the Sclerotiniaceae, while specialists and biotrophs deploy oah, or other as-yet-unknown toolbox genes, differently.	[Andrew, Marion; Barua, Reeta; Short, Steven M.; Kohn, Linda M.] Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Andrew, M (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada.	linda.kohn@utoronto.ca	Short, Steven M/F-5578-2011	Short, Steven/0000-0002-6576-4883	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by individual Discovery Grants from the Natural Science and Engineering Research Council of Canada to Kohn and Short. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AGGAB AM, 1981, T BRIT MYCOL SOC, V76, P166, DOI 10.1016/S0007-1536(81)80022-8; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Batra LR, 1991, BERLIN STUTTGART MYC, V16, P246; Benito EP, 1998, EUR J PLANT PATHOL, V104, P207, DOI 10.1023/A:1008698116106; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bishop JG, 2005, MOL BIOL EVOL, V22, P1531, DOI 10.1093/molbev/msi146; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Cettul E, 2008, MOL PLANT PATHOL, V9, P675, DOI 10.1111/J.1364-3703.2008.00492.X; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; DICKMAN MB, 1992, PHYSIOL MOL PLANT P, V41, P255, DOI 10.1016/0885-5765(92)90025-Q; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Favaron F, 2004, MOL PLANT MICROBE IN, V17, P1402, DOI 10.1094/MPMI.2004.17.12.1402; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; GERMEIER C, 1994, Z PFLANZENK PFLANZEN, V101, P498; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Govrin EM, 2006, PHYTOPATHOLOGY, V96, P299, DOI 10.1094/PHYTO-96-0299; GRAF F, 1995, MYCOL RES, V99, P113, DOI 10.1016/S0953-7562(09)80324-9; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Hammond-Kosack KE, 2008, PLANT SIGNAL BEHAV, V3, P993, DOI 10.4161/psb.6292; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; HolstJensen A, 1997, MYCOLOGIA, V89, P885, DOI 10.2307/3761109; HolstJensen A, 1997, AM J BOT, V84, P686, DOI 10.2307/2445905; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joosten HJ, 2008, PROTEINS, V70, P157, DOI 10.1002/prot.21622; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; Kasza Z, 2004, CURR MICROBIOL, V48, P208, DOI 10.1007/s00284-003-4166-6; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Kim YT, 2007, MOL PLANT PATHOL, V8, P611, DOI 10.1111/J.1364-3703.2007.00423.X; LEWIS DH, 1973, BIOL REV, V48, P261, DOI 10.1111/j.1469-185X.1973.tb00982.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Nakagawa Y., 1999, J Infect Chemother, V5, P97, DOI 10.1007/s101560050016; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Pedras MSC, 2011, PHYTOCHEMISTRY, V72, P199, DOI 10.1016/j.phytochem.2010.11.018; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poussereau N, 2001, FEMS MICROBIOL LETT, V194, P27, DOI 10.1111/j.1574-6968.2001.tb09441.x; Poussereau N, 2001, MICROBIOL-UK, V147, P717, DOI 10.1099/00221287-147-3-717; Rajaguru BAP, 2010, PLANT PATHOL, V59, P1081, DOI 10.1111/j.1365-3059.2010.02346.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Rozen S, 2000, Methods Mol Biol, V132, P365; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; SCHUMACHER T, 1985, CAN J BOT, V63, P1610, DOI 10.1139/b85-224; SCOTT SW, 1980, GRASS FORAGE SCI, V35, P159, DOI 10.1111/j.1365-2494.1980.tb01505.x; Sexton AC, 2006, FEMS MICROBIOL LETT, V258, P150, DOI 10.1111/j.1574-6968.2006.00212.x; Sexton AC, 2009, FUNGAL GENET BIOL, V46, P201, DOI 10.1016/j.fgb.2008.10.014; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Sowley ENK, 2010, EUR J PLANT PATHOL, V126, P61, DOI 10.1007/s10658-009-9524-1; Spanu P, 2010, CURR OPIN PLANT BIOL, V13, P409, DOI 10.1016/j.pbi.2010.03.004; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Spatz HC, 1997, PHILOS T ROY SOC B, V352, P1, DOI 10.1098/rstb.1997.0001; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Tudzynski P., 2008, MYCOTA, VV, P29; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Wang Z, 2009, MOL PLANT MICROBE IN, V22, P235, DOI 10.1094/MPMI-22-3-0235; WHETZEL HH, 1945, MYCOLOGIA, V37, P648, DOI 10.2307/3755132; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng L, 2000, MOL PLANT MICROBE IN, V13, P724, DOI 10.1094/MPMI.2000.13.7.724; Zuppini A, 2005, MOL PLANT MICROBE IN, V18, P849, DOI 10.1094/MPMI-18-0849	83	58	59	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29943	10.1371/journal.pone.0029943	http://dx.doi.org/10.1371/journal.pone.0029943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253834	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700068
J	Schneider, CW; Tautz, J; Grunewald, B; Fuchs, S				Schneider, Christof W.; Tautz, Juergen; Gruenewald, Bernd; Fuchs, Stefan			RFID Tracking of Sublethal Effects of Two Neonicotinoid Insecticides on the Foraging Behavior of Apis mellifera	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; UNPAIRED MEDIAN NEURONS; HONEY-BEES; LEARNING PERFORMANCES; TOXICITY; HYMENOPTERA; PESTICIDES; RELEVANCE; AGONIST; MEMORY	The development of insecticides requires valid risk assessment procedures to avoid causing harm to beneficial insects and especially to pollinators such as the honeybee Apis mellifera. In addition to testing according to current guidelines designed to detect bee mortality, tests are needed to determine possible sublethal effects interfering with the animal's vitality and behavioral performance. Several methods have been used to detect sublethal effects of different insecticides under laboratory conditions using olfactory conditioning. Furthermore, studies have been conducted on the influence insecticides have on foraging activity and homing ability which require time-consuming visual observation. We tested an experimental design using the radiofrequency identification (RFID) method to monitor the influence of sublethal doses of insecticides on individual honeybee foragers on an automated basis. With electronic readers positioned at the hive entrance and at an artificial food source, we obtained quantifiable data on honeybee foraging behavior. This enabled us to efficiently retrieve detailed information on flight parameters. We compared several groups of bees, fed simultaneously with different dosages of a tested substance. With this experimental approach we monitored the acute effects of sublethal doses of the neonicotinoids imidacloprid (0.15-6 ng/bee) and clothianidin (0.05-2 ng/bee) under field-like circumstances. At field-relevant doses for nectar and pollen no adverse effects were observed for either substance. Both substances led to a significant reduction of foraging activity and to longer foraging flights at doses of >= 0.5 ng/bee (clothianidin) and >= 1.5 ng/bee (imidacloprid) during the first three hours after treatment. This study demonstrates that the RFID-method is an effective way to record short-term alterations in foraging activity after insecticides have been administered once, orally, to individual bees. We contribute further information on the understanding of how honeybees are affected by sublethal doses of insecticides.	[Schneider, Christof W.; Gruenewald, Bernd; Fuchs, Stefan] Goethe Univ Frankfurt, Dept Biol Sci, Inst Bienenkunde, Frankfurt, Germany; [Schneider, Christof W.; Tautz, Juergen] Univ Wurzburg, Bioctr, BEEgrp, Wurzburg, Germany	Goethe University Frankfurt; University of Wurzburg	Schneider, CW (corresponding author), Goethe Univ Frankfurt, Dept Biol Sci, Inst Bienenkunde, Frankfurt, Germany.	christof.schneider@bio.uni-frankfurt.de	Grünewald, Bernd/G-2060-2012		European Union; State of Hesse [37150400]	European Union(European Commission); State of Hesse	This study was funded by the European Union and the State of Hesse (Project No: 37150400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey J, 2005, APIDOLOGIE, V36, P623, DOI 10.1051/apido:2005048; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; *EPPO, 1992, EPPO B, V22, P203; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Ihara M, 2006, J PESTIC SCI, V31, P35, DOI 10.1584/jpestics.31.35; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Moreau M, 2011, J EXP BIOL, V214, P17, DOI 10.1242/jeb.050526; OECD, 1998, OECD GUIDEL TEST CHE, P1; OECD (Organization for Economic Co-operation and Development), 1998, FISH SHORT TERM TOX; OEPP/EPPO, 2003, EPPO B, V33, P141, DOI [10.1046/j.1365-2338.2003.00636.x, DOI 10.1046/J.1365-2338.2003.00636.X]; RENNER M, 1959, Z VERGL PHYSIOL, V42, P449, DOI 10.1007/BF00297804; Schmuck R., 2003, Pflanzenschutz-Nachrichten Bayer, V56, P26; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Streit S, 2003, ZOOLOGY, V106, P169, DOI 10.1078/0944-2006-00113; Sumner S, 2007, CURR BIOL, V17, P140, DOI 10.1016/j.cub.2006.11.064; Thany SH, 2009, NEUROTOXICOLOGY, V30, P1045, DOI 10.1016/j.neuro.2009.06.013; Thompson HM, 2007, PEST MANAG SCI, V63, P1058, DOI 10.1002/ps.1458; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	37	283	293	10	373	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30023	10.1371/journal.pone.0030023	http://dx.doi.org/10.1371/journal.pone.0030023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253863	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700076
J	Chang, KH; Chuang, TJ; Lyu, RK; Ro, LS; Wu, YR; Chang, HS; Huang, CC; Kuo, HC; Hsu, WC; Chu, CC; Chen, CM				Chang, Kuo-Hsuan; Chuang, Tzi-Jung; Lyu, Rong-Kuo; Ro, Long-Sun; Wu, Yih-Ru; Chang, Hong-Shiu; Huang, Chin-Chang; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chu, Chun-Che; Chen, Chiung-Mei			Identification of Gene Networks and Pathways Associated with Guillain-Barre Syndrome	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE NEURITIS; MOTOR AXONAL NEUROPATHY; INFLAMMATORY NEUROLOGIC DISEASES; EXPERIMENTAL ALLERGIC NEURITIS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; CAMPYLOBACTER-JEJUNI; CYCLOOXYGENASE-2 INHIBITOR; MOLECULAR MIMICRY; PERIPHERAL-NERVE	Background: The underlying change of gene network expression of Guillain-Barre syndrome (GBS) remains elusive. We sought to identify GBS-associated gene networks and signaling pathways by analyzing the transcriptional profile of leukocytes in the patients with GBS. Methods and Findings: Quantitative global gene expression microarray analysis of peripheral blood leukocytes was performed on 7 patients with GBS and 7 healthy controls. Gene expression profiles were compared between patients and controls after standardization. The set of genes that significantly correlated with GBS was further analyzed by Ingenuity Pathways Analyses. 256 genes and 18 gene networks were significantly associated with GBS (fold change >= 2, P<0.05). FOS, PTGS2, HMGB2 and MMP9 are the top four of 246 significantly up-regulated genes. The most significant disease and altered biological function genes associated with GBS were those involved in inflammatory response, infectious disease, and respiratory disease. Cell death, cellular development and cellular movement were the top significant molecular and cellular functions involved in GBS. Hematological system development and function, immune cell trafficking and organismal survival were the most significant GBS-associated function in physiological development and system category. Several hub genes, such as MMP9, PTGS2 and CREB1 were identified in the associated gene networks. Canonical pathway analysis showed that GnRH, corticotrophin-releasing hormone and ERK/MAPK signaling were the most significant pathways in the up-regulated gene set in GBS. Conclusions: This study reveals the gene networks and canonical pathways associated with GBS. These data provide not only networks between the genes for understanding the pathogenic properties of GBS but also map significant pathways for the future development of novel therapeutic strategies.	[Chang, Kuo-Hsuan] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chang, KH (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Kaohsiung, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG 37056, CMRPG 38138]; National Science Council, Executive Yuan, Taiwan [NSC 99-2628-B-182A-063-MY3]	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG 37056 and CMRPG 38138), and National Science Council, Executive Yuan, Taiwan (NSC 99-2628-B-182A-063-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agthong S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-45; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Battaglia DF, 1998, ENDOCRINOLOGY, V139, P4175, DOI 10.1210/en.139.10.4175; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chiang HL, 2009, CLIN CHIM ACTA, V405, P143, DOI 10.1016/j.cca.2009.04.022; Cosi V, 2006, NEUROL SCI, V27, pS47, DOI 10.1007/s10072-006-0548-4; Creange A, 1999, NEUROLOGY, V53, P1683, DOI 10.1212/WNL.53.8.1683; D'Aguanno S, 2010, NEUROSCI LETT, V485, P49, DOI 10.1016/j.neulet.2010.08.060; Del Giudice E, 2003, ACTA PAEDIATR, V92, P398; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gabriel CM, 2000, J NEUROIMMUNOL, V104, P139, DOI 10.1016/S0165-5728(99)00269-6; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gomez-Martin D, 2009, AUTOIMMUN REV, V9, P34, DOI 10.1016/j.autrev.2009.02.035; Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784; Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105; HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512; Hao Q, 1998, J NEUROIMMUNOL, V81, P116, DOI 10.1016/S0165-5728(97)00166-5; Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; HARTUNG HP, 1987, NEUROLOGY, V37, P1006, DOI 10.1212/WNL.37.6.1006; Hu W, 2003, NEUROLOGY, V61, P1774, DOI 10.1212/01.WNL.0000098884.75756.4D; Hughes PM, 1998, BRAIN, V121, P481, DOI 10.1093/brain/121.3.481; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; JANDER S, 1993, NEUROLOGY, V43, P1809, DOI 10.1212/WNL.43.9.1809; Jin T, 2007, EUR J NEUROL, V14, P563, DOI 10.1111/j.1468-1331.2007.01761.x; Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136; Kessler C, 2008, ROM J MORPHOL EMBRYO, V49, P27; Kieseier BC, 1998, ANN NEUROL, V43, P427, DOI 10.1002/ana.410430404; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Kumar K, 2008, PARASITOL INT, V57, P150, DOI 10.1016/j.parint.2007.11.005; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Kwa MSG, 2001, J NEUROIMMUNOL, V116, P220, DOI 10.1016/S0165-5728(01)00307-1; Marchiori P E, 1990, Arq Neuropsiquiatr, V48, P465; Mata S, 2006, EUR J NEUROL, V13, P153, DOI 10.1111/j.1468-1331.2006.01161.x; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Miyamoto K, 2002, MUSCLE NERVE, V25, P280, DOI 10.1002/mus.10019; Miyamoto K, 1999, MUSCLE NERVE, V22, P1704, DOI 10.1002/(SICI)1097-4598(199912)22:12<1704::AID-MUS13>3.0.CO;2-A; Miyamoto K, 1998, NEUROREPORT, V9, P2331, DOI 10.1097/00001756-199807130-00033; MOKUNO K, 1994, ACTA NEUROL SCAND, V89, P27; Nagai A, 2000, NEUROLOGY, V55, P1828, DOI 10.1212/WNL.55.12.1828; Nishino S, 2003, NEUROLOGY, V61, P823, DOI 10.1212/01.WNL.0000081049.14098.50; Nyati KK, 2010, J NEUROSCI RES, V88, P3540, DOI 10.1002/jnr.22514; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Oren A, 2001, J NEUROL SCI, V186, P31, DOI 10.1016/S0022-510X(01)00496-8; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Petzold A, 2006, NEUROLOGY, V67, P1071, DOI 10.1212/01.wnl.0000237334.69665.92; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; RANDELL SH, 1993, AM J RESP CELL MOL, V8, P546, DOI 10.1165/ajrcmb/8.5.546; Redford EJ, 1997, BRAIN, V120, P1895, DOI 10.1093/brain/120.10.1895; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Sainaghi PP, 2010, CYTOKINE, V51, P138, DOI 10.1016/j.cyto.2010.05.005; Schroer K, 2002, CIRCULATION, V105, P2760, DOI 10.1161/01.CIR.0000018127.10968.34; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sharshar T, 2002, NEUROLOGY, V59, P1649, DOI 10.1212/01.WNL.0000033799.58866.7A; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Susuki K, 2004, NEUROLOGY, V62, P949, DOI 10.1212/01.WNL.0000115123.42929.FD; Tomaszewska-Zaremba D, 2009, REPROD BIOL, V9, P11, DOI 10.1016/S1642-431X(12)60091-6; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang BY, 2010, MOL BIOL REP, V37, P2809, DOI 10.1007/s11033-009-9829-3; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Weishaupt A, 2001, NEUROSCI LETT, V306, P77, DOI 10.1016/S0304-3940(01)01877-8; WELLER M, 1991, J NEUROL SCI, V104, P215, DOI 10.1016/0022-510X(91)90313-V; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao XL, 2010, BIOCHEM BIOPH RES CO, V392, P551, DOI 10.1016/j.bbrc.2010.01.062	77	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					80	89	e29506	10.1371/journal.pone.0029506	http://dx.doi.org/10.1371/journal.pone.0029506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253732	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900009
J	Guljamow, A; Delissen, F; Baumann, O; Thunemann, AF; Dittmann, E				Guljamow, Arthur; Delissen, Friedmar; Baumann, Otto; Thuenemann, Andreas F.; Dittmann, Elke			Unique Properties of Eukaryote-Type Actin and Profilin Horizontally Transferred to Cyanobacteria	PLOS ONE			English	Article							ANGLE SCATTERING DATA; CELL-SHAPE; PROTEINS; EVOLUTION; MEMBRANE; MREB; VISUALIZATION; MAGNETOSOMES; SEGREGATION; GENE	A eukaryote-type actin and its binding protein profilin encoded on a genomic island in the cyanobacterium Microcystis aeruginosa PCC 7806 co-localize to form a hollow, spherical enclosure occupying a considerable intracellular space as shown by in vivo fluorescence microscopy. Biochemical and biophysical characterization reveals key differences between these proteins and their eukaryotic homologs. Small-angle X-ray scattering shows that the actin assembles into elongated, filamentous polymers which can be visualized microscopically with fluorescent phalloidin. Whereas rabbit actin forms thin cylindrical filaments about 100 mu m in length, cyanobacterial actin polymers resemble a ribbon, arrest polymerization at 510 lam and tend to form irregular multi-strand assemblies. While eukaryotic profilin is a specific actin monomer binding protein, cyanobacterial profilin shows the unprecedented property of decorating actin filaments. Electron micrographs show that cyanobacterial profilin stimulates actin filament bundling and stabilizes their lateral alignment into heteropolymeric sheets from which the observed hollow enclosure may be formed. We hypothesize that adaptation to the confined space of a bacterial cell devoid of binding proteins usually regulating actin polymerization in eukaryotes has driven the co-evolution of cyanobacterial actin and profilin, giving rise to an intracellular entity	[Guljamow, Arthur; Dittmann, Elke] Univ Potsdam, Dept Microbiol, Inst Biochem & Biol, Golm, Germany; [Delissen, Friedmar; Thuenemann, Andreas F.] Bundesanstalt Mat Forsch, Berlin, Germany; [Delissen, Friedmar; Thuenemann, Andreas F.] Prufung Fed Inst Mat Res & Testing, Berlin, Germany; [Baumann, Otto] Univ Potsdam, Dept Anim Physiol, Inst Biochem & Biol, Golm, Germany	University of Potsdam; Federal Institute for Materials Research & Testing; University of Potsdam	Guljamow, A (corresponding author), Univ Potsdam, Dept Microbiol, Inst Biochem & Biol, Golm, Germany.	guljamow@uni-potsdam.de	Dittmann, Elke/B-4742-2018; Thünemann, Andreas F./B-8700-2009	Dittmann, Elke/0000-0002-7549-7918; Thünemann, Andreas F./0000-0002-9883-6134	German Ministry of Education and Science (BMBF) [02WT0799]	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant of the German Ministry of Education and Science (BMBF, 02WT0799; www.bmbf.de) to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; DELORY GE, 1945, BIOCHEM J, V39, P245, DOI 10.1042/bj0390245; EGELMAN EH, 1994, CURR BIOL, V4, P79, DOI 10.1016/S0960-9822(00)00020-8; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; GLATTER O, 1980, J APPL CRYSTALLOGR, V13, P577, DOI 10.1107/S0021889880012794; Glatter O., 1982, SMALL ANGLE X RAY SC; Guljamow A, 2007, CURR BIOL, V17, pR757, DOI 10.1016/j.cub.2007.06.063; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hu B, 2007, MOL MICROBIOL, V63, P1640, DOI 10.1111/j.1365-2958.2007.05618.x; Jenkins C, 2002, P NATL ACAD SCI USA, V99, P17049, DOI 10.1073/pnas.012516899; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kuchibhatla A, 2009, LANGMUIR, V25, P3775, DOI 10.1021/la8036605; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mittelbach P., 1961, ACTA PHYS AUSTRIACA, V14, P185; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Norman AI, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2039088; Nyman T, 2002, J BIOL CHEM, V277, P15828, DOI 10.1074/jbc.M112195200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rogers MB, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-26; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schnablegger H, 1999, J COLLOID INTERF SCI, V212, P24, DOI 10.1006/jcis.1998.5970; Schnablegger H, 1999, ACTA POLYM, V50, P391, DOI 10.1002/(SICI)1521-4044(19991201)50:11/12<391::AID-APOL391>3.0.CO;2-2; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yarmola EG, 2009, BIOESSAYS, V31, P1150, DOI 10.1002/bies.200900049	47	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					221	231	e29926	10.1371/journal.pone.0029926	http://dx.doi.org/10.1371/journal.pone.0029926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253827	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900024
J	Zalewski, A; Cecchini, EL; Deroo, BJ				Zalewski, Alexandra; Cecchini, Erin L.; Deroo, Bonnie J.			Expression of Extracellular Matrix Components Is Disrupted in the Immature and Adult Estrogen Receptor beta-Null Mouse Ovary	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; KNOCKOUT ER-BETA(-/-) MICE; BASEMENT-MEMBRANE PROTEIN; RAT GRANULOSA-CELLS; LARGE GENE LISTS; ER-BETA; REPRODUCTIVE PHENOTYPES; MESSENGER-RNA; IV COLLAGEN; ALPHA	Within the ovary, Estrogen Receptor beta (ER beta) is localized to the granulosa cells of growing follicles. 17 beta-estradiol (E2) acting via ER beta augments the actions of follicle stimulating hormone in granulosa cells, leading to granulosa cell differentiation and formation of a preovulatory follicle. Adult ER beta-null females are subfertile and possess ovaries with reduced numbers of growing follicles and corpora lutea. Because the majority of E2 production by granulosa cells occurs once puberty is reached, a role for ER beta in the ovary prior to puberty has not been well examined. We now provide evidence that lack of ER beta disrupts gene expression as early as post-natal day (PND) 13, and in particular, we identify a number of genes of the extracellular matrix (ECM) that are significantly higher in ER beta-null follicles than in wildtype (WT) follicles. Considerable changes occur to the ECM occur during normal folliculogenesis to allow for the dramatic growth, cellular differentiation, and reorganization of the follicle from the primary to preovulatory stage. Using quantitative PCR and immunofluorescence, we now show that several ECM genes are aberrantly overexpressed in ER beta-null follicles. We find that Collagen11a1, a protein highly expressed in cartilage is significantly higher in ER beta-null follicles than WT follicles as early as PND 13, and this heightened expression continues through PND 23-29 into adulthood. Similarly, Nidogen 2, a highly conserved basement membrane glycoprotein, is elevated in ER beta-null follicles at PND 13 into adulthood, and is elevated specifically in the ER beta-null focimatrix, a basal lamina-like matrix located between granulosa cells. Focimatrix laminin and Collagen IV expression were also higher in ER beta-null ovaries than in WT ovaries at various ages. Our findings suggest two novel observations: a) that ER beta regulates granulosa cell gene expression ovary prior to puberty, and b) that ER beta regulates expression of ECM components in the mouse ovary.	[Zalewski, Alexandra; Deroo, Bonnie J.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Zalewski, Alexandra; Cecchini, Erin L.; Deroo, Bonnie J.] Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario)	Zalewski, A (corresponding author), Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.	bderoo2@uwo.ca			Canadian Institutes of Health Research [MOP 93658]; University of Western Ontario; The Children's Health Research Institute; London Regional Cancer Program, London, Ontario, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Ontario; The Children's Health Research Institute; London Regional Cancer Program, London, Ontario, Canada	This work was supported by a grant from the Canadian Institutes of Health Research (www.cihr.ca) to BD (MOP 93658), and funds from The University of Western Ontario (www.uwo.ca), The Children's Health Research Institute (www.chri.org), and the London Regional Cancer Program (www.lhsc.on.ca/About_Us/LRCP/), London, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal MC, 2008, P NATL ACAD SCI USA, V105, P2433, DOI 10.1073/pnas.0712029105; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Berkholtz CB, 2006, SEMIN REPROD MED, V24, P262, DOI 10.1055/s-2006-948555; Bowen KB, 2008, J HISTOCHEM CYTOCHEM, V56, P275, DOI 10.1369/jhc.7A7310.2007; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Chang WY, 1999, ENDOCRINOLOGY, V140, P405, DOI 10.1210/en.140.1.405; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Cox DA, 2006, MOL CELL ENDOCRINOL, V247, P53, DOI 10.1016/j.mce.2005.12.020; Deroo BJ, 2009, MOL ENDOCRINOL, V23, P955, DOI 10.1210/me.2008-0213; Dharma SJ, 2009, FERTIL STERIL, V91, P2025, DOI 10.1016/j.fertnstert.2008.02.088; Drummond AE, 1999, MOL CELL ENDOCRINOL, V149, P153, DOI 10.1016/S0303-7207(98)00247-0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; FAROOKHI R, 1986, MOL CELL ENDOCRINOL, V47, P13, DOI 10.1016/0303-7207(86)90011-0; Fouler PA, 2011, J CLIN ENDOCRINOL ME; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inzunza J, 2007, P NATL ACAD SCI USA, V104, P600, DOI 10.1073/pnas.0608951103; Irving-Rodgers HF, 2006, MOL REPROD DEV, V73, P1292, DOI 10.1002/mrd.20580; Irving-Rodgers HF, 2009, REPRODUCTION, V137, P825, DOI 10.1530/REP-08-0485; Irving-Rodgers HF, 2006, SEMIN REPROD MED, V24, P195, DOI 10.1055/s-2006-948549; Irving-Rodgers HF, 2010, CELL TISSUE RES, V339, P613, DOI 10.1007/s00441-009-0905-8; Irving-Rodgers HF, 2004, MATRIX BIOL, V23, P207, DOI 10.1016/j.matbio.2004.05.008; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Jefferson WN, 2002, BIOL REPROD, V67, P1285, DOI 10.1095/biolreprod67.4.1285; JONASSEN JA, 1982, ENDOCRINOLOGY, V111, P74, DOI 10.1210/endo-111-1-74; KESSEL B, 1985, BIOL REPROD, V32, P1038, DOI 10.1095/biolreprod32.5.1038; Kimura N, 1998, EXP CELL RES, V241, P36, DOI 10.1006/excr.1998.4016; KNECHT M, 1984, ENDOCRINOLOGY, V115, P41, DOI 10.1210/endo-115-1-41; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lei L, 2010, BIOL REPROD, V82, P13, DOI 10.1095/biolreprod.109.077404; MANNAN MA, 1991, J ENDOCRINOL, V130, P101, DOI 10.1677/joe.0.1300101; Matti N, 2010, MOL CELL ENDOCRINOL, V321, P207, DOI 10.1016/j.mce.2010.02.019; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Morris NP, 2000, J HISTOCHEM CYTOCHEM, V48, P725, DOI 10.1177/002215540004800601; Nakano K, 2007, ARCH HISTOL CYTOL, V70, P243, DOI 10.1679/aohc.70.243; NAKANO R, 1982, HORM RES, V16, P230, DOI 10.1159/000179506; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAO MC, 1978, CELL, V14, P71, DOI 10.1016/0092-8674(78)90302-1; Rodgers RJ, 1999, J REPROD FERTIL, P343; Rodriguez KF, 2010, ENDOCRINOLOGY, V151, P2826, DOI 10.1210/en.2009-1446; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; VERTEL BM, 1989, J CELL BIOL, V109, P1827, DOI 10.1083/jcb.109.4.1827; WANG XN, 1993, J REPROD FERTIL, V99, P403, DOI 10.1530/jrf.0.0990403; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106	57	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					250	263	e29937	10.1371/journal.pone.0029937	http://dx.doi.org/10.1371/journal.pone.0029937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253831	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900027
J	Cox, H; Escombe, R; McDermid, C; Mtshemla, Y; Spelman, T; Azevedo, V; London, L				Cox, Helen; Escombe, Rod; McDermid, Cheryl; Mtshemla, Yolanda; Spelman, Tim; Azevedo, Virginia; London, Leslie			Wind-Driven Roof Turbines: A Novel Way to Improve Ventilation for TB Infection Control in Health Facilities	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT	Objective: Tuberculosis transmission in healthcare facilities contributes significantly to the TB epidemic, particularly in high HIV settings. Although improving ventilation may reduce transmission, there is a lack of evidence to support low-cost practical interventions. We assessed the efficacy of wind-driven roof turbines to achieve recommended ventilation rates, compared to current recommended practices for natural ventilation (opening windows), in primary care clinic rooms in Khayelitsha, South Africa. Methods: Room ventilation was assessed (CO2 gas tracer technique) in 4 rooms where roof turbines and air-intake grates were installed, across three scenarios: turbine, grate and window closed, only window open, and only turbine and grate open, with concurrent wind speed measurement. 332 measurements were conducted over 24 months. Findings: For all 4 rooms combined, median air changes per hour (ACH) increased with wind speed quartiles across all scenarios. Higher median ACH were recorded with open roof turbines and grates, compared to open windows across all wind speed quartiles. Ventilation with open turbine and grate exceeded WHO-recommended levels (60 Litres/second/patient) for 95% or more of measurements in 3 of the 4 rooms; 47% in the remaining room, where wind speeds were lower and a smaller diameter turbine was installed. Conclusion: High room ventilation rates, meeting recommended thresholds, may be achieved using wind-driven roof turbines and grates, even at low wind speeds. Roof turbines and air-intake grates are not easily closed by staff, allowing continued ventilation through colder periods. This simple, low-cost technology represents an important addition to our tools for TB infection control.	[Cox, Helen; McDermid, Cheryl; Mtshemla, Yolanda] Med Sans Frontieres, Cape Town, South Africa; [Cox, Helen; Spelman, Tim] Burnet Inst Med Res, Melbourne, Vic, Australia; [Escombe, Rod] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Azevedo, Virginia] City Cape Town, Dept Hlth, Cape Town, South Africa; [London, Leslie] Univ Cape Town, ZA-7925 Cape Town, South Africa	Burnet Institute; Imperial College London; University of Cape Town	Cox, H (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	hcox@burnet.edu.au		Cox, Helen/0000-0002-6538-7192	Medecins sans Frontieres; Jack and Robert Smorgon Foundation in Australia	Medecins sans Frontieres; Jack and Robert Smorgon Foundation in Australia	This work was funded by Medecins sans Frontieres. Staff from Medecins sans Frontieres were involved in study design, data collection and analysis, manuscript preparation and decision to publish. This work was also assisted by an award from the Jack and Robert Smorgon Foundation in Australia, who had no role in study design, data collection and analysis, manuscript preparation and decision to publish.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754; Medecins Sans Frontieres, 2011, KHAYEL 2001 2011 ACT; MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Organization WH, 2007, INF PREV CONTR EP PA; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; UNAIDS, 2010, REP GLOB AIDS EP; WHO, 2010, GLOB TUB CONTR 2010; Windfinder.com, 2011, WIND WEATH STAT CAP; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2009, NAT VENT INF CONTR H	16	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29589	10.1371/journal.pone.0029589	http://dx.doi.org/10.1371/journal.pone.0029589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253742	Green Published, gold			2022-12-25	WOS:000315865800012
J	Maia, VH; da Mata, CS; Franco, LO; Cardoso, MA; Cardoso, SRS; Hemerly, AS; Ferreira, PCG				Maia, Vitor Hugo; da Mata, Camila Souza; Franco, Luciana Ozorio; Cardoso, Monica Aires; Sodre Cardoso, Sergio Ricardo; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti			DNA Barcoding Bromeliaceae: Achievements and Pitfalls	PLOS ONE			English	Article							IDENTIFICATION; ALGORITHM; MODEL	Background: DNA barcoding has been successfully established in animals as a tool for organismal identification and taxonomic clarification. Slower nucleotide substitution rates in plant genomes have made the selection of a DNA barcode for land plants a much more difficult task. The Plant Working Group of the Consortium for the Barcode of Life (CBOL) recommended the two-marker combination rbcL/matK as a pragmatic solution to a complex trade-off between universality, sequence quality, discrimination, and cost. Methodology/Principal Findings: It is expected that a system based on any one, or a small number of plastid genes will fail within certain taxonomic groups with low amounts of plastid variation, while performing well in others. We tested the effectiveness of the proposed CBOL Plant Working Group barcoding markers for land plants in identifying 46 bromeliad species, a group rich in endemic species from the endangered Brazilian Atlantic Rainforest. Although we obtained high quality sequences with the suggested primers, species discrimination in our data set was only 43.48%. Addition of a third marker, trnH-psbA, did not show significant improvement. This species identification failure in Bromeliaceaecould also be seen in the analysis of the GenBank's matK data set. Bromeliaceae's sequence divergence was almost three times lower than the observed for Asteraceae and Orchidaceae. This low variation rate also resulted in poorly resolved tree topologies. Among the three Bromeliaceae subfamilies sampled, Tillandsioideae was the only one recovered as a monophyletic group with high bootstrap value (98.6%). Species paraphyly was a common feature in our sampling. Conclusions/Significance: Our results show that although DNA barcoding is an important tool for biodiversity assessment, it tends to fail in taxonomy complicated and recently diverged plant groups, such as Bromeliaceae. Additional research might be needed to develop markers capable to discriminate species in these complex botanical groups.	[Maia, Vitor Hugo; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [da Mata, Camila Souza; Franco, Luciana Ozorio; Cardoso, Monica Aires; Sodre Cardoso, Sergio Ricardo] Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisa Cient, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	paulof@bioqmed.ufrj.br	Ferreira, Paulo C G/I-2836-2015	Ferreira, Paulo C G/0000-0002-5510-999X; dos Santos Gomes Maia, Vitor Hugo/0000-0003-2135-7650	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq; Natura; commercial company Nature	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natura; commercial company Nature	PCGF and ASH received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico research grants. V. H. M is indebted to CNPq for graduate fellowships. The authors are also thankful to Natura for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some funding to this work was provided by the commercial company Nature. However, this funding was approved by the Minister of Culture under a law that gives tax exceptions to companies that support important collections such as libraries and so on. In our particular case funding was provided to our group to create a DNA bank of plant species of the Atlantic Rain Forest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arenas-Diaz E, 2009, J ARTIFICIAL EVOLUTI, V2009; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fay Michael F., 1997, Kew Bulletin, V52, P923, DOI 10.2307/4117819; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; NEI M, 2000, MOL EVOLUTION PHYLOG; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Savolainen V, 2004, SCIENCE, V304, P1445; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Steele PR, 2011, AM J BOT, V98, P415, DOI 10.3732/ajb.1000296; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417	31	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29877	10.1371/journal.pone.0029877	http://dx.doi.org/10.1371/journal.pone.0029877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22253812	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100040
J	Smerieri, A; Petraroli, M; Ziveri, MA; Volta, C; Bernasconi, S; Street, ME				Smerieri, Arianna; Petraroli, Maddalena; Ziveri, Maria Angela; Volta, Cecilia; Bernasconi, Sergio; Street, Maria E.			Effects of Cord Serum Insulin, IGF-II, IGFBP-2, IL-6 and Cortisol Concentrations on Human Birth Weight and Length: Pilot Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; BINDING PROTEIN-1; FETAL-GROWTH; RECEPTOR; BLOOD; INTERLEUKIN-6; CHILDREN; LEPTIN; SYSTEM; TERM	Background: The IGF system is recognised to be important for fetal growth. We previously described increased Insulin-like growth factor binding protein (IGFBP)-2 cord serum concentrations in intra-uterine growth retardation (IUGR) compared with appropriate for gestational age (AGA) newborns, and a positive relationship of IGFBP-2 with Interleukin (IL)-6. The role of cortisol in the fetus at birth is largely unknown, and interactions among peptides are their real effect on birth size is unknown. Furthermore, almost all studies have previously assayed peptides in serum several years after birth, and follow-up data from pregnancy are always lacking. This study aimed at establishing and clarifying the effect of cord serum insulin, IGFII, IGFBP-2, cortisol and IL-6 concentrations on birth length and weight. Methods: 23 IUGR and 37 AGA subjects were followed up from the beginning of pregnancy, and were of comparable gestational age. Insulin, IGF-II, IGFBP-2, cortisol and IL-6 concentrations were assayed in cord serum at birth, and a multiple regression model was designed and applied to assess which were the significant biochemical determinants of birth size. Results: Insulin, cortisol, and IL-6, showed similar concentrations in IUGR and AGA as previously described, whereas IGF-II was lower, and IGFBP-2 increased in IUGR compared with AGA. IGF-II serum concentration was found to have a significant positive effect on both birth length (r:-0.546; p:0.001) and weight (r:0.679; p:0.0001). IGFBP-2 had a near significant negative effect on both birth weight(r:-20.342; p:0.05) and length (r:-20.372; p:0.03). Conclusion: IGF-II cord serum concentration was shown to have a significant positive effect on both birth length and weight, whereas IGFBP-2 had a significant negative effect. Insulin, cortisol, and IL-6 cord serum concentrations had no significant effect on birth size.	[Smerieri, Arianna; Petraroli, Maddalena; Ziveri, Maria Angela; Volta, Cecilia; Bernasconi, Sergio; Street, Maria E.] Univ Hosp Parma, Dept Paediat, Parma, Italy	University of Parma; University Hospital of Parma	Smerieri, A (corresponding author), Univ Hosp Parma, Dept Paediat, Parma, Italy.	mariaelisabeth.street@unipr.it	Bernasconi, Sergio/AAA-9419-2021; Street, Maria E/B-7099-2011	Street, Maria E/0000-0001-8427-8971	Department of Paediatrics, University of Parma, Italy	Department of Paediatrics, University of Parma, Italy	Grant support for this study was from the Department of Paediatrics, University of Parma, Italy. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arafat AM, 2009, J CLIN ENDOCR METAB, V94, P5093, DOI 10.1210/jc.2009-0875; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Cianfarani S, 2002, PEDIATR RES, V51, P94, DOI 10.1203/00006450-200201000-00017; Cianfarani S, 1998, EUR J ENDOCRINOL, V138, P524, DOI 10.1530/eje.0.1380524; D'Ercole AJ, 1999, ACTA PAEDIATR, V88, P31, DOI 10.1111/j.1651-2227.1999.tb14348.x; de Kort SWK, 2010, J CLIN ENDOCR METAB, V95, P864, DOI 10.1210/jc.2009-1508; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; GAGLIARDI L, 1999, RIV ITAL PED, V25, P159; GIUDICE LC, 1995, J CLIN ENDOCR METAB, V80, P1548, DOI 10.1210/jc.80.5.1548; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Heald AH, 2006, EXP CLIN ENDOCR DIAB, V114, P371, DOI 10.1055/s-2006-924320; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hung Te-Yu, 2008, Acta Paediatrica Taiwanica, V49, P19; Kaku K, 2007, ACTA PAEDIATR, V96, P363, DOI 10.1111/j.1651-2227.2006.00120.x; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lo HC, 2005, JPEN-PARENTER ENTER, V29, P87, DOI 10.1177/014860710502900287; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Osorio M, 1996, EARLY HUM DEV, V46, P15, DOI 10.1016/0378-3782(96)01737-9; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; REECE EA, 1994, OBSTET GYNECOL, V84, P88; Street ME, 2011, EUR J ENDOCRINOL, V164, P45, DOI 10.1530/EJE-10-0752; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; Street ME, 2009, CLIN ENDOCRINOL, V71, P394, DOI 10.1111/j.1365-2265.2009.03533.x; VERHAEGHE J, 1993, AM J OBSTET GYNECOL, V169, P89, DOI 10.1016/0002-9378(93)90137-8; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; White YAR, 2009, ENDOCRINOLOGY, V150, P4366, DOI 10.1210/en.2009-0356	30	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29562	10.1371/journal.pone.0029562	http://dx.doi.org/10.1371/journal.pone.0029562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242132	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000048
J	Stepanyuk, AR; Borisyuk, AL; Belan, PV				Stepanyuk, Andrey R.; Borisyuk, Anya L.; Belan, Pavel V.			Efficient Maximum Likelihood Estimation of Kinetic Rate Constants from Macroscopic Currents	PLOS ONE			English	Article							GABA(A) RECEPTOR CURRENTS; SINGLE-CHANNEL KINETICS; HIDDEN MARKOV-MODELS; ION-CHANNEL; POSTSYNAPTIC CURRENTS; SYNAPTIC-TRANSMISSION; GLYCINE RECEPTORS; MINIATURE IPSCS; 1-F NOISE; MECHANISM	A new method is described that accurately estimates kinetic constants, conductance and number of ion channels from macroscopic currents. The method uses both the time course and the strength of correlations between different time points of macroscopic currents and utilizes the property of semiseparability of covariance matrix for computationally efficient estimation of current likelihood and its gradient. The number of calculation steps scales linearly with the number of channel states as opposed to the cubic dependence in a previously described method. Together with the likelihood gradient evaluation, which is almost independent of the number of model parameters, the new approach allows evaluation of kinetic models with very complex topologies. We demonstrate applicability of the method to analysis of synaptic currents by estimating accurately rate constants of a 7-state model used to simulate GABAergic macroscopic currents.	[Stepanyuk, Andrey R.; Borisyuk, Anya L.; Belan, Pavel V.] AA Bogomolets Physiol Inst, UA-252601 Kiev, Ukraine; [Stepanyuk, Andrey R.; Borisyuk, Anya L.; Belan, Pavel V.] State Key Lab Mol & Cellular Biol, Kiev, Ukraine	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Belan, PV (corresponding author), AA Bogomolets Physiol Inst, UA-252601 Kiev, Ukraine.	pasha@biph.kiev.ua	Belan, Pavel/AAV-3522-2021	Belan, Pavel/0000-0001-5429-3716	Ukrainian government	Ukrainian government	This work was supported by the Ukrainian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; BALL FG, 1989, PROC R SOC SER B-BIO, V236, P385, DOI 10.1098/rspb.1989.0029; Bartos M, 2010, SPR SER COMPUT NEURO, V5, P129, DOI 10.1007/978-1-4419-0996-1_5; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Caliebe A, 2002, J MEMBRANE BIOL, V185, P25, DOI 10.1007/s00232-001-0107-0; Cannon RC, 2006, PLOS COMPUT BIOL, V2, P862, DOI 10.1371/journal.pcbi.0020091; Celentano JJ, 2004, BIOPHYS J, V87, P276, DOI 10.1529/biophysj.103.036632; CLAY JR, 1976, BIOPHYS J, V16, P121, DOI 10.1016/S0006-3495(76)85669-X; Clements JD, 2003, J NEUROSCI METH, V130, P115, DOI 10.1016/j.jneumeth.2003.09.019; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; Colquhoun D, 2003, J PHYSIOL-LONDON, V547, P699, DOI 10.1113/jphysiol.2002.034165; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; Colquhoun D, 2009, SINGLE CHANNEL RECOR, P397; Csanady L, 2006, BIOPHYS J, V90, P3523, DOI 10.1529/biophysj.105.075135; Dewilde P, 1998, TIME VARYING SYSTEMS, P474; Dewilde P, 2005, P IEEE WORKSH STAT S; Eidelman Y, 2008, LINEAR ALGEBRA APPL, V429, P266, DOI 10.1016/j.laa.2008.02.026; Fink M, 2009, PHILOS T R SOC A, V367, P2161, DOI 10.1098/rsta.2008.0301; Franks KM, 2003, J NEUROSCI, V23, P3186; Gohberg I., 1985, INTEGR EQUAT OPER TH, V8, P780, DOI DOI 10.1007/BF01213791; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; HEINEMANN SH, 1990, BIOPHYS J, V57, P499, DOI 10.1016/S0006-3495(90)82566-2; Heinemann SH, 1991, BIOPHYS J, P60; Hinkle DJ, 2003, J NEUROSCI, V23, P11698; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Keramidas A, 2010, J GEN PHYSIOL, V135, P59, DOI 10.1085/jgp.200910317; Kirischuk S, 1999, PFLUG ARCH EUR J PHY, V438, P716, DOI 10.1007/s004240051098; Kirischuk S, 1999, P NATL ACAD SCI USA, V96, P7520, DOI 10.1073/pnas.96.13.7520; Klein S, 1997, BIOMETRICS, V53, P870, DOI 10.2307/2533549; Koller D, 2009, PROBABILISTIC GRAPHI, P849; Korshoej AR, 2010, BRIT J PHARMACOL, V159, P636, DOI 10.1111/j.1476-5381.2009.00542.x; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lema GMC, 2006, J PHYSIOL-LONDON, V572, P183, DOI 10.1113/jphysiol.2005.099093; LUNDSTROM I, 1974, J THEOR BIOL, V45, P405, DOI 10.1016/0022-5193(74)90121-0; McClellan AML, 1999, J PHYSIOL-LONDON, V515, P711, DOI 10.1111/j.1469-7793.1999.711ab.x; Menon V, 2009, P NATL ACAD SCI USA, V106, P16829, DOI 10.1073/pnas.0903766106; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Moffatt L, 2007, BIOPHYS J, V93, P74, DOI 10.1529/biophysj.106.101212; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Mozrzymas JW, 2007, J PHYSIOL-LONDON, V585, P29, DOI 10.1113/jphysiol.2007.143602; Mozrzymas JW, 2003, J NEUROPHYSIOL, V89, P871, DOI 10.1152/jn.00951.2002; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Olsen RW, 2006, P NATL ACAD SCI USA, V103, P6081, DOI 10.1073/pnas.0601121103; Pallotta BS, 1997, ANN NY ACAD SCI, V812, P133, DOI 10.1111/j.1749-6632.1997.tb48153.x; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; Perrais D, 1999, J NEUROSCI, V19, P578; Qin F, 2000, BIOPHYS J, V79, P1928, DOI 10.1016/S0006-3495(00)76442-3; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Qin Feng, 2007, V403, P253, DOI 10.1007/978-1-59745-529-9_17; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; SIGWORTH FJ, 1985, BIOPHYS J, V47, P709, DOI 10.1016/S0006-3495(85)83968-0; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Vandebril R, 2008, MATRIX COMPUTATIONS, P570; Venkataramanan L, 2002, BIOPHYS J, V82, P1930, DOI 10.1016/S0006-3495(02)75542-2; Wojtowicz T, 2008, BRIT J PHARMACOL, V154, P234, DOI 10.1038/bjp.2008.90; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	68	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29731	10.1371/journal.pone.0029731	http://dx.doi.org/10.1371/journal.pone.0029731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242142	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000059
J	Yi, C; Wang, Q; Wang, L; Huang, Y; Li, L; Liu, L; Zhou, X; Xie, G; Kang, T; Wang, H; Zeng, M; Ma, J; Zeng, Y; Yun, JP				Yi, C.; Wang, Q.; Wang, L.; Huang, Y.; Li, L.; Liu, L.; Zhou, X.; Xie, G.; Kang, T.; Wang, H.; Zeng, M.; Ma, J.; Zeng, Y.; Yun, J-P			MiR-663, a microRNA targeting p21(waf1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma	ONCOGENE			English	Article						microRNAs; miR-663; cell cycle; p21; nasopharyngeal carcinoma	EPSTEIN-BARR-VIRUS; CELL-GROWTH; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION PROFILES; C-MYC; P21; ARREST; INHIBITION; GENES; P53	MicroRNAs (miRNAs) may function as either oncogenes or tumor suppressors in the malignant progression of different tumor types. MiR-663 was recently reported to be decreased and identified as a tumor suppressor in gastric cancer. We also verified its role in repressing cell proliferation of a gastric cancer cell line. In this study, however, miR-663 was found to be upregulated in nasopharyngeal carcinoma (NPC) cells compared with human immortalized nasopharyngeal epithelium cells, using a miRNA microarray, and this higher expression was confirmed in NPC tissue samples. Indeed, inhibition of miR-663 impaired the proliferation of NPC cells in vitro and the NPC tumor growth of xenografts in nude mice. Mechanistically, miR-663 directly targeted p21(WAF1/CIP1) to promote the cellular G1/S transition, as the inhibitory effects of miR-663 on the G1/S transition could be rescued by p21(WAF1/CIP1) silencing. Our results imply that miR-663 may act as an oncogene in NPC. The newly identified miR-663/p21(WAF1/CIP1) axis clarifies the molecular mechanism of NPC cell proliferation and represents a novel strategy for the diagnosis and treatment of patients with NPC. Oncogene (2012) 31, 4421-4433; doi: 10.1038/onc.2011.629; published online 16 January 2012	[Yi, C.; Wang, Q.; Wang, L.; Huang, Y.; Li, L.; Liu, L.; Zhou, X.; Xie, G.; Yun, J-P] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China; [Yi, C.; Wang, Q.; Wang, L.; Huang, Y.; Li, L.; Liu, L.; Zhou, X.; Xie, G.; Kang, T.; Wang, H.; Zeng, M.; Ma, J.; Zeng, Y.; Yun, J-P] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Kang, T.; Wang, H.; Zeng, M.; Zeng, Y.] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Ma, J.] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yun, JP (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Pathol, 651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	yunjp@mail.sysu.edu.cn	Wang, Linli/R-5688-2018	Wang, Linli/0000-0002-8380-6135	National Natural Science Foundation of China [30973506, 81172345]; 863 Project [2006AA02A404]; Science Foundation of Key Hospital Clinical Program of Ministry of Health, China [2010-178]; Project of State Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); Science Foundation of Key Hospital Clinical Program of Ministry of Health, China; Project of State Key Laboratory of Oncology in South China	We thank Jun Li for kindly providing the human gastric cancer cells MKN-45 and SCG-7901. This work was supported by grants from the National Natural Science Foundation of China (30973506 and 81172345), the 863 Project (2006AA02A404), the Science Foundation of Key Hospital Clinical Program of Ministry of Health, China (2010-178), and the Project of State Key Laboratory of Oncology in South China.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen H, 2010, NEUROL RES, V32, P603, DOI 10.1179/174313209X455691; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lehmann U, 2007, Verh Dtsch Ges Pathol, V91, P214; Lei X, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P406; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Li HM, 2004, ONCOGENE, V23, P4488, DOI 10.1038/sj.onc.1207580; Li XS, 1996, CANCER RES, V56, P5055; Liao Wen-Ting, 2005, Ai Zheng, V24, P1317; Lin CS, 2000, J MOL BIOL, V303, P7, DOI 10.1006/jmbi.2000.4121; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Min, 2005, Ai Zheng, V24, P1230; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang ZZ, 2010, INT J ONCOL, V37, P1315, DOI 10.3892/ijo_00000783; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Wong TS, 2011, J CANCER RES CLIN, V137, P415, DOI 10.1007/s00432-010-0898-4; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Xiao JY, 2009, CELL CYCLE, V8, P889, DOI 10.4161/cc.8.6.7898; Xu S, 2011, ONCOGENE, V30, P2219, DOI 10.1038/onc.2010.596; Yun JP, 2007, BRIT J CANCER, V96, P477, DOI 10.1038/sj.bjc.6603574; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang MF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-110; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727	76	125	131	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4421	4433		10.1038/onc.2011.629	http://dx.doi.org/10.1038/onc.2011.629			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22249270				2022-12-25	WOS:000309704500001
J	Jeong, KJ; Park, SY; Cho, KH; Sohn, JS; Lee, J; Kim, YK; Kang, J; Park, CG; Han, JW; Lee, HY				Jeong, K. J.; Park, S. Y.; Cho, K. H.; Sohn, J. S.; Lee, J.; Kim, Y. K.; Kang, J.; Park, C. G.; Han, J. W.; Lee, H. Y.			The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion	ONCOGENE			English	Article						LPA; Rho/ROCK; invasion; uPA; MMP-9; ovarian cancer	NF-KAPPA-B; MATRIX-DEGRADING PROTEINASES; HUMAN UROKINASE GENE; RHO-GTPASES; CARCINOMA CELLS; MATRIX-METALLOPROTEINASE-9 EXPRESSION; PLASMINOGEN-ACTIVATOR; MEMBRANE-VESICLES; FOCAL ADHESION; GROWTH-FACTORS	Lysophosphatidic acid (LPA) is a biolipid that has diverse biological activities implicated in ovarian cancer initiation and progression. Previous studies have shown the critical role of the Rho/Rho-associated kinase (ROCK) pathway in LPA-induced ovarian cancer progression. However, detailed underlying mechanism by which the Rho/ROCK pathway induces ovarian cancer cell invasion is still incompletely understood. In the present study, we observed that the Rho/ROCK pathway is implicated in the production of proteolytic enzymes, leading to LPA-induced ovarian cancer cell invasion. LPA induced matrix metalloproteinase (MMP)-9 expression in CAOV-3 and PA-1 cells and urokinase-type plasminogen activator (uPA) expression in SKOV-3 cells. LPA-induced proteolytic enzyme expression was required for the invasion of ovarian cancer cells expressing corresponding enzymes. Pretreatment of cells with a pharmacological inhibitor of Rho/ROCK (Y-27632) or overexpression of a dominant-negative mutant of Rho (Rho N19) profoundly inhibited LPA-induced proteolytic enzyme expression as well as the invasive potential of ovarian cancer cells. In addition, transfection with dominant-negative Ras (Ras N17) significantly inhibited LPA-induced Rho activation as well as MMP-9 and uPA expression. Consistently, Y-27632 reduced LPA-induced nuclear factor (NF)-kappa B activation that is critical for proteolytic enzyme expression and cellular invasion. Collectively, we demonstrate a mechanism by which LPA promotes ovarian cancer progression through coordinate activation of a Ras/Rho/ROCK/NF-kappa B signaling pathway and the proteolytic enzyme secretion, providing novel biomarkers and promising therapeutic targets for ovarian cancer cell progression. Oncogene (2012) 31, 4279-4289; doi:10.1038/onc.2011.595; published online 16 January 2012	[Jeong, K. J.; Park, S. Y.; Cho, K. H.; Kang, J.; Park, C. G.; Lee, H. Y.] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Pharmacol, Taejon 302718, South Korea; [Sohn, J. S.] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Pathol, Taejon 302718, South Korea; [Lee, J.] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Microbiol, Taejon 302718, South Korea; [Kim, Y. K.] Sookmyung Womens Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Han, J. W.] Sungkyunkwan Univ, Sch Pharm, Dept Biochem & Mol Biol, Suwon, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Sookmyung Women's University; Sungkyunkwan University (SKKU)	Lee, HY (corresponding author), Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Pharmacol, Taejon 302718, South Korea.	hoi@konyang.ac.kr	Jeong, Kangjin/HGT-9268-2022; Kang, Jaeku/D-4933-2011	Kang, Jaeku/0000-0002-8660-7940	Ministry of Education, Science and Technology [2011-0025912, 2011-0015761, 2011-0028284]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0025912 and 2011-0015761, HYL; 2011-0028284, JWH). We thank Professor Gordon B Mills for a plasmid-containing uPA promoter and invaluable discussion, Professor Aree Moon for Ras V12 and Ras N17 and Professor Taeg Kyu Kwon for MMP-9 promoters.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bese T, 2010, J GYNECOL ONCOL, V21, P248, DOI 10.3802/jgo.2010.21.4.248; Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Chang HR, 2010, CHEM-BIOL INTERACT, V183, P172, DOI 10.1016/j.cbi.2009.10.018; DOLO V, 1995, CLIN EXP METASTAS, V13, P277, DOI 10.1007/BF00133483; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Fishman DA, 1997, CANCER-AM CANCER SOC, V80, P1457, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1457::AID-CNCR13>3.0.CO;2-4; Fishman DA, 2001, CANCER RES, V61, P3194; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Gnad R, 2001, EXP CELL RES, V264, P244, DOI 10.1006/excr.2001.5165; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; Hodge JC, 2003, CANCER RES, V63, P1359; Horiuchi A, 2008, CANCER SCI, V99, P2532, DOI 10.1111/j.1349-7006.2008.00977.x; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; KOBAYASHI H, 1992, CANCER RES, V52, P3610; Kohn EC, 2003, INT J GYNECOL OBSTET, V83, P203, DOI 10.1016/S0020-7292(03)90122-6; Lee J, 2006, CLIN CANCER RES, V12, P6351, DOI 10.1158/1078-0432.CCR-06-1252; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Mills GB, 2003, GYNECOL ONCOL, V88, pS88, DOI 10.1006/gyno.2002.6692; MILLS GB, 1990, J CLIN INVEST, V86, P851, DOI 10.1172/JCI114784; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; MOSER TL, 1994, INT J CANCER, V56, P552, DOI 10.1002/ijc.2910560415; Mukai M, 2003, INT J ONCOL, V22, P1247; NOVAK U, 1991, NUCLEIC ACIDS RES, V19, P3389, DOI 10.1093/nar/19.12.3389; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831; Sedlakova I, 2011, TUMOR BIOL, V32, P311, DOI 10.1007/s13277-010-0123-8; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Young TN, 1996, GYNECOL ONCOL, V62, P89, DOI 10.1006/gyno.1996.0195	41	89	98	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	39					4279	4289		10.1038/onc.2011.595	http://dx.doi.org/10.1038/onc.2011.595			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22249252				2022-12-25	WOS:000309520200003
J	Singh, AK; Spiessberger, B; Zheng, W; Xiao, F; Lukowski, R; Wegener, JW; Weinmeister, P; Saur, D; Klein, S; Schemann, M; Krueger, D; Seidler, U; Hofmann, F				Singh, Anurag Kumar; Spiessberger, Beate; Zheng, Wen; Xiao, Fang; Lukowski, Robert; Wegener, Joerg W.; Weinmeister, Pascal; Saur, Dieter; Klein, Sabine; Schemann, Michael; Krueger, Dagmar; Seidler, Ursula; Hofmann, Franz			Neuronal cGMP kinase I is essential for stimulation of duodenal bicarbonate secretion by luminal acid	FASEB JOURNAL			English	Article						peptic ulcer; knockout mouse models; N. vagus; proton pump inhibitor	NITRIC-OXIDE; SMALL-INTESTINE; HCO3-SECRETION; VILLIN GENE; PROTEIN; EXPRESSION; CFTR; BRAIN; MICE; PROSTAGLANDIN	Brief contact of the duodenal mucosa with luminal acid elicits a long-lasting bicarbonate (HCO3-) secretory response, which is believed to be the primary protective mechanism against mucosal damage. Here, we show that cGMP-dependent protein kinase type I-knockout (cGKI(-/-)) mice are unable to respond to a physiological H+ stimulus with a HCO3- secretory response and spontaneously develop duodenal ulcerations. Smooth muscle-selective cGKI knock-in rescued the motility disturbance but not the defective HCO3- secretion. Proton-induced HCO3- secretion was not attenuated by selective inactivation of the cGKI gene in interstitial cells of Cajal or in enterocytes, but was abolished by inactivation of cGKI in neurons (ncGKI(-/-)). cGKI was expressed in the brainstem nucleus tractus solitarius that connects the afferent with the efferent N. vagus. Accordingly, truncation of the subdiaphragmal N. vagus significantly diminished proton-induced HCO3- secretion in wild-type mice, whereas stimulation of the subdiaphragmal N. vagus elicited a similar HCO3- secretory response in cGKI(-/-), ncGKI(-/-) and wild-type mice. These findings show that protection of the duodenum from acid injury requires neuronal cGKI.-Singh, A. K., Spiessberger, B., Zheng, W., Xiao, F., Lukowski, R., Wegener, J. W., Weinmeister, P., Saur, D., Klein, S., Schemann, M., Krueger, D., Seidler, U., Hofmann, F. Neuronal cGMP kinase I is essential for stimulation of duodenal bicarbonate secretion by luminal acid. FASEB J. 26, 1745-1754 (2012). www.fasebj.org	[Spiessberger, Beate; Lukowski, Robert; Wegener, Joerg W.; Weinmeister, Pascal; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp 923, D-80802 Munich, Germany; [Singh, Anurag Kumar; Zheng, Wen; Xiao, Fang; Lukowski, Robert; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Klein, Sabine] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80802 Munich, Germany; [Schemann, Michael; Krueger, Dagmar] Tech Univ Munich, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany	Technical University of Munich; Hannover Medical School; Technical University of Munich; Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp 923, FOR 923,Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de	Saur, Dieter/G-4629-2011; Saur, Dieter/O-8355-2015; Seidler, Ursula/HII-8049-2022	Saur, Dieter/0000-0001-5874-0210; Seidler, Ursula/0000-0002-9600-2769; Wegener, Jorg/0000-0002-8129-1537; Schemann, Michael/0000-0003-1007-9843; Singh, Anurag Kumar/0000-0003-0818-0993	Deutsche Forschungsgemeinschaft [DFG HO579/17-1, HO579/19-1, DFG SE 460/13-4, SE 460/9-6, SFB621/C9, DFG SA 1374/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Teodora Kennel, Uschi Gotz, and Regina Engelhardt for expert technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft to F.H. (DFG HO579/17-1 and HO579/19-1), U.S. (DFG SE 460/13-4, SE 460/9-6, and SFB621/C9), and D.S. (DFG SA 1374/1-2).	Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; Akiba Y, 2001, J CLIN INVEST, V108, P1807, DOI 10.1172/JCI12218; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; BALLESTEROS MA, 1991, AM J PHYSIOL, V261, pG327, DOI 10.1152/ajpgi.1991.261.2.G327; Bilski J, 1994, J Physiol Pharmacol, V45, P541; Ehrlich A, 1999, METHOD FIND EXP CLIN, V21, P47, DOI 10.1358/mf.1999.21.1.527018; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Francis S. H., PHYSL REV, V91, P651; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; HEYLINGS JR, 1984, AM J PHYSIOL, V246, pG235, DOI 10.1152/ajpgi.1984.246.3.G235; Hirokawa M, 2004, GASTROENTEROLOGY, V127, P1162, DOI 10.1053/j.gastro.2004.06.057; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Holm M, 1998, ACTA PHYSIOL SCAND, V162, P461; Holm M, 2001, DIGEST DIS SCI, V46, P1765, DOI 10.1023/A:1010674109111; Huber A, 1998, AM J PHYSIOL-GASTR L, V275, pG629, DOI 10.1152/ajpgi.1998.275.4.G629; ISENBERG JI, 1986, GASTROENTEROLOGY, V91, P370, DOI 10.1016/0016-5085(86)90571-8; JONSON C, 1986, ACTA PHYSIOL SCAND, V128, P65, DOI 10.1111/j.1748-1716.1986.tb07950.x; Kaunitz J D, 2001, JOP, V2, P268; Konturek PC, 2004, EUR J PHARMACOL, V499, P15, DOI 10.1016/j.ejphar.2004.06.060; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Nagl F, 2009, LAB INVEST, V89, p141A; Nayeb-Hashemi H, 2009, CURR OPIN GASTROEN, V25, P537, DOI 10.1097/MOG.0b013e328330da7b; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Plante L, 2004, J REPROD MED, V49, P825; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Sugamoto S, 2001, DIGEST DIS SCI, V46, P1208, DOI 10.1023/A:1010603026913; Takeuchi K, 1999, GASTROENTEROLOGY, V117, P1128, DOI 10.1016/S0016-5085(99)70398-7; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	43	15	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1745	1754		10.1096/fj.11-200394	http://dx.doi.org/10.1096/fj.11-200394			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22253479				2022-12-25	WOS:000302359700035
J	Burkhardt, J; Vonck, J; Langer, JD; Salzer, R; Averhoff, B				Burkhardt, Janin; Vonck, Janet; Langer, Julian D.; Salzer, Ralf; Averhoff, Beate			Unusual N-terminal alpha alpha beta alpha beta beta alpha Fold of PilQ from Thermus thermophilus Mediates Ring Formation and Is Essential for Piliation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL GENETIC-TRANSFORMATION; NEISSERIA-GONORRHOEAE; IV PILI; DNA-BINDING; II SECRETION; TWITCHING MOTILITY; COMPETENCE; PROTEIN; HB27; BIOGENESIS	DNA translocators of natural transformation systems are complex systems critical for the uptake of free DNA and provide a powerful mechanism for adaptation to changing environmental conditions. In natural transformation machineries, outer membrane secretins are suggested to form a multimeric pore for the uptake of external DNA. Recently, we reported on a novel structure of the DNA translocator secretin complex, PilQ, in Thermus thermophilus HB27 comprising a stable cone and cup structure and six ring structures with a large central channel. Here, we report on structural and functional analyses of a set of N-terminal PilQ deletion derivatives in T. thermophilus HB27. We identified 136 N-terminal residues exhibiting an unusual alpha alpha beta alpha beta beta alpha fold as a ring-building domain. Deletion of this domain had a dramatic effect on twitching motility, adhesion, and piliation but did not abolish natural transformation. These findings provide clear evidence that the pilus structures of T. thermophilus are not essential for natural transformation. The truncated complex was not affected in inner and outer membrane association, indicating that the 136 N-terminal residues are not essential for membrane targeting. Analyses of complex formation of the truncated PilQ monomers revealed that the region downstream of residue 136 is required for multimerization, and the region downstream of residue 207 is essential for monomer stability. Possible implications of our findings for the mechanism of DNA uptake are discussed.	[Burkhardt, Janin; Salzer, Ralf; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649; Vonck, Janet/0000-0001-5659-8863; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [AV9/6-1]; Max Planck Institute of Biophysics, Frankfurt, Germany; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute of Biophysics, Frankfurt, Germany; European Union(European Commission)	The work was supported by Deutsche Forschungsgemeinschaft Grant AV9/6-1.; We are indebted to Deryck Mills and Friederike Joos (Max Planck Institute of Biophysics, Frankfurt, Germany) for the contribution to piliation analyses of HB27 cells by electron microscopy. Jose Berenguer (Universidad Autonomes de Madrid, Madrid, Spain) is gratefully acknowledged for providing antibodies against T. thermophilus HB27 S-layer protein that were used to analyze the purity of the membrane fractionation. We are also grateful to Bernd Ludwig (Goethe University, Frankfurt, Germany) for the kind gift of plasmid pDM12. We are also grateful to Volker Muller (Goethe University, Frankfurt, Germany) for the many stimulating discussions on secretin complex purification. We thank Werner Kuhlbrandt and Hartmut Michel (Max Planck Institute of Biophysics, Frankfurt, Germany) for support. The Membrane protein Core Center at the Max Planck Institute of Biophysics was supported financially by the European Strategy Forum on Research Infrastructures Instruct program of the European Union.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; de Grado M, 1999, PLASMID, V42, P241, DOI 10.1006/plas.1999.1427; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Drake SL, 1995, MOL MICROBIOL, V18, P975, DOI 10.1111/j.1365-2958.1995.18050975.x; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Han XY, 2007, J BACTERIOL, V189, P5022, DOI 10.1128/JB.00138-07; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06; HIDAKA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1338, DOI 10.1271/bbb.58.1338; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Koomey M, 1998, APMIS, V106, P56; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Koster M, 2000, INT J MED MICROBIOL, V290, P325; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Nesper J, 2008, J BACTERIOL, V190, P4568, DOI 10.1128/JB.00369-08; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	57	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8484	8494		10.1074/jbc.M111.334912	http://dx.doi.org/10.1074/jbc.M111.334912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253437	hybrid, Green Published			2022-12-25	WOS:000301349400062
J	Xu, ZZ; Payoe, R; Fahlman, RP				Xu, Zhizhong; Payoe, Roshani; Fahlman, Richard P.			The C-terminal Proteolytic Fragment of the Breast Cancer Susceptibility Type 1 Protein (BRCA1) Is Degraded by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-MEDIATED DEGRADATION; INDUCED APOPTOSIS; CARDIOVASCULAR DEVELOPMENT; UBIQUITIN LIGASES; CELLS; ARGINYLATION; ACTIVATION; CLEAVAGE; GENE; TRANSFERASE	The breast cancer susceptibility type 1 gene product (BRCA1) is cleaved by caspases upon the activation of apoptotic pathways. After proteolysis the C-terminal fragment has been reported to translocate to the cytoplasm and promote cell death. Here we report that the C-terminal fragment is unstable in cells as it is targeted for degradation by the N-end rule pathway. The data reveals that mutating the wild type N-terminal aspartate, of the C-terminal fragment, to valine stabilizes the fragment. If the N terminus is mutated to another N-terminal destabilizing residue, like arginine, the C-terminal fragment remains unstable in cells. Last, the C-terminal fragment of BRCA1 is stable in cells lacking ATE1, a component of the N-end rule pathway.	[Xu, Zhizhong; Payoe, Roshani; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Xu, Zhizhong; Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	rfahlman@ualberta.ca			Canadian Breast Cancer Foundation (CBCF)	Canadian Breast Cancer Foundation (CBCF)	This work was supported by a research grant from the Canadian Breast Cancer Foundation (CBCF) (to R. P. F.).	An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Blagosklonny MV, 1999, ONCOGENE, V18, P6460, DOI 10.1038/sj.onc.1203068; Choi YH, 2001, INT J ONCOL, V19, P687; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fung AW, 2011, J MOL BIOL, V409, P617, DOI 10.1016/j.jmb.2011.04.033; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Herman-Bachinsky Y, 2007, CELL DEATH DIFFER, V14, P861, DOI 10.1038/sj.cdd.4402079; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Liu WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014484; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Solary E, 1998, CELL BIOL TOXICOL, V14, P121, DOI 10.1023/A:1007481921502; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Wang F., 2011, MOL BIOL RE IN PRESS; Wickliffe KE, 2008, CELL MICROBIOL, V10, P1352, DOI 10.1111/j.1462-5822.2008.01131.x; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701	47	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7495	7502		10.1074/jbc.M111.301002	http://dx.doi.org/10.1074/jbc.M111.301002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262859	Green Published, hybrid			2022-12-25	WOS:000301060200050
J	Nishida, N; Mawatari, Y; Sageshima, M; Tokunaga, K				Nishida, Nao; Mawatari, Yoriko; Sageshima, Megumi; Tokunaga, Katsushi			Highly Parallel and Short-Acting Amplification with Locus-Specific Primers to Detect Single Nucleotide Polymorphisms by the DigiTag2 Assay	PLOS ONE			English	Article							MULTIPLEX AMPLIFICATION; PCR PRIMERS; STRATEGY	The DigiTag2 assay enables analysis of a set of 96 SNPs using Kapa 2GFast HotStart DNA polymerase with a new protocol that has a total running time of about 7 hours, which is 6 hours shorter than the previous protocol. Quality parameters (conversion rate, call rate, reproducibility and concordance) were at the same levels as when genotype calls were acquired using the previous protocol. Multiplex PCR with 192 pairs of locus-specific primers was available for target preparation in the DigiTag2 assay without the optimization of reaction conditions, and quality parameters had the same levels as those acquired with 96-plex PCR. The locus-specific primers were able to achieve sufficient (concentration of target amplicon >= 5 nM) and specific (concentration of unexpected amplicons <2 nM) amplification within 2 hours, were also able to achieve detectable amplifications even when working in a 96-plex or 192-plex form. The improved DigiTag2 assay will be an efficient platform for screening an intermediate number of SNPs (tens to hundreds of sites) in the replication analysis after genome-wide association study. Moreover, highly parallel and short-acting amplification with locus-specific primers may thus facilitate widespread application to other PCR-based assays.	[Nishida, Nao; Mawatari, Yoriko; Sageshima, Megumi; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Nishida, Nao; Mawatari, Yoriko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan	Nishida, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan.	nishida-75@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22710191]; Miyakawa Memorial Research Foundation; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24790728] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Miyakawa Memorial Research Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI [grant number 22710191] Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Miyakawa Memorial Research Foundation. Partial support by the SENTAN program, Japan Science and Technology Agency, is also acknowledged. The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; de la Salmoniere YOLG, 2004, J CLIN MICROBIOL, V42, P2913, DOI 10.1128/JCM.42.7.2913-2918.2004; Deter J, 2009, MOL BIOCHEM PARASIT, V167, P144, DOI 10.1016/j.molbiopara.2009.05.007; Hosseini-Maaf B, 2007, TRANSFUSION, V47, P2110, DOI 10.1111/j.1537-2995.2007.01436.x; Krjutskov K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn357; Landegren U, 1997, ANN MED, V29, P585, DOI 10.3109/07853899709007487; Meuzelaar LS, 2007, NAT METHODS, V4, P835, DOI 10.1038/NMETH1091; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Pemov A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnh184; Qu WB, 2009, BIOINFORMATICS, V25, P276, DOI 10.1093/bioinformatics/btn614; Sun Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003701; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449	13	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29967	10.1371/journal.pone.0029967	http://dx.doi.org/10.1371/journal.pone.0029967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253840	Green Submitted, gold, Green Published			2022-12-25	WOS:000301361500027
J	Pasco, JA; Nicholson, GC; Brennan, SL; Kotowicz, MA				Pasco, Julie A.; Nicholson, Geoffrey C.; Brennan, Sharon L.; Kotowicz, Mark A.			Prevalence of Obesity and the Relationship between the Body Mass Index and Body Fat: Cross-Sectional, Population-Based Data	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; DISEASE RISK-FACTORS; WAIST CIRCUMFERENCE; WEIGHT; ADIPOSITY; METAANALYSIS; OVERWEIGHT; TRENDS; CANCER; ADULTS	Background: Anthropometric measures such as the body mass index (BMI) and waist circumference are widely used as convenient indices of adiposity, yet there are limitations in their estimates of body fat. We aimed to determine the prevalence of obesity using criteria based on the BMI and waist circumference, and to examine the relationship between the BMI and body fat. Methodology/Principal Findings: This population-based, cross-sectional study was conducted as part of the Geelong Osteoporosis Study. A random sample of 1,467 men and 1,076 women aged 20-96 years was assessed 2001-2008. Overweight and obesity were identified according to BMI (overweight 25.0-29.9 kg/m(2); obesity >= 30.0 kg/m(2)) and waist circumference (overweight men 94.0-101.9 cm; women 80.0-87.9 cm; obesity men >= 102.0 cm, women >= 88.0 cm); body fat mass was assessed using dual energy X-ray absorptiometry; height and weight were measured and lifestyle factors documented by self-report. According to the BMI, 45.1% (95% CI 42.4-47.9) of men and 30.2% (95% CI 27.4-33.0) of women were overweight and a further 20.2% (95% CI 18.0-22.4) of men and 28.6% (95% CI 25.8-31.3) of women were obese. Using waist circumference, 27.5% (95% CI 25.1-30.0) of men and 23.3% (95% CI 20.8-25.9) of women were overweight, and 29.3% (95% CI 26.9-31.7) of men and 44.1% (95% CI 41.2-47.1) of women, obese. Both criteria indicate that approximately 60% of the population exceeded recommended thresholds for healthy body habitus. There was no consistent pattern apparent between BMI and energy intake. Compared with women, BMI overestimated adiposity in men, whose excess weight was largely attributable to muscular body builds and greater bone mass. BMI also underestimated adiposity in the elderly. Regression models including gender, age and BMI explained 0.825 of the variance in percent body fat. Conclusions/Significance: As the BMI does not account for differences in body composition, we suggest that gender- and age-specific thresholds should be considered when the BMI is used to indicate adiposity.	[Pasco, Julie A.; Brennan, Sharon L.; Kotowicz, Mark A.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Pasco, Julie A.; Brennan, Sharon L.] Univ Melbourne, Dept Med, NW Acad Ctr, St Albans, Vic, Australia; [Nicholson, Geoffrey C.] Univ Queensland, Sch Med, Rural Clin Sch, Toowoomba, Qld, Australia	Deakin University; University of Melbourne; University of Queensland	Pasco, JA (corresponding author), Deakin Univ, Sch Med, Geelong, Vic 3217, Australia.	juliep@barwonhealth.org.au	Brennan-Olsen, Sharon/AAM-8595-2020; Nicholson, Geoffrey C/F-1901-2010; Kotowicz, Mark/AAI-4135-2021	Nicholson, Geoffrey C/0000-0002-0152-1153; Kotowicz, Mark/0000-0002-8094-1411; Brennan-Olsen, Sharon/0000-0003-3269-5401	Victorian Health Promotion Foundation; National Health and Medical Research Council (NHMRC, Australia); Perpetual Trustees	Victorian Health Promotion Foundation; National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Perpetual Trustees	The study was supported by grants awarded by the Victorian Health Promotion Foundation (http://www.vichealth.vic.gov.au/), the National Health and Medical Research Council (NHMRC, Australia) (http://www.nhmrc.gov.au/) and Perpetual Trustees (http://www.perpetual.com.au/philanthropic-services.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 1996, BRIT MED J, V312, P377; BRIEFEL RR, 1995, AM J CLIN NUTR, V62, P1072; BURTON BT, 1985, J AM DIET ASSOC, V85, P1117; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006062.pub2; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; GARROW JS, 1985, INT J OBESITY, V9, P147; Giles GG, IRELAND PD DIETARY Q; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; HAFFNER SM, 1987, DIABETES, V36, P43, DOI 10.2337/diabetes.36.1.43; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; Parliament of Australia, 2009, FAT BEC NORM; Pasco JA, 2012, INT J EPIDEMIOL, V41, P1565, DOI 10.1093/ije/dyr148; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Quetelet LAJ, 1869, PHYS SOCIALE, V2, P92; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Steinberger J, 2005, INT J OBESITY, V29, P1346, DOI 10.1038/sj.ijo.0803026; van den Beld AW, 2000, J CLIN ENDOCR METAB, V85, P3276, DOI 10.1210/jc.85.9.3276; Wang YY, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2636; World Health Organization, 2000, WHO TECHN REP SER, V894; World Health Organization (CH), 1985, WHO TECHN REP SER	32	85	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29580	10.1371/journal.pone.0029580	http://dx.doi.org/10.1371/journal.pone.0029580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253741	gold, Green Published			2022-12-25	WOS:000301361500014
J	Ekser, B; Klein, E; He, J; Stolz, DB; Echeverri, GJ; Long, C; Lin, CC; Ezzelarab, M; Hara, H; Veroux, M; Ayares, D; Cooper, DKC; Gridelli, B				Ekser, Burcin; Klein, Edwin; He, Jing; Stolz, Donna B.; Echeverri, Gabriel J.; Long, Cassandra; Lin, Chih Che; Ezzelarab, Mohamed; Hara, Hidetaka; Veroux, Massimiliano; Ayares, David; Cooper, David K. C.; Gridelli, Bruno			Genetically-Engineered Pig-to-Baboon Liver Xenotransplantation: Histopathology of Xenografts and Native Organs	PLOS ONE			English	Article							GENE-KNOCKOUT PIGS; HYPERACUTE REJECTION; TRANSGENIC PIG; DONORS; COAGULATION; COMPLEMENT; ACTIVATION; SURVIVAL; PRIMATE; MODEL	Orthotopic liver transplantation was carried out in baboons using wild-type (WT, n = 1) or genetically-engineered pigs (alpha 1,3-galactosyltransferase gene-knockout, GTKO), n = 1; GTKO pigs transgenic for human CD46, n = 7) and a clinically-acceptable immunosuppressive regimen. Biopsies were obtained from the WT pig liver pre-Tx and at 30 min, 1, 2, 3, 4 and 5 h post-transplantation. Biopsies of genetically-engineered livers were obtained pre-Tx, 2 h after reperfusion and at necropsy (4-7 days after transplantation). Tissues were examined by light, confocal, and electron microscopy. All major native organs were also examined. The WT pig liver underwent hyperacute rejection. After genetically-engineered pig liver transplantation, hyperacute rejection did not occur. Survival was limited to 4-7 days due to repeated spontaneous bleeding in the liver and native organs (as a result of profound thrombocytopenia) which necessitated euthanasia. At 2 h, graft histology was largely normal. At necropsy, genetically-engineered pig livers showed hemorrhagic necrosis, platelet aggregation, platelet-fibrin thrombi, monocyte/macrophage margination mainly in liver sinusoids, and vascular endothelial cell hypertrophy, confirmed by confocal and electron microscopy. Immunohistochemistry showed minimal deposition of IgM, and almost absence of IgG, C3, C4d, C5b-9, and of a cellular infiltrate, suggesting that neither antibody-nor cell-mediated rejection played a major role.	[Ekser, Burcin; Echeverri, Gabriel J.; Long, Cassandra; Lin, Chih Che; Ezzelarab, Mohamed; Hara, Hidetaka; Cooper, David K. C.; Gridelli, Bruno] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Ekser, Burcin; Veroux, Massimiliano] Univ Hosp Catania, Dept Surg Transplantat & Adv Technol, Vasc Surg & Organ Transplant Unit, Catania, Italy; [Klein, Edwin] Univ Pittsburgh, Div Lab Anim Resources, Pittsburgh, PA USA; [He, Jing] Childrens Hosp Pittsburgh, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Ayares, David] Revivicor Inc, Blacksburg, VA USA; [Echeverri, Gabriel J.; Gridelli, Bruno] Mediterranean Inst Transplantat & Adv Specialized, Palermo, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Catania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United Therapeutics Corporation; Revivicor Inc.; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Ekser, B (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA.	cooperdk@upmc.edu	Hara, Hidetaka/AEY-6794-2022; Ezzelarab, Mohamed/AGJ-9904-2022; Veroux, Massimiliano/K-4821-2018; Ezzelarab, Mohamed/CAA-4267-2022; Ekser, Burcin/I-3288-2019	Hara, Hidetaka/0000-0002-4179-7365; Veroux, Massimiliano/0000-0002-2780-6421; Ekser, Burcin/0000-0003-0741-8007; ECHEVERRI, GABRIEL/0000-0001-6432-0327; Ezzelarab, Mohamed/0000-0002-3919-5250	American Society of Transplantation/European Society for Organ Transplantation; American Transplant Congress; International Xenotransplantation Association Congress; NIH NIAID [T32 AI 074490]; NIH [U19 AI090959-01, U01 AI068642, R21 A1074844, RR012317-09]; University of Pittsburgh; Revivicor, Inc., Blacksburg, VA; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090959, T32AI074490, U01AI068642, R21AI074844] Funding Source: NIH RePORTER	American Society of Transplantation/European Society for Organ Transplantation; American Transplant Congress; International Xenotransplantation Association Congress; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); Revivicor, Inc., Blacksburg, VA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Burcin Ekser, MD, is a recipient of an American Society of Transplantation/European Society for Organ Transplantation Exchange Grant, a Young Investigator Award from the American Transplant Congress, 2009, a Travel Award from the International Xenotransplantation Association Congress, 2009, and an NIH NIAID T32 AI 074490 Training Grant. Work on xenotransplantation in the Thomas E. Starzl Transplantation Institute of the University of Pittsburgh is supported in part by NIH grants #U19 AI090959-01, #U01 AI068642 and # R21 A1074844, and by Sponsored Research Agreements between the University of Pittsburgh and Revivicor, Inc., Blacksburg, VA. The baboons were provided by the Oklahoma University Health Sciences Center, Division of Animal Resources, which is supported in part by NIH P40 sponsored grant RR012317-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan AN, 2005, AM J TRANSPLANT, V5, P2671, DOI 10.1111/j.1600-6143.2005.01078.x; Burlak C, 2010, XENOTRANSPLANTATION, V17, P350, DOI 10.1111/j.1399-3089.2010.00605.x; CALNE RY, 1968, LANCET, V1, P1176; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; DONATO MF, 1993, TRANSPLANT P, V25, P850; Ekser B, 2010, AM J TRANSPLANT, V10, P273, DOI 10.1111/j.1600-6143.2009.02945.x; Ekser B, 2011, XENOTRANSPLANTATION, V18, P158, DOI 10.1111/j.1399-3089.2011.00642.x; Ekser B, 2009, TRANSPLANTATION, V88, P1041, DOI 10.1097/TP.0b013e3181ba0555; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Ezzelarab M, 2009, TRANSPLANTATION, V87, P805, DOI 10.1097/TP.0b013e318199c34f; Hara H, 2008, TRANSPL INT, V21, P1163, DOI 10.1111/j.1432-2277.2008.00736.x; Hara H, 2008, LIVER TRANSPLANT, V14, P425, DOI 10.1002/lt.21476; Hara H, 2010, XENOTRANSPLANTATION, V17, P370, DOI 10.1111/j.1399-3089.2010.00602.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Loveland BE, 2004, XENOTRANSPLANTATION, V11, P171, DOI 10.1046/j.1399-3089.2003.00103.x; Luo Y, 1998, XENOTRANSPLANTATION, V5, P197, DOI 10.1111/j.1399-3089.1998.tb00028.x; Mohiuddin MM, 2010, TRANSPLANTATION S, V90, P325; Peng Q, 2011, XENOTRANSPLANTATION, V18, P287; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; POWELSON J, 1994, TRANSPLANT P, V26, P1353; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; Ramirez P, 2005, TRANSPLANT P, V37, P4103, DOI 10.1016/j.transproceed.2005.09.186; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Shimizu A, 2008, AM J PATHOL, V172, P1471, DOI 10.2353/ajpath.2008.070672; SHIRATORI Y, 1993, SEMIN LIVER DIS, V13, P39, DOI 10.1055/s-2007-1007336; Wack KE, 2001, HEPATOLOGY, V33, P363, DOI 10.1053/jhep.2001.21998; Weatherall D, USE NONHUMAN PRIMATE, P1; Wight DGD, 1991, XENOTRANSPLANTATION, P253; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yang YG, 2010, XENOTRANSPLANTATION, V17, P267, DOI 10.1111/j.1399-3089.2010.00601.x	31	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29720	10.1371/journal.pone.0029720	http://dx.doi.org/10.1371/journal.pone.0029720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247784	Green Accepted, Green Published, gold			2022-12-25	WOS:000301355700040
J	Wysham, WZ; Mhawech-Fauceglia, P; Li, H; Hays, L; Syriac, S; Skrepnik, T; Wright, J; Pande, N; Hoatlin, M; Pejovic, T				Wysham, Weiya Z.; Mhawech-Fauceglia, Paulette; Li, Hong; Hays, Laura; Syriac, Suzanna; Skrepnik, Tijana; Wright, Jay; Pande, Nupur; Hoatlin, Maureen; Pejovic, Tanja			BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence	PLOS ONE			English	Article							HIGH-GRADE; POLYMERASE; BREAST; BRCA1; INHIBITION; EXPRESSION; CISPLATIN; FEATURES; PATHWAY; CELLS	Background: The consequences of defective homologous recombination (HR) are not understood in sporadic ovarian cancer, nor have the potential role of HR proteins other than BRCA1 and BRCA2 been clearly defined. However, it is clear that defects in HR and other DNA repair pathways are important to the effectiveness of current therapies. We hypothesize that a subset of sporadic ovarian carcinomas may harbor anomalies in HR pathways, and that a BRCAness profile (defects in HR or other DNA repair pathways) could influence response rate and survival after treatment with platinum drugs. Clinical availability of a BRCAness profile in patients and/or tumors should improve treatment outcomes. Objective: To define the BRCAness profile of sporadic ovarian carcinoma and determine whether BRCA1, PARP, FANCD2, PTEN, H2AX, ATM, and P53 protein expression correlates with response to treatment, disease recurrence, and recurrence-free survival. Materials and Methods: Protein microarray analysis of ovarian cancer tissue was used to determine protein expression levels for defined DNA repair proteins. Correlation with clinical and pathologic parameters in 186 patients with advanced stage III-IV and grade 3 ovarian cancer was analyzed using Chi square, Kaplan-Meier method, Cox proportional hazard model, and cumulative incidence function. Results: High PARP, FANCD2 and BRCA1 expressions were significantly correlated with each other; however, elevated p53 expression was associated only with high PARP and FANCD2. Of all patients, 9% recurred within the first year. Among early recurring patients, 41% had high levels of PARP, FANCD2 and P53, compared to 19.5% of patients without early recurrence (p = 0.04). Women with high levels of PARP, FANCD2 and/or P53 had first year cumulative cancer incidence of 17% compared with 7% for the other groups (P = 0.03). Conclusions: Patients with concomitantly high levels of PARP, FANCD2 and P53 protein expression are at increased risk of early ovarian cancer recurrence and platinum resistance.	[Wysham, Weiya Z.; Wright, Jay; Pande, Nupur; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Mhawech-Fauceglia, Paulette; Syriac, Suzanna] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Li, Hong] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Biostat, Portland, OR 97201 USA; [Skrepnik, Tijana] Univ Arizona, Tucson, AZ USA; [Hoatlin, Maureen] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Roswell Park Cancer Institute; Oregon Health & Science University; University of Arizona; Oregon Health & Science University	Wysham, WZ (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.	pejovict@ohsu.edu			Sherie Hildreth Ovarian Cancer (SHOC) Foundation	Sherie Hildreth Ovarian Cancer (SHOC) Foundation	This study was supported by the Sherie Hildreth Ovarian Cancer (SHOC) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audeh MW, 2009, J CLIN ONCOL, V27; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Birrer MJ, 2011, J CLIN ONCOL S, V29; Brustmann H, 2007, INT J GYNECOL PATHOL, V26, P147, DOI 10.1097/01.pgp.0000235064.93182.ec; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chionh F, 2011, ASIA-PAC J CLIN ONCO, V7, P197, DOI 10.1111/j.1743-7563.2011.01430.x; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; O'Brien T, 2009, EMBO MOL MED, V1, P297, DOI 10.1002/emmm.200900044; Parija Satyajeet, 2011, Int J Bioinform Res Appl, V7, P1, DOI 10.1504/IJBRA.2011.039166; Pejovic T, 2006, CANCER RES, V66, P9017, DOI 10.1158/0008-5472.CAN-06-0222; Rhiem K, 2010, ANTICANCER RES, V30, P3445; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Serov SF, 1973, INT CLASSIFICATION, V9; Skytte AB, 2011, ACTA OBSTET GYN SCAN, V90, P593, DOI 10.1111/j.1600-0412.2011.01121.x; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Weberpals JI, 2011, ANN ONCOL, V22, P2403, DOI 10.1093/annonc/mdq770; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029	29	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30042	10.1371/journal.pone.0030042	http://dx.doi.org/10.1371/journal.pone.0030042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253870	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700079
J	Goodale, BC; La Du, JK; Bisson, WH; Janszen, DB; Waters, KM; Tanguay, RL				Goodale, Britton C.; La Du, Jane K.; Bisson, William H.; Janszen, Derek B.; Waters, Katrina M.; Tanguay, Robert L.			AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; LIGAND BINDING DOMAIN; DEVELOPMENTAL TOXICITY; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ACTIVATION; INDUCTION; IDENTIFICATION; MUTAGENESIS	The aryl hydrocarbon receptor (AHR) is well known for mediating the toxic effects of TCDD and has been a subject of intense research for over 30 years. Current investigations continue to uncover its endogenous and regulatory roles in a wide variety of cellular and molecular signaling processes. A zebrafish line with a mutation in ahr2 (ahr2(hu3335)), encoding the AHR paralogue responsible for mediating TCDD toxicity in zebrafish, was developed via Targeting Induced Local Lesions IN Genomes (TILLING) and predicted to express a non-functional AHR2 protein. We characterized AHR activity in the mutant line using TCDD and leflunomide as toxicological probes to investigate function, ligand binding and CYP1A induction patterns of paralogues AHR2, AHR1A and AHR1B. By evaluating TCDD-induced developmental toxicity, mRNA expression changes and CYP1A protein in the AHR2 mutant line, we determined that ahr2(hu3335) zebrafish are functionally null. In silico modeling predicted differential binding of TCDD and leflunomide to the AHR paralogues. AHR1A is considered a nonfunctional pseudogene as it does not bind TCCD or mediate in vivo TCDD toxicity. Homology modeling, however, predicted a ligand binding conformation of AHR1A with leflunomide. AHR1A-dependent CYP1A immunohistochemical expression in the liver provided in vivo confirmation of the in silico docking studies. The ahr2(hu3335) functional knockout line expands the experimental power of zebrafish to unravel the role of the AHR during development, as well as highlights potential activity of the other AHR paralogues in ligand-specific toxicological responses.	[Goodale, Britton C.; La Du, Jane K.; Tanguay, Robert L.] Oregon State Univ, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Bisson, William H.] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem Grp, Geneva, Switzerland; [Janszen, Derek B.; Waters, Katrina M.] Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA	Oregon State University; University of Geneva; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tanguay, RL (corresponding author), Oregon State Univ, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu		Waters, Katrina/0000-0003-4696-5396	National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences SRP grant [3 P42 ES016465]; Core Center Grant [ES00210]; NIEHS [T32ES7060]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060, P42ES016465, P30ES000210] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences SRP grant; Core Center Grant; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences SRP grant Project #3 P42 ES016465, Core Center Grant ES00210 and the NIEHS Training Grant T32ES7060 to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234; Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403; Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carney SA, 2004, MOL PHARMACOL, V66, P512; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; EMA M, 1994, J BIOL CHEM, V269, P27337; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; Hernandez-Ochoa I, 2009, BIOCHEM PHARMACOL, V77, P547, DOI 10.1016/j.bcp.2008.09.037; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, TOXICOL APPL PHARM; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Jonsson ME, 2009, CHEM BIOL INTERACT; Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P473, DOI 10.1016/j.bcp.2008.10.037; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Murray IA, 2011, MOL PHARMACOL, V79, P508, DOI 10.1124/mol.110.069369; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEBERT DW, 1975, J CELL PHYSIOL, V85, P393, DOI 10.1002/jcp.1040850407; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P1139, DOI 10.1289/ehp.0800485; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Scott JA, 2011, AQUAT TOXICOL, V101, P165, DOI 10.1016/j.aquatox.2010.09.016; Singh KP, 2009, BIOCHEM PHARMACOL, V77, P577, DOI 10.1016/j.bcp.2008.10.001; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; Team RDC, 2010, R LANG ENV STAT COMP; Teraoka H, 2003, BIOCHEM BIOPH RES CO, V304, P223, DOI 10.1016/S0006-291X(03)00576-X; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09	59	57	60	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29346	10.1371/journal.pone.0029346	http://dx.doi.org/10.1371/journal.pone.0029346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242167	Green Submitted, gold, Green Published			2022-12-25	WOS:000312662100021
J	Aravindan, N; Thomas, CR; Aravindan, S; Mohan, AS; Veeraraghavan, J; Natarajan, M				Aravindan, Natarajan; Thomas, Charles R., Jr.; Aravindan, Sheeja; Mohan, Aswathi S.; Veeraraghavan, Jamunarani; Natarajan, Mohan			Irreversible EGFR Inhibitor EKB-569 Targets Low-LET gamma-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER CELLS; THERAPEUTIC TARGET; INDUCED APOPTOSIS; ACTIVATION; HEAD; SENSITIZATION; RESISTANCE; SURVIVIN	EKB-569 (Pelitinib), an irreversible EGFR tyrosine kinase inhibitor has shown potential therapeutic efficiency in solid tumors. However, cell-killing potential in combination with radiotherapy and its underlying molecular orchestration remain to be explored. The objective of this study was to determine the effect of EKB-569 on ionizing radiation (IR)associated NF kappa B-dependent cell death. SCC-4 and SCC-9 cells exposed to IR (2Gy) with and without EKB-569 treatment were analyzed for transactivation of 88 NF kappa B pathway molecules, NF kappa B DNA-binding activity, translation of the NF kappa B downstream mediators, Birc1, 2 and 5, cell viability, metabolic activity and apoptosis. Selective targeting of IR-induced NF kappa B by EKB-569 and its influence on cell-fate were assessed by overexpressing (p50/p65) and silencing (Delta IkB alpha) NF kappa B. QPCR profiling after IR exposure revealed a significant induction of 74 NF kappa B signal transduction molecules. Of those, 72 were suppressed with EKB-569. EMSA revealed a dose dependent inhibition of NF kappa B by EKB-569. More importantly, EKB-569 inhibited IR-induced NF kappa B in a dose-dependent manner, and this inhibition was sustained up to at least 72 h. Immunoblotting revealed a significant suppression of IR-induced Birc1, 2 and 5 by EKB-569. We observed a dosedependent inhibition of cell viability, metabolic activity and apoptosis with EKB-569. EKB-569 significantly enhanced IR-induced cell death and apoptosis. Blocking NF kappa B improved IR-induced cell death. Conversely, NF kappa B overexpression negates EKB-569 -induced cell-killing. Together, these pre-clinical data suggest that EKB-569 is a radiosensitizer of squamous cell carcinoma and may mechanistically involve selective targeting of IR-induced NF kappa B-dependent survival signaling. Further pre-clinical in-vivo studies are warranted.	[Mohan, Aswathi S.; Natarajan, Mohan] Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA; [Aravindan, Natarajan; Veeraraghavan, Jamunarani] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK USA; [Thomas, Charles R., Jr.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Radiat Med, Portland, OR 97201 USA; [Aravindan, Natarajan; Aravindan, Sheeja] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Aravindan, Natarajan; Veeraraghavan, Jamunarani] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK USA	University of Texas System; University of Texas Health San Antonio; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oregon Health & Science University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Natarajan, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA.	natarajan@uthscsa.edu	Aravindan, Natarajan/M-3203-2013	Aravindan, Natarajan/0000-0001-9150-3911; Aravindan, Sheeja/0000-0002-4810-789X; Veeraraghavan, Jamunarani/0000-0002-9524-9487	National Institutes of Health [R01 CA112175]; Office of Science (Biological and Environmental Research), United States Department of Energy [DE-FG03-02ER63449]; NATIONAL CANCER INSTITUTE [R01CA112175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (Biological and Environmental Research), United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112175 (to M.N.) and funds from the Office of Science (Biological and Environmental Research), United States Department of Energy Grant No. DE-FG03-02ER63449 (to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Aravindan N, 2009, MOL CELL BIOCHEM, V327, P29, DOI 10.1007/s11010-009-0039-z; Arlt A, 2001, ONCOGENE, V20, P859, DOI 10.1038/sj.onc.1204168; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Baeuerle P. A., 1991, MOL ASPECTS CELLULAR, P409; Baselga J, 2006, J CLIN ONCOL, V24, P2225, DOI 10.1200/JCO.2005.05.3785; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen XF, 2002, CANCER RES, V62, P1213; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; Herscher LL, 1999, ONCOLOGY-NY, V13, P11; HIGGINS KA, 1993, P NATL ACAD SCI USA, V90, P9901, DOI 10.1073/pnas.90.21.9901; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kirkwood KS, 2003, J GASTROINTEST SURG, V7, P43; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Madhusoodhanan R, 2010, NUTR CANCER, V62, P93, DOI 10.1080/01635580903191494; Madhusoodhanan R, 2009, CANCER BIOL THER, V8, P765, DOI 10.4161/cbt.8.9.8105; Madhusoodhanan R, 2009, J RADIAT RES, V50, P311, DOI 10.1269/jrr.08110; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sclabas GM, 2003, J GASTROINTEST SURG, V7, P37, DOI 10.1016/S1091-255X(02)00088-4; Sequist LV, 2007, ONCOLOGIST, V12, P325, DOI 10.1634/theoncologist.12-3-325; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Sun Y, 2007, MOL CANCER THER, V6, P2477, DOI 10.1158/1535-7163.MCT-07-0186; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TOZAWA K, 1995, CANCER RES, V55, P4162; Veeraraghavan J, 2010, ANTICANCER RES, V30, P4007; Veeraraghavan J, 2011, J BIOL CHEM, V286, P21588, DOI 10.1074/jbc.M110.193755; Veeraraghavan J, 2011, ANTICANCER RES, V31, P161; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vlantis AC, 2010, HEAD NECK-J SCI SPEC, V32, P1506, DOI 10.1002/hed.21357; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29705	10.1371/journal.pone.0029705	http://dx.doi.org/10.1371/journal.pone.0029705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242139	gold, Green Published			2022-12-25	WOS:000300677000056
J	Yang, N; Ma, P; Lang, JS; Zhang, YL; Deng, JJ; Ju, XW; Zhang, GY; Jiang, CY				Yang, Ning; Ma, Ping; Lang, Jianshe; Zhang, Yanli; Deng, Jiejie; Ju, Xiangwu; Zhang, Gongyi; Jiang, Chengyu			Phosphatidylinositol 4-Kinase III beta Is Required for Severe Acute Respiratory Syndrome Coronavirus Spike-mediated Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; CATHEPSIN-L; CONVERTING ENZYME; PROTEIN; COV; INFECTION; ACE2; GLYCOPROTEIN; TRAFFICKING; RECEPTOR	Phosphatidylinositol kinases (PI kinases) play an important role in the life cycle of several viruses after infection. Using gene knockdown technology, we demonstrate that phosphatidylinositol 4-kinase III beta (PI4KB) is required for cellular entry by pseudoviruses bearing the severe acute respiratory syndrome-coronavirus (SARS-CoV) spike protein and that the cell entry mediated by SARS-CoV spike protein is strongly inhibited by knockdown of PI4KB. Consistent with this observation, pharmacological inhibitors of PI4KB blocked entry of SARS pseudo-virions. Further research suggested that PI4P plays an essential role in SARS-CoV spike-mediated entry, which is regulated by the PI4P lipid microenvironment. We further demonstrate that PI4KB does not affect virus entry at the SARS-CoV S-ACE2 binding interface or at the stage of virus internalization but rather at or before virus fusion. Taken together, these results indicate a new function for PI4KB and suggest a new drug target for preventing SARS-CoV infection.	[Yang, Ning; Ma, Ping; Lang, Jianshe; Zhang, Yanli; Deng, Jiejie; Ju, Xiangwu; Jiang, Chengyu] Tsinghua Univ, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhang, Gongyi] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; National Jewish Health	Jiang, CY (corresponding author), Tsinghua Univ, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China.	chengyujiang@gmail.com			Ministry of Science and Technology of China [2009CB522105]; Ministry of Education [B08007]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education	This work was supported by Ministry of Science and Technology of China Grant 2009CB522105 and Ministry of Education 111 Project Grant B08007.	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dunn EF, 2011, J VIROL, V85, P422, DOI 10.1128/JVI.01671-10; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023710; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ng ML, 2003, J MED VIROL, V71, P323, DOI 10.1002/jmv.10499; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang S, 2008, VIRUS RES, V136, P8, DOI 10.1016/j.virusres.2008.03.004; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Zhang QF, 2004, J MED VIROL, V73, P332, DOI 10.1002/jmv.20095	37	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8457	8467		10.1074/jbc.M111.312561	http://dx.doi.org/10.1074/jbc.M111.312561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253445	Green Published, hybrid			2022-12-25	WOS:000301349400060
J	Zhu, MH; Fuller, DM; Zhang, WG				Zhu, Minghua; Fuller, Deirdre M.; Zhang, Weiguo			The Role of Ras Guanine Nucleotide Releasing Protein 4 in Fc epsilon RI-mediated Signaling, Mast Cell Function, and T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL-BINDING MOTIFS; MYELOID-LEUKEMIA; ACTIVATION; RASGRP4; PHOSPHORYLATION; EXPRESSION; ADAPTER; KINASE; LAT	The RasGRP (Ras guanine nucleotide-releasing protein) family proteins are guanine nucleotide exchange factors that activate Ras GTPases, ultimately leading to MAPK activation and many cellular processes. The RasGRP family has four members. Published studies demonstrate that RasGRP1, RasGRP2, and RasGRP3 play critical roles in T cells, platelets, and B cells, respectively. RasGRP4 is highly expressed in mast cells. Although previous data suggest that it is important in mast cell development and function, the role of RasGRP4 in mast cells and allergic responses has not been clearly demonstrated. In this study, we generated RasGRP4(-/-) mice to examine the function of RasGRP4. Analyses of these mice showed that mast cells were able to develop normally in vivo and in vitro. Despite high levels of RasGRP4 expression in mast cells, RasGRP4 deficiency led to only a modest reduction in Fc epsilon RI-mediated degranulation and cytokine production. Interestingly, mast cells deficient in both RasGRP1 and RasGRP4 had a much more severe block in Fc epsilon RI-mediated signaling and mast cell function. We also made the unexpected finding that RasGRP4 functions during thymocyte development. Our data suggest that after the engagement of immunoreceptors, immune cells likely employ multiple members of the RasGRP family to transduce critical signals.	[Zhu, Minghua; Fuller, Deirdre M.; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Zhang, WG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R56AI048674, R01AI048674, R01AI056156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported, in whole or in part, by National Institutes of Health Grants AI048674 and AI056156.	Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dupuy AJ, 2001, J BIOL CHEM, V276, P11804, DOI 10.1074/jbc.M008970200; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; Katsoulotos GP, 2008, J BIOL CHEM, V283, P1610, DOI 10.1074/jbc.M707042200; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Martinez-Florensa M, 2011, J LEUKOCYTE BIOL, V89, P63, DOI 10.1189/jlb.0509342; Matsuda S, 2004, EMBO J, V23, P2577, DOI 10.1038/sj.emboj.7600268; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Springett GM, 2004, BIOESSAYS, V26, P730, DOI 10.1002/bies.20057; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	22	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8135	8143		10.1074/jbc.M111.320580	http://dx.doi.org/10.1074/jbc.M111.320580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262848	Green Published, hybrid			2022-12-25	WOS:000301349400029
J	Bonzo, JA; Ferry, CH; Matsubara, T; Kim, JH; Gonzalez, FJ				Bonzo, Jessica A.; Ferry, Christina H.; Matsubara, Tsutomu; Kim, Jung-Hwan; Gonzalez, Frank J.			Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4 alpha in Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-7; HORMONE RECEPTOR SUPERFAMILY; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROSTATE-CANCER; MOUSE; HNF4-ALPHA; FIBROSIS	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) regulates genes involved in lipid and bile acid synthesis, gluconeogenesis, amino acid metabolism, and blood coagulation. In addition to its metabolic role, HNF4 alpha is critical for hepatocyte differentiation, and loss of HNF4 alpha is associated with hepatocellular carcinoma. The hepatocyte-specific Hnf4a knock-out mouse develops severe hepatomegaly and steatosis resulting in premature death, thereby limiting studies of the role of this transcription factor in the adult animal. In addition, gene compensation may complicate analysis of the phenotype of these mice. To overcome these issues, an acute Hnf4a knock-out mouse model was generated through use of the tamoxifen-inducible ErT2cre coupled to the serum albumin gene promoter. Microarray expression analysis revealed up-regulation of genes associated with proliferation and cell cycle control only in the acute liver-specific Hnf4 alpha-null mouse. BrdU and ki67 staining confirmed extensive hepatocyte proliferation in this model. Proliferation was associated with induction of the hepatomitogen Bmp7 as well as reduced basal apoptotic activity. The p53/p63 apoptosis effector gene Perp was further identified as a direct HNF4 alpha target gene. These data suggest that HNF4 alpha maintains hepatocyte differentiation in the adult healthy liver, and its loss may directly contribute to hepatocellular carcinoma development, thus indicating this factor as a possible liver tumor suppressor gene.	[Bonzo, Jessica A.; Ferry, Christina H.; Matsubara, Tsutomu; Kim, Jung-Hwan; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, 9000 Rockville Pike,Bldg 37,Rm 3106, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov		Kim, Jung Hwan/0000-0002-2975-4899	National Cancer Institute, National Institutes of Health (NIH); NIGMS, National Institutes of Health; National Institutes of Health Summer Internship Program; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Summer Internship Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the intramural research program at the National Cancer Institute, National Institutes of Health (NIH).; Supported by the Pharmacology Research Associate program through NIGMS, National Institutes of Health.; Supported by the National Institutes of Health Summer Internship Program.	Alarmo EL, 2006, GENE CHROMOSOME CANC, V45, P411, DOI 10.1002/gcc.20307; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Attardi LD, 2000, GENE DEV, V14, P704; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chayanupatkul M, 2009, EUR J PEDIATR SURG, V19, P246, DOI 10.1055/s-0029-1216378; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ferlay J, 2010, IARC CANCERBASE, V10; Fiaschetti G, 2011, ONCOGENE, V30, P2823, DOI 10.1038/onc.2011.10; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Howlader N, 2011, SEER CANC STAT REV 1; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Kalkuhl A, 1996, CARCINOGENESIS, V17, P609, DOI 10.1093/carcin/17.3.609; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; NOLTEN LA, 1995, MOL ENDOCRINOL, V9, P1488, DOI 10.1210/me.9.11.1488; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Reczek EE, 2003, MOL CANCER RES, V1, P1048; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Rothhammer T, 2005, CANCER RES, V65, P448; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shaw JJ, 2011, EXPERT REV GASTROENT, V5, P365, DOI [10.1586/egh.11.20, 10.1586/EGH.11.20]; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stanulovic VS, 2007, HEPATOLOGY, V45, P433, DOI 10.1002/hep.21456; Stroup D, 2000, J LIPID RES, V41, P1; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang SN, 2011, J CELL BIOCHEM, V112, P1130, DOI 10.1002/jcb.23027; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039	58	125	126	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7345	7356		10.1074/jbc.M111.334599	http://dx.doi.org/10.1074/jbc.M111.334599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241473	Green Published, hybrid			2022-12-25	WOS:000301060200036
J	Enoch, MA; Zhou, ZF; Kimura, M; Mash, DC; Yuan, QP; Goldman, D				Enoch, Mary-Anne; Zhou, Zhifeng; Kimura, Mitsuru; Mash, Deborah C.; Yuan, Qiaoping; Goldman, David			GABAergic Gene Expression in Postmortem Hippocampus from Alcoholics and Cocaine Addicts; Corresponding Findings in Alcohol-Naive P and NP Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GABA(A) RECEPTORS; ALLOSTERIC MODULATOR; DRINKING BEHAVIOR; PREFERRING RATS; ETHANOL; BRAIN; VULNERABILITY; NEUROGENESIS; DEPENDENCE	Background: By performing identical studies in humans and rats, we attempted to distinguish vulnerability factors for addiction from neurobiological effects of chronic drug exposure. We focused on the GABAergic system within the hippocampus, a brain region that is a constituent of the memory/conditioning neuronal circuitry of addiction that is considered to be important in drug reinforcement behaviors in animals and craving and relapse in humans. Methodology: Using RNA-Seq we quantified mRNA transcripts in postmortem total hippocampus from alcoholics, cocaine addicts and controls and also from alcohol-naive, alcohol preferring (P) and non-preferring (NP) rats selectively bred for extremes of alcohol-seeking behavior that also show a general addictive tendency. A pathway-targeted analysis of 25 GABAergic genes encoding proteins implicated in GABA synthesis, metabolism, synaptic transmission and re-uptake was undertaken. Principal Findings: Directionally consistent and biologically plausible overlapping and specific changes were detected: 14/25 of the human genes and 12/25 of the rat genes showed nominally significant differences in gene expression (global p values: 9X10(-14), 7X10(-11) respectively). Principal FDR-corrected findings were that GABBR1 was down-regulated in alcoholics, cocaine addicts and P rats with congruent findings in NSF, implicated in GABAB signaling efficacy, potentially resulting in increased synaptic GABA. GABRG2, encoding the gamma2 subunit required for postsynaptic clustering of GABAA receptors together with GPHN, encoding the associated scaffolding protein gephryin, were both down-regulated in alcoholics and cocaine addicts but were both up-regulated in P rats. There were also expression changes specific to cocaine addicts (GAD1, GAD2), alcoholics (GABRA2) and P rats (ABAT, GABRG3). Conclusions/Significance: Our study confirms the involvement of the GABAergic system in alcoholism but also reveals a hippocampal GABA input in cocaine addiction. Congruent findings in human addicts and P rats provide clues to predisposing factors for alcohol and drug addiction. Finally, the results of this study have therapeutic implications.	[Enoch, Mary-Anne; Zhou, Zhifeng; Kimura, Mitsuru; Yuan, Qiaoping; Goldman, David] NIAAA, NIH, Bethesda, MD USA; [Mash, Deborah C.] Univ Miami, Sch Med, Miami, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Miami	Enoch, MA (corresponding author), NIAAA, NIH, Bethesda, MD USA.	maenoch@niaaa.nih.gov	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Yuan, Qiaoping/0000-0002-5880-8702	National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; U.S. Public Health Service from National Institute on Drug Abuse [DA06227]; University of Miami Brain Bank; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000305, ZIAAA000301, ZIAAA000280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033684, R01DA006227] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); U.S. Public Health Service from National Institute on Drug Abuse; University of Miami Brain Bank; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, and by U.S. Public Health Service Grant from National Institute on Drug Abuse DA06227 for the human postmortem specimens from the University of Miami Brain Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Anderson NJ, 2007, ALCOHOL CLIN EXP RES, V31, P1061, DOI 10.1111/j.1530-0277.2007.00394.x; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernstein EM, 1999, J BIOL CHEM, V274, P889, DOI 10.1074/jbc.274.2.889; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Canales JJ, 2010, BEHAV PHARMACOL, V21, P379, DOI 10.1097/FBP.0b013e32833e16b6; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Colombo G, 2004, NEUROTOX RES, V6, P403, DOI 10.1007/BF03033315; Costa E, 1998, ANNU REV PHARMACOL, V38, P321, DOI 10.1146/annurev.pharmtox.38.1.321; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Edenberg HJ, 2005, GENES BRAIN BEHAV, V4, P20, DOI 10.1111/j.1601-183X.2004.00091.x; Enoch MA, 2008, PHARMACOL BIOCHEM BE, V90, P95, DOI 10.1016/j.pbb.2008.03.007; Gong N, 2009, J NEUROSCI, V29, P15836, DOI 10.1523/JNEUROSCI.4643-09.2009; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Kampov-Polevoy AB, 2000, ALCOHOL CLIN EXP RES, V24, P278, DOI 10.1097/00000374-200003000-00004; Kassahn KS, 2011, INTEGR BIOL-UK, V3, P522, DOI 10.1039/c0ib00062k; Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krystal JH, 2006, ARCH GEN PSYCHIAT, V63, P957, DOI 10.1001/archpsyc.63.9.957; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Le AD, 2006, J NEUROSCI, V26, P1872, DOI 10.1523/JNEUROSCI.4895-05.2006; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Liang JH, 2006, NEUROPHARMACOLOGY, V50, P632, DOI 10.1016/j.neuropharm.2005.11.011; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Maccioni P, 2010, DRUG ALCOHOL DEPEN, V109, P96, DOI 10.1016/j.drugalcdep.2009.12.019; Maccioni P, 2009, ALCOHOL, V43, P555, DOI 10.1016/j.alcohol.2009.09.030; Mash DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001187; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; MORZORATI S, 1994, ALCOHOL, V11, P253, DOI 10.1016/0741-8329(94)90039-6; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Murphy JM, 2002, BEHAV GENET, V32, P363, DOI 10.1023/A:1020266306135; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; Paterson NE, 2008, J PHARMACOL EXP THER, V326, P306, DOI 10.1124/jpet.108.139204; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; Saba LM, 2011, NEUROPHARMACOLOGY, V60, P1269, DOI 10.1016/j.neuropharm.2010.12.019; Sanna E, 2003, J NEUROSCI, V23, P11711; Sarviharju M, 2006, ALCOHOL, V40, P159, DOI 10.1016/j.alcohol.2006.11.003; Sofuoglu M, 2005, PHARMACOL BIOCHEM BE, V82, P569, DOI 10.1016/j.pbb.2005.10.013; Stephens BG, 2004, AM J FOREN MED PATH, V25, P11, DOI 10.1097/01.paf.0000114041.70865.24; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; STEWART RB, 1993, ALCOHOL, V10, P1, DOI 10.1016/0741-8329(93)90046-Q; Sudai E, 2011, ADDICT BIOL, V16, P251, DOI 10.1111/j.1369-1600.2010.00241.x; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Vlachou S, 2010, ADV PHARMACOL, V58, P315, DOI 10.1016/S1054-3589(10)58013-X; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Ye JH, 1997, BRAIN RES, V770, P169, DOI 10.1016/S0006-8993(97)00782-8; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108	59	67	68	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29369	10.1371/journal.pone.0029369	http://dx.doi.org/10.1371/journal.pone.0029369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253714	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500008
J	Tiwari, S; Ali, MJ; Balla, MMS; Naik, MN; Honavar, SG; Reddy, VAP; Vemuganti, GK				Tiwari, Shubha; Ali, Mohammad Javed; Balla, Murali M. S.; Naik, Milind N.; Honavar, Santosh G.; Reddy, Vijay Anand P.; Vemuganti, Geeta K.			Establishing Human Lacrimal Gland Cultures with Secretory Function	PLOS ONE			English	Article							HUMAN AMNIOTIC MEMBRANE; ACINAR-CELLS; DRY EYE; EPITHELIAL-CELLS; STEM-CELLS; IN-VITRO; TRANSPLANTATION; MORPHOLOGY; SALIVARY; RECONSTRUCTION	Purpose: Dry eye syndrome is a multifactorial chronic disabling disease mainly caused by the functional disruptions in the lacrimal gland. The treatment involves palliation like ocular surface lubrication and rehydration. Cell therapy involving replacement of the gland is a promising alternative for providing long-term relief to patients. This study aimed to establish functionally competent lacrimal gland cultures in-vitro and explore the presence of stem cells in the native gland and the established in-vitro cultures. Methods: Fresh human lacrimal gland from patients undergoing exenteration was harvested for cultures after IRB approval. The freshly isolated cells were evaluated by flow cytometry for expression of stem cell markers ABCG2, high ALDH1 levels and c-kit. Cultures were established on Matrigel, collagen and HAM and the cultured cells evaluated for the presence of stem cell markers and differentiating markers of epithelial (E-cadherin, EpCAM), mesenchymal (Vimentin, CD90) and myofibroblastic (alpha-SMA, S-100) origin by flow cytometry and immunocytochemistry. The conditioned media was tested for secretory proteins (scIgA, lactoferrin, lysozyme) post carbachol (100 mu M) stimulation by ELISA. Results: Native human lacrimal gland expressed ABCG2 (mean +/- SEM: 3.1 +/- 0.61%), high ALDH1 (3.8 +/- 1.26%) and c-kit (6.7 +/- 2.0%). Lacrimal gland cultures formed a monolayer, in order of preference on Matrigel, collagen and HAM within 15-20 days, containing a heterogeneous population of stem-like and differentiated cells. The epithelial cells formed 'spherules' with duct like connections, suggestive of ductal origin. The levels of scIgA (47.43 to 61.56 ng/ml), lysozyme (24.36 to 144.74 ng/ml) and lactoferrin (32.45 to 40.31 ng/ml) in the conditioned media were significantly higher than the negative controls (p<0.05 for all comparisons). Conclusion: The study reports the novel finding of establishing functionally competent human lacrimal gland cultures in-vitro. It also provides preliminary data on the presence of stem cells and duct-like cells in the fresh and in-vitro cultured human lacrimal gland. These significant findings could pave way for cell therapy in future.	[Tiwari, Shubha; Balla, Murali M. S.; Vemuganti, Geeta K.] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Sudhakar & Sreekant Ravi Stem Cell Biol Lab, Hyderabad, Andhra Pradesh, India; [Vemuganti, Geeta K.] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Ophthalm Pathol Serv, Hyderabad, Andhra Pradesh, India; [Vemuganti, Geeta K.] Univ Hyderabad, Sch Med Sci, Hyderabad 500134, Andhra Pradesh, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; University of Hyderabad	Tiwari, S (corresponding author), LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Sudhakar & Sreekant Ravi Stem Cell Biol Lab, Hyderabad, Andhra Pradesh, India.	deanmd@uohyd.ernet.in		Honavar, Santosh/0000-0003-1050-773X	International Atomic Energy Agency (IAEA); Hyderabad Eye Research Foundation (HERF); Champalimaud Translational Research Foundation(C-Tracer); Department of Biotechnology (DBT); Council for Scientific and Industrial Research (CSIR)	International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Hyderabad Eye Research Foundation (HERF); Champalimaud Translational Research Foundation(C-Tracer); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the International Atomic Energy Agency (IAEA), Hyderabad Eye Research Foundation (HERF), Champalimaud Translational Research Foundation(C-Tracer), Department of Biotechnology (DBT). The authors also wish to thank Council for Scientific and Industrial Research (CSIR) for a Senior Research Fellowship to Dr. Tiwari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudouin C, 2001, SURV OPHTHALMOL, V45, pS211, DOI 10.1016/S0039-6257(00)00200-9; Begley CG, 2003, INVEST OPHTH VIS SCI, V44, P4753, DOI 10.1167/iovs.03-0270; Calonge M, 2001, SURV OPHTHALMOL, V45, pS227, DOI 10.1016/S0039-6257(00)00205-8; Chen LL, 1998, AM J PHYSIOL-CELL PH, V275, pC278, DOI 10.1152/ajpcell.1998.275.1.C278; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fatima A, 2006, J POSTGRAD MED, V52, P257; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Hakim SG, 2006, INT J EXP PATHOL, V87, P65, DOI 10.1111/j.0959-9673.2006.00456.x; HANN LE, 1991, INVEST OPHTH VIS SCI, V32, P2610; HANN LE, 1989, INVEST OPHTH VIS SCI, V30, P145; Hosaka E, 2011, AM J OPHTHALMOL, V151, P18, DOI 10.1016/j.ajo.2010.07.019; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; KIM JC, 1995, CORNEA, V14, P473; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Long L, 2006, J BIOMED MATER RES B, V78B, P409, DOI 10.1002/jbm.b.30502; Man YG, 2001, ANAT REC, V263, P202, DOI 10.1002/ar.1098; Parsons J T, 1996, Oncology (Williston Park), V10, P837; Perry Henry D, 2008, Am J Manag Care, V14, pS79; RISMONDO V, 1994, INVEST OPHTH VIS SCI, V35, P1176; Schechter J, 2002, EXP EYE RES, V74, P349, DOI 10.1006/exer.2001.1158; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Schonthal AH, 2000, EXP EYE RES, V70, P639, DOI 10.1006/exer.2000.0824; Schrader S, 2007, GRAEF ARCH CLIN EXP, V245, P1699, DOI 10.1007/s00417-007-0612-7; Schrader S, 2009, BRIT J OPHTHALMOL, V93, P1121, DOI 10.1136/bjo.2008.137927; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shi XD, 2007, DEV BIOL, V312, P396, DOI 10.1016/j.ydbio.2007.09.042; Smith JA, 2007, OCUL SURF, V5, P93; STEPHENS LC, 1991, CANCER, V67, P1539, DOI 10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q; Tiffany John M, 2008, Dev Ophthalmol, V41, P1, DOI 10.1159/000131066; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Ueda Y, 2009, INVEST OPHTH VIS SCI, V50, P1978, DOI 10.1167/iovs.08-2503; Walcott B, 1998, NEWS PHYSIOL SCI, V13, P97, DOI 10.1152/physiologyonline.1998.13.2.97; WILLIAMS GM, 1974, EXP CELL RES, V89, P139, DOI 10.1016/0014-4827(74)90196-7; YOSHINO K, 1995, EXP CELL RES, V220, P138, DOI 10.1006/excr.1995.1300; You S, 2011, INVEST OPHTH VIS SCI, V52, P2087, DOI 10.1167/iovs.10-5686; Zoukhri D, 2008, INVEST OPHTH VIS SCI, V49, P4399, DOI 10.1167/iovs.08-1730; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	40	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29458	10.1371/journal.pone.0029458	http://dx.doi.org/10.1371/journal.pone.0029458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253725	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500012
J	Wendel, C; Hemping-Bovenkerk, A; Krasnyanska, J; Mees, ST; Kochetkova, M; Stoeppeler, S; Haier, J				Wendel, Claudia; Hemping-Bovenkerk, Andre; Krasnyanska, Julia; Mees, Soeren Torge; Kochetkova, Marina; Stoeppeler, Sandra; Haier, Joerg			CXCR4/CXCL12 Participate in Extravasation of Metastasizing Breast Cancer Cells within the Liver in a Rat Model	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; TUMOR-CELLS; RHO-GTPASES; IN-VIVO; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; CARCINOMA CELLS; EARLY EVENTS; ADHESION; MIGRATION	Introduction: Organ-specific composition of extracellular matrix proteins (ECM) is a determinant of metastatic host organ involvement. The chemokine CXCL12 and its receptor CXCR4 play important roles in the colonization of human breast cancer cells to their metastatic target organs. In this study, we investigated the effects of chemokine stimulation on adhesion and migration of different human breast cancer cell lines in vivo and in vitro with particular focus on the liver as a major metastatic site in breast cancer. Methods: Time lapse microscopy, in vitro adhesion and migration assays were performed under CXCL12 stimulation. Activation of small GTPases showed chemokine receptor signalling dependence from ECM components. The initial events of hepatic colonisation of MDA-MB-231 and MDA-MB-468 cells were investigated by intravital microscopy of the liver in a rat model and under shRNA inhibition of CXCR4. Results: In vitro, stimulation with CXCL12 induced increased chemotactic cell motility (p < 0.05). This effect was dependent on adhesive substrates (type I collagen, fibronectin and laminin) and induced different responses in small GTPases, such as RhoA and Rac-1 activation, and changes in cell morphology. In addition, binding to various ECM components caused redistribution of chemokine receptors at tumour cell surfaces. In vivo, blocking CXCR4 decreased extravasation of highly metastatic MDA-MB-231 cells (p < 0.05), but initial cell adhesion within the liver sinusoids was not affected. In contrast, the less metastatic MDA-MB-468 cells showed reduced cell adhesion but similar migration within the hepatic microcirculation. Conclusion: Chemokine-induced extravasation of breast cancer cells along specific ECM components appears to be an important regulator but not a rate-limiting factor of their metastatic organ colonization.	[Wendel, Claudia; Hemping-Bovenkerk, Andre; Krasnyanska, Julia; Mees, Soeren Torge; Stoeppeler, Sandra] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Kochetkova, Marina] Univ Adelaide, Sch Mol & Biomed Sci, Chemokine Biol Div, Adelaide, SA, Australia; [Haier, Joerg] Univ Hosp Muenster, Comprehens Canc Ctr Muenster, Munster, Germany	University of Munster; University of Adelaide; University of Munster	Wendel, C (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	haier@uni-muenster.de	Kochetkova, Marina/ABE-9538-2021	Kochetkova, Marina/0000-0002-0599-7378	Deutsche Krebshilfe [107010]	Deutsche Krebshilfe(Deutsche Krebshilfe)	Funded by the Deutsche Krebshilfe (107010) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Alberts B, 2002, MOL BIOL CELL, P1090; Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Baruch-Ben A, 2008, CLIN EXP METASTAS, V25, P345; Chen YC, 2003, CANCER RES, V63, P4801; Ding L, 2001, BRIT J CANCER, V85, P431, DOI 10.1054/bjoc.2001.1911; Dittma T, 2008, CLIN EXP METASTAS, V25, P11, DOI 10.1007/s10585-007-9095-5; Enns A, 2005, EUR J CANCER, V41, P1065, DOI 10.1016/j.ejca.2004.12.031; Enns AE, 2004, J GASTROINTEST SURG, V8, P1049, DOI 10.1016/j.gassur.2004.08.016; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gassmann P, 2008, CLIN EXP METASTAS, V25, P171, DOI 10.1007/s10585-007-9130-6; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Grzesiak JJ, 2007, SURGERY, V141, P804, DOI 10.1016/j.surg.2006.12.016; Haier R, 2003, J GASTROINTEST SURG, V7, P507, DOI 10.1016/S1091-255X(03)00023-4; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Ivanoff J, 2005, IMMUNOLOGY, V114, P53, DOI 10.1111/j.1365-2567.2004.02005.x; Jianguo G, 2001, J BIOL CHEM, V276, P27090; Jones J, 2007, EXP CELL RES, V313, P4051, DOI 10.1016/j.yexcr.2007.07.001; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kulbe H, 2004, INT J DEV BIOL, V48, P489, DOI 10.1387/ijdb.041814hk; Lee BC, 2004, MOL CANCER RES, V2, P327; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mook ORF, 2003, HEPATOLOGY, V38, P295, DOI 10.1053/jhep.2003.50297; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Qiu HM, 2003, AM J PATHOL, V162, P403, DOI 10.1016/S0002-9440(10)63835-7; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schluter K, 2006, AM J PATHOL, V169, P1064, DOI 10.2353/ajpath.2006.050566; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256	41	57	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30046	10.1371/journal.pone.0030046	http://dx.doi.org/10.1371/journal.pone.0030046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253872	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000301361500031
J	Levinson, D				Levinson, David			Network Structure and City Size	PLOS ONE			English	Article							AGGLOMERATION; RETURNS	Network structure varies across cities. This variation may yield important knowledge about how the internal structure of the city affects its performance. This paper systematically compares a set of surface transportation network structure variables (connectivity, hierarchy, circuity, treeness, entropy, accessibility) across the 50 largest metropolitan areas in the United States. A set of scaling parameters are discovered to show how network size and structure vary with city size. These results suggest that larger cities are physically more inter-connected. Hypotheses are presented as to why this might obtain. This paper then consistently measures and ranks access to jobs across 50 US metropolitan areas. It uses that accessibility measure, along with network structure variables and city size to help explain journey-to-work time and auto mode share in those cities. A 1 percent increase in accessibility reduces average metropolitan commute times by about 90 seconds each way. A 1 percent increase in network connectivity reduces commute time by 0.1 percent. A 1 percent increase in accessibility results in a 0.0575 percent drop in auto mode share, while a 1 percent increase in treeness reduces auto mode share by 0.061 percent. Use of accessibility and network structure measures is important for planning and evaluating the performance of network investments and land use changes.	Univ Minnesota, Dept Civil Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Levinson, D (corresponding author), Univ Minnesota, Dept Civil Engn, Minneapolis, MN USA.	dlevinson@umn.edu	Levinson, David/A-8554-2012	Levinson, David/0000-0002-4563-2963	University of Minnesota	University of Minnesota(University of Minnesota System)	This research was funded by the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES AF, 1995, Q J ECON, V110, P195, DOI 10.2307/2118515; [Anonymous], EMPLOYMENT HOURS EAR; Arbesman S, 2008, ARXIV08094994; Barthelemy M, 2010, PATIAL NETWORKS; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2009, METHODS SER, V7, P221, DOI 10.1007/978-1-4020-9663-1_8; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Derrible S, 2010, PHYSICA A, V389, P3678, DOI 10.1016/j.physa.2010.04.008; Derrible S, 2010, TRANSPORTATION, V37, P275, DOI 10.1007/s11116-009-9227-7; Derrible S, 2009, TRANSPORT RES REC, P17, DOI 10.3141/2112-03; Downs A, 2004, STILL STUCK TRAFFIC; El-Geneidy A.M., 2006, ACCESS DESTINATIONS; Glaeser Andreas, 2011, TRIUMPH CITY; Glaeser E.L., 2008, CITIES AGGLOMERATION; Glaeser EL, 2010, J REGIONAL SCI, V50, P221, DOI 10.1111/j.1467-9787.2009.00635.x; Glaeser EL, 2009, J ECON MANAGE STRAT, V18, P623, DOI 10.1111/j.1530-9134.2009.00225.x; GORDON P, 1991, J AM PLANN ASSOC, V57, P416, DOI 10.1080/01944369108975516; GORDON P, 1988, TRANSPORT RES A-POL, V22, P419, DOI 10.1016/0191-2607(88)90045-3; Graham D, 2009, TRANSPORTATION, P1; Graham DJ, 2008, ANN REGIONAL SCI, V42, P267, DOI 10.1007/s00168-007-0156-0; Graham DJ, 2007, J TRANSP ECON POLICY, V41, P317; Graham DJ, 2007, J URBAN ECON, V62, P103, DOI 10.1016/j.jue.2006.10.001; Haggett P, 1969, NETWORK ANAL GEOGRAP; HAMILTON BW, 1982, J POLIT ECON, V90, P1035, DOI 10.1086/261107; Helbing D, 2009, METHODS SER, V7, P433, DOI 10.1007/978-1-4020-9663-1_17; Jiang B, 2004, ENVIRON PLANN B, V31, P151, DOI 10.1068/b306; Jiang B, 2009, INT J GEOGR INF SCI, V23, P1119, DOI 10.1080/13658810701690448; Jiang B, 2007, PHYSICA A, V384, P647, DOI 10.1016/j.physa.2007.05.064; Jiang B, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/07/P07008; Jiang B, 2009, INT J GEOGR INF SCI, V23, P1033, DOI 10.1080/13658810802004648; Kansky K.J., 1963, STRUCTURE TRANSPORTA; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Lammer S, 2006, PHYSICA A, V363, P89, DOI 10.1016/j.physa.2006.01.051; Levinson D, 2007, NETW SPAT ECON, P1; Levinson D, 2011, ENV PLANNING B; Levinson D. M., 1995, TRANSPORT RES REC, V1466, P124; Levinson D, 2009, REG SCI URBAN ECON, V39, P732, DOI 10.1016/j.regsciurbeco.2009.07.003; Melo PC, 2009, REG SCI URBAN ECON, V39, P332, DOI 10.1016/j.regsciurbeco.2008.12.002; Mogridge M.J., 1990, TRAVEL TOWNS JAM YES; Mogridge MJH, 1987, IN TERNAT J TRANSPOR, V14, P283; Parthasarathi P, 2010, NETWORK STRUCTURE ME; Parthasarathi P, 2010, NETWORK STRUCTURE AC; Roth C, 2011, ARXIV11055294; Samaniego H, 2008, J TRANSPORT LAND USE, V1; Schrank  D., 2009, 2009 URBAN MOBILITY; Southworth M, 2003, STREETS SHAPING TOWN; Stigler GJ, 1951, J POLIT ECON, V59, P185, DOI 10.1086/257075; Strogatz S, 2009, NY TIMES        0519; Tomer A, 2011, MISSED OPPORTUNITY T; West G, 2010, GLOBAL SUSTAINABILIT, P9; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Xie F, 2011, TRANSP RES ECON POL, P3, DOI 10.1007/978-1-4419-9804-0	55	110	114	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29721	10.1371/journal.pone.0029721	http://dx.doi.org/10.1371/journal.pone.0029721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906OY	22253764	Green Submitted, Green Published, gold			2022-12-25	WOS:000301357100019
J	Roberts, KA; Abraira, VE; Tucker, AF; Goodrich, LV; Andrews, NC				Roberts, Kristina A.; Abraira, Victoria E.; Tucker, Andrew F.; Goodrich, Lisa V.; Andrews, Nancy C.			Mutation of Rubie, a Novel Long Non-Coding RNA Located Upstream of Bmp4, Causes Vestibular Malformation in Mice	PLOS ONE			English	Article							INNER-EAR DEVELOPMENT; MOUSE; GENE; MORPHOGENESIS; REGULATORS; EVOLUTION; PROMOTER; ELEMENTS; DEFECTS; NOGGIN	Background: The vestibular apparatus of the vertebrate inner ear uses three fluid-filled semicircular canals to sense angular acceleration of the head. Malformation of these canals disrupts the sense of balance and frequently causes circling behavior in mice. The Epistatic circler (Ecl) is a complex mutant derived from wildtype SWR/J and C57L/J mice. Ecl circling has been shown to result from the epistatic interaction of an SWR-derived locus on chromosome 14 and a C57L-derived locus on chromosome 4, but the causative genes have not been previously identified. Methodology/Principal Findings: We developed a mouse chromosome substitution strain (CSS-14) that carries an SWR/J chromosome 14 on a C57BL/10J genetic background and, like Ecl, exhibits circling behavior due to lateral semicircular canal malformation. We utilized CSS-14 to identify the chromosome 14 Ecl gene by positional cloning. Our candidate interval is located upstream of bone morphogenetic protein 4 (Bmp4) and contains an inner ear-specific, long non-coding RNA that we have designated Rubie (RNA upstream of Bmp4 expressed in inner ear). Rubie is spliced and polyadenylated, and is expressed in developing semicircular canals. However, we discovered that the SWR/J allele of Rubie is disrupted by an intronic endogenous retrovirus that causes aberrant splicing and premature polyadenylation of the transcript. Rubie lies in the conserved gene desert upstream of Bmp4, within a region previously shown to be important for inner ear expression of Bmp4. We found that the expression patterns of Bmp4 and Rubie are nearly identical in developing inner ears. Conclusions/Significance: Based on these results and previous studies showing that Bmp4 is essential for proper vestibular development, we propose that Rubie is the gene mutated in Ecl mice, that it is involved in regulating inner ear expression of Bmp4, and that aberrant Bmp4 expression contributes to the Ecl phenotype.	[Roberts, Kristina A.; Andrews, Nancy C.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Roberts, Kristina A.; Andrews, Nancy C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [Roberts, Kristina A.; Andrews, Nancy C.] Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA USA; [Abraira, Victoria E.; Tucker, Andrew F.; Goodrich, Lisa V.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Duke University; Duke University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roberts, KA (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	nancy.andrews@duke.edu		Andrews, Nancy/0000-0003-0243-4462	NIH [R01 DK066373, F31 DC008450, R01 DC007195]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007195, F31DC008450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH R01 DK066373 to NCA, NIH F31 DC008450 to VEA, and NIH R01 DC007195 to LVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2008, DEVELOPMENT, V135, P4091, DOI 10.1242/dev.029330; Anagnostopoulos AV, 2002, TRENDS GENET, V18, P499; Baust C, 2003, J VIROL, V77, P11448, DOI 10.1128/JVI.77.21.11448-11458.2003; Blauwkamp MN, 2007, HEARING RES, V225, P71, DOI 10.1016/j.heares.2006.12.010; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Chandler KJ, 2009, DEV BIOL, V327, P590, DOI 10.1016/j.ydbio.2008.12.033; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Chatterjee S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-68; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Cryns K, 2004, J COMP NEUROL, V468, P587, DOI 10.1002/cne.10975; Cryns K, 2002, GENOME RES, V12, P613, DOI 10.1101/gr.218402; DiLeone RJ, 2000, P NATL ACAD SCI USA, V97, P1612, DOI 10.1073/pnas.97.4.1612; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; DOOLITTLE DP, 1963, GENETICS, V48, P887; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Morsli H, 1998, J NEUROSCI, V18, P3327; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Sando I, 2001, ANN NY ACAD SCI, V942, P15; SANDO I, 1984, ANN OTOL RHINOL LA S, V112, P110; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Vervoort R, 2010, BIOCHEM BIOPH RES CO, V394, P780, DOI 10.1016/j.bbrc.2010.03.069; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	32	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29495	10.1371/journal.pone.0029495	http://dx.doi.org/10.1371/journal.pone.0029495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253730	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100012
J	Cleary, DFR; Smalla, K; Mendonca-Hagler, LCS; Gomes, NCM				Cleary, Daniel F. R.; Smalla, Kornelia; Mendonca-Hagler, Leda C. S.; Gomes, Newton C. M.			Assessment of Variation in Bacterial Composition among Microhabitats in a Mangrove Environment Using DGGE Fingerprints and Barcoded Pyrosequencing	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; NW MEDITERRANEAN SEA; ENSO-INDUCED FIRES; MICROBIAL DIVERSITY; BUTTERFLY DIVERSITY; COMMUNITIES; SOIL; RHIZOSPHERE; GENES	Here, we use DGGE fingerprinting and barcoded pyrosequencing data, at six cut-off levels (85-100%), of all bacteria, Alphaproteobacteria and Betaproteobacteria to assess composition in the rhizosphere of nursery plants and nursery-raised transplants, native plants and bulk sediment in a mangrove habitat. When comparing compositional data based on DGGE fingerprinting and barcoded pyrosequencing at different cut-off levels, all revealed highly significant differences in composition among microhabitats. Procrustes superimposition revealed that ordination results using cut-off levels from 85-100% and DGGE fingerprint data were highly congruent with the standard 97% cut-off level. The various approaches revealed a primary gradient in composition from nursery to mangrove samples. The affinity between the nursery and transplants was greatest when using Betaproteobacteria followed by Alphaproteobacteria data. There was a distinct secondary gradient in composition from transplants to bulk sediment with native plants intermediate, which was most prevalent using all bacteria at intermediate cut-off levels (92-97%). Our results show that PCR-DGGE provides a robust and cost effective exploratory approach and is effective in distinguishing among a priori defined groups.	[Cleary, Daniel F. R.; Gomes, Newton C. M.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Cleary, Daniel F. R.; Gomes, Newton C. M.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Smalla, Kornelia] Fed Res Ctr Cultivated Plants, Julius Kuhn Inst, Braunschweig, Germany; [Mendonca-Hagler, Leda C. S.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil	Universidade de Aveiro; Universidade de Aveiro; Julius Kuhn-Institut; Universidade Federal do Rio de Janeiro	Cleary, DFR (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	gomesncm@ua.pt	Gomes, Newton Carlos Marcial/AAV-4603-2021; Smalla, Kornelia/H-4002-2011; Cleary, Daniel/ABA-9393-2021; Cleary, Daniel/D-2582-2012; Gomes, Newton Carlos Marcial/K-3211-2015; Gomes, Newton CM/F-7430-2012	Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Cleary, Daniel/0000-0002-6143-3390; Cleary, Daniel/0000-0002-6143-3390; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton CM/0000-0003-1934-0091	Deutsche Forschungsgemeinschaft [SM59/4-1, SM59/4-2]; FAPERJ-Brazil; Centre for Environmental and Marine Studies (CESAM, Portugal); Foundation for Science and Technology (FCT, Portugal) [PTDC/AAC-CLI/107916/2008]; European Regional Development Fund (ERDF) through COMPETE [FCOMP-01-0124-FEDER-008657]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-CLI/107916/2008] Funding Source: FCT	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FAPERJ-Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centre for Environmental and Marine Studies (CESAM, Portugal); Foundation for Science and Technology (FCT, Portugal)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through COMPETE; Fundação para a Ciência e a Tecnologia	This study was funded by the Deutsche Forschungsgemeinschaft SM59/4-1 and 4-2 (www.dfg.de/en/index.jsp), FAPERJ-Brazil (www.faperj.br), Centre for Environmental and Marine Studies (CESAM, Portugal) (www.cesam.ua.pt), Foundation for Science and Technology (FCT, Portugal) PTDC/AAC-CLI/107916/2008 (http://alfa.fct.mctes.pt) and the European Regional Development Fund (ERDF) through COMPETE- (FCOMP-01-0124-FEDER-008657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Cleary DFR, 2004, GLOBAL ECOL BIOGEOGR, V13, P129, DOI 10.1111/j.1466-882X.2004.00074.x; Cleary DFR, 2003, OECOLOGIA, V135, P313, DOI 10.1007/s00442-003-1188-5; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; de Voogd NJ, 2006, MAR ECOL PROG SER, V309, P131, DOI 10.3354/meps309131; Diez B, 2004, LIMNOL OCEANOGR, V49, P1022; Dobell C., 1960, A VANLEEUWENHOEK HIS; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; Ghiglione JF, 2005, AQUAT MICROB ECOL, V40, P229, DOI 10.3354/ame040229; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gomes NCM, 2010, FEMS MICROBIOL ECOL, V74, P276, DOI 10.1111/j.1574-6941.2010.00962.x; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Gomes NCM, 2007, APPL ENVIRON MICROB, V73, P7392, DOI 10.1128/AEM.01099-07; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nakayama J., 2010, Bioscience and Microflora, V29, P83; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Short SM, 2002, APPL ENVIRON MICROB, V68, P1290, DOI 10.1128/AEM.68.3.1290-1296.2002; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09	34	68	70	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29380	10.1371/journal.pone.0029380	http://dx.doi.org/10.1371/journal.pone.0029380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247774	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700022
J	Dowling, DK; Simmons, LW				Dowling, Damian K.; Simmons, Leigh W.			Ejaculate Economics: Testing the Effects of Male Sexual History on the Trade-Off between Sperm and Immune Function in Australian Crickets	PLOS ONE			English	Article							FERTILIZATION SUCCESS; COMPETITION GAMES; FIELD CRICKET; VIABILITY; QUALITY; COSTS; REPRODUCTION; INVESTMENT; ATTRACTIVENESS; INTENSITY	Trade-offs between investment into male sexual traits and immune function provide the foundation for some of the most prominent models of sexual selection. Post-copulatory sexual selection on the male ejaculate is intense, and therefore trade-offs should occur between investment into the ejaculate and the immune system. Examples of such trade-offs exist, including that between sperm quality and immunity in the Australian cricket, Teleogryllus oceanicus. Here, we explore the dynamics of this trade-off, examining the effects that increased levels of sexual interaction have on the viability of a male's sperm across time, and the concomitant effects on immune function. Males were assigned to a treatment, whereby they cohabited with females that were sexually immature, sexually mature but incapable of copulation, or sexually mature and capable of copulation. Sperm viability of each male was then assessed at two time points: six and 13 days into the treatment, and immune function at day 13. Sperm viability decreased across the time points, but only for males exposed to treatment classes involving sexually mature females. This decrease was similar in magnitude across both sexually mature classes, indicating that costs to the expression of high sperm viability are incurred largely through levels of pre-copulatory investment. Males exposed to immature females produced sperm of low viability at both time points. Although we confirmed a weak negative association between sperm viability and lytic activity (a measure of immune response to bacterial infection) at day 13, this relationship was not altered across the mating treatment. Our results highlight that sperm viability is a labile trait, costly to produce, and subject to strategic allocation in these crickets.	[Dowling, Damian K.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, Australia	Monash University; University of Western Australia	Dowling, DK (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	damian.dowling@monash.edu	Dowling, Damian/C-9016-2009; Simmons, Leigh W/B-1815-2011	Dowling, Damian/0000-0003-2209-3458; Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council DP; ARC	Australian Research Council DP(Australian Research Council); ARC(Australian Research Council)	This research was supported by an Australian Research Council DP grant to LWS. DKD was supported by an ARC Australian Research Fellowship when writing this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dowling DK, 2007, J EVOLUTION BIOL, V20, P358, DOI 10.1111/j.1420-9101.2006.01189.x; Dowling DK, 2010, AM NAT, V176, P131, DOI 10.1086/653671; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Drnevich JM, 2002, PHYSIOL ENTOMOL, V27, P228, DOI 10.1046/j.1365-3032.2002.00290.x; Engqvist L, 2011, BEHAV ECOL, V22, P345, DOI 10.1093/beheco/arq211; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gershman SN, 2010, J EVOLUTION BIOL, V23, P829, DOI 10.1111/j.1420-9101.2010.01951.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Immler S, 2011, P NATL ACAD SCI USA, V108, P5325, DOI 10.1073/pnas.1009059108; Kerr AM, 2010, BEHAV ECOL, V21, P647, DOI 10.1093/beheco/arq035; Klaus SP, 2011, ETHOLOGY, V117, P154, DOI 10.1111/j.1439-0310.2010.01857.x; Lewis Z, 2011, ANIM BEHAV, V81, P579, DOI 10.1016/j.anbehav.2010.12.001; LOHER W, 1978, Z TIERPSYCHOL, V46, P225; LOHER W, 1974, J INSECT PHYSIOL, V20, P1155, DOI 10.1016/0022-1910(74)90221-2; Losdat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022221; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; PITNICK S, 1994, P NATL ACAD SCI USA, V91, P9277, DOI 10.1073/pnas.91.20.9277; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; SCHNEIDER PM, 1985, INSECT BIOCHEM, V15, P463, DOI 10.1016/0020-1790(85)90058-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; Simmons LW, 2012, BEHAV ECOL, V23, P168, DOI 10.1093/beheco/arr170; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; Simmons LW, 2003, J EVOLUTION BIOL, V16, P624, DOI 10.1046/j.1420-9101.2003.00572.x; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	50	38	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30172	10.1371/journal.pone.0030172	http://dx.doi.org/10.1371/journal.pone.0030172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253916	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700096
J	Nuez, I; Felix, MA				Nuez, Isabelle; Felix, Marie-Anne			Evolution of Susceptibility to Ingested Double-Stranded RNAs in Caenorhabditis Nematodes	PLOS ONE			English	Article							C-ELEGANS; INTERFERENCE; PROTEIN; TRANSPOSON; SEQUENCE	Background: The nematode Caenorhabditis elegans is able to take up external double-stranded RNAs (dsRNAs) and mount an RNA interference response, leading to the inactivation of specific gene expression. The uptake of ingested dsRNAs into intestinal cells has been shown to require the SID-2 transmembrane protein in C. elegans. By contrast, C. briggsae was shown to be naturally insensitive to ingested dsRNAs, yet could be rendered sensitive by transgenesis with the C. elegans sid-2 gene. Here we aimed to elucidate the evolution of the susceptibility to external RNAi in the Caenorhabditis genus. Principal Findings: We study the sensitivity of many new species of Caenorhabditis to ingested dsRNAs matching a conserved actin gene sequence from the nematode Oscheius tipulae. We find ample variation in the Caenorhabditis genus in the ability to mount an RNAi response. We map this sensitivity onto a phylogenetic tree, and show that sensitivity or insensitivity have evolved convergently several times. We uncover several evolutionary losses in sensitivity, which may have occurred through distinct mechanisms. We could render C. remanei and C. briggsae sensitive to ingested dsRNAs by transgenesis of the Cel-sid-2 gene. We thus provide tools for RNA interference studies in these species. We also show that transgenesis by injection is possible in many Caenorhabditis species. Conclusions: The ability of animals to take up dsRNAs or to respond to them by gene inactivation is under rapid evolution in the Caenorhabditis genus. This study provides a framework and tools to use RNA interference and transgenesis in various Caenorhabditis species for further comparative and evolutionary studies.	[Nuez, Isabelle; Felix, Marie-Anne] Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Nuez, I (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France.	felix@biologie.ens.fr			CNRS; Association pour la Recherche sur le Cancer [3749]; Agence Nationale de la Recherche [05-BLAN-0231, 08-BLAN-0024]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was financed by the CNRS and by grants from the Association pour la Recherche sur le Cancer (no 3749) and the Agence Nationale de la Recherche (05-BLAN-0231 and 08-BLAN-0024) to M-AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, REVERSE GENETICS, DOI 10.1895/wormbook.1.47.1; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Delattre M, 2001, THESIS U PARIS 6, P6; Dichtel-Danjoy ML, 2004, DEV BIOL, V265, P113, DOI 10.1016/j.ydbio.2003.09.010; Evans TC, TRANSFORMATION MICRO; Felix M.-A., OSCHEIUS TIPULAE, DOI 10.1895/wormbook.1.119.1; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Felix Marie-Anne, 2008, Journal of Biology (London), V7, DOI 10.1186/jbiol97; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiontke K, 1997, FUND APPL NEMATOL, V20, P305; Kiontke K, 2011, BMC EVOL BI IN PRESS; Kiontke K, 2007, CURR BIOL, V17, P1925, DOI 10.1016/j.cub.2007.10.061; Louvet-Vallee S, 2003, GENETICS, V163, P133; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; OKKEMA PG, 1993, GENETICS, V135, P385; Pires-DaSilva A, 2004, GENE DEV, V18, P1198, DOI 10.1101/gad.293504; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Shannon AJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-58; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Sudhaus W, 2011, NEMATOLOGY, V13, P61, DOI 10.1163/138855410X500334; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhuang JJ, 2011, GENETICS, V188, P235, DOI 10.1534/genetics.111.127209	41	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29811	10.1371/journal.pone.0029811	http://dx.doi.org/10.1371/journal.pone.0029811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253787	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700054
J	Schwerk, C; Papandreou, T; Schuhmann, D; Nickol, L; Borkowski, J; Steinmann, U; Quednau, N; Stump, C; Weiss, C; Berger, J; Wolburg, H; Claus, H; Vogel, U; Ishikawa, H; Tenenbaum, T; Schroten, H				Schwerk, Christian; Papandreou, Thalia; Schuhmann, Daniel; Nickol, Laura; Borkowski, Julia; Steinmann, Ulrike; Quednau, Natascha; Stump, Carolin; Weiss, Christel; Berger, Juergen; Wolburg, Hartwig; Claus, Heike; Vogel, Ulrich; Ishikawa, Hiroshi; Tenenbaum, Tobias; Schroten, Horst			Polar Invasion and Translocation of Neisseria meningitidis and Streptococcus suis in a Novel Human Model of the Blood-Cerebrospinal Fluid Barrier	PLOS ONE			English	Article							PLEXUS EPITHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; MICROVASCULAR ENDOTHELIAL-CELLS; CHOROID-PLEXUS; IN-VITRO; BRAIN-BARRIER; TIGHT JUNCTIONS; MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; GENE-EXPRESSION	Acute bacterial meningitis is a life-threatening disease in humans. Discussed as entry sites for pathogens into the brain are the blood-brain and the blood-cerebrospinal fluid barrier (BCSFB). Although human brain microvascular endothelial cells (HBMEC) constitute a well established human in vitro model for the blood-brain barrier, until now no reliable human system presenting the BCSFB has been developed. Here, we describe for the first time a functional human BCSFB model based on human choroid plexus papilloma cells (HIBCPP), which display typical hallmarks of a BCSFB as the expression of junctional proteins and formation of tight junctions, a high electrical resistance and minimal levels of macromolecular flux when grown on transwell filters. Importantly, when challenged with the zoonotic pathogen Streptococcus suis or the human pathogenic bacterium Neisseria meningitidis the HIBCPP show polar bacterial invasion only from the physiologically relevant basolateral side. Meningococcal invasion is attenuated by the presence of a capsule and translocated N. meningitidis form microcolonies on the apical side of HIBCPP opposite of sites of entry. As a functionally relevant human model of the BCSFB the HIBCPP offer a wide range of options for analysis of disease-related mechanisms at the choroid plexus epithelium, especially involving human pathogens.	[Schwerk, Christian; Papandreou, Thalia; Schuhmann, Daniel; Nickol, Laura; Borkowski, Julia; Steinmann, Ulrike; Quednau, Natascha; Stump, Carolin; Tenenbaum, Tobias; Schroten, Horst] Heidelberg Univ, Med Fac Mannheim, Dept Pediat, D-6800 Mannheim, Germany; [Weiss, Christel] Heidelberg Univ, Med Fac Mannheim, Dept Stat, D-6800 Mannheim, Germany; [Berger, Juergen] Max Planck Inst Dev Biol, Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Ishikawa, Hiroshi] Jikei Univ, Dept Anat, Sch Med, Tokyo 105, Japan	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Jikei University	Schwerk, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Pediat, D-6800 Mannheim, Germany.	christian.schwerk@medma.uni-heidelberg.de	Schwerk, Christian/GNP-5375-2022		Deutsche Forschungsgemeinschaft [TE 653/2-2]; Federal Ministry of Education and Research via the ERA-NET PathoGenoMics network; JSPS [20390501, 22659314]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research via the ERA-NET PathoGenoMics network; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (TE 653/2-2) to TT and HS, and by a grant provided to UV by the Federal Ministry of Education and Research via the ERA-NET PathoGenoMics network. Also, this work was supported by JSPS, Grant-in Aid for Scientific Research (B) 20390501 and Grant-in Aid for Challenging Exploratory Research 22659314 to HI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RA, 2004, INFECT IMMUN, V72, P3084, DOI 10.1128/IAI.72.5.3084-3087.2004; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; DICKSON PW, 1986, NEUROSCI LETT, V66, P311, DOI 10.1016/0304-3940(86)90037-6; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gath U, 1997, EUR J CELL BIOL, V74, P68; Guarner J, 2004, AM J CLIN PATHOL, V122, P754, DOI 10.1309/3489075U03LMK9AE; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haselbach M, 2001, MICROSC RES TECHNIQ, V52, P137, DOI 10.1002/1097-0029(20010101)52:1<137::AID-JEMT15>3.3.CO;2-A; Ishiwata Isamu, 2005, Hum Cell, V18, P67; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kitazawa T, 2001, PHARMACEUT RES, V18, P16, DOI 10.1023/A:1011014424212; Koedel U, 2010, CURR OPIN INFECT DIS, V23, P217, DOI 10.1097/QCO.0b013e328337f49e; Kumabe Toshihiro, 1996, Neurologia Medico-Chirurgica, V36, P179, DOI 10.2176/nmc.36.179; Lappann M, 2006, MOL MICROBIOL, V62, P1292, DOI 10.1111/j.1365-2958.2006.05448.x; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Madsen LW, 2002, J COMP PATHOL, V126, P57, DOI 10.1053/jcpa.2001.0522; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Muruganandam A, 1997, FASEB J, V11, P1187, DOI 10.1096/fasebj.11.13.9367354; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; SAITO Y, 1983, J PHYSIOL-LONDON, V336, P635, DOI 10.1113/jphysiol.1983.sp014602; SANFORD SE, 1987, CAN J VET RES, V51, P486; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Seller A, 1996, MOL MICROBIOL, V19, P841, DOI 10.1046/j.1365-2958.1996.437970.x; Shi LZC, 2005, BRAIN RES, V1057, P37, DOI 10.1016/j.brainres.2005.07.046; Smith HE, 1999, INFECT IMMUN, V67, P1750; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Strazielle N, 2011, NEUROMETHODS, V56, P161, DOI 10.1007/978-1-61779-077-5_8; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Takahashi K, 1997, J NEUROCHEM, V68, P726; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Tenenbauma T, 2008, BRAIN RES, V1229, P1, DOI 10.1016/j.brainres.2008.06.118; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; Villalobos ARA, 2002, AM J PHYSIOL-REG I, V282, pR1308, DOI 10.1152/ajpregu.00677.2001; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WILLIAMS AE, 1990, J INFECT DIS, V162, P474, DOI 10.1093/infdis/162.2.474; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	60	71	71	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30069	10.1371/journal.pone.0030069	http://dx.doi.org/10.1371/journal.pone.0030069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253884	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700088
J	Chawade, A; Linden, P; Brautigam, M; Jonsson, R; Jonsson, A; Moritz, T; Olsson, O				Chawade, Aakash; Linden, Pernilla; Brautigam, Marcus; Jonsson, Rickard; Jonsson, Anders; Moritz, Thomas; Olsson, Olof			Development of a Model System to Identify Differences in Spring and Winter Oat	PLOS ONE			English	Article							PLANT COLD-ACCLIMATION; ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; LOW-TEMPERATURE; TRANSCRIPTOME; PATHWAYS; GENES; IDENTIFICATION; METABOLITES; TRANSITION	Our long-term goal is to develop a Swedish winter oat (Avena sativa). To identify molecular differences that correlate with winter hardiness, a winter oat model comprising of both non-hardy spring lines and winter hardy lines is needed. To achieve this, we selected 294 oat breeding lines, originating from various Russian, German, and American winter oat breeding programs and tested them in the field in south-and western Sweden. By assaying for winter survival and agricultural properties during four consecutive seasons, we identified 14 breeding lines of different origins that not only survived the winter but also were agronomically better than the rest. Laboratory tests including electrolytic leakage, controlled crown freezing assay, expression analysis of the AsVrn1 gene and monitoring of flowering time suggested that the American lines had the highest freezing tolerance, although the German lines performed better in the field. Finally, six lines constituting the two most freezing tolerant lines, two intermediate lines and two spring cultivars were chosen to build a winter oat model system. Metabolic profiling of non-acclimated and cold acclimated leaf tissue samples isolated from the six selected lines revealed differential expression patterns of 245 metabolites including several sugars, amino acids, organic acids and 181 hitherto unknown metabolites. The expression patterns of 107 metabolites showed significant interactions with either a cultivar or a time-point. Further identification, characterisation and validation of these metabolites will lead to an increased understanding of the cold acclimation process in oats. Furthermore, by using the winter oat model system, differential sequencing of crown mRNA populations would lead to identification of various biomarkers to facilitate winter oat breeding.	[Chawade, Aakash] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Chawade, Aakash; Olsson, Olof] Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden; [Chawade, Aakash; Brautigam, Marcus; Jonsson, Anders; Olsson, Olof] Crop Tailor AB, Gothenburg, Sweden; [Linden, Pernilla; Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Jonsson, Rickard] Lantmannen SW Seed AB, Svalov, Sweden; [Jonsson, Anders] Swedish Univ Agr Sci, Dept Soil & Environm, Skara, Sweden; [Olsson, Olof] Lund Univ, Dept Pure & Appl Biochem, Lund, Sweden	University of Gothenburg; University of Gothenburg; Swedish University of Agricultural Sciences; Umea University; Swedish University of Agricultural Sciences; Lund University	Chawade, A (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden.	aakash.chawade@gu.se; olof.olsson@tbiokem.lth.se	Chawade, Aakash/G-7750-2011	Chawade, Aakash/0000-0002-6500-4139; Moritz, Thomas/0000-0002-4258-3190; Olsson, Olof/0000-0003-3962-9183	Swedish Farmer's foundation for agricultural research (SLF) [HO633164]	Swedish Farmer's foundation for agricultural research (SLF)	The research was funded by the grant from Swedish Farmer's foundation for agricultural research (SLF), grant number HO633164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar T, 2009, PLANT BREEDING, V128, P381, DOI 10.1111/j.1439-0523.2008.01553.x; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Brautigam M, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-18; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chawade A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-304; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Cunningham SM, 2003, CROP SCI, V43, P562, DOI 10.2135/cropsci2003.0562; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; FAO, 2008, FOOD AGR ORG PRODSTA; FOWLER DB, 1979, CROP SCI, V19, P915, DOI 10.2135/cropsci1979.0011183X001900060040x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Govindachary S, 2004, PHYSIOL PLANTARUM, V121, P322, DOI 10.1111/j.0031-9317.2004.00305.x; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Livingston DP, 2006, CRYOBIOLOGY, V52, P200, DOI 10.1016/j.cryobiol.2005.11.001; Livingston DP, 2005, CROP SCI, V45, P1545, DOI 10.2135/cropsci2004.0579; Livingston DP, 2004, CROP SCI, V44, P1966, DOI 10.2135/cropsci2004.1966; Livingston DP, 1996, CROP SCI, V36, P1568, DOI 10.2135/cropsci1996.0011183X003600060027x; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Meyer SE, 2004, ANN BOT-LONDON, V93, P653, DOI 10.1093/aob/mch088; OLIEN CHARLES ROBERT, 1964, CROP SCI, V4, P91, DOI 10.2135/cropsci1964.0011183X000400010028x; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Rohde P, 2004, PLANT J, V38, P790, DOI 10.1111/j.1365-313X.2004.02080.x; Sakamoto A, 2000, J EXP BOT, V51, P81, DOI 10.1093/jexbot/51.342.81; Schafer JF, 1978, CROP SCI, V18; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Van Buskirk HA, 2006, PHYSIOL PLANTARUM, V126, P72, DOI 10.1111/j.1399-3054.2006.00625.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006	43	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29792	10.1371/journal.pone.0029792	http://dx.doi.org/10.1371/journal.pone.0029792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253782	Green Submitted, Green Published, gold			2022-12-25	WOS:000315865800015
J	Clark, MS; Denekamp, NY; Thorne, MAS; Reinhardt, R; Drungowski, M; Albrecht, MW; Klages, S; Beck, A; Kube, M; Lubzens, E				Clark, Melody S.; Denekamp, Nadav Y.; Thorne, Michael A. S.; Reinhardt, Richard; Drungowski, Mario; Albrecht, Marcus W.; Klages, Sven; Beck, Alfred; Kube, Michael; Lubzens, Esther			Long-Term Survival of Hydrated Resting Eggs from Brachionus plicatilis	PLOS ONE			English	Article							ARTEMIA-FRANCISCANA EMBRYOS; ENERGY-LIMITED STATES; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; MESSENGER-RNA; DESICCATION TOLERANCE; MOLECULAR CHARACTERIZATION; TETRASPANIN SUPERFAMILY; NUCLEOTIDE-METABOLISM; STRESS TOLERANCE	Background: Several organisms display dormancy and developmental arrest at embryonic stages. Long-term survival in the dormant form is usually associated with desiccation, orthodox plant seeds and Artemia cysts being well documented examples. Several aquatic invertebrates display dormancy during embryonic development and survive for tens or even hundreds of years in a hydrated form, raising the question of whether survival in the non-desiccated form of embryonic development depends on pathways similar to those occurring in desiccation tolerant forms. Methodology/Principal Findings: To address this question, Illumina short read sequencing was used to generate transcription profiles from the resting and amictic eggs of an aquatic invertebrate, the rotifer, Brachionus plicatilis. These two types of egg have very different life histories, with the dormant or diapausing resting eggs, the result of the sexual cycle and amictic eggs, the non-dormant products of the asexual cycle. Significant transcriptional differences were found between the two types of egg, with amictic eggs rich in genes involved in the morphological development into a juvenile rotifer. In contrast, representatives of classical "stress'' proteins: a small heat shock protein, ferritin and Late Embryogenesis Abundant (LEA) proteins were identified in resting eggs. More importantly however, was the identification of transcripts for messenger ribonucleoprotein particles which stabilise RNA. These inhibit translation and provide a valuable source of useful RNAs which can be rapidly activated on the exit from dormancy. Apoptotic genes were also present. Although apoptosis is inconsistent with maintenance of prolonged dormancy, an altered apoptotic pathway has been proposed for Artemia, and this may be the case with the rotifer. Conclusions: These data represent the first transcriptional profiling of molecular processes associated with dormancy in a non-desiccated form and indicate important similarities in the molecular pathways activated in resting eggs compared with desiccated dormant forms, specifically plant seeds and Artemia.	[Clark, Melody S.; Thorne, Michael A. S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Denekamp, Nadav Y.; Lubzens, Esther] Israel Oceanog & Limnol Res, Haifa, Israel; [Reinhardt, Richard; Drungowski, Mario; Albrecht, Marcus W.; Klages, Sven; Beck, Alfred; Kube, Michael] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Israel Oceanographic & Limnological Research Institute; Max Planck Society	Clark, MS (corresponding author), British Antarctic Survey, NERC, High Cross, Cambridge CB3 0ET, England.	esther@ocean.org.il	Clark, Melody S/D-7371-2014	Clark, Melody S/0000-0002-3442-3824; Reinhardt, Richard/0000-0001-9376-2132; Thorne, Michael/0000-0001-7759-612X	European Community (NEST) [012674]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	European Community (NEST); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financially supported by the European Community (NEST # 012674; Sleeping Beauty). The analyses were completed by the team from the British Antarctic Survey within the Ecosystems Adaptations and Physiology Work Package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], ARCH HYDROBIOL S; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balompapueng MD, 1997, HYDROBIOLOGIA, V358, P163, DOI 10.1023/A:1003197222440; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Berjak P, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P17, DOI 10.1079/9781845931971.0017; Berjak P, 2006, SEED SCI RES, V16, P1, DOI 10.1079/SSR2005236; Bewley J.D., SEEDS PHYSL DEV GERM, V3rd; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; Buckley BA, 2006, J EXP BIOL, V209, P2660, DOI 10.1242/jeb.02292; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; Busso D, 2010, INT J DEV BIOL, V54, P857, DOI 10.1387/ijdb.092921db; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cameron RS, 2007, CELL MOTIL CYTOSKEL, V64, P19, DOI 10.1002/cm.20162; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; CARVALHO GR, 1989, FRESHWATER BIOL, V22, P459, DOI 10.1111/j.1365-2427.1989.tb01118.x; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Chen WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-52; CLEGG JS, 1986, METHOD ENZYMOL, V127, P230; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; CLEGG JS, 1969, DEV BIOL, V19, P178, DOI 10.1016/0012-1606(69)90054-2; Clegg JS, 1997, J EXP BIOL, V200, P467; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Denekamp NY, 2011, HYDROBIOLOGIA, V662, P51, DOI 10.1007/s10750-010-0518-y; Denekamp NY, 2010, TOP CURR GENET, V21, P109, DOI 10.1007/978-3-642-12422-8_7; Denekamp NY, 2010, BIOL REPROD, V82, P714, DOI 10.1095/biolreprod.109.081091; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Deruiter MC, 2001, DEV DYNAM, V221, P460, DOI 10.1002/dvdy.1156; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; DUTRIEU JANINE, 1960, ARCH ZOOL EXPTL ET GEN, V99, P1; Dykes IM, 2006, DEV GENES EVOL, V216, P185, DOI 10.1007/s00427-005-0048-1; Falany CN, 2000, BIOCHEM J, V346, P857, DOI 10.1042/0264-6021:3460857; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Gilbert JJ, 2004, FRESHWATER BIOL, V49, P1505, DOI 10.1111/j.1365-2427.2004.01282.x; Gilbert John J., 2007, Monographiae Biologicae, V84, P11; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hagiwara A, 1995, HYDROBIOLOGIA, V313, P223, DOI 10.1007/BF00025955; HAGIWARA A, 1996, TECHNICAL REPORTS JA, V24, P109; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; Hardewig I, 1996, MOL CELL BIOCHEM, V158, P139; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; HOFMANN GE, 1992, J EXP BIOL, V164, P103; HOFMANN GE, 1994, P NATL ACAD SCI USA, V91, P8492, DOI 10.1073/pnas.91.18.8492; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Islam MK, 2003, EUR J BIOCHEM, V270, P2814, DOI 10.1046/j.1432-1033.2003.03658.x; Jornvall H, 2008, CELL MOL LIFE SCI, V65, P3875, DOI 10.1007/s00018-008-8586-0; Kaneko G, 2005, HYDROBIOLOGIA, V546, P117, DOI 10.1007/s10750-005-4107-4; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kotani T, 2001, HYDROBIOLOGIA, V446, P283, DOI 10.1023/A:1017584230439; Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Li HM, 2006, TOXICOLOGY, V228, P229, DOI 10.1016/j.tox.2006.08.040; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; LUBZENS E, 1985, AQUACULTURE, V47, P27, DOI 10.1016/0044-8486(85)90005-5; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; MARCUS NH, 1994, LIMNOL OCEANOGR, V39, P154, DOI 10.4319/lo.1994.39.1.0154; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; MINKOFF G, 1983, HYDROBIOLOGIA, V104, P61, DOI 10.1007/BF00045953; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pauwels K, 2007, HYDROBIOLOGIA, V594, P91, DOI 10.1007/s10750-007-9091-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Qui Z, 2010, DORMANCY RESISTANCE, P165; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rees BB, 2011, MOL BIOL EVOL, V28, P1271, DOI 10.1093/molbev/msq314; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; SLEGERS H, 1981, EUR J BIOCHEM, V117, P111; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; STOCCO DM, 1972, DEV BIOL, V27, P479, DOI 10.1016/0012-1606(72)90187-X; Suarez-Castillo EC, 2004, GENE, V334, P133, DOI 10.1016/j.gene.2004.03.023; Tanaka S, 2001, GENE, V268, P53, DOI 10.1016/S0378-1119(01)00419-X; Tang L, 2001, J BIOL CHEM, V276, P27663, DOI 10.1074/jbc.M102205200; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; Vermelho Alane Beatriz, 2010, Open Parasitology Journal, V4, P5; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Warner AH, 2001, EUR J BIOCHEM, V268, P1568, DOI 10.1046/j.1432-1033.2001.01993.x; Weaver TA, 1995, DEVELOPMENT, V121, P4149; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; WURDAK ES, 1978, T AM MICROSC SOC, V97, P49, DOI 10.2307/3225684; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700; Zheng L., 2005, ISJ, V2, P105	118	39	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29365	10.1371/journal.pone.0029365	http://dx.doi.org/10.1371/journal.pone.0029365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253713	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000301352400002
J	Sieber, S; Lange, N; Kollmorgen, G; Erhardt, A; Quaas, A; Gontarewicz, A; Sass, G; Tiegs, G; Kreienkamp, HJ				Sieber, Sabrina; Lange, Nicole; Kollmorgen, Gwendlyn; Erhardt, Annette; Quaas, Alexander; Gontarewicz, Arthur; Sass, Gabriele; Tiegs, Gisa; Kreienkamp, Hans-Juergen			Sharpin Contributes to TNF alpha Dependent NF kappa B Activation and Anti-Apoptotic Signalling in Hepatocytes	PLOS ONE			English	Article							DOWN-REGULATION; LIVER; INFLAMMATION; DERMATITIS; COMPLEX; CELLS; COMPONENT; MICE	TNF alpha stimulates both pro-and anti-apoptotic signalling in hepatocytes. Anti-apoptotic signalling depends on a cascade of ubiquitylation steps leading to NF kappa B activation. Using Sharpin-deficient mice, we show that the ubiquitin binding protein Sharpin interacts with Hoip, an E3 ligase which generates linear ubiquitin chains. Sharpin-deficiency sensitized hepatocytes to induction of apoptosis by TNF alpha even in the absence of transcriptional inhibition. TNF alpha induced activation of NF kappa B was strongly reduced in hepatocytes from Sharpin-deficient mice, due to reduced and delayed phosphorylation and degradation of I kappa B alpha. Injection of TNF alpha-inducing lipopolysaccharides led to strongly exacerbated liver damage and premature death in Sharpin-deficient mice. Our findings point to an essential role of Sharpin in linear ubiquitin chain formation, NF kappa B activation, and protection of the liver against inflammatory damaging signals.	[Sieber, Sabrina; Kollmorgen, Gwendlyn; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Lange, Nicole; Erhardt, Annette; Sass, Gabriele; Tiegs, Gisa] Univ Klinikum Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany; [Quaas, Alexander; Gontarewicz, Arthur] Univ Klinikum Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tiegs, G (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany.	g.tiegs@uke.de; Kreienkamp@uke.de	Erhardt, Annette/AAS-5350-2021	Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Deutsche Forschungsgemeinschaft [SFB841/B1, FOR885]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support from Deutsche Forschungsgemeinschaft (www.dfg.de) is acknowledged (SFB841/B1 to GT and FOR885 to HJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bergmeyer H.U., 1984, METHOD ENZYMAT AN, P416; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gijbels MJJ, 1996, AM J PATHOL, V148, P941; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; LEIST M, 1994, J IMMUNOL, V153, P1778; LEIST M, 1995, AM J PATHOL, V146, P1220; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821	25	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29993	10.1371/journal.pone.0029993	http://dx.doi.org/10.1371/journal.pone.0029993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253853	Green Published, gold, Green Submitted			2022-12-25	WOS:000315865800021
J	Fomina-Yadlin, D; Kubicek, S; Vetere, A; He, KH; Schreiber, SL; Wagner, BK				Fomina-Yadlin, Dina; Kubicek, Stefan; Vetere, Amedeo; He, Kaihui Hu; Schreiber, Stuart L.; Wagner, Bridget K.			GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity	PLOS ONE			English	Article							PROTEIN-KINASE; CHROMATIN IMMUNOPRECIPITATION; DIABETES RESEARCH; RESPONSE ELEMENT; GENE-EXPRESSION; DNA-DAMAGE; MDM2; INHIBITOR; RAT; PHOSPHORYLATION	Background: Expression of insulin in terminally differentiated non-beta cell types in the pancreas could be important to treating type-1 diabetes. Previous findings led us to hypothesize involvement of kinase inhibition in induction of insulin expression in pancreatic alpha cells. Methodology/Principal Findings: Alpha (alpha TC1.6) cells and human islets were treated with GW8510 and other small-molecule inhibitors for up to 5 days. Alpha cells were assessed for gene-and protein-expression levels, cell-cycle status, promoter occupancy status by chromatin immunoprecipitation (ChIP), and p53-dependent transcriptional activity. GW8510, a putative CDK2 inhibitor, up-regulated insulin expression in mouse alpha cells and enhanced insulin secretion in dissociated human islets. Gene-expression profiling and gene-set enrichment analysis of GW8510-treated alpha cells suggested up-regulation of the p53 pathway. Accordingly, the compound increased p53 transcriptional activity and expression levels of p53 transcriptional targets. A predicted p53 response element in the promoter region of the mouse Ins2 gene was verified by chromatin immunoprecipitation (ChIP). Further, inhibition of Jun N-terminal kinase (JNK) and p38 kinase activities suppressed insulin induction by GW8510. Conclusions/Significance: The induction of Ins2 by GW8510 occurred through p53 in a JNK- and p38-dependent manner. These results implicate p53 activity in modulation of Ins2 expression levels in pancreatic alpha cells, and point to a potential approach toward using small molecules to generate insulin in an alternative cell type.	[Fomina-Yadlin, Dina; Vetere, Amedeo; He, Kaihui Hu; Schreiber, Stuart L.; Wagner, Bridget K.] Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA; [Fomina-Yadlin, Dina] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kubicek, Stefan] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Broad Inst Harvard & MIT, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Austrian Academy of Sciences; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Wagner, BK (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA.	bwagner@broadinstitute.org	Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Vetere, Amedeo/0000-0001-5608-0773	Juvenile Diabetes Research Foundation; NIGMS (National Institute of General Medical Sciences) [GM38627]; Type 1 Diabetes Pathfinder Award (NIH-NIDDK) [DP2-DK083048]; Ernst Schering Research Foundation; European Union FP7 Marie Curie program [PIOF-GA-2008-221135]; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Type 1 Diabetes Pathfinder Award (NIH-NIDDK); Ernst Schering Research Foundation; European Union FP7 Marie Curie program; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Juvenile Diabetes Research Foundation (S. L. S., B. K. W.), the NIGMS (National Institute of General Medical Sciences) (GM38627 to S. L. S.) and a Type 1 Diabetes Pathfinder Award (DP2-DK083048, NIH-NIDDK, to B. K. W.). S. K. acknowledges support by the Ernst Schering Research Foundation and the European Union FP7 Marie Curie program (PIOF-GA-2008-221135). D.F.-Y. acknowledges support from MCO training grant at Harvard University. S. L. S. is an Investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Holbrook N J, 1996, EXS, V77, P273; Hughes A, 2010, CURR DIABETES REV, V6, P274, DOI 10.2174/157339910793360897; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Johnson K, 2005, J NEUROCHEM, V93, P538, DOI 10.1111/j.1471-4159.2004.03004.x; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Lohrum M, 1996, ONCOGENE, V13, P2527; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Piscopo DM, 2008, CANCER RES, V68, P5581, DOI 10.1158/0008-5472.CAN-07-6346; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Sebastian S, 2010, FRONT BIOSCI-LANDMRK, V15, P1172, DOI 10.2741/3669; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231; Zawalich WS, 2004, J ENDOCRINOL, V183, P309, DOI 10.1677/joe.1.05832; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	50	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28808	10.1371/journal.pone.0028808	http://dx.doi.org/10.1371/journal.pone.0028808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242153	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100007
J	Piya, S; White, EJ; Klein, SR; Jiang, H; McDonnell, TJ; Gomez-Manzano, C; Fueyo, J				Piya, Sujan; White, Erin J.; Klein, Sarah R.; Jiang, Hong; McDonnell, Timothy J.; Gomez-Manzano, Candelaria; Fueyo, Juan			The E1B19K Oncoprotein Complexes with Beclin 1 to Regulate Autophagy in Adenovirus-Infected Cells	PLOS ONE			English	Article							MOLECULAR-BASIS; BCL-2 HOMOLOG; BH3 DOMAIN; APOPTOSIS; DEATH; PROTEIN; INTERACTS; INDUCE; 19K; BAX	The mechanisms underlying adenovirus-mediated autophagy are currently unknown. Recently, members of the Bcl-2 protein family have been associated with autophagy. It was also reported that the Bcl-2 homology-3 (BH3) domain encompassed by both Beclin 1 and Bcl-2-like proteins is essential for their pro-autophagy or anti-autophagy functions. Here, we report for the first time that E1B19K, the adenovirus BH3 domain protein, interacts with Beclin 1 to initiate autophagy. Using immunoprecipitation assays we showed that expression of E1B19K in the host cell disrupted the physical interactions between Beclin 1 and Bcl-2 proteins. The displacement of Bcl-2 was coincident with the recruitment of PI3KC3 to the Beclin 1/E1B19K complexes. As a result of the changes in the components of the Beclin 1 interactome, there was activation of PI3KC3, as showed by the identification of PI3K-mediated lipid phosphorylation, and subsequent formation of autophagosomes. Importantly, the BH3 functional domain of E1B19K protein was required for the heterodimerization with Beclin 1. We also showed that transfer of E1B19K was sufficient to trigger autophagy in cancer cells. Consistent with these data, mutant adenoviruses encompassing a deletion of the E1B19K gene produced a marked deficiency in the capability of the virus to induce autophagy as showed by examining the lipidation and cleavage of LC3-I as well as the subcellular localization of LC3-II, the decrease in the levels of p62, and the formation of autophagosomes. Our work offers new information on the mechanisms of action of the adenoviral E1B19K protein as partner of Beclin 1 and positive regulator of autophagy.	[Piya, Sujan; White, Erin J.; Klein, Sarah R.; Jiang, Hong; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [McDonnell, Timothy J.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Piya, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	cmanzano@mdanderson.org; jfueyo@mdanderson.org		Gomez-Manzano, Candelaria/0000-0002-1259-2133; Fueyo, Juan/0000-0001-6941-2335	National Institutes of Health [P50CA127001]; National Institutes of Health (Cancer Center) [CA016672]; National Brain Tumor Society; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Cancer Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (P50CA127001 and the Cancer Center Support Grant CA016672) and the National Brain Tumor Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SK, 2008, ONCOGENE, V27, P3081, DOI 10.1038/sj.onc.1210977; BOYD JM, 1995, ONCOGENE, V11, P1921; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Han J, 1996, MOL CELL BIOL, V16, P5857; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Han JH, 1998, ONCOGENE, V17, P2993, DOI 10.1038/sj.onc.1202215; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, CANC RES, V70, P7882; Jiang H, 2011, J VIROL; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rodriguez-Rocha H, 2011, VIROLOGY, V416, P9, DOI 10.1016/j.virol.2011.04.017; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tyler MA, 2009, AUTOPHAGY, V5, P856, DOI 10.4161/auto.8792; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	34	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29467	10.1371/journal.pone.0029467	http://dx.doi.org/10.1371/journal.pone.0029467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242123	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000037
J	Wang, J; Ray, PS; Sim, MS; Zhou, XZ; Lu, KP; Lee, AV; Lin, X; Bagaria, SP; Giuliano, AE; Cui, X				Wang, J.; Ray, P. S.; Sim, M-S; Zhou, X. Z.; Lu, K. P.; Lee, A. V.; Lin, X.; Bagaria, S. P.; Giuliano, A. E.; Cui, X.			FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-kappa B signaling	ONCOGENE			English	Article						basal-like breast cancer; FOXC1; NF-kappa B; p65/RelA; Pin1; protein stability	FORKHEAD/WINGED-HELIX GENE; CONSTITUTIVE ACTIVATION; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; EXPRESSION; TUMORS; SUBTYPES; PROGRESSION; CARCINOMAS; PHENOTYPE	Human basal-like breast cancer (BLBC) is an enigmatic and aggressive malignancy with a poor prognosis. There is an urgent need to identify therapeutic targets for BLBC, because current treatment modalities are limited and not effective. The forkhead box transcription factor FOXC1 has recently been identified as a critical functional biomarker for BLBC. However, how it orchestrates BLBC cells was not clear. Here we show that FOXC1 activates the transcription factor nuclear factor-kappa B (NF-kappa B) in BLBC cells by increasing p65/RelA protein stability. High NF-kappa B activity has been associated with estrogen receptor-negative breast cancer, particularly BLBC. The effect of FOXC1 on p65/RelA protein stability is mediated by increased expression of Pin1, a peptidyl-prolyl isomerase. FOXC1 requires NF-kappa B for its regulation of cell proliferation, migration and invasion. Notably, FOXC1 overexpression renders breast cancer cells more susceptible to pharmacological inhibition of NF-kappa B. These results suggest that BLBC cells may rely on FOXC1-driven NF-kappa B signaling. Interventions of this pathway may provide modalities for the treatment of BLBC.	[Cui, X.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Womens Canc Program, Samuel Oschin Comprehens Canc Inst,Dept Surg, Los Angeles, CA 90048 USA; [Wang, J.; Cui, X.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Ray, P. S.; Bagaria, S. P.; Giuliano, A. E.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Surg Oncol, Santa Monica, CA USA; [Sim, M-S] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Biostat, Santa Monica, CA USA; [Zhou, X. Z.; Lu, K. P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Biol Program,Dept Med, Boston, MA 02215 USA; [Lee, A. V.] Univ Pittsburgh, Inst Canc, Womens Canc Res Ctr, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Lin, X.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Cedars Sinai Medical Center; John Wayne Cancer Institute; John Wayne Cancer Institute; John Wayne Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Cui, X (corresponding author), Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Womens Canc Program, Samuel Oschin Comprehens Canc Inst,Dept Surg, 8635 W 3rd St,Suite 290W, Los Angeles, CA 90048 USA.	Xiaojiang.cui@cshs.org		Lee, Adrian/0000-0001-9917-514X	National Institutes of Health [CA151610]; QVC and the Fashion Footwear Association of New York Charitable Foundation; Associates for Breast & Prostate Cancer Studies; Avon Foundation [02-2010-068]; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QVC and the Fashion Footwear Association of New York Charitable Foundation; Associates for Breast & Prostate Cancer Studies; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Yixian Zheng for the HA-ubiquitin plasmid, Fred Miller for 4T1 breast cancer cells, Inder M Verma for IKK double-knockout MEFs, Amer A Beg for p65-null MEFs, and Dave Hoon and Myles Cabot for technical support. This work was supported by National Institutes of Health (CA151610), QVC and the Fashion Footwear Association of New York Charitable Foundation, Associates for Breast & Prostate Cancer Studies, and the Avon Foundation (02-2010-068) to XC.	Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; DAIRKEE SH, 1988, J NATL CANCER I, V80, P691, DOI 10.1093/jnci/80.9.691; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Gershtein ES, 2010, B EXP BIOL MED+, V150, P71, DOI 10.1007/s10517-010-1072-3; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Moulder SL, 2010, CLIN BREAST CANCER, V10, pS66, DOI 10.3816/CBC.2010.s.014; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Peng SL, 2005, CELL DEATH DIFFER, V12, P699, DOI 10.1038/sj.cdd.4401640; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Rexer BN, 2009, CLIN CANCER RES, V15, P4518, DOI 10.1158/1078-0432.CCR-09-0872; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Seewaldt VL, 2007, NEW ENGL J MED, V356, pE12, DOI 10.1056/NEJMicm063760; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; WETZELS RHW, 1989, AM J PATHOL, V134, P571; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x	32	74	80	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	45					4798	4802		10.1038/onc.2011.635	http://dx.doi.org/10.1038/onc.2011.635			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22249250	Green Accepted			2022-12-25	WOS:000311033000008
J	Yamadori, T; Ishii, Y; Homma, S; Morishima, Y; Kurishima, K; Itoh, K; Yamamoto, M; Minami, Y; Noguchi, M; Hizawa, N				Yamadori, T.; Ishii, Y.; Homma, S.; Morishima, Y.; Kurishima, K.; Itoh, K.; Yamamoto, M.; Minami, Y.; Noguchi, M.; Hizawa, N.			Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers	ONCOGENE			English	Article						Nrf2; Keap1; EGFR; cell proliferation; oxidative stress	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; OXIDATIVE STRESS; GEFITINIB; KEAP1; NRF2; MUTATIONS; PATHWAY; GENE	We previously demonstrated that the transcription factor NF-E2-related factor2 (Nrf2), expressed abundantly in non-small-cell lung cancer (NSCLC) cells, plays a pivotal role in the proliferation and chemoresistance of NSCLC. Here we show that Nrf2-mediated NSCLC cell proliferation is dually regulated by epidermal growth factor receptor (EGFR) signaling and an Nrf2 repressor protein Keap1 (Kelch-like ECH-associated protein-1). NSCLC cells expressing wild-type EGFR and Keap1 genes show enhanced proliferation on stimulation with EGFR ligand under non-stress conditions. Exposure to cigarette smoke extract (CSE) enhanced cell proliferation by modification of the Nrf2/Keap1 interaction. Although EGFR-tyrosine kinase inhibitor (TKI) inhibited the proliferation of these cells, exposure to CSE attenuated its efficacy. In NSCLC cells with Keap1 gene mutations, Nrf2 was constitutively activated owing to dysfunction of Keap1 and cells proliferated independently of EGFR signaling. Furthermore, EGFR-TKI was unable to inhibit their proliferation. In NSCLC cells with EGFR gene mutations, Nrf2 was constitutively activated by EGFR signaling. In these cells, proliferation was largely dependent on the EGFR signaling pathway. Although these cells were highly sensitive to EGFR-TKI, exposure to CSE or knockdown of Keap1 mRNA reduced sensitivity to EGFR-TKI. We found a case of NSCLC showing resistance to EGFR-TKI despite having EGFR-TKI-sensitive EGFR gene mutation because of dysfunctional mutation in Keap1 gene. Results indicate that oxidative stress reduces the anticancer effects of EGFR-TKI in wild-type Keap1 NSCLC cells. Analysis of Keap1 dysfunction may become a novel molecular marker to predict resistance to EGFR-TKI in NSCLC cells having EGFR-TKI-sensitive EGFR mutations. Finally, as the downstream molecule of both EGFR and Keap1 signaling, Nrf2 is an important molecular target for the treatment of NSCLC, where cells have mutations in EGFR, KRAS or Keap1 genes.	[Yamadori, T.; Ishii, Y.; Homma, S.; Morishima, Y.; Kurishima, K.; Hizawa, N.] Univ Tsukuba, Inst Clin Med, Dept Resp Med, Tsukuba, Ibaraki 305, Japan; [Itoh, K.] Hirosaki Univ, Sch Med, Ctr Adv Med Res, Hirosaki, Aomori 036, Japan; [Yamamoto, M.] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Minami, Y.; Noguchi, M.] Univ Tsukuba, Dept Pathol, Tsukuba, Ibaraki 305, Japan	University of Tsukuba; Hirosaki University; Tohoku University; University of Tsukuba	Ishii, Y (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Resp Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305, Japan.	ishii-y@md.tsukuba.ac.jp	Itoh, Ken/B-9506-2013; Yamamoto, Masayuki/A-4873-2010	Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436	Smoking Research Foundation	Smoking Research Foundation	This work was partially supported by a grant from the Smoking Research Foundation.	De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Huber RM, 2004, LUNG CANCER, V45, pS209, DOI 10.1016/j.lungcan.2004.07.973; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Janmaat ML, 2006, INT J CANCER, V118, P209, DOI 10.1002/ijc.21290; Kim KC, 2010, INT J BIOCHEM CELL B, V42, P297, DOI 10.1016/j.biocel.2009.11.009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kreuzer KA, 2003, ANN HEMATOL, V82, P284, DOI 10.1007/s00277-003-0644-y; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Muscarella LA, 2011, EPIGENETICS-US, V6, P710, DOI 10.4161/epi.6.6.15773; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Sakai K, 2006, FASEB J, V20, P311, DOI 10.1096/fj.05-4034fje; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Xu Y, 2010, CANCER BIOL THER, V9, P572, DOI 10.4161/cbt.9.8.11881; Yageta Y, 2011, J VIROL, V85, P4679, DOI 10.1128/JVI.02456-10; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	33	121	129	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	45					4768	4777		10.1038/onc.2011.628	http://dx.doi.org/10.1038/onc.2011.628			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22249257				2022-12-25	WOS:000311033000005
J	Kim, K; Jeong, KW; Kim, H; Choi, J; Lu, W; Stallcup, MR; An, W				Kim, K.; Jeong, K. W.; Kim, H.; Choi, J.; Lu, W.; Stallcup, M. R.; An, W.			Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription	ONCOGENE			English	Article						H1.2; p53; acetylation; phosphorylation; DNA-PK; transcription	LINKER HISTONE H1; C-TERMINAL DOMAIN; IN-VITRO; CHROMATIN-STRUCTURE; DNA-BINDING; RECRUITMENT; ACTIVATION; MOBILITY; FAMILY; VIVO	Linker histone H1.2 has been shown to suppress p53-dependent transcription through the modulation of chromatin remodeling; however, little is known about the mechanisms governing the antagonistic effects of H1.2 in DNA damage response. Here, we show that the repressive action of H1.2 on p53 function is negatively regulated via acetylation of p53 C-terminal regulatory domain and phosphorylation of H1.2 C-terminal tail. p53 acetylation by p300 impairs the interaction of p53 with H1.2 and triggers a rapid activation of p53-dependent transcription. Similarly, DNA-PK-mediated phosphorylation of H1.2 at T146 enhances p53 transcriptional activity by impeding H1.2 binding to p53 and thereby attenuating its suppressive effects on p53 transactivation. Consistent with these findings, point mutations mimicking modification states of H1.2 and p53 lead to a significant increase in p53-induced apoptosis. These data suggest that p53 acetylation-H1.2 phosphorylation cascade serves as a unique mechanism for triggering p53-dependent DNA damage response pathways. Oncogene (2012) 31, 4290-4301; doi:10.1038/onc.2011.605; published online 16 January 2012	[Kim, K.; Jeong, K. W.; Kim, H.; Choi, J.; Lu, W.; Stallcup, M. R.; An, W.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90089 USA; [Kim, K.; Jeong, K. W.; Kim, H.; Choi, J.; Stallcup, M. R.; An, W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA; [Lu, W.] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	An, W (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90089 USA.	woojinan@usc.edu			ACS RSG [DMC-1005001];  [NIH-R01GM84209];  [NIH-RO1DK04393]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084209] Funding Source: NIH RePORTER	ACS RSG(American Cancer Society); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Michael Lieber for DNA-PK and Daniela Rhodes for p601-7. This research was supported by NIH-R01GM84209 (WA), ACS RSG DMC-1005001 (WA) and NIH-RO1DK04393 (MRS).	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Caterino TL, 2011, BIOCHEM CELL BIOL, V89, P35, DOI 10.1139/O10-024; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Georgel PT, 2001, BIOCHEM CELL BIOL, V79, P313, DOI 10.1139/bcb-79-3-313; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lennox RW, 1984, H1 SUBTYPES MAMMALS; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Ma YM, 2006, METHOD ENZYMOL, V408, P502, DOI 10.1016/S0076-6879(06)08031-1; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vila R, 2000, PROTEIN SCI, V9, P627; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	35	35	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	39					4290	4301		10.1038/onc.2011.605	http://dx.doi.org/10.1038/onc.2011.605			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22249259	Green Accepted			2022-12-25	WOS:000309520200004
J	Jahnke, M; Trowsdale, J; Kelly, AP				Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.			Ubiquitination of Human Leukocyte Antigen (HLA)-DM by Different Membrane-associated RING-CH (MARCH) Protein Family E3 Ligases Targets Different Endocytic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HLA-DR; INVARIANT CHAIN; DENDRITIC CELLS; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; RAPID INTERNALIZATION; DOWN-REGULATION; AMINO-ACIDS; IN-VIVO	HLA-DMplays an essential role in the peptide loading of classical class II molecules and is present both at the cell surface and in late endosomal peptide-loading compartments. Trafficking of DM within antigen-presenting cells is complex and is, in part, controlled by a tyrosine-based targeting signal present in the cytoplasmic tail of DM beta. Here, we show that DM also undergoes post-translational modification through ubiquitination of a single lysine residue present in the cytoplasmic tail of the alpha chain, DM alpha. Ubiquitination of DM by MARCH1 and MARCH9 induced loss of DM molecules from the cell surface by a mechanism that cumulatively involved both direct attachment of ubiquitin chains to DM alpha and a functional tyrosine-based signal on DM beta. In contrast, MARCH8-induced loss of surface DM was entirely dependent upon the tyrosine signal on DM beta. In the absence of this tyrosine residue, levels of DM remained unchanged irrespective of whether DM alpha was ubiquitinated by MARCH8. The influence of MARCH8 was indirect and may have resulted from modification of components of the endocytic machinery by ubiquitination.	[Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Kelly, AP (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	apk23@mole.bio.cam.ac.uk			Wellcome Trust; Medical Research Council; National Institute of Health Research Cambridge Biomedical Research Centre; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the Medical Research Council, and the National Institute of Health Research Cambridge Biomedical Research Centre.	AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BREMNES B, 1994, J CELL SCI, V107, P2021; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Copier J, 1996, J IMMUNOL, V157, P1017; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Gauvreau ME, 2009, TRAFFIC, V10, P1518, DOI 10.1111/j.1600-0854.2009.00948.x; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hammond C, 1998, J IMMUNOL, V161, P3282; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2010, MOL CELLS, V29, P229, DOI 10.1007/s10059-010-0051-x; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; PIETERS J, 1993, J CELL SCI, V106, P831; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SOSA MA, 1993, J BIOL CHEM, V268, P12537; ten Broeke T, 2010, TRAFFIC, V11, P324, DOI 10.1111/j.1600-0854.2009.01024.x; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Walter RB, 2008, TRAFFIC, V9, P267, DOI 10.1111/j.1600-0854.2007.00682.x; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7256	7264		10.1074/jbc.M111.305961	http://dx.doi.org/10.1074/jbc.M111.305961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247549	hybrid, Green Published			2022-12-25	WOS:000301060200028
J	Araujo, GD; Fonseca, FL; Pontes, B; Torres, A; Cordero, RJB; Zancope-Oliveira, RM; Casadevall, A; Viana, NB; Nimrichter, L; Rodrigues, ML; Garcia, ES; de Souza, W; Frases, S				Araujo, Glauber de S.; Fonseca, Fernanda L.; Pontes, Bruno; Torres, Andre; Cordero, Radames J. B.; Zancope-Oliveira, Rosely M.; Casadevall, Arturo; Viana, Nathan B.; Nimrichter, Leonardo; Rodrigues, Marcio L.; Garcia, Eloi S.; de Souza, Wanderley; Frases, Susana			Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells	PLOS ONE			English	Article							NEOFORMANS; POLYSACCHARIDE; VIRULENCE; ALBIDUS; GLUCURONOXYLOMANNAN; ENLARGEMENT; ANTIGENS; SUGGEST; STRAINS; BINDING	Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly pathogenic species Cryptococcus neoformans and Cryptococcus gattii. Although the lack of virulence of many species of the Cryptococcus genus can be explained solely by the lack of mammalian thermotolerance, it is uncertain whether the capsules from these organisms are comparable to those of the pathogenic cryptococci. In this study, we compared the characteristic of the capsule from the non-pathogenic environmental yeast Cryptococcus liquefaciens with that of C. neoformans. Microscopic observations revealed that C. liquefaciens has a capsule visible in India ink preparations that was also efficiently labeled by three antibodies generated to specific C. neoformans capsular antigens. Capsular polysaccharides of C. liquefaciens were incorporated onto the cell surface of acapsular C. neoformans mutant cells. Polysaccharide composition determinations in combination with confocal microscopy revealed that C. liquefaciens capsule consisted of mannose, xylose, glucose, glucuronic acid, galactose and N-acetylglucosamine. Physical chemical analysis of the C. liquefaciens polysaccharides in comparison with C. neoformans samples revealed significant differences in viscosity, elastic properties and macromolecular structure parameters of polysaccharide solutions such as rigidity, effective diameter, zeta potential and molecular mass, which nevertheless appeared to be characteristics of linear polysaccharides that also comprise capsular polysaccharide of C. neoformans. The environmental yeast, however, showed enhanced susceptibility to the antimicrobial activity of the environmental phagocytes, suggesting that the C. liquefaciens capsular components are insufficient in protecting yeast cells against killing by amoeba. These results suggest that capsular structures in pathogenic Cryptococcus species and environmental species share similar features, but also manifest significant difference that could influence their potential to virulence.	[Araujo, Glauber de S.; Garcia, Eloi S.; de Souza, Wanderley; Frases, Susana] Inst Nacl Metrol Normalizacao & Qualidade Ind, Lab Biotecnol, Rio De Janeiro, Brazil; [Fonseca, Fernanda L.; Nimrichter, Leonardo; Rodrigues, Marcio L.] Univ Fed Rio de Janeiro, Lab Estudos Integrados Bioquim Microbiana, Inst Microbiol Prof Paulo Goes, Rio De Janeiro, Brazil; [Pontes, Bruno; Viana, Nathan B.] Univ Fed Rio de Janeiro, LPO COPEA, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil; [Torres, Andre; Zancope-Oliveira, Rosely M.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Cordero, Radames J. B.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Viana, Nathan B.] Univ Fed Rio de Janeiro, Inst Fis, Caixa, Brazil; [Garcia, Eloi S.] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Araujo, Glauber de S.; de Souza, Wanderley; Frases, Susana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Yeshiva University; Albert Einstein College of Medicine; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Araujo, GD (corresponding author), Inst Nacl Metrol Normalizacao & Qualidade Ind, Lab Biotecnol, Rio De Janeiro, Brazil.	susanafrases@biof.ufrj.br	Fonseca, Fernanda/V-3446-2019; Nimrichter, Leonardo/L-3545-2014; Pontes, Bruno/L-5121-2015; FONSECA, FERNANDA/HDN-9451-2022; Cordero, Radamés JB/F-6912-2011; de Sousa Araújo, Glauber Ribeiro/AAT-5085-2021; Rodrigues, Marcio/J-3727-2013; Frases, Susana/W-9502-2019; Complexos, INCT Fluidos/H-9172-2013; Viana, Nathan/AAH-5868-2021; Torres, André Q/E-3938-2017	Nimrichter, Leonardo/0000-0001-9281-6856; FONSECA, FERNANDA/0000-0002-0315-6479; Cordero, Radamés JB/0000-0002-3026-7094; de Sousa Araújo, Glauber Ribeiro/0000-0002-5478-9006; Rodrigues, Marcio/0000-0002-6081-3439; Frases, Susana/0000-0001-5875-9886; Viana, Nathan/0000-0002-2528-0876; Torres, André Q/0000-0001-5041-4146	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil); National Institutes of Health [AI033142, AI033774, AI052733, HL059842]; Department of Energy Center for Plant and Microbial Complex Carbohydrates [DE-FG-9-93ER-20097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, R01AI052733, R37AI033142] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Center for Plant and Microbial Complex Carbohydrates(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil). AC is supported by National Institutes of Health grants AI033142, AI033774, AI052733, and HL059842. Carbohydrate analyses were performed at the Complex Carbohydrate Research Center, University of Georgia (Atlanta), which is supported in part by the Department of Energy-funded (DE-FG-9-93ER-20097) Center for Plant and Microbial Complex Carbohydrates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon BE, 1996, CARBOHYD RES, V283, P95, DOI 10.1016/0008-6215(95)00397-5; Bergman A, 2010, MBIO, V1, DOI 10.1128/mBio.00212-10; BOLANOS B, 1989, J MED VET MYCOL, V27, P203; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Burnik C, 2007, MED MYCOL, V45, P469, DOI 10.1080/13693780701386015; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Chrisman CJ, 2010, APPL ENV MICROBIOL; Cordero RJB, 2011, MOL MICROBIOL, V79, P1101, DOI 10.1111/j.1365-2958.2010.07511.x; de Castro LEF, 2005, CORNEA, V24, P882, DOI 10.1097/01.ico.0000157404.34774.1a; Doering TL, 2000, TRENDS MICROBIOL, V8, P547, DOI 10.1016/S0966-842X(00)01890-4; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Fonseca FL, 2010, INFECT IMMUN, V78, P3861, DOI 10.1128/IAI.00111-10; Fonseca FL, 2009, EUKARYOT CELL, V8, P1543, DOI 10.1128/EC.00142-09; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Frases S, 2009, BIOPHYS J, V97, P937, DOI 10.1016/j.bpj.2009.04.043; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Garcia-Solache MA, 2010, MBIO, V1, DOI 10.1128/mBio.00061-10; Garelick JM, 2004, CORNEA, V23, P730, DOI 10.1097/01.ico.0000126322.13143.7b; Johnson LB, 1998, MYCOSES, V41, P277, DOI 10.1111/j.1439-0507.1998.tb00338.x; Khawcharoenporn T, 2007, INFECTION, V35, P51, DOI 10.1007/s15010-007-6142-8; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; Levitz S M, 1994, Immunol Ser, V60, P533; Martins-Sousa RL, 2001, MEM I OSWALDO CRUZ, V96, P391, DOI 10.1590/S0074-02762001000300019; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; McFadden D, 2006, TRENDS MICROBIOL, V14, P497, DOI 10.1016/j.tim.2006.09.003; McFadden DC, 2007, EUKARYOT CELL, V6, P1464, DOI 10.1128/EC.00162-07; MELCHER GP, 1991, J CLIN MICROBIOL, V29, P192, DOI 10.1128/JCM.29.1.192-196.1991; MURPHY JW, 1972, INFECT IMMUN, V5, P896, DOI 10.1128/IAI.5.6.896-901.1972; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nakouzi A, 2001, INFECT IMMUN, V69, P3398, DOI 10.1128/IAI.69.5.3398-3409.2001; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Petter R, 2001, MICROBIOL-SGM, V147, P2029, DOI 10.1099/00221287-147-8-2029; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2008, EUKARYOT CELL, V7, P602, DOI 10.1128/EC.00307-07; Rodrigues ML, 2009, MED MYCOL       0403, P1, DOI DOI 10.1080/13693780902788621; SMALL JM, 1986, INFECT IMMUN, V54, P742, DOI 10.1128/IAI.54.3.742-750.1986; Steenbergen JN, 2003, INFECT IMMUN, V71, P4862, DOI 10.1128/IAI.71.9.4862-4872.2003; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Trost A, 2004, J MICROBIOL METH, V56, P201, DOI 10.1016/j.mimet.2003.10.007; VECCHIARELLI A, 1995, INFECT IMMUN, V63, P2919, DOI 10.1128/IAI.63.8.2919-2923.1995; Viana NB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021914; WOODS JP, 1993, J CLIN MICROBIOL, V31, P463, DOI 10.1128/JCM.31.2.463-464.1993; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x; Zaragoza O, 2007, INFECT IMMUN, V75, P2729, DOI 10.1128/IAI.00094-07; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zerpa R, 1996, J CLIN MICROBIOL, V34, P2290, DOI 10.1128/JCM.34.9.2290-2291.1996	51	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29561	10.1371/journal.pone.0029561	http://dx.doi.org/10.1371/journal.pone.0029561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253734	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100014
J	Grynberg, P; Passos-Silva, DG; Mourao, MD; Hirata, R; Macedo, AM; Machado, CR; Bartholomeu, DC; Franco, GR				Grynberg, Priscila; Passos-Silva, Danielle Gomes; Mourao, Marina de Moraes; Hirata, Roberto, Jr.; Macedo, Andrea Mara; Machado, Carlos Renato; Bartholomeu, Daniella Castanheira; Franco, Gloria Regina			Trypanosoma cruzi Gene Expression in Response to Gamma Radiation	PLOS ONE			English	Article							IONIZING-RADIATION; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; LIFE-CYCLE; TRANSCRIPTOME; RECOMBINATION; REVEALS; BRUCEI; GENOME; SINGLE	Trypanosoma cruzi is an organism highly resistant to ionizing radiation. Following a dose of 500 Gy of gamma radiation, the fragmented genomic DNA is gradually reconstructed and the pattern of chromosomal bands is restored in less than 48 hours. Cell growth arrests after irradiation but, while DNA is completely fragmented, RNA maintains its integrity. In this work we compared the transcriptional profiles of irradiated and non-irradiated epimastigotes at different time points after irradiation using microarray. In total, 273 genes were differentially expressed; from these, 160 were up-regulated and 113 down-regulated. We found that genes with predicted functions are the most prevalent in the down-regulated gene category. Translation and protein metabolic processes, as well as generation of precursor of metabolites and energy pathways were affected. In contrast, the up-regulated category was mainly composed of obsolete sequences (which included some genes of the kinetoplast DNA), genes coding for hypothetical proteins, and Retrotransposon Hot Spot genes. Finally, the tyrosyl-DNA phosphodiesterase 1, a gene involved in double-strand DNA break repair process, was up-regulated. Our study demonstrated the peculiar response to ionizing radiation, raising questions about how this organism changes its gene expression to manage such a harmful stress.	[Grynberg, Priscila; Passos-Silva, Danielle Gomes; Macedo, Andrea Mara; Machado, Carlos Renato; Franco, Gloria Regina] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Bartholomeu, Daniella Castanheira] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Mourao, Marina de Moraes] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Genom & Biol Computac, Belo Horizonte, MG, Brazil; [Mourao, Marina de Moraes] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Inst Nacl Ciencia & Tecnol Doencas Tropicais, Belo Horizonte, MG, Brazil; [Hirata, Roberto, Jr.] Univ Sao Paulo, Inst Matemat & Estat, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Grynberg, P (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	gfranco@icb.ufmg.br	Grynberg, Priscila/AAX-3019-2020; Bartholomeu, Daniella C./J-4714-2015; MACHADO, CARLOS/AAW-1492-2020; Franco, Glória/I-3654-2013; Hirata, Roberto/E-4436-2011; Machado, Carlos Renato/H-1043-2015; Macedo, Andréa M/C-1506-2013; Mourao, Marina M/B-9314-2014	Grynberg, Priscila/0000-0003-4009-9538; Bartholomeu, Daniella C./0000-0003-0974-7357; Franco, Glória/0000-0001-5245-2365; Hirata, Roberto/0000-0003-3861-7260; Machado, Carlos Renato/0000-0002-8724-3165; Mourao, Marina M/0000-0003-1348-5521	CNPq [476782/2007-4]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq Grant Process number 476782/2007-4 (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai DJ, 2004, J EUKARYOT MICROBIOL, V51, P23, DOI 10.1111/j.1550-7408.2004.tb00157.x; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Banerjee B, 2010, MOL MICROBIOL, V78, P119, DOI 10.1111/j.1365-2958.2010.07318.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; Caillet S, 2008, J APPL MICROBIOL, V105, P1384, DOI 10.1111/j.1365-2672.2008.03891.x; Calini V, 2003, TOXICOL IN VITRO, V17, P561, DOI 10.1016/S0887-2333(03)00116-4; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; DOCAMPO R, 1990, CHEM-BIOL INTERACT, V73, P1, DOI 10.1016/0009-2797(90)90106-W; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ender, 2010, COLLIN ADO COLLINEAR; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Fitzgerald MP, 2010, RADIAT RES, V174, P290, DOI 10.1667/RR2235.1; Geoghegan DS, 2001, EXP PARASITOL, V99, P108, DOI 10.1006/expr.2001.4649; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Gong BD, 1998, RADIAT RES, V150, P505, DOI 10.2307/3579866; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Horn D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-2; Jiang CZ, 1997, GENETICS, V147, P1401; KAPPAGODA CT, 1979, J PHYSIOL-LONDON, V291, P381, DOI 10.1113/jphysiol.1979.sp012820; Kimura S, 2006, BIOCHEM BIOPH RES CO, V346, P51, DOI 10.1016/j.bbrc.2006.05.126; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Krauth-Siegel RL, 1998, BIOCHEMISTRY-US, V37, P13968, DOI 10.1021/bi980637j; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minning TA, 2003, MOL BIOCHEM PARASIT, V131, P55, DOI 10.1016/S0166-6851(03)00189-0; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; NOGAMI M, 1993, INT J RADIAT BIOL, V63, P775, DOI 10.1080/09553009314552181; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Regis-Da-Silva CG, 2006, MOL BIOCHEM PARASIT, V149, P191, DOI 10.1016/j.molbiopara.2006.05.012; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sacerdot C, 2005, YEAST, V22, P441, DOI 10.1002/yea.1222; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saxena A, 2003, MOL BIOCHEM PARASIT, V129, P103, DOI 10.1016/S0166-6851(03)00100-2; Seo Min, 1993, Korean Journal of Parasitology, V31, P277, DOI 10.3347/kjp.1993.31.3.277; SIMPSON L, 1987, J BIOL CHEM, V262, P6182; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Springer AL, 2011, MOL BIOCHEM PARASIT, V175, P68, DOI 10.1016/j.molbiopara.2010.09.005; Tachiiri S, 2006, INT J RADIAT ONCOL, V64, P272, DOI 10.1016/j.ijrobp.2005.08.030; TAKEDA GKF, 1986, REV INST MED TROP SP, V28, P15, DOI 10.1590/S0036-46651986000100004; Tan KSW, 2002, MOL BIOCHEM PARASIT, V125, P11, DOI 10.1016/S0166-6851(02)00165-2; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Teixeira Santuza M.R., 2003, Genetics and Molecular Research, V2, pUnpaginated; Waisberg M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-181; Wang JB, 2002, BIOINFORMATICS, V18, P1139, DOI 10.1093/bioinformatics/18.8.1139; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; Yang FD, 1996, GENE, V178, P63, DOI 10.1016/0378-1119(96)00335-6; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766	57	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29596	10.1371/journal.pone.0029596	http://dx.doi.org/10.1371/journal.pone.0029596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247781	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700029
J	Harmon, EY; Fronhofer, V; Keller, RS; Feustel, PJ; Brosnan, MJ; von der Thusen, JH; Loegering, DJ; Lennartz, MR				Harmon, Erin Y.; Fronhofer, Van; Keller, Rebecca S.; Feustel, Paul J.; Brosnan, M. Julia; von der Thusen, Jan H.; Loegering, Daniel J.; Lennartz, Michelle R.			Ultrasound Biomicroscopy for Longitudinal Studies of Carotid Plaque Development in Mice: Validation with Histological Endpoints	PLOS ONE			English	Article							APOLIPOPROTEIN E-DEFICIENT; E KNOCKOUT MICE; SHEAR-STRESS; ATHEROSCLEROTIC LESIONS; INFLAMMATION; MOUSE	Atherosclerosis is responsible for the death of thousands of Americans each year. The carotid constriction model of plaque development has recently been presented as a model for unstable plaque formation in mice. In this study we 1) validate ultrasound biomicroscopy (UBM) for the determination of carotid plaque size, percent stenosis, and plaque development in live animals, 2) determine the sensitivity of UBM in detecting changes in blood flow induced by carotid constriction and 3) test whether plaque formation can be predicted from blood flow parameters measured by UBM. Carotid plaques were induced by surgical constriction in Apo E-/- mice. Arteries were imaged bi-weekly by UBM, at which time PW-Doppler measurements of proximal blood flow, as well as plaque length and percent stenosis were determined. Histology was performed 9 weeks post surgery. When compared to whole mount post-mortem measurements, UBM accurately reported carotid plaque length. Percent stenosis, based on transverse B-mode UBM measurements, correlated well with that calculated from histological sections. PW-Doppler revealed that constriction reduced maximum systolic velocity (v(max)) and duration of the systolic velocity peak (t(s)/t(t)). Pre-plaque (2 week post-surgery) PW-Doppler parameters (v(max) and t(s)/t(t)) were correlated with plaque length at 9 weeks, and were predictive of plaque formation. Correlation of initiating PW-Doppler parameters (v(max) and t(s)/t(t)) with resulting plaque length established the degree of flow disturbance required for subsequent plaque development and demonstrated its power for predicting plaque development.	[Harmon, Erin Y.; Fronhofer, Van; Lennartz, Michelle R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Keller, Rebecca S.; Loegering, Daniel J.; Lennartz, Michelle R.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Feustel, Paul J.] Ordway Res Inst, Ctr Neuropharmacol & Neurosci, Albany, NY USA; [Brosnan, M. Julia] Ordway Res Inst, Ctr Metab Dis, Albany, NY USA; [von der Thusen, Jan H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	Albany Medical College; Albany Medical College; Ordway Research Institute; Ordway Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Lennartz, MR (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	lennarm@mail.amc.edu	Feustel, Paul/AAW-5157-2021	Feustel, Paul/0000-0002-6963-4349; von der Thusen, Jan/0000-0001-9699-4860	National Institutes of Health [HL089730, HL095971, GM090325]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089730, R21HL095971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health HL089730, HL095971, and GM090325 (MRL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Ding SF, 2010, AM J PHYSIOL-HEART C, V298, pH2121, DOI 10.1152/ajpheart.00308.2009; Ford JC, 2001, CARDIOVASC PATHOL, V10, P91, DOI 10.1016/S1054-8807(01)00060-6; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Gronros J, 2008, AM J PHYSIOL-HEART C, V295, pH2046, DOI 10.1152/ajpheart.00133.2008; Helderman F, 2007, CURR OPIN LIPIDOL, V18, P527, DOI 10.1097/MOL.0b013e3282ef7716; Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Miao CL, 2009, J AM COLL CARDIOL, V53, P1708, DOI 10.1016/j.jacc.2008.12.063; Ni M, 2008, ATHEROSCLEROSIS, V197, P64, DOI 10.1016/j.atherosclerosis.2007.07.039; Razuvaev A, 2008, ATHEROSCLEROSIS, V199, P310, DOI 10.1016/j.atherosclerosis.2007.11.035; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SALONEN JT, 1993, CIRCULATION, V87, P56; Seo HS, 1997, ARTERIOSCL THROM VAS, V17, P3593, DOI 10.1161/01.ATV.17.12.3593; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wu DJ, 2009, ATHEROSCLEROSIS, V207, P68, DOI 10.1016/j.atherosclerosis.2009.04.025; Zwiebel WJ, 2005, INTRODUCTION TO VASC	21	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29944	10.1371/journal.pone.0029944	http://dx.doi.org/10.1371/journal.pone.0029944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242191	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100048
J	Misawa, H; Sasaki, S; Matsushita, A; Ohba, K; Iwaki, H; Matsunaga, H; Suzuki, S; Ishizuka, K; Oki, Y; Nakamura, H				Misawa, Hiroko; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Iwaki, Hiroyuki; Matsunaga, Hideyuki; Suzuki, Shingo; Ishizuka, Keiko; Oki, Yutaka; Nakamura, Hirotoshi			Liganded Thyroid Hormone Receptor Inhibits Phorbol 12-O-Tetradecanoate-13-Acetate-Induced Enhancer Activity via Firefly Luciferase cDNA	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; DEPENDENT NEGATIVE REGULATION; BETA-SUBUNIT GENE; GLUCOCORTICOID-RECEPTOR; RESPONSE ELEMENTS; ALPHA-GENE; GATA2-DEPENDENT TRANSACTIVATION; ESTROGEN-RECEPTOR; CV1 CELLS; KAPPA-B	Thyroid hormone receptor (TR) belongs to the nuclear hormone receptor (NHR) superfamily and regulates the transcription of its target genes in a thyroid hormone (T3)-dependent manner. While the detail of transcriptional activation by T3 (positive regulation) has been clarified, the mechanism of T3-dependent repression (negative regulation) remains to be determined. In addition to naturally occurring negative regulations typically found for the thyrotropin beta gene, T3-bound TR (T3/TR) is known to cause artificial negative regulation in reporter assays with cultured cells. For example, T3/TR inhibits the transcriptional activity of the reporter plasmids harboring AP-1 site derived from pUC/pBR322-related plasmid (pUC/AP-1). Artificial negative regulation has also been suggested in the reporter assay with firefly luciferase (FFL) gene. However, identification of the DNA sequence of the FFL gene using deletion analysis was not performed because negative regulation was evaluated by measuring the enzymatic activity of FFL protein. Thus, there remains the possibility that the inhibition by T3 is mediated via a DNA sequence other than FFL cDNA, for instance, pUC/AP-1 site in plasmid backbone. To investigate the function of FFL cDNA as a transcriptional regulatory sequence, we generated pBL-FFL-CAT5 by ligating FFL cDNA in the 5' upstream region to heterologous thymidine kinase promoter in pBL-CAT5, a chloramphenicol acetyl transferase (CAT)based reporter gene, which lacks pUC/AP-1 site. In kidney-derived CV1 and choriocarcinoma-derived JEG3 cells, pBL-FFL-CAT5, but not pBL-CAT5, was strongly activated by a protein kinase C activator, phorbol 12-O-tetradecanoate-13-acetate (TPA). TPA-induced activity of pBL-FFL-CAT5 was negatively regulated by T3/TR. Mutation of nt. 626/640 in FFL cDNA attenuated the TPA-induced activation and concomitantly abolished the T3-dependent repression. Our data demonstrate that FFL cDNA sequence mediates the TPA-induced transcriptional activity, which is inhibited by T3/TR.	[Misawa, Hiroko; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Iwaki, Hiroyuki; Matsunaga, Hideyuki; Suzuki, Shingo; Ishizuka, Keiko; Oki, Yutaka; Nakamura, Hirotoshi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan	Hamamatsu University School of Medicine	Misawa, H (corresponding author), Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by a Health Sciences Research Grant to HN, and a Grant-in-Aid for Scientific Research to SS and HN from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; Annicotte JS, 2001, BIOTECHNIQUES, V31, P993; Balbas P, 1988, Biotechnology, V10, P5; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; BRENT GA, 1989, J BIOL CHEM, V264, P178; Calza L, 2000, NEUROSCIENCE, V101, P1001, DOI 10.1016/S0306-4522(00)00420-6; CARR FE, 1992, J BIOL CHEM, V267, P18689; Chan IH, 2008, THYROID, V18, P665, DOI 10.1089/thy.2008.0013; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Chin S, 1998, ENDOCRINOLOGY, V139, P3423, DOI 10.1210/en.139.8.3423; COHEN O, 1995, J BIOL CHEM, V270, P13899, DOI 10.1074/jbc.270.23.13899; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dupre SM, 2004, ENDOCRINOLOGY, V145, P2337, DOI 10.1210/en.2003-1209; Eckey M, 2003, MOL CELL ENDOCRINOL, V213, P13, DOI 10.1016/j.mce.2003.10.026; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; HALLENBECK PL, 1993, J BIOL CHEM, V268, P3825; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Ho CKM, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-10; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Kim SW, 2004, MOL ENDOCRINOL, V18, P2924, DOI 10.1210/me.2004-0255; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; Liu YY, 2008, THYROID, V18, P593, DOI 10.1089/thy.2008.0138; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MADISON LD, 1993, MOL CELL ENDOCRINOL, V94, P129, DOI 10.1016/0303-7207(93)90060-W; Maia AL, 1996, THYROID, V6, P325, DOI 10.1089/thy.1996.6.325; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; Mansen A, 2001, MOL ENDOCRINOL, V15, P2106, DOI 10.1210/me.15.12.2106; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NAGAYA T, 1992, J BIOL CHEM, V267, P13014; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; Nagayama K, 2008, J ENDOCRINOL, V199, P113, DOI 10.1677/JOE-08-0128; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Osborne SA, 2002, BIOTECHNIQUES, V33, P1240, DOI 10.2144/02336bm12; Paguio A., 2005, PROMEGA NOTES, V89, P7; PARK HY, 1993, MOL ENDOCRINOL, V7, P319, DOI 10.1210/me.7.3.319; PENNATHUR S, 1993, MOL ENDOCRINOL, V7, P797, DOI 10.1210/me.7.6.797; Pernasetti F, 1997, MOL ENDOCRINOL, V11, P986, DOI 10.1210/me.11.7.986; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; SASAKI S, 1995, MOL CELL ENDOCRINOL, V113, P109, DOI 10.1016/0303-7207(95)03621-D; Sherf BA, 1994, PROMEGA NOTES, V49, P14; Shupnik M A, 2000, Rev Endocr Metab Disord, V1, P35, DOI 10.1023/A:1010008318961; STEIN B, 1995, MOL CELL BIOL, V15, P4971; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; TILLMAN JB, 1993, MOL CELL ENDOCRINOL, V95, P101, DOI 10.1016/0303-7207(93)90034-H; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VOZ ML, 1992, MOL CELL BIOL, V12, P3991, DOI 10.1128/MCB.12.9.3991; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; Wright CE, 1999, AM J PHYSIOL-CELL PH, V276, pC883, DOI 10.1152/ajpcell.1999.276.4.C883; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARWOOD NJ, 1993, J BIOL CHEM, V268, P21984; Zhuang Y, 2001, PROMEGA NOTES, V79, P6	70	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e28916	10.1371/journal.pone.0028916	http://dx.doi.org/10.1371/journal.pone.0028916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253701	gold, Green Submitted, Green Published			2022-12-25	WOS:000301361500004
J	Rembeck, K; Alsio, A; Christensen, PB; Farkkila, M; Langeland, N; Buhl, MR; Pedersen, C; Morch, K; Westin, J; Lindh, M; Hellstrand, K; Norkrans, G; Lagging, M				Rembeck, Karolina; Alsio, Asa; Christensen, Peer Brehm; Farkkila, Martti; Langeland, Nina; Buhl, Mads Rauning; Pedersen, Court; Morch, Kristine; Westin, Johan; Lindh, Magnus; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin			Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GENETIC-VARIATION; VIRUS-INFECTION; PEGINTERFERON ALPHA-2A; TREATMENT RESPONSE; INTERLEUKIN 28B; PLUS RIBAVIRIN; VIRAL KINETICS; UP-REGULATION; IL28B	Background and Aims: Recently, several genome-wide association studies have revealed that single nucleotide polymorphisms (SNPs) in proximity to IL28B predict spontaneous clearance of HCV infection as well as outcome following peginterferon and ribavirin therapy among HCV genotype 1 infected patients. The present study aimed to evaluate the impact of IL28B SNP variability on liver histology in the context of a phase III treatment trial (NORDynamIC) for treatment-naive patients with chronic HCV genotype 2 or 3 infection, where pretreatment liver biopsies were mandatory. Methods: Three hundred and thirty-nine Caucasian patients had samples available for IL28B genotyping (rs12979860) of whom 314 had pretreatment liver biopsies that were evaluated using the Ishak protocol, allowing for detailed grading and staging of liver histopathology. Results: IL28B CCrs12979860 genotype in HCV genotype 3 infected patients was associated with higher ALT levels (p<0.0001), higher AST to platelet ratio index (APRI; p = 0.001), and higher baseline viral load (p<0.0001) as compared to patients with the CT or TT genotypes. Additionally the CCrs12979860 genotype entailed more pronounced portal inflammation (p = 0.02) and steatosis (p = 0.03). None of these associations were noted among HCV genotype 2 infected patients. Conclusion: This study shows that the CCrs12979860 SNP is associated with more pronounced liver histopathology in patients chronically infected with HCV genotype 3, which may be secondary to higher viral load. The finding that IL28B variability did not impact on liver pathology or viral load among genotype 2 infected patients implies that IL28B may differentially regulate the course of genotype 2 and 3 infection.	[Rembeck, Karolina; Alsio, Asa; Westin, Johan; Lindh, Magnus; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin] Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden; [Christensen, Peer Brehm; Pedersen, Court] Univ So Denmark, Dept Infect Dis, Odense, Denmark; [Farkkila, Martti] Univ Helsinki, Dept Gastroenterol, Helsinki, Finland; [Langeland, Nina; Morch, Kristine] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Langeland, Nina; Morch, Kristine] Univ Bergen, Inst Med, Bergen, Norway; [Buhl, Mads Rauning] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark	University of Gothenburg; University of Southern Denmark; University of Helsinki; University of Bergen; Haukeland University Hospital; University of Bergen; Aarhus University	Rembeck, K (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Christensen, Peer B./B-8042-2015; Lagging, Martin/D-7734-2015; Färkkilä, Martti/AAG-6970-2021	Lagging, Martin/0000-0002-7995-3626; Färkkilä, Martti/0000-0002-0250-8559; Christensen, Peer Brehm/0000-0003-1394-058X; Hellstrand, Kristoffer/0000-0002-6617-5976	Swedish Society of Medicine; Swedish Medical Research Council; Cancerfonden; Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; Sahlgrenska University Hospital	Swedish Society of Medicine; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancerfonden(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; Sahlgrenska University Hospital	This work was supported by the Swedish Society of Medicine, the Swedish Medical Research Council, Cancerfonden, the Torsten and Ragnar Soderberg Foundation, the Swedish Society of Microbiology, and ALF Funds at the Sahlgrenska University Hospital. Unrestricted grants from Roche affiliates in the Nordic region also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Backus LI, 2011, CLIN GASTROENTEROL H; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepatitis C-globalprevalence(update), 1999, WKLY EPIDEMIOL REC, V74, P425; Hofer H, 2002, AM J GASTROENTEROL, V97, P2880, DOI 10.1111/j.1572-0241.2002.07056.x; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	38	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29370	10.1371/journal.pone.0029370	http://dx.doi.org/10.1371/journal.pone.0029370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253715	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500009
J	Dando, SJ; Nitsos, I; Kallapur, SG; Newnham, JP; Polglase, GR; Pillow, JJ; Jobe, AH; Timms, P; Knox, CL				Dando, Samantha J.; Nitsos, Ilias; Kallapur, Suhas G.; Newnham, John P.; Polglase, Graeme R.; Pillow, J. Jane; Jobe, Alan H.; Timms, Peter; Knox, Christine L.			The Role of the Multiple Banded Antigen of Ureaplasma parvum in Intra-Amniotic Infection: Major Virulence Factor or Decoy?	PLOS ONE			English	Article							BACTERIAL-GROWTH INHIBITION; AMNIOTIC-FLUID; PHASE VARIATION; INTRAUTERINE INFECTION; MICROBIAL INVASION; PRETERM LABOR; MB ANTIGEN; UREALYTICUM; CHORIOAMNIONITIS; MIDTRIMESTER	The multiple banded antigen (MBA) is a predicted virulence factor of Ureaplasma species. Antigenic variation of the MBA is a potential mechanism by which ureaplasmas avoid immune recognition and cause chronic infections of the upper genital tract of pregnant women. We tested whether the MBA is involved in the pathogenesis of intra-amniotic infection and chorioamnionitis by injecting virulent or avirulent-derived ureaplasma clones (expressing single MBA variants) into the amniotic fluid of pregnant sheep. At 55 days of gestation pregnant ewes (n = 20) received intra-amniotic injections of virulent-derived or avirulent-derived U. parvum serovar 6 strains (2X10(4) CFU), or 10B medium (n = 5). Amniotic fluid was collected every two weeks post-infection and fetal tissues were collected at the time of surgical delivery of the fetus (140 days of gestation). Whilst chronic colonisation was established in the amniotic fluid of animals infected with avirulent-derived and virulent-derived ureaplasmas, the severity of chorioamnionitis and fetal inflammation was not different between these groups (p>0.05). MBA size variants (32-170 kDa) were generated in vivo in amniotic fluid samples from both the avirulent and virulent groups, whereas in vitro antibody selection experiments led to the emergence of MBA-negative escape variants in both strains. Anti-ureaplasma IgG antibodies were detected in the maternal serum of animals from the avirulent (40%) and virulent (55%) groups, and these antibodies correlated with increased IL-1 beta, IL-6 and IL-8 expression in chorioamnion tissue (p<0.05). We demonstrate that ureaplasmas are capable of MBA phase variation in vitro; however, ureaplasmas undergo MBA size variation in vivo, to potentially prevent eradication by the immune response. Size variation of the MBA did not correlate with the severity of chorioamnionitis. Nonetheless, the correlation between a maternal humoral response and the expression of chorioamnion cytokines is a novel finding. This host response may be important in the pathogenesis of inflammation-mediated adverse pregnancy outcomes.	[Dando, Samantha J.; Timms, Peter; Knox, Christine L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Nitsos, Ilias; Kallapur, Suhas G.; Newnham, John P.; Polglase, Graeme R.; Pillow, J. Jane; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Neonatol & Pulm Biol, Cincinnati, OH USA	Queensland University of Technology (QUT); University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Dando, SJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	c.knox@qut.edu.au	Pillow, Jane/A-3335-2009; Timms, Peter/I-9556-2012	Pillow, Jane/0000-0002-6500-0138; Knox, Christine/0000-0003-3997-6812; Polglase, Graeme/0000-0002-8906-614X; Newnham, John/0000-0001-9983-7457; Dando, Samantha/0000-0002-5119-1711; Timms, Peter/0000-0002-1682-0025	National Heart, Lung and Blood Institute [1RO1HL097064-105956]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097064] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded by the National Heart, Lung and Blood Institute Reference No. 1RO1HL097064-105956 (http://www.nhlbi.nih.gov/funding/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2007, BJOG-INT J OBSTET GY, V114, P1432, DOI 10.1111/j.1471-0528.2007.01410.x; Arntzen KJ, 1998, J PERINAT MED, V26, P17, DOI 10.1515/jpme.1998.26.1.17; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; CANNON JG, 1984, ANNU REV MICROBIOL, V38, P111; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Chang JS, 2009, VET IMMUNOL IMMUNOP, V127, P94, DOI 10.1016/j.vetimm.2008.09.026; Chapman S, 1995, Infect Dis Obstet Gynecol, V2, P210, DOI 10.1155/S1064744995000032; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Dando SJ, 2010, BIOL REPROD, V83, P616, DOI 10.1095/biolreprod.110.084954; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Egan PJ, 1996, IMMUNOLOGY, V89, P539, DOI 10.1046/j.1365-2567.1996.d01-776.x; Eidelman Arthur I, 2002, J Perinatol, V22, P467, DOI 10.1038/sj.jp.7210774; EVANS HE, 1977, OBSTET GYNECOL, V49, P35; FADEL HE, 1979, OBSTET GYNECOL, V53, P99; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Garcia-Castillo M, 2008, J ANTIMICROB CHEMOTH, V62, P1027, DOI 10.1093/jac/dkn337; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Gnanalingham MG, 2005, J PHYSIOL-LONDON, V565, P159, DOI 10.1113/jphysiol.2005.083246; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HILLIER SL, 1993, OBSTET GYNECOL, V81, P941; HOROWITZ S, 1995, J REPROD MED, V40, P375; HOROWITZ S, 1995, ACTA OBSTET GYN SCAN, V74, P132, DOI 10.3109/00016349509008922; Jacobsson B, 2005, BJOG-INT J OBSTET GY, V112, P719, DOI 10.1111/j.1471-0528.2005.00536.x; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Marconi C, 2011, AM J REPROD IN PRESS; MAZOR M, 1995, OBSTET GYNECOL, V86, P830, DOI 10.1016/0029-7844(95)00265-S; McNeilly TN, 2008, J VIROL, V82, P1526, DOI 10.1128/JVI.02148-07; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Monecke S, 2003, INT J MED MICROBIOL, V293, P203, DOI 10.1078/1438-4221-00239; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Moss TJM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.044; Peltier M, 2003, REPROD BIOL ENDOCRIN, V1, P122, DOI [10.1186/1477-7827-1-122, DOI 10.1186/1477-7827-1-122]; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polglase GR, 2010, AM J PHYSIOL-LUNG C, V299, pL232, DOI 10.1152/ajplung.00369.2009; Prestes NC, 2001, SMALL RUMINANT RES, V39, P277, DOI 10.1016/S0921-4488(00)00202-9; QUINN PA, 1986, PEDIATR INFECT DIS J, V5, pS282, DOI 10.1097/00006454-198611010-00018; Rao S, 2001, J Perinatol, V21, P537, DOI 10.1038/sj.jp.7210564; Reyes L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-9; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; ROMERO R, 1991, AM J OBSTET GYNECOL, V164, P859, DOI 10.1016/0002-9378(91)90529-Z; Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; SCHLIEVERT P, 1975, AM J OBSTET GYNECOL, V122, P809, DOI 10.1016/0002-9378(75)90719-X; SCHLIEVERT P, 1976, AM J OBSTET GYNECOL, V125, P906, DOI 10.1016/0002-9378(76)90486-5; SCHLIEVERT P, 1976, AM J OBSTET GYNECOL, V125, P899, DOI 10.1016/0002-9378(76)90485-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHEPARD MC, 1965, J BACTERIOL, V89, P265, DOI 10.1128/JB.89.2.265-270.1965; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Thomakos N, 2010, EUR J OBSTET GYN R B, V148, P147, DOI 10.1016/j.ejogrb.2009.10.027; Tully J.G., 1983, METHODS MYCOPLASMOLO, P173; Tybulewicz AT, 2004, ARCH DIS CHILD-FETAL, V89, pF328, DOI 10.1136/adc.2002.021949; Volgmann Thorsten, 2005, Archives of Gynecology and Obstetrics, V273, P133, DOI 10.1007/s00404-005-0030-1; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; WATSON HL, 1990, INFECT IMMUN, V58, P3679, DOI 10.1128/IAI.58.11.3679-3688.1990; Yoon BH, 1998, OBSTET GYNECOL, V92, P77, DOI 10.1016/S0029-7844(98)00122-7; ZHENG X, 1992, INFECT IMMUN, V60, P3472, DOI 10.1128/IAI.60.8.3472-3474.1992; ZHENG XT, 1994, ANN NY ACAD SCI, V730, P299, DOI 10.1111/j.1749-6632.1994.tb44272.x; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995; Zimmerman CUR, 2011, MOL MICROBIOL, V79, P663, DOI 10.1111/j.1365-2958.2010.07474.x; Zimmerman CUR, 2009, FEMS MICROBIOL LETT, V292, P187, DOI 10.1111/j.1574-6968.2009.01505.x	67	32	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29856	10.1371/journal.pone.0029856	http://dx.doi.org/10.1371/journal.pone.0029856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253806	Green Published, gold			2022-12-25	WOS:000301357100025
J	Kataoka, S; Baquero, A; Yang, D; Shultz, N; Vandenbeuch, A; Ravid, K; Kinnamon, SC; Finger, TE				Kataoka, Shinji; Baquero, Arian; Yang, Dan; Shultz, Nicole; Vandenbeuch, Aurelie; Ravid, Katya; Kinnamon, Sue C.; Finger, Thomas E.			A2BR Adenosine Receptor Modulates Sweet Taste in Circumvallate Taste Buds	PLOS ONE			English	Article							ATPASE ACTIVITY; FINE-STRUCTURE; MOUSE TONGUE; CELL-TYPES; III CELLS; RAT; EXPRESSION; LOCALIZATION; SEROTONIN; SYNAPSES	In response to taste stimulation taste buds release ATP, which activates ionotropic ATP receptors (P2X2/P2X3) on taste nerves as well as metabotropic (P2Y) purinergic receptors on taste bud cells. The action of the extracellular ATP is terminated by ectoriucleotidases, ultimately generating adenosine, which itself can activate one or more G-protein coupled adenosine receptors: A1, A2A, A2B, and A3. Here we investigated the expression of adenosine receptors in mouse taste buds at both the nucleotide and protein expression levels. Of the adenosine receptors, only A2B receptor (A2BR) is expressed specifically in taste epithelia. Further, A2BR is expressed abundantly only in a subset of taste bud cells of posterior (circumvallate, foliate), but not anterior (fungiforrn, palate) taste fields in mice. Analysis of double-labeled tissue indicates that A2BR occurs on Type II taste bud cells that also express G alpha 14, which is present only in sweet-sensitive taste cells of the foliate and circumvallate papillae. Glossopharyngeal nerve recordings from A2BR knockout mice show significantly reduced responses to both sucrose and synthetic sweeteners, but normal responses to tastants representing other qualities. Thus our study identified a novel regulator of sweet taste, the A2BR, which functions to potentiate sweet responses in posterior lingual taste fields.	[Kataoka, Shinji; Baquero, Arian; Shultz, Nicole; Vandenbeuch, Aurelie; Kinnamon, Sue C.; Finger, Thomas E.] Univ Colorado, Sch Med, Rocky Mt Taste & Smell Ctr, Aurora, CO USA; [Kataoka, Shinji; Shultz, Nicole; Finger, Thomas E.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA; [Baquero, Arian; Vandenbeuch, Aurelie; Kinnamon, Sue C.] Univ Colorado, Sch Med, Depatment Otolaryngol, Aurora, CO USA; [Yang, Dan; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Yang, Dan; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Yang, Dan; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Boston University; Boston University; Boston University	Kataoka, S (corresponding author), Kyushu Dent Coll, Div Anat, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 803, Japan.	Tom.Finger@ucdenver.edu	Finger, Thomas/R-2974-2017	Finger, Thomas/0000-0001-5923-5099; Ravid, Katya/0000-0002-9918-3024; Kataoka, Shinji/0000-0002-9168-1061	National Institutes of Health from NIDCD [RO1 DC007495, RO1 DC006021, P30 DC04657]; National Institutes of Health from NHLBI [RO1 HL93149]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, R01DC007495, R01DC006021] Funding Source: NIH RePORTER	National Institutes of Health from NIDCD; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants: from NIDCD: RO1 DC007495, RO1 DC006021, P30 DC04657; from NHLBI: RO1 HL93149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; BARRY MA, 1992, J HISTOCHEM CYTOCHEM, V40, P1919, DOI 10.1177/40.12.1453008; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Baryshnikov SG, 2003, J NEUROPHYSIOL, V90, P3283, DOI 10.1152/jn.00312.2003; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Cohen MV, 2010, BRIT J PHARMACOL, V159, P1595, DOI 10.1111/j.1476-5381.2010.00668.x; Dando R, 2012, J NEUROSCI IN PRESS; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; FARBMAN AI, 1985, AM J ANAT, V172, P41, DOI 10.1002/aja.1001720104; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Finger TE, 2000, NEUROBIOLOGY TASTE S, P287; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 1996, ARCH HISTOL CYTOL, V59, P433, DOI 10.1679/aohc.59.433; IWAYAMA T, 1967, EXP CELL RES, V46, P607, DOI 10.1016/0014-4827(67)90388-6; IWAYAMA T, 1969, ANAT RECORD, V163, P31, DOI 10.1002/ar.1091630104; IWAYAMA TAKASHI, 1967, ARCH HISTOL JAP, V28, P151; Kataoka S, 2004, HISTOCHEM CELL BIOL; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kataoka S, 2006, ARCH HISTOL CYTOL, V69, P281, DOI 10.1679/aohc.69.281; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; KINNAMON JC, 1985, J COMP NEUROL, V235, P48, DOI 10.1002/cne.902350105; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Masino SA, 2002, J PHARMACOL EXP THER, V303, P356, DOI 10.1124/jpet.102.036731; Murata Y, 2010, J NEUROPHYSIOL; Murray R., 1973, ULTRASTRUCTURE SENSO, P1; NELSON GM, 1993, J COMP NEUROL, V336, P507, DOI 10.1002/cne.903360404; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; ROYER SM, 1991, J COMP NEUROL, V306, P49, DOI 10.1002/cne.903060105; Ryzhov S, 2006, MOL PHARMACOL, V70, P727, DOI 10.1124/mol.106.022780; SCHIFFMAN SS, 1985, PHARMACOL BIOCHEM BE, V22, P195, DOI 10.1016/0091-3057(85)90377-6; SCHIFFMAN SS, 1986, PHARMACOL BIOCHEM BE, V24, P429, DOI 10.1016/0091-3057(86)90536-8; Sebastiao AM, 2009, CURR NEUROPHARMACOL, V7, P180, DOI 10.2174/157015909789152128; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Leslie MSZ, 2007, CHEM SENSES, V32, P255, DOI 10.1093/chemse/bjl053; Tabata S, 1995, CHEM SENSES, V20, P778; TAKEDA M, 1975, ARCH HISTOL JAPON, V37, P395, DOI 10.1679/aohc1950.37.395; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yee CL, 2003, CHEM SENSES, V28, pA9; YOSHIE S, 1990, ARCH HISTOL CYTOL, V53, P103, DOI 10.1679/aohc.53.103; ZALEWSKI AA, 1968, EXP NEUROL, V22, P40, DOI 10.1016/0014-4886(68)90018-6; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	59	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					339	351	e30032	10.1371/journal.pone.0030032	http://dx.doi.org/10.1371/journal.pone.0030032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253866	gold, Green Published, Green Submitted			2022-12-25	WOS:000301353900035
J	Smith, KM; Anthony, SJ; Switzer, WM; Epstein, JH; Seimon, T; Jia, HW; Sanchez, MD; Huynh, TT; Galland, GG; Shapiro, SE; Sleeman, JM; McAloose, D; Stuchin, M; Amato, G; Kolokotronie, SO; Lipkin, WI; Karesh, WB; Daszak, P; Marano, N				Smith, Kristine M.; Anthony, Simon J.; Switzer, William M.; Epstein, Jonathan H.; Seimon, Tracie; Jia, Hongwei; Sanchez, Maria D.; Huynh, Thanh Thao; Galland, G. Gale; Shapiro, Sheryl E.; Sleeman, Jonathan M.; McAloose, Denise; Stuchin, Margot; Amato, George; Kolokotronie, Sergios-Orestis; Lipkin, W. Ian; Karesh, William B.; Daszak, Peter; Marano, Nina			Zoonotic Viruses Associated with Illegally Imported Wildlife Products	PLOS ONE			English	Article							OXIDASE-SUBUNIT-I; FOAMY VIRUS; DNA; INFECTION; IDENTIFICATION; EMERGENCE; TYPE-1; PCR	The global trade in wildlife has historically contributed to the emergence and spread of infectious diseases. The United States is the world's largest importer of wildlife and wildlife Products, yet minimal Pathogen surveillance has Precluded assessment of the health risks posed by this practice This report details the findings of a pilot project to establish surveillance methodology for zoonotic agents in confiscated wildlife products. Initial findings from samples collected at several international airports identified Parts originating from nonhuman Primate (NHP) and rodent species, including baboon, chimpanzee, mangabey, guenon, green monkey, cane rat and rat. Pathogen screening identified retroviruses (simian foamy virus) and/or herpesviruses (cytomegalovirus and lymphocryptovirus) in the NHP samples. These results are first demonstration that illegal bushmeat importation into the United States could act as a conduit for pathogen spread, and suggest that implementation of disease surveillance of the wildlife trade will help facilitate Prevention of disease emergence.	[Smith, Kristine M.; Anthony, Simon J.; Epstein, Jonathan H.; Sanchez, Maria D.; Karesh, William B.; Daszak, Peter] EcoHealth Alliance, New York, NY USA; [Smith, Kristine M.; Seimon, Tracie; McAloose, Denise; Karesh, William B.] Wildlife Conservat Soc, Bronx, NY USA; [Switzer, William M.; Jia, Hongwei; Galland, G. Gale; Shapiro, Sheryl E.; Marano, Nina] Ctr Dis Control & Prevent, Atlanta, GA USA; [Anthony, Simon J.; Seimon, Tracie; Sanchez, Maria D.; Stuchin, Margot; Lipkin, W. Ian] Columbia Univ, New York, NY USA; [Huynh, Thanh Thao] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Sleeman, Jonathan M.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Stuchin, Margot; Amato, George; Kolokotronie, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Wildlife Conservation Society; Centers for Disease Control & Prevention - USA; Columbia University; Tufts University; United States Department of the Interior; United States Geological Survey; American Museum of Natural History (AMNH)	Smith, KM (corresponding author), EcoHealth Alliance, New York, NY USA.	ksmith@ecohealthalliance.org	Kolokotronis, Sergios-Orestis/GWM-5773-2022; daszak, peter/U-4588-2017; Kolokotronis, Sergios-Orestis/A-1910-2009; Lipkin, W. Ian/ABE-6216-2020; Karesh, William/AAU-9084-2020	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; daszak, peter/0000-0002-2046-5695; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Lipkin, W. Ian/0000-0002-8768-9386; Karesh, William/0000-0001-6042-2860	V. Kann Rasmussen Foundation; Consortium for Conservation Medicine; New York Community Trust; Eppley Foundation for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	V. Kann Rasmussen Foundation; Consortium for Conservation Medicine; New York Community Trust; Eppley Foundation for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was supplied by the V. Kann Rasmussen Foundation, the Consortium for Conservation Medicine, the New York Community Trust, and the Eppley Foundation for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briese T, 1999, LANCET, V354, P1650; BROWN P, 1978, J INFECT DIS, V137, P421, DOI 10.1093/infdis/137.4.421; Campbell M, 1996, J VIROL, V70, P6847, DOI 10.1128/JVI.70.10.6847-6855.1996; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85; Courgnaud V, 2004, J VIROL, V78, P4700, DOI 10.1128/JVI.78.9.4700-4709.2004; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hays T, 2007, MONKEY MEAT CTR NYC; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Huff JL, 2003, EMERG INFECT DIS; HUNSMANN G, 1990, NATURE, V345, P120, DOI 10.1038/345120a0; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Karesh WB, 2005, EMERG INFECT DIS; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kuzmenok OI, 2007, INT J NEUROSCI, V117, P1603, DOI 10.1080/00207450701239442; Levi K, 2003, LETT APPL MICROBIOL, V36, P418, DOI 10.1046/j.1472-765X.2003.01336.x; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Michaels MG, 2001, J VIROL, V75, P2825, DOI 10.1128/JVI.75.6.2825-2828.2001; Moghaddam A, 1998, J VIROL, V72, P3205, DOI 10.1128/JVI.72.4.3205-3212.1998; Nitsche A, 2004, J CLIN MICROBIOL, V42, P1207, DOI 10.1128/JCM.42.3.1207-1213.2004; Peeters M, 2002, EMERG INFECT DIS; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Sintasath DM, 2009, EMERG INFECT DIS; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Switzer W. M., 2011, MOL DETECTION HUMAN, V1, P131; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; United States Fish and Wildlife Service Office of Law Enforcement Intelligence Unit, US WILDL TRAD OV 199; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wolfe ND, 2009, CAM S BIO EVOL ANTHR, V57, P353; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Woolhouse MEJ, 2005, EMERG INFECT DIS; Xu RH, 2004, EMERG INFECT DIS; Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06	39	61	64	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					71	79	e29505	10.1371/journal.pone.0029505	http://dx.doi.org/10.1371/journal.pone.0029505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253731	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900008
J	Vessey, KA; Fletcher, EL				Vessey, Kirstan A.; Fletcher, Erica L.			Rod and Cone Pathway Signalling Is Altered in the P2X7 Receptor Knock Out Mouse	PLOS ONE			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; RETINAL GANGLION-CELLS; MULLER GLIAL-CELLS; P2X(7) RECEPTORS; RAT RETINA; PURINERGIC RECEPTORS; EXTRACELLULAR ATP; SPINAL-CORD; RELEASE; EXPRESSION	The P2X7 receptor (P2X7-R) is expressed in the retina and brain and has been implicated in neurodegenerative diseases. However, whether it is expressed by neurons and plays a role as a neurotransmitter receptor has been the subject of controversy. In this study, we first show that the novel vesicular transporter for ATP, VNUT, is expressed in the retina verifying the presence of the molecular machinery for ATP to act as neurotransmitter at P2X7-Rs. Secondly we show the presence of P2X7-R mRNA and protein in the retina and cortex and absence of the full length variant 1 of the receptor in the P2X7-R knock out (P2X7-KO) mouse. The role of the P2X7-R in neuronal function of the retina was assessed by comparing the electroretinogram response of P2X7-KO with WT mice. The rod photoreceptor response was found to be similar, while both rod and cone pathway post-photoreceptor responses were significantly larger in P2X7-KO mice. This suggests that activation of P2X7-Rs modulates output of second order retinal neurons. In line with this finding, P2X7-Rs were found in the outer plexiform layer and on inner retinal cell classes, including horizontal, amacrine and ganglion cells. The receptor co-localized with conventional synapses in the IPL and was expressed on amacrine cells post-synaptic to rod bipolar ribbon synapses. In view of the changes in visual function in the P2X7-KO mouse and the immunocytochemical location of the receptor in the normal retina, it is likely the P2X7-R provides excitatory input to photoreceptor terminals or to inhibitory cells that shape both the rod and cone pathway response.	[Vessey, Kirstan A.; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia	University of Melbourne	Vessey, KA (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia.	e.fletcher@unimelb.edu.au	Fletcher, Erica/E-6364-2012	Fletcher, Erica/0000-0001-9412-9523; Vessey, Kirstan/0000-0003-1031-1964	National Health and Medical Research Council (NHMRC) of Australia [566815]; Retina Australia; Macular Degeneration Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia; Macular Degeneration Foundation	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (No. 566815 to ELF), and with grants from Retina Australia and the Macular Degeneration Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Brandle U, 1998, MOL BRAIN RES, V62, P106, DOI 10.1016/S0169-328X(98)00254-X; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Bringmann A, 2001, INVEST OPHTH VIS SCI, V42, P860; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FULTON AB, 1978, VISION RES, V18, P793, DOI 10.1016/0042-6989(78)90119-0; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Ishii K, 2003, J COMP NEUROL, V459, P267, DOI 10.1002/cne.10608; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; Jabs R, 2000, MOL BRAIN RES, V76, P205, DOI 10.1016/S0169-328X(99)00339-3; Ricatti MJ, 2009, SYNAPSE, V63, P291, DOI 10.1002/syn.20605; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Marin-Garcia P, 2008, NEUROSCIENCE, V151, P361, DOI 10.1016/j.neuroscience.2007.10.038; Masin M, 2011, BR J PHARM; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; NEAL M, 1994, BRIT J PHARMACOL, V113, P1085, DOI 10.1111/j.1476-5381.1994.tb17106.x; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Pannicke T, 2000, J NEUROSCI, V20, P5965, DOI 10.1523/JNEUROSCI.20-16-05965.2000; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Plithussery T, 2007, NEUROSCIENCE, V146, P403, DOI 10.1016/j.neuroscience.2007.01.055; Puthussery T, 2004, J COMP NEUROL, V472, P13, DOI 10.1002/cne.20045; Puthussery T, 2006, EUR J NEUROSCI, V24, P7, DOI 10.1111/j.1460-9568.2006.04895.x; Puthussery T, 2009, J COMP NEUROL, V513, P430, DOI 10.1002/cne.21964; Santos PF, 1999, J NEUROBIOL, V41, P340, DOI 10.1002/(SICI)1097-4695(19991115)41:3<340::AID-NEU3>3.3.CO;2-#; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Vessey KA, 2011, J COMP NEUROL, V519, P506, DOI 10.1002/cne.22530; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Wheeler-Schilling TH, 2000, MOL BRAIN RES, V76, P415; Wheeler-Schilling TH, 2001, MOL BRAIN RES, V92, P177, DOI 10.1016/S0169-328X(01)00160-7; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Zhang X, 2007, EXP EYE RES, V85, P637, DOI 10.1016/j.exer.2007.07.016; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052	57	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					290	305	e29990	10.1371/journal.pone.0029990	http://dx.doi.org/10.1371/journal.pone.0029990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253851	Green Published, gold			2022-12-25	WOS:000301353900031
J	Wang, DF; Arapostathis, A; Wilke, CO; Markey, MK				Wang, Daifeng; Arapostathis, An; Wilke, Claus O.; Markey, Mia K.			Principal-Oscillation-Pattern Analysis of Gene Expression	PLOS ONE			English	Article							CYCLE-REGULATED GENES; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; MICROARRAY DATA; IDENTIFICATION; TRANSCRIPTION; PROFILES; NETWORKS; MODEL	Principal-oscillation-pattern (POP) analysis is a multivariate and systematic technique for identifying the dynamic characteristics of a system from time-series data. In this study, we demonstrate the first application of POP analysis to genome-wide time-series gene-expression data. We use POP analysis to infer oscillation patterns in gene expression. Typically, a genomic system matrix cannot be directly estimated because the number of genes is usually much larger than the number of time points in a genomic study. Thus, we first identify the POPs of the eigen-genomic system that consists of the first few significant eigengenes obtained by singular value decomposition. By using the linear relationship between eigengenes and genes, we then infer the POPs of the genes. Both simulation data and real-world data are used in this study to demonstrate the applicability of POP analysis to genomic data. We show that POP analysis not only compares favorably with experiments and existing computational methods, but that it also provides complementary information relative to other approaches.	[Wang, Daifeng; Arapostathis, An; Markey, Mia K.] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Sect Integrat Biol, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Wang, Daifeng; Markey, Mia K.] Univ Texas Austin, Univ Texas, Biomed Informat Lab, Austin, TX 78712 USA; [Wang, Daifeng; Markey, Mia K.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wang, DF (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.	mia.markey@mail.utexas.edu	Markey, Mia/ABE-8986-2020; Wang, Daifeng/K-2412-2019; Arapostathis, Ari/W-6189-2019; Wilke, Claus O./B-4643-2008	Markey, Mia/0000-0001-8186-4959; Arapostathis, Ari/0000-0003-2207-357X; Wilke, Claus/0000-0002-7470-9261				Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Johansson D, 2003, BIOINFORMATICS, V19, P467, DOI 10.1093/bioinformatics/btg017; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lu X, 2004, NUCLEIC ACIDS RES, V32, P447, DOI 10.1093/nar/gkh205; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Moore D. S., 2009, PRACTICE BUSINESS ST; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Shedden K, 2002, NUCLEIC ACIDS RES, V30, P2920, DOI 10.1093/nar/gkf414; Shi YX, 2007, BIOINFORMATICS, V23, pI459, DOI 10.1093/bioinformatics/btm218; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; VONSTORCH H, 1995, J CLIMATE, V8, P377, DOI 10.1175/1520-0442(1995)008<0377:POPAR>2.0.CO;2; Wang D, 2011, IEEE ACM T IN PRESS; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	18	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					29	38	e28805	10.1371/journal.pone.0028805	http://dx.doi.org/10.1371/journal.pone.0028805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253697	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900003
J	de Valais, S; Apesteguia, S; Garrido, AC				de Valais, Silvina; Apesteguia, Sebastian; Garrido, Alberto C.			Cretaceous Small Scavengers: Feeding Traces in Tetrapod Bones from Patagonia, Argentina	PLOS ONE			English	Article							NEUQUEN BASIN ARGENTINA; DINOSAUR BONE; BURROWS; GEN.	Ecological relationships among fossil vertebrate groups are interpreted based on evidence of modification features and paleopathologies on fossil bones. Here we describe an ichnological assemblage composed of trace fossils on reptile bones, mainly sphenodontids, crocodyliforms and maniraptoran theropods. They all come from La Buitrera, an early Late Cretaceous locality in the Candeleros Formation of northwestern Patagonia, Argentina. This locality is significant because of the abundance of small to medium-sized vertebrates. The abundant ichnological record includes traces on bones, most of them attributable to tetrapods. These latter traces include tooth marks that provde evidence of feeding activities made during the sub-aerial exposure of tetrapod carcasses. Other traces are attributable to arthropods or roots. The totality of evidence provides an uncommon insight into paleoecological aspects of a Late Cretaceous southern ecosystem.	[de Valais, Silvina] Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Fisque Menuco Gen Roca, Rio Negro, Argentina; [Apesteguia, Sebastian] Univ Maimonides, CEBBAD, CONICET, Fdn Hist Nat Felix de Azara, Buenos Aires, DF, Argentina; [Garrido, Alberto C.] Museo Prov Ciencias Nat Prof Dr Juan A Olsacher, Direcc Prov Mineria, Zapala, Neuquen, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	de Valais, S (corresponding author), Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Fisque Menuco Gen Roca, Rio Negro, Argentina.	sdevalais@yahoo.com.ar	Apesteguía, Sebastian/F-4034-2018	Apesteguía, Sebastian/0000-0002-0414-0524	Jurassic Foundation	Jurassic Foundation	This work was supported by The Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2005, CR PALEVOL, V4, P311, DOI 10.1016/j.crpv.2005.03.003; Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Apesteguia S, 2007, AMEGHINIANA, V44; Apesteguia S, 2008, THESIS UNLP; Apesteguia S, 2010, AMEGHINIANA IN PRESS; Apesteguia Sebastian, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P27; Bonaparte J.F., 1991, REV MUSEO ARGENTINO, V4, P15; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; CALVO J O, 1991, Ameghiniana, V28, P303; Calvo JO, 1999, NAT SCI MUS MONOGRAP, V15, P13; Calvo Jorge O., 1995, Gaia, V11, P13; CAZAU L. B., 1973, CONGRESO GEOL GI COA, V3, P131; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Corbella Hugo, 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P227; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; DASHZEVEG D, 1995, NATURE, V374, P446, DOI 10.1038/374446a0; DENYS C, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V194, P69; Farina Richard A., 2002, P97; Farke AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004252; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Hill A., 1987, P543; Hugo CA, 2001, SEGEMAR B, P1; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Kaiser TM, 2000, ANN ENTOMOL SOC AM, V93, P693, DOI 10.1603/0013-8746(2000)093[0693:PFIMTF]2.0.CO;2; Laudet F, 2004, GEOBIOS-LYON, V37, P376, DOI 10.1016/j.geobios.2003.04.005; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Longrich NR, 2010, PALAEONTOLOGY, V53, P703, DOI 10.1111/j.1475-4983.2010.00957.x; Cione AL, 2010, ALCHERINGA, V34, P433, DOI 10.1080/03115511003793470; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martinell J, 1989, PALEONTOLOGIA, P205; Mikulas R, 1999, VSTNIK CESKEHO GEOLO, V74, P289; Mikulas Radek, 2006, Ichnos, V13, P113, DOI 10.1080/10420940600850729; Montalvo C.I., 2002, ACTA GEOL HISP, V37, P37; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Paik IS, 2000, PALAEOGEOGR PALAEOCL, V157, P213, DOI 10.1016/S0031-0182(99)00166-2; Peterson JE, 2009, PALAIOS, V24, P780, DOI 10.2110/palo.2009.p09-056r; Pol D, 2006, AM MUS NOVIT, V3490, P1; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Rogers R.R., 1992, Journal of Vertebrate Paleontology, V12, P528; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; Stipanicic P.N., 1968, REV ASOC GEOL ARGENT, V23, P67; Sues H-D, 1977, ZEITSCHRIFT, V51, P173; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; TAPPEN M, 1994, J ARCHAEOL SCI, V21, P667, DOI 10.1006/jasc.1994.1066; Vizcaino SF, 2001, ACTA PALAEONTOL POL, V46, P289	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29841	10.1371/journal.pone.0029841	http://dx.doi.org/10.1371/journal.pone.0029841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253800	gold, Green Published, Green Submitted			2022-12-25	WOS:000301352400006
J	Kumar, A; Shamsuddin, N				Kumar, Ashok; Shamsuddin, Nazeem			Retinal Muller Glia Initiate Innate Response to Infectious Stimuli via Toll-Like Receptor Signaling	PLOS ONE			English	Article							IMMUNE-RESPONSE; CELLS; RECOGNITION; FLAGELLIN; TLR2; LIPOPROTEINS; LIPOPEPTIDES; BINDING	Ocular surgeries and trauma predispose the eye to develop infectious endophthalmitis, which often leads to vision loss. The mechanisms of initiation of innate defense in this disease are not well understood but are presumed to involve retinal glial cells. We hypothesize that retinal Muller glia can recognize and respond to invading pathogens via TLRs, which are key regulators of the innate immune system. Using the mouse retinal sections, human retinal Muller cell line (MIO-M1), and primary mouse retinal Muller cells, we show that they express known human TLR1-10, adaptor molecules MyD88, TRIF, TRAM, and TRAF6, and co-receptors MD2 and CD14. Consistent with the gene expression, protein levels were also detected for the TLRs. Moreover, stimulation of the Muller glia with TLR 2, 3, 4, 5, 7 and 9 agonists resulted in an increased TLR expression as assayed by Western blot and flow cytometry. Furthermore, TLR agonists or live pathogen (S. aureus, P. aeruginosa, & C. albicans)-challenged Muller glia produced significantly higher levels of inflammatory mediators (TNF-alpha, IL-1 beta, IL-6 and IL-8), concomitantly with the activation of NF-kappa B, p38 and Erk signaling. This data suggests that Muller glia directly contributes to retinal innate defense by recognizing microbial patterns under infectious conditions; such as those in endophthalmitis.	[Kumar, Ashok; Shamsuddin, Nazeem] Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48202 USA; [Kumar, Ashok] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA	Wayne State University; Wayne State University	Kumar, A (corresponding author), Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48202 USA.	akuma@med.wayne.edu			National Institutes of Health [RO1 EY19888]; Alliance for Vision Research; Research to Prevent Blindness (RPB); RPB; NATIONAL EYE INSTITUTE [R01EY019888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Vision Research; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); RPB(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health Grant RO1 EY19888 (to A. K.), Alliance for Vision Research (to A. K.), and an unrestricted grant from Research to Prevent Blindness (RPB) (to Department of Ophthalmology). A. K. is the recipient of the William & Mary Greve special scholar award from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, INVEST OPHTH VIS SCI, V52, P5758, DOI 10.1167/iovs.11-7308; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; CHANLING TL, 1994, PROG RETIN EYE RES, V13, P357, DOI 10.1016/1350-9462(94)90015-9; Dasgupta G, 2011, INVEST OPHTH VIS SCI, V52, P3321, DOI 10.1167/iovs.10-6522; Ebihara N, 2007, OPHTHAL RES, V39, P155, DOI 10.1159/000103235; Fischer M, 2008, ANN NY ACAD SCI, V1143, P21, DOI 10.1196/annals.1443.012; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kapetanovic R, 2007, EXPERT OPIN BIOL TH, V7, P907, DOI 10.1517/14712598.7.6.907; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Kong Y, 2011, INT IMMUNOPHARMACOL; Kumar A, 2004, INVEST OPHTH VIS SCI, V45, P3513, DOI 10.1167/iovs.04-0467; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lauer AK, 2011, EYE LOND; Li Q, 2008, MICROB PATHOGENESIS, V44, P426, DOI 10.1016/j.micpath.2007.11.006; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lindqvist N, 2010, INVEST OPHTH VIS SCI, V51, P1683, DOI 10.1167/iovs.09-4159; Luo C, 2010, INVEST OPHTH VIS SCI, V51, P5697, DOI 10.1167/iovs.10-5407; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; REICHENBACH A, 1993, J CHEM NEUROANAT, V6, P201, DOI 10.1016/0891-0618(93)90042-3; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Shamsuddin N, 2011, J IMMUNOL, V186, P7089, DOI 10.4049/jimmunol.1100565; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125	40	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29830	10.1371/journal.pone.0029830	http://dx.doi.org/10.1371/journal.pone.0029830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253793	Green Published, gold, Green Submitted			2022-12-25	WOS:000315865800016
J	Buizza, L; Cenini, G; Lanni, C; Ferrari-Toninelli, G; Prandelli, C; Govoni, S; Buoso, E; Racchi, M; Barcikowska, M; Styczynska, M; Szybinska, A; Butterfield, DA; Memo, M; Uberti, D				Buizza, Laura; Cenini, Giovanna; Lanni, Cristina; Ferrari-Toninelli, Giulia; Prandelli, Chiara; Govoni, Stefano; Buoso, Erica; Racchi, Marco; Barcikowska, Maria; Styczynska, Maria; Szybinska, Aleksandra; Butterfield, David Allan; Memo, Maurizio; Uberti, Daniela			Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MANGANESE-SUPEROXIDE-DISMUTASE; TUMOR-SUPPRESSOR PROTEIN; WILD-TYPE P53; LIPID-PEROXIDATION; REDOX PROTEOMICS; MOUSE MODEL; DNA-BINDING; GLUTATHIONE-REDUCTASE; NITRATED PROTEINS	In order to study oxidative stress in peripheral cells of Alzheimer's disease (AD) patients, immortalized lymphocytes derived from two peculiar cohorts of patients, referring to early onset AD (EOSAD) and subjects harboured AD related mutation (ADmut), were used. Oxidative stress was evaluated measuring i) the typical oxidative markers, such as HNE Michel adducts, 3 Nitro-Tyrosine residues and protein carbonyl on protein extracts, ii) and the antioxidant capacity, following the enzymatic kinetic of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GRD). We found that the signs of oxidative stress, measured as oxidative marker levels, were evident only in ADmut but not in EOSAD patients. However, oxidative imbalance in EOSAD as well as ADmut lymphocytes was underlined by a reduced SOD activity and GRD activity in both pathological groups in comparison with cells derived from healthy subjects. Furthermore, a redox modulated p53 protein was found conformational altered in both EOSAD and ADmut B lymphocytes in comparison with control cells. This conformational altered p53 isoform, named "unfolded p53'', was recognized by the use of two specific conformational anti-p53 antibodies. Immunoprecipitation experiments, performed with the monoclonal antibodies PAb1620 (that recognizes p53wt) and PAb240 (that is direct towards unfolded p53), and followed by the immunoblotting with anti-4-hydroxynonenal (HNE) and anti-3-nitrotyrosine (3NT) antibodies, showed a preferential increase of nitrated tyrosine residues in unfolded p53 isoform comparing to p53 wt protein, in both ADmut and EOSAD. In addition, a correlation between unfolded p53 and SOD activity was further found. Thus this study suggests that ROS/RNS contributed to change of p53 tertiary structure and that unfolded p53 can be considered as an early marker of oxidative imbalance in these patients.	[Buizza, Laura; Cenini, Giovanna; Ferrari-Toninelli, Giulia; Prandelli, Chiara; Memo, Maurizio; Uberti, Daniela] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Cenini, Giovanna; Butterfield, David Allan] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Lanni, Cristina; Govoni, Stefano; Buoso, Erica; Racchi, Marco] Univ Pavia, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy; [Barcikowska, Maria; Styczynska, Maria] Polish Acad Sci, Med Res Ctr, Warsaw, Poland; [Szybinska, Aleksandra] Int Inst Mol & Cell Biol, Lab Neurodegenerat, Warsaw, Poland	University of Brescia; University of Kentucky; University of Pavia; Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Uberti, D (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy.	uberti@med.unibs.it	Uberti, Daniela/K-1551-2019; Lanni, Cristina/AAI-2182-2020; Memo, Maurizio/AAK-7197-2020; Govoni, Stefano/K-2965-2015; Buoso, Erica/AAF-1233-2020; Racchi, Marco/G-6104-2018	Govoni, Stefano/0000-0002-7243-6837; Racchi, Marco/0000-0002-7185-7808; LANNI, CRISTINA/0000-0002-3061-4738; Cenini, Giovanna/0000-0003-1547-7007; UBERTI, Daniela Letizia/0000-0002-5926-9122; Barcikowska, Maria/0000-0001-5657-9670; Buoso, Erica/0000-0003-1728-0443; MEMO, Maurizio/0000-0002-7543-0289	PRIN from the Italian Ministry of Education, University and Research [2008R25HBW_004]	PRIN from the Italian Ministry of Education, University and Research	This research was supported by PRIN 2008 grant (2008R25HBW_004) from the Italian Ministry of Education, University and Research (principal investigator: DU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bartolome F, 2007, CELL MOL LIFE SCI, V64, P1437, DOI 10.1007/s00018-007-7081-3; Blumberg J, 2004, J NUTR, V134, p3188S, DOI 10.1093/jn/134.11.3188S; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Calmels S, 1997, CANCER RES, V57, P3365; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Cecchi C, 1999, NEUROSCI LETT, V275, P152, DOI 10.1016/S0304-3940(99)00751-X; Cecchi C, 2002, FREE RADICAL BIO MED, V33, P1372, DOI 10.1016/S0891-5849(02)01049-3; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; Drake J, 2003, J NEUROSCI RES, V74, P917, DOI 10.1002/jnr.10810; FRENKEL K, 1991, FREE RADICAL RES COM, V12-3, P783, DOI 10.3109/10715769109145860; Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson; Hainaut P, 2001, ANTIOXID REDOX SIGN, V3, P611, DOI 10.1089/15230860152542961; HAINAUT P, 1993, CANCER RES, V53, P4469; Halliwell B, 1997, FEBS LETT, V411, P157, DOI 10.1016/S0014-5793(97)00469-9; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Koppal T, 1999, J NEUROCHEM, V72, P310, DOI 10.1046/j.1471-4159.1999.0720310.x; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Lanni C, 2010, J ALZHEIMERS DIS, V20, P97, DOI 10.3233/JAD-2010-1347; Lauderback CM, 2001, J NEUROCHEM, V78, P413, DOI 10.1046/j.1471-4159.2001.00451.x; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Meplan C, 2000, ONCOGENE, V19, P5227, DOI 10.1038/sj.onc.1203907; Meplan C, 2000, BIOCHEM PHARMACOL, V59, P25, DOI 10.1016/S0006-2952(99)00297-X; Miguel F, 2009, FREE RADICAL RES, V43, P340, DOI 10.1080/10715760902751894; MILNER J, 1995, TRENDS BIOCHEM SCI, V20, P49, DOI 10.1016/S0968-0004(00)88954-9; Munoz U, 2008, NEUROBIOL AGING, V29, P1474, DOI 10.1016/j.neurobiolaging.2007.03.013; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rump TJ, FREE RADIC BIOL MED, V49, P1494; Schiffrin EL, 2010, MOL INTERV, V10, P354, DOI 10.1124/mi.10.6.4; Selkoe DJ, 2007, NUTR REV, V65, pS239, DOI 10.1301/nr.2007.dec.S239-S243; Serrano J, 2010, ONCOGENE, V29, P2165, DOI 10.1038/onc.2009.503; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Sultana R., 2009, METHOD MOL BIOL, V476, P149; Sultana R, 2007, J CELL MOL MED, V11, P839, DOI 10.1111/j.1582-4934.2007.00065.x; Sultana R, 2006, ANTIOXID REDOX SIGN, V8, P2021, DOI 10.1089/ars.2006.8.2021; Uberti D, 2006, NEUROBIOL AGING, V27, P1193, DOI 10.1016/j.neurobiolaging.2005.06.013; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Wiseman A, 2006, MED HYPOTHESES, V67, P296, DOI 10.1016/j.mehy.2006.02.013; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zekanowski C, 2003, EXP NEUROL, V184, P991, DOI 10.1016/S0014-4886(03)00384-4; Zhou X, NEUROSCI LETT, V468, P320	66	58	62	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29789	10.1371/journal.pone.0029789	http://dx.doi.org/10.1371/journal.pone.0029789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242180	gold, Green Published			2022-12-25	WOS:000312662100036
J	Nath, S; Spencer, VA; Han, J; Chang, H; Zhang, K; Fontenay, GV; Anderson, C; Hyman, JM; Nilsen-Hamilton, M; Chang, YT; Parvin, B				Nath, Sangeeta; Spencer, Virginia A.; Han, Ju; Chang, Hang; Zhang, Kai; Fontenay, Gerald V.; Anderson, Charles; Hyman, Joel M.; Nilsen-Hamilton, Marit; Chang, Young-Tae; Parvin, Bahram			Identification of Fluorescent Compounds with Non-Specific Binding Property via High Throughput Live Cell Microscopy	PLOS ONE			English	Article							LINES; LOCALIZATION; KEGG	Introduction: Compounds exhibiting low non-specific intracellular binding or non-stickiness are concomitant with rapid clearing and in high demand for live-cell imaging assays because they allow for intracellular receptor localization with a high signal/noise ratio. The non-stickiness property is particularly important for imaging intracellular receptors due to the equilibria involved. Method: Three mammalian cell lines with diverse genetic backgrounds were used to screen a combinatorial fluorescence library via high throughput live cell microscopy for potential ligands with high in-and out-flux properties. The binding properties of ligands identified from the first screen were subsequently validated on plant root hair. A correlative analysis was then performed between each ligand and its corresponding physiochemical and structural properties. Results: The non-stickiness property of each ligand was quantified as a function of the temporal uptake and retention on a cell-by-cell basis. Our data shows that (i) mammalian systems can serve as a pre-screening tool for complex plant species that are not amenable to high-throughput imaging; (ii) retention and spatial localization of chemical compounds vary within and between each cell line; and (iii) the structural similarities of compounds can infer their non-specific binding properties. Conclusion: We have validated a protocol for identifying chemical compounds with non-specific binding properties that is testable across diverse species. Further analysis reveals an overlap between the non-stickiness property and the structural similarity of compounds. The net result is a more robust screening assay for identifying desirable ligands that can be used to monitor intracellular localization. Several new applications of the screening protocol and results are also presented.	[Nath, Sangeeta; Spencer, Virginia A.; Han, Ju; Chang, Hang; Zhang, Kai; Fontenay, Gerald V.; Hyman, Joel M.; Parvin, Bahram] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Anderson, Charles] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Nilsen-Hamilton, Marit] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Inst Life Sci, Singapore 117548, Singapore; [Chang, Young-Tae] Natl Univ Singapore, MedChem Program, Inst Life Sci, Singapore 117548, Singapore; [Chang, Young-Tae] ASTAR, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Iowa State University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Parvin, B (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	b_parvin@lbl.gov	Nilsen-Hamilton, Marit/V-2796-2019; Chang, Young-Tae/B-2780-2010	Chang, Young-Tae/0000-0002-1927-3688; Anderson, Charles/0000-0001-7481-3571; Nilsen-Hamilton, Marit/0000-0002-5496-1814	Office of Science, Office of Biological and Environmental Research, Radiochemistry and Imaging Instrumentation, of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, Radiochemistry and Imaging Instrumentation, of the U.S. Department of Energy	This work was funded by the Director, Office of Science, Office of Biological and Environmental Research, Radiochemistry and Imaging Instrumentation, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2007, J AM CHEM SOC, V129, P4510, DOI 10.1021/ja068230m; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Coelho L, 2009, INT S BIOM IM NAN MA, P690; Desprez Pierre-Yves, 1993, Molecular and Cellular Differentiation, V1, P99; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fujiwara M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001211; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kocanova S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-98; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Padfield D, 2009, MED IMAGE ANAL, V13, P143, DOI 10.1016/j.media.2008.06.018; Parvin B, 2003, IEEE T SYST MAN CY B, V33, P814, DOI 10.1109/TSMCB.2003.816929; Raman S, 2007, J MICROSC-OXFORD, V225, P22, DOI 10.1111/j.1365-2818.2007.01712.x; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Scior T, 2007, MINI-REV MED CHEM, V7, P851; Thabet I, 2011, MOL BIOL REP; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Wen Q, 2009, I S BIOMED IMAGING, P9, DOI 10.1109/ISBI.2009.5192970	21	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28802	10.1371/journal.pone.0028802	http://dx.doi.org/10.1371/journal.pone.0028802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242152	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100006
J	Keller, M; Enot, DP; Hodson, MP; Igwe, EI; Deigner, HP; Dean, J; Bolouri, H; Hagberg, H; Mallard, C				Keller, Matthias; Enot, David P.; Hodson, Mark P.; Igwe, Emeka I.; Deigner, Hans-Peter; Dean, Justin; Bolouri, Hayde; Hagberg, Henrik; Mallard, Carina			Inflammatory-Induced Hibernation in the Fetus: Priming of Fetal Sheep Metabolism Correlates with Developmental Brain Injury	PLOS ONE			English	Article							REPEATED ENDOTOXIN EXPOSURE; WHITE-MATTER INJURY; MITOCHONDRIAL DYSFUNCTION; ENDOGENOUS EXCITANT; KYNURENINE PATHWAY; QUINOLINIC ACID; PRETERM BIRTH; RAT-BRAIN; IN-VIVO; 24S-HYDROXYCHOLESTEROL	Prenatal inflammation is considered an important factor contributing to preterm birth and neonatal mortality and morbidity. The impact of prenatal inflammation on fetal bioenergetic status and the correlation of specific metabolites to inflammatory-induced developmental brain injury are unknown. We used a global metabolomics approach to examine plasma metabolites differentially regulated by intrauterine inflammation. Preterm-equivalent sheep fetuses were randomized to i.v. bolus infusion of either saline-vehicle or LPS. Blood samples were collected at baseline 2 h, 6 h and daily up to 10 days for metabolite quantification. Animals were killed at 10 days after LPS injection, and brain injury was assessed by histopathology. We detected both acute and delayed effects of LPS on fetal metabolism, with a long-term down-regulation of fetal energy metabolism. Within the first 3 days after LPS, 121 metabolites were up-regulated or down-regulated. A transient phase (4-6 days), in which metabolite levels recovered to baseline, was followed by a second phase marked by an opposing down-regulation of energy metabolites, increased pO(2) and increased markers of inflammation and ADMA. The characteristics of the metabolite response to LPS in these two phases, defined as 2 h to 2 days and at 6-9 days, respectively, were strongly correlated with white and grey matter volumes at 10 days recovery. Based on these results we propose a novel concept of inflammatory-induced hibernation of the fetus. Inflammatory priming of fetal metabolism correlated with measures of brain injury, suggesting potential for future biomarker research and the identification of therapeutic targets.	[Keller, Matthias; Enot, David P.] Essen Univ Hosp, Dept Pediat 1, Essen, Germany; [Hodson, Mark P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Igwe, Emeka I.] Biocrates Life Sci AG, Innsbruck, Austria; [Deigner, Hans-Peter] Univ Rostock, Dept Nephrol, Rostock, Germany; [Deigner, Hans-Peter] Univ Rostock, Fraunhofer IZI EXIM Rostock, Rostock, Germany; [Dean, Justin; Bolouri, Hayde; Mallard, Carina] Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Hagberg, Henrik] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London, England	University of Duisburg Essen; University of Queensland; University of Rostock; University of Rostock; University of Gothenburg; Imperial College London	Keller, M (corresponding author), Essen Univ Hosp, Dept Pediat 1, Essen, Germany.	matthias.keller@uk-essen.de	Hodson, Mark P/J-7609-2013; Dean, Justin/AAD-8576-2021	Hodson, Mark P/0000-0002-5436-1886; Dean, Justin/0000-0002-1377-0878; Hagberg, Henrik/0000-0003-3962-1448; Mallard, Carina/0000-0001-8953-919X	European Commission [LSHM-CT-2006-036534]; Osterreichische Nationalbank Fonds [1275]; Swedish Research Council [2009-2630, 2009-2642]; Ahlens stiftelsen; Frimurare barnhusfonden; Lundgrenska Stiftelserna; Medical Research Council (UK) [P19381]; Wellcome Trust [WT094823MA]; Governmental Grants to University Hospitals in Sweden [ALFGBG2863, ALFGBG142881]; Action Medical Research [SP4506]; The Henry Smith Charity; Action Medical Research [1764] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Osterreichische Nationalbank Fonds; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens stiftelsen; Frimurare barnhusfonden; Lundgrenska Stiftelserna; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Governmental Grants to University Hospitals in Sweden; Action Medical Research; The Henry Smith Charity; Action Medical Research	This study was supported by the European Commission (Sixth Framework Program, LSHM-CT-2006-036534) and by research grants from the Osterreichische Nationalbank Fonds (1275, MK); Swedish Research Council (2009-2630, CM and 2009-2642, HH); Ahlens stiftelsen (CM); Frimurare barnhusfonden (CM, HH); Lundgrenska Stiftelserna (CM); Medical Research Council (UK) strategic award (P19381, HH); Wellcome Trust (WT094823MA, HH); Governmental Grants to University Hospitals in Sweden (ALFGBG2863, HH and ALFGBG142881, CM) and Action Medical Research and The Henry Smith Charity (SP4506, HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov P, 2005, NEUROREPORT, V16, P909, DOI 10.1097/00001756-200506210-00007; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; Babu GN, 2003, NEUROCHEM RES, V28, P1851, DOI 10.1023/A:1026123809033; Babu GN, 2001, NEUROSCI LETT, V300, P17, DOI 10.1016/S0304-3940(01)01538-5; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Beijar ECE, 2006, PLACENTA, V27, P322, DOI 10.1016/j.placenta.2004.12.012; BELL AW, 1986, AM J PHYSIOL, V250, pE538, DOI 10.1152/ajpendo.1986.250.5.E538; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Blackwell S, 2010, EUR J CLIN INVEST; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; CARVER TD, 1995, AM J PHYSIOL-ENDOC M, V269, pE299, DOI 10.1152/ajpendo.1995.269.2.E299; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Dean J, 2011, ANN NEUROL; Dharane Nee Ligam P, 2010, PLACENTA, V31, P997; Duncan JR, 2003, PLACENTA, V24, P786, DOI 10.1016/S0143-4004(03)00104-8; Duncan JR, 2002, PEDIATR RES, V52, P941, DOI 10.1203/01.PDR.0000034224.13885.BE; Enot DP, 2011, METHODS MOL BIOL, V719, P351, DOI 10.1007/978-1-61779-027-0_16; Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824; Food and Drug Administration, 2001, FDA GUID IND BIOAN M; Garnier Y, 2009, REPROD SCI, V16, P758, DOI 10.1177/1933719109335801; Giles GI, 2003, BIOCHEM BIOPH RES CO, V300, P719, DOI 10.1016/S0006-291X(02)02917-0; Gonzalez A, 2008, ADV CLIN CHEM, V45, P155, DOI 10.1016/S0065-2423(07)00007-8; Ha HC, 1997, P NATL ACAD SCI USA, V94, P11557, DOI 10.1073/pnas.94.21.11557; Hay WW, 2007, FETAL NEONATAL PHYSL, P509; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JENSEN JR, 1987, J NEUROCHEM, V48, P765, DOI 10.1111/j.1471-4159.1987.tb05583.x; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; KOENIG H, 1990, STROKE, V21, P98; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Levy RJ, 2007, SHOCK, V28, P24, DOI 10.1097/01.shk.0000235089.30550.2d; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Mestan K, 2010, PEDIATRICS, V125, pE891, DOI 10.1542/peds.2009-0313; Nijveldt RJ, 2003, NEPHROL DIAL TRANSPL, V18, P2542, DOI 10.1093/ndt/gfg452; Nishiyama Y, 2010, J NEUROL SCI, V290, P12, DOI 10.1016/j.jns.2009.12.020; Owe-Young R, 2008, J NEUROCHEM, V105, P1346, DOI 10.1111/j.1471-4159.2008.05241.x; Papassotiropoulos A, 2000, NEUROREPORT, V11, P1959, DOI 10.1097/00001756-200006260-00030; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Rao AM, 2000, J NEUROCHEM, V74, P1106; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Schonknecht P, 2002, NEUROSCI LETT, V324, P83, DOI 10.1016/S0304-3940(02)00164-7; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Urban M, 2010, ANAL BIOCHEM, V406, P124, DOI 10.1016/j.ab.2010.07.002; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Van den Akker CHR, 2010, CURR OPIN CLIN NUTR, V13, P75, DOI 10.1097/MCO.0b013e328333aa4f; Vary TC, 1996, SHOCK, V6, P89, DOI 10.1097/00024382-199608000-00002; Wang XY, 2009, J CHILD NEUROL, V24, P1171, DOI 10.1177/0883073809338068; Wikoff WR, 2008, J CLIN INVEST, V118, P2661, DOI 10.1172/JCI34138; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zuur Alain F., 2009, P1	71	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29503	10.1371/journal.pone.0029503	http://dx.doi.org/10.1371/journal.pone.0029503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242129	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000044
J	Muszewska, A; Hoffman-Sommer, M; Grynberg, M				Muszewska, Anna; Hoffman-Sommer, Marta; Grynberg, Marcin			LTR Retrotransposons in Fungi	PLOS ONE			English	Article							GENOME SEQUENCE; TRANSPOSABLE ELEMENTS; CHAETOMIUM-GLOBOSUM; EVOLUTION; INSIGHTS; FAMILIES; TOOL; TRANSCRIPTOME; TRANSPOSITION; MECHANISMS	Transposable elements with long terminal direct repeats (LTR TEs) are one of the best studied groups of mobile elements. They are ubiquitous elements present in almost all eukaryotic genomes. Their number and state of conservation can be a highlight of genome dynamics. We searched all published fungal genomes for LTR-containing retrotransposons, including both complete, functional elements and remnant copies. We identified a total of over 66,000 elements, all of which belong to the Ty1/Copia or Ty3/Gypsy superfamilies. Most of the detected Gypsy elements represent Chromoviridae, i.e. they carry a chromodomain in the pol ORF. We analyzed our data from a genome-ecology perspective, looking at the abundance of various types of LTR TEs in individual genomes and at the highest-copy element from each genome. The TE content is very variable among the analyzed genomes. Some genomes are very scarce in LTR TEs (<50 elements), others demonstrate huge expansions (>8000 elements). The data shows that transposon expansions in fungi usually involve an increase both in the copy number of individual elements and in the number of element types. The majority of the highest-copy TEs from all genomes are Ty3/Gypsy transposons. Phylogenetic analysis of these elements suggests that TE expansions have appeared independently of each other, in distant genomes and at different taxonomical levels. We also analyzed the evolutionary relationships between protein domains encoded by the transposon pol ORF and we found that the protease is the fastest evolving domain whereas reverse transcriptase and RNase H evolve much slower and in correlation with each other.	[Muszewska, Anna; Hoffman-Sommer, Marta; Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Muszewska, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	musze@icm.edu.pl	Muszewska, Anna/S-9406-2019	Muszewska, Anna/0000-0002-4578-844X; Hoffman-Sommer, Marta/0000-0002-1451-5967; Grynberg, Marcin/0000-0003-1887-7209				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; Balajee SA, 2009, MED MYCOL, V47, pS42, DOI 10.1080/13693780802562092; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blandin G, 2000, FEBS LETT, V487, P91, DOI 10.1016/S0014-5793(00)02287-0; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; CAMERON JR, 1979, CELL, V16, P739, DOI 10.1016/0092-8674(79)90090-4; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Craig NL, 2002, MOBILE DNA, pxviii; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Dobinson K F, 1993, Trends Microbiol, V1, P348, DOI 10.1016/0966-842X(93)90076-4; Dorn B, 2011, J APPL MICROBIOL, V111, P693, DOI 10.1111/j.1365-2672.2011.05091.x; Dutta Shuchismita, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0109s20; Eddy Sean R, 2009, Genome Inform, V23, P205; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gao X, 2008, GENOME RES, V18, P359, DOI 10.1101/gr.7146408; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hughes SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000233; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kejnovsky E, 2006, MOL GENET GENOMICS, V276, P254, DOI 10.1007/s00438-006-0140-x; Kordis D, 2005, GENE, V347, P161, DOI 10.1016/j.gene.2004.12.017; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-3; Llorens C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-276; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Malik HS, 2005, CYTOGENET GENOME RES, V110, P392, DOI 10.1159/000084971; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nakayashiki H, 1999, GENETICS, V153, P693; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; NORTHAM BE, 1951, J GEN MICROBIOL, V5, P502, DOI 10.1099/00221287-5-3-502; Novikova O S, 2010, Genetika, V46, P725; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pantou MP, 2008, GENE, V419, P7, DOI 10.1016/j.gene.2008.04.009; Paoletti M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-223; Pelizza SA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7001; Piriyapongsa J, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-31; Plett JM, 2011, TRENDS GENET, V27, P14, DOI 10.1016/j.tig.2010.10.005; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Reissinger A, 2003, MYCOL RES, V107, P1094, DOI 10.1017/S0953756203008189; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Rokas A, 2009, TRENDS GENET, V25, P60, DOI 10.1016/j.tig.2008.11.003; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; SCHMIDBERGER N, 1994, J BACTERIOL, V176, P2477, DOI 10.1128/JB.176.9.2477-2482.1994; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Turgeon BG, 2007, ADV GENET, V57, P219, DOI 10.1016/S0065-2660(06)57006-3; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Windhofer F, 2000, CURR GENET, V37, P194, DOI 10.1007/s002940050519; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu J, 2006, MED MYCOL, V44, P541, DOI 10.1080/13693780500525235; Yukawa M., 1931, B SCI FALKULTATO TER, V4, P218; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	88	63	69	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29425	10.1371/journal.pone.0029425	http://dx.doi.org/10.1371/journal.pone.0029425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242120	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000032
J	Lemaitre, C; Fischer, B; Kalousi, A; Hoffbeck, AS; Guirouilh-Barbat, J; Shahar, OD; Genet, D; Goldberg, M; Bertrand, P; Lopez, B; Brino, L; Soutoglou, E				Lemaitre, C.; Fischer, B.; Kalousi, A.; Hoffbeck, A-S; Guirouilh-Barbat, J.; Shahar, O. D.; Genet, D.; Goldberg, M.; Bertrand, P.; Lopez, B.; Brino, L.; Soutoglou, E.			The nucleoporin 153, a novel factor in double-strand break repair and DNA damage response	ONCOGENE			English	Article						DNA repair; nuclear pore; 53BP1	MAMMALIAN-CELLS; 53BP1; ATM; REPLICATION; STABILITY; DISTINCT; PATHWAY; COMPLEX; MDC1	DNA repair is essential in maintaining genome integrity and defects in different steps of the process have been linked to cancer and aging. It is a long lasting question how DNA repair is spatially and temporarily organized in the highly compartmentalized nucleus and whether the diverse nuclear compartments regulate differently the efficiency of repair. Increasing evidence suggest the involvement of nuclear pore complexes in repair of double-strand breaks (DSBs) in yeast. Here, we show that the human nucleoporin 153 (NUP153) has a role in repair of DSBs and in the activation of DNA damage checkpoints. We explore the mechanism of action of NUP153 and we propose its potential as a novel therapeutic target in cancers.	[Soutoglou, E.] CU Strasbourg, INSERM U964, UMR CNRS 7104, IGBMC,UdS, F-67404 Illkirch Graffenstaden, France; [Fischer, B.; Brino, L.] CU Strasbourg, UMR CNRS 7104, IGBMC, High Throughput Screening Facil, F-67404 Illkirch Graffenstaden, France; [Guirouilh-Barbat, J.; Genet, D.; Bertrand, P.; Lopez, B.] CNRS, UMR217, Inst Cellular & Mol Radiobiol, Fontenay Aux Roses, France; [Shahar, O. D.; Goldberg, M.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Hebrew University of Jerusalem	Soutoglou, E (corresponding author), CU Strasbourg, INSERM U964, UMR CNRS 7104, IGBMC,UdS, BP 10142, F-67404 Illkirch Graffenstaden, France.	evisou@igbmc.fr	Shahar, Or/ABG-9168-2020; Boumendil, Charlene/GPS-4811-2022; guirouilh-barbat, josée/AAX-7140-2020; Lopez, Bernard S/O-7308-2017; guirouilh-barbat, josee/O-7286-2017	Boumendil, Charlene/0000-0002-1953-3902; Lopez, Bernard S/0000-0001-5088-0155; BERTRAND, Pascale/0000-0002-9019-742X; Soutoglou, Evi/0000-0002-3724-5613; Brino, laurent/0000-0002-9036-1461; Shahar, Or/0000-0002-5039-8307; Goldberg, Michal/0000-0001-9397-2383; guirouilh-barbat, josee/0000-0002-8845-7333	Region Alsace; CNRS; ANR; INCA; HFSP	Region Alsace(Region Grand-Est); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); INCA(Institut National du Cancer (INCA) France); HFSP(Human Frontier Science Program)	We thank Amelie Weiss, Laure Froidevaux and Audrey Furst for excellent technical assistance. The GFP-NUP153 vector was provided by Ian Ellenberg (EMBL, Heidelberg). We are grateful to Zita Nagy and Tibor Pankotai for critical reading of the manuscript. C.L. is supported by the Region Alsace. The research in E.S. lab is funded by CNRS, ANR, INCA and HFSP. We thank the imaging center of IGBMC and particularly Marc Koch for the help with the multi photon laser experiments.	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mochan TA, 2003, CANCER RES, V63, P8586; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Reddy KL, 2008, METHODS, V45, P242, DOI 10.1016/j.ymeth.2008.06.013; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x	27	43	43	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	45					4803	4809		10.1038/onc.2011.638	http://dx.doi.org/10.1038/onc.2011.638			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22249246				2022-12-25	WOS:000311033000009
J	Hirota, N; Risse, PA; Novali, M; McGovern, T; Al-Alwan, L; McCuaig, S; Proud, D; Hayden, P; Hamid, Q; Martin, JG				Hirota, Nobuaki; Risse, Paul-Andre; Novali, Mauro; McGovern, Toby; Al-Alwan, Laila; McCuaig, Sarah; Proud, David; Hayden, Patrick; Hamid, Qutayba; Martin, James G.			Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells	FASEB JOURNAL			English	Article						amphiregulin; heparin-binding epidermal growth factor-like growth factor; HB-EGF; proliferation; migration; goblet cell differentiation	ALPHA-CONVERTING-ENZYME; SMOOTH-MUSCLE; EGF RECEPTOR; HB-EGF; MAST-CELL; PROLIFERATION; AMPHIREGULIN; EXPRESSION; ACTIVATION; ASTHMA	Asthma is a chronic inflammatory disease that is associated with airway remodeling, including hyperplasia of airway epithelial cells and airway smooth muscle cells, and goblet cell differentiation. We wished to address the potential role of histamine, a key biogenic amine involved in allergic reactions, in airway remodeling through the epidermal growth factor receptor (EGFR) pathway. Here, we demonstrate that histamine releases 2 EGFR ligands, amphiregulin and heparin-binding epidermal growth factor-like growth factor (HB-EGF), from airway epithelial cells. Amphiregulin and HB-EGF were expressed in airway epithelium of patients with asthma. Histamine up-regulated their mRNA expression (amphiregulin 3.2-fold, P<0.001; HB-EGF 2.3-fold, P<0.05) and triggered their release (amphiregulin EC50 0.50 mu M, 31.2 +/- 2.7 pg/ml with 10 mu M histamine, P<0.01; HB-EGF EC50 0.54 mu M, 78.5 +/- 1.8 pg/ml with 10 mu M histamine, P<0.001) compared to vehicle control (amphiregulin 19.3 +/- 0.9 pg/ml; HB-EGF 60.2 +/- 1.0 pg/ml), in airway epithelial cells. Histamine increased EGFR phosphorylation (2.1-fold by Western blot analysis) and induced goblet cell differentiation (CLCA1 up-regulation by real-time qPCR) in normal human bronchial epithelial (NHBE) cells. Moreover, amphiregulin and HB-EGF caused proliferation and migration of both NHBE cells and human airway smooth muscle cells. These results suggest that histamine may induce airway remodeling via the epithelial-derived EGFR ligands amphiregulin and HB-EGF.-Hirota, N., Risse, P.-A., Novali, M., McGovern, T., Al-Alwan, L., McCuaig, S., Proud, D., Hayden, P., Hamid, Q., Martin, J. G. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. FASEB J. 26, 1704-1716 (2012). www.fasebj.org	[Hirota, Nobuaki; Risse, Paul-Andre; Novali, Mauro; McGovern, Toby; Al-Alwan, Laila; McCuaig, Sarah; Hamid, Qutayba; Martin, James G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; [Proud, David] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hayden, Patrick] MatTek Corp, Ashland, ME USA	McGill University; University of Calgary; MatTek Corporation	Martin, JG (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, 3626 St Urbain, Montreal, PQ H2X 2P2, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363; Hayden, Patrick/0000-0001-8977-1845	Richard and Edith Strauss Canada Foundation; Canadian Institutes of Health Research [MOP-93747]; Strauss Canada Foundation; Canadian Thoracic Society	Richard and Edith Strauss Canada Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Canada Foundation; Canadian Thoracic Society	The authors thank Dr. Muhannad Hassan for his technical support with immunostaining. The authors also thank Ms. Jamilah P. Saeed and laboratory members for technical advice and useful discussions. The authors also acknowledge the assistance of Dr. R. Olivenstein and the Difficult Asthma Program (McGill University). This work was supported in part by The Richard and Edith Strauss Canada Foundation and by Canadian Institutes of Health Research grant MOP-93747. N.H. was supported by a fellowship from the Strauss Canada Foundation. T. M. was supported by a studentship of the Canadian Thoracic Society.	Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Baginski TK, 2006, AM J RESP CELL MOL, V35, P165, DOI 10.1165/rcmb.2005-0259OC; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Carrasco-Garcia E, 2011, EXP CELL RES, V317, P1476, DOI 10.1016/j.yexcr.2011.03.015; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; Chhabra J, 2007, EUR RESPIR J, V29, P861, DOI 10.1183/09031936.00106306; Chu EK, 2005, AM J RESP CELL MOL, V32, P373, DOI 10.1165/rcmb.2004-0266OC; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; Deshmukh HS, 2005, AM J RESP CRIT CARE, V171, P305, DOI 10.1164/rccm.200408-1003OC; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Govindaraju V, 2006, AM J PHYSIOL-CELL PH, V291, pC957, DOI 10.1152/ajpcell.00451.2005; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kasina S, 2009, CELL PROLIFERAT, V42, P799, DOI 10.1111/j.1365-2184.2009.00645.x; Kim KW, 2009, CHEST, V136, P805, DOI 10.1378/chest.08-2972; Kunzmann S, 2007, J ALLERGY CLIN IMMUN, V119, P1398, DOI 10.1016/j.jaci.2007.02.018; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Liles JS, 2010, CANCER BIOL THER, V10, P555, DOI 10.4161/cbt.10.6.12532; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGovern T, 2010, AM J PHYSIOL-LUNG C, V299, pL808, DOI 10.1152/ajplung.00438.2009; Noga O, 2006, J ALLERGY CLIN IMMUN, V117, P1493, DOI 10.1016/j.jaci.2006.02.028; Nopp A, 2010, ALLERGY, V65, P56, DOI 10.1111/j.1398-9995.2009.02144.x; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Ornskov D, 2007, BIOCHEM BIOPH RES CO, V354, P885, DOI 10.1016/j.bbrc.2007.01.047; PANETTIERI RA, 1990, AM J PHYSIOL, V259, pL365, DOI 10.1152/ajplung.1990.259.6.L365; Park SJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-78; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Rocks N, 2008, CELL PROLIFERAT, V41, P988, DOI 10.1111/j.1365-2184.2008.00557.x; Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Shah BH, 2004, TRENDS ENDOCRIN MET, V15, P47, DOI 10.1016/j.tem.2004.01.004; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shiomi T., 2010, AM J RESP CELL MOL B; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Suzuki M, 1997, J BIOL CHEM, V272, P31730, DOI 10.1074/jbc.272.50.31730; Tamaoka M, 2008, EUR RESPIR J, V32, P1213, DOI 10.1183/09031936.00166907; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Waterman H, 1999, EMBO J, V18, P3348, DOI 10.1093/emboj/18.12.3348; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	64	48	49	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1704	1716		10.1096/fj.11-197061	http://dx.doi.org/10.1096/fj.11-197061			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22247333				2022-12-25	WOS:000302359700031
J	Xia, HP; Cheung, WKC; Ng, SS; Jiang, XC; Jiang, SS; Sze, J; Leung, GKK; Lu, G; Chan, DTM; Bian, XW; Kung, HF; Poon, WS; Lin, MC				Xia, Hongping; Cheung, William K. C.; Ng, Samuel S.; Jiang, Xiaochun; Jiang, Songshan; Sze, Johnny; Leung, Gilberto K. K.; Lu, Gang; Chan, Danny T. M.; Bian, Xiu-Wu; Kung, Hsiang-Fu; Poon, Wai Sang; Lin, Marie C.			Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOBLASTOMA-MULTIFORME; INVASION; TUMOR; CANCER; DIFFERENTIATION; IDENTIFICATION; GENES; PROLIFERATION; PLURIPOTENCY; PROGRESSION	miR-124 is a brain-enriched microRNA that plays a crucial role in neural development and has been shown to be down-regulated in glioma and medulloblastoma, suggesting its possible involvement in brain tumor progression. Here, we show that miR-124 is down-regulated in a panel of different grades of glioma tissues and in all of the human glioma cell lines we examined. By integrated bioinformatics analysis and experimental confirmation, we identified SNAI2, which is often up-regulated in glioma, as a direct functional target of miR-124. Because SNAI2 has been shown to regulate stem cell functions, we examined the roles of miR-124 and SNAI2 in glioma cell stem-like traits. The results showed that overexpression of miR-124 and knockdown of SNAI2 reduced neurosphere formation, CD133(+) cell subpopulation, and stem cell marker (BMI1, Nanog, and Nestin) expression, and these effects could be rescued by re-expression of SNAI2. Furthermore, enhanced miR-124 expression significantly inhibited glioma cell invasion in vitro. Finally, stable overexpression of miR-124 and knockdown of SNAI2 inhibited the tumorigenicity and invasion of glioma cells in vivo. These findings reveal, for the first time, that the tumor suppressor activity of miR-124 could be partly due to its inhibitory effects on glioma stem-like traits and invasiveness through SNAI2.	[Xia, Hongping; Sze, Johnny; Lu, Gang; Chan, Danny T. M.; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Sze, Johnny; Lu, Gang; Chan, Danny T. M.; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Cheung, William K. C.; Ng, Samuel S.; Sze, Johnny; Lin, Marie C.] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Jiang, Xiaochun] Sun Yat Sen Univ, Wannan Med Coll, Yijishan Hosp, Dept Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Leung, Gilberto K. K.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Bian, Xiu-Wu; Kung, Hsiang-Fu; Lin, Marie C.] Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Bian, Xiu-Wu; Kung, Hsiang-Fu; Lin, Marie C.] Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sun Yat Sen University; Wannan Medical College; Sun Yat Sen University; University of Hong Kong; Army Medical University; Army Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Poon, WS (corresponding author), Chinese Univ Hong Kong, Brain Tumour Ctr, Shatin, Hong Kong, Peoples R China.	wpoon@cuhk.edu.hk; mcllin@surgery.cuhk.edu.hk	XIA, HONGPING/AAK-7100-2020; Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011; Bian, Xiu-Wu/D-4736-2017; Leung, Gilberto Ka Kit/C-4337-2009	Bian, Xiu-Wu/0000-0003-4383-0197; Leung, Gilberto Ka Kit/0000-0003-3147-3057; LU, Gang/0000-0001-5921-1839	Research Grants Council of the Hong Kong Special Administrative Region, China [467109, 470911]; National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Grants 467109 and 470911 from the Research Grants Council of the Hong Kong Special Administrative Region, China, and by Grants 2010CB529400 and 2010CB912800 from the National Basic Research Program of China (973 Program).	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207, DOI 10.1007/BF00691091; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006; Wong JWJ, 2010, J NEUROSCI, V30, P3868, DOI 10.1523/JNEUROSCI.0442-10.2010; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xie ZG, 2009, NEUROCHEM RES, V34, P2055, DOI 10.1007/s11064-009-0079-5; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	49	142	151	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9962	9971		10.1074/jbc.M111.332627	http://dx.doi.org/10.1074/jbc.M111.332627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22253443	Green Published, hybrid			2022-12-25	WOS:000302167200028
J	Lee, J; Kim, D; Choi, J; Choi, H; Ryu, JH; Jeong, J; Park, EJ; Kim, SH; Kim, S				Lee, Junghun; Kim, Donghyun; Choi, Jonghyun; Choi, Hyounjeong; Ryu, Jae-Ha; Jeong, Jinhyun; Park, Eun-Jin; Kim, Seon-Hee; Kim, Sunyoung			Dehydrodiconiferyl Alcohol Isolated from Cucurbita moschata Shows Anti-adipogenic and Anti-lipogenic Effects in 3T3-L1 Cells and Primary Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; GROWTH-FACTOR-I; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; TRANSGENIC MICE; BINDING PROTEINS; GENE-EXPRESSION; STEM-CELL; OBESITY; LIGNIN	A water-soluble extract from the stems of Cucurbita moschata, code named PG105, was previously found to contain strong anti-obesity activities in a high fat diet-induced obesity mouse model. One of its biological characteristics is that it inhibits 3T3-L1 adipocyte differentiation. To isolate the biologically active compound(s), conventional solvent fractionation was performed, and the various fractions were tested for anti-adipogenic activity using Oil Red O staining method. A single spot on thin layer chromatography of the chloroform fraction showed a potent anti-adipogenic activity. When purified, the structure of its major component was resolved as dehydrodiconiferyl alcohol (DHCA), a lignan, by NMR and mass spectrometry analysis. In 3T3-L1 cells, synthesized DHCA significantly reduced the expression of several adipocyte marker genes, including peroxisome proliferator-activated receptor gamma (Pparg), CCAAT/enhancer-binding protein alpha (Cebpa), fatty acid-binding protein 4 (Fabp4), sterol response element-binding protein-1c (Srebp1c), and stearoyl-coenzyme A desaturase-1 (Scd), and decreased lipid accumulation without affecting cell viability. DHCA also suppressed the mitotic clonal expansion of preadipocytes (an early event of adipogenesis), probably by suppressing the DNA binding activity of C/EBP beta, and lowered the production level of cyclinA and cyclin-dependent kinase 2 (Cdk2), coinciding with the decrease in DNA synthesis and cell division. In addition, DHCA directly inhibited the expression of SREBP-1c and SCD-1. Similar observations were made, using primary mouse embryonic fibroblasts. Taken together, our data indicate that DHCA may contain dual activities, affecting both adipogenesis and lipogenesis.	[Lee, Junghun; Kim, Donghyun; Choi, Jonghyun; Choi, Hyounjeong; Kim, Sunyoung] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Ryu, Jae-Ha] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea; [Jeong, Jinhyun] Yonsei Univ, Coll Pharm, Inchon 406840, South Korea; [Park, Eun-Jin; Kim, Seon-Hee] Viromed Co Ltd, Seoul 151747, South Korea	Seoul National University (SNU); Sookmyung Women's University; Yonsei University	Kim, S (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	sunyoung@snu.ac.kr	Kim, Donghyun/J-3609-2019	Kim, Donghyun/0000-0002-5137-2213; Lee, Junghun/0000-0003-4524-0625	National Research Foundation of Korea [2011-0030699]; Brain Research Center [2011 K000287]; Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Grants 2011-0030699 (to J.-H.R.), and 2011 K000287 (to S.K.) from the National Research Foundation of Korea, and the Brain Research Center of the 21st Century Frontier Research Program, respectively, funded by the Ministry of Education, Science and Technology, in which Viromed Co., Ltd. is a participating company.	ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Auld CA, 2007, J CELL BIOCHEM, V100, P204, DOI 10.1002/jcb.21063; Barcelo AR, 2003, FUNCT PLANT BIOL, V30, P577, DOI 10.1071/FP02096; Byers T, 2007, J NUTR, V137, P488, DOI 10.1093/jn/137.2.488; Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107; Cook A., 2008, ADIPOSE; Dani C, 1999, CELLS TISSUES ORGANS, V165, P173, DOI 10.1159/000016697; Deedwania P C, 2006, J Assoc Physicians India, V54, P797; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; FREUDENBERG K, 1965, SCIENCE, V148, P595, DOI 10.1126/science.148.3670.595; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gang DR, 1999, CHEM BIOL, V6, P143, DOI 10.1016/S1074-5521(99)89006-1; Gnudi L, 1996, P NUTR SOC, V55, P191, DOI 10.1079/PNS19960020; Greenwood M R, 1977, Curr Concepts Nutr, V5, P119; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Harp JB, 2004, CURR OPIN LIPIDOL, V15, P303, DOI 10.1097/00041433-200406000-00010; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HIRSCH J, 1969, J LIPID RES, V10, P77; Hu K, 2006, ARCH PHARM RES, V29, P563, DOI 10.1007/BF02969265; Jin SH, 2000, J BIOL CHEM, V275, P34344, DOI 10.1074/jbc.M004927200; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu KN, 2002, MOL CELL ENDOCRINOL, V194, P51, DOI 10.1016/S0303-7207(02)00188-0; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; NOSE M, 1995, PHYTOCHEMISTRY, V39, P71, DOI 10.1016/0031-9422(95)95268-Y; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Qiu ZL, 2001, J BIOL CHEM, V276, P11988, DOI 10.1074/jbc.M011729200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tchoukalova YD, 2000, OBES RES, V8, P664, DOI 10.1038/oby.2000.85; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	47	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8839	8851		10.1074/jbc.M111.263434	http://dx.doi.org/10.1074/jbc.M111.263434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262865	hybrid, Green Published			2022-12-25	WOS:000301797800016
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Neurodegeneration Induced by Clustering of Sialylated Glycosylphosphatidylinositols of Prion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; MOUSE MODEL; SCRAPIE; CELL; CHOLESTEROL; PHOSPHOLIPASE; RAFTS; THY-1	The transmissible spongiform encephalopathies, more commonly known as the prion diseases, are associated with the production and aggregation of disease-related isoforms of the prion protein (PrPSc). The mechanisms by which PrPSc accumulation causes neurodegeneration in these diseases are poorly understood. In cultured neurons, the addition of PrPSc alters cell membranes, increasing cholesterol, activating cytoplasmic phospholipase A(2) (cPLA(2)), and triggering synapse damage. These effects of PrPSc are dependent upon its glycosylphosphatidylinositol (GPI) anchor, suggesting that it is the increased density of GPIs that occurs following the aggregation of PrPSc molecules that triggers neurodegeneration. This hypothesis was supported by observations that cross-linkage of the normal cellular prion protein (PrPC) also increased membrane cholesterol, activated cPLA2, and triggered synapse damage. These effects were not seen after cross-linkage of Thy-1, another GPI-anchored protein, and were dependent on the GPI anchor attached to PrPC containing two acyl chains and sialic acid. We propose that the aggregation of PrPSc, or the cross-linkage of PrPC, causes the clustering of sialic acid-containing GPI anchors at high densities, resulting in altered membrane composition, the pathological activation of cPLA(2), and synapse damage.	[Bate, Clive] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-13; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; Haviv Y, 2008, ARCH NEUROL-CHICAGO, V65, P762, DOI 10.1001/archneur.65.6.762; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; LUNDJOHANSEN F, 1993, EUR J IMMUNOL, V23, P2782, DOI 10.1002/eji.1830231110; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7935	7944		10.1074/jbc.M111.275743	http://dx.doi.org/10.1074/jbc.M111.275743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262833	Green Published, hybrid			2022-12-25	WOS:000301349400010
J	Colletti, GA; Miedel, MT; Quinn, J; Andharia, N; Weisz, OA; Kiselyov, K				Colletti, Grace A.; Miedel, Mark T.; Quinn, James; Andharia, Neel; Weisz, Ora A.; Kiselyov, Kirill			Loss of Lysosomal Ion Channel Transient Receptor Potential Channel Mucolipin-1 (TRPML1) Leads to Cathepsin B-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL ABERRATIONS; PROTEIN; IV; MUTATIONS; AUTOPHAGY; TRAFFICKING; INHIBITORS; RELEASE	Mucolipidosis type IV (MLIV) is a lysosomal storage disease caused by mutations in the gene MCOLN1, which codes for the transient receptor potential family ion channel TRPML1. MLIV has an early onset and is characterized by developmental delays, motor and cognitive deficiencies, gastric abnormalities, retinal degeneration, and corneal cloudiness. The degenerative aspects of MLIV have been attributed to cell death, whose mechanisms remain to be delineated in MLIV and in most other storage diseases. Here we report that an acute siRNA-mediated loss of TRPML1specifically causes a leak of lysosomal protease cathepsin B (CatB) into the cytoplasm. CatB leak is associated with apoptosis, which can be prevented by CatB inhibition. Inhibition of the proapoptotic protein Bax prevents TRPML1 KD-mediated apoptosis but does not prevent cytosolic release of CatB. This is the first evidence of a mechanistic link between acute TRPML1 loss and cell death.	[Colletti, Grace A.; Quinn, James; Andharia, Neel; Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Miedel, Mark T.; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Miedel, Mark T.; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kiselyov, K (corresponding author), 4249 5th Ave, Pittsburgh, PA 15260 USA.	kiselyov@pitt.edu		Miedel, Mark/0000-0002-0132-6032; Kiselyov, Kirill/0000-0001-6683-2895	National Institutes of Health [HD058577, ES01678]; National Institutes of Health CTSI [5TL1RR 024155]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058577] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants HD058577 and ES01678 (to K. K.).; Supported by National Institutes of Health predoctoral CTSI fellowship 5TL1RR 024155. Present address: Dept. of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Cheriyath V, 2011, BRIT J CANCER, V104, P957, DOI 10.1038/bjc.2011.42; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frei KP, 1998, NEUROLOGY, V51, P565, DOI 10.1212/WNL.51.2.565; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; HANEWINKEL H, 1987, J BIOL CHEM, V262, P12351; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Krepela E, 2001, NEOPLASMA, V48, P332; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; MACH L, 1992, BIOCHEM J, V282, P577, DOI 10.1042/bj2820577; Michallet MC, 2003, BLOOD, V102, P3719, DOI 10.1182/blood-2003-04-1075; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Moles A, 2012, J BIOL CHEM, V287, P1178, DOI 10.1074/jbc.M111.272393; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Rommelaere G, 2011, AM J PHYSIOL-CELL PH, V300, pC1090, DOI 10.1152/ajpcell.00037.2010; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiffmann R, 1998, P NATL ACAD SCI USA, V95, P1207, DOI 10.1073/pnas.95.3.1207; SCORNIK OA, 1984, J CELL PHYSIOL, V121, P257, DOI 10.1002/jcp.1041210132; SEGLEN PO, 1981, ACTA BIOL MED GER, V40, P1587; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Siegel H, 1998, ELECTROEN CLIN NEURO, V106, P400, DOI 10.1016/S0013-4694(98)00013-3; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun LM, 2010, TOXICOL IN VITRO, V24, P1504, DOI 10.1016/j.tiv.2010.07.013; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Weimer JM, 2002, NEUROMOL MED, V1, P111, DOI 10.1385/NMM:1:2:111; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yeung BHY, 2006, J BIOL CHEM, V281, P11923, DOI 10.1074/jbc.M508533200; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x	63	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8082	8091		10.1074/jbc.M111.285536	http://dx.doi.org/10.1074/jbc.M111.285536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262857	Green Published, hybrid			2022-12-25	WOS:000301349400024
J	Niehaus, TD; Kinison, S; Okada, S; Yeo, YS; Bell, SA; Cui, P; Devarenne, TP; Chappell, J				Niehaus, Tom D.; Kinison, Scott; Okada, Shigeru; Yeo, Yun-soo; Bell, Stephen A.; Cui, Ping; Devarenne, Timothy P.; Chappell, Joe			Functional Identification of Triterpene Methyltransferases from Botryococcus braunii Race B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-ALGA; O-METHYLTRANSFERASES; ARABIDOPSIS-THALIANA; HIGHER-PLANTS; VAR SHOWA; BIOSYNTHESIS; HYDROCARBONS; EVOLUTION; STRAINS; METHYLATION	Botryococcus braunii race B is a colony-forming, green algae that accumulates triterpene oils in excess of 30% of its dry weight. The composition of the triterpene oils is dominated by dimethylated to tetramethylated forms of botryococcene and squalene. Although unusual mechanisms for the biosynthesis of botryococcene and squalene were recently described, the enzyme(s) responsible for decorating these triterpene scaffolds with methyl substituents were unknown. A transcriptome of B. braunii was screened computationally assuming that the triterpene methyltransferases (TMTs) might resemble the S-adenosyl methionine-dependent enzymes described for methylating the side chain of sterols. Six sterol methyltransferase-like genes were isolated and functionally characterized. Three of these genes when co-expressed in yeast with complementary squalene synthase or botryococcene synthase expression cassettes resulted in the accumulation of mono-and dimethylated forms of both triterpene scaffolds. Surprisingly, TMT-1 and TMT-2 exhibited preference for squalene as the methyl acceptor substrate, whereas TMT-3 showed a striking preference for botryococcene as its methyl acceptor substrate. These in vivo preferences were confirmed with in vitro assays utilizing microsomal preparations from yeast overexpressing the respective genes, which encode for membrane-associated enzymes. Structural examination of the in vivo yeast generated mono-and dimethylated products by NMR identified terminal carbons, C-3 and C-22/C-20, as the atomic acceptor sites for the methyl additions to squalene and botryococcene, respectively. These sites are identical to those previously reported for the triterpenes extracted from the algae. The availability of closely related triterpene methyltransferases exhibiting distinct substrate selectivity and successive catalytic activities provides important tools for investigating the molecular mechanisms responsible for the specificities exhibited by these unique enzymes.	[Niehaus, Tom D.; Kinison, Scott; Yeo, Yun-soo; Bell, Stephen A.; Chappell, Joe] Univ Kentucky, Plant Biol Program, Lexington, KY 40546 USA; [Okada, Shigeru] Univ Tokyo, Dept Aquat Biosci, Tokyo 1138657, Japan; [Cui, Ping; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of Kentucky; University of Tokyo; Texas A&M University System; Texas A&M University College Station	Chappell, J (corresponding author), Univ Kentucky, Plant Biol Program, 1405 Vet Dr, Lexington, KY 40546 USA.	chappell@uky.edu	Okada, Shigeru/U-8305-2017	Okada, Shigeru/0000-0003-3663-7778; Devarenne, Timothy/0000-0001-6032-8049; Niehaus, Thomas/0000-0002-3575-8001	National Science Foundation [CBET-0828817]; Sapphire Energy; Japanese Society for the Promotion of Science [21380130]	National Science Foundation(National Science Foundation (NSF)); Sapphire Energy; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the National Science Foundation (CBET-0828817) and Sapphire Energy (to J. C.) and Grant-in-Aid for Scientific Research (B) (21380130) from the Japanese Society for the Promotion of Science (to S. O.).	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Carland F, 2010, PLANT PHYSIOL, V153, P741, DOI 10.1104/pp.109.152587; Derenne S, 1997, GEOCHIM COSMOCHIM AC, V61, P1879, DOI 10.1016/S0016-7037(97)00042-2; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Gang DR, 2005, ANNU REV PLANT BIOL, V56, P301, DOI 10.1146/annurev.arplant.56.032604.144128; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; GELPI E, 1968, SCIENCE, V161, P700, DOI 10.1126/science.161.3842.700; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; Grebenok RJ, 1997, PLANT MOL BIOL, V34, P891, DOI 10.1023/A:1005818210641; Han Y, 2007, GENETICS, V176, P2625, DOI 10.1534/genetics.107.073650; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3043, DOI 10.1016/0031-9422(89)80276-6; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; KAGAN R, 1995, ARCH BIOCHEM BIOPHYS, V316, P657, DOI 10.1006/abbi.1995.1087; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Leustek T, 1997, J BIOL CHEM, V272, P2744, DOI 10.1074/jbc.272.5.2744; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; MALHOTRA HC, 1971, J BIOL CHEM, V246, P4934; Mastalerz M, 1996, ORG GEOCHEM, V24, P301, DOI 10.1016/0146-6380(96)00027-7; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; METZGER P, 1988, PHYTOCHEMISTRY, V27, P1383, DOI 10.1016/0031-9422(88)80199-7; Metzger P, 2002, PHYTOCHEMISTRY, V59, P839, DOI 10.1016/S0031-9422(02)00005-5; METZGER P, 1983, TETRAHEDRON LETT, V24, P4013, DOI 10.1016/S0040-4039(00)88250-7; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Metzger P, 1999, TETRAHEDRON, V55, P167, DOI 10.1016/S0040-4020(98)01036-9; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; Morrison R. T., 1973, ORGANIC CHEM, P109; Nes WD, 2000, BBA-MOL CELL BIOL L, V1529, P63, DOI 10.1016/S1388-1981(00)00138-4; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; Okada S, 1997, TETRAHEDRON, V53, P11307, DOI 10.1016/S0040-4020(97)00705-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rodriguez D, 2004, J BIOL CHEM, V279, P8149, DOI 10.1074/jbc.M312351200; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Song LS, 2003, ANAL BIOCHEM, V317, P180, DOI 10.1016/S0003-2697(03)00138-6; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Ueki N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-103; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Yang Y, 2006, ARCH BIOCHEM BIOPHYS, V448, P123, DOI 10.1016/j.abb.2005.08.006; Zhang W, 2007, J BIOL CHEM, V282, P25717, DOI 10.1074/jbc.M703437200; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	51	33	42	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8163	8173		10.1074/jbc.M111.316059	http://dx.doi.org/10.1074/jbc.M111.316059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22241476	Green Published, hybrid			2022-12-25	WOS:000301349400032
J	Karo, J; Peterson, P; Vendelin, M				Karo, Jaanus; Peterson, Pearu; Vendelin, Marko			Molecular Dynamics Simulations of Creatine Kinase and Adenine Nucleotide Translocase in Mitochondrial Membrane Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-HEART MITOCHONDRIA; COARSE-GRAINED MODEL; INNER MEMBRANE; DIFFUSION RESTRICTIONS; ADP/ATP CARRIER; ATP SYNTHESIS; FORCE-FIELD; ENERGY; CARDIOLIPIN; TRANSPORT	Interaction between mitochondrial creatine kinase (MtCK) and adenine nucleotide translocase (ANT) can play an important role in determining energy transfer pathways in the cell. Although the functional coupling between MtCK and ANT has been demonstrated, the precise mechanism of the coupling is not clear. To study the details of the coupling, we turned to molecular dynamics simulations. We introduce a new coarse-grained molecular dynamics model of a patch of the mitochondrial inner membrane containing a transmembrane ANT and an MtCK above the membrane. The membrane model consists of three major types of lipids (phosphatidylcholine, phosphatidylethanolamine, and cardiolipin) in a roughly 2: 1: 1 molar ratio. A thermodynamics-based coarse-grained force field, termed MARTINI, has been used together with the GROMACS molecular dynamics package for all simulated systems in this work. Several physical properties of the system are reproduced by the model and are in agreement with known data. This includes membrane thickness, dimension of the proteins, and diffusion constants. We have studied the binding of MtCK to the membrane and demonstrated the effect of cardiolipin on the stabilization of the binding. In addition, our simulations predict which part of the MtCK protein sequence interacts with the membrane. Taken together, the model has been verified by dynamical and structural data and can be used as the basis for further studies.	[Karo, Jaanus; Peterson, Pearu; Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia	Tallinn University of Technology	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad Tee 21, EE-12618 Tallinn, Estonia.	markov@sysbio.ioc.ee	Vendelin, Marko/AAE-7137-2020	Vendelin, Marko/0000-0002-6459-0391; Peterson, Pearu/0000-0001-7328-4305	Wellcome Trust [WT081755]; Estonian Science Foundation MOBILITAS [MJD80]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Science Foundation MOBILITAS(Estonian Research Council)	This work was supported by Wellcome Trust Fellowship WT081755 (to M. V. and P. P.) and Estonian Science Foundation MOBILITAS Postdoctoral Research Grant MJD80.	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; BARBOUR RL, 1984, J BIOL CHEM, V259, P8246; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Carbone P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829409; Dahlberg M, 2008, J PHYS CHEM B, V112, P11655, DOI 10.1021/jp803414g; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; GUPTE SS, 1991, BIOCHIM BIOPHYS ACTA, V1069, P131, DOI 10.1016/0005-2736(91)90114-N; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hettling H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002130; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; Jepihhina N, 2011, BIOPHYS J, V101, P2112, DOI 10.1016/j.bpj.2011.09.025; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; KREBS JJR, 1979, J BIOL CHEM, V254, P5308; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lipskaya TY, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1098, DOI 10.1023/A:1012428812780; Lopez CA, 2009, J CHEM THEORY COMPUT, V5, P3195, DOI 10.1021/ct900313w; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Milano G, 2005, J PHYS CHEM B, V109, P18609, DOI 10.1021/jp0523571; Montgomery D., 2010, APPL STAT PROBABILIT, P524; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murtola T, 2011, SOFT MATTER, V7, P8135, DOI 10.1039/c1sm05367a; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Ollila OHS, 2011, BIOPHYS J, V100, P1651, DOI 10.1016/j.bpj.2011.02.027; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; ROJO M, 1991, FEBS LETT, V281, P123, DOI 10.1016/0014-5793(91)80374-C; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Saks VA, 2004, MOL CELL BIOCHEM, V256, P185, DOI 10.1023/B:MCBI.0000009868.92189.fb; SAKS VA, 1975, EUR J BIOCHEM, V57, P273, DOI 10.1111/j.1432-1033.1975.tb02299.x; Saks VA, 2000, ACTA PHYSIOL SCAND, V168, P635, DOI 10.1046/j.1365-201x.2000.00715.x; SAKS VA, 1986, BIOCHEM BIOPH RES CO, V139, P1262, DOI 10.1016/S0006-291X(86)80314-X; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Sepp M, 2010, BIOPHYS J, V98, P2785, DOI 10.1016/j.bpj.2010.03.025; Sokolova N, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-90; Song B, 2011, MOL PHYS, V109, P1511, DOI 10.1080/00268976.2011.569511; Sun Q, 2005, COMPUT CHEM ENG, V29, P2380, DOI 10.1016/j.compchemeng.2005.05.026; Vendelin M, 2004, BIOPHYS J, V87, P696, DOI 10.1529/biophysj.103.036210; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; Vendelin M, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.N110.147116; Vendelin M, 2010, J BIOL CHEM, V285, P37240, DOI 10.1074/jbc.M110.147116; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Voth Gregory A., 2009, P1; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wee CL, 2010, BIOPHYS J, V98, P1558, DOI 10.1016/j.bpj.2009.12.4321; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; Wohlert J, 2011, J CHEM THEORY COMPUT, V7, P753, DOI 10.1021/ct100489z; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0167-4838(92)90506-9; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	71	16	16	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7467	7476		10.1074/jbc.M111.332320	http://dx.doi.org/10.1074/jbc.M111.332320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241474	hybrid, Green Published			2022-12-25	WOS:000301060200047
J	Lai, CB; Mager, DL				Lai, C. Benjamin; Mager, Dixie L.			Role of Runt-related Transcription Factor 3 (RUNX3) in Transcription Regulation of Natural Cytotoxicity Receptor 1 (NCR1/NKp46), an Activating Natural Killer (NK) Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LINEAGE CHOICE; GENE; MOUSE; EXPRESSION; NKP46; DIFFERENTIATION; PROTEINS; CD8; FAMILY	Natural cytotoxicity receptor 1 (NCR1), also known as NKp46, is a natural killer (NK) lymphocyte-activating receptor. It is involved in major aspects of NK immune function and shows a high degree of lineage specificity in blood and bone marrow. The nature of its NK-restricted expression is not well understood. In this study, we confirm that human NCR1 NK-specific expression is achieved at the mRNA level. We found two key cis-regulatory elements in the immediate vicinity upstream of the gene. One element acts as an essential promoter, whereas the other acts as a tissue-dependent enhancer/repressor. This latter regulatory element contains a runt related-transcription factor (RUNX) recognition motif that preferentially binds RUNX3. Interfering with RUNX proteins using a dominant negative form results in decreased Ncr1 expression. RUNX3 over-expression had the opposite effect. These findings shed light on the role of RUNX3 in the control of an important NK-activating receptor.	[Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Lai, Chieh Min Benjamin/0000-0002-4130-9413	Canadian Institutes of Health Research; British Columbia Cancer Agency	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Agency	This work was supported by a grant from the Canadian Institutes of Health Research with core support provided by the British Columbia Cancer Agency.	Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Fu YX, 2011, J BIOL CHEM, V286, P11803, DOI 10.1074/jbc.M111.222331; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GONG JH, 1994, LEUKEMIA, V8, P652; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guo Y, 2008, BLOOD, V112, P480, DOI 10.1182/blood-2007-10-120261; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Jozaki K, 2010, ANIM BIOTECHNOL, V21, P156, DOI 10.1080/10495391003617663; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Lai CB, 2009, NUCLEIC ACIDS RES, V37, P3032, DOI 10.1093/nar/gkp174; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2009, BLOOD CELL MOL DIS, V43, P1, DOI 10.1016/j.bcmd.2009.01.009; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Storset AK, 2004, EUR J IMMUNOL, V34, P669, DOI 10.1002/eji.200324504; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Vilches C, 2000, J IMMUNOL, V165, P6416, DOI 10.4049/jimmunol.165.11.6416; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004	53	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7324	7334		10.1074/jbc.M111.306936	http://dx.doi.org/10.1074/jbc.M111.306936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253448	Green Published, hybrid			2022-12-25	WOS:000301060200034
J	Evans, SJ; Prossin, AR; Harrington, GJ; Kamali, M; Ellingrod, VL; Burant, CF; McInnis, MG				Evans, Simon J.; Prossin, Alan R.; Harrington, Gloria J.; Kamali, Masoud; Ellingrod, Vicki L.; Burant, Charles F.; McInnis, Melvin G.			Fats and Factors: Lipid Profiles Associate with Personality Factors and Suicidal History in Bipolar Subjects	PLOS ONE			English	Article							ACIDS; DISORDER; DEPRESSION; IDEATION; VIOLENT; TRAITS; STATE; MOOD; N-3	Polyunsaturated fatty acids (PUFA) have shown efficacy in the treatment of bipolar disorder, however their specific role in treating the illness is unclear. Serum PUFA and dietary intakes of PUFA associate with suicidal behavior in epidemiological studies. The objective of this study was to assess serum n-3 and n-6 PUFA levels in bipolar subjects and determine possible associations with suicidal risk, including suicidal history and relevant personality factors that have been associated with suicidality. We studied 27 bipolar subjects using the NEO-PI to assess the big five personality factors, structured interviews to verify diagnosis and assess suicidal history, and lipomics to quantify n-3 and n-6 PUFA in serum. We found positive associations between personality factors and ratios of n-3 PUFA, suggesting that conversion of short chain to long chain n-3s and the activity of enzymes in this pathway may associate with measures of personality. Thus, ratios of docosahexaenoic acid (DHA) to alpha linolenic acid (ALA) and the activity of fatty acid desaturase 2 (FADS2) involved in the conversion of ALA to DHA were positively associated with openness factor scores. Ratios of eicosapentaenoic acid (EPA) to ALA and ratios of EPA to DHA were positively associated with agreeableness factor scores. Finally, serum concentrations of the n-6, arachidonic acid (AA), were significantly lower in subjects with a history of suicide attempt compared to non-attempters. The data suggest that specific lipid profiles, which are controlled by an interaction between diet and genetics, correlate with suicidal history and personality factors related to suicidal risk. This study provides preliminary data for future studies to determine whether manipulation of PUFA profiles (through diet or supplementation) can affect personality measures and disease outcome in bipolar subjects and supports the need for further investigations into individualized specific modulations of lipid profiles to add adjunctive value to treatment paradigms.	[Evans, Simon J.; Prossin, Alan R.; Harrington, Gloria J.; Kamali, Masoud; McInnis, Melvin G.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Ellingrod, Vicki L.] Univ Michigan, Sch Pharm, Ann Arbor, MI 48109 USA; [Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Evans, SJ (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	evanssi@umich.edu	Ellingrod, Vicki Lynn/G-8764-2012; Burant, Charles/GPC-5690-2022; Kamali, Masoud/J-4268-2012; Kamali, Masoud/GLQ-5784-2022; McInnis, Melvin G/F-6963-2012; Prossin, Alan/K-2967-2015	Burant, Charles/0000-0001-9189-5003; Kamali, Masoud/0000-0003-1453-5201; Kamali, Masoud/0000-0003-1453-5201; McInnis, Melvin G/0000-0002-0375-6247; Evans, Simon/0000-0001-8112-9487; Prossin, Alan/0000-0003-1262-522X	Michigan Institute for Clinical Health Research; National Alliance for Research in Schizophrenia and Depression (NARSAD); National Institutes of Mental Health (NIMH) [R01 MH082784-01]; Heinz C. Prechter Bipolar Research Fund; National Institutes of Helath-National Center for Research Resources (NIH-NCCR), General Clinic Research Center (GCRC) [M01-RR-59, UL1RR024986]; Chemistry Core of the Michigan Diabetes Research and Training Center [NIH5P60 DK 20572]; Michigan Nutrition Obesity Research Center [DK089503]; Washtenaw Community Health Organization (WCHO); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK089503, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA033454] Funding Source: NIH RePORTER	Michigan Institute for Clinical Health Research; National Alliance for Research in Schizophrenia and Depression (NARSAD)(NARSAD); National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Heinz C. Prechter Bipolar Research Fund; National Institutes of Helath-National Center for Research Resources (NIH-NCCR), General Clinic Research Center (GCRC); Chemistry Core of the Michigan Diabetes Research and Training Center; Michigan Nutrition Obesity Research Center; Washtenaw Community Health Organization (WCHO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by grants from the Michigan Institute for Clinical Health Research to SJE, the National Alliance for Research in Schizophrenia and Depression (NARSAD) Independent Investigator Award and National Institutes of Mental Health (NIMH) grant (R01 MH082784-01) to VLE, the Heinz C. Prechter Bipolar Research Fund to MGM; and services and resources from the National Institutes of Helath-National Center for Research Resources (NIH-NCCR), General Clinic Research Center (GCRC) Program (M01-RR-59 and UL1RR024986), the Chemistry Core of the Michigan Diabetes Research and Training Center (NIH5P60 DK 20572), the Michigan Nutrition Obesity Research Center (DK089503) and the Washtenaw Community Health Organization (WCHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MH, 2005, SUICIDE LIFE-THREAT, V35, P671, DOI 10.1521/suli.2005.35.6.671; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Barnett J.H., 2010, PSYCHOL MED, P1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; De Berardis D, 2009, J BIOL REG HOMEOS AG, V23, P133; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; Ellingrod VL, 2011, J CLIN PSYC IN PRESS; Gawrisch K, 2008, PROSTAG LEUKOTR ESS, V79, P131, DOI 10.1016/j.plefa.2008.09.002; Gitlin M, 2006, MOL PSYCHIATR, V11, P227, DOI 10.1038/sj.mp.4001793; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Hibbeln Joseph R., 2009, V99, P17, DOI 10.1159/000192992; Hibbeln JR, 1998, BIOL PSYCHIAT, V44, P243, DOI 10.1016/S0006-3223(98)00143-7; Huan MM, 2004, BIOL PSYCHIAT, V56, P490, DOI 10.1016/j.biopsych.2004.06.028; Janowsky D S, 2001, Curr Psychiatry Rep, V3, P444, DOI 10.1007/s11920-001-0037-7; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim B, 2011, PSYCHIAT RES, V185, P135, DOI 10.1016/j.psychres.2010.05.020; Lee HJ, 2010, MOL PSYCHIATR, V15, P602, DOI 10.1038/mp.2008.117; Liu YH, 2011, J PSYCHIATR RES, V45, P269, DOI 10.1016/j.jpsychires.2010.06.010; McCann SJH, 2010, ARCH SUICIDE RES, V14, P368, DOI 10.1080/13811118.2010.524070; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003; Turnbull T, 2008, ARCH PSYCHIAT NURS, V22, P305, DOI 10.1016/j.apnu.2008.02.011	28	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29297	10.1371/journal.pone.0029297	http://dx.doi.org/10.1371/journal.pone.0029297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906QI	22253709	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500007
J	Olsen, M; Hummelgard, M; Olin, H				Olsen, Martin; Hummelgard, Magnus; Olin, Hakan			Surface Modifications by Field Induced Diffusion	PLOS ONE			English	Article							ELECTRIC-FIELD; GOLD SURFACES; NANOSTRUCTURES; MICROSCOPE; FABRICATION; CREATION; AU(111)	By applying a voltage pulse to a scanning tunneling microscope tip the surface under the tip will be modified. We have in this paper taken a closer look at the model of electric field induced surface diffusion of adatoms including the van der Waals force as a contribution in formations of a mound on a surface. The dipole moment of an adatom is the sum of the surface induced dipole moment (which is constant) and the dipole moment due to electric field polarisation which depends on the strength and polarity of the electric field. The electric field is analytically modelled by a point charge over an infinite conducting flat surface. From this we calculate the force that cause adatoms to migrate. The calculated force is small for voltage used, typical 1 pN, but due to thermal vibration adatoms are hopping on the surface and even a small net force can be significant in the drift of adatoms. In this way we obtain a novel formula for a polarity dependent threshold voltage for mound formation on the surface for positive tip. Knowing the voltage of the pulse we then can calculate the radius of the formed mound. A threshold electric field for mound formation of about 2 V/nm is calculated. In addition, we found that van der Waals force is of importance for shorter distances and its contribution to the radial force on the adatoms has to be considered for distances smaller than 1.5 nm for commonly used voltages.	[Olsen, Martin; Hummelgard, Magnus; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden	Mid-Sweden University	Olsen, M (corresponding author), Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden.	Martin.Olsen@miun.se	Olsen, Martin/N-7768-2019; Olsen, Martin/D-1702-2012; Olin, Håkan/A-8175-2008	Olsen, Martin/0000-0002-4376-2676; Olsen, Martin/0000-0002-4376-2676; Olin, Håkan/0000-0001-7329-3359; Hummelgard, Magnus/0000-0001-9137-3440				Allen ML, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/17/175201; [Anonymous], 1992, INTERMOLECULAR SURFA; BESSHO K, 1994, APPL PHYS LETT, V65, P2142, DOI 10.1063/1.112770; CHANG TC, 1995, APPL PHYS LETT, V67, P903, DOI 10.1063/1.114689; Erts D, 2002, APPL SURF SCI, V188, P460, DOI 10.1016/S0169-4332(01)00933-3; Erts D, 2000, PHYS REV B, V61, P12725, DOI 10.1103/PhysRevB.61.12725; Fujita D, 2003, APPL PHYS LETT, V82, P2329, DOI 10.1063/1.1565509; GIRARD C, 1993, SURF SCI, V282, P400, DOI 10.1016/0039-6028(93)90944-F; GROSSEL P, 1983, PHYS REV A, V28, P524, DOI 10.1103/PhysRevA.28.524; HSIAO GS, 1994, APPL PHYS LETT, V64, P1350, DOI 10.1063/1.111931; Hu XM, 1998, APPL PHYS A-MATER, V66, pS707, DOI 10.1007/s003390051226; Hummelgard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017209; Kittel C, 2004, INTRO SOLID STATE PH, V8th; KONDO S, 1994, APPL SURF SCI, V75, P39, DOI 10.1016/0169-4332(94)90133-3; KONDO S, 1995, J APPL PHYS, V78, P155, DOI 10.1063/1.360733; Kurpick U, 1997, PHYS REV LETT, V78, P1086, DOI 10.1103/PhysRevLett.78.1086; LINDER B, 1976, PHYS REV B, V13, P1532, DOI 10.1103/PhysRevB.13.1532; MAMIN HJ, 1990, PHYS REV LETT, V65, P2418, DOI 10.1103/PhysRevLett.65.2418; MASCHER C, 1994, J APPL PHYS, V75, P5438, DOI 10.1063/1.355701; Mayer TM, 1999, J APPL PHYS, V85, P8170, DOI 10.1063/1.370656; Mendez J, 1996, J VAC SCI TECHNOL B, V14, P1145, DOI 10.1116/1.588417; Mordehai D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096101; Nafari A, 2011, NANOSCI TECHNOL, P59, DOI 10.1007/978-3-642-10497-8_3; Naitoh Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF10; Naji A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060601; Nyffenegger RM, 1997, CHEM REV, V97, P1195, DOI 10.1021/cr960069i; OHI A, 1995, J VAC SCI TECHNOL B, V13, P1252, DOI 10.1116/1.588246; Park JY, 2002, J APPL PHYS, V92, P2139, DOI 10.1063/1.1495889; PASCUAL JI, 1993, PHYS REV LETT, V71, P1852, DOI 10.1103/PhysRevLett.71.1852; Podgornik R, 2006, EUROPHYS LETT, V74, P712, DOI 10.1209/epl/i2006-10019-7; Svensson K, 2003, REV SCI INSTRUM, V74, P4945, DOI 10.1063/1.1614872; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; TSONG TT, 1991, PHYS REV B, V44, P13703, DOI 10.1103/PhysRevB.44.13703; TSONG TT, 1975, PHYS REV B, V12, P1343, DOI 10.1103/PhysRevB.12.1343; Tsong TT, 1990, ATOM PROBE FIELD ION; Zhang HL, 2002, MICROELECTRON ENG, V63, P381, DOI 10.1016/S0167-9317(02)00553-1	36	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30106	10.1371/journal.pone.0030106	http://dx.doi.org/10.1371/journal.pone.0030106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253894	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500032
J	An, L; Zhao, XW; Wu, J; Jia, JG; Zou, YZ; Guo, XZ; He, L; Zhu, HX				An, Lin; Zhao, Xiwen; Wu, Jian; Jia, Jianguo; Zou, Yunzeng; Guo, Xizhi; He, Lin; Zhu, Hongxin			Involvement of Autophagy in Cardiac Remodeling in Transgenic Mice with Cardiac Specific Over-Expression of Human Programmed Cell Death 5	PLOS ONE			English	Article							HEART-DISEASE; RHEUMATOID-ARTHRITIS; HEMODYNAMIC STRESS; TUMOR-CELLS; IN-VITRO; APOPTOSIS; PDCD5; GENE; CARDIOMYOCYTES; HYPERTROPHY	Programmed cell death 5 (PDCD5) is a cytosolic protein suppressing growth of multiple types of cancer cells through activating p53. We hypothesized that PDCD5 plays an essential role in cardiac remodeling and function. PDCD5 was significantly up-regulated in the hearts from mice subjected to angiotensin II treatment or transverse aortic constriction. Thus, we generated transgenic mice over-expressing human PDCD5 under the control of alpha myosin heavy chain promoter to examine the role of PDCD5 in cardiac remodeling. Transgenic founder died spontaneously displayed enlarged heart. The high PDCD5 over-expressing line (10-fold) showed reduced survival rate, increase in heart weight normalized to body weight. Real-Time RT-PCR analysis revealed fetal gene program was up-regulated. Echocardiography and histopathological examination showed characteristics of dilated cardiomyopathy and heart failure in transgenic mice. Western blot and immunohistochemistry analysis showed autophagy was dramatically increased in transgenic mice as compared to WT littermates control mice, while apoptosis remained unchanged. The enhanced autophagy in high over-expressing line was associated with significant increase in p53 activity and its downstream target damage-regulated autophagy modulator expression. The low over-expressing line (3.5-fold) appeared normal, but was more susceptible to angiotensin II-induced cardiac hypertrophy. This study is the first providing evidence that PDCD5 plays an important role in cardiac remodeling.	[An, Lin; Zhao, Xiwen; Guo, Xizhi; He, Lin; Zhu, Hongxin] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wu, Jian; Jia, Jianguo; Zou, Yunzeng; He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	An, L (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China.	hxzhu@sjtu.edu.cn	Zhu, Hongxin/HCI-9872-2022	Guo, Xizhi/0000-0001-8047-6049; Wu, Jian/0000-0003-4259-8322	National Natural Scientific Foundation of China [30971095]; National Key Scientific Program [2007CB947303]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Program	This study was supported by the Program of National Natural Scientific Foundation of China (grant number 30971095) and The National Key Scientific Program (grant number 2007CB947303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YY, 2001, FEBS LETT, V509, P191, DOI 10.1016/S0014-5793(01)03062-9; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Jiang J, 2010, ARTIF CELL BLOOD SUB, V38, P38, DOI 10.3109/10731190903495769; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li L, 2010, HYPERTENS RES, V33, P1289, DOI 10.1038/hr.2010.182; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mellor KM, 2011, AUTOPHAGY, V7, P1263, DOI 10.4161/auto.7.10.17148; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Ruan GR, 2008, APOPTOSIS, V13, P641, DOI 10.1007/s10495-008-0206-9; Sadoshima J, 2008, AUTOPHAGY, V4, P402, DOI 10.4161/auto.5924; Salakou S, 2007, IN VIVO, V21, P123; Salvi M, 2009, BIOCHEM BIOPH RES CO, V387, P606, DOI 10.1016/j.bbrc.2009.07.067; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Wang N, 2007, APOPTOSIS, V12, P1433, DOI 10.1007/s10495-007-0070-z; Wang XJ, 2003, CIRC RES, V93, P998, DOI 10.1161/01.RES.0000102401.77712.ED; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wang ZV, 2010, J BIOL CHEM, V285, P8509, DOI 10.1074/jbc.R109.025023; Xie M, 2009, APOPTOSIS, V14, P1086, DOI 10.1007/s10495-009-0373-3; Xu LJ, 2009, NEOPLASIA, V11, P345, DOI 10.1593/neo.81524; Yang YH, 2006, APOPTOSIS, V11, P993, DOI 10.1007/s10495-006-6714-6; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	43	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30097	10.1371/journal.pone.0030097	http://dx.doi.org/10.1371/journal.pone.0030097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253891	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700089
J	Hofstetter, CP; Burkhardt, JK; Shin, BJ; Gursel, DB; Mubita, L; Gorrepati, R; Brennan, C; Holland, EC; Boockvar, JA				Hofstetter, Christoph P.; Burkhardt, Jan-Karl; Shin, Benjamin J.; Guersel, Demirkan B.; Mubita, Lynn; Gorrepati, Ramana; Brennan, Cameron; Holland, Eric C.; Boockvar, John A.			Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OKADAIC ACID; DNA-DAMAGE; HUMAN GLIOMAS; NORMAL BRAIN; HIF-ALPHA; INHIBITION; IDENTIFICATION; METABOLISM; EXPRESSION	Purpose: The hypoxic microenvironment of glioblastoma multiforme (GBM) is thought to increase resistance to cancer therapies. Recent evidence suggests that hypoxia induces protein phosphatase 2A (PP2A), a regulator of cell cycle and cell death. The effects of PP2A on GBM tumor cell proliferation and survival during hypoxic conditions have not been studied. Experimental Design: Expression of PP2A subunits and HIF-alpha proteins was measured in 65 high-grade astrocytoma and 18 non-neoplastic surgical brain specimens by western blotting. PP2A activity was measured by an immunoprecipitation assay. For in vitro experiments, GBM-derived tumor stem cell-like cells (TSCs) were exposed to severe hypoxia produced by either CoCl2 or 1% O-2. PP2A activity was inhibited either by okadaic acid or by shRNA depletion of the PP2A C subunit. Effects of PP2A activity on cell cycle progression and cell survival during hypoxic conditions were assessed using flow cytometry. Results: In our patient cohort, PP2A activity was positively correlated with HIF-1 alpha protein expression (P = 0.002). Patients with PP2A activity levels above 160 pMP had significantly worse survival compared to patients with levels below this threshold (P = 0.002). PP2A activity was an independent predictor of survival on multivariable analysis (P = 0.009). In our in vitro experiments, we confirmed that severe hypoxia induces PP2A activity in TSCs 6 hours after onset of exposure. PP2A activity mediated G1/S phase growth inhibition and reduced cellular ATP consumption in hypoxic TSCs. Conversely, inhibition of PP2A activity led to increased cell proliferation, exhaustion of intracellular ATP, and accelerated P53-independent cell death of hypoxic TSCs. Conclusions: Our results suggest that PP2A activity predicts poor survival in GBM. PP2A appears to reduce the metabolic demand of hypoxic TSCs and enhances tumor cell survival. Modulation of PP2A may be a potential target for cancer therapy.	[Hofstetter, Christoph P.; Burkhardt, Jan-Karl; Shin, Benjamin J.; Guersel, Demirkan B.; Mubita, Lynn; Gorrepati, Ramana; Boockvar, John A.] New York Presbyterian Hosp, Weill Cornell Med Coll, Weill Cornell Brain Tumor Ctr, Dept Neurol Surg, New York, NY USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Hofstetter, CP (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Weill Cornell Brain Tumor Ctr, Dept Neurol Surg, New York, NY USA.	chh9045@nyp.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891	NCI/NIH [K08CA130985]; Neurosurgery Research and Education Foundation; NATIONAL CANCER INSTITUTE [K08CA130985] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neurosurgery Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI/NIH K08CA130985 and Neurosurgery Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bando H, 2003, BIOMED PHARMACOTHER, V57, P333, DOI 10.1016/S0753-3322(03)00098-2; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; CASILLAS AM, 1993, BIOCHEM J, V290, P545, DOI 10.1042/bj2900545; Chen EY, 2001, CANCER RES, V61, P2429; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Favaro E, 2008, AM J PATHOL, V173, P1186, DOI 10.2353/ajpath.2008.071183; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Gursel DB, 2011, J NEUROONCOL; Gursel Demirkan B, 2011, Cancers (Basel), V3, P2655, DOI 10.3390/cancers3022655; Hamada K, 1996, Noshuyo Byori, V13, P115; Heikkinen PT, 2010, CANCER RES, V70, P5984, DOI 10.1158/0008-5472.CAN-09-3777; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; HELLER IH, 1955, CAN J BIOCHEM PHYS, V33, P395; Hofstetter CP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10173; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; HOSSMANN KA, 1986, ACTA NEUROPATHOL, V69, P139, DOI 10.1007/BF00687050; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kawano T, 2001, J CEREBR BLOOD F MET, V21, P1268, DOI 10.1097/00004647-200111000-00003; Korkolopoulou P, 2004, NEUROPATH APPL NEURO, V30, P267, DOI 10.1111/j.1365-2990.2003.00535.x; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; MACKINTOSH C, 1989, BIOCHEM J, V262, P335, DOI 10.1042/bj2620335; MAHALEY MS, 1966, CANCER RES, V26, P195; Martiniova L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014678; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; MIES G, 1990, J NEURO-ONCOL, V9, P17, DOI 10.1007/BF00167064; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Satoh T, 2000, NEUROSCI LETT, V288, P163, DOI 10.1016/S0304-3940(00)01229-5; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Warburg O., 1926, STOFFWECHSEL TUMOREN; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Yung HW, 2003, J NEUROCHEM, V86, P1281, DOI 10.1046/j.1471-4159.2003.01946.x; Zhang TT, 2008, METAB BRAIN DIS, V23, P95, DOI 10.1007/s11011-007-9074-1	60	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30059	10.1371/journal.pone.0030059	http://dx.doi.org/10.1371/journal.pone.0030059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253878	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700084
J	Wiweger, MI; Zhao, Z; van Merkesteyn, RJP; Roehl, HH; Hogendoorn, PCW				Wiweger, Malgorzata I.; Zhao, Zhe; van Merkesteyn, Richard J. P.; Roehl, Henry H.; Hogendoorn, Pancras C. W.			HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas	PLOS ONE			English	Article							PHARYNGEAL DENTITION; DANIO-RERIO; MOUSE MODEL; EXPRESSION; EXT1; HETEROZYGOSITY; MECHANISMS; DACKEL; GENES; TEETH	Multiple Osteochondromas (MO; previously known as multiple hereditary exostosis) is an autosomal dominant genetic condition that is characterized by the formation of cartilaginous bone tumours (osteochondromas) at multiple sites in the skeleton, secondary bursa formation and impingement of nerves, tendons and vessels, bone curving, and short stature. MO is also known to be associated with arthritis, general pain, scarring and occasional malignant transformation of osteochondroma into secondary peripheral chondrosarcoma. MO patients present additional complains but the relevance of those in relation to the syndromal background needs validation. Mutations in two enzymes that are required during heparan sulphate synthesis (EXT1 or EXT2) are known to cause MO. Previously, we have used zebrafish which harbour mutations in ext2 as a model for MO and shown that ext2(-/-) fish have skeletal defects that resemble those seen in osteochondromas. Here we analyse dental defects present in ext2(-/-) fish. Histological analysis reveals that ext2(-/-) fish have very severe defects associated with the formation and the morphology of teeth. At 5 days post fertilization 100% of ext2(-/-) fish have a single tooth at the end of the 5(th) pharyngeal arch, whereas wild-type fish develop three teeth, located in the middle of the pharyngeal arch. ext2(-/-) teeth have abnormal morphology (they were shorter and thicker than in the WT) and patchy ossification at the tooth base. Deformities such as split crowns and enamel lesions were found in 20% of ext2(+/-) adults. The tooth morphology in ext2(-/-) was partially rescued by FGF8 administered locally (bead implants). Our findings from zebrafish model were validated in a dental survey that was conducted with assistance of the MHE Research Foundation. The presence of the malformed and/or displaced teeth with abnormal enamel was declared by half of the respondents indicating that MO might indeed be also associated with dental problems.	[Wiweger, Malgorzata I.; Zhao, Zhe; Hogendoorn, Pancras C. W.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [van Merkesteyn, Richard J. P.] Leiden Univ, Dept Oral & Maxillofacial Surg, Med Ctr, Leiden, Netherlands; [Roehl, Henry H.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Sheffield	Wiweger, MI (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	P.C.W.Hogendoorn@lumc.nl	Wiweger, Małgorzata/AAX-6584-2021; Korzeniowska, Małgorzata Irena/AFS-1696-2022; van Merkesteyn, Richard/ABE-2622-2021; Hogendoorn, Pancras C.W./H-5859-2015; Hogendoorn, Pancras/O-6494-2019	Wiweger, Małgorzata/0000-0002-9537-9257; van Merkesteyn, Richard/0000-0003-1729-0510; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Hogendoorn, Pancras/0000-0002-1513-8104	European network of excellence EuroBoNeT [018814 (LSHC-CT-2006-018814)]; Wellcome Trust [WT072346MA]; Medical Research Council [MR/J001457/1] Funding Source: researchfish; MRC [MR/J001457/1] Funding Source: UKRI	European network of excellence EuroBoNeT; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the European network of excellence EuroBoNeT (http://www.eurobonet.eu) grant number 018814 (LSHC-CT-2006-018814) and Wellcome Trust grant number WT072346MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablooglu AJ, 2007, DEV DYNAM, V236, P2268, DOI 10.1002/dvdy.21229; BAI XM, 1994, J HISTOCHEM CYTOCHEM, V42, P1043, DOI 10.1177/42.8.8027524; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Bovee JV, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-3; Bovee JV., 2002, WHO CLASSIFICATION T, P360; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Darilek S, 2005, J PEDIATR ORTHOPED, V25, P369, DOI 10.1097/01.bpo.0000150813.18673.ad; Grandel H, 2000, DEVELOPMENT, V127, P4169; Hameetman L, 2007, JNCI-J NATL CANCER I, V99, P396, DOI 10.1093/jnci/djk067; Hong L, 2002, J HUM GENET, V47, P262, DOI 10.1007/s100380200036; Hosalkar H, 2007, J PEDIATR ORTHOPED, V27, P333, DOI 10.1097/BPO.0b013e3180326732; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kucukesmen Cigdem, 2007, Eur J Dent, V1, P183; LANDAU H, 1988, Fortschritte der Kieferorthopaedie, V49, P132, DOI 10.1007/BF02163372; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Mundy C, 2011, DEV BIOL, V351, P70, DOI 10.1016/j.ydbio.2010.12.022; Neues F, 2006, MATERIALWISS WERKST, V37, P426, DOI 10.1002/mawe.200600009; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Stock DW, 2006, DEVELOPMENT, V133, P3127, DOI 10.1242/dev.02459; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Yasuda T, 2010, J DENT RES, V89, P1111, DOI 10.1177/0022034510373766; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Zak BM, 2011, BONE, V48, P979, DOI 10.1016/j.bone.2011.02.001; Zuntini M, 2010, ONCOGENE, V29, P3827, DOI 10.1038/onc.2010.135	37	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29734	10.1371/journal.pone.0029734	http://dx.doi.org/10.1371/journal.pone.0029734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253766	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000301355700042
J	Ferreira, N; Saraiva, MJ; Almeida, MR				Ferreira, Nelson; Saraiva, Maria Joao; Almeida, Maria Rosario			Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: "In Vivo" Evidence from FAP Mice Models	PLOS ONE			English	Article							REDUCES TRANSTHYRETIN DEPOSITION; TRANSGENIC MOUSE MODEL; GREEN TEA POLYPHENOLS; POLYNEUROPATHY; GALLATE; EGCG; FIBRILS; BIOMARKERS; TOXICITY; BINDING	Background: Familial amyloidotic polyneuropathy (FAP) is a neurodegenerative disease caused by the extracellular deposition of mutant transthyretin (TTR), with special involvement of the peripheral nervous system (PNS). Currently, hepatic transplantation is considered the most efficient therapy to halt the progression of clinical symptoms in FAP since more than 95% of TTR is produced by the liver. However, less invasive and more reliable therapeutic approaches have been proposed for FAP therapy, namely based on drugs acting as inhibitors of amyloid formation or as amyloid disruptors. We have recently reported that epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, is able to inhibit TTR aggregation and fibril formation, "in vitro" and in a cellular system, and is also able to disrupt pre-formed amyloid fibrils "in vitro". Methodology and Principal Findings: In the present study, we assessed the effect of EGCG subchronic administration on TTR amyloidogenesis "in vivo", using well characterized animal models for FAP. Semiquantitative immunohistochemistry (SQ-IHC) and Western blot analysis of mice tissues after treatment demonstrated that EGCG inhibits TTR toxic aggregates deposition in about 50% along the gastrointestinal tract (GI) and peripheral nervous system (PNS). Moreover EGCG treatment considerably lowered levels of several biomarkers associated with non-fibrillar TTR deposition, namely endoplasmic reticulum (ER)-stress, protein oxidation and apoptosis markers. Treatment of old FAP mice with EGCG resulted not only in the decrease of non-fibrillar TTR deposition but also in disaggregation of amyloid deposits. Consistently, matrix metalloproteinase (MMP)-9 and serum amyloid P component (SAP), both markers of amyloid deposition, were also found reduced in treated old FAP mice. Conclusions and Significance: The dual effect of EGCG both as TTR aggregation inhibitor and amyloid fibril disruptor together with the high tolerability and low toxicity of EGCG in humans, point towards the potential use of this compound, or optimized derivatives, in the treatment of TTR-related amyloidoses.	[Ferreira, Nelson; Saraiva, Maria Joao; Almeida, Maria Rosario] Univ Porto, IBMC Inst Biol Mol & Celular, Grp Neurobiol Mol, P-4100 Oporto, Portugal; [Ferreira, Nelson; Saraiva, Maria Joao; Almeida, Maria Rosario] Univ Porto, ICBAS Inst Ciencias Biomed Abel Salazar, Dept Biol Mol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Ferreira, N (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Grp Neurobiol Mol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ralmeida@ibmc.up.pt	Saraiva, Maria João/K-3907-2013; Almeida, Maria Rosario/K-3938-2013; Ferreira, Nelson/ABD-7187-2020	Saraiva, Maria João/0000-0002-3360-6899; Almeida, Maria Rosario/0000-0001-9289-3835; Ferreira, Nelson/0000-0002-0305-9097	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia - FCT) [POCI/SAU-MMO/57321/2004, SFRH/BD/28566/2006]	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia - FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia - FCT) through a grant [POCI/SAU-MMO/57321/2004] and fellowship to Nelson Ferreira [SFRH/BD/28566/2006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Altland K, 2004, NEUROGENETICS, V5, P61, DOI 10.1007/s10048-003-0160-1; Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Cardoso I, 2002, J MOL BIOL, V317, P683, DOI 10.1006/jmbi.2002.5441; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Del Rio D, 2010, NUTRITION, V26, P1110, DOI 10.1016/j.nut.2009.09.021; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; Hunstein W, 2007, BLOOD, V110, P2216, DOI 10.1182/blood-2007-05-089243; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P626, DOI 10.1016/j.fct.2005.07.005; Kim HS, 2004, ANTICANCER RES, V24, P747; Kohno K, 1997, AM J PATHOL, V150, P1497; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Macedo B, 2008, BBA-MOL BASIS DIS, V1782, P517, DOI 10.1016/j.bbadis.2008.05.005; Macedo B, 2007, MOL MED, V13, P584, DOI 10.2119/2007-00068.Macedo; Macedo B, 2010, PHARMACOL RES, V62, P514, DOI 10.1016/j.phrs.2010.08.001; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Mereles D, 2010, CLIN RES CARDIOL, V99, P483, DOI 10.1007/s00392-010-0142-x; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; Nakagawa K, 2008, J NEUROL SCI, V272, P186, DOI 10.1016/j.jns.2008.05.014; Nanjo F, 1996, FREE RADICAL BIO MED, V21, P895, DOI 10.1016/0891-5849(96)00237-7; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Santos SD, 2010, NEUROBIOL AGING, V31, P280, DOI 10.1016/j.neurobiolaging.2008.04.001; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Sousa MM, 2004, FASEB J, V18, P124, DOI 10.1096/fj.04-2022fje; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Teixeira PF, 2006, J BIOL CHEM, V281, P21998, DOI 10.1074/jbc.M602302200; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299	41	78	80	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					232	241	e29933	10.1371/journal.pone.0029933	http://dx.doi.org/10.1371/journal.pone.0029933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253829	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900025
J	Lehtonen, TK; McCrary, JK; Meyer, A				Lehtonen, Topi K.; McCrary, Jeffrey K.; Meyer, Axel			Introduced Predator Elicits Deficient Brood Defence Behaviour in a Crater Lake Fish	PLOS ONE			English	Article							CICHLID SPECIES COMPLEX; CICHLASOMA-CITRINELLUM; SYMPATRIC SPECIATION; GENETIC DIVERSITY; INVASIONS; SELECTION; ECOLOGY; CONSEQUENCES; BIODIVERSITY; POPULATIONS	Introduced species represent one of the most serious global threats to biodiversity. In this field-based study, we assessed behavioural responses of brood tending cichlid fish to an invasive predator of their offspring. This was achieved by comparing parental defence responses of the endangered arrow cichlid (Amphilophus zaliosus), a fish species endemic to the crater lake Apoyo in Nicaragua, towards the bigmouth sleeper (Gobiomorus dormitor), a formidable predator of cichlid fry, and all other potential fish predators of offspring. The bigmouth sleeper was recently introduced into Apoyo but naturally co-exists with cichlids in a few other Nicaraguan lakes. Arrow cichlid parents allowed bigmouth sleepers to advance much closer to their fry than other predators before initiating aggressive brood defence behaviours. Interestingly, parents of a very closely related species, A. sagittae, which has coevolved with bigmouth sleepers in crater lake Xiloa, reacted to approaching bigmouth sleepers at comparable distances as to other predators of cichlid fry. These results provide a novel demonstration of the specific mechanism (i.e. naive parental behaviour) by which invasive predators may negatively affect species that lack the adequate behavioural repertoire.	[Lehtonen, Topi K.; Meyer, Axel] Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany; [Lehtonen, Topi K.] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [McCrary, Jeffrey K.] FUNDECI GAIA, Estn Biol, Laguna De Apoyo Nat Reserv, Nicaragua	University of Konstanz; University of Turku	Lehtonen, TK (corresponding author), Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009; Lehtonen, Topi/A-6679-2010	Meyer, Axel/0000-0002-0888-8193; Lehtonen, Topi/0000-0002-1372-9509	Academy of Finland; Alexander von Humboldt Foundation; DFG; Department of Biology, University of Turku	Academy of Finland(Academy of Finland); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); Department of Biology, University of Turku	This work was supported by the Academy of Finland (http://www.aka.fi/en-gb/A/), the Alexander von Humboldt Foundation (http://www.humboldtfoundation.de/web/home.html), the DFG(http://www.dfg.de/en/index.jsp), and the Department of Biology, University of Turku (http://www.sci.utu.fi/biologia/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Bacheler NM, 2004, ECOL FRESHW FISH, V13, P111, DOI 10.1111/j.1600-0633.2004.00040.x; Barlow G.W., 1976, P359; Barlow G.W., 1976, P333; Barlow GW, 1998, AM ZOOL, V38, P59; BARLOW GW, 1973, SCIENCE, V179, P806, DOI 10.1126/science.179.4075.806; Barlow GW., 2000, CICHLID FISHES NATUR; Barluenga M, 2004, MOL ECOL, V13, P2061, DOI 10.1111/j.1365-294X.2004.02211.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Bedarf AT, 2001, BIOL INVASIONS, V3, P391, DOI 10.1023/A:1015806700705; Bunje PME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-25; C?lix M., 2018, EUROPEAN RED LIST SA; Canonico GC, 2005, AQUAT CONSERV, V15, P463, DOI 10.1002/aqc.699; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; DILL LM, 1987, CAN J ZOOL, V65, P803, DOI 10.1139/z87-128; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edgell TC, 2008, BIOL LETTERS, V4, P385, DOI 10.1098/rsbl.2008.0204; Elmer KR, 2010, PHILOS T R SOC B, V365, P1763, DOI 10.1098/rstb.2009.0271; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Ferrari MCO, 2010, BEHAV ECOL, V21, P532, DOI 10.1093/beheco/arq023; Freeman AS, 2006, SCIENCE, V313, P831, DOI 10.1126/science.1125485; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Gavrilets S, 2007, MOL ECOL, V16, P2893, DOI 10.1111/j.1365-294X.2007.03305.x; Gomez-Mestre I, 2011, P ROY SOC B-BIOL SCI, V278, P3364, DOI 10.1098/rspb.2010.2762; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; Klingenberg CP, 2003, BIOL J LINN SOC, V80, P397, DOI 10.1046/j.1095-8312.2003.00246.x; Lehtonen TK, 2008, BIOL LETTERS, V4, P610, DOI 10.1098/rsbl.2008.0378; Lehtonen TK, 2011, BEHAV ECOL SOCIOBIOL, V65, P607, DOI 10.1007/s00265-010-1061-6; Lehtonen TK, 2011, BEHAV ECOL SOCIOBIOL, V65, P613, DOI 10.1007/s00265-010-1062-5; Lehtonen TK, 2010, BEHAV PROCESS, V84, P598, DOI 10.1016/j.beproc.2010.02.021; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McCrary JK, 2007, ENVIRON BIOL FISH, V78, P107, DOI 10.1007/s10641-006-9080-x; MCCRARY JK, 2008, REV NICARAGNENSE BIO, V1, P43; McKaye K.R., 2002, CUADERNOS INVESTIGAC, V12, P19; MCKAYE KR, 1977, ECOLOGY, V58, P291, DOI 10.2307/1935604; MCKAYE KR, 1980, ENVIRON BIOL FISH, V5, P75, DOI 10.1007/BF00000953; MEYER A, 1990, J ZOOL, V221, P237, DOI 10.1111/j.1469-7998.1990.tb03994.x; MEYER A, 1989, OECOLOGIA, V80, P431, DOI 10.1007/BF00379047; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; MILLER RR, 1966, COPEIA, P773, DOI 10.2307/1441406; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; ROGERS W, 1987, BEHAV ECOL SOCIOBIOL, V21, P47, DOI 10.1007/BF00324434; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Stauffer JR, 2008, P BIOL SOC WASH, V121, P117, DOI 10.2988/06-37.1; WAID RM, 1999, ENCUENTRO, V51, P65, DOI DOI 10.5377/encuentro.v0i51.3832	52	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30064	10.1371/journal.pone.0030064	http://dx.doi.org/10.1371/journal.pone.0030064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253881	Green Published, gold			2022-12-25	WOS:000301352400012
J	Noda, S; Mantini, C; Meloni, D; Inoue, JI; Kitade, O; Viscogliosi, E; Ohkuma, M				Noda, Satoko; Mantini, Clea; Meloni, Dionigia; Inoue, Jun-Ichi; Kitade, Osamu; Viscogliosi, Eric; Ohkuma, Moriya			Molecular Phylogeny and Evolution of Parabasalia with Improved Taxon Sampling and New Protein Markers of Actin and Elongation Factor-1 alpha	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; TERMITE COPTOTERMES-FORMOSANUS; HISTOMONAS-MELEAGRIDIS; TETRATRICHOMONAS-GALLINARUM; RETICULITERMES-SPERATUS; COCKROACH CRYPTOCERCUS; BACTEROIDALES BACTERIA; TRICHOMONAS-VAGINALIS; ORDER TRICHOMONADIDA; GLYCOLYTIC PATHWAY	Background: Inferring the evolutionary history of phylogenetically isolated, deep-branching groups of taxa-in particular determining the root-is often extraordinarily difficult because their close relatives are unavailable as suitable outgroups. One of these taxonomic groups is the phylum Parabasalia, which comprises morphologically diverse species of flagellated protists of ecological, medical, and evolutionary significance. Indeed, previous molecular phylogenetic analyses of members of this phylum have yielded conflicting and possibly erroneous inferences. Furthermore, many species of Parabasalia are symbionts in the gut of termites and cockroaches or parasites and therefore formidably difficult to cultivate, rendering available data insufficient. Increasing the numbers of examined taxa and informative characters (e.g., genes) is likely to produce more reliable inferences. Principal Findings: Actin and elongation factor-1 alpha genes were identified newly from 22 species of termite-gut symbionts through careful manipulations and seven cultured species, which covered major lineages of Parabasalia. Their protein sequences were concatenated and analyzed with sequences of previously and newly identified glyceraldehyde-3-phosphate dehydrogenase and the small-subunit rRNA gene. This concatenated dataset provided more robust phylogenetic relationships among major groups of Parabasalia and a more plausible new root position than those previously reported. Conclusions/Significance: We conclude that increasing the number of sampled taxa as well as the addition of new sequences greatly improves the accuracy and robustness of the phylogenetic inference. A morphologically simple cell is likely the ancient form in Parabasalia as opposed to a cell with elaborate flagellar and cytoskeletal structures, which was defined as most basal in previous inferences. Nevertheless, the evolution of Parabasalia is complex owing to several independent multiplication and simplification events in these structures. Therefore, systematics based solely on morphology does not reflect the evolutionary history of parabasalids.	[Noda, Satoko; Inoue, Jun-Ichi; Ohkuma, Moriya] RIKEN BioResource Ctr, Microbe Div Japan Collect Microorganisms, Wako, Saitama, Japan; [Noda, Satoko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan; [Mantini, Clea; Meloni, Dionigia; Viscogliosi, Eric] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Mantini, Clea; Meloni, Dionigia; Viscogliosi, Eric] CNRS, INSERM, UMR 8204, U1019, Lille, France; [Mantini, Clea; Meloni, Dionigia; Viscogliosi, Eric] Univ Lille Nord France, Lille, France; [Meloni, Dionigia] Univ Sassari, Dept Biomed Sci, Div Expt & Clin Microbiol, I-07100 Sassari, Italy; [Kitade, Osamu] Ibaraki Univ, Coll Sci, Nat Hist Lab, Mito, Ibaraki, Japan	RIKEN; University of Yamanashi; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Sassari; Ibaraki University	Noda, S (corresponding author), RIKEN BioResource Ctr, Microbe Div Japan Collect Microorganisms, Wako, Saitama, Japan.	nsatoko@yamanashi.ac.jp; mohkuma@riken.jp	Meloni, Dionigia/K-4840-2015; Ohkuma, Moriya/A-8100-2011	Meloni, Dionigia/0000-0003-0188-5747; Noda, Satoko/0000-0002-3849-8348; Viscogliosi, Eric/0000-0002-5805-7179	RIKEN; Japan Society for the Promotion of Science (JSPS) [19780067, 19380055, 20658024]; French Ministere de l'Education Nationale, de la Recherche et de la Technologie; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Institut Pasteur of Lille; University Lille-Nord de France; ERASMUS; Regione Automa della Sardegna; Grants-in-Aid for Scientific Research [23657013] Funding Source: KAKEN	RIKEN; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); French Ministere de l'Education Nationale, de la Recherche et de la Technologie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur of Lille; University Lille-Nord de France; ERASMUS; Regione Automa della Sardegna; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a grant from the Biomass Engineering Program from RIKEN, Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Nos. 19780067 to SN, and 19380055 and 20658024 to MO, respectively), and a grant from the French Ministere de l'Education Nationale, de la Recherche et de la Technologie to CM, and by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Institut Pasteur of Lille, the University Lille-Nord de France. EV was the recipient of the JSPS Invitation Fellowship Program for Research in Japan FY2010 and the JSPS BRIDGE Fellowship Program FY2011. CM was the recipient of the JSPS Predoctoral-Postdoctoral Fellowship for Foreign Researchers FY2009. DM was supported by grants from the ERASMUS Program and Regione Automa della Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Berchtold Manfred, 1995, Systematic and Applied Microbiology, V18, P567; Bilic I, 2009, PARASITOLOGY, V136, P379, DOI 10.1017/S0031182008005477; Bricheux G, 1997, FEMS MICROBIOL LETT, V153, P205, DOI 10.1111/j.1574-6968.1997.tb10483.x; Brugerolle G, 2001, ORG DIVERS EVOL, V1, P147, DOI 10.1078/1439-6092-00012; Brugerolle G, 2001, EUR J PROTISTOL, V37, P103, DOI 10.1078/0932-4739-00814; BRUGEROLLE G, 1976, ANN STAT BIOL BESSE, V10, P1; BRUGEROLLE G, 2001, ILLUSTRATED GUIDE PR, P1196; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Carpenter KJ, 2010, PROTIST, V161, P122, DOI 10.1016/j.protis.2009.06.003; Carpenter KJ, 2009, J EUKARYOT MICROBIOL, V56, P305, DOI 10.1111/j.1550-7408.2009.00406.x; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Cepicka I, 2006, MOL PHYLOGENET EVOL, V39, P542, DOI 10.1016/j.ympev.2006.01.005; Cepicka I, 2005, VET PARASITOL, V128, P11, DOI 10.1016/j.vetpar.2004.11.003; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; Dacks JB, 1998, J EUKARYOT MICROBIOL, V45, P445, DOI 10.1111/j.1550-7408.1998.tb05097.x; Delgado-Viscogliosi P, 2000, J EUKARYOT MICROBIOL, V47, P70, DOI 10.1111/j.1550-7408.2000.tb00013.x; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Desai MS, 2010, ENVIRON MICROBIOL, V12, P2120, DOI 10.1111/j.1462-2920.2009.02080.x; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Dolan M, 1997, SYMBIOSIS, V22, P229; Edgcomb V, 1998, PROTIST, V149, P359, DOI 10.1016/S1434-4610(98)70042-2; Frohlich J, 1999, SYST APPL MICROBIOL, V22, P249, DOI 10.1016/S0723-2020(99)80072-1; Gerbod D, 2001, J EUKARYOT MICROBIOL, V48, P498, DOI 10.1111/j.1550-7408.2001.tb00185.x; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gerbod D, 2002, MOL PHYLOGENET EVOL, V25, P545, DOI 10.1016/S1055-7903(02)00300-7; Gile GH, 2012, PROTIST, V163, P274, DOI 10.1016/j.protis.2011.07.002; GUNDERSON J, 1995, J EUKARYOT MICROBIOL, V42, P411, DOI 10.1111/j.1550-7408.1995.tb01604.x; Hampl V, 2006, INT J SYST EVOL MICR, V56, P305, DOI 10.1099/ijs.0.63754-0; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hampl V, 2004, MOL PHYLOGENET EVOL, V32, P711, DOI 10.1016/j.ympev.2004.03.005; Hampl V, 2007, PROTIST, V158, P365, DOI 10.1016/j.protis.2007.02.003; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hauck R, 2010, J PARASITOL, V96, P396, DOI 10.1645/GE-2267.1; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; HOLLANDE A, 1986, Protistologica, V22, P331; HOLLANDE A, 1971, Protistologica, V7, P5; Hongoh Y, 2007, APPL ENVIRON MICROB, V73, P6270, DOI 10.1128/AEM.00750-07; Honigberg B.M., 1978, P163; Honigberg B. M., 1978, PARASITIC PROTOZOA, P275; HONIGBERG BM, 1971, J PROTOZOOL, V18, P183, DOI 10.1111/j.1550-7408.1971.tb03306.x; HONIGBERG BM, 1963, J PROTOZOOL, V10, P20, DOI 10.1111/j.1550-7408.1963.tb01635.x; Honigberg BM, 1990, TRICHOMONADS PARASIT, P2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeda-Ohtsubo W, 2007, MICROBIOL-SGM, V153, P3458, DOI 10.1099/mic.0.2007/009217-0; Inoue JI, 2008, MICROBES ENVIRON, V23, P94, DOI 10.1264/jsme2.23.94; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; Keeling PJ, 2004, J MOL EVOL, V58, P550, DOI 10.1007/s00239-003-2577-4; Keeling PJ, 1998, J EUKARYOT MICROBIOL, V45, P643, DOI 10.1111/j.1550-7408.1998.tb04561.x; KIRBY H, 1947, J PARASITOL, V33, P214, DOI 10.2307/3273552; Kitade O, 1997, SOCIOBIOLOGY, V30, P161; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Liapounova NA, 2006, EUKARYOT CELL, V5, P2138, DOI 10.1128/EC.00258-06; Malik SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020774; Mantini C, 2009, PARASITOL RES, V106, P163, DOI 10.1007/s00436-009-1643-2; Moriya S, 2001, J MOL EVOL, V52, P6, DOI 10.1007/s002390010129; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Noda Satoko, 2006, Microbes and Environments, V21, P16, DOI 10.1264/jsme2.21.16; Noda S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-158; Noda S, 2009, MOL PHYLOGENET EVOL, V52, P217, DOI 10.1016/j.ympev.2009.03.011; Noel C, 2007, J EUKARYOT MICROBIOL, V54, P93, DOI 10.1111/j.1550-7408.2006.00234.x; Ohkuma M, 2000, J EUKARYOT MICROBIOL, V47, P249, DOI 10.1111/j.1550-7408.2000.tb00044.x; Ohkuma M, 2005, MOL PHYLOGENET EVOL, V35, P646, DOI 10.1016/j.ympev.2005.02.013; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ohkuma M, 1998, J EUKARYOT MICROBIOL, V45, P439, DOI 10.1111/j.1550-7408.1998.tb05096.x; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohkuma M, 2007, MOL PHYLOGENET EVOL, V42, P847, DOI 10.1016/j.ympev.2006.09.016; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Roger AJ, 1999, MOL BIOL EVOL, V16, P218, DOI 10.1093/oxfordjournals.molbev.a026104; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Silberman JD, 1996, MOL BIOCHEM PARASIT, V76, P311, DOI 10.1016/0166-6851(95)02516-2; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Strassert JFH, 2009, PROTIST, V160, P522, DOI 10.1016/j.protis.2009.04.002; Tachezy J, 2002, J EUKARYOT MICROBIOL, V49, P154, DOI 10.1111/j.1550-7408.2002.tb00360.x; Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; VISCOGLIOSI E, 1994, CELL MOTIL CYTOSKEL, V29, P82, DOI 10.1002/cm.970290108; VISCOGLIOSI E, 1993, J EUKARYOT MICROBIOL, V40, P411, DOI 10.1111/j.1550-7408.1993.tb04935.x; Viscogliosi E, 1998, J MOL EVOL, V47, P190, DOI 10.1007/PL00006376; YAMIN M A, 1979, Sociobiology, V4, P5; Yubuki N, 2010, J EUKARYOT MICROBIOL, V57, P554, DOI 10.1111/j.1550-7408.2010.00509.x	98	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29938	10.1371/journal.pone.0029938	http://dx.doi.org/10.1371/journal.pone.0029938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253832	Green Published, gold, Green Submitted			2022-12-25	WOS:000301352400008
J	Poaty, H; Coullin, P; Peko, JF; Dessen, P; Diatta, AL; Valent, A; Leguern, E; Prevot, S; Gombe-Mbalawa, C; Candelier, JJ; Picard, JY; Bernheim, A				Poaty, Henriette; Coullin, Philippe; Peko, Jean Felix; Dessen, Philippe; Diatta, Ange Lucien; Valent, Alexander; Leguern, Eric; Prevot, Sophie; Gombe-Mbalawa, Charles; Candelier, Jean-Jacques; Picard, Jean-Yves; Bernheim, Alain			Genome-Wide High-Resolution aCGH Analysis of Gestational Choriocarcinomas	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PLASMA-PROTEIN-A; IMPRINTED GENE; ESTROGEN SULFOTRANSFERASE; HYDATIDIFORM MOLES; STEROID SULFATASE; NLRP7 MUTATIONS; COPY NUMBER; IN-VITRO; EXPRESSION	Eleven samples of DNA from choriocarcinomas were studied by high resolution CGH-array 244 K. They were studied after histopathological confirmation of the diagnosis, of the androgenic etiology and after a microsatellite marker analysis confirming the absence of contamination of tumor DNA from maternal DNA. Three cell lines, BeWo, JAR, JEG were also studied by this high resolution pangenomic technique. According to aCGH analysis, the de novo choriocarcinomas exhibited simple chromosomal rearrangements or normal profiles. The cell lines showed various and complex chromosomal aberrations. 23 Minimal Critical Regions were defined that allowed us to list the genes that were potentially implicated. Among them, unusually high numbers of microRNA clusters and imprinted genes were observed.	[Poaty, Henriette; Dessen, Philippe; Bernheim, Alain] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Poaty, Henriette; Coullin, Philippe; Dessen, Philippe; Prevot, Sophie; Candelier, Jean-Jacques; Picard, Jean-Yves; Bernheim, Alain] Univ Paris 11, Orsay, France; [Poaty, Henriette; Coullin, Philippe; Prevot, Sophie; Candelier, Jean-Jacques; Picard, Jean-Yves] INSERM, U782, Clamart, France; [Peko, Jean Felix; Gombe-Mbalawa, Charles] CHU Brazzaville, Serv Carcinol, Serv Anat Pathol, Brazzaville, Rep Congo; [Diatta, Ange Lucien] Hop A Le Dantec, Serv Obstet, Lab Cytogenet & Reprod, Dakar, Senegal; [Leguern, Eric] Hop La Pitie Salpetriere, UF Neurogenet Mol & Cellulaire, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Poaty, H (corresponding author), Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France.	bernheim@igr.fr			IGR Taxe d'apprentissage; INSERM	IGR Taxe d'apprentissage; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	IGR Taxe d'apprentissage and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MN, 2000, CANCER GENET CYTOGEN, V116, P10, DOI 10.1016/S0165-4608(99)00103-X; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Bergeron MB, 2010, PEDIATR DEVEL PATHOL, V13, P66, DOI 10.2350/09-02-0606-CR.1; Bulut I, 2009, AM J MED SCI, V337, P241, DOI 10.1097/MAJ.0b013e31818967a3; Burke B, 2006, GYNECOL ONCOL, V103, P642, DOI 10.1016/j.ygyno.2006.04.015; Cisse C T, 2002, Gynecol Obstet Fertil, V30, P862, DOI 10.1016/S1297-9589(02)00456-3; Cisse C T, 2004, Dakar Med, V49, P143; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; COUILLIN P, 1987, ANN GENET-PARIS, V30, P197; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; Doria S, 2010, EPIGENETICS, V5; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Estelles A, 1996, AM J PATHOL, V149, P1229; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Ganapathy V, 2002, HUMAN CELL CULTURE, P141; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; HERTZ R, 1959, P SOC EXP BIOL MED, V102, P77; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Hui P, 2004, MODERN PATHOL, V17, P248, DOI 10.1038/modpathol.3800025; Huret JL, ATLAS GENET CYTOGENE; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itzhar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016623; JACOBS PA, 1982, ANN HUM GENET, V46, P223, DOI 10.1111/j.1469-1809.1982.tb00714.x; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; KAJII T, 1972, ANN GENET-PARIS, V15, P11; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KOHLER PO, 1971, ACTA ENDOCRINOL-COP, P137; Lai CYL, 2004, MODERN PATHOL, V17, P40, DOI 10.1038/modpathol.3800010; Latour P, 2001, CLIN CHEM, V47, P829; Lee SU, 2008, CELL BIOL INT, V32, P401, DOI 10.1016/j.cellbi.2007.12.009; Ley TJ, 2010, N ENGL J MED; Leyens G, 2004, MOL REPROD DEV, V69, P243, DOI 10.1002/mrd.20145; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; Mohri Y, 2010, FERTIL STERIL; Moukassa D, 1997, MOLES HYDATIFORMES; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ohno S, 2008, ANTICANCER RES, V28, P2493; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; PATTILLO RA, 1968, CANCER RES, V28, P1231; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; PHILIPPE E, 1980, ANN ANAT PATHOL, V25, P13; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Royer-Pokora B, 2010, HUM MOL GENET, V19, P1651, DOI 10.1093/hmg/ddq042; Salmassi A, 2010, FERTIL STERIL, V93, P116, DOI 10.1016/j.fertnstert.2008.09.083; Schropfer A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-553; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shibue T, 2006, EMBO J, V25, P4952, DOI 10.1038/sj.emboj.7601359; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suzuki T, 2003, CANCER RES, V63, P2762; Tanaka Y, 2004, INT J CANCER, V109, P336, DOI 10.1002/ijc.11700; Toujani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007089; Tuncer ZS, 2000, GYNECOL ONCOL, V77, P389, DOI 10.1006/gyno.2000.5777; Utsunomiya H, 2004, CLIN CANCER RES, V10, P5850, DOI 10.1158/1078-0432.CCR-04-0040; Verbeek W, 2004, HUM PATHOL, V35, P1427, DOI 10.1016/j.humpath.2004.06.005; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Xue WC, 2004, J MOL DIAGN, V6, P326, DOI 10.1016/S1525-1578(10)60528-4; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	71	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29426	10.1371/journal.pone.0029426	http://dx.doi.org/10.1371/journal.pone.0029426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253721	Green Published, gold, Green Submitted			2022-12-25	WOS:000301352400003
J	Nairismagi, ML; Vislovukh, A; Meng, Q; Kratassiouk, G; Beldiman, C; Petretich, M; Groisman, R; Fuchtbauer, EM; Harel-Bellan, A; Groisman, I				Nairismagi, M-L; Vislovukh, A.; Meng, Q.; Kratassiouk, G.; Beldiman, C.; Petretich, M.; Groisman, R.; Fuchtbauer, E-M; Harel-Bellan, A.; Groisman, I.			Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression	ONCOGENE			English	Article						breast cancer; CPEB; microRNA; translational regulation; TWIST1	CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; TRANSCRIPTION FACTORS; PROTEIN; CPEB; METASTASIS; PROMOTES; MORPHOGENESIS; ONCOGENE; MCF10AT	TWIST1 is a highly conserved basic helix-loop-helix transcription factor that promotes epithelial-mesenchymal transition (EMT). Its misregulation has been observed in various types of tumors. Using the MCF-10A-series of cell lines that recapitulate the early stages of breast cancer formation and EMT, we found TWIST1 to be upregulated during EMT and downregulated early in carcinogenesis. The TWIST1 3'UTR contains putative regulatory elements, including miRNA target sites and two cytoplasmic polyadenylation elements (CPE). We found that miR-580, CPEB1, and CPEB2 act as negative regulators of TWIST1 expression in a sequence-specific and additive/cooperative manner.	[Nairismagi, M-L; Kratassiouk, G.; Beldiman, C.; Petretich, M.; Groisman, R.; Harel-Bellan, A.; Groisman, I.] CEA Saclay, CNRS FRE 3377, F-91191 Gif Sur Yvette, France; [Meng, Q.] Harbin Med Univ, Affiliated Hosp 3, Breast Dept, Harbin, Peoples R China; [Vislovukh, A.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Translat Mechanisms, Kiev, Ukraine; [Nairismagi, M-L; Fuchtbauer, E-M] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	CEA; UDICE-French Research Universities; Universite Paris Saclay; Harbin Medical University; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Aarhus University	Groisman, I (corresponding author), CEA Saclay, CNRS FRE 3377, F-91191 Gif Sur Yvette, France.	irina.groisman@gmail.com	Harel-Bellan, Annick/M-9795-2015	Kratassiouk, Gueorgui/0000-0003-1174-004X; Groisman, Irina/0000-0001-8909-678X; Harel-Bellan, Annick/0000-0002-2339-153X; Groisman, Regina/0000-0003-3990-7622; Groisman, Sonia/0000-0003-1153-3841	European Commission [LSHG-CT-2006-037900]; Danish Cancer Society [DP08036]	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Cancer Society(Danish Cancer Society)	We thank Valentina Evdokimova for providing us with the MCF-10ANeoT-MSCV and MCF-10ANeoT-YB-1 cell lines, Linda Louise Pritchard for editorial and scientific advice, and Leslie-Ann Largitte for technical assistance. This work was supported in part by grant no LSHG-CT-2006-037900 from the European Commission Sixth Framework Programme to AHB and by grant no DP08036 from The Danish Cancer Society to EMF.	BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Dawson PJ, 1996, AM J PATHOL, V148, P313; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Evdokimova VM, 1999, INT J BIOCHEM CELL B, V31, P139, DOI 10.1016/S1357-2725(98)00137-X; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; SOULE HD, 1990, CANCER RES, V50, P6075; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	27	60	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	47					4960	4966		10.1038/onc.2011.650	http://dx.doi.org/10.1038/onc.2011.650			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22266852				2022-12-25	WOS:000311430200007
J	Astanehe, A; Finkbeiner, MR; Krzywinski, M; Fotovati, A; Dhillon, J; Berquin, IM; Mills, GB; Marra, MA; Dunn, SE				Astanehe, A.; Finkbeiner, M. R.; Krzywinski, M.; Fotovati, A.; Dhillon, J.; Berquin, I. M.; Mills, G. B.; Marra, M. A.; Dunn, S. E.			MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition	ONCOGENE			English	Article						trastuzumab resistance; breast cancer; MNK; RSK; YB-1	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PROTEIN-1 SERINE 102; INTERACTING KINASE 1; RIBOSOMAL S6 KINASE; BINDING; MNK1; EXPRESSION; PHOSPHORYLATION; CONTRIBUTES	Trastuzumab (Herceptin) resistance is a major obstacle in the treatment of patients with HER2-positive breast cancers. We recently reported that the transcription factor Y-box binding protein-1 (YB-1) leads to acquisition of resistance to trastuzumab in a phosphorylation-dependent manner that relies on p90 ribosomal S6 kinase (RSK). To explore how this may occur we compared YB-1 target genes between trastuzumab-sensitive cells (BT474) and those with acquired resistance (HR5 and HR6) using genome-wide chromatin immunoprecipitation sequencing (ChIP-sequencing), which identified 1391 genes uniquely bound by YB-1 in the resistant cell lines. We then examined differences in protein expression and phosphorylation between these cell lines using the Kinexus Kinex antibody microarrays. Cross-referencing these two data sets identified the mitogen-activated protein kinase-interacting kinase (MNK) family as potentially being involved in acquired resistance downstream from YB-1. MNK1 and MNK2 were subsequently shown to be overexpressed in the resistant cell lines; however, only the former was a YB-1 target based on ChIP-PCR and small interfering RNA (siRNA) studies. Importantly, loss of MNK1 expression using siRNA enhanced sensitivity to trastuzumab. Further, MNK1 overexpression was sufficient to confer resistance to trastuzumab in cells that were previously sensitive. We then developed a de novo model of acquired resistance by exposing BT474 cells to trastuzumab for 60 days (BT474LT). Similar to the HR5/HR6 cells, the BT474LT cells had elevated MNK1 levels and were dependent on it for survival. In addition, we demonstrated that RSK phosphorylated MNK1, and that this phosphorylation was required for ability of MNK1 to mediate resistance to trastuzumab. Furthermore, inhibition of RSK with the small molecule BI-D1870 repressed the MNK1-mediated trastuzumab resistance. In conclusion, this unbiased integrated approach identified MNK1 as a player in mediating trastuzumab resistance as a consequence of YB-1 activation, and demonstrated RSK inhibition as a means to overcome recalcitrance to trastuzumab. Oncogene (2012) 31, 4434-4446; doi: 10.1038/onc.2011.617; published online 16 January 2012	[Astanehe, A.; Finkbeiner, M. R.; Fotovati, A.; Dhillon, J.; Dunn, S. E.] Univ British Columbia, Dept Paediat, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Krzywinski, M.; Marra, M. A.] Univ British Columbia, BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4H4, Canada; [Berquin, I. M.] Wake Forest Univ, Dept Canc Biol, Winston Salem, NC 27109 USA; [Mills, G. B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Mills, G. B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	Child & Family Research Institute; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Dunn, SE (corresponding author), Univ British Columbia, Dept Paediat, Child & Family Res Inst, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	sedunn@mail.ubc.ca	Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175	Canadian Institute of Health Research; Canadian Cancer Research Institute; Canadian Institute of Health Research MD/PhD; Michael Smith Foundation for Health Research (MSFHR) Studentships;  [RO1 CA114017]; NATIONAL CANCER INSTITUTE [R01CA114017] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Research Institute; Canadian Institute of Health Research MD/PhD(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR) Studentships; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Institute of Health Research (SED), the Canadian Cancer Research Institute (formerly National Cancer Institute of Canada (SED)) and RO1 CA114017 (IMB and SED). AA was a recipient of the Canadian Institute of Health Research MD/PhD and the Michael Smith Foundation for Health Research (MSFHR) Studentships. MAM is a scholar of MSFHR.	Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Camirand Anne, 2002, Med Sci Monit, V8, pBR521; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Davies AH, 2011, ONCOGENE, V30, P3649, DOI 10.1038/onc.2011.82; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Diermeier S, 2005, EXP CELL RES, V304, P604, DOI 10.1016/j.yexcr.2004.12.008; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mahalingam M, 2001, PROG MOLEC, V27, P131; Martin AP, 2008, MOL PHARMACOL, V74, P807, DOI 10.1124/mol.108.047365; Motoyama AB, 2002, CANCER RES, V62, P3151; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith JA, 2005, CANCER RES, V65, P1027; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; Treeck O, 2004, ANTI-CANCER DRUG, V15, P787, DOI 10.1097/00001813-200409000-00008; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	52	42	42	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4434	4446		10.1038/onc.2011.617	http://dx.doi.org/10.1038/onc.2011.617			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22249268				2022-12-25	WOS:000309704500002
J	Lin, PH; Zhu, H; Cai, CX; Wang, XH; Cao, CM; Xiao, RP; Pan, Z; Weisleder, N; Takeshima, H; Ma, JJ				Lin, Peihui; Zhu, Hua; Cai, Chuanxi; Wang, Xianhua; Cao, Chunmei; Xiao, Ruiping; Pan, Zui; Weisleder, Noah; Takeshima, Hiroshi; Ma, Jianjie			Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair	FASEB JOURNAL			English	Article						confocal imaging; nucleation; COS-7 cells	MUSCULAR-DYSTROPHY; DYSFERLIN; MG53; CAVEOLIN-3; EXOCYTOSIS	Repair of injury to the plasma membrane is an essential mechanism for maintenance of cellular homeostasis and integrity that involves coordinated movement of intracellular vesicles to membrane injury sites to facilitate patch formation. We have previously identified MG53 as an essential component of the cell membrane repair machinery. In order for MG53 and intracellular vesicles to translocate to membrane injury sites, motor proteins must be involved. Here, we show that nonmuscle myosin type IIA (NM-IIA) interacts with MG53 to regulate vesicle trafficking during cell membrane repair. In cells that are deficient for NM-IIA expression, MG53 cannot translocate to acute injury sites, whereas rescue of NM-IIA expression in these cells can restore MG53-mediated membrane repair. Compromised cell membrane repair is observed in cells with RNAi-mediated knockdown of NM-IIA expression, or following pharmacological alteration of NM-IIA motor function. Together, our data reveal NM-IIA as a key cytoskeleton motor protein that facilitates vesicle trafficking during MG53-mediated cell membrane repair.-Lin, P., Zhu, H., Cai, C., Wang, X., Cao, C., Xiao, R., Pan, Z., Weisleder, N., Takeshima, H., Ma, J. Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J. 26, 1875-1883 (2012). www.fasebj.org	[Lin, Peihui; Zhu, Hua; Cai, Chuanxi; Pan, Zui; Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Wang, Xianhua; Cao, Chunmei; Xiao, Ruiping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Peking University; Kyoto University	Ma, JJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Xiao, Rui-Ping/AAE-2629-2019; Lin, Pei-Hui/I-3011-2015; Zhu, Hua/G-4409-2010; Weisleder, Noah L/A-7098-2013; Yimei, Wang/AAE-4083-2019; Cai, Chuanxi/AAW-1488-2020	Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah L/0000-0002-2619-8022; Pan, Zui/0000-0003-4105-901X; Takeshima, Hiroshi/0000-0003-4525-3725; Zhu, Hua/0000-0001-7136-7326; Weisleder, Noah/0000-0003-2710-3088	U.S. National Institute of Health [R01-HL069000, R01-AR061385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by U.S. National Institute of Health grants R01-HL069000 and R01-AR061385 to J.M.	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barton ER, 2010, MUSCLE NERVE, V42, P22, DOI 10.1002/mus.21645; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Chase TH, 2009, AM J PATHOL, V175, P2299, DOI 10.2353/ajpath.2009.080930; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Chung LTK, 2010, BIOCHEM BIOPH RES CO, V391, P995, DOI 10.1016/j.bbrc.2009.12.004; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LaPlaca M. C., 2009, C P IEEE ENG MED BIO, V2009, P1113; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Li Y, 2008, DNA CELL BIOL, V27, P117, DOI 10.1089/dna.2007.0661; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	33	52	54	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					1875	1883		10.1096/fj.11-188599	http://dx.doi.org/10.1096/fj.11-188599			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253476	Green Published			2022-12-25	WOS:000303680800016
J	Keane, SC; Liu, PH; Leibowitz, JL; Giedroc, DP				Keane, Sarah C.; Liu, Pinghua; Leibowitz, Julian L.; Giedroc, David P.			Functional Transcriptional Regulatory Sequence (TRS) RNA Binding and Helix Destabilizing Determinants of Murine Hepatitis Virus (MHV) Nucleocapsid (N) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; TERMINAL DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SARS-COV; SYNDROME CORONAVIRUS; MOLECULAR-BIOLOGY; REPLICATION FORK; DNA; INFECTIVITY	Coronavirus (CoV) nucleocapsid (N) protein contains two structurally independent RNA binding domains. These are denoted N-terminal domain (NTD) and C-terminal domain and are joined by a charged linker region rich in serine and arginine residues (SR linker). In mouse hepatitis virus (MHV), the NTD binds the transcriptional regulatory sequence (TRS) RNA, a conserved hexanucleotide sequence required for subgenomic RNA synthesis. The NTD is also capable of disrupting a short RNA duplex. We show here that three residues on the beta 3 (Arg-125 and Tyr-127) and beta 5 (Tyr-190) strands play key roles in TRS RNA binding and helix destabilization with Ala substitutions of these residues lethal to the virus. NMR studies of the MHV NTD-TRS complex revealed that this region defines a major RNA binding interface in MHV with site-directed spin labeling studies consistent with a model in which the adenosine-rich 3'-region of TRS is anchored by Arg-125, Tyr-127, and Tyr-190 in a way that is critical for efficient subgenomic RNA synthesis in MHV. Characterization of CoV N NTDs from infectious bronchitis virus and from severe acute respiratory syndrome CoV revealed that, although detailed NTD-TRS determinants are distinct from those of MHVNTD, rapid helix destabilization activity of CoV N NTDs is most strongly correlated with CoV function and virus viability.	[Keane, Sarah C.; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Liu, Pinghua; Leibowitz, Julian L.] Texas A&M Univ Syst, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, 212 S Hawthorne Ave, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Giedroc, David/A-8608-2018	Giedroc, David/0000-0002-2342-1620	National Institutes of Health [R01 AI067416]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI067416.	Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106; BARIC RS, 1988, J VIROL, V62, P4280, DOI 10.1128/JVI.62.11.4280-4287.1988; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Clarkson MW, 2009, J BIOMOL NMR, V45, P217, DOI 10.1007/s10858-009-9347-6; COMPTON SR, 1987, J VIROL, V61, P1814, DOI 10.1128/JVI.61.6.1814-1820.1987; Cowley TJ, 2010, J VIROL, V84, P1752, DOI 10.1128/JVI.01758-09; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; CURTH U, 1993, BIOCHEMISTRY-US, V32, P2585, DOI 10.1021/bi00061a016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b; Hurst KR, 2010, J VIROL, V84, P10276, DOI 10.1128/JVI.01287-10; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Johnson RF, 2005, J VIROL, V79, P14570, DOI 10.1128/JVI.79.23.14570-14585.2005; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; LAI MMC, 1984, P NATL ACAD SCI-BIOL, V81, P3626, DOI 10.1073/pnas.81.12.3626; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Ma YL, 2010, PROTEIN CELL, V1, P688, DOI 10.1007/s13238-010-0079-x; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; MONAGHAN A, 1994, NUCLEIC ACIDS RES, V22, P742, DOI 10.1093/nar/22.5.742; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; PARKER MM, 1990, VIROLOGY, V179, P463, DOI 10.1016/0042-6822(90)90316-J; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; STUMP WT, 1993, NUCLEIC ACIDS RES, V21, P5480, DOI 10.1093/nar/21.23.5480; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Urbaneja MA, 2002, J MOL BIOL, V318, P749, DOI 10.1016/S0022-2836(02)00043-8; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002; Yount B, 2006, P NATL ACAD SCI USA, V103, P12546, DOI 10.1073/pnas.0605438103; Zuniga S, 2004, J VIROL, V78, P980, DOI 10.1128/JVI.78.2.980-994.2004; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	52	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7063	7073		10.1074/jbc.M111.287763	http://dx.doi.org/10.1074/jbc.M111.287763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241479	Green Published, hybrid			2022-12-25	WOS:000301060200011
J	Regnier, V; Billard, JM; Gupta, S; Potier, B; Woerner, S; Paly, E; Ledru, A; David, S; Luilier, S; Bizot, JC; Vacano, G; Kraus, JP; Patterson, D; Kruger, WD; Delabar, JM; London, J				Regnier, Vinciane; Billard, Jean-Marie; Gupta, Sapna; Potier, Brigitte; Woerner, Stephanie; Paly, Evelyne; Ledru, Aurelie; David, Sabrina; Luilier, Sabrina; Bizot, Jean-Charles; Vacano, Guido; Kraus, Jan P.; Patterson, David; Kruger, Warren D.; Delabar, Jean M.; London, Jaqueline			Brain Phenotype of Transgenic Mice Overexpressing Cystathionine beta-Synthase	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOWN-SYNDROME; MOUSE MODEL; SYNAPTIC PLASTICITY; PASSIVE-AVOIDANCE; HOMOCYSTEINE METABOLISM; HYDROGEN-SULFIDE; RAT-LIVER; EXPRESSION; HIPPOCAMPUS	Background: The cystathionine beta-synthase (CBS) gene, located on human chromosome 21q22.3, is a good candidate for playing a role in the Down Syndrome (DS) cognitive profile: it is overexpressed in the brain of individuals with DS, and it encodes a key enzyme of sulfur-containing amino acid (SAA) metabolism, a pathway important for several brain physiological processes. Methodology/Principal Findings: Here, we have studied the neural consequences of CBS overexpression in a transgenic mouse line (60.4P102D1) expressing the human CBS gene under the control of its endogenous regulatory regions. These mice displayed a similar to 2-fold increase in total CBS proteins in different brain areas and a similar to 1.3-fold increase in CBS activity in the cerebellum and the hippocampus. No major disturbance of SAA metabolism was observed, and the transgenic mice showed normal behavior in the rotarod and passive avoidance tests. However, we found that hippocampal synaptic plasticity is facilitated in the 60.4P102D1 line. Conclusion/Significance: We demonstrate that CBS overexpression has functional consequences on hippocampal neuronal networks. These results shed new light on the function of the CBS gene, and raise the interesting possibility that CBS overexpression might have an advantageous effect on some cognitive functions in DS.	[Regnier, Vinciane; Woerner, Stephanie; Paly, Evelyne; Ledru, Aurelie; Delabar, Jean M.; London, Jaqueline] Univ Paris Diderot, CNRS EAC 4413, Unite Biol Fonct & Adaptat, Paris, France; [Billard, Jean-Marie; Potier, Brigitte] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM UMR 894, Paris, France; [Gupta, Sapna; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [David, Sabrina; Luilier, Sabrina; Bizot, Jean-Charles] Key Obs SAS, Orleans, France; [Vacano, Guido; Patterson, David] Univ Denver, Eleanor Roosevelt Inst, Denver, CO USA; [Vacano, Guido; Patterson, David] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Kraus, Jan P.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fox Chase Cancer Center; University of Denver; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Regnier, V (corresponding author), CNRS UPR 3404, Ctr Genet Mol, Bat 26, Gif Sur Yvette, France.	vinciane.regnier@univ-paris-diderot.fr	kruger, warren/A-6407-2008; Vacano, Guido/W-8439-2019; Billard, Jean-Marie/ABD-4987-2020; Kruger, Warren/Y-2541-2018	kruger, warren/0000-0002-4990-3695; Vacano, Guido/0000-0001-5979-9310; 	Fondation Jerome Lejeune; European Commission [037627]; National Institutes of Health (NIH) [HD17449, HL50299, CA06927]; Hempling Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD017449] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	Fondation Jerome Lejeune; European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hempling Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fondation Jerome Lejeune (to DP, JL, VR, JPK); the European Commission (anEUploidy, 037627 to J-CB, JMD); and the National Institutes of Health (NIH) (HD17449 to DP). SG and WK were supported in part by the NIH (HL50299, CA06927), the Hempling Foundation, and an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Almaguer-Milian W, 2000, SYNAPSE, V38, P369, DOI 10.1002/1098-2396(20001215)38:4<369::AID-SYN1>3.0.CO;2-Q; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Banerjee R, 2008, TRENDS BIOCHEM SCI, V33, P413, DOI 10.1016/j.tibs.2008.06.006; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; BOGO V, 1981, NEUROTOXICOLOGY, V2, P765; Butler C, 2006, BEHAV GENET, V36, P429, DOI 10.1007/s10519-006-9046-y; Cao XJ, 2008, EUR J PHARMACOL, V595, P30, DOI 10.1016/j.ejphar.2008.07.061; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Contestabile A, 2010, PROG NEUROBIOL, V91, P1, DOI 10.1016/j.pneurobio.2010.01.003; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Coppus AW, 2007, J NEURAL TRANSM, V114, P1041, DOI 10.1007/s00702-007-0656-1; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; del Olmo N, 2004, EUR J NEUROSCI, V19, P1875, DOI 10.1111/j.1460-9568.2004.03309.x; Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Gimenez E, 2001, LAB ANIM-UK, V35, P153, DOI 10.1258/0023677011911525; Ichinohe A, 2005, BIOCHEM BIOPH RES CO, V338, P1547, DOI 10.1016/j.bbrc.2005.10.118; Infantino V, 2011, MOL GENET METAB, V102, P378, DOI 10.1016/j.ymgme.2010.11.166; Izquierdo I, 1997, EUR J NEUROSCI, V9, P786, DOI 10.1111/j.1460-9568.1997.tb01427.x; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P488, DOI 10.1016/0005-2744(70)90255-X; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P501; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; Lalonde R, 1996, NEUROBIOL LEARN MEM, V65, P113, DOI 10.1006/nlme.1996.0013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lorenzini CGA, 1997, BRAIN RES, V768, P242, DOI 10.1016/S0006-8993(97)00651-3; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mischoulon D, 2002, AM J CLIN NUTR, V76, p1158S, DOI 10.1093/ajcn/76.5.1158S; MUDD SH, 1965, J BIOL CHEM, V240, P4382; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Pereira PL, 2009, HUM MOL GENET, V18, P4756, DOI 10.1093/hmg/ddp438; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Potier B, 2000, EXP GERONTOL, V35, P1185, DOI 10.1016/S0531-5565(00)00122-4; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Pugh PL, 2004, BEHAV BRAIN RES, V155, P283, DOI 10.1016/j.bbr.2004.04.021; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roubertoux PL, 2010, AM J MED GENET C, V154C, P400, DOI 10.1002/ajmg.c.30280; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; SKOVBY F, 1984, J BIOL CHEM, V259, P583; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Vicari S, 2006, BEHAV GENET, V36, P355, DOI 10.1007/s10519-006-9057-8; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu JY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S1; Xu XH, 2011, TOXICOL APPL PHARM, V255, P221, DOI 10.1016/j.taap.2011.06.022; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179	69	22	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29056	10.1371/journal.pone.0029056	http://dx.doi.org/10.1371/journal.pone.0029056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253703	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100005
J	Chen, XD; Guo, WZ; Liu, BL; Zhang, YM; Song, XL; Cheng, Y; Zhang, LL; Zhang, TZ				Chen, Xiangdong; Guo, Wangzhen; Liu, Bingliang; Zhang, Yuanming; Song, Xianliang; Cheng, Yu; Zhang, Lili; Zhang, Tianzhen			Molecular Mechanisms of Fiber Differential Development between G. barbadense and G. hirsutum Revealed by Genetical Genomics	PLOS ONE			English	Article							BACKCROSS-SELF APPROACH; COTTON FIBER; GOSSYPIUM-HIRSUTUM; CELL ELONGATION; FLAVONOID ACCUMULATION; TRANSCRIPTION FACTORS; AUXIN TRANSPORT; SECONDARY WALLS; IN-VITRO; EXPRESSION	Cotton fiber qualities including length, strength and fineness are known to be controlled by genes affecting cell elongation and secondary cell wall (SCW) biosynthesis, but the molecular mechanisms that govern development of fiber traits are largely unknown. Here, we evaluated an interspecific backcrossed population from G. barbadense cv. Hai7124 and G. hirsutum acc. TM-1 for fiber characteristics in four-year environments under field conditions, and detected 12 quantitative trait loci (QTL) and QTL-by-environment interactions by multi-QTL joint analysis. Further analysis of fiber growth and gene expression between TM-1 and Hai7124 showed greater differences at 10 and 25 days post-anthesis (DPA). In this two period important for fiber performances, we integrated genome-wide expression profiling with linkage analysis using the same genetic materials and identified in total 916 expression QTL (eQTL) significantly (P<0.05) affecting the expression of 394 differential genes. Many positional cis-/trans-acting eQTL and eQTL hotspots were detected across the genome. By comparative mapping of eQTL and fiber QTL, a dataset of candidate genes affecting fiber qualities was generated. Real-time quantitative RT-PCR (qRT-PCR) analysis confirmed the major differential genes regulating fiber cell elongation or SCW synthesis. These data collectively support molecular mechanism for G. hirsutum and G. barbadense through differential gene regulation causing difference of fiber qualities. The down-regulated expression of abscisic acid (ABA) and ethylene signaling pathway genes and high-level and long-term expression of positive regulators including auxin and cell wall enzyme genes for fiber cell elongation at the fiber developmental transition stage may account for superior fiber qualities.	[Chen, Xiangdong; Guo, Wangzhen; Liu, Bingliang; Zhang, Yuanming; Song, Xianliang; Cheng, Yu; Zhang, Lili; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Chen, XD (corresponding author), Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021		National Natural Science Foundation of China [30730067]; Jiangsu Natural Science Foundation [BK2008036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from the National Natural Science Foundation of China (No. 30730067) and the Jiangsu Natural Science Foundation (BK2008036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alabady MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-295; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BENEDICT CR, 1973, CROP SCI, V13, P88, DOI 10.2135/cropsci1973.0011183X001300010028x; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Boerjan W, 2009, NAT GENET, V41, P144, DOI 10.1038/ng0209-144; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Chee P, 2005, THEOR APPL GENET, V111, P757, DOI 10.1007/s00122-005-2063-z; Delmer DP, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P85; Draye X, 2005, THEOR APPL GENET, V111, P764, DOI 10.1007/s00122-005-2061-1; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; GIPSON JR, 1969, CROP SCI, V9, P339, DOI 10.2135/cropsci1969.0011183X000900030027x; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Jordan MC, 2007, PLANT BIOTECHNOL J, V5, P442, DOI 10.1111/j.1467-7652.2007.00253.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2005, CROP SCI, V45, P123, DOI 10.2135/cropsci2005.0123a; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Qin YM, 2008, PLANT SIGNAL BEHAV, V3, P194, DOI 10.4161/psb.3.3.5208; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHUBERT AM, 1973, CROP SCI, V13, P704, DOI 10.2135/cropsci1973.0011183X001300060035x; SCHUBERT AM, 1976, CROP SCI, V16, P539, DOI 10.2135/cropsci1976.0011183X001600040026x; Shi C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-22; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Simpson C, 2009, PLANT CELL, V21, P581, DOI 10.1105/tpc.108.060145; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; 't Hoen PAC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh038; Voorrips, 2001, JOINMAP VERSION 3 0; Wang HH, 2010, PLANT MOL BIOL, V72, P397, DOI 10.1007/s11103-009-9578-7; Wang J, 2010, PLANT J, V63, P1063, DOI 10.1111/j.1365-313X.2010.04303.x; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wigoda N, 2006, PLANT J, V48, P796, DOI 10.1111/j.1365-313X.2006.02917.x; Wilkins Thea A., 1996, P21; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702	61	31	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30056	10.1371/journal.pone.0030056	http://dx.doi.org/10.1371/journal.pone.0030056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253876	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700082
J	Ren, BP; Li, DY; Garber, PA; Li, M				Ren, Baoping; Li, Dayong; Garber, Paul A.; Li, Ming			Evidence of Allomaternal Nursing across One-Male Units in the Yunnan Snub-Nosed Monkey (Rhinopithecus Bieti)	PLOS ONE			English	Article							FEMALE; ROXELLANA; BENEFITS; BEHAVIOR; CARE	Background: Allomaternal nursing, common in several species of social mammals, also has been reported in nonhuman primates. However, the function of this behavior in enhancing infant survivorship remains poorly understood. Methodology and Principal Findings: The study was conducted on a free-ranging group of the Yunnan snub-nosed monkey (Rhinopithecus bieti) in the Baimaxueshan Natural Reserve. Direct observation and ad libitum sampling were used to record allocare behavior during a 20 month field study. R. bieti exhibits a multilevel social organization in which a large single troop, consisting of over 100 individuals, is divided into many one-male units (OMUs: 6 similar to 41). These OMUs coordinate their daily activities, and feed, forage, travel, and rest together. Here we report on one case of infant temporary adoption in which an adult female from one OMU engaged in allomaternal nursing and cared for an infant from a different OMU of the same troop. This event began when the mother and her five-month-old infant were found to became separated accidentally. The victim infant was observed staying in another OMU. Over the next several days we observed a lactating female in the new OMU to care for and nurse both her infant and the immigrant infant, who also was tolerated by and cared for by the harem male. Conclusions and Significance: Our findings suggest that lactating primate females are primed to care for young infants and, that the misdirected parental care hypothesis may offer the strongest explanation for allomaternal nursing in R. bieti.	[Ren, Baoping; Li, Dayong; Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Dayong] China W Normal Univ, Coll Life Sci, Nanchong, Sichuan, Peoples R China; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; China West Normal University; University of Illinois System; University of Illinois Urbana-Champaign	Ren, BP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	p-garber@illinois.edu; lim@ioz.ac.cn	Ren, Baoping/HGE-5822-2022	Ren, Baoping/0000-0002-3574-0522	973 Program [2007CB411600]; Natural Science Foundation of China [30970442]; Project of Public Benefit [201104073]; Nature Conservancy	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Public Benefit; Nature Conservancy	This study was funded by 973 Program (2007CB411600), the project of Natural Science Foundation of China (No. 30970442), the Project of Public Benefit (No. 201104073), and The Nature Conservancy. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boness DJ, 1998, J MAMMAL, V79, P1060, DOI 10.2307/1383115; Dolhinow P, 1984, FEMALE PRIMATES STUD, P37; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; Garber Paul A., 1997, Evolutionary Anthropology, V5, P187, DOI 10.1002/(SICI)1520-6505(1997)5:6<187::AID-EVAN1>3.0.CO;2-A; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; HOOGLAND JL, 1989, BEHAV ECOL SOCIOBIOL, V24, P91, DOI 10.1007/BF00299640; Hrdy SB, 2010, ESTIMATING PREVALENC; Kirkpatrick RC, 1998, INT J PRIMATOL, V19, P13, DOI 10.1023/A:1020302809584; Kirkpatrick RC, 2011, PRIMATES PERSPECTIVE, P189; Liang Bing, 2001, Acta Zoologica Sinica, V47, P381; LONG YC, 1994, PRIMATES, V35, P241, DOI 10.1007/BF02382060; MacKinnon KC, 2011, PRIMATES PERSPECTIVE, P440; OBRIEN TG, 1991, BEHAVIOUR, V119, P30, DOI 10.1163/156853991X00355; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; Ren BP, 2003, INT J PRIMATOL, V24, P575; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Sussman R.W., 2011, PRIMATES PERSPECTIVE, P587; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; WILKINSON GS, 1992, BEHAV ECOL SOCIOBIOL, V31, P225; WILLIAMS L, 1994, AM J PRIMATOL, V34, P145, DOI 10.1002/ajp.1350340206; Xi WZ, 2008, INT J PRIMATOL, V29, P593, DOI 10.1007/s10764-008-9260-y; Xiang ZF, 2009, J ZOOL, V278, P157, DOI 10.1111/j.1469-7998.2009.00563.x	22	8	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30041	10.1371/journal.pone.0030041	http://dx.doi.org/10.1371/journal.pone.0030041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253869	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700078
J	Valero, MC; Huntsman, HD; Liu, JM; Zou, K; Boppart, MD				Valero, M. Carmen; Huntsman, Heather D.; Liu, Jianming; Zou, Kai; Boppart, Marni D.			Eccentric Exercise Facilitates Mesenchymal Stem Cell Appearance in Skeletal Muscle	PLOS ONE			English	Article							SIDE POPULATION CELLS; ADULT BONE-MARROW; SATELLITE CELL; ALPHA-7-BETA-1 INTEGRIN; MOUSE MODEL; HYPERTROPHY; FIBER; PROLIFERATION; LAMININ-111; PROGENITOR	Eccentric, or lengthening, contractions result in injury and subsequently stimulate the activation and proliferation of satellite stem cells which are important for skeletal muscle regeneration. The discovery of alternative myogenic progenitors in skeletal muscle raises the question as to whether stem cells other than satellite cells accumulate in muscle in response to exercise and contribute to post-exercise repair and/or growth. In this study, stem cell antigen-1 (Sca-1) positive, non-hematopoetic (CD45(-)) cells were evaluated in wild type (WT) and alpha 7 integrin transgenic (alpha 7Tg) mouse muscle, which is resistant to injury yet liable to strain, 24 hr following a single bout of eccentric exercise. Sca-1(+)CD45(-) stem cells were increased 2-fold in WT muscle post-exercise. The alpha 7 integrin regulated the presence of Sca-1(+) cells, with expansion occurring in alpha 7Tg muscle and minimal cells present in muscle lacking the alpha 7 integrin. Sca-1(+)CD45(-) cells isolated from alpha 7Tg muscle following exercise were characterized as mesenchymal-like stem cells (mMSCs), predominantly pericytes. In vitro multiaxial strain upregulated mMSC stem cells markers in the presence of laminin, but not gelatin, identifying a potential mechanistic basis for the accumulation of these cells in muscle following exercise. Transplantation of DiI-labeled mMSCs into WT muscle increased Pax7(+) cells and facilitated formation of eMHC(+)DiI(-) fibers. This study provides the first demonstration that mMSCs rapidly appear in skeletal muscle in an alpha 7 integrin dependent manner post-exercise, revealing an early event that may be necessary for effective repair and/or growth following exercise. The results from this study also support a role for the alpha 7 integrin and/or mMSCs in molecular-and cellular-based therapeutic strategies that can effectively combat disuse muscle atrophy.	[Valero, M. Carmen] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Valero, MC (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	mboppart@illinois.edu	Zou, Kai/Y-9318-2019	Zou, Kai/0000-0003-4164-7129	Illinois Regenerative Medicine Institute; Ellison Medical Foundation; Mary Jane Neer Foundation (University of Illinois at Urbana Champaign); University of Illinois at Urbana Champaign; National Science Foundation; American Heart Association	Illinois Regenerative Medicine Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Mary Jane Neer Foundation (University of Illinois at Urbana Champaign); University of Illinois at Urbana Champaign; National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by grants from the Illinois Regenerative Medicine Institute, Ellison Medical Foundation, Mary Jane Neer Foundation (University of Illinois at Urbana Champaign), and Arnold O. Beckman Award (University of Illinois at Urbana Champaign) (to MB). HH was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship graduate fellowship in Cellular & Molecular Mechanics and Bio-Nanotechnology (CMMB). JL was supported by an American Heart Association postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio F, 2010, TISSUE ENG PT A, V16, P839, DOI [10.1089/ten.tea.2009.0113, 10.1089/ten.TEA.2009.0113]; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BAO ZZ, 1993, J CELL SCI, V106, P579; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Boppart MD, 2008, AM J PHYSIOL-REG I, V295, pR1623, DOI 10.1152/ajpregu.00089.2008; Boppart MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1660, DOI 10.1152/ajpcell.00317.2005; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Gang EJ, 2008, EXP CELL RES, V314, P1721, DOI 10.1016/j.yexcr.2008.02.016; Goudenege S, 2010, MOL THER, V18, P2155, DOI 10.1038/mt.2010.165; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hyldahl RD, 2011, FASEB J, V25, P2956, DOI 10.1096/fj.10-177105; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kadi F, 1999, HISTOCHEM CELL BIOL, V112, P73, DOI 10.1007/s004180050393; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kino-Oka M, 2009, TISSUE ENG PART C-ME, V15, P717, DOI [10.1089/ten.tec.2008.0429, 10.1089/ten.TEC.2008.0429]; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Liu JM, 2008, AM J PHYSIOL-CELL PH, V294, pC627, DOI 10.1152/ajpcell.00329.2007; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lueders TN, 2011, AM J PHYSIOL-CELL PH, V301, pC938, DOI 10.1152/ajpcell.00515.2010; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Parise G, 2006, APPL PHYSIOL NUTR ME, V31, P773, DOI [10.1139/H06-055, 10.1139/h06-055]; Paul AC, 2002, CELL TISSUE RES, V308, P255, DOI 10.1007/s00441-002-0526-y; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Snijders T, 2009, AGEING RES REV, V8, P328, DOI 10.1016/j.arr.2009.05.003; SONG WK, 1993, J CELL SCI, V106, P1139; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Whitney MJ, 2009, TISSUE ENG PT A, V15, P33, DOI 10.1089/ten.tea.2007.0266; YUTOKU M, 1974, J IMMUNOL, V112, P1774; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zou K, 2011, J APPL PHYS IN PRESS	50	66	71	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29760	10.1371/journal.pone.0029760	http://dx.doi.org/10.1371/journal.pone.0029760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253772	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700046
J	Bohan, DA; Caron-Lormier, G; Muggleton, S; Raybould, A; Tamaddoni-Nezhad, A				Bohan, David A.; Caron-Lormier, Geoffrey; Muggleton, Stephen; Raybould, Alan; Tamaddoni-Nezhad, Alireza			Automated Discovery of Food Webs from Ecological Data Using Logic-Based Machine Learning	PLOS ONE			English	Article							MODIFIED HERBICIDE-TOLERANT; FARM-SCALE EVALUATIONS; GENERALIST PREDATORS; INVERTEBRATE ABUNDANCE; INTRAGUILD PREDATION; BIOLOGICAL-CONTROL; ECOSYSTEM SERVICE; WEED SEEDBANK; MANAGEMENT; COLLEMBOLA	Networks of trophic links (food webs) are used to describe and understand mechanistic routes for translocation of energy (biomass) between species. However, a relatively low proportion of ecosystems have been studied using food web approaches due to difficulties in making observations on large numbers of species. In this paper we demonstrate that Machine Learning of food webs, using a logic-based approach called A/ILP, can generate plausible and testable food webs from field sample data. Our example data come from a national-scale Vortis suction sampling of invertebrates from arable fields in Great Britain. We found that 45 invertebrate species or taxa, representing approximately 25% of the sample and about 74% of the invertebrate individuals included in the learning, were hypothesized to be linked. As might be expected, detritivore Collembola were consistently the most important prey. Generalist and omnivorous carabid beetles were hypothesized to be the dominant predators of the system. We were, however, surprised by the importance of carabid larvae suggested by the machine learning as predators of a wide variety of prey. High probability links were hypothesized for widespread, potentially destabilizing, intra-guild predation; predictions that could be experimentally tested. Many of the high probability links in the model have already been observed or suggested for this system, supporting our contention that A/ILP learning can produce plausible food webs from sample data, independent of our preconceptions about "who eats whom." Well-characterised links in the literature correspond with links ascribed with high probability through A/ILP. We believe that this very general Machine Learning approach has great power and could be used to extend and test our current theories of agricultural ecosystem dynamics and function. In particular, we believe it could be used to support the development of a wider theory of ecosystem responses to environmental change.	[Bohan, David A.; Caron-Lormier, Geoffrey] W Common, Rothamsted Res, Harpenden, Herts, England; [Bohan, David A.] INRA, UMR Biol & Gest Adventices 1210, F-21034 Dijon, France; [Muggleton, Stephen; Tamaddoni-Nezhad, Alireza] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Computat Bioinformat Lab, London, England; [Raybould, Alan] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; INRAE; Imperial College London; Syngenta	Bohan, DA (corresponding author), W Common, Rothamsted Res, Harpenden, Herts, England.	weed.dynamics@gmail.com	Caron-Lormier, Geoffrey/B-6677-2009; Bohan, David A/D-7992-2012	Bohan, David A/0000-0001-5656-775X	Syngenta Ltd; Imperial College	Syngenta Ltd(Syngenta); Imperial College	This research was partly supported by monies in support of Alireza Tamaddoni-Nezhad and Stephen Muggleton through a strategic link between Syngenta Ltd and Imperial College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; Bell JR, 2010, ECOGRAPHY, V33, P64, DOI 10.1111/j.1600-0587.2009.06046.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bilde T, 2000, J APPL ECOL, V37, P672, DOI 10.1046/j.1365-2664.2000.00527.x; Bohan DA, 2007, B ENTOMOL RES, V97, P265, DOI 10.1017/S0007485307004890; Bohan DA, 2011, WEED RES, V51, P422, DOI 10.1111/j.1365-3180.2011.00860.x; Bohan DA, 2005, P ROY SOC B-BIOL SCI, V272, P463, DOI 10.1098/rspb.2004.3049; Bohan DA, 2011, J APPL ECOL, V48, P888, DOI 10.1111/j.1365-2664.2011.02008.x; Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; Caron-Lormier G, 2011, ECOL MODEL, V222, P1163, DOI 10.1016/j.ecolmodel.2010.11.028; Caron-Lormier G, 2009, ECOL MODEL, V220, P1935, DOI 10.1016/j.ecolmodel.2009.04.021; Champion GT, 2003, PHILOS T ROY SOC B, V358, P1801, DOI 10.1098/rstb.2003.1405; Cohen JE, 2009, P NATL ACAD SCI USA, V106, P22335, DOI 10.1073/pnas.0910582106; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Dickinson G., 1998, ECOSYSTEMS FUNCTIONA; Dietterich TG, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P8; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Eitzinger B, 2011, J APPL ECOL, V48, P591, DOI 10.1111/j.1365-2664.2010.01947.x; Firbank LG, 2003, J APPL ECOL, V40, P2, DOI 10.1046/j.1365-2664.2003.00787.x; Firbank LG., 2003, IMPLICATIONS SPRING; Flach PA, 2000, APPL LOGIC SERIES; Frank SD, 2010, ECOL ENTOMOL, V35, P61, DOI 10.1111/j.1365-2311.2009.01156.x; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; HAUSSLER D, 1994, MACH LEARN, V14, P83, DOI 10.1007/BF00993163; Hawes C, 2009, BASIC APPL ECOL, V10, P34, DOI 10.1016/j.baae.2007.11.007; IWDB, 2011, INTERACTION WEB DATA; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Marcussen BM, 1999, ENTOMOL EXP APPL, V92, P29, DOI 10.1023/A:1003787208256; Muggleton S., 1991, New Generation Computing, V8, P295, DOI 10.1007/BF03037089; Muggleton S. H., 2000, Inductive Logic Programming. 10th International Conference, ILP 2000. Proceedings (Lecture Notes in Artificial Intelligence Vol.1866), P130; Muggleton Stephen, 1996, ADV INDUCTIVE LOGIC, V32, P254; ODUM E P, 1971, P574; Perry JN, 2003, J APPL ECOL, V40, P17, DOI 10.1046/j.1365-2664.2003.00786.x; Pons X, 2005, EUR J ENTOMOL, V102, P519, DOI 10.14411/eje.2005.074; Prasad RP, 2004, BIOL CONTROL, V31, P428, DOI 10.1016/j.biocontrol.2004.07.005; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Rosenheim JA, 2005, BIOL CONTROL, V32, P172, DOI 10.1016/j.biocontrol.2004.09.007; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Smith' V, 2008, ARTHROPOD-PLANT INTE, V2, P21, DOI 10.1007/s11829-007-9027-y; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Squire GR, 2003, PHILOS T R SOC B, V358, P1779, DOI 10.1098/rstb.2003.1403; SUNDERLAND KD, 1975, J APPL ECOL, V12, P507, DOI 10.2307/2402171; SUNDERLAND KD, 1987, J APPL ECOL, V24, P907, DOI 10.2307/2403989; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Tamaddoni-Nezhad A, 2006, MACH LEARN, V64, P209, DOI 10.1007/s10994-006-8988-x; Toft S, 2005, EUR J ENTOMOL, V102, P371, DOI 10.14411/eje.2005.054; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Turchin P., 2003, MONOGRAPHS POPULATIO; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013	54	42	44	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29028	10.1371/journal.pone.0029028	http://dx.doi.org/10.1371/journal.pone.0029028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242111	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000013
J	Kim, JW; Jang, SM; Kim, CH; An, JH; Kang, EJ; Choi, KH				Kim, Jung-Woong; Jang, Sang-Min; Kim, Chul-Hong; An, Joo-Hee; Kang, Eun-Jin; Choi, Kyung-Hee			New Molecular Bridge between RelA/p65 and NF-kappa B Target Genes via Histone Acetyltransferase TIP60 Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TRANSCRIPTIONAL ACTIVITY; DNA-BINDING; RECEPTOR COACTIVATOR; PRECURSOR PROTEIN; ACTIVATION; EXPRESSION; ACETYLATION; APOPTOSIS; ALPHA	The nuclear factor-kappa B (NF-kappa B) family is involved in the expressions of numerous genes, in development, apoptosis, inflammatory responses, and oncogenesis. In this study we identified four NF-kappa B target genes that are modulated by TIP60. We also found that TIP60 interacts with the NF-kappa B RelA/p65 subunit and increases its transcriptional activity through protein-protein interaction. Although TIP60 binds with RelA/p65 using its histone acetyltransferase domain, TIP60 does not directly acetylate RelA/p65. However, TIP60 maintained acetylated Lys310 RelA/p65 levels in the TNF-alpha-dependent NF-kappa B signaling pathway. In chromatin immunoprecipitation assay, TIP60 was primarily recruited to the IL-6, IL-8, C-IAP1, and XIAP promoters in TNF-alpha stimulation followed by acetylation of histones H3 and H4. Chromatin remodeling by TIP60 involved the sequential recruitment of acetyl-Lys-310 RelA/p65 to its target gene promoters. Furthermore, we showed that up-regulated TIP60 expression was correlated with acetyl-Lys-310 RelA/p65 expressions in hepatocarcinoma tissues. Taken together these results suggest that TIP60 is involved in the NF-kappa B pathway through protein interaction with RelA/p65 and that it modulates the transcriptional activity of RelA/p65 in NF-kappa B-dependent gene expression.	[Kim, Jung-Woong; Jang, Sang-Min; Kim, Chul-Hong; An, Joo-Hee; Kang, Eun-Jin; Choi, Kyung-Hee] Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea	Chung Ang University	Choi, KH (corresponding author), Chung Ang Univ, Sch Biol Sci, 221 Heuksuk Dong, Seoul 156756, South Korea.	khchoi@cau.ac.kr		Kim, Chulhong/0000-0001-7249-1257	National Research Foundation of Korea [2009-0079913, 2010-0000409, 2011-0000160]; Korean government (MEST; Ministry of Education, Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST; Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Mid-career Researcher Program through National Research Foundation of Korea Grants 2009-0079913, 2010-0000409, and 2011-0000160 funded by the Korean government (MEST; Ministry of Education, Science and Technology).	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim JW, 2008, J BIOL CHEM, V283, P20077, DOI 10.1074/jbc.M800161200; Kim JW, 2011, FEBS J, V278, P4394, DOI 10.1111/j.1742-4658.2011.08362.x; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann DA, 2005, J HEPATOL, V42, P610, DOI 10.1016/j.jhep.2005.01.007; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252	61	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7780	7791		10.1074/jbc.M111.278465	http://dx.doi.org/10.1074/jbc.M111.278465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249179	Green Published, hybrid			2022-12-25	WOS:000301060200076
J	Valente, C; Hinds, J; Pinto, F; Brugger, SD; Gould, K; Muhlemann, K; de Lencastre, H; Sa-Leao, R				Valente, Carina; Hinds, Jason; Pinto, Francisco; Brugger, Silvio D.; Gould, Katherine; Muehlemann, Kathrin; de Lencastre, Herminia; Sa-Leao, Raquel			Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; DAY-CARE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; SEROTYPES; CHILDREN; DISEASE; COCOLONIZATION; TRANSMISSION; REGRESSION	Understanding the epidemiology of pneumococcal co-colonization is important for monitoring vaccine effectiveness and the occurrence of horizontal gene transfer between pneumococcal strains. In this study we aimed to evaluate the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal co-colonization among Portuguese children. Nasopharyngeal samples from children up to 6 years old yielding a pneumococcal culture were clustered into three groups: pre-vaccine era (n = 173), unvaccinated children of the vaccine era (n = 169), and fully vaccinated children (4 doses; n = 150). Co-colonization, serotype identification, and relative serotype abundance were detected by analysis of DNA of the total bacterial growth of the primary culture plate using the plyNCR-RFLP method and a molecular serotyping microarray-based strategy. The plyNCR-RFLP method detected an overall co-colonization rate of 20.1%. Microarray analysis confirmed the plyNCR-RFLP results. Vaccination status was the only factor found to be significantly associated with co-colonization: co-colonization rates were significantly lower (p = 0.004; Fisher's exact test) among fully vaccinated children (8.0%) than among children from the pre-PCV7 era (17.3%) or unvaccinated children of the PCV7 era (18.3%). In the PCV7 era there were significantly less non-vaccine type (NVT) co-colonization events than would be expected based on the NVT distribution observed in the pre-PCV7 era (p = 0.024). In conclusion, vaccination with PCV7 resulted in a lower co-colonization rate due to an asymmetric distribution between NVTs found in single and co-colonized samples. We propose that some NVTs prevalent in the PCV7 era are more competitive than others, hampering their co-existence in the same niche. This result may have important implications since a decrease in co-colonization events is expected to translate in decreased opportunities for horizontal gene transfer, hindering pneumococcal evolution events such as acquisition of antibiotic resistance determinants or capsular switch. This might represent a novel potential benefit of conjugate vaccines.	[Valente, Carina; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Valente, Carina; de Lencastre, Herminia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, Oeiras, Portugal; [Hinds, Jason; Gould, Katherine] Univ London, Bacterial Microarray Grp, London, England; [Pinto, Francisco] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal; [Brugger, Silvio D.; Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of London; Universidade de Lisboa; University of Bern; Rockefeller University	Valente, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal.	rsaleao@itqb.unl.pt	Pinto, Francisco/A-7443-2008; Sá-Leão, Raquel/A-9341-2011; Kummer, Juerg/B-3322-2011; Valente, Carina/A-4955-2015; Brugger, Silvio Daniel/AAY-7090-2020	Pinto, Francisco/0000-0002-4217-0054; Sá-Leão, Raquel/0000-0001-9804-827X; Valente, Carina/0000-0003-1864-6080; Brugger, Silvio Daniel/0000-0001-9492-9088; /0000-0001-6816-8932; Gould, Katherine/0000-0002-2528-9512; Hinds, Jason/0000-0002-2739-1908	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/SAU-ESA/65048/2006, PTDC/BIA-BEC/098289/2008, SFRH/BD/70058/2010, PEst-OE/EQB/LA0004/2011]; Wellcome Trust [086547]; Pfizer	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome TrustEuropean Commission); Pfizer(Pfizer)	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (PTDC/SAU-ESA/65048/2006 and PTDC/BIA-BEC/098289/2008 to RSL, SFRH/BD/70058/2010 to CV, and PEst-OE/EQB/LA0004/2011 to Associate Laboratory). We acknowledge the Wellcome Trust for funding the Bacterial Microarray Group at St. Geroge's, University of London (BmG@S) [grant 086547]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RSL has received research funding (for other projects distinct from this study) from Pfizer through the Investigator Initiated Research Program. All other authors declare that no conflicts exist. This does not alter authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; BARNES DM, 1995, J INFECT DIS, V171, P890, DOI 10.1093/infdis/171.4.890; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hinds J, 2010, 7 INT S PNEUM PNEUM, P129; HODGES RG, 1946, AM J HYG, V44, P207, DOI 10.1093/oxfordjournals.aje.a119090; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Mato R, 2005, MICROB DRUG RESIST, V11, P309, DOI 10.1089/mdr.2005.11.309; Millar EV, 2006, CLIN INFECT DIS, V43, P8, DOI 10.1086/504802; MONTGOMERY JM, 1990, REV INFECT DIS, V12, pS1006; Newton R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-88; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2002, J CLIN MICROBIOL, V40, P3577, DOI 10.1128/JCM.40.10.3577-3585.2002; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Simoes AS, 2011, J CLIN MICROBIOL; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weinberger DM, 2011, LANCET	34	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30235	10.1371/journal.pone.0030235	http://dx.doi.org/10.1371/journal.pone.0030235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253924	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000301357100048
J	Koester, B; Rea, TJ; Templeton, AR; Szalay, AS; Sing, CF				Koester, Benjamin; Rea, Thomas J.; Templeton, Alan R.; Szalay, Alexander S.; Sing, Charles F.			Long-Range Autocorrelations of CpG Islands in the Human Genome	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; GENE; ORGANIZATION; NUCLEOSOME; EVOLUTION; FEATURES; MODEL; METHYLATION; EPIGENETICS; ESTIMATORS	In this paper, we use a statistical estimator developed in astrophysics to study the distribution and organization of features of the human genome. Using the human reference sequence we quantify the global distribution of CpG islands (CGI) in each chromosome and demonstrate that the organization of the CGI across a chromosome is non-random, exhibits surprisingly long range correlations (10 Mb) and varies significantly among chromosomes. These correlations of CGI summarize functional properties of the genome that are not captured when considering variation in any particular separate (and local) feature. The demonstration of the proposed methods to quantify the organization of CGI in the human genome forms the basis of future studies. The most illuminating of these will assess the potential impact on phenotypic variation of inter-individual variation in the organization of the functional features of the genome within and among chromosomes, and among individuals for particular chromosomes.	[Koester, Benjamin; Rea, Thomas J.; Sing, Charles F.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Szalay, Alexander S.] Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; [Templeton, Alan R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Washington University (WUSTL)	Koester, B (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	csing@umich.edu	Templeton, Alan R./F-5963-2011	Templeton, Alan/0000-0002-0167-845X; Sing, Charles/0000-0001-5872-7956	National Institutes of Health [HL072905]; National Institute of General Medical Science [GM065509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant number HL072905 and National Institute of General Medical Science grant number GM065509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISSANI B, 1991, GENE, V106, P173, DOI 10.1016/0378-1119(91)90197-J; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; [Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; Baddeley AJ, 1998, STOCHASTIC GEOMETRY, P37; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bevington PR, 2003, DATA REDUCTION ERROR, P328; Bhardwaj N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000755; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Bornfleth H, 2000, GENOMICS AND PROTEOMICS, P133; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chapeau-Blondeau F, 2007, PHYSICA A, V380, P1, DOI 10.1016/j.physa.2007.02.077; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; DAVIS M, 1983, ASTROPHYS J, V267, P465, DOI 10.1086/160884; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hackenberg M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-327; HAMILTON AJS, 1993, ASTROPHYS J, V417, P19, DOI 10.1086/173288; Han L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r79; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; JOSSE J, 1961, J BIOL CHEM, V236, P864; Kerscher M, 2000, ASTROPHYS J, V535, pL13, DOI 10.1086/312702; Knoch TA, 2009, EUR BIOPHYS J BIOPHY, V38, P757, DOI 10.1007/s00249-009-0489-y; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANDY SD, 1993, ASTROPHYS J, V412, P64, DOI 10.1086/172900; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lewontin R, 2002, TRIPLE HELIX GENE OR, P144; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; Li WT, 1997, COMPUT CHEM, V21, P257, DOI 10.1016/S0097-8485(97)00022-3; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2011, SCI AM, V304, P66, DOI 10.1038/scientificamerican0211-66; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Necsulea A, 2009, MOL BIOL EVOL, V26, P729, DOI 10.1093/molbev/msn303; Nobel D, 2006, MUSIC LIFE BIOL GENO, P176; OHNO S, 1993, CURR OPIN GENET DEV, V3, P911, DOI 10.1016/0959-437X(93)90013-F; Ohser J, 1991, RES INFORM, V4, P147; Peebles P. J. E., 1980, LARGE SCALE STRUCTUR; Polak P, 2009, GENOME BIOL EVOL, V1, P189, DOI 10.1093/gbe/evp024; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Press W. H., 1992, ART SCI COMPUTING; Ripley B.D., 1981, SPATIAL STAT, P272; Seringhaus M, 2008, AM SCI, V96, P466, DOI 10.1511/2008.75.466; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stoyan D, 2000, SCAND J STAT, V27, P641, DOI 10.1111/1467-9469.00213; Stoyan D., 1995, STOCHASTIC GEOMETRY; SUEOKA N, 1959, P NATL ACAD SCI USA, V45, P1480, DOI 10.1073/pnas.45.10.1480; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; Weiss KM, 2009, INT J DEV BIOL, V53, P753, DOI 10.1387/ijdb.072497kw; Wu H, 2010, IEEE T PATTERN ANAL, V32, P1443, DOI 10.1109/TPAMI.2009.135; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076	79	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29889	10.1371/journal.pone.0029889	http://dx.doi.org/10.1371/journal.pone.0029889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253817	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700062
J	Malacarne, G; Perazzolli, M; Cestaro, A; Sterck, L; Fontana, P; Van de Peer, Y; Viola, R; Velasco, R; Salamini, F				Malacarne, Giulia; Perazzolli, Michele; Cestaro, Alessandro; Sterck, Lieven; Fontana, Paolo; Van de Peer, Yves; Viola, Roberto; Velasco, Riccardo; Salamini, Francesco			Deconstruction of the (Paleo)Polyploid Grapevine Genome Based on the Analysis of Transposition Events Involving NBS Resistance Genes	PLOS ONE			English	Article							PH1 LOCUS; EVOLUTION; SEQUENCE; ARABIDOPSIS; DUPLICATION; ANCIENT; PROTEIN; FAMILY; REORGANIZATION; IDENTIFICATION	Plants have followed a reticulate type of evolution and taxa have frequently merged via allopolyploidization. A polyploid structure of sequenced genomes has often been proposed, but the chromosomes belonging to putative component genomes are difficult to identify. The 19 grapevine chromosomes are evolutionary stable structures: their homologous triplets have strongly conserved gene order, interrupted by rare translocations. The aim of this study is to examine how the grapevine nucleotide-binding site (NBS)-encoding resistance (NBS-R) genes have evolved in the genomic context and to understand mechanisms for the genome evolution. We show that, in grapevine, i) helitrons have significantly contributed to transposition of NBS-R genes, and ii) NBS-R gene cluster similarity indicates the existence of two groups of chromosomes (named as Va and Vc) that may have evolved independently. Chromosome triplets consist of two Va and one Vc chromosomes, as expected from the tetraploid and diploid conditions of the two component genomes. The hexaploid state could have been derived from either allopolyploidy or the separation of the Va and Vc component genomes in the same nucleus before fusion, as known for Rosaceae species. Time estimation indicates that grapevine component genomes may have fused about 60 mya, having had at least 40-60 mya to evolve independently. Chromosome number variation in the Vitaceae and related families, and the gap between the time of eudicot radiation and the age of Vitaceae fossils, are accounted for by our hypothesis.	[Malacarne, Giulia; Perazzolli, Michele; Cestaro, Alessandro; Fontana, Paolo; Viola, Roberto; Velasco, Riccardo; Salamini, Francesco] Fdn Edmund Mach, IASMA Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Sterck, Lieven; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Fondazione Edmund Mach; Flanders Institute for Biotechnology (VIB); Ghent University	Malacarne, G (corresponding author), Fdn Edmund Mach, IASMA Res & Innovat Ctr, San Michele All Adige, Trento, Italy.	michele.perazzolli@iasma.it	Van de Peer, Yves/AAE-7666-2019; Sterck, Lieven/A-9439-2016; Malacarne, Giulia/N-4244-2015; Viola, Roberto/D-2277-2010; Perazzolli, Michele/B-3636-2012; Viola, Roberto/F-3657-2014	Van de Peer, Yves/0000-0003-4327-3730; Sterck, Lieven/0000-0001-7116-4000; Malacarne, Giulia/0000-0003-1439-5958; Perazzolli, Michele/0000-0001-7218-9963; Viola, Roberto/0000-0002-8202-8503; Velasco, Riccardo/0000-0002-8760-5031; Cestaro, Alessandro/0000-0003-1439-5165	Provincia Autonoma di Trento; Post-Doc Project "FLAVONOIDI"; Post-Doc Project "Resistevite"; Ghent University; Interuniversity Attraction Poles Programme [IUAP P6/25]	Provincia Autonoma di Trento(Autonomous Province of Trento); Post-Doc Project "FLAVONOIDI"; Post-Doc Project "Resistevite"; Ghent University(Ghent University); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	The research was supported by the Provincia Autonoma di Trento. GM and MP were supported by the Post-Doc Projects 2006 "FLAVONOIDI" and "Resistevite" funded by the Provincia Autonoma di Trento. YVdP acknowledges support from Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks") and the Interuniversity Attraction Poles Programme (IUAP P6/25), initiated by the Belgian State, Science Policy Office (BioMaGNet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Al-Kaff N, 2008, ANN BOT-LONDON, V101, P863, DOI 10.1093/aob/mcm252; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Arnold ML, 1994, NATURAL HYBRIDISATIO; Borgato L, 2007, PLANTA, V226, P961, DOI 10.1007/s00425-007-0542-y; Bowers JE, 2003, GENETICS, V165, P367; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen I, 2007, AM J BOT, V94, P1534, DOI 10.3732/ajb.94.9.1534; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; Crane PR, 2004, AM J BOT, V91, P1683, DOI 10.3732/ajb.91.10.1683; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Durbin R., 1998, BIOL SEQUENCE ANAL P; Falginella L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-562; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLAVELL RB, 1984, BIOESSAYS, V1, P21, DOI 10.1002/bies.950010109; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Friedman AR, 2007, CURR OPIN GENET DEV, V17, P493, DOI 10.1016/j.gde.2007.08.014; Friedman WE, 2004, AM J BOT, V91, P1726, DOI 10.3732/ajb.91.10.1726; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Friis EM, 2005, CURR OPIN PLANT BIOL, V8, P5, DOI 10.1016/j.pbi.2004.11.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kanazin V, 1996, P NATL ACAD SCI USA, V93, P11746, DOI 10.1073/pnas.93.21.11746; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Leister D, 1998, P NATL ACAD SCI USA, V95, P370, DOI 10.1073/pnas.95.1.370; Leister D, 1996, NAT GENET, V14, P421, DOI 10.1038/ng1296-421; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Liu JJ, 2007, PHYTOPATHOLOGY, V97, P728, DOI 10.1094/PHYTO-97-6-0728; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nybom H, 2006, J EVOLUTION BIOL, V19, P635, DOI 10.1111/j.1420-9101.2005.01010.x; PATEL GI, 1955, AM J BOT, V42, P141, DOI 10.2307/2438464; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Ritz CM, 2005, J HERED, V96, P4, DOI 10.1093/jhered/esi011; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Tiffney BH, 1994, CENOZOIC PLANTS CLIM, P267; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Xu Q, 2007, MOL PHYLOGENET EVOL, V44, P315, DOI 10.1016/j.ympev.2006.12.029; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yu YG, 1996, P NATL ACAD SCI USA, V93, P11751, DOI 10.1073/pnas.93.21.11751; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu HY, 2002, MOL PLANT MICROBE IN, V15, P529, DOI 10.1094/MPMI.2002.15.6.529	69	26	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29762	10.1371/journal.pone.0029762	http://dx.doi.org/10.1371/journal.pone.0029762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253773	Green Published, gold			2022-12-25	WOS:000301355700047
J	Milenkovic, D; Deval, C; Gouranton, E; Landrier, JF; Scalbert, A; Morand, C; Mazur, A				Milenkovic, Dragan; Deval, Christiane; Gouranton, Erwan; Landrier, Jean-Francois; Scalbert, Augustin; Morand, Christine; Mazur, Andrzej			Modulation of miRNA Expression by Dietary Polyphenols in apoE Deficient Mice: A New Mechanism of the Action of Polyphenols	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MICRORNAS; CANCER; PROFILES; SIGNATURES; QUERCETIN; LIVER	Background: Polyphenols are the most abundant antioxidants in the human diet and are widespread constituents of fruits and beverages, such as tea, coffee or wine. Epidemiological, clinical and animal studies support a role of polyphenols in the prevention of various diseases, such as cardiovascular diseases, cancers or neurodegenerative diseases. Recent findings suggest that polyphenols could interact with cellular signaling cascades regulating the activity of transcription factors and consequently affecting the expression of genes. However, the impact of polyphenol on the expression of microRNA, small non-coding RNAs, has not yet been studied. The aim of this study was to investigate the impact of dietary supplementation with polyphenols at nutritional doses on miRNA expression in the livers of apolipoprotein E-deficient mice (apoE(-/-)) jointly with mRNA expression profiling. Methodology/Principal Findings: Using microarrays, we measured the global miRNA expression in the livers of wild-type (C57B6/J) mice or apoE(-/-) mice fed diets supplemented with one of nine different polyphenols or a control diet. This analysis revealed that knock-out of the apoE gene induced significant modulation in the expression of miRNA. Moreover, changes in miRNA expression were observed after polyphenol supplementation, and five miRNAs (mmu-miR-291b-5p, mmu-miR-296-5p, mmu-miR-30c-1*, mmu-miR-467b* and mmu-miR-374*) were identified as being commonly modulated by these polyphenols. We also observed that these polyphenols counteracted the modulation of miRNA expression induced by apoE mutation. Pathway analyses on these five miRNA-target genes revealed common pathways, some of which were also identified from a pathway analysis on mRNA profiles. Conclusion:This in vivo study demonstrated for the first time that polyphenols at nutritional doses modulate the expression of miRNA in the liver. Even if structurally different, all polyphenols induced a similar miRNA expression profile. Common pathways were identified from both miRNA-target and mRNA analysis, revealing cellular functions that could be regulated by polyphenols at both the miRNA and mRNA level.	[Milenkovic, Dragan; Deval, Christiane; Scalbert, Augustin; Morand, Christine; Mazur, Andrzej] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, INRA,UNH,CRNH Auvergne,UMR1019, Clermont Ferrand, France; [Gouranton, Erwan; Landrier, Jean-Francois] INRA, UMR1260, Marseille, France; [Gouranton, Erwan; Landrier, Jean-Francois] Univ Aix Marseille 1, Marseille, France; [Gouranton, Erwan; Landrier, Jean-Francois] Univ Aix Marseille 2, F-13284 Marseille 07, France	INRAE; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Milenkovic, D (corresponding author), Univ Auvergne, Clermont Univ, Unite Nutr Humaine, INRA,UNH,CRNH Auvergne,UMR1019, Clermont Ferrand, France.	dragan.milenkovic@clermont.inra.fr	Mazur, Andre/AAG-9751-2020; Scalbert, Augustin/AAX-8160-2021; Landrier, Jean-Francois/AAH-2757-2019; MORAND, Christine/P-6988-2018	Mazur, Andre/0000-0002-1067-5066; Scalbert, Augustin/0000-0001-6651-6710; Landrier, Jean-Francois/0000-0002-8690-8014; Milenkovic, Dragan/0000-0001-6353-0912; MORAND, Christine/0000-0001-8128-1032	European Community [FLAVOFOOD-CT-2004-513960]; Human Nutrition Department of INRA; European Community [FLAVOFOOD-CT-2004-513960]; Human Nutrition Department of INRA	European Community(European Commission); Human Nutrition Department of INRA; European Community(European Commission); Human Nutrition Department of INRA	This work was partially supported by the European Community (FLAVOFOOD-CT-2004-513960) and Human Nutrition Department of INRA. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boesch-Saadatmandi C, 2009, INT J MOL SCI, V10, P4168, DOI 10.3390/ijms10094168; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Camargo A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-253; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chanet A, 2011, J NUTR BIOC IN PRESS; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Davis CD, 2008, NUTR REV, V66, P477, DOI 10.1111/j.1753-4887.2008.00080.x; de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z; Dentelli P, 2010, ARTERIOSCLER THROMB; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garcia-Conesa MT, 2009, MOL NUTR FOOD RES, V53, P266, DOI 10.1002/mnfr.200800134; Hishikawa K, 2005, ARTERIOSCL THROM VAS, V25, P442, DOI 10.1161/01.ATV.0000148404.24271.fc; Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490; Huang GS, 2000, LIFE SCI, V68, P19, DOI 10.1016/S0024-3205(00)00912-7; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Luceri C, 2008, FOOD CHEM TOXICOL, V46, P1213, DOI 10.1016/j.fct.2007.10.007; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mauray A, 2010, NUTR METAB IN PRESS; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Perez-Jimenez J, 2010, J AGR FOOD CHEM, V58, P4959, DOI 10.1021/jf100128b; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Spencer JPE, 2010, P NUTR SOC, V69, P244, DOI 10.1017/S0029665110000054; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vickers Kasey C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P150, DOI 10.1097/MED.0b013e32833727a1; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x	41	124	134	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					156	167	e29837	10.1371/journal.pone.0029837	http://dx.doi.org/10.1371/journal.pone.0029837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253797	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900018
J	Klotz, B; Mentrup, B; Regensburger, M; Zeck, S; Schneidereit, J; Schupp, N; Linden, C; Merz, C; Ebert, R; Jakob, F				Klotz, Barbara; Mentrup, Birgit; Regensburger, Martina; Zeck, Sabine; Schneidereit, Jutta; Schupp, Nicole; Linden, Christian; Merz, Cornelia; Ebert, Regina; Jakob, Franz			1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; TRANSCRIPTION FACTORS; BONE-MARROW; DIFFERENTIATION; MICE; HOMEOSTASIS; ABLATION; SELENIUM; CULTURE; PROTEIN	1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment. We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC). Effects of 100 nM 1,25D3 on hMSC were analyzed by cell proliferation and apoptosis assay, beta-galactosidase staining, VDR and surface marker immunocytochemistry, RT-PCR of 1,25D3-responsive, quiescence-and replicative senescence-associated genes. 1,25D3 treatment significantly inhibited hMSC proliferation and apoptosis after 72 h and delayed the development of replicative senescence in long-term cultures according to beta-galactosidase staining and P16 expression. Cell morphology changed from a fibroblast like appearance to broad and rounded shapes. Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways. In conclusion, 1,25D3 delays replicative senescence in primary hMSC while the pro-aging effects seen in mouse models might mainly be due to elevated systemic phosphate levels, which propagate organismal aging.	[Klotz, Barbara; Mentrup, Birgit; Regensburger, Martina; Zeck, Sabine; Schneidereit, Jutta; Merz, Cornelia; Ebert, Regina; Jakob, Franz] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Wurzburg, Germany; [Schupp, Nicole] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Linden, Christian] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Jakob, F (corresponding author), Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Wurzburg, Germany.	f-jakob.klh@uni-wuerzburg.de	Jakob, Franz/F-9894-2015; Ebert, Regina/D-5760-2016; Jakob, Franz/D-8526-2015	Ebert, Regina/0000-0002-8192-869X; Schupp, Nicole/0000-0002-1836-6348	German Research Foundation DFG [JA 504/8-1]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by the German Research Foundation DFG (JA 504/8-1; http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2009, J CELL PHYSIOL, V218, P9, DOI 10.1002/jcp.21572; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Byers S.W., 2011, REV ENDOCR METAB DIS; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Christakos S, 2007, ANN NY ACAD SCI, V1116, P340, DOI 10.1196/annals.1402.070; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dreier R, 2008, J BIOL CHEM, V283, P1104, DOI 10.1074/jbc.M703336200; Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117; Endoh M, 2009, BIOGERONTOLOGY, V10, P213, DOI 10.1007/s10522-008-9173-3; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gonzalez-Pardo V, 2010, ENDOCRINOLOGY, V151, P23, DOI 10.1210/en.2009-0650; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Jeong M, 2009, J IMMUNOL, V183, P2495, DOI 10.4049/jimmunol.0804221; Johnson CS, 2002, UROLOGY, V60, P123, DOI 10.1016/S0090-4295(02)01591-1; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kantoff PW, 2002, UROLOGY, V60, P130; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kohrle J, 2005, ENDOCR REV, V26, P944, DOI 10.1210/er.2001-0034; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li J, 2011, EXP HEMATOL, V39, P511, DOI 10.1016/j.exphem.2011.01.008; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Noth U, 2002, J ORTHOP RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Razzaque MS, 2006, TRENDS MOL MED, V12, P298, DOI 10.1016/j.molmed.2006.05.002; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Schupp N, 2007, AM J PHYSIOL-RENAL, V292, pF1427, DOI 10.1152/ajprenal.00458.2006; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Spugnini EP, 2007, J EXP CLIN CANC RES, V26, P443; Takahashi T, 1997, LEUKEMIA LYMPHOMA, V27, P25, DOI 10.3109/10428199709068268; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	45	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29959	10.1371/journal.pone.0029959	http://dx.doi.org/10.1371/journal.pone.0029959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242193	Green Published, gold			2022-12-25	WOS:000312662100050
J	Marlin, R; Duriez, M; Berkane, N; de Truchis, C; Madec, Y; Rey-Cuille, MA; Cummings, JS; Cannou, C; Quillay, H; Barre-Sinoussi, F; Nugeyre, MT; Menu, E				Marlin, Romain; Duriez, Marion; Berkane, Nadia; de Truchis, Claire; Madec, Yoann; Rey-Cuille, Marie-Anne; Cummings, Jean-Saville; Cannou, Claude; Quillay, Heloise; Barre-Sinoussi, Francoise; Nugeyre, Marie-Therese; Menu, Elisabeth			Dynamic Shift from CD85j/ILT-2 to NKG2D NK Receptor Expression Pattern on Human Decidual NK during the First Trimester of Pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; FETAL-MATERNAL INTERFACE; EXTRAVILLOUS TROPHOBLAST; MYELOMONOCYTIC CELLS; GESTATIONAL-AGE; HIV-1 INFECTION; DENDRITIC CELLS; GROWTH-FACTORS; HLA-G; LIGANDS	During the first trimester of human pregnancy, Natural Killer (NK) cells of the maternal uterine mucosa (e. g. decidua) have a unique phenotype and are involved in crucial physiological processes during pregnancy. We investigated whether modifications of the NK receptor repertoire occur during the first trimester of pregnancy. We found significantly decreased expression of KIR2DL1/S1 and KIR2DL2/L3/S2 receptors, NKp30 and NKp44 activatory receptors, and the CD85j (ILT-2) inhibitory receptor. We also observed significantly increased expression of the NKG2D activatory receptor at the decidual NK cell surface. By flow cytometry, we further highlighted an evolution of NK subsets between 8 and 12 weeks of gestation, with a shift from the KIR2DL1/S1(+)/KIR2DL2/L3/S2(+) subset towards the double negative subset, coupled with a decrease of the CD85j(+)/NKG2D(-) subset in favour of the CD85j(-)/NKG2D(+) subset. Furthermore, cell surface expression of NK receptor ligands, including CD85j and NKG2D ligands, has been characterized by flow cytometry on decidual immune CD14(+) and CD3(+) cells. HLA-G, the high affinity ligand of CD85j, was detected on both cell types. In contrast, NKG2D ligands ULBP-2 ULBP-3 and MICA/B were not expressed on CD14(+) and CD3(+) cells, however a variable expression of ULBP-1 was observed. The ligand expression of KIR2DL1/S1 and KIR2DL2/L3/S2 was also analyzed: the HLA-C molecule was expressed at a low level on some CD14(+) cells whereas it was not detected on CD3(+) cell surface. NK receptor ligands are known to be also expressed on the invading placental trophoblast cells. Thus, the phenotypic evolutions of decidual NK cells described in this present study may preserve their activation/inhibition balance during the first trimester of pregnancy.	[Marlin, Romain; Duriez, Marion; Cummings, Jean-Saville; Cannou, Claude; Quillay, Heloise; Barre-Sinoussi, Francoise; Nugeyre, Marie-Therese; Menu, Elisabeth] Inst Pasteur, Regulat Retroviral Infect Unit, Dept Virol, Paris, France; [Berkane, Nadia] UMPC, Tenon Hosp, AP HP, Dept Gynecol Obstet & Reprod Med, Paris, France; [de Truchis, Claire] A Beclere Hosp, AP HP, Gynecol Obstet Serv, Clamart, France; [Madec, Yoann; Rey-Cuille, Marie-Anne] Inst Pasteur, Dept Infect & Epidemiol, Emerging Dis Epidemiol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Menu, E (corresponding author), Inst Pasteur, Regulat Retroviral Infect Unit, Dept Virol, Paris, France.	elisabeth.menu@pasteur.fr	Barre-Sinoussi, Françoise/G-8355-2011; Rey-Cuille, Marie-Anne/J-7486-2012; MENU, Elisabeth/B-2886-2010	MENU, Elisabeth/0000-0001-8844-9328; Madec, Yoann/0000-0002-6201-1261	Institut Pasteur; INSERM; AP-HP; ANRS [2008/062]; Sidaction [50007-05-00/AO17-2]; Ministere de l'Enseignement superieur et de la Recherche; SESAME program for the LSRII	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Ministere de l'Enseignement superieur et de la Recherche(Estonian Research CouncilEuropean Commission); SESAME program for the LSRII	This work was supported by Institut Pasteur, INSERM and AP-HP and by grants from ANRS (#2008/062) and Sidaction (#50007-05-00/AO17-2). RM has been a recipient of the "Ministere de l'Enseignement superieur et de la Recherche'' and then Sidaction fellowships. MD was a recipient of the Sidaction fellowship and HQ of the "Ministere de l'Enseignement superieur et de la Recherche'' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Pr Antonio Siccardi for the kind gift of the L31 antibody, Dr Daniel Scott-Algara and Dr Gerard Chaouat for scientific discussion, Dr Katherine Kean for critical review of the manuscript, all the women who gave their informed consent, Dr Anne le Breton and the clinical staffs for providing the samples, the PIRC (Pole Integre de Recherche Clinique) at Institut Pasteur for their help in the biomedical regulatory aspects of the project and the SESAME program for the LSRII device funding.	Apps R, 2008, HUM REPROD, V23, P2535, DOI 10.1093/humrep/den223; Biassoni Roberto, 2009, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1410s84; Bulmer JN, 2005, MOL IMMUNOL, V42, P511, DOI 10.1016/j.molimm.2004.07.035; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hiby SE, 1999, TISSUE ANTIGENS, V53, P1, DOI 10.1034/j.1399-0039.1999.530101.x; Hunt JS, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-S1-S10; King A, 2000, PLACENTA, V21, P376, DOI 10.1053/plac.1999.0496; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lash GE, 2010, HUM REPROD, V25, P1137, DOI 10.1093/humrep/deq050; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Le Bouteiller P, 2008, AM J REPROD IMMUNOL, V59, P401, DOI 10.1111/j.1600-0897.2008.00597.x; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Loke YW, 1995, HUMAN IMPLANTATION C, P82; Male V, 2011, EUR J IMMUNOL, V41, P3017, DOI 10.1002/eji.201141445; Marlin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005971; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Sandusky MM, 2006, EUR J IMMUNOL, V36, P3268, DOI 10.1002/eji.200636146; Schrama D, 2006, EUR J IMMUNOL, V36, P65, DOI 10.1002/eji.200535115; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Scott-Algara D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001975; Sharkey AM, 2008, J IMMUNOL, V181, P39, DOI 10.4049/jimmunol.181.1.39; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; Vacca P, 2008, INT IMMUNOL; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Williams PJ, 2009, J REPROD IMMUNOL, V82, P24, DOI 10.1016/j.jri.2009.08.001; Yagel S, 2009, AM J OBSTET GYNECOL, V201, P344, DOI 10.1016/j.ajog.2009.02.030	44	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e30017	10.1371/journal.pone.0030017	http://dx.doi.org/10.1371/journal.pone.0030017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242197	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100054
J	Kimura, T; Han, W; Pagel, P; Nairn, AC; Caplan, MJ				Kimura, Toru; Han, WonSun; Pagel, Philipp; Nairn, Angus C.; Caplan, Michael J.			Protein Phosphatase 2A Interacts with the Na+,K+-ATPase and Modulates Its Trafficking by Inhibition of Its Association with Arrestin	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR KINASE; SITE-DIRECTED MUTAGENESIS; CELL-SURFACE EXPRESSION; SODIUM-POTASSIUM PUMP; SHORT-TERM REGULATION; NA+-K+-ATPASE; GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; BETA-ARRESTINS; LEUCINE/ISOLEUCINE ZIPPERS	Background: The P-type ATPase family constitutes a collection of ion pumps that form phosphorylated intermediates during ion transport. One of the best known members of this family is the Na+, K+-ATPase. The catalytic subunit of the Na+, K+-ATPase includes several functional domains that determine its enzymatic and trafficking properties. Methodology/Principal Findings: Using the yeast two-hybrid system we found that protein phosphatase 2A (PP2A) catalytic C-subunit is a specific Na+, K+-ATPase interacting protein. PP-2A C-subunit interacted with the Na+, K+-ATPase, but not with the homologous sequences of the H+, K+-ATPase. We confirmed that the Na+, K+-ATPase interacts with a complex of A-and C-subunits in native rat kidney. Arrestins and G-protein coupled receptor kinases (GRKs) are important regulators of G-protein coupled receptor (GPCR) signaling, and they also regulate Na+, K+-ATPase trafficking through direct association. PP2A inhibits association between the Na+, K+-ATPase and arrestin, and diminishes the effect of arrestin on Na+, K+-ATPase trafficking. GRK phosphorylates the Na+, K+-ATPase and PP2A can at least partially reverse this phosphorylation. Conclusions/Significance: Taken together, these data demonstrate that the sodium pump belongs to a growing list of ion transport proteins that are regulated through direct interactions with the catalytic subunit of a protein phosphatase.	[Kimura, Toru] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan; [Kimura, Toru; Han, WonSun; Pagel, Philipp; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Kyorin University; Yale University; Yale University	Kimura, T (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan.	michael.caplan@yale.edu		Nairn, Angus/0000-0002-7075-0195; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK072612, DK17433, MH40899, MH074866]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899, P50MH074866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health DK072612 and DK17433 (MJC), and MH40899 and MH074866 (ACN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; BASKIN DG, 1982, HISTOCHEMISTRY, V73, P535, DOI 10.1007/BF00493367; Bauman AL, 2000, J NEUROSCI, V20, P7571; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BERTORELLO A, 1990, AM J HYPERTENS, V3, pS51, DOI 10.1093/ajh/3.6.51S; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BIEMESDERFER D, 1992, AM J PHYSIOL, V262, pF55, DOI 10.1152/ajprenal.1992.262.1.F55; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Blostein R, 2003, ANN NY ACAD SCI, V986, P420, DOI 10.1111/j.1749-6632.2003.tb07224.x; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; COUTRY N, 1995, J MEMBRANE BIOL, V145, P99; CRAMBERT G, 2003, SCI STKE, pRE1; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Feschenko MS, 2000, J BIOL CHEM, V275, P34693, DOI 10.1074/jbc.M005869200; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; FISONE G, 1994, J BIOL CHEM, V269, P9368; FISONE G, 1995, J BIOL CHEM, V270, P2427, DOI 10.1074/jbc.270.6.2427; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geering K, 2003, ANN NY ACAD SCI, V986, P388, DOI 10.1111/j.1749-6632.2003.tb07219.x; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; HORIUCHI A, 1993, MOL PHARMACOL, V43, P281; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lecuona E, 2000, FEBS LETT, V481, P217, DOI 10.1016/S0014-5793(00)02009-3; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; Maeda M, 1998, CELL STRUCT FUNCT, V23, P315, DOI 10.1247/csf.23.315; Marks AR, 2002, TRENDS CARDIOVAS MED, V12, P166, DOI 10.1016/S1050-1738(02)00156-1; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MEISTER B, 1993, SEMIN NEPHROL, V13, P41; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nestor NB, 1997, ANN NY ACAD SCI, V834, P579, DOI 10.1111/j.1749-6632.1997.tb52324.x; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Pagel P, 2003, ANN NY ACAD SCI, V986, P360, DOI 10.1111/j.1749-6632.2003.tb07215.x; Pedemonte CH, 2001, J BIOENERG BIOMEMBR, V33, P439, DOI 10.1023/A:1010675708820; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Scarborough GA, 2002, J BIOENERG BIOMEMBR, V34, P235, DOI 10.1023/A:1020211016696; SCHEINERBOBIS G, 1994, BBA-BIOMEMBRANES, V1193, P226, DOI 10.1016/0005-2736(94)90157-0; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Soares-da-Silva P, 1995, Hypertens Res, V18 Suppl 1, pS47, DOI 10.1291/hypres.18.SupplementI_S47; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sweadner KJ, 2003, ANN NY ACAD SCI, V986, P382, DOI 10.1111/j.1749-6632.2003.tb07218.x; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; TAKADA T, 1992, HISTOCHEMISTRY, V98, P183, DOI 10.1007/BF00315877; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Therien AG, 2001, J BIOENERG BIOMEMBR, V33, P407, DOI 10.1023/A:1010619623841; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; Yokoyama N, 2003, ARCH BIOCHEM BIOPHYS, V417, P87, DOI 10.1016/S0003-9861(03)00333-3; Zouzoulas A, 2003, J BIOL CHEM, V278, P40437, DOI 10.1074/jbc.M308610200	69	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29269	10.1371/journal.pone.0029269	http://dx.doi.org/10.1371/journal.pone.0029269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242112	Green Submitted, Green Published, gold			2022-12-25	WOS:000300677000023
J	Yang, X; Xu, SH				Yang, Xiong; Xu, Shuhua		HUGO Pan-Asian SNP Consortium	Identification of Close Relatives in the HUGO Pan-Asian SNP Database	PLOS ONE			English	Article							RELATIONSHIP INFERENCE; GENETIC RELATEDNESS; GENOME; ADMIXTURE; PAIRS	The HUGO Pan-Asian SNP Consortium has recently released a genome-wide dataset, which consists of 1,719 DNA samples collected from 71 Asian populations. For studies of human population genetics such as genetic structure and migration history, this provided the most comprehensive large-scale survey of genetic variation to date in East and Southeast Asia. However, although considered in the analysis, close relatives were not clearly reported in the original paper. Here we performed a systematic analysis of genetic relationships among individuals from the Pan-Asian SNP (PASNP) database and identified 3 pairs of monozygotic twins or duplicate samples, 100 pairs of first-degree and 161 second-degree of relationships. Three standardized subsets with different levels of unrelated individuals were suggested here for future applications of the samples in most types of population-genetics studies (denoted by PASNP1716, PASNP1640 and PASNP1583 respectively) based on the relationships inferred in this study. In addition, we provided gender information for PASNP samples, which were not included in the original dataset, based on analysis of X chromosome data.	[Yang, Xiong] Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Partner Inst Computat Biol, Max Planck Soc CAS MPG, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Yang, X (corresponding author), Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China.	xushua@picb.ac.cn	Lee, Jong-Young/M-6319-2013; Xu, Shuhua/AAH-7620-2020; Hoh, Boon-Peng/H-8682-2016; XU, SHUHUA/D-5345-2009; Ahmed, Ikhlak/Q-2494-2019; De Ungria, Maria Corazon Abogado/T-9736-2019	Lee, Jong-Young/0000-0002-0092-9958; Xu, Shuhua/0000-0002-1975-1002; Hoh, Boon-Peng/0000-0001-9249-4965; XU, SHUHUA/0000-0002-1975-1002; De Ungria, Maria Corazon Abogado/0000-0001-7722-5193; MITRA, AMIT/0000-0003-4046-7070; Phipps, Maude/0000-0001-8314-068X; batra, Jyotsna/0000-0003-4646-6247; Ahmed, Ikhlak/0000-0002-5753-9627; Chaurasia, Amit/0000-0002-9719-1135; YAO, YIN/0000-0003-3053-8429	National Science Foundation of China [30971577, 31171218]; Shanghai Rising-Star Program [11QA1407600]; Science Foundation of the Chinese Academy of Sciences [KSCX2-EW-Q-1-11, KSCX2-EW-R-01-05, KSCX2-EW-J-15-05]; Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong; Grants-in-Aid for Scientific Research [19101008] Funding Source: KAKEN	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Science Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Shuhua Xu was supported by the National Science Foundation of China (30971577; 31171218), Shanghai Rising-Star Program (11QA1407600), and Science Foundation of the Chinese Academy of Sciences (KSCX2-EW-Q-1-11; KSCX2-EW-R-01-05; KSCX2-EW-J-15-05). This research was supported in part by the Ministry of Science and Technology (MoST) International Cooperation Base of China. Shuhua Xu is a Max-Planck Independent Junior Research Group Leader and a member of CAS Youth Innovation Promotion Association. Shuhua Xu also gratefully acknowledges the support of K. C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Epstein MP, 2000, AM J HUM GENET, V67, P308; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gil D, 1998, J PRAGMATICS, V29, P93, DOI 10.1016/S0378-2166(97)81449-X; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Oota H, 2005, PLOS BIOL, V3, P536, DOI 10.1371/journal.pbio.0030071; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Xu SH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-18	15	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29502	10.1371/journal.pone.0029502	http://dx.doi.org/10.1371/journal.pone.0029502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242128	Green Published, Green Submitted, gold			2022-12-25	WOS:000300677000043
J	Rothschild, SI; Tschan, MP; Federzoni, EA; Jaggi, R; Fey, MF; Gugger, M; Gautschi, O				Rothschild, S. I.; Tschan, M. P.; Federzoni, E. A.; Jaggi, R.; Fey, M. F.; Gugger, M.; Gautschi, O.			MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma	ONCOGENE			English	Article						miR-29b; inhibitor of differentiation protein 1; ID1; Src; c-Myc; lung cancer	CHRONIC LYMPHOCYTIC-LEUKEMIA; HUMAN BREAST-CANCER; TUMOR-GROWTH; EXPRESSION; SRC; GENES; CELLS; ID1; SIGNATURE; CARCINOMA	The c-Src kinase regulates cancer cell invasion through inhibitor of DNA binding/differentiation 1 (ID1). Src and ID1 are frequently overexpressed in human lung adenocarcinoma. The current study aimed at identifying microRNAs (miRNAs) involved in the Src-ID1 signaling in lung cancer. Incubation of lung cancer cells with the Src inhibitor saracatinib led to the upregulation of several miRNAs including miR-29b, which was the most highly upregulated miRNA with predicted binding to the ID1 3'-untranslated region (UTR). Luciferase reporter assays confirmed direct binding of miR-29b to the ID1 3'-UTR. Expression of miR-29b suppressed ID1 levels and significantly reduced migration and invasion. Expression of antisense-miR-29b (anti-miR-29b), on the other hand, enhanced ID1 mRNA and protein levels, and significantly increased lung cancer cell migration and invasion, a hallmark of the Src-ID1 pathway. The ectopic expression of ID1 in miR-29b-overexpressing cells was able to rescue the migratory potential of these cells. Both, anti-miR-29b and ID1 overexpression diminished the effects of the Src inhibitors saracatinib and dasatinib on migration and invasion. Saracatinib and dasatinib decreased c-Myc transcriptional repression on miR-29b and led to increased ID1 protein levels, whereas forced expression of c-Myc repressed miR-29b and induced ID1. In agreement, we showed direct recruitment of c-Myc to the miR-29b promoter. miR-29b was significantly downregulated in primary lung adenocarcinoma samples compared with matched alveolar lung tissue, and miR-29b expression was a significant prognostic factor for patient outcome. These results suggest that miR-29b is involved in the Src-ID1 signaling pathway, is dysregulated in lung adenocarcinoma and is a potential predictive marker for Src kinase inhibitors. Oncogene (2012) 31, 4221-4232; doi:10.1038/onc.2011.578; published online 16 January 2012	[Rothschild, S. I.; Tschan, M. P.; Federzoni, E. A.; Jaggi, R.; Gautschi, O.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Rothschild, S. I.] Univ Basel Hosp, Dept Med Oncol, CH-4031 Basel, Switzerland; [Tschan, M. P.; Fey, M. F.] Univ Hosp Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland; [Gugger, M.] Univ Bern, Inst Pathol, Bern, Switzerland; [Gautschi, O.] Luzerner Kantonsspital, Klin Onkol, Luzern, Switzerland	University of Bern; University of Basel; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital	Gautschi, O (corresponding author), Univ Bern, Dept Clin Res, Murtenstr 35, CH-3010 Bern, Switzerland.	oliver.gautschi@onkologie.ch	Rothschild, Sacha/AAV-4003-2020	Rothschild, Sacha/0000-0003-1304-9340; Tschan, Mario P./0000-0001-5897-3647	Swiss Cancer League [KLS 02164-02-2008]; Bernese Cancer League; Werner and Hedy Berger-Janser Foundation of Cancer Research; Bernese Foundation of Cancer Research; Marlies-Schwegler Foundation; Ursula-Hecht-Foundation for Leukemia Research	Swiss Cancer League; Bernese Cancer League; Werner and Hedy Berger-Janser Foundation of Cancer Research; Bernese Foundation of Cancer Research; Marlies-Schwegler Foundation; Ursula-Hecht-Foundation for Leukemia Research	Deborah Shan is gratefully acknowledged for excellent technical support. We acknowledge Dr John Minna (UT Southwestern, Medical Center, Dallas, TX, USA) and Dr Yitzhak Zimmer for providing us with cell lines. We thank Wieslawa Blank for support with Western blotting and Dr Daniel Betticher for providing us with primary tumors from the tumor tissue bank. We also thank Dr Jasmin Batliner for support with luciferase assays. We thank AstraZeneca (Manchester, UK) for providing saracatinib. This study was supported by Swiss Cancer League (Grant KLS 02164-02-2008 to OG and MG), the Bernese Cancer League (to MG, OG and MPT), the Werner and Hedy Berger-Janser Foundation of Cancer Research (to MFF and MPT), the Bernese Foundation of Cancer Research, the Marlies-Schwegler Foundation and the Ursula-Hecht-Foundation for Leukemia Research (to MFF).	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fong S, 2004, TRENDS MOL MED, V10, P387, DOI 10.1016/j.molmed.2004.06.008; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Leighl NB, 2005, J CLIN ONCOL, V23, P2831, DOI 10.1200/JCO.2005.04.044; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Rothschild SI, 2011, LUNG CANCER, V71, P306, DOI 10.1016/j.lungcan.2010.06.018; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wu X, 2009, J THORAC ONCOL, V4, P1028, DOI 10.1097/JTO.0b013e3181a99c77; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	50	59	66	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	38					4221	4232		10.1038/onc.2011.578	http://dx.doi.org/10.1038/onc.2011.578			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22249264				2022-12-25	WOS:000308975800005
J	Goplen, N; Karim, Z; Guo, L; Zhuang, YH; Huang, H; Gorska, MM; Gelfand, E; Pages, G; Pouyssegur, J; Alam, R				Goplen, Nicholas; Karim, Zunayet; Guo, Lei; Zhuang, Yonghua; Huang, Hua; Gorska, Magdalena M.; Gelfand, Erwin; Pages, Gilles; Pouyssegur, Jacques; Alam, Rafeul			ERK1 is important for Th2 differentiation and development of experimental asthma	FASEB JOURNAL			English	Article						apoptosis; IgE; mitogen-activated protein kinase; transcription factor	ACTIVATED PROTEIN-KINASE; THYMIC STROMAL LYMPHOPOIETIN; T-CELL-ACTIVATION; AIRWAY INFLAMMATION; MAP KINASE; IL-4 EXPRESSION; B-LYMPHOCYTES; PATHWAY; RESPONSES; TRANSCRIPTION	The ERK1/2 signaling pathway regulates a variety of T-cell functions. We observed dynamic changes in the expression of ERK1/2 during T-helper cell differentiation. Specifically, the expression of ERK1/2 was decreased and increased by IL-12 and IL-4, respectively. To address this subject further, we examined the specific role of ERK1 in Th2 differentiation and development of experimental asthma using ERK1(-/-) mice. ERK1(-/-) mice were unable to mount airway inflammation and hyperreactivity in two different models of asthma, acute and chronic. ERK1(-/-) mice had reduced expression of Th2 cytokines IL-4 and IL-5 but not IL-17A or IFN-gamma. They had reduced levels of allergen-specific IgE and blood eosinophils. T cells from immunized ERK1(-/-) mice manifested reduced proliferation in response to the sensitizing allergen. ERK1(-/-) T cells had reduced and short-lived expression of JunB following TCR stimulation, which likely contributed to their impaired Th2 differentiation. Immunized ERK1(-/-) mice showed reduced numbers of CD44(high) CD4 T cells in the spleen. In vitro studies demonstrated that Th2 but not Th1 cells from ERK1(-/-) mice had reduced numbers of CD44(high) cells. Finally, CD4 T cells form ERK1(-/-) mice expressed higher levels of BIM under growth factor-deprived conditions and reduced Mcl-1 on stimulation. As a result, the survival of CD4 T cells, especially CD44(high) Th2 cells, was much reduced in ERK1(-/-) mice. We conclude that ERK1 plays a nonredundant role in Th2 differentiation and development of experimental asthma. ERK1 controls Th2 differentiation and survival through its effect on JunB and BIM, respectively.-Goplen, N., Karim, Z., Guo, L., Zhuang, Y., Huang, H., Gorska, M. M., Gelfand, E., Pages, G., Pouyssegur, J., Alam, R. ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J. 26, 1934-1945 (2012). www.fasebj.org	[Goplen, Nicholas; Karim, Zunayet; Guo, Lei; Zhuang, Yonghua; Huang, Hua; Gorska, Magdalena M.; Alam, Rafeul] Natl Jewish Hlth, Dept Med, Div Allergy & Immunol, Denver, CO 80206 USA; [Gelfand, Erwin] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA; [Huang, Hua; Gorska, Magdalena M.; Gelfand, Erwin; Alam, Rafeul] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Pages, Gilles; Pouyssegur, Jacques] Univ Nice Sophia Antipolis, Inst Signaling Dev Biol & Canc Res, Nice, France	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; UDICE-French Research Universities; Universite Cote d'Azur	Alam, R (corresponding author), Natl Jewish Hlth, Dept Med, Div Allergy & Immunol, 1400 Jackson St, Denver, CO 80206 USA.	alamr@njhealth.org	Zhuang, Yonghua/A-2946-2013; Pages, Gilles/N-7135-2017	Zhuang, Yonghua/0000-0002-1822-2395; Huang, Hua/0000-0001-7317-8983	U.S. National Institutes of Health [RO1 AI68088, AI091614, PPG HL36577]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068088, R01AI091614] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health grants RO1 AI68088, AI091614, and PPG HL36577. The authors declare no conflict of interest.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Gorska MM, 2010, J IMMUNOL, V184, P4488, DOI 10.4049/jimmunol.0903115; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Lelliott A, 2012, EUR J PHARMACOL, V674, P407, DOI 10.1016/j.ejphar.2011.10.042; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Liu WM, 2010, MOL CELL BIOL, V30, P1783, DOI 10.1128/MCB.01003-09; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mostecki J, 2011, J IMMUNOL, V187, P2794, DOI 10.4049/jimmunol.0902569; Nakazawa T, 2008, J NEUROSCI RES, V86, P136, DOI 10.1002/jnr.21472; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Ohnishi H, 2009, J ALLERGY CLIN IMMUN, V123, P249, DOI 10.1016/j.jaci.2008.10.054; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; Shibata Y, 2002, J IMMUNOL, V169, P2134, DOI 10.4049/jimmunol.169.4.2134; Stafford S, 2002, J IMMUNOL, V168, P1978, DOI 10.4049/jimmunol.168.4.1978; Tam NWN, 1999, EUR J BIOCHEM, V262, P149, DOI 10.1046/j.1432-1327.1999.00360.x; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tewfik MA, 2009, ALLERGY, V64, P746, DOI 10.1111/j.1398-9995.2008.01889.x; Tong JK, 2010, AM J RESP CELL MOL, V43, P342, DOI 10.1165/rcmb.2008-0454OC; Tripathi P, 2012, IMMUNOL CELL BIOL, V90, P676, DOI 10.1038/icb.2011.87; Wensveen FM, 2010, IMMUNITY, V32, P754, DOI 10.1016/j.immuni.2010.06.005; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	53	29	34	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1934	1945		10.1096/fj.11-196477	http://dx.doi.org/10.1096/fj.11-196477			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22262639	Green Published			2022-12-25	WOS:000303680800021
J	Zhou, FF; Zhang, XF; van Dam, H; ten Dijke, P; Huang, HZ; Zhang, L				Zhou, FangFang; Zhang, Xiaofei; van Dam, Hans; ten Dijke, Peter; Huang, Huizhe; Zhang, Long			Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME; TRAF6; REQUIRES; KINASE; ALPHA; USP4; TAK1; COMPLEX; CYLD	Background: The TRAF6-mediated Toll-like receptor (TLR)/IL-1 receptor (IL-1R) pathway is essential for innate immune responses and immune homeostasis. Results: USP4 deubiquitinates Lys-63-linked polyubiquitination of TRAF6 and thereby prevents the TLR/IL-1R-induced activation of NF-kappa B and AP-1 transcription factors and subsequent proinflammatory responses. Conclusion: USP4 plays an essential role in the negative regulation of the TLR/IL-1R signaling-mediated innate immune response. Significance: USP4 is an attractive new therapeutic target for modulation of innate immune responses.	[Huang, Huizhe] Chongqing Med Univ, Sch Basic Med, Fac Basic Med Sci, Chongqing 400016, Peoples R China; [Zhou, FangFang; Zhang, Xiaofei; van Dam, Hans; ten Dijke, Peter; Zhang, Long] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Chongqing Medical University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Huang, HZ (corresponding author), Chongqing Med Univ, Sch Basic Med, Fac Basic Med Sci, E Teaching Bldg,Rm 217, Chongqing 400016, Peoples R China.	devbiology@cqmu.edu.cn; l.zhang@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Zhang, Xiafoei/C-8471-2014; Zhang, Long/AAT-6571-2021	Dijke, Peter ten/0000-0002-7234-342X; Zhang, Long/0000-0001-8139-0474; van Dam, Hans/0000-0002-8307-4325	Netherlands Organization for Scientific Research [VICI 016.066.606]; Centre for Biomedical Genetics; National Nature Science Foundation of China [30900748, 31171388]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Netherlands Organization for Scientific Research Grant VICI 016.066.606, the Centre for Biomedical Genetics (to P. t. D.), and National Nature Science Foundation of China Grants 30900748 and 31171388 (to H. H.).	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Gilchrist CA, 1997, J BIOL CHEM, V272, P32280, DOI 10.1074/jbc.272.51.32280; GUPTA K, 1994, ONCOGENE, V9, P1729; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P731, DOI 10.1016/j.bbrc.2005.11.076; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	39	67	68	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11002	11010		10.1074/jbc.M111.328187	http://dx.doi.org/10.1074/jbc.M111.328187			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22262844	hybrid, Green Published			2022-12-25	WOS:000302780100028
J	Chaudhri, RA; Olivares-Navarrete, R; Cuenca, N; Hadadi, A; Boyan, BD; Schwartz, Z				Chaudhri, Reyhaan A.; Olivares-Navarrete, Rene; Cuenca, Natalia; Hadadi, Agreen; Boyan, Barbara D.; Schwartz, Zvi			Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-alpha 36 (ER alpha 36)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-PLATE CHONDROCYTES; RECEPTOR-ALPHA; PLASMA-MEMBRANE; BONE METASTASIS; ER-ALPHA; EXPRESSION; VARIANT; ACTIVATION	Protein kinase C (PKC) signaling can be activated rapidly by 17 beta-estradiol (E-2) via nontraditional signaling in ER alpha-positive MCF7 and ER alpha-negative HCC38 breast cancer cells and is associated with tumorigenicity. Additionally, E-2 has been shown to elicit anti-apoptotic effects in cancer cells counteracting pro-apoptotic effects of chemotherapeutics. Supporting evidence suggests the existence of a membrane-associated ER that differs from the traditional receptors, ER alpha and ER beta. Our aim was to identify the ER responsible for rapid PKC activation and to evaluate downstream effects, such as proliferation, apoptosis, and metastasis. RT-PCR, Western blot, and immunofluorescence were used to determine the presence of ER splice variants in multiple cell lines. E-2 effects on PKC activity were measured with and without ER-blocking antibodies. Cell proliferation was determined by [H-3] thymidine incorporation, and cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, (MTT) whereas apoptosis was determined by DNA fragmentation and TUNEL. Quantitative RT-PCR and sandwich ELISA were used to determine the effects on metastatic factors. The role of membrane-dependent signaling in cancer cell invasiveness was examined using an in vitro assay. The results indicate the presence of an ER alpha splice variant, ER alpha 36, in ER alpha-positive MCF7 and ER alpha-negative HCC38 breast cancer cells, which localized to plasma membranes and rapidly activated PKC in response to E-2, leading to deleterious effects such as enhancement of proliferation, protection against apoptosis, and enhancement of metastatic factors. These findings propose ER alpha 36 as a novel target for the development of therapies that can prevent progression of breast cancer in the primary tumor as well as during metastasis.	[Boyan, Barbara D.] Georgia Inst Technol, Dept Biomed Engn, Sch Biol, Atlanta, GA 30332 USA; [Chaudhri, Reyhaan A.; Boyan, Barbara D.] Emory Univ, Atlanta Clin & Translat Sci Inst, Robert W Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA; [Olivares-Navarrete, Rene; Cuenca, Natalia; Boyan, Barbara D.; Schwartz, Zvi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	Boyan, BD (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Sch Biol, 315 Ferst Dr NW, Atlanta, GA 30332 USA.	barbara.boyan@bme.gatech.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164; Chaudhri, Reyhaan/0000-0003-0482-0412	National Institutes of Health from USPHS [UL1 RR025008]; National Institutes of Health from NCRR [TL1 RR025010]; Price Gilbert, Jr., Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000456, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025010, UL1RR025008] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NCRR; Price Gilbert, Jr., Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants UL1 RR025008 from USPHS and TL1 RR025010 (Clinical and Translational Science Award Program) from NCRR. This work was also supported by the Price Gilbert, Jr., Foundation.	Akhtari M, 2008, CANCER BIOL THER, V7, P3, DOI 10.4161/cbt.7.1.5163; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Boyan BD, 2006, STEROIDS, V71, P286, DOI 10.1016/j.steroids.2005.09.018; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Carey I, 1999, INT J ONCOL, V15, P127; Connolly JM, 1997, INT J ONCOL, V10, P71; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; Deng H, 2010, ONCOL REP, V24, P171, DOI 10.3892/or_00000842; Denison TA, 2009, J CELL BIOCHEM, V107, P155, DOI 10.1002/jcb.22111; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; FERNO M, 1995, BREAST CANCER RES TR, V36, P23, DOI 10.1007/BF00690181; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kampa M, 2008, STEROIDS, V73, P953, DOI 10.1016/j.steroids.2007.12.009; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Levin ER, 1999, TRENDS ENDOCRIN MET, V10, P374, DOI 10.1016/S1043-2760(99)00192-7; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; MADSEN MW, 1995, MOL CELL ENDOCRINOL, V109, P197, DOI 10.1016/0303-7207(95)03503-Y; Marino M, 2001, J CELL PHYSIOL, V188, P170, DOI 10.1002/jcp.1105; McMillan J, 2006, BBA-MOL CELL RES, V1763, P381, DOI 10.1016/j.bbamcr.2006.02.010; Merrell M, 2003, BREAST CANCER RES TR, V81, P231, DOI 10.1023/A:1026126430905; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Peng J, 2010, INT J ONCOL, V36, P451, DOI 10.3892/ijo_00000519; Poola I, 2000, J STEROID BIOCHEM, V72, P249, DOI 10.1016/S0960-0760(00)00033-9; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rose AAN, 2006, B CANCER, V93, P931; Schwartz Z, 2002, J STEROID BIOCHEM, V80, P401, DOI 10.1016/S0960-0760(02)00038-9; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Sylvia VL, 2000, J STEROID BIOCHEM, V73, P211, DOI 10.1016/S0960-0760(00)00078-9; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; TOUITOU I, 1990, BIOCHEM BIOPH RES CO, V169, P109, DOI 10.1016/0006-291X(90)91440-4; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Weldon CB, 2005, INT J ONCOL, V26, P763; Zhong M, 2011, ENDOCRINOLOGY, V152, P82, DOI 10.1210/en.2010-0509; Zhong M, 2009, CELLS TISSUES ORGANS, V189, P56, DOI 10.1159/000152913	49	80	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7169	7181		10.1074/jbc.M111.292946	http://dx.doi.org/10.1074/jbc.M111.292946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247547	Green Published, hybrid			2022-12-25	WOS:000301060200020
J	Alcina, A; Abad-Grau, MD; Fedetz, M; Izquierdo, G; Lucas, M; Fernandez, O; Ndagire, D; Catala-Rabasa, A; Ruiz, A; Gayan, J; Delgado, C; Arnal, C; Matesanz, F				Alcina, Antonio; del Mar Abad-Grau, Maria; Fedetz, Maria; Izquierdo, Guillermo; Lucas, Miguel; Fernandez, Oscar; Ndagire, Dorothy; Catala-Rabasa, Antonio; Ruiz, Agustin; Gayan, Javier; Delgado, Concepcion; Arnal, Carmen; Matesanz, Fuencisla			Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; SUSCEPTIBILITY LOCI; COMMON; HLA; ALLELES; DISEASE; MHC; MECHANISMS; EPISTASIS	The human leukocyte antigen (HLA) DRB1*1501 has been consistently associated with multiple sclerosis (MS) in nearly all populations tested. This points to a specific antigen presentation as the pathogenic mechanism though this does not fully explain the disease association. The identification of expression quantitative trait loci (eQTL) for genes in the HLA locus poses the question of the role of gene expression in MS susceptibility. We analyzed the eQTLs in the HLA region with respect to MS-associated HLA-variants obtained from genome-wide association studies (GWAS). We found that the Tag of DRB1*1501, rs3135388 A allele, correlated with high expression of DRB1, DRB5 and DQB1 genes in a Caucasian population. In quantitative terms, the MS-risk AA genotype carriers of rs3135388 were associated with 15.7-, 5.2- and 8.3-fold higher expression of DQB1, DRB5 and DRB1, respectively, than the non-risk GG carriers. The haplotype analysis of expression-associated variants in a Spanish MS cohort revealed that high expression of DRB1 and DQB1 alone did not contribute to the disease. However, in Caucasian, Asian and African American populations, the DRB1*1501 allele was always highly expressed. In other immune related diseases such as type 1 diabetes, inflammatory bowel disease, ulcerative colitis, asthma and IgA deficiency, the best GWAS-associated HLA SNPs were also eQTLs for different HLA Class II genes. Our data suggest that the DR/DQ expression levels, together with specific structural properties of alleles, seem to be the causal effect in MS and in other immunopathologies rather than specific antigen presentation alone.	[Alcina, Antonio; Fedetz, Maria; Ndagire, Dorothy; Catala-Rabasa, Antonio; Matesanz, Fuencisla] CSIC, IPBLN, Granada, Spain; [del Mar Abad-Grau, Maria] Univ Granada, CITIC, Dept Lenguajes & Sistemas Informat, Granada, Spain; [Izquierdo, Guillermo; Matesanz, Fuencisla] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain; [Lucas, Miguel] Hosp Virgen Macarena, Serv Biol Mol, Seville, Spain; [Fernandez, Oscar] Hosp Carlos Haya, Inst Neurociencias Clin, Serv Neurol, Malaga, Spain; [Ruiz, Agustin; Gayan, Javier] Neocodex, Dept Genom Estruct, Seville, Spain; [Delgado, Concepcion] Ctr Reg Transfus Sanguinea Granada Almeria, Ganada, Spain; [Arnal, Carmen] Hosp Virgen de las Nieves, Serv Neurol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena; Hospital Carlos Haya; Hospital Universitario Virgen de las Nieves	Alcina, A (corresponding author), CSIC, IPBLN, Granada, Spain.	pulgoso@ipb.csic.es; lindo@ipb.csic.es	Alcina, Antonio/T-1893-2017; Ruiz, Agustin/G-5677-2012; Abad Grau, María del Mar/B-2172-2012; Matesanz, Fuencisla/F-3715-2016	Alcina, Antonio/0000-0001-7294-0948; Abad Grau, María del Mar/0000-0001-8470-9719; Matesanz, Fuencisla/0000-0002-9429-1819; Ruiz Laza, Agustin/0000-0003-2633-2495	Ministerio de Ciencia e Innovacion - Fondos Feder [PN-SAF2009-11491]; Junta de Andalucia [P07-CVI-02551]; Fondo de Investigacion Sanitaria [FIS PI081636, CP10/00526]; Fundacion Espanola de Esclerosis Multple (FEDEM)	Ministerio de Ciencia e Innovacion - Fondos Feder(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Espanola de Esclerosis Multple (FEDEM)	This work was supported by the Ministerio de Ciencia e Innovacion - Fondos Feder [PN-SAF2009-11491 to AA], Junta de Andalucia [P07-CVI-02551 to AA], and Fondo de Investigacion Sanitaria [FIS PI081636, CP10/00526 to FM]. MF and DN are holders of a fellowship from Fundacion Espanola de Esclerosis Multple (FEDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x; Chao MJ, 2008, P NATL ACAD SCI USA, V105, P13069, DOI 10.1073/pnas.0801042105; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Ramagopalan SV, 2009, CURR OPIN NEUROL, V22, P219, DOI 10.1097/WCO.0b013e32832b5417; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vincent R, 1996, J IMMUNOL, V156, P603; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	45	69	70	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29819	10.1371/journal.pone.0029819	http://dx.doi.org/10.1371/journal.pone.0029819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253788	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500022
J	Tanzler, R; Sagata, K; Surbakti, S; Balke, M; Riedel, A				Taenzler, Rene; Sagata, Katayo; Surbakti, Suriani; Balke, Michael; Riedel, Alexander			DNA Barcoding for Community Ecology - How to Tackle a Hyperdiverse, Mostly Undescribed Melanesian Fauna	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; SPECIES-DIVERSITY; NEW-GUINEA; TAXONOMY; WEEVILS; IDENTIFICATIONS; COLEOPTERA; MORPHOLOGY; DIPTERA; GENES	Background: Trigonopterus weevils are widely distributed throughout Melanesia and hyperdiverse in New Guinea. They are a dominant feature in natural forests, with narrow altitudinal zonation. Their use in community ecology has been precluded by the "taxonomic impediment". Methodology/Principal Findings: We sampled.6,500 specimens from seven areas across New Guinea; 1,002 specimens assigned to 270 morphospecies were DNA sequenced. Objective clustering of a refined dataset (excluding nine cryptic species) at 3% threshold revealed 324 genetic clusters (DNA group count relative to number of morphospecies = 20.0% overestimation of species diversity, or 120.0% agreement) and 85.6% taxonomic accuracy (the proportion of DNA groups that "perfectly" agree with morphology-based species hypotheses). Agreement and accuracy were best at an 8% threshold. GMYC analysis revealed 328 entities (21.5% overestimation) with 227 perfect GMYC entities (84.1% taxonomic accuracy). Both methods outperform the parataxonomist (19% underestimation; 31.6% taxonomic accuracy). The number of species found in more than one sampling area was highest in the Eastern Highlands and Huon (Sorensen similarity index 0.07, 4 shared species); 1/3 of all areas had no species overlap. Success rates of DNA barcoding methods were lowest when species showed a pronounced geographical structure. In general, Trigonopterus show high alpha and beta-diversity across New Guinea. Conclusions/Significance: DNA barcoding is an excellent tool for biodiversity surveys but success rates might drop when closer localities are included. Hyperdiverse Trigonopterus are a useful taxon for evaluating forest remnants in Melanesia, allowing finer-grained analyses than would be possible with vertebrate taxa commonly used to date. Our protocol should help establish other groups of hyperdiverse fauna as target taxa for community ecology. Sequencing delivers objective data on taxa of incredible diversity but mostly without a solid taxonomic foundation and should help pave the road for the eventual formal naming of new species.	[Taenzler, Rene; Balke, Michael] Zool Staatssammlung, Dept Entomol, Munich, Germany; [Sagata, Katayo] Papua New Guinea Inst Biol Res, Goroka, Papua N Guinea; [Surbakti, Suriani] Univ Cendrawasih, Dept Biol, Jayapura, Indonesia; [Balke, Michael] Univ Munich, GeoBioCtr, Munich, Germany; [Riedel, Alexander] Staatliches Museum Nat Kunde, Dept Entomol, Karlsruhe, Germany	Cenderawasih University; University of Munich	Tanzler, R (corresponding author), Zool Staatssammlung, Dept Entomol, Munich, Germany.	riedel@smnk.de	Riedel, Alexander/V-2608-2019	Riedel, Alexander/0000-0002-8291-4425	German Research Foundation (DFG) [RI 1817/3-1, BA2152/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by grants RI 1817/3-1 and BA2152/7-1 from the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrin JJ, 2008, INVERTEBR SYST, V22, P503, DOI 10.1071/IS07057; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Caesar RM, 2006, DIVERS DISTRIB, V12, P483, DOI 10.1111/j.1366-9516.2006.00237.x; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Ekrem T, 2010, ORG DIVERS EVOL, V10, P397, DOI 10.1007/s13127-010-0034-y; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gotelli NJ, 2004, PHILOS T R SOC B, V359, P585, DOI 10.1098/rstb.2003.1443; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; McKenna DD, 2005, MOL PHYLOGENET EVOL, V37, P117, DOI 10.1016/j.ympev.2005.06.011; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0021326, 10.1371/journal.pone.0018318]; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Normark BB, 1999, P ROY SOC B-BIOL SCI, V266, P2253, DOI 10.1098/rspb.1999.0916; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Pineau P, 2005, MOL BIOL EVOL, V22, P582, DOI 10.1093/molbev/msi053; Pinzon-Navarro S, 2010, MOL PHYLOGENET EVOL, V56, P281, DOI 10.1016/j.ympev.2010.02.022; Polhemus DA, 2007, ECOLOGY PAPUA 1, VVI, P137; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, COLLAPSE DESCRIBING; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Riedel Alexander, 2011, Zootaxa, V2977, P1; Riedel Alexander, 2010, Zootaxa, V2403, P59; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x; Silvestro D, 2010, RAXMLGUI GRAPHICAL F; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sorensen T, 1957, BIOL SKR, V5, P1, DOI DOI 10.1016/J.NEUROIMAGE.2006.09.051; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; Wallace A. R., 1869, MALAY ARCHIPELAGO LA, V2; Wallace AR, 1869, MALAY ARCHIPELAGO LA, V1; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.1111/j.1558-5646.1959.tb02996.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	46	82	84	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e28832	10.1371/journal.pone.0028832	http://dx.doi.org/10.1371/journal.pone.0028832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253699	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500002
J	Gruden, K; Hren, M; Herman, A; Blejec, A; Albrecht, T; Selbig, J; Bauer, C; Schuchardt, J; Or-Guil, M; Zupancic, K; Svajger, U; Stabuc, B; Ihan, A; Kopitar, AN; Ravnikar, M; Knezevic, M; Rozman, P; Jeras, M				Gruden, Kristina; Hren, Matjaz; Herman, Ana; Blejec, Andrej; Albrecht, Tanja; Selbig, Joachim; Bauer, Chris; Schuchardt, Johannes; Or-Guil, Michal; Zupancic, Klemen; Svajger, Urban; Stabuc, Borut; Ihan, Alojz; Kopitar, Andreja Natasa; Ravnikar, Maja; Knezevic, Miomir; Rozman, Primoz; Jeras, Matjaz			A "Crossomics" Study Analysing Variability of Different Components in Peripheral Blood of Healthy Caucasoid Individuals	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; REVEALS DIFFERENCES; IMMUNE-SYSTEM; WHOLE-BLOOD; CELLS; SERUM; PROFILES; CYTOKINE; SURVIVAL	Background: Different immunotherapy approaches for the treatment of cancer and autoimmune diseases are being developed and tested in clinical studies worldwide. Their resulting complex experimental data should be properly evaluated, therefore reliable normal healthy control baseline values are indispensable. Methodology/Principal Findings: To assess intra- and inter-individual variability of various biomarkers, peripheral blood of 16 age and gender equilibrated healthy volunteers was sampled on 3 different days within a period of one month. Complex "crossomics'' analyses of plasma metabolite profiles, antibody concentrations and lymphocyte subset counts as well as whole genome expression profiling in CD4(+)T and NK cells were performed. Some of the observed age, gender and BMI dependences are in agreement with the existing knowledge, like negative correlation between sex hormone levels and age or BMI related increase in lipids and soluble sugars. Thus we can assume that the distribution of all 39.743 analysed markers is well representing the normal Caucasoid population. All lymphocyte subsets, 20% of metabolites and less than 10% of genes, were identified as highly variable in our dataset. Conclusions/Significance: Our study shows that the intra- individual variability was at least two-fold lower compared to the inter-individual one at all investigated levels, showing the importance of personalised medicine approach from yet another perspective.	[Gruden, Kristina; Hren, Matjaz; Blejec, Andrej; Zupancic, Klemen; Ravnikar, Maja] Natl Inst Biol, Ljubljana, Slovenia; [Hren, Matjaz] Ctr Excellence Biosensor Instrumentat & Proc Cont, Solkan, Slovenia; [Herman, Ana; Svajger, Urban; Rozman, Primoz; Jeras, Matjaz] Ctr Blood Transfus, Ljubljana, Slovenia; [Albrecht, Tanja; Selbig, Joachim] Univ Potsdam, Potsdam, Germany; [Bauer, Chris; Schuchardt, Johannes] MicroDiscovery GmbH, Berlin, Germany; [Or-Guil, Michal] Humboldt Univ, D-10099 Berlin, Germany; [Stabuc, Borut] Univ Med Ctr Ljubljana, Gastroenterol Clin, Ljubljana, Slovenia; [Ihan, Alojz; Kopitar, Andreja Natasa] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Jeras, Matjaz] Celica Biomed Ctr, Ljubljana, Slovenia; [Jeras, Matjaz] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Knezevic, Miomir] Biobanka Ltd, Ljubljana, Slovenia	National Institute of Biology - Slovenia; University of Potsdam; Humboldt University of Berlin; University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Gruden, K (corresponding author), Natl Inst Biol, Ljubljana, Slovenia.	matjaz.jeras@ffa.uni-lj.si	Blejec, Andrej/A-8470-2010; Rozman, Primoz/ABD-4051-2020; Švajger, Urban/ABD-8035-2021; Švajger, Urban/AAQ-1756-2020; Blejec, Andrej/M-5215-2019; Or-Guil, Michal/AAC-7336-2020; Gruden, kristina/AAI-6439-2020	Blejec, Andrej/0000-0001-7484-6031; Švajger, Urban/0000-0002-1908-4254; Blejec, Andrej/0000-0001-7484-6031; Or-Guil, Michal/0000-0001-5576-8883; gruden, kristina/0000-0001-5906-8569; Ravnikar, Maja/0000-0002-6630-1362	Slovenian-German INREMOS-SYSTHER; Slovenian Research Agency [P4-0165, P2-0103]; Ministry of Higher Education, Science and Technology [4302-38/2006/4]; German Ministry of Education and Research (BMBF) [0315005A, 0315005C]	Slovenian-German INREMOS-SYSTHER; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Higher Education, Science and Technology; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded within the Slovenian-German INREMOS-SYSTHER project, by the Slovenian Research Agency grants P4-0165 and P2-0103, Ministry of Higher Education, Science and Technology grant No. 4302-38/2006/4, and the German Ministry of Education and Research (BMBF, Grant No 0315005A and 0315005C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2009, BIOMARKERS, V14, P572, DOI 10.3109/13547500903261354; Annonymous, 2005, R LANGUAGE ENV STAT; Atzori L, 2009, J MATERN-FETAL NEO M, V22, P50, DOI 10.1080/14767050903181500; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandacher G, 2007, CURR DRUG METAB, V8, P289, DOI 10.2174/138920007780362590; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cotterill L, 2010, CAN J GASTROENTEROL, V24, P297, DOI 10.1155/2010/480458; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; de Groot RHM, 2009, BRIT J NUTR, V102, P1058, DOI 10.1017/S0007114509359103; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; DelaRosa O, 2006, BIOGERONTOLOGY, V7, P471, DOI 10.1007/s10522-006-9062-6; Dorshkind K, 2009, CURR OPIN IMMUNOL, V21, P404, DOI 10.1016/j.coi.2009.07.001; Douek DC, 1997, INT IMMUNOL, V9, P355, DOI 10.1093/intimm/9.3.355; Duvigneau JC, 2003, J IMMUNOL METHODS, V272, P11, DOI 10.1016/S0022-1759(02)00372-1; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; FERRARO R, 1992, J CLIN INVEST, V90, P780, DOI 10.1172/JCI115951; Geppert J, 2010, PROSTAG LEUKOTR ESS, V82, P51, DOI 10.1016/j.plefa.2009.09.002; Gwinner W, 2007, WORLD J UROL, V25, P445, DOI 10.1007/s00345-007-0211-6; Hartel C, 2001, J IMMUNOL METHODS, V249, P63, DOI 10.1016/S0022-1759(00)00334-3; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Huzarewich RLCH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/613504; Le Dieu R, 2009, BLOOD, V114, P3909, DOI 10.1182/blood-2009-02-206946; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Manco M, 2007, J CLIN ENDOCR METAB, V92, P483, DOI 10.1210/jc.2006-0960; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; McCombe PA, 2009, CURR MOL MED, V9, P1058, DOI 10.2174/156652409789839116; Michaud A, 2010, J IMMUNOTHER, V33, P382, DOI 10.1097/CJI.0b013e3181cd872d; Nady S, 2009, CLIN VACCINE IMMUNOL, V16, P798, DOI 10.1128/CVI.00022-09; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Radich JP, 2004, GENOMICS, V83, P980, DOI 10.1016/j.ygeno.2003.12.013; Ritchie SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-13; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schuchhardt J, 2008, PROTEOMICS, V8, P1162, DOI 10.1002/pmic.200700743; Takahashi S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-103; Tanner MA, 2002, CLIN LAB HAEMATOL, V24, P337, DOI 10.1046/j.1365-2257.2002.00474.x; TRAUTWEIN EA, 1990, AM J CLIN NUTR, V52, P758, DOI 10.1093/ajcn/52.4.758; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Xu T, 2004, CANCER RES, V64, P3661, DOI 10.1158/0008-5472.CAN-03-3396; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; Yu ZY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015843, 10.1371/journal.pone.0017951]	46	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e28761	10.1371/journal.pone.0028761	http://dx.doi.org/10.1371/journal.pone.0028761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253695	gold, Green Submitted, Green Published			2022-12-25	WOS:000301357100004
J	Ohi, K; Hashimoto, R; Yasuda, Y; Nemoto, K; Ohnishi, T; Fukumoto, M; Yamamori, H; Umeda-Yano, S; Okada, T; Iwase, M; Kazui, H; Takeda, M				Ohi, Kazutaka; Hashimoto, Ryota; Yasuda, Yuka; Nemoto, Kiyotaka; Ohnishi, Takashi; Fukumoto, Motoyuki; Yamamori, Hidenaga; Umeda-Yano, Satomi; Okada, Takeya; Iwase, Masao; Kazui, Hiroaki; Takeda, Masatoshi			Impact of the Genome Wide Supported NRGN Gene on Anterior Cingulate Morphology in Schizophrenia	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INTERMEDIATE PHENOTYPES; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; BRAIN; NEUROGRANIN; RISK; POLYMORPHISM; ABNORMALITIES; ENDOPHENOTYPE	Background: The rs12807809 single-nucleotide polymorphism in NRGN is a genetic risk variant with genome-wide significance for schizophrenia. The frequency of the T allele of rs12807809 is higher in individuals with schizophrenia than in those without the disorder. Reduced immunoreactivity of NRGN, which is expressed exclusively in the brain, has been observed in Brodmann areas (BA) 9 and 32 of the prefrontal cortex in postmortem brains from patients with schizophrenia compared with those in controls. Methods: Genotype effects of rs12807809 were investigated on gray matter (GM) and white matter (WM) volumes using magnetic resonance imaging (MRI) with a voxel-based morphometry (VBM) technique in a sample of 99 Japanese patients with schizophrenia and 263 healthy controls. Results: Although significant genotype-diagnosis interaction either on GM or WM volume was not observed, there was a trend of genotype-diagnosis interaction on GM volume in the left anterior cingulate cortex (ACC). Thus, the effects of NRGN genotype on GM volume of patients with schizophrenia and healthy controls were separately investigated. In patients with schizophrenia, carriers of the risk T allele had a smaller GM volume in the left ACC (BA32) than did carriers of the non-risk C allele. Significant genotype effect on other regions of the GM or WM was not observed for either the patients or controls. Conclusions: Our findings suggest that the genome-wide associated genetic risk variant in the NRGN gene may be related to a small GM volume in the ACC in the left hemisphere in patients with schizophrenia.	[Ohi, Kazutaka; Hashimoto, Ryota; Yasuda, Yuka; Fukumoto, Motoyuki; Yamamori, Hidenaga; Okada, Takeya; Iwase, Masao; Kazui, Hiroaki; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Ohi, Kazutaka] Natl Hosp Org, Yamato Mental Med Ctr, Nara, Japan; [Ohi, Kazutaka; Hashimoto, Ryota; Yasuda, Yuka; Fukumoto, Motoyuki; Yamamori, Hidenaga; Okada, Takeya] Japan Sci & Technol Agcy, Saitama, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Hamamatsu Univ Sch Med, Osaka, Japan; [Nemoto, Kiyotaka] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Ibaraki, Japan; [Ohnishi, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychosomat Res, Tokyo, Japan; [Ohnishi, Takashi] Janssen Pharmaceut KK, Sci Affairs Div, CNS Sci Dept, Tokyo, Japan; [Yamamori, Hidenaga; Umeda-Yano, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Kanazawa University; Osaka University; Hamamatsu University School of Medicine; University of Tsukuba; National Center for Neurology & Psychiatry - Japan; Johnson & Johnson; Janssen Pharmaceuticals; Osaka University	Ohi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan.	hashimor@psy.med.osaka-u.ac.jp	Nemoto, Kiyotaka/C-4987-2013; Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Ohi, Kazutaka/J-7851-2019	Nemoto, Kiyotaka/0000-0001-8623-9829; Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640	Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-001]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22390225, 23659565]; CREST of JST; Japan Foundation for Neuroscience and Mental Health; Janssen Pharmaceutical; Dainippon Sumitomo Pharma Co., Ltd.; All Nippon Airways Co., Ltd.; Tsumura Co.; Eisai Co., Ltd.; Zeria Pharmaceutical Co., Ltd.; Yoshitomiyakuhin Corporation; Pfizer Japan Inc.; Astellas Pharma Inc.; H2O Retailing Corporation; GlaxoSmithKline; Grants-in-Aid for Scientific Research [22390225, 21591514] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Janssen Pharmaceutical; Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); All Nippon Airways Co., Ltd.; Tsumura Co.(Tsumura & Company); Eisai Co., Ltd.(Eisai Co Ltd); Zeria Pharmaceutical Co., Ltd.(Zeria Pharmaceutical Co Ltd); Yoshitomiyakuhin Corporation; Pfizer Japan Inc.(Pfizer); Astellas Pharma Inc.(Astellas Pharmaceuticals); H2O Retailing Corporation; GlaxoSmithKline(GlaxoSmithKline); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Japanese Ministry of Health, Labor and Welfare (H22-seishin-ippan-001); the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (22390225-Grant-in-Aid for Scientific Research (B) and 23659565-Grant-in-Aid for Challenging Exploratory Research); the CREST of JST; the Japan Foundation for Neuroscience and Mental Health and Janssen Pharmaceutical K.K. Ryota Hashimoto has received funding from Janssen Pharmaceutical K.K. and Dainippon Sumitomo Pharma Co., Ltd. Kiyotaka Nemoto has received funding from Janssen Pharmaceutical K.K. Masatoshi Takeda has received funding from Janssen Pharmaceutical K.K., Dainippon Sumitomo Pharma Co., Ltd., All Nippon Airways Co., Ltd., Tsumura & Co., Eisai Co., Ltd., Zeria Pharmaceutical Co., Ltd., Yoshitomiyakuhin Corporation, Pfizer Japan Inc., Astellas Pharma Inc., H2O Retailing Corporation, and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Bhojraj TS, 2011, NEUROIMAGE, V54, pS272, DOI 10.1016/j.neuroimage.2010.04.257; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; deArrieta CM, 1997, GENOMICS, V41, P243, DOI 10.1006/geno.1997.4622; Di X, 2009, PROG NEURO-PSYCHOPH, V33, P1390, DOI 10.1016/j.pnpbp.2009.08.020; Donohoe G, 2011, SCHIZOPHR RES, V125, P304, DOI 10.1016/j.schres.2010.10.019; Fornito A, 2009, SCHIZOPHRENIA BULL, V35, P973, DOI 10.1093/schbul/sbn025; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goghari VM, 2007, CEREB CORTEX, V17, P415, DOI 10.1093/cercor/bhj158; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2009, GENES BRAIN BEHAV, V8, P43, DOI 10.1111/j.1601-183X.2008.00440.x; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto R, 2010, AM J MED GENET B, V153B, P1459, DOI 10.1002/ajmg.b.31123; Hayashi Y, 2009, EMBO J, V28, P2859, DOI 10.1038/emboj.2009.273; Huang FL, 2007, LEARN MEMORY, V14, P512, DOI 10.1101/lm.636107; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Kaymaz N, 2009, INT REV NEUROBIOL, V89, P85, DOI 10.1016/S0074-7742(09)89005-3; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Lindenmayer Jean-Pierre, 1994, Psychiatric Quarterly (New York), V65, P299, DOI 10.1007/BF02354306; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Ohi K, 2009, GENES BRAIN BEHAV, V8, P473, DOI 10.1111/j.1601-183X.2009.00497.x; Ohi K, 2011, WORLD J BIO IN PRESS; Ohi K, 2011, PROG NEURO-PSYCHOPH, V35, P1309, DOI 10.1016/j.pnpbp.2011.04.008; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; Pohlack ST, 2011, MOL PSYCHIATR, V2011, P7; Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829; Prasad KM, 2008, SCHIZOPHRENIA BULL, V34, P774, DOI 10.1093/schbul/sbn017; Rijsdijsk FV, 2010, ARCH GEN PSYCHIAT, V67, P406, DOI 10.1001/archgenpsychiatry.2010.20; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Tan HY, 2008, MOL PSYCHIATR, V13, P233, DOI 10.1038/sj.mp.4002145	37	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29780	10.1371/journal.pone.0029780	http://dx.doi.org/10.1371/journal.pone.0029780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253779	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100021
J	Spadaccini, R; Ercole, C; Gentile, MA; Sanfelice, D; Boelens, R; Wechselberger, R; Batta, G; Bernini, A; Niccolai, N; Picone, D				Spadaccini, Roberta; Ercole, Carmine; Gentile, Maria A.; Sanfelice, Domenico; Boelens, Rolf; Wechselberger, Rainer; Batta, Gyula; Bernini, Andrea; Niccolai, Neri; Picone, Delia			NMR Studies on Structure and Dynamics of the Monomeric Derivative of BS-RNase: New Insights for 3D Domain Swapping	PLOS ONE			English	Article							BOVINE SEMINAL RIBONUCLEASE; C-TERMINAL DOMAIN; MOLECULAR-DYNAMICS; HYDROGEN-EXCHANGE; CRYSTAL-STRUCTURE; RELAXATION INTERFERENCE; BIOLOGICAL-ACTIVITIES; OLIGOMER FORMATION; CHEMICAL-SHIFT; PROTEIN	Three-dimensional domain swapping is a common phenomenon in pancreatic-like ribonucleases. In the aggregated state, these proteins acquire new biological functions, including selective cytotoxicity against tumour cells. RNase A is able to dislocate both N- and C-termini, but usually this process requires denaturing conditions. In contrast, bovine seminal ribonuclease (BS-RNase), which is a homo-dimeric protein sharing 80% of sequence identity with RNase A, occurs natively as a mixture of swapped and unswapped isoforms. The presence of two disulfides bridging the subunits, indeed, ensures a dimeric structure also to the unswapped molecule. In vitro, the two BS-RNase isoforms interconvert under physiological conditions. Since the tendency to swap is often related to the instability of the monomeric proteins, in these paper we have analysed in detail the stability in solution of the monomeric derivative of BS-RNase (mBS) by a combination of NMR studies and Molecular Dynamics Simulations. The refinement of NMR structure and relaxation data indicate a close similarity with RNase A, without any evidence of aggregation or partial opening. The high compactness of mBS structure is confirmed also by H/D exchange, urea denaturation, and TEMPOL mapping of the protein surface. The present extensive structural and dynamic investigation of (monomeric) mBS did not show any experimental evidence that could explain the known differences in swapping between BS-RNase and RNase A. Hence, we conclude that the swapping in BS-RNase must be influenced by the distinct features of the dimers, suggesting a prominent role for the interchain disulfide bridges.	[Spadaccini, Roberta] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy; [Ercole, Carmine; Gentile, Maria A.; Sanfelice, Domenico; Picone, Delia] Univ Naples Federico II, Dipartimento Chim, Naples, Italy; [Boelens, Rolf; Wechselberger, Rainer] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept NMR Spect, Utrecht, Netherlands; [Batta, Gyula] Univ Debrecen, Inst Chem, Debrecen, Hungary; [Bernini, Andrea; Niccolai, Neri] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy	University of Sannio; University of Naples Federico II; Utrecht University; University of Debrecen; University of Siena	Spadaccini, R (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy.	delia.picone@unina.it	Batta, Gyula/H-4567-2011; Sanfelice, domenico/E-8083-2018; Picone, Delia/I-5605-2012; Boelens, Rolf/B-4702-2009; Picone, Delia/L-2480-2015; Bernini, Andrea/H-9412-2012	Batta, Gyula/0000-0002-0442-1828; Sanfelice, domenico/0000-0002-8908-0347; Picone, Delia/0000-0002-7582-2581; Boelens, Rolf/0000-0002-6939-8913; Picone, Delia/0000-0002-7582-2581; Bernini, Andrea/0000-0002-7528-2749; SPADACCINI, Roberta/0000-0002-2262-1065	OTKA (Hungarian Scientific Research Fund) [CK-77515]; TAMOP (Operative Program for the Renewal of the Society) [4.2.1/B-09/1/KONV- 2010-0007, 20088L3BP3_001]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP (Operative Program for the Renewal of the Society)	This work was supported by grants OTKA (Hungarian Scientific Research Fund) CK-77515 and TAMOP (Operative Program for the Renewal of the Society) 4.2.1/B-09/1/KONV- 2010-0007 (GB) (Convergence) and 20088L3BP3_001 (DP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz LA, 2008, FEBS J, V275, P3299, DOI 10.1111/j.1742-4658.2008.06478.x; Avitabile F, 2003, BIOCHEMISTRY-US, V42, P8704, DOI 10.1021/bi0342517; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Berisio R, 2003, FEBS LETT, V554, P105, DOI 10.1016/S0014-5793(03)01114-1; Bernini A, 2006, J AM CHEM SOC, V128, P9290, DOI 10.1021/ja062109y; Bernini A, 2009, PROG NUCL MAG RES SP, V54, P278, DOI 10.1016/j.pnmrs.2008.10.003; Bruix M, 2008, BIOPHYS J, V94, P2297, DOI 10.1529/biophysj.107.122952; Canals A, 2001, STRUCTURE, V9, P967, DOI 10.1016/S0969-2126(01)00659-1; Catanzano F, 1997, BIOCHEMISTRY-US, V36, P14403, DOI 10.1021/bi971358j; Clarke J, 1996, FOLD DES, V1, P243, DOI 10.1016/S1359-0278(96)00038-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRESTFIELD A M, 1962, Arch Biochem Biophys, VSuppl 1, P217; D'Alessio G, 1999, EUR J BIOCHEM, V266, P699, DOI 10.1046/j.1432-1327.1999.00912.x; D'Alessio G., 1997, RIBONUCLEASES STRUCT; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dastidar SG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021921; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; Dechene M, 2009, PROTEINS, V76, P861, DOI 10.1002/prot.22393; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIDONATO A, 1986, BIOCHEMISTRY-US, V25, P8361, DOI 10.1021/bi00374a005; Ercole C, 2003, EUR J BIOCHEM, V270, P4729, DOI 10.1046/j.1432-1033.2003.03872.x; Ercole C, 2007, BIOCHEMISTRY-US, V46, P2227, DOI 10.1021/bi0613630; Ercole C, 2009, BIOPOLYMERS, V91, P1009, DOI 10.1002/bip.21176; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Geiger R, 2011, J BIOL CHEM, V286, P5813, DOI 10.1074/jbc.M110.171694; Giancola C, 2011, FEBS J, V278, P111, DOI 10.1111/j.1742-4658.2010.07937.x; GOLDMAN M, 1984, J MAGN RESON, V60, P437, DOI 10.1016/0022-2364(84)90055-6; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KIM JS, 1995, BIOCHEM J, V308, P547, DOI 10.1042/bj3080547; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kover KE, 2008, J MOL BIOL, V379, P953, DOI 10.1016/j.jmb.2008.04.042; Kroenke CD, 1998, J AM CHEM SOC, V120, P7905, DOI 10.1021/ja980832l; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lopez-Alonso JP, 2006, J BIOL CHEM, V281, P9400, DOI 10.1074/jbc.M510491200; LOUNNAS V, 1994, PROTEINS, V18, P133, DOI 10.1002/prot.340180206; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; MERLINO A, 2009, BIOPOLYMERS; Merlino A, 2009, PROTEIN SCI, V18, P50, DOI 10.1002/pro.6; Miller KH, 2010, J MOL BIOL, V400, P567, DOI 10.1016/j.jmb.2010.05.017; PARENTE A, 1976, BIOCHIM BIOPHYS ACTA, V445, P377, DOI 10.1016/0005-2744(76)90091-7; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Lopez-Alonso JP, 2010, J AM CHEM SOC, V132, P1621, DOI 10.1021/ja9081638; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Picone D, 2005, J BIOL CHEM, V280, P13771, DOI 10.1074/jbc.M413157200; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Sessions RB, 1998, BIOPHYS J, V74, P138, DOI 10.1016/S0006-3495(98)77775-6; TAMBURRINI M, 1986, ITAL J BIOCHEM, V35, P22; Tellinghuisen J, 2000, J CHEM EDUC, V77, P1233, DOI 10.1021/ed077p1233; Tessari M, 1997, J AM CHEM SOC, V119, P8985, DOI 10.1021/ja970573k; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Varrazzo D, 2005, BIOINFORMATICS, V21, P2856, DOI 10.1093/bioinformatics/bti444; VUISTER GW, 1993, J BIOMOL NMR, V3, P67	72	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29076	10.1371/journal.pone.0029076	http://dx.doi.org/10.1371/journal.pone.0029076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253705	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100007
J	Li, FB; Niu, BL; Huang, YP; Meng, ZQ				Li, FengBo; Niu, BaoLong; Huang, YongPing; Meng, ZhiQi			Application of High-Resolution DNA Melting for Genotyping in Lepidopteran Non-Model Species: Ostrinia furnacalis (Crambidae)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EUROPEAN CORN-BORER; BOMBYX-MORI; GENETIC-ANALYSIS; SILKWORM BOMBYX; MICROSATELLITES; GENOMES; DIAGNOSTICS; NUBILALIS; INSECT	Development of an ideal marker system facilitates a better understanding of the genetic diversity in lepidopteran non-model organisms, which have abundant species, but relatively limited genomic resources. Single nucleotide polymorphisms (SNPs) discovered within single-copy genes have proved to be desired markers, but SNP genotyping by current techniques remain laborious and expensive. High resolution melting (HRM) curve analysis represents a simple, rapid and inexpensive genotyping method that is primarily confined to clinical and diagnostic studies. In this study, we evaluated the potential of HRM analysis for SNP genotyping in the lepidopteran non-model species Ostrinia furnacalis (Crambidae). Small amplicon and unlabeled probe assays were developed for the SNPs, which were identified in 30 females of O. furnacalis from 3 different populations by our direct sequencing. Both assays were then applied to genotype 90 unknown female DNA by prior mixing with known wild-type DNA. The genotyping results were compared with those that were obtained using bidirectional sequencing analysis. Our results demonstrated the efficiency and reliability of the HRM assays. HRM has the potential to provide simple, cost-effective genotyping assays and facilitates genotyping studies in any non-model lepidopteran species of interest.	[Li, FengBo; Niu, BaoLong; Meng, ZhiQi] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Lab Entomomol Biol, Sericulture Res Inst, Hangzhou, Zhejiang, Peoples R China; [Huang, YongPing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Zhejiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, FB (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Lab Entomomol Biol, Sericulture Res Inst, Hangzhou, Zhejiang, Peoples R China.	yphuang@sibs.ac.cn; mengzq@zaas.org		/0000-0001-8227-7537	National Natural Foundation Key Program of China [31030060]; China Postdoctoral Science Foundation [20090461404]	National Natural Foundation Key Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Foundation Key Program of China (31030060) and the China Postdoctoral Science Foundation (20090461404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Avise J.C., 2004, MOL MARKERS NATURAL; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Cradic KW, 2004, CLIN CHEM, V50, P1080, DOI 10.1373/clinchem.2004.033183; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Goldsmith M.R., 2010, MOL BIOL GENETICS LE; Granados-Cifuentes C, 2011, MOL ECOL RESOUR, V11, P394, DOI 10.1111/j.1755-0998.2010.02933.x; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Hill HR, 2010, J MOL DIAGN, V12, P368, DOI 10.2353/jmoldx.2010.090147; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Malausa T, 2007, GENETICS, V176, P2343, DOI 10.1534/genetics.107.072108; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Muleo R, 2009, GENOME, V52, P252, DOI 10.1139/G09-002; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/genetics.104.031005; Reddy KD, 1999, GENOME, V42, P1057, DOI 10.1139/gen-42-6-1057; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang ML., 2009, G3GENES GENOMES GENE, V3, P54; Wang ZY., 2000, J SHENYANG AGR U, V31, P402; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yasukochi Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165894; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020; Zhou Hongchun, 2003, Yingyong Shengtai Xuebao, V14, P725; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322	51	11	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29664	10.1371/journal.pone.0029664	http://dx.doi.org/10.1371/journal.pone.0029664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253755	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700035
J	Lin, FC; Zhou, Y; Du, YS; Qin, LD; Zhao, ZM; Xu, JR; Lei, H				Lin, Fuchun; Zhou, Yan; Du, Yasong; Qin, Lindi; Zhao, Zhimin; Xu, Jianrong; Lei, Hao			Abnormal White Matter Integrity in Adolescents with Internet Addiction Disorder: A Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							PROPOSED DIAGNOSTIC-CRITERIA; HUMAN CORPUS-CALLOSUM; DIFFUSION-TENSOR; COCAINE DEPENDENCE; ORBITOFRONTAL CORTEX; DECISION-MAKING; DRUG-ADDICTION; BRAIN; MRI; MICROSTRUCTURE	Background: Internet addiction disorder (IAD) is currently becoming a serious mental health issue around the globe. Previous studies regarding IAD were mainly focused on associated psychological examinations. However, there are few studies on brain structure and function about IAD. In this study, we used diffusion tensor imaging (DTI) to investigate white matter integrity in adolescents with IAD. Methodology/Principal Findings: Seventeen IAD subjects and sixteen healthy controls without IAD participated in this study. Whole brain voxel-wise analysis of fractional anisotropy (FA) was performed by tract-based spatial statistics (TBSS) to localize abnormal white matter regions between groups. TBSS demonstrated that IAD had significantly lower FA than controls throughout the brain, including the orbito-frontal white matter, corpus callosum, cingulum, inferior fronto-occipital fasciculus, and corona radiation, internal and external capsules, while exhibiting no areas of higher FA. Volume-of-interest (VOI) analysis was used to detect changes of diffusivity indices in the regions showing FA abnormalities. In most VOIs, FA reductions were caused by an increase in radial diffusivity while no changes in axial diffusivity. Correlation analysis was performed to assess the relationship between FA and behavioral measures within the IAD group. Significantly negative correlations were found between FA values in the left genu of the corpus callosum and the Screen for Child Anxiety Related Emotional Disorders, and between FA values in the left external capsule and the Young's Internet addiction scale. Conclusions: Our findings suggest that IAD demonstrated widespread reductions of FA in major white matter pathways and such abnormal white matter structure may be linked to some behavioral impairments. In addition, white matter integrity may serve as a potential new treatment target and FA may be as a qualified biomarker to understand the underlying neural mechanisms of injury or to assess the effectiveness of specific early interventions in IAD.	[Lin, Fuchun; Lei, Hao] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Zhou, Yan; Qin, Lindi; Xu, Jianrong] Jiao Tong Univ, Sch Med, Dept Radiol, RenJi Hosp, Shanghai 200030, Peoples R China; [Du, Yasong; Zhao, Zhimin] Jiao Tong Univ, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lin, FC (corresponding author), Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance, Wuhan Inst Phys & Math, Wuhan, Peoples R China.	xujianr@hotmail.com; leihao@wipm.ac.cn	, 雷皓/H-8147-2019; Lei, Hao/A-7004-2008; Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019	, 雷皓/0000-0003-3412-1241; Lei, Hao/0000-0003-3412-1241; Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474	Natural Science Foundation of China [30800252, 20921004]; National Basic Research Program of China (973 Program) [2011CB707802]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was partially supported by Natural Science Foundation of China (Nos. 30800252 and 20921004), National Basic Research Program of China (973 Program) Grant No. 2011CB707802, and the Knowledge Innovation Program of Chinese Academy of Sciences, and Excellent Doctoral Thesis Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, J COMPUT ASSIST TOMO, V28, P533, DOI 10.1097/00004728-200407000-00016; Aboujaoude E, 2010, WORLD PSYCHIATRY, V9, P85; Alicata D, 2009, PSYCHIAT RES-NEUROIM, V174, P1, DOI 10.1016/j.pscychresns.2009.03.011; Arnone D, 2006, NEUROPSYCHOBIOLOGY, V54, P107, DOI 10.1159/000096992; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bora E, 2010, ADDICT BIOL IN PRESS; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; De Bellis MD, 2008, ALCOHOL CLIN EXP RES, V32, P395, DOI 10.1111/j.1530-0277.2007.00603.x; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Douglas AC, 2008, COMPUT HUM BEHAV, V24, P3027, DOI 10.1016/j.chb.2008.05.009; Du YS, 2010, AUST NZ J PSYCHIAT, V44, P129, DOI 10.3109/00048670903282725; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Han DH, 2011, COMPR PSYCHIAT, V52, P88, DOI 10.1016/j.comppsych.2010.04.004; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; Huang XQ, 2010, CYBERPSYCH BEH SOC N, V13, P401, DOI 10.1089/cyber.2009.0222; Kim IS, 2009, NEUROTOXICOLOGY, V30, P209, DOI 10.1016/j.neuro.2008.12.002; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liao YH, 2010, BRAIN, V133, P2115, DOI 10.1093/brain/awq131; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu J, 2010, CHINESE MED J-PEKING, V123, P1904, DOI 10.3760/cma.j.issn.0366-6999.2010.14.014; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Moeller FG, 2007, AM J DRUG ALCOHOL AB, V33, P777, DOI 10.1080/00952990701651564; Moeller FG, 2007, PSYCHIAT RES-NEUROIM, V154, P253, DOI 10.1016/j.pscychresns.2006.11.004; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Romero MJ, 2010, PSYCHIAT RES-NEUROIM, V181, P57, DOI 10.1016/j.pscychresns.2009.07.004; Salo R, 2009, BIOL PSYCHIAT, V65, P122, DOI 10.1016/j.biopsych.2008.08.004; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Tobias MC, 2010, PSYCHOPHARMACOLOGY, V209, P13, DOI 10.1007/s00213-009-1761-7; Vocci FJ, 2008, EXP CLIN PSYCHOPHARM, V16, P484, DOI 10.1037/a0014101; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Young K., 1998, CAUGHT NET RECOGNIZE; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; 黄希庭, 2001, [心理学报, Acta Psychologica Sinica], V33, P338	69	132	141	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30253	10.1371/journal.pone.0030253	http://dx.doi.org/10.1371/journal.pone.0030253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906ON	22253926	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700101
J	Najafi, M; Soltanian-Zadeh, H; Jafari-Khouzani, K; Scarpace, L; Mikkelsen, T				Najafi, Mohammad; Soltanian-Zadeh, Hamid; Jafari-Khouzani, Kourosh; Scarpace, Lisa; Mikkelsen, Tom			Prediction of Glioblastoma Multiform Response to Bevacizumab Treatment Using Multi-Parametric MRI	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; TUMOR CHANGE MEASUREMENT; TRUTH DATA; MALIGNANT GLIOMAS; BRAIN-TUMORS; SURVIVAL; TRANSFORMATION; CHEMOTHERAPY; TOMOGRAPHY; CANCER	Glioblastoma multiform (GBM) is a highly malignant brain tumor. Bevacizumab is a recent therapy for stopping tumor growth and even shrinking tumor through inhibition of vascular development (angiogenesis). This paper presents a non-invasive approach based on image analysis of multi-parametric magnetic resonance images (MRI) to predict response of GBM to this treatment. The resulting prediction system has potential to be used by physicians to optimize treatment plans of the GBM patients. The proposed method applies signal decomposition and histogram analysis methods to extract statistical features from Gd-enhanced regions of tumor that quantify its microstructural characteristics. MRI studies of 12 patients at multiple time points before and up to four months after treatment are used in this work. Changes in the Gd-enhancement as well as necrosis and edema after treatment are used to evaluate the response. Leave-one-out cross validation method is applied to evaluate prediction quality of the models. Predictive models developed in this work have large regression coefficients (maximum R-2 = 0.95) indicating their capability to predict response to therapy.	[Najafi, Mohammad; Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, CIPCE, Tehran, Iran; [Soltanian-Zadeh, Hamid; Jafari-Khouzani, Kourosh] Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI USA; [Scarpace, Lisa; Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Hermelin Brain Tumor Res Ctr, Detroit, MI USA	University of Tehran; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Najafi, M (corresponding author), Univ Tehran, Sch Elect & Comp Engn, CIPCE, Tehran, Iran.	hamids@rad.hfh.edu	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856				Ananthnarayan S, 2008, J NEURO-ONCOL, V88, P339, DOI 10.1007/s11060-008-9573-x; [Anonymous], GLIOBLASTOMA MULTIFO; Bauerle T, 2010, EUR J RADIOL, V73, P280, DOI 10.1016/j.ejrad.2008.10.020; Barnhart HX, 2009, TRANSL ONCOL, V2, P231, DOI 10.1593/tlo.09268; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezabeh T, 2005, AM J NEURORADIOL, V26, P2108; Bulnes S, 2007, J MOL NEUROSCI, V33, P163, DOI 10.1007/s12031-007-0061-0; Carlson MRJ, 2007, CLIN CANCER RES, V13, P2592, DOI 10.1158/1078-0432.CCR-06-2772; Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Dube S, 2007, P JOINT ANN INT C IS; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Gong QY, 2004, BRIT J RADIOL, V77, P405, DOI 10.1259/BJR/85294528; Henson JW, 2008, AM J NEURORADIOL, V29, P419, DOI 10.3174/ajnr.A0963; Holub O, 2006, COMPUT PHYS COMMUN, V175, P620, DOI 10.1016/j.cpc.2006.06.014; Jackson EF, 2009, TRANSL ONCOL, V2, P211, DOI 10.1593/tlo.09241; Kinahan PE, 2009, TRANSL ONCOL, V2, P223, DOI 10.1593/tlo.09223; Lemaire L, 1999, MAGN RESON MATER PHY, V8, P20; Mardor Y, 2004, NEOPLASIA, V6, P136, DOI 10.1593/neo.03349; Marill KA, 2004, ACAD EMERG MED, V11, P87, DOI 10.1197/S1069-6563(03)00600-6; McNitt-Gray MF, 2009, TRANSL ONCOL, V2, P216, DOI 10.1593/tlo.09226; Meyer CR, 2009, TRANSL ONCOL, V2, P198, DOI 10.1593/tlo.09208; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; Nieder C, 2009, CLIN ONCOL-UK, V21, P515, DOI 10.1016/j.clon.2009.05.003; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Pope WB, 2006, NEUROLOGY, V66, P1258, DOI 10.1212/01.wnl.0000208958.29600.87; Provenzale JM, 2005, AM J ROENTGENOL, V185, P763, DOI 10.2214/ajr.185.3.01850763; Rodriguez M, 1999, ACTA RADIOL, V40, P191, DOI 10.3109/02841859909177737; Rubinfeld Daniel L., 2000, REFERENCE MANUAL SCI; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Shah GD, 2006, NEURO-ONCOLOGY, V8, P38, DOI 10.1215/S1522851705000529; Soltanian-Zadeh H, 1998, NMR BIOMED, V11, P201, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<201::AID-NBM508>3.0.CO;2-6; Soltanian-Zadeh H, 1998, MAGNET RESON MED, V40, P443, DOI 10.1002/mrm.1910400315; SoltanianZadeh H, 1996, IEEE T MED IMAGING, V15, P749, DOI 10.1109/42.544494; SOLTANIANZADEH H, 1993, IEEE T NUCL SCI, V40, P1204, DOI 10.1109/23.256737; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863	40	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29945	10.1371/journal.pone.0029945	http://dx.doi.org/10.1371/journal.pone.0029945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253835	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700069
J	Ren, Y; Zhao, H; Kou, QH; Jiang, J; Guo, SG; Zhang, HY; Hou, WJ; Zou, XH; Sun, HH; Gong, GY; Levi, A; Xu, Y				Ren, Yi; Zhao, Hong; Kou, Qinghe; Jiang, Jiao; Guo, Shaogui; Zhang, Haiying; Hou, Wenju; Zou, Xiaohua; Sun, Honghe; Gong, Guoyi; Levi, Amnon; Xu, Yong			A High Resolution Genetic Map Anchoring Scaffolds of the Sequenced Watermelon Genome	PLOS ONE			English	Article							POLYMORPHIC DNA MARKERS; LINKAGE MAP; CITRULLUS-LANATUS; MEIOTIC RECOMBINATION; INBRED LINES; CONSTRUCTION; MAIZE; COLOCYNTHIS; CUCUMBER; RAPD	As part of our ongoing efforts to sequence and map the watermelon (Citrullus spp.) genome, we have constructed a high density genetic linkage map. The map positioned 234 watermelon genome sequence scaffolds (an average size of 1.41 Mb) that cover about 330 Mb and account for 93.5% of the 353 Mb of the assembled genomic sequences of the elite Chinese watermelon line 97103 (Citrullus lanatus var. lanatus). The genetic map was constructed using an F-8 population of 103 recombinant inbred lines (RILs). The RILs are derived from a cross between the line 97103 and the United States Plant Introduction (PI) 296341-FR (C. lanatus var. citroides) that contains resistance to fusarium wilt (races 0, 1, and 2). The genetic map consists of eleven linkage groups that include 698 simple sequence repeat (SSR), 219 insertion-deletion (InDel) and 36 structure variation (SV) markers and spans similar to 800 cM with a mean marker interval of 0.8 cM. Using fluorescent in situ hybridization (FISH) with 11 BACs that produced chromosome-specifc signals, we have depicted watermelon chromosomes that correspond to the eleven linkage groups constructed in this study. The high resolution genetic map developed here should be a useful platform for the assembly of the watermelon genome, for the development of sequence-based markers used in breeding programs, and for the identification of genes associated with important agricultural traits.	[Ren, Yi; Zhao, Hong; Kou, Qinghe; Jiang, Jiao; Guo, Shaogui; Zhang, Haiying; Hou, Wenju; Zou, Xiaohua; Sun, Honghe; Gong, Guoyi; Xu, Yong] BAAFS, Natl Engn Res Ctr Vegetables, Beijing, Peoples R China; [Kou, Qinghe; Jiang, Jiao] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Levi, Amnon] ARS, US Vegetable Lab, USDA, Charleston, SC USA	Beijing Academy of Agriculture & Forestry; Capital Normal University; United States Department of Agriculture (USDA)	Ren, Y (corresponding author), BAAFS, Natl Engn Res Ctr Vegetables, Beijing, Peoples R China.	xuyong@nercv.org		Ren, Yi/0000-0003-3770-6093	Ministry of Science and Technology of the People's Republic of China [2010AA10A107, 2009BADB8B02, 2010DFB33740]; Ministry of Agriculture of the People's Republic of China [CARS-26, 2008-Z42[3]]; Beijing Municipal Science & Technology Commission, China [D08070500690803, D111100001311002, KJCX201101010, Z09090501040902]; National Natural Science Foundation of China [30972015, 31171980]; Natural Science Foundation of Beijing [5100001]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Beijing Municipal Science & Technology Commission, China(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This research was supported by grants from the Ministry of Science and Technology of the People's Republic of China (2010AA10A107, 2009BADB8B02, 2010DFB33740), Ministry of Agriculture of the People's Republic of China (CARS-26, 2008-Z42[3]), Beijing Municipal Science & Technology Commission, China (D08070500690803, D111100001311002, KJCX201101010, Z09090501040902), the National Natural Science Foundation of China (30972015 and 31171980) and Natural Science Foundation of Beijing (5100001) to Y.X. and H.Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Anderson LK, 2004, GENETICS, V166, P1923, DOI 10.1534/genetics.166.4.1923; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Guo SG, 2010, ACTA HORTIC, V871, P599; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Hashizume T, 2003, THEOR APPL GENET, V106, P779, DOI 10.1007/s00122-002-1030-1; Hashizume T, 1996, EUPHYTICA, V90, P265, DOI 10.1007/BF00027475; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Joobeur T, 2006, THEOR APPL GENET, V112, P1553, DOI 10.1007/s00122-006-0258-6; Kuittinen H, 2004, GENETICS, V168, P1575, DOI 10.1534/genetics.103.022343; Kunzel G, 2000, GENETICS, V154, P397; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Levi A, 2006, J AM SOC HORTIC SCI, V131, P393, DOI 10.21273/JASHS.131.3.393; Levi A, 2002, THEOR APPL GENET, V105, P555, DOI [10.1007/s00122-001-0860-6, 10.1007/S00122-001-0860-6]; Levi A, 2001, GENET RESOUR CROP EV, V48, P559, DOI 10.1023/A:1013888418442; Levi A, 2001, J AM SOC HORTIC SCI, V126, P730, DOI 10.21273/JASHS.126.6.730; Levi Amnon, 2009, Plant Genetic Resources Characterization and Utilization, V7, P16, DOI 10.1017/S1479262108014366; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NAVOT N, 1987, PLANT SYST EVOL, V156, P61, DOI 10.1007/BF00937202; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; UDOVICIC F, 1995, MOL PHYLOGENET EVOL, V4, P247, DOI 10.1006/mpev.1995.1023; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Yao H, 2002, P NATL ACAD SCI USA, V99, P6157, DOI 10.1073/pnas.082562199; Yi Ke, 2004, Acta Horticulturae Sinica, V31, P53; ZAMIR D, 1984, PLANT SYST EVOL, V146, P163, DOI 10.1007/BF00989543; Zhang RB, 2004, J AM SOC HORTIC SCI, V129, P237, DOI 10.21273/JASHS.129.2.0237	43	107	120	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29453	10.1371/journal.pone.0029453	http://dx.doi.org/10.1371/journal.pone.0029453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247776	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700024
J	Risch, D; Corkeron, PJ; Ellison, WT; Van Parijs, SM				Risch, Denise; Corkeron, Peter J.; Ellison, William T.; Van Parijs, Sofie M.			Changes in Humpback Whale Song Occurrence in Response to an Acoustic Source 200 km Away	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; BEHAVIORAL-RESPONSES; MARINE MAMMALS; NOISE; SOUND; ABUNDANCE	The effect of underwater anthropogenic sound on marine mammals is of increasing concern. Here we show that humpback whale (Megaptera novaeangliae) song in the Stellwagen Bank National Marine Sanctuary (SBNMS) was reduced, concurrent with transmissions of an Ocean Acoustic Waveguide Remote Sensing (OAWRS) experiment approximately 200 km away. We detected the OAWRS experiment in SBNMS during an 11 day period in autumn 2006. We compared the occurrence of song for 11 days before, during and after the experiment with song over the same 33 calendar days in two later years. Using a quasi-Poisson generalized linear model (GLM), we demonstrate a significant difference in the number of minutes with detected song between periods and years. The lack of humpback whale song during the OAWRS experiment was the most substantial signal in the data. Our findings demonstrate the greatest published distance over which anthropogenic sound has been shown to affect vocalizing baleen whales, and the first time that active acoustic fisheries technology has been shown to have this effect. The suitability of Ocean Acoustic Waveguide Remote Sensing technology for in-situ, long term monitoring of marine ecosystems should be considered, bearing in mind its possible effects on non-target species, in particular protected species.	[Risch, Denise] Integrated Stat, Woods Hole, MA USA; [Corkeron, Peter J.; Van Parijs, Sofie M.] NE Fisheries Sci Ctr, Woods Hole, MA USA; [Ellison, William T.] Marine Acoust Inc, Middletown, RI USA	National Oceanic Atmospheric Admin (NOAA) - USA	Risch, D (corresponding author), Integrated Stat, Woods Hole, MA USA.	denise.risch@noaa.gov	Corkeron, Peter/I-1170-2019; Risch, Denise/W-1070-2019	Corkeron, Peter/0000-0003-1553-1253; Risch, Denise/0000-0002-3719-7420	US National Oceanic and Atmospheric Administration's (NOAA); US NOAA Fisheries' Northeast Fisheries Science Center and Regional Office; National Oceanographic Partnership Program (NOPP) [N00014-07-1-1029]; N45 Energy and Environmental Readiness Division	US National Oceanic and Atmospheric Administration's (NOAA); US NOAA Fisheries' Northeast Fisheries Science Center and Regional Office(National Oceanic Atmospheric Admin (NOAA) - USA); National Oceanographic Partnership Program (NOPP); N45 Energy and Environmental Readiness Division	Funding for this work was received from the US National Oceanic and Atmospheric Administration's (NOAA), National Marine Sanctuary Programs and the US NOAA Fisheries' Northeast Fisheries Science Center and Regional Office. Additionally, the work was supported by grant number N00014-07-1-1029 from the National Oceanographic Partnership Program (NOPP) and the N45 Energy and Environmental Readiness Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BOWLES AE, 1994, J ACOUST SOC AM, V96, P2469, DOI 10.1121/1.410120; Cerchio S, 2010, INT WHAL COMM, pSC62/SH12; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Clark CW, 2006, INT WHAL COMM; Cornell Bioacoustic Research Program, 2011, MAR AC REC UN MARUS; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Figueroa H, 2011, XBAT EXENSIBLE BIOAC; Finneran JJ, 2000, J ACOUST SOC AM, V108, P417, DOI 10.1121/1.429475; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Frankel AS, 2000, J ACOUST SOC AM, V108, P1930, DOI 10.1121/1.1289668; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Gong Z, 2010, J ACOUST SOC AM, V128, P2328; Gong Z, 2010, J ACOUST SOC AM, V127, P104, DOI 10.1121/1.3268595; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jagannathan S, 2009, MAR ECOL PROG SER, V395, P137, DOI 10.3354/meps08266; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Morton AB, 2002, ICES J MAR SCI, V59, P71, DOI 10.1006/jmsc.2001.1136; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rendell LE, 1999, MAR MAMMAL SCI, V15, P198, DOI 10.1111/j.1748-7692.1999.tb00790.x; Sousa-Lima RS., 2008, CAN ACOUST, V36, P174, DOI DOI 10.1227/01.NEU.0000255476.06247.F1; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; Vu ET, AQUATIC BIO IN PRESS; [No title captured], DOI DOI 10.4031/002533203787536998	39	41	42	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29741	10.1371/journal.pone.0029741	http://dx.doi.org/10.1371/journal.pone.0029741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253769	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700044
J	Chong, KY; Capurro, A; Karout, S; Pearce, TC				Chong, Kwok Ying; Capurro, Alberto; Karout, Salah; Pearce, Timothy Charles			Stimulus and Network Dynamics Collide in a Ratiometric Model of the Antennal Lobe Macroglomerular Complex	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; TRANSIENT DYNAMICS; PROJECTION NEURONS; PHEROMONE BLENDS; MANDUCA-SEXTA; MOTH; DISCRIMINATION; RESPONSES; REPRESENTATIONS; INTERNEURONS	Time is considered to be an important encoding dimension in olfaction, as neural populations generate odour-specific spatiotemporal responses to constant stimuli. However, during pheromone mediated anemotactic search insects must discriminate specific ratios of blend components from rapidly time varying input. The dynamics intrinsic to olfactory processing and those of naturalistic stimuli can therefore potentially collide, thereby confounding ratiometric information. In this paper we use a computational model of the macroglomerular complex of the insect antennal lobe to study the impact on ratiometric information of this potential collision between network and stimulus dynamics. We show that the model exhibits two different dynamical regimes depending upon the connectivity pattern between inhibitory interneurons (that we refer to as fixed point attractor and limit cycle attractor), which both generate ratio-specific trajectories in the projection neuron output population that are reminiscent of temporal patterning and periodic hyperpolarisation observed in olfactory antennal lobe neurons. We compare the performance of the two corresponding population codes for reporting ratiometric blend information to higher centres of the insect brain. Our key finding is that whilst the dynamically rich limit cycle attractor spatiotemporal code is faster and more efficient in transmitting blend information under certain conditions it is also more prone to interference between network and stimulus dynamics, thus degrading ratiometric information under naturalistic input conditions. Our results suggest that rich intrinsically generated network dynamics can provide a powerful means of encoding multidimensional stimuli with high accuracy and efficiency, but only when isolated from stimulus dynamics. This interference between temporal dynamics of the stimulus and temporal patterns of neural activity constitutes a real challenge that must be successfully solved by the nervous system when faced with naturalistic input.	[Chong, Kwok Ying; Capurro, Alberto; Karout, Salah; Pearce, Timothy Charles] Univ Leicester, Dept Engn, Ctr Bioengn, Leicester LE1 7RH, Leics, England	University of Leicester	Chong, KY (corresponding author), MathWorks Ltd, Matrix House,Business Pk, Cambridge, England.	t.c.pearce@le.ac.uk			EU [FP6-032275]	EU(European Commission)	This work was supported by EU Framework VI FET Project iCHEM (FP6-032275). http://www2.warwick.ac.uk/fac/sci/eng/eed/research/ichem/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich VS, 2004, INT J BIFURCAT CHAOS, V14, P1195, DOI 10.1142/S0218127404009806; AKERS RP, 1988, J COMP PHYSIOL A, V163, P641, DOI 10.1007/BF00603848; AKERS RP, 1991, PHYSIOL ENTOMOL, V16, P1, DOI 10.1111/j.1365-3032.1991.tb00538.x; Av-Ron E, 1994, MODELING OLFACTORY N, P173; AVRON E, 1995, BIOSYSTEMS, V36, P101, DOI 10.1016/0303-2647(95)01531-O; AvRon E, 1996, BIOSYSTEMS, V39, P241, DOI 10.1016/0303-2647(96)01620-6; Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Balkovsky E, 2002, P NATL ACAD SCI USA, V99, P12589, DOI 10.1073/pnas.192393499; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Capurro A, 2011, COMPLEX BLEND UNPUB; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Carlsson MA, 2002, J INSECT PHYSIOL, V48, P443, DOI 10.1016/S0022-1910(02)00065-3; Chong KY, 2007, THESIS U LEICESTER; CHRISTENSEN TA, 1989, CHEM SENSES, V14, P463, DOI 10.1093/chemse/14.3.463; CHRISTENSEN TA, 1989, ARCH INSECT BIOCHEM, V10, P281, DOI 10.1002/arch.940100404; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hansson BS, FUNCTIONAL CHARACTER, P125; Harlieb E, OLFACTORY RELEASED B, P315; Heinbockel T, 2004, J COMP PHYSIOL A, V190, P1023, DOI 10.1007/s00359-004-0559-7; Heinbockel T, 1999, J COMP NEUROL, V409, P1; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Huerta R, 2004, PHYS REV LETT, V93, P1; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kaissling K.-E., 1990, Verhandlungen der Deutschen Zoologischen Gesellschaft, V83, P109; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Linster C, 1996, CHEM SENSES, V21, P19, DOI 10.1093/chemse/21.1.19; LINSTER C, 1993, NEURAL COMPUT, V5, P228, DOI 10.1162/neco.1993.5.2.228; Linster C, 1992, ADV NEURAL INFORM PR, V5, P239; Linster C, CM PHEROMONE DETECTI, P179; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Muezzinoglu MK, 2009, NEURAL COMPUT, V21, P1018, DOI 10.1162/neco.2008.05-08-780; Muezzinoglu MK, 2008, NIPS, P1121; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2000, J PHYSIOLOGY-PARIS, V94, P465, DOI 10.1016/S0928-4257(00)01092-5; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Shang Y, 2009, CELL, V128, P601; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sun XJ, 1997, J COMP NEUROL, V379, P2, DOI 10.1002/(SICI)1096-9861(19970303)379:1<2::AID-CNE2>3.0.CO;2-8; Valeur PG, 1996, ENTOMOL EXP APPL, V79, P51, DOI 10.1007/BF00333821; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wu WQ, 1996, P NATL ACAD SCI USA, V93, P8022, DOI 10.1073/pnas.93.15.8022; Zavada A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016308	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					107	117	e29602	10.1371/journal.pone.0029602	http://dx.doi.org/10.1371/journal.pone.0029602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253743	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900012
J	Jauvion, V; Rivard, M; Bouteiller, N; Elmayan, T; Vaucheret, H				Jauvion, Vincent; Rivard, Maud; Bouteiller, Nathalie; Elmayan, Taline; Vaucheret, Herve			RDR2 Partially Antagonizes the Production of RDR6-Dependent siRNA in Sense Transgene-Mediated PTGS	PLOS ONE			English	Article							TO-CELL MOVEMENT; DNA METHYLATION; SILENCING SIGNAL; RNA; ARABIDOPSIS; PLANTS; GENES; MECHANISMS; PROTEIN	Background: RNA-DEPENDENT RNA POLYMERASE6 (RDR6) and SUPPRESSOR of GENE SILENCING 3 (SGS3) are required for DNA methylation and post-transcriptional gene silencing (PTGS) mediated by 21-nt siRNAs produced by sense transgenes (S-PTGS). In contrast, RDR2, but not RDR6, is required for DNA methylation and TGS mediated by 24-nt siRNAs, and for cell-to-cell spreading of IR-PTGS mediated by 21-nt siRNAs produced by inverted repeat transgenes under the control of a phloem-specific promoter. Principal Findings: In this study, we examined the role of RDR2 and RDR6 in S-PTGS. Unlike RDR6, RDR2 is not required for DNA methylation of transgenes subjected to S-PTGS. RDR6 is essential for the production of siRNAs by transgenes subjected to S-PTGS, but RDR2 also contributes to the production of transgene siRNAs when RDR6 is present because rdr2 mutations reduce transgene siRNA accumulation. However, the siRNAs produced via RDR2 likely are counteractive in wildtype plants because impairement of RDR2 increases S-PTGS efficiency at a transgenic locus that triggers limited silencing, and accelerates S-PTGS at a transgenic locus that triggers efficient silencing. Conclusions/Significance: These results suggest that RDR2 and RDR6 compete for RNA substrates produced by transgenes subjected to S-PTGS. RDR2 partially antagonizes RDR6 because RDR2 action likely results in the production of counteractive siRNA. As a result, S-PTGS efficiency is increased in rdr2 mutants.	[Jauvion, Vincent; Rivard, Maud; Bouteiller, Nathalie; Elmayan, Taline; Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vaucheret, H (corresponding author), INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988	Region Ile-de-France; Agence Nationale de la Recherche [ANR-06-BLAN-0203, ANR-10-BLAN-1707-03]	Region Ile-de-France(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a PhD fellowship from the Region Ile-de-France (http://www.iledefrance.fr/?xtor=SEC-1000-GOO) to V.J. and grants from the Agence Nationale de la Recherche (ANR-06-BLAN-0203 and ANR-10-BLAN-1707-03; http://www.agence-nationale-recherche.fr/) to H. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Gasciolli V, 2005, CURR BIOL; Greenberg MVC, 2011, EPIGENETICS-US, V6, P344, DOI 10.4161/epi.6.3.14242; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Martinez de Alba AE, 2011, NUCL ACIDS RES; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Searle IR, 2010, GENE DEV, V24, P986, DOI 10.1101/gad.579910; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2010, NUCL ACIDS RES; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141	28	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29785	10.1371/journal.pone.0029785	http://dx.doi.org/10.1371/journal.pone.0029785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242179	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100035
J	Opoku-Acheampong, AB; Nelsen, MK; Unis, D; Lindshield, BL				Opoku-Acheampong, Alexander B.; Nelsen, Michelle K.; Unis, Dave; Lindshield, Brian L.			The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice	PLOS ONE			English	Article							STEROID 5-ALPHA-REDUCTASE; CELL-LINES; GENE-EXPRESSION; INHIBITORS; ENZYME; ANDROGENS; PREDICT	Background: 5 alpha-reductase 1 (5 alpha R1) and 5 alpha-reductase 2 (5 alpha R2) convert testosterone into the more potent androgen dihydrotestosterone. 5 alpha R2 is the main isoenzyme in normal prostate tissue; however, most prostate tumors have increased 5 alpha R1 and decreased 5 alpha R2 expression. Previously, finasteride (5 alpha R2 inhibitor) treatment begun 3 weeks post-tumor implantation had no effect on Dunning R3327-H rat prostate tumor growth. We believe the tumor compensated for finasteride treatment by increasing tumor 5 alpha R1 expression or activity. We hypothesize that finasteride treatment would not significantly alter tumor growth even if begun before tumor implantation, whereas dutasteride (5 alpha R1 and 5 alpha R2 inhibitor) treatment would decrease tumor growth regardless of whether treatment was initiated before or after tumor implantation. Methodology/Principal Findings: Sixty 8-week-old male nude mice were randomized to Control, Pre- and Post-Finasteride, and Pre- and Post-Dutasteride (83.3 mg drug/kg diet) diet groups. Pre- and post-groups began their treatment diets 1-2 weeks prior to or 3 weeks after subcutaneous injection of 1 x 10(5) WPE1-NA22 human prostate cancer cells, respectively. Tumors were allowed to grow for 22 weeks; tumor areas, body weights, and food intakes were measured weekly. At study's conclusion, prostate and seminal vesicle weights were significantly decreased in all treatment groups versus the control; dutasteride intake significantly decreased seminal vesicle weights compared to finasteride intake. No differences were measured in final tumor areas or tumor weights between groups, likely due to poor tumor growth. In follow-up studies, proliferation of WPE1-NA22 prostate cancer cells and parent line RWPE-1 prostate epithelial cells were unaltered by treatment with testosterone, dihydrotestosterone, or mibolerone, suggesting that these cell lines are not androgen-sensitive. Conclusion: The lack of response of WPE1-NA22 prostate cancer cells to androgen treatment may explain the inadequate tumor growth observed. Additional studies are needed to determine whether finasteride and dutasteride are effective in decreasing prostate cancer development/growth.	[Opoku-Acheampong, Alexander B.; Nelsen, Michelle K.; Unis, Dave; Lindshield, Brian L.] Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA	Kansas State University	Lindshield, BL (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	blindsh@k-state.edu		Opoku-Acheampong, Alexander/0000-0002-4589-3776	National Institute for Health (NIH) [P20 RR017686]; Institutional Development Award Program of the National Center for Research Resources; Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER	National Institute for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award Program of the National Center for Research Resources; Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by National Institute for Health (NIH) Grant Number P20 RR017686, the Institutional Development Award Program of the National Center for Research Resources, and by the Johnson Center for Basic Cancer Research at Kansas State University (http://cancer.ksu.edu/). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Center of Biomedical Research Excellence for Epithelial Function in Health and Disease or NIH. This is contribution no. 12-033-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG 2011; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Das K, 2010, ENDOCR-RELAT CANCER, V17, P757, DOI 10.1677/ERC-10-0022; FDA Drug Safety Communication, 5 ALPH RED INH 5 ARI; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; GELLER J, 1991, J ANDROL, V12, P364; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Iehle C, 1999, J STEROID BIOCHEM, V68, P189, DOI 10.1016/S0960-0760(99)00030-8; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Klus GT, 1996, CANCER RES, V56, P4956; Lazier CB, 2004, PROSTATE, V58, P130, DOI 10.1002/pros.10340; Lindshield BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010423; Long BJ, 2000, CANCER RES, V60, P6630; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Nickel J Curtis, 2004, Rev Urol, V6 Suppl 9, pS31; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; SHAO TC, 1993, J ANDROL, V14, P79; Soderstrom TG, 2001, J CLIN ENDOCR METAB, V86, P855, DOI 10.1210/jc.86.2.855; Song Y, 2008, PROSTATE, V68, P281, DOI 10.1002/pros.20637; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Webber MM, 2001, PROSTATE, V47, P1; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29068	10.1371/journal.pone.0029068	http://dx.doi.org/10.1371/journal.pone.0029068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242155	Green Submitted, Green Published, gold			2022-12-25	WOS:000312662100009
J	Hansen, L; Kim, NK; Marino-Ramirez, L; Landsman, D				Hansen, Loren; Kim, Nak-Kyeong; Marino-Ramirez, Leonardo; Landsman, David			Analysis of Biological Features Associated with Meiotic Recombination Hot and Cold Spots in Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GENE-EXPRESSION DATA; CHROMATIN-STRUCTURE; FEATURE-SELECTION; INITIATION SITES; FISSION YEAST; DNA BREAKS; NUCLEOSOME ORGANIZATION; SAMPLE CLASSIFICATION; HISTONE MODIFICATIONS	Meiotic recombination is not distributed uniformly throughout the genome. There are regions of high and low recombination rates called hot and cold spots, respectively. The recombination rate parallels the frequency of DNA double-strand breaks (DSBs) that initiate meiotic recombination. The aim is to identify biological features associated with DSB frequency. We constructed vectors representing various chromatin and sequence-based features for 1179 DSB hot spots and 1028 DSB cold spots. Using a feature selection approach, we have identified five features that distinguish hot from cold spots in Saccharomyces cerevisiae with high accuracy, namely the histone marks H3K4me3, H3K14ac, H3K36me3, and H3K79me3; and GC content. Previous studies have associated H3K4me3, H3K36me3, and GC content with areas of mitotic recombination. H3K14ac and H3K79me3 are novel predictions and thus represent good candidates for further experimental study. We also show nucleosome occupancy maps produced using next generation sequencing exhibit a bias at DSB hot spots and this bias is strong enough to obscure biologically relevant information. A computational approach using feature selection can productively be used to identify promising biological associations. H3K14ac and H3K79me3 are novel predictions of chromatin marks associated with meiotic DSBs. Next generation sequencing can exhibit a bias that is strong enough to lead to incorrect conclusions. Care must be taken when interpreting high throughput sequencing data where systematic biases have been documented.	[Hansen, Loren; Marino-Ramirez, Leonardo; Landsman, David] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Hansen, Loren] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kim, Nak-Kyeong] Old Dominion Univ, Dept Math & Stat, Norfolk, VA 23529 USA; [Marino-Ramirez, Leonardo] PanAmerican Bioinformat Inst, Santa Marta, Magdalena, Colombia	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Boston University; Old Dominion University	Marino-Ramirez, L (corresponding author), NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	marino@ncbi.nlm.nih.gov	Mariño-Ramírez, Leonardo/I-5759-2013; Landsman, David/GZK-5496-2022; Landsman, David/C-5923-2009; Mariño-Ramírez, Leonardo/N-5395-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Landsman, David/0000-0002-9819-6675; Mariño-Ramírez, Leonardo/0000-0002-5716-8512	National Institutes of Health; National Library of Medicine; National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE [ZIALM000084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine and National Center for Biotechnology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1989, GENETIC ALGORITHMS S; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung MS, 2011, NUCL ACIDS RES; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Gat-Viks I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000282; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Hansen L, 2009, COMB CHEM HIGH T SCR, V12, P514, DOI 10.2174/138620709788488984; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW47, DOI 10.1093/nar/gkm217; Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kniewel R, 2009, EMBO J, V28, P81, DOI 10.1038/emboj.2008.277; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Li LP, 2001, COMB CHEM HIGH T SCR, V4, P727; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Locke G, 2010, P NATL ACAD SCI USA, V107, P20998, DOI 10.1073/pnas.1003838107; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Mizuno K, 1997, GENE DEV, V11, P876, DOI 10.1101/gad.11.7.876; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Ooi CH, 2003, BIOINFORMATICS, V19, P37, DOI 10.1093/bioinformatics/19.1.37; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sha NJ, 2004, BIOMETRICS, V60, P812, DOI 10.1111/j.0006-341X.2004.00233.x; Shin H, 2008, J BIOMED INFORM, V41, P124, DOI 10.1016/j.jbi.2007.04.003; SMAGULOVA F, 2011, NATURE; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xiong MM, 2001, GENOME RES, V11, P1878, DOI 10.1101/gr.190001; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhou T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-223	79	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29711	10.1371/journal.pone.0029711	http://dx.doi.org/10.1371/journal.pone.0029711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242140	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000057
J	Okubo, J; Takita, J; Chen, Y; Oki, K; Nishimura, R; Kato, M; Sanada, M; Hiwatari, M; Hayashi, Y; Igarashi, T; Ogawa, S				Okubo, J.; Takita, J.; Chen, Y.; Oki, K.; Nishimura, R.; Kato, M.; Sanada, M.; Hiwatari, M.; Hayashi, Y.; Igarashi, T.; Ogawa, S.			Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma	ONCOGENE			English	Article						neuroblastoma; ALK; truncated form ALK; amplification	RECEPTOR TYROSINE KINASE; ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL-GROWTH-FACTOR; EXPRESSION; GENE; IDENTIFICATION; MUTATIONS; CHEMOTHERAPY; DIAGNOSIS; VARIANTS	Anaplastic lymphoma kinase (ALK) was originally identified from a rare subtype of non-Hodgkin's lymphomas carrying t(2;5)(p23;q35) translocation, where ALK was constitutively activated as a result of a fusion with nucleophosmin (NPM). Aberrant ALK fusion proteins were also generated in inflammatory fibrosarcoma and a subset of non-small-cell lung cancers, and these proteins are implicated in their pathogenesis. Recently, ALK has been demonstrated to be constitutively activated by gene mutations and/or amplifications in sporadic as well as familial cases of neuroblastoma. Here we describe another mechanism of aberrant ALK activation observed in a neuroblastoma-derived cell line (NB-1), in which a short-form ALK protein (ALK(del2-3)) having a truncated extracellular domain is overexpressed because of amplification of an abnormal ALK gene that lacks exons 2 and 3. ALK(del2-3) was autophosphorylated in NB-1 cells as well as in ALK(del2-3)-transduced cells and exhibited enhanced in vitro kinase activity compared with the wild-type kinase. ALK(del2-3)-transduced NIH3T3 cells exhibited increased colony-forming capacity in soft agar and tumorigenicity in nude mice. RNAi-mediated ALK knockdown resulted in the growth suppression of ALK(del2-3)-expressing cells, arguing for the oncogenic role of this mutant. Our findings provide a novel insight into the mechanism of deregulation of the ALK kinase and its roles in neuroblastoma pathogenesis.	[Takita, J.] Univ Tokyo, Grad Sch Med, Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Okubo, J.; Takita, J.; Chen, Y.; Oki, K.; Nishimura, R.; Kato, M.; Hiwatari, M.; Igarashi, T.] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Sanada, M.; Ogawa, S.] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo 1138655, Japan; [Hayashi, Y.] Gunma Childrens Med Ctr, Maebashi, Gunma, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Gunma Children's Medical Centre	Takita, J (corresponding author), Univ Tokyo, Grad Sch Med, Cell Therapy & Transplantat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	jtakita-tky@umin.ac.jp	Chen, Yuyan/V-7279-2019; HIWATARI, Mitsuteru/HDM-0869-2022; Nishimura, Riki/K-1672-2019; Ogawa, Seishi/AAE-7088-2019	Chen, Yuyan/0000-0002-2894-1430; Kato, Motohiro/0000-0001-5145-1774; Hiwatari, Mitsuteru/0000-0003-3683-4472	Research on Measures for Intractable Diseases, Health and Labor Sciences Research Grants; Ministry of Health, Labor and Welfare, Research on Health Sciences focusing on Drug Innovation; Japan Health Sciences Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22591171, 22659196] Funding Source: KAKEN	Research on Measures for Intractable Diseases, Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labor and Welfare, Research on Health Sciences focusing on Drug Innovation; Japan Health Sciences Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Mrs Matsumura, Mrs Hoshino, Mrs Yin, Miss Ogino and Mrs Saito for their excellent technical assistance. We would also thank Dr Tanaka, Dr Saito, Mr Shiosaka and Mrs Mori for useful advice concerning biological analysis; Dr AT Look, Harvard Medical University, and Dr A Inoue, St Jude Children's Research Hospital, for their generous gifts of neuroblastoma cell lines. This work was supported by Research on Measures for Intractable Diseases, Health and Labor Sciences Research Grants, Ministry of Health, Labor and Welfare, Research on Health Sciences focusing on Drug Innovation, the Japan Health Sciences Foundation and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency.	BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; De Bernardi B, 2003, J CLIN ONCOL, V21, P1592, DOI 10.1200/JCO.2003.05.191; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Griffin CA, 1999, CANCER RES, V59, P2776; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Lu Y, 2007, CANCER LETT, V257, P157, DOI 10.1016/j.canlet.2007.08.007; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Pearson ADJ, 2008, LANCET ONCOL, V9, P247, DOI 10.1016/S1470-2045(08)70069-X; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Prigent SA, 1996, J BIOL CHEM, V271, P25639, DOI 10.1074/jbc.271.41.25639; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; RONSIN C, 1993, ONCOGENE, V8, P1195; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Smith JL, 2011, AM J PHYSIOL-CELL PH, V301, pC75, DOI 10.1152/ajpcell.00494.2010; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takita J, 1998, ONCOGENE, V17, P3137, DOI 10.1038/sj.onc.1202232; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Wang MH, 2000, CARCINOGENESIS, V21, P1507, DOI 10.1093/carcin/21.8.1507; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	37	34	35	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	44					4667	4676		10.1038/onc.2011.616	http://dx.doi.org/10.1038/onc.2011.616			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22249260				2022-12-25	WOS:000310724400002
J	Sahraei, M; Roy, LD; Curry, JM; Teresa, TL; Nath, S; Besmer, D; Kidiyoor, A; Dalia, R; Gendler, SJ; Mukherjee, P				Sahraei, M.; Roy, L. D.; Curry, J. M.; Teresa, T. L.; Nath, S.; Besmer, D.; Kidiyoor, A.; Dalia, R.; Gendler, S. J.; Mukherjee, P.			MUC1 regulates PDGFA expression during pancreatic cancer progression	ONCOGENE			English	Article						pancreatic cancer; MUC1; PDGFA; beta-catenin	GROWTH-FACTOR RECEPTOR; CELL-SURFACE; SIGNAL-TRANSDUCTION; TUMOR PROGRESSION; CYTOPLASMIC TAIL; RANDOMIZED-TRIAL; MOUSE MODEL; MUCINS; ADENOCARCINOMA; CARCINOMA	Pancreatic ductal adenocarcinoma (PDA) has one of the worst prognoses of all cancers. Mucin 1 (MUC1), a transmembrane mucin glycoprotein, is a key modulator of several signaling pathways that affect oncogenesis, motility and metastasis. Its expression is known to be associated with poor prognosis in patients. However, the precise mechanism remains elusive. We report a novel association of MUC1 with platelet-derived growth factor-A (PDGFA). PDGFA is one of the many drivers of tumor growth, angiogenesis and metastasis in PDA. Using mouse PDA models as well as human samples, we show clear evidence that MUC1 regulates the expression and secretion of PDGFA. This, in turn, influences proliferation and invasion of pancreatic cancer cells leading to higher tumor burden in vivo. In addition, we reveal that MUC1 overexpressing cells are heavily dependent on PDGFA both for proliferation and invasion, whereas MUC1-null cells are not. Moreover, PDGFA and MUC1 are critical for translocation of beta catenin to the nucleus for oncogenesis to ensue. Finally, we elucidate the underlying mechanism by which MUC1 regulates PDGFA expression and secretion in pancreatic cancer cells. We show that MUC1 associates with Hif1-alpha, a known transcription factor involved in controlling PDGFA expression. Furthermore, MUC1 facilitates Hif1-alpha translocation to the nucleus. In summary, we have demonstrated that MUC1-induced invasion and proliferation occurs via increased exogenous production of PDGFA. Thus, impeding MUC1 regulation of PDGFA signaling may be therapeutically beneficial for patients with PDA.	[Sahraei, M.; Roy, L. D.; Curry, J. M.; Teresa, T. L.; Nath, S.; Besmer, D.; Kidiyoor, A.; Dalia, R.; Mukherjee, P.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Gendler, S. J.] Mayo Clin, Ctr Canc, Dept Biochem & Mol Biol, Scottsdale, AZ USA	University of North Carolina; University of North Carolina Charlotte; Mayo Clinic; Mayo Clinic Phoenix	Mukherjee, P (corresponding author), Univ N Carolina, Dept Biol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	pmukherj@uncc.edu	Nath, Sritama/J-7725-2019		NIH;  [RO1 CA118944];  [P50CA102701]; NATIONAL CANCER INSTITUTE [R01CA118944, P50CA102701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Mukherjee's and Gendler's work has been funded by the NIH. The remaining authors declare no conflict of interest.; We acknowledge the Mayo Clinic Histology Core and the UNC-Charlotte vivarium staff for maintaining our mouse colonies. This study is supported by RO1 CA118944 and P50CA102701.	Adsay NV, 2005, SEMIN RADIAT ONCOL, V15, P254, DOI 10.1016/j.semradonc.2005.04.001; Adsay NV, 2002, MODERN PATHOL, V15, P1087, DOI 10.1097/01.MP.0000028647.98725.8B; Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Al-Batran SE, 2007, CANCER, V109, P1897, DOI 10.1002/cncr.22622; Appelmann I, 2010, RECENT RESULTS CANC, V180, P51, DOI 10.1007/978-3-540-78281-0_5; Baldus SE, 1998, CANCER, V82, P1019, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1019::AID-CNCR3>3.0.CO;2-9; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chhieng DC, 2003, CANCER CYTOPATHOL, V99, P365, DOI 10.1002/cncr.11857; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fujimoto K, 1998, EUR J CANCER, V34, P1439, DOI 10.1016/S0959-8049(98)00069-0; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hwang RF, 2003, CLIN CANCER RES, V9, P6534; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LAN MS, 1990, CANCER RES, V50, P2997; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Mantur Maria, 2008, Pol Merkur Lekarski, V24, P173; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Society AC, 2010, AM CANC SOC CANC FAC; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Szajda SD, 2011, BIOCHEM SOC T, V39, P340, DOI 10.1042/BST0390340; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4	44	53	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	47					4935	4945		10.1038/onc.2011.651	http://dx.doi.org/10.1038/onc.2011.651			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22266848	Green Accepted			2022-12-25	WOS:000311430200005
J	Lee, DW; Futami, M; Carroll, M; Feng, Y; Wang, Z; Fernandez, M; Whichard, Z; Chen, Y; Kornblau, S; Shpall, EJ; Bueso-Ramos, CE; Corey, SJ				Lee, D. W.; Futami, M.; Carroll, M.; Feng, Y.; Wang, Z.; Fernandez, M.; Whichard, Z.; Chen, Y.; Kornblau, S.; Shpall, E. J.; Bueso-Ramos, C. E.; Corey, S. J.			Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155	ONCOGENE			English	Article						SHIP-1; Akt; leukemia	CELL-SURVIVAL; BONE-MARROW; PTEN; GENE; TEC; HEMATOPOIESIS; PHOSPHATASES; PATHOGENESIS; AKT/PKB; TARGETS	The myelodysplastic syndromes (MDSs) comprise a group of disorders characterized by multistage progression from cytopenias to acute myeloid leukemia (AML). They display exaggerated apoptosis in early stages, but lose this behavior during evolution to AML. The molecular basis for loss of apoptosis is unknown. To investigate this critical event, we analyzed phosphatidylinositol (PI) 3'kinase signaling, implicated as a critical pathway of cell survival control in epithelial and hematological malignancies. PI 3'kinase activates Akt through its production of 3' phosphoinositides. In turn, the phosphoinositides are dephosphorylated by two lipid phosphatases, PTEN and SHIP-1, in myeloid cells. We studied primary MDS-enriched bone marrow cells and bone marrow sections by western blotting, immunohistochemistry, immunocytochemistry and quantitative PCR for components of the SHIP/PTEN/PI 3'kinase signaling circuit. We reported constitutively activated Akt, variable levels of PTEN and uniformly decreased SHIP-1 expression in MDS progenitor cells. Overexpression of SHIP-1, but not the phosphatase-deficient form, inhibited myeloid leukemic growth. Levels of microRNA (miR)-210 and miR-155 transcripts, which target SHIP-1, were increased in CD34(+) MDS cells compared with their normal counterparts. Direct binding of miR-210 to the 3' untranslated region of SHIP-1 was confirmed by luciferase reporter assay. Transfection of a myeloid cell line with miR-210 resulted in loss of SHIP-1 protein expression. These data suggest that miR-155 and miR-210/SHIP-1/Akt pathways could serve as clinical biomarkers for disease progression, and that miR-155 and miR-210 might serve as novel therapeutic targets in MDS. Oncogene (2012) 31, 4085-4094; doi:10.1038/onc.2011.579; published online 16 January 2012	[Futami, M.; Feng, Y.; Wang, Z.; Whichard, Z.; Chen, Y.; Corey, S. J.] Northeastern Univ, Feinberg Sch Med, Div Pediat, Chicago, IL 60611 USA; [Futami, M.; Feng, Y.; Wang, Z.; Whichard, Z.; Chen, Y.; Corey, S. J.] Northeastern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Carroll, M.] Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Fernandez, M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Kornblau, S.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Shpall, E. J.] Univ Texas MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; [Lee, D. W.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Corey, SJ (corresponding author), Northeastern Univ, Dept Pediat, Childrens Mem Hosp & Robert H Lurie Comprehens Ca, Lurie 5-107,303 E Super St, Chicago, IL 60611 USA.	s-corey@northwestern.edu			NIH [KO2-HL03794, RO1-CA108992, PO1CA55164]; American Cancer Society [DHP-135]; Ladies Leukemia League; JP McCarthy Foundation; Leukemia SPORE [CA100632]; AA/MDS International Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA108992, P01CA055164, P50CA100632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL003794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ladies Leukemia League; JP McCarthy Foundation; Leukemia SPORE; AA/MDS International Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Martin H Nguyen for technical assistance. We thank Drs Gerald Krystal for providing the cDNA for SHIP-1 and Maria-Magdalena Georgescu for control lysates. SJC was funded by the NIH Independent Scientist Award KO2-HL03794, RO1-CA108992, American Cancer Society Research Scholar Grant DHP-135, Ladies Leukemia League, JP McCarthy Foundation, NIH PO1CA55164 and Leukemia SPORE CA100632. Funding also came from the AA/MDS International Foundation to both SJC and MF.	Aul C, 1998, LEUKEMIA RES, V22, P93, DOI 10.1016/S0145-2126(97)00089-1; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Fenaux P, 2004, SEMIN HEMATOL, V41, P6, DOI 10.1053/j.seminhematol.2004.02.002; Follo MY, 2007, CANCER RES, V67, P4287, DOI 10.1158/0008-5472.CAN-06-4409; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; Gilby DC, 2007, LEUKEMIA, V21, P2390, DOI 10.1038/sj.leu.2404864; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Greenberg PL, 1998, LEUKEMIA RES, V22, P1123, DOI 10.1016/S0145-2126(98)00112-X; Hazen AL, 2009, BLOOD, V113, P2924, DOI 10.1182/blood-2008-02-138008; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kalesnikoff J, 2004, REV PHYSIOL BIOCH P, V149, P87, DOI 10.1007/s10254-003-0016-y; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lakhanpal GK, 2010, BLOOD, V116, P428, DOI 10.1182/blood-2009-10-250217; Luo Jian-Min, 2004, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V12, P420; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuda M, 2004, LEUKEMIA, V18, P1038, DOI 10.1038/sj.leu.2403301; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Moody JL, 2004, BLOOD, V103, P4503, DOI 10.1182/blood-2003-09-3262; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nyakern M, 2006, LEUKEMIA, V20, P230, DOI 10.1038/sj.leu.2404057; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; Robertson GP, 1998, P NATL ACAD SCI USA, V95, P9418, DOI 10.1073/pnas.95.16.9418; Rosenfeld C, 2000, LEUKEMIA, V14, P2, DOI 10.1038/sj.leu.2401618; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ruschmann J, 2010, EXP HEMATOL, V38, P392, DOI 10.1016/j.exphem.2010.03.010; SATO K, 1994, LEUKEMIA, V8, P1663; Sattler M, 1999, MOL CELL BIOL, V19, P7473; Thompson JE, 2007, EXP HEMATOL, V35, P21, DOI 10.1016/j.exphem.2006.08.017; Tomlinson MG, 2004, J BIOL CHEM, V279, P55089, DOI 10.1074/jbc.M408141200; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Ware MD, 1996, BLOOD, V88, P2833, DOI 10.1182/blood.V88.8.2833.bloodjournal8882833; Whichard ZL, 2011, J BIOL CHEM, V286, P4742, DOI 10.1074/jbc.M110.166348; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	45	49	55	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	37					4085	4094		10.1038/onc.2011.579	http://dx.doi.org/10.1038/onc.2011.579			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22249254				2022-12-25	WOS:000308688900001
J	Mori, Y; Yamaguchi, M; Terao, Y; Hamada, S; Ooshima, T; Kawabata, S				Mori, Yuka; Yamaguchi, Masaya; Terao, Yutaka; Hamada, Shigeyuki; Ooshima, Takashi; Kawabata, Shigetada			alpha-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; SURFACE; PLASMINOGEN; DNA; TRANSMIGRATION; DEGRADATION; RECRUITMENT; PYOGENES; IMMUNITY; CELLS	Streptococcus pneumoniae is the most common causative agent of community-acquired pneumonia throughout the world, with high morbidity and mortality rates. A major feature of pneumococcal pneumonia is abundant neutrophil infiltration. In this study, we identified S. pneumoniae alpha-enolase as a neutrophil binding protein in ligand blot assay and mass spectrometry findings. Scanning electron microscopic and fluorescence microscopic analyses also revealed that S. pneumoniae alpha-enolase induces formation of neutrophil extracellular traps, which have been reported to bind and kill microbes. In addition, cytotoxic assay results showed that alpha-enolase dose-dependently increased the release of extracellular lactate dehydrogenase from human neutrophils as compared with untreated neutrophils. Furthermore, an in vitro cell migration assay using Chemotaxicell culture chambers demonstrated that alpha-enolase possesses neutrophil migrating activity. Interestingly, bactericidal assay findings showed that alpha-enolase increased neutrophil extracellular trap-dependent killing of S. pneumoniae in human blood. Moreover, pulldown assay and mass spectrometry results identified myoblast antigen 24.1D5 as an alpha-enolase-binding protein on human neutrophils, whereas flow cytometric analysis revealed that 24.1D5 was expressed on human neutrophils, but not on human monocytes or T cells. Together, our results indicate that alpha-enolase from S. pneumoniae increases neutrophil migrating activity and induces cell death of human neutrophils by releasing neutrophil extracellular traps. Furthermore, we found that myoblast antigen 24.1D5, which expressed on the surface of neutrophils, bound to alpha-enolase of S. pneumoniae.	[Mori, Yuka; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Mori, Yuka; Ooshima, Takashi] Osaka Univ, Dept Pediat Dent, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Yamaguchi, Masaya] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect 6, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; Osaka University; Ministry of Public Health - Thailand	Terao, Y (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	terao@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23593027, 10J01281, 23592700] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as grants-in-aid for scientific research (B), Young Scientists (A), Challenging Exploratory Research, and Research Activity Start-up from the Japan Society for the Promotion of Science, a fellowship from the Japan Society for the Promotion of Science, and a grant from the Takeda Science Foundation.	Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Momose H, 2003, J IMMUNOL, V171, P4227, DOI 10.4049/jimmunol.171.8.4227; Moraes TJ, 2006, CURR OPIN HEMATOL, V13, P21, DOI 10.1097/01.moh.0000190113.31027.d5; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yamaguchi M, 2009, BIOCHEM BIOPH RES CO, V390, P155, DOI 10.1016/j.bbrc.2009.09.099; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	35	82	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10472	10481		10.1074/jbc.M111.280321	http://dx.doi.org/10.1074/jbc.M111.280321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262863	hybrid, Green Published			2022-12-25	WOS:000302167200074
J	Gu, S; Kelly, G; Wang, XH; Frenkiel, T; Shevchik, VE; Pickersgill, RW				Gu, Shuang; Kelly, Geoff; Wang, Xiaohui; Frenkiel, Tom; Shevchik, Vladimir E.; Pickersgill, Richard W.			Solution Structure of Homology Region (HR) Domain of Type II Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI; PROTEIN SECRETION; NEISSERIA-MENINGITIDIS; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; CHEMICAL-SHIFTS; VIBRIO-CHOLERAE; OUTC; PATHWAY; COMPLEX	The type II secretion system of Gram-negative bacteria is important for bacterial pathogenesis and survival; it is composed of 12 mostly multimeric core proteins, which build a sophisticated secretion machine spanning both bacterial membranes. OutC is the core component of the inner membrane subcomplex thought to be involved in both recognition of substrate and interaction with the outer membrane secretin OutD. Here, we report the solution structure of the HR domain of OutC and explore its interaction with the secretin. The HR domain adopts a beta-sandwich-like fold consisting of two beta-sheets each composed of three anti-parallel beta-strands. This structure is strikingly similar to the periplasmic region of PilP, an inner membrane lipoprotein from the type IV pilus system highlighting the common evolutionary origin of these two systems and showing that all the core components of the type II secretion system have a structural or sequence ortholog within the type IV pili system. The HR domain is shown to interact with the N0 domain of the secretin. The importance of this interaction is explored in the context of the functional secretion system.	[Wang, Xiaohui; Shevchik, Vladimir E.] Univ Lyon, F-69003 Lyon, France; [Wang, Xiaohui; Shevchik, Vladimir E.] Univ Lyon 1, F-69622 Villeurbanne, France; [Wang, Xiaohui; Shevchik, Vladimir E.] INSA, F-69621 Villeurbanne, France; [Wang, Xiaohui; Shevchik, Vladimir E.] CNRS, UMR5240, F-69622 Villeurbanne, France; [Gu, Shuang; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Kelly, Geoff; Frenkiel, Tom] Natl Inst Med Res, MRC Biomed NMR Ctr, London NW7 1AA, England	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of London; Queen Mary University London; MRC National Institute for Medical Research	Shevchik, VE (corresponding author), Univ Lyon, F-69003 Lyon, France.	vladimir.shevchik@insa-lyon.fr; r.w.pickersgill@qmul.ac.uk		Shevchik, Vladimir/0000-0002-8031-8638	Biology and Biotechnology Sciences Research Council (U.K); Higher Education Funding Council for England; Queen Mary University of London; French SecPath program [ANR-2010-BLANC-1531]; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish	Biology and Biotechnology Sciences Research Council (U.K); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Queen Mary University of London; French SecPath program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biology and Biotechnology Sciences Research Council (U.K), Higher Education Funding Council for England, and Queen Mary University of London.; Supported by a grant from French ANR-2010-BLANC-1531 SecPath program. To whom correspondence may be addressed: Universite de Lyon, F-69003, Universite Lyon 1, Lyon, F-69622, INSA-Lyon, Villeurbanne F-69621, CNRS, UMR5240, Microbiologie Adaptation et Pathogenie, Lyon F-69622, France. Tel.: 04-72-44-58-27; Fax: 04-72-43-15-84; E-mail: vladimir.shevchik@insa-lyon.fr.	Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Golovanov AP, 2006, J MOL BIOL, V364, P186, DOI 10.1016/j.jmb.2006.08.078; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603	33	19	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9072	9080		10.1074/jbc.M111.300624	http://dx.doi.org/10.1074/jbc.M111.300624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22253442	Green Published, hybrid			2022-12-25	WOS:000301797800037
J	Mallik, L; Arif, E; Sharma, P; Rathore, YS; Wong, HN; Holzman, LB; Ashish; Nihalani, D				Mallik, Leena; Arif, Ehtesham; Sharma, Pankaj; Rathore, Yogendra S.; Wong, Hetty N.; Holzman, Lawrence B.; Ashish; Nihalani, Deepak			Solution Structure Analysis of Cytoplasmic Domain of Podocyte Protein Neph1 Using Small/Wide Angle X-ray Scattering (SWAXS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIT DIAPHRAGM; ACTIN POLYMERIZATION; PDZ DOMAIN; KINASE; DISSOCIATION; ACTIVATION; MEMBRANE; BINDING; ZO-1	Neph1 is present in podocytes, where it plays a critical role in maintaining the filtration function of the glomerulus, in part through signaling events mediated by its cytoplasmic domain that are involved in actin cytoskeleton organization. To understand the function of this protein, a detailed knowledge of the structure of the Neph1 cytoplasmic domain (Neph1-CD) is required. In this study, the solution structure of this domain was determined by small/wide angle x-ray scattering (SWAXS). Analysis of Neph1-CD by SWAXS suggested that this protein adopts a global shape with a radius of gyration and a maximum linear dimension of 21.3 and 70 angstrom, respectively. These parameters and the data from circular dichroism experiments were used to construct a structural model of this protein. The His-ZO- 1-PDZ1 (first PDZ domain of zonula occludens) domain that binds Neph1-CD was also analyzed by SWAXS, to confirm that it adopts a global structure similar to its crystal structure. We used the SWAXS intensity profile, the structural model of Neph1-CD, and the crystal structure of ZO-1-PDZ1 to construct a structural model of the Neph1-CD.ZO-1-PDZ1 complex. Mapping of the intermolecular interactions suggested that in addition to the C-terminal residues Thr-His-Val, residues Lys-761 and Tyr-762 in Neph1 are also critical for stabilizing the complex. Estimated intensity values from the SWAXS data and in vivo and in vitro pull-down experiments demonstrated loss of binding to ZO-1 when these residues were individually mutated to alanines. Our findings present a structural model that provides novel insights into the molecular structure and function of Neph1-CD.	[Mallik, Leena; Sharma, Pankaj; Rathore, Yogendra S.; Ashish] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Arif, Ehtesham; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Ashish (corresponding author), CSIR Inst Microbial Technol, Chandigarh 160036, India.	ashgang@imtech.res.in; deepakn@mail.med.upenn.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020; Mallik, Leena/AAM-4619-2020	Arif, Ehtesham/0000-0001-9638-3189; Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health, NIDDK [K01 DK072047-03, 5K01DK072047-04, RO1 1R01DK087956, DK080751]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; CSIR; UGC INDIA; CSIR-INDIA [SIP-10, FAC-03]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, K01DK072047, R01DK080751] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC INDIA(University Grants Commission, India); CSIR-INDIA(Council of Scientific & Industrial Research (CSIR) - India); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants K01 DK072047-03, 5K01DK072047-04, and RO1 1R01DK087956 (to D. N.) and National Institutes of Health, NIDDK, Grant DK080751 (to L. B. H.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.; Recipient of research fellowships from CSIR and UGC INDIA.; Work at the laboratory of A. and travel of A. and Y. S. R. from India to Brookhaven National Laboratory was provided by CSIR-INDIA Grants SIP-10 and FAC-03.; Supported in part by the Department of Veterans Affairs.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Moreno JA, 2008, CURR MED CHEM, V15, P1645, DOI 10.2174/092986708784911542; Nihalani D, 2007, MOL CELL BIOL, V27, P2431, DOI 10.1128/MCB.01479-06; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200	25	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9441	9453		10.1074/jbc.M111.284927	http://dx.doi.org/10.1074/jbc.M111.284927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262837	Green Published, hybrid			2022-12-25	WOS:000301797800073
J	Zurita-Lopez, CI; Sandberg, T; Kelly, R; Clarke, SG				Zurita-Lopez, Cecilia I.; Sandberg, Troy; Kelly, Ryan; Clarke, Steven G.			Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming omega-N-G-Monomethylated Arginine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; SM PROTEINS; HISTONE H3; SYMMETRIC DIMETHYLARGININE; SUBCELLULAR-LOCALIZATION; IN-VITRO; METHYLATION; BINDING; FAMILY; MEMBER	Full-length human protein arginine methyltransferase 7 (PRMT7) expressed as a fusion protein in Escherichia coli was initially found to generate only omega-N-G-monomethylated arginine residues in small peptides, suggesting that it is a type III enzyme. A later study, however, characterized fusion proteins of PRMT7 expressed in bacterial and mammalian cells as a type II/type I enzyme, capable of producing symmetrically dimethylated arginine (type II activity) as well as small amounts of asymmetric dimethylarginine (type I activity). We have sought to clarify the enzymatic activity of human PRMT7. We analyzed the in vitro methylation products of a glutathione S-transferase (GST)-PRMT7 fusion protein with robust activity using a variety of arginine-containing synthetic peptides and protein substrates, including a GST fusion with the N-terminal domain of fibrillarin (GST-GAR), myelin basic protein, and recombinant human histones H2A, H2B, H3, and H4. Regardless of the methylation reaction conditions (incubation time, reaction volume, and substrate concentration), we found that PRMT7 only produces omega-N-G-monomethylarginine with these substrates. In control experiments, we showed that mammalian GST-PRMT1 and Myc-PRMT5 were, unlike PRMT7, able to dimethylate both peptide P-SmD3 and SmB/D3 to give the expected asymmetric and symmetric products, respectively. These experiments show that PRMT7 is indeed a type III human methyltransferase capable of forming only omega-N-G-monomethylarginine, not asymmetric omega-N-G,N-G-dimethylarginine or symmetric omega-N-G,N-G'-dimethylarginine, under the conditions tested.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Sandberg, Troy/0000-0003-3240-3659; Kelly, Ryan/0000-0001-5003-9104	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; Bonham K, 2010, FEBS J, V277, P2096, DOI 10.1111/j.1742-4658.2010.07623.x; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Castellano S, 2010, CHEMMEDCHEM, V5, P398, DOI 10.1002/cmdc.200900459; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng DH, 2011, CHEMBIOCHEM, V12, P323, DOI 10.1002/cbic.201000522; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Fielenbach N, 2007, DEV CELL, V12, P443, DOI 10.1016/j.devcel.2007.01.018; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gros L, 2003, CANCER RES, V63, P164; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kim SJ, 2011, BBA-PROTEINS PROTEOM, V1814, P308, DOI 10.1016/j.bbapap.2010.11.006; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811; LEHMEIER T, 1994, P NATL ACAD SCI USA, V91, P12317, DOI 10.1073/pnas.91.25.12317; Li YJ, 2004, J VIROL, V78, P13325, DOI 10.1128/JVI.78.23.13325-13334.2004; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Miranda TB, 2006, BIOCHEM J, V395, P563, DOI 10.1042/BJ20051771; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Takahashi Y, 2011, J RECEPT SIG TRANSD, V31, P168, DOI 10.3109/10799893.2011.555768; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Thomas D, 2010, PROTEIN SCI, V19, P2141, DOI 10.1002/pro.492; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zheng ZY, 2005, P NATL ACAD SCI USA, V102, P2502, DOI 10.1073/pnas.0409786102	72	168	178	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7859	7870		10.1074/jbc.M111.336271	http://dx.doi.org/10.1074/jbc.M111.336271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22241471	Green Published, hybrid			2022-12-25	WOS:000301349400003
J	Greenwood, TA; Light, GA; Swerdlow, NR; Radant, AD; Braff, DL				Greenwood, Tiffany A.; Light, Gregory A.; Swerdlow, Neal R.; Radant, Allen D.; Braff, David L.			Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes	PLOS ONE			English	Article							1ST-DEGREE BIOLOGICAL RELATIVES; P50 SUPPRESSION; ANTISACCADE PERFORMANCE; COGNITIVE DEFICITS; PREPULSE INHIBITION; WORKING-MEMORY; NEUROPSYCHOLOGICAL DEFICITS; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY GENES; BIPOLAR DISORDER	While it is clear that schizophrenia is highly heritable, the genetic basis of this heritability is complex. Human genetic, brain imaging, and model organism studies have met with only modest gains. A complementary research tactic is to evaluate the genetic substrates of quantitative endophenotypes with demonstrated deficits in schizophrenia patients. We used an Illumina custom 1,536-SNP array to interrogate 94 functionally relevant candidate genes for schizophrenia and evaluate association with both the qualitative diagnosis of schizophrenia and quantitative endophenotypes for schizophrenia. Subjects included 219 schizophrenia patients and normal comparison subjects of European ancestry and 76 schizophrenia patients and normal comparison subjects of African ancestry, all ascertained by the UCSD Schizophrenia Research Program. Six neurophysiological and neurocognitive endophenotype test paradigms were assessed: prepulse inhibition (PPI), P50 suppression, the antisaccade oculomotor task, the Letter-Number Span Test, the California Verbal Learning Test-II, and the Wisconsin Card Sorting Test-64 Card Version. These endophenotype test paradigms yielded six primary endophenotypes with prior evidence of heritability and demonstrated schizophrenia-related impairments, as well as eight secondary measures investigated as candidate endophenotypes. Schizophrenia patients showed significant deficits on ten of the endophenotypic measures, replicating prior studies and facilitating genetic analyses of these phenotypes. A total of 38 genes were found to be associated with at least one endophenotypic measure or schizophrenia with an empirical p-value<0.01. Many of these genes have been shown to interact on a molecular level, and eleven genes displayed evidence for pleiotropy, revealing associations with three or more endophenotypic measures. Among these genes were ERBB4 and NRG1, providing further support for a role of these genes in schizophrenia susceptibility. The observation of extensive pleiotropy for some genes and singular associations for others in our data may suggest both converging and independent genetic (and neural) pathways mediating schizophrenia risk and pathogenesis.	[Greenwood, Tiffany A.; Light, Gregory A.; Swerdlow, Neal R.; Braff, David L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Light, Gregory A.; Braff, David L.] VISN 22 Mental Illness Res Educ & Clin Ctr MIRECC, Dept Vet Affairs, San Diego, CA USA; [Radant, Allen D.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Radant, Allen D.] Puget Sound Vet Adm Hlth Care Syst, Seattle, WA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Greenwood, TA (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	dbraff@ucsd.edu	Greenwood, Tiffany/F-6356-2012; Swerdlow, Neal/AAU-4912-2020; Light, Gregory/AAA-5696-2020	Greenwood, Tiffany/0000-0002-6080-6503; Light, Gregory/0000-0003-4730-8646	National Institute of Mental Health (NIMH) [R01-MH042228, MH079777, K01-MH087889]; Consortium on the Genetics of Schizophrenia [MH065571]; Brain & Behavior Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065571, R01MH042228, K01MH087889, R01MH079777] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Consortium on the Genetics of Schizophrenia; Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the National Institute of Mental Health (NIMH; www.nimh.nih.org) to the University of California San Diego Schizophrenia Research Project (R01-MH042228 and MH079777) and the Consortium on the Genetics of Schizophrenia (MH065571). Additional funding was provided by a Distinguished Investigators Award from the Brain & Behavior Research Foundation (www.narsad.org) to Dr. Braff and a career development award from the NIMH to Dr. Greenwood (K01-MH087889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; BLANCHARD JJ, 1994, AM J PSYCHIAT, V151, P40; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Braff DL, 2007, BIOL PSYCHIAT, V61, P1204, DOI 10.1016/j.biopsych.2006.08.015; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; Calkins ME, 2004, SCHIZOPHR RES, V71, P167, DOI 10.1016/j.schres.2003.12.005; Cirillo MA, 2003, NEUROPSYCHOL REV, V13, P43, DOI 10.1023/A:1023870821631; Clementz BA, 1998, AM J PSYCHIAT, V155, P1691, DOI 10.1176/ajp.155.12.1691; Clementz BA, 1998, SCHIZOPHR RES, V30, P71, DOI 10.1016/S0920-9964(97)00122-9; Wilde OM, 2007, SCHIZOPHR RES, V97, P137, DOI 10.1016/j.schres.2007.04.028; Dickinson D, 2008, BIOL PSYCHIAT, V64, P823, DOI 10.1016/j.biopsych.2008.04.005; Dominguez E, 2007, SCHIZOPHR RES, V90, P123, DOI 10.1016/j.schres.2006.09.022; Fanous AH, 2007, AM J MED GENET B, V144B, P207, DOI 10.1002/ajmg.b.30423; First M. B., 2014, SCID 5 105 STRUCTURE; First M. B., 2002, STRUCTURED CLIN INTE; FUKUSHIMA J, 1990, J PSYCHIAT RES, V24, P9, DOI 10.1016/0022-3956(90)90021-H; Gogos JA, 2006, TRENDS PHARMACOL SCI, V27, P226, DOI 10.1016/j.tips.2006.02.005; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Gur RC, 2001, NEUROPSYCHOPHARMACOL, V25, P777, DOI 10.1016/S0893-133X(01)00279-2; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heaton R, 2000, WCST WISCONSIN CARD; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hemminger BM, 2006, BIOINFORMATICS, V22, P626, DOI 10.1093/bioinformatics/btk025; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Horan WP, 2008, SCHIZOPHR RES, V103, P218, DOI 10.1016/j.schres.2008.02.014; Li DW, 2007, GENET MED, V9, P4, DOI 10.1097/01.gim.0000250507.96760.4b; Liang SG, 2005, AM J MED GENET B, V138B, P27; Light GA, 2000, AM J PSYCHIAT, V157, P767, DOI 10.1176/appi.ajp.157.5.767; Light GA, 2001, AM J PSYCHIAT, V158, P2066, DOI 10.1176/appi.ajp.158.12.2066; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McDowell JE, 1997, EXP BRAIN RES, V115, P333, DOI 10.1007/PL00005702; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ohtsuki T, 2001, MOL PSYCHIATR, V6, P211, DOI 10.1038/sj.mp.4000808; PARK S, 1995, ARCH GEN PSYCHIAT, V52, P821; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Pickard BS, 2006, MOL PSYCHIATR, V11, P847, DOI 10.1038/sj.mp.4001867; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radant AD, 2007, SCHIZOPHR RES, V89, P320, DOI 10.1016/j.schres.2006.08.010; Radant AD, 2010, PSYCHOPHYSIOLOGY, V47, P846, DOI 10.1111/j.1469-8986.2010.01004.x; Root TL, 2011, EUR EAT DISORD REV; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schork NJ, 2007, SCHIZOPHRENIA BULL, V33, P95, DOI 10.1093/schbul/sbl045; SIEGEL C, 1984, ARCH GEN PSYCHIAT, V41, P607; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Stone WS, 2011, SCHIZOPHR RES, V128, P102, DOI 10.1016/j.schres.2011.01.005; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Swerdlow NR, 2007, SCHIZOPHR RES, V92, P237, DOI 10.1016/j.schres.2007.01.012; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Twamley EW, 2002, AM J PSYCHIAT, V159, P2013, DOI 10.1176/appi.ajp.159.12.2013; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang ZQ, 2006, AM J MED GENET B, V141B, P902, DOI 10.1002/ajmg.b.30383; Zhang XA, 2004, PSYCHIAT GENET, V14, P43, DOI 10.1097/00041444-200403000-00007	66	98	102	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29630	10.1371/journal.pone.0029630	http://dx.doi.org/10.1371/journal.pone.0029630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253750	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500016
J	Rajanala, K; Nandicoori, VK				Rajanala, Kalpana; Nandicoori, Vinay Kumar			Localization of Nucleoporin Tpr to the Nuclear Pore Complex Is Essential for Tpr Mediated Regulation of the Export of Unspliced RNA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ATTACHED INTRANUCLEAR FILAMENTS; CONSTITUTIVE TRANSPORT ELEMENT; INTRON-CONTAINING RNA; HSP70 MESSENGER-RNA; PROTEIN TPR; NUCLEOCYTOPLASMIC TRANSPORT; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; TAP	Nucleoporin Tpr is a component of the nuclear pore complex (NPC) that localizes exclusively to intranuclear filaments. Tpr functions as a scaffolding element in the nuclear phase of the NPC and plays a role in mitotic spindle checkpoint signalling. Export of intron-containing mRNA in Mason Pfizer Monkey Virus is regulated by direct interaction of cellular proteins with the cis-acting Constitutive Transport Element (CTE). In mammalian cells, the transport of Gag/Pol-CTE reporter construct is not very efficient, suggesting a regulatory mechanism to retain this unspliced RNA. Here we report that the knockdown of Tpr in mammalian cells leads to a drastic enhancement in the levels of Gag proteins (p24) in the cytoplasm, which is rescued by siRNA resistant Tpr. Tpr's role in the retention of unspliced RNA is independent of the functions of Sam68 and Tap/Nxf1 proteins, which are reported to promote CTE dependent export. Further, we investigated the possible role for nucleoporins that are known to function in nucleocytoplasmic transport in modulating unspliced RNA export. Results show that depletion of Nup153, a nucleoporin required for NPC anchoring of Tpr, plays a role in regulating the export, while depletion of other FG repeat-containing nucleoporins did not alter the unspliced RNA export. Results suggest that Tpr and Nup153 both regulate the export of unspliced RNA and they are most likely functioning through the same pathway. Importantly, we find that localization of Tpr to the NPC is necessary for Tpr mediated regulation of unspliced RNA export. Collectively, the data indicates that perinuclear localization of Tpr at the nucleopore complex is crucial for regulating intron containing mRNA export by directly or indirectly participating in the processing and degradation of aberrant mRNA transcripts.	[Rajanala, Kalpana; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rajanala, K (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in		Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work is supported by intramural and extramural funding provided by the Department of Biotechnology, India, to VKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Coyle JH, 2011, RNA; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; GRECO A, 1992, ONCOGENE, V7, P237; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Herold A, 2001, RNA, V7, P1768; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Jacob Y, 2007, PLANT PHYSIOL, V144, P1383, DOI 10.1104/pp.107.100735; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kang YB, 2000, J VIROL, V74, P5863, DOI 10.1128/JVI.74.13.5863-5871.2000; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Krull S, 2010, EMBO J, V29, P1659, DOI 10.1038/emboj.2010.54; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X; Levesque L, 2006, MOL BIOL CELL, V17, P931, DOI 10.1091/mbc.E04-07-0634; Levesque L, 2001, J BIOL CHEM, V276, P44953, DOI 10.1074/jbc.M106558200; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MITCHELL PJ, 1992, ONCOGENE, V7, P2329; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Ren Y, 2010, P NATL ACAD SCI USA, V107, P10406, DOI 10.1073/pnas.1005389107; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shibata S, 2002, GENES CELLS, V7, P421, DOI 10.1046/j.1365-2443.2002.00525.x; Skaggs HS, 2007, J BIOL CHEM, V282, P33902, DOI 10.1074/jbc.M704054200; Skruzny M, 2009, PLOS BIOL, V7, P164, DOI 10.1371/journal.pbio.1000008; SMITH AJ, 1990, J VIROL, V64, P2743, DOI 10.1128/JVI.64.6.2743-2750.1990; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wiegand HL, 2002, MOL CELL BIOL, V22, P245, DOI 10.1128/MCB.22.1.245-256.2002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Zimowska G, 2002, EXP CELL RES, V276, P223, DOI 10.1006/excr.2002.5525	62	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29921	10.1371/journal.pone.0029921	http://dx.doi.org/10.1371/journal.pone.0029921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253824	Green Submitted, Green Published, gold			2022-12-25	WOS:000301361500026
J	Hondowicz, BD; Schwedhelm, KV; Kas, A; Tasch, MA; Rawlings, C; Ramchurren, N; McIntosh, M; D'Amico, LA; Sanda, S; Standifer, NE; Shendure, J; Stone, B				Hondowicz, Brian D.; Schwedhelm, Katharine V.; Kas, Arnold; Tasch, Michael A.; Rawlings, Crystal; Ramchurren, Nirasha; McIntosh, Martin; D'Amico, Leonard A.; Sanda, Srinath; Standifer, Nathan E.; Shendure, Jay; Stone, Brad			Discovery of T Cell Antigens by High-Throughput Screening of Synthetic Minigene Libraries	PLOS ONE			English	Article							CLASS-I MOLECULES; ADHESION MOLECULE; PEPTIDE; IDENTIFICATION; RESPONSES; EPITOPES; EPCAM	The identification of novel T cell antigens is central to basic and translational research in autoimmunity, tumor immunology, transplant immunology, and vaccine design for infectious disease. However, current methods for T cell antigen discovery are low throughput, and fail to explore a wide range of potential antigen-receptor interactions. To overcome these limitations, we developed a method in which programmable microarrays are used to cost-effectively synthesize complex libraries of thousands of minigenes that collectively encode the content of hundreds of candidate protein targets. Minigene-derived mRNA are transfected into autologous antigen presenting cells and used to challenge complex populations of purified peripheral blood CD8+ T cells in multiplex, parallel ELISPOT assays. In this proof-of-concept study, we apply synthetic minigene screening to identify two novel pancreatic islet autoantigens targeted in a patient with Type I Diabetes. To our knowledge, this is the first successful screen of a highly complex, synthetic minigene library for identification of a T cell antigen. In principle, responses against the full protein complement of any tissue or pathogen can be assayed by this approach, suggesting that further optimization of synthetic libraries holds promise for high throughput antigen discovery.	[Hondowicz, Brian D.; Schwedhelm, Katharine V.; Kas, Arnold; Tasch, Michael A.; Rawlings, Crystal; Ramchurren, Nirasha; D'Amico, Leonard A.; Sanda, Srinath; Stone, Brad] Benaroya Res Inst, Translat Res Program, Seattle, WA USA; [Standifer, Nathan E.] Amgen Inc, Clin Immunol, Seattle, WA USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [McIntosh, Martin] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Benaroya Research Institute; Amgen; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Hondowicz, BD (corresponding author), Benaroya Res Inst, Translat Res Program, Seattle, WA USA.	bstone@benaroyaresearch.org	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865	National Institutes of Health [3U19AI070352-0351]; Benaroya Research Institute; Juvenile Diabetes Research Foundation [27-2011-282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Benaroya Research Institute; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 3U19AI070352-0351 and Benaroya Research Institute internal funding. BDH is also supported by a Juvenile Diabetes Research Foundation grant # 27-2011-282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 2002, TRANSPLANTATION, V74, P1773, DOI 10.1097/01.TP.0000039166.86548.93; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Fuhrmann M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni058; Janetzki S, 2008, CANCER IMMUNOL IMMUN, V57, P303, DOI 10.1007/s00262-007-0380-6; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Kim JH, 2003, CLIN CANCER RES, V9, P4782; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Kutchma A, 2007, NUCLEIC ACIDS RES, V35, pD674, DOI 10.1093/nar/gkl990; Ladiges WC, 1989, METHODS ANIMAL EXPT, P103; Lee ST, 2008, J IMMUNOL METHODS, V331, P13, DOI 10.1016/j.jim.2007.09.006; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Liebig Tanja M, 2009, J Vis Exp, DOI 10.3791/1373; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; Mosolits S, 1999, CANCER IMMUNOL IMMUN, V47, P315, DOI 10.1007/s002620050536; Nagorsen D, 2000, CANCER RES, V60, P4850; NIJMAN HW, 1993, EUR J IMMUNOL, V23, P1215, DOI 10.1002/eji.1830230603; PARKER KC, 1994, J IMMUNOL, V152, P163; Qin OY, 2006, DIABETES, V55, P3068, DOI 10.2337/db06-0065; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Simon GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008574; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Valmori D, 1998, J IMMUNOL, V161, P6956; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104	35	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29949	10.1371/journal.pone.0029949	http://dx.doi.org/10.1371/journal.pone.0029949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253836	Green Submitted, gold, Green Published			2022-12-25	WOS:000301357100031
J	Gonzalez-Romero, R; Rivera-Casas, C; Frehlick, LJ; Mendez, J; Ausio, J; Eirin-Lopez, JM				Gonzalez-Romero, Rodrigo; Rivera-Casas, Ciro; Frehlick, Lindsay J.; Mendez, Josefina; Ausio, Juan; Eirin-Lopez, Jose M.			Histone H2A (H2A.X and H2A.Z) Variants in Molluscs: Molecular Characterization and Potential Implications For Chromatin Dynamics	PLOS ONE			English	Article							EVOLUTIONARY; PROTEINS; SPERM; P53; H1; NUCLEOSOMES; HSP90; ACETYLATION; CHROMOSOME; STABILITY	Histone variants are used by the cell to build specialized nucleosomes, replacing canonical histones and generating functionally specialized chromatin domains. Among many other processes, the specialization imparted by histone H2A (H2A.X and H2A.Z) variants to the nucleosome core particle constitutes the earliest response to DNA damage in the cell. Consequently, chromatin-based genotoxicity tests have been developed in those cases where enough information pertaining chromatin structure and dynamics is available (i.e., human and mouse). However, detailed chromatin knowledge is almost absent in most organisms, specially protostome animals. Molluscs (which represent sentinel organisms for the study of pollution) are not an exception to this lack of knowledge. In the present work we first identified the existence of functionally differentiated histone H2A.X and H2A.Z variants in the mussel Mytilus galloprovincialis (MgH2A.X and MgH2A.Z), a marine organism widely used in biomonitoring programs. Our results support the functional specialization of these variants based on: a) their active expression in different tissues, as revealed by the isolation of native MgH2A.X and MgH2A.Z proteins in gonad and hepatopancreas; b) the evolutionary conservation of different residues encompassing functional relevance; and c) their ability to confer specialization to nucleosomes, as revealed by nucleosome reconstitution experiments using recombinant MgH2A.X and MgH2A.Z histones. Given the seminal role of these variants in maintaining genomic integrity and regulating gene expression, their preliminary characterization opens up new potential applications for the future development of chromatin-based genotoxicity tests in pollution biomonitoring programs.	[Gonzalez-Romero, Rodrigo; Rivera-Casas, Ciro; Mendez, Josefina; Eirin-Lopez, Jose M.] Univ A Coruna, Dept Biol Celular & Mol, La Coruna, Spain; [Frehlick, Lindsay J.; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Universidade da Coruna; University of Victoria	Gonzalez-Romero, R (corresponding author), Univ A Coruna, Dept Biol Celular & Mol, La Coruna, Spain.	jeirin@udc.es	Eirin-Lopez, Jose Maria/A-5618-2008; González-Romero, Rodrigo/K-9188-2013; Mendez, Josefina/H-7318-2016	Eirin-Lopez, Jose Maria/0000-0002-8041-9770; González-Romero, Rodrigo/0000-0002-9848-0182; Mendez, Josefina/0000-0002-7567-980X	Xunta de Galicia [10-PXIB-103-077-PR]; Ministerio de Ciencia e Innovacion of Spain [MICINN-CGL2011-24812]; Natural Sciences and Engineering Research Council of Canada [NSERC-OGP-0046399-02]; postdoctoral contract; FPU; Ramon y Cajal Subprogramme; Ministerio de Ciencia e Innovacion of Spain (MICINN)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); postdoctoral contract; FPU(Spanish Government); Ramon y Cajal Subprogramme; Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Xunta de Galicia (10-PXIB-103-077-PR) and from the Ministerio de Ciencia e Innovacion of Spain (MICINN-CGL2011-24812) to JME-L; and from the Natural Sciences and Engineering Research Council of Canada (NSERC-OGP-0046399-02, to JA). RG-R is supported by a postdoctoral contract, CR-C is supported by a FPU fellowship and JME-L is the recipient of a contract within the Ramon y Cajal Subprogramme, all funded by the Ministerio de Ciencia e Innovacion of Spain (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2005, J BIOL CHEM, V280, P16437, DOI 10.1074/jbc.M500170200; AUSIO J, 1988, J BIOL CHEM, V263, P10141; AUSIO J, 1986, COMP BIOCHEM PHYS B, V85, P439, DOI 10.1016/0305-0491(86)90025-8; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J., 2004, NEW COMPREHENSIVE BI, V39, P241; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barker CM, 1997, EXP CELL RES, V232, P240, DOI 10.1006/excr.1997.3513; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Dryhurst D, 2004, BIOCHEM CELL BIOL, V82, P490, DOI 10.1139/O04-043; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Eirin-Lopez JM, 2007, CURR GENOMICS, V8, P59, DOI 10.2174/138920207780076965; Eirin-Lopez JM, 2006, J BIOL CHEM, V281, P1, DOI 10.1074/jbc.R500018200; Eirin-Lopez JM, 2004, J MOL EVOL, V58, P131, DOI 10.1007/s00239-003-2531-5; Eirin-Lopez JM, 2006, MOL BIOL EVOL, V23, P1304, DOI 10.1093/molbev/msk021; Eirin-Lopez JM, 2009, EVOLUTIONARY BIOLOGY: CONCEPT, MODELING, AND APPLICATION, P139, DOI 10.1007/978-3-642-00952-5_8; Eirin-Lopez JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-31; Eirin-Lopez JM, 2008, FASEB J, V22, P316, DOI 10.1096/fj.07-9255com; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Frehlick LJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-99; Gimenez-Bonafe P, 2000, MOL REPROD DEV, V57, P185, DOI 10.1002/1098-2795(200010)57:2<185::AID-MRD10>3.0.CO;2-5; Gonzalez-Romero R, 2011, COMP BIOCH IN PRESS; Gonzalez-Romero R, 2008, J MOL EVOL, V66, P505, DOI 10.1007/s00239-008-9109-1; Gonzalez-Romero R, 2008, GENE, V413, P1, DOI 10.1016/j.gene.2008.02.003; Kelley ML, 2001, ONCOGENE, V20, P748, DOI 10.1038/sj.onc.1204144; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LAEMMLI UK, 1976, CELL, V7, P191, DOI 10.1016/0092-8674(76)90018-0; Li A, 2005, BIOCHEM CELL BIOL, V83, P505, DOI 10.1139/O05-114; Li A, 2005, BIOCHEMISTRY-US, V44, P2529, DOI 10.1021/bi048061n; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; McKillen DJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-34; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Pantzartzi CN, 2009, GENE, V431, P47, DOI 10.1016/j.gene.2008.10.028; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Schulze E, 1995, J MOL EVOL, V41, P833; Sitnikova T, 1996, MOL BIOL EVOL, V13, P605, DOI 10.1093/oxfordjournals.molbev.a025620; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TATCHELL K, 1979, BIOCHEMISTRY-US, V18, P2870, DOI 10.1021/bi00580a031; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; van Holde K.E., 1988, CHROMATIN; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; YAGER TD, 1984, J BIOL CHEM, V259, P4212; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	62	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30006	10.1371/journal.pone.0030006	http://dx.doi.org/10.1371/journal.pone.0030006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253857	Green Published, gold			2022-12-25	WOS:000301355700074
J	Kittikraisak, W; Kingkaew, P; Teerawattananon, Y; Yothasamut, J; Natesuwan, S; Manosuthi, W; Chongsuvivatwong, V; Whitehead, SJ				Kittikraisak, Wanitchaya; Kingkaew, Pritaporn; Teerawattananon, Yot; Yothasamut, Jomkwan; Natesuwan, Supalert; Manosuthi, Weerawat; Chongsuvivatwong, Virasakdi; Whitehead, Sara J.			Health Related Quality of Life among Patients with Tuberculosis and HIV in Thailand	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; CARE; TB; SURVIVAL; PEOPLE; LATENT	Introduction: Health utilities of tuberculosis (TB) patients may be diminished by side effects from medication, prolonged treatment duration, physical effects of the disease itself, and social stigma attached to the disease. Methods: We collected health utility data from Thai patients who were on TB treatment or had been successfully treated for TB for the purpose of economic modeling. Structured questionnaire and EuroQol (EQ-5D) and EuroQol visual analog scale (EQ-VAS) instruments were used as data collection tools. We compared utility of patients with two co-morbidities calculated using multiplicative model (U-CAL) with the direct measures and fitted Tobit regression models to examine factors predictive of health utility and to assess difference in health utilities of patients in various medical conditions. Results: Of 222 patients analyzed, 138 (62%) were male; median age at enrollment was 40 years (interquartile range [IQR], 35-47). Median monthly household income was 6,000 Baht (187 US$; IQR, 4,000-15,000 Baht [125-469 US$]). Concordance correlation coefficient between utilities measured using EQ-5D and EQ-VAS (UEQ-5D and U-VAS, respectively) was 0.6. U-CAL for HIV-infected TB patients was statistically different from the measured UEQ-5D (p-value<0.01) and U-VAS (p-value<0.01). In tobit regression analysis, factors independently predictive of UEQ-5D included age and monthly household income. Patients aged >= 40 years old rated UEQ-5D significantly lower than younger persons. Higher UEQ-5D was significantly associated with higher monthly household income in a dose response fashion. The median UEQ-5D was highest among patients who had been successfully treated for TB and lowest among multi-drug resistant TB (MDR-TB) patients who were on treatment. Conclusions: U-CAL of patients with two co-morbidities overestimated the measured utilities, warranting further research of how best to estimate utilities of patients with such conditions. TB and MDR-TB treatments impacted on patients' self perceived health status. This effect diminished after successful treatment.	[Kittikraisak, Wanitchaya; Whitehead, Sara J.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Kingkaew, Pritaporn; Teerawattananon, Yot; Yothasamut, Jomkwan] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand; [Natesuwan, Supalert] Chiang Rai Reg Hosp, Chiang Rai, Thailand; [Manosuthi, Weerawat] Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Epidemiol Unit, Hat Yai, Thailand; [Whitehead, Sara J.] Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Prince of Songkla University; Centers for Disease Control & Prevention - USA	Kittikraisak, W (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand.	wanitchayak@th.cdc.gov		Kingkaew, Pritaporn/0000-0003-2626-7806; Yothasamut, Jomkwan/0000-0001-6101-1756; Nyirenda, Mulinda/0000-0003-2037-7449; Teerawattananon, Yot/0000-0003-2217-2930	United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	The authors gratefully acknowledge the United States Agency for International Development for funding this study. The funding agency had no role in study design, conduct, data analysis, or manuscript preparation.	Aghakhani N, 2011, CASP J INTERN MED, V2, P183; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 1948, Br Med J, V2, P769; [Anonymous], 2009, THAI POPULATION BASE; [Anonymous], 2011, GLOB TUB CONTR 2011; Bayoumi AM, 1999, QUAL LIFE RES, V8, P471, DOI 10.1023/A:1008969512182; Begg S., 2007, BURDEN DIS INJURY AU; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Deribew A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-105; Dhingra V K, 2005, J Commun Dis, V37, P261; Dion MJ, 2004, QUAL LIFE RES, V13, P653, DOI 10.1023/B:QURE.0000021320.89524.64; Dion MJ, 2002, MED DECIS MAKING, V22, pS102, DOI 10.1177/027298902237706; Duyan V, 2005, INT J TUBERC LUNG D, V9, P1361; Gold MR, COST EFFECTIVENESS H; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; He Chao-yang, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P187; HOLM S, 1979, SCAND J STAT, V6, P65; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Jirawattanapisal T, 2009, VALUE HEALTH, V12, pS4, DOI 10.1111/j.1524-4733.2009.00620.x; Jittimanee S, 2009, INT J INFECT DIS, V13, P436, DOI 10.1016/j.ijid.2008.07.025; Jordan TS, 2010, INT J TUBERC LUNG D, V14, P683; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954; Kittikraisak Wanitchaya, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P1061; Long J. S., ADV QUANTITATIVE TEC, V7; Macran S, 2001, MED CARE, V39, P217, DOI 10.1097/00005650-200103000-00003; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Mercier C, 1998, COMMUNITY MENT HLT J, V34, P487, DOI 10.1023/A:1018790429573; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; Miners A H, 2001, HIV Clin Trials, V2, P484, DOI 10.1310/48ET-TT7G-35RA-D4C3; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Narain JP, 2003, J HEALTHC MANAG, V5, P297; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nyamathi A, 2005, WESTERN J NURS RES, V27, P896, DOI 10.1177/0193945905278385; Patrick DL, HLTH STATUS HLTH POL; Puhan MA, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-30; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Sakthong Phantipa, 2008, J Med Assoc Thai, V91 Suppl 2, pS43; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Steichen TJ, 2008, STATA J, V8, P594; Steichen TJ, 1998, STATA J, V43, P35; Szende A, EQ 5D VALUE SETS INV; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	50	35	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29775	10.1371/journal.pone.0029775	http://dx.doi.org/10.1371/journal.pone.0029775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906ON	22253777	Green Published, gold			2022-12-25	WOS:000301355700049
J	Yergeau, E; Sanschagrin, S; Beaumier, D; Greer, CW				Yergeau, Etienne; Sanschagrin, Sylvie; Beaumier, Danielle; Greer, Charles W.			Metagenomic Analysis of the Bioremediation of Diesel-Contaminated Canadian High Arctic Soils	PLOS ONE			English	Article							DEGRADING BACTERIA; CAULOBACTER-CRESCENTUS; LOW-TEMPERATURES; ANTARCTIC SOIL; RHODOCOCCUS SP; GENES; BIODEGRADATION; HYDROCARBONS; DIVERSITY; NITROGEN	As human activity in the Arctic increases, so does the risk of hydrocarbon pollution events. On site bioremediation of contaminated soil is the only feasible clean up solution in these remote areas, but degradation rates vary widely between bioremediation treatments. Most previous studies have focused on the feasibility of on site clean-up and very little attention has been given to the microbial and functional communities involved and their ecology. Here, we ask the question: which microorganisms and functional genes are abundant and active during hydrocarbon degradation at cold temperature? To answer this question, we sequenced the soil metagenome of an ongoing bioremediation project in Alert, Canada through a time course. We also used reverse-transcriptase real-time PCR (RT-qPCR) to quantify the expression of several hydrocarbon-degrading genes. Pseudomonas species appeared as the most abundant organisms in Alert soils right after contamination with diesel and excavation (t = 0) and one month after the start of the bioremediation treatment (t = 1m), when degradation rates were at their highest, but decreased after one year (t = 1y), when residual soil hydrocarbons were almost depleted. This trend was also reflected in hydrocarbon degrading genes, which were mainly affiliated with Gammaproteobacteria at t = 0 and t = 1m and with Alphaproteobacteria and Actinobacteria at t = 1y. RT-qPCR assays confirmed that Pseudomonas and Rhodococcus species actively expressed hydrocarbon degradation genes in Arctic biopile soils. Taken together, these results indicated that biopile treatment leads to major shifts in soil microbial communities, favoring aerobic bacteria that can degrade hydrocarbons.	[Yergeau, Etienne; Sanschagrin, Sylvie; Beaumier, Danielle; Greer, Charles W.] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Yergeau, E (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	Etienne.Yergeau@cnrc-nrc.gc.ca	Yergeau, Etienne/B-5344-2008; Yergeau, Etienne/AAZ-6145-2020	Yergeau, Etienne/0000-0002-7112-3425	National Research Council of Canada	National Research Council of Canada	Internal funds from the National Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie J, 2000, POLAR BIOL, V23, P183, DOI 10.1007/s003000050025; Aislabie J, 2006, EXTREMOPHILES, V10, P171, DOI 10.1007/s00792-005-0498-4; Aislabie JM, 2004, ENVIRON SCI TECHNOL, V38, P1265, DOI 10.1021/es0305149; Baraniecki CA, 2002, MICROB ECOL, V43, P44, DOI 10.1007/s00248-001-1019-3; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Beller HR, 2002, ENVIRON SCI TECHNOL, V36, P3977, DOI 10.1021/es025556w; Braddock JF, 1997, ENVIRON SCI TECHNOL, V31, P2078, DOI 10.1021/es960904d; Braz VS, 2005, FEMS MICROBIOL LETT, V251, P289, DOI 10.1016/j.femsle.2005.08.013; Fetzner Susanne, 2007, V7, P63, DOI 10.1007/7171_2007_09; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Greer, 1999, BIOREMEDIAT J, V3, P69, DOI [DOI 10.1080/10889869991219217, 10.1080/10889869991219217]; Greer CW, 2007, ASSESSMENT REMEDIATI, P3; Greer CW, 2009, POLAR MICROBIOLOGY E, P321; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.micro.46.1.565; Herrick JB, 1997, APPL ENVIRON MICROB, V63, P2330, DOI 10.1128/AEM.63.6.2330-2337.1997; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Iwai S, 2010, ISME J, V4, P279, DOI 10.1038/ismej.2009.104; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Mannisto MK, 1999, ARCH MICROBIOL, V171, P189, DOI 10.1007/s002030050698; Margesin R, 1997, APPL MICROBIOL BIOT, V47, P462, DOI 10.1007/s002530050957; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Mazzon RR, 2008, FEMS MICROBIOL LETT, V288, P178, DOI 10.1111/j.1574-6968.2008.01337.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moore ERB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P646, DOI 10.1007/0-387-30746-x_21; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Sipila TP, 2010, BIODEGRADATION, V21, P771, DOI 10.1007/s10532-010-9342-3; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Walworth J, 2007, COLD REG SCI TECHNOL, V48, P84, DOI 10.1016/j.coldregions.2006.07.001; Walworth JL, 1997, J SOIL CONTAM, V6, P465, DOI 10.1080/15320389709383580; Warren R, 2004, J BACTERIOL, V186, P7783, DOI 10.1128/JB.186.22.7783-7795.2004; Whyte LG, 1998, APPL ENVIRON MICROB, V64, P2578; Whyte LG, 2002, FEMS MICROBIOL ECOL, V41, P141, DOI 10.1111/j.1574-6941.2002.tb00975.x; Whyte LG, 1997, APPL ENVIRON MICROB, V63, P3719, DOI 10.1128/AEM.63.9.3719-3723.1997; Whyte LG, 2001, COLD REG SCI TECHNOL, V32, P121, DOI 10.1016/S0165-232X(00)00025-2; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yergeau E, 2010, APPL ENVIRON MICROB, V76, P5432, DOI 10.1128/AEM.00873-10; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09; Yousaf S, 2010, J HAZARD MATER, V184, P523, DOI 10.1016/j.jhazmat.2010.08.067; Yrjala K, 1997, FEMS MICROBIOL LETT, V154, P403, DOI 10.1111/j.1574-6968.1997.tb12674.x	39	141	143	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30058	10.1371/journal.pone.0030058	http://dx.doi.org/10.1371/journal.pone.0030058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253877	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700083
J	Mount, PF; Gleich, K; Tam, S; Fraser, SA; Choy, SW; Dwyer, KM; Lu, B; Van Denderen, B; Fingerle-Rowson, G; Bucala, R; Kemp, BE; Power, DA				Mount, Peter F.; Gleich, Kurt; Tam, Shanna; Fraser, Scott A.; Choy, Suet-Wan; Dwyer, Karen M.; Lu, Bo; Van denderen, Bryce; Fingerle-Rowson, Guenter; Bucala, Richard; Kemp, Bruce E.; Power, David A.			The Outcome of Renal Ischemia-Reperfusion Injury Is Unchanged in AMPK-beta 1 Deficient Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MIGRATION INHIBITORY FACTOR; ADENOSINE-MONOPHOSPHATE; GLUCOSE-UPTAKE; AMPK; PHOSPHORYLATION; HEART; UPSTREAM; STROKE; CELLS	Aim: Activation of the master energy-regulator AMP-activated protein kinase (AMPK) in the heart reduces the severity of ischemia-reperfusion injury (IRI) but the role of AMPK in renal IRI is not known. The aim of this study was to determine whether activation of AMPK by acute renal ischemia influences the severity of renal IRI. Methods: AMPK expression and activation and the severity of renal IRI was studied in mice lacking the AMPK beta 1 subunit and compared to wild type (WT) mice. Results: Basal expression of activated AMPK, phosphorylayed at alpha Thr(172), was markedly reduced by 96% in AMPK-beta 1(-/-) mice. Acute renal ischaemia caused a 3.2-fold increase in alpha 1-AMPK activity and a 2.5-fold increase in alpha 2-AMPK activity (P<0.001) that was associated with an increase in AMPK phosphorylation of the AMPK-alpha subunit at Thr(172) and Ser(485), and increased inhibitory phosphorylation of the AMPK substrate acetyl-CoA carboxylase. After acute renal ischemia AMPK activity was reduced by 66% in AMPK-beta 1(-/-) mice compared with WT. There was no difference, however, in the severity of renal IRI at 24-hours between AMPK-beta 1(-/-) and WT mice, as measured by serum urea and creatinine and histological injury score. In the heart, macrophage migration inhibitory factor (MIF) released during IRI contributes to AMPK activation and protects from injury. In the kidney, however, no difference in AMPK activation by acute ischemia was observed between MIF-/- and WT mice. Compared with the heart, expression of the MIF receptor CD74 was found to be reduced in the kidney. Conclusion: The failure of AMPK activation to influence the outcome of IRI in the kidney contrasts with what is reported in the heart. This difference might be due to a lack of effect of MIF on AMPK activation and lower CD74 expression in the kidney.	[Mount, Peter F.; Gleich, Kurt; Fraser, Scott A.; Choy, Suet-Wan; Power, David A.] Austin Hlth, Dept Nephrol, Melbourne, Vic, Australia; [Mount, Peter F.; Gleich, Kurt; Fraser, Scott A.; Choy, Suet-Wan; Power, David A.] Inst Breathing & Sleep, Kidney Lab, Melbourne, Vic, Australia; [Tam, Shanna; Van denderen, Bryce; Kemp, Bruce E.] St Vincents Inst, Prot Chem & Metab Unit, Melbourne, Vic, Australia; [Choy, Suet-Wan; Kemp, Bruce E.; Power, David A.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Dwyer, Karen M.; Lu, Bo] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia; [Fingerle-Rowson, Guenter] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany; [Bucala, Richard] Yale Univ, Sch Med, Dept Med Pathol & Epidemiol & Publ Hlth, New Haven, CT USA	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Cologne; Yale University	Mount, PF (corresponding author), Austin Hlth, Dept Nephrol, Melbourne, Vic, Australia.	Peter.Mount@austin.org.au	Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019; van Denderen, Bryce/AAW-5454-2021; Power, David/AAM-6012-2021	Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082; Power, David/0000-0003-3983-0581; Mount, Peter/0000-0001-7637-3661; Dwyer, Karen/0000-0002-4376-9720	Australian National Health and Medical Research Council (NHMRC); Austin Hospital Medical Research Foundation (AHMRF)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Austin Hospital Medical Research Foundation (AHMRF)	This study was performed with funding from the Australian National Health and Medical Research Council (NHMRC) (www.nhmrc.gov.au) and the Austin Hospital Medical Research Foundation (AHMRF) (www.ahmrf.org.au). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ardito TA, 2011, AM J PHYSL RENAL PHY; Cammisotto PG, 2008, AM J PHYSIOL-RENAL, V294, pF881, DOI 10.1152/ajprenal.00373.2007; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Carvajal K, 2007, AM J PHYSIOL-HEART C, V292, pH3136, DOI 10.1152/ajpheart.00683.2006; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Folmes CDL, 2009, AM J PHYSIOL-HEART C, V297, pH313, DOI 10.1152/ajpheart.01298.2008; Fraser S, 2005, AM J PHYSIOL-RENAL, V288, pF578, DOI 10.1152/ajprenal.00190.2004; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Han QF, 2011, J AM SOC NEPHROL, V22, P1897, DOI 10.1681/ASN.2010080822; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Lan HY, 1996, AM J PATHOL, V149, P1119; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Li J, 2010, NEUROSCI LETT, V482, P62, DOI 10.1016/j.neulet.2010.07.007; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lin A, 2004, TRANSPLANTATION, V78, P654, DOI 10.1097/01.tp.0000131664.18670.17; Lu B, 2008, TRANSPLANTATION, V86, P1707, DOI 10.1097/TP.0b013e31819022bc; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhang L, 2011, AM J PHYSL RENAL PHY	45	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29887	10.1371/journal.pone.0029887	http://dx.doi.org/10.1371/journal.pone.0029887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253816	Green Published, gold			2022-12-25	WOS:000315865800018
J	Shao, WJ; Yu, ZW; Chiang, YT; Yang, Y; Chai, TY; Foltz, W; Lu, HG; Fantus, IG; Jin, TR				Shao, Weijuan; Yu, Zhiwen; Chiang, Yuting; Yang, Yi; Chai, Tuanyao; Foltz, Warren; Lu, Huogen; Fantus, I. George; Jin, Tianru			Curcumin Prevents High Fat Diet Induced Insulin Resistance and Obesity via Attenuating Lipogenesis in Liver and Inflammatory Pathway in Adipocytes	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; WNT SIGNALING PATHWAYS; BETA-CATENIN; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; INDUCED SUPPRESSION; GENE-TRANSCRIPTION; HEPATIC STEATOSIS; CELL; ACTIVATION	Background: Mechanisms underlying the attenuation of body weight gain and insulin resistance in response to high fat diet (HFD) by the curry compound curcumin need to be further explored. Although the attenuation of the inflammatory pathway is an accepted mechanism, a recent study suggested that curcumin stimulates Wnt signaling pathway and hence suppresses adipogenic differentiation. This is in contrast with the known repressive effect of curcumin on Wnt signaling in other cell lineages. Methodology and Principal Findings: We conducted the examination on low fat diet, or HFD fed C57BL/6J mice with or without curcumin intervention for 28 weeks. Curcumin significantly attenuated the effect of HFD on glucose disposal, body weight/fat gain, as well as the development of insulin resistance. No stimulatory effect on Wnt activation was observed in the mature fat tissue. In addition, curcumin did not stimulate Wnt signaling in vitro in primary rat adipocytes. Furthermore, curcumin inhibited lipogenic gene expression in the liver and blocked the effects of HFD on macrophage infiltration and the inflammatory pathway in the adipose tissue. Conclusions and Significance: We conclude that the beneficial effect of curcumin during HFD consumption is mediated by attenuating lipogenic gene expression in the liver and the inflammatory response in the adipose tissue, in the absence of stimulation of Wnt signaling in mature adipocytes.	[Shao, Weijuan; Chiang, Yuting; Yang, Yi; Chai, Tuanyao; Lu, Huogen; Fantus, I. George; Jin, Tianru] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada; [Yu, Zhiwen] Sun Yat Sen Univ, Inst Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Chiang, Yuting; Lu, Huogen; Fantus, I. George; Jin, Tianru] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Foltz, Warren] Univ Hlth Network, Princess Margaret Hosp, STTARR Innovat Ctr, Radiat Med Program, Toronto, ON, Canada; [Lu, Huogen; Fantus, I. George; Jin, Tianru] Univ Toronto, Banting & Best Diabet Ctr, Fac Med, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Sun Yat Sen University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Jin, TR (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada.	tianru.jin@utoronto.ca			CIHR, Canadian Institutes of Health Research	CIHR, Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	CIHR, Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, pC1510, DOI 10.1152/ajpcell.00369.2009; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Choi HY, 2010, PROSTATE CANCER P D, V13, P343, DOI 10.1038/pcan.2010.26; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jin TR, 1996, MOL CELL BIOL, V16, P19; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; PHILIPPE J, 1989, J CLIN INVEST, V84, P672, DOI 10.1172/JCI114214; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, pG865, DOI 10.1152/ajpgi.00339.2009; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sirek AS, 2009, ENDOCRINOLOGY, V150, P3483, DOI 10.1210/en.2008-1702; Sun J, 2009, ONCOGENE, V28, P3132, DOI 10.1038/onc.2009.167; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tian WX, 2011, MOL CELL BIOCH; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yu FX, 2010, J BIOL CHEM, V285, P25822, DOI 10.1074/jbc.M110.108290; Zhang Z, 2010, DIABETOLOGIA	52	190	202	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28784	10.1371/journal.pone.0028784	http://dx.doi.org/10.1371/journal.pone.0028784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253696	gold, Green Submitted, Green Published			2022-12-25	WOS:000315865800004
J	Battista, N; Meloni, MA; Bari, M; Mastrangelo, N; Galleri, G; Rapino, C; Dainese, E; Agro, AF; Pippia, P; Maccarrone, M				Battista, Natalia; Meloni, Maria A.; Bari, Monica; Mastrangelo, Nicolina; Galleri, Grazia; Rapino, Cinzia; Dainese, Enrico; Agro, Alessandro Finazzi; Pippia, Proto; Maccarrone, Mauro			5-Lipoxygenase-dependent apoptosis of human lymphocytes in the International Space Station: data from the ROALD experiment	FASEB JOURNAL			English	Article						fatty acids; immunosuppression; lipoxygenase pathway; space environment	IN-VITRO; MICROGRAVITY; SPACEFLIGHT; CELLS; LIPOXYGENASES; CYTOSKELETON; INVOLVEMENT; SUPPRESSION; ACTIVATION; EXPRESSION	The functional adaptation of the immune system to the surrounding environment is also a fundamental issue in space. It has been suggested that a decreased number of lymphocytes might be a cause of immunosuppression, possibly due to the induction of apoptosis. Early activation of 5-lipoxygenase (5-LOX) might play a central role in the initiation of the apoptotic program. The goal of the role of apoptosis in lymphocyte depression (ROALD) experiment, flown on the International Space Station as part of the BIO-4 mission of the European Space Agency, was to ascertain the induction of apoptosis in human lymphocytes under authentic microgravity, and to elucidate the possible involvement of 5-LOX. Our results demonstrate that exposure of human lymphocytes to microgravity for 48 h onboard the ISS remarkably increased apoptotic hallmarks such as DNA fragmentation (similar to 3-fold compared to ground-based controls) and cleaved-poly (ADP-ribose) polymerase (PARP) protein expression (similar to 3-fold), as well as mRNA levels of apoptosis-related markers such as p53 (similar to 3-fold) and calpain (similar to 4-fold); these changes were paralleled by an early increase of 5-LOX activity (similar to 2-fold). Our findings provide a molecular background for the immune dysfunction observed in astronauts during space missions, and reveal potential new markers to monitor health status of ISS crew members.-Battista, N., Meloni, M. A., Bari, M., Mastrangelo, N., Galleri, G., Rapino, C., Dainese, E., Finazzi Agro, A., Pippia, P., Maccarrone, M. 5-Lipoxygenase-dependent apoptosis of human lymphocytes in the International Space Station: data from the ROALD experiment. FASEB J. 26, 1791-1798 (2012). www.fasebj.org	[Battista, Natalia; Rapino, Cinzia; Dainese, Enrico; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Meloni, Maria A.; Galleri, Grazia; Pippia, Proto] Univ Sassari, Dept Physiol Biochem & Cellular Sci, I-07100 Sassari, Italy; [Bari, Monica; Mastrangelo, Nicolina; Agro, Alessandro Finazzi] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Maccarrone, Mauro] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Maccarrone, Mauro] Santa Lucia Fdn, Rome, Italy	University of Teramo; University of Sassari; University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Santa Lucia	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it	Galleri, Grazia/AAD-3278-2021; Maccarrone, Mauro/K-5398-2012; Battista, Natalia/AAC-2529-2019	Galleri, Grazia/0000-0001-5379-9387; Maccarrone, Mauro/0000-0002-3990-2963; Dainese, Enrico/0000-0001-7163-9344; Battista, Natalia/0000-0002-1936-6710	Zero g Life Tec, Zurich, Switzerland; Agenzia Spaziale Italiana; Fondazione Banco di Sardegna	Zero g Life Tec, Zurich, Switzerland; Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	The authors are grateful to Dr. Augusto Cogoli (Zero g Life Tec, Zurich, Switzerland) for his continuing support to the ROALD project; and to Dr. Natalie Leys [Belgian Nuclear Research Center (SCK.CEN), Mol, Belgium], Dr. Raimondo Fortezza (Mars Center, Naples, Italy), and all members of Kayser Italia, ESA, Energia, and NASA who have been involved in the different phases of the ROALD experiment. This work was supported by Agenzia Spaziale Italiana (Disturbi del Controllo Motorio e Cardiorespiratorio and From Molecules to Man projects, 2006-2009; to A. F. A. and M. M.), and in part by Fondazione Banco di Sardegna (to P.P.).	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Arneth B. M., 2010, CURR PROTOC CYTOM, V51, P6281; Bai SS, 2011, IMMUNOL INVEST, V40, P535, DOI 10.3109/08820139.2011.568032; Bakos A, 2001, J GRAVIT PHYSL, V8, P69; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Battista N., 2007, J GRAVIT PHYSL, V14, P131; Berger W, 2007, INT J CLIN PRACT, V61, P663, DOI 10.1111/j.1742-1241.2007.01320.x; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chang H, 2011, J CELL BIOCHEM, V112, P571, DOI 10.1002/jcb.22947; Cho YJ, 2011, CELL MOL LIFE SCI, V68, P1883, DOI 10.1007/s00018-011-0666-x; Chu J, 2011, AM J PATHOL, V178, P1762, DOI 10.1016/j.ajpath.2010.12.032; Claria J, 2006, RECENT PAT ANTI-CANC, V1, P369, DOI 10.2174/157489206778776961; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; Cooper D, 2001, IN VITRO CELL DEV-AN, V37, P63; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Dainese E, 2010, FASEB J, V24, P1725, DOI 10.1096/fj.09-141390; Fitzgerald W, 2009, IN VITRO CELL DEV-AN, V45, P622, DOI 10.1007/s11626-009-9225-2; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Heitz F, 2010, EXPERT REV ANTICANC, V10, P1125, DOI 10.1586/ERA.10.53; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Liggieri L, 1997, J COLLOID INTERF SCI, V186, P46, DOI 10.1006/jcis.1996.4580; Lovat PE, 2002, CANCER RES, V62, P5158; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Maccarrone M, 2001, BIOPHYS CHEM, V90, P301, DOI 10.1016/S0301-4622(01)00160-0; Maccarrone M, 2009, CELL CYCLE, V8, P3, DOI 10.4161/cc.8.1.7671; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mic FA, 1999, CELL DEATH DIFFER, V6, P593; Ming Y., 2009, FASEB J, V23, pLB97; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; Nieves D, 2006, BIOCHEM PHARMACOL, V72, P1022, DOI 10.1016/j.bcp.2006.07.021; Ohnishi T, 1999, MUTAT RES-FUND MOL M, V430, P271, DOI 10.1016/S0027-5107(99)00138-4; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Pompeia C, 2002, BIOL CELL, V94, P251, DOI 10.1016/S0248-4900(02)01200-5; Ritz BW, 2006, FASEB J, V20, P305, DOI 10.1096/fj.04-3122fje; Scadding GW, 2010, CURR OPIN ALLERGY CL, V10, P370, DOI 10.1097/ACI.0b013e32833bfa20; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Simons DM, 2006, J APPL PHYSIOL, V100, P1287, DOI 10.1152/japplphysiol.00887.2005; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	55	37	40	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1791	1798		10.1096/fj.11-199406	http://dx.doi.org/10.1096/fj.11-199406			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22253478				2022-12-25	WOS:000303680800007
J	Qureshi, OS; Kaur, S; Hou, TZ; Jeffery, LE; Poulter, NS; Briggs, Z; Kenefeck, R; Willox, AK; Royle, SJ; Rappoport, JZ; Sansom, DM				Qureshi, Omar S.; Kaur, Satdip; Hou, Tie Zheng; Jeffery, Louisa E.; Poulter, Natalie S.; Briggs, Zoe; Kenefeck, Rupert; Willox, Anna K.; Royle, Stephen J.; Rappoport, Joshua Z.; Sansom, David M.			Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-ASSOCIATED MOLECULE-4; SURFACE EXPRESSION; TYROSINE PHOSPHORYLATION; CYTOPLASMIC TAIL; SRC KINASES; ANTIGEN-4; CD28; PROTEIN; GLYCOSPHINGOLIPIDS; LOCALIZATION	CTLA-4 is one of the most important negative regulators of the T cell immune response. However, the subcellular distribution of CTLA-4 is unusual for a receptor that interacts with cell surface transmembrane ligands in that CTLA-4 is rapidly internalized from the plasma membrane. It has been proposed that T cell activation can lead to stabilization of CTLA-4 expression at the cell surface. Here we have analyzed in detail the internalization, recycling, and degradation of CTLA-4. We demonstrate that CTLA-4 is rapidly internalized from the plasma membrane in a clathrin-and dynamin-dependent manner driven by the well characterized YVKM trafficking motif. Furthermore, we show that once internalized, CTLA-4 co-localizes with markers of recycling endosomes and is recycled to the plasma membrane. Although we observed limited co-localization of CTLA-4 with lysosomal markers, CTLA-4 was nonetheless degraded in a manner inhibited by lysosomal blockade. T cell activation stimulated mobilization of CTLA-4, as judged by an increase in cell surface expression; however, this pool of CTLA-4 continued to endocytose and was not stably retained at the cell surface. These data support a model of trafficking whereby CTLA-4 is constitutively internalized in a ligand-independent manner undergoing both recycling and degradation. Stimulation of T cells increases CTLA-4 turnover at the plasma membrane; however, CTLA-4 endocytosis continues and is not stabilized during activation of human T cells. These findings emphasize the importance of clathrin-mediated endocytosis in regulating CTLA-4 trafficking throughout T cell activation.	[Qureshi, Omar S.; Kaur, Satdip; Hou, Tie Zheng; Jeffery, Louisa E.; Briggs, Zoe; Kenefeck, Rupert; Sansom, David M.] Univ Birmingham, MRC Ctr Immune Regulat, Sch Immun & Infect, Sch Med, Birmingham B15 2TT, W Midlands, England; [Poulter, Natalie S.; Rappoport, Joshua Z.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Willox, Anna K.; Royle, Stephen J.] Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Willox, Anna K.; Royle, Stephen J.] Univ Liverpool, Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Birmingham; University of Liverpool; Cancer Research UK; University of Liverpool	Sansom, DM (corresponding author), Univ Birmingham, MRC Ctr Immune Regulat, Sch Immun & Infect, Sch Med, Birmingham B15 2TT, W Midlands, England.	D.M.Sansom@bham.ac.uk	HOU, TIEZHENG/B-4848-2015; Qureshi, Omar/CAF-4545-2022	Poulter, Natalie/0000-0002-3187-2130; Sansom, David/0000-0001-6506-3115; Kaur, Satdip/0000-0002-0901-9141; Royle, Stephen/0000-0001-8927-6967	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Medical Research Council; Wellcome Trust [092578]; Arthritis Research UK; Biotechnology and Biological Sciences Research Council [BB/H013598/1, BB/D011000/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish; Versus Arthritis [19364] Funding Source: researchfish; BBSRC [BB/H013598/1, BB/D011000/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported by an Medical Research Council Ph.D. studentship.; Supported by the Wellcome Trust (Grant 092578).; Supported by Arthritis Research UK.	Alegre ML, 1998, J IMMUNOL, V161, P3347; Barrat FJ, 1999, P NATL ACAD SCI USA, V96, P8645, DOI 10.1073/pnas.96.15.8645; Benmerah A, 1999, J CELL SCI, V112, P1303; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Catalfamo M, 2008, IMMUNOLOGY, V125, P70, DOI 10.1111/j.1365-2567.2008.02822.x; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chuang E, 1999, J IMMUNOL, V162, P1270; Chuang E, 1997, J IMMUNOL, V159, P144; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Follows ER, 2001, BIOCHEM J, V359, P427, DOI 10.1042/0264-6021:3590427; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Hu H, 2001, BIOCHEM BIOPH RES CO, V288, P573, DOI 10.1006/bbrc.2001.5814; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Miyatake S, 1998, BIOCHEM BIOPH RES CO, V249, P444, DOI 10.1006/bbrc.1998.9191; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Schneider H, 1999, J IMMUNOL, V163, P1868; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002	34	87	91	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9429	9440		10.1074/jbc.M111.304329	http://dx.doi.org/10.1074/jbc.M111.304329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262842	hybrid, Green Published			2022-12-25	WOS:000301797800072
J	von Bulow, J; Muller-Lucks, A; Kai, L; Bernhard, F; Beitz, E				von Buelow, Julia; Mueller-Lucks, Annika; Kai, Lei; Bernhard, Frank; Beitz, Eric			Functional Characterization of a Novel Aquaporin from Dictyostelium discoideum Amoebae Implies a Unique Gating Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; CELL-FREE EXPRESSION; PLASMODIUM-FALCIPARUM; CONTRACTILE VACUOLE; WATER CHANNEL; GENE FAMILY; MIP FAMILY; GLYCEROL; PERMEABILITY; TRANSPORT	The social amoeba Dictyostelium discoideum is a widely used model organism for studying basic functions of protozoan and metazoan cells, such as osmoregulation and cell motility. There is evidence from other species that cellular water channels, aquaporins (AQP), are central to both processes. Yet, data on D. discoideum AQPs is almost absent. Despite cloning of two putative D. discoideum AQPs, WacA, and AqpA, water permeability has not been shown. Further, WacA and AqpA are expressed at the late multicellular stage and in spores but not in amoebae. We cloned a novel AQP, AqpB, from amoeboidal D. discoideum cells. Wild-type AqpB was impermeable to water, glycerol, and urea when expressed in Xenopus laevis oocytes. Neither stepwise truncation of the N terminus nor selected point mutations activated the water channel. However, mutational truncation by 12 amino acids of an extraordinary long intracellular loop induced water permeability of AqpB, hinting at a novel gating mechanism. This AqpB mutant was inhibited by mercuric chloride, confirming the presence of a cysteine residue in the selectivity filter as predicted by our structure model. We detected AqpB by Western blot analysis in a glycosylated and a non-glycosylated form throughout all developmental stages. When expressed in D. discoideum amoebae, AqpB-GFP fusion constructs localized to vacuolar structures, to the plasma membrane, and to lamellipodia-like membrane protrusions. We conclude that the localization pattern in conjunction with channel gating may be indicative of AqpB functions in osmoregulation as well as cell motility of D. discoideum.	[Beitz, Eric] Univ Kiel, Inst Pharmaceut, Dept Med & Pharmaceut Chem, D-24118 Kiel, Germany; [Kai, Lei; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	University of Kiel; Goethe University Frankfurt	Beitz, E (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Med & Pharmaceut Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de	Kai, Lei/ABI-2652-2020	Kai, Lei/0000-0003-0879-7918; Bernhard, Frank/0000-0002-4860-1783	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to E. B.).	Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Beitz E, 2005, BIOL CELL, V97, P373, DOI 10.1042/BC20040095; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Flick KM, 1997, GENE, V195, P127, DOI 10.1016/S0378-1119(97)00078-4; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; GRIMBLEBY F, 1961, NATURE, V189, P835, DOI 10.1038/189835a0; Gupta R, 1999, GLYCOBIOLOGY, V9, P1009, DOI 10.1093/glycob/9.10.1009; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Haynes PA, 1998, GLYCOBIOLOGY, V8, P1, DOI 10.1093/glycob/8.1.1; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Mitra BN, 2000, GENE, V251, P131, DOI 10.1016/S0378-1119(00)00201-8; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; Pavlovic-Djuranovic S, 2006, BBA-BIOMEMBRANES, V1758, P1012, DOI 10.1016/j.bbamem.2005.12.002; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; RAPER KB, 1950, SCIENCE, V112, P450; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wu BH, 2010, J BIOL CHEM, V285, P40081, DOI 10.1074/jbc.M110.184457; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Zeuthen T, 2006, MOL MICROBIOL, V61, P1598, DOI 10.1111/j.1365-2958.2006.05325.x; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	46	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7487	7494		10.1074/jbc.M111.329102	http://dx.doi.org/10.1074/jbc.M111.329102			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262860	hybrid, Green Published			2022-12-25	WOS:000301060200049
J	Ihler, F; Vetter, EV; Pan, J; Kammerer, R; Debey-Pascher, S; Schultze, JL; Zimmermann, W; Enders, G				Ihler, Fritz; Vetter, Elena Viviana; Pan, Jie; Kammerer, Robert; Debey-Pascher, Svenja; Schultze, Joachim L.; Zimmermann, Wolfgang; Enders, Georg			Expression of a Neuroendocrine Gene Signature in Gastric Tumor Cells from CEA 424-SV40 Large T Antigen-Transgenic Mice Depends on SV40 Large T Antigen	PLOS ONE			English	Article							MOUSE MODEL; STEM-CELLS; SELF-RENEWAL; CARCINOMA; P53; RB; DIFFERENTIATION; POLYOMAVIRUS; INACTIVATION; CANCER	Background: A large fraction of murine tumors induced by transgenic expression of SV40 large T antigen (SV40 TAg) exhibits a neuroendocrine phenotype. It is unclear whether SV40 TAg induces the neuroendocrine phenotype by preferential transformation of progenitor cells committed to the neuroendocrine lineage or by transcriptional activation of neuroendocrine genes. Methodology/Principal Findings: To address this question we analyzed CEA424-SV40 TAg-transgenic mice that develop spontaneous tumors in the antral stomach region. Immunohistology revealed expression of the neuroendocrine marker chromogranin A in tumor cells. By ELISA an 18-fold higher level of serotonin could be detected in the blood of tumor-bearing mice in comparison to nontransgenic littermates. Transcriptome analyses of antral tumors combined with gene set enrichment analysis showed significant enrichment of genes considered relevant for human neuroendocrine tumor biology. This neuroendocrine gene signature was also expressed in 424GC, a cell line derived from a CEA424-SV40 TAg tumor, indicating that the tumor cells exhibit a similar neuroendocrine phenotype also in vitro. Treatment of 424GC cells with SV40 TAg-specific siRNA downregulated expression of the neuroendocrine gene signature. Conclusions/Significance: SV40 TAg thus appears to directly induce a neuroendocrine gene signature in gastric carcinomas of CEA424-SV40 TAg-transgenic mice. This might explain the high incidence of neuroendocrine tumors in other murine SV40 TAg tumor models. Since the oncogenic effect of SV40 TAg is caused by inactivation of the tumor suppressor proteins p53 and RB1 and loss of function of these proteins is commonly observed in human neuroendocrine tumors, a similar mechanism might cause neuroendocrine phenotypes in human tumors.	[Ihler, Fritz; Pan, Jie; Enders, Georg] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Ihler, Fritz] Univ Munich Hosp, IFBLMU Integrated Ctr Res & Treatment Vertigo, Munich, Germany; [Ihler, Fritz] Univ Gottingen Hosp, Dept ENT Head & Neck Surg, Gottingen, Germany; [Vetter, Elena Viviana; Pan, Jie; Zimmermann, Wolfgang] Univ Munich Hosp, LIFE Ctr, Tumor Immunol Lab, Munich, Germany; [Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Debey-Pascher, Svenja; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany	University of Munich; University of Munich; University of Gottingen; University of Munich; Friedrich Loeffler Institute; University of Bonn	Ihler, F (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.	fritz-ihler@gmx.net	Schultze, Joachim L/D-7794-2011; Zimmermann, Wolfgang/L-9277-2013; Kammerer, Robert/AAQ-1338-2021; Schultze, Joachim L./ABA-8176-2020	Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Ihler, Friedrich/0000-0001-7066-4994; Kammerer, Robert/0000-0003-3038-8205	Faculty of Medicine; University of Munich	Faculty of Medicine; University of Munich	This work was partly funded by the FoFoLe program of the Faculty of Medicine and a grant to JP from the CSC program of the University of Munich and is part of the doctoral theses of FI, EVV and JP at the University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Cantalupo PG, 2009, VIROLOGY, V386, P183, DOI 10.1016/j.virol.2008.12.038; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Czeh M, 2010, ONCOGENE, V29, P6591, DOI 10.1038/onc.2010.388; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FEUCHTER AE, 1992, VIROLOGY, V187, P242, DOI 10.1016/0042-6822(92)90312-D; Furth PA, 1998, DEV BIOL STAND, V94, P281; Gasi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016332; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goedert JJ, 2009, J CLIN ONCOL, V27, P4021, DOI 10.1200/JCO.2009.22.6605; Gum JR, 2004, MOL CANCER RES, V2, P504; Hiroshima K, 2004, CANCER-AM CANCER SOC, V100, P1190, DOI 10.1002/cncr.20108; Hofsli Eva, 2006, Pituitary, V9, P165, DOI 10.1007/s11102-006-0262-5; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Hulleman E, 2009, J CELL MOL MED, V13, P136, DOI 10.1111/j.1582-4934.2008.00307.x; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Lin PP, 2009, CARCINOGENESIS, V30, P1789, DOI 10.1093/carcin/bgp180; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nockel J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-57; Reiner T, 2007, MOL CANCER RES, V5, P1171, DOI 10.1158/1541-7786.MCR-07-0024; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2009, AM J TRANSL RES, V1, P148; Syder AJ, 2004, P NATL ACAD SCI USA, V101, P4471, DOI 10.1073/pnas.0307983101; Thompson J, 2000, INT J CANCER, V86, P863, DOI 10.1002/(SICI)1097-0215(20000615)86:6<863::AID-IJC16>3.0.CO;2-4; Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO;2-F; Ulanet DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012454; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	40	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29846	10.1371/journal.pone.0029846	http://dx.doi.org/10.1371/journal.pone.0029846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253802	Green Submitted, gold, Green Published			2022-12-25	WOS:000301361500023
J	Le Nouen, C; Toquin, D; Muller, H; Raue, R; Kean, KM; Langlois, P; Cherbonnel, M; Eterradossi, N				Le Nouen, Cyril; Toquin, Didier; Mueller, Hermann; Raue, Ruediger; Kean, Katherine M.; Langlois, Patrick; Cherbonnel, Martine; Eterradossi, Nicolas			Different Domains of the RNA Polymerase of Infectious Bursal Disease Virus Contribute to Virulence	PLOS ONE			English	Article							CAPSID PROTEIN VP3; GENOME SEGMENT-B; BIRNAVIRUS VP1; ACTIVE-SITE; IN-VITRO; NONSTRUCTURAL PROTEIN; GENETIC-RELATIONSHIPS; PATHOGENIC PHENOTYPE; AMINO-ACIDS; CLONED CDNA	Background: Infectious bursal disease virus (IBDV) is a pathogen of worldwide significance to the poultry industry. IBDV has a bi-segmented double-stranded RNA genome. Segments A and B encode the capsid, ribonucleoprotein and non-structural proteins, or the virus polymerase (RdRp), respectively. Since the late eighties, very virulent (vv) IBDV strains have emerged in Europe inducing up to 60% mortality. Although some progress has been made in understanding the molecular biology of IBDV, the molecular basis for the pathogenicity of vvIBDV is still not fully understood. Methodology, Principal Findings: Strain 88180 belongs to a lineage of pathogenic IBDV phylogenetically related to vvIBDV. By reverse genetics, we rescued a molecular clone (mc88180), as pathogenic as its parent strain. To study the molecular basis for 88180 pathogenicity, we constructed and characterized in vivo reassortant or mosaic recombinant viruses derived from the 88180 and the attenuated Cu-1 IBDV strains. The reassortant virus rescued from segments A of 88180 (A88) and B of Cu-1 (BCU1) was milder than mc88180 showing that segment B is involved in 88180 pathogenicity. Next, the exchange of different regions of BCU1 with their counterparts in B88 in association with A88 did not fully restore a virulence equivalent to mc88180. This demonstrated that several regions if not the whole B88 are essential for the in vivo pathogenicity of 88180. Conclusion, Significance: The present results show that different domains of the RdRp, are essential for the in vivo pathogenicity of IBDV, independently of the replication efficiency of the mosaic viruses.	[Le Nouen, Cyril; Toquin, Didier; Cherbonnel, Martine; Eterradossi, Nicolas] French Agcy Food Environm & Occupat Hlth Safety A, OIE Reference Lab Infect Bursal Dis, Immunol & Parasitol Unit, Ploufragan, France; [Mueller, Hermann; Raue, Ruediger] Univ Leipzig, Fac Vet Med, Inst Virol, Leipzig, Germany; [Kean, Katherine M.] Inst Pasteur, CNRS URA 3015, Paris, France; [Langlois, Patrick] French Agcy Food Environm & Occupat Hlth Safety A, Virus Genet & Biosecur Unit, Ploufragan, France	Leipzig University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Le Nouen, C (corresponding author), NIAID, LID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	nicolas.eterradossi@anses.fr			AFSSA [PR-2002/7]; European Union; Conseil Regional de Bretagne	AFSSA; European Union(European Commission); Conseil Regional de Bretagne(Region Bretagne)	This work was supported by AFSSA grant PR-2002/7, by European Union Concerted Action Cost 839, and by Conseil Regional de Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Boot HJ, 2000, J VIROL, V74, P6701, DOI 10.1128/JVI.74.15.6701-6711.2000; Boot HJ, 2005, ARCH VIROL, V150, P137, DOI 10.1007/s00705-004-0405-9; Boot HJ, 2004, NUCLEIC ACIDS RES, V32, P211, DOI 10.1093/nar/gkh177; Boot HJ, 1999, VIROLOGY, V265, P330, DOI 10.1006/viro.1999.0042; Borman AM, 2002, J BIOL CHEM, V277, P36818, DOI 10.1074/jbc.M205065200; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; BROWN MD, 1994, J GEN VIROL, V75, P675, DOI 10.1099/0022-1317-75-3-675; BYGRAVE AC, 1970, VET REC, V86, P758; CALVERT JG, 1991, J GEN VIROL, V72, P2563, DOI 10.1099/0022-1317-72-10-2563; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Cornell CT, 2004, J VIROL, V78, P13007, DOI 10.1128/JVI.78.23.13007-13018.2004; Cornell CT, 2004, J VIROL, V78, P4397, DOI 10.1128/JVI.78.9.4397-4407.2004; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Delmas B, 2004, VIRUS TAXONOMY, P561; DUNCAN R, 1991, VIROLOGY, V181, P541, DOI 10.1016/0042-6822(91)90887-H; Eterradossi N, 1999, AVIAN PATHOL, V28, P36, DOI 10.1080/03079459995028; Eterradossi N, 1998, ARCH VIROL, V143, P1627, DOI 10.1007/s007050050404; Eterradossi N, 2004, AVIAN PATHOL, V33, P423, DOI 10.1080/03079450410001724049; ETERRADOSSI N, 1992, J VET MED B, V39, P683, DOI 10.1111/j.1439-0450.1992.tb01222.x; Eterradossi N, 1997, ARCH VIROL, V142, P255, DOI 10.1007/s007050050075; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Herrera M, 2007, PLOS PATHOG, V3, P498, DOI 10.1371/journal.ppat.0030053; Hon CC, 2006, J VIROL, V80, P8503, DOI 10.1128/JVI.00585-06; HUDSON PJ, 1986, NUCLEIC ACIDS RES, V14, P5001, DOI 10.1093/nar/14.12.5001; Islam MR, 2001, ARCH VIROL, V146, P2481, DOI 10.1007/s007050170018; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; LASHER HN, 1994, WORLD POULTRY SCI J, V50, P133, DOI 10.1079/WPS19940013; Le Nouen C, 2006, J GEN VIROL, V87, P209, DOI 10.1099/vir.0.81184-0; Le Nouen C, 2005, ARCH VIROL, V150, P313, DOI 10.1007/s00705-004-0409-5; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Letzel T, 2007, J VIROL, V81, P12827, DOI 10.1128/JVI.01501-07; Letzel T, 2007, J GEN VIROL, V88, P2824, DOI 10.1099/vir.0.82890-0; Lim BL, 1999, J VIROL, V73, P2854, DOI 10.1128/JVI.73.4.2854-2862.1999; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; MACREADIE IG, 1993, BIOCHEM MOL BIOL INT, V30, P1169; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; MULLER H, 1987, VIROLOGY, V159, P174, DOI 10.1016/0042-6822(87)90363-1; Mundt E, 1999, J GEN VIROL, V80, P2067, DOI 10.1099/0022-1317-80-8-2067; Mundt E, 1996, P NATL ACAD SCI USA, V93, P11131, DOI 10.1073/pnas.93.20.11131; MUNDT E, 1995, J GEN VIROL, V76, P437, DOI 10.1099/0022-1317-76-2-437; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Pan JH, 2009, VIROLOGY, V395, P87, DOI 10.1016/j.virol.2009.09.004; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Raue R, 2004, AVIAN PATHOL, V33, P181, DOI 10.1080/03079450310001652112; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHNITZLER D, 1993, J GEN VIROL, V74, P1563, DOI 10.1099/0022-1317-74-8-1563; Schroder A, 2000, J GEN VIROL, V81, P533, DOI 10.1099/0022-1317-81-2-533; Schroder A, 2001, J GEN VIROL, V82, P159, DOI 10.1099/0022-1317-82-1-159; Shwed PS, 2002, VIROLOGY, V296, P241, DOI 10.1006/viro.2001.1334; SKEELES JK, 1979, AVIAN DIS, V23, P456, DOI 10.2307/1589576; Tacken MGJ, 2000, J GEN VIROL, V81, P209, DOI 10.1099/0022-1317-81-1-209; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; van den Berg TP, 2000, AVIAN PATHOL, V29, P175, DOI 10.1080/03079450050045431; van Loon AAWM, 2002, J GEN VIROL, V83, P121, DOI 10.1099/0022-1317-83-1-121; VANDENBERG TP, 1991, AVIAN PATHOL, V20, P133, DOI 10.1080/03079459108418748; Vignuzzi M, 2005, NATURE; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Wei YW, 2008, VIRUS RES, V131, P279, DOI 10.1016/j.virusres.2007.08.013; Wei YW, 2006, BIOCHEM BIOPH RES CO, V350, P277, DOI 10.1016/j.bbrc.2006.09.040; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Xu HT, 2004, VIROLOGY, V322, P199, DOI 10.1016/j.virol.2004.01.024; Yao K, 2001, VIROLOGY, V285, P50, DOI 10.1006/viro.2001.0947; Zierenberg K, 2004, VIRUS RES, V105, P23, DOI 10.1016/j.virusres.2004.04.009	78	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e28064	10.1371/journal.pone.0028064	http://dx.doi.org/10.1371/journal.pone.0028064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253687	Green Submitted, Green Published, gold			2022-12-25	WOS:000301361500001
J	Zhang, D; Shao, C; Hu, SQ; Ma, SC; Gao, YH				Zhang, Dan; Shao, Chen; Hu, Siqi; Ma, Sucan; Gao, Youhe			Novel Nonphosphorylated Peptides with Conserved Sequences Selectively Bind to Grb7 SH2 Domain with Affinity Comparable to Its Phosphorylated Ligand	PLOS ONE			English	Article							STRUCTURAL BASIS; PROTEIN; GROWTH; RECEPTOR; IDENTIFICATION; ASSOCIATION; INHIBITION; MIGRATION; REVEALS; COMPLEX	The Grb7 (growth factor receptor-bound 7) protein, a member of the Grb7 protein family, is found to be highly expressed in such metastatic tumors as breast cancer, esophageal cancer, liver cancer, etc. The src-homology 2 (SH2) domain in the C-terminus is reported to be mainly involved in Grb7 signaling pathways. Using the random peptide library, we identified a series of Grb7 SH2 domain-binding nonphosphorylated peptides in the yeast two-hybrid system. These peptides have a conserved GIPT/K/N sequence at the N-terminus and G/WD/IP at the C-terminus, and the region between the N- and C-terminus contains fifteen amino acids enriched with serines, threonines and prolines. The association between the nonphosphorylated peptides and the Grb7 SH2 domain occurred in vitro and ex vivo. When competing for binding to the Grb7 SH2 domain in a complex, one synthesized nonphosphorylated ligand, containing the twenty-two amino acid-motif sequence, showed at least comparable affinity to the phosphorylated ligand of ErbB3 in vitro, and its overexpression inhibited the proliferation of SK-BR-3 cells. Such nonphosphorylated peptides may be useful for rational design of drugs targeted against cancers that express high levels of Grb7 protein.	[Zhang, Dan; Shao, Chen; Ma, Sucan; Gao, Youhe] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll,Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol,Sch Basic Med, Beijing 100730, Peoples R China; [Hu, Siqi] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College	Zhang, D (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll,Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol,Sch Basic Med, Beijing 100730, Peoples R China.	gaoyouhe@pumc.edu.cn			National Natural Science Foundation [30725009, 30870502]; Ministry of Public Health [20082007]; Beijing Natural Science Foundation [5072037]; Research Fund for the Doctoral Program of Higher Education [20070023021]; Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT [IRT0909]; 111 Project [B08007]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Public Health; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation (30725009, 30870502), a Research Grant for Public Interest from the Ministry of Public Health (20082007), the Beijing Natural Science Foundation (5072037), the Research Fund for the Doctoral Program of Higher Education (20070023021), the Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT (IRT0909), and the 111 Project (B08007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaye ND, 2011, BIOORGAN MED CHEM, V19, P693, DOI 10.1016/j.bmc.2010.10.030; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bradshaw JM, 2003, ADV PROTEIN CHEM, V61, P161; Cailliau K, 2003, FEBS LETT, V548, P43, DOI 10.1016/S0014-5793(03)00726-9; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; dos Santos SM, 2010, PLATELETS, V21, P60, DOI 10.3109/09537100903410609; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Haran M, 2004, LEUKEMIA, V18, P1948, DOI 10.1038/sj.leu.2403512; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Ivancic M, 2003, J BIOMOL NMR, V27, P205, DOI 10.1023/A:1025498409113; Kasus-Jacobi A, 2000, ONCOGENE, V19, P2052, DOI 10.1038/sj.onc.1203469; Keane MM, 1996, CANCER RES, V56, P4236; KOCH CA, 1992, MOL CELL BIOL, V12, P1366, DOI 10.1128/MCB.12.3.1366; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lucas-Fernandez E, 2008, CURR GENOMICS, V9, P60, DOI 10.2174/138920208783884847; MULLER AJ, 1992, MOL CELL BIOL, V12, P5087, DOI 10.1128/MCB.12.11.5087; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; OOI J, 1995, ONCOGENE, V10, P1621; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; Pero SC, 2007, BRIT J CANCER, V96, P1520, DOI 10.1038/sj.bjc.6603732; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Pias SC, 2010, CRIT REV IMMUNOL, V30, P299, DOI 10.1615/CritRevImmunol.v30.i3.70; Porter CJ, 2005, EUR BIOPHYS J BIOPHY, V34, P454, DOI [10.1007/s00249-005-0480-1, 10.1007/s00249-005-0480-l]; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Spuches AM, 2007, J MOL RECOGNIT, V20, P245, DOI 10.1002/jmr.834; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Vayssiere B, 2000, FEBS LETT, V467, P91, DOI 10.1016/S0014-5793(99)01530-6; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29902	10.1371/journal.pone.0029902	http://dx.doi.org/10.1371/journal.pone.0029902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253820	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700064
J	Fujita, M; Onami, S				Fujita, Masashi; Onami, Shuichi			Cell-to-Cell Heterogeneity in Cortical Tension Specifies Curvature of Contact Surfaces in Caenorhabditis elegans Embryos	PLOS ONE			English	Article							C-ELEGANS; POLARITY; MECHANICS; DIVISION; ADHESION; TISSUE; ASYMMETRY; ESTABLISH; PROTEINS; COMPLEX	In the two cell stage embryos of Caenorhabditis elegans, the contact surface of the two blastomeres forms a curve that bulges from the AB blastomere to the Pi blastomere. This curve is a consequence of the high intracellular hydrostatic pressure of AB compared with that of P-1. However, the higher pressure in AB is intriguing because AB has a larger volume than P-1. In soap bubbles, which are a widely used model of cell shape, a larger bubble has lower pressure than a smaller bubble. Here, we reveal that the higher pressure in AB is mediated by its higher cortical tension. The cell fusion experiments confirmed that the curvature of the contact surface is related to the pressure difference between the cells. Chemical and genetic interferences showed that the pressure difference is mediated by actomyosin. Fluorescence imaging indicated that non-muscle myosin is enriched in the AB cortex. The cell killing experiments provided evidence that AB but not P-1 is responsible for the Pressure difference. Computer simulation clarified that the cell-to-cell heterogeneity of cortical tensions is indispensable for explaining the pressure difference. This study demonstrates that heterogeneity in surface tension results significant deviations of cell behavior compared to simple soap bubble models, and thus must be taken into consideration in understanding cell shape within embryos.	[Fujita, Masashi; Onami, Shuichi] RIKEN, Quantitat Biol Ctr, Lab Dev Dynam, Kobe, Hyogo, Japan; [Fujita, Masashi; Onami, Shuichi] RIKEN, Adv Sci Inst, Dev Syst Modeling Team, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Fujita, M (corresponding author), RIKEN, Quantitat Biol Ctr, Lab Dev Dynam, Kobe, Hyogo, Japan.	sonami@riken.jp	Fujita, Masashi/R-6998-2018; Onami, Shuichi/N-5498-2015	Fujita, Masashi/0000-0002-1457-6233; Onami, Shuichi/0000-0002-8255-1724	Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH National Center for Research Resources (NCRR)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants from KAKENHI (Grant-in-Aid for Scientific Research) on the "Systems Genomics" Priority Area from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jon Audhya for the GFP::PH strain. Other strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We thank all the members of the Onami laboratory for discussions and critical reading of the manuscript.	Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Brakke K, 1992, EXP MATH, V1, P141, DOI DOI 10.1080/10586458.1992.10504253; BRENNER S, 1974, GENETICS, V77, P71; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Corson F, 2009, P NATL ACAD SCI USA, V106, P8453, DOI 10.1073/pnas.0812493106; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Dougherty ER, 2003, SPIE TUTORIAL TEXTS; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hilgenfeldt S, 2008, P NATL ACAD SCI USA, V105, P907, DOI 10.1073/pnas.0711077105; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Liu J, 2010, DEV BIOL, V339, P366, DOI 10.1016/j.ydbio.2009.12.041; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; SCHIERENBERG E, 1984, DEV BIOL, V101, P240, DOI 10.1016/0012-1606(84)90136-2; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Thompson D.W, 1917, GROWTH FORM; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Vianay B, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128101; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Weaire D., 1999, PHYS FOAMS; Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997	34	10	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					463	471	e30224	10.1371/journal.pone.0030224	http://dx.doi.org/10.1371/journal.pone.0030224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253922	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900047
J	Sato, H; Tanaka, T; Tanaka, N				Sato, Hiroaki; Tanaka, Toshiko; Tanaka, Noriyuki			The Effect of p38 Mitogen-Activated Protein Kinase Activation on Inflammatory Liver Damage following Hemorrhagic Shock in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; CYTOKINE PRODUCTION; KUPFFER CELLS; LUNG INJURY; DYSFUNCTION; TRAUMA; MICE; FR167653; HEMORRHAGE/RESUSCITATION	Hemorrhagic shock is a frequent cause of liver failure and often leads to a fatal outcome. Several studies have revealed that p38 MAPK is a key mediator in hemorrhagic damage of the primary organs through the activation of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. However, the precise role of these factors in liver damage following hemorrhagic shock is unclear. In this study, we used FR167653, a specific inhibitor of p38 MAPK phosphorylation, to examine the role of p38 MAPK in liver damage occurring up to 5 hours after a hemorrhagic episode in a rat model. Activation of p38 MAPK in the liver as well as an increase in hepatic mRNA expression and serum concentrations of TNF-alpha and IL-1 beta occurred during the early phase after hemorrhage. Increased serum levels of hepatic enzymes, as well as histological damage and activated neutrophil accumulation in the liver, were observed in the late phase following hemorrhagic shock. FR167653 inhibited the inflammation-related hepatic injury following hemorrhagic shock. Bacterial lipopolysaccharide (LPS) derived from the gut appeared to have little effects on the hepatic damage. These results demonstrate that p38 MAPK activation is induced by hepatic ischemia during hemorrhagic shock and plays an important role both in the hepatic expression of proinflammatory cytokines and in the development of inflammation-related liver damage.	[Sato, Hiroaki; Tanaka, Toshiko; Tanaka, Noriyuki] Univ Occupat & Environm Hlth, Dept Forens Med, Kitakyushu, Fukuoka 807, Japan	University of Occupational & Environmental Health - Japan	Sato, H (corresponding author), Univ Occupat & Environm Hlth, Dept Forens Med, Kitakyushu, Fukuoka 807, Japan.	h-sato@med.uoeh-u.ac.jp			University of Occupational and Environmental Health, Japan Foundation	University of Occupational and Environmental Health, Japan Foundation	This work has been financially supported by the University of Occupational and Environmental Health, Japan Foundation. The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Alchera E, 2010, WORLD J GASTROENTERO, V16, P6058, DOI 10.3748/wjg.v16.i48.6058; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; BITTERMAN H, 1991, CIRC SHOCK, V33, P183; Chen C, 2009, SHOCK, V31, P486, DOI 10.1097/SHK.0b013e318188f7e1; Chen Xu-Lin, 2005, Zhonghua Wai Ke Za Zhi, V43, P185; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; Granger DN, 1981, ANNU REV PHYSIOL, V43, P409, DOI 10.1146/annurev.ph.43.030181.002205; Guo XC, 2003, J BIOL CHEM, V278, P22237, DOI 10.1074/jbc.M300847200; Hato S, 2001, EUR SURG RES, V33, P202, DOI 10.1159/000049707; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; JIANG JX, 1995, ANN SURG, V221, P100, DOI 10.1097/00000658-199501000-00012; Jiang JX, 2002, SHOCK, V18, P336, DOI 10.1097/00024382-200210000-00008; Kan WH, 2008, J APPL PHYSIOL, V105, P1076, DOI 10.1152/japplphysiol.90495.2008; Khadaroo RG, 2002, SURGERY, V132, P360, DOI 10.1067/msy.2002.126096; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; KINOSHITA G, 1995, J VET MED SCI, V57, P703, DOI 10.1292/jvms.57.703; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Lehnert M, 2003, SHOCK, V19, P345, DOI 10.1097/00024382-200304000-00009; Lehnert M, 2006, AM J PHYSIOL-GASTR L, V291, pG456, DOI 10.1152/ajpgi.00480.2005; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Matsumoto Y, 2002, SHOCK, V17, P411, DOI 10.1097/00024382-200205000-00012; Matsutani T, 2007, AM J PHYSIOL-GASTR L, V292, pG268, DOI 10.1152/ajpgi.00313.2006; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P1368, DOI 10.1016/j.freeradbiomed.2011.02.021; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Rao JH, 2010, BIOL PHARM BULL, V33, P869, DOI 10.1248/bpb.33.869; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f; Sato H, 2008, MED SCI MONITOR, V14, pBR79; Sato H, 2007, SHOCK, V28, P291, DOI 10.1097/SHK.0b013e3180326e3d; Takahashi S, 2001, J PHARMACOL EXP THER, V296, P48; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; van den Berg HR, 2009, SHOCK, V31, P285, DOI 10.1097/SHK.0b013e31817fd62a; WOMACK NA, 1957, ANN SURG, V146, P691, DOI 10.1097/00000658-195710000-00015	34	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30124	10.1371/journal.pone.0030124	http://dx.doi.org/10.1371/journal.pone.0030124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253904	Green Submitted, gold, Green Published			2022-12-25	WOS:000315865800027
J	Duarte, CW; Willey, CD; Zhi, DG; Cui, XQ; Harris, JJ; Vaughan, LK; Mehta, T; McCubrey, RO; Khodarev, NN; Weichselbaum, RR; Gillespie, GY				Duarte, Christine W.; Willey, Christopher D.; Zhi, Degui; Cui, Xiangqin; Harris, Jacqueline J.; Vaughan, Laura Kelly; Mehta, Tapan; McCubrey, Raymond O.; Khodarev, Nikolai N.; Weichselbaum, Ralph R.; Gillespie, G. Yancey			Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner	PLOS ONE			English	Article							MALIGNANT GLIOMA; RADIATION; STAT1; CELLS; RADIORESISTANCE; CHEMOTHERAPY; TEMOZOLOMIDE; RESISTANCE; THERAPY; BREAST	Previous reports have implicated an induction of genes in IFN/STAT1 (Interferon/STAT1) signaling in radiation resistant and prosurvival tumor phenotypes in a number of cancer cell lines, and we have hypothesized that upregulation of these genes may be predictive of poor survival outcome and/or treatment response in Glioblastoma Multiforme (GBM) patients. We have developed a list of 8 genes related to IFN/STAT1 that we hypothesize to be predictive of poor survival in GBM patients. Our working hypothesis that over-expression of this gene signature predicts poor survival outcome in GBM patients was confirmed, and in addition, it was demonstrated that the survival model was highly subtype-dependent, with strong dependence in the Proneural subtype and no detected dependence in the Classical and Mesenchymal subtypes. We developed a specific multi-gene survival model for the Proneural subtype in the TCGA (the Cancer Genome Atlas) discovery set which we have validated in the TCGA validation set. In addition, we have performed network analysis in the form of Bayesian Network discovery and Ingenuity Pathway Analysis to further dissect the underlying biology of this gene signature in the etiology of GBM. We theorize that the strong predictive value of the IFN/STAT1 gene signature in the Proneural subtype may be due to chemotherapy and/or radiation resistance induced through prolonged constitutive signaling of these genes during the course of the illness. The results of this study have implications both for better prediction models for survival outcome in GBM and for improved understanding of the underlying subtype-specific molecular mechanisms for GBM tumor progression and treatment response.	[Duarte, Christine W.; Zhi, Degui; Cui, Xiangqin; Harris, Jacqueline J.; Vaughan, Laura Kelly; Mehta, Tapan; McCubrey, Raymond O.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg Neurosurg, Birmingham, AL USA; [Khodarev, Nikolai N.; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Chicago	Duarte, CW (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	cduarte@uab.edu		Willey, Christopher/0000-0001-9953-0279; Cui, Xiangqin/0000-0003-0621-9313; Gillespie, George/0000-0001-6436-9542	Science Applications International Corporation (SAIC) [S08-221ST TO4]; National Institutes of Health (NIH) [T32-Hl007457, CA097247, CA071933, K01 DK080188]; NATIONAL CANCER INSTITUTE [P01CA071933, P50CA097247, P20CA151129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080188] Funding Source: NIH RePORTER	Science Applications International Corporation (SAIC); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Science Applications International Corporation (SAIC) (S08-221ST TO4), National Institutes of Health (NIH) T32-Hl007457 (JJH), NIH CA097247 and CA071933, K01 DK080188 (LKV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkova L, 2007, FOLIA BIOL-PRAGUE, V53, P1; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Chandana SR, 2008, AM FAM PHYSICIAN, V77, P1423; Dimco G, 2010, CELL CYCLE, V9, P4638, DOI 10.4161/cc.9.23.13955; Dobelbower MC, 2011, J MED IMAG RADIAT ON, V55, P77, DOI 10.1111/j.1754-9485.2010.02232.x; Duex JE, 2011, J BIOL CHEM; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Parker JN, 2009, NEUROTHERAPEUTICS, V6, P558, DOI 10.1016/j.nurt.2009.04.011; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Stupp R, 2009, ANN ONCOL, V20, P126, DOI 10.1093/annonc/mdp151; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	22	92	96	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29653	10.1371/journal.pone.0029653	http://dx.doi.org/10.1371/journal.pone.0029653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242177	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100032
J	Schrauder, MG; Strick, R; Schulz-Wendtland, R; Strissel, PL; Kahmann, L; Loehberg, CR; Lux, MP; Jud, SM; Hartmann, A; Hein, A; Bayer, CM; Bani, MR; Richter, S; Adamietz, BR; Wenkel, E; Rauh, C; Beckmann, MW; Fasching, PA				Schrauder, Michael G.; Strick, Reiner; Schulz-Wendtland, Ruediger; Strissel, Pamela L.; Kahmann, Laura; Loehberg, Christian R.; Lux, Michael P.; Jud, Sebastian M.; Hartmann, Arndt; Hein, Alexander; Bayer, Christian M.; Bani, Mayada R.; Richter, Swetlana; Adamietz, Boris R.; Wenkel, Evelyn; Rauh, Claudia; Beckmann, Matthias W.; Fasching, Peter A.			Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection	PLOS ONE			English	Article							MYCN-AMPLIFIED NEUROBLASTOMA; LYMPH-NODE METASTASIS; ESTROGEN-RECEPTOR; EXPRESSION PROFILES; LUNG-CANCER; BIOMARKERS; MIRNAS; TARGET; LET-7; PROGNOSIS	Introduction: MicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detection due to their remarkable stability in blood and their characteristic expression in many different diseases. We investigated whether microarray-based miRNA profiling on whole blood could discriminate between early stage breast cancer patients and healthy controls. Methods: We performed microarray-based miRNA profiling on whole blood of 48 early stage breast cancer patients at diagnosis along with 57 healthy individuals as controls. This was followed by a real-time semi-quantitative Polymerase Chain Reaction (RT-qPCR) validation in a separate cohort of 24 early stage breast cancer patients from a breast cancer screening unit and 24 age matched controls using two differentially expressed miRNAs (miR-202, miR-718). Results: Using the significance level of p<0.05, we found that 59 miRNAs were differentially expressed in whole blood of early stage breast cancer patients compared to healthy controls. 13 significantly up-regulated miRNAs and 46 significantly down-regulated miRNAs in our microarray panel of 1100 miRNAs and miRNA star sequences could be detected. A set of 240 miRNAs that was evaluated by radial basis function kernel support vector machines and 10-fold cross validation yielded a specificity of 78.8%, and a sensitivity of 92.5%, as well as an accuracy of 85.6%. Two miRNAs were validated by RT-qPCR in an independent cohort. The relative fold changes of the RT-qPCR validation were in line with the microarray data for both miRNAs, and statistically significant differences in miRNA-expression were found for miR-202. Conclusions: MiRNA profiling in whole blood has potential as a novel method for early stage breast cancer detection, but there are still challenges that need to be addressed to establish these new biomarkers in clinical use.	[Schrauder, Michael G.; Strick, Reiner; Strissel, Pamela L.; Kahmann, Laura; Loehberg, Christian R.; Lux, Michael P.; Jud, Sebastian M.; Hein, Alexander; Bayer, Christian M.; Bani, Mayada R.; Richter, Swetlana; Rauh, Claudia; Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Obstet & Gynaecol, D-91054 Erlangen, Germany; [Schrauder, Michael G.; Strick, Reiner; Strissel, Pamela L.; Kahmann, Laura; Loehberg, Christian R.; Lux, Michael P.; Jud, Sebastian M.; Hein, Alexander; Bayer, Christian M.; Bani, Mayada R.; Richter, Swetlana; Rauh, Claudia; Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen Nuremberg, D-91054 Erlangen, Germany; [Schulz-Wendtland, Ruediger; Adamietz, Boris R.; Wenkel, Evelyn] Univ Hosp Erlangen, Inst Diagnost Radiol, Erlangen, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schrauder, MG (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Obstet & Gynaecol, D-91054 Erlangen, Germany.	Michael.Schrauder@uk-erlangen.de	Hein, Alexander/F-6999-2010; Fasching, Peter A/ABH-9912-2020; Jud, Sebastian Michael/G-2752-2010	Hein, Alexander/0000-0003-2601-3398; Fasching, Peter A/0000-0003-4885-8471; Jud, Sebastian Michael/0000-0002-8894-2785; Lux, Michael Patrick/0000-0002-2781-2178	ELAN-Fonds of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg [09.11.09.1]	ELAN-Fonds of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg	This research was supported by a grant to MGS by the ELAN-Fonds of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg (reference number: 09.11.09.1) (http://www.elan.uk-erlangen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beekman Johanna M., 2009, Journal of Pharmacological and Toxicological Methods, V59, P44, DOI 10.1016/j.vascn.2008.10.003; Benjamin H, 2010, J MOL DIAGN; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Britton P, 2011, BR J RADIOL; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; D'Orsi CJ, 2011, SEMIN ONCOL, V38, P119, DOI 10.1053/j.seminoncol.2010.11.004; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Di Stefano V, 2011, VASCUL PHARM; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, GUT, V59, P1002, DOI 10.1136/gut.2009.200121; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Heneghan HM, 2010, CURR OPIN PHARM; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kastl L, 2011, BREAST CANC RES TREA; Keller A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-539; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Miglioretti DL, 2011, RADIOLOGY, V258, P372, DOI 10.1148/radiol.10100974; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinclair N, 2011, AM J ROENTGENOL, V197, P1268, DOI 10.2214/AJR.10.5442; Smeets A, 2011, BREAST CANCER RES TR, V129, P767, DOI 10.1007/s10549-010-1265-5; Sun G, 2011, TRENDS PHARM SCI; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	80	202	216	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29770	10.1371/journal.pone.0029770	http://dx.doi.org/10.1371/journal.pone.0029770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242178	gold, Green Submitted, Green Published			2022-12-25	WOS:000312662100034
J	Asada, R; Saito, A; Kawasaki, N; Kanemoto, S; Iwamoto, H; Oki, M; Miyagi, H; Izumi, S; Imaizumi, K				Asada, Rie; Saito, Atsushi; Kawasaki, Noritaka; Kanemoto, Soshi; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Izumi, Soutarou; Imaizumi, Kazunori			The Endoplasmic Reticulum Stress Transducer OASIS Is involved in the Terminal Differentiation of Goblet Cells in the Large Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR XBP-1; ER STRESS; CELLULAR PHYSIOLOGY; CREB/ATF-FAMILY; GENE-EXPRESSION; MICE; ASTROCYTES; EPITHELIUM	OASIS is a basic leucine zipper transmembrane transcription factor localized in the endoplasmic reticulum (ER) that is cleaved in its transmembrane region in response to ER stress. This novel ER stress transducer has been demonstrated to express in osteoblasts and astrocytes and promote terminal maturation of these cells. Additionally, OASIS is highly expressed in goblet cells of the large intestine. In this study, we investigated the roles of OASIS in goblet cell differentiation in the large intestine. To analyze the functions of OASIS in goblet cells, we examined morphological changes and the expression of goblet cell differentiation markers in the large intestine of Oasis(-/-) mice. By disrupting the Oasis gene, the number of goblet cells and production of mucus were decreased in the large intestine. Oasis(-/-) goblet cells showed abnormal morphology of mucous vesicles and rough ER. The expression levels of mature goblet cell markers were lower, and conversely those of early goblet cell markers were higher in Oasis(-/-) mice, indicating that differentiation from early to mature goblet cells is impaired in Oasis(-/-) mice. To determine the association of OASIS with other factors involved in goblet cell differentiation, in vitro experiments using a cell culture model were performed. We found that OASIS was activated in response to mild ER stress that is induced in differentiating goblet cells. Knockdown of the Oasis transcript perturbed goblet cell terminal differentiation. Together, our data indicate that OASIS plays crucial roles in promoting the differentiation of early goblet cells to mature goblet cells in the large intestine.	[Asada, Rie; Saito, Atsushi; Kawasaki, Noritaka; Kanemoto, Soshi; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Izumi, Soutarou; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Imaizumi, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science [22020030, 22800049]; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Pharmacological Research Foundation Tokyo; Daiichi-Sankyo Foundation of Life Science; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Pharmacological Research Foundation Tokyo(Pharmacological Research Foundation, Tokyo); Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation)	This work was partly supported by Japan Society for the Promotion of Science KAKENHI Grants 22020030 and 22800049 and by the Sumitomo Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Astellas Foundation for Research on Metabolic Disorders, Takeda Science Foundation, the Pharmacological Research Foundation Tokyo, the Daiichi-Sankyo Foundation of Life Science, and the Naito Foundation.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Chihara K, 2009, J NEUROCHEM, V110, P956, DOI 10.1111/j.1471-4159.2009.06188.x; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Funamoto T, 2011, BONE, V49, P724, DOI 10.1016/j.bone.2011.06.012; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatayama H, 2007, BIOCHEM BIOPH RES CO, V356, P599, DOI 10.1016/j.bbrc.2007.03.025; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2011, BONE, V48, P514, DOI 10.1016/j.bone.2010.10.176; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	52	44	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8144	8153		10.1074/jbc.M111.332593	http://dx.doi.org/10.1074/jbc.M111.332593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262831	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000301349400030
J	Hanna, J; Schutz, A; Zimmermann, F; Behlke, J; Sommer, T; Heinemann, U				Hanna, Jennifer; Schuetz, Anja; Zimmermann, Franziska; Behlke, Joachim; Sommer, Thomas; Heinemann, Udo			Structural and Biochemical Basis of Yos9 Protein Dimerization and Possible Contribution to Self-association of 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Degradation Ubiquitin-Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; TRAPP; SIGNAL; BET3; RETROTRANSLOCATION; CLASSIFICATION; EXTRACTION; SUGGESTS	In yeast, the membrane-bound HMG-CoA reductase degradation (HRD) ubiquitin-ligase complex is a key player of the ER-associated protein degradation pathway that targets misfolded proteins for proteolysis. Yos9, a component of the luminal submodule of the ligase, scans proteins for specific oligosaccharide modifications, which constitute a critical determinant of the degradation signal. Here, we report the crystal structure of the Yos9 domain that was previously suggested to confer binding to Hrd3, another component of the HRD complex. We observe an alpha beta-roll domain architecture and a dimeric assembly which are confirmed by analytical ultracentrifugation of both the crystallized domain and full-length Yos9. Our binding studies indicate that, instead of this domain, the N-terminal part of Yos9 including the mannose 6-phosphate receptor homology domain mediates the association with Hrd3 in vitro. Our results support the model of a dimeric state of the HRD complex and provide first-time evidence of self-association on its luminal side.	[Hanna, Jennifer; Schuetz, Anja; Zimmermann, Franziska; Behlke, Joachim; Sommer, Thomas; Heinemann, Udo] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany; [Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Free University of Berlin	Heinemann, U (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850; Schutz, Anja/0000-0002-0606-2574	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [740]; Leibniz Graduate School of Molecular Biophysics, Berlin; Helmholtz Association of German Research Centers	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Leibniz Graduate School of Molecular Biophysics, Berlin; Helmholtz Association of German Research Centers(Helmholtz Association)	This work was supported by Deutsche Forschungsgemeinschaft grants (to U. H. and T. S.) and by Sonderforschungsbereich 740.; Supported by the Leibniz Graduate School of Molecular Biophysics, Berlin.; Associated with the Protein Sample Production Facility at the Max Delbruck Center, which is funded by the Helmholtz Association of German Research Centers.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Heinemann U, 2003, ACCOUNTS CHEM RES, V36, P157, DOI 10.1021/ar010129t; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Kummel D, 2005, EMBO REP, V6, P787, DOI 10.1038/sj.embor.7400463; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102	50	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8633	8640		10.1074/jbc.M111.317644	http://dx.doi.org/10.1074/jbc.M111.317644			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262864	Green Published, hybrid			2022-12-25	WOS:000301349400075
J	Huang, WQ; Hu, LP; Bei, L; Hjort, E; Eklund, EA				Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.			The Leukemia-associated Fusion Protein Tel-Platelet-derived Growth Factor Receptor beta (Tel-PdgfR beta) Inhibits Transcriptional Repression of PTPN13 Gene by Interferon Consensus Sequence Binding Protein (Icsbp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATING MYELOID CELLS; TYROSINE-PHOSPHATASE; GP91(PHOX) EXPRESSION; BCR-ABL; FAS; PU.1; FAP-1; DEATH; MACROPHAGES; P67(PHOX)	Icsbp is an interferon regulatory transcription factor with leukemia suppressor activity. In previous studies, we identified the gene encoding Fas-associated phosphatase 1 (Fap1; the PTPN13 gene) as an Icsbp target. In the current study, we determine that repression of PTPN13 by Icsbp requires cooperation with Tel and histone deacetylase 3 (Hdac3). These factors form a multiprotein complex that requires pre-binding of Tel to the PTPN13 cis element with subsequent recruitment of Icsbp and Hdac3. We found that knockdown of Tel or Hdac3 in myeloid cells increases Fap1 expression and results in Fap1-dependent resistance to Fas-induced apoptosis. The TEL gene was initially identified due to involvement in leukemia-associated chromosomal translocations. The first identified TEL translocation partner was the gene encoding platelet-derived growth factor receptor beta (PdgfR beta). The resulting Tel-PdgfR beta fusion protein exhibits constitutive tyrosine kinase activity and influences cellular proliferation. In the current studies, we find that Tel-PdgfR beta influences apoptosis in a manner that is independent of tyrosine kinase activity. We found that Tel-PdgfR beta expressing myeloid cells have increased Fap1 expression and Fap1-dependent Fas resistance. We determined that interaction between Tel and Tel-PdgfR beta decreases Tel/Icsbp/Hdac3 binding to the PTPN13 cis element, resulting in increased transcription. Therefore, these studies identify a novel mechanism by which the Tel-PdgfR beta oncoprotein may contribute to leukemogenesis.	[Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Hjort, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu						Atfi A, 1999, ONCOGENE, V18, P3878, DOI 10.1038/sj.onc.1202734; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Inazawa J, 1996, GENOMICS, V31, P240, DOI 10.1006/geno.1996.0039; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; Komada Y, 1997, BRIT J HAEMATOL, V99, P325, DOI 10.1046/j.1365-2141.1997.3903204.x; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; LARRICK JW, 1980, J IMMUNOL, V125, P6; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Otten HG, 2004, LEUKEMIA, V18, P1401, DOI 10.1038/sj.leu.2403414; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sharf R, 1997, J BIOL CHEM, V272, P9785; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8110	8125		10.1074/jbc.M111.294884	http://dx.doi.org/10.1074/jbc.M111.294884			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262849	Green Published, hybrid			2022-12-25	WOS:000301349400027
J	Ijuin, T; Takenawa, T				Ijuin, Takeshi; Takenawa, Tadaomi			Regulation of Insulin Signaling and Glucose Transporter 4 (GLUT4) Exocytosis by Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) Phosphatase, Skeletal Muscle, and Kidney Enriched Inositol Polyphosphate Phosphatase (SKIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; MICE LACKING; ADIPOSE-TISSUE; PTEN; RESISTANCE; TRANSLOCATION; FUSION; KINASE; SHIP2	The glucose transporter 4 (GLUT4) is responsible for glucose uptake in the skeletal muscle. Insulin-induced translocation of GLUT4 to the plasma membrane requires phosphatidylinositol 3-kinase activation-mediated generation of phosphatidylinositol 3,4,5-trisphosphate PIP3 and subsequent activation of Akt. Previous studies suggested that skeletal muscle and kidney enriched inositol polyphosphate phosphatase (SKIP) has negative effects on the regulation of insulin signaling in the skeletal muscle cells. Here, we compared its effects on insulin signaling by selective inhibition of SKIP, SHIP2, and phosphatase and tensin homologue on chromosome 10 (PTEN) by short interfering RNA in the C2C12 myoblast cells. Suppression of SKIP significantly increased the insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate levels and Akt phosphorylation. Furthermore, silencing of SKIP, but not of PTEN, increased the insulin-dependent recruitment of GLUT4 vesicles to the plasma membrane. Taken together, these results imply that SKIP negatively regulates insulin signaling and glucose uptake by inhibiting GLUT4 docking and/or fusion to the plasma membrane.	[Ijuin, Takeshi; Takenawa, Tadaomi] Kobe Univ, Dept Lipid Biochem, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kobe University	Takenawa, T (corresponding author), Kobe Univ, Dept Lipid Biochem, Grad Sch Med, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Ijuin, Takeshi/H-7016-2017	Ijuin, Takeshi/0000-0002-0618-1776				Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Farese RV, 2005, BIOCHEM SOC T, V33, P350, DOI 10.1042/BST0330350; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaoka T, 2001, DIABETOLOGIA, V44, P1258, DOI 10.1007/s001250100645; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	31	33	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6991	6999		10.1074/jbc.M111.335539	http://dx.doi.org/10.1074/jbc.M111.335539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247557	Green Published, hybrid			2022-12-25	WOS:000301060200005
J	Abdel-Moneim, AS; Bamaga, MS; Shehab, GMG; Abu-Elsaad, AASA; Farahat, FM				Abdel-Moneim, Ahmed S.; Bamaga, Mohammad S.; Shehab, Gaber M. G.; Abu-Elsaad, Abdel-Aziz S. A.; Farahat, Fayssal M.			HCV Infection among Saudi Population: High Prevalence of Genotype 4 and Increased Viral Clearance Rate	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; POLYMERASE-CHAIN-REACTION; NON-B-HEPATITIS; SEQUENCE-ANALYSIS; UNITED-STATES; NON-A; ARABIA; AMPLIFICATION; NOMENCLATURE; ANTIBODIES	HCV is a major etiological agent of liver disease with a high rate of chronic evolution. The virus possesses 6 genotypes with many subtypes. The rate of spontaneous clearance among HCV infected individuals denotes a genetic determinant factor. The current study was designed in order to estimate the rate of HCV infection and ratio of virus clearance among a group of infected patients in Saudi Arabia from 2008 to 2011. It was additionally designed to determine the genotypes of the HCV in persistently infected patients. HCV seroprevalence was conducted on a total of 15,323 individuals. Seropositive individuals were tested by Cobas AmpliPrep/Cobas TaqMan HCV assay to determine the ratio of persistently infected patients to those who showed spontaneous viral clearance. HCV genotyping on random samples from persistently infected patients were conducted based on the differences in the 5'untranslated region (5'UTR). Anti-HCV antibodies were detected in 7.3% of the totally examined sera. A high percentage of the HCV infected individuals experienced virus clearance (48.4%). HCV genotyping revealed the presence of genotypes 1 and 4, the latter represented 97.6% of the tested strains. Evidences of the widespread of the HCV genotype 4 and a high rate of HCV virus clearance were found in Saudi Arabia.	[Abdel-Moneim, Ahmed S.; Shehab, Gaber M. G.; Abu-Elsaad, Abdel-Aziz S. A.] Taif Univ, Coll Med, Al Taif, Saudi Arabia; [Abdel-Moneim, Ahmed S.] Beni Suef Univ, Fac Vet Med, Dept Virol, Bani Suwayf, Egypt; [Bamaga, Mohammad S.] Al Hada Armed Forces Hosp, Dept Mol Pathol, Al Taif, Saudi Arabia; [Shehab, Gaber M. G.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [Abu-Elsaad, Abdel-Aziz S. A.] Beni Suef Univ, Fac Sci, Dept Zool, Bani Suwayf, Egypt; [Farahat, Fayssal M.] Armed Forces Hosp, Postgrad Training & Res Ctr, Al Taif, Saudi Arabia; [Farahat, Fayssal M.] Menoufia Univ, Fac Med, Publ Hlth & Community Med Dept, Menoufia, Egypt	Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Al Hada Armed Forces Hospital; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Menofia University	Abdel-Moneim, AS (corresponding author), Taif Univ, Coll Med, Al Taif, Saudi Arabia.	asa@tu.edu.sa	Abdel-Moneim, Ahmed S./G-7445-2012; Farahat, Fayssal/AAF-3226-2019	Abdel-Moneim, Ahmed S./0000-0002-3148-6782; Farahat, Fayssal/0000-0001-5186-2872	Taif University, Saudi Arabia [1-432-1187]	Taif University, Saudi Arabia	This study was supported by a research grant (Project No. 1-432-1187) through the Research Support of Taif University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAAL M, 1994, TRANSFUSION, V34, P135, DOI 10.1046/j.1537-2995.1994.34294143941.x; AlFaleh FZ, 1995, J VIRAL HEPATITIS, V2, P293, DOI 10.1111/j.1365-2893.1995.tb00044.x; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ALTER MJ, 1989, JAMA-J AM MED ASSOC, V262, P1201, DOI 10.1001/jama.262.9.1201; Alzahrani AJ, 2009, J INFECT DEV COUNTR, V3, P235; Bakr I, 2006, GUT, V55, P1183, DOI [10.1136/gut.2005.078147, 10.1136/gut.2006.078147]; Bamaga MS, 2006, SAUDI MED J, V27, P781; Clinical Laboratory Standards Institute, 2004, EP5A2 CLIN LAB STAND; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; ESTEBAN JI, 1990, NEW ENGL J MED, V323, P1107, DOI 10.1056/NEJM199010183231605; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Germer JJ, 1999, J CLIN MICROBIOL, V37, P2625, DOI 10.1128/JCM.37.8.2625-2630.1999; Harris HE, 2002, BMJ-BRIT MED J, V324, P450, DOI 10.1136/bmj.324.7335.450; Inoue G, 2000, J GASTROEN HEPATOL, V15, P1054, DOI 10.1046/j.1440-1746.2000.02276.x; KANEKO S, 1994, INTERVIROLOGY, V37, P108, DOI 10.1159/000150364; Karkar Ayman, 2007, Hemodial Int, V11, P354, DOI 10.1111/j.1542-4758.2007.00192.x; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Osoba AO, 2000, ANN SAUDI MED, V20, P394, DOI 10.5144/0256-4947.2000.394; Paladino N, 2006, J VIROL, V80, P9144, DOI 10.1128/JVI.00339-06; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sarrazin C, 2000, HEPATOLOGY, V32, P818, DOI 10.1053/jhep.2000.17709; Sarrazin C, 2006, J CLIN MICROBIOL, V44, P729, DOI 10.1128/JCM.44.3.729-737.2006; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Seeff Leonard B., 1999, American Journal of Medicine, V107, p10S; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Tamalet C, 2003, J MED VIROL, V71, P391, DOI 10.1002/jmv.10505; Tamimi W, 2003, CLIN DIAGN LAB IMMUN, V10, P1159, DOI 10.1128/CDLI.10.6.1159-1160.2003; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; VANDERPOEL CL, 1990, LANCET, V335, P558, DOI 10.1016/0140-6736(90)90347-8; Verbeeck J, 2008, J CLIN MICROBIOL, V46, P1901, DOI 10.1128/JCM.02390-07; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; Zeuzem S, 1995, J HEPATOL, V23, P654, DOI 10.1016/0168-8278(95)80030-1	39	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29781	10.1371/journal.pone.0029781	http://dx.doi.org/10.1371/journal.pone.0029781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253780	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500021
J	Chang, WC; Lee, CH; Hirota, T; Wang, LF; Doi, S; Miyatake, A; Enomoto, T; Tomita, K; Sakashita, M; Yamada, T; Fujieda, S; Ebe, K; Saeki, H; Takeuchi, S; Furue, M; Chen, WC; Chiu, YC; Chang, WP; Hong, CH; Hsi, E; Juo, SHH; Yu, HS; Nakamura, Y; Tamari, M				Chang, Wei-Chiao; Lee, Chih-Hung; Hirota, Tomomitsu; Wang, Li-Fang; Doi, Satoru; Miyatake, Akihiko; Enomoto, Tadao; Tomita, Kaori; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu; Ebe, Koji; Saeki, Hidehisa; Takeuchi, Satoshi; Furue, Masutaka; Chen, Wei-Chiao; Chiu, Yi-Ching; Chang, Wei Pin; Hong, Chien-Hui; Hsi, Edward; Juo, Suh-Hang Hank; Yu, Hsin-Su; Nakamura, Yusuke; Tamari, Mayumi			ORAI1 Genetic Polymorphisms Associated with the Susceptibility of Atopic Dermatitis in Japanese and Taiwanese Populations	PLOS ONE			English	Article							ACTIVATED CALCIUM-CHANNELS; LEUKOTRIENE C-4 SECRETION; ACVD TASK-FORCE; MICE LACKING; CA2+ INFLUX; STIM1; CRAC; CELL; RELEASE; PROMOTER	Atopic dermatitis is a chronic inflammatory skin disease. Multiple genetic and environmental factors are thought to be responsible for susceptibility to AD. In this study, we collected 2,478 DNA samples including 209 AD patients and 729 control subjects from Taiwanese population and 513 AD patients and 1027 control subject from Japanese population for sequencing and genotyping ORAI1. A total of 14 genetic variants including 3 novel single-nucleotide polymorphisms (SNPs) in the ORAI1 gene were identified. Our results indicated that a non-synonymous SNP (rs3741596, Ser218Gly) associated with the susceptibility of AD in the Japanese population but not in the Taiwanese population. However, there is another SNP of ORAI1 (rs3741595) associated with the risk of AD in the Taiwanese population but not in the Japanese population. Taken together, our results indicated that genetic polymorphisms of ORAI1 are very likely to be involved in the susceptibility of AD.	[Chang, Wei-Chiao; Chen, Wei-Chiao; Chiu, Yi-Ching; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Hirota, Tomomitsu; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Resp Dis, Kanagawa, Japan; [Doi, Satoru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pediat Allergy, Osaka, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Osaka, Japan; [Enomoto, Tadao] NPO Japan Hlth Promot Supporting Network, Wakayama, Japan; [Tomita, Kaori; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu] Univ Fukui, Div Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Ebe, Koji] Takao Hosp, Kyoto, Japan; [Saeki, Hidehisa] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Takeuchi, Satoshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Chang, Wei Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Lee, Chih-Hung; Hong, Chien-Hui; Yu, Hsin-Su] Kaohsiung Med Univ, Grad Inst Med, Dept Dermatol, Kaohsiung, Taiwan; [Wang, Li-Fang] Natl Taiwan Univ, Coll Med, Dept Dermatol, Taipei 10764, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Ctr Resources Res & Dev, Kaohsiung, Taiwan; [Hsi, Edward; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; RIKEN; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; University of Fukui; Jikei University; Kyushu University; University of Tokyo; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chang, WC (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.	wcc@kmu.edu.tw; thirota@src.riken.jp	Hsi, Edward/A-1356-2013; Tamari, Mayumi/N-5378-2015; Lee, Chih-Hung/AAJ-5551-2020; Juo, Suh-Hang/C-9545-2009	Hsi, Edward/0000-0002-8272-6707; Lee, Chih-Hung/0000-0001-9804-3874; WANG, LI-FANG/0000-0002-1709-9401	Rotary Club of Osaka-Midosuji District; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Excellence for Cancer Research Center [NHRI-100A1-PDCO-03000001]; Department of Health, Executive Yuan, Taiwan, ROC [DOH100-TD-C-111-002]; National Science Council, Taiwan, ROC [NSC 98-2320-B-037-028-MY2, 100-2320-B-037-002]; Grants-in-Aid for Scientific Research [22659306] Funding Source: KAKEN	Rotary Club of Osaka-Midosuji District; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, ROC; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to the members of The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and from the Ministry of Health, Labor, and Welfare, Japan. This study was also partly supported by funding from NHRI-100A1-PDCO-03000001, Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, ROC (NO. DOH100-TD-C-111-002) and from the National Science Council, Taiwan, ROC (NSC 98-2320-B-037-028-MY2; 100-2320-B-037-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Akdis M, 2006, CURR OPIN IMMUNOL, V18, P738, DOI 10.1016/j.coi.2006.06.003; BerthJones J, 1996, J AM ACAD DERMATOL, V34, P1016, DOI 10.1016/S0190-9622(96)90281-9; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chou YH, 2011, J UROLOGY, V185, P1742, DOI 10.1016/j.juro.2010.12.094; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Enomoto H, 2008, J HUM GENET, V53, P615, DOI 10.1007/s10038-008-0293-z; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hill PB, 2001, VET IMMUNOL IMMUNOP, V81, P199, DOI 10.1016/S0165-2427(01)00299-9; Korkiamaki T, 2002, AM J PATHOL, V160, P1981, DOI 10.1016/S0002-9440(10)61148-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oh DY, 2009, ALLERGY, V64, P1608, DOI 10.1111/j.1398-9995.2009.02066.x; Oiso N, 2000, BRIT J DERMATOL, V142, P1003, DOI 10.1046/j.1365-2133.2000.03485.x; Olivry T, 2001, VET IMMUNOL IMMUNOP, V81, P305, DOI 10.1016/S0165-2427(01)00305-1; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Rafatpanah H, 2003, J ALLERGY CLIN IMMUN, V112, P593, DOI 10.1067/mai.2003.1699; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Takahashi N, 2005, HUM MOL GENET, V14, P3149, DOI 10.1093/hmg/ddi347; Trautmann A, 2000, APOPTOSIS, V5, P425, DOI 10.1023/A:1009620329213; Tsunemi Y, 2002, J DERMATOL SCI, V30, P100, DOI 10.1016/S0923-1811(02)00065-8; Vickery BP, 2007, CURR OPIN PEDIATR, V19, P89, DOI 10.1097/MOP.0b013e328012315a; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wei CC, 2011, PLOS ONE, V6; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	36	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29387	10.1371/journal.pone.0029387	http://dx.doi.org/10.1371/journal.pone.0029387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253717	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500011
J	Xu, K; Wu, XY; Shapiro, E; Huang, HG; Zhang, LX; Hickling, D; Deng, Y; Lee, P; Li, J; Lepor, H; Grishina, I				Xu, Kun; Wu, Xinyu; Shapiro, Ellen; Huang, Honging; Zhang, Lixia; Hickling, Duane; Deng, Yan; Lee, Peng; Li, Juan; Lepor, Herbert; Grishina, Irina			Bmp7 Functions via a Polarity Mechanism to Promote Cloacal Septation	PLOS ONE			English	Article							EXTERNAL GENITAL DEVELOPMENT; SONIC-HEDGEHOG; EPIDERMAL DIFFERENTIATION; ANORECTAL-MALFORMATIONS; KIDNEY DEVELOPMENT; PROSTATE-GLAND; MICE; MORPHOGENESIS; GASTRULATION; EXPERIENCE	Background: During normal development in human and other placental mammals, the embryonic cloacal cavity separates along the axial longitudinal plane to give rise to the urethral system, ventrally, and the rectum, dorsally. Defects in cloacal development are very common and present clinically as a rectourethral fistula in about 1 in 5,000 live human births. Yet, the cellular mechanisms of cloacal septation remain poorly understood. Methodology/Principal Findings: We previously detected Bone morphogenetic protein 7 (Bmp7) expression in the urorectal mesenchyme (URM), and have shown that loss of Bmp7 function results in the arrest of cloacal septation. Here, we present evidence that cloacal partitioning is driven by Bmp7 signaling in the cloacal endoderm. We performed TUNEL and immunofluorescent analysis on cloacal sections from Bmp7 null and control littermate embryos. We found that loss of Bmp7 results in a dramatic decrease in the endoderm survival and a delay in differentiation. We used immunological methods to show that Bmp7 functions by activating the c-Jun N-terminal kinase (JNK) pathway. We carried out confocal and 3D imaging analysis of mitotic chromosome bundles to show that during normal septation cells in the cloacal endoderm divide predominantly in the apical-basal direction. Loss of Bmp7/JNK signaling results in randomization of mitotic angles in the cloacal endoderm. We also conducted immunohistochemical analysis of human fetal sections to show that BMP/phospho-SMAD and JNK pathways function in the human cloacal region similar as in the mouse. Conclusion/Significance: Our results strongly indicate that Bmp7/JNK signaling regulates remodeling of the cloacal endoderm resulting in a topological separation of the urinary and digestive systems. Our study points to the importance of Bmp and JNK signaling in cloacal development and rectourethral malformations.	[Xu, Kun; Wu, Xinyu; Shapiro, Ellen; Zhang, Lixia; Hickling, Duane; Lee, Peng; Lepor, Herbert; Grishina, Irina] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Xu, Kun; Li, Juan] Jilin Univ, Dept Toxicol, Changchun 130023, Peoples R China; [Wu, Xinyu; Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Huang, Honging] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	New York University; Jilin University; New York University; Memorial Sloan Kettering Cancer Center	Xu, K (corresponding author), NYU, Sch Med, Dept Urol, New York, NY 10003 USA.	irina.grishina@nyumc.org			National Institute of Diabetes and Digestive and Kidney Diseases [DK068007]; Department of Urology New York University School of Medicine; Kidney and Urology Foundation of America; National Institutes of Health National Center for Research Resources [S10 RR023704]; China Scholarship Council [2008617069]; University of Ottawa, Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK068007] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Urology New York University School of Medicine; Kidney and Urology Foundation of America; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); China Scholarship Council(China Scholarship Council); University of Ottawa, Canada; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases DK068007 grant and American Recovery and Reinvestment Grant Supplement to Dr. Grishina, the Department of Urology New York University School of Medicine discretionary funding to Dr. Grishina and Dr. Shapiro, the Kidney and Urology Foundation of America award to IG, and the National Institutes of Health National Center for Research Resources grant S10 RR023704 to the New York University School of Medicine Microscopy Core. Dr. Xu was supported by the pre-doctoral Fellowship 2008617069 by the China Scholarship Council, and Dr. Hickling was supported by the International Fellowship for New Faculty by the University of Ottawa, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAMMAL PHYLOGENY MES; [Anonymous], J ANAT; [Anonymous], J ANAT PHYSL; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Blank U, 2009, DEVELOPMENT, V136, P3557, DOI 10.1242/dev.036335; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Corder G. W., 2009, NONPARAMETRIC STAT N, DOI DOI 10.1002/; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Godin RE, 1998, DEVELOPMENT, V125, P3473; Griffiths M, 1978, BIOL MONOTREMS; Grishina I, 2005, CELL CYCLE, V4, P1120; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Hendren W H, 1996, Semin Pediatr Surg, V5, P72; Hendren WH, 1998, ANN SURG, V228, P331, DOI 10.1097/00000658-199809000-00006; HENDREN WH, 1992, J PEDIATR SURG, V27, P890, DOI 10.1016/0022-3468(92)90393-L; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P27, DOI 10.1016/j.bjps.2003.08.019; Kaufman M.H, 1999, ATLAS MOUSE DEV; KLUTH D, 1995, J PEDIATR SURG, V30, P1143, DOI 10.1016/0022-3468(95)90007-1; KLUTH D, 1991, EUR J PEDIATR SURG, V1, P183, DOI 10.1055/s-2008-1042484; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li FF, 2011, INT J COLORECTAL DIS, V26, P983, DOI 10.1007/s00384-011-1191-y; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Lopes R.H.C., 2007, 11 INT WORKSH ADV CO; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Nowak R, 1991, WALKERS MAMMALS WORL, V1, P10; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Ohta S, 2010, CELL ADHES MIGR, V4, P440, DOI 10.4161/cam.4.3.12000; Oxburgh L, 2005, DEV BIOL, V286, P637, DOI 10.1016/j.ydbio.2005.08.024; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Podkowa M, 2010, MOL CELL BIOL, V30, P2241, DOI 10.1128/MCB.01166-09; Sasaki C, 2004, ANAT REC PART A, V279A, P761, DOI 10.1002/ar.a.20062; Seifert AW, 2008, DEV BIOL, V318, P143, DOI 10.1016/j.ydbio.2008.03.017; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Seifert AW, 2009, DEVELOPMENT, V136, P3949, DOI 10.1242/dev.042291; Seifert AW, 2009, DEVELOPMENT, V136, P2643, DOI 10.1242/dev.036830; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; van de Ven C, 2011, DEVELOPMENT, V138, P3451, DOI 10.1242/dev.066118; van der Putte SCJ, 2004, ADV ANATOMY EMBRYO R, V177 R; Wang C, 2011, DEV BIOL, V360, P186, DOI 10.1016/j.ydbio.2011.09.020; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29372	10.1371/journal.pone.0029372	http://dx.doi.org/10.1371/journal.pone.0029372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253716	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500010
J	Chitwood, DH; Headland, LR; Filiault, DL; Kumar, R; Jimenez-Gomez, JM; Schrager, AV; Park, DS; Peng, J; Sinha, NR; Maloof, JN				Chitwood, Daniel H.; Headland, Lauren R.; Filiault, Daniele L.; Kumar, Ravi; Jimenez-Gomez, Jose M.; Schrager, Amanda V.; Park, Daniel S.; Peng, Jie; Sinha, Neelima R.; Maloof, Julin N.			Native Environment Modulates Leaf Size and Response to Simulated Foliar Shade across Wild Tomato Species	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHYTOCHROME-B; AVOIDANCE RESPONSES; PETIOLE ELONGATION; GROWTH-RESPONSES; CELL ELONGATION; LIGHT; GENE; EXPRESSION; SHAPE	The laminae of leaves optimize photosynthetic rates by serving as a platform for both light capture and gas exchange, while minimizing water losses associated with thermoregulation and transpiration. Many have speculated that plants maximize photosynthetic output and minimize associated costs through leaf size, complexity, and shape, but a unifying theory linking the plethora of observed leaf forms with the environment remains elusive. Additionally, the leaf itself is a plastic structure, responsive to its surroundings, further complicating the relationship. Despite extensive knowledge of the genetic mechanisms underlying angiosperm leaf development, little is known about how phenotypic plasticity and selective pressures converge to create the diversity of leaf shapes and sizes across lineages. Here, we use wild tomato accessions, collected from locales with diverse levels of foliar shade, temperature, and precipitation, as a model to assay the extent of shade avoidance in leaf traits and the degree to which these leaf traits correlate with environmental factors. We find that leaf size is correlated with measures of foliar shade across the wild tomato species sampled and that leaf size and serration correlate in a species-dependent fashion with temperature and precipitation. We use far-red induced changes in leaf length as a proxy measure of the shade avoidance response, and find that shade avoidance in leaves negatively correlates with the level of foliar shade recorded at the point of origin of an accession. The direction and magnitude of these correlations varies across the leaf series, suggesting that heterochronic and/or ontogenic programs are a mechanism by which selective pressures can alter leaf size and form. This study highlights the value of wild tomato accessions for studies of both morphological and light-regulated development of compound leaves, and promises to be useful in the future identification of genes regulating potentially adaptive plastic leaf traits.	[Chitwood, Daniel H.; Headland, Lauren R.; Filiault, Daniele L.; Kumar, Ravi; Jimenez-Gomez, Jose M.; Schrager, Amanda V.; Sinha, Neelima R.; Maloof, Julin N.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Park, Daniel S.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Peng, Jie] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chitwood, DH (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	jnmaloof@ucdavis.edu	Chitwood, Daniel/M-2841-2013	Chitwood, Daniel/0000-0003-4875-1447; Jimenez-Gomez, Jose M/0000-0002-5033-7192; Filiault, Daniele/0000-0002-2938-3071; Park, Daniel/0000-0003-2783-530X; Headland, Lauren/0000-0002-3242-0806; Maloof, Julin/0000-0002-9623-2599	National Science Foundation [IOS-0820854]	National Science Foundation(National Science Foundation (NSF))	This work was funded through a National Science Foundation grant (IOS-0820854) to N.R.S, J.N.M., and J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBY E, 1948, NEW PHYTOL, V47, P153, DOI 10.1111/j.1469-8137.1948.tb05098.x; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; BAIN AB, 1988, J EXP BOT, V39, P1759, DOI 10.1093/jxb/39.12.1759; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Blackman GE, 1956, INFLUENCE LIGHT TEMP, P151; Boccalandro HE, 2009, PLANT PHYSIOL, V150, P1083, DOI 10.1104/pp.109.135509; Brown WH, 1919, PHILIPPINE BUREAU SC, V13, P1; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; CAIN SA, 1956, AM J BOT, V43, P911, DOI 10.2307/2439008; CAMERON RJ, 1970, AUST J BOT, V18, P29, DOI 10.1071/BT9700029; Carpenter R. J., 1994, AUSTR VEGETATION HIS, P276; Clements ES, 1904, T AM MICROSC SOC, V26, P19; Dilcher DL., 1973, VEGETATION VEGETATIO, P39; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; DOLPH GE, 1980, B TORREY BOT CLUB, V107, P154, DOI 10.2307/2484220; DOLPH GE, 1980, BIOTROPICA, V12, P91, DOI 10.2307/2387724; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; DUDLEY SA, 1995, FUNCT ECOL, V9, P655, DOI 10.2307/2390158; Endo M, 2005, PLANT CELL, V17, P1941, DOI 10.1105/tpc.105.032342; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; Goebel K., 1908, EINLEITUNG EXPT MORP; Graner EA, 1942, POHL BRAGANTIA, V2, P13; GREENWOOD DR, 1992, REV PALAEOBOT PALYNO, V71, P149, DOI 10.1016/0034-6667(92)90161-9; Hisamatsu T, 2005, PLANT PHYSIOL, V138, P1106, DOI 10.1104/pp.104.059055; JONES CS, 1995, AM J BOT, V82, P346, DOI 10.2307/2445580; Kang J, 2002, PLANTA, V216, P212, DOI 10.1007/s00425-002-0847-9; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; Kim GT, 2005, PHOTOCH PHOTOBIO SCI, V4, P770, DOI 10.1039/b418440h; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; Kim GT, 2002, EMBO J, V21, P1267, DOI 10.1093/emboj/21.6.1267; Kozuka T, 2005, PLANT CELL PHYSIOL, V46, P213, DOI 10.1093/pcp/pci016; Kozuka T, 2010, PLANT PHYSIOL, V153, P1608, DOI 10.1104/pp.110.156802; Maliakal SK, 1999, INT J PLANT SCI, V160, P723, DOI 10.1086/314157; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Montaldi ER, 1963, REV INVESTIGACIONES, V17, P321; MORGAN DC, 1978, PLANTA, V142, P187, DOI 10.1007/BF00388211; MORGAN DC, 1981, NEW PHYTOL, V88, P239, DOI 10.1111/j.1469-8137.1981.tb01720.x; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MORGAN DC, 1976, NATURE, V262, P210, DOI 10.1038/262210a0; Moyle LC, 2008, EVOLUTION, V62, P2995, DOI 10.1111/j.1558-5646.2008.00487.x; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; NAGATANI A, 1991, PLANT CELL PHYSIOL, V32, P1119, DOI 10.1093/oxfordjournals.pcp.a078177; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Neff MM, 2000, GENE DEV, V14, P257; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; NJOKU E., 1956, New Phytologist, V55, P91, DOI 10.1111/j.1469-8137.1956.tb05268.x; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Peralta I. E., 2008, Systematic Botany Monographs, V84; Pierik R, 2004, PLANT PHYSIOL, V136, P2928, DOI 10.1104/pp.104.045120; Pierik R, 2004, PLANT J, V38, P310, DOI 10.1111/j.1365-313X.2004.02044.x; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Poorter H, 2010, J EXP BOT, V61, P2043, DOI 10.1093/jxb/erp358; *R DEV COR TEAM, R LANG ENV STAT COMP; Rasband WS, 1997, IMAGEJ; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Richards P W, 1964, TROPICAL RAIN FOREST, V2nd; ROBSON PRH, 1993, PLANT PHYSIOL, V102, P1179, DOI 10.1104/pp.102.4.1179; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Schmitt J, 1997, PLANT CELL ENVIRON, V20, P826, DOI 10.1046/j.1365-3040.1997.d01-96.x; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; SHIELDS LM, 1950, BOT REV, V16, P399, DOI 10.1007/BF02869988; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; TALBERT CM, 1957, ECOLOGY, V38, P655, DOI 10.2307/1943135; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P1221, DOI 10.1093/pcp/pcf147; Van Tienderen Peter H., 1996, Plant Species Biology, V11, P87; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; WEBB LJ, 1968, ECOLOGY, V49, P296, DOI 10.2307/1934459; Weller JL, 2000, PLANT J, V24, P345, DOI 10.1046/j.1365-313x.2000.00879.x; Whitelam GC, 1997, PLANT CELL ENVIRON, V20, P752, DOI 10.1046/j.1365-3040.1997.d01-100.x; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2	81	43	45	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29570	10.1371/journal.pone.0029570	http://dx.doi.org/10.1371/journal.pone.0029570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253737	Green Published, gold			2022-12-25	WOS:000301357100015
J	Keravis, T; Monneaux, F; Yougbare, I; Gazi, L; Bourguignon, JJ; Muller, S; Lugnier, C				Keravis, Therese; Monneaux, Fanny; Yougbare, Issaka; Gazi, Lucien; Bourguignon, Jean-Jacques; Muller, Sylviane; Lugnier, Claire			Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor	PLOS ONE			English	Article							ROLIPRAM BINDING-SITE; AMP-PHOSPHODIESTERASES; SELECTIVE-INHIBITION; RAT AORTA; ERYTHEMATOSUS; TISSUE; CELLS; 9-BENZYLADENINE; MACROPHAGES; RESPONSES	Systemic lupus erythematosus is a polymorphic and multigenic inflammatory autoimmune disease. Cyclic AMP (cAMP) modulates inflammation and the inhibition of cyclic nucleotide phosphodiesterase type 4 (PDE4), which specifically hydrolyzes cAMP, inhibits TNF alpha secretion. This study was aimed at investigating the evolution of PDE activity and expression levels during the course of the disease in MRL/lpr lupus-prone mice, and to evaluate in these mice the biological and clinical effects of treatments with pentoxifylline, denbufylline and NCS 613 PDE inhibitors. This study reveals that compared to CBA/ J control mice, kidney PDE4 activity of MRL/lpr mice increases with the disease progression. Furthermore, it showed that the most potent and selective PDE4 inhibitor NCS 613 is also the most effective molecule in decreasing proteinuria and increasing survival rate of MRL/lpr mice. NCS 613 is a potent inhibitor, which is more selective for the PDE4C subtype (IC50 = 1.4 nM) than the other subtypes (PDE4A, IC50 = 44 nM; PDE4B, IC50 = 48 nM; and PDE4D, IC50 = 14 nM). Interestingly, its affinity for the High Affinity Rolipram Binding Site is relatively low (K-i = 148 nM) in comparison to rolipram (K-i = 3 nM). Finally, as also observed using MRL/lpr peripheral blood lymphocytes (PBLs), NCS 613 inhibits basal and LPS-induced TNF alpha secretion from PBLs of lupus patients, suggesting a therapeutic potential of NCS 613 in systemic lupus. This study reveals that PDE4 represent a potential therapeutic target in lupus disease.	[Keravis, Therese; Bourguignon, Jean-Jacques] Univ Strasbourg, Fac Pharm, CNRS, Lab Innovat Therapeut, Illkirch Graffenstaden, France; [Monneaux, Fanny; Muller, Sylviane] CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Keravis, T (corresponding author), Univ Strasbourg, Fac Pharm, CNRS, Lab Innovat Therapeut, Illkirch Graffenstaden, France.	claire.lugnier@unistra.fr	Muller, Sylviane/J-5319-2014; lugnier, claire/AAF-3911-2020	Lugnier, Claire/0000-0002-0850-1331	Centre National de la Recherche Scientifique; Universite of Strasbourg	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite of Strasbourg	Centre National de la Recherche Scientifique and Universite of Strasbourg have supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahloulay M, 2005, LIVER INT, V25, P403, DOI 10.1111/j.1478-3231.2005.01034.x; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396; Barreto EO, 2004, INT IMMUNOPHARMACOL, V4, P755, DOI 10.1016/j.intimp.2004.03.001; Boichot E, 2000, J PHARMACOL EXP THER, V292, P647; Bourguignon JJ, 1997, J MED CHEM, V40, P1768, DOI 10.1021/jm960827x; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; FOLLENIUS A, 1984, BIOCHEM BIOPH RES CO, V119, P1154, DOI 10.1016/0006-291X(84)90896-9; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; HECHT M, 1995, J LEUKOCYTE BIOL, V57, P242, DOI 10.1002/jlb.57.2.242; Hirose R, 2007, EUR J PHARMACOL, V573, P93, DOI 10.1016/j.ejphar.2007.06.045; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Houslay MD, 2010, NAT BIOTECHNOL, V28, P38, DOI 10.1038/nbt0110-38; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Keravis Therese, 2005, V307, P63; KOMAS N, 1991, BRIT J PHARMACOL, V104, P495, DOI 10.1111/j.1476-5381.1991.tb12457.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; LUGNIER C, 1985, EUR J MED CHEM, V20, P121; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; MARIVET MC, 1989, J MED CHEM, V32, P1450, DOI 10.1021/jm00127a009; Monneaux F, 2003, EUR J IMMUNOL, V33, P287, DOI 10.1002/immu.200310002; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Mori F, 2010, J CHEM NEUROANAT, V40, P36, DOI 10.1016/j.jchemneu.2010.03.004; MULLER B, 1990, J CARDIOVASC PHARM, V16, P796, DOI 10.1097/00005344-199011000-00016; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nandi J S, 1980, Adv Myocardiol, V1, P359; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reimund JM, 2001, BIOCHEM BIOPH RES CO, V288, P427, DOI 10.1006/bbrc.2001.5786; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; SCHNEIDER HH, 1986, EUR J PHARMACOL, V127, P105, DOI 10.1016/0014-2999(86)90210-4; Segal R, 2001, LUPUS, V10, P23, DOI 10.1191/096120301675275538; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Tenor H., 1996, HANDB IMMUNOPHARM, P21; Wang HC, 2007, BIOCHEM J, V408, P193, DOI 10.1042/BJ20070970; WILKE R, 1989, ARZNEIMITTEL-FORSCH, V39-1, P665; Yougbare I, 2011, AM J PHYSIOL-LUNG C, V301, pL441, DOI 10.1152/ajplung.00407.2010	44	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28899	10.1371/journal.pone.0028899	http://dx.doi.org/10.1371/journal.pone.0028899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247763	Green Published, gold			2022-12-25	WOS:000301355700011
J	Lamrabet, O; Medie, FM; Drancourt, M				Lamrabet, Otmane; Medie, Felix Mba; Drancourt, Michel			Acanthamoeba polyphaga-Enhanced Growth of Mycobacterium smegmatis	PLOS ONE			English	Article							AMEBA-RESISTING BACTERIA; WATER; CASTELLANII; INFECTION; AVIUM; PERSISTENCE; IDENTIFICATION; BIODIVERSITY; REPLICATION; SURVIVAL	Background: Mycobacterium smegmatis is a rapidly-growing mycobacterium causing rare opportunistic infections in human patients. It is present in soil and water environments where free-living amoeba also reside, but data regarding M. smegmatis-amoeba relationships have been contradictory from mycobacteria destruction to mycobacteria survival. Methodology/Principal Findings: Using optic and electron microscopy and culture-based microbial enumeration we investigated the ability of M. smegmatis mc(2) 155, M. smegmatis ATCC 19420(T) and M. smegmatis ATCC 27204 organisms to survive into Acanthamoeba polyphaga trophozoites and cysts. We observed that M. smegmatis mycobacteria penetrated and survived in A. polyphaga trophozoites over five-day co-culture resulting in amoeba lysis and the release of viable M. smegmatis mycobacteria without amoebal cyst formation. We further observed that amoeba-co-culture, and lysed amoeba and supernatant and pellet, significantly increased five-day growth of the three tested M. smegmatis strains, including a four-fold increase in intra-amoebal growth. Conclusions/Significance: Amoebal co-culture increases the growth of M. smegmatis resulting in amoeba killing by replicating M. smegmatis mycobacteria. This amoeba-M. smegmatis co-culture system illustrates an unusual paradigm in the mycobacteria-amoeba interactions as mycobacteria have been mainly regarded as amoeba-resistant organisms. Using these model organisms, this co-culture system could be used as a simple and rapid model to probe mycobacterial factors implicated in the intracellular growth of mycobacteria.	[Lamrabet, Otmane; Medie, Felix Mba; Drancourt, Michel] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, IRD 3R198, CNRS,UMR 6236,IFR48, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Lamrabet, O (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, IRD 3R198, CNRS,UMR 6236,IFR48, Marseille, France.	michel.drancourt@univmed.fr		Lamrabet, Otmane/0000-0002-7015-1942; Mba Medie, Felix/0000-0002-8265-4563				Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Ben Salah I, 2009, CLIN MICROBIOL INFEC, V15, P894; Ben Salah I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-99; Chen YC, 2008, EMERG INFECT DIS, V14, P1818, DOI 10.3201/eid1411.080003; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Douesnard-Malo F, 2011, APPL ENVIRON MICROB, V77, P7640, DOI 10.1128/AEM.00699-11; Drancourt M, 2007, J HOSP INFECT, V65, P138, DOI 10.1016/j.jhin.2006.10.006; Eddyani M, 2008, APPL ENVIRON MICROB, V74, P6547, DOI 10.1128/AEM.01066-08; Eid AJ, 2007, CLIN INFECT DIS, V45, P687, DOI 10.1086/520982; Goy G, 2007, RES MICROBIOL, V158, P393, DOI 10.1016/j.resmic.2007.01.003; Greub G, 2004, EMERG INFECT DIS, V10, P470, DOI 10.3201/eid1003.020792; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Imbert G, 2005, J HOSP INFECT, V61, P268, DOI 10.1016/j.jhin.2005.01.030; Jadin JB, 1975, ACTA LEPROL, V59, P57; La Scola B, 2003, EMERG INFECT DIS, V9, P815, DOI 10.3201/eid0907.030065; Lahiri R, 2008, LEPROSY REV, V79, P401; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; MICHEL R, 1995, ZBL HYG UMWELTMED, V196, P532; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Narang R, 2009, INDIAN J MED MICROBI, V27, P247, DOI 10.4103/0255-0857.53208; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; PRASAD BNK, 1978, CURR SCI INDIA, V47, P245; Sharbati-Tehrani S, 2005, MICROBIOL-SGM, V151, P2403, DOI 10.1099/mic.0.27969-0; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Steinert M, 2011, SEMIN CELL DEV BIOL, V22, P70, DOI 10.1016/j.semcdb.2010.11.003; Taylor SJ, 2003, APPL ENVIRON MICROB, V69, P4316, DOI 10.1128/AEM.69.7.4316-4319.2003; Tenant R, 2006, CURR MICROBIOL, V52, P128, DOI 10.1007/s00284-005-0218-4; Thomas V, 2007, LETT APPL MICROBIOL, V45, P349, DOI 10.1111/j.1472-765X.2007.02206.x; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x	35	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29833	10.1371/journal.pone.0029833	http://dx.doi.org/10.1371/journal.pone.0029833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253795	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700058
J	Shannon, K; Leiter, K; Phaladze, N; Hlanze, Z; Tsai, AC; Heisler, M; Iacopino, V; Weiser, SD				Shannon, Kate; Leiter, Karen; Phaladze, Nthabiseng; Hlanze, Zakhe; Tsai, Alexander C.; Heisler, Michele; Iacopino, Vincent; Weiser, Sheri D.			Gender Inequity Norms Are Associated with Increased Male-Perpetrated Rape and Sexual Risks for HIV Infection in Botswana and Swaziland	PLOS ONE			English	Article							SOUTH-AFRICA; VIOLENCE; POWER; WOMEN; MASCULINITY; PREVALENCE; REDUCTION; HIV/AIDS; EXAMINE; MEN	Background: There is limited empirical research on the underlying gender inequity norms shaping gender-based violence, power, and HIV risks in sub-Saharan Africa, or how risk pathways may differ for men and women. This study is among the first to directly evaluate the adherence to gender inequity norms and epidemiological relationships with violence and sexual risks for HIV infection. Methods: Data were derived from population-based cross-sectional samples recruited through two-stage probability sampling from the 5 highest HIV prevalence districts in Botswana and all districts in Swaziland (2004-5). Based on evidence of established risk factors for HIV infection, we aimed 1) to estimate the mean adherence to gender inequity norms for both men and women; and 2) to model the independent effects of higher adherence to gender inequity norms on a) male sexual dominance (male-controlled sexual decision making and rape (forced sex)); b) sexual risk practices (multiple/concurrent sex partners, transactional sex, unprotected sex with non-primary partner, intergenerational sex). Findings: A total of 2049 individuals were included, n = 1255 from Botswana and n = 796 from Swaziland. In separate multivariate logistic regression analyses, higher gender inequity norms scores remained independently associated with increased male-controlled sexual decision making power (AORmen = 1.90, 95%CI: 1.09-2.35; AORwomen = 2.05, 95%CI: 1.32-2.49), perpetration of rape (AORmen = 2.19 95%CI: 1.22-3.51), unprotected sex with a non-primary partner (AORmen = 1.90, 95%CI: 1.14-2.31), intergenerational sex (AORwomen = 1.36, 95%CI: 1.08-1.79), and multiple/concurrent sex partners (AORmen = 1.42, 95%CI: 1.10-1.93). Interpretation: These findings support the critical evidence-based need for gender-transformative HIV prevention efforts including legislation of women's rights in two of the most HIV affected countries in the world.	[Shannon, Kate] Univ British Columbia, Dept Med, Div Aids, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Leiter, Karen; Iacopino, Vincent] Phys Human Rights, Cambridge, MA USA; [Phaladze, Nthabiseng] Univ Botswana, Dept Nursing, Gaborone, Botswana; [Hlanze, Zakhe] Women & Law So Africa Res Trust, Mbabane, Swaziland; [Tsai, Alexander C.] Harvard Univ, Robert Wood Johnson Hlth & Soc Scholars Program, Cambridge, MA 02138 USA; [Heisler, Michele] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Iacopino, Vincent] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Posit Hlth Program, San Francisco, CA 94143 USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of Botswana; Harvard University; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Shannon, K (corresponding author), Univ British Columbia, Dept Med, Div Aids, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca	Tsai, Alexander C./F-4247-2015; Heisler, Michele/B-5774-2015	Tsai, Alexander C./0000-0001-6397-7917; Heisler, Michele/0000-0002-6889-2063	Physicians for Human Rights; Tides Foundation; United States National Institutes of Health; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; United States National Institute of Mental Health (NIMH) [R25 MH-060482]; NIMH [K23 MH079713-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713, R25MH060482] Funding Source: NIH RePORTER	Physicians for Human Rights; Tides Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); United States National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The survey was funded by Physicians for Human Rights and the Tides Foundation. KS acknowledges funding from the United States National Institutes of Health, the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research. AT acknowledges funding through United States National Institute of Mental Health (NIMH) Institutional Training Award R25 MH-060482 and SW through NIMH K23 MH079713-01.	Allen S., 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; AMARO H, 1995, AM PSYCHOL, V50, P437, DOI 10.1037/0003-066X.50.6.437; Anon J, 2006, PREVENTING FURTHER S; Bourgois P, 1996, BRIT J CRIMINOL, V36, P412; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dunkle KL, 2007, SEX TRANSM INFECT, V83, P173, DOI 10.1136/sti.2007.024950; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; Gable L, 2008, AM J PUBLIC HEALTH, V98, P1779, DOI 10.2105/AJPH.2008.138669; Garcia-Moreno C, 2000, AIDS, V14, pS253; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Martin S, 1999, JAMA, P282; Niehaus I, 2005, MEN BAHAV DIFFERENTL; Peacock D, 2009, JAIDS-J ACQ IMM DEF, V51, pS119, DOI 10.1097/QAI.0b013e3181aafd8a; Pettifor AE, 2005, TROP MED INT HEALTH, V10, P971, DOI 10.1111/j.1365-3156.2005.01483.x; PHR, 2007, EPID IN WOM RIGHTS H; PIOT P, 1999, HIV AIDS VIOLENCE WO; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; UN, 2004, FAC FURT TOG REP UN; UNAIDS, 2008, REP GLOB HIV EPID; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Wood K, 2001, CHANGING MEN SO AFRI; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	33	102	103	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28739	10.1371/journal.pone.0028739	http://dx.doi.org/10.1371/journal.pone.0028739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906ON	22247761	gold, Green Published			2022-12-25	WOS:000301355700009
J	Whitworth, AW				Whitworth, Andrew William			An Investigation into the Determining Factors of Zoo Visitor Attendances in UK Zoos	PLOS ONE			English	Article							CONSERVATION; PREFERENCES	The debate as to which animals are most beneficial to keep in zoos in terms of financial and conservative value is readily disputed; however, demographic factors have also been shown to relate to visitor numbers on an international level. The main aims of this research were: (1) To observe the distribution and location of zoos across the UK, (2) to develop a way of calculating zoo popularity in terms of the species kept within a collection and (3) to investigate the factors related to visitor numbers regarding admission costs, popularity of the collection in terms of the species kept and local demographic factors. Zoo visitor numbers were positively correlated with generated popularity ratings for zoos based on the species kept within a collection and admission prices (Pearson correlation: n = 34, r = 0.268, P = 0.126 and n = 34, r = -0.430, P = 0.011). Animal collections are aggregated around large cities and tourist regions, particularly coastal areas. No relationship between demographic variables and visitor numbers was found (Pearson correlation: n = 34, r = 0.268, P = 0.126), which suggests that the popularity of a zoo's collection relative to the types and numbers of species kept is more indicative of a collection's visitor numbers than its surrounding demographic figures. Zoos should incorporate generating high popularity scores as part of their collection planning strategies, to ensure that they thrive in the future, not only as tourist attractions but also as major conservation organizations.	[Whitworth, Andrew William] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Whitworth, Andrew William] CREES Fdn, London, England	University of Glasgow	Whitworth, AW (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	research@crees-manu.org	Whitworth, Andrew/AAG-5673-2020	Whitworth, Andrew/0000-0002-9971-4665; Whitworth, Andrew/0000-0001-6197-996X			Acknowledgments I would like to thank Dr Jianquan Cheng at Manchester Metropolitan University for expert advice with the study, particularly demographics. I also wish to thank Dr Jan Chapman and Dr Barry Stevens-Wood at Manchester Metropolitan University for their help and advice with project and questionnaire design. Thanks are given to staff at BIAZA for supporting the project. Thanks to those zoos that replied and accepted to allow the release of their visitor number figures. I would like to thank staff and students at Manchester Metropolitan University, staff and students at The Blue Coat School (Oldham), members of The Vine Fellowship (Littleborough) and the keeping staff at Trotter's World of Animals whom agreed to complete questionnaires. Thanks are also given to The CREES Foundation in allowing me to dedicate time in writing up this research whilst working for them. Finally, thanks to Glasgow University also for allowing me to take time to write up this research whilst studying and in particular to Dr Ross MacLeod for his help in reviewing drafts and responses.	Balmford A, 2000, CONSERV BIOL, V14, P1193, DOI 10.1046/j.1523-1739.2000.99078.x; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Davey G., 2007, International Zoo Yearbook, V41, P217, DOI 10.1111/j.1748-1090.2007.00007.x; Gusset M., 2010, International Zoo Yearbook, V44, P183, DOI 10.1111/j.1748-1090.2009.00101.x; Gusset M, 2011, ZOO BIOL, V30, P566, DOI 10.1002/zoo.20369; Hutchins M, 2003, J AM VET MED ASSOC, V223, P958, DOI 10.2460/javma.2003.223.958-2; Lorenz K., 1971, STUDIES ANIMAL HUMAN, V2, P115; Mason P., 2000, Journal of Sustainable Tourism, V8, P333, DOI 10.1080/09669580008667368; Morris D, 1961, INT ZOO YEARB, V2, P60, DOI DOI 10.1111/J.1748-1090.1960.TB02723.X; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Price MRS, 2005, ORYX, V39, P109, DOI 10.1017/S0030605305000505; Rees Paul A., 2004, IZN International Zoo News, V51, P484; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Surinova M., 1971, INT ZOO YEARB, V11, P165, DOI [https://doi.org/10.1111/j.1748-1090.1971.tb01895.x, DOI 10.1111/J.1748-1090.1971.TB01895.X]; Turley S. K., 1999, Journal of Vacation Marketing, V5, P340, DOI 10.1177/135676679900500404; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Ward PI, 2000, CONSERV BIOL, V14, P1196, DOI 10.1046/j.1523-1739.2000.00026.x	17	17	19	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29839	10.1371/journal.pone.0029839	http://dx.doi.org/10.1371/journal.pone.0029839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906ON	22253799	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700060
J	Doi, N; Yamakawa, N; Matsumoto, H; Yamamoto, Y; Nagano, T; Matsumura, N; Horisawa, K; Yanagawa, H				Doi, Nobuhide; Yamakawa, Natsuko; Matsumoto, Hideaki; Yamamoto, Yasutsugu; Nagano, Tetsuya; Matsumura, Nobutaka; Horisawa, Kenichi; Yanagawa, Hiroshi			DNA Display Selection of Peptide Ligands for a Full-Length Human G Protein-Coupled Receptor on CHO-K1 Cells	PLOS ONE			English	Article							IN-VITRO SELECTION; ANGIOTENSIN-II; AT(1) RECEPTOR; RIBOSOME DISPLAY; PHAGE LIBRARIES; EVOLUTION; SEQUENCE; RECOGNITION; ANTAGONISTS; ACTIVATION	The G protein-coupled receptors (GPCRs), which form the largest group of transmembrane proteins involved in signal transduction, are major targets of currently available drugs. Thus, the search for cognate and surrogate peptide ligands for GPCRs is of both basic and therapeutic interest. Here we describe the application of an in vitro DNA display technology to screening libraries of peptide ligands for full-length GPCRs expressed on whole cells. We used human angiotensin II (Ang II) type-1 receptor (hAT1R) as a model GPCR. Under improved selection conditions using hAT1R-expressing Chinese hamster ovary (CHO)-K1 cells as bait, we confirmed that Ang II gene could be enriched more than 10,000-fold after four rounds of selection. Further, we successfully selected diverse Ang II like peptides from randomized peptide libraries. The results provide more precise information on the sequence-function relationships of hAT1R ligands than can be obtained by conventional alanine-scanning mutagenesis. Completely in vitro DNA display can overcome the limitations of current display technologies and is expected to prove widely useful for screening diverse libraries of mutant peptide and protein ligands for receptors that can be expressed functionally on the surface of CHO-K1 cells.	[Doi, Nobuhide; Yamakawa, Natsuko; Matsumoto, Hideaki; Yamamoto, Yasutsugu; Nagano, Tetsuya; Matsumura, Nobutaka; Horisawa, Kenichi; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Doi, N (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	doi@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Doi, Nobuhide/0000-0002-2402-6390	Japan Science and Technology Agency [09-479]; New Energy and Industrial Technology Development Organization of Japan [03A01007a]; Japan Society for the Promotion of Science [19360377]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22658111] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research for Promoting Technological Seeds grant (09-479) from the Japan Science and Technology Agency; the Industrial Technology Research Grant Program (03A01007a) and a Grant for Practical Application of University Research & Development Results under the Matching Fund Method from the New Energy and Industrial Technology Development Organization of Japan; a Grant-in-Aid for Scientific Research (19360377) from the Japan Society for the Promotion of Science; and a Special Coordination Fund grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1990, BIOCHEM BIOPH RES CO, V170, P1236, DOI 10.1016/0006-291X(90)90526-S; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen N, 2003, NEUROSCIENCE, V120, P163, DOI 10.1016/S0306-4522(03)00259-8; Civelli O, 2006, PHARMACOL THERAPEUT, V110, P525, DOI 10.1016/j.pharmthera.2005.10.001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davenport AP, 2003, CURR OPIN PHARMACOL, V3, P127, DOI 10.1016/S1471-4892(03)00003-1; Dickinson J., 2002, PROTEIN PROTOCOLS HD, P429, DOI DOI 10.1385/1-59259-169-8:429; Doi N, 1999, FEBS LETT, V457, P227, DOI 10.1016/S0014-5793(99)01041-8; Doi N, 2001, COMB CHEM HIGH T SCR, V4, P497; Doi N, 2007, J BIOTECHNOL, V131, P231, DOI 10.1016/j.jbiotec.2007.07.947; DOORBAR J, 1994, J MOL BIOL, V244, P361, DOI 10.1006/jmbi.1994.1736; Dower WJ, 2002, CURR OPIN CHEM BIOL, V6, P390, DOI 10.1016/S1367-5931(02)00332-0; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Franca LP, 2003, EUR J PHARMACOL, V476, P25, DOI 10.1016/S0014-2999(03)02172-1; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hennecke M, 1998, EUR J BIOCHEM, V252, P36, DOI 10.1046/j.1432-1327.1998.2520036.x; Houimel M, 2001, EUR J IMMUNOL, V31, P3535, DOI 10.1002/1521-4141(200112)31:12<3535::AID-IMMU3535>3.0.CO;2-3; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; KHOSLA MC, 1972, J MED CHEM, V15, P792, DOI 10.1021/jm00278a003; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 1999, J HYPERTENS, V17, P397, DOI 10.1097/00004872-199917030-00013; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; OLEJNIK J, 1995, P NATL ACAD SCI USA, V92, P7590, DOI 10.1073/pnas.92.16.7590; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Ozawa A, 2010, AAPS J, V12, P378, DOI 10.1208/s12248-010-9198-9; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Roberts RW, 1999, CURR OPIN CHEM BIOL, V3, P268, DOI 10.1016/S1367-5931(99)80042-8; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Sumida T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp776; Szardenings M, 1997, J BIOL CHEM, V272, P27943, DOI 10.1074/jbc.272.44.27943; TAKAYANAGI R, 1992, BIOCHEM BIOPH RES CO, V183, P910, DOI 10.1016/0006-291X(92)90570-B; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Vanderheyden PML, 1999, BRIT J PHARMACOL, V126, P1057, DOI 10.1038/sj.bjp.0702398; Yonezawa M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng119; Yonezawa M, 2004, J BIOCHEM, V135, P285, DOI 10.1093/jb/mvh034	47	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					412	419	e30084	10.1371/journal.pone.0030084	http://dx.doi.org/10.1371/journal.pone.0030084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253889	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900042
J	Sixt, BS; Hiess, B; Konig, L; Horn, M				Sixt, Barbara S.; Hiess, Birgit; Koenig, Lena; Horn, Matthias			Lack of Effective Anti-Apoptotic Activities Restricts Growth of Parachlamydiaceae in Insect Cells	PLOS ONE			English	Article							CHLAMYDIA-INFECTED CELLS; SIMKANIA-NEGEVENSIS; INTRACELLULAR BACTERIUM; IN-SITU; PROTOCHLAMYDIA-AMOEBOPHILA; CHLAMYDOPHILA-PNEUMONIAE; ACANTHAMOEBA-POLYPHAGA; PROAPOPTOTIC PROTEINS; TRACHOMATIS INFECTION; EPITHELIAL-CELLS	The fundamental role of programmed cell death in host defense is highlighted by the multitude of anti-apoptotic strategies evolved by various microbes, including the well-known obligate intracellular bacterial pathogens Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. As inhibition of apoptosis is assumed to be essential for a successful infection of humans by these chlamydiae, we analyzed the anti-apoptotic capacity of close relatives that occur as symbionts of amoebae and might represent emerging pathogens. While Simkania negevensis was able to efficiently replicate within insect cells, which served as model for metazoan-derived host cells, the Parachlamydiaceae (Parachlamydia acanthamoebae and Protochlamydia amoebophila) displayed limited intracellular growth, yet these bacteria induced typical features of apoptotic cell death, including formation of apoptotic bodies, nuclear condensation, internucleosomal DNA fragmentation, and effector caspase activity. Induction of apoptosis was dependent on bacterial activity, but not bacterial de novo protein synthesis, and was detectable already at very early stages of infection. Experimental inhibition of host cell death greatly enhanced parachlamydial replication, suggesting that lack of potent anti-apoptotic activities in Parachlamydiaceae may represent an important factor compromising their ability to successfully infect non-protozoan hosts. These findings highlight the importance of the evolution of anti-apoptotic traits for the success of chlamydiae as pathogens of humans and animals.	[Sixt, Barbara S.; Hiess, Birgit; Koenig, Lena; Horn, Matthias] Univ Vienna, Dept Microbial Ecol, Vienna, Austria	University of Vienna	Horn, M (corresponding author), Univ Vienna, Dept Microbial Ecol, Vienna, Austria.	horn@microbial-ecology.net	Sixt, Barbara/AAY-5140-2020; Horn, Matthias/G-1136-2011	Sixt, Barbara/0000-0002-5607-8902; Horn, Matthias/0000-0002-8309-5855	Austrian Academy of Sciences at the Department of Microbial Ecology, University of Vienna, Austria; Austrian Science Fund (FWF) [Y277-B03]; Austrian Science Fund (FWF) [Y 277] Funding Source: researchfish	Austrian Academy of Sciences at the Department of Microbial Ecology, University of Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Barbara S. Sixt is recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Microbial Ecology, University of Vienna, Austria. This work was funded by Austrian Science Fund (FWF) grant Y277-B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Airenne S, 2002, SCAND J IMMUNOL, V55, P390, DOI 10.1046/j.1365-3083.2002.01075.x; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; Casson N, 2008, EMERG INFECT DIS, V14, P168, DOI 10.3201/eid1401.070980; Casson N, 2006, MICROBES INFECT, V8, P1294, DOI 10.1016/j.micinf.2005.12.011; Casson N, 2008, MICROB PATHOGENESIS, V45, P92, DOI 10.1016/j.micpath.2008.04.003; CHANG GT, 1978, INFECT IMMUN, V19, P827, DOI 10.1128/IAI.19.3.827-832.1978; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Cherry S, 2008, CURR OPIN MICROBIOL, V11, P262, DOI 10.1016/j.mib.2008.05.007; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; CLEM RJ, 1993, J VIROL, V67, P3730, DOI 10.1128/JVI.67.7.3730-3738.1993; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; Corsaro D, 2002, RES MICROBIOL, V153, P563, DOI 10.1016/S0923-2508(02)01369-4; Corsaro D, 2006, CRIT REV MICROBIOL, V32, P185, DOI 10.1080/10408410601023102; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Deponte M, 2008, BBA-MOL CELL RES, V1783, P1396, DOI 10.1016/j.bbamcr.2008.01.018; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Friedman MG, 2003, MICROBES INFECT, V5, P1013, DOI 10.1016/S1286-4579(03)00188-6; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gonzalez-Robles A, 2006, EXP PARASITOL, V114, P133, DOI 10.1016/j.exppara.2006.02.023; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2005, CELL MICROBIOL, V7, P581, DOI 10.1111/j.1462-5822.2004.00488.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Greub G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008423; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hackstadt T, 1999, CHLAMYDIA, P101; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hayashi Y, 2010, MICROBIOL IMMUNOL, V54, P707, DOI 10.1111/j.1348-0421.2010.00265.x; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; HERSHBERGER PA, 1992, J VIROL, V66, P5525, DOI 10.1128/JVI.66.9.5525-5533.1992; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Hess S, 2001, ARTHRITIS RHEUM-US, V44, P2392, DOI 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Huettenbrenner S, 2003, MUTAT RES-REV MUTAT, V543, P235, DOI 10.1016/S1383-5742(02)00110-2; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jha R, 2011, INFLAMM RES, V60, P69, DOI 10.1007/s00011-010-0237-x; KAHANE S, 1995, FEMS MICROBIOL LETT, V126, P203, DOI 10.1111/j.1574-6968.1995.tb07417.x; Kahane S, 2002, MICROBIOL-SGM, V148, P735, DOI 10.1099/00221287-148-3-735; KAHANE S, 1993, FEMS MICROBIOL LETT, V109, P329, DOI 10.1016/0378-1097(93)90041-Y; Kahane S, 2001, APPL ENVIRON MICROB, V67, P4789, DOI 10.1128/AEM.67.10.4789-4795.2001; Kahane S, 1999, INT J SYST BACTERIOL, V49, P815, DOI 10.1099/00207713-49-2-815; Kahane Simona, 2007, J Infect, V55, pe13, DOI 10.1016/j.jinf.2007.03.002; Kahane S, 2008, FEMS IMMUNOL MED MIC, V52, P219, DOI 10.1111/j.1574-695X.2007.00361.x; Karunakaran K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022528; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kostanjsek R, 2004, INT J SYST EVOL MICR, V54, P543, DOI 10.1099/ijs.0.02802-0; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Kumarswamy R, 2010, CELL BIOL INT, V34, P851, DOI 10.1042/CBI20100035; KUO CC, 1988, J CLIN MICROBIOL, V26, P812, DOI 10.1128/JCM.26.5.812-815.1988; KUO CC, 1976, INFECT IMMUN, V13, P1103, DOI 10.1128/IAI.13.4.1103-1109.1976; KUO CC, 1978, INFECT IMMUN, V20, P613, DOI 10.1128/IAI.20.3.613-618.1978; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Martelli AM, 2001, J CELL BIOCHEM, V82, P634, DOI 10.1002/jcb.1186; Maurin M, 2002, ANTIMICROB AGENTS CH, V46, P3065, DOI 10.1128/AAC.46.9.3065-3067.2002; Michel R, 2005, ACTA PROTOZOOL, V44, P113; MOULDER JW, 1976, INFECT IMMUN, V14, P277, DOI 10.1128/IAI.14.1.277-289.1976; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Ojcius DM, 1998, J IMMUNOL, V161, P4220; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Perfettini JL, 2000, INFECT IMMUN, V68, P2237, DOI 10.1128/IAI.68.4.2237-2244.2000; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Poppert S, 2002, APPL ENVIRON MICROB, V68, P4081, DOI 10.1128/AEM.68.8.4081-4089.2002; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Roger T, 2010, INFECT IMMUN, V78, P5195, DOI 10.1128/IAI.00786-10; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schoier J, 2001, MICROB PATHOGENESIS, V31, P173, DOI 10.1006/mpat.2001.0460; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Van Noorden CJF, 2001, ACTA HISTOCHEM, V103, P241, DOI 10.1078/0065-1281-00601; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wagner M, 2003, CURR OPIN MICROBIOL, V6, P302, DOI 10.1016/S1369-5274(03)00054-7; Wizel B, 2008, MICROBES INFECT, V10, P1420, DOI 10.1016/j.micinf.2008.08.006; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Yamaguchi T, 2004, JPN J INFECT DIS, V57, P103; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Ying SM, 2008, J INFECT DIS, V198, P1536, DOI 10.1086/592755; Ying Songmin, 2007, Curr Immunol Rev, V3, P31, DOI 10.2174/157339507779802179; Ying SM, 2006, INFECT IMMUN, V74, P6057, DOI 10.1128/IAI.00760-06; Zhong YM, 2006, J INFECTION, V53, P408, DOI 10.1016/j.jinf.2005.12.028	122	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29565	10.1371/journal.pone.0029565	http://dx.doi.org/10.1371/journal.pone.0029565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253735	Green Published, gold, Green Submitted			2022-12-25	WOS:000315865800010
J	Typlt, M; Englitz, B; Sonntag, M; Dehmel, S; Kopp-Scheinpflug, C; Ruebsamen, R				Typlt, Marei; Englitz, Bernhard; Sonntag, Mandy; Dehmel, Susanne; Kopp-Scheinpflug, Cornelia; Ruebsamen, Rudolf			Multidimensional Characterization and Differentiation of Neurons in the Anteroventral Cochlear Nucleus	PLOS ONE			English	Article							GLOBULAR BUSHY CELLS; SUPERIOR OLIVARY COMPLEX; AUDITORY-NERVE; GUINEA-PIG; HORSERADISH-PEROXIDASE; MERIONES-UNGUICULATUS; RESPONSE PROPERTIES; MONGOLIAN GERBIL; TRAPEZOID BODY; PHYSIOLOGICAL-MECHANISMS	Multiple parallel auditory pathways ascend from the cochlear nucleus. It is generally accepted that the origin of these pathways are distinct groups of neurons differing in their anatomical and physiological properties. In extracellular in vivo recordings these neurons are typically classified on the basis of their peri-stimulus time histogram. In the present study we reconsider the question of classification of neurons in the anteroventral cochlear nucleus (AVCN) by taking a wider range of response properties into account. The study aims at a better understanding of the AVCN's functional organization and its significance as the source of different ascending auditory pathways. The analyses were based on 223 neurons recorded in the AVCN of the Mongolian gerbil. The range of analysed parameters encompassed spontaneous activity, frequency coding, sound level coding, as well as temporal coding. In order to categorize the unit sample without any presumptions as to the relevance of certain response parameters, hierarchical cluster analysis and additional principal component analysis were employed which both allow a classification on the basis of a multitude of parameters simultaneously. Even with the presently considered wider range of parameters, high number of neurons and more advanced analytical methods, no clear boundaries emerged which would separate the neurons based on their physiology. At the current resolution of the analysis, we therefore conclude that the AVCN units more likely constitute a multi-dimensional continuum with different physiological characteristics manifested at different poles. However, more complex stimuli could be useful to uncover physiological differences in future studies.	[Typlt, Marei; Englitz, Bernhard; Sonntag, Mandy; Dehmel, Susanne; Kopp-Scheinpflug, Cornelia; Ruebsamen, Rudolf] Univ Leipzig, Inst Biol, Leipzig, Germany; [Englitz, Bernhard] Max Planck Inst Math Sci, Leipzig, Germany	Leipzig University; Max Planck Society	Typlt, M (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.	mtyplt@uwo.ca	Sonntag, Mandy/A-5925-2017; Englitz, Bernhard/K-7636-2018	Englitz, Bernhard/0000-0001-9106-0356; Typlt, Marei/0000-0002-1627-7560; Kopp-Scheinpflug, Conny/0000-0002-8083-6232	Graduate College InterNeuro at the University of Leipzig (DFG GRK) [1097]; Resarch Academy Leipzig (RAL); Deutsche Forschungsgemeinschaft (DFG) [Ru 390-18/2, Ru 390-19/1]	Graduate College InterNeuro at the University of Leipzig (DFG GRK); Resarch Academy Leipzig (RAL); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank the Graduate College InterNeuro at the University of Leipzig (DFG GRK 1097), the Resarch Academy Leipzig (RAL) and the Deutsche Forschungsgemeinschaft (DFG Ru 390-18/2; Ru 390-19/1) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLE JE, 1991, BIOL CYBERN, V64, P273, DOI 10.1007/BF00199590; Arnott RH, 2004, JARO-J ASSOC RES OTO, V5, P153, DOI 10.1007/s10162-003-4036-8; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Bilak SR, 1998, SYNAPSE, V28, P251; BLACKBURN CC, 1989, J NEUROPHYSIOL, V62, P1303, DOI 10.1152/jn.1989.62.6.1303; Bleeck S, 2007, HEARING - FROM SENSORY PROCESSING TO PERCEPTION, P27, DOI 10.1007/978-3-540-73009-5_4; BRAWER JR, 1974, J COMP NEUROL, V155, P251, DOI 10.1002/cne.901550302; BRAWER JR, 1975, J COMP NEUROL, V160, P491, DOI 10.1002/cne.901600406; CANT NB, 1981, NEUROSCIENCE, V6, P2643, DOI 10.1016/0306-4522(81)90109-3; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Cant NB, 2006, HEARING RES, V216, P64, DOI 10.1016/j.heares.2006.01.008; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; deNo R Lorente, 1981, PRIMARY ACOUSTIC NUC; Duda R.O., 2006, PATTERN CLASSIFICATI; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Englitz B, 2010, NETWORK-COMP NEURAL, V21, P91, DOI 10.3109/09548981003801996; Englitz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007014; Ferragamo MJ, 1998, J NEUROPHYSIOL, V79, P51, DOI 10.1152/jn.1998.79.1.51; FRIAUF E, 1988, EXP BRAIN RES, V73, P263; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; FRISINA RD, 1982, HEARING RES, V6, P259, DOI 10.1016/0378-5955(82)90059-4; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Josephson EM, 1998, J NEUROCYTOL, V27, P841, DOI 10.1023/A:1006959532686; JUIZ JM, 1994, BRAIN RES, V639, P193, DOI 10.1016/0006-8993(94)91730-2; KIM DO, 1979, J NEUROPHYSIOL, V42, P16, DOI 10.1152/jn.1979.42.1.16; Kopp-Scheinpflug C, 2003, J NEUROSCI, V23, P9199, DOI 10.1523/jneurosci.23-27-09199.2003; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Louage DHG, 2004, J NEUROPHYSIOL, V91, P2051, DOI 10.1152/jn.00816.2003; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; MULLER M, 1990, EXP BRAIN RES, V81, P140; Needham K, 2006, HEARING RES, V216, P31, DOI 10.1016/j.heares.2006.01.016; Nicol MJ, 2002, J PHYSIOL-LONDON, V539, P713, DOI 10.1113/jphysiol.2001.012972; NODA Y, 1974, ARCH OTO-RHINO-LARYN, V208, P107, DOI 10.1007/BF00453924; Oertel D, 2008, NEUROSCIENCE, V154, P77, DOI 10.1016/j.neuroscience.2008.01.085; OERTEL D, 1983, J NEUROSCI, V3, P2043; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; OSTAPOFF EM, 1994, J COMP NEUROL, V346, P19, DOI 10.1002/cne.903460103; OSTAPOFF EM, 1991, J COMP NEUROL, V314, P598, DOI 10.1002/cne.903140314; OSTAPOFF EM, 1989, HEARING RES, V37, P141, DOI 10.1016/0378-5955(89)90036-1; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; PFEIFFER RR, 1966, EXP BRAIN RES, V1, P220; PHILLIPS DP, 1989, HEARING RES, V40, P137, DOI 10.1016/0378-5955(89)90107-X; Por A, 2005, BRAIN RES, V1039, P63, DOI 10.1016/j.brainres.2005.01.057; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; RHODE WS, 1983, J COMP NEUROL, V213, P448, DOI 10.1002/cne.902130408; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3070, DOI 10.1152/jn.00125.2002; ROUILLER EM, 1984, J COMP NEUROL, V225, P167, DOI 10.1002/cne.902250203; RYAN AF, 1982, J COMP NEUROL, V207, P369, DOI 10.1002/cne.902070408; RYUGO DK, 1991, J COMP NEUROL, V305, P35, DOI 10.1002/cne.903050105; Saint Marie RL, 1993, MAMMALIAN COCHLEAR N; SMITH PH, 1987, J COMP NEUROL, V266, P360, DOI 10.1002/cne.902660305; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; SMITH PH, 1989, J COMP NEUROL, V282, P595, DOI 10.1002/cne.902820410; SOKOLOWSKI BHA, 1989, HEARING RES, V41, P115, DOI 10.1016/0378-5955(89)90005-1; Spirou GA, 2005, NEUROSCIENCE, V136, P843, DOI 10.1016/j.neuroscience.2005.08.068; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; STATLER KD, 1990, HEARING RES, V50, P275, DOI 10.1016/0378-5955(90)90051-P; Sumner CJ, 2009, BRAIN RES, V1247, P221, DOI 10.1016/j.brainres.2008.09.054; Thompson AM, 2000, MICROSC RES TECHNIQ, V51, P330, DOI 10.1002/1097-0029(20001115)51:4<330::AID-JEMT4>3.0.CO;2-X; Typlt M, 2010, EUR J NEUROSCI, V31, P1574, DOI 10.1111/j.1460-9568.2010.07188.x; VATER M, 1985, J COMP PHYSIOL A, V157, P671, DOI 10.1007/BF01351361; WANG XQ, 1995, J NEUROPHYSIOL, V73, P1600, DOI 10.1152/jn.1995.73.4.1600; WEBSTER DB, 1971, J COMP NEUROL, V143, P323, DOI 10.1002/cne.901430305; WENTHOLD RJ, 1988, J COMP NEUROL, V276, P423, DOI 10.1002/cne.902760307; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4; WU SH, 1984, J NEUROSCI, V4, P1577; Young ED, 2008, NEUROSCIENCE, V154, P127, DOI 10.1016/j.neuroscience.2008.01.036; YOUNG ED, 1988, J NEUROPHYSIOL, V60, P1, DOI 10.1152/jn.1988.60.1.1; Yu SM, 2011, MED MOL MORPHOL, V44, P158, DOI 10.1007/s00795-010-0523-2	76	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29965	10.1371/journal.pone.0029965	http://dx.doi.org/10.1371/journal.pone.0029965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253838	Green Submitted, Green Published, gold			2022-12-25	WOS:000301352400009
J	Baker, C; Antonovics, J				Baker, Christi; Antonovics, Janis			Evolutionary Determinants of Genetic Variation in Susceptibility to Infectious Diseases in Humans	PLOS ONE			English	Article							INFLUENZA-A H5N1; TRADE-OFFS; DROSOPHILA-MELANOGASTER; COSTLY RESISTANCE; EMERGING FIELD; POLYMORPHISM; SELECTION; MALARIA; MHC; IMMUNOGENETICS	Although genetic variation among humans in their susceptibility to infectious diseases has long been appreciated, little focus has been devoted to identifying patterns in levels of variation in susceptibility to different diseases. Levels of genetic variation in susceptibility associated with 40 human infectious diseases were assessed by a survey of studies on both pedigree-based quantitative variation, as well as studies on different classes of marker alleles. These estimates were correlated with pathogen traits, epidemiological characteristics, and effectiveness of the human immune response. The strongest predictors of levels of genetic variation in susceptibility were disease characteristics negatively associated with immune effectiveness. High levels of genetic variation were associated with diseases with long infectious periods and for which vaccine development attempts have been unsuccessful. These findings are consistent with predictions based on theoretical models incorporating fitness costs associated with the different types of resistance mechanisms. An appreciation of these observed patterns will be a valuable tool in directing future research given that genetic variation in disease susceptibility has large implications for vaccine development and epidemiology.	[Baker, Christi; Antonovics, Janis] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Antonovics, J (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	ja8n@virginia.edu			National Science Foundation (NSF) [DEB 0640777]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was partially supported by the National Science Foundation (NSF) Grant DEB 0640777 and by a Fellowship to Dr. Antonovics at the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Bellamy R., 2004, SUSCEPTIBILITY INFEC; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.1111/j.1558-5646.1996.tb02350.x, 10.2307/2410650]; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2004, P ROY SOC B-BIOL SCI, V271, P715, DOI 10.1098/rspb.2003.2655; BOWERS RG, 1994, P ROY SOC B-BIOL SCI, V257, P247, DOI 10.1098/rspb.1994.0122; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Clegg JB, 1999, P ASSOC AM PHYSICIAN, V111, P278, DOI 10.1046/j.1525-1381.1999.99235.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; GEDDA L, 1984, ACTA GENET MED GEMEL, V33, P497, DOI 10.1017/S000156600000595X; Grigoriu D, 1987, MED MYCOLOGY; Haldane J. B. S., 1932, CAUSES EVOLUTION; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Haldane JBS., 1949, RIC SCI S, V19, P2; HILL AVS, 1992, BAILLIERE CLIN HAEM, V5, P209, DOI 10.1016/S0950-3536(11)80042-9; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; HOLMES KK, 1990, SEXUALLY TRANSMITTED; HUGHEE AL, 1992, GENETICS, V132, P863; Jacobson RM, 2007, VACCINE, V25, P3160, DOI 10.1016/j.vaccine.2007.01.048; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Jepson A, 1998, B I PASTEUR, V96, P71, DOI 10.1016/S0020-2452(98)80001-8; John D. T., 2006, MARKELL VOGES MED PA; Jorgensen G, 1974, HDB ALLGEMEINEN PATH, P581; Kaslow R. A., 2008, GENETIC SUSCEPTIBILI; Kimman T.G., 2001, GENETICS INFECT DIS; Kiple K.F., 1993, CAMBRIDGE WORLD HIST; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lenski RE, 1985, AM NAT, V125, P602; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; MANDELL GL, 2005, MANDELL DOUGLAS BENN; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mealor MA, 2006, J EVOLUTION BIOL, V19, P326, DOI 10.1111/j.1420-9101.2005.01031.x; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Picard C, 2006, CURR OPIN IMMUNOL, V18, P383, DOI 10.1016/j.coi.2006.05.005; Pitzer VE, 2007, EMERG INFECT DIS, V13, P1074, DOI 10.3201/eid1307.061538; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]; Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]; R Core Team, 2022, R LANG ENV STAT COMP; SAS Institute Inc, 2002, SAS SYST WIND 9 2; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stansberry LR, 2000, SEXUALLY TRANSMITTED; TURKINGTON C, 1998, ENCY INFECT DIS	56	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29089	10.1371/journal.pone.0029089	http://dx.doi.org/10.1371/journal.pone.0029089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242158	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100012
J	Enroth, S; Bornelov, S; Wadelius, C; Komorowski, J				Enroth, Stefan; Bornelov, Susanne; Wadelius, Claes; Komorowski, Jan			Combinations of Histone Modifications Mark Exon Inclusion Levels	PLOS ONE			English	Article							CHROMATIN; TRANSCRIPTION; METHYLATIONS; SELECTION	Splicing is a complex process regulated by sequence at the classical splice sites and other motifs in exons and introns with an enhancing or silencing effect. In addition, specific histone modifications on nucleosomes positioned over the exons have been shown to correlate both positively and negatively with exon expression. Here, we trained a model of "IF ... THEN ... '' rules to predict exon inclusion levels in a transcript from histone modification patterns. Furthermore, we showed that combinations of histone modifications, in particular those residing on nucleosomes preceding or succeeding the exon, are better predictors of exon inclusion levels than single modifications. The resulting model was evaluated with cross validation and had an average accuracy of 72% for 27% of the exons, which demonstrates that epigenetic signals substantially mark alternative splicing.	[Wadelius, Claes] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Enroth, Stefan; Bornelov, Susanne; Komorowski, Jan] Uppsala Univ, Dept Cell & Mol Biol, Linnaeus Ctr Bioinformat, Sci Life Lab,Biomed Ctr, Uppsala, Sweden; [Komorowski, Jan] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland	Uppsala University; Uppsala University; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling	Wadelius, C (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	claes.wadelius@igp.uu.se; jan.komorowski@icm.uu.se	Komorowski, Jan/AAP-1685-2020; Enroth, Stefan/C-7396-2009; Bornelöv, Susanne/I-8225-2019; Komorowski, Jan/A-9175-2010; Komorowski, Jan/M-2667-2013	Komorowski, Jan/0000-0002-0766-8789; Enroth, Stefan/0000-0002-5056-9137; Bornelöv, Susanne/0000-0001-9276-9981; Komorowski, Jan/0000-0002-0766-8789	Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Polish Ministry of Science and Higher Education [N301 239536]; Swedish Research Council; Swedish Cancer Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	SE, SB and JK were partially supported by The Knut and Alice Wallenberg Foundation and by The Swedish Foundation for Strategic Research. JK was partially supported by the Polish Ministry of Science and Higher Education, grant N301 239536. CW was supported by the Swedish Research Council and the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Draminski M, 2008, BIOINFORMATICS, V24, P110, DOI 10.1093/bioinformatics/btm486; Enroth S, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-4; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fox-Walsh K, 2010, DEV CELL, V18, P336, DOI 10.1016/j.devcel.2010.03.002; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Komorowski J, 2002, HANDBOOK OF DATA MIN; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Newman AJ, 2010, CURR OPIN STRUC BIOL, V20, P82, DOI 10.1016/j.sbi.2009.12.003; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Tilgner H, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.3.11319; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154	29	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29911	10.1371/journal.pone.0029911	http://dx.doi.org/10.1371/journal.pone.0029911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242188	gold, Green Published, Green Submitted			2022-12-25	WOS:000312662100045
J	Miraucourt, LS; da Silva, JS; Burgos, K; Li, JL; Abe, H; Ruthazer, ES; Cline, HT				Miraucourt, Lois S.; da Silva, Jorge Santos; Burgos, Kasandra; Li, Jianli; Abe, Hikari; Ruthazer, Edward S.; Cline, Hollis T.			GABA Expression and Regulation by Sensory Experience in the Developing Visual System	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ACTIVITY-DEPENDENT REGULATION; GAMMA-AMINOBUTYRIC-ACID; KINASE GENE-EXPRESSION; BARREL FIELD CORTEX; XENOPUS-LAEVIS; PROTEIN-KINASE; SYNAPTIC-TRANSMISSION; NEUROTROPHIC FACTOR; OPTIC TECTUM	The developing retinotectal system of the Xenopus laevis tadpole is a model of choice for studying visual experience-dependent circuit maturation in the intact animal. The neurotransmitter gamma-aminobutyric acid (GABA) has been shown to play a critical role in the formation of sensory circuits in this preparation, however a comprehensive neuroanatomical study of GABAergic cell distribution in the developing tadpole has not been conducted. We report a detailed description of the spatial expression of GABA immunoreactivity in the Xenopus laevis tadpole brain at two key developmental stages: stage 40/42 around the onset of retinotectal innervation and stage 47 when the retinotectal circuit supports visually-guided behavior. During this period, GABAergic neurons within specific brain structures appeared to redistribute from clusters of neuronal somata to a sparser, more uniform distribution. Furthermore, we found that GABA levels were regulated by recent sensory experience. Both ELISA measurements of GABA concentration and quantitative analysis of GABA immunoreactivity in tissue sections from the optic tectum show that GABA increased in response to a 4 hr period of enhanced visual stimulation in stage 47 tadpoles. These observations reveal a remarkable degree of adaptability of GABAergic neurons in the developing brain, consistent with their key contributions to circuit development and function.	[Li, Jianli; Cline, Hollis T.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Li, Jianli; Cline, Hollis T.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Miraucourt, Lois S.; Abe, Hikari; Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [da Silva, Jorge Santos; Burgos, Kasandra; Li, Jianli] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Burgos, Kasandra] SUNY Stony Brook, Stony Brook Sch Med, Stony Brook, NY 11794 USA	Scripps Research Institute; Scripps Research Institute; McGill University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	cline@scripps.edu	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151	National Institutes of Health-National Eye Institute [EY011261]; Nancy Lurie Marks Family Foundation; Canadian Institutes for Health Research (CIHR) [MOP-77567]; Montreal Neurological Institute Centre for Excellence in Commercialization and Research (MNI CERC) [52]; Epilepsy Canada; MNI Centre for Excellence in Commercialization and Research; EMBO [ALTF 704-2004]; HFSPO [LT00708/2005-L]; NATIONAL EYE INSTITUTE [R01EY011261] Funding Source: NIH RePORTER	National Institutes of Health-National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Nancy Lurie Marks Family Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Montreal Neurological Institute Centre for Excellence in Commercialization and Research (MNI CERC); Epilepsy Canada; MNI Centre for Excellence in Commercialization and Research; EMBO(European Molecular Biology Organization (EMBO)); HFSPO(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health-National Eye Institute (award EY011261; http://www.nei.nih.gov/) and the Nancy Lurie Marks Family Foundation (http://nlmfoundation.org) to HTC, the Canadian Institutes for Health Research (CIHR, award MOP-77567; http://www.cihr-irsc.gc.ca/) and the Montreal Neurological Institute Centre for Excellence in Commercialization and Research (MNI CERC award 52; http://apps.mni.mcgill.ca/mnicecr/index.php) to ESR, a postdoctoral fellowship (no number given) from Epilepsy Canada (http://www.epilepsy.ca/en-CA/Epilepsy-Canada.html) and an internal award (no number) from the MNI Centre for Excellence in Commercialization and Research to LSM. JSdS was supported by fellowships from EMBO (award ALTF 704-2004; http://www.embo.org/) and HFSPO (award LT00708/2005-L; http://www.hfsp.org/). ESR is a Canada Research Chair and Killam Scholar. HTC is the Hahn Professor of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; AKHTAR ND, 1991, J COMP NEUROL, V307, P200, DOI 10.1002/cne.903070204; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bachy I, 2006, DEV BIOL, V291, P218, DOI 10.1016/j.ydbio.2005.10.023; Bachy I, 2002, MECH DEVELOP, V117, P163, DOI 10.1016/S0925-4773(02)00199-5; Barale E, 1996, J COMP NEUROL, V368, P285, DOI 10.1002/(SICI)1096-9861(19960429)368:2<285::AID-CNE8>3.0.CO;2-#; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; BENSON DL, 1991, J NEUROSCI, V11, P1540; BENSON DL, 1991, J NEUROSCI, V11, P31; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bestman JE, 2011, J COMP NEUR IN PRESS; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BONAVENTURE N, 1989, DOC OPHTHALMOL, V72, P71, DOI 10.1007/BF00155216; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brox A, 2003, J COMP NEUROL, V461, P370, DOI 10.1002/cne.10688; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; CHEN XF, 2011, VISUAL NEUROSCI, V28, P28, DOI DOI 10.3184/096034011X12976994640586; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DIRKX R, 1995, J BIOL CHEM, V270, P2241, DOI 10.1074/jbc.270.5.2241; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ERONDU NE, 1985, J NEUROSCI, V5, P3270; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Fode C, 2000, GENE DEV, V14, P67; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gonzalez A, 2002, NEUROSCIENCE, V114, P567, DOI 10.1016/S0306-4522(02)00326-3; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HOLLYFIELD J G, 1980, Neurochemistry International, V1, P93, DOI 10.1016/0197-0186(80)90053-4; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Huang S, 1998, VISUAL NEUROSCI, V15, P969, DOI 10.1017/S0952523898155153; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jin X, 2003, J NEUROSCI, V23, P5662; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Kreczko A, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/415135; LAZAR G, 1973, J ANAT, V116, P347; Li JL, 2010, J COMP NEUROL, V518, P2365, DOI 10.1002/cne.22338; Li Z, 1998, VISUAL NEUROSCI, V15, P995, DOI 10.1017/S0952523898155207; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maffei A, 2008, PROG BRAIN RES, V169, P211, DOI 10.1016/S0079-6123(07)00012-X; Marc RE, 2001, J NEUROCYTOL, V30, P593, DOI 10.1023/A:1016516818393; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MICHEVA KD, 1995, J COMP NEUROL, V361, P574, DOI 10.1002/cne.903610403; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Micheva KD, 1997, CAN J PHYSIOL PHARM, V75, P470, DOI 10.1139/cjpp-75-5-470; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miyashita T, 2007, EUR J NEUROSCI, V26, P1193, DOI 10.1111/j.1460-9568.2007.05745.x; Morales B, 2002, J NEUROSCI, V22, P8084; MOSINGER JL, 1986, EXP EYE RES, V42, P631, DOI 10.1016/0014-4835(86)90052-7; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Mueller T, 2006, J COMP NEUROL, V494, P620, DOI 10.1002/cne.20824; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Reed KL, 2002, BRAIN BEHAV EVOLUT, V60, P1, DOI 10.1159/000064117; Richards BA, 2010, NAT NEUROSCI, V13, P1098, DOI 10.1038/nn.2612; ROBERTS A, 1987, J COMP NEUROL, V261, P435, DOI 10.1002/cne.902610308; Robertson B, 2007, J COMP NEUROL, V503, P47, DOI 10.1002/cne.21348; Robertson B, 2006, J COMP NEUROL, V499, P106, DOI 10.1002/cne.21078; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Ruthazer ES, 2010, TRENDS NEUROSCI, V33, P183, DOI 10.1016/j.tins.2010.01.003; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; RYBICKA KK, 1994, EUR J NEUROSCI, V6, P1567, DOI 10.1111/j.1460-9568.1994.tb00547.x; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Sanchez-Huertas C, 2011, CEREB CORTEX, V21, P777, DOI 10.1093/cercor/bhq150; Schwartz N, 2011, NEURON, V70, P455, DOI 10.1016/j.neuron.2011.02.055; Sharma P, 2010, NEURON, V68, P442, DOI 10.1016/j.neuron.2010.09.028; Shen W, 2011, J NEUROPHYSIOL; Shen WH, 2009, J NEUROSCI, V29, P5032, DOI 10.1523/JNEUROSCI.5331-08.2009; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tighilet B, 1998, J COMP NEUROL, V390, P278, DOI 10.1002/(SICI)1096-9861(19980112)390:2<278::AID-CNE10>3.0.CO;2-U; Tomioka R, 2007, J COMP NEUROL, V505, P526, DOI 10.1002/cne.21504; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Werblin FS, 2010, VISUAL NEUROSCI, V27, P1, DOI 10.1017/S0952523810000076; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wullimann MF, 2005, J COMP NEUROL, V489, P387, DOI 10.1002/cne.20634; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	121	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29086	10.1371/journal.pone.0029086	http://dx.doi.org/10.1371/journal.pone.0029086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242157	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000312662100011
J	Wang, Y; Huang, XY; Zhou, JQ; Yang, X; Li, D; Mao, HY; Sun, HH; Liu, NS; Lian, JF				Wang, Ying; Huang, Xiaoyan; Zhou, Jianqing; Yang, Xi; Li, Di; Mao, Haiyan; Sun, Huan Huan; Liu, Ningsheng; Lian, Jiangfang			Trafficking-Deficient G572R-hERG and E637K-hERG Activate Stress and Clearance Pathways in Endoplasmic Reticulum	PLOS ONE			English	Article							LONG-QT SYNDROME; UNFOLDED PROTEIN RESPONSE; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; QUALITY-CONTROL; HERG; MUTATIONS; ATF6; PROTEOLYSIS; SPECTRUM	Background: Long QT syndrome type 2 (LQT2) is the second most common type of all long QT syndromes. It is well-known that trafficking deficient mutant human ether-a-go-go-related gene (hERG) proteins are often involved in LQT2. Cells respond to misfolded and trafficking-deficient proteins by eliciting the unfolded protein response (UPR) and Activating Transcription Factor (ATF6) has been identified as a key regulator of the mammalian UPR. In this study, we investigated the role of ER chaperone proteins (Calnexin and Calreticulin) in the processing of G572R-hERG and E637K-hERG mutant proteins. Methods: pcDNA3-WT-hERG, pcDNA3-G572R-hERG and pcDNA3-E637K-hERG plasmids were transfected into U2OS and HEK293 cells. Confocal microscopy and western blotting were used to analyze subcellular localization and protein expression. Interaction between WT or mutant hERGs and Calnexin/Calreticulin was tested by coimmunoprecipitation. To assess the role of the ubiquitin proteasome pathway in the degradation of mutant hERG proteins, transfected HEK293 cells were treated with proteasome inhibitors and their effects on the steady state protein levels of WT and mutant hERGs were examined. Conclusion: Our results showed that levels of core-glycosylated immature forms of G572R-hERG and E637K-hERG in association with Calnexin and Calreticulin were higher than that in WT-hERG. Both mutant hERG proteins could activate the UPR by upregulating levels of active ATF6. Furthermore, proteasome inhibition increased the levels of core-glycosylated immature forms of WT and mutant hERGs. In addition, interaction between mutant hERGs and Calnexin/Calreticulin was stronger after proteasome inhibition, compared to WT-hERG. These results suggest that trafficking-deficient G572R-hERG and E637K-hERG mutant proteins can activate ER stress pathways and are targeted to the proteasome for degradation. Calnexin and Calreticulin play important roles in these processes.	[Liu, Ningsheng] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Sun, Huan Huan] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Wang, Ying; Huang, Xiaoyan; Zhou, Jianqing; Yang, Xi; Li, Di; Mao, Haiyan; Lian, Jiangfang] Ningbo Univ, LiHuiLi Hosp, Sch Med, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China	Nanjing Medical University; University of Rochester; Ningbo University	Liu, NS (corresponding author), Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China.	liuns@njmu.edu.cn; hjmpin@163.com			National Natural Science Foundation of China [30772155]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Natural Science Foundation of Zhejiang Province [Y206608]; Youth and Doctor foundation of Ningbo [2005A610016]; Medical Science and Technology Project of Ningbo [2009A02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Youth and Doctor foundation of Ningbo; Medical Science and Technology Project of Ningbo	The research was supported by the grants from: National Natural Science Foundation of China (30772155), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Natural Science Foundation of Zhejiang Province (Y206608), Youth and Doctor foundation of Ningbo (2005A610016), and Medical Science and Technology Project of Ningbo (2009A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Chevet E, 1999, SEMIN CELL DEV BIOL, V10, P473, DOI 10.1006/scdb.1999.0316; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fodstad H, 2004, ANN MED, V36, P53, DOI 10.1080/17431380410032689; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong QM, 2004, AM J PHYSIOL-HEART C, V287, pH652, DOI 10.1152/ajpheart.00052.2004; Hayashi K, 2002, CARDIOVASC RES, V54, P67, DOI 10.1016/S0008-6363(02)00240-7; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Lian JF, 2010, CAN J CARDIOL, V26, P417, DOI 10.1016/S0828-282X(10)70439-6; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Roden DM, 1999, J CARDIOVASC ELECTR, V10, P1664, DOI 10.1111/j.1540-8167.1999.tb00231.x; Saenen JB, 2008, J MOL CELL CARDIOL, V44, P633, DOI 10.1016/j.yjmcc.2008.01.006; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Steiner H, 2001, NEUROBIOL DIS, V8, P717, DOI 10.1006/nbdi.2001.0405; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	26	18	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29885	10.1371/journal.pone.0029885	http://dx.doi.org/10.1371/journal.pone.0029885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242185	gold, Green Submitted, Green Published			2022-12-25	WOS:000312662100042
J	Yang, T; Liu, NN				Yang, Ting; Liu, Nannan			Genome Analysis of Cytochrome P450s and Their Expression Profiles in Insecticide Resistant Mosquitoes, Culex quinquefasciatus	PLOS ONE			English	Article							PYRETHROID-RESISTANT; GENE-EXPRESSION; DETOXIFICATION ENZYMES; METABOLIC RESISTANCE; HOUSE-FLIES; CYP4 FAMILY; SUPPRESSION; STRAINS; OVEREXPRESSION; BIOSYNTHESIS	Here we report a study of the 204 P450 genes in the whole genome sequence of larvae and adult Culex quinquefasciatus mosquitoes. The expression profiles of the P450 genes were compared for susceptible (S-Lab) and resistant mosquito populations, two different field populations of mosquitoes (HAmCq and MAmCq), and field parental mosquitoes (HAmCq (G0) and MAmCq(G0)) and their permethrin selected offspring (HAmCq (G8) and MAmCq(G6)). While the majority of the P450 genes were expressed at a similar level between the field parental strains and their permethrin selected offspring, an up-or down-regulation feature in the P450 gene expression was observed following permethrin selection. Compared to their parental strains and the susceptible S-Lab strain, HAmCq(G8) and MAmCq(G6) were found to up-regulate 11 and 6% of total P450 genes in larvae and 7 and 4% in adults, respectively, while 5 and 11% were down-regulated in larvae and 4 and 2% in adults. Although the majority of these up- and down-regulated P450 genes appeared to be developmentally controlled, a few were either up-or down-regulated in both the larvae and adult stages. Interestingly, a different gene set was found to be up- or down-regulated in the HAmCq(G8) and MAmCq(G6) mosquito populations in response to insecticide selection. Several genes were identified as being up-or down-regulated in either the larvae or adults for both HAmCq(G8) and MAmCq(G6); of these, CYP6AA7 and CYP4C52v1 were up-regulated and CYP6BY3 was down-regulated across the life stages and populations of mosquitoes, suggesting a link with the permethrin selection in these mosquitoes. Taken together, the findings from this study indicate that not only are multiple P450 genes involved in insecticide resistance but up-or down-regulation of P450 genes may also be co-responsible for detoxification of insecticides, insecticide selection, and the homeostatic response of mosquitoes to changes in cellular environment.	[Yang, Ting; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Yang, T (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu			National Institute of Allergy and Infectious Diseases [R21AI076893]; AAES [ALA08-045, ALA015-1-10026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076893] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award number R21AI076893 to N.L. from the National Institute of Allergy and Infectious Diseases, AAES Hatch/Multistate Grants ALA08-045 and ALA015-1-10026 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Berenbaum M.R., 1991, P221; CARINO F, 1992, ACS SYM SER, V505, P31; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cui PH, 2010, BRIT J PHARMACOL, V159, P1440, DOI 10.1111/j.1476-5381.2009.00628.x; Davies L, 2006, INSECT BIOCHEM MOLEC, V36, P801, DOI 10.1016/j.ibmb.2006.08.001; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; HODGSON E, 1983, INSECT BIOCHEM, V13, P237, DOI 10.1016/0020-1790(83)90044-6; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Li B, 2005, SCI CHINA SER C, V48, P414, DOI 10.1360/04yc0057; Li T, 2010, J MED ENTOMOL, V47, P1127, DOI 10.1603/ME10142; Li XC, 2002, INSECT BIOCHEM MOLEC, V32, P311, DOI 10.1016/S0965-1748(01)00092-3; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU AYH, 1979, PHARMACOL REV, V31, P277; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MORGAN ET, 1989, MOL PHARMACOL, V36, P699; Nelson David R., 2009, Human Genomics, V4, P59; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; REED JR, 1994, P NATL ACAD SCI USA, V91, P10000, DOI 10.1073/pnas.91.21.10000; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Riddick DS, 2004, DRUG METAB DISPOS, V32, P367, DOI 10.1124/dmd.32.4.367; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shen B, 2003, PESTIC BIOCHEM PHYS, V75, P19, DOI 10.1016/S0048-3575(03)00014-2; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sutherland TD, 1998, P NATL ACAD SCI USA, V95, P12884, DOI 10.1073/pnas.95.22.12884; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; *WHO, 1957, WHO TECH RPT SER; Winter J, 2001, BIOL CHEM, V382, P1541, DOI 10.1515/BC.2001.188; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Zhu F, 2008, ARCH INSECT BIOCH PH, V34, P147; Zhu F., 2008, INSECT MOL BIOL, V20, P1365, DOI DOI 10.1186/1472-6793-8-18; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	65	98	104	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29418	10.1371/journal.pone.0029418	http://dx.doi.org/10.1371/journal.pone.0029418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242119	Green Submitted, gold, Green Published			2022-12-25	WOS:000300677000031
J	Yoon, CH; Kim, MJ; Kim, RK; Lim, EJ; Choi, KS; An, S; Hwang, SG; Kang, SG; Suh, Y; Park, MJ; Lee, SJ				Yoon, C-H; Kim, M-J; Kim, R-K; Lim, E-J; Choi, K-S; An, S.; Hwang, S-G; Kang, S-G; Suh, Y.; Park, M-J; Lee, S-J			c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells	ONCOGENE			English	Article						c-Jun N-terminal kinase; glioma stem-like cells; Notch-2; resistance to anticancer treatments	TUMOR-INITIATING CELLS; HUMAN BRAIN-TUMORS; HUMAN GLIOBLASTOMA; GROWTH-FACTOR; NH2-TERMINAL KINASE; NOTCH; CANCER; ACTIVATION; PATHWAY; EXPRESSION	Uncovering the mechanisms that govern the maintenance of stem-like cancer cells is critical for developing therapeutic strategies for targeting these cells. Constitutive activation of c-Jun N-terminal kinase (JNK) has been reported in gliomas and correlates with histological grade. Here, we found that JNK signaling is crucial for the maintenance of 'stemness' in glioma cells. Sphere-cultured glioma cells showed more phosphorylation of JNK compared with serum-containing monolayer cultures. Importantly, blockade of JNK signaling with SP600125 or small interfering RNAs targeting JNK1 or JNK2 significantly reduced the CD133(+)/Nestin(+) population and suppressed sphere formation, colony formation in soft agar, and expression of stem cell markers in sphere-cultured glioma cells. Intriguingly, sphere-cultured glioma cells exhibited enhanced expression of Notch-2, but not Notch-1, -3 or -4, and JNK inhibition almost completely abrogated this increase. Blocking the phosphoinoside 3-kinase (PI3K)/Akt pathway with LY294002 or si-Akt also suppressed the self-renewal of sphere-cultured glioma cells. PI3K, but not Akt, had a role as an upstream kinase in JNK1/2 activation. In addition, treatment with si-JNK greatly increased etoposide- and ionizing radiation (IR)-induced cell death in glioma spheres. Consistent with glioma cell lines, glioma stem-like cells isolated from primary patient glioma cells also had a higher activity of JNK and Notch-2 expression. Importantly, inhibition of JNK2 led to a decrease of Notch-2 expression and suppressed the CD133(+)/Nestin(+) cell population in patient-derived primary glioma cells. Finally, downregulation of JNK2 almost completely suppressed intracranial tumor formation by glioma cells in nude mice. Taken together, these data demonstrate that JNK signaling is crucial for the maintenance of self-renewal and tumorigenicity of glioma stem-like cells and drug/IR resistance, and can be considered a promising target for eliminating stem-like cancer cells in gliomas.	[Hwang, S-G; Park, M-J] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [Yoon, C-H; Kim, R-K; Lim, E-J; Suh, Y.; Lee, S-J] Hanyang Univ, Res Inst Nat Sci, Dept Chem, Seoul 133791, South Korea; [Kim, M-J] Korea Atom Energy Res Inst, Environm Radiat Res Grp, Dept Radiat Biol, Taejon, South Korea; [Choi, K-S] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [An, S.] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul, South Korea; [Kang, S-G] Catholic Univ, Seoul St Marys Hosp, Dept Neurosurg, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Hanyang University; Korea Atomic Energy Research Institute (KAERI); Sungkyunkwan University (SKKU); Samsung Medical Center; Konkuk University; Catholic University of Korea; Seoul St. Mary's Hospital	Park, MJ (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea.	mjpark@kcch.re.kr; sj0420@hanyang.ac.kr	Yoon, Changhwan/AAK-7842-2021	Yoon, Changhwan/0000-0002-8420-9818; Kang, Seok-Gu/0000-0001-5676-2037	Korea Research Foundation (KRF); Ministry of Education, Science and Technology (MEST), Korean government [2008-2003935]; Ministry for Health, Welfare and Family affairs, Republic of Korea [1020340]	Korea Research Foundation (KRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), Korean government(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	We thank Dr Akio Soeda (Department of Neurological Surgery, University of Virginia, USA) for providing patient-derived glioma cells. This work was supported by the Korea Research Foundation (KRF) and Ministry of Education, Science and Technology (MEST), Korean government, through its National Nuclear Technology Program (2008-2003935) and the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (1020340).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Hyun KH, 2011, TOXICOL APPL PHARM, V254, P32, DOI 10.1016/j.taap.2011.04.006; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tsuiki H, 2003, CANCER RES, V63, P250; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yi L, 2007, MODERN PATHOL, V20, P1061, DOI 10.1038/modpathol.3800942; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; Zhong Y, 2007, BIOCHEM BIOPH RES CO, V364, P338, DOI 10.1016/j.bbrc.2007.10.016; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	62	79	80	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	44					4655	4666		10.1038/onc.2011.634	http://dx.doi.org/10.1038/onc.2011.634			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22249269				2022-12-25	WOS:000310724400001
J	Barison, N; Lambers, J; Hurwitz, R; Kolbe, M				Barison, Nicola; Lambers, Jutta; Hurwitz, Robert; Kolbe, Michael			Interaction of MxiG with the cytosolic complex of the type III secretion system controls Shigella virulence	FASEB JOURNAL			English	Article						FHA domain; protein phosphorylation; Spa33; protein transport	EPITHELIAL-CELLS; NEEDLE COMPLEX; PROTEIN SECRETION; FLEXNERI; IPAB; MODEL; CONSERVATION; INVASINS; RELEASE; SIGNAL	Gram-negative bacteria use the type 3 secretion system (T3SS) to colonize host cells. T3SSs are ring-shaped macromolecular complexes specific for the transport of effector molecules into host cells. It was recently suggested that a cytosolic ring-shaped protein complex delivers effector molecules to the T3SS. However, how transport of effector proteins is regulated is not known. Here, we report the high-resolution X-ray crystal structure of the whole cytosolic domain of MxiG (MxiG(1-126)), a major component of the inner T3SS rings in Shigella flexneri. MxiG(1-126) folds as an FHA domain, which specifically binds phosphorylated threonines. Indeed, MxiG(1-126) binds to Spa33, a cytoplasmic-ring component of Shigella, as revealed in pulldown studies. Surface plasmon resonance analysis showed specific interaction of MxiG with a Spa33 peptide only if phosphorylated. In total, 24 copies of the MxiG(1-126) crystal structure were fitted into the cryo-EM map of the Shigella T3SS. The phosphoprotein binding site of each MxiG molecule faces the channel of the T3SS, allowing interaction with cytosolic binding partners. Secretion assays and host cell invasion studies of complemented Shigella knockout cells indicated that the phosphoprotein binding of MxiG is essential for bacterial virulence. Our findings suggest that MxiG is involved in T3SS regulation.-Barison, N., Lambers, J., Hurwitz, R., Kolbe, M. Interaction of MxiG with the cytosolic complex of the type III secretion system controls Shigella virulence. FASEB J. 26, 1717-1726 (2012). www.fasebj.org	[Barison, Nicola; Lambers, Jutta; Kolbe, Michael] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; [Hurwitz, Robert] Max Planck Inst Infect Biol, Prot Purificat Core Facil, D-10117 Berlin, Germany	Max Planck Society; Max Planck Society	Kolbe, M (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Charitepl 1, D-10117 Berlin, Germany.	kolbe@mpiib-berlin.mpg.de						Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Botteaux A, 2010, MICROBIOL-SGM, V156, P2807, DOI 10.1099/mic.0.039651-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano WL, 2006, PYMOL INCENTIVE PROD; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; McDowell MA, 2011, J BIOL CHEM, V286, P30606, DOI 10.1074/jbc.M111.243865; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peng JP, 2010, SCI CHINA LIFE SCI, V53, P1284, DOI 10.1007/s11427-010-4089-y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schuch R, 2001, INFECT IMMUN, V69, P2180, DOI 10.1128/IAI.69.4.2180-2189.2001; Smith B. J., 2002, PROTEIN PROTOCOLS HD, P237; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438	51	18	18	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1717	1726		10.1096/fj.11-197160	http://dx.doi.org/10.1096/fj.11-197160			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22247334				2022-12-25	WOS:000302359700032
J	Karst, JC; Barker, R; Devi, U; Swann, MJ; Davi, M; Roser, SJ; Ladant, D; Chenal, A				Karst, Johanna C.; Barker, Robert; Devi, Usha; Swann, Marcus J.; Davi, Marilyne; Roser, Stephen J.; Ladant, Daniel; Chenal, Alexandre			Identification of a Region That Assists Membrane Insertion and Translocation of the Catalytic Domain of Bordetella pertussis CyaA Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; VIRULENCE FACTORS; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; MURINE MACROPHAGES; SHEEP ERYTHROCYTES; PORE FORMATION; T-DOMAIN; CALCIUM; PROTEIN	The adenylate cyclase (CyaA) toxin, one of the virulence factors secreted by Bordetella pertussis, the pathogenic bacteria responsible for whooping cough, plays a critical role in the early stages of respiratory tract colonization by this bacterium. The CyaA toxin is able to invade eukaryotic cells by translocating its N-terminal catalytic domain directly across the plasma membrane of the target cells, where, activated by endogenous calmodulin, it produces supraphysiological levels of cAMP. How the catalytic domain is transferred from the hydrophilic extracellular medium into the hydrophobic environment of the membrane and then to the cell cytoplasm remains an unsolved question. In this report, we have characterized the membrane-interacting properties of the CyaA catalytic domain. We showed that a protein covering the catalytic domain (AC384, encompassing residues 1-384 of CyaA) displayed no membrane association propensity. However, a longer polypeptide (AC489), encompassing residues 1-489 of CyaA, exhibited the intrinsic property to bind to membranes and to induce lipid bilayer destabilization. We further showed that deletion of residues 375-485 within CyaA totally abrogated the toxin's ability to increase intracellular cAMP in target cells. These results indicate that, whereas the calmodulin dependent enzymatic domain is restricted to the amino-terminal residues 1-384 of CyaA, the membrane-interacting, translocation-competent domain extends up to residue 489. This thus suggests an important role of the region adjacent to the catalytic domain of CyaA in promoting its interaction with and its translocation across the plasma membrane of target cells.	[Karst, Johanna C.; Davi, Marilyne; Ladant, Daniel; Chenal, Alexandre] CNRS UMR 3528, Inst Pasteur, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Barker, Robert] Inst Laue Langevin, Large Scale Struct Grp, F-38042 Grenoble 9, France; [Devi, Usha; Swann, Marcus J.] Farfield Grp Ltd, Manchester Airport M90 3DQ, England; [Roser, Stephen J.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut Laue-Langevin (ILL); University of Bath	Ladant, D (corresponding author), CNRS UMR 3528, Inst Pasteur, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 6 Rue Jules Horowitz, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Barker, Robert D/E-6386-2012; Chenal, Alexandre/C-2240-2009	Barker, Robert D/0000-0002-8645-5385; Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X	CNRS; Institut Pasteur [374]; Agence Nationale de la Recherche [ANR-09-JCJC-0012]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, Institut Pasteur (Projet Transversal de Recherche) Grant PTR#374 and the Agence Nationale de la Recherche, Programme Jeunes Chercheurs, Grant ANR-09-JCJC-0012.	Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; EHRMANN IE, 1992, FEBS LETT, V304, P51, DOI 10.1016/0014-5793(92)80587-7; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fiser R, 2009, BBA-BIOMEMBRANES, V1788, P1249, DOI 10.1016/j.bbamem.2009.03.019; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hirst DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P503, DOI 10.1007/s00249-010-0664-1; Holubova J., 2012, INFECT IMMU IN PRESS; Hughes AV, 2008, LANGMUIR, V24, P1989, DOI 10.1021/la702050b; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Knapp O, 2003, BIOCHEMISTRY-US, V42, P8077, DOI 10.1021/bi034295f; Knapp O, 2008, BBA-BIOMEMBRANES, V1778, P260, DOI 10.1016/j.bbamem.2007.09.026; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017383; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Mock M, 1993, Trends Microbiol, V1, P187, DOI 10.1016/0966-842X(93)90089-A; Mosior M, 1997, MOL MEMBR BIOL, V14, P65, DOI 10.3109/09687689709068436; MULLER G, 1989, BIOCHEMISTRY-US, V28, P9974; PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; Perkins DJ, 2007, MOL MICROBIOL, V66, P1003, DOI 10.1111/j.1365-2958.2007.05972.x; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; Reig N, 2006, FEBS LETT, V580, P5572, DOI 10.1016/j.febslet.2006.08.033; ROGEL A, 1992, J BIOL CHEM, V267, P22599; Sanghera N, 2009, BBA-BIOMEMBRANES, V1788, P2245, DOI 10.1016/j.bbamem.2009.08.005; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; White SH, 1998, METHOD ENZYMOL, V295, P62	59	47	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9200	9212		10.1074/jbc.M111.316166	http://dx.doi.org/10.1074/jbc.M111.316166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22241477	Green Published, hybrid			2022-12-25	WOS:000301797800048
J	Bao, JX; Chang, H; Lv, YG; Yu, JW; Bai, YG; Liu, H; Cai, Y; Wang, L; Ma, J; Chang, YM				Bao, Jun-Xiang; Chang, Hui; Lv, Yong-Gang; Yu, Jin-Wen; Bai, Yun-Gang; Liu, Huan; Cai, Yue; Wang, Ling; Ma, Jin; Chang, Yao-Ming			Lysosome-Membrane Fusion Mediated Superoxide Production in Hyperglycaemia-Induced Endothelial Dysfunction	PLOS ONE			English	Article							REDOX SIGNALING PLATFORMS; REGULATES CA2+-DEPENDENT EXOCYTOSIS; ACID SPHINGOMYELINASE; PLASMA-MEMBRANE; NADPH OXIDASE; LIPID RAFTS; CELLS; ACTIVATION; CERAMIDE; REPAIR	Lysosomal exocytosis and fusion to cellular membrane is critical in the oxidative stress formation of endothelium under apoptotic stimulus. We investigated the role therein of it in hyperglycaemia-induced endothelial dysfunction. The lysosome-membrane fusion was shown by the expression of lamp1, the lysosomal membrane marker, on cellular membrane and the transportation of lysosomal symbolic enzymes into cultural medium. We also examined the ceramide production, lipid rafts (LRs) clustering, colocalization of gp91(phox), a NADPH oxidase subunit (NOX) to LRs clusters, superoxide (O-2(center dot-)) formation and nitric oxide (NO) content in human umbilical vein endothelial cells (HUVEC) and the endothelium-dependent NO-mediated vasodilation in isolated rat aorta. As compared to normal glucose (5.6 mmol/l, Ctrl) incubation, high glucose (22 mmol/l, HG) exposure facilitated the lysosome-membrane fusion in HUVEC shown by significantly increased quantity of lamp1 protein on cellular membrane and enhanced activity of lysosomal symbolized enzymes in cultural medium. HG incubation also elicited ceramide generation, LRs clustering and gp91(phox) colocalization to LRs clusters which were proved to mediate the HG induced O-2(center dot-) formation and NO depletion in HUVEC. Functionally, the endothelium-dependent NO-mediated vasodilation in aorta was blunted substantially after HG incubation. Moreover, the HG-induced effect including ceramide production, LRs clustering, gp91(phox) colocalization to LRs clusters, O-2(center dot-) formation and endothelial dysfunction could be blocked significantly by the inhibition of lysosome-membrane fusion. We propose that hyperglycaemia-induced endothelial impairment is closely related to the lysosome-membrane fusion and the following LRs clustering, LRs-NOX platforms formation and O-2(center dot-) production.	[Bao, Jun-Xiang; Chang, Hui; Yu, Jin-Wen; Bai, Yun-Gang; Liu, Huan; Cai, Yue; Ma, Jin] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian 710032, Peoples R China; [Lv, Yong-Gang; Wang, Ling] Fourth Mil Med Univ, Dept Vasc & Endocrine Surg, Xi Jing Hosp, Xian 710032, Peoples R China; [Chang, Yao-Ming] Fourth Mil Med Univ, Dept Aerosp Hyg & Hlth Serv, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Bao, JX (corresponding author), Fourth Mil Med Univ, Dept Aerosp Physiol, Xian 710032, Peoples R China.	vascular@fmmu.edu.cn; jin-ma@fmmu.edu.cn; changym@fmmu.edu.cn			National Natural Science Foundation of China [31071045, 30971423, 81171871]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant number 31071045, 30971423, 81171871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Avogaro A, 2006, NUTR METAB CARDIOVAS, V16, pS39, DOI 10.1016/j.numecd.2005.10.015; Bao JX, 2010, AM J PHYSIOL-HEART C, V298, pH992, DOI 10.1152/ajpheart.00958.2009; Bishara NB, 2010, AM J PHYSIOL-HEART C, V298, pH171, DOI 10.1152/ajpheart.00699.2009; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Boini KM, 2010, BBA-MOL CELL BIOL L, V1801, P1294, DOI 10.1016/j.bbalip.2010.09.001; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Griffiths G M, 1995, Curr Top Microbiol Immunol, V198, P39; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jin S, 2011, ANTIOXID REDOX SIGNA; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P2056, DOI 10.1161/ATVBAHA.108.172478; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; Jin S, 2007, ANTIOXID REDOX SIGN, V9, P1417, DOI 10.1089/ars.2007.1660; Kangralkar V.A., 2010, INT J PHARM APPL, V1, P38, DOI DOI 10.1176/PN.45.23.PSYCHNEWS_45_23_048; Li PL, 2007, ANTIOXID REDOX SIGN, V9, P1457, DOI 10.1089/ars.2007.1667; Li PL, 2007, ANTIOXID REDOX SIGN, V9, P1411, DOI 10.1089/ars.2007.1736; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maier KG, 2008, VASC ENDOVASC SURG, V42, P305, DOI 10.1177/1538574408320172; Mandal AK, 2006, HISTOL HISTOPATHOL, V21, P941, DOI 10.14670/HH-21.941; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mirnikjoo B, 2009, J BIOL CHEM, V284, P6918, DOI 10.1074/jbc.M805288200; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Pavoine C, 2009, CARDIOVASC RES, V82, P175, DOI 10.1093/cvr/cvp030; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Reichel M, 2011, ALCOHOL CLIN EXP RES; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Touyz RM, 2006, HYPERTENSION, V47, P16, DOI 10.1161/01.HYP.0000196730.13216.f3; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Wang YC, 2009, J CELL BIOCHEM, V107, P357, DOI 10.1002/jcb.22134; Yi F, 2009, J CELL MOL MED, V13, P3303, DOI 10.1111/j.1582-4934.2009.00743.x; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang AY, 2007, ANTIOXID REDOX SIGN, V9, P817, DOI 10.1089/ars.2007.1509; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	45	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30387	10.1371/journal.pone.0030387	http://dx.doi.org/10.1371/journal.pone.0030387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253932	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100054
J	Baral, TN; Chao, SY; Li, SH; Tanha, J; Arbabi-Ghahroudi, M; Zhang, JB; Wang, SY				Baral, Toya Nath; Chao, Shi-Yu; Li, Shenghua; Tanha, Jamshid; Arbabi-Ghahroudi, Mehdi; Zhang, Jianbing; Wang, Shuying			Crystal Structure of a Human Single Domain Antibody Dimer Formed through V-H-V-H Non-Covalent Interactions	PLOS ONE			English	Article							STABILITY; FRAGMENTS; MODEL; IMMUNOGLOBULIN; INTERFACE; SELECTION; SOFTWARE; RESIDUES; MOLECULE; EPITOPES	Single-domain antibodies (sdAbs) derived from human V-H are considered to be less soluble and prone to aggregate which makes it difficult to determine the crystal structures. In this study, we isolated and characterized two anti-human epidermal growth factor receptor-2 (HER2) sdAbs, Gr3 and Gr6, from a synthetic human V-H phage display library. Size exclusion chromatography and surface plasmon resonance analyses demonstrated that Gr3 is a monomer, but that Gr6 is a strict dimer. To understand this different molecular behavior, we solved the crystal structure of Gr6 to 1.6 angstrom resolution. The crystal structure revealed that the homodimer assembly of Gr6 closely mimics the V-H-V-L heterodimer of immunoglobulin variable domains and the dimerization interface is dominated by hydrophobic interactions.	[Baral, Toya Nath; Li, Shenghua; Tanha, Jamshid; Arbabi-Ghahroudi, Mehdi; Zhang, Jianbing] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Chao, Shi-Yu; Wang, Shuying] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Research Council Canada; National Cheng Kung University; National Cheng Kung University	Baral, TN (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	jianbing.zhang@nrc-cnrc.gc.ca; sswang23@mail.ncku.edu.tw	wang, shuying/HHZ-4516-2022		Genome and Health Initiative (GHI) - National Research Council Canada; National Science Council, Taiwan [NSC97-2311-B-006-006]; National Science Council of Taiwan, ROC	Genome and Health Initiative (GHI) - National Research Council Canada; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by a grant ("The Identification of Proteins Targeting the Tumor Microenvironment for Therapeutic and Diagnostic Applications") to J.Z. from the Genome and Health Initiative (GHI) - National Research Council Canada and by a grant (NSC97-2311-B-006-006) to S. W. from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Center for Gene Regulation and Signal Transduction Research at National Cheng Kung University, Tainan, Taiwan for providing the crystallization robot platform for initial screening. Portions of this research were carried out at the National Synchrotron Radiation Research Center (BL-13B1), a national user facility supported by the National Science Council of Taiwan, ROC. We thank Dr. Roger MacKenzie and Aaron Cowan for reviewing the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Behar G, 2008, PROTEIN ENG DES SEL, V21, P1, DOI 10.1093/protein/gzm064; Behar G, 2009, FEBS J, V276, P4305, DOI 10.1111/j.1742-4658.2009.07101.x; Bell A, 2009, CANC LETT; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatellier J, 1996, J MOL BIOL, V264, P1, DOI 10.1006/jmbi.1996.0618; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Dottorini T, 2004, BIOCHEMISTRY-US, V43, P622, DOI 10.1021/bi035800b; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN ZC, 1992, J MOL BIOL, V228, P188, DOI 10.1016/0022-2836(92)90500-J; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; KABAT EA, 1991, J IMMUNOL, V147, P1709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muyldermans S, 2001, J Biotechnol, V74, P277; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Vargas-Madrazo E, 2003, J MOL RECOGNIT, V16, P113, DOI 10.1002/jmr.613; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WILLIAMSON AR, 1976, ANNU REV BIOCHEM, V45, P467, DOI 10.1146/annurev.bi.45.070176.002343; Willuda J, 1999, CANCER RES, V59, P5758	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30149	10.1371/journal.pone.0030149	http://dx.doi.org/10.1371/journal.pone.0030149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253912	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100044
J	Kotnis, A; Namkung, J; Kannan, S; Jayakrupakar, N; Park, T; Sarin, R; Mulherkar, R				Kotnis, Ashwin; Namkung, Junghyun; Kannan, Sadhana; Jayakrupakar, Nallala; Park, Taesung; Sarin, Rajiv; Mulherkar, Rita			Multiple Pathway-Based Genetic Variations Associated with Tobacco Related Multiple Primary Neoplasms	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; SQUAMOUS-CELL CARCINOMA; EXCISION-REPAIR PATHWAY; COLORECTAL-CANCER RISK; ARG72PRO POLYMORPHISM; XRCC1 POLYMORPHISMS; BREAST-CANCER; DNA; HEAD; P53	Background: In order to elucidate a combination of genetic alterations that drive tobacco carcinogenesis we have explored a unique model system and analytical method for an unbiased qualitative and quantitative assessment of gene-gene and gene-environment interactions. The objective of this case control study was to assess genetic predisposition in a biologically enriched clinical model system of tobacco related cancers (TRC), occurring as Multiple Primary Neoplasms (MPN). Methods: Genotyping of 21 candidate Single Nucleotide Polymorphisms (SNP) from major metabolic pathways was performed in a cohort of 151 MPN cases and 210 cancer-free controls. Statistical analysis using logistic regression and Multifactor Dimensionality Reduction (MDR) analysis was performed for studying higher order interactions among various SNPs and tobacco habit. Results: Increased risk association was observed for patients with at least one TRC in the upper aero digestive tract (UADT) for variations in SULT1A1 Arg(213)His, mEH Tyr(113)His, hOGG1 Ser(326)Cys, XRCC1 Arg(280)His and BRCA2 Asn(372)His. Gene environment interactions were assessed using MDR analysis. The overall best model by MDR was tobacco habit/p53(Arg/Arg)/XRCC1(Arg(399)His)/mEH(Tyr(113)His) that had highest Cross Validation Consistency (8.3) and test accuracy (0.69). This model also showed significant association using logistic regression analysis. Conclusion: This is the first Indian study on a multipathway based approach to study genetic susceptibility to cancer in tobacco associated MPN. This approach could assist in planning additional studies for comprehensive understanding of tobacco carcinogenesis.	[Kotnis, Ashwin; Kannan, Sadhana; Jayakrupakar, Nallala; Sarin, Rajiv; Mulherkar, Rita] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India; [Namkung, Junghyun] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Case Western Reserve University; Seoul National University (SNU)	Kotnis, A (corresponding author), Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England.	rsarin@actrec.gov.in; rmulherkar@actrec.gov.in	namkung, junghyun/AAM-6647-2020	Nallala, Jayakrupakar/0000-0002-9473-5782; Sarin, Rajiv/0000-0002-6405-8282	Department of Biotechnology (DBT), Government of India [BT/PR5588/Med/12/231/2004]; Council for Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partially supported by the Department of Biotechnology (DBT), Government of India (No. BT/PR5588/Med/12/231/2004). Fellowship to AK from Council for Scientific and Industrial Research (CSIR), Government of India is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador AG, 2002, ORAL SURG ORAL MED O, V93, P440, DOI 10.1067/moe.2002.122586; Anantharaman D, 2011, ORAL ONCOL, V47, P866, DOI 10.1016/j.oraloncology.2011.06.015; Angiero F, 2008, ANTICANCER RES, V28, P2535; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Bisof V, 2010, EUR J GYNAECOL ONCOL, V31, P539; Blomquist T, 2009, CANCER RES, V69, P8629, DOI 10.1158/0008-5472.CAN-09-1568; Buch SC, 2008, HEAD NECK-J SCI SPEC, V30, P1139, DOI 10.1002/hed.20867; Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Dahabreh IJ, 2010, CANCER EPIDEM BIOMAR, V19, P1840, DOI 10.1158/1055-9965.EPI-10-0156; De Feo E, 2009, MUTAT RES-GEN TOX EN, V675, P60, DOI 10.1016/j.mrgentox.2009.02.009; Economopoulos KP, 2010, ONKOLOGIE, V33, P666, DOI 10.1159/000322210; Galli P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-137; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V83, P1; Jeffries S, 2001, ORAL ONCOL, V37, P115, DOI 10.1016/S1368-8375(00)00065-8; Jhavar S, 2004, ORAL ONCOL, V40, P84, DOI 10.1016/S1368-8375(03)00140-4; Jhavar Sameer G, 2005, J Carcinog, V4, P6, DOI 10.1186/1477-3163-4-6; Jiang DK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.04.044; Jourenkova-Mironova N, 2000, CANCER RES, V60, P534; Koppikar Priya, 2006, Indian Journal of Biotechnology, V5, P477; Kotnis A, 2008, BRIT J CANCER, V99, P1340, DOI 10.1038/sj.bjc.6604683; Kotnis A, 2005, J BIOSCIENCES, V30, P93, DOI 10.1007/BF02705154; Kuligina E, 2010, EPIDEMIOLOGY, V21, P366, DOI 10.1097/EDE.0b013e3181cc8871; Lacko M, 2008, HEAD NECK-J SCI SPEC, V30, P836, DOI 10.1002/hed.20781; Lee JM, 2001, INT J CANCER, V95, P240, DOI 10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1; Lee SG, 2002, CANCER LETT, V187, P53, DOI 10.1016/S0304-3835(02)00381-6; Lin TS, 2007, ONCOL REP, V17, P565; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Mitra AK, 2011, INDIAN J MED RES, V133, P605; Namkung J, 2009, GENET EPIDEMIOL, V33, P646, DOI 10.1002/gepi.20416; Nathanson KL, 2001, HUM MOL GENET, V10, P715, DOI 10.1093/hmg/10.7.715; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Paz-Elizur T, 2006, CANCER RES, V66, P11683, DOI 10.1158/0008-5472.CAN-06-2294; Qu T, 2005, CANCER DETECT PREV, V29, P215, DOI 10.1016/j.cdp.2005.04.002; Ramachandran S, 2006, ORAL ONCOL, V42, P350, DOI 10.1016/j.oraloncology.2005.08.010; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Salagovic J, 2011, MED ONCOL; Soumittra N, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-13; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P125; Tan XL, 2007, PHARMACOGENET GENOM, V17, P639, DOI 10.1097/FPC.0b013e3280d5121c; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; Zheng HL, 2009, LUNG CANCER, V65, P268, DOI 10.1016/j.lungcan.2009.02.002; Zheng YL, 2010, INT J CANCER, V126, P2199, DOI 10.1002/ijc.24771	48	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30013	10.1371/journal.pone.0030013	http://dx.doi.org/10.1371/journal.pone.0030013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253860	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700075
J	Liu, YJ; Wang, LQ; Han, RX; Beier, UH; Hancock, WW				Liu, Yujie; Wang, Liqing; Han, Rongxiang; Beier, Ulf H.; Hancock, Wayne W.			Two Lysines in the Forkhead Domain of Foxp3 Are Key to T Regulatory Cell Function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA-BINDING; HOMEOSTATIC PROLIFERATION; PROMOTER OCCUPANCY; GENE-EXPRESSION; TARGET GENES; ACETYLATION; PROTEIN; SCURFIN; DIFFERENTIATION	Background: The forkhead box transcription factor, Foxp3, is master regulator of the development and function of CD4+CD25+ T regulatory (Treg) cells that limit autoimmunity and maintain immune homeostasis. The carboxyl-terminal forkhead (FKH) domain is required for the nuclear localization and DNA binding of Foxp3. We assessed how individual FKH lysines contribute to the functions of Foxp3 in Treg cells. Methodology/Principal Findings: We found that mutation of FKH lysines at position 382 (K17) and at position 393 (K18) impaired Foxp3 DNA binding and inhibited Treg suppressive function in vivo and in vitro. These lysine mutations did not affect the level of expression of Foxp3 but inhibited IL-2 promoter remodeling and had important and differing effects on Treg-associated gene expression. Conclusions/Significance: These data point to complex effects of post-translational modifications at individual lysines within the Foxp3 FKH domain that affect Treg function. Modulation of these events using small molecule inhibitors may allow regulation of Foxp3+ Treg function clinically.	[Liu, Yujie; Wang, Liqing; Han, Rongxiang; Hancock, Wayne W.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Lab Med,Div Transplant Immunol,Dept Pathol, Philadelphia, PA 19104 USA; [Beier, Ulf H.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Nephrol,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Liu, YJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Lab Med,Div Transplant Immunol,Dept Pathol, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu		Beier, Ulf/0000-0002-3672-572X	National Institute of Allergy and Infectious Diseases [AI073489, CA158941, K08AI095353]; NATIONAL CANCER INSTITUTE [R01CA158941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095353, P01AI073489] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to WWH (AI073489, CA158941) and UHB (K08AI095353) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aruna BV, 2005, P NATL ACAD SCI USA, V102, P10285, DOI 10.1073/pnas.0504578102; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hancock WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007890; Holmes D, 2011, VIROLOGY; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	45	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29035	10.1371/journal.pone.0029035	http://dx.doi.org/10.1371/journal.pone.0029035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247766	Green Submitted, Green Published, gold			2022-12-25	WOS:000301355700014
J	Mauser, JF; Prehoda, KE				Mauser, Jonathon F.; Prehoda, Kenneth E.			Inscuteable Regulates the Pins-Mud Spindle Orientation Pathway	PLOS ONE			English	Article							ASYMMETRIC CELL DIVISIONS; DROSOPHILA NEUROBLASTS; CORTICAL POLARITY; NUMA; LOCALIZATION; DIFFERENTIATION; PROTEINS; PARTNER; COMPLEX	During asymmetric cell division, alignment of the mitotic spindle with the cell polarity axis ensures that the cleavage furrow separates fate determinants into distinct daughter cells. The protein inscuteable (Insc) is thought to link cell polarity and spindle positioning in diverse systems by binding the polarity protein Bazooka (Baz; aka Par-3) and the spindle orienting protein Partner of Inscuteable (Pins; mPins or LGN in mammals). Here we investigate the mechanism of spindle orientation by the Insc-Pins complex. Previously, we defined two Pins spindle orientation pathways: a complex with Mushroom body defect (Mud; NuMA in mammals) is required for full activity, whereas binding to Discs large (Dig) is sufficient for partial activity. In the current study, we have examined the role of inscuteable in mediating downstream Pins mediated spindle orientation pathways. We find that the Insc-Pins complex requires G alpha i for partial activity and that the complex specifically recruits Dig but not Mud. In vitro competition experiments revealed that insc and Mud compete for binding to the Pins TPR motifs, while Dig can form a ternary complex with Insc-Pins. Our results suggest that insc does not passively couple polarity and spindle orientation but preferentially inhibits the Mud pathway, while allowing the Dig pathway to remain active. Insc-regulated complex assembly may ensure that the spindle is attached to the cortex (via Dig) before activation of spindle pulling forces by Dynein/Dynactin (via Mud).	[Mauser, Jonathon F.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Mauser, JF (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@uoregon.edu		Prehoda, Ken/0000-0003-4214-6158; Mauser, Jonathon/0000-0002-7567-9455	NIH [GM068032, GM087457]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032, R01GM087457, T32GM007759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Grants GM068032 and GM087457 to KEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Glotzer M, 2004, J CELL BIOL, V164, P347, DOI 10.1083/jcb.200310112; Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Moore JK, 2010, SEMIN CELL DEV BIOL, V21, P283, DOI 10.1016/j.semcdb.2010.01.020; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Tio M, 1999, J CELL SCI, V112, P1541; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu F, 2000, MOL CELL BIOL, V22, P4230; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	31	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					118	124	e29611	10.1371/journal.pone.0029611	http://dx.doi.org/10.1371/journal.pone.0029611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253744	Green Submitted, Green Published, gold			2022-12-25	WOS:000301353900013
J	Ferro, M; Savino, MT; Ortensi, B; Finetti, F; Genovese, L; Masi, G; Ulivieri, C; Benati, D; Pelicci, G; Baldari, CT				Ferro, Micol; Savino, Maria Teresa; Ortensi, Barbara; Finetti, Francesca; Genovese, Luca; Masi, Giulia; Ulivieri, Cristina; Benati, Daniela; Pelicci, Giuliana; Baldari, Cosima T.			The Shc Family Protein Adaptor, Rai, Negatively Regulates T Cell Antigen Receptor Signaling by Inhibiting ZAP-70 Recruitment and Activation	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION; MAP KINASES; EXPRESSION; MOLECULE; AUTOIMMUNITY; TRANSDUCTION; ROLES; ACTS; RET	Rai/ShcC is a member of the Shc family of protein adaptors expressed with the highest abundance in the central nervous system, where it exerts a protective function by coupling neurotrophic receptors to the PI3K/Akt survival pathway. Rai is also expressed, albeit at lower levels, in other cell types, including T and B lymphocytes. We have previously reported that in these cells Rai attenuates antigen receptor signaling, thereby impairing not only cell proliferation but also, opposite to neurons, cell survival. Here we have addressed the mechanism underlying the inhibitory activity of Rai on TCR signaling. We show that Rai interferes with the TCR signaling cascade one of the earliest steps -recruitment of the initiating kinase ZAP-70 to the phosphorylated subunit of the TCR/CD3 complex, which results in a generalized dampening of the downstream signaling events. The inhibitory activity of Rai is associated to its inducible recruitment to phosphorylated CD3, which occurs in the physiological signaling context of the immune synapse. Rai is moreover found as a pre-assembled complex with ZAP-70 and also constitutively interacts with the regulatory p85 subunit of PI3K, similar to neuronal cells, notwithstanding the opposite biological outcome, i.e. impairment of PI-3K/Akt activation. The data highlight the ability of Rai to establish interactions with the TCR and key signaling mediators which, either directly (e.g. by inhibiting ZAP-70 recruitment to the TCR or sequestering ZAP-70/PI3K in the cytosol) or indirectly (e.g. by promoting the recruitment of effectors responsible for signal extinction) prevent full triggering of the TCR signaling cascade.	[Ferro, Micol; Savino, Maria Teresa; Finetti, Francesca; Genovese, Luca; Masi, Giulia; Ulivieri, Cristina; Benati, Daniela; Baldari, Cosima T.] European Inst Oncol, Dept Evolutionary Biol, Milan, Italy; [Ortensi, Barbara; Pelicci, Giuliana] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Baldari, Cosima T.] Univ Siena, Ist Toscano Tumori, I-53100 Siena, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena	Baldari, CT (corresponding author), European Inst Oncol, Dept Evolutionary Biol, Milan, Italy.	cosima.baldari@unisi.it	Finetti, Francesca/T-3788-2019; Pelicci, Giuliana/AAA-8921-2022; Ulivieri, Cristina/AAH-7543-2020	Finetti, Francesca/0000-0002-3421-1637; Pelicci, Giuliana/0000-0003-0986-8255; Baldari, Cosima/0000-0002-4414-6744; Ulivieri, Cristina/0000-0002-1710-7977; Ortensi, Barbara/0000-0001-7296-670X; Benati, Daniela/0000-0002-6599-7193	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was carried out with the financial support of the Italian Association for Cancer Research (AIRC). The contribution of the Istituto Toscano Tumori (ITT) Regione Toscana is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO;2-C; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Conti L, 2001, NAT NEUROSCI, V4, P579, DOI 10.1038/88395; De Falco V, 2005, ONCOGENE, V24, P6303, DOI 10.1038/sj.onc.1208776; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Finetti F, 2008, BLOOD, V111, P5017, DOI 10.1182/blood-2007-12-130856; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Finetti F, 2009, IMMUNOL REV, V232, P115, DOI 10.1111/j.1600-065X.2009.00826.x; Fooksman DR, ANN REV IMMUNOL, V28, P79; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Iwashima M, 2002, P NATL ACAD SCI USA, V99, P4544, DOI 10.1073/pnas.082647499; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Miyake I, 2009, ONCOGENE, V28, P662, DOI 10.1038/onc.2008.413; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Nakamura T, 1996, ONCOGENE, V13, P1111; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; Nakazawa T, 2002, J NEUROSCI RES, V68, P668, DOI 10.1002/jnr.10259; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Pelicci G, 1996, ONCOGENE, V13, P633; Pelicci G, 2002, MOL CELL BIOL, V22, P7351, DOI 10.1128/MCB.22.20.7351-7363.2002; PULVERTAFT RJV, 1964, LANCET, V1, P238; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Savino MT, 2009, J IMMUNOL, V182, P301, DOI 10.4049/jimmunol.182.1.301; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Simeoni L, 2008, IMMUNOL REV, V224, P215, DOI 10.1111/j.1600-065X.2008.00656.x; Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074; Terui E, 2005, CLIN CANCER RES, V11, P3280, DOI 10.1158/1078-0432.CCR-04-1681; Troglio F, 2004, P NATL ACAD SCI USA, V101, P15476, DOI 10.1073/pnas.0403283101; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P206, DOI 10.1111/j.1365-2982.2007.01017.x; Weiss A, 2009, IMMUNOL REV, V228, P5, DOI 10.1111/j.1600-065X.2009.00761.x; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zhu MH, 2005, J IMMUNOL, V174, P5612, DOI 10.4049/jimmunol.174.9.5612; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025	37	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29899	10.1371/journal.pone.0029899	http://dx.doi.org/10.1371/journal.pone.0029899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242145	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000063
J	Hama, T; Norizoe, C; Suga, H; Mimura, T; Kato, T; Moriyama, H; Urashima, M				Hama, Takanori; Norizoe, Chihiro; Suga, Hiroaki; Mimura, Takeshi; Kato, Takakuni; Moriyama, Hiroshi; Urashima, Mitsuyoshi			Prognostic Significance of Vitamin D Receptor Polymorphisms in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							CIRCULATING 25-HYDROXYVITAMIN-D LEVELS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CALCIUM SUPPLEMENTATION; CANCER PREVENTION; ANALOG EB1089; GENE; SURVIVAL; RISK; METASTASIS; INHIBITION	Background: In patients with advanced non-small-cell lung cancer, vitamin D receptor (VDR) polymorphisms and haplotypes are reported to be associated with survival. We hypothesized that a similar association would be observed in patients with head and neck squamous-cell carcinoma (HNSCC). Methods: In a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection. Progression-free survival was compared between VDR polymorphisms using Kaplan-Meier survival curves with log-rank tests and Cox proportional hazard models adjusting for age, gender, smoking status, primary tumor sites, postoperative stages, existence of residual tumor, and postoperative treatment with chemotherapy or radiotherapy. Results: During a median follow-up of 1,047 days, tumor progression and death occurred in 76 (37.3%) and 27 (13.2%) patients, respectively. The FokI T/T genotype was associated with poor progression-free survival: median survival for T/T was 265 days compared with 1,127 days for C/C or C/T (log-rank test: P = 0.0004; adjusted hazard ratio, 3.03; 95% confidence interval, 1.62 to 5.67; P = 0.001). In contrast, the other polymorphisms (Cdx2, BsmI, ApaI, TaqI) showed no significant association with progression-free survival. The A-T-G (Cdx2-FokI-ApaI) haplotype demonstrated a significant association with a higher progression rate (P = 0.02). Conclusion: These results suggest that VDR polymorphisms and haplotypes may be associated with prognosis in patients with HNSCC, although the sample size is not large enough to draw definitive conclusions.	[Hama, Takanori; Norizoe, Chihiro; Suga, Hiroaki; Mimura, Takeshi; Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Hama, Takanori; Moriyama, Hiroshi] Jikei Univ, Sch Med, Dept Oto Rhino Laryngol, Tokyo, Japan; [Suga, Hiroaki; Mimura, Takeshi; Urashima, Mitsuyoshi] Meiji Pharmaceut Univ, Tokyo, Japan; [Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan	Jikei University; Jikei University; Meiji Pharmaceutical University; Jikei University	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp			The Jikei University; High Technology Research Center Project for Private University	The Jikei University(Jikei University); High Technology Research Center Project for Private University	This research was supported by The Jikei University Research Fund and High Technology Research Center Project for Private University. This research was internally funded by The Jikei University School of Medicine, to which the authors belong. There is no web site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; El Abdaimi K, 2000, CANCER RES, V60, P4412; Fedirko V, 2009, CANCER PREV RES, V2, P213, DOI 10.1158/1940-6207.CAPR-08-0157; Gandini S, 2009, EUR J CANCER, V45, P634, DOI 10.1016/j.ejca.2008.10.003; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014; Hager G, 2004, ACTA OTO-LARYNGOL, V124, P90, DOI 10.1080/00016480310015353; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kulbersh JS, 2009, OTOLARYNG HEAD NECK, V140, P235, DOI 10.1016/j.otohns.2008.11.011; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Liu ZS, 2005, PHARMACOGENET GENOM, V15, P159, DOI 10.1097/01213011-200503000-00004; Lu LJ, 2008, MOL CANCER THER, V7, P1268, DOI 10.1158/1535-7163.MCT-07-2222; Lundin AC, 1999, CANCER RES, V59, P2332; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Meier JD, 2007, ARCH OTOLARYNGOL, V133, P1149, DOI 10.1001/archotol.133.11.1149; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Prudencio J, 2001, J NATL CANCER I, V93, P745, DOI 10.1093/jnci/93.10.745; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Satake K, 2003, AURIS NASUS LARYNX, V30, P403, DOI 10.1016/S0385-8146(03)00091-9; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358	32	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29634	10.1371/journal.pone.0029634	http://dx.doi.org/10.1371/journal.pone.0029634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242137	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000053
J	Lai, AZ; Durrant, M; Zuo, DM; Ratcliffe, CDH; Park, M				Lai, Andrea Z.; Durrant, Michael; Zuo, Dongmei; Ratcliffe, Colin D. H.; Park, Morag			Met Kinase-dependent Loss of the E3 Ligase Cbl in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GENE COPY NUMBER; C-CBL; UBIQUITIN LIGASE; DOWN-REGULATION; MEDIATED DIMERIZATION; JUXTAMEMBRANE DOMAIN; NEGATIVE REGULATION	Strict regulation of signaling by receptor tyrosine kinases (RTKs) is essential for normal biological processes, and disruption of this regulation can lead to tumor initiation and progression. Signal duration by the Met RTK is mediated in part by the E3 ligase Cbl. Cbl is recruited to Met upon kinase activation and promotes ubiquitination, trafficking, and degradation of the receptor. The Met RTK has been demonstrated to play a role in various types of cancer. Here, we show that Met-dependent loss of Cbl protein in MET-amplified gastric cancer cell lines represents another mechanism contributing to signal dysregulation. Loss of Cbl protein is dependent on Met kinase activity and is partially rescued with a proteasome inhibitor, lactacystin. Moreover, Cbl loss not only uncouples Met from Cbl-mediated negative regulation but also releases other Cbl targets, such as the EGF receptor, from Cbl-mediated signal attenuation. Thus, Met-dependent Cbl loss may also promote cross-talk through indirect enhancement of EGF receptor signaling.	[Lai, Andrea Z.; Zuo, Dongmei; Ratcliffe, Colin D. H.; Park, Morag] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Lai, Andrea Z.; Durrant, Michael; Ratcliffe, Colin D. H.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), Goodman Canc Ctr, 1160 Ave Des Pins Ouest,Canc Pavil Room 511, Montreal, PQ H3A 1A3, Canada.	morag.park@mcgill.ca			Cancer Consortium from the Canadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research (CIHR)	Cancer Consortium from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Graduate Scholarship (CGS) doctoral research award (to A. L.), a Cancer Consortium grant (to M. D.), and an operating grant (to M. P.), all from the Canadian Institutes of Health Research (CIHR).	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; [Anonymous], 2008, NATURE, V455, P1061; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bisson SA, 2002, ONCOGENE, V21, P3677, DOI 10.1038/sj.onc.1205510; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Christensen JG, 2003, CANCER RES, V63, P7345; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lo FY, 2011, CANCER-AM CANCER SOC, V117, P5344, DOI 10.1002/cncr.26153; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mak HHL, 2007, ONCOGENE, V26, P7213, DOI 10.1038/sj.onc.1210522; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McLean LA, 2004, CLIN CANCER RES, V10, P155, DOI 10.1158/1078-0432.CCR-0784-3; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 2011, ONCOTARGET, V2, P245; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Wang Y, 1999, J CELL BIOCHEM, V72, P119	57	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8048	8059		10.1074/jbc.M112.339820	http://dx.doi.org/10.1074/jbc.M112.339820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262855	Green Published, hybrid			2022-12-25	WOS:000301349400021
J	Chen, C; Gorlatova, N; Herzberg, O				Chen, Chen; Gorlatova, Natalia; Herzberg, Osnat			Pliable DNA Conformation of Response Elements Bound to Transcription Factor p63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CORE DOMAIN; BINDING DOMAIN; P53 BINDING; SEQUENCE; RECOGNITION; HOMOLOG; SITES; LIMB	We show that changes in the nucleotide sequence alter the DNA conformation in the crystal structures of p63 DNA-binding domain (p63DBD) bound to its response element. The conformation of a 22-bp canonical response element containing an AT spacer between the two half-sites is unaltered compared with that containing a TA spacer, exhibiting superhelical trajectory. In contrast, a GC spacers abolishes the DNA superhelical trajectory and exhibits less bent DNA, suggesting that increased GC content accompanies increased double helix rigidity. A 19-bp DNA, representing an AT-rich response element with overlapping half-sites, maintains superhelical trajectory and reveals two interacting p63DBD dimers crossing one another at 120. p63DBD binding assays to response elements of increasing length complement the structural studies. We propose that DNA deformation may affect promoter activity, that the ability of p63DBD to bind to superhelical DNA suggests that it is capable of binding to nucleosomes, and that overlapping response elements may provide a mechanism to distinguish between p63 and p53 promoters.	[Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; Univ Maryland, Dept Chem & Biochem, Rockville, MD 20850 USA		Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health [R01-GM087922]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM087922. This work was also supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; DeLano W, 2002, PYMOL 0 99; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Malecka KA, 2009, ONCOGENE, V28, P325, DOI 10.1038/onc.2008.400; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nait-Kaoudjt R, 1998, EUR J BIOCHEM, V254, P111, DOI 10.1046/j.1432-1327.1998.2540111.x; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	45	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7477	7486		10.1074/jbc.M111.315820	http://dx.doi.org/10.1074/jbc.M111.315820			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247550	Green Published, hybrid			2022-12-25	WOS:000301060200048
J	Jennings, BC; Linder, ME				Jennings, Benjamin C.; Linder, Maurine E.			DHHC Protein S-Acyltransferases Use Similar Ping-Pong Kinetic Mechanisms but Display Different Acyl-CoA Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PALMITOYLATION; ACYLATION; TRAFFICKING; IDENTIFICATION; LOCALIZATION; ARACHIDONATE; HUNTINGTIN; MEMBRANE; HIP14	DHHCproteins catalyze the reversible S-acylation of proteins at cysteine residues, a modification important for regulating protein localization, stability, and activity. However, little is known about the kinetic mechanism of DHHC proteins. A high-performance liquid chromatography (HPLC), fluorescent peptide-based assay for protein S-acylation activity was developed to characterize mammalian DHHC2 and DHHC3. Time courses and substrate saturation curves allowed the determination of V-max and K-m values for both the peptide N-myristoylated-GCG and palmitoyl-coenzyme A. DHHC proteins acylate themselves upon incubation with palmitoyl-CoA, which is hypothesized to reflect a transient acyl enzyme transfer intermediate. Single turnover assays with DHHC2 and DHHC3 demonstrated that a radiolabeled acyl group on the enzyme transferred to the protein substrate, consistent with a two-step ping-pong mechanism. Enzyme autoacylation and acyltransfer to substrate displayed the same acyl-CoA specificities, further supporting a two-step mechanism. Interestingly, DHHC2 efficiently transferred acyl chains 14 carbons and longer, whereas DHHC3 activity was greatly reduced by acyl-CoAs with chain lengths longer than 16 carbons. The rate and extent of autoacylation of DHHC3, as well as the rate of acyl chain transfer to protein substrate, were reduced with stearoyl-CoA when compared with palmitoyl-CoA. This is the first observation of lipid substrate specificity among DHHC proteins and may account for the differential S-acylation of proteins observed in cells.	[Jennings, Benjamin C.; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Jennings, Benjamin C.] Washington Univ, Grad Program Biochem, St Louis, MO 63110 USA	Cornell University; Washington University (WUSTL)	Linder, ME (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, CVM Box 41, Ithaca, NY 14853 USA.	mel237@cornell.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM51466]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51466 (to M. E. L.).; Supported by an American Heart Association predoctoral fellowship (Midwest Affiliate).	CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cook P. F., 2007, ENZYME KINETICS MECH, P59; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; FERYFORGUES S, 1993, J PHOTOCH PHOTOBIO A, V70, P229, DOI 10.1016/1010-6030(93)85048-D; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lorentzen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.20001370; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; MUSZBEK L, 1993, J BIOL CHEM, V268, P18243; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schroeder H, 1996, J CELL BIOL, V134, P647, DOI 10.1083/jcb.134.3.647; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Varner AS, 2002, ANAL BIOCHEM, V308, P160, DOI 10.1016/S0003-2697(02)00212-9; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zeidman R, 2011, MOL MEMBR BIOL, V28, P473, DOI 10.3109/09687688.2011.630682	34	133	134	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7236	7245		10.1074/jbc.M111.337246	http://dx.doi.org/10.1074/jbc.M111.337246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247542	hybrid, Green Published			2022-12-25	WOS:000301060200026
J	Zheng, XY; Gessel, MM; Wisniewski, ML; Viswanathan, K; Wright, DL; Bahr, BA; Bowers, MT				Zheng, Xueyun; Gessel, Megan M.; Wisniewski, Meagan L.; Viswanathan, Kishore; Wright, Dennis L.; Bahr, Ben A.; Bowers, Michael T.			Z-Phe-Ala-diazomethylketone (PADK) Disrupts and Remodels Early Oligomer States of the Alzheimer Disease A beta 42 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; SMALL-MOLECULE INHIBITORS; IN-VIVO; MONOMER STRUCTURE; AGGREGATION; NEUROTOXICITY; PATHWAYS; MECHANISMS; DISORDERS; DISTINCT	The oligomerization of the amyloid-beta protein (A beta) is an important event in Alzheimer disease (AD) pathology. Developing small molecules that disrupt formation of early oligomeric states of A beta and thereby reduce the effective amount of toxic oligomers is a promising therapeutic strategy for AD. Here, mass spectrometry and ion mobility spectrometry were used to investigate the effects of a small molecule, Z-Phe-Ala-diazomethylketone(PADK), on the A beta 42 form of the protein. The mass spectrum of a mixture of PADK and A beta 42 clearly shows that PADK binds directly to A beta 42 monomers and small oligomers. Ion mobility results indicate that PADK not only inhibits the formation of A beta 42 dodecamers, but also removes preformed A beta 42 dodecamers from the solution. Electron microscopy images show that PADK inhibits A beta 42 fibril formation in the solution. These results are consistent with a previous study that found that PADK has protective effects in an AD transgenic mouse model. The study of PADK and A beta 42 provides an example of small molecule therapeutic development for AD and other amyloid diseases.	[Zheng, Xueyun; Gessel, Megan M.; Bowers, Michael T.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Wisniewski, Meagan L.; Bahr, Ben A.] Univ N Carolina, Biotechnol Res & Training Ctr, William C Friday Lab, Pembroke, NC 28372 USA; [Viswanathan, Kishore; Wright, Dennis L.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Viswanathan, Kishore] Synapt Dynam Inc, Farmington, CT 06032 USA	University of California System; University of California Santa Barbara; University of North Carolina; University of Connecticut	Bowers, MT (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	bowers@chem.ucsb.edu	Zheng, Xueyun/GWR-2316-2022	Zheng, Xueyun/0000-0001-9782-4521; Wright, Dennis/0000-0003-4634-3351; Gessel, Megan/0000-0001-5706-787X	National Institutes of Health [IPOIAG 027818-010003, R25 GM077634]; Institute for the Study of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM077634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for the Study of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants IPOIAG 027818-010003 (to M. T. B.) and R25 GM077634 (to B. A. B.). This work was also supported by the Institute for the Study of Aging (to B. A. B.).	Bahr B. A., 2012, REJUVENATIO IN PRESS; Bahr BA, 2009, CURR ALZHEIMER RES, V6, P438, DOI 10.2174/156720509789207903; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Convertino M, 2011, J BIOL CHEM, V286, P41578, DOI 10.1074/jbc.M111.285957; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Grabenauer M, 2010, J AM CHEM SOC, V132, P8816, DOI 10.1021/ja100243h; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyttenbach T, 2003, TOP CURR CHEM, V225, P207, DOI 10.1007/b10470; Wyttenbach T, 2001, INT J MASS SPECTROM, V212, P13, DOI 10.1016/S1387-3806(01)00517-6; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	42	32	32	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6084	6088		10.1074/jbc.C111.328575	http://dx.doi.org/10.1074/jbc.C111.328575			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22253440	hybrid, Green Published			2022-12-25	WOS:000300791800002
J	Rauner, G; Barash, I				Rauner, Gat; Barash, Itamar			Cell Hierarchy and Lineage Commitment in the Bovine Mammary Gland	PLOS ONE			English	Article							SIGNALING PATHWAY CONTROLS; CHARACTERIZATION IN-VITRO; EPITHELIAL STEM-CELLS; MYOEPITHELIAL CELLS; PROGENITOR CELLS; FUNCTIONAL-CHARACTERIZATION; GENE-EXPRESSION; LIFE-SPAN; MOUSE; BREAST	The bovine mammary gland is a favorable organ for studying mammary cell hierarchy due to its robust milk-production capabilities that reflect the adaptation of its cell populations to extensive expansion and differentiation. It also shares basic characteristics with the human breast, and identification of its cell composition may broaden our understanding of the diversity in cell hierarchy among mammals. Here, Lin(-) epithelial cells were sorted according to expression of CD24 and CD49f into four populations: CD24(med)CD49f(pos) (putative stem cells, puStm), CD24(neg)CD49f(pos) (Basal), CD24(high)CD49f(neg) (putative progenitors, puPgt) and CD24(med)CD49f(neg) (luminal, Lum). These populations maintained differential gene expression of lineage markers and markers of stem cells and luminal progenitors. Of note was the high expression of Stat5a in the puPgt cells, and of Notch1, Delta1, Jagged1 and Hey1 in the puStm and Basal populations. Cultured puStm and Basal cells formed lineage-restricted basal or luminal clones and after re-sorting, colonies that preserved a duct-like alignment of epithelial layers. In contrast, puPgt and Lum cells generated only luminal clones and unorganized colonies. Under non-adherent culture conditions, the puPgt and puStm populations generated significantly more floating colonies. The increase in cell number during culture provides a measure of propagation potential, which was highest for the puStm cells. Taken together, these analyses position puStm cells at the top of the cell hierarchy and denote the presence of both bi-potent and luminally restricted progenitors. In addition, a population of differentiated luminal cells was marked. Finally, combining ALDH activity with cell-surface marker analyses defined a small subpopulation that is potentially stem cell-enriched.	[Rauner, Gat; Barash, Itamar] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Rauner, Gat] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Jerusalem, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Rauner, G (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel.	barashi@agri.huji.ac.il			Head of the ARO; Volcani Center for a breakthrough; Chief Scientist, Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israeli Milk Marketing Board; Israel Science Foundation, Israel Academy of Sciences [289/11]	Head of the ARO; Volcani Center for a breakthrough; Chief Scientist, Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israeli Milk Marketing Board; Israel Science Foundation, Israel Academy of Sciences(Israel Science Foundation)	This study was supported by grants from the Head of the ARO, Volcani Center for a breakthrough project, the Chief Scientist, Israeli Ministry of Agriculture (Biotechnology and Animal Science), the Israeli Milk Marketing Board and the Israel Science Foundation, Israel Academy of Sciences, contract number: 289/11 to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkafafy M, 2011, ACTA HISTOC IN PRESS; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Capuco AV, 2007, EXP BIOL MED, V232, P1381, DOI 10.3181/0703-RM-58; Capuco AV, 2009, EXP BIOL MED, V234, P475, DOI 10.3181/0811-RM-320; Capuco AV, 2003, J ANIM SCI, V81, P18; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Cardiff RD, 1998, J MAMMARY GLAND BIOL, V3, P3, DOI 10.1023/A:1018714016205; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Cregan MD, 2007, CELL TISSUE RES, V329, P129, DOI 10.1007/s00441-007-0390-x; Cremers N, 2010, CELL MOL LIFE SCI, V67, P2311, DOI 10.1007/s00018-010-0342-6; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; DEOME KB, 1959, CANCER RES, V19, P515; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DUNDAS SR, 1991, J CELL SCI, V100, P459; Ellis S, 2002, TISSUE CELL, V34, P155, DOI 10.1016/S0040-8166(02)00025-3; FERGUSON DJP, 1988, CELL TISSUE RES, V252, P581, DOI 10.1007/BF00216645; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Hellmen E, 1997, J DAIRY RES, V64, P197, DOI 10.1017/S0022029997002148; Holland MS, 2003, AM J VET RES, V64, P396, DOI 10.2460/ajvr.2003.64.396; HOSHINO K, 1967, NATURE, V213, P193, DOI 10.1038/213193a0; Hovey RC, 1999, J MAMMARY GLAND BIOL, V4, P53, DOI 10.1023/A:1018704603426; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kolar Z, 2007, VIRCHOWS ARCH, V450, P607, DOI 10.1007/s00428-007-0403-x; KOUKOULIS GK, 1991, AM J PATHOL, V139, P787; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li H, 2007, CANCER RES, V67, P501, DOI 10.1158/0008-5472.CAN-05-4571; Li SJ, 2010, J HISTOCHEM CYTOCHEM, V58, P509, DOI 10.1369/jhc.2009.954644; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Loor JJ, 2009, J ANIM SCI, V87, P813, DOI 10.2527/jas.2008-1375; Martignani E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013372; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Muschler J, 1999, MOL BIOL CELL, V10, P2817, DOI 10.1091/mbc.10.9.2817; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; OHARE MJ, 1991, DIFFERENTIATION, V46, P209, DOI 10.1111/j.1432-0436.1991.tb00883.x; Paranjape AN, 2011, ONCOGENE IN PRESS; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Reichenstein M, 2011, MOL REPROD DEV, V78, P585, DOI 10.1002/mrd.21345; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SHEFFIELD LG, 1986, J DAIRY SCI, V69, P1141, DOI 10.3168/jds.S0022-0302(86)80513-6; SHEFFIELD LG, 1988, J DAIRY SCI, V71, P2855, DOI 10.3168/jds.S0022-0302(88)79881-1; Shyamala G, 2002, J STEROID BIOCHEM, V80, P137, DOI 10.1016/S0960-0760(01)00182-0; Simian M, 2001, DEVELOPMENT, V128, P3117; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smalley MJ, 2005, CYTOTHERAPY, V7, P497, DOI 10.1080/14653240500361145; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SMITH GH, 1990, CELL GROWTH DIFFER, V1, P161; SMITH GH, 1988, J CELL SCI, V90, P173; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tiede B, 2011, CELL RES, V21, P245, DOI 10.1038/cr.2011.11; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109; Yan XL, 2011, BREAST CANC IN PRESS; Zeps N, 1998, DIFFERENTIATION, V62, P221, DOI 10.1046/j.1432-0436.1998.6250221.x; Zeps N, 1996, CELL TISSUE RES, V286, P525, DOI 10.1007/s004410050722	97	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30113	10.1371/journal.pone.0030113	http://dx.doi.org/10.1371/journal.pone.0030113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253899	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500034
J	Ioannidis, NE; Cruz, JA; Kotzabasis, K; Kramer, DM				Ioannidis, Nikolaos E.; Cruz, Jeffrey A.; Kotzabasis, Kiriakos; Kramer, David M.			Evidence That Putrescine Modulates the Higher Plant Photosynthetic Proton Circuit	PLOS ONE			English	Article							ARGININE DECARBOXYLASE; MOTIVE FORCE; PHOTOSYSTEM-I; CHLOROPLASTS; ACCUMULATION; ELECTRON; IDENTIFICATION; EXPRESSION; POLYAMINES; TOLERANCE	The light reactions of photosynthesis store energy in the form of an electrochemical gradient of protons, or proton motive force (pmf), comprised of electrical (Delta psi) and osmotic (Delta pH) components. Both components can drive the synthesis of ATP at the chloroplast ATP synthase, but the Delta pH component also plays a key role in regulating photosynthesis, down-regulating the efficiency of light capture by photosynthetic antennae via the q(E) mechanism, and governing electron transfer at the cytochrome b(6)f complex. Differential partitioning of pmf into Delta pH and Delta psi has been observed under environmental stresses and proposed as a mechanism for fine-tuning photosynthetic regulation, but the mechanism of this tuning is unknown. We show here that putrescine can alter the partitioning of pmf both in vivo (in Arabidopsis mutant lines and in Nicotiana wild type) and in vitro, suggesting that the endogenous titer of weak bases such as putrescine represents an unrecognized mechanism for regulating photosynthetic responses to the environment.	[Ioannidis, Nikolaos E.; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Ioannidis, Nikolaos E.; Cruz, Jeffrey A.; Kramer, David M.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Cruz, Jeffrey A.; Kramer, David M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Cruz, Jeffrey A.; Kramer, David M.] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA	University of Crete; Washington State University; Michigan State University; Michigan State University; United States Department of Energy (DOE)	Ioannidis, NE (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	ioannidis@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021; Kramer, David/B-9588-2016	Kotzabasis, Kiriakos/0000-0002-1002-6365; Kramer, David/0000-0003-2181-6888	European Molecular Biology Organisation; United States Department of Energy, Chemical Sciences, Geosciences and Biosciences Division Office of Science, Basic Energy Sciences [DE-FG02-11ER16220]	European Molecular Biology Organisation; United States Department of Energy, Chemical Sciences, Geosciences and Biosciences Division Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the European Molecular Biology Organisation for post-doctoral research in the Institute of Biological Chemistry (Washington State, United States of America). DK and JC were supported by a grant from the United States Department of Energy, Chemical Sciences, Geosciences and Biosciences Division Office of Science, Basic Energy Sciences (DE-FG02-11ER16220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Bagni N, 2006, PLANT PHYSIOL BIOCH, V44, P776, DOI 10.1016/j.plaphy.2006.10.011; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; BORRELL A, 1995, PLANT PHYSIOL, V109, P771, DOI 10.1104/pp.109.3.771; Bortolotti C, 2004, PHYSIOL PLANTARUM, V120, P84, DOI 10.1111/j.0031-9317.2004.0216.x; Capell T, 2004, P NATL ACAD SCI USA, V101, P9909, DOI 10.1073/pnas.0306974101; CROFTS AR, 1967, J BIOL CHEM, V242, P3352; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; De Robertis A, 2001, TALANTA, V54, P1135, DOI 10.1016/S0039-9140(01)00380-0; GAENSSLEN RE, 1971, ARCH BIOCHEM BIOPHYS, V147, P55, DOI 10.1016/0003-9861(71)90309-2; Galston AW, 2001, CURR SCI, V80, P150; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GUARINO LA, 1979, P NATL ACAD SCI USA, V76, P3184, DOI 10.1073/pnas.76.7.3184; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Ioannidis NE, 2006, BBA-BIOENERGETICS, V1757, P821, DOI 10.1016/j.bbabio.2006.05.034; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Kohzuma K, 2009, PLANT CELL ENVIRON, V32, P209, DOI 10.1111/j.1365-3040.2008.01912.x; KOTZABASIS K, 1993, ANAL BIOCHEM, V214, P484, DOI 10.1006/abio.1993.1526; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Kramer DM, 1998, PHOTOSYNTH RES, V56, P103, DOI 10.1023/A:1005968211506; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; Malmberg RL, 1998, CRIT REV PLANT SCI, V17, P199, DOI 10.1016/S0735-2689(98)00358-X; Mehta RA, 2002, NAT BIOTECHNOL, V20, P613, DOI 10.1038/nbt0602-613; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; ROBINSON SP, 1983, PLANT PHYSIOL, V73, P238, DOI 10.1104/pp.73.2.238; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Urano K, 2005, FEBS LETT, V579, P1557, DOI 10.1016/j.febslet.2005.01.048; Urano K, 2004, BIOCHEM BIOPH RES CO, V313, P369, DOI 10.1016/j.bbrc.2003.11.119; Zhang R, 2009, PLANT CELL ENVIRON, V32, P1538, DOI 10.1111/j.1365-3040.2009.02018.x	38	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29864	10.1371/journal.pone.0029864	http://dx.doi.org/10.1371/journal.pone.0029864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253808	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100026
J	Sun, B; Liu, R; Xiao, ZD; Zhu, X				Sun, Bo; Liu, Rui; Xiao, Zhong-Dang; Zhu, Xuan			c-MET Protects Breast Cancer Cells from Apoptosis Induced by Sodium Butyrate	PLOS ONE			English	Article							CARCINOMA CELLS; STEM-CELLS; MODULATION; EXPRESSION; PROTEINS; TARGET; GROWTH	Sodium Butyrate (NaBu) is regarded as a potential reagent for cancer therapy. In this study, a specific breast cancer cell population that is resistant NaBu treatment was identified. These cells possess cancer stem cell characters, such as the capability of sphere formation in vitro and high tumor incident rate (85%) in mouse model. Forty percent of the NaBu resistant cells express the cancer stem cells marker, the CD133, whereas only 10% intact cells present the CD133 antigen. Furthermore, the endogenous expressing c-MET contributes to the survival of cancer stem cell population from the treatment of NaBu. The CD133+ group also presents a higher level of c-MET. A combination treatment of MET siRNA and NaBu efficiently prohibited the breast cancer progression, and the incident rate of the tumor decrease to 18%. This study may help to develop a new and alternative strategy for breast cancer therapy.	[Sun, Bo; Xiao, Zhong-Dang] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Rui] Seoul Natl Univ, Sch Biol Sci, Biophys Lab, Seoul, South Korea; [Zhu, Xuan] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China	Southeast University - China; Seoul National University (SNU); Xiamen University	Sun, B (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.	sunbo@seu.edu.cn; zhuxuan@xmu.edu.cn			New Faculty Start-Up Program on Science Research; Southeast University; Key Project of Fujian Social Development [2010Y0054]	New Faculty Start-Up Program on Science Research; Southeast University; Key Project of Fujian Social Development	This work was supported by the New Faculty Start-Up Program on Science Research funded by Southeast University and Key Project of Fujian Social Development (2010Y0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 1999, J BIOL CHEM, V274, P29274, DOI 10.1074/jbc.274.41.29274; Bu R, 2010, LAB INVEST, V91, P124; Chopin V, 2002, BRIT J PHARMACOL, V135, P79, DOI 10.1038/sj.bjp.0704456; Easmon J, 2002, EXPERT OPIN THER PAT, V12, P789, DOI 10.1517/13543776.12.6.789; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fotovati A, 2011, PATHOL ONCOL RES, V17, P525, DOI 10.1007/s12253-010-9342-y; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Lallemand F, 1999, EXP CELL RES, V247, P432, DOI 10.1006/excr.1998.4370; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Nohara Kazunari, 2007, Kobe J Med Sci, V53, P265; Pellizzaro C, 2002, CARCINOGENESIS, V23, P735, DOI 10.1093/carcin/23.5.735; Pellizzaro C, 2001, INT J CANCER, V91, P654, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1117>3.0.CO;2-I; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pulukuri SMK, 2010, MOL CANCER RES, V8, P1074, DOI 10.1158/1541-7786.MCR-09-0495; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Ratajczak MZ, 2005, FOLIA HISTOCHEM CYTO, V43, P175; Soldatenkov VA, 1998, CELL DEATH DIFFER, V5, P307, DOI 10.1038/sj.cdd.4400345; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; Vincan E, 2000, ONCOL RES, V12, P193	23	17	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30143	10.1371/journal.pone.0030143	http://dx.doi.org/10.1371/journal.pone.0030143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253909	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100042
J	Zaman, M; Abdel-Aal, ABM; Fujita, Y; Phillipps, KSM; Batzloff, MR; Good, MF; Toth, I				Zaman, Mehfuz; Abdel-Aal, Abu-Baker M.; Fujita, Yoshio; Phillipps, Karen S. M.; Batzloff, Michael R.; Good, Michael F.; Toth, Istvan			Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship	PLOS ONE			English	Article							M-PROTEIN; IMMUNOCONTRACEPTIVE VACCINES; SYNTHETIC LIPOPEPTIDE; MUCOSAL COLONIZATION; PEPTIDE VACCINE; IMMUNOGENICITY; EPITOPES; IMMUNITY; IMMUNIZATION; PROTECTION	Streptococcus pyogenes (group A streptococcus, GAS) is a Gram-positive bacterial pathogen responsible for a wide variety of diseases. To date, GAS vaccine development has focused primarily on the M-protein. The M-protein is highly variable at the amino (N)-terminus (determining serotype) but is conserved at the carboxyl (C)-terminus. Previously a 29 amino acid peptide (named J14) from the conserved region of the M-protein was identified as a potential vaccine candidate. J14 was capable of eliciting protective antibodies that recognized many GAS serotypes when co-administered with immunostimulants. This minimal epitope however showed no immunogenicity when administered alone. In an attempt overcome this immunological non-responsiveness, we developed a self-adjuvanting vaccine candidate composed of three components: the B-cell epitope (J14), a universal helper T-cell epitope (P25) and a lipid moiety consisting of lipoamino acids (Laas) which target Toll-like receptor 2 (TLR2). Immunological evaluation in B10. BR (H-2k) mice demonstrated that the epitope attachment to the point of lipid moiety, and the length of the Laa alkyl chain have a profound effect on vaccine immunogenicity after intranasal administration. It was demonstrated that a vaccine featuring C-terminal lipid moiety containing alkyl chains of 16 carbons, with P25 located at the N-terminus, and J14 attached to the side chain of a central lysine residue was capable of inducing optimal antibody response. These findings have considerable relevance to the development of a broad spectrum J14-based GAS vaccine and in particular provided a rational basis for peptide vaccine design based on this self-adjuvanting lipopeptide technology.	[Zaman, Mehfuz; Abdel-Aal, Abu-Baker M.; Fujita, Yoshio; Phillipps, Karen S. M.; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Batzloff, Michael R.; Good, Michael F.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	University of Queensland; Griffith University	Zaman, M (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	i.toth@uq.edu.au	Toth, Istvan/C-1965-2013; Abdel-Aal, Abu-Baker M./GRE-9425-2022	Toth, Istvan/0000-0002-4572-397X; Abdel-Aal, Abu-Baker M./0000-0003-1759-5090; Zaman, Mehfuz/0000-0001-9367-567X	National Health and Medical Research Council of Australia (NHMRC) [496600]; University of Queensland; Grants-in-Aid for Scientific Research [23790144] Funding Source: KAKEN	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Health and Medical Research Council of Australia (NHMRC Programme Grant 496600). MZ acknowledges the University of Queensland for the financial support through a Ph.D. funding scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; BenMohamed L, 2002, IMMUNOLOGY, V106, P113, DOI 10.1046/j.1365-2567.2002.01396.x; BESSEN D, 1990, J IMMUNOL, V145, P1251; BESSEN D, 1988, INFECT IMMUN, V56, P2666, DOI 10.1128/IAI.56.10.2666-2672.1988; Bessler WG, 1997, BACTERIAL LIPOPEPTID, P390; Brandt ER, 2000, INFECT IMMUN, V68, P6587, DOI 10.1128/IAI.68.12.6587-6594.2000; BRONZE MS, 1988, J IMMUNOL, V141, P2767; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Cohen-Poradosu R, 2007, CLIN INFECT DIS, V45, P863, DOI 10.1086/521263; Guilherme L, 2009, METHODS, V49, P316, DOI 10.1016/j.ymeth.2009.03.024; Hayman WA, 2002, IMMUNOL CELL BIOL, V80, P178, DOI 10.1046/j.1440-1711.2002.01067.x; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; McNeela EA, 2001, ADV DRUG DELIVER REV, V51, P43, DOI 10.1016/S0169-409X(01)00169-7; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Metzgar D, 2010, VIRULENCE, V1, P247, DOI 10.4161/viru.1.4.11979; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Olive C., 2001, Mini-Reviews in Medicinal Chemistry, V1, P429, DOI 10.2174/1389557013406666; Olive Colleen, 2004, Expert Rev Vaccines, V3, P43, DOI 10.1586/14760584.3.1.43; PRUKSAKORN S, 1994, LANCET, V344, P639, DOI 10.1016/S0140-6736(94)92083-4; Relf WA, 1996, PEPTIDE RES, V9, P12; ROBINSON JH, 1992, IMMUNOL TODAY, V13, P362, DOI 10.1016/0167-5699(92)90173-5; Steer Andrew C, 2009, Pediatr Clin North Am, V56, P1401, DOI 10.1016/j.pcl.2009.09.011; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905	27	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30146	10.1371/journal.pone.0030146	http://dx.doi.org/10.1371/journal.pone.0030146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253911	gold, Green Published			2022-12-25	WOS:000301357100043
J	Lord, E; Leclercq, M; Boc, A; Diallo, AB; Makarenkov, V				Lord, Etienne; Leclercq, Mickael; Boc, Alix; Diallo, Abdoulaye Banire; Makarenkov, Vladimir			Armadillo 1.1: An Original Workflow Platform for Designing and Conducting Phylogenetic Analysis and Simulations	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CLUSTAL-W; SOFTWARE; CONSTRUCTION; INFORMATICS; ALGORITHM; FRAMEWORK; INFERENCE; SELECTION; ACCURATE	In this paper we introduce Armadillo v1.1, a novel workflow platform dedicated to designing and conducting phylogenetic studies, including comprehensive simulations. A number of important phylogenetic and general bioinformatics tools have been included in the first software release. As Armadillo is an open-source project, it allows scientists to develop their own modules as well as to integrate existing computer applications. Using our workflow platform, different complex phylogenetic tasks can be modeled and presented in a single workflow without any prior knowledge of programming techniques. The first version of Armadillo was successfully used by professors of bioinformatics at Universite du Quebec a Montreal during graduate computational biology courses taught in 2010-11. The program and its source code are freely available at: <http://www.bioinfo.uqam.ca/armadillo>.	[Lord, Etienne; Leclercq, Mickael; Diallo, Abdoulaye Banire; Makarenkov, Vladimir] Univ Montreal, Dept Informat, Montreal, PQ, Canada; [Boc, Alix] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Lord, E (corresponding author), Univ Montreal, Dept Informat, Montreal, PQ, Canada.	vladimir.makarenkov@uqam.ca	Leclercq, Mickael/K-5246-2019	Leclercq, Mickael/0000-0001-6205-888X	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	EL and AB are Natural Science and Engineering Research Council of Canada fellows (NSERC). VM and ABD hold NSERC discovery grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Addario-Berry L, 2003, Pac Symp Biocomput, P279; Altintas I, 2004, 16TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P423; Beaulah SA, 2008, DRUG DISCOV TODAY, V13, P771, DOI 10.1016/j.drudis.2008.06.005; Boc A, 2010, SYST BIOL, V59, P195, DOI 10.1093/sysbio/syp103; Brazas MD, 2010, NUCLEIC ACIDS RES, V38, pW3, DOI 10.1093/nar/gkq553; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2010, BIOINFORMATICS, V26, P1125, DOI 10.1093/bioinformatics/btq086; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Deelman E., 2005, Scientific Programming, V13, P219; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dinov ID, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-304; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Drummond AJ, 2009, GENEIOUS V 5 5; Dudley JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000589; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gil Y, 2011, IEEE INTELL SYST, V26, P62, DOI 10.1109/MIS.2010.9; Gilbert DG, 2010, READSEQ DG GILBERT V; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hipp DR, 2003, SQLITE EMBEDDABLE SQ; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Hoon S, 2003, GENOME RES, V13, P1904, DOI 10.1101/gr.1363103; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lin J, 2001, IEEE INTERNATIONAL CONFERENCE ON ADVANCED LEARNING TECHNOLOGIES, PROCEEDINGS, P349, DOI 10.1109/ICALT.2001.943942; Lushbough CM, 2011, NUCLEIC ACIDS RES, V39, pW528, DOI 10.1093/nar/gkr286; Ma J, 2010, LECT NOTES COMPUT SC, V6095, P188; Maddison WP, 2009, MESQUITE MODULAR SYS; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; Oinn T., 2007, WORKFLOWS E SCI, P300, DOI DOI 10.1007/978-1-84628-757-2_19; Oinn T, 2006, CONCURR COMP-PRACT E, V18, P1067, DOI 10.1002/cpe.993; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Romano P, 2008, BRIEF BIOINFORM, V9, P57, DOI 10.1093/bib/bbm056; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stevens R, 2007, BRIEF BIOINFORM, V8, P183, DOI 10.1093/bib/bbm015; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valentin F, 2010, BRIEF BIOINFORM, V11, P375, DOI 10.1093/bib/bbp065; Van Der Veen J., 2000, Computer Science Education, V10, P283, DOI 10.1076/0899-3408(200012)10:3;1-S;FT283; Vouk MA, 1999, IEEE T KNOWL DATA EN, V11, P673, DOI 10.1109/69.790839; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Woollard D, 2008, IEEE SOFTWARE, V25, P37, DOI 10.1109/MS.2008.92; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan D, 2010, FUTURE GENER COMP SY, V26, P1200, DOI 10.1016/j.future.2010.02.004; Zhang FE, 2009, IEEE: 2009 INTERNATIONAL CONFERENCE ON E-LEARNING, E-BUSINESS, ENTERPRISE INFORMATION SYSTEMS AND E-GOVERNMENT, P263, DOI 10.1109/EEEE.2009.85; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; Zwickl D., 2006, GARLI GENETIC ALGORI	66	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29903	10.1371/journal.pone.0029903	http://dx.doi.org/10.1371/journal.pone.0029903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253821	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000301355700065
J	Lipowsky, A; Roscher, C; Schumacher, J; Schmid, B				Lipowsky, Annett; Roscher, Christiane; Schumacher, Jens; Schmid, Bernhard			Density-Independent Mortality and Increasing Plant Diversity Are Associated with Differentiation of Taraxacum officinale into r- and K-Strategists	PLOS ONE			English	Article							DANDELIONS TARAXACUM; SPECIES-DIVERSITY; COMPETITIVE RELATIONSHIPS; GENETIC DIFFERENTIATION; POPULATION; IDENTITY; GROWTH; RESPONSES; ESTABLISHMENT; BIODIVERSITY	Background: Differential selection between clones of apomictic species may result in ecological differentiation without mutation and recombination, thus offering a simple system to study adaptation and life-history evolution in plants. Methodology/Principal Findings: We caused density-independent mortality by weeding to colonizer populations of the largely apomictic Taraxacum officinale (Asteraceae) over a 5-year period in a grassland biodiversity experiment (Jena Experiment). We compared the offspring of colonizer populations with resident populations deliberately sown into similar communities. Plants raised from cuttings and seeds of colonizer and resident populations were grown under uniform conditions. Offspring from colonizer populations had higher reproductive output, which was in general agreement with predictions of r-selection theory. Offspring from resident populations had higher root and leaf biomass, fewer flower heads and higher individual seed mass as predicted under K-selection. Plants grown from cuttings and seeds differed to some degree in the strength, but not in the direction, of their response to the r- vs. K-selection regime. More diverse communities appeared to exert stronger K-selection on resident populations in plants grown from cuttings, while we did not find significant effects of increasing species richness on plants grown from seeds. Conclusions/Significance: Differentiation into r- and K-strategists suggests that clones with characteristics of r-strategists were selected in regularly weeded plots through rapid colonization, while increasing plant diversity favoured the selection of clones with characteristics of K-strategists in resident populations. Our results show that different selection pressures may result in a rapid genetic differentiation within a largely apomictic species. Even under the assumption that colonizer and resident populations, respectively, happened to be r- vs. K-selected already at the start of the experiment, our results still indicate that the association of these strategies with the corresponding selection regimes was maintained during the 5-year experimental period.	[Lipowsky, Annett] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Lipowsky, Annett; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Roscher, Christiane] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany	Max Planck Society; University of Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena	Lipowsky, A (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	annett.lipowsky@access.uzh.ch	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	German Science Foundation [FOR 456]; Friedrich Schiller University of Jena; Max Planck Society; Swiss National Science Foundation [31003A-107531]	German Science Foundation(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Science Foundation (FOR 456) with support from the Friedrich Schiller University of Jena, the Max Planck Society, and the Swiss National Science Foundation (31003A-107531 to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1973, AM NAT, V107, P651, DOI 10.1086/282864; Alpert P, 2000, PERSPECT PLANT ECOL, V3, P52, DOI DOI 10.1078/1433-8319-00004; Bates D, 2006, LME4 LINEAR MIXED EF; Bazzaz FA, 1996, PLANTS CHANGING ENV, P320, DOI DOI 10.1038/416389A; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; COX T, 1987, ANN BOT-LONDON, V59, P81, DOI 10.1093/oxfordjournals.aob.a087288; Crawley MJ., 2007, R BOOK; DEKROON H, 2003, ROOT ECOLOGY; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; FORD H, 1981, BIOL J LINN SOC, V15, P355, DOI 10.1111/j.1095-8312.1981.tb00769.x; FORD H, 1985, HEREDITY, V55, P289, DOI 10.1038/hdy.1985.110; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; GADGIL M, 1972, AM NAT, V106, P14, DOI 10.1086/282748; GLEESON SK, 1994, FUNCT ECOL, V8, P543, DOI 10.2307/2390080; GREENE DF, 1989, ECOLOGY, V70, P339, DOI 10.2307/1937538; Higgins SI, 1996, ECOLOGY, V77, P2043, DOI 10.2307/2265699; Holm L., 1997, NATURAL HIST DISTRIB; HUGHES J, 1985, HEREDITY, V54, P245, DOI 10.1038/hdy.1985.32; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; Leishman MR, 1999, NEW PHYTOL, V141, P487, DOI 10.1046/j.1469-8137.1999.00354.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lloret F, 1999, FUNCT ECOL, V13, P210, DOI 10.1046/j.1365-2435.1999.00309.x; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; LYMAN JC, 1984, HEREDITY, V53, P1, DOI 10.1038/hdy.1984.58; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Marco D. E., 2002, BIOL INVASIONS, V4, P193, DOI DOI 10.1023/A:1020518915320; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Menken SBJ, 1995, EVOLUTION, V49, P1108, DOI 10.2307/2410435; MOGIE M, 1990, OIKOS, V59, P175, DOI 10.2307/3545532; MOLGAARD P, 1977, OIKOS, V29, P376, DOI 10.2307/3543629; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nestmann S, 2011, MOL ECOL, V20, P2188, DOI 10.1111/j.1365-294X.2011.05027.x; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Roscher C, 2008, ANN BOT-LONDON, V102, P113, DOI 10.1093/aob/mcn070; Roscher C, 2009, OIKOS, V118, P1524, DOI 10.1111/j.1600-0706.2009.17601.x; SAWADA S, 1982, Japanese Journal of Ecology, V32, P347; SCHMID B, 1990, ECOLOGY, V71, P523, DOI 10.2307/1940306; Silvertown J, 2009, ECOL LETT, V12, P165, DOI 10.1111/j.1461-0248.2008.01273.x; SOLBRIG OT, 1974, J ECOL, V62, P473, DOI 10.2307/2258993; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Sultan SE, 1996, ECOLOGY, V77, P1791, DOI 10.2307/2265784; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; TURKINGTON R, 1989, J ECOL, V77, P717, DOI 10.2307/2260981; Tweney J, 1999, ANN BOT-LONDON, V83, P45, DOI 10.1006/anbo.1998.0790; Uhlemann I., 2001, Feddes Repertorium, V112, P15; van Dijk PJ, 2003, PHILOS T R SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; Van Dijk PJ, 1999, HEREDITY, V83, P715, DOI 10.1038/sj.hdy.6886200; Vavrek MC, 1998, AM J BOT, V85, P947, DOI 10.2307/2446361; Vavrek MC, 1996, ECOLOGY, V77, P2098, DOI 10.2307/2265704; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Vellend M, 2009, WEED SCI, V57, P410, DOI 10.1614/WS-09-004.1; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x	64	16	18	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28121	10.1371/journal.pone.0028121	http://dx.doi.org/10.1371/journal.pone.0028121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253688	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000315865800002
J	Nazri, A; Lio, P				Nazri, Azree; Lio, Pietro			Investigating Meta-Approaches for Reconstructing Gene Networks in a Mammalian Cellular Context	PLOS ONE			English	Article							REGULATORY NETWORKS; MICROARRAY; EXPRESSION; INFERENCE; METAANALYSIS; DISCOVERY	The output of state-of-the-art reverse-engineering methods for biological networks is often based on the fitting of a mathematical model to the data. Typically, different datasets do not give single consistent network predictions but rather an ensemble of inconsistent networks inferred under the same reverse-engineering method that are only consistent with the specific experimentally measured data. Here, we focus on an alternative approach for combining the information contained within such an ensemble of inconsistent gene networks called meta-analysis, to make more accurate predictions and to estimate the reliability of these predictions. We review two existing meta-analysis approaches; the Fisher transformation combined coefficient test (FTCCT) and Fisher's inverse combined probability test (FICPT); and compare their performance with five well-known methods, ARACNe, Context Likelihood or Relatedness network (CLR), Maximum Relevance Minimum Redundancy (MRNET), Relevance Network (RN) and Bayesian Network (BN). We conducted in-depth numerical ensemble simulations and demonstrated for biological expression data that the meta-analysis approaches consistently outperformed the best gene regulatory network inference (GRNI) methods in the literature. Furthermore, the meta-analysis approaches have a low computational complexity. We conclude that the meta-analysis approaches are a powerful tool for integrating different datasets to give more accurate and reliable predictions for biological networks.	[Nazri, Azree] Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Dept Comp Sci, Serdang, Malaysia; [Nazri, Azree; Lio, Pietro] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Nazri, Azree] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Universiti Putra Malaysia; University of Cambridge; University of Cambridge; University of Cambridge	Nazri, A (corresponding author), Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Dept Comp Sci, Serdang, Malaysia.	asa43@cam.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021	P. Lió, Pietro Lio/0000-0002-0540-5053	Minisry of Higher Education Malaysia	Minisry of Higher Education Malaysia	This work was supported by the Minisry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Bader JS, 2003, BIOINFORMATICS, V19, P1869, DOI 10.1093/bioinformatics/btg358; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bernstein R, 1999, OUTLINE THEORY PROBL; Butte AJ, 1999, J AM MED INFORM ASSN, P711; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Cochran, COCHRAN STAT METHODS, P185; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Drogovtsev S. N., 2000, PHYS REV LETT, V85, P4633; Emmert-Streib F, 2010, IET SYSEM BIOL; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gupta A, 2005, COMPUT CHEM ENG, V29, P565, DOI 10.1016/j.compchemeng.2004.08.030; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Iba H, 2002, INFORM SCIENCES, V145, P225, DOI 10.1016/S0020-0255(02)00234-7; Iba Hitoshi, 2010, BMC BIOINFORMATICS, V18, P11; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jostins L, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-17; Liang S, 1998, Pac Symp Biocomput, P18; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Park WD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-88; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Rhodes DR, 2002, CANCER RES, V62, P4427; Stevens JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-57; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; van Someren EP, 2002, PHARMACOGENOMICS, V3, P507, DOI 10.1517/14622416.3.4.507; VANSOMEREN EP, 2001, P IEEE EURASIP WORKS; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang LW, 2010, J GENET, V89, P73, DOI 10.1007/s12041-010-0013-2	35	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28713	10.1371/journal.pone.0028713	http://dx.doi.org/10.1371/journal.pone.0028713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253694	Green Published, Green Submitted, gold			2022-12-25	WOS:000315865800003
J	Nunez-Corcuera, B; Birch, JL; Yamada, Y; Williams, JG				Nunez-Corcuera, Beatriz; Birch, Joanna L.; Yamada, Yoko; Williams, Jeffrey G.			Transcriptional Repression by a bZIP Protein Regulates Dictyostelium Prespore Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITE; DISCOIDEUM; DIF-1; PROMOTER; ELEMENT; CELLS	In response to the signaling polyketide DIF-1 DimB directly activates transcription of the ecmB gene in pstB cells; a subset of the prestalk cells that are the precursors of the basal disc. We show that the promoter of pspA, a prespore-specific gene, also contains a DimB binding site. Mutation of this site causes ectopic expression in the prestalk region and ChIP analysis shows that DIF-1 induces binding of DimB to the pspA promoter. DIF-1 represses pspA gene expression in a suspension cell assay but this repression is abrogated in a dimB null strain. These results suggest a coupled control mechanism, whereby the same DIF-DimB signaling pathway that directly activates ecmB gene expression directly represses pspA gene expression.	[Nunez-Corcuera, Beatriz; Birch, Joanna L.; Yamada, Yoko; Williams, Jeffrey G.] Univ Dundee, Coll Life Sci, Dundee, Scotland	University of Dundee	Williams, JG (corresponding author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	j.g.williams@dundee.ac.uk		NUNEZ-CORCUERA, BEATRIZ/0000-0001-6551-9215; Birch, Joanna/0000-0001-9522-8435; Yamada, Yoko/0000-0001-8273-0012	Medical Research Council [MRC G0600244]; Wellcome Trust [082579/Z]; MRC [G0600244] Funding Source: UKRI; Medical Research Council [G0600244] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was initially funded by an Medical Research Council project grant (MRC G0600244) and completed with the support of a Wellcome Trust program grant (082579/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EARLY AE, 1988, DEVELOPMENT, V103, P519; EARLY AE, 1989, NUCLEIC ACIDS RES, V17, P6473; Fukuzawa M, 1997, DEVELOPMENT, V124, P2719; HOPPER NA, 1994, DEV BIOL, V163, P285, DOI 10.1006/dbio.1994.1145; Hsu YS, 1999, BBA-GENE STRUCT EXPR, V1447, P64, DOI 10.1016/S0167-4781(99)00117-7; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; KAY RR, 1983, NATURE, V303, P242, DOI 10.1038/303242a0; Kay RR, 2001, DEVELOPMENT, V128, P4959; Kelley KMM, 2003, GENE, V307, P87, DOI 10.1016/S0378-1119(03)00445-1; Kristjuhan A, 1995, EUR J BIOCHEM, V234, P827, DOI 10.1111/j.1432-1033.1995.827_a.x; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; POWELLCOFFMAN JA, 1994, MOL CELL BIOL, V14, P5840, DOI 10.1128/MCB.14.9.5840; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; Williams JG, 2011, DEV BIOL; Yamada Y, 2008, DEVELOPMENT, V135, P3093, DOI 10.1242/dev.026377; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29895	10.1371/journal.pone.0029895	http://dx.doi.org/10.1371/journal.pone.0029895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253818	gold, Green Published, Green Submitted			2022-12-25	WOS:000315865800019
J	Van Voorhies, WA				Van Voorhies, Wayne A.			Robust Metabolic Responses to Varied Carbon Sources in Natural and Laboratory Strains of Saccharomyces cerevisiae	PLOS ONE			English	Article							CARBOHYDRATE-METABOLISM; FERMENTATIVE CAPACITY; GENE-EXPRESSION; YEAST; GLUCOSE; LANDSCAPE; GROWTH; RESTRICTION; CALORIMETRY; BATCH	Understanding factors that regulate the metabolism and growth of an organism is of fundamental biologic interest. This study compared the influence of two different carbon substrates, dextrose and galactose, on the metabolic and growth rates of the yeast Saccharomyces cerevisiae. Yeast metabolic and growth rates varied widely depending on the metabolic substrate supplied. The metabolic and growth rates of a yeast strain maintained under long-term laboratory conditions was compared to strain isolated from natural condition when grown on different substrates. Previous studies had determined that there are numerous genetic differences between these two strains. However, the overall metabolic and growth rates of a wild isolate of yeast was very similar to that of a strain that had been maintained under laboratory conditions for many decades. This indicates that, at in least this case, metabolism and growth appear to be well buffered against genetic differences. Metabolic rate and cell number did not co-vary in a simple linear manner. When grown in either dextrose or galactose, both strains showed a growth pattern in which the number of cells continued to increase well after the metabolic rate began a sharp decline. Previous studied have reported that O-2 consumption in S. cerevisiae grown in reduced dextrose levels were elevated compared to higher levels. Low dextrose levels have been proposed to induce caloric restriction and increase life span in yeast. However, there was no evidence that reduced levels of dextrose increased metabolic rates, measured by either O-2 consumption or CO2 production, in the strains used in this study.				wvanvoor@nmsu.edu			U.S. National Cancer Institute [MSI CCP NCI U56 CA96286]; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the U.S. National Cancer Institute (MSI CCP NCI U56 CA96286) to WAVV and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BARFORD JP, 1979, J GEN MICROBIOL, V114, P267, DOI 10.1099/00221287-114-2-267; BECK C, 1968, J BACTERIOL, V96, P479, DOI 10.1128/JB.96.2.479-486.1968; Bell PJL, 2001, LETT APPL MICROBIOL, V32, P224, DOI 10.1046/j.1472-765X.2001.00894.x; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Brachmann CB, 1998, YEAST, V14, P115; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BRETTEL R, 1980, RADIAT ENVIRON BIOPH, V18, P301, DOI 10.1007/BF01324273; Cappello MS, 2004, J APPL MICROBIOL, V97, P1274, DOI 10.1111/j.1365-2672.2004.02412.x; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gancedo C., 1989, YEASTS, V3, P205; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Hartwell LH, 2002, BIOSCIENCE REP, V22, P373, DOI 10.1023/A:1020918107706; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koschwanez JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001122; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Hoek P, 2000, ENZYME MICROB TECH, V26, P724, DOI 10.1016/S0141-0229(00)00164-2; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P4226; van Maris AJA, 2001, FEMS YEAST RES, V1, P139, DOI 10.1016/S1567-1356(01)00022-8; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; WALSBERG GE, 1995, J EXP BIOL, V198, P213; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653	44	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30053	10.1371/journal.pone.0030053	http://dx.doi.org/10.1371/journal.pone.0030053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253874	Green Published, Green Submitted, gold			2022-12-25	WOS:000315865800024
J	Zhang, CY; Chen, J; Yin, DC; Lin, SX				Zhang, Chen-Yan; Chen, Jiong; Yin, Da-Chuan; Lin, Sheng-Xiang			The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells	PLOS ONE			English	Article							HUMAN 17-BETA-HYDROXYSTEROID DEHYDROGENASES; HEK-293 CELLS; EXPRESSION; SULFATASE; ENZYMES; PROLIFERATION; METABOLISM; REDUCTION; PREDICTS; NADPH	Estrone and estradiol are both estrogens with estrone being the less potent form and estradiol being the most potent estrogen. The binding of the latter to cellular regulatory elements stimulates the proliferation of breast cancer cells. A high ratio of estradiol/estrone is related to increased cell proliferation, and is of great importance to understanding of breast cancer mechanisms. 17beta-hydroxysteroid dehydrogenase type 1 and type 2 play important roles in the activation of estrone and inactivation of estradiol. Breast cancer cells T47D, MCF-7, BT 20, and JEG 3 as control cells, were chosen to evaluate the contribution of these two enzymes to the ratio. Twenty four hours after addition of different concentrations of estrone and estradiol, the ratio stabilized to around 9/1 in breast cancer cell lines with high expression of type 1 (T47D, BT 20, and JEG 3), whereas it approached 1/5 in cells with low expression of type 1 (MCF-7). The estradiol/estrone concentration ratio was modified to 9/1 in MCF-7 and HEK-293 cells over-expressing type 1. In T47D and BT 20, this ratio was decreased from 9/1 to nearly 1/5 (19/81 and 17/83 respectively) after type 1 knockdown by specific siRNAs. Type 2 is mainly involved in the conversion of estradiol into estrone. This ratio was decreased from 9/1 to 7/3 after over-expression of type 2 in MCF-7 cells already over-expressing type 1. The ratio was further decreased by the addition of the oxidative cofactor, NAD, to the cell culture to facilitate the estradiol to estrone conversion catalyzed by type 2. These results demonstrate that the estradiol/estrone ratio is controlled by both type 1 and type 2 with an additional contribution by NAD, although type 1 is the first determining factor in the cellular environment compared with type 2 and cofactors. Moreover, kinetic studies were carried out in intact cells as a new approach, using HEK-293 cells over-expressing type 1 and T47D breast cancer cells.	[Zhang, Chen-Yan; Lin, Sheng-Xiang] CHUQ, CHU Laval, Lab Mol Endocrinol & Oncol, Res Ctr, Quebec City, PQ, Canada; [Zhang, Chen-Yan; Lin, Sheng-Xiang] Univ Laval, Quebec City, PQ, Canada; [Zhang, Chen-Yan; Yin, Da-Chuan] Northwestern Polytech Univ, Fac Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China; [Chen, Jiong] Shanghai Inst Biol Sci, Lab Struct Biol Visiting Scientists, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Lin, Sheng-Xiang] WHO Collaborat Ctr Human Reprod Res, Shanghai, Peoples R China	Laval University; Laval University; Northwestern Polytechnical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, SX (corresponding author), CHUQ, CHU Laval, Lab Mol Endocrinol & Oncol, Res Ctr, Quebec City, PQ, Canada.	sheng-xiang.lin@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X	Canadian Institutes of Health Research [90489] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; Aka JA, 2009, MOL CELL ENDOCRINOL, V301, P183, DOI 10.1016/j.mce.2008.10.042; American Cancer Society, BREAST CANC FACTS FI; American Cancer Society, WHAT KEY STAT LUNG C; Castoria G, 2010, STEROIDS, V75, P524, DOI 10.1016/j.steroids.2009.10.007; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Gunnarsson C, 2001, CANCER RES, V61, P8448; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jansson A, 2006, ENDOCR-RELAT CANCER, V13, P875, DOI 10.1677/erc.1.01181; Jansson A, 2009, CLIN CANCER RES, V15, P3610, DOI 10.1158/1078-0432.CCR-08-2599; Jansson A, 2009, J STEROID BIOCHEM, V114, P64, DOI 10.1016/j.jsbmb.2008.12.012; Jin JZ, 1999, BIOCHEM BIOPH RES CO, V259, P489, DOI 10.1006/bbrc.1999.0704; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Laplante Y, 2009, MOL CELL ENDOCRINOL, V301, P146, DOI 10.1016/j.mce.2008.08.026; Lin SX, 2010, NAT REV ENDOCRINOL, V6, P485, DOI 10.1038/nrendo.2010.92; Lu ML, 2002, J BIOL CHEM, V277, P22123, DOI 10.1074/jbc.M111726200; Meier M, 2009, ANN NY ACAD SCI, V1155, P15, DOI 10.1111/j.1749-6632.2009.03702.x; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Miyoshi Y, 2001, INT J CANCER, V94, P685, DOI 10.1002/ijc.1525; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; PASQUALINI JR, 1995, J STEROID BIOCHEM, V53, P407, DOI 10.1016/0960-0760(95)00116-H; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; Sherbet DP, 2009, ENDOCRINOLOGY, V150, P4154, DOI 10.1210/en.2008-1817; Smuc T, 2009, CHEM-BIOL INTERACT, V178, P228, DOI 10.1016/j.cbi.2008.10.038; Suzuki T, 2005, ENDOCR-RELAT CANCER, V12, P701, DOI 10.1677/erc.1.00834; WU L, 1993, J BIOL CHEM, V268, P12964	31	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29835	10.1371/journal.pone.0029835	http://dx.doi.org/10.1371/journal.pone.0029835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253796	gold, Green Published, Green Submitted			2022-12-25	WOS:000315865800017
J	Branas-Garza, P; Rustichini, A				Branas-Garza, Pablo; Rustichini, Aldo			Organizing Effects of Testosterone and Economic Behavior: Not Just Risk Taking	PLOS ONE			English	Article							4TH DIGIT RATIO; MODERATED MEDIATION; GENDER-DIFFERENCES; ABILITY; PREFERENCES; AVERSION; RECOMMENDATIONS; ATTITUDES; SUCCESS; CHOICES	Recent literature emphasizes the role that testosterone, as well as markers indicating early exposure to T and its organizing effect on the brain (such as the ratio of second to fourth finger, 2D : 4D), have on performance in financial markets. These results may suggest that the main effect of T, either circulating or in fetal exposure, on economic behavior occurs through the increased willingness to take risks. However, these findings indicate that traders with a low digit ratio are not only more profitable, but more able to survive in the long run, thus the effect might consist of more than just lower risk aversion. In addition, recent literature suggests a positive correlation between abstract reasoning ability and higher willingness to take risks. To test the two hypotheses of testosterone on performance in financial activities (effect on risk attitude versus a complex effect involving risk attitude and reasoning ability), we gather data on the three variables in a sample of 188 ethnically homogeneous college students (Caucasians). We measure a 2D : 4D digit ratio, abstract reasoning ability with the Raven Progressive Matrices task, and risk attitude with choice among lotteries. Low digit ratio in men is associated with higher risk taking and higher scores in abstract reasoning ability when a combined measure of risk aversion over different tasks is used. This explains both the higher performance and higher survival rate observed in traders, as well as the observed correlation between abstract reasoning ability and risk taking. We also analyze how much of the total effect of digit ratio on risk attitude is direct, and how much is mediated. Mediation analysis shows that a substantial part of the effect of T on attitude to risk is mediated by abstract reasoning ability.	[Branas-Garza, Pablo] Univ Granada, GLOBE Dept Econ, Granada, Spain; [Rustichini, Aldo] Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA; [Rustichini, Aldo] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN USA	University of Granada; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Branas-Garza, P (corresponding author), Univ Granada, GLOBE Dept Econ, Granada, Spain.	pbg@ugr.es	Branas-Garza, Pablo/AAH-8894-2020; Brañas-Garza, Pablo/Q-1532-2018	Branas-Garza, Pablo/0000-0001-8456-6009; Brañas-Garza, Pablo/0000-0001-8456-6009	MCI [SEJ2007-62081]; Junta Andalucia [PO7-SEJ-02547]; NSF [SES-0924896]	MCI; Junta Andalucia; NSF(National Science Foundation (NSF))	The authors acknowledge financial aid from MCI (SEJ2007-62081) and Junta Andalucia (PO7-SEJ-02547) for PBG, and NSF (SES-0924896) for AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Austin EJ, 2002, PERS INDIV DIFFER, V33, P1115, DOI 10.1016/S0191-8869(02)00002-8; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Benjamin D., 2007, WHO IS BEHAV; BLUME L, 1992, J ECON THEORY, V58, P9, DOI 10.1016/0022-0531(92)90099-4; Blume L, 2006, ECONOMETRICA, V74, P929, DOI 10.1111/j.1468-0262.2006.00691.x; Bollen K.A., 1990, SOCIOL METHODOL, V20, P115, DOI [DOI 10.2307/271084, 10.2307/271084]; Branas-Garza P, 2008, ECON LETT, V99, P332, DOI 10.1016/j.econlet.2007.08.008; Bull R, 2006, HORM BEHAV, V50, P194, DOI 10.1016/j.yhbeh.2006.02.008; Burks S, 2007, P NATL ACAD SCI USA, V106, P7745; CASTHO A, 2003, LEARN INDIVID DIFFER, V13, P239; Caswell N, 2009, ARCH SEX BEHAV, V38, P143, DOI 10.1007/s10508-007-9202-3; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coates JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008036; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dohmen T, 2007, AM ECON REV, V100, P1238; Dreber A., 2007, RISK PREFERENC UNPUB; Eckel CC, 2008, J ECON BEHAV ORGAN, V68, P1, DOI 10.1016/j.jebo.2008.04.006; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Garbarino E, 2011, J RISK UNCERTAINTY, V42, P1, DOI 10.1007/s11166-010-9109-6; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Holt CA, 2005, AM ECON REV, V95, P902, DOI 10.1257/0002828054201459; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Kempel P, 2005, INTELLIGENCE, V33, P215, DOI 10.1016/j.intell.2004.11.004; Luxen MF, 2005, PERS INDIV DIFFER, V39, P959, DOI 10.1016/j.paid.2005.03.016; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Manning JT, 2011, PERS INDIV DIFFER, V51, P387, DOI 10.1016/j.paid.2010.05.040; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2004, EARLY HUM DEV, V80, P161, DOI 10.1016/j.earlhumdev.2004.06.004; Manning JT., 2002, DIGIT RATIO POINTER; Moffat SD, 1996, PSYCHONEUROENDOCRINO, V9, P405; Pearson M, 2012, EXPT EC IN PRESS; Poulin M, 2004, EVOL HUM BEHAV, V25, P174, DOI 10.1016/j.evolhumbehav.2004.03.004; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Raven J. C., 1936, THESIS U LONDON; RESNICK SM, 1986, DEV PSYCHOL, V22, P191, DOI 10.1037/0012-1649.22.2.191; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Scarbrough PS, 2005, EVOL HUM BEHAV, V26, P509, DOI 10.1016/j.evolhumbehav.2005.03.002; Schipper B. C., 2011, SEX HORMONES CHOICE; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; van Anders SM, 2005, HORM BEHAV, V47, P92, DOI 10.1016/j.yhbeh.2004.09.003	52	66	68	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29842	10.1371/journal.pone.0029842	http://dx.doi.org/10.1371/journal.pone.0029842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SP	22242144	Green Published, gold, Green Accepted			2022-12-25	WOS:000300677000062
J	Marusic, J; Podlipnik, C; Jevsevar, S; Kuzman, D; Vesnaver, G; Lah, J				Marusic, Jaka; Podlipnik, Crtomir; Jevsevar, Simona; Kuzman, Drago; Vesnaver, Gorazd; Lah, Jurij			Recognition of Human Tumor Necrosis Factor alpha (TNF-alpha) by Therapeutic Antibody Fragment ENERGETICS AND STRUCTURAL FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DOCKING; GRAPHICS PROCESSORS; FORCE-FIELD; BINDING; MECHANISMS; IDENTIFICATION; CHROMATOGRAPHY; DOMAIN; SERVER; TRIMER	Human tumor necrosis factor alpha (TNF-alpha) exists in its functional state as a homotrimeric protein and is involved in inflammation processes and immune response of a human organism. Overproduction of TNF-alpha results in the development of chronic autoimmune diseases that can be successfully treated by inhibitors such as monoclonal antibodies. However, the nature of antibody-TNF-alpha recognition remains elusive due to insufficient understanding of its molecular driving forces. Therefore, we studied the energetics of binding of a therapeutic antibody fragment (Fab) to the native and non-native forms of TNF-alpha by employing calorimetric and spectroscopic methods. Global thermodynamic analysis of data obtained from the corresponding binding and urea-induced denaturation experiments has been supported by structural modeling. We demonstrate that the observed high affinity binding of Fab to TNF-alpha is an enthalpy-driven process due mainly to specific noncovalent interactions taking place at the TNF-alpha-Fab binding interface. It is coupled to entropically unfavorable conformational changes and accompanied by entropically favorable solvation contributions. Moreover, the three-state model analysis of TNF-alpha unfolding shows that at physiological concentrations, TNF-alpha may exist not only as a biologically active trimer but also as an inactive monomer. It further suggests that even small changes of TNF-alpha concentration could have a considerable effect on the TNF-alpha activity. We believe that this study sets the energetic basis for understanding of TNF-alpha inhibition by antibodies and its unfolding linked with the concentration-dependent activity regulation.	Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Marusic, Jaka; Jevsevar, Simona; Kuzman, Drago] Lek Pharmaceut Dd, Sandoz Biopharmaceut, SI-1234 Menges, Slovenia	University of Ljubljana; Novartis; Sandoz		jurij.lah@fkkt.uni-lj.si	Podlipnik, Crtomir/R-6467-2019	Podlipnik, Crtomir/0000-0002-8429-0273	Ministry of Higher Education, Science and Technology; Agency for Research of the Republic of Slovenia [P1-0201, P1-0340]; European Social Fund (ESF)	Ministry of Higher Education, Science and Technology; Agency for Research of the Republic of Slovenia; European Social Fund (ESF)(European Social Fund (ESF))	This work was supported by the Ministry of Higher Education, Science and Technology and by the Agency for Research of the Republic of Slovenia through Grants P1-0201 and P1-0340.; Supported by the European Social Fund (ESF).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKAWA T, 1987, J BIOL CHEM, V262, P7484; Barbara JAJ, 1996, IMMUNOL CELL BIOL, V74, P434, DOI 10.1038/icb.1996.73; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; Drobnak I, 2010, J PHYS CHEM B, V114, P8713, DOI 10.1021/jp100525m; Drobnak I, 2009, J MOL BIOL, V392, P63, DOI 10.1016/j.jmb.2009.05.086; ECK MJ, 1989, J BIOL CHEM, V264, P17595; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HLODAN R, 1994, FEBS LETT, V343, P256, DOI 10.1016/0014-5793(94)80567-9; Hubbard S. J., 1993, NACCES VERSION 2 1 1; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; LEWITBENTLEY A, 1988, J MOL BIOL, V199, P389, DOI 10.1016/0022-2836(88)90323-3; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Santora LC, 2001, ANAL BIOCHEM, V299, P119, DOI 10.1006/abio.2001.5380; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Terlikowski S J, 2001, Rocz Akad Med Bialymst, V46, P5; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; VILCEK J, 1991, J BIOL CHEM, V266, P7313; Warzocha K, 1997, J CLIN ONCOL, V15, P499, DOI 10.1200/JCO.1997.15.2.499; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1	38	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8613	8620		10.1074/jbc.M111.318451	http://dx.doi.org/10.1074/jbc.M111.318451			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262846	hybrid, Green Published			2022-12-25	WOS:000301349400073
J	Akin, BL; Jones, LR				Akin, Brandy L.; Jones, Larry R.			Characterizing Phospholamban to Sarco(endo) plasmic Reticulum Ca2+-ATPase 2a (SERCA2a) Protein Binding Interactions in Human Cardiac Sarcoplasmic Reticulum Vesicles Using Chemical Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-ATPASE INHIBITION; FUNCTIONAL INTERACTIONS; HEART-FAILURE; PHYSICAL INTERACTIONS; DYNAMIC INTERACTIONS; CALCIUM-PUMP; DOMAIN; PHOSPHORYLATION; MECHANISM; SKELETAL	Chemical cross-linking was used to study protein binding interactions between native phospholamban (PLB) and SERCA2a in sarcoplasmic reticulum (SR) vesicles prepared from normal and failed human hearts. Lys(27) of PLB was cross-linked to the Ca2+ pump at the cytoplasmic extension of M4(at or near Lys(328)) with the homobifunctional cross-linker, disuccinimidyl glutarate (7.7 angstrom). Cross-linking was augmented by ATP but abolished by Ca2+ or thapsigargin, confirming in native SR vesicles that PLB binds preferentially to E2 (low Ca2+ affinity conformation of the Ca2+-ATPase) stabilized by ATP. To assess the functional effects of PLB binding on SERCA2a activity, the antiPLB antibody, 2D12, was used to disrupt the physical interactions between PLB and SERCA2a in SR vesicles. We observed a tight correlation between 2D12-induced inhibition of PLB cross-linking to SERCA2a and 2D12 stimulation of Ca2+ ATPase activity and Ca2+ transport. The results suggest that the inhibitory effect of PLB on Ca2+-ATPase activity in SR vesicles results from mutually exclusive binding of PLB and Ca2+ to the Ca2+ pump, requiring PLB dissociation for catalytic activation. Importantly, the same result was obtained with SR vesicles prepared from normal and failed human hearts; therefore, we conclude that PLB binding interactions with the Ca2+ pump are largely unchanged in failing myocardium.	[Jones, Larry R.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Jones, LR (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428.	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2011, BIOCHEM J, V439, P313, DOI 10.1042/BJ20110926; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FUJII J, 1991, J BIOL CHEM, V266, P11669; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1981, J BIOL CHEM, V256, P1809; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Linck B, 1996, CARDIOVASC RES, V31, P625; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; MORRIS GL, 1991, J BIOL CHEM, V266, P11270; MOVSESIAN MA, 1994, CIRCULATION, V90, P653, DOI 10.1161/01.CIR.90.2.653; MOVSESIAN MA, 1990, J CLIN INVEST, V85, P1698, DOI 10.1172/JCI114623; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344, DOI 10.1152/ajpheart.1991.261.4.H1344; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wang HS, 2011, PHYSIOL GENOMICS, V43, P357, DOI 10.1152/physiolgenomics.00032.2010; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y; Zhao W, 2006, CIRCULATION, V113, P995, DOI 10.1161/CIRCULATIONAHA.105.583351	39	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7582	7593		10.1074/jbc.M111.334987	http://dx.doi.org/10.1074/jbc.M111.334987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247554	Green Published, hybrid			2022-12-25	WOS:000301060200058
J	Bernardo, TJ; Dubrovsky, EB				Bernardo, Travis J.; Dubrovsky, Edward B.			The Drosophila Juvenile Hormone Receptor Candidates Methoprene-tolerant (MET) and Germ Cell-expressed (GCE) Utilize a Conserved LIXXL Motif to Bind the FTZ-F1 Nuclear Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEETLE TRIBOLIUM-CASTANEUM; BHLH-PAS FAMILY; FUSHI-TARAZU; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REGULATORS; GENE-EXPRESSION; COACTIVATOR; LIGAND; PROTEIN; DOMAIN	Juvenile hormone (JH) has been implicated in many developmental processes in holometabolous insects, but its mechanism of signaling remains controversial. We previously found that in Drosophila Schneider 2 cells, the nuclear receptor FTZ-F1 is required for activation of the E75A gene by JH. Here, we utilized insect two-hybrid assays to show that FTZ-F1 interacts with two JH receptor candidates, the bHLH-PAS paralogs MET and GCE, in a JH-dependent manner. These interactions are severely reduced when helix 12 of the FTZ-F1 activation function 2 (AF2) is removed, implicating AF2 as an interacting site. Through homology modeling, we found that MET and GCE possess a C-terminal alpha-helix featuring a conserved motif LIXXL that represents a novel nuclear receptor (NR) box. Docking simulations supported by two-hybrid experiments revealed that FTZ-F1-MET and FTZ-F1-GCE heterodimer formation involves a typical NR box-AF2 interaction but does not require the canonical charge clamp residues of FTZ-F1 and relies primarily on hydrophobic contacts, including a unique interaction with helix 4. Moreover, we identified paralog-specific features, including a secondary interaction site found only in MET. Our findings suggest that a novel NR box enables MET and GCE to interact JH-dependently with the AF2 of FTZ-F1.	[Bernardo, Travis J.; Dubrovsky, Edward B.] Fordham Univ, Dept Biol, Bronx, NY 10458 USA; [Dubrovsky, Edward B.] Fordham Univ, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA	Fordham University; Fordham University	Dubrovsky, EB (corresponding author), Fordham Univ, Dept Biol, 441 E Fordham Rd, Bronx, NY 10458 USA.	dubrovsky@fordham.edu		Bernardo, Travis/0000-0003-4432-9724	National Science Foundation [0653567]; Fordham University Graduate School of Arts and Sciences	National Science Foundation(National Science Foundation (NSF)); Fordham University Graduate School of Arts and Sciences	This work was supported by National Science Foundation Grant 0653567 (to E.B.D.) and a Fordham University Graduate School of Arts and Sciences research fellowship (to T.J.B.).	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li DS, 1999, MOL CELL BIOL, V19, P7191; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Mon H, 2009, ANAL BIOCHEM, V392, P180, DOI 10.1016/j.ab.2009.05.033; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rowlands JC, 1996, MOL PHARMACOL, V50, P538; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; Suzuki T, 2001, P NATL ACAD SCI USA, V98, P12403, DOI 10.1073/pnas.221552998; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xu PL, 2004, MOL ENDOCRINOL, V18, P1887, DOI 10.1210/me.2003-0334; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo J, 2011, J BIOL CHEM, V286, P31225, DOI 10.1074/jbc.M111.252916; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	56	35	40	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7821	7833		10.1074/jbc.M111.327254	http://dx.doi.org/10.1074/jbc.M111.327254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249180	Green Published, hybrid			2022-12-25	WOS:000301060200080
J	Wu, TT; Zhou, HB; Hong, YF; Li, J; Jiang, XQ; Huang, H				Wu, Tingting; Zhou, Haibo; Hong, Yongfeng; Li, Jing; Jiang, Xinquan; Huang, Hui			miR-30 Family Members Negatively Regulate Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; STEM-CELLS; SMALL RNAS; SMAD1; MICRORNAS; BMP; EXPRESSION; PATHWAYS	miRNAs are endogenously expressed 18- to 25-nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. Recently, it has been indicated that miRNAs are closely related to osteogenesis. Our previous data suggested that miR-30 family members might be important regulators during the biomineralization process. However, whether and how they modulate osteogenic differentiation have not been explored. In this study, we demonstrated that miR-30 family members negatively regulate BMP-2-induced osteoblast differentiation by targeting Smad1 and Runx2. Evidentially, overexpression of miR-30 family members led to a decrease of alkaline phosphatase activity, whereas knockdown of them increased the activity. Then bioinformatic analysis identified potential target sites of the miR-30 family located in the 3' untranslated regions of Smad1 and Runx2. Western blot analysis and quantitative RT-PCR assays demonstrated that miR-30 family members inhibit Smad1 gene expression on the basis of repressing its translation. Furthermore, dual-luciferase reporter assays confirmed that Smad1 is a direct target of miR-30 family members. Rescue experiments that overexpress Smad1 and Runx2 significantly eliminated the inhibitory effect of miR-30 on osteogenic differentiation and provided strong evidence that miR-30 mediates the inhibition of osteogenesis by targeting Smad1 and Runx2. Also, the inhibitory effects of the miR-30 family were validated in mouse bone marrow mesenchymal stem cells. Therefore, our study uncovered that miR-30 family members are key negative regulators of BMP-2-mediated osteogenic differentiation.	[Huang, Hui] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Prosthodont, Shanghai Key Lab Stomatol,Sch Med, Shanghai 200011, Peoples R China; [Zhou, Haibo] Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai 200025, Peoples R China; [Zhou, Haibo] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Renji Hosp, Shanghai 200025, Peoples R China; [Zhou, Haibo] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Hong, Yongfeng] Anhui Med Univ, Hosp 2, Hefei 230601, Peoples R China; [Jiang, Xinquan] Shanghai Res Inst Stomatol, Oral Bioengn Lab, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Anhui Medical University	Huang, H (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Prosthodont, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zaoju Rd, Shanghai 200011, Peoples R China.	huanghui_68@126.com	ZHOU, Haibo/M-7373-2017	Zhou, Haibo/0000-0003-2239-7793	National Nature Science Foundation of China [30670555, 81170988]; Shanghai Leading Academic Discipline Project [S30206]; Science and Technology Commission of Shanghai Municipality [11ZR1420200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Nature Science Foundation of China Grants 30670555 and 81170988, by Shanghai Leading Academic Discipline Project S30206 and by Science and Technology Commission of Shanghai Municipality Grant 11ZR1420200.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Goda S, 2008, J DENT RES, V87, P782, DOI 10.1177/154405910808700805; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Itoh T, 2010, J BIOL CHEM, V285, P27745, DOI 10.1074/jbc.M110.105080; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Wang M, 2011, OSTEOARTHR CARTILAGE, V19, P751, DOI 10.1016/j.joca.2011.03.004; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	39	137	160	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7503	7511		10.1074/jbc.M111.292722	http://dx.doi.org/10.1074/jbc.M111.292722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253433	hybrid, Green Published			2022-12-25	WOS:000301060200051
J	Al-Wadei, HAN; Al-Wadei, MH; Schuller, HM				Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Schuller, Hildegard M.			Cooperative Regulation of Non-Small Cell Lung Carcinoma by Nicotinic and Beta-Adrenergic Receptors: A Novel Target for Intervention	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; GAMMA-AMINOBUTYRIC-ACID; PROMOTES TUMOR-GROWTH; ACETYLCHOLINE-RECEPTORS; CANCER CELLS; ADENOCARCINOMA; MODULATION; NEUROTRANSMITTERS; NITROSAMINES; ACTIVATION	Lung cancer is the leading cause of cancer death; 80-85% of lung cancer cases are non-small cell lung cancer (NSCLC). Smoking is a documented risk factor for the development of this cancer. Although nicotine does not have the ability to initiate carcinogenic events, recent studies have implicated nicotine in growth stimulation of NSCLC. Using three NSCLC cell lines (NCI-H322, NCI-H441 and NCI-H1299), we identified the cooperation of nicotinic acetylcholine receptors (nAChRs) and beta-adrenergic receptors (beta-ARs) as principal regulators of these effects. Proliferation was measured by thymidine incorporation and MTT assays, and Western blots were used to monitor the upregulation of the nAChRs and activation of signaling molecules. Noradrenaline and GABA were measured by immunoassays. Nicotine-treated NSCLC cells showed significant induction of the alpha 7nAChR and alpha 4nAChR, along with significant inductions of p-CREB and p-ERK1/2 accompanied by increases in the stress neurotransmitter noradrenaline, which in turn led to the observed increase in DNA synthesis and cell proliferation. Effects on cell proliferation and signaling proteins were reversed by the a7nAChR antagonist alpha-BTX or the beta-blocker propranolol. Nicotine treatment also down-regulated expression of the GABA synthesizing enzyme GAD 65 and the level of endogenous GABA, while treatment of NSCLC cells with GABA inhibited cell proliferation. Interestingly, GABA acts by reducing beta-adrenergic activated cAMP signaling. Our findings suggest that nicotine-induced activation of this autocrine noradrenaline-initiated signaling cascade and concomitant deficiency in inhibitory GABA, similar to modulation of these neurotransmitters in the nicotine-addicted brain, may contribute to the development of NSCLC in smokers. Our data suggest that exposure to nicotine either by tobacco smoke or nicotine supplements facilitates growth and progression of NSCLC and that pharmacological intervention by beta blocker may lower the risk for NSCLC development among smokers and could be used to enhance the clinical outcome of standard cancer therapy.	[Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Schuller, Hildegard M.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Expt Oncol Lab, Knoxville, TN 37996 USA; [Al-Wadei, Hussein A. N.] Sanaa Univ, Dept Prevent Med, Sanaa, Yemen	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Al-Wadei, HAN (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Expt Oncol Lab, Knoxville, TN 37996 USA.	hmsch@utk.edu			National Lung Cancer Partnership; LUNGevity Foundation; University of Tennessee Center of Excellence in Livestock Diseases and Human Health	National Lung Cancer Partnership; LUNGevity Foundation; University of Tennessee Center of Excellence in Livestock Diseases and Human Health	This project was financially supported by a grant from the National Lung Cancer Partnership and LUNGevity Foundation and by the University of Tennessee Center of Excellence in Livestock Diseases and Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HA, 2011, CUUR CANC D IN PRESS; Al-Wadei HAN, 2006, INT J CANCER, V118, P1370, DOI 10.1002/ijc.21537; Al-Wadei HAN, 2010, LUNG CANCER, V69, P33, DOI 10.1016/j.lungcan.2009.09.011; Al-Wadei HAN, 2009, J PATHOL, V218, P437, DOI 10.1002/path.2542; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Barik J, 2006, MOL PHARMACOL, V69, P618, DOI 10.1124/mol.105.018184; Bunn PA, 2008, ONCOLOGIST, V13, P1, DOI 10.1634/theoncologist.13-S1-1; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Drell TL, 2003, BREAST CANCER RES TR, V80, P63, DOI 10.1023/A:1024491219366; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; GAZDAR AF, 1988, CANCER RES, V48, P4078; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Harkness PC, 2002, J NEUROSCI, V22, P10172; Hoffmann BB, 1990, PHARMACOL BASIS THER, P187; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Laag E, 2006, INT J CANCER, V119, P1547, DOI 10.1002/ijc.21987; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lawson GM, 1998, J CLIN PHARMACOL, V38, P502, DOI 10.1002/j.1552-4604.1998.tb05787.x; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; Majidi M, 2007, CANCER RES, V67, P6863, DOI 10.1158/0008-5472.CAN-07-0483; MANECKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294, DOI 10.1073/pnas.87.9.3294; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Masur K, 2001, CANCER RES, V61, P2866; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Mozayan M, 2007, AM J PHYSIOL-HEART C, V293, pH1737, DOI 10.1152/ajpheart.00269.2007; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; PARK PG, 1995, CANCER RES, V55, P3504; RUFFOLO RR, 1995, J MED CHEM, V38, P3681, DOI 10.1021/jm00019a001; Schuller HM, 2008, CARCINOGENESIS, V29, P1979, DOI 10.1093/carcin/bgn041; Schuller HM, 2008, ANTI-CANCER DRUG, V19, P655, DOI 10.1097/CAD.0b013e3283025b58; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1999, CANCER RES, V59, P4510; Schuller HM, 2000, J CANCER RES CLIN, V126, P624, DOI 10.1007/PL00008474; SCHULLER HM, 1989, BIOCHEM PHARMACOL, V38, P3439, DOI 10.1016/0006-2952(89)90112-3; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; West KA, 2004, CANCER RES, V64, P446, DOI 10.1158/0008-5472.CAN-03-3241; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270	48	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29915	10.1371/journal.pone.0029915	http://dx.doi.org/10.1371/journal.pone.0029915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253823	Green Published, gold			2022-12-25	WOS:000301357100029
J	Friberg, E; Jansson, C; Mittendorfer-Rutz, E; Rosenhall, U; Alexanderson, K				Friberg, Emilie; Jansson, Catarina; Mittendorfer-Rutz, Ellenor; Rosenhall, Ulf; Alexanderson, Kristina			Sickness Absence Due to Otoaudiological Diagnoses and Risk of Disability Pension: A Nationwide Swedish Prospective Cohort Study	PLOS ONE			English	Article							HEARING-LOSS; REGISTER; HEALTH; PREVALENCE; LEAVE	Background: Hearing difficulties are a large public health problem. Knowledge is scarce regarding risk of disability pension among people who have been sickness absent due to these difficulties. Methods: A cohort including all 4,687,756 individuals living in Sweden in 2005, aged 20-64, and not on disability or old-age pension, was followed through 2009. Incidence rate ratios (RR) of disability pension with 95% confidence intervals (CI) were estimated using Cox proportional hazard models. Results: In multivariable models, individuals who had a sick-leave spell due to otoaudiological diagnoses in 2005 had a 1.52-fold (95% CI: 1.43-1.62) increased risk of being granted a disability pension compared to individuals on sick leave due to other diagnoses. Hearing and tinnitus sick-leave diagnoses were associated with risk of disability pension: RR 3.38, 95% CI: 3.04-3.75, and 3.30, 95% CI: 2.95-3.68, respectively. No association was observed between sick leave due to vertigo diagnoses and disability pension whereas otological diagnoses and no sick leave were inversely associated with risk of disability pension compared to non-otoaudiological sick-leave diagnoses. Sick leave due to otoaudiological diagnoses was positively associated with risk of disability pension due to otoaudiological diagnoses and sick leave due to a tinnitus diagnosis was also associated with risk of disability pension due to mental diagnoses. The risk of disability pension among individuals with hearing or tinnitus sick-leave diagnoses was highest in the age group 35-44. Moreover, men had a slightly higher risk. Conclusion: This large cohort study suggests an increased risk of disability pension among those with sickness absence due to otoaudiological diagnoses, particularly hearing and tinnitus diagnoses, compared to those with sickness absence due to non-otoaudiological diagnoses.	[Friberg, Emilie; Jansson, Catarina; Mittendorfer-Rutz, Ellenor; Alexanderson, Kristina] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Inst, Dept Clin Neurosci, Ctr Hearing & Commun Res, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Univ Hosp, Dept Audiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Friberg, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	Emilie.Friberg@ki.se	Alexanderson, Kristina A/J-3429-2013	Friberg, Emilie/0000-0001-7874-4243; Alexanderson, Kristina/0000-0002-9313-3413	Swedish Council for Working Life and Social Research Center on Hearing Disabilities in Working Life and Society; Swedish Council for Working Life and Social Research; Swedish Research Council	Swedish Council for Working Life and Social Research Center on Hearing Disabilities in Working Life and Society; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was financed by the Swedish Council for Working Life and Social Research Center on Hearing Disabilities in Working Life and Society, by the Swedish Council for Working Life and Social Research, and by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Alexanderson K, 1998, MEASURING HLTH INDIC, P121; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V63, P1, DOI DOI 10.1080/14034950410021808; Andersson G, 2000, Int Tinnitus J, V6, P127; Barlow JH, 2007, INT J AUDIOL, V46, P442, DOI 10.1080/14992020701355108; Bjorne A, 2003, CRANIO, V21, P136, DOI 10.1080/08869634.2003.11746242; Danermark B., 2005, IMPACT GENETIC HEARI, P106; Gustafsson K, 2011, SCAND J PUBLIC  0307; Hallam R, 2006, INT J AUDIOL, V45, P715, DOI 10.1080/14992020600957335; Hensing G, 2004, SCAND J PUBLIC HEALT, V32, P44, DOI 10.1080/14034950410021844; Ide C, 2007, OCCUP MED-OXFORD, V57, P203, DOI 10.1093/occmed/kql180; Kochkin S., 2005, HEAR REV, V12, P16; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; RUDIN R, 1987, ACTA OTO-LARYNGOL, V104, P454, DOI 10.3109/00016488709128274; Sewell RK, 2004, LARYNGOSCOPE, V114, P2147, DOI 10.1097/01.mlg.0000149448.60511.22; Skoien AK, 2008, BRIT J GEN PRACT, V58, P619, DOI 10.3399/bjgp08X330744; Sorri M, 2001, SCAND AUDIOL, V30, P5; Svedberg P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-763; Wallhagen MI, 1997, AM J PUBLIC HEALTH, V87, P440, DOI 10.2105/AJPH.87.3.440; *WHO, 1992, ICD10 WHO	23	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29966	10.1371/journal.pone.0029966	http://dx.doi.org/10.1371/journal.pone.0029966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906OY	22253839	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100032
J	Gonzalez, JM; Portillo, MC; Belda-Ferre, P; Mira, A				Gonzalez, Juan M.; Portillo, Maria C.; Belda-Ferre, Pedro; Mira, Alex			Amplification by PCR Artificially Reduces the Proportion of the Rare Biosphere in Microbial Communities	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SPECIES RICHNESS; SARGASSO SEA; CYCLE NUMBER; COPY NUMBER; DIVERSITY; GENES; SEQUENCES; POLYMERASE; SOIL	The microbial world has been shown to hold an unimaginable diversity. The use of rRNA genes and PCR amplification to assess microbial community structure and diversity present biases that need to be analyzed in order to understand the risks involved in those estimates. Herein, we show that PCR amplification of specific sequence targets within a community depends on the fractions that those sequences represent to the total DNA template. Using quantitative, real-time, multiplex PCR and specific Taqman probes, the amplification of 16S rRNA genes from four bacterial species within a laboratory community were monitored. Results indicate that the relative amplification efficiency for each bacterial species is a nonlinear function of the fraction that each of those taxa represent within a community or multispecies DNA template. Consequently, the low-proportion taxa in a community are under-represented during PCR-based surveys and a large number of sequences might need to be processed to detect some of the bacterial taxa within the 'rare biosphere'. The structure of microbial communities from PCR-based surveys is clearly biased against low abundant taxa which are required to decipher the complete extent of microbial diversity in nature.	[Gonzalez, Juan M.; Portillo, Maria C.] IRNAS CSIC, Spanish Council Res, Inst Nat Resources & Agrobiol, Seville, Spain; [Belda-Ferre, Pedro; Mira, Alex] Ctr Adv Res Publ Hlth CSISP, Genom & Hlth Dept, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Gonzalez, JM (corresponding author), IRNAS CSIC, Spanish Council Res, Inst Nat Resources & Agrobiol, Seville, Spain.	jmgrau@irnase.csic.es	Portillo, Maria Carmen/AAB-6220-2019; Belda-Ferre, Pedro/C-9825-2010; Gonzalez, Juan/L-5561-2015; Portillo, Maria Carmen/N-3257-2014; Belda-Ferre, Pedro/E-7699-2013; Mira, Alex/A-7244-2010	Portillo, Maria Carmen/0000-0002-4576-0244; Belda-Ferre, Pedro/0000-0001-6532-1161; Gonzalez, Juan/0000-0003-4746-6775; Portillo, Maria Carmen/0000-0002-4576-0244; Mira, Alex/0000-0002-9127-3877	Spanish Ministry of Science and Innovation [CGL2009-12328/BOS, CSD2009-00006]; Feder funds	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Feder funds(European Commission)	This work was supported through projects from the Spanish Ministry of Science and Innovation (CGL2009-12328/BOS; Consolider CSD2009-00006). The participation of Feder funds in these projects is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Gonzalez JM, 1995, HYDROBIOLOGIA, V316, P109, DOI 10.1007/BF00016892; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Hughes JB, 2005, METHOD ENZYMOL, V397, P292, DOI 10.1016/S0076-6879(05)97017-1; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schriewer A, 2011, J MICROBIOL METH, V85, P16, DOI 10.1016/j.mimet.2010.12.027; Shannon C., 1964, MATH THEORY COMMUNIC; SHELDON AL, 1969, ECOLOGY, V50, P466, DOI 10.2307/1933900; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sokal RR, 1995, BIOMETRY; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintzingerode Friedrich V., 1997, FEMS Microbiology Reviews, V21, P213; WOESE CR, 1994, MICROBIOL REV, V58, P1; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	49	81	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29973	10.1371/journal.pone.0029973	http://dx.doi.org/10.1371/journal.pone.0029973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253843	gold, Green Published			2022-12-25	WOS:000301355700070
J	Reddy, PA; Gour, DS; Bhavanishankar, M; Jaggi, K; Hussain, SM; Harika, K; Shivaji, S				Reddy, Patlolla Anuradha; Gour, Digpal Singh; Bhavanishankar, Maradani; Jaggi, Kanika; Hussain, Shaik Mohammed; Harika, Katakam; Shivaji, Sisinthy			Genetic Evidence of Tiger Population Structure and Migration within an Isolated and Fragmented Landscape in Northwest India	PLOS ONE			English	Article							PROTECTED AREAS; ASSIGNMENT METHODS; DYNAMICS; WILD; CONNECTIVITY; INDIVIDUALS; SCENARIOS; VIABILITY; INFERENCE; SAMPLES	Background: Majority of the tiger habitat in Indian subcontinent lies within high human density landscapes and is highly sensitive to surrounding pressures. These forests are unable to sustain healthy tiger populations within a tiger-hostile matrix, despite considerable conservation efforts. Ranthambore Tiger Reserve (RTR) in Northwest India is one such isolated forest which is rapidly losing its links with other tiger territories in the Central Indian landscape. Non-invasive genetic sampling for individual identification is a potent technique to understand the relationships between threatened tiger populations in degraded habitats. This study is an attempt to establish tiger movement across a fragmented landscape between RTR and its neighboring forests, Kuno-Palpur Wildlife Sanctuary (KPWLS) and Madhav National Park (MNP) based on non-invasively obtained genetic data. Methods: Data from twelve microsatellite loci was used to define population structure and also to identify first generation migrants and admixed individuals in the above forests. Results: Population structure was consistent with the Central Indian landscape and we could determine significant gene flow between RTR and MNP. We could identify individuals of admixed ancestry in both these forests, as well as first generation migrants from RTR to KPWLS and MNP. Conclusions: Our results indicate reproductive mixing between animals of RTR and MNP in the recent past and migration of animals even today, despite fragmentation and poaching risk, from RTR towards MNP. Substantial conservation efforts should be made to maintain connectivity between these two subpopulations and also higher protection status should be conferred on Madhav National Park.	[Reddy, Patlolla Anuradha; Gour, Digpal Singh; Bhavanishankar, Maradani; Jaggi, Kanika; Hussain, Shaik Mohammed; Harika, Katakam; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Reddy, PA (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	shivas@ccmb.res.in	Reddy, Anuradha/U-5864-2019		Department of Biotechnology, Government of India; Forest Departments of Bandhavgarh Tiger Reserve, Pench Tiger Reserve, Kuno-Palpur Wildlife Sanctuary and Ranthambore Tiger Reserve	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Forest Departments of Bandhavgarh Tiger Reserve, Pench Tiger Reserve, Kuno-Palpur Wildlife Sanctuary and Ranthambore Tiger Reserve	This study was funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge Mr. Alok Kumar, former Director of Madhav National Park, for taking a keen interest and initiating this work in Madhav. We sincerely thank Dr. Lalji Singh for his involvement and encouragement in the initial stages of the project. We acknowledge support extended by Forest Departments of Bandhavgarh Tiger Reserve, Pench Tiger Reserve, Kuno-Palpur Wildlife Sanctuary and Ranthambore Tiger Reserve.	Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 1978, MULTIVARIATE ANAL VE; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Bagchi S, 2003, TROP ECOL, V44, P177; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Bhagavatula J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-48; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Cornuet JM, 1999, GENETICS, V153, P1989; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gude PH, 2007, ECOL APPL, V17, P1004, DOI 10.1890/05-1108; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Jackson P., 1996, BIOL CONSERVATION; Jhala Y, 2008, STATUS TIGERS COPRED; Johnsingh AJT, 2007, ORYX, V41, P93, DOI 10.1017/S0030605307001512; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; MacKinnon J., 1986, REV PROTECTED AREAS; MacKinnon K, 1999, RIDING TIGER; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mittermeier R. A., 2005, MEGADIVERSITY EARTHS; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PAMILO P, 1985, HEREDITAS, V103, P195, DOI 10.1111/j.1601-5223.1985.tb00501.x; Panwar H.S., 1987, P110; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reed JZ, 1997, MOL ECOL, V6, P225, DOI 10.1046/j.1365-294X.1997.00175.x; Roeder AD, 2004, MOL ECOL NOTES, V4, P761, DOI 10.1111/j.1471-8286.2004.00737.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Segelbacher G, 2002, MOL ECOL, V11, P1669, DOI 10.1046/j.1365-294X.2002.01565.x; Sherwin WB, 2000, CONSERV BIOL SER, V4, P9; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Sunquist M.E, 1981, SMITHSONIAN CONTRIBU; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vina A, 2007, ECOL APPL, V17, P1019, DOI 10.1890/05-1288; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wikramanayake Eric D., 1999, P255; Wright S., 1978, EVOLUTION GENETICS P, V4	60	47	49	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29827	10.1371/journal.pone.0029827	http://dx.doi.org/10.1371/journal.pone.0029827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253791	Green Published, gold, Green Submitted			2022-12-25	WOS:000301355700056
J	Shah, M; Huang, DX; Blick, T; Connor, A; Reiter, LA; Hardink, JR; Lynch, CC; Waltham, M; Thompson, EW				Shah, Manisha; Huang, Dexing; Blick, Tony; Connor, Andrea; Reiter, Lawrence A.; Hardink, Joel R.; Lynch, Conor C.; Waltham, Mark; Thompson, Erik W.			An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; PYRIMIDINETRIONE-BASED INHIBITORS; COLLAGENASE-3 MMP-13; NUDE-MICE; PARATHYROID-HORMONE; 13-DEFICIENT MICE; BONE METASTASIS; EXPRESSION; OSTEOCLASTS; CELLS	We investigated the effects of the matrix metalloproteinase 13 (MMP13)-selective inhibitor, 5-(4-{4-[4-(4-fluorophenyl)-1,3-oxazol-2-yl]phenoxy}phenoxy)-5-(2-methoxyethyl) pyrimidine-2,4,6(1H,3H,5H)-trione (Cmpd-1), on the primary tumor growth and breast cancer-associated bone remodeling using xenograft and syngeneic mouse models. We used human breast cancer MDA-MB-231 cells inoculated into the mammary fat pad and left ventricle of BALB/c Nu/Nu mice, respectively, and spontaneously metastasizing 4T1.2-Luc mouse mammary cells inoculated into mammary fat pad of BALB/c mice. In a prevention setting, treatment with Cmpd-1 markedly delayed the growth of primary tumors in both models, and reduced the onset and severity of osteolytic lesions in the MDA-MB-231 intracardiac model. Intervention treatment with Cmpd-1 on established MDA-MB-231 primary tumors also significantly inhibited subsequent growth. In contrast, no effects of Cmpd-1 were observed on soft organ metastatic burden following intracardiac or mammary fat pad inoculations of MDA-MB-231 and 4T1.2-Luc cells respectively. MMP13 immunostaining of clinical primary breast tumors and experimental mice tumors revealed intra-tumoral and stromal expression in most tumors, and vasculature expression in all. MMP13 was also detected in osteoblasts in clinical samples of breast-to-bone metastases. The data suggest that MMP13-selective inhibitors, which lack musculoskeletal side effects, may have therapeutic potential both in primary breast cancer and cancer-induced bone osteolysis.	[Shah, Manisha; Huang, Dexing; Blick, Tony; Connor, Andrea; Waltham, Mark; Thompson, Erik W.] St Vincents Hosp, St Vincents Inst Med Res, Melbourne, Vic, Australia; [Connor, Andrea; Thompson, Erik W.] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic, Australia; [Reiter, Lawrence A.; Hardink, Joel R.] Pfizer Global Res & Dev, Groton Labs, Groton, CT USA; [Lynch, Conor C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Pfizer; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Shah, M (corresponding author), St Vincents Hosp, St Vincents Inst Med Res, Melbourne, Vic, Australia.	manisha@medstv.unimelb.edu.au	Thompson, Erik/GPK-2067-2022; Thompson, Erik W/A-1425-2009	Thompson, Erik/0000-0002-9723-4924; Thompson, Erik W/0000-0002-9723-4924	Victorian Breast Cancer Research Consortium; National Health and Medical Research Consortium (Australia) [502622]; Victorian Government; Susan G. Komen Foundation for the Cure, USA [KG080837]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Victorian Breast Cancer Research Consortium; National Health and Medical Research Consortium (Australia); Victorian Government; Susan G. Komen Foundation for the Cure, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the Victorian Breast Cancer Research Consortium, the National Health and Medical Research Consortium (Australia; grant #502622) and the Victorian Government's Operational Infrastructure Support Program. Dr. M. Shah was supported by postdoctoral Fellowship (KG080837) from the Susan G. Komen Foundation for the Cure, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Blagg JA, 2005, BIOORG MED CHEM LETT, V15, P1807, DOI 10.1016/j.bmcl.2005.02.038; Cowan RW, 2009, BONE, V44, P865, DOI 10.1016/j.bone.2009.01.393; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; HILL PA, 1994, J CELL SCI, V107, P3055; Hsu CP, 2006, LUNG CANCER, V52, P349, DOI 10.1016/j.lungcan.2006.01.011; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kominsky SL, 2008, CLIN EXP METASTAS, V25, P865, DOI 10.1007/s10585-008-9202-2; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Lafleur MA, 2005, INT J CANCER, V114, P544, DOI 10.1002/ijc.20763; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Leeman MF, 2002, J CLIN PATHOL, V55, P758, DOI 10.1136/jcp.55.10.758; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Lynch CC, 2011, BONE, V48, P44, DOI 10.1016/j.bone.2010.06.007; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Migliorati CA, 2006, LANCET ONCOL, V7, P508, DOI 10.1016/S1470-2045(06)70726-4; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Nielsen BS, 2001, CANCER RES, V61, P7091; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Ory B, 2005, CANCER-AM CANCER SOC, V104, P2522, DOI 10.1002/cncr.21530; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Reiter LA, 2006, BIOORG MED CHEM LETT, V16, P5822, DOI 10.1016/j.bmcl.2006.08.066; SASAKI A, 1995, CANCER RES, V55, P3551; Sato T, 1997, J CELL SCI, V110, P589; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Shah R, 2004, AM J PHYSIOL-ENDOC M, V287, pE289, DOI 10.1152/ajpendo.00517.2003; Sharp JA, 2004, CLIN EXP METASTAS, V21, P19, DOI 10.1023/B:CLIN.0000017167.17065.61; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tardif Ginette, 2004, Mod Rheumatol, V14, P197; Tester AM, 2002, CLIN EXP METASTAS, V19, P377, DOI 10.1023/A:1016381416463; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; TEZUKA K, 1994, J BIOL CHEM, V269, P1106; Thiolloy S, 2009, CANCER RES, V69, P6747, DOI 10.1158/0008-5472.CAN-08-3949; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Wernicke D, 2006, AUTOIMMUNITY, V39, P307, DOI 10.1080/08916930600807709; Wilson TJ, 2008, BBA-REV CANCER, V1785, P85, DOI 10.1016/j.bbcan.2007.11.001; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	56	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29615	10.1371/journal.pone.0029615	http://dx.doi.org/10.1371/journal.pone.0029615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253746	Green Published, gold			2022-12-25	WOS:000301355700032
J	Hadid, Y; Nemeth, A; Snir, S; Pavlicek, T; Csorba, G; Kazmer, M; Major, A; Mezhzherin, S; Rusin, M; Coskun, Y; Nevo, E				Hadid, Yarin; Nemeth, Attila; Snir, Sagi; Pavlicek, Tomas; Csorba, Gabor; Kazmer, Miklos; Major, Agnes; Mezhzherin, Sergey; Rusin, Mikhail; Coskun, Yuksel; Nevo, Eviatar			Is Evolution of Blind Mole Rats Determined by Climate Oscillations?	PLOS ONE			English	Article							SPALAX-EHRENBERGI; LATE MIOCENE; TURKEY; RODENTIA; HYBRIDIZATION; SPECIATION; DIVERSITY; KARYOTYPE; SELECTION; ANATOLIA	The concept of climate variability facilitating adaptive radiation supported by the "Court Jester'' hypothesis is disputed by the "Red Queen'' one, but the prevalence of one or the other might be scale-dependent. We report on a detailed, comprehensive phylo-geographic study on the similar to 4 kb mtDNA sequence in underground blind mole rats of the family Spalacidae (or subfamily Spalacinae) from the East Mediterranean steppes. Our study aimed at testing the presence of periodicities in branching patterns on a constructed phylogenetic tree and at searching for congruence between branching events, tectonic history and paleoclimates. In contrast to the strong support for the majority of the branching events on the tree, the absence of support in a few instances indicates that network-like evolution could exist in spalacids. In our tree, robust support was given, in concordance with paleontological data, for the separation of spalacids from muroid rodents during the first half of the Miocene when open, grass-dominated habitats were established. Marine barriers formed between Anatolia and the Balkans could have facilitated the separation of the lineage "Spalax'' from the lineage "Nannospalax'' and of the clade "leucodon'' from the clade "xanthodon''. The separation of the clade "ehrenbergi'' occurred during the late stages of the tectonically induced uplift of the Anatolian high plateaus and mountains, whereas the separation of the clade "vasvarii" took place when the rapidly uplifting Taurus mountain range prevented the Mediterranean rainfalls from reaching the Central Anatolian Plateau. The separation of Spalax antiquus and S. graecus occurred when the southeastern Carpathians were uplifted. Despite the role played by tectonic events, branching events that show periodicity corresponding to 400-kyr and 100-kyr eccentricity bands illuminate the important role of orbital fluctuations on adaptive radiation in spalacids. At the given scale, our results supports the "Court Jester'' hypothesis over the "Red Queen'' one.	[Hadid, Yarin; Snir, Sagi; Pavlicek, Tomas; Nevo, Eviatar] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Hadid, Yarin; Snir, Sagi; Pavlicek, Tomas; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Nemeth, Attila; Kazmer, Miklos] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Budapest, Hungary; [Nemeth, Attila; Kazmer, Miklos] Eotvos Lorand Univ, Dept Paleontol, Budapest, Hungary; [Csorba, Gabor; Major, Agnes] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Mezhzherin, Sergey; Rusin, Mikhail] Schmalhausen Inst Zool, Kiev, Ukraine; [Coskun, Yuksel] Dicle Univ, Sci & Art Fac, Dept Biol, Diyarbakir, Turkey	University of Haifa; University of Haifa; Eotvos Lorand University; Eotvos Lorand University; National Academy of Sciences Ukraine; Schmalhausen Institute of Zoology of NASU; Dicle University	Hadid, Y (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	pavlicek@research.haifa.ac.il	S, Mezhzherin/L-1583-2019; Kazmer, Miklos/D-1517-2013; Pavlicek, Tomas/C-4768-2008; Rusin, Mikhail/O-5809-2016	S, Mezhzherin/0000-0002-8863-0562; Kazmer, Miklos/0000-0003-1092-1316; Rusin, Mikhail/0000-0003-4349-4795	Ministry of Science and Technology (Israel); Council for Higher Education (Israel); European Union; European Social Fund; Hungarian National Science Fund (OTKA) [K67583]; Ancell-Teicher Research Foundation of Genetics and Molecular Evolution;  [TAMOP 4.2.1./B-09/1/KMR-2010-0003]	Ministry of Science and Technology (Israel)(Ministry of Science, Technology and Space (MOST), Israel); Council for Higher Education (Israel); European Union(European Commission); European Social Fund(European Social Fund (ESF)); Hungarian National Science Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ancell-Teicher Research Foundation of Genetics and Molecular Evolution; 	We thank the Ministry of Science and Technology and Council for Higher Education (both Israel) for providing scholarships to YH. The European Union and the European Social Fund have provided financial support to AN and MK during the project under the grant agreement no. TAMOP 4.2.1./B-09/1/KMR-2010-0003. MK acknowledges the Hungarian National Science Fund (OTKA) grant K67583. We thank the Ancell-Teicher Research Foundation of Genetics and Molecular Evolution for its continuous support to EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2002, GEOL CARPATH, V57, P201; Akgun F, 2007, PALAEOGEOGR PALAEOCL, V253, P56, DOI 10.1016/j.palaeo.2007.03.034; Akkiraz MS, 2011, PALAEOGEOGR PALAEOCL, V304, P276, DOI 10.1016/j.palaeo.2010.05.002; Aksu AE, 1999, MAR GEOL, V153, P275, DOI 10.1016/S0025-3227(98)00078-4; Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Barnosky Anthony D., 2005, Journal of Mammalian Evolution, V12, P247, DOI 10.1007/s10914-005-4858-8; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; CATZEFLIS FM, 1989, J MOL EVOL, V29, P223, DOI 10.1007/BF02100206; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chalot-Prat F, 2000, TECTONOPHYSICS, V327, P83, DOI 10.1016/S0040-1951(00)00155-4; Cook JA, 2000, LIFE UNDERGROUND, P332; Cosentino D, GEOLOGICAL IN PRESS, DOI [10.1130/B30466.1, DOI 10.1130/B30466.1]; Coskun Y, 2006, MAMM BIOL, V71, P244, DOI 10.1016/j.mambio.2006.02.005; de Leeuw A, 2011, PALAEOGEOGR PALAEOCL, V310, P400, DOI 10.1016/j.palaeo.2011.08.001; DEBRUIJN H, 1970, PROC K NED AKAD B-PH, V73, P535; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HENDRIKS W, 1987, P NATL ACAD SCI USA, V84, P5320, DOI 10.1073/pnas.84.15.5320; Hugueney Marguerite, 1993, Journal of Mammalian Evolution, V1, P215, DOI 10.1007/BF01024708; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; KLEINSCHMIDT T, 1985, BIOL CHEM H-S, V366, P679, DOI 10.1515/bchm3.1985.366.2.679; Kroon D., 1998, OCEAN DRILLING PROGR, V160, P181; Krystufek B, 2009, HEREDITY, V103, P129, DOI 10.1038/hdy.2009.41; Krystufek B, 2012, BIOL J LINN SOC, V105, P446, DOI 10.1111/j.1095-8312.2011.01795.x; Mulch A, 2010, TECTONIC CROSSROADS, P11; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nesin Valentin A., 2001, Acta Zoologica Cracoviensia, V44, P107; NEVO E, 1995, BIOL J LINN SOC, V54, P203; Nevo E, 2000, BIOL J LINN SOC, V69, P263; NEVO E, 1976, EVOLUTION, V30, P831, DOI 10.1111/j.1558-5646.1976.tb00964.x; Nevo E., 2000, MOSAIC EVOLUTION SUB; Nevo Eviatar, 1993, Quaternary International, V19, P13, DOI 10.1016/1040-6182(93)90017-A; Perissoratis C, 2003, MAR GEOL, V196, P145, DOI 10.1016/S0025-3227(03)00047-1; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Popov SV, 2006, PALAEOGEOGR PALAEOCL, V238, P91, DOI 10.1016/j.palaeo.2006.03.020; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; PREPARATA FP, 1977, COMMUN ACM, V20, P87, DOI 10.1145/359423.359430; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Saintot A, 2006, GEOL SOC MEM, V32, P277, DOI 10.1144/GSL.MEM.2006.032.01.16; SAVIC IR, 1990, PROG CLIN BIOL RES, V335, P129; Schildgen TF, EARTH PLANE IN PRESS; SENGOR AMC, 1979, TECTONOPHYSICS, V55, P361, DOI 10.1016/0040-1951(79)90184-7; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Storch G, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P135; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; Sun S, 2011, MOL BIOL EVOL, V28, P2549, DOI 10.1093/molbev/msr076; Suzuki H, 1996, MOL BIOL EVOL, V13, P85, DOI 10.1093/oxfordjournals.molbev.a025574; Titov V V, 2006, Dokl Biol Sci, V411, P508, DOI 10.1134/S001249660606024X; Topachevskii VA, 1969, FAUNA USSR MAMMALS M; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Vincek V, 1987, MOL BIOL EVOL, V4, P287; Wade BS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001042; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913; YANG ZB, 1994, J MOL EVOL, V39, P105	59	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e30043	10.1371/journal.pone.0030043	http://dx.doi.org/10.1371/journal.pone.0030043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253871	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000301352400011
J	Barrett, AB; Murphy, M; Bruno, MA; Noirhomme, Q; Boly, M; Laureys, S; Seth, AK				Barrett, Adam B.; Murphy, Michael; Bruno, Marie-Aurelie; Noirhomme, Quentin; Boly, Melanie; Laureys, Steven; Seth, Anil K.			Granger Causality Analysis of Steady-State Electroencephalographic Signals during Propofol-Induced Anaesthesia	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; INTEGRATED INFORMATION; LINEAR-DEPENDENCE; CONSCIOUSNESS; SLEEP; BREAKDOWN; HUMANS; SYNCHRONY; NETWORKS; FEEDBACK	Changes in conscious level have been associated with changes in dynamical integration and segregation among distributed brain regions. Recent theoretical developments emphasize changes in directed functional (i.e., causal) connectivity as reflected in quantities such as 'integrated information' and 'causal density'. Here we develop and illustrate a rigorous methodology for assessing causal connectivity from electroencephalographic (EEG) signals using Granger causality (GC). Our method addresses the challenges of non-stationarity and bias by dividing data into short segments and applying permutation analysis. We apply the method to EEG data obtained from subjects undergoing propofol-induced anaesthesia, with signals source-localized to the anterior and posterior cingulate cortices. We found significant increases in bidirectional GC in most subjects during loss-of-consciousness, especially in the beta and gamma frequency ranges. Corroborating a previous analysis we also found increases in synchrony in these ranges; importantly, the Granger causality analysis showed higher inter-subject consistency than the synchrony analysis. Finally, we validate our method using simulated data generated from a model for which GC values can be analytically derived. In summary, our findings advance the methodology of Granger causality analysis of EEG data and carry implications for integrated information and causal density theories of consciousness.	[Barrett, Adam B.; Seth, Anil K.] Univ Sussex, Dept Informat, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Murphy, Michael; Boly, Melanie] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Bruno, Marie-Aurelie; Noirhomme, Quentin; Boly, Melanie; Laureys, Steven] Univ Liege, Dept Neurol, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium	University of Sussex; University of Wisconsin System; University of Wisconsin Madison; University of Liege	Barrett, AB (corresponding author), Univ Sussex, Dept Informat, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England.	adam.barrett@sussex.ac.uk	Seth, Anil/AAE-8499-2019; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011	Seth, Anil/0000-0002-1421-6051; Laureys, Steven/0000-0002-3096-3807; Boly, Melanie/0000-0001-9584-0907; Murphy, Michael/0000-0002-8014-763X; Noirhomme, Quentin/0000-0001-8247-4493	Engineering and Physical Sciences Research Council Leadership Fellowship [EP/G007543/1]; Dr. Mortimer and Theresa Sackler Foundation; European Commission (DECODER); Fondazione Europea di Ricerca Biomedica; McDonnell Foundation; Mind Science Foundation; Public Utility Foundation "Universite Europeenne du Travail"; University of Liege; EPSRC [EP/G007543/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007543/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council Leadership Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Dr. Mortimer and Theresa Sackler Foundation; European Commission (DECODER); Fondazione Europea di Ricerca Biomedica; McDonnell Foundation; Mind Science Foundation; Public Utility Foundation "Universite Europeenne du Travail"; University of Liege(University of Liege); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AKS and ABB are supported by Engineering and Physical Sciences Research Council Leadership Fellowship EP/G007543/1. Support is also gratefully acknowledged from the Dr. Mortimer and Theresa Sackler Foundation. SL is a Belgian Funds for Scientific Research (FRS) Senior Research Associate and MAB, QN and MB are FRS Postdoctoral Researchers. This work was also supported by the European Commission (DECODER), Fondazione Europea di Ricerca Biomedica, McDonnell Foundation, Mind Science Foundation, Public Utility Foundation "Universite Europeenne du Travail" and the University of Liege. Possible inaccuracies of information are the responsibility of the project team. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; [Anonymous], 2006, HDB TIME SERIES ANAL; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Barrett AB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001052; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Bernasconi C, 1999, BIOL CYBERN, V81, P199, DOI 10.1007/s004220050556; Boly M, ARCH ITAL B IN PRESS, Vxx, pxx; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; Kay S. M., 1988, MODERN SPECTRAL ESTI; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Mashour GA, 2005, SCIENCE, V310, P1768; Mashour GA, 2011, SLEEP, V34, P247, DOI 10.1093/sleep/34.3.247; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; Olbrich E, 2003, NEUROCOMPUTING, V52-4, P857, DOI 10.1016/S0925-2312(02)00816-0; Palais B, 2001, MATH INTELL, V23, P7; Pardey J, 1996, J SLEEP RES, V5, P201, DOI 10.1111/j.1365-2869.1996.00201.x; Pockett S, 2009, CLIN NEUROPHYSIOL, V120, P695, DOI 10.1016/j.clinph.2008.12.044; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Seth AK, 2011, PHILOS T R SOC A, V369, P3748, DOI 10.1098/rsta.2011.0079; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; SHAFER A, 1995, ANESTHESIOLOGY, V83, P1331, DOI 10.1097/00000542-199512000-00024; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Wiener N, 1956, THEORY PREDICTION MO	56	106	107	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29072	10.1371/journal.pone.0029072	http://dx.doi.org/10.1371/journal.pone.0029072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242156	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000312662100010
J	Chen, JY; Liou, YM; Wu, HDI; Lin, KH; Chang, KC				Chen, Jan-Yow; Liou, Ying-Ming; Wu, Hong-Dar Isaac; Lin, Kuo-Hung; Chang, Kuan-Cheng			Promoter Polymorphism G-6A, which Modulates Angiotensinogen Gene Expression, Is Associated with Non-Familial Sick Sinus Syndrome	PLOS ONE			English	Article							AT(1) RECEPTOR; SIGNAL-TRANSDUCTION; ATRIAL-FIBRILLATION; CONDUCTION SYSTEM; HUMAN GENOME; HAPLOTYPE; HEART; OVEREXPRESSION; HYPERPLASIA; BRADYCARDIA	Background: It is well known that familial sick sinus syndrome (SSS) is caused by functional alterations of ion channels and gap junction. Limited information is available on the mechanism of age-related non-familial SSS. Although evidence shows a close link between arrhythmia and the renin-angiotensin system (RAS), it remains to be determined whether the RAS is involved in the pathogenesis of non-familial SSS. Methods: In this study, 113 patients with documented non-familial SSS and 125 controls were screened for angiotensinogen (AGT) and gap junction protein-connexin 40 (Cx40) promoter polymorphisms by gene sequencing, followed by an association study. A luciferase assay was used to determine the transcriptional activity of the promoter polymorphism. The interaction between nuclear factors and the promoter polymorphism was characterized by an electrophoretic mobility shift assay (EMSA). Results: Association study showed the Cx40 -44/+71 polymorphisms are not associated with non-familial SSS; however, it indicated that four polymorphic sites at positions -6, -20, -152, and -217 in the AGT promoter are linked to non-familial SSS. Compared to controls, SSS patients had a lower frequency of the G-6A AA genotype (OR 2.88, 95% CI 1.58-5.22, P = 0.001) and a higher frequency of the G allele at -6 position (OR 2.65, 95% CI 1.54-4.57, P = 0.0003). EMSA and luciferase assays confirmed that nucleotide G at position -6 modulates the binding affinity with nuclear factors and yields a lower transcriptional activity than nucleotide A (P<0.01). Conclusion: G-6A polymorphism, which modulates the transcriptional activity of the AGT promoter, may contribute to non-familial SSS susceptibility.	[Chen, Jan-Yow; Liou, Ying-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chen, Jan-Yow; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ Hosp, Dept Med, Div Cardiol, Taichung, Taiwan; [Chen, Jan-Yow; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ, Sch Med, Taichung, Taiwan; [Liou, Ying-Ming] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung 40227, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University	Liou, YM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	ymlion@dragon.nchu.edu.tw	lin, shihnuan/C-8578-2012	Liou, Ying-Ming/0000-0002-8190-7629	China Medical University Hospital [DMR-98-006, DMR-97-014]	China Medical University Hospital	This study is supported by funding from China Medical University Hospital (Grant numbers: DMR-98-006 and DMR-97-014; URL: http://www.cmuh.cmu.edu.tw/cmuh/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ctieber J, 2004, TRENDS CARDIOVAS MED, V14, P23; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/0008-6363(95)00088-7; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goette A, 2008, EUROPACE, V10, P238, DOI 10.1093/europace/eum283; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; HAMMILL SC, 1986, MAYO CLIN PROC, V61, P478, DOI 10.1016/S0025-6196(12)61984-3; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Herrmann Stefan, 2011, CARDIOVASC RES, V92, P179; HLADIKOVA M, 2011, NEUROL SCI, V303, P31, DOI DOI 10.1016/J.JNS.2011.01.020; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Kowey PR, 2003, CIRCULATION, V108, pE31, DOI 10.1161/01.CIR.0000082930.04238.8C; Lamas GA, 2000, AM HEART J, V140, P541, DOI 10.1067/mhj.2000.109652; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; NARULA OS, 1972, CIRCULATION, V45, P140, DOI 10.1161/01.CIR.45.1.140; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; SAITO K, 1987, AM J PHYSIOL, V253, pH1618, DOI 10.1152/ajpheart.1987.253.6.H1618; SAWA H, 1992, CIRCULATION, V86, P138, DOI 10.1161/01.CIR.86.1.138; Schmidt H, 2004, STROKE, V35, P2592, DOI 10.1161/01.STR.0000144646.96121.d2; Tamura K, 1999, J ENDOCRINOL, V160, P401, DOI 10.1677/joe.0.1600401; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; van Duijn CM, 2001, STROKE, V32, P405; Vongvatcharanon U, 2004, J RENIN-ANGIO-ALDO S, V5, P135, DOI 10.3317/jraas.2004.030; Zankov DP, 2006, CIRCULATION, V113, P1278, DOI 10.1161/CIRCULATIONAHA.104.530592	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29951	10.1371/journal.pone.0029951	http://dx.doi.org/10.1371/journal.pone.0029951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242192	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100049
J	Sampson, CJ; Williams, MJ				Sampson, Christopher J.; Williams, Michael J.			Real-Time Analysis of Drosophila Post-Embryonic Haemocyte Behaviour	PLOS ONE			English	Article							CELL POLARIZATION; SMALL GTPASES; RHO-GTPASES; MELANOGASTER; INTEGRIN; ADHESION; INSIGHTS; ORIGINS; PROTEIN	Background: The larval stage of the model organism Drosophila is frequently used to study host-pathogen interactions. During embryogenesis the cellular arm of the immune response, consisting of macrophage-like cells known as plasmatocytes, is extremely motile and functions to phagocytise pathogens and apoptotic bodies, as well as produce extracellular matrix. The cellular branch of the larval (post-embryonic) innate immune system consists of three cell types-plasmatocytes, crystal cells and lamellocytes-which are involved in the phagocytosis, encapsulation and melanisation of invading pathogens. Post-embryonic haemocyte motility is poorly understood thus further characterisation is required, for the purpose of standardisation. Methodology: In order to examine post-embryonic haemocyte cytoskeletal dynamics or migration, the most commonly used system is in vitro cell lines. The current study employs an ex vivo system (an adaptation of in vitro cell incubation using primary cells), in which primary larval or pre-pupal haemocytes are isolated for short term analysis, in order to discover various aspects of their behaviour during events requiring cytoskeleton dynamics. Significance: The ex vivo method allows for real-time analysis and manipulation of primary post-embryonic haemocytes. This technique was used to characterise, and potentially standardised, larval and pre-pupal haemocyte cytoskeleton dynamics, assayed on different extracellular matrices. Using this method it was determined that, while larval haemocytes are unable to migrate, haemocytes recovered from pre-pupae are capable of migration.	[Sampson, Christopher J.; Williams, Michael J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Williams, MJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	michael.williams@neuro.uu.se		Sampson, Christopher/0000-0002-0078-4605	BBBSRC; Royal Society; University of Aberdeen College of Life Science and Medicine	BBBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Aberdeen College of Life Science and Medicine	Chris Sampson's salary and some reagents were supported by a graduate student grant from the BBBSRC (www.bbsrc.ac.uk). The Royal Society funded some reagents for the current study (http://royalsociety.org/). The University of Aberdeen College of Life Science and Medicine provided funding for equipment, including incubators and a stereo microscope, necessary for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001356; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Baek SH, 2010, BIOCHEM BIOPH RES CO, V394, P488, DOI 10.1016/j.bbrc.2010.02.124; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Boisvert M, 2010, EUR J IMMUNOL, V40, P2710, DOI 10.1002/eji.201040307; Bretscher MS, 2008, J CELL SCI, V121, P2625, DOI 10.1242/jcs.031120; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P21; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; McDonald Jocelyn A., 2004, V294, P175; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Pfaendtner J, 2010, J MOL BIOL, V396, P252, DOI 10.1016/j.jmb.2009.11.034; Songklanakarin J, 2010, SONGKLANAKARIN J SCI, V32, P327; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; Williams MJ, 2007, J CELL SCI, V120, P502, DOI 10.1242/jcs.03341; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28783	10.1371/journal.pone.0028783	http://dx.doi.org/10.1371/journal.pone.0028783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242151	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100005
J	Angus, SP; Nevins, JR				Angus, S. P.; Nevins, J. R.			A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest	ONCOGENE			English	Article						tumor suppressor; cell cycle; senescence	RETINOBLASTOMA TUMOR-SUPPRESSOR; CELL-CYCLE ARREST; ONCOGENE-INDUCED SENESCENCE; IN-VIVO; S-PHASE; TRANSCRIPTIONAL REGULATION; TARGET GENES; C/EBP-BETA; ZNF217; PROTEIN	The Rb/E2F pathway is deregulated in virtually all human tumors. It is clear that, in addition to Rb itself, essential cofactors required for transcriptional repression and silencing of E2F target genes are mutated or lost in cancer. To identify novel cofactors required for Rb/E2F-mediated inhibition of cell proliferation, we performed a genome-wide short hairpin RNA screen. In addition to several known Rb cofactors, the screen identified components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription. We show that the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition.	[Angus, S. P.; Nevins, J. R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA.	j.nevins@duke.edu		Angus, Steven/0000-0002-7655-657X	National Cancer Institute Integrative Cancer Biology Program via grant National Institutes of Health [5-U54-CA112952]; NIH [F32CA113177]; NATIONAL CANCER INSTITUTE [U54CA112952, R01CA104663, F32CA113177] Funding Source: NIH RePORTER	National Cancer Institute Integrative Cancer Biology Program via grant National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All aspects of the research were supported under the National Cancer Institute Integrative Cancer Biology Program via grant National Institutes of Health 5-U54-CA112952. SPA was supported by NIH F32CA113177. We thank Lazlo Jakoi for technical assistance and all the members of the Nevins lab for their critical feedback and suggestions. We are grateful to Bernard Mathey-Prevot and Jeffrey Chang for comments on the manuscript. We thank Kaye Culler for assistance in submitting the manuscript. We are grateful to T Kitamura for providing Plat-E and Plat-A retroviral packaging cells, J DeCaprio for providing the T98G-EcoR cells, and E Knudsen for providing the -608Cyclin A-Luc and PSM-Rb plasmids.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Angus SP, 2004, MOL CELL BIOL, V24, P5404, DOI 10.1128/MCB.24.12.5404-5420.2004; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Greider Carol W., 2004, Cell, VS116, pS83, DOI 10.1016/S0092-8674(04)00053-4; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen KE, 1999, J BIOL CHEM, V274, P27632, DOI 10.1074/jbc.274.39.27632; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Meloni AR, 2005, MOL CANCER RES, V3, P575, DOI 10.1158/1541-7786.MCR-05-0088; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nonet GH, 2001, CANCER RES, V61, P1250; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Quinlan KGR, 2007, BBA-REV CANCER, V1775, P333, DOI 10.1016/j.bbcan.2007.05.001; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Sun G, 2008, INT J ONCOL, V32, P1065; Wang L, 2008, GENETICS, V180, P269, DOI 10.1534/genetics.108.092478; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Yang H, 2002, MOL CELL BIOL, V22, P3103, DOI 10.1128/MCB.22.9.3103-3110.2002; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	62	21	21	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	44					4709	4717		10.1038/onc.2011.622	http://dx.doi.org/10.1038/onc.2011.622			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22249253	Green Accepted			2022-12-25	WOS:000310724400006
J	Barnes, J; Warejcka, D; Simpliciano, J; Twining, S; Steet, R				Barnes, Jarrod; Warejcka, Debra; Simpliciano, Jennifer; Twining, Sally; Steet, Richard			Latency-associated Peptide of Transforming Growth Factor-beta 1 Is Not Subject to Physiological Mannose Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; GROWTH-FACTOR-BETA; LEUKEMIA INHIBITORY FACTOR; TGF-BETA; 6-PHOSPHATE RECEPTORS; PROCATHEPSIN-D; ACTIVATION; ENZYME; PRECURSOR; THROMBOSPONDIN-1	Latent TGF-beta 1 was one of the first non-lysosomal glycoproteins reported to bear mannose 6-phosphate (Man-6-P) residues on its N-glycans. Prior studies have suggested that this sugar modification regulates the activation of latent TGF-beta 1 by allowing it to bind cell surface-localized Man-6-P receptors. Man-6-P has also been proposed as an anti-scarring therapy based on its ability to directly block the activation of latent TGF-beta 1. A complete understanding of the physiological relevance of latent TGF-beta 1 mannose phosphorylation, however, is still lacking. Here we investigate the degree of mannose phosphorylation on secreted latent TGF-beta 1 and examine its Man-6-P-dependent activation in primary human corneal stromal fibroblasts. Contrary to earlier reports, minimal to no Man-6-P modification was found on secreted and cell-associated latent TGF-beta 1 produced from multiple primary and transformed cell types. Results showed that the inability to detect Man-6-P residues was not due to masking by the latent TGF-beta 1-binding protein (LTBP). Moreover, the efficient processing of glycans on latent TGF-beta 1 to complex type structures was consistent with the lack of mannose phosphorylation during biosynthesis. We further demonstrated that the conversion of corneal stromal fibroblast to myofibroblasts, a well known TGF-beta 1-dependent process, was not altered by Man-6-P addition when latent forms of this growth factor were present. Collectively, these findings indicate that Man-6P- dependent effects on latent TGF-beta 1 activation are not mediated by direct modification of its latency-associated peptide.	[Barnes, Jarrod; Simpliciano, Jennifer; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Warejcka, Debra; Twining, Sally] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53202 USA	University System of Georgia; University of Georgia; Medical College of Wisconsin	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Barnes, Jarrod/V-6127-2019	Barnes, Jarrod/0000-0002-1027-6591	National Institutes of Health, NIGMS [1R01GM086524-01]; National Institutes of Health, NEI [1 R01 EY012731-07]; Cousins Foundation; NATIONAL EYE INSTITUTE [R01EY012731, R01EY021152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cousins Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant 1R01GM086524-01 (to R. S.) and National Institutes of Health, NEI, Grant 1 R01 EY012731-07 (to S. S. T.). This work was also supported by a graduate fellowship from the Cousins Foundation (to J. B.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Angunawela RI, 2010, J CATARACT REFR SURG, V36, P121, DOI 10.1016/j.jcrs.2009.07.042; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Barnes J, 2011, J BIOL CHEM, V286, P24855, DOI 10.1074/jbc.M111.221432; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; FAUST PL, 1987, J CELL BIOL, V105, P1947, DOI 10.1083/jcb.105.5.1947; Flaumenhaft R, 1993, Adv Pharmacol, V24, P51, DOI 10.1016/S1054-3589(08)60933-3; FLAUMENHAFT R, 1992, J CELL BIOL, V118, P901, DOI 10.1083/jcb.118.4.901; Ghahary A, 1999, EXP CELL RES, V251, P111, DOI 10.1006/excr.1999.4561; Ghahary A, 2000, GROWTH FACTORS, V17, P167, DOI 10.3109/08977190009001066; Ghahary A, 1999, J CELL PHYSIOL, V180, P61, DOI 10.1002/(SICI)1097-4652(199907)180:1<61::AID-JCP7>3.0.CO;2-R; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KOVACINA KS, 1989, BIOCHEM BIOPH RES CO, V160, P393, DOI 10.1016/0006-291X(89)91669-0; Kreiling JL, 2003, J BIOL CHEM, V278, P20628, DOI 10.1074/jbc.M302249200; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; ODEKON LE, 1994, J CELL PHYSIOL, V158, P398, DOI 10.1002/jcp.1041580303; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Sutton G., 1996, LASERS LIGHT OPHTHAL, V6, P117; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Xia Chang-suo, 2010, Orthopedics, V33, P727, DOI 10.3928/01477447-20100826-06; Xia Changsuo, 2011, Orthopedics, V34, P21, DOI 10.3928/01477447-20101123-09; Yang LJ, 2000, WOUND REPAIR REGEN, V8, P538, DOI 10.1046/j.1524-475x.2000.00538.x; Yang Ruixiang, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P64	47	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7526	7534		10.1074/jbc.M111.308825	http://dx.doi.org/10.1074/jbc.M111.308825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262853	Green Published, hybrid			2022-12-25	WOS:000301060200053
J	Brodie, KM; Henderson, BR				Brodie, Kirsty M.; Henderson, Beric R.			Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome A ROLE FOR THE NUCLEAR EXPORT SIGNAL, CRM1, AND AURORA A KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR AMPLIFIED KINASE; GAMMA-TUBULIN-BINDING; E3 LIGASE ACTIVITY; BREAST-CANCER; CELL-CYCLE; UBIQUITIN LIGASE; MICROTUBULE NUCLEATION; MITOTIC SPINDLE; BRCA1-DEPENDENT UBIQUITINATION; GENETIC INSTABILITY	BRCA1 is a DNA damage response protein and functions in the nucleus to stimulate DNA repair and at the centrosome to inhibit centrosome overduplication in response to DNA damage. The loss or mutation of BRCA1 causes centrosome amplification and abnormal mitotic spindle assembly in breast cancer cells. The BRCA1-BARD1 heterodimer binds and ubiquitinates gamma-tubulin to inhibit centrosome amplification and promote microtubule nucleation; however regulation of BRCA1 targeting and function at the centrosome is poorly understood. Here we show that both N and C termini of BRCA1 are required for its centrosomal localization and that BRCA1 moves to the centrosome independently of BARD1 and gamma-tubulin. Mutations in the C-terminal phosphoprotein-binding BRCT domain of BRCA1 prevented localization to centrosomes. Photobleaching experiments identified dynamic (60%) and immobilized (40%) pools of ectopic BRCA1 at the centrosome, and these are regulated by the nuclear export receptor CRM1 (chromosome region maintenance 1) and BARD1. CRM1 mediates nuclear export of BRCA1, and mutation of the export sequence blocked BRCA1 regulation of centrosome amplification in irradiated cells. CRM1 binds to undimerized BRCA1 and is displaced by BARD1. Photobleaching assays implicate CRM1 in driving undimerized BRCA1 to the centrosome and revealed that when BRCA1 subsequently binds to BARD1, it is less well retained at centrosomes, suggesting a mechanism to accelerate BRCA1 release after formation of the active heterodimer. Moreover, Aurora A binding and phosphorylation of BRCA1 enhanced its centrosomal retention and regulation of centrosome amplification. Thus, CRM1, BARD1 and Aurora A promote the targeting and function of BRCA1 at centrosomes.	[Brodie, Kirsty M.; Henderson, Beric R.] Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Darcy Rd,POB 412, Westmead, NSW 2145, Australia.	beric.henderson@sydney.edu.au			Australian Research Council; National Health and Medical Research Council (NHMRC); Cancer Council of New South Wales	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of New South Wales(Cancer Council New South Wales)	This study was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC) and the Cancer Council of New South Wales.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Brodie KM, 2012, CELL SIGNAL, V24, P451, DOI 10.1016/j.cellsig.2011.09.024; Brodie KM, 2010, CELL SIGNAL, V22, P291, DOI 10.1016/j.cellsig.2009.09.034; Budhu AS, 2005, CELL CYCLE, V4, P1510, DOI 10.4161/cc.4.11.2187; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Deng CX, 2001, MUTAT RES-FUND MOL M, V477, P183, DOI 10.1016/S0027-5107(01)00119-1; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Gillingham AK, 2000, EMBO REP, V1, P524; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Han X, 2008, ONCOGENE, V27, P2969, DOI 10.1038/sj.onc.1210968; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Hsu LC, 2001, CANCER RES, V61, P7713; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Levy-Lahad E, 2007, BRIT J CANCER, V96, P11, DOI 10.1038/sj.bjc.6603535; Liu QY, 2009, BIOCHEM BIOPH RES CO, V384, P383, DOI 10.1016/j.bbrc.2009.04.154; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.e02-07-0377; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Ouchi T, 2006, CANCER BIOL THER, V5, P470, DOI 10.4161/cbt.5.5.2845; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Pascreau G, 2010, P NATL ACAD SCI USA, V107, P2932, DOI 10.1073/pnas.0914874107; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Roghi C, 1998, J CELL SCI, V111, P557; Saladino C, 2009, ENVIRON MOL MUTAGEN, V50, P725, DOI 10.1002/em.20477; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Schuchner S, 2005, J BIOL CHEM, V280, P8855, DOI 10.1074/jbc.M413741200; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Shimomura A, 2009, J CANCER RES CLIN, V135, P421, DOI 10.1007/s00432-008-0472-5; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Thomson TM, 2010, BIOCHEM SOC T, V38, P116, DOI 10.1042/BST0380116; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	68	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7701	7716		10.1074/jbc.M111.327296	http://dx.doi.org/10.1074/jbc.M111.327296			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262852	Green Published, hybrid			2022-12-25	WOS:000301060200069
J	Courtemanche, N; Pollard, TD				Courtemanche, Naomi; Pollard, Thomas D.			Determinants of Formin Homology 1 (FH1) Domain Function in Actin Filament Elongation by Formins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; PROCESSIVE ELONGATION; CAPPING PROTEIN; PROFILIN; NUCLEATION; COMPLEX; POLYMERIZATION; CYTOKINESIS; MECHANISM; REQUIREMENTS	Formin-mediated elongation of actin filaments proceeds via association of Formin Homology 2 (FH2) domain dimers with the barbed end of the filament, allowing subunit addition while remaining processively attached to the end. The flexible Formin Homology 1 (FH1) domain, located directly N-terminal to the FH2 domain, contains one or more stretches of polyproline that bind the actin-binding protein profilin. Diffusion of FH1 domains brings associated profilin-actin complexes into contact with the FH2-bound barbed end of the filament, thereby enabling direct transfer of actin. We investigated how the organization of the FH1 domain of budding yeast formin Bni1p determines the rates of profilin-actin transfer onto the end of the filament. Each FH1 domain transfers actin to the barbed end independently of the other and structural evidence suggests a preference for actin delivery from each FH1 domain to the closest long-pitch helix of the filament. The transfer reaction is diffusion-limited and influenced by the affinities of the FH1 polyproline tracks for profilin. Position-specific sequence variations optimize the efficiency of FH1-stimulated polymerization by binding profilin weakly near the FH2 domain and binding profilin more strongly farther away. FH1 domains of many other formins follow this organizational trend. This particular sequence architecture may optimize the efficiency of FH1-stimulated elongation.	[Courtemanche, Naomi; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, KBT 548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			National Institutes of Health [GM-026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM-026338.	Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Paul AS, 2009, J BIOL CHEM, V284, P12533, DOI 10.1074/jbc.M808587200; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RONISH EW, 1974, BIOPOLYMERS, V13, P1635, DOI 10.1002/bip.1974.360130810; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7	31	49	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7812	7820		10.1074/jbc.M111.322958	http://dx.doi.org/10.1074/jbc.M111.322958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247555	Green Published, hybrid			2022-12-25	WOS:000301060200079
J	Siniscalchi, M; Dimatteo, S; Pepe, AM; Sasso, R; Quaranta, A				Siniscalchi, Marcello; Dimatteo, Salvatore; Pepe, Anna Maria; Sasso, Raffaella; Quaranta, Angelo			Visual Lateralization in Wild Striped Dolphins (Stenella coeruleoalba) in Response to Stimuli with Different Degrees of Familiarity	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; TURSIOPS-TRUNCATUS; DOMESTIC CHICK; EYE USE; BRAIN; BEHAVIOR; FISH; INSPECTION; ADVANTAGE; ASYMMETRY	Background: Apart from findings on both functional and motor asymmetries in captive aquatic mammals, only few studies have focused on lateralized behaviour of these species in the wild. Methodology/Principal Findings: In this study we focused on lateralized visual behaviour by presenting wild striped dolphins with objects of different degrees of familiarity (fish, ball, toy). Surveys were conducted in the Gulf of Taranto, the northern Ionian Sea portion delimited by the Italian regions of Calabria, Basilicata and Apulia. After sighting striped dolphins from a research vessel, different stimuli were presented in a random order by a telescopic bar connected to the prow of the boat. The preferential use of the right/left monocular viewing during inspection of the stimuli was analysed. Conclusion: Results clearly showed a monocular viewing preference with respect to the type of the stimulus employed. Due to the complete decussation of the optical nerves in dolphin brain our results reflected a different specialization of brain hemispheres for visual scanning processes confirming that in this species different stimuli evoked different patterns of eye use. A preferential use of the right eye (left hemisphere) during visual inspection of unfamiliar targets was observed supporting the hypothesis that, in dolphins, the organization of the functional neural structures which reflected cerebral asymmetries for visual object recognition could have been subjected to a deviation from the evolutionary line of most terrestrial vertebrates.	[Siniscalchi, Marcello; Dimatteo, Salvatore; Pepe, Anna Maria; Sasso, Raffaella; Quaranta, Angelo] Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Siniscalchi, M (corresponding author), Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy.	m.siniscalchi@veterinaria.uniba.it		Quaranta, Angelo/0000-0001-7835-2485	University of Bari, Italy; Fondazione Cassa di Risparmio di Puglia, Bari, Italy	University of Bari, Italy; Fondazione Cassa di Risparmio di Puglia, Bari, Italy	This research is part of the following projects: "Jonian Cetacean Project" supported by the University of Bari, Italy, through a financial grantship to AQ, and "Cetacea" supported by Fondazione Cassa di Risparmio di Puglia, Bari, Italy, through a financial grantship to AQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisazza A, 2001, NEUROPSYCHOLOGIA, V39, P1077, DOI 10.1016/S0028-3932(01)00034-3; Burne THJ, 2002, BEHAV BRAIN RES, V133, P293, DOI 10.1016/S0166-4328(02)00009-8; CLAPHAM PJ, 1995, ANIM BEHAV, V50, P73, DOI 10.1006/anbe.1995.0222; Clara E, 2005, LATERALITY, V10, P487, DOI 10.1080/13576500442000247; De Santi A, 2001, ANIM BEHAV, V61, P305, DOI 10.1006/anbe.2000.1566; Delfour F, 2006, BEHAV PROCESS, V71, P41, DOI 10.1016/j.beproc.2005.09.005; Dimatteo S, 2011, ITAL J ZOOL, V78, P130, DOI 10.1080/11250003.2010.532161; HOESE HD, 1971, J MAMMAL, V52, P222, DOI 10.2307/1378455; JACOBS MS, 1975, BRAIN RES, V88, P346, DOI 10.1016/0006-8993(75)90397-2; Karenina K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013787; Kasuya T, 1970, Scient. Rep. Whales Res. Inst., Tokyo, VNo. 22, P39; Kilian A, 2000, BEHAV BRAIN RES, V116, P211, DOI 10.1016/S0166-4328(00)00273-4; Kilian A, 2005, BEHAV PROCESS, V68, P179, DOI 10.1016/j.beproc.2004.11.003; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Poliakova EC., 1978, ELECTROPHYSIOLOGICAL; Ridgway S.H., 1986, P31; RIGLEY L, 1981, Proceedings of the Pennsylvania Academy of Science, V55, P157; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; ROGERS LJ, 1979, PHARMACOL BIOCHEM BE, V10, P679, DOI 10.1016/0091-3057(79)90320-4; Rogers LJ., 2002, COMP VERTEBRATE LATE; Sakai M, 2006, BEHAV BRAIN RES, V170, P204, DOI 10.1016/j.bbr.2006.02.018; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Silber Gregory K., 1995, Aquatic Mammals, V21, P183; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2004, BEHAV BRAIN RES, V152, P385, DOI 10.1016/j.bbr.2003.10.022; Sovrano VA, 2001, PHYSIOL BEHAV, V74, P237, DOI 10.1016/S0031-9384(01)00552-2; TARPLEY RJ, 1994, J MORPHOL, V222, P91, DOI 10.1002/jmor.1052220109; Thieltges H, 2011, ANIM COGN, V14, P303, DOI 10.1007/s10071-010-0354-5; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 1999, COGNITIVE BRAIN RES, V7, P307, DOI 10.1016/S0926-6410(98)00033-0; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; von Fersen L, 2000, BEHAV BRAIN RES, V107, P177, DOI 10.1016/S0166-4328(99)00142-4; Yaman S, 2003, BEHAV BRAIN RES, V142, P109, DOI 10.1016/S0166-4328(02)00385-6	34	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30001	10.1371/journal.pone.0030001	http://dx.doi.org/10.1371/journal.pone.0030001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253855	Green Published, Green Submitted, gold			2022-12-25	WOS:000301361500029
J	Demuth, JP; Naidu, A; Mydlarz, LD				Demuth, Jeffery P.; Naidu, Amrita; Mydlarz, Laura D.			Sex, War, and Disease: The Role of Parasite Infection on Weapon Development and Mating Success in a Horned Beetle (Gnatocerus cornutus)	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; IMMUNE FUNCTION; HYMENOLEPIS-DIMINUTA; TENEBRIO-MOLITOR; TRADE-OFFS; PHENOLOXIDASE ACTIVITY; INTERMEDIATE HOST; ACANTHOCEPHALAN PARASITES; GENETIC CORRELATIONS; JUVENILE-HORMONE	While parasites and immunity are widely believed to play important roles in the evolution of male ornaments, their potential influence on systems where male weaponry is the object of sexual selection is poorly understood. We experimentally infect larval broad-horned flour beetles with a tapeworm and study the consequent effects on: 1) adult male morphology 2) male-male contests for mating opportunities, and 3) induction of the innate immune system. We find that infection significantly reduces adult male size in ways that are expected to reduce mating opportunities in nature. The sum of our morphological, competition, and immunological data indicate that during a life history stage where no new resources are acquired, males allocate their finite resources in a way that increases future mating potential.	[Demuth, Jeffery P.; Naidu, Amrita; Mydlarz, Laura D.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Demuth, JP (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	jpdemuth@uta.edu	Mydlarz, Laura/B-8132-2011		National Institutes of Health [2R01GM065414-05A1]; University of Texas at Arlington; Thomas F. Pyburn graduate student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at Arlington; Thomas F. Pyburn graduate student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Health (grant number 2R01GM065414-05A1) and The University of Texas at Arlington startup funding to J.P.D. and L. D. M. A.N. was supported by the Thomas F. Pyburn graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Blankespoor CL, 1997, PARASITOLOGY, V115, P105, DOI 10.1017/S0031182097008901; Bollache L, 2001, BEHAV ECOL SOCIOBIOL, V49, P296, DOI 10.1007/s002650000300; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Cole TJ, 2003, J INSECT PHYSIOL, V49, P583, DOI 10.1016/S0022-1910(03)00030-1; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Darwin G., 1871, P423; Dowling D, 2009, P ROYAL SOC B; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Ezenwa VO, 2008, ANIM BEHAV, V75, P2013, DOI 10.1016/j.anbehav.2007.12.013; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harano T, 2010, CURR BIOL, V20, P2036, DOI 10.1016/j.cub.2010.10.023; HOWARD RD, 1990, OIKOS, V58, P120, DOI 10.2307/3565368; Hung SY, 1996, J INVERTEBR PATHOL, V67, P35, DOI 10.1006/jipa.1996.0006; Hurd H, 2003, P ROY SOC B-BIOL SCI, V270, pS172, DOI 10.1098/rsbl.2003.0033; HURD H, 1991, CAN J ZOOL, V69, P2291, DOI 10.1139/z91-321; HURD H, 1986, J INVERTEBR PATHOL, V47, P225, DOI 10.1016/0022-2011(86)90050-9; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; KEYMER AE, 1980, PARASITOLOGY, V81, P405, DOI 10.1017/S0031182000056134; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, P523, DOI 10.1098/rspb.2003.2641; Knell RJ, 2009, ECOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-2311.2008.01022.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Latham ADM, 2001, MAR BIOL, V139, P1147; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Moczek AP, 2006, AM NAT, V168, P711, DOI 10.1086/509051; MOLLER AP, 1990, J EVOLUTION BIOL, V3, P319, DOI 10.1046/j.1420-9101.1990.3050319.x; Moller AP, 1999, Q REV BIOL, V74, P3, DOI 10.1086/392949; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Mullen LM, 2006, J INSECT PHYSIOL, V52, P389, DOI 10.1016/j.jinsphys.2005.10.008; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Newton K, 2004, DEV COMP IMMUNOL, V28, P565, DOI 10.1016/j.dci.2003.10.004; Nigam Y, 1997, J INVERTEBR PATHOL, V69, P279, DOI 10.1006/jipa.1996.4652; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; Okada K, 2006, J INSECT BEHAV, V19, P457, DOI 10.1007/s10905-006-9038-z; Okada K, 2010, BIOL LETTERS, V6, P593, DOI 10.1098/rsbl.2010.0225; Okada K, 2010, BEHAV ECOL SOCIOBIOL, V64, P361, DOI 10.1007/s00265-009-0852-0; Okada K, 2009, ANIM BEHAV, V77, P1057, DOI 10.1016/j.anbehav.2009.01.008; Pomfret JC, 2006, BEHAV ECOL, V17, P466, DOI 10.1093/beheco/arj050; Pope DS, 2000, BEHAV ECOL SOCIOBIOL, V47, P432, DOI 10.1007/s002650050687; Rantala MJ, 2007, BIOL J LINN SOC, V90, P509, DOI 10.1111/j.1095-8312.2007.00741.x; Rantala MJ, 2003, P ROY SOC B-BIOL SCI, V270, P2257, DOI 10.1098/rspb.2003.2472; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Rantala MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2453, DOI 10.1098/rspb.2000.1305; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Ryder JJ, 2000, P ROY SOC B-BIOL SCI, V267, P1171, DOI 10.1098/rspb.2000.1125; SAVVIDOU N, 1994, J STORED PROD RES, V30, P17, DOI 10.1016/0022-474X(94)90268-2; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schwarzenbach GA, 2007, J EVOLUTION BIOL, V20, P2192, DOI 10.1111/j.1420-9101.2007.01430.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHUSTER SM, 2003, MG BEH ECOL, pR7; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 2005, ANIM BEHAV, V69, P1235, DOI 10.1016/j.anbehav.2004.09.011; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Tomkins JL, 1998, ANIM BEHAV, V56, P347, DOI 10.1006/anbe.1998.0838; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Yamane T, 2010, P ROYAL SOC LONDON B; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	67	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28690	10.1371/journal.pone.0028690	http://dx.doi.org/10.1371/journal.pone.0028690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247759	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700007
J	Jiang, XT; Zhang, H; Sheng, HF; Wang, Y; He, Y; Zou, F; Zhou, HW				Jiang, Xiao-Tao; Zhang, Hai; Sheng, Hua-Fang; Wang, Yu; He, Yan; Zou, Fei; Zhou, Hong-Wei			Two-Stage Clustering (TSC): A Pipeline for Selecting Operational Taxonomic Units for the High-Throughput Sequencing of PCR Amplicons	PLOS ONE			English	Article							RARE BIOSPHERE; MICROBIAL DIVERSITY; MILLIONS; WRINKLES	Clustering 16S/18S rRNA amplicon sequences into operational taxonomic units (OTUs) is a critical step for the bioinformatic analysis of microbial diversity. Here, we report a pipeline for selecting OTUs with a relatively low computational demand and a high degree of accuracy. This pipeline is referred to as two-stage clustering (TSC) because it divides tags into two groups according to their abundance and clusters them sequentially. The more abundant group is clustered using a hierarchical algorithm similar to that in ESPRIT, which has a high degree of accuracy but is computationally costly for large datasets. The rarer group, which includes the majority of tags, is then heuristically clustered to improve efficiency. To further improve the computational efficiency and accuracy, two preclustering steps are implemented. To maintain clustering accuracy, all tags are grouped into an OTU depending on their pairwise Needleman-Wunsch distance. This method not only improved the computational efficiency but also mitigated the spurious OTU estimation from 'noise' sequences. In addition, OTUs clustered using TSC showed comparable or improved performance in beta-diversity comparisons compared to existing OTU selection methods. This study suggests that the distribution of sequencing datasets is a useful property for improving the computational efficiency and increasing the clustering accuracy of the high-throughput sequencing of PCR amplicons. The software and user guide are freely available at http://hwzhoulab.smu.edu.cn/paperdata/.	[Jiang, Xiao-Tao; Sheng, Hua-Fang; Wang, Yu; He, Yan; Zou, Fei; Zhou, Hong-Wei] So Med Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Hai] So Med Univ, NetworkCtr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Jiang, XT (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth, Guangzhou, Guangdong, Peoples R China.	biodegradation@gmail.com	Zhou, Hongwei/B-4193-2008	JIANG, Xiao-Tao/0000-0003-1804-5314; He, Yan/0000-0002-6611-2959	Natural Science Foundation of China [31040013]; Ph.D. Programs Foundation of the Education Ministry of China [20094433120017]; Guangdong Natural Science Foundation [S2011010004136]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201114]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Education Ministry of China; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); School of Public Health and Tropical Medicine of Southern Medical University, China	This work was supported by the Natural Science Foundation of China (No. 31040013), the Ph.D. Programs Foundation of the Education Ministry of China (No. 20094433120017), Guangdong Natural Science Foundation (No. S2011010004136), and the Grant from School of Public Health and Tropical Medicine of Southern Medical University, China (Grant No. GW201114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun Y, 2011, BRIEF BIOINFORM, DOI [10.1093/bib/bbr1009, DOI 10.1093/BIB/BBR1009]; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	22	26	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30230	10.1371/journal.pone.0030230	http://dx.doi.org/10.1371/journal.pone.0030230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253923	Green Submitted, gold, Green Published			2022-12-25	WOS:000301355700100
J	Reissmann, S; Gillen, CM; Fulde, M; Bergmann, R; Nerlich, A; Rajkumari, R; Brahmadathan, KN; Chhatwal, GS; Nitsche-Schmitz, DP				Reissmann, Silvana; Gillen, Christine M.; Fulde, Marcus; Bergmann, Rene; Nerlich, Andreas; Rajkumari, Reena; Brahmadathan, Kootallur N.; Chhatwal, Gursharan S.; Nitsche-Schmitz, D. Patric			Region Specific and Worldwide Distribution of Collagen-Binding M Proteins with PARF Motifs among Human Pathogenic Streptococcal Isolates	PLOS ONE			English	Article							DYSGALACTIAE SUBSP EQUISIMILIS; COILED-COIL STRUCTURE; RHEUMATIC-FEVER; EMM TYPES; GROUP-C; PYOGENES; VACCINE; IMMUNOGENICITY; STABILITY; SAFETY	Some of the variety of Streptococcus pyogenes and Streptococcus dysgalactiae ssp. equisimilis (SDSE) M proteins act as collagen-binding adhesins that facilitate acute infection. Moreover, their potential to trigger collagen autoimmunity has been implicated in the pathogenesis of acute rheumatic fever and attributed to a collagen-binding motif called PARF (peptide associated with rheumatic fever). For the first time we determine the rate of clinical isolates with collagen-binding M proteins that use a PARF motif (A/T/E) XYLXX(L/F)N in a defined geographic region, Vellore in South India. In this region both, incidence of streptococcal infections and prevalence of acute rheumatic fever are high. M proteins with PARF motif conferred collagen-binding activity to 3.9% of 153 S. pyogenes and 10.6% of 255 SDSE clinical isolates from Vellore. The PARF motif occurred in three S. pyogenes and 22 SDSE M protein types. In one of the S. pyogenes and five of the SDSE M proteins that contained the motif, collagen-binding was impaired, due to influences of other parts of the M protein molecule. The accumulated data on the collagen binding activity of certain M protein types allowed a reanalysis of published worldwide emm-typing data with the aim to estimate the rates of isolates that bind collagen via PARF. The results indicate that M proteins, which bind collagen via a PARF motif, are epidemiologically relevant in human infections, not only in Vellore. It is imperative to include the most relevant collagen-binding M types in vaccines. But when designing M protein based vaccines it should be considered that collagen binding motifs within the vaccine antigen remain potential risk factors.	[Reissmann, Silvana; Gillen, Christine M.; Fulde, Marcus; Bergmann, Rene; Nerlich, Andreas; Chhatwal, Gursharan S.; Nitsche-Schmitz, D. Patric] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany; [Rajkumari, Reena; Brahmadathan, Kootallur N.] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India	Helmholtz Association; Helmholtz-Center for Infection Research; Christian Medical College & Hospital (CMCH) Vellore	Reissmann, S (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany.	Patric.Nitsche@helmholtz-hzi.de	Nerlich, Andreas/F-9336-2012; Gillen, Christine M/A-2717-2014; Baskaran, Reena Rajkumari/T-4957-2019	Nerlich, Andreas/0000-0001-8577-2744; Duplancic, Christine/0000-0002-1775-3055; Baskaran, Reena Rajkumari/0000-0002-2467-4080	Helmholtz Foundation (Virtual Institute); European Community [FP6-2004-INCO-DEV-3-032390]; DAAD-DST	Helmholtz Foundation (Virtual Institute); European Community(European Commission); DAAD-DST	This work was supported by the Impulse and Networking Fund of the Helmholtz Foundation (Virtual Institute: Oral Streptococci) (http://www.helmholtz.de/en/), by a grant of the European Community's Sixth Framework Program [FP6-2004-INCO-DEV-3-032390] (http://cordis.europa.eu/fp6/dc/index.cfm?fuseaction=UserSite.FP6HomePage), and by a DAAD-DST Bilateral Grant to KNB and GSC (http://www.daad.de/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARACCO GJ, 2006, GRAM POSITIVE PATHOG, P223; Barroso V, 2009, INT J MED MICROBIOL, V299, P547, DOI 10.1016/j.ijmm.2009.04.004; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BISNO AL, 1987, INFECT IMMUN, V55, P753, DOI 10.1128/IAI.55.3.753-757.1987; Bober M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020345; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Cedervall T, 1997, BIOCHEMISTRY-US, V36, P4987, DOI 10.1021/bi962971q; Cole JN, 2008, PROTEOM CLIN APPL, V2, P387, DOI 10.1002/prca.200780048; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dinkla K, 2007, J BIOL CHEM, V282, P18686, DOI 10.1074/jbc.M701047200; Dinkla K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004666; Efstratiou A, 1997, J APPL MICROBIOL, V83, pS72, DOI 10.1046/j.1365-2672.83.s1.8.x; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Haidan A, 2000, LANCET, V356, P1167, DOI 10.1016/S0140-6736(00)02765-3; Kittang BR, 2008, APMIS, V116, P457, DOI 10.1111/j.1600-0463.2008.00976.x; KOSTRZYNSKA M, 1989, FEMS MICROBIOL LETT, V59, P229; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Ma Y, 2009, EPIDEMIOL INFECT, V137, P1414, DOI 10.1017/S0950268809002118; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; McDonald M, 2007, EMERG INFECT DIS, V13, P1694, DOI 10.3201/eid1311.061258; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McMillan DJ, 2005, CURR OPIN MOL THER, V7, P11; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Nath LM, 1994, COMMUNITY CONTROL RH, P81; NILSON BHK, 1995, BIOCHEMISTRY-US, V34, P13688, DOI 10.1021/bi00041a051; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Nitsche-Schmitz DP, 2007, MOL BIOL STREPTOCOCC, P487; Oehmcke S, 2010, CLIN CHIM ACTA, V411, P1172, DOI 10.1016/j.cca.2010.04.032; Penfound TA, 2010, VACCINE, V28, P5017, DOI 10.1016/j.vaccine.2010.05.018; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; Reissmann S, 2010, EMERG INFECT DIS, V16, P656, DOI 10.3201/eid1604.090448; SIMPSON WJ, 1987, MICROB PATHOGENESIS, V3, P339, DOI 10.1016/0882-4010(87)90004-0; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stollerman GH, 1997, LANCET, V349, P935, DOI 10.1016/S0140-6736(96)06364-7; Sunaoshi K, 2010, J MED MICROBIOL, V59, P82, DOI 10.1099/jmm.0.013201-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng SP, 2010, J CLIN MICROBIOL, V48, P2975, DOI 10.1128/JCM.00444-10; WANNAMAKER LW, 1973, CIRCULATION, V48, P9, DOI 10.1161/01.CIR.48.1.9; Zaman M, 2010, NANOMEDICINE	48	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30122	10.1371/journal.pone.0030122	http://dx.doi.org/10.1371/journal.pone.0030122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253902	Green Published, Green Submitted, gold			2022-12-25	WOS:000301355700092
J	Slyker, JA; Chung, MH; Lehman, DA; Kiarie, J; Kinuthia, J; Holte, S; Tapia, K; Njiri, F; Overbaugh, J; John-Stewart, G				Slyker, Jennifer A.; Chung, Michael H.; Lehman, Dara A.; Kiarie, James; Kinuthia, John; Holte, Sarah; Tapia, Kenneth; Njiri, Francis; Overbaugh, Julie; John-Stewart, Grace			Incidence and Correlates of HIV-1 RNA Detection in the Breast Milk of Women Receiving HAART for the Prevention of HIV-1 Transmission	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; VIRAL LOAD; DRUG-RESISTANCE; VIREMIA BLIPS; TYPE-1 RNA; PREGNANCY; PLASMA; DNA	Background: The incidence and correlates of breast milk HIV-1 RNA detection were determined in intensively sampled women receiving highly active antiretroviral therapy (HAART) for the prevention of mother-to-child HIV-1 transmission. Methods: Women initiated HAART at 34 weeks of pregnancy. Breast milk was collected every 2-5 days during 1 month postpartum for measurements of cell-associated HIV DNA and cell-free HIV RNA. Plasma and breast milk were also collected at 2 weeks, 1, 3 and 6 months for concurrent HIV-1 RNA and DNA measurements. Regression was used to identify cofactors for breast milk HIV-1 RNA detection. Results: Of 259 breast milk specimens from 25 women receiving HAART, 34 had detectable HIV-1 RNA (13%, incidence 1.4 episodes/100 person-days 95% CI = 0.97-1.9). Fourteen of 25 (56%) women had detectable breast milk HIV-1 RNA [mean 2.5 log(10) copies/ml (range 2.0-3.9)] at least once. HIV-1 DNA was consistently detected in breast milk cells despite HAART, and increased slowly over time, at a rate of approximately 1 copy/10(6) cells per day (p = 0.02). Baseline CD4, plasma viral load, HAART duration, and frequency of breast problems were similar in women with and without detectable breast milk HIV-1 RNA. Women with detectable breast milk HIV-1 RNA were more likely to be primiparous than women without (36% vs 0%, p = 0.05). Plasma HIV-1 RNA detection (OR = 9.0, 95% CI = 1.8-44) and plasma HIV-1 RNA levels (OR = 12, 95% CI = 2.5-56) were strongly associated with concurrent detection of breast milk HIV-1 RNA. However, no association was found between breast milk HIV-1 DNA level and concurrent breast milk HIV-1 RNA detection (OR = 0.96, 95% CI = 0.54-1.7). Conclusions: The majority of women on HAART had episodic detection of breast milk HIV-1 RNA. Breast milk HIV-1 RNA detection was associated with systemic viral burden rather than breast milk HIV-1 DNA.	[Slyker, Jennifer A.; Chung, Michael H.; Holte, Sarah; Tapia, Kenneth; John-Stewart, Grace] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chung, Michael H.; John-Stewart, Grace] Univ Washington, Dept Med, Seattle, WA USA; [Kinuthia, John] Kenyatta Natl Hosp, Dept Obstet & Gynaecol, Nairobi, Kenya; [Lehman, Dara A.; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Kiarie, James; Njiri, Francis] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Holte, Sarah] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chung, Michael H.; John-Stewart, Grace] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenyatta National Hospital; Fred Hutchinson Cancer Center; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Slyker, JA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jslyker@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Slyker, Jennifer/J-5439-2018	kiarie, james/0000-0003-4180-7858; John-Stewart, Grace/0000-0002-4301-1573	Elizabeth Glaser Pediatric AIDS Foundation [11-03]; National Institute of Child Health and Disease, National Institutes of Health (NIH) [K24HD054314]; National Institute of Allergy and Infectious Diseases, NIH [K01AI087369, K23AI065222]; University of Washington Center for AIDS Research (CFAR); NIH [P30 AI027757]; NIH National Institute of Allergy and Infectious Diseases; NIH National Cancer Institute; NIH National Institute of Mental Health; NIH National Institute on Drug Abuse; NIH National Institute of Child Health and Human Development (NICHD); NIH National Heart, Lung, and Blood Institute; NIH National Center for Complementary and Alternative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI065222, K01AI087369] Funding Source: NIH RePORTER	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Child Health and Disease, National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible with support from an Elizabeth Glaser Pediatric AIDS Foundation Scientist Award (#11-03) and grant K24HD054314 from the National Institute of Child Health and Disease, National Institutes of Health (NIH); PI GJ-S. JS is supported by K01AI087369 and MC is supported by K23AI065222, both from National Institute of Allergy and Infectious Diseases, NIH. This research was also supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute, National Center for Complementary and Alternative Medicine). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NICHD. The funding sources were not involved in the analyses or interpretation of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benki S, 2006, J CLIN MICROBIOL, V44, P4357, DOI 10.1128/JCM.01481-06; Chama CM, 2010, J OBSTET GYNAECOL, V30, P362, DOI 10.3109/01443611003672104; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chung MH, 2008, ANTIVIR THER, V13, P799; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Giuliano M, 2007, JAIDS-J ACQ IMM DEF, V44, P286, DOI 10.1097/QAI.0b013e31802c5441; Gray RR, 2011, AIDS, V25, P143, DOI 10.1097/QAD.0b013e328340fdaf; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Jones LE, 2007, JAIDS-J ACQ IMM DEF, V45, P483, DOI 10.1097/QAI.0b013e3180654836; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Lehman DA, 2008, AIDS, V22, P1475, DOI 10.1097/QAD.0b013e328302cc11; Macias J, 2005, J INFECTION, V51, P195, DOI 10.1016/j.jinf.2004.11.010; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Panteleeff DD, 1999, J CLIN MICROBIOL, V37, P350, DOI 10.1128/JCM.37.2.350-353.1999; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Phiri W, 2006, AIDS RES HUM RETROV, V22, P607, DOI 10.1089/aid.2006.22.607; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; WEINBERG A, 2009, INFECT DIS OBSTET GY; World Health Organization, 2021, ANT DRUGS TREAT PREG	28	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29777	10.1371/journal.pone.0029777	http://dx.doi.org/10.1371/journal.pone.0029777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253778	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700050
J	Terhzaz, S; Cabrero, P; Robben, JH; Radford, JC; Hudson, BD; Milligan, G; Dow, JAT; Davies, SA				Terhzaz, Selim; Cabrero, Pablo; Robben, Joris H.; Radford, Jonathan C.; Hudson, Brian D.; Milligan, Graeme; Dow, Julian A. T.; Davies, Shireen-A.			Mechanism and Function of Drosophila capa GPCR: A Desiccation Stress-Responsive Receptor with Functional Homology to Human NeuromedinU Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; BIOLUMINESCENCE-RESONANCE; MALPIGHIAN TUBULES; DRUG-DISCOVERY; MELANOGASTER; IDENTIFICATION; EXPRESSION; NEUROPEPTIDE; PEPTIDES	The capa peptide receptor, capaR (CG14575), is a G-protein coupled receptor (GPCR) for the D. melanogaster capa neuropeptides, Drm-capa-1 and -2 (capa-1 and -2). To date, the capa peptide family constitutes the only known nitridergic peptides in insects, so the mechanisms and physiological function of ligand-receptor signalling of this peptide family are of interest. Capa peptide induces calcium signaling via capaR with EC50 values for capa-1 = 3.06 nM and capa-2 = 4.32 nM. capaR undergoes rapid desensitization, with internalization via a b-arrestin-2 mediated mechanism but is rapidly re-sensitized in the absence of capa-1. Drosophila capa peptides have a C-terminal FPRXamide motif and insect-PRXamide peptides are evolutionarily related to vertebrate peptide neuromedinU (NMU). Potential agonist effects of human NMU-25 and the insect -PRLamides [Drosophila pyrokinins Drm-PK-1 (capa-3), Drm-PK-2 and hugin-gamma [hugg]] against capaR were investigated. NMU-25, but not hugg nor Drm-PK-2, increases intracellular calcium ([Ca2+](i)) levels via capaR. In vivo, NMU-25 increases [Ca2+](i) and fluid transport by the Drosophila Malpighian (renal) tubule. Ectopic expression of human NMU receptor 2 in tubules of transgenic flies results in increased [Ca2+](i) and fluid transport. Finally, anti-porcine NMU-8 staining of larval CNS shows that the most highly immunoreactive cells are capa-producing neurons. These structural and functional data suggest that vertebrate NMU is a putative functional homolog of Drm-capa-1 and -2. capaR is almost exclusively expressed in tubule principal cells; cell-specific targeted capaR RNAi significantly reduces capa-1 stimulated [Ca2+](i) and fluid transport. Adult capaR RNAi transgenic flies also display resistance to desiccation. Thus, capaR acts in the key fluid-transporting tissue to regulate responses to desiccation stress in the fly.	[Terhzaz, Selim; Cabrero, Pablo; Radford, Jonathan C.; Hudson, Brian D.; Milligan, Graeme; Dow, Julian A. T.; Davies, Shireen-A.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Robben, Joris H.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	University of Glasgow; Radboud University Nijmegen	Terhzaz, S (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Selim.Terhzaz@glasgow.ac.uk; Shireen.Davies@glasgow.ac.uk	Hudson, B. D./H-4845-2013; Milligan, Graeme/F-9426-2011; Radford, Jonathan/AAN-5046-2020; Dow, Julian/M-2371-2019	Hudson, B. D./0000-0001-7059-0091; Milligan, Graeme/0000-0002-6946-3519; Dow, Julian/0000-0002-9595-5146; Terhzaz, Selim/0000-0002-6192-6558; Cabrero, Pablo/0000-0003-2141-7852	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G020620]; Biotechnology and Biological Sciences Research Council [BB/G020620/1] Funding Source: researchfish; BBSRC [BB/G020620/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) project grant BB/G020620 to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2004, PHARMACOLOGY, V72, P33, DOI 10.1159/000078630; Bader R, 2007, FLY, V1, P228, DOI 10.4161/fly.4749; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Broderick KE, 2004, J BIOL CHEM, V279, P8159, DOI 10.1074/jbc.M304679200; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHEUNG CC, 1992, FEBS LETT, V313, P165, DOI 10.1016/0014-5793(92)81436-P; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Davies SA, 2009, J EXP BIOL, V212, P387, DOI 10.1242/jeb.024513; Day JR, 2008, BIOCHEM J, V414, P363, DOI 10.1042/BJ20080560; Deen PMT, 2002, AM J PHYSIOL-RENAL, V282, pF330, DOI 10.1152/ajprenal.0168.2001; DOW JAT, 1994, J EXP BIOL, V197, P421; Dow JAT, 2011, ELS; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gilleard JS, 2005, TRENDS PARASITOL, V21, P302, DOI 10.1016/j.pt.2005.05.007; GIULIANO E, 2008, PROTEOMICS, V8, P4012; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Jurenka R, INSECT MOL BIOL, V20, P323; Kahsai L, PLOS ONE, V5; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Melcher C, 2006, PLOS BIOL, V4, P316, DOI 10.1371/journal.pbio.0040068; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Milligan G, 2004, EUR J PHARM SCI, V21, P397, DOI 10.1016/j.ejps.2003.11.010; Olsen SS, 2007, BIOCHEM BIOPH RES CO, V362, P245, DOI 10.1016/j.bbrc.2007.06.190; Paluzzi JP, 2010, P NATL ACAD SCI USA, V107, P10290, DOI 10.1073/pnas.1003666107; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pollock VP, 2004, J EXP BIOL, V207, P4135, DOI 10.1242/jeb.01255; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Roman G, 2000, GENETICS, V155, P1281; Rosay P, 1997, J CELL SCI, V110, P1683; Southall TD, 2006, PHYSIOL GENOMICS, V26, P35, DOI 10.1152/physiolgenomics.00038.2006; Terhzaz S, 2009, PHYSL GENOMICS; Terhzaz S, 2006, J BIOL CHEM, V281, P18849, DOI 10.1074/jbc.M603002200; Terhzaz S, 2010, CELL SIGNAL, V22, P737, DOI 10.1016/j.cellsig.2009.12.009; Xu TR, 2008, BIOCHEM J, V413, P51, DOI 10.1042/BJ20080685	42	66	66	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29897	10.1371/journal.pone.0029897	http://dx.doi.org/10.1371/journal.pone.0029897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253819	Green Published, Green Accepted, gold			2022-12-25	WOS:000301355700063
J	Xia, KF; Wang, R; Ou, XJ; Fang, ZM; Tian, CG; Duan, J; Wang, YQ; Zhang, MY				Xia, Kuaifei; Wang, Ren; Ou, Xiaojin; Fang, Zhongming; Tian, Changen; Duan, Jun; Wang, Yaqin; Zhang, Mingyong			OsTIR1 and OsAFB2 Downregulation via OsmiR393 Overexpression Leads to More Tillers, Early Flowering and Less Tolerance to Salt and Drought in Rice	PLOS ONE			English	Article							PLANT MICRORNAS; SMALL RNAS; AUXIN; GENE; ARABIDOPSIS; TIME; STRESS; EXPRESSION; SALINITY; IDENTIFICATION	The microRNA miR393 has been shown to play a role in plant development and in the stress response by targeting mRNAs that code for the auxin receptors in Arabidopsis. In this study, we verified that two rice auxin receptor gene homologs (OsTIR1 and OsAFB2) could be targeted by OsmiR393 (Os for Oryza sativa). Two new phenotypes (increased tillers and early flowering) and two previously observed phenotypes (reduced tolerance to salt and drought and hyposensitivity to auxin) were observed in the OsmiR393-overexpressing rice plants. The OsmiR393-overexpressing rice demonstrated hyposensitivity to synthetic auxin-analog treatments. These data indicated that the phenotypes of OsmiR393-overexpressing rice may be caused through hyposensitivity to the auxin signal by reduced expression of two auxin receptor genes (OsTIR1 and OsAFB2). The expression of an auxin transporter (OsAUX1) and a tillering inhibitor (OsTB1) were downregulated by overexpression of OsmiR393, which suggested that a gene chain from OsmiR393 to rice tillering may be from OsTIR1 and OsAFB2 to OsAUX1, which affected the transportation of auxin, then to OsTB1, which finally controlled tillering. The positive phenotypes (increased tillers and early flowering) and negative phenotypes (reduced tolerance to salt and hyposensitivity to auxin) of OsmiR393-overexpressing rice present a dilemma for molecular breeding.	[Xia, Kuaifei; Wang, Ren; Ou, Xiaojin; Fang, Zhongming; Duan, Jun; Zhang, Mingyong] Chinese Acad Sci, S China Bot Garden, Key Lab S China Agr Plant Genet & Breeding, Guangzhou, Guangdong, Peoples R China; [Xia, Kuaifei; Duan, Jun; Zhang, Mingyong] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Wang, Ren; Ou, Xiaojin; Fang, Zhongming] Chinese Acad Sci, Grad Univ, Guangzhou, Guangdong, Peoples R China; [Tian, Changen] Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Yaqin] S China Normal Univ, Guangdong Key Lab Biotechnol Plant Dev, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou University; South China Normal University	Xia, KF (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab S China Agr Plant Genet & Breeding, Guangzhou, Guangdong, Peoples R China.	576653141@qq.com; zhangmy@scbg.ac.cn	Zhang, Mingyong/GQZ-6217-2022	Zhang, Mingyong/0000-0001-5613-6458	Chinese Academy of Science [KSCX3-EW-N-07]; Chinese Natural Science Foundation (CNSF) [30871583/30900116]; Guangdong Province [8251065005000005/2010B011000009]	Chinese Academy of Science(Chinese Academy of Sciences); Chinese Natural Science Foundation (CNSF)(National Natural Science Foundation of China (NSFC)); Guangdong Province	This study was supported by a grant KSCX3-EW-N-07 from the Chinese Academy of Science, grants 30871583/30900116 from the Chinese Natural Science Foundation (CNSF) and grant (8251065005000005/2010B011000009) from Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar G, 2006, ECOTOXICOLOGY, V15, P443, DOI 10.1007/s10646-006-0079-z; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; Feng XM, 2010, ACTA PHYSIOL PLANT, V32, P997, DOI 10.1007/s11738-010-0490-1; Gao P, 2008, THESIS NE AGR U CHIN, pp71; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gleason C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017245; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Iglesias MJ, 2010, PLANT MOL BIOL, V74, P215, DOI 10.1007/s11103-010-9667-7; KURAISHI S, 1991, PLANT CELL PHYSIOL, V32, P585, DOI 10.1093/oxfordjournals.pcp.a078120; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; [林拥军 Lin Yongjun], 2002, [作物学报, Acta Agronomica Sinica], V28, P294; Moxon S, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-3; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Taiz L, 2006, PLANT PHYSL 2010; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tang GL, 2010, SEMIN CELL DEV BIOL, V21, P782, DOI 10.1016/j.semcdb.2010.07.009; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	51	218	255	9	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					364	373	e30039	10.1371/journal.pone.0030039	http://dx.doi.org/10.1371/journal.pone.0030039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253868	gold, Green Submitted, Green Published			2022-12-25	WOS:000301353900037
J	Femia, AP; Swidsinski, A; Dolara, P; Salvadori, M; Amedei, A; Caderni, G				Femia, Angelo Pietro; Swidsinski, Alexander; Dolara, Piero; Salvadori, Maddalena; Amedei, Amedeo; Caderni, Giovanna			Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; INTESTINAL TUMORIGENESIS; EXPRESSION; MICE; TUMORS; RATS; CARCINOGENESIS; COLITIS	Mucin depleted foci (MDF) are precancerous lesions of the colon in carcinogen-treated rodents and humans at high risk. Since MDF show signs of inflammation we hypothesized that the defective mucous production would expose them to the risk of being penetrated by intestinal bacteria, which can be sensed by Toll-like receptors (Tlrs) and activate inflammatory pathways. To verify this hypothesis we tested the expression of 84 genes coding for Tlrs and associated pathways using RT-qPCR in MDF (n = 7) from 1,2-dimethylhydrazine (DMH)-treated rats. Among the 84 tested genes, 26 were differentially expressed in MDF with 5 genes significantly up-regulated and 21 down-regulated when compared to the normal mucosa. Tlr2, as well as other downstream genes (Map4k4, Hspd1, Irak1, Ube2n), was significantly up-regulated. Among the genes regulating the NFkB pathway, only Map4k4 was significantly up-regulated, while 19 genes were not varied and 6 were down-regulated. Tlr2 protein was weakly expressed both in normal mucosa and MDF. To determine whether inflammation observed in MDF could be caused by bacteria contacting or infiltrating crypts, we performed fluorescence in situ hybridization (FISH) experiments with a rRNA universal bacterial probe. None of the 21 MDF tested, showed bacteria inside the crypts, while among the colonic tumors (n = 15), only one had very few bacteria on the surface and on the surrounding normal mucosa. In conclusion, the up-regulation of Tlr2 in MDF, suggests a link between this receptor and carcinogenesis, possibly related to a defective barrier function of these lesions. The data of FISH experiments do not support the hypothesis that inflammation in MDF and tumors is stimulated by bacterial infiltration.	[Femia, Angelo Pietro; Dolara, Piero; Salvadori, Maddalena; Caderni, Giovanna] Univ Florence, Dept Pharmacol, Florence, Italy; [Swidsinski, Alexander] Charite, Dept Med, Lab Mol Genet Polymicrobial Infect & Bacterial Bi, D-13353 Berlin, Germany; [Swidsinski, Alexander] Charite, Dept Med, Gastroenterol Sect, D-13353 Berlin, Germany; [Amedei, Amedeo] Univ Florence, Dept Internal Med, Florence, Italy; [Amedei, Amedeo] AOUC, Dept Biomed, Florence, Italy	University of Florence; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Caderni, G (corresponding author), Univ Florence, Dept Pharmacol, Florence, Italy.	Giovanna.caderni@unifi.it	Amedei, Amedeo/G-5378-2011	Amedei, Amedeo/0000-0002-6797-9343; Swidsinski, Alexander/0000-0002-7071-0417; CADERNI, GIOVANNA/0000-0002-0039-4738	WCRF NL (World Cancer Research Fund, The Netherlands); AICR (American Institute for Cancer Research); University of Florence	WCRF NL (World Cancer Research Fund, The Netherlands)(Netherlands Government); AICR (American Institute for Cancer Research); University of Florence	This work was supported by WCRF NL (World Cancer Research Fund, The Netherlands) and AICR (American Institute for Cancer Research) and by Fondo Ateneo ex-60% of the University of Florence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahmadi A, 2009, WORLD J GASTROENTERO, V15, P61, DOI 10.3748/wjg.15.61; Caderni G, 2003, CANCER RES, V63, P2388; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Femia AP, 2008, INT J CANCER, V122, P117, DOI 10.1002/ijc.23065; Femia AP, 2007, CANCER RES, V67, P445, DOI 10.1158/0008-5472.CAN-06-3861; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Femia AP, 2009, INT J CANCER, V125, P541, DOI 10.1002/ijc.24417; Femia AP, 2008, CANCER PREV RES, V1, P562, DOI 10.1158/1940-6207.CAPR-08-0125; Femia AP, 2005, INT J CANCER, V116, P9, DOI 10.1002/ijc.20981; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Niedzielska I, 2009, J PHYSIOL PHARMACOL, V60, P65; Pagnini C, 2011, J CLIN GASTROENTEROL, V45, P602, DOI 10.1097/MCG.0b013e31820abf29; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; TANNOCK GW, 1987, APPL ENVIRON MICROB, V53, P1965, DOI 10.1128/AEM.53.8.1965-1968.1987; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598	35	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29918	10.1371/journal.pone.0029918	http://dx.doi.org/10.1371/journal.pone.0029918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242189	Green Published, gold, Green Submitted			2022-12-25	WOS:000312662100046
J	Nandakumar, V; Kelbauskas, L; Hernandez, KF; Lintecum, KM; Senechal, P; Bussey, KJ; Davies, PCW; Johnson, RH; Meldrum, DR				Nandakumar, Vivek; Kelbauskas, Laimonas; Hernandez, Kathryn F.; Lintecum, Kelly M.; Senechal, Patti; Bussey, Kimberly J.; Davies, Paul C. W.; Johnson, Roger H.; Meldrum, Deirdre R.			Isotropic 3D Nuclear Morphometry of Normal, Fibrocystic and Malignant Breast Epithelial Cells Reveals New Structural Alterations	PLOS ONE			English	Article							CARCINOMA IN-SITU; GENE-EXPRESSION; CANCER HETEROGENEITY; IMAGE-ANALYSIS; LESIONS; PROGRESSION; FEATURES; LINES; RECURRENCE; PROFILES	Background: Grading schemes for breast cancer diagnosis are predominantly based on pathologists' qualitative assessment of altered nuclear structure from 2D brightfield microscopy images. However, cells are three-dimensional (3D) objects with features that are inherently 3D and thus poorly characterized in 2D. Our goal is to quantitatively characterize nuclear structure in 3D, assess its variation with malignancy, and investigate whether such variation correlates with standard nuclear grading criteria. Methodology: We applied micro-optical computed tomographic imaging and automated 3D nuclear morphometry to quantify and compare morphological variations between human cell lines derived from normal, benign fibrocystic or malignant breast epithelium. To reproduce the appearance and contrast in clinical cytopathology images, we stained cells with hematoxylin and eosin and obtained 3D images of 150 individual stained cells of each cell type at sub-micron, isotropic resolution. Applying volumetric image analyses, we computed 42 3D morphological and textural descriptors of cellular and nuclear structure. Principal Findings: We observed four distinct nuclear shape categories, the predominant being a mushroom cap shape. Cell and nuclear volumes increased from normal to fibrocystic to metastatic type, but there was little difference in the volume ratio of nucleus to cytoplasm (N/C ratio) between the lines. Abnormal cell nuclei had more nucleoli, markedly higher density and clumpier chromatin organization compared to normal. Nuclei of non-tumorigenic, fibrocystic cells exhibited larger textural variations than metastatic cell nuclei. At p<0.0025 by ANOVA and Kruskal-Wallis tests, 90% of our computed descriptors statistically differentiated control from abnormal cell populations, but only 69% of these features statistically differentiated the fibrocystic from the metastatic cell populations. Conclusions: Our results provide a new perspective on nuclear structure variations associated with malignancy and point to the value of automated quantitative 3D nuclear morphometry as an objective tool to enable development of sensitive and specific nuclear grade classification in breast cancer diagnosis.	[Nandakumar, Vivek; Kelbauskas, Laimonas; Hernandez, Kathryn F.; Lintecum, Kelly M.; Senechal, Patti; Bussey, Kimberly J.; Johnson, Roger H.; Meldrum, Deirdre R.] Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA; [Nandakumar, Vivek; Meldrum, Deirdre R.] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA; [Hernandez, Kathryn F.; Lintecum, Kelly M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Bussey, Kimberly J.] Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ USA; [Davies, Paul C. W.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe	Johnson, RH (corresponding author), Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA.	roger.h.johnson@asu.edu	Bussey, Kimberly J./D-2567-2011	Bussey, Kimberly/0000-0003-1001-8207	National Cancer Institute Center for Convergence of Physical Science and Cancer Biology [U54CA143862]; NATIONAL CANCER INSTITUTE [U54CA143862] Funding Source: NIH RePORTER	National Cancer Institute Center for Convergence of Physical Science and Cancer Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Center for Convergence of Physical Science and Cancer Biology, grant number U54CA143862 (Paul Davies, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2006, JNCI-J NATL CANCER I, V98, P948, DOI 10.1093/jnci/djj295; Axelrod DE, 2008, CANCER INFORM, V6, P99; Bacus JW, 1999, CANCER EPIDEM BIOMAR, V8, P1087; Belien JAM, 2002, CYTOMETRY, V49, P12, DOI 10.1002/cyto.10138; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Bussolati G, 2008, J CELL MOL MED, V12, P209, DOI 10.1111/j.1582-4934.2007.00176.x; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chapman JAW, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-174; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Cui Y, 2007, BREAST CANCER RES TR, V104, P103, DOI 10.1007/s10549-006-9396-4; da Silva VD, 2001, ANAL QUANT CYTOL, V23, P40; Doudkine A., 1995, Pathologica (Genoa), V87, P286; Fauver M, 2005, OPT EXPRESS, V13, P4210, DOI 10.1364/OPEX.13.004210; Ferlay J, 2010, BREAST CANCER EPIDEMIOLOGY, P1, DOI 10.1007/978-1-4419-0685-4_1; Geyer PK, 2011, CURRENT OPINION CELL; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Hoque A, 2001, CANCER EPIDEM BIOMAR, V10, P249; Hsiao YH, 2010, J CANCER, V1, P6; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kak A. C., 2001, PRINCIPLES COMPUTERI; Kemp RA, 2007, J THORAC ONCOL, V2, P993, DOI 10.1097/JTO.0b013e318158d488; Knowles DW, 2006, P NATL ACAD SCI USA, V103, P4445, DOI 10.1073/PNAS.0509944102; Kronqvist P, 1998, BRIT J CANCER, V78, P800, DOI 10.1038/bjc.1998.582; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lim CN, 2006, J CLIN PATHOL, V59, P1283, DOI 10.1136/jcp.2005.035428; Liu SQ, 1997, HISTOCHEM CELL BIOL, V107, P267, DOI 10.1007/s004180050112; Luftner Diana, 2002, Expert Rev Mol Diagn, V2, P23, DOI 10.1586/14737159.2.1.23; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Mariuzzi GM, 1996, PATHOL RES PRACT, V192, P428, DOI 10.1016/S0344-0338(96)80004-5; Mariuzzi L, 2002, MODERN PATHOL, V15, P18, DOI 10.1038/modpathol.3880485; Meyer MG, 2009, PATTERN RECOGN, V42, P141, DOI 10.1016/j.patcog.2008.06.018; Nandakumar V, 2011, CYTOM PART A, V79A, P25, DOI 10.1002/cyto.a.20997; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nyirenda N, 2011, BREAST CANCER RES TR, V126, P345, DOI 10.1007/s10549-010-0914-z; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; Ruiz Amparo, 2002, Breast J, V8, P139, DOI 10.1046/j.1524-4741.2002.08303.x; Siegel R, 2011, CA CANC J CLIN CAAC; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; SOULE HD, 1990, CANCER RES, V50, P6075; Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2; Tan PH, 2001, MODERN PATHOL, V14, P937, DOI 10.1038/modpathol.3880415; Veltri RW, 2005, CANC DRUG DISC DEV, P97; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	47	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29230	10.1371/journal.pone.0029230	http://dx.doi.org/10.1371/journal.pone.0029230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242161	gold, Green Submitted, Green Published			2022-12-25	WOS:000312662100015
J	Alonso-Peral, MM; Oliver, SN; Casao, MC; Greenup, AA; Trevaskis, B				Alonso-Peral, Maria M.; Oliver, Sandra N.; Cristina Casao, M.; Greenup, Aaron A.; Trevaskis, Ben			The Promoter of the Cereal VERNALIZATION1 Gene Is Sufficient for Transcriptional Induction by Prolonged Cold	PLOS ONE			English	Article							OPEN READING FRAMES; VEGETATIVE-PHASE; MOLECULAR-BASIS; BARLEY; EXPRESSION; TRANSITION; DAYLENGTH; UPSTREAM; VRN1; REPRESSOR	The VERNALIZATION1 (VRN1) gene of temperate cereals is transcriptionally activated by prolonged cold during winter (vernalization) to promote flowering. To investigate the mechanisms controlling induction of VRN1 by prolonged cold, different regions of the VRN1 gene were fused to the GREEN FLUORESCENT PROTEIN (GFP) reporter and expression of the resulting gene constructs was assayed in transgenic barley (Hordeum vulgare). A 2 kb segment of the promoter of VRN1 was sufficient for GFP expression in the leaves and shoot apex of transgenic barley plants. Fluorescence increased at the shoot apex prior to inflorescence initiation and was subsequently maintained in the developing inflorescence. The promoter was also sufficient for low-temperature induction of GFP expression. A naturally occurring insertion in the proximal promoter, which is associated with elevated VRN1 expression and early flowering in some spring wheats, did not abolish induction of VRN1 transcription by prolonged cold, however. A translational fusion of the promoter and transcribed regions of VRN1 to GFP, VRN1:: GFP, was localised to nuclei of cells at the shoot apex of transgenic barley plants. The distribution of VRN1:: GFP at the shoot apex was similar to the expression pattern of the VRN1 promoter-GFP reporter gene. Fluorescence from the VRN1:: GFP fusion protein increased in the developing leaves after prolonged cold treatment. These observations suggest that the promoter of VRN1 is targeted by mechanisms that trigger vernalization-induced flowering in economically important temperate cereal crops.	[Alonso-Peral, Maria M.; Oliver, Sandra N.; Cristina Casao, M.; Greenup, Aaron A.; Trevaskis, Ben] Commonwealth Sci & Ind Res Org, Div Plant Ind, Canberra, ACT, Australia; [Cristina Casao, M.] CSIC, Aula Expt Stn, Dept Genet & Plant Prod, Zaragoza, Aragon, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Alonso-Peral, MM (corresponding author), Commonwealth Sci & Ind Res Org, Div Plant Ind, Canberra, ACT, Australia.	Ben.Trevaskis@csiro.au	Trevaskis, Ben/B-5350-2011; Alonso Peral, Maria/C-5123-2011	Trevaskis, Ben/0000-0001-7277-4994; 	Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive; Australian Grains Research and Development Corporation [CSP00131]	Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Grains Research and Development Corporation(Grains R&D Corp)	This research was funded by a Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive postdoctoral fellowship to SNO, then MMA-P. Near-isogenic wheat lines were developed in the project CSP00131, funded by the Australian Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2010, MOL GENET GENOMICS, V283, P223, DOI 10.1007/s00438-009-0510-2; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Golovnina KA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-168; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Greenup AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017900; Greenup AG, 2010, PLANT PHYSIOL, V153, P1062, DOI 10.1104/pp.109.152488; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hemming MN, 2009, MOL GENET GENOMICS, V282, P107, DOI 10.1007/s00438-009-0449-3; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Kane NA, 2007, PLANT J, V51, P670, DOI 10.1111/j.1365-313X.2007.03172.x; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Matthews PR, 2001, MOL BREEDING, V7, P195, DOI 10.1023/A:1011333321893; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pidal B, 2009, J HERED, V100, P355, DOI 10.1093/jhered/esp002; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schmitz J, 2000, PLANT MOL BIOL, V42, P899, DOI 10.1023/A:1006425619953; Seppanen MM, 2010, ANN BOT-LONDON, V106, P697, DOI 10.1093/aob/mcq174; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	41	32	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29456	10.1371/journal.pone.0029456	http://dx.doi.org/10.1371/journal.pone.0029456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242122	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000035
J	Lee, MP; Yutzey, KE				Lee, Mary P.; Yutzey, Katherine E.			Twist1 Directly Regulates Genes That Promote Cell Proliferation and Migration in Developing Heart Valves	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DISEASED AORTIC VALVES; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; COEXPRESSED GENES; EXPRESSION; GROWTH; MORPHOGENESIS; FAMILY	Twist1, a basic helix-loop-helix transcription factor, is expressed in mesenchymal precursor populations during embryogenesis and in metastatic cancer cells. In the developing heart, Twist1 is highly expressed in endocardial cushion (ECC) valve mesenchymal cells and is down regulated during valve differentiation and remodeling. Previous studies demonstrated that Twist1 promotes cell proliferation, migration, and expression of primitive extracellular matrix (ECM) molecules in ECC mesenchymal cells. Furthermore, Twist1 expression is induced in human pediatric and adult diseased heart valves. However, the Twist1 downstream target genes that mediate increased cell proliferation and migration during early heart valve development remain largely unknown. Candidate gene and global gene profiling approaches were used to identify transcriptional targets of Twist1 during heart valve development. Candidate target genes were analyzed for evolutionarily conserved regions (ECRs) containing E-box consensus sequences that are potential Twist1 binding sites. ECRs containing conserved E-box sequences were identified for Twist1 responsive genes Tbx20, Cdh11, Sema3C, Rab39b, and Gadd45a. Twist1 binding to these sequences in vivo was determined by chromatin immunoprecipitation (ChIP) assays, and binding was detected in ECCs but not late stage remodeling valves. In addition identified Twist1 target genes are highly expressed in ECCs and have reduced expression during heart valve remodeling in vivo, which is consistent with the expression pattern of Twist1. Together these analyses identify multiple new genes involved in cell proliferation and migration that are differentially expressed in the developing heart valves, are responsive to Twist1 transcriptional function, and contain Twist1-responsive regulatory sequences.	[Lee, Mary P.; Yutzey, Katherine E.] Cincinnati Childrens Hosp, Med Ctr, Div Mol Cardiovascular Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Mol Cardiovascular Biol, Cincinnati, OH 45229 USA.	Katherine.Yutzey@cchmc.org	Lee, Mary Patricia/W-2710-2018	Lee, Mary Patricia/0000-0002-1160-5166; Yutzey, Katherine/0000-0002-1444-7124	National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL082716]; American Heart Association [MPL 11PRE7240023]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082716] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the National Institutes of Health/National Heart, Lung, and Blood Institute, R01 HL082716 to KEY, and an American Heart Association Great Rivers Affiliate Pre-Doctoral Fellowship to MPL 11PRE7240023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Castanon I, 2001, DEVELOPMENT, V128, P3145; Chakraborty S, 2010, DEV BIOL, V347, P167, DOI 10.1016/j.ydbio.2010.08.021; Chakraborty S, 2008, PHYSIOL GENOMICS, V35, P75, DOI 10.1152/physiolgenomics.90212.2008; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Combs MD, 2011, DEVELOPMENT, V138, P1747, DOI 10.1242/dev.060996; Combs MD, 2009, CIRC RES, V105, P565, DOI 10.1161/CIRCRESAHA.109.196469; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Ehrman LA, 1999, DEV BIOL, V207, P163, DOI 10.1006/dbio.1998.9167; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Feiner L, 2001, DEVELOPMENT, V128, P3061; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; MARTIN KA, 1994, GENE, V142, P275, DOI 10.1016/0378-1119(94)90274-7; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Meyers SG, 2010, DEV BIOL, V346, P224, DOI 10.1016/j.ydbio.2010.07.025; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Oshima A, 2002, J CELL BIOCHEM, V86, P792, DOI 10.1002/jcb.10272; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Wang XY, 2004, J BIOL CHEM, V279, P29606, DOI 10.1074/jbc.M312279200; Wirrig EE, 2011, CARDIOVASC PATHOL, V20, P162, DOI 10.1016/j.carpath.2010.06.010; Wirrig EE, 2011, J MOL CELL CARDIOL, V50, P561, DOI 10.1016/j.yjmcc.2010.12.005; Zhou J, 2006, INVEST OPHTH VIS SCI, V47, P1794, DOI 10.1167/iovs.05-0759; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	48	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29758	10.1371/journal.pone.0029758	http://dx.doi.org/10.1371/journal.pone.0029758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242143	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000060
J	Ucker, DS; Jain, MR; Pattabiraman, G; Palasiewicz, K; Birge, RB; Li, H				Ucker, David S.; Jain, Mohit Raja; Pattabiraman, Goutham; Palasiewicz, Karol; Birge, Raymond B.; Li, Hong			Externalized Glycolytic Enzymes Are Novel, Conserved, and Early Biomarkers of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; PROGRAMMED CELL-DEATH; HUMAN ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BINDING-PROTEIN; CYTOCHROME-C; ANNEXIN-II; TRIOSEPHOSPHATE ISOMERASE; STREPTOCOCCUS-PNEUMONIAE; ENDOPLASMIC-RETICULUM	The intriguing cell biology of apoptotic cell death results in the externalization of numerous autoantigens on the apoptotic cell surface, including protein determinants for specific recognition, linked to immune responses. Apoptotic cells are recognized by phagocytes and trigger an active immunosuppressive response ("innate apoptotic immunity" (IAI)) even in the absence of engulfment. IAI is responsible for the lack of inflammation associated normally with the clearance of apoptotic cells; its failure also has been linked to inflammatory and autoimmune pathology, including systemic lupus erythematosus and rheumatic diseases. Apoptotic recognition determinants underlying IAI have yet to be identified definitively; we argue that these molecules are surface-exposed (during apoptotic cell death), ubiquitously expressed, protease-sensitive, evolutionarily conserved, and resident normally in viable cells (SUPER). Using independent and unbiased quantitative proteomic approaches to characterize apoptotic cell surface proteins and identify candidate SUPER determinants, we made the surprising discovery that components of the glycolytic pathway are enriched on the apoptotic cell surface. Our data demonstrate that glycolytic enzyme externalization is a common and early aspect of cell death in different cell types triggered to die with distinct suicidal stimuli. Exposed glycolytic enzyme molecules meet the criteria for IAI-associated SUPER determinants. In addition, our characterization of the apoptosis-specific externalization of glycolytic enzyme molecules may provide insight into the significance of previously reported cases of plasminogen binding to beta-enolase on mammalian cells, as well as mechanisms by which commensal bacteria and pathogens maintain immune privilege.	[Ucker, David S.; Pattabiraman, Goutham; Palasiewicz, Karol] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Jain, Mohit Raja; Li, Hong] UMDNJ New Jersey Med Sch Canc Ctr, Ctr Adv Prote Res, Newark, NJ 07214 USA; [Jain, Mohit Raja; Birge, Raymond B.; Li, Hong] UMDNJ New Jersey Med Sch Canc Ctr, Dept Biochem & Mol Biol, Newark, NJ 07214 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ucker, DS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol MC 790, 835 S Wolcott, Chicago, IL 60612 USA.	duck@uic.edu; liho2@umdnj.edu	JAIN, MOHIT/E-8230-2012	Pattabiraman, Goutham/0000-0002-5196-8279; Li, Hong/0000-0001-5731-5335; Palasiewicz, Karol/0000-0002-2894-6047	National Institutes of Health [AG029633, NS046593]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG029633 (to D. S. U.) and NS046593 (to H. L., for the support of a UMDNJ Neuroproteomics Core Facility).	Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Barcinski Marcello A, 2003, Kinetoplastid Biol Dis, V2, P6, DOI 10.1186/1475-9292-2-6; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chang SH, 2002, EXP CELL RES, V277, P15, DOI 10.1006/excr.2002.5539; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; D'Herde K, 2000, CELL DEATH DIFFER, V7, P331, DOI 10.1038/sj.cdd.4400655; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Dudani AK, 1996, BRIT J HAEMATOL, V95, P168, DOI 10.1046/j.1365-2141.1996.7482367.x; Eguchi Y, 1997, CANCER RES, V57, P1835; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; FELEZ J, 1993, BLOOD, V82, P2433, DOI 10.1182/blood.V82.8.2433.bloodjournal8282433; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Fujii A, 2005, J NEUROIMMUNOL, V162, P130, DOI 10.1016/j.jneuroim.2005.02.004; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; GilNavarro I, 1997, J BACTERIOL, V179, P4992, DOI 10.1128/jb.179.16.4992-4999.1997; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; Gracy R W, 1975, Methods Enzymol, V41, P442; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Hawley SB, 2000, THROMB HAEMOSTASIS, V84, P882; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Jain MR, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-25; Jain Mohit Raja, 2008, Open Proteomics J, V1, P40, DOI 10.2174/1875039700801010040; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jin M, 2005, PROTEOMICS, V5, P1940, DOI 10.1002/pmic.200401057; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KANAPKA JA, 1971, ARCH BIOCHEM BIOPHYS, V146, P167, DOI 10.1016/S0003-9861(71)80053-X; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lama A, 2009, INFECT IMMUN, V77, P2703, DOI 10.1128/IAI.00157-09; Laster SM, 1996, MICROSC RES TECHNIQ, V34, P272, DOI 10.1002/(SICI)1097-0029(19960615)34:3<272::AID-JEMT10>3.0.CO;2-J; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Manjili MH, 2005, IMMUNOBIOLOGY, V210, P295, DOI 10.1016/j.imbio.2005.04.002; Mannherz HG, 2005, EUR J CELL BIOL, V84, P503, DOI 10.1016/j.ejcb.2004.11.008; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Mullane MJ, 1998, EXP CELL RES, V242, P153, DOI 10.1006/excr.1998.4067; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Oremek GM, 2003, ANTICANCER RES, V23, P1131; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Pratesi F, 2000, J RHEUMATOL, V27, P109; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Roozendaal C, 1998, CLIN EXP IMMUNOL, V112, P10; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sabbatini A, 1997, CLIN EXP RHEUMATOL, V15, P655; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Sasajima T, 2006, J NEUROIMMUNOL, V181, P150, DOI 10.1016/j.jneuroim.2006.09.003; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Srere PA, 1998, TRENDS BIOCHEM SCI, V23, P319, DOI 10.1016/S0968-0004(98)01262-6; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Thorp EB, 2010, APOPTOSIS, V15, P1124, DOI 10.1007/s10495-010-0516-6; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2009, J BIOL CHEM, V284, P5876, DOI 10.1074/jbc.M807756200; Ucker David S., 2009, P163, DOI 10.1007/978-1-4020-9292-3_6; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Xiang Y, 2004, ARTHRITIS RHEUM-US, V50, P1511, DOI 10.1002/art.20189; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	106	41	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10325	10343		10.1074/jbc.M111.314971	http://dx.doi.org/10.1074/jbc.M111.314971			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262862	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000302167200061
J	Dey, SS; Xue, YH; Joachimiak, MP; Friedland, GD; Burnett, JC; Zhou, Q; Arkin, AP; Schaffer, DV				Dey, Siddharth S.; Xue, Yuhua; Joachimiak, Marcin P.; Friedland, Gregory D.; Burnett, John C.; Zhou, Qiang; Arkin, Adam P.; Schaffer, David V.			Mutual Information Analysis Reveals Coevolving Residues in Tat That Compensate for Two Distinct Functions in HIV-1 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA-POLYMERASE-II; CHROMATIN-REMODELING COMPLEX; LONG TERMINAL REPEAT; TYPE-1 SUBTYPE-C; TRANSCRIPTIONAL ACTIVITY; CORRELATED MUTATIONS; PROTEIN; TRANSACTIVATION; PHOSPHORYLATION	Viral genomes are continually subjected to mutations, and functionally deleterious ones can be rescued by reversion or additional mutations that restore fitness. The error prone nature of HIV-1 replication has resulted in highly diverse viral sequences, and it is not clear how viral proteins such as Tat, which plays a critical role in viral gene expression and replication, retain their complex functions. Although several important amino acid positions in Tat are conserved, we hypothesized that it may also harbor functionally important residues that may not be individually conserved yet appear as correlated pairs, whose analysis could yield new mechanistic insights into Tat function and evolution. To identify such sites, we combined mutual information analysis and experimentation to identify coevolving positions and found that residues 35 and 39 are strongly correlated. Mutation of either residue of this pair into amino acids that appear in numerous viral isolates yields a defective virus; however, simultaneous introduction of both mutations into the heterologous Tat sequence restores gene expression close to wild-type Tat. Furthermore, in contrast to most coevolving protein residues that contribute to the same function, structural modeling and biochemical studies showed that these two residues contribute to two mechanistically distinct steps in gene expression: binding P-TEFb and promoting P-TEFb phosphorylation of the C-terminal domain in RNAPII. Moreover, Tat variants that mimic HIV-1 subtypes B or C at sites 35 and 39 have evolved orthogonal strengths of P-TEFb binding versus RNAPII phosphorylation, suggesting that subtypes have evolved alternate transcriptional strategies to achieve similar gene expression levels.	[Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dey, Siddharth S.; Burnett, John C.; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Dey, Siddharth S.; Burnett, John C.; Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Xue, Yuhua; Zhou, Qiang] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Joachimiak, Marcin P.; Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Joachimiak, Marcin P.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Energy, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Friedland, Gregory D.] Joint BioEnergy Inst, Div Technol, Emeryville, CA 94608 USA; [Friedland, Gregory D.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA 94551 USA; [Xue, Yuhua] Xiamen Univ, Sch Pharmaceut Sci, Xiamen 361005, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; Xiamen University	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov; schaffer@berkeley.edu	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Burnett, John/0000-0002-8817-6064; Dey, Siddharth S./0000-0002-1161-1654; joachimiak, marcin/0000-0001-8175-045X	National Institutes of Health [R01GM073058, R01AI41757-11, R01AI41757-11S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073058 (to A. P. A. and D. V. S.) and Grants R01AI41757-11 and R01AI41757-11S1 (to Q. Z.).	Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Cimarelli A, 2000, J VIROL, V74, P4273, DOI 10.1128/JVI.74.9.4273-4283.2000; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; del Alamo M, 2005, J MOL BIOL, V345, P893, DOI 10.1016/j.jmb.2004.10.086; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jain C, 1996, CELL, V87, P115, DOI 10.1016/S0092-8674(00)81328-8; Johnson Victoria A, 2009, Top HIV Med, V17, P138; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; LI NX, 1994, ONCOGENE, V9, P3457; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; Negroni M, 2001, ANNU REV GENET, V35, P275, DOI 10.1146/annurev.genet.35.102401.090551; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; Tachedjian G, 2000, P NATL ACAD SCI USA, V97, P6334, DOI 10.1073/pnas.97.12.6334; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; Verhoef K, 1999, J VIROL, V73, P2781, DOI 10.1128/JVI.73.4.2781-2789.1999; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	51	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7945	7955		10.1074/jbc.M111.302653	http://dx.doi.org/10.1074/jbc.M111.302653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253435	Green Published, hybrid			2022-12-25	WOS:000301349400011
J	Lillehoj, EP; Hyun, SW; Feng, CG; Zhang, L; Liu, AG; Guang, W; Nguyen, C; Luzina, IG; Atamas, SP; Passaniti, A; Twaddell, WS; Puche, AC; Wang, LX; Cross, AS; Goldblum, SE				Lillehoj, Erik P.; Hyun, Sang Won; Feng, Chiguang; Zhang, Lei; Liu, Anguo; Guang, Wei; Nguyen, Chinh; Luzina, Irina G.; Atamas, Sergei P.; Passaniti, Antonino; Twaddell, William S.; Puche, Adam C.; Wang, Lai-Xi; Cross, Alan S.; Goldblum, Simeon E.			NEU1 Sialidase Expressed in Human Airway Epithelia Regulates Epidermal Growth Factor Receptor (EGFR) and MUC1 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA FLAGELLIN; TOLL-LIKE RECEPTOR-5; CELL-SURFACE MUCIN; LYSOSOMAL SIALIDASE; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; ELASTIN RECEPTOR; CANCER CELLS; PARACELLULAR PATHWAY; KINASE ACTIVATION	Epithelial cells (ECs) lining the airways provide a protective barrier between the external environment and the internal host milieu. These same airway epithelia express receptors that respond to danger signals and initiate repair programs. Because the sialylation state of a receptor can influence its function and is dictated in part by sialidase activity, we asked whether airway epithelia express catalytically active sialidase(s). Human primary small airway and A549 ECs expressed NEU1 sialidase at the mRNA and protein levels, and NEU1 accounted for >70% of EC sialidase activity. Blotting with Maackia amurensis and peanut agglutinin lectins established epidermal growth factor receptor (EGFR) and MUC1 as in vivo substrates for NEU1. NEU1 associated with EGFR and MUC1, and NEU1-EGFR association was regulated by EGF stimulation. NEU1 overexpression diminished EGF-stimulated EGFR Tyr-1068 autophosphorylation by up to 44% but enhanced MUC1-dependent Pseudomonas aeruginosa adhesion by 1.6-1.7-fold and flagellin-stimulated ERK1/2 activation by 1.7-1.9-fold. In contrast, NEU1 depletion increased EGFR activation (1.5-fold) and diminished MUC1-mediated bacterial adhesion (38-56%) and signaling (73%). These data indicate for the first time that human airway epithelia express catalytically active NEU1 sialidase that regulates EGFR-and MUC1-dependent signaling and bacterial adhesion. NEU1 catalytic activity may offer an additional level of regulation over the airway epithelial response to ligands, pathogens, and injurious stimuli.	[Lillehoj, Erik P.; Hyun, Sang Won; Liu, Anguo; Nguyen, Chinh; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Lillehoj, Erik P.; Guang, Wei] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Luzina, Irina G.; Atamas, Sergei P.; Cross, Alan S.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Passaniti, Antonino; Twaddell, William S.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Feng, Chiguang; Zhang, Lei; Cross, Alan S.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Wang, Lai-Xi/E-8755-2019; Wang, Lai-Xi/E-8790-2019; Wang, Xin/AAN-8435-2021; wang, xl/Y-8251-2019	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	National Institutes of Health [HL084223, HL070155, AI072291, AI083463, HL086933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933, R01HL070155, R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083463, R21AI072291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant HL084223 and HL070155 (to S. E. G.), AI072291 and AI083463 (to E. P. L.), and HL086933 (to A. S. C.).	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Antonicelli F, 2009, WOUND REPAIR REGEN, V17, P631, DOI 10.1111/j.1524-475X.2009.00525.x; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Champigny MJ, 2003, GENE, V319, P177, DOI 10.1016/S0378-1119(03)00808-4; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Costa NR, 2008, WORLD J GASTROENTERO, V14, P1411, DOI 10.3748/wjg.14.1411; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; d'Azzo A, 2010, BIOCHEM SOC T, V38, P1453, DOI 10.1042/BST0381453; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gallego MP, 2006, COLLOID SURFACE B, V52, P154, DOI 10.1016/j.colsurfb.2006.04.013; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Guang W, 2010, J BIOL CHEM, V285, P20547, DOI 10.1074/jbc.M110.121319; Gupta SK, 1997, INFECT IMMUN, V65, P2747, DOI 10.1128/IAI.65.7.2747-2753.1997; HANISCH FG, 1995, CANCER RES, V55, P4036; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kato Kosuke, 2010, Front Biosci (Elite Ed), V2, P68, DOI 10.2741/e67; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; KAWAGUCHI T, 1974, J BIOL CHEM, V249, P2786; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lillehoj EP, 2001, AM J PHYSIOL-LUNG C, V280, pL181, DOI 10.1152/ajplung.2001.280.1.L181; Lindorfer MA, 2001, J IMMUNOL, V167, P2240, DOI 10.4049/jimmunol.167.4.2240; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Meuillet EJ, 1999, CANCER RES, V59, P234; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 1999, GLYCOBIOLOGY, V9, P1313, DOI 10.1093/glycob/9.12.1313; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; MORREAU H, 1992, J BIOL CHEM, V267, P17949; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parker P, 2010, GLYCOCONJUGATE J, V27, P89, DOI 10.1007/s10719-009-9269-2; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; SAIMAN L, 1993, J CLIN INVEST, V92, P1875, DOI 10.1172/JCI116779; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Starcher B, 2008, AM J PHYSIOL-LUNG C, V295, pL637, DOI 10.1152/ajplung.90346.2008; Steelant WFA, 1999, CLIN EXP METASTAS, V17, P245, DOI 10.1023/A:1006639804430; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Uehara F, 2002, JPN J OPHTHALMOL, V46, P237, DOI 10.1016/S0021-5155(02)00472-0; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; Wu WY, 1997, GLYCOBIOLOGY, V7, P349, DOI 10.1093/glycob/7.3.349; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	80	59	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8214	8231		10.1074/jbc.M111.292888	http://dx.doi.org/10.1074/jbc.M111.292888			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247545	Green Published, hybrid			2022-12-25	WOS:000301349400037
J	Storti, B; Bizzarri, R; Cardarelli, F; Beltram, F				Storti, Barbara; Bizzarri, Ranieri; Cardarelli, Francesco; Beltram, Fabio			Intact Microtubules Preserve Transient Receptor Potential Vanilloid 1 (TRPV1) Functionality through Receptor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; CHANNEL; FRET; NUMBER; IDENTIFICATION; ORGANIZATION; BRIGHTNESS; ACTIVATION; PROTEINS; DYNAMICS	The transient receptor potential cation channel subfamily V member 1 (TRPV1) is a protein currently under scrutiny as a pharmacological target for pain management therapies. Recently, the role of TRPV1-microtubule interaction in transducing nociception stimuli to cells by cytoskeletal rearrangement was proposed. In this work, we investigate TRPV1-microtubule interaction in living cells under the resting or activated state of TRPV1, as well as in presence of structurally intact or depolymerized cytoskeletal microtubules. We combined a tool-box of high resolution/high sensitivity fluorescence imaging techniques (such as FRET, correlation spectroscopy, and fluorescence anisotropy) to monitor TRPV1 aggregation status, membrane mobility, and interaction with microtubules. We found that TRPV1 is a dimeric membrane protein characterized by two populations with different diffusion properties in basal condition. After stimulation with resiniferatoxin, TRPV1 dimers tetramerize. The tetramers and the slower population of TRPV1 dimers bind dynamically to intact microtubules but not to tubulin dimers. Upon microtubule disassembly, the interaction with TRPV1 is lost thereby inducing receptor self-aggregation with partial loss of functionality. Intact microtubules play an essential role in maintaining TRPV1 functionality toward activation stimuli. This previously undisclosed property mirrors the recently reported role of TRPV1 in modulating microtubule assembly/disassembly and suggests the participation of these two players in a feedback cycle linking nociception and cytoskeletal remodeling.	[Storti, Barbara; Bizzarri, Ranieri; Beltram, Fabio] Scuola Normale Super Pisa, Natl Enterprise NanoSci & NanoTechnol NEST, I-56127 Pisa, Italy; [Storti, Barbara; Bizzarri, Ranieri; Beltram, Fabio] CNR, Ist Nanosci, I-56127 Pisa, Italy; [Storti, Barbara; Bizzarri, Ranieri; Cardarelli, Francesco; Beltram, Fabio] Ist Italiano Tecnol, Ctr Nanotechnol Innovat, NEST, I-56127 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Storti, B (corresponding author), Scuola Normale Super Pisa, Natl Enterprise NanoSci & NanoTechnol NEST, Piazza S Silvestro 12, I-56127 Pisa, Italy.	barbara.storti@sns.it	Storti, Barbara/AAB-7791-2019; Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/ABH-8343-2020; Bizzarri, Ranieri/H-1779-2011	Storti, Barbara/0000-0002-2758-0426; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672	Italian Ministry for University and Research [RBLA03ER38, RBPR05JH2P, PRIN 2008JZ4MLB_002]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for University and Research under the framework of FIRB Projects RBLA03ER38, RBPR05JH2P, and PRIN 2008JZ4MLB_002.	Abbruzzetti S, 2010, PHOTOCH PHOTOBIO SCI, V9, P1307, DOI 10.1039/c0pp00189a; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; MILLS JW, 1994, FASEB J, V8, P1161, DOI 10.1096/fasebj.8.14.7958622; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Tramier M, 2008, METHOD CELL BIOL, V85, P395, DOI 10.1016/S0091-679X(08)85017-0; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	36	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7803	7811		10.1074/jbc.M111.332296	http://dx.doi.org/10.1074/jbc.M111.332296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262838	hybrid, Green Published			2022-12-25	WOS:000301060200078
J	Wu, ZP; Aron, AW; Macksoud, EE; Iozzo, RV; Hai, CM; Lechner, BE				Wu, Zhiping; Aron, Abraham W.; Macksoud, Elyse E.; Iozzo, Renato V.; Hai, Chi-Ming; Lechner, Beatrice E.			Uterine Dysfunction in Biglycan and Decorin Deficient Mice Leads to Dystocia during Parturition	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; PROTEOGLYCAN BIGLYCAN; TARGETED DISRUPTION; COLLAGEN FIBRILS; KNOCKOUT MICE; FIBROBLASTS; EXPRESSION; PREGNANCY; CONTRACTILITY; FIBROMODULIN	Cesarean birth rates are rising. Uterine dysfunction, the exact mechanism of which is unknown, is a common indication for Cesarean delivery. Biglycan and decorin are two small leucine-rich proteoglycans expressed in the extracellular matrix of reproductive tissues and muscle. Mice deficient in biglycan display a mild muscular dystrophy, and, along with mice deficient in decorin, are models of Ehlers-Danlos Syndrome, a connective tissue anomaly associated with uterine rupture. As a variant of Ehlers-Danlos Syndrome is caused by a genetic mutation resulting in abnormal biglycan and decorin secretion, we hypothesized that biglycan and decorin play a role in uterine function. Thus, we assessed wild-type, biglycan, decorin and double knockout pregnancies for timing of birth and uterine function. Uteri were harvested at embryonic days 12, 15 and 18. Nonpregnant uterine samples of the same genotypes were assessed for tissue failure rate and spontaneous and oxytocin-induced contractility. We discovered that biglycan/decorin mixed double-knockout dams displayed dystocia, were at increased risk of delayed labor onset, and showed increased tissue failure in a predominantly decorin-dependent manner. In vitro spontaneous uterine contractile amplitude and oxytocin-induced contractile force were decreased in all biglycan and decorin knockout genotypes compared to wild-type. Notably, we found no significant compensation between biglycan and decorin using quantitative real time PCR or immunohistochemistry. We conclude that the biglycan/decorin mixed double knockout mouse is a model of dystocia and delayed labor onset. Moreover, decorin is necessary for uterine function in a dose-dependent manner, while biglycan exhibits partial compensatory mechanisms in vivo. Thus, this model is poised for use as a model for testing novel targets for preventive or therapeutic manipulation of uterine dysfunction.	[Wu, Zhiping; Aron, Abraham W.; Macksoud, Elyse E.; Lechner, Beatrice E.] Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Providence, RI 02912 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Hai, Chi-Ming] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Jefferson University; Brown University	Wu, ZP (corresponding author), Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Providence, RI 02912 USA.	blechner@wihri.org	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112	National Institute of Child Health and Human Development [1K08HD054676]; National Cancer Institute [R01CA39481]; National Heart, Lung and Blood Institute [R56HL-52714]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD054676] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL052714] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Child Health and Human Development 1K08HD054676, National Cancer Institute R01CA39481 and National Heart, Lung and Blood Institute R56HL-52714 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Calmus ML, 2011, REPRODUCTION; Chen CP, 2007, PLACENTA, V28, P97, DOI 10.1016/j.placenta.2006.02.009; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Choudhury AP, 2009, J OBSTET GYNAECOL, V29, P714, DOI 10.3109/01443610903191269; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Erez Y, 2008, FETAL DIAGN THER, V23, P7, DOI 10.1159/000109218; Fonseca V, 2010, VASC PHARMACOL, V52, P215, DOI 10.1016/j.vph.2009.12.005; Gogiel T, 2003, INT J BIOCHEM CELL B, V35, P1461, DOI 10.1016/S1357-2725(03)00128-6; Gogiel T, 2000, ACTA BIOCHIM POL, V47, P1081, DOI 10.18388/abp.2000_3961; Hayashi Y, 2005, DEV BIOL, V277, P222, DOI 10.1016/j.ydbio.2004.09.022; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hjelm AM, 2002, EUR J OBSTET GYN R B, V100, P146, DOI 10.1016/S0301-2115(01)00476-6; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 2010, FEBS J; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kimura T, 1999, REV REPROD, V4, P73, DOI 10.1530/ror.0.0040073; KRESSE H, 1987, AM J HUM GENET, V41, P436; Lechner BE, 2006, MUSCLE NERVE, V34, P347, DOI 10.1002/mus.20596; Lind J, 2002, ACTA OBSTET GYN SCAN, V81, P293, DOI 10.1034/j.1600-0412.2002.810403.x; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lowe NK, 2011, MED HYPOTHESES, V76, P755, DOI 10.1016/j.mehy.2011.02.018; Main DM, 2000, AM J OBSTET GYNECOL, V182, P1312, DOI 10.1067/mob.2000.106249; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Pierce SL, 2008, BIOL REPROD, V78, P1058, DOI 10.1095/biolreprod.107.066423; Ploeckinger B, 1997, AM J PERINAT, V14, P99, DOI 10.1055/s-2007-994106; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Roop KA, 1999, AM J OBSTET GYNECOL, V181, P752, DOI 10.1016/S0002-9378(99)70524-7; San Martin S, 2003, CELL MOL BIOL, V49, P673; San Martin S, 2003, REPRODUCTION, V125, P585, DOI 10.1530/rep.0.1250585; Sanches JC, J ANAT, V216, P144; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Valiyaveettil M, 2004, GLYCOCONJUGATE J, V21, P361, DOI 10.1023/B:GLYC.0000046276.77147.b2; Wadhwa S, 2004, CRIT REV EUKAR GENE, V14, P301, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.50; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; WRAY S, 1993, AM J PHYSIOL, V264, pC1, DOI 10.1152/ajpcell.1993.264.1.C1; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352	47	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29627	10.1371/journal.pone.0029627	http://dx.doi.org/10.1371/journal.pone.0029627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253749	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500015
J	Mogensen, SS; Aksglaede, L; Mouritsen, A; Sorensen, K; Main, KM; Gideon, P; Juul, A				Mogensen, Signe Sloth; Aksglaede, Lise; Mouritsen, Annette; Sorensen, Kaspar; Main, Katharina M.; Gideon, Peter; Juul, Anders			Pathological and Incidental Findings on Brain MRI in a Single-Center Study of 229 Consecutive Girls with Early or Precocious Puberty	PLOS ONE			English	Article							SEXUAL PRECOCITY; HORMONE; DIAGNOSIS; CHILDREN; AGE; MANAGEMENT; ETIOLOGY; GROWTH; TUMORS	Central precocious puberty may result from organic brain lesions, but is most frequently of idiopathic origin. Clinical or biochemical factors which could predict a pathological brain MRI in girls with CPP have been searched for. With the recent decline in age at pubertal onset among US and European girls, it has been suggested that only girls with CPP below 6 years of age should have brain MRI performed. Objective: To evaluate the outcome of brain MRI in girls referred with early signs of puberty in relation to age at presentation as well as clinical and biochemical parameters. Method: A single-center study of 229 consecutive girls with early or precocious puberty who had brain imaging performed. We evaluated medical history, clinical and biochemical factors, and four groups were defined based on the outcome of their MRI. Results: Thirteen out of 208 (6.3%) girls with precocious puberty, but no other sign of CNS symptoms, had a pathological brain MRI. Importantly, all 13 girls were above 6 years of age, and 6 girls were even 8-9 years old. Twenty girls (9.6%) had incidental findings on brain MRI. Furthermore, 21 girls had known CNS pathology at time of evaluation. Basal LH was significantly higher in girls with newly diagnosed CNS pathology compared to girls with a non-pathological MRI (p = 0.025); no cut of value was found as values overlapped. Conclusion: A high frequency of 6-8 year old girls with precocious puberty in our study had a pathological brain MRI, which could not be predicted from any clinical nor biochemical parameters. Thus, we believe that girls with precocious pubertal development of central origin before 8 years of age should continue to be examined by a brain MRI.	[Mogensen, Signe Sloth; Aksglaede, Lise; Mouritsen, Annette; Sorensen, Kaspar; Main, Katharina M.; Juul, Anders] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Gideon, Peter] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Radiol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Mogensen, SS (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark.	anders.juul@rh.regionh.dk	Aksglaede, Lise/AAI-7163-2020; Juul, Anders/F-5864-2013	Juul, Anders/0000-0002-0534-4350; Main, Katharina Maria/0000-0001-7259-1039; Sloth, Signe/0000-0002-3758-3807; Mouritsen, Annette/0000-0001-7574-2752				Adan L, 2000, EUR J PEDIATR, V159, P348, DOI 10.1007/s004310051285; Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Andersen E, 1974, Ugeskr Laeger, V136, P2796; Argyropoulou MI, 2005, PEDIATR RADIOL, V35, P1045, DOI 10.1007/s00247-005-1512-9; Biro FM, 2010, PEDIATRICS; BRIDGES NA, 1994, ARCH DIS CHILD, V70, P116, DOI 10.1136/adc.70.2.116; Brito VN, 2008, ARQ BRAS ENDOCRINOL, V52, P18, DOI 10.1590/S0004-27302008000100005; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; Chalumeau M, 2002, PEDIATRICS, V109, P61, DOI 10.1542/peds.109.1.61; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; Choi JH, 2007, PEDIATR INT, V49, P806, DOI 10.1111/j.1442-200X.2007.02475.x; Cisternino M, 2000, J PEDIATR ENDOCR MET, V13, P695; Fahmy JL, 2000, BRIT J RADIOL, V73, P560, DOI 10.1259/bjr.73.869.10884758; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Guillamo JS, 2003, BRAIN, V126, P152, DOI 10.1093/brain/awg016; Huang HP, 2004, PEDIATR NEUROL, V30, P143, DOI 10.1016/S0887-8994(03)00418-1; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; KORNREICH L, 1995, PEDIATR RADIOL, V25, P7, DOI 10.1007/BF02020830; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Mogensen SS, 2011, J CLIN ENDOCR METAB, V96, P1393, DOI 10.1210/jc.2010-2745; NEELY EK, 1995, J PEDIATR-US, V127, P47, DOI 10.1016/S0022-3476(95)70255-5; Ng SM, 2003, ARCH DIS CHILD, V88, P414, DOI 10.1136/adc.88.5.414; Nysom Karsten, 2002, Ugeskr Laeger, V164, P5773; Partsch CJ, 2002, CLIN ENDOCRINOL, V56, P129, DOI 10.1046/j.0300-0664.2001.01490.x; RIETH KG, 1987, AM J ROENTGENOL, V148, P1231, DOI 10.2214/ajr.148.6.1231; Rivarola MA, 2001, ACTA PAEDIATR, V90, P751, DOI 10.1080/080352501750315654; Sehested A, 2000, J CLIN ENDOCR METAB, V85, P1634, DOI 10.1210/jc.85.4.1634; Soriano-Guillen L, 2010, J CLIN ENDOCRINOL ME; Stanhope R, 2003, J PEDIATR-US, V143, P426, DOI 10.1067/S0022-3476(03)00492-X; Taher BM, 2004, EUR J CLIN INVEST, V34, P599, DOI 10.1111/j.1365-2362.2004.01399.x; Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x	33	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29829	10.1371/journal.pone.0029829	http://dx.doi.org/10.1371/journal.pone.0029829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253792	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100023
J	Barraquand, F; Murrell, DJ				Barraquand, Frederic; Murrell, David J.			Intense or Spatially Heterogeneous Predation Can Select against Prey Dispersal	PLOS ONE			English	Article							EVOLUTION; DYNAMICS; POPULATIONS; MODELS; RISK; CONSEQUENCES; ENVIRONMENTS; STRATEGIES; PATTERN; BIRDS	Dispersal theory generally predicts kin competition, inbreeding, and temporal variation in habitat quality should select for dispersal, whereas spatial variation in habitat quality should select against dispersal. The effect of predation on the evolution of dispersal is currently not well-known: because predation can be variable in both space and time, it is not clear whether or when predation will promote dispersal within prey. Moreover, the evolution of prey dispersal affects strongly the encounter rate of predator and prey individuals, which greatly determines the ecological dynamics, and in turn changes the selection pressures for prey dispersal, in an eco-evolutionary feedback loop. When taken all together the effect of predation on prey dispersal is rather difficult to predict. We analyze a spatially explicit, individual-based predator-prey model and its mathematical approximation to investigate the evolution of prey dispersal. Competition and predation depend on local, rather than landscape-scale densities, and the spatial pattern of predation corresponds well to that of predators using restricted home ranges (e. g. central-place foragers). Analyses show the balance between the level of competition and predation pressure an individual is expected to experience determines whether prey should disperse or stay close to their parents and siblings, and more predation selects for less prey dispersal. Predators with smaller home ranges also select for less prey dispersal; more prey dispersal is favoured if predators have large home ranges, are very mobile, and/or are evenly distributed across the landscape.	[Barraquand, Frederic] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Barraquand, Frederic] Univ Paris 06, Paris, France; [Barraquand, Frederic] Univ Tromso, Dep Arct & Marine Biol, Tromso, Norway; [Murrell, David J.] UCL, Dept Genet Environm & Evolut, London, England; [Murrell, David J.] UCL, CoMPLEX, London, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UiT The Arctic University of Tromso; University of London; University College London; University of London; University College London	Barraquand, F (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	frederic.barraquand@uit.no	Murrell, David/B-7833-2010; Murrell, David/AAG-3916-2019; Barraquand, Frédéric/G-1599-2011	Murrell, David/0000-0002-4830-8966; Barraquand, Frédéric/0000-0002-4759-0269	French Ministry of Research; BiodivAgriM; Natural Environment Research Council [NE/D009367/2]; NERC [NE/D009367/2] Funding Source: UKRI	French Ministry of Research(Ministry of Research, FranceEuropean Commission); BiodivAgriM; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	FB was supported by a PhD grant from the French Ministry of Research, and partially by BiodivAgriM research program. Part of this work was funded by the Natural Environment Research Council grant NE/D009367/2 to DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolker B, 1997, THEOR POPUL BIOL, V52, P179, DOI 10.1006/tpbi.1997.1331; Bolker B. M., 2009, SPATIAL ECOLOGY; Bolker BM, 2003, THEOR POPUL BIOL, V64, P255, DOI 10.1016/S0040-5809(03)00090-X; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Cadet C, 2003, AM NAT, V162, P427, DOI 10.1086/378213; Chase JM, 1998, ECOLOGY, V79, P1236, DOI 10.1890/0012-9658(1998)079[1236:CPFEOF]2.0.CO;2; Dieckmann U., 2000, GEOMETRY ECOLOGICAL, P412; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gyllenberg M, 2002, J MATH BIOL, V45, P79, DOI 10.1007/s002850200151; Hagen SB, 2010, BIOL LETTERS, V6, P566, DOI 10.1098/rsbl.2009.1002; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hiebeler DE, 2007, J THEOR BIOL, V246, P136, DOI 10.1016/j.jtbi.2006.12.024; Holt RD, 1996, AM NAT, V148, P709, DOI 10.1086/285949; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Le Galliard JF, 2003, EVOLUTION, V57, P1; McCauley E, 1996, OIKOS, V76, P485, DOI 10.2307/3546342; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; MECH LD, 1977, SCIENCE, V198, P320, DOI 10.1126/science.198.4314.320; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Moorcroft P.R., 2006, MECHANISTIC HOME RAN; Murrell DJ, 2010, ECOLOGY, V91, P1605, DOI 10.1890/09-0832.1; Murrell DJ, 2005, AM NAT, V166, P354, DOI 10.1086/432035; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Nichols J., 2001, DISPERSAL; North A, 2011, EVOLUTION, V65, P1739, DOI 10.1111/j.1558-5646.2011.01254.x; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Powell LA, 2000, BEHAV ECOL, V11, P437, DOI 10.1093/beheco/11.4.437; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; Savill NJ, 1999, THEOR POPUL BIOL, V56, P243, DOI 10.1006/tpbi.1999.1431; Sherratt JA, 2008, J R SOC INTERFACE, V5, P483, DOI 10.1098/rsif.2007.1327; Shultz S, 2002, P ROY SOC B-BIOL SCI, V269, P1797, DOI 10.1098/rspb.2002.2098; TINBERGEN N, 1967, BEHAVIOUR, V28, P307, DOI 10.1163/156853967X00064; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Weisser W, 2001, EFFECTS PREDATION DI; White KAJ, 1996, P ROY SOC B-BIOL SCI, V263, P299, DOI 10.1098/rspb.1996.0046	42	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e28924	10.1371/journal.pone.0028924	http://dx.doi.org/10.1371/journal.pone.0028924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247764	gold, Green Submitted, Green Published			2022-12-25	WOS:000301355700012
J	Birnie, K; Ben-Shlomo, Y; Holly, JMP; Gunnell, D; Ebrahim, S; Bayer, A; Gallacher, J; Martin, RM				Birnie, Kate; Ben-Shlomo, Yoav; Holly, Jeff M. P.; Gunnell, David; Ebrahim, Shah; Bayer, Antony; Gallacher, John; Martin, Richard M.			Associations of Insulin and Insulin-Like Growth Factors with Physical Performance in Old Age in the Boyd Orr and Caerphilly Studies	PLOS ONE			English	Article							IGF-BINDING PROTEIN-3; 65-YEAR FOLLOW-UP; FACTOR-I; MUSCLE STRENGTH; FACTOR SYSTEM; DIET; CANCER; RESISTANCE; CHILDHOOD; ADULTHOOD	Objective: Insulin and the insulin-like growth factor (IGF) system regulate growth and are involved in determining muscle mass, strength and body composition. We hypothesised that IGF-I and IGF-II are associated with improved, and insulin with worse, physical performance in old age. Methods: Physical performance was measured using the get-up and go timed walk and flamingo balance test at 63-86 years. We examined prospective associations of insulin, IGF-I, IGF-II and IGFBP-3 with physical performance in the UK-based Caerphilly Prospective Study (CaPS; n=739 men); and cross-sectional insulin, IGF-I, IGF-II, IGFBP-2 and IGFBP-3 in the Boyd Orr cohort (n=182 men, 223 women). Results: In confounder-adjusted models, there was some evidence in CaPS that a standard deviation (SD) increase in IGF-I was associated with 1.5% faster get-up and go test times (95% CI: -0.2%, 3.2%; p = 0.08), but little association with poor balance, 19 years later. Coefficients in Boyd Orr were in the same direction as CaPS, but consistent with chance. Higher levels of insulin were weakly associated with worse physical performance (CaPS and Boyd Orr combined: get-up and go time = 1.3% slower per SD log-transformed insulin; 95% CI: 0.0%, 2.7%; p = 0.07; OR poor balance 1.13; 95% Cl; 0.98, 1.29; p = 0.08), although associations were attenuated after controlling for body mass index (BMI) and co-morbidities. In Boyd Orr, a one SD increase in IGFBP-2 was associated with 2.6% slower get-up and go times (95% Cl: 0.4%, 4.8% slower; p = 0.02), but this was only seen when controlling for BMI and co-morbidities. There was no consistent evidence of associations of IGF-II, or IGFBP-3 with physical performance. Conclusions:There was some evidence that high IGF-I and low insulin levels in middle-age were associated with improved physical performance in old age, but estimates were imprecise. Larger cohorts are required to confirm or refute the findings.	[Birnie, Kate; Ben-Shlomo, Yoav; Gunnell, David; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Holly, Jeff M. P.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Bayer, Antony; Gallacher, John] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales	University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Cardiff University	Birnie, K (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Kate.Birnie@Bristol.ac.uk	Bayer, Antony/H-4434-2019; Bayer, Antony/H-4376-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Gunnell, David/ABE-6653-2020	Bayer, Antony/0000-0002-7514-248X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Gunnell, David/0000-0002-0829-6470; Martin, Richard/0000-0002-7992-7719	Research into Ageing; Alzheimer's Society; Medical Research Council; World Cancer Research Fund; United Kingdom Survivors; Economic and Social Research Council; Wellcome Trust; British Heart Foundation; Wellcome Research Training Fellowship in Clinical Epidemiology [GR063779FR]	Research into Ageing; Alzheimer's Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); United Kingdom Survivors; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Wellcome Research Training Fellowship in Clinical Epidemiology	This work was supported by a Research into Ageing PhD studentship to KB (reference: 302, http://www.ageuk.org.uk/). The Caerphilly Prospective Study was undertaken by the former Medical Research Council Epidemiology Unit (South Wales), and the School of Social and Community Medicine, University of Bristol, acts as the data custodian. CaPS phase V was funded by the Alzheimer's Society (http://alzheimers.org.uk/). The Boyd Orr cohort has received funding from the Medical Research Council, the World Cancer Research Fund, Research into Ageing, United Kingdom Survivors, the Economic and Social Research Council, the Wellcome Trust, and the British Heart Foundation. The Boyd Orr follow-up clinics in 2002 were funded within a Wellcome Research Training Fellowship in Clinical Epidemiology to RMM (grant number GR063779FR). DG is a National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilay JI, 2007, ARCH INTERN MED, V167, P635, DOI 10.1001/archinte.167.7.635; Barzilay JI, 2009, DIABETES CARE, V32, P736, DOI 10.2337/dc08-1781; Birnie K, 2011, J EPIDEMIOL COMMUN H, V65, P1014, DOI 10.1136/jech.2009.103648; Borofsky ND, 2002, CLIN CHEM, V48, P2248; Bray I, 2006, J CLIN ENDOCR METAB, V91, P1382, DOI 10.1210/jc.2005-1722; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Cheetham TD, 1998, J ENDOCRINOL, V157, P81, DOI 10.1677/joe.0.1570081; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Elwood PC, 2008, J AM COLL NUTR, V27, p723S, DOI 10.1080/07315724.2008.10719750; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; FEHILY AM, 1993, BRIT J NUTR, V69, P303, DOI 10.1079/BJN19930035; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gelato MC, 1997, ENDOCRINE, V7, P81, DOI 10.1007/BF02778069; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gunnell D, 2004, J CLIN ENDOCR METAB, V89, P213, DOI 10.1210/jc.2003-030507; Gunnell D, 2003, BRIT J CANCER, V88, P1682, DOI 10.1038/sj.bjc.6600946; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ito Y, 2005, J EPIDEMIOL S73, V15; Kaplan RC, 2008, J AM GERIATR SOC, V56, P652, DOI 10.1111/j.1532-5415.2007.01637.x; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuo Chen-Ko, 2009, BMC Geriatr, V9, P49, DOI 10.1186/1471-2318-9-49; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Lukanova A, 2002, CANCER CAUSE CONTROL, V13, P509, DOI 10.1023/A:1016392129279; Martin RM, 2006, J CLIN ENDOCR METAB, V91, P3287, DOI 10.1210/jc.2006-0745; Martin RM, 2005, INT J EPIDEMIOL, V34, P742, DOI 10.1093/ije/dyi124; Norat T, 2007, EUR J CLIN NUTR, V61, P91, DOI 10.1038/sj.ejcn.1602494; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Onder G, 2006, AM J PHYSIOL-ENDOC M, V291, pE829, DOI 10.1152/ajpendo.00138.2006; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Price GM, 1995, J HUM NUTR DIET, V8, P417, DOI 10.1111/j.1365-277X.1995.tb00337.x; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Rowlands MA, 2009, INT J CANCER, V124, P2416, DOI 10.1002/ijc.24202; Sandhu MJS, 2003, DIABETES, V52, P1403, DOI 10.2337/diabetes.52.6.1403; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Savage M O, 2001, Growth Horm IGF Res, V11 Suppl A, pS65, DOI 10.1016/S1096-6374(01)80011-3; Taekema DG, 2011, EUR J ENDOCRINOL, V164, P189, DOI 10.1530/EJE-10-0703; van den Beld AW, 2003, EUR J ENDOCRINOL, V148, P627, DOI 10.1530/eje.0.1480627; Voskuil DW, 2005, CANCER EPIDEM BIOMAR, V14, P195	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					420	428	e30096	10.1371/journal.pone.0030096	http://dx.doi.org/10.1371/journal.pone.0030096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	906OA	22253890	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900043
J	Obregon-Henao, A; Duque-Correa, MA; Rojas, M; Garcia, LF; Brennan, PJ; Ortiz, BL; Belisle, JT				Obregon-Henao, Andres; Duque-Correa, Maria A.; Rojas, Mauricio; Garcia, Luis F.; Brennan, Patrick J.; Ortiz, Blanca L.; Belisle, John T.			Stable Extracellular RNA Fragments of Mycobacterium tuberculosis Induce Early Apoptosis in Human Monocytes via a Caspase-8 Dependent Mechanism	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; MACROPHAGE APOPTOSIS; INNATE IMMUNITY; TNF-ALPHA; CUTTING EDGE; CELL-DEATH; VIRULENT; RECOGNITION	The molecular basis of pathogen-induced host cell apoptosis is well characterized for a number of microorganisms. Mycobacterium tuberculosis is known to induce apoptosis and it was shown that live but not heat killed M. tuberculosis stimulates this biological pathway in monocytes. The dependence of this activity on live bacilli led us to hypothesize that products released or secreted by M. tuberculosis are the primary apoptotic factors for human monocytes. Thus, the culture filtrate of in vitro grown M. tuberculosis strain H37Rv was fractioned by conventional chromatography and the apoptosis-inducing activity of individual fractions was measured on human monocytes. The tests employed included measurement of cell membrane damage, caspase activation, and cytokine release. Small molecular weight RNAs of M. tuberculosis were recognized as the predominant apoptosis inducing factors. The RNA was comprised primarily of tRNA and rRNA fragments that stably accumulate in the culture filtrate during early log-phase growth. The RNA fragments signaled through a caspase-8 dependent, caspase-1 and TNF-alpha independent pathway that ultimately compromised the human monocytes' ability to control M. tuberculosis infection. These studies provide the first report of bacterial RNA inducing apoptosis. They also provide a foundation to pursue pathways for secretion or release of nucleic acids from M. tuberculosis and the impact of secreted RNA fragments on pathogenesis.	[Obregon-Henao, Andres; Duque-Correa, Maria A.; Rojas, Mauricio; Garcia, Luis F.; Ortiz, Blanca L.] Univ Antioquia, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Obregon-Henao, Andres; Brennan, Patrick J.; Belisle, John T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Universidad de Antioquia; Colorado State University	Obregon-Henao, A (corresponding author), Univ Antioquia, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia.	bortiz@une.net.co; jbelisle@colostate.edu	Brennan, Patrick J/G-6896-2017; Belisle, John T/B-8944-2017; García, Luis V/GQA-9712-2022; Rojas Lopez, Mauricio/P-4924-2018	Belisle, John T/0000-0002-2539-2798; Duque Correa, Maria Adelaida/0000-0002-0567-0412; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; Rojas Lopez, Mauricio/0000-0002-7791-9328	NIAID (National Institute of Allergies and Infectious Diseases) [HHSN266200400091c]; Fundacion para la Promocion de la Investigacion y la Tecnologia [200205]; Proyecto Estrategia Sostenibilidad [00472, 13-15136]	NIAID (National Institute of Allergies and Infectious Diseases); Fundacion para la Promocion de la Investigacion y la Tecnologia; Proyecto Estrategia Sostenibilidad	This work was supported by NIAID (National Institute of Allergies and Infectious Diseases) contract HHSN266200400091c (http://www.niaid.nih.gov/Pages/default.aspx), the Fundacion para la Promocion de la Investigacion y la Tecnologia (http://www.banrepcultural.org/fpit/inicio) grant Proyecto Cod: 2173, contrato No. 200205, and the Proyecto Estrategia Sostenibilidad grant COD 2001-2003. Co: 00472, Resolucion Rectoral 13-15136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Balcewicz-Sablinska MK, 1999, J INFECT DIS, V180, P1230, DOI 10.1086/315011; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; Ciaramella A, 2000, CELL DEATH DIFFER, V7, P1270, DOI 10.1038/sj.cdd.4400761; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; DOBOS KM, 1995, INFECT IMMUN, V63, P2846, DOI 10.1128/IAI.63.8.2846-2853.1995; Duan L, 2002, J IMMUNOL, V169, P5181, DOI 10.4049/jimmunol.169.9.5181; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Gupta S., 2001, Current Molecular Medicine (Hilversum), V1, P317, DOI 10.2174/1566524013363780; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kramnik I, 2008, CURR TOP MICROBIOL, V321, P123; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Leong ASY, 2008, J CLIN PATHOL, V61, P366, DOI 10.1136/jcp.2007.050690; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; McCloskey JA, 2005, NUCLEIC ACIDS RES, V33, pD135, DOI 10.1093/nar/gki015; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Nuzzo I, 2002, J INFECTION, V44, P229, DOI 10.1053/jinf.2002.1001; Oddo M, 1998, J IMMUNOL, V160, P5448; Ozeki Y, 1997, INFECT IMMUN, V65, P1793, DOI 10.1128/IAI.65.5.1793-1799.1997; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Rojas M, 1997, J IMMUNOL, V159, P1352; Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676; Rojas M, 1999, J IMMUNOL, V162, P6122; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Silva CL, 1999, MICROBES INFECT, V1, P429, DOI 10.1016/S1286-4579(99)80046-X; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sonnenberg MG, 1997, INFECT IMMUN, V65, P4515, DOI 10.1128/IAI.65.11.4515-4524.1997; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Vaculova A, 2008, METHOD ENZYMOL, V442, P157, DOI 10.1016/S0076-6879(08)01408-0; Walker KB, 2007, CURR MOL MED, V7, P339; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; WIKER HG, 1991, J GEN MICROBIOL, V137, P875, DOI 10.1099/00221287-137-4-875; Youmans AS, 1979, TUBERCULOSIS, P236; Youmans GP, 1979, TUBERCULOSIS, P268	67	28	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29970	10.1371/journal.pone.0029970	http://dx.doi.org/10.1371/journal.pone.0029970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253841	gold, Green Published, Green Submitted			2022-12-25	WOS:000301352400010
J	Mazier, M; Flamain, F; Nicolai, M; Sarnette, V; Caranta, C				Mazier, Marianne; Flamain, Fabrice; Nicolai, Maryse; Sarnette, Verane; Caranta, Carole			Knock-Down of Both eIF4E1 and eIF4E2 Genes Confers Broad-Spectrum Resistance against Potyviruses in Tomato	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; VENOUS-MOTTLE-VIRUS; LYCOPERSICON-ESCULENTUM; RECESSIVE RESISTANCE; NUCLEOTIDE-SEQUENCE; CAPSICUM-ANNUUM; PLANT-VIRUSES; MOSAIC-VIRUS; GENOMIC RNA; PEPPER	Background: The eukaryotic translation initiation factor eIF4E plays a key role in plant-potyvirus interactions. eIF4E belongs to a small multigenic family and three genes, eIF4E1, eIF4E2 and eIF(iso)4E, have been identified in tomato. It has been demonstrated that eIF4E-mediated natural recessive resistances against potyviruses result from non-synonymous mutations in an eIF4E protein, which impair its direct interaction with the potyviral protein VPg. In tomato, the role of eIF4E proteins in potyvirus resistance is still unclear because natural or induced mutations in eIF4E1 confer only a narrow resistance spectrum against potyviruses. This contrasts with the broad spectrum resistance identified in the natural diversity of tomato. These results suggest that more than one eIF4E protein form is involved in the observed broad spectrum resistance. Methodology/Principal Findings: To gain insight into the respective contribution of each eIF4E protein in tomato-potyvirus interactions, two tomato lines silenced for both eIF4E1 and eIF4E2 (RNAi-4E) and two lines silenced for eIF(iso) 4E (RNAi-iso4E) were obtained and characterized. RNAi-4E lines are slightly impaired in their growth and fertility, whereas no obvious growth defects were observed in RNAi-iso4E lines. The F1 hybrid between RNAi-4E and RNAi-iso4E lines presented a pronounced semi-dwarf phenotype. Interestingly, the RNAi-4E lines silenced for both eIF4E1 and eIF4E2 showed broad spectrum resistance to potyviruses while the RNAi-iso4E lines were fully susceptible to potyviruses. Yeast two-hybrid interaction assays between the three eIF4E proteins and a set of viral VPgs identified two types of VPgs: those that interacted only with eIF4E1 and those that interacted with either eIF4E1 or with eIF4E2. Conclusion/Significance: These experiments provide evidence for the involvement of both eIF4E1 and eIF4E2 in broad spectrum resistance of tomato against potyviruses and suggest a role for eIF4E2 in tomato-potyvirus interactions.	[Mazier, Marianne; Flamain, Fabrice; Nicolai, Maryse; Sarnette, Verane; Caranta, Carole] INRA, UR1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France	INRAE	Mazier, M (corresponding author), INRA, UR1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France.	mazier@avignon.inra.fr			GENOPLANTE, TRANSVIR [GNP05003G]	GENOPLANTE, TRANSVIR	This work was supported by GENOPLANTE, TRANSVIR project (GNP05003G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON R, 1986, VIROLOGY, V154, P9, DOI 10.1016/0042-6822(86)90425-3; Asano M, 2005, FEBS LETT, V579, P4479, DOI 10.1016/j.febslet.2005.07.021; BERNATZKY R, 1986, THEOR APPL GENET, V72, P314, DOI 10.1007/BF00288567; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Combe JP, 2005, PLANT MOL BIOL, V57, P749, DOI 10.1007/s11103-005-3098-x; Cournoyer P, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P149; Dubois V, 2005, J EXP BOT, V56, P2379, DOI 10.1093/jxb/eri230; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; FELDMAN JM, 1977, PHYTOPATHOLOGY, V73, P115; Fernandez-Calvino L, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P121; Frizzi A, 2010, PLANT BIOTECHNOL J, V8, P655, DOI 10.1111/j.1467-7652.2010.00505.x; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; HAMZA S, 1993, J EXP BOT, V44, P1837, DOI 10.1093/jxb/44.12.1837; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Inoue-Nagata AK, 2002, ARCH VIROL, V147, P849, DOI 10.1007/s007050200032; Janzac B, 2008, ARCH VIROL, V153, P1543, DOI 10.1007/s00705-008-0132-8; Jenner CE, 2010, MOL PLANT MICROBE IN, V23, P1498, DOI 10.1094/MPMI-05-10-0104; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kruskal H.W., 1952, J AM STAT ASSOC, V47, P583; Le Gall O, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P177; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rodrigues SP, 2009, BRAZ ARCH BIOL TECHN, V52, P795, DOI 10.1590/S1516-89132009000400002; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; SELASSIE KG, 1985, AGRONOMIE, V5, P621, DOI 10.1051/agro:19850708; Spetz C, 2003, J GEN VIROL, V84, P2565, DOI 10.1099/vir.0.19208-0; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; VANCE VB, 1992, VIROLOGY, V191, P19, DOI 10.1016/0042-6822(92)90162-I; Wani S. H., 2010, American Journal of Plant Sciences, V1, P55, DOI 10.4236/ajps.2010.12008; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	39	73	85	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29595	10.1371/journal.pone.0029595	http://dx.doi.org/10.1371/journal.pone.0029595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242134	Green Published, gold			2022-12-25	WOS:000300677000050
J	Rahmanto, YS; Kalinowski, DS; Lane, DJR; Lok, HC; Richardson, V; Richardson, DR				Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Lane, Darius J. R.; Lok, Hiu Chuen; Richardson, Vera; Richardson, Des R.			Nitrogen Monoxide (NO) Storage and Transport by Dinitrosyl-Dithiol-Iron Complexes: Long-lived NO That Is Trafficked by Interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUTATHIONE-S-TRANSFERASE; MULTIDRUG-RESISTANCE PROTEIN; ELECTRON-PARAMAGNETIC-RESONANCE; CYTOTOXIC ACTIVATED MACROPHAGES; NITRIC-OXIDE SYNTHESIS; IN-VIVO DISTRIBUTION; CANCER CELL-LINE; L-ARGININE; 4-NITROQUINOLINE 1-OXIDE; METASTASIS SUPPRESSOR	Nitrogen monoxide (NO) markedly affects intracellular iron metabolism, and recent studies have shown that molecules traditionally involved in drug resistance, namely GST and MRP1 (multidrug resistance-associated protein 1), are critical molecular players in this process. This is mediated by interaction of these proteins with dinitrosyl-dithiol-iron complexes (Watts, R. N., Hawkins, C., Ponka, P., and Richardson, D. R. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 7670-7675; Lok, H. C., Suryo Rahmanto, Y., Hawkins, C. L., Kalinowski, D. S., Morrow, C. S., Townsend, A. J., Ponka, P., and Richardson, D. R. (2012) J. Biol. Chem. 287, 607-618). These complexes are bioavailable, have a markedly longer half-life compared with free NO, and form in cells after an interaction between iron, NO, and glutathione. The generation of dinitrosyl-dithiol-iron complexes acts as a common currency for NO transport and storage by MRP1 and GST P1-1, respectively. Understanding the biological trafficking mechanisms involved in the metabolism of NO is vital for elucidating its many roles in cellular signaling and cytotoxicity and for development of new therapeutic targets.	[Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Lane, Darius J. R.; Lok, Hiu Chuen; Richardson, Vera; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Suryo Rahmanto, Yohan/K-8043-2018	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274; Kalinowski, Danuta/0000-0002-9303-7405; Lane, Darius/0000-0001-8725-6903	Australian Research Council [DP1092734]; Cancer Institute NSW [08/ECF/1-36, 08/ECF/1-30, 10/ECF/2-18]; Peter Doherty postdoctoral fellowship; Senior Principal Research Fellowship [571123]; National Health and Medical Research Council of Australia [632778, 632698]	Australian Research Council(Australian Research Council); Cancer Institute NSW; Peter Doherty postdoctoral fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092734 from the Australian Research Council (to D. R. R.); Cancer Institute NSW Early Career Fellowships 08/ECF/1-36 (to Y. S. R.), 08/ECF/1-30 (to D. S. K.), and 10/ECF/2-18 (to D. J. R. L.); and a Peter Doherty postdoctoral fellowship (to D. J. R. L.) and Senior Principal Research Fellowship 571123 and Project Grants 632778 and 632698 (to D. R. R.) from the National Health and Medical Research Council of Australia.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Alencar JL, 2003, BIOCHEM PHARMACOL, V66, P2365, DOI 10.1016/j.bcp.2003.07.017; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Chang XB, 2010, METHODS MOL BIOL, V596, P223, DOI 10.1007/978-1-60761-416-6_11; Chen YJ, 2008, J AM CHEM SOC, V130, P10929, DOI 10.1021/ja711494m; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Flens MJ, 1996, AM J PATHOL, V148, P1237; GIFFORD GE, 1987, J NATL CANCER I, V78, P121, DOI 10.1093/jnci/78.1.121; Giliano NY, 2011, NITRIC OXIDE-BIOL CH, V24, P151, DOI 10.1016/j.niox.2011.02.005; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HIBBS JB, 1992, J CLIN INVEST, V89, P867, DOI 10.1172/JCI115666; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1977, SCIENCE, V197, P279, DOI 10.1126/science.327547; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; JACOBS A, 1977, BLOOD, V50, P433; Kawakatsu M, 2011, BIOCHEM BIOPH RES CO, V411, P745, DOI 10.1016/j.bbrc.2011.07.018; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; Kim YM, 2000, J BIOL CHEM, V275, P10954, DOI 10.1074/jbc.275.15.10954; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Kleschyov AL, 2006, FREE RADICAL BIO MED, V40, P1340, DOI 10.1016/j.freeradbiomed.2005.12.001; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; LEE MH, 1994, BIOCHEMISTRY-US, V33, P3679, DOI 10.1021/bi00178a026; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Lok HC, 2012, J BIOL CHEM, V287, P607, DOI 10.1074/jbc.M111.310987; Lomonosova EE, 1998, FREE RADICAL BIO MED, V25, P493, DOI 10.1016/S0891-5849(98)00080-X; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; MULSCH A, 1991, FEBS LETT, V294, P252, DOI 10.1016/0014-5793(91)81441-A; MULSCH A, 1993, BIOCHEM BIOPH RES CO, V196, P1303, DOI 10.1006/bbrc.1993.2394; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Peklak-Scott C, 2005, BIOCHEMISTRY-US, V44, P4426, DOI 10.1021/bi047810y; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Qazi SS, 2011, DRUG METAB DISPOS, V39, P1122, DOI 10.1124/dmd.111.039362; Remizova MI, 2011, EUR J PHARMACOL, V662, P40, DOI 10.1016/j.ejphar.2011.04.046; Richardson Des R., 2007, P97, DOI 10.1016/B978-044452236-8/50004-6; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; RICHARDSON DR, 1995, BLOOD, V86, P3211; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; SCHNEIDER E, 1994, CANCER RES, V54, P152; Severina IS, 2003, NITRIC OXIDE-BIOL CH, V8, P155, DOI 10.1016/S1089-8603(03)00002-8; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Shumaev KB, 2008, NITRIC OXIDE-BIOL CH, V18, P37, DOI 10.1016/j.niox.2007.09.085; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Ueno T, 1999, FREE RADICAL RES, V31, P525, DOI 10.1080/10715769900301101; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Vanin AF, 1997, NITRIC OXIDE-BIOL CH, V1, P191, DOI 10.1006/niox.1997.0122; VANIN AF, 1991, FEBS LETT, V289, P1, DOI 10.1016/0014-5793(91)80894-9; Vanin AF, 1998, BIOCHEMISTRY-MOSCOW+, V63, P782; Vanin AF, 2009, NITRIC OXIDE-BIOL CH, V21, P1, DOI 10.1016/j.niox.2009.03.005; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2004, BBA-MOL CELL RES, V1692, P1, DOI 10.1016/j.bbamcr.2004.02.004; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; Watts RN, 2002, EUR J BIOCHEM, V269, P3383, DOI 10.1046/j.1432-1033.2002.02987.x; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Watts RN, 2000, J LAB CLIN MED, V136, P149, DOI 10.1067/mlc.2000.108152; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	100	43	50	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6960	6968		10.1074/jbc.R111.329847	http://dx.doi.org/10.1074/jbc.R111.329847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262835	Green Published, hybrid			2022-12-25	WOS:000301060200001
J	Romanowski, K; Zaborin, A; Valuckaite, V; Rolfes, RJ; Babrowski, T; Bethel, C; Olivas, A; Zaborina, O; Alverdy, JC				Romanowski, Kathleen; Zaborin, Alexander; Valuckaite, Vesta; Rolfes, Ronda J.; Babrowski, Trissa; Bethel, Cindy; Olivas, Andrea; Zaborina, Olga; Alverdy, John C.			Candida albicans Isolates from the Gut of Critically Ill Patients Respond to Phosphate Limitation by Expressing Filaments and a Lethal Phenotype	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; VIRULENCE EXPRESSION; COLONIZATION; GENE; SEPSIS; HOST; RECOGNITION; DISRUPTION; ACTIVATION; STRATEGIES	Candida albicans is an opportunistic pathogen that proliferates in the intestinal tract of critically ill patients where it continues to be a major cause of infectious-related mortality. The precise cues that shift intestinal C. albicans from its ubiquitous indolent colonizing yeast form to an invasive and lethal filamentous form remain unknown. We have previously shown that severe phosphate depletion develops in the intestinal tract during extreme physiologic stress and plays a major role in shifting intestinal Pseudomonas aeruginosa to express a lethal phenotype via conserved phosphosensory-phosphoregulatory systems. Here we studied whether phosphate dependent virulence expression could be similarly demonstrated for C. albicans. C. albicans isolates from the stool of critically ill patients and laboratory prototype strains (SC5314, BWP17, SN152) were evaluated for morphotype transformation and lethality against C. elegans and mice during exposure to phosphate limitation. Isolates ICU1 and ICU12 were able to filament and kill C. elegans in a phosphate dependent manner. In a mouse model of intestinal phosphate depletion (30% hepatectomy), direct intestinal inoculation of C. albicans caused mortality that was prevented by oral phosphate supplementation. Prototype strains displayed limited responses to phosphate limitation; however, the pho4D mutant displayed extensive filamentation during low phosphate conditions compared to its isogenic parent strain SN152, suggesting that mutation in the transcriptional factor Pho4p may sensitize C. albicans to phosphate limitation. Extensive filamentation was also observed in strain ICU12 suggesting that this strain is also sensitized to phosphate limitation. Analysis of the sequence of PHO4 in strain ICU12, its transcriptional response to phosphate limitation, and phosphatase assays confirmed that ICU12 demonstrates a profound response to phosphate limitation. The emergence of strains of C. albicans with marked responsiveness to phosphate limitation may represent a fitness adaptation to the complex and nutrient scarce environment typical of the gut of a critically ill patient.	[Romanowski, Kathleen; Zaborin, Alexander; Valuckaite, Vesta; Babrowski, Trissa; Olivas, Andrea; Zaborina, Olga; Alverdy, John C.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Rolfes, Ronda J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Bethel, Cindy] Univ Chicago, Clin Microbiol Immunol Labs, Chicago, IL 60637 USA	University of Chicago; Georgetown University; University of Chicago	Romanowski, K (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021; Romanowski, Kathleen/L-3400-2019	Romanowski, Kathleen/0000-0002-4431-2423	NIH [5R01GM062344-11, 1-R03-AI075226-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI075226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant 5R01GM062344-11 (JCA) and 1-R03-AI075226-01 (RJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Calderon J, 2010, MICROBIOL-SGM, V156, P2484, DOI 10.1099/mic.0.038000-0; CASSONE A, 1983, J GEN MICROBIOL, V129, P1569; Furtado GH, 2009, J CRIT CARE, V24, pe629; Furtado GHC, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.03.006; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Jacobsen SM, 2008, FEMS IMMUNOL MED MIC, V52, P180, DOI 10.1111/j.1574-695X.2007.00358.x; Kerwin CL, 2009, GENETICS, V182, P471, DOI 10.1534/genetics.109.101063; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; KURTZ MB, 1986, MOL CELL BIOL, V6, P142, DOI 10.1128/MCB.6.1.142; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Laughlin RS, 2000, ANN SURG, V232, P133, DOI 10.1097/00000658-200007000-00019; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lim CS, 2011, EUR J CLIN MICROBIOL; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Maki DG, 2004, CRIT CARE MED, V32, P1075, DOI 10.1097/01.CCM.0000120048.81149.78; Manolakaki D, 2010, VIRULENCE, V1, P367, DOI 10.4161/viru.1.5.12796; Montero M, 2009, INFECTION, V37, P16, DOI 10.1007/s15010-008-8125-9; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Patel NJ, 2007, AM J PHYSIOL-GASTR L, V292, pG134, DOI 10.1152/ajpgi.00276.2006; Payne Samantha, 2003, Curr Issues Intest Microbiol, V4, P1; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Pierce CG, 2009, J ANTIMICROB CHEMOTH, V63, P473, DOI 10.1093/jac/dkn515; Pinheiro MRS, 2008, BRAZ J INFECT DIS, V12, P509, DOI 10.1590/S1413-86702008000600013; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sacristan B, 2011, MED MYCOL; Samonis G, 2006, MED MYCOL, V44, P193, DOI 10.1080/13693780500265980; Samonis G, 2005, ANTIMICROB AGENTS CH, V49, P5189, DOI 10.1128/AAC.49.12.5189.2005; Samonis G, 2008, MYCOSES, V51, P324, DOI 10.1111/j.1439-0507.2008.01500.x; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; SMITH RF, 1973, APPL MICROBIOL, V26, P364, DOI 10.1128/AEM.26.3.364-367.1973; Sonoyama K, 2011, MED MYCOL; Struck MF, 2009, J BURN CARE RES, V30, P894, DOI 10.1097/BCR.0b013e3181b48794; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Kruger WMA, 2006, PROTEOMICS, V6, P1495, DOI 10.1002/pmic.200500238; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wisplinghoff H, 2006, CLIN MICROBIOL INFEC, V12, P170, DOI 10.1111/j.1469-0691.2005.01318.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang J, 1996, ACTA BIOCH BIOPH SIN, V28, P516; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043; Zaborina Olga, 2006, Ann Clin Microbiol Antimicrob, V5, P14, DOI 10.1186/1476-0711-5-14; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zaborina O, 2011, CURR PHARM DESIGN, V17, P1254, DOI 10.2174/138161211795703771; Zollner-Schwetz I, 2008, J INFECT DIS, V198, P150, DOI 10.1086/588827	51	53	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e30119	10.1371/journal.pone.0030119	http://dx.doi.org/10.1371/journal.pone.0030119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253901	Green Submitted, Green Published, gold			2022-12-25	WOS:000301361500035
J	Young, JL; Mora, A; Cerny, A; Czech, MP; Woda, B; Kurt-Jones, EA; Finberg, RW; Corvera, S				Young, James L.; Mora, Alfonso; Cerny, Anna; Czech, Michael P.; Woda, Bruce; Kurt-Jones, Evelyn A.; Finberg, Robert W.; Corvera, Silvia			CD14 Deficiency Impacts Glucose Homeostasis in Mice through Altered Adrenal Tone	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; C-REACTIVE PROTEIN; INDUCED INSULIN-RESISTANCE; RESPIRATORY SYNCYTIAL VIRUS; DIET-INDUCED OBESITY; HIGH-FAT DIET; NF-KAPPA-B; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDE; ADIPOSE-TISSUE	The toll-like receptors comprise one of the most conserved components of the innate immune system, signaling the presence of molecules of microbial origin. It has been proposed that signaling through TLR4, which requires CD14 to recognize bacterial lipopolysaccharide (LPS), may generate low-grade inflammation and thereby affect insulin sensitivity and glucose metabolism. To examine the long-term influence of partial innate immune signaling disruption on glucose homeostasis, we analyzed knockout mice deficient in CD14 backcrossed into the diabetes-prone C57BL6 background at 6 or 12 months of age. CD14-ko mice, fed either normal or high-fat diets, displayed significant glucose intolerance compared to wild type controls. They also displayed elevated norepinephrine urinary excretion and increased adrenal medullary volume, as well as an enhanced norepinephrine secretory response to insulin-induced hypoglycemia. These results point out a previously unappreciated crosstalk between innate immune-and sympathoadrenal-systems, which exerts a major long-term effect on glucose homeostasis.	[Young, James L.; Mora, Alfonso; Czech, Michael P.; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Young, James L.] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA USA; [Cerny, Anna; Woda, Bruce; Kurt-Jones, Evelyn A.; Finberg, Robert W.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Young, JL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu	Mora, Alfonso/D-2759-2017; Woda, Bruce/AAS-5898-2020	Mora, Alfonso/0000-0002-6397-4836; 	US National Institutes of Health (NIH) [DK54479, DK60564, AI51405, AI064349]; Juvenile Diabetes Research Foundation (JDRF) [JDRF 24-2008-950]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051405, R01AI064349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054479, P01DK060564, R01DK089101, P30DK032520] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the US National Institutes of Health (NIH) DK54479 and DK60564 to S.C., AI51405 to E.K.J., and AI064349 to R.F., as well as grant JDRF 24-2008-950 from the Juvenile Diabetes Research Foundation (JDRF) to R.F. Support for the use of the morphology core facility was through the Diabetes Endocrinology Research Center Grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTORFER RM, 1981, ACTA ENDOCRINOL-COP, V98, P413, DOI 10.1530/acta.0.0980413; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bienkowski MS, 2008, NEUROSCIENCE, V156, P1093, DOI 10.1016/j.neuroscience.2008.08.011; Bo S, 2005, EUR J CLIN INVEST, V35, P265, DOI 10.1111/j.1365-2362.2005.01490.x; Bornstein SR, 2004, P NATL ACAD SCI USA, V101, P16695, DOI 10.1073/pnas.0407550101; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; COELHO MM, 1992, AM J PHYSIOL, V263, pR423, DOI 10.1152/ajpregu.1992.263.2.R423; Cuda C, 2011, METABOLISM, V60, P1131, DOI 10.1016/j.metabol.2010.12.006; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; DiPenta JM, 2007, APPL PHYSIOL NUTR ME, V32, P1025, DOI 10.1139/H07-094; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; KOBAYASHI K, 1992, P NATL ACAD SCI USA, V89, P1631, DOI 10.1073/pnas.89.5.1631; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LANG CH, 1993, METABOLISM, V42, P1351, DOI 10.1016/0026-0495(93)90137-D; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; MORROW LA, 1993, DIABETES, V42, P307, DOI 10.2337/diabetes.42.2.307; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Muthu K, 2010, J LEUKOCYTE BIOL, V88, P715, DOI 10.1189/jlb.0410186; OHSHIMA K, 1984, AM J PHYSIOL, V246, pE193, DOI 10.1152/ajpendo.1984.246.2.E193; Nicola JP, 2009, ENDOCRINOLOGY, V150, P500, DOI 10.1210/en.2008-0345; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; RAMACHANDRA RN, 1992, BRAIN BEHAV IMMUN, V6, P157, DOI 10.1016/0889-1591(92)90015-G; Reyes TM, 2003, J NEUROSCI, V23, P5607; Rorato R, 2008, HORM BEHAV, V54, P134, DOI 10.1016/j.yhbeh.2008.02.011; Sadeghi S, 1999, IMMUNOLOGY, V96, P404, DOI 10.1046/j.1365-2567.1999.00701.x; Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Shah PK, 2007, CIRC RES, V100, P1531, DOI 10.1161/CIRCRESAHA.107.101104; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SHIRE JGM, 1968, J ENDOCRINOL, V40, P215, DOI 10.1677/joe.0.0400215; SOLOMON J, 1977, HORM METAB RES, V9, P152, DOI 10.1055/s-0028-1093566; Thaler JP, 2009, ENDOCRINOLOGY; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; van Enckevort FHJ, 2001, J ENDOCRINOL INVEST, V24, P786, DOI 10.1007/BF03343928; VIRKAMAKI A, 1994, ENDOCRINOLOGY, V134, P2072, DOI 10.1210/en.134.5.2072; Vitseva OI, 2008, OBESITY, V16, P932, DOI 10.1038/oby.2008.25; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Weyrich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013980; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; WITTMERS LE, 1983, METABOLISM, V32, P1093, DOI 10.1016/0026-0495(83)90054-9; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zacharowski K, 2006, P NATL ACAD SCI USA, V103, P6392, DOI 10.1073/pnas.0601527103	67	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29688	10.1371/journal.pone.0029688	http://dx.doi.org/10.1371/journal.pone.0029688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253759	Green Published, gold			2022-12-25	WOS:000301361500018
J	Barbier, M; Sabbagh, A; Kasper, E; Asheuer, M; Ahouansou, O; Pribill, I; Forss-Petter, S; Vidaud, M; Berger, J; Aubourg, P				Barbier, Mathieu; Sabbagh, Audrey; Kasper, Edwige; Asheuer, Muriel; Ahouansou, Ornella; Pribill, Ingrid; Forss-Petter, Sonja; Vidaud, Michel; Berger, Johannes; Aubourg, Patrick			CD1 Gene Polymorphisms and Phenotypic Variability in X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							ANTIGEN PRESENTATION	X-linked adrenoleukodystrophy (X-ALD) is characterized by marked phenotypic variation ranging from adrenomyeloneuropathy (AMN) to childhood cerebral ALD (CCALD). X-ALD is caused by mutations in the ABCD1 gene, but no genotype-phenotype correlation has been established so far and modifier gene variants are suspected to modulate phenotypes. Specific classes of lipids, enriched in very long-chain fatty acids that accumulate in plasma and tissues from X-ALD patients are suspected to be involved in the neuroinflammatory process of CCALD. CD1 proteins are lipid-antigen presenting molecules encoded by five CD1 genes in human (CD1A-E). Association studies with 23 tag SNPs covering the CD1 locus was performed in 52 patients with AMN and 87 patients with CCALD. The minor allele of rs973742 located 4-kb downstream from CD1D was significantly more frequent in AMN patients (chi(2) = 7.6; P = 0.006). However, this association was no longer significant after Bonferroni correction for multiple testing. The other polymorphisms of the CD1 locus did not reveal significant association. Further analysis of other CD1D polymorphisms did not detect stronger association with X-ALD phenotypes. Although the association with rs973742 warrants further investigations, these results indicate that the genetic variants of CD1 genes do not contribute markedly to the phenotypic variance of X-ALD.	[Barbier, Mathieu; Sabbagh, Audrey; Kasper, Edwige; Asheuer, Muriel; Ahouansou, Ornella; Vidaud, Michel; Aubourg, Patrick] Univ Paris 05, Fac Sci Pharmaceut & Biol, UMR 745, Paris, France; [Pribill, Ingrid; Forss-Petter, Sonja; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Sabbagh, Audrey] IRD, UMR 216, Paris, France; [Sabbagh, Audrey] Univ Paris 05, Fac Sci Pharmaceut & Biol, Parasitol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Medical University of Vienna; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Barbier, M (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, UMR 745, Paris, France.	mathieu.barbier@inserm.fr	Vidaud, Michel/O-7346-2017; Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Barbier, Mathieu/0000-0002-5154-2163; SABBAGH, Audrey/0000-0003-0283-8803; Kasper, Edwige/0000-0003-1699-0670	INSERM; European Leukodystrophy Foundation [2008-001C4]; Association Francaise contre les Myopathies [Ddt1 2011-0242]; Vienna Science and Technology Fund (WWTF) [LS154]; EU [HEALTH-F2-2010-241622]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Leukodystrophy Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Vienna Science and Technology Fund (WWTF); EU(European Commission)	This work was supported by funds from INSERM, European Leukodystrophy Foundation (grant 2008-001C4), Association Francaise contre les Myopathies (grant Ddt1 2011-0242), the Vienna Science and Technology Fund (WWTF-project LS154) and the EU-project "Leukotreat" HEALTH-F2-2010-241622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Gautron AS, 2010, J NEUROIMMUNOL, V229, P204, DOI 10.1016/j.jneuroim.2010.09.003; Ito M, 2001, J NEUROPATH EXP NEUR, V60, P1004, DOI 10.1093/jnen/60.10.1004; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 2010, BRAIN PATHOL, V20, P831, DOI 10.1111/j.1750-3639.2010.00391.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Linnebank M, 2006, NEUROLOGY, V66, P442, DOI 10.1212/01.wnl.0000196491.42058.6f; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; Matsukawa T, 2011, NEUROGENETICS, V12, P41, DOI 10.1007/s10048-010-0253-6; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866	22	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29872	10.1371/journal.pone.0029872	http://dx.doi.org/10.1371/journal.pone.0029872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253809	Green Published, gold, Green Submitted			2022-12-25	WOS:000301357100027
J	Chakraborty, S; Pratihar, S; Hosur, RV				Chakraborty, Swagata; Pratihar, Supriya; Hosur, Ramakrishna V.			NMR Derived Model of GTPase Effector Domain (GED) Self Association: Relevance to Dynamin Assembly	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; COMMON AMINO-ACIDS; CHEMICAL-SHIFTS; DENATURED STATE; C-13 NMR; INSIGHTS; SPIRALS; DISEASE; BINDING; ORDER	Self-association of dynamin to form spiral structures around lipidic vesicles during endocytosis is largely mediated by its 'coiled coil' GTPase Effector Domain (GED), which, in vitro, self-associates into huge helical assemblies. Residue-level structural characterizations of these assemblies and understanding the process of association have remained a challenge. It is also impossible to get folded monomers in the solution phase. In this context, we have developed here a strategy to probe the self-association of GED by first dissociating the assembly using Dimethyl Sulfoxide (DMSO) and then systematically monitoring the refolding into helix and concomitant re-association using NMR spectroscopy, as DMSO concentration is progressively reduced. The short segment, Arg109 - Met116, acts as the nucleation site for helix formation and self-association. Hydrophobic and complementary charge interactions on the surfaces drive self-association, as the helices elongate in both the directions resulting in an antiparallel stack. A small N-terminal segment remains floppy in the assembly. Following these and other published results on inter-domain interactions, we have proposed a plausible mode of dynamin self assembly.	[Chakraborty, Swagata; Pratihar, Supriya; Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Hosur, RV (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	hosur@tifr.res.in		Supriya, Pratihar/0000-0001-6779-1490	Government of India	Government of India	Funding was provided by the Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chakraborty S, 2011, BIOMOL NMR ASSIGN, V5, P59, DOI 10.1007/s12104-010-9267-0; Chakraborty S, 2011, J MOL BIOL, V405, P1202, DOI 10.1016/j.jmb.2010.11.050; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chugh J, 2006, FEBS J, V273, P388, DOI 10.1111/j.1742-4658.2005.05072.x; Chugh J, 2008, PROTEIN SCI, V17, P1319, DOI 10.1110/ps.035840.108; Chugh J, 2007, BIOCHEMISTRY-US, V46, P11819, DOI 10.1021/bi701280p; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GRATHWOHL C, 1974, J MAGN RESON, V13, P217, DOI 10.1016/0022-2364(74)90008-0; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Keller R., COMPUTER AIDED RESON; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; TUMA PL, 1993, J BIOL CHEM, V268, P17240; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30109	10.1371/journal.pone.0030109	http://dx.doi.org/10.1371/journal.pone.0030109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253896	Green Published, gold			2022-12-25	WOS:000301357100038
J	Nakamura, S; Watakabe, I; Nishimura, T; Toyoda, A; Taniguchi, Y; Tanaka, M				Nakamura, Shuhei; Watakabe, Ikuko; Nishimura, Toshiya; Toyoda, Atsushi; Taniguchi, Yoshihito; Tanaka, Minoru			Analysis of Medaka sox9 Orthologue Reveals a Conserved Role in Germ Cell Maintenance	PLOS ONE			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; ORYZIAS-LATIPES; CAMPOMELIC DYSPLASIA; TELEOST FISH; DIFFERENTIATION; EXPRESSION; GONAD; IDENTIFICATION; CHROMOSOME	The sex determining gene is divergent among different animal species. However, sox9 is up-regulated in the male gonads in a number of species in which it is the essential regulator of testis determination. It is therefore often discussed that the sex determining gene-sox9 axis functions in several vertebrates. In our current study, we show that sox9b in the medaka (Oryzias latipes) is one of the orthologues of mammalian Sox9 at syntenic and expression levels. Medaka sox9b affects the organization of extracellular matrices, which represents a conserved role of sox9, but does not directly regulate testis determination. We made this determination via gene expression and phenotype analyses of medaka with different copy numbers of sox9b. Sox9b is involved in promoting cellular associations and is indispensible for the proper proliferation and survival of germ cells in both female and male medaka gonads. Medaka mutants that lack sox9b function exhibit a seemingly paradoxical phenotype of sex reversal to male. This is explained by a reduction in the germ cell number associated with aberrant extracellular matrices. Together with its identified roles in other vertebrate gonads, a testis-determining role for Sox9 in mammals is likely to have been neofunctionalized and appended to its conserved role in germ cell maintenance.	[Nakamura, Shuhei; Watakabe, Ikuko; Nishimura, Toshiya; Tanaka, Minoru] Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 444, Japan; [Nishimura, Toshiya; Tanaka, Minoru] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Taniguchi, Yoshihito] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Keio University	Nakamura, S (corresponding author), Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 444, Japan.	mtanaka@nibb.ac.jp	Taniguchi, Yoshihito/L-5746-2013; Shuhei, Nakamura/AGZ-2173-2022; Nakamura, Shuhei/G-8571-2011	Shuhei, Nakamura/0000-0002-1488-8317; TANAKA, MINORU/0000-0001-9100-1487	 [21116509];  [22132007];  [21770072];  [21370101]	; ; ; 	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (21116509 and 22132007), for Young Scientists (B) (21770072) and for Scientific Research on Priority Areas (B) (21370101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Aoki Y, 2008, DEV DYNAM, V237, P800, DOI 10.1002/dvdy.21448; Bagheri-Fam S, 2010, INT J BIOCHEM CELL B, V42, P472, DOI 10.1016/j.biocel.2009.07.001; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Barske LA, 2010, DEV BIOL, V341, P305, DOI 10.1016/j.ydbio.2010.02.010; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jakob S, 2011, FEBS J, V278, P1002, DOI 10.1111/j.1742-4658.2011.08029.x; KANAMORI A, 1985, ZOOL SCI, V2, P695; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Matoba S, 2008, DEV BIOL, V324, P76, DOI 10.1016/j.ydbio.2008.09.004; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Morais da Silva S., 1996, NAT GENET, V14, P62, DOI DOI 10.1038/NG0996-62; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Nakamoto M, 2005, BIOCHEM BIOPH RES CO, V333, P729, DOI 10.1016/j.bbrc.2005.05.158; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nakamura S, 2009, DEV DYNAM, V238, P2652, DOI 10.1002/dvdy.22068; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Saito D, 2007, DEV BIOL, V310, P280, DOI 10.1016/j.ydbio.2007.07.039; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Tanaka M, 2008, DEV GROWTH DIFFER, V50, P273, DOI [10.1111/j.1440-169x.2008.01015.x, 10.1111/j.1440-169X.2008.01015.x]; Tanaka M, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P219, DOI 10.1007/978-4-431-92691-7_14; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Western PS, 1999, DEV DYNAM, V214, P171, DOI 10.1002/(SICI)1097-0177(199903)214:3<171::AID-AJA1>3.0.CO;2-S; Yokoi H, 2002, MOL REPROD DEV, V63, P5, DOI 10.1002/mrd.10169	40	70	76	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29982	10.1371/journal.pone.0029982	http://dx.doi.org/10.1371/journal.pone.0029982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253846	Green Submitted, gold, Green Published			2022-12-25	WOS:000301357100034
J	Talaei, F; Schmidt, M; Henning, RH				Talaei, Fatemeh; Schmidt, Martina; Henning, Robert H.			Induction of VMAT-1 and TPH-1 Expression Induces Vesicular Accumulation of Serotonin and Protects Cells and Tissue from Cooling/Rewarming Injury	PLOS ONE			English	Article							HYDROGEN-SULFIDE; PRESERVATION; HYPOTHERMIA; DOPAMINE; KIDNEY	DDT1 MF-2 hamster ductus deferens cells are resistant to hypothermia due to serotonin secretion from secretory vesicles and subsequent cystathionine beta synthase (CBS) mediated formation of H2S. We investigated whether the mechanism promoting resistance to hypothermia may be translationally induced in cells vulnerable to cold storage. Thus, VMAT-1 (vesicular monoamino transferase) and TPH-1 (tryptophan hydroxylase) were co-transfected in rat aortic smooth muscle cells (SMAC) and kidney tissue to create a serotonin-vesicular phenotype (named VTSMAC and VTkidney, respectively). Effects on hypothermic damage were assessed. VTSMAC showed a vesicular phenotype and an 8-fold increase in serotonin content and 5-fold increase in its release upon cooling. Cooled VTSMAC produced up to 10 fold higher concentrations of H2S, and were protected from hypothermia, as shown by a 50% reduction of caspase 3/7 activity and 4 times higher survival compared to SMAC. Hypothermic resistance was abolished by the inhibition of CBS activity or blockade of serotonin reuptake. In VTkidney slices, expression of CBS was 3 fold increased in cold preserved kidney tissue, with two-fold increase in H2S concentration. While cooling induced substantial damage to empty vector transfected kidney as shown by caspase 3/7 activity and loss of FABP1, VTkidney was fully protected and comparable to non-cooled control. Thus, transfection of VMAT-1 and TPH-1 induced vesicular storage of serotonin which is triggered release upon cooling and has protective effects against hypothermia. The vesicular serotonergic phenotype protects against hypothermic damage through re-uptake of serotonin inducing CBS mediated H2S production both in cells and kidney slices.	[Talaei, Fatemeh; Henning, Robert H.] Univ Groningen, Dept Clin Pharmacol, Univ Med Ctr Groningen, Groningen, Netherlands; [Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Fac Pharm, Groningen, Netherlands	University of Groningen; University of Groningen	Talaei, F (corresponding author), Univ Groningen, Dept Clin Pharmacol, Univ Med Ctr Groningen, Groningen, Netherlands.	Talaei@irimc.org	Schmidt, Martina/C-5339-2018; Henning, Robert H/AAY-5222-2020	Schmidt, Martina/0000-0003-3075-0630; Henning, Robert/0000-0002-5135-4621	GUIDE sector from university medical center Groningen	GUIDE sector from university medical center Groningen	GUIDE sector from university medical center Groningen funded the PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Duck Sun, 1994, Yonsei Medical Journal, V35, P162; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Betten A, 2001, J LEUKOCYTE BIOL, V70, P65; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Boutilier RG, 2001, J EXP BIOL, V204, P3171; DSa CM, 1996, J NEUROCHEM, V67, P900; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Happold FC, 1934, BIOCHEM J, V28, P1171, DOI 10.1042/bj0281171; Lee DA, 1998, J MATER SCI-MATER M, V9, P47, DOI 10.1023/A:1008882628142; Maurel A, 2007, AM J PHYSIOL-RENAL, V292, pF1592, DOI 10.1152/ajprenal.00514.2006; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Rauen U, 2002, BIOL CHEM, V383, P477, DOI 10.1515/BC.2002.050; RUBIN RP, 1970, PHARMACOL REV, V22, P389; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; SCHUFFWERNER P, 1995, EUR J CLIN INVEST, V25, P477, DOI 10.1111/j.1365-2362.1995.tb01733.x; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SUNDBERG R, 1991, CRYOBIOLOGY, V28, P150, DOI 10.1016/0011-2240(91)90017-I; Talaei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022568; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; Tripatara P, 2009, EUR J PHARMACOL, V606, P205, DOI 10.1016/j.ejphar.2009.01.041; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020	26	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30400	10.1371/journal.pone.0030400	http://dx.doi.org/10.1371/journal.pone.0030400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22253933	gold, Green Submitted, Green Published			2022-12-25	WOS:000301357100055
J	Alkelai, A; Greenbaum, L; Lupoli, S; Kohn, Y; Sarner-Kanyas, K; Ben-Asher, E; Lancet, D; Macciardi, F; Lerer, B				Alkelai, Anna; Greenbaum, Lior; Lupoli, Sara; Kohn, Yoav; Sarner-Kanyas, Kyra; Ben-Asher, Edna; Lancet, Doron; Macciardi, Fabio; Lerer, Bernard			Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIAGNOSTIC CRITERIA; KOREAN POPULATION; RISK-FACTORS; POLYMORPHISMS; METAANALYSIS; VARIANTS; LINKAGE; LOCUS; EXPRESSION	Many reports in different populations have demonstrated linkage of the 10q24-q26 region to schizophrenia, thus encouraging further analysis of this locus for detection of specific schizophrenia genes. Our group previously reported linkage of the 10q24-q26 region to schizophrenia in a unique, homogeneous sample of Arab-Israeli families with multiple schizophrenia-affected individuals, under a dominant model of inheritance. To further explore this candidate region and identify specific susceptibility variants within it, we performed re-analysis of the 10q24-26 genotype data, taken from our previous genome-wide association study (GWAS) (Alkelai et al, 2011). We analyzed 2089 SNPs in an extended sample of 57 Arab Israeli families (189 genotyped individuals), under the dominant model of inheritance, which best fits this locus according to previously performed MOD score analysis. We found significant association with schizophrenia of the TCF7L2 gene intronic SNP, rs12573128, (p = 7.01 x 10(-6)) and of the nearby intergenic SNP, rs1033772, (p = 6.59 x 10(-6)) which is positioned between TCF7L2 and HABP2. TCF7L2 is one of the best confirmed susceptibility genes for type 2 diabetes (T2D) among different ethnic groups, has a role in pancreatic beta cell function and may contribute to the comorbidity of schizophrenia and T2D. These preliminary results independently support previous findings regarding a possible role of TCF7L2 in susceptibility to schizophrenia, and strengthen the importance of integrating linkage analysis models of inheritance while performing association analyses in regions of interest. Further validation studies in additional populations are required.	[Alkelai, Anna; Greenbaum, Lior; Kohn, Yoav; Sarner-Kanyas, Kyra; Lerer, Bernard] Hadassah Hebrew Univ, Med Ctr, Biol Psychiat Lab, Dept Psychiat, Jerusalem, Israel; [Lupoli, Sara] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy; [Lupoli, Sara; Macciardi, Fabio] Univ Milan, Dept Sci & Biomed Technol, I-20122 Milan, Italy; [Ben-Asher, Edna; Lancet, Doron] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Weizmann Institute of Science; University of California System; University of California Irvine	Alkelai, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Biol Psychiat Lab, Dept Psychiat, Jerusalem, Israel.	lerer@cc.huji.ac.il	Macciardi, Fabio/N-3768-2014	Macciardi, Fabio/0000-0003-0537-4266	Israel Science Foundation (Israel Academy of Sciences) [348/09]; EU [FP7-ICT-2007-216088]	Israel Science Foundation (Israel Academy of Sciences)(Israel Science Foundation); EU(European Commission)	This work was supported by the Israel Science Foundation (Israel Academy of Sciences, Grant 348/09) and by the 7th EU project POCEMON (FP7-ICT-2007-216088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkelai A, 2009, AM J MED GENET B, V150B, P914, DOI 10.1002/ajmg.b.30918; Alkelai A, 2011, FASEB J, V25, P4011, DOI 10.1096/fj.11-184937; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; Ben-David E, 2010, AM J MED GENET B, V153B, P1244, DOI 10.1002/ajmg.b.31093; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Brinkmeler ML, 2007, DEV BIOL, V311, P396, DOI 10.1016/j.ydbio.2007.08.046; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chien IC, 2009, SCHIZOPHR RES, V111, P17, DOI 10.1016/j.schres.2009.04.003; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P140, DOI 10.1248/bpb.24.140; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; Dimas AS, 2009, CURR OPIN GENET DEV, V19, P586, DOI 10.1016/j.gde.2009.10.012; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Holliday EG, 2009, ARCH GEN PSYCHIAT, V66, P1058, DOI 10.1001/archgenpsychiatry.2009.136; Holt Richard I G, 2005, J Psychopharmacol, V19, P56, DOI 10.1177/0269881105058379; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Irmansyah, 2008, AM J MED GENET B, V147B, P1245, DOI 10.1002/ajmg.b.30763; Irvin MR, 2009, SCHIZOPHR RES, V114, P50, DOI 10.1016/j.schres.2009.07.008; Jaber L, 2000, CLIN GENET, V58, P106, DOI 10.1034/j.1399-0004.2000.580203.x; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Kim HJ, 2008, SCHIZOPHR RES, V103, P201, DOI 10.1016/j.schres.2008.04.031; Kim T, 2010, PSYCHIAT RES, V178, P266, DOI 10.1016/j.psychres.2009.05.007; Kohn Y, 2005, MOL PSYCHIATR, V10, P1062, DOI 10.1038/sj.mp.4001738; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lee S, 2009, J COMP NEUROL, V517, P925, DOI 10.1002/cne.22199; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Mayans S, 2007, EUR J HUM GENET, V15, P342, DOI 10.1038/sj.ejhg.5201773; Mowry BJ, 2000, AM J MED GENET, V96, P864, DOI 10.1002/1096-8628(20001204)96:6<864::AID-AJMG35>3.3.CO;2-4; Muhl L, 2009, FEBS LETT, V583, P1994, DOI 10.1016/j.febslet.2009.05.012; Murray KD, 2007, P NATL ACAD SCI USA, V104, P1989, DOI 10.1073/pnas.0610742104; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nazwar TA, 2009, J NEUROSCI RES, V87, P1532, DOI 10.1002/jnr.21989; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nica AC, 2011, PLOS GENET, V6; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; O'Donovan MC, 2009, MOL PSYCHIATR, V14, P30, DOI 10.1038/mp.2008.108; Okochi T, 2009, SCHIZOPHR RES, V110, P140, DOI 10.1016/j.schres.2009.02.019; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Prokunina-Olsson L, 2010, DIABETOLOGIA, V53, P712, DOI 10.1007/s00125-009-1640-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivero O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012254; Saddichha S, 2008, ACTA PSYCHIAT SCAND, V117, P342, DOI 10.1111/j.1600-0447.2008.01158.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Struewing I, 2010, BIOCHEM BIOPH RES CO, V399, P245, DOI 10.1016/j.bbrc.2010.07.062; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Van Steen Kristel, 2005, Hum Genomics, V2, P67; Verma SK, 2009, J CLIN PSYCHIAT, V70, P997, DOI 10.4088/JCP.08m04508; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Xu MQ, 2010, AM J MED GENET B, V153B, P1266, DOI 10.1002/ajmg.b.31096	73	47	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29228	10.1371/journal.pone.0029228	http://dx.doi.org/10.1371/journal.pone.0029228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247771	Green Published, gold			2022-12-25	WOS:000301355700019
J	Kochneva-Pervukhova, NV; Alexandrov, AI; Ter-Avanesyan, MD				Kochneva-Pervukhova, Natalia V.; Alexandrov, Alexander I.; Ter-Avanesyan, Michael D.			Amyloid-Mediated Sequestration of Essential Proteins Contributes to Mutant Huntingtin Toxicity in Yeast	PLOS ONE			English	Article							TRANSLATION TERMINATION; SACCHAROMYCES-CEREVISIAE; EXPANDED POLYGLUTAMINE; CELLULAR TOXICITY; BINDING PROTEIN; SUP35 POLYMERS; RELEASE FACTOR; MESSENGER-RNA; FACTOR ERF3; PRION	Background: Polyglutamine expansion is responsible for several neurodegenerative disorders, among which Huntington disease is the most well-known. Studies in the yeast model demonstrated that both aggregation and toxicity of a huntingtin (htt) protein with an expanded polyglutamine region strictly depend on the presence of the prion form of Rnq1 protein ([PIN+]), which has a glutamine/asparagine-rich domain. Principal Findings: Here, we showed that aggregation and toxicity of mutant htt depended on [PIN+] only quantitatively: the presence of [PIN+] elevated the toxicity and the levels of htt detergent-insoluble polymers. In cells lacking [PIN+], toxicity of mutant htt was due to the polymerization and inactivation of the essential glutamine/asparagine-rich Sup35 protein and related inactivation of another essential protein, Sup45, most probably via its sequestration into Sup35 aggregates. However, inhibition of growth of [PIN+] cells depended on Sup35/Sup45 depletion only partially, suggesting that there are other sources of mutant htt toxicity in yeast. Conclusions: The obtained data suggest that induced polymerization of essential glutamine/asparagine-rich proteins and related sequestration of other proteins which interact with these polymers represent an essential source of htt toxicity.	[Kochneva-Pervukhova, Natalia V.; Alexandrov, Alexander I.; Ter-Avanesyan, Michael D.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Kochneva-Pervukhova, NV (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	mdter@inbi.ras.ru	Alexandrov, Alexander/C-9579-2019; Alexandrov, Alexander/N-7620-2013	Alexandrov, Alexander/0000-0001-7250-4740; 	Russian Foundation for Basic Research [11-04-00442]; Ministry of Education and Science of the Russian Federation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by a grant from the Russian Foundation for Basic Research (#11-04-00442), www.rfbr.ru, and by the Ministry of Education and Science of the Russian Federation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; DAGKESAMANSKAYA AR, 1991, GENETICS, V128, P513; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Ghaemmaghami S, 2004, NATURE, V16, P737; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Kiktev D, 2007, PRION, V1, P136, DOI 10.4161/pri.1.2.4533; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Merritt GH, 2010, NUCLEIC ACIDS RES, V38, P5479, DOI 10.1093/nar/gkq338; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Peters TW, 2007, PRION, V1, P144, DOI 10.4161/pri.1.2.4630; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tauber E, 2011, J BIOL CHEM, V286, P410, DOI 10.1074/jbc.M110.101527; Urakov VN, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-34; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Valouev IA, 2004, MOL MICROBIOL, V53, P687, DOI 10.1111/j.1365-2958.2004.04157.x; Valouev IA, 2002, CELL MOTIL CYTOSKEL, V52, P161, DOI 10.1002/cm.10040; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	37	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29832	10.1371/journal.pone.0029832	http://dx.doi.org/10.1371/journal.pone.0029832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253794	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700057
J	Lindsey, PA; Balme, GA; Booth, VR; Midlane, N				Lindsey, Peter Andrew; Balme, Guy Andrew; Booth, Vernon Richard; Midlane, Neil			The Significance of African Lions for the Financial Viability of Trophy Hunting and the Maintenance of Wild Land	PLOS ONE			English	Article							CONSERVATION; POPULATION	Recent studies indicate that trophy hunting is impacting negatively on some lion populations, notably in Tanzania. In 2004 there was a proposal to list lions on CITES Appendix I and in 2011 animal-welfare groups petitioned the United States government to list lions as endangered under their Endangered Species Act. Such listings would likely curtail the trophy hunting of lions by limiting the import of lion trophies. Concurrent efforts are underway to encourage the European Union to ban lion trophy imports. We assessed the significance of lions to the financial viability of trophy hunting across five countries to help determine the financial impact and advisability of the proposed trade restrictions. Lion hunts attract the highest mean prices (US$24,000-US$71,000) of all trophy species. Lions generate 5-17% of gross trophy hunting income on national levels, the proportional significance highest in Mozambique, Tanzania, and Zambia. If lion hunting was effectively precluded, trophy hunting could potentially become financially unviable across at least 59,538 km 2 that could result in a concomitant loss of habitat. However, the loss of lion hunting could have other potentially broader negative impacts including reduction of competitiveness of wildlife-based land uses relative to ecologically unfavourable alternatives. Restrictions on lion hunting may also reduce tolerance for the species among communities where local people benefit from trophy hunting, and may reduce funds available for anti-poaching. If lion off-takes were reduced to recommended maximums (0.5/1000 km(2)), the loss of viability and reduction in profitability would be much lower than if lion hunting was stopped altogether (7,005 km(2)). We recommend that interventions focus on reducing off-takes to sustainable levels, implementing age-based regulations and improving governance of trophy hunting. Such measures could ensure sustainability, while retaining incentives for the conservation of lions and their habitat from hunting.	[Lindsey, Peter Andrew] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Gauteng, South Africa; [Midlane, Neil] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa	University of Pretoria; University of Cape Town	Lindsey, PA (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Gauteng, South Africa.	palindsey@gmail.com	Lindsey, Peter A/J-8368-2012	Lindsey, Peter A/0000-0002-9197-2897	Panthera [016682-0002-02521-NY02.2532753.2]	Panthera	The work was funded by Panthera (http://www.panthera.org/?splash=off) Grant number: 016682-0002-02521-NY02.2532753.2. Three of the authors (Peter Lindsey, Guy Balme, Neil Midlane) are affiliated with the funder and were involved in the design of the study, implementation, analysis and write up. However, the study was conducted in a completely impartial and objective manner.	[Anonymous], 2009, RECREATIONAL HUNTING; Bauer H, 2008, IUCN 2011 IUCN RED L; Begg C, 2009, NIASSA CARNIVORE PRO; Blanc J, 2007, 33 IUCN SPEC SURV CO, P256; Booth V, 2011, CONTRIBUTION TOURISM; Booth VR, 2009, COMP PRICES HUNTING; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Chardonnet P., 2002, CONSERVATION AFRICAN; Croes B, BIOL CONSERVATION; Cumming DHM., 2004, PARKS TRANSITION BIO, P105; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Group ICS, 2006, CONSERVATION STRATEG; Hatton J., 2001, BIODIVERSITY WAR CAS; Jones B., 2009, EVOLUTION INNOVATION, P223; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Lewis DM, 1997, CONSERV BIOL, V11, P59, DOI 10.1046/j.1523-1739.1997.94389.x; Lindsey P, 2011, ILLEGAL HUNTING BUSH; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey P.A., 2011, ANAL GAME MEAT PRODU; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2009, RECREATIONAL HUNTING, P108; Martin R.B, 1986, ESTABLISHMENT AFRICA; Mesochina P, 2010, CONSERVATION STATUS; Mozambique Ministry of Tourism, 2010, NIASS NAT RES MAN PL; Naidoo R, 2011, J APPL ECOL, V48, P310, DOI 10.1111/j.1365-2664.2010.01955.x; Nelson F, 2009, 12 CHR MICH I; Norton-Griffiths M, 2008, WORLD ECON, V8, P41; Nowell K, 2004, CAT NEWS, V41, P29; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Palazy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022424; Rosser A.M., 2009, RECREATIONAL HUNTING, P319; Simasiku P, 2008, IMPACT WILDLIFE MANA; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066	36	79	79	3	205	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e29332	10.1371/journal.pone.0029332	http://dx.doi.org/10.1371/journal.pone.0029332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22247772	Green Published, gold			2022-12-25	WOS:000301355700020
J	van den Driesche, S; Kolovos, P; Platts, S; Drake, AJ; Sharpe, RM				van den Driesche, Sander; Kolovos, Petros; Platts, Sophie; Drake, Amanda J.; Sharpe, Richard M.			Inter-Relationship between Testicular Dysgenesis and Leydig Cell Function in the Masculinization Programming Window in the Rat	PLOS ONE			English	Article							IN-UTERO EXPOSURE; REPRODUCTIVE DEVELOPMENT; DI(N-BUTYL) PHTHALATE; ANDROGEN ACTION; FETAL TESTIS; END-POINTS; TRACT; DISRUPTION; STEROIDOGENESIS; BIOPSIES	The testicular dysgenesis syndrome (TDS) hypothesis proposes that maldevelopment of the testis, irrespective of cause, leads to malfunction of the somatic (Leydig, Sertoli) cells and consequent downstream TDS disorders. Studies in rats exposed in utero to di(n-butyl) phthalate (DBP) have strongly supported the TDS concept, but so far no direct evidence has been produced that links dysgenesis per se to somatic cell dysfunction, in particular to androgen production/action during the 'masculinization programming window' (MPW; e15.5-e18.5). Normal reproductive tract development and anogenital distance (AGD) are programmed within the MPW, and TDS disorders arise because of deficiencies in this programming. However, DBP-induced focal testicular dysgenesis (Leydig cell aggregation, ectopic Sertoli cells, malformed seminiferous cords) is not evident until after the MPW. Therefore, we used AGD as a read-out of androgen exposure in the MPW, and investigated if this measure was related to objectively quantified dysgenesis (Leydig cell aggregation) at e21.5 in male fetuses exposed to vehicle, DBP (500 or 750 mg/kg/day) or the synthetic glucocorticoid dexamethasone (Dex; alone or plus DBP-500) from e15.5-e18.5 (MPW), e13.5-e20.5 or e19.5-e20.5 (late window). Dysgenesis was found only in animals exposed to DBP during the MPW, and was negatively correlated (R-2 = -0.5) with AGD at e21.5 and at postnatal day 8, irrespective of treatment period. Dysgenesis was also negatively correlated (R-2 = -0.5) with intratesticular testosterone (ITT) at e21.5, but only when treatments in short windows (MPW, late window) were excluded; the same was true for correlation between AGD and ITT. We conclude that AGD, reflecting Leydig cell function solely within the MPW, is strongly related to focal dysgenesis. Our results point to this occurring because of a common early mechanism, targeted by DBP that determines both dysgenesis and early (during the MPW) fetal Leydig cell dysfunction. The findings provide strong validation of the TDS hypothesis.	[van den Driesche, Sander; Kolovos, Petros; Platts, Sophie; Sharpe, Richard M.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Drake, Amanda J.] Univ Edinburgh, Univ BHF Ctr Cardiovascular Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	van den Driesche, S (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	s.vandendriesche@ed.ac.uk	van den Driesche, Sander/H-7094-2019; Sharpe, Richard M/D-2725-2013	Sharpe, Richard M/0000-0003-1686-8085; van den Driesche, Sander/0000-0002-8092-6588; Kolovos, Petros/0000-0002-0787-6158	European Union [FP7-ENV-2007-1-212844]; UK Medical Research Council [G33253, G0501904]; Medical Research Council [G1100358, G1002033, G0501904] Funding Source: researchfish; MRC [G1002033, G0501904, G1100358] Funding Source: UKRI	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Grant FP7-ENV-2007-1-212844 from the European Union and Grants G33253 from the UK Medical Research Council and G0501904 (to AJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335; Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2005, TOXICOL SCI, V85, P1024, DOI 10.1093/toxsci/kfi159; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; Grigor KM, 2007, INT J ANDROL, V30, P204; Hoei-Hansen CE, 2003, J PATHOL, V200, P370, DOI 10.1002/path.1372; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Hutchison GR, 2008, INT J ANDROL, V31, P103, DOI 10.1111/j.1365-2605.2007.00816.x; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366; Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Mendiola J, 2011, ENVIRON HEALTH PERSP, V119, P958, DOI 10.1289/ehp.1103421; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5; Nistal M, 2007, AM J SURG PATHOL, V31, P1269, DOI 10.1097/PAS.0b013e318030979a; Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241	37	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2012	7	1							e30111	10.1371/journal.pone.0030111	http://dx.doi.org/10.1371/journal.pone.0030111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ON	22253897	gold, Green Published, Green Submitted			2022-12-25	WOS:000301355700091
J	Panigrahi, S; Stetefeld, J; Jangamreddy, JR; Mandal, S; Mandal, SK; Los, M				Panigrahi, Soumya; Stetefeld, Joerg; Jangamreddy, Jaganmohan R.; Mandal, Soma; Mandal, Sanat K.; Los, Marek			Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design	PLOS ONE			English	Article							PROTEIN-STRUCTURE; CELL-DEATH; C-ABL; MICROARRAY DATA; SH3 DOMAIN; KINASE; ACTIVATION; APOPTOSIS; BCR/ABL; DOCKING	In this study we have calculated a 3D structure of apoptin and through modeling and docking approaches, we show its interaction with Bcr-Abl oncoprotein and its downstream signaling components, following which we confirm some of the newly-found interactions by biochemical methods. Bcr-Abl oncoprotein is aberrantly expressed in chronic myelogenous leukaemia (CIVIL). It has several distinct functional domains in addition to the Abl kinase domain. The SH3 and SH2 domains cooperatively play important roles in autoinhibiting its kinase activity. Adapter molecules such as Grb2 and CrkL interact with proline-rich region and activate multiple Bcr-Abl downstream signaling pathways that contribute to growth and survival. Therefore, the oncogenic effect of Bcr-Abl could be inhibited by the interaction of small molecules with these domains. Apoptin is a viral protein with well-documented cancer-selective cytotoxicity. Apoptin attributes such as SH2-like sequence similarity with CrkL SH2 domain, unique SH3 domain binding sequence, presence of proline-rich segments, and its nuclear affinity render the molecule capable of interaction with Bcr-Abl. Despite almost two decades of research, the mode of apoptin's action remains elusive because 3D structure of apoptin is unavailable. We performed in silico three-dimensional modeling of apoptin, molecular docking experiments between apoptin model and the known structure of Bcr-Abl, and the 3D structures of SH2 domains of CrkL and Bcr-Abl. We also biochemically validated some of the interactions that were first predicted in silica. This structure-property relationship of apoptin may help in unlocking its cancer-selective toxic properties. Moreover, such models will guide us in developing of a new class of Potent apoptin-like molecules with greater selectivity and potency.	[Panigrahi, Soumya] Lerner Res Inst NB 50, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Mandal, Soma] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3T 2N2, Canada; [Mandal, Sanat K.] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Mandal, Sanat K.] Coll,N Atlantic, Clarenville, NF, Canada; [Los, Marek] BioApplicat Enterprises, Winnipeg, MB, Canada; [Jangamreddy, Jaganmohan R.; Los, Marek] Linkoping Univ, Dept Clin & Expt Med IKE, Linkoping, Sweden; [Jangamreddy, Jaganmohan R.; Los, Marek] Linkoping Univ, Integrat Regenerat Med Ctr IGEN, Linkoping, Sweden	University of Manitoba; University of Manitoba; Memorial University Newfoundland; Linkoping University; Linkoping University	Panigrahi, S (corresponding author), Lerner Res Inst NB 50, Dept Mol Cardiol, Cleveland, OH 44195 USA.	marek.los@liu.se	Reddy, Jaganmohan/R-9379-2019; Stetefeld, Joerg/H-7630-2017; Jangamreddy, Jaganmohan Reddy/J-8085-2013	Stetefeld, Joerg/0000-0003-1478-3248; Jangamreddy, Jaganmohan Reddy/0000-0001-6105-1213; Los, Marek/0000-0001-9518-1411	Memorial University; College of the North Atlantic, Clarenville Campus; Canada Research Chair program; Linkoping University, Integrative Regenerative Medicine Center (IGEN); Cancerfonden [CAN 2011/521]	Memorial University; College of the North Atlantic, Clarenville Campus; Canada Research Chair program(Canada Research Chairs); Linkoping University, Integrative Regenerative Medicine Center (IGEN); Cancerfonden(Swedish Cancer Society)	Memorial University and College of the North Atlantic, Clarenville Campus, are gratefully acknowledged for their support (SKM). JS thankfully acknowledges the support by the Canada Research Chair program. ML kindly acknowledges the core/startup support from Linkoping University, from Integrative Regenerative Medicine Center (IGEN, a non-for profit research structure within the university), and from Cancerfonden (CAN 2011/521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BM, 2000, DEV COMP IMMUNOL, V24, P247, DOI 10.1016/S0145-305X(99)00076-2; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chomel JC, 2011, ONCOTARGET, V2, P713; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Danen-van Oorschot AAAM, 2003, J BIOL CHEM, V278, P27729, DOI 10.1074/jbc.M303114200; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Frisch M., 2016, GAUSSIAN 16 REVISION; Fujitsu I, 2008, SCIGRESS EXPLORER UL; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Ghavami S, 2010, BBA-MOL CELL RES, V1803, P452, DOI 10.1016/j.bbamcr.2009.12.005; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Ghavami S, 2009, BBA-MOL CELL RES, V1793, P546, DOI 10.1016/j.bbamcr.2009.01.002; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hallek M, 1996, BRIT J HAEMATOL, V94, P5, DOI 10.1046/j.1365-2141.1996.6102053.x; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; Heilman DW, 2006, J VIROL, V80, P7535, DOI 10.1128/JVI.02741-05; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Jiang J, 2010, CANCER RES, V70, P7242, DOI 10.1158/0008-5472.CAN-10-1204; Kardinal C, 2001, BLOOD, V98, P1773, DOI 10.1182/blood.V98.6.1773; Klein E, 1976, INTJ CANC, V18, P421; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Leliveld SR, 2003, J BIOL CHEM, V278, P9042, DOI 10.1074/jbc.M210803200; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; Los M, 2009, BBA-MOL CELL RES, V1793, P1335, DOI 10.1016/j.bbamcr.2009.04.002; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maddika S, 2008, ONCOGENE, V27, P3060, DOI 10.1038/sj.onc.1210958; Maddika S, 2007, CELL PROLIFERAT, V40, P835, DOI 10.1111/j.1365-2184.2007.00475.x; Maddika S, 2006, CANCER BIOL THER, V5, P10, DOI 10.4161/cbt.5.1.2400; Maddika S, 2005, J CELL SCI, V118, P4485, DOI 10.1242/jcs.02580; Maddika S, 2009, MOL CELL BIOL, V29, P1235, DOI 10.1128/MCB.00668-08; Mandal S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-181; Mandal S, 2009, EUR J PHARMACOL, V625, P90, DOI 10.1016/j.ejphar.2009.06.065; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Peng C, 2010, ONCOTARGET, V1, P156, DOI 10.18632/oncotarget.119; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Posern G, 2000, ONCOGENE, V19, P6361, DOI 10.1038/sj.onc.1204027; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; RAMACHANDRAN GN, 1963, SCIENCE, V141, P288, DOI 10.1126/science.141.3577.288; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Rohn JL, 2002, J BIOL CHEM, V277, P50820, DOI 10.1074/jbc.M208557200; Rychlewski L, 1999, PROTEIN SCI, V8, P614; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sattler M, 1996, ONCOGENE, V12, P839; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Schiffer CA, 2007, NEW ENGL J MED, V357, P258, DOI 10.1056/NEJMct071828; Schnaiter A, 2010, ONCOTARGET, V1, P472; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wagstaff KM, 2009, EUR J PHARMACOL, V625, P174, DOI 10.1016/j.ejphar.2009.06.069; Workman P, 2004, BIOCHEM SOC T, V32, P393, DOI 10.1042/BST0320393; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	72	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					6	20	e28395	10.1371/journal.pone.0028395	http://dx.doi.org/10.1371/journal.pone.0028395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253690	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000301353900001
J	Walker, CL; Walker, MJ; Liu, NK; Risberg, EC; Gao, X; Chen, JH; Xu, XM				Walker, Chandler L.; Walker, Melissa J.; Liu, Nai-Kui; Risberg, Emelie C.; Gao, Xiang; Chen, Jinhui; Xu, Xiao-Ming			Systemic Bisperoxovanadium Activates Akt/mTOR, Reduces Autophagy, and Enhances Recovery following Cervical Spinal Cord Injury	PLOS ONE			English	Article							PROTEIN-KINASE-B; TYROSINE-PHOSPHATASE INHIBITION; CONTUSION INJURY; UP-REGULATION; CELL-DEATH; PTEN; SURVIVAL; AKT; EXPRESSION; BRAIN	Secondary damage following primary spinal cord injury extends pathology beyond the site of initial trauma, and effective management is imperative for maximizing anatomical and functional recovery. Bisperoxovanadium compounds have proven neuroprotective effects in several central nervous system injury/disease models, however, no mechanism has been linked to such neuroprotection from bisperoxovanadium treatment following spinal trauma. The goal of this study was to assess acute bisperoxovanadium treatment effects on neuroprotection and functional recovery following cervical unilateral contusive spinal cord injury, and investigate a potential mechanism of the compound's action. Two experimental groups of rats were established to 1) assess twice-daily 7 day treatment of the compound, potassium bisperoxo (picolinato) vanadium, on long-term recovery of skilled forelimb activity using a novel food manipulation test, and neuroprotection 6 weeks following injury and 2) elucidate an acute mechanistic link for the action of the drug post-injury. Immunofluorescence and Western blotting were performed to assess cellular signaling 1 day following SCI, and histochemistry and forelimb functional analysis were utilized to assess neuroprotection and recovery 6 weeks after injury. Bisperoxovanadium promoted significant neuroprotection through reduced motorneuron death, increased tissue sparing, and minimized cavity formation in rats. Enhanced forelimb functional ability during a treat-eating assessment was also observed. Additionally, bisperoxovanadium significantly enhanced downstream Akt and mammalian target of rapamycin signaling and reduced autophagic activity, suggesting inhibition of the phosphatase and tensin homologue deleted on chromosome ten as a potential mechanism of bisperoxovanadium action following traumatic spinal cord injury. Overall, this study demonstrates the efficacy of a clinically applicable pharmacological therapy for rapid initiation of neuroprotection post-spinal cord injury, and sheds light on the signaling involved in its action.	[Walker, Chandler L.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Walker, Melissa J.; Xu, Xiao-Ming] Indiana Univ Sch Med, Med Neurosci Grad Program, Stark Neurosci Res Inst, Indianapolis, IN USA; [Walker, Chandler L.; Walker, Melissa J.; Liu, Nai-Kui; Risberg, Emelie C.; Gao, Xiang; Chen, Jinhui; Xu, Xiao-Ming] Indiana Univ Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Walker, CL (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	xu26@iupui.edu	Walker, Chandler L./D-2256-2014	Walker, Chandler L./0000-0002-8616-8263; Xu, Xiao-ming/0000-0002-7229-0081	National Institutes of Health [NS36350, NS52290, NS50243]; Mari Hulman George Endowment Fund; State of Indiana; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036350, R01NS052290, R01NS050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mari Hulman George Endowment Fund; State of Indiana; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS36350, NS52290, and NS50243 to X-M.X.]; Mari Hulman George Endowment Fund; and the State of Indiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Cai QY, 2009, ANAT REC, V292, P498, DOI 10.1002/ar.20834; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Cho JY, 2002, NEUROSCI LETT, V334, P131, DOI 10.1016/S0304-3940(02)01122-9; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Irvine Karen-Amanda, 2010, J Vis Exp, DOI 10.3791/2246; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Lehman JA, 2002, BIOCHEM BIOPH RES CO, V293, P463, DOI 10.1016/S0006-291X(02)00238-3; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Martinez M, 2009, J NEUROTRAUM, V26, P1043, DOI 10.1089/neu.2008.0717; Nakashima S, 2008, J NEUROSCI, V28, P7293, DOI 10.1523/JNEUROSCI.1826-08.2008; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Rami A, 2008, AUTOPHAGY, V4, P422, DOI 10.4161/auto.5778; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sury MD, 2011, NEUROBIOL DIS, V41, P201, DOI 10.1016/j.nbd.2010.09.007; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu JT, 2010, BRAIN RES, V1336, P46, DOI 10.1016/j.brainres.2010.04.010; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Yan P, 1999, J NEUROSCI, V19, P9355; Yang P, 2007, EUR J NEUROSCI, V25, P1332, DOI 10.1111/j.1460-9568.2007.05384.x; Yu FS, 2005, NEUROBIOL DIS, V20, P491, DOI 10.1016/j.nbd.2005.04.004; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	55	174	185	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					315	326	e30012	10.1371/journal.pone.0030012	http://dx.doi.org/10.1371/journal.pone.0030012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253859	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900033
J	Xiao, XJ; Liu, KW; Zheng, YY; Zhang, YT; Tsai, WC; Hsiao, YY; Zhang, GQ; Chen, LJ; Liu, ZJ				Xiao, Xin-Ju; Liu, Ke-Wei; Zheng, Yu-Yun; Zhang, Yu-Ting; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Zhang, Guo-Qiang; Chen, Li-Jun; Liu, Zhong-Jian			Predicted Disappearance of Cephalantheropsis obcordata in Luofu Mountain Due to Changes in Rainfall Patterns	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; CO2; STRESS	Background: In the past century, the global average temperature has increased by approximately 0.74 degrees C and extreme weather events have become prevalent. Recent studies have shown that species have shifted from high-elevation areas to low ones because the rise in temperature has increased rainfall. These outcomes challenge the existing hypothesis about the responses of species to climate change. Methodology/Principal Findings: With the use of data on the biological characteristics and reproductive behavior of Cephalantheropsis obcordata in Luofu Mountain, Guangdong, China, trends in the population size of the species were predicted based on several factors. The response of C. obcordata to climate change was verified by integrating it with analytical findings on meteorological data and an artificially simulated environment of water change. The results showed that C. obcordata can grow only in waterlogged streams. The species can produce fruit with many seeds by insect pollination; however, very few seeds can burgeon to become seedlings, with most of those seedlings not maturing into the sexually reproductive phase, and grass plants will die after reproduction. The current population's age pyramid is kettle-shaped; it has a Deevey type I survival curve; and its net reproductive rate, intrinsic rate of increase, as well as finite rate of increase are all very low. The population used in the artificial simulation perished due to seasonal drought. Conclusions:The change in rainfall patterns caused by climate warming has altered the water environment of C. obcordata in Luofu Mountain, thereby restricting seed burgeoning as well as seedling growth and shortening the life span of the plant. The growth rate of the C. obcordata population is in descending order, and models of population trend predict that the population in Luofu Mountain will disappear in 23 years.	[Xiao, Xin-Ju; Liu, Ke-Wei; Zheng, Yu-Yun; Zhang, Yu-Ting; Zhang, Guo-Qiang; Chen, Li-Jun; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Xiao, Xin-Ju] Beijing Forestry Univ, Continuing Educ Coll, Beijing, Peoples R China; [Liu, Ke-Wei; Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Beijing Forestry University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; South China Agricultural University	Xiao, XJ (corresponding author), Orchid Conservat & Res Ctr Shenzhen, Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	chenlj@sinicaorchid.org; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Liu, Zhong-Jian/0000-0003-4390-3878	Forestry Construction of State Forestry Administration of China [2010-240]; Forestry Construction of Guangdong Province, China [2010-317]	Forestry Construction of State Forestry Administration of China; Forestry Construction of Guangdong Province, China	This work was supported in part by grants from the Forestry Construction of State Forestry Administration of China (No. 2010-240) and the Forestry Construction of Guangdong Province, China (No. 2010-317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S., 2003, ACTA BOT SIN, V45, P2; Chen SC, 2009, FLORA CHINA, V25, P288; Crawley M.J., 1986, PLANT ECOL, V2; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; HAO YP, 1998, ADV EARTH SCI, V13, P564; HARCOMBE PA, 1987, BIOSCIENCE, V37, P557, DOI 10.2307/1310666; Harper J.L., 1997, POPULATION BIOL PLAN; Hu Y. J., 1988, Acta Ecologica Sinica, V8, P104; Janacek J, 1997, PHOTOSYNTHETICA, V34, P473, DOI 10.1023/A:1006880521888; [李先琨 Li Xiankun], 2002, [生态学报, Acta Ecologica Sinica], V22, P2246; Liang NS, 1995, ENVIRON EXP BOT, V35, P353, DOI 10.1016/0098-8472(95)00009-8; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu Z.J., 2006, GENUS CYMBIDIUM CHIN; [刘仲健 LIU Zhong-Jian], 2009, [生态学报, Acta Ecologica Sinica], V29, P3443; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P111; Luo YB, 2003, BIODIVERS SCI, V11, P70, DOI DOI 10.3321/J.ISSN:1005-0094.2003.01.010; Manuel C., 2002, ECOLOGY CONCEPT APPL; Meier M, 1997, ENVIRON EXP BOT, V38, P251, DOI 10.1016/S0098-8472(97)00020-8; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Pan RC, 2005, PHYSL CYMBIDIUM; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sun RY, 2003, BASIC ECOLOGY; Tang H, 1992, STUDY POPULATION ECO; [岳春雷 Yue Chunlei], 2002, [生态学报, Acta Ecologica Sinica], V22, P793; Zhang W. H., 1999, ACTA PHYTOECOLOGICA, V23, P76; 刘金福, 1999, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V5, P247	29	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					125	132	e29718	10.1371/journal.pone.0029718	http://dx.doi.org/10.1371/journal.pone.0029718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253763	gold, Green Submitted, Green Published			2022-12-25	WOS:000301353900014
J	Cozar, A; Bruno, M; Bergamino, N; Ubeda, B; Bracchini, L; Dattilo, AM; Loiselle, SA				Cozar, Andres; Bruno, Miguel; Bergamino, Nadia; Ubeda, Barbara; Bracchini, Luca; Dattilo, Arduino M.; Loiselle, Steven A.			Basin-Scale Control on the Phytoplankton Biomass in Lake Victoria, Africa	PLOS ONE			English	Article							OCEAN COLOR SENSORS; CLIMATE-CHANGE; EAST-AFRICA; VARIABILITY; WATER; EUTROPHICATION; PRODUCTIVITY; PHOSPHORUS; NITROGEN; SEAWIFS	The relative bio-optical variability within Lake Victoria was analyzed through the spatio-temporal decomposition of a 19972004 dataset of remotely-sensed reflectance ratios in the visible spectral range. Results show a regular seasonal pattern with a phase shift (around 2 months) between the south and north parts of the lake. Interannual trends suggested a teleconnection between the lake dynamics and El-Nino phenomena. Both seasonal and interannual patterns were associated to conditions of light limitation for phytoplankton growth and basin-scale hydrodynamics on phytoplankton access to light. Phytoplankton blooms developed during the periods of lake surface warming and water column stability. The temporal shift apparent in the bio-optical seasonal cycles was related to the differential cooling of the lake surface by southeastern monsoon winds. North-south differences in the exposure to trade winds are supported by the orography of the Eastern Great Rift Valley. The result is that surface layer warming begins in the northern part of the lake while the formation of cool and dense water continues in the southern part. The resulting buoyancy field is sufficient to induce a lake-wide convective circulation and the tilting of the isotherms along the north-south axis. Once surface warming spreads over the whole lake, the phytoplankton bloom dynamics are subjected to the internal seiche derived from the relaxation of thermocline tilting. In 1997-98, El-Nino phenomenon weakened the monsoon wind flow which led to an increase in water column stability and a higher phytoplankton optical signal throughout the lake. This suggests that phytoplankton response to expected climate scenarios will be opposite to that proposed for nutrient-limited great lakes. The present analysis of remotely-sensed bio-optical properties in combination with environmental data provides a novel basin-scale framework for research and management strategies in Lake Victoria.	[Cozar, Andres; Ubeda, Barbara] Univ Cadiz, Dept Biol, Cadiz, Spain; [Bruno, Miguel] Univ Cadiz, Ctr Andaluz Ciencia & Tecnol Marinas CACYTMAR, Cadiz, Spain; [Bergamino, Nadia; Bracchini, Luca; Dattilo, Arduino M.; Loiselle, Steven A.] Univ Siena, Environm Spect Grp, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Bergamino, Nadia; Bracchini, Luca; Dattilo, Arduino M.; Loiselle, Steven A.] Consorzio Interuniv Sviluppo Sistemi Grande Inter, Florence, Italy	Universidad de Cadiz; Universidad de Cadiz; University of Siena	Cozar, A (corresponding author), Univ Cadiz, Dept Biol, Cadiz, Spain.	andres.cozar@uca.es	Loiselle, Steven/ABA-3324-2020; Ubeda, Barbara/AAT-6839-2020; Úbeda Sánchez, Bárbara/AAZ-8930-2021; Cozar, Andres/G-2141-2016	Loiselle, Steven/0000-0001-7414-0389; Úbeda Sánchez, Bárbara/0000-0001-8165-2091; Cozar, Andres/0000-0003-1370-9935	European Commission RTD INCO programme [ICA4CT2001-10036]; NERC ESPA grant [NE/1003266/1]; Italian Interuniversity Consortium CSGI; Natural Environment Research Council [NE/I003266/1] Funding Source: researchfish; NERC [NE/I003266/1] Funding Source: UKRI	European Commission RTD INCO programme; NERC ESPA grant; Italian Interuniversity Consortium CSGI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the European Commission RTD INCO programme (ICA4CT2001-10036), a NERC ESPA grant (NE/1003266/1), and the Italian Interuniversity Consortium CSGI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin SR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002881; Anyah RO, 2004, THEOR APPL CLIMATOL, V79, P55, DOI 10.1007/s00704-004-0057-4; Awange JL, 2008, WATER RESOUR MANAG, V22, P775, DOI 10.1007/s11269-007-9191-y; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Coulter GW, 1996, LIMNOLOGY CLIMATOLOG, P141; Cozar A, 2005, ECOL MODEL, V186, P29, DOI 10.1016/j.ecolmodel.2005.01.029; Fietz S, 2005, J PLANKTON RES, V27, P793, DOI 10.1093/plankt/fbi054; Fish, 1957, COL OF FISH PUBL LON, V10, P1; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Guildford SJ, 2003, J GREAT LAKES RES, V29, P89, DOI 10.1016/S0380-1330(03)70541-3; Hamblin PF, 2003, J GREAT LAKES RES, V29, P34, DOI 10.1016/S0380-1330(03)70537-1; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; HECKY RE, 1994, LIMNOL OCEANOGR, V39, P1476, DOI 10.4319/lo.1994.39.6.1476; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; IPCC, 2007, CLIM CHANG 2007; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kling H.J., 2001, P47; LEHMAN JT, 1993, PROC INT ASSOC THEOR, V25, P850; Loiselle SA, 2008, FRESHWATER BIOL, V53, P535, DOI 10.1111/j.1365-2427.2007.01918.x; Loiselle SA, 2007, FRESHWATER BIOL, V52, P305, DOI 10.1111/j.1365-2427.2006.01693.x; MacIntyre S, 2002, LIMNOL OCEANOGR, V47, P656, DOI 10.4319/lo.2002.47.3.0656; Maravall A, 2003, TRAMO SEATS BANK SPA; Morel A, 2007, REMOTE SENS ENVIRON, V111, P69, DOI 10.1016/j.rse.2007.03.012; Morel A, 2006, REMOTE SENS ENVIRON, V102, P237, DOI 10.1016/j.rse.2006.01.022; MUGIDDE R, 1993, PROC INT ASSOC THEOR, V25, P846; Mugidde R, 2003, J GREAT LAKES RES, V29, P76, DOI 10.1016/S0380-1330(03)70540-1; Mugidde R., 2001, THESIS U WATERLOO; Mukabana JR, 1996, MON WEATHER REV, V124, P224, DOI 10.1175/1520-0493(1996)124<0224:ITIOSS>2.0.CO;2; Nicholson S.E., 1996, LIMNOLOGY CLIMATOLOG, V1st ed., P25, DOI [DOI 10.1201/9780203748978-2, 10.1201/9780203748978-2]; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; OCHUMBA P. B. O., 1996, LIMNOLOGY CLIMATOLOG, P155; OgutuOhwayo R, 1997, ENVIRON BIOL FISH, V50, P117, DOI 10.1023/A:1007320932349; Peeters F, 2007, LIMNOL OCEANOGR, V52, P286, DOI 10.4319/lo.2007.52.1.0286; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Reynolds C.S., 2000, Aquatic Ecosystem Health & Management, V3, P1; Scheren PAGM, 2000, J ENVIRON MANAGE, V58, P235, DOI 10.1006/jema.2000.0322; Schreck CJ, 2004, INT J CLIMATOL, V24, P681, DOI 10.1002/joc.1019; Schwab DJ, 2009, J GREAT LAKES RES, V35, P50, DOI 10.1016/j.jglr.2008.09.003; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Silsbe GM, 2006, LIMNOL OCEANOGR, V51, P2052, DOI 10.4319/lo.2006.51.5.2052; Simonit S, 2005, ICES J MAR SCI, V62, P483, DOI 10.1016/j.icesjms.2005.01.012; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Stager JC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008362; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; Talling J.F., 1998, ECOLOGICAL DYNAMICS; Talling JF, 1966, INT REV GESAMTEN HYD, V50, P1; Verburg P, 2011, LIMNOL OCEANOGR, V56, P910, DOI 10.4319/lo.2011.56.3.0910; Williams AE, 2005, AQUAT BOT, V81, P300, DOI 10.1016/j.aquabot.2005.01.003; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942	53	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e29962	10.1371/journal.pone.0029962	http://dx.doi.org/10.1371/journal.pone.0029962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	22253837	Green Submitted, Green Published, gold			2022-12-25	WOS:000315865800020
J	Do Lam, ATA; Axmacher, N; Fell, J; Staresina, BP; Gauggel, S; Wagner, T; Olligs, J; Weis, S				Do Lam, Anne T. A.; Axmacher, Nikolai; Fell, Juergen; Staresina, Bernhard P.; Gauggel, Siegfried; Wagner, Tobias; Olligs, Jan; Weis, Susanne			Monitoring the Mind: The Neurocognitive Correlates of Metamemory	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; BRAIN ACTIVITY; FRONTAL-CORTEX; JUDGMENTS; MEMORY; RETRIEVAL; GYRUS; TIME; CUE	Memory performance in everyday life is often far from perfect and therefore needs to be monitored and controlled by metamemory evaluations, such as judgments of learning (JOLs). JOLs support monitoring for goal-directed modification of learning. Behavioral studies suggested retrieval processes as providing a basis for JOLs. Previous functional imaging research on JOLs found a dissociation between processes underlying memory prediction, located in the medial prefrontal cortex (mPFC), and actual encoding success, located in the medial temporal lobe. However, JOL-specific neural correlates could not be identified unequivocally, since JOLs were given simultaneously with encoding. Here, we aimed to identify the neurocognitive basis of JOLs, i.e., the cognitive processes and neural correlates of JOL, separate from initial encoding. Using functional magnetic resonance imaging (fMRI), we implemented a face-name paired associative design. In general, we found that actual memory success was associated with increased brain activation of the hippocampi bilaterally, whereas predicted memory success was accompanied by increased activation in mPFC, orbital frontal and anterior cingulate cortices. Masking brain activation during predicted memory success with activation during retrieval success revealed BOLD increases of the mPFC. Our findings indicate that JOLs actually incorporate retrieval processes.	[Do Lam, Anne T. A.; Axmacher, Nikolai; Fell, Juergen; Staresina, Bernhard P.; Wagner, Tobias; Olligs, Jan] Univ Bonn, Dept Epileptol, Bonn, Germany; [Do Lam, Anne T. A.] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [Axmacher, Nikolai] German Ctr Neurodegenerat Dis, Bonn, Germany; [Staresina, Bernhard P.] MRC Cognit & Brain Sci Unit, Cambridge, England; [Gauggel, Siegfried] Rhein Westfal TH Aachen, Dept Med Psychol & Sociol, Aachen, Germany; [Wagner, Tobias] Univ Bonn, Helmholtz Inst Radiat & Nucl Phys, Bonn, Germany; [Weis, Susanne] Univ Durham, Dept Psychol, Durham DH1 3LE, England	University of Bonn; RWTH Aachen University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); RWTH Aachen University; Helmholtz Association; University of Bonn; Durham University	Do Lam, ATA (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	anne.dolam@ukb.uni-bonn.de	Staresina, Bernhard P/N-4496-2014	Staresina, Bernhard P/0000-0002-0558-9745; Axmacher, Nikolai/0000-0002-0475-6492; Gauggel, Siegfried/0000-0002-2742-4917	RWTH Aachen University [START 690641]; Deutsche Forschungsgemeinschaft (DFG) DFG [FE 366/5-1, WE 2793/2-1]; University of Bonn BONFOR grant	RWTH Aachen University; Deutsche Forschungsgemeinschaft (DFG) DFG(German Research Foundation (DFG)); University of Bonn BONFOR grant	This research was supported by the RWTH Aachen University START 690641 (http://www.ukaache.de), ADL was supported by the Deutsche Forschungsgemeinschaft (DFG) DFG FE 366/5-1 (http://www.dfg.de), SW was supported by DFG WE 2793/2-1 (http://www.dfg.de), JO by the University of Bonn BONFOR grant (http://www.ukb.uni-bonn.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1998, EDUC PSYCHO, P249; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Flavell J. H., 1977, PERSPECTIVES DEV MEM, P3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; GARDINER JM, 1973, MEM COGNITION, V1, P213, DOI 10.3758/BF03198098; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kao YC, 2005, NAT NEUROSCI, V8, P1776, DOI 10.1038/nn1595; KING JF, 1980, AM J PSYCHOL, V93, P329, DOI 10.2307/1422236; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; Lyle KB, 2007, MEM COGNITION, V35, P1024, DOI 10.3758/BF03193475; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Martin D, 2009, EXP PSYCHOL, V6, P1; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; Metcalfe J, 2005, J MEM LANG, V52, P463, DOI 10.1016/j.jml.2004.12.001; Metcalfe J, 2008, J EXP PSYCHOL LEARN, V34, P1084, DOI 10.1037/a0012580; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Petrella JR, 2005, J NEUROPSYCH CLIN N, V17, P75, DOI 10.1176/appi.neuropsych.17.1.75; REDER LM, 1987, COGNITIVE PSYCHOL, V19, P90, DOI 10.1016/0010-0285(87)90005-3; Reggev N, 2011, NEUROPSYCHOLOGIA, V49, P1332, DOI 10.1016/j.neuropsychologia.2011.01.013; Rhodes MG, 2011, PSYCHOL BULL, V137, P131, DOI 10.1037/a0021705; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Skavhaug IM, 2010, BRAIN RES, V1318, P87, DOI 10.1016/j.brainres.2009.11.047; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SOMMER W, 1995, MEM COGNITION, V23, P1, DOI 10.3758/BF03210552; Son LK, 2000, J EXP PSYCHOL LEARN, V26, P204, DOI 10.1037/0278-7393.26.1.204; SPELLMAN BA, 1992, PSYCHOL SCI, V3, P315, DOI 10.1111/j.1467-9280.1992.tb00680.x; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Suzuki M, 2011, HIPPOCAMPUS, V21, P575, DOI 10.1002/hipo.20781; van Boxtel GJM, 2005, J PSYCHOPHYSIOL, V19, P1, DOI 10.1027/0269-8803.19.1.1; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; ZACKS RT, 1969, J EXP PSYCHOL, V82, P441, DOI 10.1037/h0028369; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	63	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e30009	10.1371/journal.pone.0030009	http://dx.doi.org/10.1371/journal.pone.0030009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	058VE	22242196	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000312662100053
J	Nguyen, AV; Toepel, J; Burgess, S; Uhmeyer, A; Blifernez, O; Doebbe, A; Hankamer, B; Nixon, P; Wobbe, L; Kruse, O				Anh Vu Nguyen; Toepel, Joerg; Burgess, Steven; Uhmeyer, Andreas; Blifernez, Olga; Doebbe, Anja; Hankamer, Ben; Nixon, Peter; Wobbe, Lutz; Kruse, Olaf			Time-Course Global Expression Profiles of Chlamydomonas reinhardtii during Photo-Biological H-2 Production	PLOS ONE			English	Article							HYDROGEN PHOTOPRODUCTION; CHLOROPHYLL FLUORESCENCE; GENE; ELECTRON; CHLOROPLAST; METABOLISM; PROTEIN; STARCH; PHOSPHORYLATION; DEPRIVATION	We used a microarray study in order to compare the time course expression profiles of two Chlamydomonas reinhardtii strains, namely the high H-2 producing mutant stm6glc4 and its parental WT strain during H-2 production induced by sulfur starvation. Major cellular reorganizations in photosynthetic apparatus, sulfur and carbon metabolism upon H-2 production were confirmed as common to both strains. More importantly, our results pointed out factors which lead to the higher H-2 production in the mutant including a higher starch accumulation in the aerobic phase and a lower competition between the H(2)ase pathway and alternative electron sinks within the H-2 production phase. Key candidate genes of interest with differential expression pattern include LHCSR3, essential for efficient energy quenching (qE). The reduced LHCSR3 protein expression in mutant stm6glc4 could be closely related to the high-light sensitive phenotype. H-2 measurements carried out with the LHCSR3 knock-out mutant npq4 however clearly demonstrated that a complete loss of this protein has almost no impact on H-2 yields under moderate light conditions. The nuclear gene disrupted in the high H-2 producing mutant stm6glc4 encodes for the mitochondrial transcription termination factor (mTERF) MOC1, whose expression strongly increases during - S-induced H-2 production in WT strains. Studies under phototrophic high-light conditions demonstrated that the presence of functional MOC1 is a prerequisite for proper LHCSR3 expression. Furthermore knock-down of MOC1 in a WT strain was shown to improve the total H-2 yield significantly suggesting that this strategy could be applied to further enhance H-2 production in other strains already displaying a high H-2 production capacity. By combining our array data with previously published metabolomics data we can now explain some of the phenotypic characteristics which lead to an elevated H-2 production in stm6glc4.	[Anh Vu Nguyen; Toepel, Joerg; Uhmeyer, Andreas; Blifernez, Olga; Doebbe, Anja; Wobbe, Lutz; Kruse, Olaf] Univ Bielefeld, Fac Biol, Dept Algae Biotechnol & Bioenergy, D-33615 Bielefeld, Germany; [Burgess, Steven; Nixon, Peter] Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London, England; [Hankamer, Ben] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 2, Australia	University of Bielefeld; Imperial College London; University of Queensland	Nguyen, AV (corresponding author), Univ Bielefeld, Fac Biol, Dept Algae Biotechnol & Bioenergy, D-33615 Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015; Nguyen, Anh/C-5389-2013; Hankamer, Ben/C-9688-2015	Nguyen, Anh/0000-0001-6703-2291; Kruse, Olaf/0000-0001-9874-382X; Burgess, Steven/0000-0003-2353-7794; Wobbe, Lutz/0000-0001-5141-9897; Nixon, Peter/0000-0003-1952-6937; Hankamer, Ben/0000-0001-9284-4929	EU [212508]; German Federal Ministry of Science BMBF [0315265A]; Australian Research Council [DP0877147]; Engineering and Physical Sciences Research Council [EP/F00270X/1]; EPSRC [EP/F00270X/1] Funding Source: UKRI	EU(European Commission); German Federal Ministry of Science BMBF(Federal Ministry of Education & Research (BMBF)); Australian Research Council(Australian Research Council); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank the EU/Energy FP7 project SOLAR-H2 (contract 212508, OK), the German Federal Ministry of Science BMBF-ForSys-Partner project (contract 0315265A, OK), the Australian Research Council (DP0877147, BH) as well as the Engineering and Physical Sciences Research Council (EP/F00270X/1, PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Banet G, 2000, PLANTA, V210, P947, DOI 10.1007/s004250050702; BENAMOTZ A, 1983, PLANT PHYSIOL, V72, P593, DOI 10.1104/pp.72.3.593; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Cardol P, 2010, BBA-BIOENERGETICS, V1797, P177, DOI 10.1016/j.bbabio.2009.10.002; Chen M, 2010, J PROTEOME RES, V9, P3854, DOI 10.1021/pr100076c; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Doebbe A, 2007, J BIOTECHNOL, V131, P27, DOI 10.1016/j.jbiotec.2007.05.017; Doebbe A, 2010, J BIOL CHEM, V285, P30247, DOI 10.1074/jbc.M110.122812; Eberhard S, 2006, CURR GENET, V49, P106, DOI 10.1007/s00294-005-0041-2; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Kosourov S, 2003, PLANT CELL PHYSIOL, V44, P146, DOI 10.1093/pcp/pcg020; Kosourov S, 2007, J BIOTECHNOL, V128, P776, DOI 10.1016/j.jbiotec.2006.12.025; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; LERS A, 1991, J BIOL CHEM, V266, P13698; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Nakayama M, 2000, J INORG BIOCHEM, V82, P27, DOI 10.1016/S0162-0134(00)00138-0; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; NISHIMAKI T, 1984, J BIOCHEM, V95, P1315, DOI 10.1093/oxfordjournals.jbchem.a134737; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Ritte G, 2004, PLANT PHYSIOL, V135, P2068, DOI 10.1104/pp.104.041301; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Rupprecht J, 2006, APPL MICROBIOL BIOT, V72, P442, DOI 10.1007/s00253-006-0528-x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Tolleter D, 2011, PLANT CELL, V23, P2619, DOI 10.1105/tpc.111.086876; Voss B, 2011, PLANT PHYSIOL, V155, P892, DOI 10.1104/pp.110.158683; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; White AL, 2006, INT J HYDROGEN ENERG, V31, P455, DOI 10.1016/j.ijhydene.2005.04.028; Wobbe L, 2009, P NATL ACAD SCI USA, V106, P13290, DOI 10.1073/pnas.0900670106; Wu SX, 2011, BIORESOURCE TECHNOL, V102, P2610, DOI 10.1016/j.biortech.2010.09.123; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Zhang LP, 2002, PLANTA, V214, P552, DOI 10.1007/s004250100660; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	56	25	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29364	10.1371/journal.pone.0029364	http://dx.doi.org/10.1371/journal.pone.0029364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242116	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000028
J	Davisson, MT; Bronson, RT; Tadenev, ALD; Motley, WW; Krishnaswamy, A; Seburn, KL; Burgess, RW				Davisson, Muriel T.; Bronson, Roderick T.; Tadenev, Abigail L. D.; Motley, William W.; Krishnaswamy, Arjun; Seburn, Kevin L.; Burgess, Robert W.			A Spontaneous Mutation in Contactin 1 in the Mouse	PLOS ONE			English	Article							PROMOTES NEURITE OUTGROWTH; ADHESION MOLECULES; PROTEIN; DOMAINS; RETINA; F11; DSCAM; FASCICULATION; NEUROFASCIN; INDUCTION	Mutations in the gene encoding the immunoglobulin-superfamily member cell adhesion molecule contactin1 (CNTN1) cause lethal congenital myopathy in human patients and neurodevelopmental phenotypes in knockout mice. Whether the mutant mice provide an accurate model of the human disease is unclear; resolving this will require additional functional tests of the neuromuscular system and examination of Cntn1 mutations on different genetic backgrounds that may influence the phenotype. Toward these ends, we have analyzed a new, spontaneous mutation in the mouse Cntn1 gene that arose in a BALB/c genetic background. The overt phenotype is very similar to the knockout of Cntn1, with affected animals having reduced body weight, a failure to thrive, locomotor abnormalities, and a lifespan of 2-3 weeks. Mice homozygous for the new allele have CNTN1 protein undetectable by western blotting, suggesting that it is a null or very severe hypomorph. In an analysis of neuromuscular function, neuromuscular junctions had normal morphology, consistent with previous studies in knockout mice, and the muscles were able to generate appropriate force when normalized for their reduced size in late stage animals. Therefore, the Cntn1 mutant mice do not show evidence for a myopathy, but instead the phenotype is likely to be caused by dysfunction in the nervous system. Given the similarity of CNTN1 to other Ig-superfamily proteins such as DSCAMs, we also characterized the expression and localization of Cntn1 in the retinas of mutant mice for developmental defects. Despite widespread expression, no anomalies in retinal anatomy were detected histologically or using a battery of cell-type specific antibodies. We therefore conclude that the phenotype of the Cntn1 mice arises from dysfunction in the brain, spinal cord or peripheral nervous system, and is similar in either a BALB/c or B6;129;Black Swiss background, raising a possible discordance between the mouse and human phenotypes resulting from Cntn1 mutations.	[Davisson, Muriel T.; Bronson, Roderick T.; Tadenev, Abigail L. D.; Motley, William W.; Seburn, Kevin L.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Krishnaswamy, Arjun] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Jackson Laboratory; Harvard University	Davisson, MT (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	muriel.davisson@jax.org		Burgess, Robert/0000-0002-9229-3407; Tadenev, Abigail/0000-0003-0801-8267	Natural Sciences and Engineering Research Council of Canada (NSERC);  [P40 RR001183];  [R01 EY018605];  [R01 NS054154];  [NS29269]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054154] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD011163] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants P40 RR001183 to the Mouse Mutant Resource at The Jackson Laboratory and R01 EY018605 and R01 NS054154 (to RWB). Arjun Krishnaswamy was supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and grant NS29269 to J.R. Sanes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; BRUMMENDORF T, 1993, NEURON, V10, P711; Burgess RW, 2010, METHODS MOL BIOL, V602, P347, DOI 10.1007/978-1-60761-058-8_20; Buttiglione M, 1996, MOL CELL NEUROSCI, V8, P53, DOI 10.1006/mcne.1996.0043; Buttiglione M, 1998, J NEUROSCI, V18, P6853; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; DAVISSON MT, 1990, LAB ANIM, V19, P23; DURBEC P, 1992, J CELL BIOL, V117, P877, DOI 10.1083/jcb.117.4.877; Fetissov SO, 2005, EUR J NEUROSCI, V22, P3217, DOI 10.1111/j.1460-9568.2005.04513.x; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Green EL, 1985, MOUSE NEWS LETT, V73, P20; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203	28	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29538	10.1371/journal.pone.0029538	http://dx.doi.org/10.1371/journal.pone.0029538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242131	gold, Green Published, Green Submitted			2022-12-25	WOS:000300677000046
J	Guo, ZL; Liu, S; Hu, SM; Li, T; Huang, YS; Liu, GX; Zhang, H; Lin, SJ				Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao; Huang, Yousong; Liu, Guangxing; Zhang, Huan; Lin, Senjie			Prevalent Ciliate Symbiosis on Copepods: High Genetic Diversity and Wide Distribution Detected Using Small Subunit Ribosomal RNA Gene	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; PFIESTERIA-PISCICIDA; PROTOZOAN EPIBIONTS; PLANKTONIC COPEPODS; EUPHAUSIACEA; PERITRICHIA; ZOOPLANKTON; CRUSTACEANS; CILIOPHORA; PHYLOGENY	Toward understanding the genetic diversity and distribution of copepod-associated symbiotic ciliates and the evolutionary relationships with their hosts in the marine environment, we developed a small subunit ribosomal RNA gene (18S rDNA)based molecular method and investigated the genetic diversity and genotype distribution of the symbiotic ciliates on copepods. Of the 10 copepod species representing six families collected from six locations of Pacific and Atlantic Oceans, 9 were found to harbor ciliate symbionts. Phylogenetic analysis of the 391 ciliate 18S rDNA sequences obtained revealed seven groups (ribogroups), six (containing 99% of all the sequences) belonging to subclass Apostomatida, the other clustered with peritrich ciliate Vorticella gracilis. Among the Apostomatida groups, Group III were essentially identical to Vampyrophrya pelagica, and the other five groups represented the undocumented ciliates that were close to Vampyrophrya/Gymnodinioides/Hyalophysa. Group VI ciliates were found in all copepod species but one (Calanus sinicus), and were most abundant among all ciliate sequences obtained, indicating that they are the dominant symbiotic ciliates universally associated with copepods. In contrast, some ciliate sequences were found only in some of the copepods examined, suggesting the host selectivity and geographic differentiation of ciliates, which requires further verification by more extensive sampling. Our results reveal the wide occurrence and high genetic diversity of symbiotic ciliates on marine copepods and highlight the need to systematically investigate the host- and geography-based genetic differentiation and ecological roles of these ciliates globally.	[Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Guo, Zhiling; Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Lin, Senjie] Xiamen Univ, Marine Biodivers & Global Change Lab, Xiamen, Fujian, Peoples R China; [Huang, Yousong; Liu, Guangxing; Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; University of Connecticut; Xiamen University; Ocean University of China	Guo, ZL (corresponding author), Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015; Guo, chentao/G-7320-2016	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Lei, Xu/0000-0003-2271-1287; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X	Key Topics in Innovation Engineering [KZCX2-YW-JS206]; National Science Foundation of China-Overseas Collaboration Fund [41129001, 40828006]; National Science Foundation of China [41076085, 41006067, 41076096, U1033003]; National Science Foundation grant [EF-0629624]	Key Topics in Innovation Engineering; National Science Foundation of China-Overseas Collaboration Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation grant(National Science Foundation (NSF))	The study was supported by Key Topics in Innovation Engineering (No. KZCX2-YW-JS206) (http://www.cas.cn/), National Science Foundation of China-Overseas Collaboration Fund (41129001, 40828006) (http://www.nsfc.gov.cn/), the National Science Foundation of China (41076085, 41006067, 41076096, U1033003) (http://www.nsfc.gov.cn/), and National Science Foundation grant EF-0629624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, CALANOIDAVOL, V7, P20; BASSON L, 1991, SYST PARASITOL, V18, P147, DOI 10.1007/BF00017668; Bozkurt A, 2009, CRUSTACEANA, V82, P515, DOI 10.1163/156854009X407687; BRADBURY PC, 1973, J PROTOZOOL, V20, P210, DOI 10.1111/j.1550-7408.1973.tb00865.x; Bradbury Phyllis C., 1994, P139; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Chatton E., 1935, Archives de Zoologie Experimentale et Generale Paris, V77, P1; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Clamp John C., 2008, Denisia, V23, P395; Doherty M, 2010, APPL ENVIRON MICROB, V76, P3924, DOI 10.1128/AEM.01604-09; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P643, DOI 10.1163/156854000504705; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P1205, DOI 10.1163/156854000505209; Fernandez-Leborans G, 2006, J NAT HIST, V40, P1983, DOI 10.1080/00222930601010861; Gerber R. P, 2000, IDENTIFICATION MAN 1; Gerber RP, 2000, IDENTIFICATION MAN 2; Gomez-Gutierrez J, 2010, DIS AQUAT ORGAN, V88, P249, DOI 10.3354/dao02155; GRIMES BH, 1992, J PROTOZOOL, V39, P65, DOI 10.1111/j.1550-7408.1992.tb01285.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENEBRY MS, 1979, T AM MICROSC SOC, V98, P495, DOI 10.2307/3225899; HOCKIN DC, 1984, CRUSTACEANA, V46, P319, DOI 10.1163/156854084X00261; Ismar SMH, 2008, MAR BIOL, V154, P335, DOI 10.1007/s00227-008-0928-9; Jayasree L, 2001, J NAT HIST, V35, P157, DOI 10.1080/00222930150215297; Landers SC, 2010, EUR J PROTISTOL, V46, P171, DOI 10.1016/j.ejop.2010.03.001; Lin SJ, 2006, J PLANKTON RES, V28, P667, DOI 10.1093/plankt/fbi150; LINDLEY JA, 1978, MAR BIOL, V46, P131, DOI 10.1007/BF00391528; Liu Sheng, 2010, Acta Ecologica Sinica, V30, P22; Lynn D.H., 2008, CIL PROT CHAR CLASS; Lynn DH, 2005, J EUKARYOT MICROBIOL, V52, p7S; Morado J. Frank, 1995, Reviews in Fisheries Science, V3, P275; NAGASAWA S, 1988, HYDROBIOLOGIA, V167, P255, DOI 10.1007/BF00026312; Ohtsuka S, 2004, MAR ECOL PROG SER, V282, P129, DOI 10.3354/meps282129; Ohtsuka Susumu, 2011, V15, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Qiu DJ, 2010, APPL ENVIRON MICROB, V76, P5639, DOI 10.1128/AEM.03009-09; Regali-Seleghim MH, 2004, J PLANKTON RES, V26, P501, DOI 10.1093/plankt/fbh055; Silva-Briano M, 2011, J LIMNOL, V70, P329, DOI 10.4081/jlimnol.2011.329; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner JT, 2004, ZOOL STUD, V43, P255; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; VALBONESI A, 1988, B ZOOL, V55, P179; Visse Marko, 2007, Proceedings of the Estonian Academy of Sciences Biology Ecology, V56, P173; Wahl M, 1997, HYDROBIOLOGIA, V355, P49, DOI 10.1023/A:1003054802699; Walkusz W, 2007, OCEANOLOGIA, V49, P369; WEISSMAN P, 1993, LIMNOL OCEANOGR, V38, P613, DOI 10.4319/lo.1993.38.3.0613; XU ZK, 1991, HYDROBIOLOGIA, V209, P183, DOI 10.1007/BF00015341; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	50	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44847	10.1371/journal.pone.0044847	http://dx.doi.org/10.1371/journal.pone.0044847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	22242146	Green Submitted, gold, Green Published			2022-12-25	WOS:000308860100026
J	Lee, CL; Lin, YT; Chang, FR; Chen, GY; Backlund, A; Yang, JC; Chen, SL; Wu, YC				Lee, Chia-Lin; Lin, Ying-Ting; Chang, Fang-Rong; Chen, Guan-Yu; Backlund, Anders; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang			Synthesis and Biological Evaluation of Phenanthrenes as Cytotoxic Agents with Pharmacophore Modeling and ChemGPS-NP Prediction as Topo II Inhibitors	PLOS ONE			English	Article							DENBINOBIN INDUCES APOPTOSIS; CANCER; CELLS	In a structure-activity relationship (SAR) study, 3-methoxy-1,4-phenanthrenequinones, calanquinone A (6a), denbinobin (6b), 5-OAc-calanquinone A (7a) and 5-OAc-denbinobin (7b), have significantly promising cytotoxicity against various human cancer cell lines (IC50 0.08-1.66 mu g/mL). Moreover, we also established a superior pharmacophore model for cytotoxicity (r = 0.931) containing three hydrogen bond acceptors (HBA1, HBA2 and HBA3) and one hydrophobic feature (HYD) against MCF-7 breast cancer cell line. The pharmacophore model indicates that HBA3 is an essential feature for the oxygen atom of 5-OH in 6a-b and for the carbonyl group of 5-OCOCH3 in 7a-b, important for their cytotoxic properties. The SAR for moderately active 5a-b (5-OCH3), and highly active 6a-b and 7a-b, are also elaborated in a spatial aspect model. Further rational design and synthesis of new cytotoxic phenanthrene analogs can be implemented via this model. Additionally, employing a ChemGPS-NP based model for cytotoxicity mode of action (MOA) provides support for a preliminary classification of compounds 6a-b as topoisomerase II inhibitors.	[Lee, Chia-Lin; Wu, Yang-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lee, Chia-Lin; Chen, Guan-Yu; Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Lin, Ying-Ting] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yang, Juan-Chang; Chen, Shu-Li; Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Backlund, Anders] Uppsala Univ, BMC, Dept Med Chem, Div Pharmacognosy, Uppsala, Sweden; [Wu, Yang-Chang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Uppsala University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, CL (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	aaronfrc@kmu.edu.tw; yachwu@mail.cmu.edu.tw	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	National Science Council, Taiwan [NSC99-2113-M-039-003]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-C-111-002]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from National Science Council, Taiwan awarded to YW (NSC99-2113-M-039-003) and the Department of Health, Executive Yuan, Taiwan awarded to KMU (DOH99-TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P155, DOI 10.1016/j.jtice.2008.07.010; Chen TH, 2008, N-S ARCH PHARMACOL, V378, P447, DOI 10.1007/s00210-008-0324-5; FARINA F, 1986, SYNTHETIC COMMUN, V16, P1015, DOI 10.1080/00397918608056343; Huang YC, 2005, J BIOMED SCI, V12, P113, DOI 10.1007/s11373-004-8171-y; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; Kraus GA, 2002, TETRAHEDRON LETT, V43, P9597, DOI 10.1016/S0040-4039(02)02411-5; Kraus GA, 2002, TETRAHEDRON LETT, V43, P5319, DOI 10.1016/S0040-4039(02)01026-2; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Kuo CT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-43; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee CL, 2008, BIOORG MED CHEM LETT, V18, P4275, DOI 10.1016/j.bmcl.2008.06.099; Lee CL, 2009, J NAT PROD, V72, P210, DOI 10.1021/np800622a; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Magwere T, 2009, BRIT J PHARMACOL, V157, P1172, DOI 10.1111/j.1476-5381.2009.00286.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rosen J, 2009, QSAR COMB SCI, V28, P436, DOI 10.1002/qsar.200810162; Sadiq AA, 2010, INVEST NEW DRUG, V28, P20, DOI 10.1007/s10637-008-9209-1; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Schmalle HW, 2001, ARKIVOC, V1, P88; Yang CR, 2009, BRIT J PHARMACOL, V157, P1175, DOI 10.1111/j.1476-5381.2009.00237.x; Yang KC, 2005, WORLD J GASTROENTERO, V11, P3040, DOI 10.3748/wjg.v11.i20.3040	21	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e37897	10.1371/journal.pone.0037897	http://dx.doi.org/10.1371/journal.pone.0037897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22253887	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349600038
J	Fu, YS; Qin, WB; Cao, H; Xu, R; Tan, Y; Lu, T; Wang, HR; Tong, WX; Rong, X; Li, G; Yuan, MQ; Li, CH; Abe, KJ; Lu, L; Chen, GH				Fu, Yongshui; Qin, Weibing; Cao, Hong; Xu, Ru; Tan, Yi; Lu, Teng; Wang, Hongren; Tong, Wangxia; Rong, Xia; Li, Gang; Yuan, Manqiong; Li, Chunhua; Abe, Kenji; Lu, Ling; Chen, Guihua			HCV 6a Prevalence in Guangdong Province Had the Origin from Vietnam and Recent Dissemination to Other Regions of China: Phylogeographic Analyses	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INJECTION-DRUG USERS; MAXIMUM-LIKELIHOOD-ESTIMATION; MOLECULAR EPIDEMIOLOGY; GENOTYPE DISTRIBUTION; HEROIN USERS; INFECTION; SEQUENCES; HIV; HETEROGENEITY	Background: Recently in China, HCV 6a infection has shown a fast increase among patients and blood donors, possibly due to IDU linked transmission. Methodology/Findings: We recruited 210 drug users in Shanwei city, Guangdong province. Among them, HCV RNA was detected in 150 (71.4%), both E1 and NS5B genes were sequenced in 136, and 6a genotyped in 70. Of the 6a sequences, most were grouped into three clusters while 23% represent emerging strains. For coalescent analysis, additional 6a sequences were determined among 21 blood donors from Vietnam, 22 donors from 12 provinces of China, and 36 IDUs from Liuzhou City in Guangxi Province. Phylogeographic analyses indicated that Vietnam could be the origin of 6a in China. The Guangxi Province, which borders Vietnam, could be the first region to accept 6a for circulation. Migration from Yunnan, which also borders Vietnam, might be equally important, but it was only detected among IDUs in limited regions. From Guangxi, 6a could have further spread to Guangdong, Yunnan, Hainan, and Hubei provinces. However, evidence showed that only in Guangdong has 6a become a local epidemic, making Guangdong the second source region to disseminate 6a to the other 12 provinces. With a rate of 2.737 x 10(-3) (95% CI: 1.792 x 10(-3) to 3.745 x 10(-3)), a Bayesian Skyline Plot was portrayed. It revealed an exponential 6a growth during 1994-1998, while before and after 1994-1998 slow 6a growths were maintained. Concurrently, 1994-1998 corresponded to a period when contaminated blood transfusion was common, which caused many people being infected with HIV and HCV, until the Chinese government outlawed the use of paid blood donations in 1998. Conclusions/Significance: With an origin from Vietnam, 6a has become a local epidemic in Guangdong Province, where an increasing prevalence has subsequently led to 6a spread to many other regions of China.	[Fu, Yongshui] Sun Yat Sen Univ, Coll Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Fu, Yongshui; Xu, Ru; Rong, Xia] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Qin, Weibing] Family Planning Res Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Qin, Weibing; Wang, Hongren; Li, Gang] Sun Yat Sen Univ, Affiliated Hosp 3, Vaccine Inst, Guangzhou, Guangdong, Peoples R China; [Cao, Hong; Tong, Wangxia] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Tan, Yi] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lu, Teng] Univ So Calif, Los Angeles, CA USA; [Yuan, Manqiong; Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Viral Oncol Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Lu, Ling; Chen, Guihua] Sun Yat Sen Univ, Affiliated Hosp 3, Lab Hepatol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Blood Center; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Southern California; University of Kansas; University of Kansas Medical Center; National Institute of Infectious Diseases (NIID); Sun Yat Sen University	Lu, L (corresponding author), Univ Kansas, Med Ctr, Viral Oncol Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	llu@kumc.edu	Janssens, Ivan A/P-1331-2014; Fu, Yongshuo/AAO-4663-2021; Campioli, Matteo/N-9380-2015; Fu, Yongshuo/AAH-7434-2019; Fu, Yongshuo/AAF-9446-2021	Janssens, Ivan A/0000-0002-5705-1787; Fu, Yongshuo/0000-0002-9761-5292; Fu, Yongshuo/0000-0002-9761-5292; Xu, Ru/0000-0001-5926-9213; Campioli, Matteo/0000-0002-3427-2368	National Institute of Allergy and Infectious Diseases [1R01AI080734-01A]; Bureau of Health, Guangzhou City, China [2008-ZDi-10, 2009-ZDa-05]; National Natural Science Foundation of China [30872162]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bureau of Health, Guangzhou City, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by a grant from the National Institute of Allergy and Infectious Diseases (1R01AI080734-01A, Dr. Ling Lu); two grants from the Bureau of Health, Guangzhou City, China (No. 2008-ZDi-10, 2009-ZDa-05, Dr. Yongshui Fu) (http://www.gzmed.gov.cn); and a grant from the National Natural Science Foundation of China (No. 30872162, Dr. Yongshui Fu) (http://www.nsfc.gov.cn). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; [Anonymous], 2006, CBS NEWS        0811; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Bao Yanping, 2009, HIV Therapy, V3, P237, DOI [10.2217/hiv.09.4, 10.2217/HIV.09.4]; Cowhig D., 2000, LIANHE ZAOBAO   1002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; GU X, 1995, MOL BIOL EVOL, V12, P546; JI Y, 1998, ACTA ACAD MED SINICA, V203, P240; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Lee K, 2008, INT J INFECT DIS, V12, pE424, DOI 10.1016/j.ijid.2008.05.1234; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shi XL, 1999, TRANSFUSION, V39, P913, DOI 10.1046/j.1537-2995.1999.39080913.x; SLATKIN M, 1989, GENETICS, V123, P603; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889	30	129	142	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28006	10.1371/journal.pone.0028006	http://dx.doi.org/10.1371/journal.pone.0028006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	23071786	gold, Green Submitted, Green Published			2022-12-25	WOS:000315865800001
J	Luo, C; Qiu, C; Guo, ZW; Fang, JJ; Li, QF; Lei, X; Xia, Y; Lai, YX; Gong, QY; Zhou, D; Yao, DZ				Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Fang, Jiajia; Li, Qifu; Lei, Xu; Xia, Yang; Lai, Yongxiu; Gong, Qiyong; Zhou, Dong; Yao, Dezhong			Disrupted Functional Brain Connectivity in Partial Epilepsy: A Resting-State fMRI Study	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INDEPENDENT COMPONENT ANALYSIS; ALZHEIMERS-DISEASE; DEFAULT NETWORK; SPONTANEOUS FLUCTUATIONS; CINGULATE CORTEX; BOLD SIGNAL; MRI; SCHIZOPHRENIA; ATTENTION	Examining the spontaneous activity to understand the neural mechanism of brain disorder is a focus in recent resting-state fMRI. In the current study, to investigate the alteration of brain functional connectivity in partial epilepsy in a systematical way, two levels of analyses (functional connectivity analysis within resting state networks (RSNs) and functional network connectivity (FNC) analysis) were carried out on resting-state fMRI data acquired from the 30 participants including 14 healthy controls(HC) and 16 partial epilepsy patients. According to the etiology, all patients are subdivided into temporal lobe epilepsy group (TLE, included 7 patients) and mixed partial epilepsy group (MPE, 9 patients). Using group independent component analysis, eight RSNs were identified, and selected to evaluate functional connectivity and FNC between groups. Compared with the controls, decreased functional connectivity within all RSNs was found in both TLE and MPE. However, dissociating patterns were observed within the 8 RSNs between two patient groups, i.e, compared with TLE, we found decreased functional connectivity in 5 RSNs increased functional connectivity in 1 RSN, and no difference in the other 2 RSNs in MPE. Furthermore, the hierarchical disconnections of FNC was found in two patient groups, in which the intra-system connections were preserved for all three subsystems while the lost connections were confined to intersystem connections in patients with partial epilepsy. These findings may suggest that decreased resting state functional connectivity and disconnection of FNC are two remarkable characteristics of partial epilepsy. The selective impairment of FNC implicated that it is unsuitable to understand the partial epilepsy only from global or local perspective. We presumed that studying epilepsy in the multi-perspective based on RSNs may be a valuable means to assess the functional changes corresponding to specific RSN and may contribute to the understanding of the neuro-pathophysiological mechanism of epilepsy.	[Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Lei, Xu; Xia, Yang; Lai, Yongxiu; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Fang, Jiajia; Li, Qifu; Zhou, Dong] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Li, Qifu] Hainan Med Coll, Affiliated Hosp, Dept Neurol, Haikou, Peoples R China; [Lei, Xu] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Gong, Qiyong] Sichuan Univ, W China Hosp, Dept Radiol, HMRRC, Chengdu 610064, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; Hainan Medical University; Southwest University - China; Sichuan University	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	zhoudong66@yahoo.de; dyao@uestc.edu.cn	Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015; Guo, chentao/G-7320-2016	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Lei, Xu/0000-0003-2271-1287; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X	973 project [2011CB707803]; National Nature Science Foundation of China [30870655, 81071222, 60736029, 81160166, 81100974]; 863 Project [2009AA02Z301]; PCSIRT project; project of Hainan Provincial Department of Health [Qiongwei 2009-52]	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); PCSIRT project(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); project of Hainan Provincial Department of Health	This project was funded by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China #30870655, #81071222, #60736029, #81160166, #81100974, the 863 Project #2009AA02Z301, the PCSIRT project, the project of Hainan Provincial Department of Health (Qiongwei 2009-52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benbadis SR, 2001, NEUROL CLIN, V19, P251, DOI 10.1016/S0733-8619(05)70018-9; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Calhoun VD, 2004, BIOL PSYCHIAT, V55, P842, DOI 10.1016/j.biopsych.2004.01.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Frings L, 2009, J NEUROL, V256, P2021, DOI 10.1007/s00415-009-5233-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Laufs H, 2007, CURR OPIN NEUROL, V20, P417, DOI 10.1097/WCO.0b013e3282202b92; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; Lei X, 2010, NEUROIMAGE, V52, P1123, DOI 10.1016/j.neuroimage.2010.01.024; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Masterton RAJ, 2010, NEUROIMAGE, V51, P252, DOI 10.1016/j.neuroimage.2010.01.109; Medvedev A. V., 2001, Australasian Physical and Engineering Sciences in Medicine, V24, P37, DOI 10.1007/BF03178284; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Pavlou E, 2011, CHILD NERV SYST, V27, P373, DOI 10.1007/s00381-010-1321-9; Qiao PF, 2011, BRAIN DEV IN PRESS; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wieser HG, 2004, EPILEPSIA, V45, P32; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	71	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28196	10.1371/journal.pone.0028196	http://dx.doi.org/10.1371/journal.pone.0028196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242146	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100002
J	Simoes, RD; Emmert-Streib, F				Simoes, Ricardo de Matos; Emmert-Streib, Frank			Influence of Statistical Estimators of Mutual Information and Data Heterogeneity on the Inference of Gene Regulatory Networks	PLOS ONE			English	Article							EXPRESSION DATA; ENTROPY ESTIMATION; NORMALIZATION	The inference of gene regulatory networks from gene expression data is a difficult problem because the performance of the inference algorithms depends on a multitude of different factors. In this paper we study two of these. First, we investigate the influence of discrete mutual information (MI) estimators on the global and local network inference performance of the C3NET algorithm. More precisely, we study 4 different MI estimators (Empirical, Miller-Madow, Shrink and Schurmann-Grassberger) in combination with 3 discretization methods (equal frequency, equal width and global equal width discretization). We observe the best global and local inference performance of C3NET for the Miller-Madow estimator with an equal width discretization. Second, our numerical analysis can be considered as a systems approach because we simulate gene expression data from an underlying gene regulatory network, instead of making a distributional assumption to sample thereof. We demonstrate that despite the popularity of the latter approach, which is the traditional way of studying MI estimators, this is in fact not supported by simulated and biological expression data because of their heterogeneity. Hence, our study provides guidance for an efficient design of a simulation study in the context of network inference, supporting a systems approach.	[Simoes, Ricardo de Matos; Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Simoes, RD (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work has been supported by the Engineering and Physical Sciences Research Council (EPSRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 1955, AM DOCUMENTATION PRE, V6, P93, DOI [10.1002/, DOI 10.1002/ASI.5090060209]; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Alon U, 2007, INTRO SYSTEMS BIOL D; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bulashevska S, 2005, BIOINFORMATICS, V21, P2706, DOI 10.1093/bioinformatics/bti388; Butte A J, 2000, Pac Symp Biocomput, P418; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; Csardi N., 2006, INT J COMP SYST, V1695, P1; Dehmer M, APPL STAT NETWORK BI; Dudoit S, 2008, SPRINGER SER STAT, P1; Emmert-Streib F, 2010, IET SYST BIOL, V4, P277, DOI 10.1049/iet-syb.2010.0028; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Harrell, 2010, HMISC HARRELL MISCEL; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liang S, 1998, Pac Symp Biocomput, P18; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; Nemenman I, 2002, ADV NEURAL INFORM PR, V14, P569; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Palsson B O, 2006, SYSTEMS BIOL; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; R Core Team, 2021, R LANG ENV STAT COMP; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Scheines R., 2000, CAUSATION PREDICTION; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Shannon CE., 1949, MATH THEORY COMMUNIC; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Steinhoff C, 2006, BRIEF BIOINFORM, V7, P166, DOI 10.1093/bib/bbl002; Stolovitzky G, REVERSE ENG BIOL NET; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stouffer S. A., 1949, AM SOLDIER, V1; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Verma T, 1990, P 4 WORKSH UNC ART I, P352; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Yang Y, 2001, P EMCL 01 P 12 EUR C	56	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29279	10.1371/journal.pone.0029279	http://dx.doi.org/10.1371/journal.pone.0029279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242113	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000024
J	Zhao, XW; Zhang, WY; Xu, X; Ma, ZQ; Yin, MH				Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao			Prediction of Protein Phosphorylation Sites by Using the Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; INTRINSIC DISORDER; P38 MAPK; SEQUENCE; DATABASE; UBIQUITYLATION; GLYCOSYLATION; LOCALIZATION; SERVER; TOOL	As one of the most widespread protein post-translational modifications, phosphorylation is involved in many biological processes such as cell cycle, apoptosis. Identification of phosphorylated substrates and their corresponding sites will facilitate the understanding of the molecular mechanism of phosphorylation. Comparing with the labor-intensive and time-consuming experiment approaches, computational prediction of phosphorylation sites is much desirable due to their convenience and fast speed. In this paper, a new bioinformatics tool named CKSAAP_PhSite was developed that ignored the kinase information and only used the primary sequence information to predict protein phosphorylation sites. The highlight of CKSAAP_PhSite was to utilize the composition of k-spaced amino acid pairs as the encoding scheme, and then the support vector machine was used as the predictor. The performance of CKSAAP_PhSite was measured with a sensitivity of 84.81%, a specificity of 86.07% and an accuracy of 85.43% for serine, a sensitivity of 78.59%, a specificity of 82.26% and an accuracy of 80.31% for threonine as well as a sensitivity of 74.44%, a specificity of 78.03% and an accuracy of 76.21% for tyrosine. Experimental results obtained from cross validation and independent benchmark suggested that our method was very promising to predict phosphorylation sites and can be served as a useful supplement tool to the community. For public access, CKSAAP_PhSite is available at http://59.73.198.144/cksaap_phsite/.	[Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China	Northeast Normal University - China	Ma, ZQ (corresponding author), NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China.	zhiqiang.ma967@gmail.com; minghao.yin197@gmail.com	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	National Natural Science Foundation of China [60803102, 61070084]; Natural Science Foundation of Jilin Province [20101506, 20110104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This research is partially supported by the National Natural Science Foundation of China under Grant Nos. 60803102, 61070084, and also funded by the Natural Science Foundation of Jilin Province (Nos. 20101506 and 20110104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-273; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu LL, 2011, BIOPOLYMERS, V95, P763, DOI 10.1002/bip.21645; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang JH, 2012, BIOCHIMIE, V94, P1697, DOI 10.1016/j.biochi.2012.03.022; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Ressurreicao M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-6; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wang YY, 2010, ACTA PHARMACOL SIN, V31, P160, DOI 10.1038/aps.2009.201; Wood CD, 2009, INT J BIOL SCI, V5, P428; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Zhao XW, 2011, INT J MOL SCI, V12, P8347, DOI 10.3390/ijms12128347	48	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46302	10.1371/journal.pone.0046302	http://dx.doi.org/10.1371/journal.pone.0046302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	22253830	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400004
J	Simoes, RR; Aires-de-Sousa, M; Conceicao, T; Antunes, F; da Costa, PM; de Lencastre, H				Simoes, Romeo Rocha; Aires-de-Sousa, Marta; Conceicao, Teresa; Antunes, Filipa; da Costa, Paulo Martins; de Lencastre, Herminia			High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PCR STRATEGY; COMMUNITY; STRAINS; CLONE; MRSA; TRANSPORT; INFECTIONS; EMERGENCE	Background: The nosocomial prevalence of methicillin resistant Staphylococcus aureus (MRSA) in Portugal remains one of highest in Europe and is currently around 50%. Transmission of S. aureus, including MRSA, occurs principally by direct human-to-human skin contact. However, S. aureus can survive for long periods on inanimate objects, which may represent an important reservoir for dissemination as well. Methodology/Principal Findings: Between May 2009 and February 2010, handrails of 85 public urban buses circulating in Oporto, Portugal, were screened for the occurrence of MRSA. Twenty-two (26%) buses showed MRSA contamination. The molecular characterization of a total of 55 MRSA, by pulsed-field gel electrophoresis (PFGE), staphylococcal cassette chromosome (SCC) mec typing, spa typing, and multilocus sequence typing (MLST), clustered the isolates into three clonal types. However, the overwhelming majority (n = 50; 91%) of the isolates belonged to a single clone (PFGE A, spa types t747, t032, t025 or t020, ST22, SCCmec type IVh) that exhibits the characteristics of the pandemic EMRSA-15, currently the major lineage circulating in Portuguese hospitals, namely in the Oporto region. Two additional clones were found but in much lower numbers: (i) PFGE B, ST5, spa type t002, SCCmec IVa (n = 3), and (ii) PFGE C, spa type t008, ST8, SCCmec IVa (n = 2). None of the 55 isolates was PVL positive. Conclusions/Significance: Public buses in Oporto seem to be an important reservoir of MRSA of nosocomial origin, providing evidence that the major hospital-associated MRSA clone in Portugal is escaping from the primary ecological niche of hospitals to the community environment. Infection control measures are urgently warranted to limit the spread of EMRSA-15 to the general population and future studies are required to assess the eventual increase of MRSA in the Portuguese community, which so far remains low.	[Simoes, Romeo Rocha; Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Romeo Rocha; Antunes, Filipa; da Costa, Paulo Martins] Univ Porto, Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa, Lisbon, Portugal; [da Costa, Paulo Martins] CIIMAR Ctr Interdisciplinar Invest Marinha & Ambi, Oporto, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade do Porto; Universidade do Porto; Rockefeller University	Simoes, RR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockefeller.edu	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	European Community [TROCAR-HEALTH-F3-2008-223031, 095/BI-BI/2010]; EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by Project TROCAR (TROCAR-HEALTH-F3-2008-223031) from the European Community to HL and by grant 095/BI-BI/2010 from the same Project to T. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Allen KD, 1997, J HOSP INFECT, V35, P307, DOI 10.1016/S0195-6701(97)90225-5; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Bocher S, 2010, J ANTIMICROB CHEMOTH, V65, P717, DOI 10.1093/jac/dkq001; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, VEleventh; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kassem II, 2009, LETT APPL MICROBIOL, V48, P268, DOI 10.1111/j.1472-765X.2008.02518.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Manning N, 2004, J HOSP INFECT, V56, P250, DOI 10.1016/j.jhin.2003.12.021; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; RAMALHINHO I, EVOLUCAO CONSUMO ANT; Roline CE, 2007, PREHOSP EMERG CARE, V11, P241, DOI 10.1080/10903120701205125; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Sexton JD, 2010, AM J INFECT CONTROL, V38, P368, DOI 10.1016/j.ajic.2010.01.004; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31	36	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17630	10.1371/journal.pone.0017630	http://dx.doi.org/10.1371/journal.pone.0017630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	22242113	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300037
J	Lee, KW; Zhao, X; Im, JY; Grosso, H; Jang, WH; Chan, TW; Sonsalla, PK; German, DC; Ichijo, H; Junn, E; Mouradian, MM				Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Jang, Won Hee; Chan, Teresa W.; Sonsalla, Patricia K.; German, Dwight C.; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Mara			Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; DOPAMINERGIC NEURODEGENERATION; MOUSE MODEL; CELL-DEATH; ASK1; DEGENERATION; CYCLOOXYGENASE-2; NEURONS	Apoptosis signal-regulating kinase 1 ASIK1) member of the mitogen-activated protein kinase 3 family, is activated by oxidative stress. The death-signaling pathway mediated by ASK1 is inhibited by DJ 1, which is linked to recessively inherited Parkinson's disease (PD). Considering that DJ-1 deficiency exacerbates the toxicity of the mitochondrial complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we sought to investigate the direct role and mechanism of ASK1 in MPTP-induced dopamine neuron toxicity. In the present study, we found that MPTP administration to wild-type mice activates ASK1 in the midbrain. In ASK1 null mice, MPTP-induced motor impairment was less profound, and striatal dopamine content and nigral dopamine neuron counts were relatively preserved compared to wild type littermates. Further, microglia and astrocyte activation seen in wild-type mice challenged with MPTP was markedly attenuated in,ASK1(-/-) mice. These data suggest that ASK1 is a key player in MPTP-induced glial activation linking oxidative stress with neuroinflammation, two well recognized pathogenetic factors in PD. These findings demonstrate that ASK1 is an important effector of MPTP-induced toxicity and suggest that inhibiting this kinase is a plausible therapeutic strategy for protecting dopamine neurons in PD.	[Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Chan, Teresa W.; Sonsalla, Patricia K.; Junn, Eunsung; Mouradian, M. Mara] UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA; [Jang, Won Hee] Inje Univ, Coll Med, Dept Biochem, Pusan, South Korea; [German, Dwight C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Inje University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo	Lee, KW (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA.	Mouradian@umdnj.edu	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	NINDS/NIH [NS059869, NS53517]; American Parkinson Disease Association; Foundation of UMDNJ	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Foundation of UMDNJ	This work was supported by NINDS/NIH grants NS059869 and NS53517 to M.M.M. and by grants from the American Parkinson Disease Association and the Foundation of UMDNJ to E.J. M.M.M. is the William Dow Lovett Professor of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito PD, 2003, J NEUROSCI, V23, P10982; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Gao HM, 2003, J NEUROSCI, V23, P6181; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kandil S, 2010, FASEB J, V56, P611; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kumakura K, 2010, NEUROSCI RES, V66, P313, DOI 10.1016/j.neures.2009.12.003; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Saeed U, 2009, NEUROTOX RES, V16, P116, DOI 10.1007/s12640-009-9058-5; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; SONSALLA PK, 1991, J PHARMACOL EXP THER, V256, P506; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; UPCHURCH M, 1983, BEHAV NEURAL BIOL, V39, P221, DOI 10.1016/S0163-1047(83)90876-2; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	45	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					242	249	e29935	10.1371/journal.pone.0029935	http://dx.doi.org/10.1371/journal.pone.0029935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253830	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900026
J	Yang, HS; Fu, DZ; Shao, H; Kong, XF; Wang, W; Yang, XJ; Nyachoti, CM; Yin, YL				Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yang, Xiaojian; Nyachoti, Charles M.; Yin, Yulong			Impacts of Birth Weight on Plasma, Liver and Skeletal Muscle Neutral Amino Acid Profiles and Intestinal Amino Acid Transporters in Suckling Huanjiang Mini-Piglets	PLOS ONE			English	Article							ULTRA-FINE POWDER; GROWTH-PERFORMANCE; ADIPOSE-TISSUE; SUPPLEMENTATION; DIGESTIBILITY; METABOLISM; CAPACITY; ILEAL; GAIN; PIGS	Genetic selection strategies towards increased prolificacy have resulted in more and more increased littler size and incidences of impaired fetal development. Low birth weight (LBW) piglets, with long-term alterations in structure, physiology and metabolism, have lower survival rates and poor growth performance. The aim of the study was to compare the plasma, liver and skeletal muscle contents of neutral amino acids (NAA) and the intestinal expression of NAA transporters between LBW and high birth weight (HBW) suckling Huanjiang mini-piglets. Forty piglets with either LBW or HBW (20 piglets per group) were sampled on day 0, 7, 14 and 21 of age to give 5 observations per day per group. The contents of NAA in plasma, liver and skeletal muscle were measured, and jejunal expression of transporters for NAA, including Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2), were determined by real-time RT-PCR and Western Blot, respectively. Results showed that the suckling piglets with LBW had higher contents of Thr, Ser, Gly, Ala, Val, Met, Ile, Leu, Tyr, Phe and Pro in liver, and Gly in skeletal muscle, whereas lower contents of Met, Ser and Ala in plasma when compared with the HBW littermates. Consistent with the content differences in plasma NAA, the jejunal expression profiles of both Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2) in the LBW piglets were lower in compared with the HBW littermates during the early suckling period. These findings suggested that intestinal dysfunction in the LBW piglets may be one of the reasons in altered physiology and metabolism states of other organs, which result in lower survival and growth rate.	[Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Res Ctr Hlth Breeding Livestock & Poultry, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Kong, Xiangfeng] Chinese Acad Sci, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Guangxi, Peoples R China; [Yang, Xiaojian] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Nyachoti, Charles M.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Shao, Hua] Univ Ottawa, Res Inst, Ottawa Hosp, Ottawa, ON, Canada; [Yang, Huansheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Guelph; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kong, XF (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	National Basic Research Program of China [2012CB124704]; National Natural Science Foundation of China [31110103909, 30901040, 30928018, 31101729]; National Scientific and Technology Support Project [2011BAD26B002-5]; Chinese Academy of Sciences [2011T2S15]; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technology Support Project; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was jointly supported by the National Basic Research Program of China (2012CB124704), National Natural Science Foundation of China (No. 31110103909, 30901040, 30928018, and 31101729), National Scientific and Technology Support Project (2011BAD26B002-5) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant No. 2011T2S15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAUSSINGER D, 1992, ENZYME, V46, P72; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kong XF, 2007, LIVEST SCI, V108, P94, DOI 10.1016/j.livsci.2007.01.002; Kong XF, 2009, LIVEST SCI, V123, P261, DOI 10.1016/j.livsci.2008.11.015; Kong XF, 2009, AMINO ACIDS, V37, P573, DOI 10.1007/s00726-008-0176-9; Milligan BN, 2002, PREV VET MED, V56, P119, DOI 10.1016/S0167-5877(02)00157-5; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Morise A, 2008, ANIMAL, V2, P73, DOI 10.1017/S175173110700095X; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Ritacco G, 1997, J ANIM SCI, V75, P1237; Sangild PT, 2002, BIOL GROW ANIM, V1, P111, DOI 10.1016/S1877-1823(09)70119-5; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Thorn SR, 2009, ENDOCRINOLOGY, V150, P3021, DOI 10.1210/en.2008-1789; THORNBURY JC, 1993, PEDIATR PATHOL, V13, P59, DOI 10.3109/15513819309048193; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2000, LIVEST PROD SCI, V62, P119, DOI 10.1016/S0301-6226(99)00129-3; Zhang M, 1996, SWINE PROD, V2, P30; Zhao DS, 2008, LIVEST POULTRY HUSBA, V3, P16	31	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50921	10.1371/journal.pone.0050921	http://dx.doi.org/10.1371/journal.pone.0050921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	22253702	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100044
J	Fu, YSH; Campioli, M; Deckmyn, G; Janssens, IA				Fu, Yongshuo H.; Campioli, Matteo; Deckmyn, Gaby; Janssens, Ivan A.			The Impact of Winter and Spring Temperatures on Temperate Tree Budburst Dates: Results from an Experimental Climate Manipulation	PLOS ONE			English	Article							LEAF BUD BURST; DORMANCY RELEASE; PHENOLOGICAL MODELS; PLANT PHENOLOGY; THERMAL TIME; BOREAL; PREDICT; GROWTH; FOREST	Budburst phenology is a key driver of ecosystem structure and functioning, and it is sensitive to global change. Both cold winter temperatures (chilling) and spring warming (forcing) are important for budburst. Future climate warming is expected to have a contrasting effect on chilling and forcing, and subsequently to have a non-linear effect on budburst timing. To clarify the different effects of warming during chilling and forcing phases of budburst phenology in deciduous trees, (i) we conducted a temperature manipulation experiment, with separate winter and spring warming treatments on well irrigated and fertilized saplings of beech, birch and oak, and (ii) we analyzed the observations with five temperature-based budburst models (Thermal Time model, Parallel model, Sequential model, Alternating model, and Unified model). The results show that both winter warming and spring warming significantly advanced budburst date, with the combination of winter plus spring warming accelerating budburst most. As expected, all three species were more sensitive to spring warming than to winter warming. Although the different chilling requirement, the warming sensitivity was not significantly different among the studied species. Model evaluation showed that both one- and two- phase models (without and with chilling, respectively) are able to accurately predict budburst. For beech, the Sequential model reproduced budburst dates best. For oak and birch, both Sequential model and the Thermal Time model yielded good fit with the data but the latter was slightly better in case of high parameter uncertainty. However, for late-flushing species, the Sequential model is likely be the most appropriate to predict budburst data in a future warmer climate.	[Fu, Yongshuo H.; Campioli, Matteo; Deckmyn, Gaby; Janssens, Ivan A.] Univ Antwerp, Dept Biol, Antwerp, Belgium	University of Antwerp	Fu, YSH (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.	Yongshuo.Fu@ua.ac.be	Janssens, Ivan A/P-1331-2014; Fu, Yongshuo/AAO-4663-2021; Campioli, Matteo/N-9380-2015; Fu, Yongshuo/AAH-7434-2019; Fu, Yongshuo/AAF-9446-2021	Janssens, Ivan A/0000-0002-5705-1787; Fu, Yongshuo/0000-0002-9761-5292; Fu, Yongshuo/0000-0002-9761-5292; Xu, Ru/0000-0001-5926-9213; Campioli, Matteo/0000-0002-3427-2368	EU [244122]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	EU(European Commission); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project GHG-Europe-Greenhouse gas management in European Land use systems in EU (http://www.ghg-europe.eu/index.php?id = 84) contract no. 244122 and the China Scholarship Council (http://en.csc.edu.cn) provided dissertation funding (fees and living stipend) for Yongshuo H. Fu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; BOYER WD, 1973, ECOLOGY, V54, P420, DOI 10.2307/1934351; Caffarra A, 2011, CLIM RES, V46, P147, DOI 10.3354/cr00980; Campioli M, 2012, J FOREST RES-JPN, V17, P1, DOI 10.1007/s10310-011-0255-8; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; D'Haese D, 2004, J THEOR BIOL, V227, P175, DOI 10.1016/j.jtbi.2003.10.011; Dijkstra JA, 2011, GLOBAL CHANGE BIOL, V17, P2360, DOI 10.1111/j.1365-2486.2010.02371.x; Fu YSH, 2012, ECOL MODEL, V230, P92, DOI 10.1016/j.ecolmodel.2012.01.010; Fu YH, 2012, INT J BIOMETEOROL, V56, P153, DOI 10.1007/s00484-011-0408-7; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; Hanninen H., 1987, Silva Fennica, V21, P279; Hanninen H, 2007, SILVA FENN, V41, P167, DOI 10.14214/sf.313; Harrington CA, 2010, FOREST ECOL MANAG, V259, P798, DOI 10.1016/j.foreco.2009.06.018; HEIDE OM, 1993, PHYSIOL PLANTARUM, V88, P531, DOI 10.1111/j.1399-3054.1993.tb01368.x; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Leinonen I, 2002, CLIMATIC CHANGE, V55, P99, DOI 10.1023/A:1020251507469; Linkosalo T, 2008, TREE PHYSIOL, V28, P1873, DOI 10.1093/treephys/28.12.1873; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165, DOI 10.1093/treephys/26.9.1165; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; MYKING T, 1995, TREE PHYSIOL, V15, P697, DOI 10.1093/treephys/15.11.697; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry ML, 2007, CLIMATE CHANGE 2007; Partanen J, 2001, SILVA FENN, V35, P111, DOI 10.14214/sf.608; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Romberger JA, 1963, MERISTEMS GROWTH DEV; Sarvas R., 1974, Metsantutkimuslaitoksen Julkaisuja, V84; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sogaard G, 2008, TREE PHYSIOL, V28, P311, DOI 10.1093/treephys/28.2.311; Thompson R, 2008, HOLOCENE, V18, P95, DOI 10.1177/0959683607085599; van den Berge J, 2011, ENV EXPT BOT, V70, P51; Van Oijen M, 2005, TREE PHYSIOL, V25, P915, DOI 10.1093/treephys/25.7.915; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003	49	129	142	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47324	10.1371/journal.pone.0047324	http://dx.doi.org/10.1371/journal.pone.0047324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071786	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200105
J	Yang, HP; Zuna, RE; Schiffman, M; Walker, JL; Sherman, ME; Landrum, LM; Moxley, K; Gold, MA; Dunn, ST; Allen, RA; Zhang, R; Long, R; Wang, SS; Wentzensen, N				Yang, Hannah P.; Zuna, Rosemary E.; Schiffman, Mark; Walker, Joan L.; Sherman, Mark E.; Landrum, Lisa M.; Moxley, Katherine; Gold, Michael A.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy; Long, Rodney; Wang, Sophia S.; Wentzensen, Nicolas			Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; EARLY END-POINTS; NATURAL-HISTORY; LOOP EXCISION; CANCER; LESIONS; WOMEN; DETERMINANTS; METAANALYSIS; PROGRESSION	Objective: Cervical intraepithelial neoplasia grade 3 (CIN3), the immediate cervical cancer precursor, is a target of cervical cancer prevention. However, less than half of CIN3s will progress to cancer. Routine treatment of all CIN3s and the majority of CIN2s may lead to overtreatment of many lesions that would not progress. To improve our understanding of CIN3 natural history, we performed a detailed characterization of CIN3 heterogeneity in a large referral population in the US. Methods: We examined 309 CIN3 cases in the SUCCEED, a large population-based study of women with abnormal cervical cancer screening results. Histology information for 12 individual loop electrosurgical excision procedure (LEEP) segments was evaluated for each woman. We performed case-case comparisons of CIN3s to analyze determinants of heterogeneity and screening test performance. Results: CIN3 cases varied substantially by size (1-10 LEEP segments) and by presentation with concomitant CIN2 and CIN1. All grades of CINs were equally distributed over the cervical surface. In half of the women, CIN3 lesions were found as multiple distinct lesions on the cervix. Women with large and solitary CIN3 lesions were more likely to be older, have longer sexual activity span, and have fewer multiple high risk HPV infections. Screening frequency, but not HPV16 positivity, was an important predictor of CIN3 size. Large CIN3 lesions were also characterized by high-grade clinical test results. Conclusions: We demonstrate substantial heterogeneity in clinical and pathological presentation of CIN3 in a US population. Time since sexual debut and participation in screening were predictors of CIN3 size. We did not observe a preferential site of CIN3 on the cervical surface that could serve as a target for cervical biopsy. Cervical cancer screening procedures were more likely to detect larger CIN3s, suggesting that CIN3s detected by multiple independent diagnostic tests may represent cases with increased risk of invasion.	[Yang, Hannah P.; Schiffman, Mark; Sherman, Mark E.; Wentzensen, Nicolas] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Zuna, Rosemary E.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Walker, Joan L.; Landrum, Lisa M.; Moxley, Katherine] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Gold, Michael A.] Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN USA; [Long, Rodney] Natl Lib Med, Bethesda, MD USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Canc Etiol, Duarte, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); City of Hope; Beckman Research Institute of City of Hope	Yang, HP (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yanghan@mail.nih.gov	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard Jay E, 2005, J Low Genit Tract Dis, V9, P36, DOI 10.1097/00128360-200501000-00008; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Guido RS, 2005, AM J OBSTET GYNECOL, V193, P1331, DOI 10.1016/j.ajog.2005.05.008; HEATLEY M, 1995, J CLIN PATHOL, V48, P323, DOI 10.1136/jcp.48.4.323; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lurie S, 2007, AM J OBSTET GYNECOL, V125, pe121; Massad LS, 1996, GYNECOL ONCOL, V60, P400, DOI 10.1006/gyno.1996.0062; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P45, DOI 10.1097/01.lgt.0000192697.31291.42; RICHART RM, 1965, CANCER, V18, P950, DOI 10.1002/1097-0142(196508)18:8<950::AID-CNCR2820180805>3.0.CO;2-T; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P372; Shiffman M, 2008, LANCET ONCOL, V9, P404, DOI 10.1016/S1470-2045(08)70110-4; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Szurkus DC, 2003, AM J OBSTET GYNECOL, V188, P1180, DOI 10.1067/mob.2003.282; TIDBURY P, 1992, BRIT J OBSTET GYNAEC, V99, P583, DOI 10.1111/j.1471-0528.1992.tb13825.x; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Wang SS, 2009, CANCER EPIDEM BIOMAR, V18, P113, DOI 10.1158/1055-9965.EPI-08-0591; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	27	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29051	10.1371/journal.pone.0029051	http://dx.doi.org/10.1371/journal.pone.0029051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253702	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500005
J	Lee, CT; Zhong, LW; Mace, TA; Repasky, EA				Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.			Elevation in Body Temperature to Fever Range Enhances and Prolongs Subsequent Responsiveness of Macrophages to Endotoxin Challenge	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK PROTEINS; NF-KAPPA-B; LIPOPOLYSACCHARIDE TOLERANCE; THERMOREGULATORY RESPONSES; SYSTEMIC INFLAMMATION; HOST-DEFENSE; CYTOKINE; HYPERTHERMIA; ACTIVATION	Macrophages are often considered the sentries in innate immunity, sounding early immunological alarms, a function which speeds the response to infection. Compared to the large volume of studies on regulation of macrophage function by pathogens or cytokines, relatively little attention has been devoted to the role of physical parameters such as temperature. Given that temperature is elevated during fever, a long-recognized cardinal feature of inflammation, it is possible that macrophage function is responsive to thermal signals. To explore this idea, we used LPS to model an aseptic endotoxin induced inflammatory response in BALB/c mice and found that raising mouse body temperature by mild external heat treatment significantly enhances subsequent LPS-induced release of TNF-alpha into the peritoneal fluid. It also reprograms macrophages, resulting in sustained subsequent responsiveness to LPS, i.e., this treatment reduces "endotoxin tolerance" in vitro and in vivo. At the molecular level, elevating body temperature of mice results in a increase in LPS-induced downstream signaling including enhanced phosphorylation of IKK and I kappa B, NF kappa B nuclear translocation and binding to the TNF-alpha promoter in macrophages upon secondary stimulation. Mild heat treatment also induces expression of HSP70 and use of HSP70 inhibitors (KNK437 or Pifithrin-mu) largely abrogates the ability of the thermal treatment to enhance TNF-alpha, suggesting that the induction of HSP70 is important for mediation of thermal effects on macrophage function. Collectively, these results support the idea that there has been integration between the evolution of body temperature regulation and macrophage function that could help to explain the known survival benefits of fever in organisms following infection.	[Lee, Chen-Ting; Zhong, Lingwen; Mace, Thomas A.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Lee, CT (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	elizabeth.repasky@roswellpark.org	Lee, Chia-Lin/P-2038-2015; Wu, Yang-Chang/C-5682-2009; Yang, Juan-Cheng/D-1442-2011	Lee, Chia-Lin/0000-0002-5949-1989; Wu, Yang-Chang/0000-0001-7815-2686; Chang, Fang-Rong/0000-0003-2549-4193; Chen, Guan-Yu/0000-0002-2773-8748	NIH [P01 CA094045, R01 CA135368, R01 CA071599]; NATIONAL CANCER INSTITUTE [R01CA071599, P01CA094045, R01CA135368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants NIH P01 CA094045, R01 CA135368 and R01 CA071599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINS C, 1991, PHYSIOL BEHAV, V50, P461, DOI 10.1016/0031-9384(91)90095-6; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; ASTIZ ME, 1995, CRIT CARE MED, V23, P9, DOI 10.1097/00003246-199501000-00006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BLATTEIS CM, 1980, EXPERIENTIA, V36, P1086, DOI 10.1007/BF01965985; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Dai WJ, 1997, J IMMUNOL, V158, P5297; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; Depraetere V, 2000, NAT CELL BIOL, V2, pE104, DOI 10.1038/35014098; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FREUDENBERG MA, 1988, INFECT IMMUN, V56, P1352, DOI 10.1128/IAI.56.5.1352-1357.1988; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; Gordon CJ, 1993, FEVER TEMPERATURE RE, P45; Guptill V, 2011, ANESTHESIOLOGY, V114, P1190, DOI 10.1097/ALN.0b013e318212515b; HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Hasday JD, 1996, INFLUENCE TEMPERATUR; Horan P K, 1990, Methods Cell Biol, V33, P469; Ivanov AI, 2000, AUTON NEUROSCI-BASIC, V85, P111, DOI 10.1016/S1566-0702(00)00229-0; Jiang QQ, 1999, INFECT IMMUN, V67, P1539; Jiang QQ, 2000, INFECT IMMUN, V68, P1265, DOI 10.1128/IAI.68.3.1265-1270.2000; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Kluger M J, 1979, Int Rev Physiol, V20, P209; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Kluger MJ., 1979, FEVER ITS BIOL EVOLU; Kluger MJ, 1991, ADAPTIVE VALUE FEVER, P105; Kox M, 2011, CRIT CARE MED, V39, P1866, DOI 10.1097/CCM.0b013e3182190d5d; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Lenz AM, 2011, CYTOKINE, V53, P84, DOI 10.1016/j.cyto.2010.08.012; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; MACKOWIAK PA, 1981, REV INFECT DIS, V3, P508; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V43, P387, DOI 10.1002/jlb.43.5.387; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Paul WE, 1989, INFLAMMATION FUNDAME, P721; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Robert R, 2009, CRIT CARE MED, V37, P2860, DOI 10.1097/CCM.0b013e3181b3a0e1; Romanovsky AA, 1998, MED HYPOTHESES, V50, P219, DOI 10.1016/S0306-9877(98)90022-6; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2006, CELL CYCLE, V5, P2195, DOI 10.4161/cc.5.19.3321; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Steiner AA, 2008, J APPL PHYSIOL, V105, P1028, DOI 10.1152/japplphysiol.90619.2008; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; TITE JP, 1991, J IMMUNOL, V147, P3161; Torigoe T, 2009, INT J HYPERTHER, V25, P610, DOI 10.3109/02656730903315831; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Xaus J, 2001, IMMUNOBIOLOGY, V204, P543, DOI 10.1078/0171-2985-00091; Yokota S, 2000, CANCER RES, V60, P2942	76	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					393	405	e30077	10.1371/journal.pone.0030077	http://dx.doi.org/10.1371/journal.pone.0030077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253887	Green Published, gold, Green Submitted			2022-12-25	WOS:000301353900040
J	Li, RG; Gao, S; Hernandez, AG; Wechter, WP; Fei, ZJ; Ling, KS				Li, Rugang; Gao, Shan; Hernandez, Alvaro G.; Wechter, W. Patrick; Fei, Zhangjun; Ling, Kai-Shu			Deep Sequencing of Small RNAs in Tomato for Virus and Viroid Identification and Strain Differentiation	PLOS ONE			English	Article							PEPINO-MOSAIC-VIRUS; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; DISCOVERY; ALIGNMENT; EVOLUTION; PATHOGEN; INSIGHTS; REVEALS	Small RNAs (sRNA), including microRNAs (miRNA) and small interfering RNAs (siRNA), are produced abundantly in plants and animals and function in regulating gene expression or in defense against virus or viroid infection. Analysis of siRNA profiles upon virus infection in plant may allow for virus identification, strain differentiation, and de novo assembly of virus genomes. In the present study, four suspected virus-infected tomato samples collected in the U. S. and Mexico were used for sRNA library construction and deep sequencing. Each library generated between 5-7 million sRNA reads, of which more than 90% were from the tomato genome. Upon in-silico subtraction of the tomato sRNAs, the remaining highly enriched, virus-like siRNA pools were assembled with or without reference virus or viroid genomes. A complete genome was assembled for Potato spindle tuber viroid (PSTVd) using siRNA alone. In addition, a near complete virus genome (98%) also was assembled for Pepino mosaic virus (PepMV). A common mixed infection of two strains of PepMV (EU and US1), which shared 82% of genome nucleotide sequence identity, also could be differentially assembled into their respective genomes. Using de novo assembly, a novel potyvirus with less than 60% overall genome nucleotide sequence identity to other known viruses was discovered and its full genome sequence obtained. Taken together, these data suggest that the sRNA deep sequencing technology will likely become an efficient and powerful generic tool for virus identification in plants and animals.	[Li, Rugang; Wechter, W. Patrick; Ling, Kai-Shu] ARS, US Vegetable Lab, USDA, Charleston, SC USA; [Gao, Shan; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Li, RG (corresponding author), ARS, US Vegetable Lab, USDA, Charleston, SC USA.	zf25@Cornell.edu; kai.ling@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [SCRI-600-25320]; National Science Foundation [IOS-1110080]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by a grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (SCRI-600-25320) to KSL and by National Science Foundation (IOS-1110080) to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; JONES RAC, 1980, ANN APPL BIOL, V94, P61, DOI 10.1111/j.1744-7348.1980.tb03896.x; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Ling KS, 2009, PLANT DIS, V93, P1075, DOI 10.1094/PDIS-93-10-1075B; Ling KS, 2009, PLANT DIS, V93, P839, DOI 10.1094/PDIS-93-8-0839B; Ling KS, 2007, VIRUS GENES, V34, P1, DOI 10.1007/s11262-006-0003-x; Ling KS, 2008, PLANT DIS, V92, P1683, DOI 10.1094/PDIS-92-12-1683; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Maroon-Lango CJ, 2005, ARCH VIROL, V150, P1187, DOI 10.1007/s00705-005-0495-z; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; The Tomato Genome Consortium, 2012, NATURE IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37127	10.1371/journal.pone.0037127	http://dx.doi.org/10.1371/journal.pone.0037127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623984	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500061
J	Li, RW; Wu, ST; Baldwin, RL; Li, WZ; Li, CJ				Li, Robert W.; Wu, Sitao; Baldwin, Ransom L.; Li, Weizhong; Li, Congjun			Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; HUMAN GUT; BUTYRIVIBRIO-FIBRISOLVENS; RUMINAL BUTYRATE; RESISTANT STARCH; LARGE-INTESTINE; FAST PROGRAM; DAIRY-COWS; MILK-YIELD; METABOLISM	The capacity of the rumen microbiota to produce volatile fatty acids (VFAs) has important implications in animal well-being and production. We investigated temporal changes of the rumen microbiota in response to butyrate infusion using pyrosequencing of the 16S rRNA gene. Twenty one phyla were identified in the rumen microbiota of dairy cows. The rumen microbiota harbored 54.5 +/- 6.1 genera (mean +/- SD) and 127.3 +/- 4.4 operational taxonomic units (OTUs), respectively. However, the core microbiome comprised of 26 genera and 82 OTUs. Butyrate infusion altered molar percentages of 3 major VFAs. Butyrate perturbation had a profound impact on the rumen microbial composition. A 72 h-infusion led to a significant change in the numbers of sequence reads derived from 4 phyla, including 2 most abundant phyla, Bacteroidetes and Firmicutes. As many as 19 genera and 43 OTUs were significantly impacted by butyrate infusion. Elevated butyrate levels in the rumen seemingly had a stimulating effect on butyrate-producing bacteria populations. The resilience of the rumen microbial ecosystem was evident as the abundance of the microorganisms returned to their pre-disturbed status after infusion withdrawal. Our findings provide insight into perturbation dynamics of the rumen microbial ecosystem and should guide efforts in formulating optimal uses of probiotic bacteria treating human diseases.	[Li, Robert W.; Baldwin, Ransom L.; Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUHTANEN P, 1993, J DAIRY SCI, V76, P1114, DOI 10.3168/jds.S0022-0302(93)77440-8; Kristensen NB, 2004, J ANIM SCI, V82, P2033; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez S, 2003, J ANIM SCI, V81, P2609; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Ohkawara S, 2006, CLIN VACCINE IMMUNOL, V13, P1231, DOI 10.1128/CVI.00267-06; Pitt RE, 1996, J ANIM SCI, V74, P226; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Silvi S, 1999, J APPL MICROBIOL, V86, P521, DOI 10.1046/j.1365-2672.1999.00696.x; STORRY JE, 1966, BRIT J NUTR, V20, P217, DOI 10.1079/BJN19660023; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	35	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29392	10.1371/journal.pone.0029392	http://dx.doi.org/10.1371/journal.pone.0029392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22623984	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100009
J	Ferreira, CM; Chen, JL; Li, JR; Shimomura, K; Yang, XN; Lussier, YA; Pinto, LH; Solway, J				Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Shimomura, Kazuhiro; Yang, Xinan; Lussier, Yves A.; Pinto, Lawrence H.; Solway, Julian			Genetic Interactions between Chromosomes 11 and 18 Contribute to Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SMOOTH-MUSCLE; CHOLESTEROL; ASTHMA; TRAIT; MOUSE; C1; RESPONSIVENESS; ATHEROSCLEROSIS; HYPERREACTIVITY	We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice. We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F-2 and twenty-seven (A/J X C57BL/6J) F2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice. Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype. Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7, Rock1, Limk2; and Npc1, Npc1/1. Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness. Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.	[Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Yang, Xinan; Lussier, Yves A.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ferreira, Caroline M.; Shimomura, Kazuhiro; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Ferreira, CM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jsolway@medicine.bsd.uchicago.edu	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	CNPq (National Council for Scientific and Technological Development) [UL1RR024999-04]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [U54CA121852-5, K22LM008308, R01HL079398]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by CNPq (National Council for Scientific and Technological Development), UL1RR024999-04, National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; U54CA121852-5), K22LM008308, R01HL079398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Chen BH, 2006, J APPL PHYSIOL, V101, P249, DOI 10.1152/japplphysiol.01010.2004; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Davis HR, 2008, ATHEROSCLEROSIS SUPP, V9, P77, DOI 10.1016/j.atherosclerosissup.2008.05.008; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Dowell ML, 2010, EUR RESPIR J, V36, P630, DOI 10.1183/09031936.00160209; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Iyer SPN, 2005, BBA-GEN SUBJECTS, V1722, P282, DOI 10.1016/j.bbagen.2004.12.021; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Nicholson AG, 2006, HISTOPATHOLOGY, V48, P596, DOI 10.1111/j.1365-2559.2006.02355.x; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Otera H, 2009, AM J PHYSIOL-LUNG C, V296, pL594, DOI 10.1152/ajplung.90530.2008; Palmeri S, 2005, NEUROL SCI, V26, P171, DOI 10.1007/s10072-005-0456-z; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer B, 2009, CAN J PHYSIOL PHARM, V87, P180, DOI [10.1139/Y08-114, 10.1139/y08-114]; Tossa P, 2010, AM J RESP CRIT CARE, V182, P738, DOI 10.1164/rccm.200903-0415OC; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC; Woolcock AJ, 1997, ASTHMA, P27; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	49	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					100	106	e29579	10.1371/journal.pone.0029579	http://dx.doi.org/10.1371/journal.pone.0029579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	23071617	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900011
J	Chen, S; Cai, WP; He, JY; Vidal, N; Lai, CH; Guo, WZ; He, HL; Chen, XJ; Fu, LS; Peeters, M; Delaporte, E; Andrieu, JM; Lu, W				Chen, Song; Cai, Weiping; He, Jingyang; Vidal, Nicole; Lai, Chunhui; Guo, Weizhong; He, Haolan; Chen, Xiejie; Fu, Linsheng; Peeters, Martine; Delaporte, Eric; Andrieu, Jean-Marie; Lu, Wei			Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DRUG-RESISTANCE; SUBTYPE C; HIV-1; TRANSMISSION; RISK; DIVERSITY	Background: Although the outbreak of human immunodeficiency virus type 1 (HIV-1) in Guangdong has been documented for more than a decade, the molecular characteristics of such a regional HIV-1 epidemic remained unknown. Methodology/Principal Findings: By sequencing of HIV-1 pol/env genes and phylogenetic analysis, we performed a molecular epidemiologic study in a representative subset (n = 200) of the 508 HIV-1-seropositive individuals followed up at the center for HIV/AIDS care and treatment of Guangzhou Hospital of Infectious Diseases. Of 157 samples (54.1% heterosexual acquired adults, 20.4% needle-sharing drug users, 5.7% receivers of blood transfusion, 1.3% men who have sex with men, and 18.5% remained unknown) with successful sequencing for both pol and env genes, 105 (66.9%) HIV-1 subtype CRF01_AE and 24 (15.3%) CRF07_BC, 9 (5.7%) B', 5 (3.2%) CRF08_BC, 5 (3.2%) B, 1 (0.6%) C, 3 (1.9%) CRF02_AG, and 5 (3.2%) inter-region recombinants were identified within pol/env sequences. Thirteen (8.3%) samples (3 naives, 6 and 5 received with antiretroviral treatment [ART] 1-21 weeks and >= 24 weeks respectively) showed mutations conferring resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors or protease inhibitors. Among 63 ART-naive patients, 3 (4.8%) showed single or multiple drug resistant mutations. Phylogenetic analysis showed 8 small clusters (2-3 sequences/cluster) with only 17 (10.8%) sequences involved. Conclusion/Significance: This study confirms that sexual transmission with dominant CRF01_AE strain is a major risk for current HIV-1 outbreak in the Guangdong's general population. The transmission with drug-resistant variants is starting to emerge in this region.	[Chen, Song; He, Jingyang; Lai, Chunhui; Guo, Weizhong; Fu, Linsheng; Lu, Wei] Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie] Univ Paris 05, Lab Oncol & Virol Mol, Paris, France; [Cai, Weiping; He, Haolan; Chen, Xiejie] Guangzhou Hosp Infect Dis, Guangzhou, Guangdong, Peoples R China; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Inst Rech Dev, UMI 233, Montpellier, France; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Univ Monpellier 1, Montpellier, France	Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). S. C. was supported by a fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Lin P, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P194; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	33	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48747	10.1371/journal.pone.0048747	http://dx.doi.org/10.1371/journal.pone.0048747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23071617	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800118
J	Ferreira, TH; Gentile, A; Vilela, RD; Costa, GGL; Dias, LI; Endres, L; Menossi, M				Ferreira, Thais Helena; Gentile, Agustina; Vilela, Romel Duarte; Lacerda Costa, Gustavo Gilson; Dias, Lara Isys; Endres, Lauricio; Menossi, Marcelo			microRNAs Associated with Drought Response in the Bioenergy Crop Sugarcane (Saccharum spp.)	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; SMALL RNAS; TRANSCRIPTION FACTORS; SOYBEAN MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; SALT TOLERANCE; ORYZA-SATIVA; ARABIDOPSIS; IDENTIFICATION	Sugarcane (Saccharum spp.) is one of the most important crops in the world. Drought stress is a major abiotic stress factor that significantly reduces sugarcane yields. However the gene network that mediates plant responses to water stress remains largely unknown in several crop species. Although several microRNAs that mediate post-transcriptional regulation during water stress have been described in other species, the role of the sugarcane microRNAs during drought stress has not been studied. The objective of this work was to identify sugarcane miRNAs that are differentially expressed under drought stress and to correlate this expression with the behavior of two sugarcane cultivars with different drought tolerances. The sugarcane cultivars RB867515 (higher drought tolerance) and RB855536 (lower drought tolerance) were cultivated in a greenhouse for three months and then subjected to drought for 2, 4, 6 or 8 days. By deep sequencing of small RNAs, we were able to identify 18 miRNA families. Among all of the miRNAs thus identified, seven were differentially expressed during drought. Six of these miRNAs were differentially expressed at two days of stress, and five miRNAs were differentially expressed at four days. The expression levels of five miRNAs (ssp-miR164, ssp-miR394, ssp-miR397, ssp-miR399-seq 1 and miR528) were validated by RT-qPCR (quantitative reverse transcriptase PCR). Six precursors and the targets of the differentially expressed miRNA were predicted using an in silico approach and validated by RT-qPCR; many of these targets may play important roles in drought tolerance. These findings constitute a significant increase in the number of identified miRNAs in sugarcane and contribute to the elucidation of the complex regulatory network that is activated by drought stress.	[Ferreira, Thais Helena; Gentile, Agustina; Dias, Lara Isys; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vilela, Romel Duarte; Endres, Lauricio] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Lacerda Costa, Gustavo Gilson] Univ Estadual Campinas, Lab Cent Tecnol Alto Desempenho, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alagoas; Universidade Estadual de Campinas	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	menossi@unicamp.br	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation); CNPq (The National Council for Scientific and Technological Development); CAPES (Co-ordination of Improvement of Higher Education Personnel); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Co-ordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the following Brazilian funding institutions: FINEP (The Financiadora de Estudos e Projetos), FAPESP (Sao Paulo Research Foundation), CNPq (The National Council for Scientific and Technological Development) and CAPES (Co-ordination of Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; CACHORRO P, 1993, PHYTON-ANN REI BOT A, V33, P33; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ditt RF, 2011, SCI AGR, V68, P454, DOI 10.1590/S0103-90162011000400010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Islam MS, 2010, HORTIC ENVIRON BIOTE, V51, P556; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	81	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46703	10.1371/journal.pone.0046703	http://dx.doi.org/10.1371/journal.pone.0046703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071617	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700025
